Citrus Sinensis ID: 002883

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-
Protein Sequence
MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIVFVFYQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQAIKL
Secondary Structure (PSIPRED)
cccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccHHHcccccccEEEccccccccccccccccccccccccccccEEEEccccccccccccccEEEEcccEEEEcccccccccccccccccccccccEEEcccccccccccccccccccccccccccEEEcccccccccccHHHHHcccccccEEccccEEEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHcccccccEEcccccccccccccccccccccEEEcccccccccccHHHHcccccccEEcccccccccccHHHHcccccccEEcccccccccccHHHHccccccEEEcccccccccccHHHcccccccccccccccccccccHHHHccccccEEccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEEccccEEEEEEEEccccccccHHHHHHHHHHHcccccccccEEEEccccccccccEEEEEEccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHccccccccccccccHHHHHHHHccccccccccHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHccc
Secondary Structure Prediction (SSPRO)
cccccccHHHHccccccEEEccEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHccccccEEEEcccccccccccHHHHHccccccEEEEccccccccccHHHcccccccHHHcccccccEEEEccccccccccccccccHHHccccccEEEEEccccccccccHHHHccccccEEEEcccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEEccccccccccHcHccccccEEEEEccccEEccccHHHHHcccccEEEEEEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEccccccEEcccHHHHHcccccEEEccccEEEEEccccccHHHccHHHcccccEEEcccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHccccHHcEEEccccEEEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHccHHHHHHHHEEEccccccccccEEEEEEEcccccHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEcccccHHHEEEcccccEEEccccccHEEcccccccccEEEEEccccEcccHcccccEEcccccHHHHHHHHHHHHccccccccHccccccHHHHHHHHccccHHHHccHHHHcccccccccHHHccccccccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHcccccccccc
Coil and Loop (DISEMBL)
mlqgeipanithcsELRILDLVVNKlegnipselGNLFKLVglgltgnnytgsipqslsnlsFLQQLSlsenslsgnipselgLLKQLNMFQVSanyltgsipiqlfnissmDYFAVTQNKLvgeiphyvgftlpNIRVLLLgsnwftgeippsisnassipedlgkLKNLIRLNFArnnlgtgkgndlrFLDSLVNCTFLEVVSLSsnslsgvlpnsiANFSSHLIYLYMSAnrisgtiptgvgnlKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFgnkisgeipsslgnlifltevdlqgnsirgsipsalgNCLQlqkldlsdnnlsgtipreviGLSSFVLLDLsrnhlsgpiplevgrlkgiqqldlsenklsgeiptslascvgleylnfsdnsfqgpihsgfsslkglqdldlsrnnfsgkipMFLNTFRFLQKLNLSFnnlegevpsegvfkNVRAVSIIgnnklcggspelhlhscrsrgsrklwqhSTFKIVISAVLLPCLLSTCFIVFVFYQRRKRRRRSKALVNSSIEDKYLKISYAELLKategfssanligiggyGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEfmpngslenWLNQKEdeqnqrpklnLMQRLSIAIDVANVLEYLHHHchtsivhcdlkpsnvlldnemvahvgdfglsrllhdnspdqtstsrvkgsigyvapeygalgevsthgdeysFGILMLEmftgkrptddmfeegLSLHKYakmglpdqvaeIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGIlcseelprdRMKIQDAIMELQEAQKMRQAIKL
Flexible Loop (DISEMBL)
mlqgeipanithcseLRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIVFVfyqrrkrrrrskalvnssiedkylKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIItscssidtrGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLhdnspdqtstsrvkgsIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQAIKL
Low Complexity Region (SEG)
MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPqslsnlsflqqlslsenslsgnIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEippsisnassipEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEvvslssnslsgvlpnsIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIVFVFYQrrkrrrrSKALVNSSIEDKYLKISYAELLKATEGFSSANLigiggygyvykgilgTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQAIKL
Disordered region (IsUnstruct)
*******ANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQL*********NIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSI*****IPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIVFVFYQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL************LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL**************GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEEL**************************
Disordered Region (DISOPRED)
MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPE*********************IVISAVLLPCLLSTCFIVFVFY********************YLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH**********RVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQA********NLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQ*I**
Disordered Region (DISEMBL)
MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIVFVFYQRR*********VNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN**********KGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA*********
Disordered Region (DISPRO)
*LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIVFVFYQRRKRR***********EDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIVFVFYQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQAIKL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	871	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.969	0.835	0.451	0.0
C0LGT6	1031	LRR receptor-like serine/	no	no	0.957	0.808	0.444	0.0
Q9SD62	1025	Putative receptor-like pr	no	no	0.965	0.820	0.453	0.0
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.938	0.833	0.373	1e-138
Q9FL28	1173	LRR receptor-like serine/	no	no	0.948	0.704	0.343	1e-122
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.911	0.666	0.339	1e-118
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.949	0.660	0.332	1e-116
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.957	0.667	0.330	1e-113
O49318	1124	Probable leucine-rich rep	no	no	0.942	0.730	0.327	1e-111
Q9LP24	1120	Probable leucine-rich rep	no	no	0.863	0.671	0.339	1e-111

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  734 bits (1894), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 399/883 (45%), Positives = 564/883 (63%), Gaps = 39/883 (4%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           L+G IP  + +CS L  L L  N+L G++PSELG+L  LV L L GNN  G +P SL NL
Sbjct: 126 LRGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNL 185

Query: 62  SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
           + L+QL+LS N+L G IPS++  L Q+   Q+ AN  +G  P  L+N+SS+    +  N 
Sbjct: 186 TLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNH 245

Query: 122 LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNAS--------------SIPEDLGK 167
             G +   +G  LPN+    +G N+FTG IP ++SN S              SIP   G 
Sbjct: 246 FSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGN 304

Query: 168 LKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLI 227
           + NL  L    N+LG+    DL FL SL NCT LE + +  N L G LP SIAN S+ L+
Sbjct: 305 VPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLV 364

Query: 228 YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
            L +    ISG+IP  +GNL NL  + ++ N+L+G +PTS+G LL L+ LSLF N++SG 
Sbjct: 365 TLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGG 424

Query: 288 IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV 347
           IP+ +GN+  L  +DL  N   G +P++LGNC  L +L + DN L+GTIP E++ +   +
Sbjct: 425 IPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLL 484

Query: 348 LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP 407
            LD+S N L G +P ++G L+ +  L L +NKLSG++P +L +C+ +E L    N F G 
Sbjct: 485 RLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGD 544

Query: 408 IHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRA 467
           I      L G++++DLS N+ SG IP +  +F  L+ LNLSFNNLEG+VP +G+F+N   
Sbjct: 545 IPD-LKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATT 603

Query: 468 VSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTF--KIVIS---AVLLPCLLSTCFIVF 522
           VSI+GNN LCGG     L  C S+    + +HS+   K+VI     + L  LL    +  
Sbjct: 604 VSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTL 663

Query: 523 VFYQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGT 582
           ++ ++RK+ + +     S++E  + KISY +L  AT GFSS+N++G G +G VYK +L T
Sbjct: 664 IWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLT 723

Query: 583 EETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           E+  VAVKVL++Q+RGA KSF+AECE+L+ IRHRNLVK++T+CSSID +GNEF+AL+YEF
Sbjct: 724 EKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEF 783

Query: 643 MPNGSLENWLNQKEDEQNQRPK--LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           MPNGSL+ WL+ +E E+  RP   L L++RL+IAIDVA+VL+YLH HCH  I HCDLKPS
Sbjct: 784 MPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPS 843

Query: 701 NVLLDNEMVAHVGDFGLSRLL----HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           NVLLD+++ AHV DFGL+RLL     ++  +Q S++ V+G+IGY APEYG  G+ S +GD
Sbjct: 844 NVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGD 903

Query: 757 EYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIV 816
            YSFGIL+LEMFTGKRPT+++F    +L+ Y K  LP+++ +I+D +IL   L +   +V
Sbjct: 904 VYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVV 963

Query: 817 KELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL 859
                       E    +  VG+ C EE P +R+     + EL
Sbjct: 964 ------------ECLTMVFEVGLRCCEESPMNRLATSIVVKEL 994

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  677 bits (1747), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 394/887 (44%), Positives = 545/887 (61%), Gaps = 53/887 (5%)

Query: 1   MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSN 60
           +L+G IP+++++CS L  +DL  N L   +PSELG+L KL  L L+ NN TG+ P SL N
Sbjct: 132 LLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGN 191

Query: 61  LSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
           L+ LQ+L  + N + G IP E+  L Q+  FQ++ N  +G  P  L+NISS++  ++  N
Sbjct: 192 LTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADN 251

Query: 121 KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASS--------------IPEDLG 166
              G +    G+ LPN+R LLLG+N FTG IP +++N SS              IP   G
Sbjct: 252 SFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFG 311

Query: 167 KLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHL 226
           KL+NL  L    N+LG    + L F+ ++ NCT LE + +  N L G LP SIAN S+ L
Sbjct: 312 KLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTL 371

Query: 227 IYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISG 286
             L++  N ISGTIP  +GNL +L  +++E N+L+G +P S G LL LQV+ L+ N ISG
Sbjct: 372 TSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISG 431

Query: 287 EIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSF 346
           EIPS  GN+  L ++ L  NS  G IP +LG C  L  L +  N L+GTIP+E++ + S 
Sbjct: 432 EIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSL 491

Query: 347 VLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQG 406
             +DLS N L+G  P EVG+L+ +  L  S NKLSG++P ++  C+ +E+L    NSF G
Sbjct: 492 AYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDG 551

Query: 407 PIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVR 466
            I    S L  L+++D S NN SG+IP +L +   L+ LNLS N  EG VP+ GVF+N  
Sbjct: 552 AIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNAT 610

Query: 467 AVSIIGNNKLCGGSPELHLHSCRSRGS-RKLWQHSTFKIVISAVLLPCLLSTCFIVFV-- 523
           AVS+ GN  +CGG  E+ L  C  + S RK    S  K V+S + +  + S   I+ V  
Sbjct: 611 AVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIG-IASLLLIIIVAS 669

Query: 524 ---FYQRRKRRRRSKALVNSSIEDKYL--KISYAELLKATEGFSSANLIGIGGYGYVYKG 578
              F +R+K+   S    + S        K+SY EL  AT  FSS NLIG G +G V+KG
Sbjct: 670 LCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKG 729

Query: 579 ILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL 638
           +LG E   VAVKVL+L + GA+KSF+AECE  + IRHRNLVK+IT CSS+D+ GN+F+AL
Sbjct: 730 LLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRAL 789

Query: 639 VYEFMPNGSLENWLNQKEDEQ--NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           VYEFMP GSL+ WL  ++ E+  +    L   ++L+IAIDVA+ LEYLH HCH  + HCD
Sbjct: 790 VYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCD 849

Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLH----DNSPDQTSTSRVKGSIGYVAPEYGALGEVS 752
           +KPSN+LLD+++ AHV DFGL++LL+    ++  +Q S++ V+G+IGY APEYG  G+ S
Sbjct: 850 IKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPS 909

Query: 753 THGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQ 812
             GD YSFGIL+LEMF+GK+PTD+ F    +LH Y K  L    +     AI +E L + 
Sbjct: 910 IQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILSGCTSSGGSNAI-DEGLRL- 967

Query: 813 AGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL 859
                                +L+VGI CSEE PRDRM+  +A+ EL
Sbjct: 968 ---------------------VLQVGIKCSEEYPRDRMRTDEAVREL 993

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  649 bits (1674), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 404/891 (45%), Positives = 546/891 (61%), Gaps = 50/891 (5%)

Query: 1    MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSN 60
            +  G IP  +++CS L  LDL  N LE  +P E G+L KLV L L  NN TG  P SL N
Sbjct: 140  LFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGN 199

Query: 61   LSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
            L+ LQ L    N + G IP ++  LKQ+  F+++ N   G  P  ++N+SS+ + ++T N
Sbjct: 200  LTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGN 259

Query: 121  KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASS-----IPEDLGKLKNLIRLN 175
               G +    G  LPN+++L +G N FTG IP ++SN SS     IP +   L   I L+
Sbjct: 260  SFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSN--HLTGKIPLS 317

Query: 176  FARNNLGTG-----------KGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSS 224
            F R                    DL FL +L NC+ L+ +++  N L G LP  IAN S+
Sbjct: 318  FGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLST 377

Query: 225  HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKI 284
             L  L +  N ISG+IP G+GNL +L  + +  NLLTG +P S+G L +L+ + L+ N +
Sbjct: 378  QLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGL 437

Query: 285  SGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLS 344
            SGEIPSSLGN+  LT + L  NS  GSIPS+LG+C  L  L+L  N L+G+IP E++ L 
Sbjct: 438  SGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELP 497

Query: 345  SFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSF 404
            S V+L++S N L GP+  ++G+LK +  LD+S NKLSG+IP +LA+C+ LE+L    NSF
Sbjct: 498  SLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSF 557

Query: 405  QGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKN 464
             GPI      L GL+ LDLS+NN SG IP ++  F  LQ LNLS NN +G VP+EGVF+N
Sbjct: 558  VGPIPD-IRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRN 616

Query: 465  VRAVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVL-----LPCLLSTCF 519
              A+S+ GN  LCGG P L L  C     R+   HS+ + +I+  +        LL  C 
Sbjct: 617  TSAMSVFGNINLCGGIPSLQLQPCSVELPRR---HSSVRKIITICVSAVMAALLLLCLCV 673

Query: 520  IVFVFYQRRKRRRRSKALVN----SSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYV 575
            +   +Y+ R +  R+    N    S ++  Y KISY EL K T GFSS+NLIG G +G V
Sbjct: 674  VYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAV 733

Query: 576  YKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF 635
            +KG LG++   VA+KVL+L +RGA+KSFIAECEAL  IRHRNLVK++T CSS D  GN+F
Sbjct: 734  FKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDF 793

Query: 636  KALVYEFMPNGSLENWLNQKEDEQNQRPK--LNLMQRLSIAIDVANVLEYLHHHCHTSIV 693
            +ALVYEFMPNG+L+ WL+  E E+   P   L L  RL+IAIDVA+ L YLH +CH  I 
Sbjct: 794  RALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIA 853

Query: 694  HCDLKPSNVLLDNEMVAHVGDFGLSRLL----HDNSPDQTSTSRVKGSIGYVAPEYGALG 749
            HCD+KPSN+LLD ++ AHV DFGL++LL     D    Q S++ V+G+IGY APEYG  G
Sbjct: 854  HCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGG 913

Query: 750  EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD-QVAEIIDPAILEEA 808
              S  GD YSFGI++LE+FTGKRPT+ +F +GL+LH + K  L   Q  +I D  IL  A
Sbjct: 914  HPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGA 973

Query: 809  LEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL 859
                  +V            E    + RVG+ CSEE P +R+ + +AI +L
Sbjct: 974  YAQHFNMV------------ECLTLVFRVGVSCSEESPVNRISMAEAISKL 1012

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  494 bits (1271), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 339/907 (37%), Positives = 494/907 (54%), Gaps = 90/907 (9%)

Query: 19  LDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL-SFLQQLSLSENSLSGN 77
           LD+    L G I   + NL  L  L L+ N + G IP  + +L   L+QLSLSEN L GN
Sbjct: 71  LDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGN 130

Query: 78  IPSELGLLKQLNMFQVSANYLTGSIPIQLF---NISSMDYFAVTQNKLVGEIPHYVGFTL 134
           IP ELGLL +L    + +N L GSIP+QLF   + SS+ Y  ++ N L GEIP      L
Sbjct: 131 IPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHL 190

Query: 135 PNIRVLLLGSNWFTGEIPPSISNASSIP---------------EDLGKLKNLIRLNFARN 179
             +R LLL SN  TG +P S+SN++++                + + K+  L  L  + N
Sbjct: 191 KELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYN 250

Query: 180 NLGTGKGND--LRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRIS 237
           +  +   N     F  SL N + L+ + L+ NSL G + +S+ + S +L+ +++  NRI 
Sbjct: 251 HFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIH 310

Query: 238 GTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIF 297
           G+IP  + NL NL L+ +  NLL+G IP  +  L KL+ + L  N ++GEIP  LG++  
Sbjct: 311 GSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPR 370

Query: 298 LTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPR--------EVIGLSSFVL- 348
           L  +D+  N++ GSIP + GN  QL++L L  N+LSGT+P+        E++ LS   L 
Sbjct: 371 LGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLT 430

Query: 349 -----------------LDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASC 391
                            L+LS NHLSGPIPLE+ ++  +  +DLS N+LSG+IP  L SC
Sbjct: 431 GTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSC 490

Query: 392 VGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNN 451
           + LE+LN S N F   + S    L  L++LD+S N  +G IP        L+ LN SFN 
Sbjct: 491 IALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNL 550

Query: 452 LEGEVPSEGVFKNVRAVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLL 511
           L G V  +G F  +   S +G++ LCG      + +C+ +             +I+  +L
Sbjct: 551 LSGNVSDKGSFSKLTIESFLGDSLLCGSIKG--MQACKKKHKYPSVLLPVLLSLIATPVL 608

Query: 512 PCLLSTCFIVFVFYQRRKRRRRSKALVNSSIED---------KYLKISYAELLKATEGFS 562
                 C   +   QR +  +         +ED         KY +ISY +L+ AT GF+
Sbjct: 609 ------CVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFN 662

Query: 563 SANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKI 621
           +++LIG G +G+VYKG+L    T VAVKVLD +     S SF  EC+ L+  RHRNL++I
Sbjct: 663 ASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRI 721

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
           IT+CS        F ALV   MPNGSLE  L   E        L+L+Q ++I  DVA  +
Sbjct: 722 ITTCSKPG-----FNALVLPLMPNGSLERHLYPGEYSSKN---LDLIQLVNICSDVAEGI 773

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH--------DNSPDQTSTSR 733
            YLHH+    +VHCDLKPSN+LLD+EM A V DFG+SRL+         D+S    ST  
Sbjct: 774 AYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDG 833

Query: 734 -VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL 792
            + GS+GY+APEYG     STHGD YSFG+L+LE+ +G+RPTD +  EG SLH++ K   
Sbjct: 834 LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHY 893

Query: 793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI 852
           PD +  II+ A+     + +    ++L       + E+ + ++ +G++C++  P  R  +
Sbjct: 894 PDSLEGIIEQALSRWKPQGKPEKCEKL-------WREVILEMIELGLVCTQYNPSTRPDM 946

Query: 853 QDAIMEL 859
            D   E+
Sbjct: 947 LDVAHEM 953

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  440 bits (1131), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 323/940 (34%), Positives = 490/940 (52%), Gaps = 114/940 (12%)

Query: 1    MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSN 60
            +L+G+IPA I +CS L  L+L  N+L G IP+ELGNL +L  L +  N  T SIP SL  
Sbjct: 251  LLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFR 310

Query: 61   LSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
            L+ L  L LSEN L G I  E+G L+ L +  + +N  TG  P  + N+ ++    V  N
Sbjct: 311  LTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFN 370

Query: 121  KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNAS--------------SIPEDLG 166
             + GE+P  +G  L N+R L    N  TG IP SISN +               IP   G
Sbjct: 371  NISGELPADLGL-LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFG 429

Query: 167  KLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHL 226
            ++ NL  ++  RN+  TG+       D + NC+ LE +S++ N+L+G L   I      L
Sbjct: 430  RM-NLTFISIGRNHF-TGE-----IPDDIFNCSNLETLSVADNNLTGTLKPLIGKL-QKL 481

Query: 227  IYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQ----------- 275
              L +S N ++G IP  +GNLK+L ++ +  N  TG IP  +  L  LQ           
Sbjct: 482  RILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEG 541

Query: 276  -------------VLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQL 322
                         VL L  NK SG+IP+    L  LT + LQGN   GSIP++L +   L
Sbjct: 542  PIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLL 601

Query: 323  QKLDLSDNNLSGTIPREVIG-LSSFVL-LDLSRNHLSGPIPLEVGRLKGIQQLDLSENKL 380
               D+SDN L+GTIP E++  L +  L L+ S N L+G IP E+G+L+ +Q++DLS N  
Sbjct: 602  NTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLF 661

Query: 381  SGEIPTSLASCVGLEYLNFSD-------------------------NSFQGPIHSGFSSL 415
            SG IP SL +C  +  L+FS                          NSF G I   F ++
Sbjct: 662  SGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNM 721

Query: 416  KGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNK 475
              L  LDLS NN +G+IP  L     L+ L L+ NNL+G VP  GVFKN+ A  ++GN  
Sbjct: 722  THLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTD 781

Query: 476  LCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIVFVFYQRRKRRRRSK 535
            LCG    L   + + + S     H + +  +  ++L    +   ++ +       +++ K
Sbjct: 782  LCGSKKPLKPCTIKQKSS-----HFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEK 836

Query: 536  ALVNSSIE-----DKYLKISY---AELLKATEGFSSANLIGIGGYGYVYKGILGTEETNV 587
             + NSS       D  LK+      EL +AT+ F+SAN+IG      VYKG L  + T +
Sbjct: 837  KIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVI 895

Query: 588  AVKVLDLQQRGA--SKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
            AVKVL+L++  A   K F  E + L  ++HRNLVKI+           + KALV  FM N
Sbjct: 896  AVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTKALVLPFMEN 951

Query: 646  GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
            G+LE+ ++      +  P  +L++++ + + +A+ ++YLH      IVHCDLKP+N+LLD
Sbjct: 952  GNLEDTIH-----GSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLD 1006

Query: 706  NEMVAHVGDFGLSRLL--HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
            ++ VAHV DFG +R+L   ++     STS  +G+IGY+APE+  + +V+T  D +SFGI+
Sbjct: 1007 SDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGII 1066

Query: 764  MLEMFTGKRPT--DDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQP 821
            M+E+ T +RPT  +D   + ++L +  +  + +    ++   +L+  +E+   IV     
Sbjct: 1067 MMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMV--RVLD--MELGDSIVS---- 1118

Query: 822  NLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE 861
                K  E     L++ + C+   P DR  + + +  L +
Sbjct: 1119 ---LKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMK 1155

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  427 bits (1099), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 310/913 (33%), Positives = 469/913 (51%), Gaps = 119/913 (13%)

Query: 4    GEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSF 63
            GEIP  I  C  L+ L L  N L G+IP EL     L  + L+GN  +G+I +     S 
Sbjct: 343  GEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTIEEVFDGCSS 402

Query: 64   LQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLV 123
            L +L L+ N ++G+IP +L  L  L    + +N  TG IP  L+  +++  F  + N+L 
Sbjct: 403  LGELLLTNNQINGSIPEDLWKLP-LMALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLE 461

Query: 124  GEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGT 183
            G +P  +G    +++ L+L  N  TGEIP           ++GKL +L  LN    N+  
Sbjct: 462  GYLPAEIG-NAASLKRLVLSDNQLTGEIP----------REIGKLTSLSVLNL-NANMFQ 509

Query: 184  GKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPT- 242
            GK         L +CT L  + L SN+L G +P+ I   +  L  L +S N +SG+IP+ 
Sbjct: 510  GK-----IPVELGDCTSLTTLDLGSNNLQGQIPDKITALA-QLQCLVLSYNNLSGSIPSK 563

Query: 243  -----------GVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSS 291
                        +  L++  +  +  N L+G IP  +G  L L  +SL  N +SGEIP+S
Sbjct: 564  PSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPAS 623

Query: 292  LGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDL 351
            L  L  LT +DL GN++ GSIP  +GN L+LQ L+L++N L+G IP     L S V L+L
Sbjct: 624  LSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNL 683

Query: 352  SRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSG 411
            ++N L GP+P  +G LK +  +DLS N LSGE+ + L++   L  L    N F G I S 
Sbjct: 684  TKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSE 743

Query: 412  FSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSII 471
              +L  L+ LD+S N  SG+IP  +     L+ LNL+ NNL GEVPS+GV ++     + 
Sbjct: 744  LGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLS 803

Query: 472  GNNKLCGGSPELHLHSCRSRGS--RKLWQHSTFKIVISAVLLPCLLSTCFIVFVFYQRR- 528
            GN +LCG    +    C+  G+  R  W  +   +  + ++          VFVF  RR 
Sbjct: 804  GNKELCG---RVVGSDCKIEGTKLRSAWGIAGLMLGFTIIVF---------VFVFSLRRW 851

Query: 529  ------KRR--------RRSKALVNSSI-------------------EDKYLKISYAELL 555
                  K+R         R K  V+ ++                   E   LK+   +++
Sbjct: 852  AMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIV 911

Query: 556  KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRH 615
            +AT+ FS  N+IG GG+G VYK  L  E+T VAVK L   +   ++ F+AE E L  ++H
Sbjct: 912  EATDHFSKKNIIGDGGFGTVYKACLPGEKT-VAVKKLSEAKTQGNREFMAEMETLGKVKH 970

Query: 616  RNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI 675
             NLV ++  CS      +E K LVYE+M NGSL++WL    ++      L+  +RL IA+
Sbjct: 971  PNLVSLLGYCSF-----SEEKLLVYEYMVNGSLDHWL---RNQTGMLEVLDWSKRLKIAV 1022

Query: 676  DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
              A  L +LHH     I+H D+K SN+LLD +    V DFGL+RL+  ++ +   ++ + 
Sbjct: 1023 GAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLI--SACESHVSTVIA 1080

Query: 736  GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEE-------GLSLHKYA 788
            G+ GY+ PEYG     +T GD YSFG+++LE+ TGK PT   F+E       G ++ K  
Sbjct: 1081 GTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKIN 1140

Query: 789  KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRD 848
            +     +  ++IDP ++  AL+                    Q+ +L++ +LC  E P  
Sbjct: 1141 Q----GKAVDVIDPLLVSVALK------------------NSQLRLLQIAMLCLAETPAK 1178

Query: 849  RMKIQDAIMELQE 861
            R  + D +  L+E
Sbjct: 1179 RPNMLDVLKALKE 1191

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  419 bits (1076), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 302/907 (33%), Positives = 462/907 (50%), Gaps = 80/907 (8%)

Query: 2    LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
            L GEIPA I++C  L++LDL  N L G IP  L  L +L  L L  N+  G++  S+SNL
Sbjct: 349  LSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNL 408

Query: 62   SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
            + LQ+ +L  N+L G +P E+G L +L +  +  N  +G +P+++ N + +       N+
Sbjct: 409  TNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNR 468

Query: 122  LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISN--------------ASSIPEDLGK 167
            L GEIP  +G  L ++  L L  N   G IP S+ N              + SIP   G 
Sbjct: 469  LSGEIPSSIG-RLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGF 527

Query: 168  LKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLI 227
            L  L       N+L   +GN     DSL+N   L  ++ SSN  +G + + +   SS+L 
Sbjct: 528  LTALELFMIYNNSL---QGN---LPDSLINLKNLTRINFSSNKFNGSI-SPLCGSSSYLS 580

Query: 228  YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
            +  ++ N   G IP  +G   NL  + +  N  TG IP + G + +L +L +  N +SG 
Sbjct: 581  F-DVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGI 639

Query: 288  IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV 347
            IP  LG    LT +DL  N + G IP+ LG    L +L LS N   G++P E+  L++ +
Sbjct: 640  IPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNIL 699

Query: 348  LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP 407
             L L  N L+G IP E+G L+ +  L+L EN+LSG +P+++     L  L  S N+  G 
Sbjct: 700  TLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGE 759

Query: 408  IHSGFSSLKGLQD-LDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE------- 459
            I      L+ LQ  LDLS NNF+G+IP  ++T   L+ L+LS N L GEVP +       
Sbjct: 760  IPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSL 819

Query: 460  ---------------GVFKNVRAVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKI 504
                             F   +A + +GN  LC GSP  H +   S+  R L   +   +
Sbjct: 820  GYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLC-GSPLSHCNRAGSKNQRSLSPKTV--V 876

Query: 505  VISAV--LLPCLLSTCFIVFVFYQRRKRRRRSKALVNSSIEDKYL-------------KI 549
            +ISA+  L    L    I+  F Q     ++ +   ++   +                 I
Sbjct: 877  IISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDI 936

Query: 550  SYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEA 609
             + ++++AT   +   +IG GG G VYK  L   ET    K+L      ++KSF  E + 
Sbjct: 937  KWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKT 996

Query: 610  LRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQ 669
            L +IRHR+LVK++  CSS   + +    L+YE+M NGS+ +WL+  E+ + ++  L    
Sbjct: 997  LGTIRHRHLVKLMGYCSS---KADGLNLLIYEYMANGSVWDWLHANENTK-KKEVLGWET 1052

Query: 670  RLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQT 729
            RL IA+ +A  +EYLH+ C   IVH D+K SNVLLD+ + AH+GDFGL+++L  N    T
Sbjct: 1053 RLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNT 1112

Query: 730  -STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA 788
             S +   GS GY+APEY    + +   D YS GI+++E+ TGK PT+ MF+E   + ++ 
Sbjct: 1113 ESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRW- 1171

Query: 789  KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRD 848
                   V  ++D     EA E    I  EL+  L  +  E    +L + + C++  P++
Sbjct: 1172 -------VETVLDTPPGSEARE--KLIDSELKSLLPCE-EEAAYQVLEIALQCTKSYPQE 1221

Query: 849  RMKIQDA 855
            R   + A
Sbjct: 1222 RPSSRQA 1228

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  411 bits (1056), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 307/930 (33%), Positives = 468/930 (50%), Gaps = 96/930 (10%)

Query: 2    LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
            L GEIP  ++ C  L+ LDL  N L G+IP  L  L +L  L L  N   G++  S+SNL
Sbjct: 348  LSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNL 407

Query: 62   SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
            + LQ L L  N+L G +P E+  L++L +  +  N  +G IP ++ N +S+    +  N 
Sbjct: 408  TNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNH 467

Query: 122  LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISN--------------ASSIPEDLGK 167
              GEIP  +G  L  + +L L  N   G +P S+ N              + SIP   G 
Sbjct: 468  FEGEIPPSIG-RLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGF 526

Query: 168  LKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVL------------ 215
            LK L +L    N+L   +GN     DSL++   L  ++LS N L+G +            
Sbjct: 527  LKGLEQLMLYNNSL---QGN---LPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSF 580

Query: 216  -----------PNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSI 264
                       P  + N S +L  L +  N+++G IP  +G ++ L L+ M  N LTG+I
Sbjct: 581  DVTNNGFEDEIPLELGN-SQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTI 639

Query: 265  PTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQK 324
            P  +    KL  + L  N +SG IP  LG L  L E+ L  N    S+P+ L NC +L  
Sbjct: 640  PLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLV 699

Query: 325  LDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEI 384
            L L  N+L+G+IP+E+  L +  +L+L +N  SG +P  +G+L  + +L LS N L+GEI
Sbjct: 700  LSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEI 759

Query: 385  PTSLASCVGLE-YLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQ 443
            P  +     L+  L+ S N+F G I S   +L  L+ LDLS N  +G++P  +   + L 
Sbjct: 760  PVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLG 819

Query: 444  KLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFK 503
             LN+SFNNL G++  +  F    A S +GN  LCG SP    +  RS   ++     +  
Sbjct: 820  YLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGLCG-SPLSRCNRVRSNNKQQGLSARSVV 876

Query: 504  IVISAVLLPCLLSTCFIVFVFYQRR-----KRRRRSKALVNSSIEDKYL----------- 547
            I+ +   L  +     ++ +F+++R     K    S A  +SS   +             
Sbjct: 877  IISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASK 936

Query: 548  -KISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAE 606
              I + ++++AT   S   +IG GG G VYK  L   ET    K+L      ++KSF  E
Sbjct: 937  SDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSRE 996

Query: 607  CEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL- 665
             + L  IRHR+LVK++  CSS   +      L+YE+M NGS+ +WL++ +    ++ KL 
Sbjct: 997  VKTLGRIRHRHLVKLMGYCSS---KSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLL 1053

Query: 666  NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNS 725
            +   RL IA+ +A  +EYLHH C   IVH D+K SNVLLD+ M AH+GDFGL+++L +N 
Sbjct: 1054 DWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENC 1113

Query: 726  PDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSL 784
               T S +    S GY+APEY    + +   D YS GI+++E+ TGK PTD +F   + +
Sbjct: 1114 DTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDM 1173

Query: 785  HKYAKMGLPDQVA-----EIIDPAILEEALEIQAGIVKELQPNLRAKFHE-IQVSILRVG 838
             ++ +  L  +VA     ++IDP +            K L P     F E     +L + 
Sbjct: 1174 VRWVETHL--EVAGSARDKLIDPKL------------KPLLP-----FEEDAACQVLEIA 1214

Query: 839  ILCSEELPRDRMKIQDAIMELQEAQKMRQA 868
            + C++  P++R   + A   L      R A
Sbjct: 1215 LQCTKTSPQERPSSRQACDSLLHVYNNRTA 1244

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  404 bits (1038), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 296/904 (32%), Positives = 451/904 (49%), Gaps = 83/904 (9%)

Query: 1    MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSN 60
             + GE+P  I    +L+ + L  NK  G IP ++GNL  L  L L GN+  G IP  + N
Sbjct: 240  FISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGN 299

Query: 61   LSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
            +  L++L L +N L+G IP ELG L ++     S N L+G IP++L  IS +    + QN
Sbjct: 300  MKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQN 359

Query: 121  KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASS--------------IPEDLG 166
            KL G IP+ +   L N+  L L  N  TG IPP   N +S              IP+ LG
Sbjct: 360  KLTGIIPNELS-KLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLG 418

Query: 167  KLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHL 226
                L  ++F+ N L    G    F+    N   L +++L SN + G +P  +    S L
Sbjct: 419  LYSPLWVVDFSENQL---SGKIPPFICQQSN---LILLNLGSNRIFGNIPPGVLRCKS-L 471

Query: 227  IYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISG 286
            + L +  NR++G  PT +  L NL  I ++ N  +G +P  +G   KLQ L L  N+ S 
Sbjct: 472  LQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSS 531

Query: 287  EIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSF 346
             +P+ +  L  L   ++  NS+ G IPS + NC  LQ+LDLS N+  G++P E+  L   
Sbjct: 532  NLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQL 591

Query: 347  VLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEY-LNFSDNSFQ 405
             +L LS N  SG IP  +G L  + +L +  N  SG IP  L     L+  +N S N F 
Sbjct: 592  EILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFS 651

Query: 406  GPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNV 465
            G I     +L  L  L L+ N+ SG+IP        L   N S+NNL G++P   +F+N+
Sbjct: 652  GEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNM 711

Query: 466  RAVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQH-STFK--------IVISAVLLPCLLS 516
               S +GN  LCGG    HL SC    S   W H S+ K        I+I    +   +S
Sbjct: 712  TLTSFLGNKGLCGG----HLRSCDP--SHSSWPHISSLKAGSARRGRIIIIVSSVIGGIS 765

Query: 517  TCFIVFVFYQRRKRRRRSKALVNSS-----IEDKYL----KISYAELLKATEGFSSANLI 567
               I  V +  R     +   V+         D Y     + +  ++L+AT+GF  + ++
Sbjct: 766  LLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIV 825

Query: 568  GIGGYGYVYKGILGTEETNVAVKVLD-------LQQRGASKSFIAECEALRSIRHRNLVK 620
            G G  G VYK ++ + +T +AVK L+               SF AE   L  IRHRN+V+
Sbjct: 826  GRGACGTVYKAVMPSGKT-IAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVR 884

Query: 621  IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
            + + C     +G+    L+YE+M  GSL   L+  +      P      R +IA+  A  
Sbjct: 885  LYSFCYH---QGSNSNLLLYEYMSRGSLGELLHGGKSHSMDWPT-----RFAIALGAAEG 936

Query: 681  LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
            L YLHH C   I+H D+K +N+L+D    AHVGDFGL++++  + P   S S V GS GY
Sbjct: 937  LAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVI--DMPLSKSVSAVAGSYGY 994

Query: 741  VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ--VAE 798
            +APEY    +V+   D YSFG+++LE+ TGK P   + E+G  L  + +  + D    +E
Sbjct: 995  IAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPL-EQGGDLATWTRNHIRDHSLTSE 1053

Query: 799  IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME 858
            I+DP + +   ++   I+  +            +++ ++ +LC++  P DR  +++ ++ 
Sbjct: 1054 ILDPYLTKVEDDV---ILNHM------------ITVTKIAVLCTKSSPSDRPTMREVVLM 1098

Query: 859  LQEA 862
            L E+
Sbjct: 1099 LIES 1102

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  402 bits (1033), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 295/870 (33%), Positives = 425/870 (48%), Gaps = 118/870 (13%)

Query: 2    LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
            L G IP  + +   +  L L  NKL G+IPS LGNL  L+ L L  N  TG IP  + N+
Sbjct: 210  LTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGNM 269

Query: 62   SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
              +  L+LS+N L+G+IPS LG LK L +  +  NYLTG IP +L NI SM    ++ NK
Sbjct: 270  ESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNK 329

Query: 122  LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASS--------------------- 160
            L G IP  +G  L N+ +L L  N+ TG IPP + N  S                     
Sbjct: 330  LTGSIPSSLG-NLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGN 388

Query: 161  -----------------IPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEV 203
                             IP++LG ++++I L+ ++N L TG        DS  N T LE 
Sbjct: 389  LKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKL-TGS-----VPDSFGNFTKLES 442

Query: 204  VSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGS 263
            + L  N LSG +P  +AN SSHL  L +  N  +G  P  V   + L  I+++ N L G 
Sbjct: 443  LYLRVNHLSGAIPPGVAN-SSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGP 501

Query: 264  IPTSVGYLLKLQVLSLFGNKISGEIPSSLG-----NLIFLTEVDLQG------------- 305
            IP S+     L      GNK +G+I  + G     N I  +     G             
Sbjct: 502  IPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLG 561

Query: 306  ------NSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGP 359
                  N+I G+IP+ + N  QL +LDLS NNL G +P  +  L++   L L+ N LSG 
Sbjct: 562  ALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGR 621

Query: 360  IPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIH---------- 409
            +P  +  L  ++ LDLS N  S EIP +  S + L  +N S N F G I           
Sbjct: 622  VPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIPRLSKLTQLTQ 681

Query: 410  -------------SGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEV 456
                         S  SSL+ L  LDLS NN SG IP        L  +++S N LEG +
Sbjct: 682  LDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPL 741

Query: 457  PSEGVFKNVRAVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPCLLS 516
            P    F+   A ++  N  LC   P+  L  CR     K   +    I++  + +  +LS
Sbjct: 742  PDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILVPILGVLVILS 801

Query: 517  TCFIVFVFYQRRKRRRRSKALVNSSIEDKYL-----KISYAELLKATEGFSSANLIGIGG 571
             C   F +  R+++ +  +     + E+  +     K  Y +++++T  F   +LIG GG
Sbjct: 802  ICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGG 861

Query: 572  YGYVYKGILGTEETNVAVKVL------DLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
            Y  VY+  L  ++T +AVK L      ++ +    + F+ E +AL  IRHRN+VK+   C
Sbjct: 862  YSKVYRANL--QDTIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFC 919

Query: 626  SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
            S    R + F  L+YE+M  GSL   L    DE+ +R  L   +R+++   VA+ L Y+H
Sbjct: 920  SH---RRHTF--LIYEYMEKGSLNKLL--ANDEEAKR--LTWTKRINVVKGVAHALSYMH 970

Query: 686  HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY 745
            H   T IVH D+   N+LLDN+  A + DFG ++LL     D ++ S V G+ GYVAPE+
Sbjct: 971  HDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKT---DSSNWSAVAGTYGYVAPEF 1027

Query: 746  GALGEVSTHGDEYSFGILMLEMFTGKRPTD 775
                +V+   D YSFG+L+LE+  GK P D
Sbjct: 1028 AYTMKVTEKCDVYSFGVLILELIIGKHPGD 1057

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	871
359482058	1040	PREDICTED: probable LRR receptor-like se	0.988	0.827	0.514	0.0
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.988	0.452	0.513	0.0
356566660	1020	PREDICTED: probable LRR receptor-like se	0.978	0.835	0.489	0.0
224097752	1025	predicted protein [Populus trichocarpa]	0.981	0.834	0.494	0.0
224127492	1022	predicted protein [Populus trichocarpa]	0.978	0.833	0.482	0.0
444737622	1032	Putative LRR receptor-like serine/threon	0.978	0.825	0.487	0.0
224141953	1026	predicted protein [Populus trichocarpa]	0.966	0.820	0.487	0.0
224113117	1006	predicted protein [Populus trichocarpa]	0.983	0.851	0.486	0.0
255581223	1015	receptor-kinase, putative [Ricinus commu	0.964	0.827	0.487	0.0
359486510	965	PREDICTED: probable LRR receptor-like se	0.978	0.882	0.501	0.0

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  832 bits (2148), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 458/890 (51%), Positives = 594/890 (66%), Gaps = 29/890 (3%)

Query: 2    LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
              GEIPAN++ CS L    L  N L G IPS LG+  K+V + L  NN TG +P SL NL
Sbjct: 141  FSGEIPANLSRCSNLVYFRLGFNNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSLGNL 200

Query: 62   SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
            + ++ LS + N L G+IP  LG L+ L    +  N  +G IP  ++N+SS++ F++  NK
Sbjct: 201  TSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNK 260

Query: 122  LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPE--------------DLGK 167
            L G +P  + FTLPN++VL +G+N FTG +P S+SNAS++ E              D G 
Sbjct: 261  LYGSLPWDLAFTLPNLQVLNIGNNDFTGSLPSSLSNASNLLEFDITMSNFTGKVSIDFGG 320

Query: 168  LKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLI 227
            + NL  L  A N LG G+ +DL FL+SL+ C  L+V+ LS +   GVLPNSIAN S+ L+
Sbjct: 321  MPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLM 380

Query: 228  YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
             L +  N++SGTIP G+GNL NL  + +  N  TGSIP  +G L  L  + L  N++SG 
Sbjct: 381  KLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGH 440

Query: 288  IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV 347
            IPSSLGN+  L  + LQ N + G IPS+ GN L LQ+LDLS N+L+GTIP +V+ L S  
Sbjct: 441  IPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLT 500

Query: 348  L-LDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQG 406
            + L+L+RN L+G +P EV +LK +  LD+SENKLSGEIP  L SC+ LE+L+   N F+G
Sbjct: 501  ISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKG 560

Query: 407  PIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVR 466
             I   F SL+GL DLDLSRNN SG+IP FL     L  LNLSFNN EG++P++GVF N  
Sbjct: 561  SIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNAT 619

Query: 467  AVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIVFVFYQ 526
            + S+ GNNKLCGG PELHL +C     +        K++I   LL   L    I+ +   
Sbjct: 620  STSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIG--LLTGFLGLVLIMSLLVI 677

Query: 527  RRKRR-RRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEET 585
             R RR +R  +  ++S +D  L +SY  L KAT GFSSANLIG GG+G VYKGILG +ET
Sbjct: 678  NRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDET 737

Query: 586  NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
             VAVKV+ L QRGA KSF AECEALR+IRHRNLVK++T+CSS+D +GN+FKALVYEFMPN
Sbjct: 738  VVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPN 797

Query: 646  GSLENWLN--QKEDEQNQRPK-LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
            GSLENWL+     DE N   + L+L QRL+IAIDVA+ L+YLHHHCH  IVHCDLKPSN+
Sbjct: 798  GSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNI 857

Query: 703  LLDNEMVAHVGDFGLSRLLHDNS----PDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEY 758
            LLDN+M AHVGDFGL+R + + +    P Q+S+  +KG+IGY APEYG   +VS  GD Y
Sbjct: 858  LLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTY 917

Query: 759  SFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEAL---EIQAGI 815
            S+GIL+LEMFTGKRPT+ MF + L+LH + KM LP+++A+IIDP  L       E  A  
Sbjct: 918  SYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAAD 977

Query: 816  VKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM 865
               L    R K HE  +SILR+G+ CS E PR+RM I +AI ELQ  +K+
Sbjct: 978  SSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKI 1027

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  828 bits (2140), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 457/890 (51%), Positives = 593/890 (66%), Gaps = 29/890 (3%)

Query: 2    LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
              GEIPAN++ CS L    L  N L G IPS LG+  K+V + L  NN TG +P SL NL
Sbjct: 172  FSGEIPANLSRCSNLVYFRLGFNNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSLGNL 231

Query: 62   SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
            + ++ LS + N L G+IP  LG L+ L    +  N  +G IP  ++N+SS++ F++  NK
Sbjct: 232  TSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNK 291

Query: 122  LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPE--------------DLGK 167
            L G +P  + FTLPN++VL +G+N FTG +P S+SNAS++ E              D G 
Sbjct: 292  LYGSLPWDLAFTLPNLQVLNIGNNDFTGPLPSSLSNASNLLEFDITMSNFTGKVSIDFGG 351

Query: 168  LKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLI 227
            + NL  L  A N LG G+ +DL FL+SL+ C  L+V+ LS +   GVLPNSIAN S+ L+
Sbjct: 352  MPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLM 411

Query: 228  YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
             L +  N++SGTIP G+GNL NL  + +  N  TGSIP  +G L  L  + L  N++SG 
Sbjct: 412  KLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGH 471

Query: 288  IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV 347
            IPSSLGN+  L  + LQ N + G IPS+ GN L LQ+LDLS N+L+GTIP +V+ L S  
Sbjct: 472  IPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLT 531

Query: 348  L-LDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQG 406
            + L+L+RN L+G +P EV +LK +  LD+SENKLSGEIP  L SC+ LE+L+   N F+G
Sbjct: 532  ISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKG 591

Query: 407  PIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVR 466
             I   F SL+GL DLDLSRNN SG+IP FL     L  LNLSFNN EG++P++GVF N  
Sbjct: 592  SIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNAT 650

Query: 467  AVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIVFVFYQ 526
            + S+ GNNKLCGG PELHL +C     +        K++I   LL   L    I+ +   
Sbjct: 651  STSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIG--LLTGFLGLVLIMSLLVI 708

Query: 527  RRKRR-RRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEET 585
             R RR +R  +  ++S +D  L +SY  L KAT GFSSANLIG GG+G VYKG LG +ET
Sbjct: 709  NRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQDET 768

Query: 586  NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
             VAVKV+ L QRGA KSF AECEALR+IRHRNLVK++T+CSS+D +GN+FKALVYEFMPN
Sbjct: 769  VVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPN 828

Query: 646  GSLENWLN--QKEDEQNQRPK-LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
            GSLENWL+     DE N   + L+L QRL+IAIDVA+ L+YLHHHCH  IVHCDLKPSN+
Sbjct: 829  GSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNI 888

Query: 703  LLDNEMVAHVGDFGLSRLLHDNS----PDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEY 758
            LLDN+M AHVGDFGL+R + + +    P Q+S+  +KG+IGY APEYG   +VS  GD Y
Sbjct: 889  LLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTY 948

Query: 759  SFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEAL---EIQAGI 815
            S+GIL+LEMFTGKRPT+ MF + L+LH + KM LP+++A+IIDP  L       E  A  
Sbjct: 949  SYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAAD 1008

Query: 816  VKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM 865
               L    R K HE  +SILR+G+ CS E PR+RM I +AI ELQ  +K+
Sbjct: 1009 SSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKI 1058

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356566660|ref|XP_003551548.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Glycine max]

 Score =  796 bits (2056), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 436/890 (48%), Positives = 591/890 (66%), Gaps = 38/890 (4%)

Query: 2    LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
              GE P  +     L+ +++  N   G+IPS L +  +L  L    NNYTG+IP  + N 
Sbjct: 125  FHGEFPHEVGLLQYLQHINISYNSFGGSIPSNLSHCTELSILSAGHNNYTGTIPAWIGNS 184

Query: 62   SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
            S L  L+L+ N+L GNIP+E+G L +L +  ++ NYL+G+IP  +FNISS+ +F V+QN 
Sbjct: 185  SSLSLLNLAVNNLHGNIPNEIGQLSRLTLLALNGNYLSGTIPGTIFNISSLFFFTVSQNH 244

Query: 122  LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNAS--------------SIPEDLGK 167
            L G IP  VG+T PN+     G N FTG IP S+SNAS              ++P+++G+
Sbjct: 245  LHGNIPADVGYTFPNLETFAGGVNSFTGTIPESLSNASRLEILDFAENGLTGTLPKNIGR 304

Query: 168  LKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLI 227
            L  L RLNF  N LGTGK  DL FL SLVNCT L+V+ LS NS  G LP++IAN S+ L 
Sbjct: 305  LPLLKRLNFDDNRLGTGKAGDLNFLASLVNCTALKVLGLSDNSFGGELPSTIANLSTQLT 364

Query: 228  YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
             L +  N I G++P G+ NL NL  + +E N L+G +P ++G L  L  L L GN  SG 
Sbjct: 365  SLTLGGNGIHGSVPIGIRNLVNLTFLGLEENNLSGFVPHTIGMLRLLNGLDLNGNNFSGV 424

Query: 288  IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSF- 346
            IPSS+GNL  LT + ++ N+  GSIP+ LG C  L  L+LS N L+GTIPR+V+ LSS  
Sbjct: 425  IPSSIGNLTRLTRLQMEENNFEGSIPANLGKCQSLLMLNLSHNMLNGTIPRQVLTLSSLS 484

Query: 347  VLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQG 406
            + LDLS N L+GP+  EVG+L  + QLDLSENKLSG IP+SL SC+GLE+++   N F+G
Sbjct: 485  IYLDLSHNALTGPVLAEVGKLVNLAQLDLSENKLSGMIPSSLGSCIGLEWIHLQGNFFEG 544

Query: 407  PIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVR 466
             I S    L+GLQD+DLS NNFSGKIP FL  F+ L+ LNLS+N+  G++P  G+FKN  
Sbjct: 545  NIPSTMRYLRGLQDIDLSCNNFSGKIPEFLGEFKVLEHLNLSYNDFSGKLPMNGIFKNAT 604

Query: 467  AVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAV--LLPCLLSTCFIVFVF 524
            + S+ GN+KLCGG+PEL L +C  + +    +    K+VIS +  L+  LL  CF+    
Sbjct: 605  SYSVYGNSKLCGGAPELDLPACTIKKASSFRKFHDPKVVISVIVALVFVLLLFCFLAISM 664

Query: 525  YQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEE 584
                 +R R KA  +++ +D  L+ISY+E+ K T GFS  NL+G G +G VYKG L ++ 
Sbjct: 665  V----KRARKKASRSTTTKDLDLQISYSEIAKCTGGFSPDNLVGSGSFGSVYKGTLSSDG 720

Query: 585  TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
            ++VAVKVL+L+QRGASKSFI EC+ LRSIRHRNL+KIIT+ SS+D +GN+FKALV+EFMP
Sbjct: 721  SSVAVKVLNLEQRGASKSFIDECQVLRSIRHRNLLKIITAISSVDHQGNDFKALVFEFMP 780

Query: 645  NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            NGSLE+WL+  +++Q Q   L+ +QRL+IAIDVA  LEYLHH CHT IVHCD+KPSNVLL
Sbjct: 781  NGSLEDWLHPVDNQQKQTKTLSFIQRLNIAIDVACALEYLHHFCHTPIVHCDIKPSNVLL 840

Query: 705  DNEMVAHVGDFGLSRLLHD---NSPDQTSTSRV-KGSIGYVAPEYGALGEVSTHGDEYSF 760
            DN+MVAHVGDFGL+  L +    SP Q++ S V KGSIGY+ PEYG  G  S  GD YS+
Sbjct: 841  DNDMVAHVGDFGLATFLFEESSGSPQQSTMSGVLKGSIGYIPPEYGMGGHPSALGDIYSY 900

Query: 761  GILMLEMFTGKRPTDDMFEE-GLSLHKYAKMGLPDQVAEIIDPAIL---------EEALE 810
            GIL+LE+FTGKRPT +MFE   + +H+   + LP+   EIIDP +L         E+   
Sbjct: 901  GILLLEIFTGKRPTHEMFEGVSMGIHQLTALSLPNHAMEIIDPLLLPKREFDDRNEQVST 960

Query: 811  IQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ 860
             +  I++E +P +        VS+L++G+ CS   PR+R+ + + + +L 
Sbjct: 961  EEEAILRENEPEV---IEGCLVSVLQIGVSCSVTSPRERVPMTEVVNKLH 1007

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa]

 Score =  793 bits (2048), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 440/889 (49%), Positives = 582/889 (65%), Gaps = 34/889 (3%)

Query: 2    LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
              G+IP NI+HCS L IL L  N L G +P ELG+L KL       N   G IP S  NL
Sbjct: 136  FDGKIPVNISHCSNLLILSLSGNNLTGKLPIELGSLSKLQVFFFQFNYLVGGIPSSFGNL 195

Query: 62   SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
            S + Q+  + N L G IP+ +G LK L  F    N +TG IP  ++N+SS+  FAV  N+
Sbjct: 196  SAIIQIFGAGNYLQGGIPNSIGQLKSLKSFSFGRNNMTGMIPPSIYNLSSLMRFAVPVNQ 255

Query: 122  LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIP-------------EDLGKL 168
            L G +P  +G TLPN+ +LL+  N F+G IPP+ SNAS+I               DL  L
Sbjct: 256  LHGNLPPDLGLTLPNLEILLMSFNRFSGSIPPTFSNASTIAVIELSNNNLTGRVPDLSSL 315

Query: 169  KNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIY 228
              L  L    N LG G  +DL FL  L N T LE +S++ N+  G+LP  I+NFS +L  
Sbjct: 316  SKLRWLIVDVNYLGNGNDDDLSFLPPLANKTSLEELSINDNNFGGLLPKIISNFSENLKR 375

Query: 229  LYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEI 288
            +    N+I G+IP+G+GNL  L  + +E+N LTG IP S+G L  L VL+L GNKISG I
Sbjct: 376  MTFGRNQIRGSIPSGIGNLIGLDTLGLEMNQLTGVIPNSIGKLQNLGVLALGGNKISGNI 435

Query: 289  PSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGL-SSFV 347
            PSS+GN+  L EV L  N+++G IPS+LGNC  L  L L  NNLSG+IP+EVI + SS  
Sbjct: 436  PSSMGNITSLLEVYLSANNLQGRIPSSLGNCQNLLILHLDQNNLSGSIPKEVISIPSSSR 495

Query: 348  LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP 407
            +L LS N L+G +PLEVG+L  +   +LS N+LSGEIP +L SCV LE+L    N FQGP
Sbjct: 496  ILVLSENQLTGSLPLEVGKLANLGYFNLSHNRLSGEIPRTLGSCVSLEFLYMEGNLFQGP 555

Query: 408  IHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRA 467
            I    SSL+ LQ L+LS NN SG+IP FL   + L  L+LSFNNLEGEVP +G+F     
Sbjct: 556  IPESLSSLRALQILNLSHNNLSGEIPKFLAELKLLTSLDLSFNNLEGEVPVQGIFARASG 615

Query: 468  VSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPC-----LLSTCFIVF 522
             S++GN KLCGG P+L+L  C S+ SRKL   +  K++I+   +PC     +L   +++F
Sbjct: 616  FSMLGNKKLCGGMPQLNLSRCTSKKSRKLKSSTKLKLIIA---IPCGFVGIILVVSYMLF 672

Query: 523  VFYQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGT 582
             F + +K R  S     S  E  + +++Y +LL+AT GFS ANLIG G +G VYKGIL +
Sbjct: 673  FFLKEKKSRPAS----GSPWESTFQRVAYEDLLQATNGFSPANLIGAGSFGSVYKGILRS 728

Query: 583  EETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
            +   VAVKV +L + GASKSF+AEC AL +IRHRNLVK++T+CS ID +GN+FKALVYEF
Sbjct: 729  DGAAVAVKVFNLLREGASKSFMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEF 788

Query: 643  MPNGSLENWLN--QKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
            M NGSLE WL+  Q  DE ++R  L+L+QRL+IAIDVA+ L+YLH+HC  +IVHCDLKPS
Sbjct: 789  MVNGSLEEWLHPAQISDEAHRRRDLSLLQRLNIAIDVASALDYLHNHCQIAIVHCDLKPS 848

Query: 701  NVLLDNEMVAHVGDFGLSRLL----HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
            NVLLD ++ AHVGDFGL+RLL    H    DQTS+  +KG+IGY APEYG   EVS +GD
Sbjct: 849  NVLLDGDLTAHVGDFGLARLLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGD 908

Query: 757  EYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIV 816
             YS+GIL+LE+FTG+RPTD +F++GL+LH +AK  LP  VAE++DP ++ EA E      
Sbjct: 909  VYSYGILLLEVFTGRRPTDGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEETSGDAS 968

Query: 817  KELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM 865
            + +         E   +I++VG+ CS E PR+RM+I    +EL+  + +
Sbjct: 969  RRMSH--IGNHMECLAAIVKVGVACSAEFPRERMEISSVAVELRRIRHI 1015

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa]

 Score =  790 bits (2040), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 428/887 (48%), Positives = 586/887 (66%), Gaps = 35/887 (3%)

Query: 2    LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
              G IPANI+ C+ LRILD     L G +P+ELG L KL  L +  NN+ G IP S  NL
Sbjct: 136  FDGGIPANISRCANLRILDFSRGNLTGKLPAELGLLSKLQVLTIELNNFVGEIPYSFGNL 195

Query: 62   SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
            S +  +  S N+L G+IP+  G LK+L +  + AN L+G IP  +FN+SS+   +   N+
Sbjct: 196  SAINAIYGSINNLEGSIPNVFGQLKRLKILSLGANNLSGMIPPSIFNLSSLTLLSFPVNQ 255

Query: 122  LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSI-------------PEDLGKL 168
            L G +PH +G TLPN++V  + +N F G IP + SNAS++                L   
Sbjct: 256  LYGSLPHTLGLTLPNLQVFNIHTNQFGGLIPATFSNASNLLSFQIGSNNFNGKVPPLSSS 315

Query: 169  KNLIRLNFARNNLGTGKGNDLRFLDSLVN-CTFLEVVSLSSNSLSGVLPNSIANFSSHLI 227
             +L  L    NNLG G+ NDL F+  L N  T LE +  S N+  GVLP  ++NFS+ L+
Sbjct: 316  HDLQVLGVGDNNLGKGENNDLNFVYPLANNMTSLEALDTSDNNFGGVLPEIVSNFSTKLM 375

Query: 228  YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
             +  + N+I G+IPT +GNL NL  + +E N LTG IP+S+G L KL  L L GNKISG 
Sbjct: 376  KMTFARNQIRGSIPTQIGNLINLEALGLETNQLTGMIPSSMGKLQKLSDLFLNGNKISGM 435

Query: 288  IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV 347
            IPSS+GN+  L  V+++ N++ GSIP +LGN  +L  L LS NNLSG IP+E++ + S  
Sbjct: 436  IPSSMGNMTSLGRVNMRLNNLEGSIPPSLGNWQKLLSLALSQNNLSGPIPKELVSIPSLS 495

Query: 348  L-LDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQG 406
            + L LS N L+G +P+E+ +L  +  LD+S+N+ SGEIP SL SCV LE L+  +N  QG
Sbjct: 496  MYLVLSENELTGSLPIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCVSLESLHLEENFLQG 555

Query: 407  PIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVR 466
            PI    SSL+ +Q+L+LS NN +G+IP FL  F+ L+ LNLSFN+ EGEVP +G F+N  
Sbjct: 556  PIPITLSSLRAIQELNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPVQGAFQNTS 615

Query: 467  AVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAV--LLPCLLSTCFIVFVF 524
            A+SI GN KLCGG P+L+L  C S         +    +I +V   L  +L   F++F  
Sbjct: 616  AISIFGNKKLCGGIPQLNLTRCPSSEPTNSKSPTKLIWIIGSVCGFLGVILIISFLLFYC 675

Query: 525  YQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEE 584
            ++++K +    A    S+E  + +++Y +LL AT+GFSSANLIG G +G V+KGILG ++
Sbjct: 676  FRKKKDK---PAASQPSLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPDK 732

Query: 585  TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
              VAVKVL+L ++GASKSF+AECEAL+SIRHRNLVK++T+CSSID +GN+FKALVYEFM 
Sbjct: 733  IVVAVKVLNLLRKGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFMV 792

Query: 645  NGSLENWLN--QKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
            NG+LE WL+  Q  DE N    L+LM RL+IAI +A+ L YLHH C   I+HCDLKPSN+
Sbjct: 793  NGNLEEWLHPVQTSDEANGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPSNI 852

Query: 703  LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGI 762
            LLD  M AHVGDFGL+R  H  + +QTS+  +KG+IGY APEYG  G+VST+GD YS+GI
Sbjct: 853  LLDTNMTAHVGDFGLAR-FHSEASNQTSSVGLKGTIGYAAPEYGIGGKVSTYGDVYSYGI 911

Query: 763  LMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGI---VKEL 819
            L+LEMFTGKRP D MF++GL+LH YAKM LPD++ E++DP ++ E   + +     +  +
Sbjct: 912  LLLEMFTGKRPVDGMFKDGLNLHSYAKMALPDRIVEVVDPLLVREIRSVNSSDEMGMYHI 971

Query: 820  QPNLRAKFHEIQ---VSILRVGILCSEELPRDRMKIQDAIMELQEAQ 863
             P      HEI    ++I+++G+ CS ELPR+RM I D + EL   +
Sbjct: 972  GP------HEISACLMTIIKMGVACSVELPRERMDIGDVVTELNRIK 1012

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|444737622|emb|CCM07279.1| Putative LRR receptor-like serine/threonine-protein kinase FLS2 [Musa balbisiana]

 Score =  788 bits (2034), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 434/891 (48%), Positives = 590/891 (66%), Gaps = 39/891 (4%)

Query: 2    LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
            L+G IPA +  CS LR + +  N L G IP ++G L K++   L  NN TGSIP SL N+
Sbjct: 137  LEGPIPATLIRCSNLRQVSVRSNLLTGEIPRDVGLLSKMLVFNLAQNNLTGSIPSSLGNM 196

Query: 62   SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
            + L  L L  N+L G+IP  +G LK L + Q++ N L+G+IP  L+N+SSM  F+V  N 
Sbjct: 197  TSLFALFLQSNTLEGSIPESIGNLKSLQLLQIAYNRLSGAIPSSLYNLSSMSIFSVGSNL 256

Query: 122  LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNAS--------------SIPEDLGK 167
            L G +P  +  TLP++ +LL+ +N F G IP S+SNAS              ++P  L  
Sbjct: 257  LEGTLPANMFDTLPSLEMLLMNNNHFQGHIPASLSNASYMGDIELSVNYFTGTVPSHLEN 316

Query: 168  LKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLI 227
            L+ L  +N + N L     +D  FL SL NC+ L V+ L +N+  G+LP S+ANFSS L 
Sbjct: 317  LRRLYFINLSDNQLEATDSSDWEFLASLTNCSLLHVLVLGTNNFGGMLPTSLANFSSSLN 376

Query: 228  YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
             + + +N ISGTIPTG+GNL NL  +++  N LTG IP ++G L  L  L L GN+++G+
Sbjct: 377  TMTLESNHISGTIPTGIGNLFNLTTLSLSDNHLTGLIPPTIGGLRNLHGLGLSGNRLTGQ 436

Query: 288  IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSF- 346
            IP S+GNL  L  + LQ N + G IP ++GNC +++++DLS N LSG IP ++  +SS  
Sbjct: 437  IPDSIGNLTELNLIYLQDNDLGGRIPESIGNCRRVEEMDLSHNKLSGQIPMQLYSISSLS 496

Query: 347  VLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQG 406
              L+LS N L+G +PL+VG L+ +  L L+ NKLSG+IPT+L  C  LEYL   DNSFQG
Sbjct: 497  TYLNLSNNLLNGTLPLQVGNLRNLGALVLAHNKLSGDIPTTLGQCQSLEYLYLHDNSFQG 556

Query: 407  PIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVR 466
             I    S+L+GL +LDLS NN SG IP FL     LQ LNLS+N+LEG VP++GVF+N+ 
Sbjct: 557  SIPQSLSNLRGLSELDLSNNNISGNIPEFLADLLALQHLNLSYNDLEGNVPNDGVFRNIT 616

Query: 467  AVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKI-----VISAVLLPCLLSTCFIV 521
            A S+IGNNKLCGG+  LHL  C     RK   H +  +     VIS VL   +L    I 
Sbjct: 617  AFSVIGNNKLCGGNQGLHLPPCHIHSGRK---HKSLALEVVIPVISVVLCAVIL---LIA 670

Query: 522  FVFYQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILG 581
                 R K  ++ K+  N  IE+++ +ISY ELL+AT+ FS++NLIG+G +G VYKG + 
Sbjct: 671  LAVLHRTKNLKKKKSFTNY-IEEQFKRISYNELLRATDEFSASNLIGMGSFGSVYKGAMD 729

Query: 582  TEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
             + T VAVKVL+L++ GAS+SFI+ECEALR+IRHRNLVKI+T C S+D RGN+FKALV  
Sbjct: 730  ADGTTVAVKVLNLERHGASQSFISECEALRNIRHRNLVKILTICLSVDNRGNDFKALVLN 789

Query: 642  FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            +M NGSLENWL+ KE E + R KL L QRLSIAIDV++ L+YLHHH    IVHCDLKPSN
Sbjct: 790  YMSNGSLENWLHPKESEASTRRKLTLPQRLSIAIDVSSALDYLHHHGPMPIVHCDLKPSN 849

Query: 702  VLLDNEMVAHVGDFGLSRLLH----DNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE 757
            VLLD EM AHVGDFGL+R L     D   ++T ++ +KG+IGYVAPEY   G+VST+GD 
Sbjct: 850  VLLDQEMCAHVGDFGLARFLQGTMLDTDRNRTISTGIKGTIGYVAPEYAMGGKVSTNGDI 909

Query: 758  YSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPA----ILEEALEIQA 813
            YS+GIL+LEM TGKRPT+DMF++GLSLHKY +M   + +  ++DP     ++E   + + 
Sbjct: 910  YSYGILLLEMLTGKRPTEDMFKDGLSLHKYVEMTPIEDLFMVLDPGLGLLLVENGQQGEQ 969

Query: 814  GIV-KELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ 863
             +V +++    R +  +  VS + VG+ CS+E PR+RM++ D I EL E +
Sbjct: 970  NVVYRDVD---RLEVQKCFVSAVNVGLACSKENPRERMQMGDVIKELSETR 1017

Source: Musa balbisiana

Species: Musa balbisiana

Genus: Musa

Family: Musaceae

Order: Zingiberales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224141953|ref|XP_002324325.1| predicted protein [Populus trichocarpa] gi|222865759|gb|EEF02890.1| predicted protein [Populus trichocarpa]

 Score =  785 bits (2026), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 430/882 (48%), Positives = 584/882 (66%), Gaps = 40/882 (4%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           ++G+IPAN++ CS L  L +  NKL G IP+ELG L KL  L    NN  G IP S+ NL
Sbjct: 134 IEGKIPANLSGCSSLAELYIDRNKLGGEIPTELGFLSKLTILSFRQNNLLGKIPHSIGNL 193

Query: 62  SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
           + L+ LSL  N L G IP  LG LK+L    +  N L+G IP  L+N+S +  F +  N 
Sbjct: 194 TSLESLSLKRNVLEGTIPDSLGRLKRLTSLLLGENKLSGFIPPSLYNLSLITTFYLGGNG 253

Query: 122 LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNAS--------------SIPEDLGK 167
             G +P  +G + P+++ L L  N F+G IP S++NAS               IP+  GK
Sbjct: 254 FRGSLPSNLGLSFPHLQWLALWQNQFSGPIPGSLTNASELQIVSFTYNSLTGKIPDIFGK 313

Query: 168 LKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLI 227
           L +L  L+F  NNLGTG  +++ FL SL NC+ L+VVS+++N L G LP ++ N S++++
Sbjct: 314 LHHLSGLHFGSNNLGTGGDDEMAFLASLTNCSMLKVVSINNNRLEGSLPITVGNLSTYMV 373

Query: 228 YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
           Y  +S N I G IP+G+GNL NL  + M+ N  TG IPTS G L KL+  SLF N++SG+
Sbjct: 374 YFGLSGNHIVGRIPSGIGNLVNLTFLYMDRNHFTGEIPTSFGNLRKLEQFSLFSNRLSGK 433

Query: 288 IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV 347
           IPSSLGNL  L+ + L  N ++ +IP++LG C  L  L LS  NL+G+IP ++ G SS +
Sbjct: 434 IPSSLGNLSLLSVLYLDDNKLKDTIPASLGGCKNLVSLGLSRKNLNGSIPEQLFGTSSVL 493

Query: 348 L-LDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQG 406
             L+LS N  +G +P  +G LKG+ +LD+S N LSGEIPTS   C  LE L+  DN FQG
Sbjct: 494 FSLNLSHNQFTGSLPSTIGSLKGLSELDVSWNMLSGEIPTSFGGCTSLEVLHMEDNFFQG 553

Query: 407 PIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVR 466
            I S FSSL+G+Q LDLS NN SG++P FL T  F+  LNLS+NN EGEVP +GVF N  
Sbjct: 554 SIPSSFSSLRGIQFLDLSCNNLSGQLPNFLVTIPFIS-LNLSYNNFEGEVPRKGVFTNES 612

Query: 467 AVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIV--FVF 524
           AVS++GN+KLCGG  ELHL  C ++  +K  + S  + ++ A+ +PC L     V  F+F
Sbjct: 613 AVSVVGNDKLCGGILELHLPECPNKEPKKT-KMSHLQYLL-AITIPCALVGAITVSSFLF 670

Query: 525 YQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEE 584
              +K+R+   +  ++ +++ + +ISY  L KAT+GFS+ NLIG+G +  VYKG +  + 
Sbjct: 671 CWFKKKRKEHSS--DTLLKESFPQISYERLFKATDGFSTTNLIGVGSFSSVYKGRIDEDG 728

Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+KVL+LQ+RGASKSF  ECEALR+IRHRNLVKIITSCSSID +GN FKALVYE+MP
Sbjct: 729 TLVAIKVLNLQRRGASKSFKDECEALRNIRHRNLVKIITSCSSIDFQGNNFKALVYEYMP 788

Query: 645 NGSLENWLN---QKEDEQ--NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            GSLE WL+   +  D+Q  NQ  + NL++R++IAIDVA  L+YLHHHCH+ I+HCD+KP
Sbjct: 789 KGSLEKWLHPTQETHDDQQINQVQRPNLLERINIAIDVAAALDYLHHHCHSPIIHCDVKP 848

Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPD--QTSTSRVKGSIGYVAPEYGALGEVSTHGDE 757
           SN+LLD +M+ H+GDFGL+R+  + S    ++S++ +KG+ GY APEYG   EVS  GD 
Sbjct: 849 SNILLDKDMIGHLGDFGLARIFQEFSEPSLESSSAGIKGTTGYAAPEYGQGREVSIDGDV 908

Query: 758 YSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVK 817
           YS+GIL+LEM TGKRP DD FE+GL+LH +AKM LPD V EI DP +L E     A    
Sbjct: 909 YSYGILLLEMMTGKRPIDDTFEKGLNLHMFAKMALPDHVIEITDPVLLSERHLENA---- 964

Query: 818 ELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL 859
                  A   E   S++++G+ CS + PRDRM +   + EL
Sbjct: 965 -------ASMEECLTSLVKIGVACSMDSPRDRMDMSRVVREL 999

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113117|ref|XP_002316396.1| predicted protein [Populus trichocarpa] gi|222865436|gb|EEF02567.1| predicted protein [Populus trichocarpa]

 Score =  784 bits (2025), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 429/881 (48%), Positives = 579/881 (65%), Gaps = 24/881 (2%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
             GEIPANI++CS L+++DL  N L G IP+ELG+L  L    L  N+  G IP S  NL
Sbjct: 117 FSGEIPANISNCSNLQLIDLKGNNLIGKIPAELGSLLNLQACLLVTNHLVGEIPLSFENL 176

Query: 62  SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
           S ++ + + +N L G+IP  +G LK+L    V  N L+G+IP  ++N+SS+  F+V  N+
Sbjct: 177 SSVEIIGVGDNHLQGSIPYGIGKLKRLRKLSVPLNNLSGTIPPSIYNLSSLTLFSVAINQ 236

Query: 122 LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPE-DLGK------------L 168
             G +P  +G  LP++ VL+  +N F G IP +ISNAS++   D G             L
Sbjct: 237 FHGSLPSDLGQKLPSLEVLVFYANRFNGPIPVTISNASTLSVIDFGNNSFTGKVPPFANL 296

Query: 169 KNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIY 228
            NL  L    N LG G+  DL FL SL N T LE + +S N+L G+ P  I+NFSS    
Sbjct: 297 PNLQYLGIDSNELGNGEEGDLSFLQSLANYTNLEELGMSDNNLGGMFPEIISNFSSQFTT 356

Query: 229 LYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEI 288
           L M  N++ G+IP  +GNL +L  + +E N LTG IPTS+G L  L  L+L  NKISG I
Sbjct: 357 LSMGRNQVRGSIPVDIGNLISLDTLMLETNQLTGVIPTSIGKLKNLHGLTLVENKISGNI 416

Query: 289 PSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSF-V 347
           PSSLGN+  L E+ L  N+++G IPS+L NC  L  L L+ NNLSG + ++VIG++S  V
Sbjct: 417 PSSLGNVTSLVELYLSANNLQGGIPSSLANCQNLMSLKLAQNNLSGPLTKQVIGMASLSV 476

Query: 348 LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP 407
            LDLS N L GP+P EVGRL  +  LD+S N+LSGEIP SL SC+ LEYL+   N  QG 
Sbjct: 477 SLDLSHNQLIGPLPSEVGRLVNLGYLDVSHNRLSGEIPGSLGSCIMLEYLHLEGNFLQGS 536

Query: 408 IHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRA 467
           I    SSL+ LQ L+LS NN +G+IP FL  F+ LQ+L+LSFN+LEGE+P++ VF NV A
Sbjct: 537 IPELLSSLRALQYLNLSYNNLTGQIPRFLADFQLLQRLDLSFNHLEGEMPTQRVFGNVSA 596

Query: 468 VSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPC-LLSTCFIVFVFYQ 526
           VS++GN+KLCGG  +L+L  C S   RK    +  K+VIS   +PC  +    ++     
Sbjct: 597 VSVLGNDKLCGGISQLNLSRCTSNELRKPKFSTKLKLVIS---IPCGFIIALLLISSLLI 653

Query: 527 RRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETN 586
              R+ +++    +S E  + +++Y EL +AT GFSS+N IG G +G VYK IL  +   
Sbjct: 654 HSWRKTKNEPASGASWEVSFRRVTYEELYQATGGFSSSNFIGGGSFGSVYKAILAPDGMI 713

Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVKV +L ++GASKS++AEC AL +IRHRNLVKI+T+CSS+D RGN+FKALVYEFM NG
Sbjct: 714 VAVKVFNLLRKGASKSYMAECAALINIRHRNLVKILTACSSLDFRGNDFKALVYEFMVNG 773

Query: 647 SLENWLN--QKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           SLE WL+     DE+ ++  LNL+QRL++AIDVA+ L+YLH+HC  ++VHCDLKPSNVLL
Sbjct: 774 SLEEWLHPVHTSDEEREQGNLNLIQRLNVAIDVASALDYLHYHCQMAVVHCDLKPSNVLL 833

Query: 705 DNEMVAHVGDFGLSRLLHDN----SPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           D +M AHVGDFGL+R   +     S +Q S+  +KG++GY APEYG   EVST+GD YS+
Sbjct: 834 DGDMTAHVGDFGLARFRPEASVQLSSNQNSSIGLKGTVGYAAPEYGIGNEVSTYGDVYSY 893

Query: 761 GILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQ 820
           GIL+LE+ TGK PTD  F+EGL+LHKY KM LPD+V E++DP +L E  +  A     ++
Sbjct: 894 GILLLEILTGKTPTDGSFKEGLNLHKYVKMALPDRVVEVVDPILLREIEQTSANASDGMK 953

Query: 821 PNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE 861
                K  E  VSI+ VG+ CS +LPR+R  I + + EL  
Sbjct: 954 RIGNDKVLECLVSIMEVGVSCSVDLPRERTNISNVVAELHR 994

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255581223|ref|XP_002531424.1| receptor-kinase, putative [Ricinus communis] gi|223528974|gb|EEF30966.1| receptor-kinase, putative [Ricinus communis]

 Score =  784 bits (2025), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 433/888 (48%), Positives = 579/888 (65%), Gaps = 48/888 (5%)

Query: 2    LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
            L G IP+NI+ CS+L  +    N+LEG IP EL  L KL  + +  N ++GSIP S+ NL
Sbjct: 135  LTGNIPSNISACSKLSEIYFAYNQLEGEIPEELSLLAKLQVISIQKNYFSGSIPPSIGNL 194

Query: 62   SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
            S LQ LS  EN LSGNIP  +G L  L    +S N L+G+IP  ++N+SS++   +  N+
Sbjct: 195  SSLQVLSAPENYLSGNIPDAIGQLNNLIFISLSVNNLSGTIPPSIYNLSSINTLNIVYNQ 254

Query: 122  LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIP-------------EDLGKL 168
            + G +P  +G TLPN++V  +  N F G IP S SNAS++                L +L
Sbjct: 255  IQGRLPSNLGITLPNLQVFAIARNDFIGSIPSSFSNASNLVWLIMSENKLTGRVPSLEQL 314

Query: 169  KNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIY 228
             NL  L    N LG  + NDL F+ SLVNCT L  + + +N   GVLP SI+NFS+    
Sbjct: 315  HNLQILGLGYNYLGL-EANDLDFVSSLVNCTNLWRLEIHNNKFHGVLPESISNFSTTFSQ 373

Query: 229  LYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEI 288
            L ++ N I+G IP+ + NL NL  + M  N L+G+IP++ G L  L+VL LFGNK+SG I
Sbjct: 374  LVIAENNIAGRIPSSISNLVNLERLEMANNQLSGNIPSNFGNLNMLKVLHLFGNKLSGTI 433

Query: 289  PSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSF-V 347
            PSSLGNL  L  +    N+++G IPS+L  C  L  LDL+ NNLSG+IP +V GLSS  +
Sbjct: 434  PSSLGNLTMLLTLSFYDNNLQGRIPSSLAECENLMVLDLAKNNLSGSIPLQVFGLSSLSI 493

Query: 348  LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP 407
             LDLS NH +G IP+EVG LK ++QL +S+N LSG IP SL SC+ LE L    N F G 
Sbjct: 494  ALDLSANHFTGVIPMEVGNLKDLEQLGISDNMLSGRIPDSLGSCIKLEVLALQGNFFDGL 553

Query: 408  IHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRA 467
            + S  SSL+GL+ LD S NN SG+IP FL +F  L+ LNLS+NN EG VP EG+F+N   
Sbjct: 554  VPSSLSSLRGLRVLDFSSNNLSGEIPEFLQSFDLLESLNLSYNNFEGRVPVEGIFRNAST 613

Query: 468  VSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIV---FVF 524
              ++GN+KLCGG PE HL  C ++  +KL      KIVIS +    LL   FI+     F
Sbjct: 614  TLVMGNDKLCGGIPEFHLAKCNAKSPKKLTL--LLKIVISTIC--SLLGLSFILIFALTF 669

Query: 525  YQRRKRRRRSKALVNSSIEDKY----LKISYAELLKATEGFSSANLIGIGGYGYVYKGIL 580
            + R+K+   +         D Y    L +S+  LL+AT+GFSSANLIG G +G+VYKG L
Sbjct: 670  WLRKKKEEPTS--------DPYGHLLLNVSFQSLLRATDGFSSANLIGRGSFGHVYKGFL 721

Query: 581  GTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
                  +AVKVL+L   GAS SFIAECEALR+IRHRNLVK++T+CS ID +GN+FKALVY
Sbjct: 722  DEGNVTIAVKVLNLLHHGASTSFIAECEALRNIRHRNLVKVLTACSGIDYQGNDFKALVY 781

Query: 641  EFMPNGSLENWLNQ-KEDEQNQRPK-LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK 698
            E+M NGSLE WL+     E+ + P+ LNL+QRL+IAIDVA+ L+YLH+ C T IVHCDLK
Sbjct: 782  EYMVNGSLEEWLHPIPRTEEVEPPRSLNLLQRLNIAIDVASALDYLHNQCTTPIVHCDLK 841

Query: 699  PSNVLLDNEMVAHVGDFGLSRLLHDNS----PDQTSTSRVKGSIGYVAPEYGALGEVSTH 754
            PSNVLLD+EM  HV DFGL+++L +++      Q+S+  V+G++G+  PEYG    VST+
Sbjct: 842  PSNVLLDSEMNGHVSDFGLAKILSESTNSFPVSQSSSIGVRGTVGFAPPEYGVGSNVSTY 901

Query: 755  GDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAG 814
            GD YS+GIL+LE+FTGKRPTDDMF+E L+LH +A++   DQ+AE+ DP +L+E       
Sbjct: 902  GDVYSYGILLLELFTGKRPTDDMFKEDLNLHNFAEIAFRDQLAEVADPILLQET------ 955

Query: 815  IVKELQPNLRA--KFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ 860
             V+E + N R   +  E   S+LR+G+ CS E+P++RMKI D +  L 
Sbjct: 956  AVRETRLNSRKCQRLEECLFSMLRIGVACSTEMPQERMKINDVVTGLH 1003

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera]

 Score =  782 bits (2019), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 447/892 (50%), Positives = 599/892 (67%), Gaps = 40/892 (4%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           L GEIPAN++ CS+L  + +  N+L G IP+ELG+L KL  L +  N+ +G IP+S  NL
Sbjct: 69  LSGEIPANLSSCSKLMYIYVGWNRLVGKIPAELGSLSKLQYLFIHANSLSGGIPRSFGNL 128

Query: 62  SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
           S L++LS ++N++ G IP+ L  L  L    ++AN L+G+IP  L N+SS+ +FAV+ N 
Sbjct: 129 SSLERLSATQNNIVGTIPASLFQLITLTHVALNANGLSGTIPPSLSNLSSLIFFAVSFNH 188

Query: 122 LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIP-------------EDLGKL 168
           L G +P  +G TLPN++ L L  N FTG IP S+SNAS++                L KL
Sbjct: 189 LHGNLPSNLGITLPNLQDLSLSGNRFTGSIPVSLSNASNLEYFSCNGNNLTGKVPSLEKL 248

Query: 169 KNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIY 228
           + L   +   NNLG G+  DL FL SL N + LEV++L+ N+  GVLP SI N+S+ L  
Sbjct: 249 QRLHFFSVTSNNLGNGEIEDLGFLSSLTNVSNLEVLALNVNNFGGVLPESIGNWSTKLAT 308

Query: 229 LYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEI 288
           L +  N+I G+IP G+GNL +L  + M  N L+GSIP  +G L  L+VL L  NK+SG +
Sbjct: 309 LLLDGNKIGGSIPAGIGNLVSLERLEMWENQLSGSIPVDIGKLQNLRVLMLIKNKLSGIL 368

Query: 289 PSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFV 347
           PSSLGNL  L ++ L  N  +G IPS+LG C  L  LDLS NNLSGTIP +V+   S  +
Sbjct: 369 PSSLGNLENLIQLVLGRNYFQGKIPSSLGKCQNLLFLDLSLNNLSGTIPPQVVSLSSLSI 428

Query: 348 LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP 407
            LD+S N L+G +P+EVG LK +  LD+S N LSG IP+S+ SC  LEYL+   N FQG 
Sbjct: 429 SLDISDNRLTGALPIEVGNLKNLGVLDVSNNMLSGGIPSSVGSCTSLEYLSMKGNFFQGS 488

Query: 408 IHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRA 467
           I S FSSL+G++ LDLS NN SGKIP FL    F Q +NLS+N+ EG +P+EGVFKNV A
Sbjct: 489 IPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIHF-QLVNLSYNDFEGILPTEGVFKNVSA 547

Query: 468 VSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAV----LLPCLLSTCFIVFV 523
            SI+GN+KLCGG PE  L  C  +  +K       KI+I+ V     + C+LS  F++F+
Sbjct: 548 TSIMGNSKLCGGIPEFQLPKCNLQEPKKRGLSLALKIIIATVSGLLAITCVLS--FLIFL 605

Query: 524 FYQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTE 583
           + +++K         +SS E   LK+SY  LL+AT+GFSS+NLIG+G +G VYKGIL  +
Sbjct: 606 WLRKKKGEP-----ASSSSEKSLLKVSYQSLLRATDGFSSSNLIGVGSFGSVYKGILDHD 660

Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
            T +AVKVL+L ++GASKSFIAECEALR+IRHRNLVK++T+CS +D +GN+FKA+VYEFM
Sbjct: 661 GTAIAVKVLNLLRKGASKSFIAECEALRNIRHRNLVKVLTACSGVDYQGNDFKAVVYEFM 720

Query: 644 PNGSLENWLNQKED--EQNQRP-KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
            NGSLE WL+      E +  P KLN +QRL+IAIDVA  L+YLHH C T IVHCDLKPS
Sbjct: 721 VNGSLEQWLHPTPTTAEASAPPRKLNFLQRLNIAIDVACALDYLHHQCQTPIVHCDLKPS 780

Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNS---PD-QTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           NVLLD EM  HVGDFG+++ L + +   P+ Q+S+  ++G+IGY APEYG   EVST GD
Sbjct: 781 NVLLDTEMTGHVGDFGIAKFLPEAATRVPEIQSSSIGIRGTIGYAAPEYGMGSEVSTSGD 840

Query: 757 EYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIV 816
            YSFGIL+LEMFTGKRPT+DMF++ L++H + K  +P++VAEI DP +L+E +E+     
Sbjct: 841 VYSFGILLLEMFTGKRPTEDMFKDSLNIHNFVKTAVPERVAEIADPVLLQEGVEMDNTTS 900

Query: 817 KELQPNLRAKFHEIQ---VSILRVGILCSEELPRDRMKIQDAIMELQEAQKM 865
           +       A  H+ Q   +SI  +G+ CS ELPR+R  I DA  EL   + +
Sbjct: 901 QRRM----ASSHDAQECLISIFGIGLACSAELPRERKNITDAAAELNSVRDI 948

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	871
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.970	0.836	0.412	3e-172
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.964	0.819	0.426	8.2e-170
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.967	0.835	0.405	2.3e-165
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.970	0.835	0.404	4.3e-164
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.957	0.808	0.410	1.7e-162
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.971	0.825	0.399	5.8e-153
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.944	0.839	0.353	3.3e-118
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.764	0.819	0.382	9.1e-116
TAIR|locus:2139885	1013	AT4G28650 [Arabidopsis thalian	0.882	0.759	0.291	9.4e-105
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.615	0.486	0.339	2e-96

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1674 (594.3 bits), Expect = 3.0e-172, P = 3.0e-172
 Identities = 364/882 (41%), Positives = 515/882 (58%)

Query:     2 LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPXXXXXX 61
             L+G IP  + +CS L  L L  N+L G++PSELG+L  LV L L GNN  G +P      
Sbjct:   126 LRGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNL 185

Query:    62 XXXXXXXXXXXXXXXXIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
                             IPS++  L Q+   Q+ AN  +G  P  L+N+SS+    +  N 
Sbjct:   186 TLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNH 245

Query:   122 LVGEIPHYVGFTLPNIRVLLLGSNWFTGEXXXXXXXXXXXXE-------------DLGKL 168
               G +   +G  LPN+    +G N+FTG                             G +
Sbjct:   246 FSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPTFGNV 305

Query:   169 KNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEXXXXXXXXXXXXXXXXIANFSSHLIY 228
              NL  L    N+LG+    DL FL SL NCT LE                IAN S+ L+ 
Sbjct:   306 PNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVT 365

Query:   229 LYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEI 288
             L +    ISG+IP  +GNL NL  + ++ N+L+G +PTS+G LL L+ LSLF N++SG I
Sbjct:   366 LDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGI 425

Query:   289 PSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVL 348
             P+ +GN+  L  +DL  N   G +P++LGNC  L +L + DN L+GTIP E++ +   + 
Sbjct:   426 PAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLR 485

Query:   349 LDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPI 408
             LD+S N L G +P ++G L+ +  L L +NKLSG++P +L +C+ +E L    N F G I
Sbjct:   486 LDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDI 545

Query:   409 HSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAV 468
                   L G++++DLS N+ SG IP +  +F  L+ LNLSFNNLEG+VP +G+F+N   V
Sbjct:   546 PD-LKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTV 604

Query:   469 SIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTF--KIVISA---VLLPCLLSTCFIVFV 523
             SI+GNN LCGG     L  C S+    + +HS+   K+VI     + L  LL    +  +
Sbjct:   605 SIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLI 664

Query:   524 FYQXXXXXXXSKALVNSSIEDKYLKISYAELLKATEGFSSANLXXXXXXXXXXXXXXXTE 583
             + +       +     S++E  + KISY +L  AT GFSS+N+               TE
Sbjct:   665 WLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTE 724

Query:   584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
             +  VAVKVL++Q+RGA KSF+AECE+L+ IRHRNLVK++T+CSSID +GNEF+AL+YEFM
Sbjct:   725 KKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFM 784

Query:   644 PNGSLENWLNQKEDEQNQRPK--LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
             PNGSL+ WL+ +E E+  RP   L L++RL+IAIDVA+VL+YLH HCH  I HCDLKPSN
Sbjct:   785 PNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSN 844

Query:   702 VLLDNEMVAHVGDFGLSRLL----HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE 757
             VLLD+++ AHV DFGL+RLL     ++  +Q S++ V+G+IGY APEYG  G+ S +GD 
Sbjct:   845 VLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDV 904

Query:   758 YSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVK 817
             YSFGIL+LEMFTGKRPT+++F    +L+ Y K  LP+++ +I+D +IL   L +   +V 
Sbjct:   905 YSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVV- 963

Query:   818 ELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL 859
                        E    +  VG+ C EE P +R+     + EL
Sbjct:   964 -----------ECLTMVFEVGLRCCEESPMNRLATSIVVKEL 994

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1651 (586.2 bits), Expect = 8.2e-170, P = 8.2e-170
 Identities = 378/886 (42%), Positives = 512/886 (57%)

Query:     4 GEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPXXXXXXXX 63
             G IP  +++CS L  LDL  N LE  +P E G+L KLV L L  NN TG  P        
Sbjct:   143 GVIPVVLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTS 202

Query:    64 XXXXXXXXXXXXXXIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLV 123
                           IP ++  LKQ+  F+++ N   G  P  ++N+SS+ + ++T N   
Sbjct:   203 LQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFS 262

Query:   124 GEIPHYVGFTLPNIRVLLLGSNWFTGEXXXXXXXXXXXXE-DL-------------GKLK 169
             G +    G  LPN+++L +G N FTG             + D+             G+L+
Sbjct:   263 GTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQ 322

Query:   170 NLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEXXXXXXXXXXXXXXXXIANFSSHLIYL 229
             NL+ L    N+LG     DL FL +L NC+ L+                IAN S+ L  L
Sbjct:   323 NLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTEL 382

Query:   230 YMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIP 289
              +  N ISG+IP G+GNL +L  + +  NLLTG +P S+G L +L+ + L+ N +SGEIP
Sbjct:   383 SLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIP 442

Query:   290 SSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLL 349
             SSLGN+  LT + L  NS  GSIPS+LG+C  L  L+L  N L+G+IP E++ L S V+L
Sbjct:   443 SSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVL 502

Query:   350 DLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIH 409
             ++S N L GP+  ++G+LK +  LD+S NKLSG+IP +LA+C+ LE+L    NSF GPI 
Sbjct:   503 NVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP 562

Query:   410 SGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVS 469
                  L GL+ LDLS+NN SG IP ++  F  LQ LNLS NN +G VP+EGVF+N  A+S
Sbjct:   563 D-IRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMS 621

Query:   470 IIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFK----IVISAVLLPCLL-STCFIVFVF 524
             + GN  LCGG P L L  C     R+   HS+ +    I +SAV+   LL   C +   +
Sbjct:   622 VFGNINLCGGIPSLQLQPCSVELPRR---HSSVRKIITICVSAVMAALLLLCLCVVYLCW 678

Query:   525 YQXXXXXXXSKALVN----SSIEDKYLKISYAELLKATEGFSSANLXXXXXXXXXXXXXX 580
             Y+       +    N    S ++  Y KISY EL K T GFSS+NL              
Sbjct:   679 YKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFL 738

Query:   581 XTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
              ++   VA+KVL+L +RGA+KSFIAECEAL  IRHRNLVK++T CSS D  GN+F+ALVY
Sbjct:   739 GSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVY 798

Query:   641 EFMPNGSLENWLNQKEDEQNQRPK--LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK 698
             EFMPNG+L+ WL+  E E+   P   L L  RL+IAIDVA+ L YLH +CH  I HCD+K
Sbjct:   799 EFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIK 858

Query:   699 PSNVLLDNEMVAHVGDFGLSRLL----HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH 754
             PSN+LLD ++ AHV DFGL++LL     D    Q S++ V+G+IGY APEYG  G  S  
Sbjct:   859 PSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIM 918

Query:   755 GDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD-QVAEIIDPAILEEALEIQA 813
             GD YSFGI++LE+FTGKRPT+ +F +GL+LH + K  L   Q  +I D  IL  A     
Sbjct:   919 GDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHF 978

Query:   814 GIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL 859
              +V            E    + RVG+ CSEE P +R+ + +AI +L
Sbjct:   979 NMV------------ECLTLVFRVGVSCSEESPVNRISMAEAISKL 1012

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 1609 (571.5 bits), Expect = 2.3e-165, P = 2.3e-165
 Identities = 358/883 (40%), Positives = 507/883 (57%)

Query:     2 LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPXXXXXX 61
             L+GEIPA++++CS L  LDL  N L   +PSELG+L KL+ L L  N+  G  P      
Sbjct:   126 LEGEIPASLSNCSRLLYLDLFSNNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPVFIRNL 185

Query:    62 XXXXXXXXXXXXXXXXIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
                             IP ++ +L Q+    ++ N  +G  P   +N+SS++   +  N 
Sbjct:   186 TSLIVLNLGYNHLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNG 245

Query:   122 LVGEIPHYVGFTLPNIRVLLLGSNWFTGEXXXXXXXXXXX--------------XEDLGK 167
               G +    G  LPNI  L L  N+ TG                            + GK
Sbjct:   246 FSGNLKPDFGNLLPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGK 305

Query:   168 LKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEXXXXXXXXXXXXXXXXIANFSSHLI 227
             L+NL  L  A N+LG+    DL FLD+L NC+ L                 I N S+ L 
Sbjct:   306 LENLHYLELANNSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELT 365

Query:   228 YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
              L +  N I G+IP  +GNL  L  + +  NLLTG +PTS+G L+ L  L LF N+ SGE
Sbjct:   366 VLNLKGNLIYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGE 425

Query:   288 IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV 347
             IPS +GNL  L ++ L  NS  G +P +LG+C  +  L +  N L+GTIP+E++ + + V
Sbjct:   426 IPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLV 485

Query:   348 LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP 407
              L++  N LSG +P ++GRL+ + +L L  N LSG +P +L  C+ +E +   +N F G 
Sbjct:   486 HLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGT 545

Query:   408 IHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRA 467
             I      L G++++DLS NN SG I  +   F  L+ LNLS NN EG VP+EG+F+N   
Sbjct:   546 IPD-IKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATL 604

Query:   468 VSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTF--KIVISAVLLPCLLSTCFIVFVFY 525
             VS+ GN  LCG   EL L  C ++      +H +   K+ I   +   LL   FIV + +
Sbjct:   605 VSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSW 664

Query:   526 QXXXXXXXSKALVNSS---IEDKYLKISYAELLKATEGFSSANLXXXXXXXXXXXXXXXT 582
                     ++ + NS+   +E  + K+SY +L  AT+GFSS+N+               T
Sbjct:   665 --FKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQT 722

Query:   583 EETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
             E   VAVKVL++Q+RGA KSF+AECE+L+ IRHRNLVK++T+C+SID +GNEF+AL+YEF
Sbjct:   723 ENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEF 782

Query:   643 MPNGSLENWLNQKEDEQNQRPK--LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
             MPNGSL+ WL+ +E E+  RP   L L++RL+IAIDVA+VL+YLH HCH  I HCDLKPS
Sbjct:   783 MPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPS 842

Query:   701 NVLLDNEMVAHVGDFGLSRLL--HDNSP--DQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
             N+LLD+++ AHV DFGL+RLL   D     +Q S++ V+G+IGY APEYG  G+ S HGD
Sbjct:   843 NILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGD 902

Query:   757 EYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIV 816
              YSFG+L+LEMFTGKRPT+++F    +L+ Y K  LP++V +I D +IL   L +   ++
Sbjct:   903 VYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSILHSGLRVGFPVL 962

Query:   817 KELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL 859
             + L+             IL VG+ C EE P +R+   +A  EL
Sbjct:   963 ECLK------------GILDVGLRCCEESPLNRLATSEAAKEL 993

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1597 (567.2 bits), Expect = 4.3e-164, P = 4.3e-164
 Identities = 357/883 (40%), Positives = 505/883 (57%)

Query:     2 LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPXXXXXX 61
             L+G IPA +++CS L  LDL  N L   +PSELG+L KLV L L  NN  G +P      
Sbjct:   126 LEGGIPATLSNCSRLLNLDLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNL 185

Query:    62 XXXXXXXXXXXXXXXXIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
                             +P EL  L Q+    +S N   G  P  ++N+S+++   +  + 
Sbjct:   186 TSLKSLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSG 245

Query:   122 LVGEIPHYVGFTLPNIRVLLLGSNWFTGEXXXXXXXXXXXXE--------------DLGK 167
               G +    G  LPNIR L LG N   G             +              + GK
Sbjct:   246 FSGSLKPDFGNLLPNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGK 305

Query:   168 LKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEXXXXXXXXXXXXXXXXIANFSSHLI 227
             + +L  L+ + N LG+    DL F+DSL NCT L+                IAN S+ LI
Sbjct:   306 VPSLQYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELI 365

Query:   228 YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
              L +  N   G+IP  +GNL  L  + +  N+LTG +PTS+G LL+L +LSL+ N++SGE
Sbjct:   366 SLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGE 425

Query:   288 IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV 347
             IPS +GNL  L  + L  NS  G +P +LG C  +  L +  N L+GTIP+E++ + + V
Sbjct:   426 IPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLV 485

Query:   348 LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP 407
              L +  N LSG +P ++G L+ + +L L  NK SG +P +L +C+ +E L    NSF G 
Sbjct:   486 NLSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGA 545

Query:   408 IHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRA 467
             I +    L G++ +DLS N+ SG IP +   F  L+ LNLS NN  G+VPS+G F+N   
Sbjct:   546 IPN-IRGLMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTI 604

Query:   468 VSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTF----KIVIS-AVLLPCLLSTCFIVF 522
             V + GN  LCGG  +L L  C ++      +HS+      I++S  + L  LL    +V 
Sbjct:   605 VFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVL 664

Query:   523 VFYQXXXXXXXSKALVNSSIEDKYLKISYAELLKATEGFSSANLXXXXXXXXXXXXXXXT 582
              +++       +  LV S +E  + KISY +L  AT GFSS+N+               T
Sbjct:   665 CWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPT 724

Query:   583 EETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
             E   VAVKVL++Q+RGA KSF+AECE+L+  RHRNLVK++T+C+S D +GNEF+AL+YE+
Sbjct:   725 ESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEY 784

Query:   643 MPNGSLENWLNQKEDEQNQRPK--LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
             +PNGS++ WL+ +E E+ +RP   L L++RL+I IDVA+VL+YLH HCH  I HCDLKPS
Sbjct:   785 LPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPS 844

Query:   701 NVLLDNEMVAHVGDFGLSRLL----HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
             NVLL++++ AHV DFGL+RLL     ++  +Q S++ V+G+IGY APEYG  G+ S HGD
Sbjct:   845 NVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGD 904

Query:   757 EYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIV 816
              YSFG+L+LEMFTGKRPTD++F   L+LH Y K+ LP++V EI D AIL   L +     
Sbjct:   905 VYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIGLRV----- 959

Query:   817 KELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL 859
                    R    E    +L VG+ C EE P +R+   +   EL
Sbjct:   960 -----GFRTA--ECLTLVLEVGLRCCEEYPTNRLATSEVAKEL 995

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 1582 (562.0 bits), Expect = 1.7e-162, P = 1.7e-162
 Identities = 364/887 (41%), Positives = 502/887 (56%)

Query:     1 MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPXXXXX 60
             +L+G IP+++++CS L  +DL  N L   +PSELG+L KL  L L+ NN TG+ P     
Sbjct:   132 LLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGN 191

Query:    61 XXXXXXXXXXXXXXXXXIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
                              IP E+  L Q+  FQ++ N  +G  P  L+NISS++  ++  N
Sbjct:   192 LTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADN 251

Query:   121 KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEXXXXXXXXXXXXE-DL-------------G 166
                G +    G+ LPN+R LLLG+N FTG               D+             G
Sbjct:   252 SFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFG 311

Query:   167 KLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEXXXXXXXXXXXXXXXXIANFSSHL 226
             KL+NL  L    N+LG    + L F+ ++ NCT LE                IAN S+ L
Sbjct:   312 KLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTL 371

Query:   227 IYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISG 286
               L++  N ISGTIP  +GNL +L  +++E N+L+G +P S G LL LQV+ L+ N ISG
Sbjct:   372 TSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISG 431

Query:   287 EIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSF 346
             EIPS  GN+  L ++ L  NS  G IP +LG C  L  L +  N L+GTIP+E++ + S 
Sbjct:   432 EIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSL 491

Query:   347 VLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQG 406
               +DLS N L+G  P EVG+L+ +  L  S NKLSG++P ++  C+ +E+L    NSF G
Sbjct:   492 AYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDG 551

Query:   407 PIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVR 466
              I    S L  L+++D S NN SG+IP +L +   L+ LNLS N  EG VP+ GVF+N  
Sbjct:   552 AIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNAT 610

Query:   467 AVSIIGNNKLCGGSPELHLHSCRSRGS-RKLWQHSTFKIVISAVLLPCLLSTCFIVFV-- 523
             AVS+ GN  +CGG  E+ L  C  + S RK    S  K V+S + +  + S   I+ V  
Sbjct:   611 AVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIG-IASLLLIIIVAS 669

Query:   524 ---FYQXXXXXXXSKALVNSS--IEDKYLKISYAELLKATEGFSSANLXXXXXXXXXXXX 578
                F +       S    + S  +   + K+SY EL  AT  FSS NL            
Sbjct:   670 LCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKG 729

Query:   579 XXXTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL 638
                 E   VAVKVL+L + GA+KSF+AECE  + IRHRNLVK+IT CSS+D+ GN+F+AL
Sbjct:   730 LLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRAL 789

Query:   639 VYEFMPNGSLENWLNQKEDEQ-NQRPK-LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
             VYEFMP GSL+ WL  ++ E+ N   + L   ++L+IAIDVA+ LEYLH HCH  + HCD
Sbjct:   790 VYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCD 849

Query:   697 LKPSNVLLDNEMVAHVGDFGLSRLLH--DNSP--DQTSTSRVKGSIGYVAPEYGALGEVS 752
             +KPSN+LLD+++ AHV DFGL++LL+  D     +Q S++ V+G+IGY APEYG  G+ S
Sbjct:   850 IKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPS 909

Query:   753 THGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQ 812
               GD YSFGIL+LEMF+GK+PTD+ F    +LH Y K             +IL       
Sbjct:   910 IQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTK-------------SILSGCTS-- 954

Query:   813 AGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL 859
             +G    +   LR         +L+VGI CSEE PRDRM+  +A+ EL
Sbjct:   955 SGGSNAIDEGLRL--------VLQVGIKCSEEYPRDRMRTDEAVREL 993

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1492 (530.3 bits), Expect = 5.8e-153, P = 5.8e-153
 Identities = 351/878 (39%), Positives = 492/878 (56%)

Query:     2 LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFK-LVGLGLTGNNYTGSIPXXXXX 60
             +QG IPA I  C++L  LDL  N+L G IP E+G   K L  L L  N  +G IP     
Sbjct:   139 IQGSIPAAIGACTKLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGN 198

Query:    61 XXXXXXXXXXXXXXXXXIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
                              IPS LG L  L    +  N L+G IP  ++N+SS+  F+V +N
Sbjct:   199 LTSLQEFDLSFNRLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVREN 258

Query:   121 KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEXXXXXXXXXXXX--------------EDLG 166
             KL G IP     TL  + V+ +G+N F G+                             G
Sbjct:   259 KLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFG 318

Query:   167 KLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEXXXXXXXXXXXXXXXXIANFSSHL 226
             +L+NL  L   RN   T + +D  F+  L NC+ L+                 +N S+ L
Sbjct:   319 RLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSL 378

Query:   227 IYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISG 286
              +L +  N+I+G+IP  +GNL  L  + +  N   GS+P+S+G L  L +L  + N +SG
Sbjct:   379 SFLALELNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSG 438

Query:   287 EIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSF 346
              IP ++GNL  L  + L  N   G IP  L N   L  L LS NNLSG IP E+  + + 
Sbjct:   439 SIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTL 498

Query:   347 -VLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQ 405
              +++++S+N+L G IP E+G LK + +     N+LSG+IP +L  C  L YL   +N   
Sbjct:   499 SIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLS 558

Query:   406 GPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNV 465
             G I S    LKGL+ LDLS NN SG+IP  L     L  LNLSFN+  GEVP+ G F   
Sbjct:   559 GSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAA 618

Query:   466 RAVSIIGNNKLCGGSPELHL-HSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIVFVF 524
               +SI GN KLCGG P+LHL   C    +RK +      + ++A L   +LS+ +++  +
Sbjct:   619 SGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLPISVSLAAAL--AILSSLYLLITW 676

Query:   525 YQXXXXXXXSKALVNSSIEDKYLKISYAELLKATEGFSSANLXXXXXXXXXXXXXXXTEE 584
             ++       S+    +S++   L +SY++L+KAT+GF+  NL                ++
Sbjct:   677 HKRTKKGAPSR----TSMKGHPL-VSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQD 731

Query:   585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
              +VAVKVL L+   A KSF AECEALR++RHRNLVKI+T CSSID RGN+FKA+VY+FMP
Sbjct:   732 -HVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMP 790

Query:   645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
             NGSLE+W++ + ++Q  +  LNL +R++I +DVA  L+YLH H    +VHCD+K SNVLL
Sbjct:   791 NGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLL 850

Query:   705 DNEMVAHVGDFGLSRLLHDN-SPDQTSTSRVK--GSIGYVAPEYGALGEVSTHGDEYSFG 761
             D++MVAHVGDFGL+R+L D  S  Q STS +   G+IGY APEYG     STHGD YS+G
Sbjct:   851 DSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYG 910

Query:   762 ILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQP 821
             IL+LE+ TGKRPTD  F   L L +Y ++GL  +V +++D  ++   L+ +  +      
Sbjct:   911 ILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLI---LDSENWLNSTNNS 967

Query:   822 NLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL 859
               R +  E  V +LR+G+ CS+ELP  R    D I EL
Sbjct:   968 PCR-RITECIVWLLRLGLSCSQELPSSRTPTGDIIDEL 1004

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 1164 (414.8 bits), Expect = 3.3e-118, P = 3.3e-118
 Identities = 312/883 (35%), Positives = 446/883 (50%)

Query:     4 GEIPANITHCSE-LRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPXXXXXXX 62
             G+IP  I    E L+ L L  N L GNIP ELG L +LV L L  N   GSIP       
Sbjct:   104 GKIPPEIGSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNG 163

Query:    63 XXXXXXXXXXXXXXXIPSELGL-----LKQLNMFQVSANYLTGSIPIQLFNISSMDYFAV 117
                            +  E+ L     LK+L    + +N LTG++P  L N +++ +  +
Sbjct:   164 SSSSLQYIDLSNNS-LTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDL 222

Query:   118 TQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEXXXXXXXXXXXXEDLGKLKNLIRLNFA 177
               N L GE+P  V   +P ++ L L  N F                 L    +L  L  A
Sbjct:   223 ESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFAS--LANSSDLQELELA 280

Query:   178 RNNLGTGKGNDLRFLDSLVNCTFLEXXXXXXXXXXXXXXXXIANFSSHLIYLYMSANRIS 237
              N+LG    + +R L   VN   +                 + N    L  L +S+N +S
Sbjct:   281 GNSLGGEITSSVRHLS--VNLVQIHLDQNRIHGSIPPEISNLLN----LTLLNLSSNLLS 334

Query:   238 GTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIF 297
             G IP  +  L  L  + +  N LTG IP  +G + +L +L +  N +SG IP S GNL  
Sbjct:   335 GPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQ 394

Query:   298 LTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIG-LSSFVL-LDLSRNH 355
             L  + L GN + G++P +LG C+ L+ LDLS NNL+GTIP EV+  L +  L L+LS NH
Sbjct:   395 LRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNH 454

Query:   356 LSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSL 415
             LSGPIPLE+ ++  +  +DLS N+LSG+IP  L SC+ LE+LN S N F   + S    L
Sbjct:   455 LSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQL 514

Query:   416 KGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNK 475
               L++LD+S N  +G IP        L+ LN SFN L G V  +G F  +   S +G++ 
Sbjct:   515 PYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSL 574

Query:   476 LCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIVFVFYQXXXXXXXSK 535
             LCG    +   +C+ +     +      +++S +  P L   C   +   Q         
Sbjct:   575 LCGSIKGMQ--ACKKKHK---YPSVLLPVLLSLIATPVL---CVFGYPLVQRSRFGKNLT 626

Query:   536 ALVNSSIED---------KYLKISYAELLKATEGFSSANLXXXXXXXXXXXXXXXTEETN 586
                   +ED         KY +ISY +L+ AT GF++++L                  T 
Sbjct:   627 VYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNN-TK 685

Query:   587 VAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
             VAVKVLD +     S SF  EC+ L+  RHRNL++IIT+CS     G  F ALV   MPN
Sbjct:   686 VAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSK---PG--FNALVLPLMPN 740

Query:   646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
             GSLE  L   E        L+L+Q ++I  DVA  + YLHH+    +VHCDLKPSN+LLD
Sbjct:   741 GSLERHLYPGEYSSKN---LDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLD 797

Query:   706 NEMVAHVGDFGLSRLLH--------DNSPDQTSTSRVK-GSIGYVAPEYGALGEVSTHGD 756
             +EM A V DFG+SRL+         D+S    ST  +  GS+GY+APEYG     STHGD
Sbjct:   798 DEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGD 857

Query:   757 EYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIV 816
              YSFG+L+LE+ +G+RPTD +  EG SLH++ K   PD +  II+ A+     + +    
Sbjct:   858 VYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKC 917

Query:   817 KELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL 859
             ++L       + E+ + ++ +G++C++  P  R  + D   E+
Sbjct:   918 EKL-------WREVILEMIELGLVCTQYNPSTRPDMLDVAHEM 953

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1141 (406.7 bits), Expect = 9.1e-116, P = 9.1e-116
 Identities = 264/691 (38%), Positives = 387/691 (56%)

Query:     2 LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPXXXXXX 61
             L G+IP  ++  S L+ L L  N L G IP+ LGNL  L  L LT N  +G+IP      
Sbjct:   114 LSGKIPQELSRLSRLQQLVLNFNSLSGEIPAALGNLTSLSVLELTNNTLSGAIPSSLGKL 173

Query:    62 XXXXXXXXXXXXXXXXIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
                             IPS  G L++L+   ++ N L+G+IP  ++NISS+  F V  NK
Sbjct:   174 TGLTDLALAENTLSGSIPSSFGQLRRLSFLSLAFNNLSGAIPDPIWNISSLTIFEVISNK 233

Query:   122 LVGEIPHYVGFTLPNIRVLLLGSNWFTGEXXXXXXXXXXXX--------------EDLGK 167
             L G +P      LP+++ + +  N F G                            ++G+
Sbjct:   234 LSGTLPTNAFSNLPSLQEVYMYYNQFHGRIPASIGNASNISIFTIGLNSFSGVVPPEIGR 293

Query:   168 LKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEXXXXXXXXXXXXXXXXIANFSSHLI 227
             ++NL RL          + ND +F+ +L NC+ L+                ++N SS L+
Sbjct:   294 MRNLQRLELPETLSEAEETNDWKFMTALTNCSNLQEVELGGCKFGGVLPDSVSNLSSSLV 353

Query:   228 YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
              L +  N+ISG++P  +GNL NL  +++  N LTGS+P+S   L  L+ L++  NK+ G 
Sbjct:   354 SLSIRDNKISGSLPRDIGNLVNLQYLSLANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGS 413

Query:   288 IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV 347
             +P ++GNL  LT +++Q N+  G+IPS LGN  +L +++L  NN  G IP E+  + +  
Sbjct:   414 LPLTIGNLTQLTNMEVQFNAFGGTIPSTLGNLTKLFQINLGHNNFIGQIPIEIFSIPALS 473

Query:   348 -LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQG 406
              +LD+S N+L G IP E+G+LK I +     NKLSGE P+++  C  L++L   +N   G
Sbjct:   474 EILDVSHNNLEGSIPKEIGKLKNIVEFHADSNKLSGENPSTIGECQLLQHLFLQNNFLNG 533

Query:   407 PIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVR 466
              I    + LKGL  LDLS NN SG+IPM L     L  LNLSFN+  GEVP+ GVF N  
Sbjct:   534 SIPIALTQLKGLDTLDLSGNNLSGQIPMSLGDMPLLHSLNLSFNSFHGEVPTNGVFANAS 593

Query:   467 AVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIVFVFYQ 526
              + I GN  +CGG PELHL +C S  SRK  +H   +I++  V++ CL+ST  +  + Y 
Sbjct:   594 EIYIQGNAHICGGIPELHLPTC-SLKSRKKKKH---QILLLVVVI-CLVSTLAVFSLLYM 648

Query:   527 XXXXXXXSKALVNSSIEDK-YLKISYAELLKATEGFSSANLXXXXXXXXXXXXXXXTEE- 584
                     K  V ++   + +  I+Y +L+KAT+GFSS++L               +++ 
Sbjct:   649 LLTCHKRRKKEVPATTSMQGHPMITYKQLVKATDGFSSSHLLGSGSFGSVYKGEFDSQDG 708

Query:   585 --TN-VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
               T+ VAV+VL L+   A KSF AECE LR+ RHRNLVKI+T CSSID RGN+FKA+VY+
Sbjct:   709 EITSLVAVRVLKLETPKALKSFTAECETLRNTRHRNLVKIVTICSSIDNRGNDFKAIVYD 768

Query:   642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLS 672
             FMPNGSLE+WL+ + ++Q ++  L L QR+S
Sbjct:   769 FMPNGSLEDWLHPETNDQAEQRHLTLHQRVS 799

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)]

 Score = 859 (307.4 bits), Expect = 9.4e-105, Sum P(2) = 9.4e-105
 Identities = 239/821 (29%), Positives = 395/821 (48%)

Query:     2 LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPXXXXXX 61
             L G +  ++ +   L +LDL  N  +G++PS   NL KL  LGL+GNN TG +P      
Sbjct:   152 LSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNNLTGELPSVLGQL 211

Query:    62 XXXXXXXXXXXXXXXXIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
                             IP E G +  L    ++   L+G IP +L  + S++   + +N 
Sbjct:   212 PSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENN 271

Query:   122 LVGEIPHYVGFTLPNIRVLLLGSNWFTGEXXXXXXXXXXXXEDLGKLKNLIRLNFARNNL 181
               G IP  +G ++  ++VL    N  TGE             ++ KLKNL  LN  RN L
Sbjct:   272 FTGTIPREIG-SITTLKVLDFSDNALTGEIPM----------EITKLKNLQLLNLMRNKL 320

Query:   182 GTGKGNDLRFLDSLVNCTFLEXXXXXXXXXXXXXXXXIANFSSHLIYLYMSANRISGTIP 241
                 G+    + SL     LE                    +S L +L +S+N  SG IP
Sbjct:   321 S---GSIPPAISSLAQLQVLELWNNTLSGELPSDLGK----NSPLQWLDVSSNSFSGEIP 373

Query:   242 TGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEV 301
             + + N  NL  + +  N  TG IP ++     L  + +  N ++G IP   G L  L  +
Sbjct:   374 STLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRL 433

Query:   302 DLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIP 361
             +L GN + G IP  + + + L  +D S N +  ++P  ++ + +     ++ N +SG +P
Sbjct:   434 ELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVP 493

Query:   362 LEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDL 421
              +      +  LDLS N L+G IP+S+ASC  L  LN  +N+  G I    +++  L  L
Sbjct:   494 DQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVL 553

Query:   422 DLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSP 481
             DLS N+ +G +P  + T   L+ LN+S+N L G VP  G  K +    + GN+ LCGG  
Sbjct:   554 DLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGV- 612

Query:   482 ELHLHSCRSRGSRKLWQHSTF--KIVISAVLL--PCLLSTCFIVFV---FYQXXXXXXXS 534
                L  C S+  R    HS+   K +++  L+    +L+   +  V    Y+        
Sbjct:   613 ---LPPC-SKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFC 668

Query:   535 KALVNSSIEDKYLKISYAEL-LKATEGFS---SANLXXXXXXXXXXXXXXXTEETNVAVK 590
                  S  E  +  +++  L   A++  +    +N+                  T +AVK
Sbjct:   669 GDETASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVLAVK 728

Query:   591 VL-----DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
              L     D++  G +  F+ E   L  +RHRN+V+++    +     ++   +VYEFM N
Sbjct:   729 KLWRSAADIED-GTTGDFVGEVNLLGKLRHRNIVRLLGFLYN-----DKNMMIVYEFMLN 782

Query:   646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
             G+L + ++ K      R  ++ + R +IA+ VA+ L YLHH CH  ++H D+K +N+LLD
Sbjct:   783 GNLGDAIHGKNAAG--RLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLD 840

Query:   706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
               + A + DFGL+R++   +  + + S V GS GY+APEYG   +V    D YS+G+++L
Sbjct:   841 ANLDARIADFGLARMM---ARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLL 897

Query:   766 EMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA--EIIDPAI 804
             E+ TG+RP +  F E + + ++ +  + D ++  E +DP +
Sbjct:   898 ELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEEALDPNV 938

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=ISS

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 712 (255.7 bits), Expect = 2.0e-96, Sum P(3) = 2.0e-96
 Identities = 196/577 (33%), Positives = 288/577 (49%)

Query:   226 LIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKIS 285
             L+ L ++ N + G  P+ +    N+  I +  N   GSIP  VG    LQ L L  N  +
Sbjct:   459 LVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFT 518

Query:   286 GEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSS 345
             GE+P  +G L  L  +++  N + G +PS + NC  LQ+LD+  NN SGT+P EV  L  
Sbjct:   519 GELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQ 578

Query:   346 FVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEY-LNFSDNSF 404
               LL LS N+LSG IP+ +G L  + +L +  N  +G IP  L S  GL+  LN S N  
Sbjct:   579 LELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKL 638

Query:   405 QGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKN 464
              G I    S+L  L+ L L+ NN SG+IP        L   N S+N+L G +P   + +N
Sbjct:   639 TGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRN 695

Query:   465 VRAVSIIGNNKLCGGSPELHLHS---CRSRGSRKLWQHSTFKIV-ISAVLLP--CLLSTC 518
             +   S IGN  LCG      + +     S+ + K     + KI+ I+A ++    L+   
Sbjct:   696 ISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIA 755

Query:   519 FIVFVFYQXXXXXXXSKALVNSSIE---DKYLK----ISYAELLKATEGFSSANLXXXXX 571
              IV++  +       S A      E   D Y       ++ +L+ AT+ F  + +     
Sbjct:   756 LIVYLM-RRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGA 814

Query:   572 XXXXXXXXXXTEETNVAVKVLDLQQRGASK-----SFIAECEALRSIRHRNLVKIITSCS 626
                          T +AVK L     G +      SF AE   L +IRHRN+VK+   C+
Sbjct:   815 CGTVYKAVLPAGYT-LAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCN 873

Query:   627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNL--MQRLSIAIDVANVLEYL 684
                 +G+    L+YE+MP GSL   L+         P  NL   +R  IA+  A  L YL
Sbjct:   874 H---QGSNL--LLYEYMPKGSLGEILHD--------PSCNLDWSKRFKIALGAAQGLAYL 920

Query:   685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
             HH C   I H D+K +N+LLD++  AHVGDFGL++++  + P   S S + GS GY+APE
Sbjct:   921 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPHSKSMSAIAGSYGYIAPE 978

Query:   745 YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG 781
             Y    +V+   D YS+G+++LE+ TGK P   + + G
Sbjct:   979 YAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGG 1015

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGP4	Y3475_ARATH	2, ., 7, ., 1, 1, ., 1	0.4518	0.9690	0.8356	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00080287 hypothetical protein (1025 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	871
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-101
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-66
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-58
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-46
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-41
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-40
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-37
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-37
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-36
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-35
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-25
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-24
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-23
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-23
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-23
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-20
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-18
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-18
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-16
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-15
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-13
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-12
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-12
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-11
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-11
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-11
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-11
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-11
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-10
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-10
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-10
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-09
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-09
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-09
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-08
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-08
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	3e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-08
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	9e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-07
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-06
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-06
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-05
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	1e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-04
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-04
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-04
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	0.001
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	0.001
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	0.002
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.003

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  336 bits (864), Expect = e-101
 Identities = 264/852 (30%), Positives = 381/852 (44%), Gaps = 117/852 (13%)

Query: 1   MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSN 60
           ML GEIP +I   S L++LDL  N L G IP+ L NL  L  L L  N   G IP+ L  
Sbjct: 151 MLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ 210

Query: 61  LSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
           +  L+ + L  N+LSG IP E+G L  LN   +  N LTG IP  L N+ ++ Y  + QN
Sbjct: 211 MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQN 270

Query: 121 KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNN 180
           KL G IP  + F+L  +  L L  N  +GE          IPE + +L+N          
Sbjct: 271 KLSGPIPPSI-FSLQKLISLDLSDNSLSGE----------IPELVIQLQN---------- 309

Query: 181 LGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTI 240
                               LE++ L SN+ +G +P ++ +    L  L + +N+ SG I
Sbjct: 310 --------------------LEILHLFSNNFTGKIPVALTSL-PRLQVLQLWSNKFSGEI 348

Query: 241 PTGVGNLKNLILIAMEVNLLTGSIPTSV---GYLLKLQVLSLFGNKISGEIPSSLGNLIF 297
           P  +G   NL ++ +  N LTG IP  +   G L K   L LF N + GEIP SLG    
Sbjct: 349 PKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK---LILFSNSLEGEIPKSLGACRS 405

Query: 298 LTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLS 357
           L  V LQ NS  G +PS       +  LD+S+NNL G I      + S  +L L+RN   
Sbjct: 406 LRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFF 465

Query: 358 GPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKG 417
           G +P +    K ++ LDLS N+ SG +P  L S   L  L  S+N   G I    SS K 
Sbjct: 466 GGLP-DSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK 524

Query: 418 LQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEV--------------------- 456
           L  LDLS N  SG+IP   +    L +L+LS N L GE+                     
Sbjct: 525 LVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLH 584

Query: 457 ---PSEGVFKNVRAVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPC 513
              PS G F  + A ++ GN  LCGG     L  C+       W    F I  +      
Sbjct: 585 GSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWW---FYITCTLGAFLV 641

Query: 514 LLSTCFIVFVFYQRRKRRRRSKALVNSS-------IEDKYLK-ISYAELLKATEGFSSAN 565
           L    F  FVF  R +     K + N          + K  K I+  ++L + +     N
Sbjct: 642 LALVAF-GFVF-IRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLK---EEN 696

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
           +I  G  G  YKG          VK ++        S IA+   +  ++H N+VK+I  C
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGLC 752

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
                R  +   L++E++   +L   L            L+  +R  IAI +A  L +LH
Sbjct: 753 -----RSEKGAYLIHEYIEGKNLSEVLRN----------LSWERRRKIAIGIAKALRFLH 797

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY 745
             C  ++V  +L P  +++D +   H+    L  LL  ++    S++       YVAPE 
Sbjct: 798 CRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISSA-------YVAPET 849

Query: 746 GALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD-QVAEIIDPAI 804
               +++   D Y FG++++E+ TGK P D  F    S+ ++A+    D  +   IDP+I
Sbjct: 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI 909

Query: 805 LEEALEIQAGIV 816
             +    Q  IV
Sbjct: 910 RGDVSVNQNEIV 921

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  240 bits (614), Expect = 1e-66
 Identities = 169/490 (34%), Positives = 247/490 (50%), Gaps = 49/490 (10%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNL-FKLVGLGLTGNNYTGSIPQSLSN 60
           + G+I + I     ++ ++L  N+L G IP ++      L  L L+ NN+TGSIP+   +
Sbjct: 81  ISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG--S 138

Query: 61  LSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
           +  L+ L LS N LSG IP+++G    L +  +  N L G IP  L N++S+++  +  N
Sbjct: 139 IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASN 198

Query: 121 KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNN 180
           +LVG+IP  +G  + +++ + LG N  +GEIP  I          G L +L  L+   NN
Sbjct: 199 QLVGQIPRELG-QMKSLKWIYLGYNNLSGEIPYEI----------GGLTSLNHLDLVYNN 247

Query: 181 LGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTI 240
           L TG         SL N   L+ + L  N LSG +P SI +    LI L +S N +SG I
Sbjct: 248 L-TGP-----IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQK-LISLDLSDNSLSGEI 300

Query: 241 PTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTE 300
           P  V  L+NL ++ +  N  TG IP ++  L +LQVL L+ NK SGEIP +LG    LT 
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360

Query: 301 VDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPI 360
           +DL  N++ G IP  L +   L KL L  N+L G IP+ +    S   + L  N  SG +
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420

Query: 361 PLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQD 420
           P E  +L  +  LD+S N L G I               +   +  P          LQ 
Sbjct: 421 PSEFTKLPLVYFLDISNNNLQGRI---------------NSRKWDMP---------SLQM 456

Query: 421 LDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE-GVFKNVRAVSIIGNNKLCGG 479
           L L+RN F G +P    + R L+ L+LS N   G VP + G    +  + +   NKL G 
Sbjct: 457 LSLARNKFFGGLPDSFGSKR-LENLDLSRNQFSGAVPRKLGSLSELMQLKLSE-NKLSGE 514

Query: 480 SPELHLHSCR 489
            P+  L SC+
Sbjct: 515 IPD-ELSSCK 523

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  215 bits (550), Expect = 2e-58
 Identities = 146/448 (32%), Positives = 215/448 (47%), Gaps = 71/448 (15%)

Query: 36  NLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSEL-GLLKQLNMFQVS 94
           N  ++V + L+G N +G I  ++  L ++Q ++LS N LSG IP ++      L    +S
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126

Query: 95  ANYLTGSIPI-QLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPP 153
            N  TGSIP   + N+ ++D   ++ N L GEIP+ +G    +++VL LG N   G+IP 
Sbjct: 127 NNNFTGSIPRGSIPNLETLD---LSNNMLSGEIPNDIGS-FSSLKVLDLGGNVLVGKIPN 182

Query: 154 SISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSG 213
           S++N +S                                        LE ++L+SN L G
Sbjct: 183 SLTNLTS----------------------------------------LEFLTLASNQLVG 202

Query: 214 VLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLK 273
            +P  +    S L ++Y+  N +SG IP  +G L +L  + +  N LTG IP+S+G L  
Sbjct: 203 QIPRELGQMKS-LKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKN 261

Query: 274 LQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLS 333
           LQ L L+ NK+SG IP S+ +L  L  +DL  NS+ G IP  +     L+ L L  NN +
Sbjct: 262 LQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFT 321

Query: 334 GTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSG----------- 382
           G IP  +  L    +L L  N  SG IP  +G+   +  LDLS N L+G           
Sbjct: 322 GKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGN 381

Query: 383 -------------EIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFS 429
                        EIP SL +C  L  +   DNSF G + S F+ L  +  LD+S NN  
Sbjct: 382 LFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQ 441

Query: 430 GKIPMFLNTFRFLQKLNLSFNNLEGEVP 457
           G+I         LQ L+L+ N   G +P
Sbjct: 442 GRINSRKWDMPSLQMLSLARNKFFGGLP 469

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  179 bits (455), Expect = 2e-46
 Identities = 118/318 (37%), Positives = 167/318 (52%), Gaps = 33/318 (10%)

Query: 200 FLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTG---------------- 243
           +++ ++LS+N LSG +P+ I   SS L YL +S N  +G+IP G                
Sbjct: 94  YIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLS 153

Query: 244 ------VGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIF 297
                 +G+  +L ++ +  N+L G IP S+  L  L+ L+L  N++ G+IP  LG +  
Sbjct: 154 GEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKS 213

Query: 298 LTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLS 357
           L  + L  N++ G IP  +G    L  LDL  NNL+G IP  +  L +   L L +N LS
Sbjct: 214 LKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLS 273

Query: 358 GPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKG 417
           GPIP  +  L+ +  LDLS+N LSGEIP  +     LE L+   N+F G I    +SL  
Sbjct: 274 GPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333

Query: 418 LQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVP-----SEGVFKNVRAVSIIG 472
           LQ L L  N FSG+IP  L     L  L+LS NNL GE+P     S  +FK      I+ 
Sbjct: 334 LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK-----LILF 388

Query: 473 NNKLCGGSPELHLHSCRS 490
           +N L G  P+  L +CRS
Sbjct: 389 SNSLEGEIPK-SLGACRS 405

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  150 bits (381), Expect = 2e-41
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 20/204 (9%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASK-SFIAECEALRSIRHRNLVKIITSC 625
           +G GG+G VY          VA+K++  +   +     + E E L+ + H N+VK+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
                       LV E+   GSL++ L      +    KL+  + L I + +   LEYLH
Sbjct: 61  ED-----ENHLYLVMEYCEGGSLKDLL------KENEGKLSEDEILRILLQILEGLEYLH 109

Query: 686 HHCHTSIVHCDLKPSNVLLDN-EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
            +    I+H DLKP N+LLD+      + DFGLS+LL  +         + G+  Y+APE
Sbjct: 110 SN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGTPAYMAPE 163

Query: 745 -YGALGEVSTHGDEYSFGILMLEM 767
                G  S   D +S G+++ E+
Sbjct: 164 VLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  148 bits (375), Expect = 6e-40
 Identities = 77/275 (28%), Positives = 123/275 (44%), Gaps = 40/275 (14%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIIT 623
             +G G +G VY          VA+KV+  +  +   +  + E + L+ ++H N+V++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLY- 63

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
                +     +  LV E+   G L + L +       R +L+  +       + + LEY
Sbjct: 64  --DVFEDEDKLY--LVMEYCEGGDLFDLLKK-------RGRLSEDEARFYLRQILSALEY 112

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
           LH      IVH DLKP N+LLD +    + DFGL+R L    P +  T+ V G+  Y+AP
Sbjct: 113 LHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLD---PGEKLTTFV-GTPEYMAP 165

Query: 744 E------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK-YAKMGLPDQV 796
           E      YG    V    D +S G+++ E+ TGK P    F     L + + K+G P   
Sbjct: 166 EVLLGKGYG--KAV----DIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPP 215

Query: 797 AEIIDPAILEEALE-IQAGIVKELQPNLRAKFHEI 830
               +  I  EA + I+  +VK+  P  R    E 
Sbjct: 216 FPPPEWDISPEAKDLIRKLLVKD--PEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  141 bits (357), Expect = 2e-37
 Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 22/219 (10%)

Query: 565 NLIGIGGYGYVYKGIL---GTEETNVAVKVL----DLQQRGASKSFIAECEALRSIRHRN 617
             +G G +G VYKG L     + T VAVK L      ++R   K F+ E   ++ + H N
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER---KDFLKEARVMKKLGHPN 57

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL--NQKEDEQNQRPKLNLMQRLSIAI 675
           +V+++  C+        +  LV E+M  G L ++L  ++      ++  L+L   LS AI
Sbjct: 58  VVRLLGVCT---EEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
            +A  +EYL        VH DL   N L+  ++V  + DFGLSR    +       +  K
Sbjct: 113 QIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGK 168

Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
             I ++APE    G  ++  D +SFG+L+ E+FT G  P
Sbjct: 169 LPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  139 bits (353), Expect = 4e-37
 Identities = 74/220 (33%), Positives = 113/220 (51%), Gaps = 28/220 (12%)

Query: 567 IGIGGYGYVYKGIL----GTEETNVAVKVL----DLQQRGASKSFIAECEALRSIRHRNL 618
           +G G +G VYKG L    G ++  VAVK L      QQ    + F+ E   +R + H N+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI---EEFLREARIMRKLDHPNV 63

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
           VK++  C+        +  +V E+M  G L ++L      +  RPKL+L   LS A+ +A
Sbjct: 64  VKLLGVCTE---EEPLY--IVMEYMEGGDLLSYL------RKNRPKLSLSDLLSFALQIA 112

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSI 738
             +EYL        +H DL   N L+   +V  + DFGLSR L+D+  D       K  I
Sbjct: 113 RGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--DYYRKRGGKLPI 167

Query: 739 GYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
            ++APE    G+ ++  D +SFG+L+ E+FT G++P   M
Sbjct: 168 RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 207

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  139 bits (352), Expect = 6e-37
 Identities = 81/272 (29%), Positives = 127/272 (46%), Gaps = 32/272 (11%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITS 624
           +G G +G VYK         VAVK+L  +   + K  +   E   LR + H N+V++I  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI-- 64

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
                   +    LV E+   G L ++L++          L+  +   IA+ +   LEYL
Sbjct: 65  --DAFEDKDHL-YLVMEYCEGGDLFDYLSRG-------GPLSEDEAKKIALQILRGLEYL 114

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
           H +    I+H DLKP N+LLD   V  + DFGL++ L  +S   T+     G+  Y+APE
Sbjct: 115 HSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT---FVGTPWYMAPE 168

Query: 745 YGALGEVSTHG---DEYSFGILMLEMFTGKRP-TDDMFEEGLSLHKYAKMGLPDQVAEII 800
              L   + +G   D +S G+++ E+ TGK P + +   + L L     +G P +  E  
Sbjct: 169 --VLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI-RRILGPPLEFDEPK 225

Query: 801 DPAILEEALEIQAGIVKELQ--PNLRAKFHEI 830
             +  EEA ++   I K L   P+ R    EI
Sbjct: 226 WSSGSEEAKDL---IKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  136 bits (346), Expect = 4e-36
 Identities = 76/251 (30%), Positives = 124/251 (49%), Gaps = 37/251 (14%)

Query: 567 IGIGGYGYVYKGIL----GTEETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKI 621
           +G G +G VYKG L       ET VAVK L         + F+ E   ++ + H N+V++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
           +  C    T+G     +V E+MP G L ++L      +    KL L   L +A+ +A  +
Sbjct: 67  LGVC----TQGEPLY-IVTEYMPGGDLLDFL------RKHGEKLTLKDLLQMALQIAKGM 115

Query: 682 EYLH-HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           EYL   +     VH DL   N L+   +V  + DFGLSR ++++   +      K  I +
Sbjct: 116 EYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGG-KLPIKW 170

Query: 741 VAPEYGAL--GEVSTHGDEYSFGILMLEMFT-GKRPTDDM--------FEEGLSLHKYAK 789
           +APE  +L  G+ ++  D +SFG+L+ E+FT G++P   M         E+G  L +   
Sbjct: 171 MAPE--SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPEN 228

Query: 790 MGLPDQVAEII 800
              PD++ E++
Sbjct: 229 C--PDELYELM 237

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  135 bits (342), Expect = 1e-35
 Identities = 73/220 (33%), Positives = 111/220 (50%), Gaps = 27/220 (12%)

Query: 567 IGIGGYGYVYKGIL----GTEETNVAVKVL----DLQQRGASKSFIAECEALRSIRHRNL 618
           +G G +G VYKG L      +E  VAVK L      QQ    + F+ E   +R + H N+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI---EEFLREARIMRKLDHPNI 63

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
           VK++  C+           +V E+MP G L ++L      +N+  +L+L   LS A+ +A
Sbjct: 64  VKLLGVCTE---EEPLM--IVMEYMPGGDLLDYL-----RKNRPKELSLSDLLSFALQIA 113

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSI 738
             +EYL        +H DL   N L+   +V  + DFGLSR L+D+  D       K  I
Sbjct: 114 RGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--DYYKVKGGKLPI 168

Query: 739 GYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
            ++APE    G+ ++  D +SFG+L+ E+FT G+ P   M
Sbjct: 169 RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM 208

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  119 bits (302), Expect = 3e-30
 Identities = 62/234 (26%), Positives = 111/234 (47%), Gaps = 16/234 (6%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGA--SKSFIAECEALRSIRHRNLVKII 622
            L+G G +G VY  +       +AVK ++L        ++   E   L S++H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
            S    D   N    +  E++  GSL + L     ++  +    ++++      +   L 
Sbjct: 66  GSE--RDEEKNTLN-IFLEYVSGGSLSSLL-----KKFGKLPEPVIRKY--TRQILEGLA 115

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           YLH +    IVH D+K +N+L+D++ V  + DFG ++ L D    + + S V+G+  ++A
Sbjct: 116 YLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS-VRGTPYWMA 171

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV 796
           PE     E     D +S G  ++EM TGK P  ++     +L+K    G P ++
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEI 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 2e-28
 Identities = 80/251 (31%), Positives = 128/251 (50%), Gaps = 35/251 (13%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
            IG G +G V  G    ++  VAVK L      A+++F+AE   + ++RH NLV+++   
Sbjct: 13  TIGKGEFGDVMLGDYRGQK--VAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLL--- 66

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
             +  +GN    +V E+M  GSL ++L  +      R  + L Q+L  A+DV   +EYL 
Sbjct: 67  -GVVLQGNPL-YIVTEYMAKGSLVDYLRSRG-----RAVITLAQQLGFALDVCEGMEYLE 119

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY 745
                + VH DL   NVL+  ++VA V DFGL++   + S  Q S    K  + + APE 
Sbjct: 120 EK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSG---KLPVKWTAPEA 170

Query: 746 GALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLH--KYAKM----GLPDQVAE 798
               + ST  D +SFGIL+ E+++ G+ P   +  + +  H  K  +M    G P +V +
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYK 230

Query: 799 I------IDPA 803
           +      +DPA
Sbjct: 231 VMKDCWELDPA 241

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  107 bits (270), Expect = 7e-26
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 17/215 (7%)

Query: 565 NLIGIGGYGYVYKGILGTEETN----VAVKVLDLQQRGASKS-FIAECEALRSIRHRNLV 619
             +G G +G V          N    VAVK L+       +S F  E E LR++ H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
           K    C      G   + L+ E++P+GSL ++L      Q  R ++NL + L  +  +  
Sbjct: 70  KYKGVCE--KPGGRSLR-LIMEYLPSGSLRDYL------QRHRDQINLKRLLLFSSQICK 120

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            ++YL        +H DL   N+L+++E +  + DFGL+++L ++          +  I 
Sbjct: 121 GMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177

Query: 740 YVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPT 774
           + APE     + S+  D +SFG+ + E+FT   P+
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 1e-25
 Identities = 70/213 (32%), Positives = 108/213 (50%), Gaps = 20/213 (9%)

Query: 567 IGIGGYGYVYKGI-LGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
           +G G +G V+ G   GT  T VAVK L      + ++F+ E + ++ +RH  LV++   C
Sbjct: 14  LGAGQFGEVWMGTWNGT--TKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
           S       E   +V E+M  GSL ++L  K  E     KL L Q + +A  +A  + YL 
Sbjct: 71  S-----EEEPIYIVTEYMSKGSLLDFL--KSGEGK---KLRLPQLVDMAAQIAEGMAYLE 120

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY 745
              +   +H DL   N+L+   +V  + DFGL+RL+ D+  + T+    K  I + APE 
Sbjct: 121 SRNY---IHRDLAARNILVGENLVCKIADFGLARLIEDD--EYTAREGAKFPIKWTAPEA 175

Query: 746 GALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
              G  +   D +SFGIL+ E+ T G+ P   M
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  104 bits (262), Expect = 6e-25
 Identities = 70/220 (31%), Positives = 107/220 (48%), Gaps = 18/220 (8%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNL 618
           E F+    +G G +G V++G L      VA+K+L        + F  E +AL+ +RH++L
Sbjct: 6   EEFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
           + +   CS       E   ++ E M  GSL  +L   E +      L     + +A  VA
Sbjct: 65  ISLFAVCS-----VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVA 114

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSI 738
             + YL      + +H DL   N+L+  ++V  V DFGL+RL+ +   D   +S  K   
Sbjct: 115 EGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE---DVYLSSDKKIPY 168

Query: 739 GYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
            + APE  + G  ST  D +SFGIL+ EMFT G+ P   M
Sbjct: 169 KWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 8e-25
 Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 28/222 (12%)

Query: 565 NLIGIGGYGYVYKGIL---GTEETNVAVKVL-----DLQQRGASKSFIAECEALRSIRHR 616
            +IG G +G V +G L   G +E +VA+K L     D Q+      F+ E   +    H 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD----FLTEASIMGQFDHP 65

Query: 617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAID 676
           N++++      + T+      ++ E+M NGSL+ +L + +       K  + Q + +   
Sbjct: 66  NIIRLE----GVVTKSRPV-MIITEYMENGSLDKFLRENDG------KFTVGQLVGMLRG 114

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
           +A+ ++YL    +   VH DL   N+L+++ +V  V DFGLSR L D+    T T   K 
Sbjct: 115 IASGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT-TKGGKI 170

Query: 737 SIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
            I + APE  A  + ++  D +SFGI+M E+ + G+RP  DM
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 2e-24
 Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 26/218 (11%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNL 618
           +   +LIG G +G VYKG+       VA+K + L+  +  A KS + E + L++++H N+
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
           VK I S        ++   ++ E+  NGSL   +           K        +A+ V 
Sbjct: 62  VKYIGS-----IETSDSLYIILEYAENGSLRQIIK----------KFGPFPESLVAVYVY 106

Query: 679 NV---LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
            V   L YLH      ++H D+K +N+L   + V  + DFG++  L+D S D  S   V 
Sbjct: 107 QVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VV 160

Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  ++APE   +   ST  D +S G  ++E+ TG  P
Sbjct: 161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  103 bits (257), Expect = 2e-24
 Identities = 70/225 (31%), Positives = 116/225 (51%), Gaps = 33/225 (14%)

Query: 566 LIGIGGYGYVYKGIL---GTEETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNL 618
           +IG G +G V +G L   G  E  VA+K L      +QR   + F++E   +    H N+
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHPNI 67

Query: 619 VK---IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI 675
           +    ++T    +         ++ EFM NG+L+++L Q + +        ++Q + +  
Sbjct: 68  IHLEGVVTKSRPV--------MIITEFMENGALDSFLRQNDGQ------FTVIQLVGMLR 113

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
            +A  ++YL      + VH DL   N+L+++ +V  V DFGLSR L D++ D T TS + 
Sbjct: 114 GIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170

Query: 736 GSIG--YVAPEYGALGEVSTHGDEYSFGILMLE-MFTGKRPTDDM 777
           G I   + APE  A  + ++  D +S+GI+M E M  G+RP  DM
Sbjct: 171 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  102 bits (255), Expect = 7e-24
 Identities = 71/229 (31%), Positives = 109/229 (47%), Gaps = 39/229 (17%)

Query: 567 IGIGGYGYVYKG-----ILGTEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVK 620
           +G G +G V+ G         ++  VAVK L +     A K F  E E L + +H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWL-------NQKEDEQNQRPKLNLMQRLSI 673
               C    T G+    +V+E+M +G L  +L          +   +   +L L Q L I
Sbjct: 73  FYGVC----TEGDPP-IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 674 AIDVANVLEYL--HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTST 731
           A+ +A+ + YL   H      VH DL   N L+  ++V  +GDFG+SR       D  +T
Sbjct: 128 AVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR-------DVYTT 175

Query: 732 S--RVKGS----IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
              RV G     I ++ PE     + +T  D +SFG+++ E+FT GK+P
Sbjct: 176 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  101 bits (253), Expect = 7e-24
 Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 16/205 (7%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
           + +G G YG VY+G+       VAVK L  +     + F+ E   ++ I+H NLV+++  
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
           C    TR   F  ++ EFM  G+L ++L      +  R ++N +  L +A  +++ +EYL
Sbjct: 71  C----TREPPF-YIITEFMTYGNLLDYL-----RECNRQEVNAVVLLYMATQISSAMEYL 120

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
                 + +H DL   N L+    +  V DFGLSRL+  ++   T+ +  K  I + APE
Sbjct: 121 EKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 175

Query: 745 YGALGEVSTHGDEYSFGILMLEMFT 769
             A  + S   D ++FG+L+ E+ T
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 99.7 bits (248), Expect = 3e-23
 Identities = 74/253 (29%), Positives = 126/253 (49%), Gaps = 39/253 (15%)

Query: 566 LIGIGGYGYVYKGIL---GTEETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNL 618
           +IG G +G V++GIL   G +E  VA+K L      +QR   + F++E   +    H N+
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR---QDFLSEASIMGQFSHHNI 68

Query: 619 VKIITSCSSIDTRGNEFK--ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAID 676
           +++    +       +FK   ++ E+M NG+L+ +L   + E       +  Q + +   
Sbjct: 69  IRLEGVVT-------KFKPAMIITEYMENGALDKYLRDHDGE------FSSYQLVGMLRG 115

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
           +A  ++YL      + VH DL   N+L+++ +   V DFGLSR+L D+     +TS  K 
Sbjct: 116 IAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172

Query: 737 SIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM--------FEEGLSLHKY 787
            I + APE  A  + ++  D +SFGI+M E+ + G+RP  DM          +G  L   
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP-- 230

Query: 788 AKMGLPDQVAEII 800
           A M  P  V +++
Sbjct: 231 APMDCPSAVYQLM 243

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 99.2 bits (248), Expect = 4e-23
 Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 18/213 (8%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVK 620
           F     IG GG+G VYK         VA+KV+ L+ +   +  I E + L+  +H N+VK
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
              S         +   +V EF   GSL++ L            L   Q   +  ++   
Sbjct: 62  YYGSYLK-----KDELWIVMEFCSGGSLKDLLKSTNQ------TLTESQIAYVCKELLKG 110

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           LEYLH +    I+H D+K +N+LL ++    + DFGLS  L D     T      G+  +
Sbjct: 111 LEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV----GTPYW 163

Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           +APE           D +S GI  +E+  GK P
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 99.5 bits (248), Expect = 5e-23
 Identities = 69/225 (30%), Positives = 109/225 (48%), Gaps = 28/225 (12%)

Query: 565 NLIGIGGYGYVYKGIL------GTEETNVAVKVLDLQQRGAS----KSFIAECEALRSIR 614
           N +G G +G VY+G        G+    VAVK L   ++GA+    K F+ E   + +  
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
           H N+VK++  C       NE + ++ E M  G L ++L     E+   P L L + L I 
Sbjct: 58  HPNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLL-----DNEMVAHVGDFGLSRLLHDNSPDQT 729
           +DVA    YL        +H DL   N L+     D + V  +GDFGL+R ++ +   + 
Sbjct: 113 LDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK 169

Query: 730 STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
                   + ++APE    G+ +T  D +SFG+LM E+ T G++P
Sbjct: 170 EGEG-LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  101 bits (251), Expect = 7e-23
 Identities = 69/222 (31%), Positives = 103/222 (46%), Gaps = 26/222 (11%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRH-RNLVKI 621
            +G G +G VY   L  +   VA+KVL  +   +    + F+ E + L S+ H  N+VK+
Sbjct: 7   KLGEGSFGEVY---LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
                           LV E++  GSLE+ L +   +        L     I   + + L
Sbjct: 64  YDFFQD-----EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEAL----FILAQILSAL 114

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLD-NEMVAHVGDFGLSRLLHDN---SPDQTSTSRVKGS 737
           EYLH      I+H D+KP N+LLD +  V  + DFGL++LL D    S      S   G+
Sbjct: 115 EYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 738 IGYVAPEY---GALGEVSTHGDEYSFGILMLEMFTGKRPTDD 776
            GY+APE     +L   S+  D +S GI + E+ TG  P + 
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213

Length = 384

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 98.1 bits (244), Expect = 1e-22
 Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 25/214 (11%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGA--SKSFIAECEALRSIRHRNLVKIITS 624
           IG G +G V+ G    E+  VA+K +   + GA   + FI E + +  + H  LV++   
Sbjct: 12  IGSGQFGLVWLGYW-LEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
           C+           LV+EFM +G L ++L      + QR K +    L + +DV   + YL
Sbjct: 68  CTE-----RSPICLVFEFMEHGCLSDYL------RAQRGKFSQETLLGMCLDVCEGMAYL 116

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQ-TSTSRVKGSIGYVAP 743
                  ++H DL   N L+    V  V DFG++R + D   DQ TS++  K  + + +P
Sbjct: 117 ESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD---DQYTSSTGTKFPVKWSSP 170

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDD 776
           E  +  + S+  D +SFG+LM E+F+ GK P ++
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 97.2 bits (243), Expect = 2e-22
 Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 22/236 (9%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIIT 623
           +G G +G V            A+KVL    + +R   +  + E   L  I H  +VK+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
              +  T    +  LV E+ P G L + L+++     +R +         A ++   LEY
Sbjct: 60  --YAFQTEEKLY--LVLEYAPGGELFSHLSKEGRFSEERARF-------YAAEIVLALEY 108

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
           LH      I++ DLKP N+LLD +    + DFGL++   + S + + T+   G+  Y+AP
Sbjct: 109 LHSL---GIIYRDLKPENILLDADGHIKLTDFGLAK---ELSSEGSRTNTFCGTPEYLAP 162

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFTGKRP-TDDMFEEGLSLHKYAKMGLPDQVAE 798
           E           D +S G+L+ EM TGK P   +  +E         +  P+ ++ 
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSP 218

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 96.8 bits (241), Expect = 3e-22
 Identities = 65/207 (31%), Positives = 96/207 (46%), Gaps = 19/207 (9%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKV--LDLQQRGASKSFIAECEALRSIRHRNLVKIIT 623
            IG G +G VYKG+L    T VAVK     L      K F+ E E L+   H N+VK+I 
Sbjct: 2   KIGKGNFGDVYKGVLKGN-TEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIG 59

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
            C        +   +V E +P GSL  +L +K++       L + + L +++D A  +EY
Sbjct: 60  VCVQ-----KQPIYIVMELVPGGSLLTFLRKKKNR------LTVKKLLQMSLDAAAGMEY 108

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
           L        +H DL   N L+    V  + DFG+SR          S    +  I + AP
Sbjct: 109 LESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-TVSDGLKQIPIKWTAP 164

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFTG 770
           E    G  ++  D +S+GIL+ E F+ 
Sbjct: 165 EALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 95.9 bits (239), Expect = 6e-22
 Identities = 66/216 (30%), Positives = 98/216 (45%), Gaps = 21/216 (9%)

Query: 567 IGIGGYGYVYKGIL---GTEETNVAVKVLDLQQRGASKS-FIAECEALRSIRHRNLVKII 622
           +G G +G V KG+      +E  VAVK L  +   A K  F+ E   +  + H  +V++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
             C        E   LV E  P G L  +L ++ +      K    Q       VA  + 
Sbjct: 63  GVCKG------EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ-------VAMGMA 109

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           YL    H   VH DL   NVLL N   A + DFG+SR L   S    +T+  +  + + A
Sbjct: 110 YLES-KH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA 166

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           PE    G+ S+  D +S+G+ + E F+ G +P  +M
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 22/214 (10%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRG--ASKSFIAECEALRSIRHRNLVKIITS 624
           +G G +G V++G L    T VAVK L   + G    K F+AE + ++ +RH  L+++   
Sbjct: 14  LGAGQFGEVWEG-LWNNTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
           C    T   E   +V E M  GSL  +L            L L Q + +A  VA+ + YL
Sbjct: 70  C----TLE-EPIYIVTELMKYGSLLEYLQGGAGRA-----LKLPQLIDMAAQVASGMAYL 119

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
                 + +H DL   NVL+    +  V DFGL+R++ ++     +    K  I + APE
Sbjct: 120 EAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED--IYEAREGAKFPIKWTAPE 174

Query: 745 YGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
                  S   D +SFGIL+ E+ T G+ P   M
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 95.3 bits (238), Expect = 1e-21
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 42/220 (19%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVK---I 621
           IG G YG VYK         VA+K + ++    G   + I E + L+ +RH N+V+   I
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 622 ITSCSSIDTRGNEFKALVYEFMP---NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
           +TS      +G+ +  +V+E+M     G L++   +  + Q +      M++L       
Sbjct: 67  VTSK----GKGSIY--MVFEYMDHDLTGLLDSPEVKFTESQIKC----YMKQLLEG---- 112

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSI 738
             L+YLH +    I+H D+K SN+L++N+ V  + DFGL+R     +     T+RV  ++
Sbjct: 113 --LQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVI-TL 165

Query: 739 GYVAPE-------YGALGEVSTHGDEYSFGILMLEMFTGK 771
            Y  PE       YG   EV    D +S G ++ E+F GK
Sbjct: 166 WYRPPELLLGATRYG--PEV----DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 68/214 (31%), Positives = 107/214 (50%), Gaps = 27/214 (12%)

Query: 567 IGIGGYGYVYKGI-LGTEETNVAVKVLDLQQRGA--SKSFIAECEALRSIRHRNLVKIIT 623
           +G G +G V+ G   G  + +VA+K++   + GA     FI E + +  + H NLV++  
Sbjct: 12  LGSGQFGVVHLGKWRG--KIDVAIKMI---REGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
            C+    +   F  +V E+M NG L N+L      + ++ KL     L +  DV   +EY
Sbjct: 67  VCTK---QRPIF--IVTEYMANGCLLNYL------RERKGKLGTEWLLDMCSDVCEAMEY 115

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQ-TSTSRVKGSIGYVA 742
           L  +     +H DL   N L+  + V  V DFGL+R + D   DQ TS+   K  + +  
Sbjct: 116 LESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD---DQYTSSQGTKFPVKWAP 169

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTD 775
           PE       S+  D +SFG+LM E+F+ GK P +
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 69/220 (31%), Positives = 102/220 (46%), Gaps = 31/220 (14%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKII 622
           N IG G +G VY  +       +AVK + +Q       K    E + L  ++H NLVK  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63

Query: 623 TSCSSIDTRGNEFKALVYEFMP---NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
                ++    +    VY FM     G+LE  L             ++++  ++ +    
Sbjct: 64  --YYGVEVHREK----VYIFMEYCSGGTLEELLEHGRILD-----EHVIRVYTLQLLEG- 111

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            L YLH H    IVH D+KP+N+ LD+  V  +GDFG +  L +N+   T    V+   G
Sbjct: 112 -LAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT--TTMGEEVQSLAG 165

Query: 740 ---YVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP 773
              Y+APE    G+   HG   D +S G ++LEM TGKRP
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 93.8 bits (233), Expect = 4e-21
 Identities = 76/247 (30%), Positives = 119/247 (48%), Gaps = 41/247 (16%)

Query: 566 LIGIGGYGYVYKGIL---GTEETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNL 618
           +IG G +G V  G L   G  E  VA+K L      +QR   + F++E   +    H N+
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR---RDFLSEASIMGQFDHPNI 67

Query: 619 VK---IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI 675
           +    ++T    +         +V E+M NGSL+ +L +K D Q       ++Q + +  
Sbjct: 68  IHLEGVVTKSKPV--------MIVTEYMENGSLDAFL-RKHDGQ-----FTVIQLVGMLR 113

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
            +A+ ++YL        VH DL   N+L+++ +V  V DFGLSR+L D+     +T   K
Sbjct: 114 GIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170

Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLE-MFTGKRPTDDM--------FEEGLSLHK 786
             I + APE  A  + ++  D +S+GI+M E M  G+RP  +M         EEG  L  
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP- 229

Query: 787 YAKMGLP 793
            A M  P
Sbjct: 230 -APMDCP 235

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 22/217 (10%)

Query: 560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHR 616
            F    +IG G +G V        +   A+K ++ Q   ++G+ ++ + E   L+ + H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAID 676
            LV +     S     N +  LV + +  G L   L+QK     ++ K           +
Sbjct: 61  FLVNL---WYSFQDEENMY--LVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICE 108

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
           +   LEYLH      I+H D+KP N+LLD +   H+ DF ++  +    PD  +TS   G
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVT---PDTLTTSTS-G 161

Query: 737 SIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + GY+APE       S   D +S G+   E   GKRP
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 92.5 bits (230), Expect = 1e-20
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 22/216 (10%)

Query: 567 IGIGGYGYVYKGILGTEETN----VAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKI 621
           +G G +G VYKG+   E       VA+KVL +     A+K  + E   + S+ H ++V++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
           +  C S          L+ + MP G L +++   +D       +     L+  + +A  +
Sbjct: 75  LGICLS------SQVQLITQLMPLGCLLDYVRNHKDN------IGSQYLLNWCVQIAKGM 122

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
            YL       +VH DL   NVL+       + DFGL++LL D    +      K  I ++
Sbjct: 123 SYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL-DVDEKEYHAEGGKVPIKWM 178

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDD 776
           A E       +   D +S+G+ + E+ T G +P + 
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 92.0 bits (228), Expect = 2e-20
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 21/213 (9%)

Query: 567 IGIGGYGYVYKGIL-GTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
           +G G +G V+ G   GT  T VA+K L      + ++F+ E + ++ +RH  LV++    
Sbjct: 14  LGQGCFGEVWMGTWNGT--TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
           S       E   +V E+M  GSL ++L  +  +      L L Q + +A  +A+ + Y+ 
Sbjct: 71  SE------EPIYIVTEYMSKGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVE 119

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY 745
                + VH DL+ +N+L+   +V  V DFGL+RL+ DN  + T+    K  I + APE 
Sbjct: 120 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEA 174

Query: 746 GALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
              G  +   D +SFGIL+ E+ T G+ P   M
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 92.2 bits (230), Expect = 2e-20
 Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 43/219 (19%)

Query: 567 IGIGGYGYVYKGILGTEETN--VAVKV--LDLQQRGASKSFIAECEALRSIRHRNLVK-- 620
           +G G YG VYK     ++T   VA+K   LD ++ G   + + E   L+ ++H N+VK  
Sbjct: 7   LGEGTYGVVYKAR--DKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 621 -IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
            +I +   +         LV+E+     L+ +L+       +   L+     SI   +  
Sbjct: 65  DVIHTERKL--------YLVFEYCDM-DLKKYLD------KRPGPLSPNLIKSIMYQLLR 109

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            L Y H H    I+H DLKP N+L++ + V  + DFGL+R      P +T T  V  ++ 
Sbjct: 110 GLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFG--IPLRTYTHEVV-TLW 163

Query: 740 YVAPE-------YGALGEVSTHGDEYSFGILMLEMFTGK 771
           Y APE       Y     V    D +S G +  EM TGK
Sbjct: 164 YRAPEILLGSKHYST--AV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 90.8 bits (225), Expect = 3e-20
 Identities = 78/271 (28%), Positives = 123/271 (45%), Gaps = 32/271 (11%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVL--DLQQRGASKSFIAECEALRSIRHRNLVKIIT 623
           L+G G +G V+KG L  ++T VAVK    DL Q    K F++E   L+   H N+VK+I 
Sbjct: 2   LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIG 59

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
            C+       +   +V E +P G   ++L +K+DE      L   Q +  A+D A  + Y
Sbjct: 60  VCTQ-----RQPIYIVMELVPGGDFLSFLRKKKDE------LKTKQLVKFALDAAAGMAY 108

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
           L      + +H DL   N L+    V  + DFG+SR   D     +   ++   I + AP
Sbjct: 109 LES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAP 163

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQVAEII 800
           E    G  S+  D +S+GIL+ E F+ G  P   M  +     + K  +M  P +  + +
Sbjct: 164 EALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDV 223

Query: 801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQ 831
              +             + +P  R KF E+Q
Sbjct: 224 YKVMQR---------CWDYKPENRPKFSELQ 245

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.4 bits (224), Expect = 5e-20
 Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 21/213 (9%)

Query: 567 IGIGGYGYVYKGIL-GTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
           +G G +G V+ G   G   T VAVK L      + +SF+ E + ++ +RH  LV++    
Sbjct: 14  LGNGQFGEVWMGTWNGN--TKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
           S       E   +V E+M  GSL ++L   E    + P L     + +A  VA  + Y+ 
Sbjct: 71  SE------EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL-----VDMAAQVAAGMAYIE 119

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY 745
                + +H DL+ +N+L+ + +V  + DFGL+RL+ DN  + T+    K  I + APE 
Sbjct: 120 R---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN--EYTARQGAKFPIKWTAPEA 174

Query: 746 GALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
              G  +   D +SFGIL+ E+ T G+ P   M
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 89.7 bits (222), Expect = 7e-20
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 21/213 (9%)

Query: 567 IGIGGYGYVYKGIL-GTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
           +G G +G V+ G   GT  T VA+K L        ++F+ E + ++ +RH  LV +    
Sbjct: 14  LGQGCFGEVWMGTWNGT--TKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVV 70

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
           S       E   +V EFM  GSL ++L + + +      L L Q + +A  +A+ + Y+ 
Sbjct: 71  SE------EPIYIVTEFMGKGSLLDFLKEGDGKY-----LKLPQLVDMAAQIADGMAYIE 119

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY 745
                + +H DL+ +N+L+ + +V  + DFGL+RL+ DN  + T+    K  I + APE 
Sbjct: 120 R---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN--EYTARQGAKFPIKWTAPEA 174

Query: 746 GALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
              G  +   D +SFGIL+ E+ T G+ P   M
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 87.8 bits (217), Expect = 3e-19
 Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 19/212 (8%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS 626
           +G G +G V+      + T VAVK +         +F+AE   +++++H  LVK+     
Sbjct: 14  LGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKL----H 67

Query: 627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH 686
           ++ T+  E   ++ EFM  GSL ++L   E  +   PKL     +  +  +A  + ++  
Sbjct: 68  AVVTK--EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQ 120

Query: 687 HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYG 746
               + +H DL+ +N+L+   +V  + DFGL+R++ DN  + T+    K  I + APE  
Sbjct: 121 R---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAI 175

Query: 747 ALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
             G  +   D +SFGIL++E+ T G+ P   M
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 88.0 bits (218), Expect = 3e-19
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 21/209 (10%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKS-FIAECEALRSIRHRNLVKIITSC 625
           +G G +G V+   LG     + V +  + +   S+  FI E + +  + H  LV++   C
Sbjct: 12  LGSGQFGVVH---LGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
           +       +   +V EFM NG L N+L Q+      + KL+    LS+  DV   +EYL 
Sbjct: 69  TQ-----QKPLYIVTEFMENGCLLNYLRQR------QGKLSKDMLLSMCQDVCEGMEYLE 117

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY 745
                S +H DL   N L+ +  V  V DFG++R + D+  + TS+S  K  + +  PE 
Sbjct: 118 R---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD--EYTSSSGAKFPVKWSPPEV 172

Query: 746 GALGEVSTHGDEYSFGILMLEMFT-GKRP 773
               + S+  D +SFG+LM E+FT GK P
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 87.7 bits (217), Expect = 4e-19
 Identities = 75/272 (27%), Positives = 126/272 (46%), Gaps = 46/272 (16%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS 626
           IG G +G V +G    E T   V V +++    +++F+ E   +  + H+NLV+++    
Sbjct: 14  IGEGEFGAVLQG----EYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLL---G 66

Query: 627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH 686
            I   G     +V E M  G+L N+L  +      R  ++++Q L  ++DVA  +EYL  
Sbjct: 67  VILHNG---LYIVMELMSKGNLVNFLRTR-----GRALVSVIQLLQFSLDVAEGMEYLES 118

Query: 687 HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYG 746
                +VH DL   N+L+  + VA V DFGL+R+           S++   + + APE  
Sbjct: 119 ---KKLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKL--PVKWTAPEAL 169

Query: 747 ALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAIL 805
              + S+  D +S+G+L+ E+F+ G+ P             Y KM L  +V E ++    
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAP-------------YPKMSL-KEVKECVEKGYR 215

Query: 806 EEALEIQAGIVK-------ELQPNLRAKFHEI 830
            E  E     V        E +P  R  FH++
Sbjct: 216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKL 247

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 18/212 (8%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS 626
           +G G +G V+ G      T VAVK L        ++F+ E   +++++H  LV++    +
Sbjct: 14  LGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSV-QAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH 686
                  E   ++ E+M  GSL ++L   E  +   PKL     +  +  +A  + Y+  
Sbjct: 72  K-----EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL-----IDFSAQIAEGMAYIER 121

Query: 687 HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYG 746
               + +H DL+ +NVL+   ++  + DFGL+R++ DN  + T+    K  I + APE  
Sbjct: 122 ---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAI 176

Query: 747 ALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
             G  +   D +SFGIL+ E+ T GK P   M
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 75/243 (30%), Positives = 118/243 (48%), Gaps = 37/243 (15%)

Query: 567 IGIGGYGYV----YKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKII 622
           IG G +G V    Y+G        VAVK +  +    +++F+AE   +  +RH NLV+++
Sbjct: 14  IGKGEFGDVMLGDYRG------NKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLL 65

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
                ++ +G  +  +V E+M  GSL ++L  +      R  L     L  ++DV   +E
Sbjct: 66  GVI--VEEKGGLY--IVTEYMAKGSLVDYLRSR-----GRSVLGGDCLLKFSLDVCEAME 116

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           YL  +   + VH DL   NVL+  + VA V DFGL++    +S   T    VK    + A
Sbjct: 117 YLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVK----WTA 167

Query: 743 PEYGALGE--VSTHGDEYSFGILMLEMFTGKR---PTDDMFEEGLSLHKYAKMGLPDQVA 797
           PE  AL E   ST  D +SFGIL+ E+++  R   P   + +    + K  KM  PD   
Sbjct: 168 PE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 225

Query: 798 EII 800
            ++
Sbjct: 226 PVV 228

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 86.0 bits (214), Expect = 2e-18
 Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 42/224 (18%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKII 622
             IG G +G VY     ++     +K +DL        +  + E + L+ + H N   II
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN---II 62

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPK-------LNLMQRLSIAI 675
               S + +G     +V E+   G L    +QK  +Q +  K       L+   +L +A 
Sbjct: 63  KYYESFEEKGKLC--IVMEYADGGDL----SQKIKKQKKEGKPFPEEQILDWFVQLCLA- 115

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
                L+YLH      I+H D+KP N+ L +  +  +GDFG+S++L     D   T  V 
Sbjct: 116 -----LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLAKT--VV 164

Query: 736 GSIGYVAPE------YGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  Y++PE      Y      +   D +S G ++ E+ T K P
Sbjct: 165 GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 66/217 (30%), Positives = 104/217 (47%), Gaps = 36/217 (16%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVL----DLQQRGASKSFIAECEALRSIRHRNLVKII 622
           +G G  G VYK          A+K +    D + R   K  + E + LRS     +VK  
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR---KQLLRELKTLRSCESPYVVK-- 63

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
             C     +  E  ++V E+M  GSL + L +      + P+  L     IA  +   L+
Sbjct: 64  --CYGAFYKEGEI-SIVLEYMDGGSLADLLKKVG----KIPEPVLA---YIARQILKGLD 113

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           YLH   H  I+H D+KPSN+L++++    + DFG+S++L +N+ DQ +T    G++ Y++
Sbjct: 114 YLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL-ENTLDQCNTF--VGTVTYMS 168

Query: 743 PE------YGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           PE      Y      S   D +S G+ +LE   GK P
Sbjct: 169 PERIQGESY------SYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 23/215 (10%)

Query: 566 LIGIGGYGYVYKGI---LGTEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKI 621
            +G G +G V +G     G +   VAVK L   +       F+ E   + S+ H NL+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 622 --ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
             +     +         +V E  P GSL + L      ++      +      A+ +AN
Sbjct: 62  YGVVLTHPL--------MMVTELAPLGSLLDRL-----RKDALGHFLISTLCDYAVQIAN 108

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            + YL        +H DL   N+LL ++    +GDFGL R L  N         +K    
Sbjct: 109 GMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA 165

Query: 740 YVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
           + APE       S   D + FG+ + EMFT G+ P
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 85.4 bits (211), Expect = 4e-18
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 13/184 (7%)

Query: 587 VAVKVLDLQQRGA-SKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           VAVK L  +  G        E E LR++ H N+VK    C+  +  GN  K L+ EF+P+
Sbjct: 36  VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT--EDGGNGIK-LIMEFLPS 92

Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           GSL+ +L + ++      K+NL Q+L  A+ +   ++YL    +   VH DL   NVL++
Sbjct: 93  GSLKEYLPRNKN------KINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVE 143

Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
           +E    +GDFGL++ +  +    T    +   + + APE     +     D +SFG+ + 
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203

Query: 766 EMFT 769
           E+ T
Sbjct: 204 ELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 84.9 bits (211), Expect = 5e-18
 Identities = 63/237 (26%), Positives = 96/237 (40%), Gaps = 40/237 (16%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEAL-RSIRHRNLVKI 621
           +IG G +  V            A+K+LD   L +    K    E E L R   H  ++K+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
             +        N +   V E+ PNG L  ++ +          L+       A ++   L
Sbjct: 68  YYTFQD---EENLY--FVLEYAPNGELLQYIRK-------YGSLDEKCTRFYAAEILLAL 115

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN--------------SPD 727
           EYLH      I+H DLKP N+LLD +M   + DFG +++L  N              S  
Sbjct: 116 EYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 728 QTSTSRVKGSIG---YVAPEYGALGE--VSTHGDEYSFGILMLEMFTGKRPTDDMFE 779
           + +  R    +G   YV+PE   L E       D ++ G ++ +M TGK P     E
Sbjct: 173 EKNRRRFASFVGTAEYVSPE--LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 84.3 bits (208), Expect = 8e-18
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 31/225 (13%)

Query: 567 IGIGGYGYVYKG-----ILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKI 621
           +G G +G V+       +   ++  VAVK L      A + F  E E L  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQK-------EDEQNQRP-KLNLMQRLSI 673
              C+           +V+E+M +G L  +L             ++  P +L L Q L+I
Sbjct: 73  YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +A+ + YL        VH DL   N L+   +V  +GDFG+SR ++      T   R
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-----STDYYR 179

Query: 734 VKGS----IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
           V G     I ++ PE     + +T  D +SFG+++ E+FT GK+P
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 83.8 bits (207), Expect = 9e-18
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 33/217 (15%)

Query: 567 IGIGGYGYV----YKGILGTEETNVAVKVLDLQQRGASKS---FIAECEALRSIRHRNLV 619
           +G G +G V    ++G     + +VA+K++    +  S S   FI E + +  + H  LV
Sbjct: 12  LGTGQFGVVKYGKWRG-----QYDVAIKMI----KEGSMSEDEFIEEAKVMMKLSHEKLV 62

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
           ++   C+           +V E+M NG L N+L +         +    Q L +  DV  
Sbjct: 63  QLYGVCTK-----QRPIYIVTEYMSNGCLLNYLRE------HGKRFQPSQLLEMCKDVCE 111

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            + YL        +H DL   N L+D++    V DFGLSR + D+  + TS+   K  + 
Sbjct: 112 GMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD--EYTSSVGSKFPVR 166

Query: 740 YVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTD 775
           +  PE     + S+  D ++FG+LM E+++ GK P +
Sbjct: 167 WSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 83.8 bits (207), Expect = 9e-18
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 19/215 (8%)

Query: 567 IGIGGYGYVYKGI--LGTEETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIIT 623
           +G G +G V KG+  +  ++ +VA+KVL  + ++      + E E +  + +  +V++I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
            C +      E   LV E    G L  +L+ K+DE      + LM ++S+       ++Y
Sbjct: 63  VCEA------EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG------MKY 110

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
           L      + VH DL   NVLL N+  A + DFGLS+ L  +     + S  K  + + AP
Sbjct: 111 LEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           E     + S+  D +S+GI M E F+ G++P   M
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 19/212 (8%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS 626
           +G G +G V+ G      T VA+K L  Q   + ++F+AE   ++ ++H  LV++     
Sbjct: 14  LGAGQFGEVWMGYY-NGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRL----Y 67

Query: 627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH 686
           ++ T+  E   ++ E+M NGSL ++L   E       KL + + + +A  +A  + ++  
Sbjct: 68  AVVTQ--EPIYIITEYMENGSLVDFLKTPEGI-----KLTINKLIDMAAQIAEGMAFIER 120

Query: 687 HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYG 746
               + +H DL+ +N+L+   +   + DFGL+RL+ DN  + T+    K  I + APE  
Sbjct: 121 K---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN--EYTAREGAKFPIKWTAPEAI 175

Query: 747 ALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
             G  +   D +SFGIL+ E+ T G+ P   M
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 28/224 (12%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDL----------QQRGASKSFIAECEALRSIRH 615
           LIG G YG VY  +  T    +AVK ++L          +Q+   K+  +E E L+ + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 616 RNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI 675
            N+V+ +           E+ ++  E++P GS+ + L      + Q  +    Q L    
Sbjct: 68  LNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE--- 119

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
                L YLH      I+H DLK  N+L+D + +  + DFG+S+   D+  D      ++
Sbjct: 120 ----GLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK-KSDDIYDNDQNMSMQ 171

Query: 736 GSIGYVAPEYGALGEVSTHG--DEYSFGILMLEMFTGKRPTDDM 777
           GS+ ++APE             D +S G ++LEMF G+RP  D 
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 31/218 (14%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS-KSFIAECEALRSIRHRNLVKIITSC 625
           IG+G    VY  I       VA+K +DL++   S      E +A+    H N+VK  TS 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI---DVANVLE 682
                 G+E   LV  ++  GSL + +               +    IA    +V   LE
Sbjct: 69  ----VVGDEL-WLVMPYLSGGSLLDIMKSSY-------PRGGLDEAIIATVLKEVLKGLE 116

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR--VKGSIGY 740
           YLH +     +H D+K  N+LL  +    + DFG+S  L D   D+T   R    G+  +
Sbjct: 117 YLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGG-DRTRKVRKTFVGTPCW 172

Query: 741 VAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRP 773
           +APE   + +V  HG     D +SFGI  +E+ TG  P
Sbjct: 173 MAPE--VMEQV--HGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 82.7 bits (204), Expect = 3e-17
 Identities = 70/251 (27%), Positives = 117/251 (46%), Gaps = 39/251 (15%)

Query: 552 AELLKATEGFSSANLIGIGGYGYVYKGILGTE----ETNVAVKVLDLQQRGASKSFIAEC 607
           A +LK TE      L+G G +G V+KGI   E    +  VA+K +  Q R   ++F    
Sbjct: 1   ARILKETE-LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEIT 57

Query: 608 E---ALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPK 664
           +   A+ S+ H  +V+++  C     +      LV +  P GSL + + Q  D  + +  
Sbjct: 58  DHMLAMGSLDHAYIVRLLGICPGASLQ------LVTQLSPLGSLLDHVRQHRDSLDPQRL 111

Query: 665 LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
           LN        + +A  + YL  H    +VH +L   N+LL ++ +  + DFG++ LL+  
Sbjct: 112 LNW------CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY-- 160

Query: 725 SPD--QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-------GKRPTD 775
            PD  +   S  K  I ++A E    G  +   D +S+G+ + EM +       G RP +
Sbjct: 161 -PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219

Query: 776 --DMFEEGLSL 784
             D+ E+G  L
Sbjct: 220 VPDLLEKGERL 230

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 82.3 bits (203), Expect = 3e-17
 Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 29/221 (13%)

Query: 566 LIGIGGYGYVYKGIL---GTEETNVAVKVL-----DLQQRGASKSFIAECEALRSIRHRN 617
           ++G G +G + +G L      E  VA+  L     D Q+RG    F+AE   L    H N
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG----FLAEALTLGQFDHSN 67

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           +V++      + TRGN    +V E+M NG+L+++L + E +      L   Q + +   +
Sbjct: 68  IVRL----EGVITRGNTM-MIVTEYMSNGALDSFLRKHEGQ------LVAGQLMGMLPGL 116

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
           A+ ++YL        VH  L    VL+++++V  +  F   RL  D S    +T   K  
Sbjct: 117 ASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSP 171

Query: 738 IGYVAPEYGALGEVSTHGDEYSFGILMLE-MFTGKRPTDDM 777
           + + APE       S+  D +SFGI+M E M  G+RP  DM
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 81.2 bits (201), Expect = 7e-17
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 34/220 (15%)

Query: 567 IGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQRGASKS----FIAECEALRSIRHRN 617
           +G G +G VY+G+      G  ET VA+K +      AS      F+ E   ++     +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTV---NENASMRERIEFLNEASVMKEFNCHH 70

Query: 618 LVKIITSCSSIDTRGNEFKALV-YEFMPNGSLENWLNQ---KEDEQNQRPKLNLMQRLSI 673
           +V+++   S     G     LV  E M  G L+++L     + +         L + + +
Sbjct: 71  VVRLLGVVS----TGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A ++A+ + YL        VH DL   N ++  ++   +GDFG++R ++     +T   R
Sbjct: 125 AAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY-----ETDYYR 176

Query: 734 VKGS----IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT 769
             G     + ++APE    G  +T  D +SFG+++ EM T
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 81.3 bits (201), Expect = 8e-17
 Identities = 60/185 (32%), Positives = 91/185 (49%), Gaps = 16/185 (8%)

Query: 587 VAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK   LQ   A   + F  E E L+S++H N+VK    C S    G     LV E++P
Sbjct: 36  VAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRRNLRLVMEYLP 90

Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L      Q  R +L+  + L  A  +   +EYL        VH DL   N+L+
Sbjct: 91  YGSLRDYL------QKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILV 141

Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
           ++E    +GDFGL+++L  +          +  I + APE     + S   D +SFG+++
Sbjct: 142 ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVL 201

Query: 765 LEMFT 769
            E+FT
Sbjct: 202 YELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.1 bits (201), Expect = 9e-17
 Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 33/220 (15%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIIT 623
           I  G YG V+     +     A+KV+   D+ ++      + E + L   +   +VK+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANVL 681
              S   + N +  LV E++P G L + L      DE         + R+ IA ++   L
Sbjct: 60  --YSFQGKKNLY--LVMEYLPGGDLASLLENVGSLDED--------VARIYIA-EIVLAL 106

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL----LHDNSPDQTS-TSRVKG 736
           EYLH +    I+H DLKP N+L+D+     + DFGLS++       N  D      R+ G
Sbjct: 107 EYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163

Query: 737 SIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP 773
           +  Y+APE   LG+   H    D +S G ++ E   G  P
Sbjct: 164 TPDYIAPEV-ILGQ--GHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.6 bits (204), Expect = 9e-17
 Identities = 70/218 (32%), Positives = 101/218 (46%), Gaps = 34/218 (15%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIA-ECEALRSIRHRNLVKIIT 623
           N IG G  G VYK I        A+KV+        +  I  E E LR + H N+VK   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK--- 136

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
            C  +     E + L+ EFM  GSLE       DEQ             +A  + + + Y
Sbjct: 137 -CHDMFDHNGEIQVLL-EFMDGGSLEG--THIADEQ---------FLADVARQILSGIAY 183

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN-SPDQTSTSRVKGSIGYVA 742
           LH      IVH D+KPSN+L+++     + DFG+SR+L     P  +S     G+I Y++
Sbjct: 184 LHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV----GTIAYMS 236

Query: 743 PE-------YGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           PE       +GA    +  GD +S G+ +LE + G+ P
Sbjct: 237 PERINTDLNHGAYDGYA--GDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 22/213 (10%)

Query: 566 LIGIGGYGYVYKGI---LGTEETNVAVKVLDLQQRGASKS-FIAECEALRSIRHRNLVKI 621
            IG G +G VY+G+      E+  VAVK        + +  F+ E   +R   H ++VK+
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
           I   +           +V E  P G L ++L   +        L+L   +  +  ++  L
Sbjct: 73  IGVITENPV------WIVMELAPLGELRSYLQVNKYS------LDLASLILYSYQLSTAL 120

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
            YL        VH D+   NVL+ +     +GDFGLSR L D S      S+ K  I ++
Sbjct: 121 AYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES--YYKASKGKLPIKWM 175

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
           APE       ++  D + FG+ M E+   G +P
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 14/221 (6%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEET---NVAVKV--LDLQQRGASKSFIAECEALRSIRH 615
                ++G G +G V +G L  ++     VAVK   LD+      + F++E   ++   H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 616 RNLVKIITSCSSIDTRGNEFKALV-YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
            N++K+I  C    +     K +V   FM +G L ++L           KL L   L   
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE-KLPLQTLLKFM 119

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
           +D+A  +EYL +    + +H DL   N +L  +M   V DFGLS+ ++  S D     R+
Sbjct: 120 VDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIY--SGDYYRQGRI 174

Query: 735 -KGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
            K  + ++A E  A    ++  D ++FG+ M E+ T G+ P
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 33/227 (14%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS-----KSFIA----ECEALRSIRHR 616
           LIG G +G VY G+  +    +AVK ++L    AS     +S +     E   L+ ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAID 676
           N+V+ +   S      N F     E++P GS+   LN     +    +  + Q L     
Sbjct: 67  NIVQYL-GSSLDADHLNIF----LEYVPGGSVAALLNNYGAFEETLVRNFVRQILK---- 117

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR--- 733
               L YLH+     I+H D+K +N+L+DN+    + DFG+S+ L  NS    ST     
Sbjct: 118 ---GLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANS---LSTKTNGA 168

Query: 734 ---VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
              ++GS+ ++APE       +   D +S G L++EM TGK P  D 
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 80.1 bits (197), Expect = 3e-16
 Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 27/201 (13%)

Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L      A K F  E E L +++H ++VK    C   D        +V+E+M +G
Sbjct: 38  VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL-----IMVFEYMKHG 92

Query: 647 SLENWLNQKE-------DEQNQRPK--LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
            L  +L           D Q ++ K  L L Q L IA  +A+ + YL        VH DL
Sbjct: 93  DLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDL 149

Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPEYGALGEVST 753
              N L+   ++  +GDFG+SR ++      T   RV G     I ++ PE     + +T
Sbjct: 150 ATRNCLVGANLLVKIGDFGMSRDVY-----STDYYRVGGHTMLPIRWMPPESIMYRKFTT 204

Query: 754 HGDEYSFGILMLEMFT-GKRP 773
             D +SFG+++ E+FT GK+P
Sbjct: 205 ESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 35/228 (15%)

Query: 567 IGIGGYGYVYKG-ILGTEE----TNVAVKVLDLQQRGASKS-FIAECEALRSIRHRNLVK 620
           +G G +G VYKG + G  E    T+VA+K L        +  F  E E +  ++H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWL----------NQKEDEQNQRPKLNLMQR 670
           ++  C+       +   +++E++ +G L  +L           +  DE  +   L+    
Sbjct: 73  LLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS-LDCSDF 126

Query: 671 LSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTS 730
           L IAI +A  +EYL  H     VH DL   N L+   +   + DFGLSR ++  S D   
Sbjct: 127 LHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY--SADYY- 180

Query: 731 TSRVKGS----IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
             RV+      + ++ PE    G+ +T  D +SFG+++ E+F+ G +P
Sbjct: 181 --RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 61/197 (30%), Positives = 95/197 (48%), Gaps = 30/197 (15%)

Query: 581 GTEETNVAVKVLDLQQRGASK----SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK 636
           GT E  VAVK L   +R   +     +  E   L+++ H N+VK    CS    +G +  
Sbjct: 31  GTGEM-VAVKTL---KRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKGL 83

Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
            L+ E++P GSL ++L         + KLNL Q L  A  +   + YLH   +   +H D
Sbjct: 84  QLIMEYVPLGSLRDYL--------PKHKLNLAQLLLFAQQICEGMAYLHSQHY---IHRD 132

Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK----GSIGYVAPEYGALGEVS 752
           L   NVLLDN+ +  +GDFGL++ +    P+     RV+      + + A E     + S
Sbjct: 133 LAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWYAVECLKENKFS 188

Query: 753 THGDEYSFGILMLEMFT 769
              D +SFG+ + E+ T
Sbjct: 189 YASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 37/234 (15%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVL------DLQQRGASKSFIAECEALRSIRHRNLVK 620
           IG G +G V+ G L  + T VAVK        DL+ +     F+ E   L+   H N+V+
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
           +I  C+       +   +V E +  G    +L      + + P+L + + + +  + A  
Sbjct: 58  LIGVCTQ-----KQPIYIVMELVQGGDFLTFL------RTEGPRLKVKELIQMVENAAAG 106

Query: 681 LEYLH-HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
           +EYL   HC    +H DL   N L+  + V  + DFG+SR   D     T   + +  + 
Sbjct: 107 MEYLESKHC----IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK-QIPVK 161

Query: 740 YVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP--------TDDMFEEGLSL 784
           + APE    G  S+  D +SFGIL+ E F+ G  P        T +  E+G+ L
Sbjct: 162 WTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL 215

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 76.9 bits (189), Expect = 3e-15
 Identities = 56/193 (29%), Positives = 99/193 (51%), Gaps = 23/193 (11%)

Query: 587 VAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           VAVK+L     + A   F+ E + +  +++ N+++++  C S D        ++ E+M N
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPL-----CMITEYMEN 101

Query: 646 GSLENWLNQKEDEQ-----NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           G L  +L+Q+E E      N  P +++   L +A+ +A+ ++YL      + VH DL   
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATR 158

Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHGD 756
           N L+ N     + DFG+SR L+          R++G     I ++A E   LG+ +T  D
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLY-----SGDYYRIQGRAVLPIRWMAWESILLGKFTTASD 213

Query: 757 EYSFGILMLEMFT 769
            ++FG+ + EMFT
Sbjct: 214 VWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 76.1 bits (188), Expect = 3e-15
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 29/219 (13%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITS 624
           IG G +G V K    ++   +  K +D         +  ++E   LR ++H N+V+    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY-- 65

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPK----LNLMQRLSIAIDVANV 680
              I  R N+   +V E+   G L   L QK  ++ +  +      ++ +L +A+     
Sbjct: 66  -DRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLLAL----- 118

Query: 681 LEYLHHHCHT------SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
                + CH       +++H DLKP+N+ LD      +GDFGL+++L  +S    + + V
Sbjct: 119 -----YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS--SFAKTYV 171

Query: 735 KGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
            G+  Y++PE           D +S G L+ E+     P
Sbjct: 172 -GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 76.0 bits (187), Expect = 5e-15
 Identities = 60/234 (25%), Positives = 109/234 (46%), Gaps = 24/234 (10%)

Query: 561 FSSANL-----IGIGGYGYVYKG-ILGTEETN----VAVKVLD-LQQRGASKSFIAECEA 609
           F  +NL     +G G +G V+     G EE      V VK L   +       F  E + 
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 610 LRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL--NQKEDEQNQRPKLNL 667
            R + H+N+V+++  C     R  E   ++ E+   G L+ +L   + +DE+ + P L+ 
Sbjct: 62  FRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116

Query: 668 MQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD 727
            Q++++   +A  +++L +      VH DL   N L+ ++    V    LS+ ++  + +
Sbjct: 117 KQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVY--NSE 171

Query: 728 QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEE 780
                     + ++APE     + ST  D +SFG+LM E+FT G+ P   + +E
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE 225

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 78.3 bits (193), Expect = 7e-15
 Identities = 37/102 (36%), Positives = 60/102 (58%), Gaps = 1/102 (0%)

Query: 192 LDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLI 251
            DS     F++ + L +  L G +PN I+    HL  + +S N I G IP  +G++ +L 
Sbjct: 411 FDSTKGKWFIDGLGLDNQGLRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLE 469

Query: 252 LIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLG 293
           ++ +  N   GSIP S+G L  L++L+L GN +SG +P++LG
Sbjct: 470 VLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 75.2 bits (185), Expect = 8e-15
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 29/216 (13%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVK-VLDLQQRGASKSFIAECEA----LRSIRHRNLVK 620
           L+G G +G VY+G+   +    AVK V         +  + + E     L  ++H N+V+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
            + +      R  +   +  E +P GSL   L +         +L   Q L         
Sbjct: 67  YLGT-----EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-------G 114

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           LEYLH     + VH D+K +N+L+D   V  + DFG+++ + + S         KGS  +
Sbjct: 115 LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS----FAKSFKGSPYW 167

Query: 741 VAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP 773
           +APE   + +   +G   D +S G  +LEM TGK P
Sbjct: 168 MAPE--VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.9 bits (192), Expect = 9e-15
 Identities = 37/108 (34%), Positives = 62/108 (57%), Gaps = 1/108 (0%)

Query: 297 FLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHL 356
           F+  + L    +RG IP+ +     LQ ++LS N++ G IP  +  ++S  +LDLS N  
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 357 SGPIPLEVGRLKGIQQLDLSENKLSGEIPTSL-ASCVGLEYLNFSDNS 403
           +G IP  +G+L  ++ L+L+ N LSG +P +L    +     NF+DN+
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA 526

Length = 623

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 75.0 bits (184), Expect = 9e-15
 Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 30/222 (13%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGA---SKSFIAECEALRSIRHRNLVKIIT 623
           IG G +G V  G + +  T   V V +L+   +      F+ E +  RS++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
            C+ +         LV EF P G L+ +L      +   P    +QR+  A ++A  L +
Sbjct: 63  QCTEVTPY-----LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLH 115

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN----SPDQTSTSRVKGSIG 739
           LH +   + +H DL   N LL  ++   +GD+GLS   +      +PDQ         + 
Sbjct: 116 LHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV-----PLR 167

Query: 740 YVAPE-----YGALGEV--STHGDEYSFGILMLEMFT-GKRP 773
           ++APE     +G L  V  +   + +S G+ + E+F  G +P
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.5 bits (191), Expect = 1e-14
 Identities = 37/84 (44%), Positives = 50/84 (59%)

Query: 260 LTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNC 319
           L G IP  +  L  LQ ++L GN I G IP SLG++  L  +DL  NS  GSIP +LG  
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 320 LQLQKLDLSDNNLSGTIPREVIGL 343
             L+ L+L+ N+LSG +P  + G 
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 65/226 (28%), Positives = 111/226 (49%), Gaps = 37/226 (16%)

Query: 566 LIGIGGYGYVYKGIL-----GTEETNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRN 617
            +G G +G V K          E + VAVK+L  D  ++  S   ++E E ++ I +H+N
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKN 77

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL---------NQKEDEQNQRPKLNLM 668
           ++ ++  C+     G  +  +V E+  +G+L ++L            +D +     L   
Sbjct: 78  IINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 669 QRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD- 727
             +S A  VA  +E+L        +H DL   NVL+  + V  + DFGL+R +H    D 
Sbjct: 133 DLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI--DY 187

Query: 728 --QTSTSRVKGSIGYVAPEYGALGE-VSTH-GDEYSFGILMLEMFT 769
             +T+  R+   + ++APE  AL + V TH  D +SFG+L+ E+FT
Sbjct: 188 YRKTTNGRL--PVKWMAPE--ALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 30/212 (14%)

Query: 567 IGIGGYGYVYK-GILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIIT 623
           IG G +G V+K     T ET VA+K + L++   G     + E +AL++ +H  +VK++ 
Sbjct: 8   IGEGAHGIVFKAKDRETGET-VALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL- 65

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
               +   G+ F  LV E+MP   L   L  +E     RP L   Q  S    +   + Y
Sbjct: 66  ---DVFPHGSGF-VLVMEYMP-SDLSEVLRDEE-----RP-LPEAQVKSYMRMLLKGVAY 114

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
           +H      I+H DLKP+N+L+  + V  + DFGL+RL       +  + +V  +  Y AP
Sbjct: 115 MHA---NGIMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQV-ATRWYRAP 169

Query: 744 E--YGAL---GEVSTHGDEYSFGILMLEMFTG 770
           E  YGA      V    D ++ G +  E+  G
Sbjct: 170 ELLYGARKYDPGV----DLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 44/224 (19%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
           ++G G YG VY     + +  +A+K +  +     +    E      ++HRN+V+ + S 
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQK----EDEQNQRPKLNLMQRLSIAIDVANVL 681
           S        FK +  E +P GSL   L  K    +D +            +I      +L
Sbjct: 75  SE----NGFFK-IFMEQVPGGSLSALLRSKWGPLKDNEQ-----------TIIFYTKQIL 118

Query: 682 E---YLHHHCHTSIVHCDLKPSNVLLDN-EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
           E   YLH +    IVH D+K  NVL++    V  + DFG S+ L   +P    T    G+
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP---CTETFTGT 172

Query: 738 IGYVAPE--------YGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + Y+APE        YGA  ++      +S G  ++EM TGK P
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADI------WSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 30/214 (14%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVL------DLQQRGASKSFIAECEALRSIRHRNLV 619
            +G G +G V+       E   A+KV+       L+Q     +   E   L+ + H  ++
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKEVSHPFII 64

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
           ++    +  D R   F  ++ E++P G L ++L      +N     N       A ++  
Sbjct: 65  RLF--WTEHDQR---FLYMLMEYVPGGELFSYL------RNSGRFSNSTGLF-YASEIVC 112

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            LEYLH      IV+ DLKP N+LLD E    + DFG ++ L D       T  + G+  
Sbjct: 113 ALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------TWTLCGTPE 163

Query: 740 YVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           Y+APE       +   D ++ GIL+ EM  G  P
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 66/245 (26%), Positives = 103/245 (42%), Gaps = 49/245 (20%)

Query: 567 IGIGGYGYVYK----GILGTEE-TNVAVKVLDLQQRGAS----KSFIAECEALRSIRHRN 617
           IG G +G V++    G+L  E  T VAVK+L   +  AS      F  E   +    H N
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDHPN 69

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQ---------------R 662
           +VK++  C+       +   L++E+M  G L  +L  +                      
Sbjct: 70  IVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 663 PKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH 722
             L+  ++L IA  VA  + YL        VH DL   N L+   MV  + DFGLSR ++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 723 DNSPDQTSTSRVKGS------IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTD 775
                  S    K S      I ++ PE       +T  D +++G+++ E+F+ G +P  
Sbjct: 182 -------SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234

Query: 776 DMFEE 780
            M  E
Sbjct: 235 GMAHE 239

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 69/246 (28%), Positives = 119/246 (48%), Gaps = 33/246 (13%)

Query: 554 LLKATEGFSSANLIGIGGYGYVYKGILGTE----ETNVAVKVLDLQQRG--ASKSFIAEC 607
           +LK TE      ++G G +G VYKGI   E    +  VA+K+L+ +  G  A+  F+ E 
Sbjct: 3   ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEA 60

Query: 608 EALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNL 667
             + S+ H +LV+++  C S   +      LV + MP+G L +++++ +D    +  LN 
Sbjct: 61  LIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW 114

Query: 668 MQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD 727
                  + +A  + YL       +VH DL   NVL+ +     + DFGL+RLL  +  +
Sbjct: 115 ------CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165

Query: 728 QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTD--------DMF 778
             +    K  I ++A E     + +   D +S+G+ + E+ T G +P D        D+ 
Sbjct: 166 YNADGG-KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Query: 779 EEGLSL 784
           E+G  L
Sbjct: 225 EKGERL 230

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 62/243 (25%), Positives = 112/243 (46%), Gaps = 43/243 (17%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETN----VAVKVLDLQQRGASKS----FIAECEAL 610
           +  + ++L+  G +G ++ GIL  E+      V VK +   +  AS+      + E   L
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV---KDHASEIQVTLLLQESCLL 62

Query: 611 RSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ-KEDEQNQRPKLNLMQ 669
             + H+N++ I+  C        E   ++Y +M  G+L+ +L Q +  E N    L+  Q
Sbjct: 63  YGLSHQNILPILHVCIE----DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQ 118

Query: 670 RLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL-------- 721
            + +AI +A  + YLH      ++H D+   N ++D E+   + D  LSR L        
Sbjct: 119 LVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL 175

Query: 722 --HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM- 777
             ++N P           + ++A E     E S+  D +SFG+L+ E+ T G+ P  ++ 
Sbjct: 176 GDNENRP-----------VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224

Query: 778 -FE 779
            FE
Sbjct: 225 PFE 227

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 24/198 (12%)

Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L      A K F  E E L +++H ++VK    C   D        +V+E+M +G
Sbjct: 38  VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL-----IMVFEYMKHG 92

Query: 647 SLENWLNQKED------EQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
            L  +L           E N+  +L   Q L IA  +A  + YL        VH DL   
Sbjct: 93  DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATR 149

Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPEYGALGEVSTHGD 756
           N L+   ++  +GDFG+SR ++      T   RV G     I ++ PE     + +T  D
Sbjct: 150 NCLVGENLLVKIGDFGMSRDVY-----STDYYRVGGHTMLPIRWMPPESIMYRKFTTESD 204

Query: 757 EYSFGILMLEMFT-GKRP 773
            +S G+++ E+FT GK+P
Sbjct: 205 VWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 74.9 bits (184), Expect = 9e-14
 Identities = 36/82 (43%), Positives = 55/82 (67%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           L+G IP +I+    L+ ++L  N + GNIP  LG++  L  L L+ N++ GSIP+SL  L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 62  SFLQQLSLSENSLSGNIPSELG 83
           + L+ L+L+ NSLSG +P+ LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 72.8 bits (179), Expect = 1e-13
 Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 23/213 (10%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVK--VLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
           IG G +G V+K      +  VA+K  +++ ++ G   + + E + L+ ++H N+V +I  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 625 CSSIDTRGNEFKA---LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
           C +  T  N +K    LV+EF  +  L   L+ K  +        +M+ L       N L
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKML------LNGL 132

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTS--TSRVKGSIG 739
            Y+H +    I+H D+K +N+L+  + +  + DFGL+R    +   + +  T+RV  ++ 
Sbjct: 133 YYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLW 188

Query: 740 YVAPEYGALGEVSTHG---DEYSFGILMLEMFT 769
           Y  PE   LGE   +G   D +  G +M EM+T
Sbjct: 189 YRPPEL-LLGE-RDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 72.0 bits (176), Expect = 2e-13
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 35/229 (15%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTE--ETNVAVKVL-DLQQRGASKSFIAECEALRSI-R 614
           E     ++IG G +G V + ++  +  + N A+K+L +       + F  E E L  +  
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE---------DEQNQRPKL 665
           H N++ ++ +C   + RG  + A+  E+ P G+L ++L +            E      L
Sbjct: 62  HPNIINLLGAC---ENRGYLYIAI--EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116

Query: 666 NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNS 725
              Q L  A DVA  ++YL        +H DL   NVL+   + + + DFGLSR      
Sbjct: 117 TSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR------ 167

Query: 726 PDQTSTSRVKGSIGYVAPEYGALGEV-----STHGDEYSFGILMLEMFT 769
                   VK ++G +   + A+  +     +T  D +SFG+L+ E+ +
Sbjct: 168 ---GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 67/251 (26%), Positives = 114/251 (45%), Gaps = 26/251 (10%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS 626
           IG G  G VY  I       VA+K ++LQQ+   +  I E   +R  +H N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY- 85

Query: 627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH 686
                G+E   +V E++  GSL + + +   ++ Q          ++  +    LE+LH 
Sbjct: 86  ---LVGDEL-WVVMEYLAGGSLTDVVTETCMDEGQIA--------AVCRECLQALEFLHS 133

Query: 687 HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYG 746
           +    ++H D+K  N+LL  +    + DFG    +   +P+Q+  S + G+  ++APE  
Sbjct: 134 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVV 187

Query: 747 ALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL-SLHKYAKMGLPD-QVAEIIDPA- 803
                    D +S GI+ +EM  G+ P   + E  L +L+  A  G P+ Q  E +    
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPY--LNENPLRALYLIATNGTPELQNPEKLSAIF 245

Query: 804 --ILEEALEIQ 812
              L   LE+ 
Sbjct: 246 RDFLNRCLEMD 256

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 75/291 (25%), Positives = 136/291 (46%), Gaps = 49/291 (16%)

Query: 567 IGIGGYGYVYKGIL-----GTEETNVAVKVLD----LQQRGASKSFIAECEALRSIRHRN 617
           +G G +G VY+G       G  ET VAVK ++    L++R     F+ E   ++     +
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHH 70

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLN--QKEDEQNQ-RPKLNLMQRLSIA 674
           +V+++   S       +   +V E M +G L+++L   + E E N  RP   L + + +A
Sbjct: 71  VVRLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
            ++A+ + YL+       VH DL   N ++ ++    +GDFG++R ++     +T   R 
Sbjct: 126 AEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY-----ETDYYRK 177

Query: 735 KGS----IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAK 789
            G     + ++APE    G  +T  D +SFG+++ E+ +  ++P      +GLS  +  K
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY-----QGLSNEQVLK 232

Query: 790 M----GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILR 836
                G  DQ      P    E +     +  +  P +R  F EI V++L+
Sbjct: 233 FVMDGGYLDQ------PDNCPERVTDLMRMCWQFNPKMRPTFLEI-VNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 69/249 (27%), Positives = 105/249 (42%), Gaps = 44/249 (17%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVK--VLDLQQRGASKSFIAECEALRSIR---HRNLV 619
             IG G YG VYK         VA+K   + L + G   S + E   L+ +    H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 620 KIITSCSSIDTRGNEFK-ALVYEFM-----------PNGSLENWLNQKEDEQNQRPKLNL 667
           +++  C    T   E K  LV+E +           P   L     +           +L
Sbjct: 65  RLLDVCHGPRT-DRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIK-----------DL 112

Query: 668 MQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD 727
           M++L         +++LH H    IVH DLKP N+L+ ++    + DFGL+R+       
Sbjct: 113 MRQL------LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA- 162

Query: 728 QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK- 786
              TS V  ++ Y APE       +T  D +S G +  E+F  +RP      E   L K 
Sbjct: 163 --LTSVVV-TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQLDKI 218

Query: 787 YAKMGLPDQ 795
           +  +GLP +
Sbjct: 219 FDVIGLPSE 227

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 24/215 (11%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIIT 623
           ++G G +G V+      ++  V +K + ++Q  +    +   EC+ L+ + H N+++   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 624 SCSSIDTRGNEFKAL--VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
           +         E KAL  V E+ P G+L  ++ ++ +         L+   +I      +L
Sbjct: 67  NFL-------EDKALMIVMEYAPGGTLAEYIQKRCNS--------LLDEDTILHFFVQIL 111

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLD-NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
             LHH     I+H DLK  N+LLD ++MV  +GDFG+S++L   S   T    V G+  Y
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT----VVGTPCY 167

Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTD 775
           ++PE       +   D ++ G ++ E+ + KR  +
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 21/216 (9%)

Query: 567 IGIGGYGYVYKGILGTEETN--VAVKVL--DLQQRGASKSFIAECEALRSIRHRNLVKII 622
           +G G +G V KG+   +++   VAVK+L  D          + E   ++ + +  +V++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
             C +      E   LV E    G L  +L QK     ++    L+ ++S+       ++
Sbjct: 63  GICEA------ESWMLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMG------MK 109

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           YL      + VH DL   NVLL  +  A + DFGLS+ L  +     + +  K  + + A
Sbjct: 110 YLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           PE     + S+  D +SFG+LM E F+ G++P   M
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 60/216 (27%), Positives = 111/216 (51%), Gaps = 17/216 (7%)

Query: 567 IGIGGYGYVYKGILGTEET--NVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKII 622
           +G G +G V +G L  +++   VAVK + +    R   + F++E   ++   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 623 TSC-SSIDTRGNEFKALVYEFMPNGSLENWL--NQKEDEQNQRPKLNLMQRLSIAIDVAN 679
             C  ++++ G     ++  FM +G L ++L  ++  D     P   L++ ++   D+A+
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT---DIAS 123

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV-KGSI 738
            +EYL      S +H DL   N +L+  M   V DFGLS+ +++   D     R+ K  +
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG--DYYRQGRIAKMPV 178

Query: 739 GYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
            ++A E  A    +T  D +SFG+ M E+ T G+ P
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 70.8 bits (173), Expect = 4e-13
 Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 27/230 (11%)

Query: 554 LLKATEGFSSANLIGIGGYGYVYKGILGTEETN----VAVKVL-DLQQRGASKSFIAECE 608
           +LK TE F    ++G G +G VYKG+   E       VA+K L +     A+K  + E  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 609 ALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLM 668
            + S+ + ++ +++  C +   +      L+ + MP G L +++ + +D    +  LN  
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNW- 114

Query: 669 QRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH-DNSPD 727
                 + +A  + YL       +VH DL   NVL+       + DFGL++LL  D    
Sbjct: 115 -----CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY 166

Query: 728 QTSTSRVKGSIGYVAPEYGALGEVSTH-GDEYSFGILMLEMFT-GKRPTD 775
                +V   I ++A E   L  + TH  D +S+G+ + E+ T G +P D
Sbjct: 167 HAEGGKV--PIKWMALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 69.5 bits (170), Expect = 6e-13
 Identities = 64/246 (26%), Positives = 106/246 (43%), Gaps = 31/246 (12%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS-----KSFIAECEALRSIRHRNLVK 620
           L+G G +G VY          +AVK +              +   E + L++++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
               C   D    E  ++  E+MP GS+++ L              + ++ +  I     
Sbjct: 69  YY-GCLRDD----ETLSIFMEYMPGGSVKDQLKAYGALTE-----TVTRKYTRQI--LEG 116

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           +EYLH +    IVH D+K +N+L D+     +GDFG S+ L       T    V G+  +
Sbjct: 117 VEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 741 VAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG----LP 793
           ++PE    GE   +G   D +S G  ++EM T K P  + FE   ++ K A       LP
Sbjct: 174 MSPEV-ISGE--GYGRKADVWSVGCTVVEMLTEKPPWAE-FEAMAAIFKIATQPTNPQLP 229

Query: 794 DQVAEI 799
             V+  
Sbjct: 230 SHVSPD 235

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 70.2 bits (172), Expect = 6e-13
 Identities = 72/230 (31%), Positives = 112/230 (48%), Gaps = 39/230 (16%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKV--LDLQQRGASKSFIAECEALRSIRHRNL 618
           F     IG G YG VYK         VA+K   LD ++ G   + I E + LR + HRN+
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 619 VK---IITSCSSIDTRGNEFKA------LVYEFMPN---GSLENWLNQKEDEQNQRPKLN 666
           V    I+T          +FK       LV+E+M +   G LE+ L    ++  +    +
Sbjct: 69  VNLKEIVTD----KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK----S 120

Query: 667 LMQRLSIAIDVANVLEYLHHHCH-TSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNS 725
            M++L         LE L++ CH  + +H D+K SN+LL+N+    + DFGL+RL +   
Sbjct: 121 FMKQL---------LEGLNY-CHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Query: 726 PDQTSTSRVKGSIGYVAPEYGALGE--VSTHGDEYSFGILMLEMFTGKRP 773
             +  T++V  ++ Y  PE   LGE       D +S G ++ E+FT K+P
Sbjct: 171 -SRPYTNKVI-TLWYRPPEL-LLGEERYGPAIDVWSCGCILGELFT-KKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 69.9 bits (172), Expect = 7e-13
 Identities = 66/227 (29%), Positives = 101/227 (44%), Gaps = 52/227 (22%)

Query: 567 IGIGGYGYV----YKGILGTEETNVAVKVLDLQQRGASKS---FIAECEALRSIRHRNLV 619
           +G G +G V    +KG   + +   A+K+L   +    K     + E   L+SIRH  LV
Sbjct: 9   LGTGSFGRVMLVRHKG---SGKY-YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLV 64

Query: 620 KIITSCSSIDTRGNEFK-----ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
            +  S          F+      LV E++P G L + L +     + R     + R   A
Sbjct: 65  NLYGS----------FQDDSNLYLVMEYVPGGELFSHLRK-----SGRFPEP-VARFYAA 108

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
             V   LEYLH      IV+ DLKP N+LLD++    + DFG ++ +      +T T  +
Sbjct: 109 -QVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYT--L 158

Query: 735 KGSIGYVAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRPTDD 776
            G+  Y+APE      + + G     D ++ GIL+ EM  G  P  D
Sbjct: 159 CGTPEYLAPEI-----ILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 69.4 bits (170), Expect = 8e-13
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 26/218 (11%)

Query: 565 NLIGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQRGASKS-FIAECEALRSIRHRNL 618
             +G G +G VY+G+         E  VAVK L        +S F+ E   +    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
           V++I        R      ++ E M  G L+++L +      +   L +   L  A DVA
Sbjct: 72  VRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
              +YL  +     +H D+   N LL  +    VA + DFG++R ++     + S  R  
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY-----RASYYRKG 178

Query: 736 GS----IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT 769
           G     I ++ PE    G  ++  D +SFG+L+ E+F+
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.0 bits (174), Expect = 1e-12
 Identities = 37/89 (41%), Positives = 56/89 (62%)

Query: 277 LSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTI 336
           L L    + G IP+ +  L  L  ++L GNSIRG+IP +LG+   L+ LDLS N+ +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 337 PREVIGLSSFVLLDLSRNHLSGPIPLEVG 365
           P  +  L+S  +L+L+ N LSG +P  +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 22/209 (10%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSC 625
           +G G Y  VYKG   T    VA+K + L  + G   + I E   ++ ++H N+V++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLH--- 64

Query: 626 SSIDTRGNEFK-ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
              D    E K  LV+E+M     +  L +  D    R  L+     S    +   + + 
Sbjct: 65  ---DVIHTENKLMLVFEYM-----DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
           H +    ++H DLKP N+L++      + DFGL+R      P  T ++ V  ++ Y AP+
Sbjct: 117 HEN---RVLHRDLKPQNLLINKRGELKLADFGLARAF--GIPVNTFSNEVV-TLWYRAPD 170

Query: 745 YGALGE--VSTHGDEYSFGILMLEMFTGK 771
              LG    ST  D +S G +M EM TG+
Sbjct: 171 V-LLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 69.2 bits (169), Expect = 1e-12
 Identities = 68/262 (25%), Positives = 115/262 (43%), Gaps = 43/262 (16%)

Query: 567 IGIGGYGYVYKG----ILGTEE-TNVAVKVLDLQQRGASKS----FIAECEALRSIRHRN 617
           +G G +G V K     + G    T VAVK+L   +  AS S     ++E   L+ + H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHPH 64

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL-----------------NQKEDEQN 660
           ++K+  +CS      +    L+ E+   GSL ++L                 N    +  
Sbjct: 65  VIKLYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 661 QRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR- 719
               L +   +S A  ++  ++YL       +VH DL   NVL+       + DFGLSR 
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176

Query: 720 LLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMF 778
           +  ++S  + S  R+   + ++A E       +T  D +SFG+L+ E+ T G  P   + 
Sbjct: 177 VYEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234

Query: 779 EEGL-SLHKYA-KMGLPDQVAE 798
            E L +L K   +M  P+  +E
Sbjct: 235 PERLFNLLKTGYRMERPENCSE 256

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 74/248 (29%), Positives = 109/248 (43%), Gaps = 36/248 (14%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKV--LDLQQRGASKSFIAECEALRSIRHRNL 618
           F     IG G YG VYK         VA+K   LD +  G   + I E   L+ + H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 619 VKIITSCSSIDTRGNEFKA-LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           VK++      D    E K  LV+EF+ +  L+ +++           L L++  S    +
Sbjct: 62  VKLL------DVIHTENKLYLVFEFL-HQDLKKFMDASPLSG---IPLPLIK--SYLFQL 109

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
              L + H H    ++H DLKP N+L++ E    + DFGL+R      P +T T  V  +
Sbjct: 110 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVV-T 163

Query: 738 IGYVAPEYGALGE--VSTHGDEYSFGILMLEM------FTGKRPTDDMFEEGLSLHKYAK 789
           + Y APE   LG    ST  D +S G +  EM      F G    D +F        +  
Sbjct: 164 LWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR------IFRT 216

Query: 790 MGLPDQVA 797
           +G PD+V 
Sbjct: 217 LGTPDEVV 224

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.0 bits (174), Expect = 2e-12
 Identities = 35/89 (39%), Positives = 48/89 (53%)

Query: 370 IQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFS 429
           I  L L    L G IP  ++    L+ +N S NS +G I     S+  L+ LDLS N+F+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 430 GKIPMFLNTFRFLQKLNLSFNNLEGEVPS 458
           G IP  L     L+ LNL+ N+L G VP+
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 24/217 (11%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS 626
           +G G +G VYK          A K++ ++     + F+ E + L   +H N+V +     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGL----- 67

Query: 627 SIDTRGNEFKALVY-EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
             +    E K  +  EF   G+L++ + + E     R  L   Q   +   +   L +LH
Sbjct: 68  -YEAYFYENKLWILIEFCDGGALDSIMLELE-----RG-LTEPQIRYVCRQMLEALNFLH 120

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY 745
            H    ++H DLK  N+LL  +    + DFG+S      S  Q   + + G+  ++APE 
Sbjct: 121 SH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKN--KSTLQKRDTFI-GTPYWMAPEV 174

Query: 746 GALGEVSTH-----GDEYSFGILMLEMFTGKRPTDDM 777
            A      +      D +S GI ++E+   + P  ++
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 21/209 (10%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGA-SKSFIAECEALRSIRHRNLVKIITSC 625
           +G G  G V K +       +AVK + L+   A  K  + E + L       +V    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLS-IAIDVANVLEYL 684
            +    G+    +  E+M  GSL+  L + +    +R        L  IA+ V   L YL
Sbjct: 69  YN---NGDISICM--EYMDGGSLDKILKEVQGRIPERI-------LGKIAVAVLKGLTYL 116

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
           H      I+H D+KPSN+L+++     + DFG+S  L  NS  +T      G+  Y+APE
Sbjct: 117 HEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTFV----GTSSYMAPE 169

Query: 745 YGALGEVSTHGDEYSFGILMLEMFTGKRP 773
                + S   D +S G+ ++E+ TG+ P
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 26/199 (13%)

Query: 585 TNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYE 641
           T VAVK+L  D  ++  S   I+E E ++ I +H+N++ ++ +C    T+      +V E
Sbjct: 51  TKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV-E 104

Query: 642 FMPNGSLENWLNQKED---EQNQRPKLNLMQRLSI------AIDVANVLEYLHHHCHTSI 692
           +   G+L  +L  +     E    P     ++LS       A  VA  +EYL        
Sbjct: 105 YASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKC 161

Query: 693 VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALGEV 751
           +H DL   NVL+  + V  + DFGL+R +H  +   +T+  R+   + ++APE      +
Sbjct: 162 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL--PVKWMAPE-ALFDRI 218

Query: 752 STH-GDEYSFGILMLEMFT 769
            TH  D +SFG+L+ E+FT
Sbjct: 219 YTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 23/209 (11%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVK--VLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
           IG G YG VYK         VA+K   L  +  G  K+ + E + L+ + H N++K++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL-- 64

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
              +     +   LV+EFM         +  +  ++++  L      S    +   L + 
Sbjct: 65  --DVFRHKGDL-YLVFEFMDT-------DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC 114

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
           H H    I+H DLKP N+L++ E V  + DFGL+R     SP +  T  V  +  Y APE
Sbjct: 115 HSH---GILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYV-VTRWYRAPE 168

Query: 745 --YGALGEVSTHGDEYSFGILMLEMFTGK 771
              G  G  ST  D +S G +  E+ + +
Sbjct: 169 LLLGDKG-YSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 70.2 bits (172), Expect = 3e-12
 Identities = 34/88 (38%), Positives = 52/88 (59%)

Query: 19  LDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNI 78
           L L    L G IP+++  L  L  + L+GN+  G+IP SL +++ L+ L LS NS +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 79  PSELGLLKQLNMFQVSANYLTGSIPIQL 106
           P  LG L  L +  ++ N L+G +P  L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 71/292 (24%), Positives = 135/292 (46%), Gaps = 34/292 (11%)

Query: 557 ATEGFSSANLIGIGGYGYVY----KGILGTE-ETNVAVKVLDLQQRGASK-SFIAECEAL 610
           A E  + +  +G G +G VY    KG++  E ET VA+K ++       +  F+ E   +
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 611 RSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL---NL 667
           +     ++V+++   S       +   ++ E M  G L+++L     E    P     +L
Sbjct: 64  KEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118

Query: 668 MQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD 727
            + + +A ++A+ + YL+ +     VH DL   N ++  +    +GDFG++R ++     
Sbjct: 119 KKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY----- 170

Query: 728 QTSTSRVKGS----IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGL 782
           +T   R  G     + +++PE    G  +T+ D +SFG+++ E+ T  ++P   M  E +
Sbjct: 171 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV 230

Query: 783 SLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSI 834
            L    + GL D+      P +L E +     +  +  P +R  F EI  SI
Sbjct: 231 -LRFVMEGGLLDKPDNC--PDMLFELMR----MCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 30/229 (13%)

Query: 567 IGIGGYGYVYKGIL--GTEETNVAVKVLDLQQRGASK---SFIAECEALRSIRHRNLVKI 621
           IG G +G V  G    G  +  V VK  +L+          F+ E +  R + H N+++ 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVK--ELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
           +  C            LV EF P G L+N+L        Q  + +++QR+  A +VA+ L
Sbjct: 61  LGQCIESIPY-----LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGL 113

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSP-DQTSTSRVKG-SIG 739
            +LH       +H DL   N  L  ++   +GD+GL+    +  P D   T       + 
Sbjct: 114 LWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA---LEQYPEDYYITKDCHAVPLR 167

Query: 740 YVAPEYGAL-------GEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEE 780
           ++APE   +        + +   + +S G+ M E+FT   +P  D+ +E
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE 216

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 3e-12
 Identities = 67/237 (28%), Positives = 99/237 (41%), Gaps = 29/237 (12%)

Query: 554 LLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFI-AECEALRS 612
           L   T  F    +IG G YG VYK         VA+K++D+      +  I  E   LR 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI--IEDEEEEIKEEYNILRK 58

Query: 613 I-RHRNLVKIITSCSSIDTRGNEFKA-LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQR 670
              H N+     +    +  GN+ +  LV E    GS+ + L +   ++ +R K   +  
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIA- 116

Query: 671 LSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG--DFGLSRLLHDNSPDQ 728
             I  +    L YLH +    ++H D+K  N+LL     A V   DFG+S  L       
Sbjct: 117 -YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKN--AEVKLVDFGVSAQL------D 164

Query: 729 TSTSRVKGSIG---YVAPEYGALGE-----VSTHGDEYSFGILMLEMFTGKRPTDDM 777
           ++  R    IG   ++APE  A  E          D +S GI  +E+  GK P  DM
Sbjct: 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 25/217 (11%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKV--LDLQQRGASKSFIAECEALRSIRHRNL 618
           F   N IG G YG VY+    T    VA+K   +D ++ G   S + E   L ++RH N+
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 619 VKI--ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAID 676
           V++  +     +D   + F  LV E+     L + L     +    P  +  Q   + + 
Sbjct: 69  VELKEVVVGKHLD---SIF--LVMEYCEQ-DLASLL-----DNMPTP-FSESQVKCLMLQ 116

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
           +   L+YLH +    I+H DLK SN+LL ++    + DFGL+R      P +  T +V  
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL--PAKPMTPKVV- 170

Query: 737 SIGYVAPE--YGALGEVSTHGDEYSFGILMLEMFTGK 771
           ++ Y APE   G     +T  D ++ G ++ E+   K
Sbjct: 171 TLWYRAPELLLGCT-TYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 67.7 bits (165), Expect = 4e-12
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIR---HRNLVKI 621
           IG+G YG VYK         VA+K + +Q  + G   S + E   L+ +    H N+V++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL------NLMQRLSIAI 675
           +  C++  T       LV+E + +  L  +L     ++   P L      +LM++     
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYL-----DKVPPPGLPAETIKDLMRQFLRG- 120

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
                L++LH +C   IVH DLKP N+L+ +     + DFGL+R+       Q + + V 
Sbjct: 121 -----LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVV 168

Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGK 771
            ++ Y APE       +T  D +S G +  EMF  K
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 68.1 bits (166), Expect = 4e-12
 Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 30/199 (15%)

Query: 587 VAVKVLDLQQRGASKSF---IAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           VAVK+L  +     K     I+E E ++ I +H+N++ ++  C    T+      +V E+
Sbjct: 47  VAVKML--KDNATDKDLADLISEMELMKLIGKHKNIINLLGVC----TQEGPLYVIV-EY 99

Query: 643 MPNGSLENWLNQKE----DEQNQRPK-----LNLMQRLSIAIDVANVLEYLH-HHCHTSI 692
              G+L  +L  +     D      K     L+    +S A  VA  +EYL    C    
Sbjct: 100 AAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC---- 155

Query: 693 VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALGEV 751
           +H DL   NVL+  + V  + DFGL+R +HD +   +TS  R+   + ++APE      V
Sbjct: 156 IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL--PVKWMAPE-ALFDRV 212

Query: 752 STH-GDEYSFGILMLEMFT 769
            TH  D +SFGILM E+FT
Sbjct: 213 YTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 63/225 (28%), Positives = 112/225 (49%), Gaps = 22/225 (9%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETN---VAVKVL--DLQQRGASKSFIAECEALRSIRH 615
           F+   ++G G +G V +  L +E+ +   VAVK+L  D+      + F+ E   ++   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 616 RNLVKIITSCSSIDTRGN-EFKALVYEFMPNGSLENWL--NQKEDEQNQRPKLNLMQRLS 672
            N++K+I        +G      ++  FM +G L  +L  ++  +E    P   L++ + 
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM- 119

Query: 673 IAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD---QT 729
             ID+A+ +EYL      + +H DL   N +L+  M   V DFGLS+ ++  S D   Q 
Sbjct: 120 --IDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIY--SGDYYRQG 172

Query: 730 STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
             S++   + ++A E  A    +TH D ++FG+ M E+ T G+ P
Sbjct: 173 CASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 67.6 bits (166), Expect = 4e-12
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 59/220 (26%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASK-----SFIAECEALRSIRHRN-- 617
             +G G Y  VYK         VA+K + L +R  +K     + + E + L+ ++H N  
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 618 -LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAID 676
            L+ +    S+I+        LV+EFM    LE  +  K                SI + 
Sbjct: 66  GLLDVFGHKSNIN--------LVFEFME-TDLEKVIKDK----------------SIVLT 100

Query: 677 VANV----------LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSP 726
            A++          LEYLH +    I+H DLKP+N+L+ ++ V  + DFGL+R     SP
Sbjct: 101 PADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSF--GSP 155

Query: 727 DQTSTSRVKGSIGYVAPE--YGALGEVSTHGDEYSFGILM 764
           ++  T +V  +  Y APE  +GA          Y  G+ M
Sbjct: 156 NRKMTHQVV-TRWYRAPELLFGA--------RHYGVGVDM 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 67.6 bits (166), Expect = 5e-12
 Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 46/226 (20%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVL-----DLQQRGASKSFIAECEALRSIRHRNLV 619
             IG G YG V   +       VA+K +     DL     +K  + E + LR +RH N++
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLID---AKRILREIKLLRHLRHENII 62

Query: 620 KIITSCSSIDTRGNEFKAL--VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
            ++           +F  +  V E M    L   +   +   +   +  L Q L      
Sbjct: 63  GLLDI--LRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILR----- 114

Query: 678 ANVLEYLHHHCHTS--IVHCDLKPSNVLLDNEMVAHVGDFGLSRLL-HDNSPDQTSTSRV 734
              L+YLH     S  ++H DLKPSN+L+++     + DFGL+R +  D       T   
Sbjct: 115 --GLKYLH-----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT--- 164

Query: 735 KGSIGYV------APEYGALGEVSTHG---DEYSFGILMLEMFTGK 771
                YV      APE   L   S +    D +S G +  E+ T K
Sbjct: 165 ----EYVVTRWYRAPE--LLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 69.1 bits (169), Expect = 6e-12
 Identities = 39/106 (36%), Positives = 58/106 (54%), Gaps = 1/106 (0%)

Query: 349 LDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPI 408
           L L    L G IP ++ +L+ +Q ++LS N + G IP SL S   LE L+ S NSF G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 409 HSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEG 454
                 L  L+ L+L+ N+ SG++P  L   R L + + +F +  G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGG-RLLHRASFNFTDNAG 527

Length = 623

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 67.4 bits (164), Expect = 7e-12
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 38/205 (18%)

Query: 585 TNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYE 641
             VAVK+L  D   +  S   ++E E ++ I +H+N++ ++ +C    T+      LV E
Sbjct: 45  VTVAVKMLKDDATDKDLS-DLVSEMEMMKMIGKHKNIINLLGAC----TQDGPLYVLV-E 98

Query: 642 FMPNGSLENWLNQKEDEQNQRP---------------KLNLMQRLSIAIDVANVLEYLHH 686
           +   G+L  +L  +      RP               +L     +S A  VA  +EYL  
Sbjct: 99  YASKGNLREYLRAR------RPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL-- 150

Query: 687 HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEY 745
                 +H DL   NVL+  + V  + DFGL+R +H+ +   +T+  R+   + ++APE 
Sbjct: 151 -ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL--PVKWMAPE- 206

Query: 746 GALGEVSTH-GDEYSFGILMLEMFT 769
                V TH  D +SFG+L+ E+FT
Sbjct: 207 ALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 67.0 bits (163), Expect = 7e-12
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 36/206 (17%)

Query: 583 EETNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALV 639
           E   VAVK+L  D  ++  S   ++E E ++ I +H+N++ ++ +C    T+      +V
Sbjct: 46  EAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV 100

Query: 640 YEFMPNGSLENWL--------------NQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
            E+   G+L  +L               +  DEQ     +     +S    VA  +EYL 
Sbjct: 101 -EYASKGNLREYLRARRPPGMEYSYDIARVPDEQ-----MTFKDLVSCTYQVARGMEYL- 153

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPE 744
                  +H DL   NVL+    V  + DFGL+R +++ +   +T+  R+   + ++APE
Sbjct: 154 --ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL--PVKWMAPE 209

Query: 745 YGALGEVSTH-GDEYSFGILMLEMFT 769
                 V TH  D +SFG+LM E+FT
Sbjct: 210 -ALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 55/223 (24%), Positives = 103/223 (46%), Gaps = 35/223 (15%)

Query: 565 NLIGIGGYGYVYKGILGTE--ETNVAVKVL-DLQQRGASKSFIAECEALRSI-RHRNLVK 620
           ++IG G +G V K  +  +    + A+K + +   +   + F  E E L  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE---------DEQNQRPKLNLMQRL 671
           ++ +C   + RG  + A+  E+ P+G+L ++L +              +    L+  Q L
Sbjct: 61  LLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115

Query: 672 SIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTST 731
             A DVA  ++YL        +H DL   N+L+    VA + DFGLSR            
Sbjct: 116 HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---------GQE 163

Query: 732 SRVKGSIGYVAPEYGALGEV-----STHGDEYSFGILMLEMFT 769
             VK ++G +   + A+  +     +T+ D +S+G+L+ E+ +
Sbjct: 164 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 66.7 bits (163), Expect = 8e-12
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 31/220 (14%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETN--VAVKVL--DLQQRGASKSFIAECEALRSIR 614
           E + +  L+G G YG V K     +ET   VA+K        +   K  + E   L+ +R
Sbjct: 1   EKYENLGLVGEGSYGMVMK--CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPK-LNLMQRLSI 673
           H NLV +I        R  +   LV+EF+ +  L        D+  + P  L+  +    
Sbjct: 59  HENLVNLIEVF-----RRKKRLYLVFEFVDHTVL--------DDLEKYPNGLDESRVRKY 105

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
              +   +E+ H H   +I+H D+KP N+L+    V  + DFG +R L   +P +  T  
Sbjct: 106 LFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYTDY 160

Query: 734 VKGSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTG 770
           V  +  Y APE   +G+   +G   D ++ G L+ EM TG
Sbjct: 161 V-ATRWYRAPEL-LVGDTK-YGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 67.3 bits (164), Expect = 1e-11
 Identities = 82/253 (32%), Positives = 126/253 (49%), Gaps = 15/253 (5%)

Query: 239 TIPTGVGNLKNLILIAM---EVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNL 295
           +   G  NL NL+ +      +N L  +I   +  L  L  L L  N I+ +IP  +G L
Sbjct: 81  SSLDGSENLLNLLPLPSLDLNLNRLRSNISELLE-LTNLTSLDLDNNNIT-DIPPLIGLL 138

Query: 296 -IFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRN 354
              L E+DL  N I  S+PS L N   L+ LDLS N+LS  +P+ +  LS+   LDLS N
Sbjct: 139 KSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGN 196

Query: 355 HLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSS 414
            +S  +P E+  L  +++LDLS N +  E+ +SL++   L  L  S+N  +        +
Sbjct: 197 KIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLP-ESIGN 253

Query: 415 LKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNN 474
           L  L+ LDLS N         L +   L++L+LS N+L   +P   +   +    ++ N 
Sbjct: 254 LSNLETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLL--ELLLNL 309

Query: 475 KLCGGSPELHLHS 487
            L   + EL L+S
Sbjct: 310 LLTLKALELKLNS 322

Length = 394

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 18/216 (8%)

Query: 560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASK--SFIAECEALRSIRHRN 617
            F     +G G YG VYK    ++    A+K +DL      +    + E   L S+ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           ++      + +D  GN+   +V E+ P G L   +++++ ++   P+  +     I I +
Sbjct: 61  IISY--KEAFLD--GNKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW---RIFIQL 112

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
              L+ LH      I+H DLK +N+LL    +  +GD G+S++L      +       G+
Sbjct: 113 LRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL-----KKNMAKTQIGT 164

Query: 738 IGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
             Y+APE       S   D +S G L+ EM T   P
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 25/222 (11%)

Query: 565 NLIGIGGYGYVYKGILGTE---ETNVAVKVL----DLQQRGASKSFIAECEALRSIRHRN 617
            +IG G +G VY G L      + + AVK L    DL++    + F+ E   ++   H N
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE---VEQFLKEGIIMKDFSHPN 57

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           ++ ++  C  + + G+    +V  +M +G L N++     E +     +L+      + V
Sbjct: 58  VLSLLGIC--LPSEGSPL--VVLPYMKHGDLRNFI---RSETHNPTVKDLI---GFGLQV 107

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR-VKG 736
           A  +EYL        VH DL   N +LD      V DFGL+R ++D            K 
Sbjct: 108 AKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164

Query: 737 SIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
            + ++A E     + +T  D +SFG+L+ E+ T G  P  D+
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 68.3 bits (167), Expect = 1e-11
 Identities = 65/238 (27%), Positives = 101/238 (42%), Gaps = 50/238 (21%)

Query: 587 VAVKVL------DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           VA+K+L      +  QR   +   A C  L    H N+V ++ S  +           V+
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLY---HPNIVALLDSGEA----PPGLLFAVF 58

Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAID----VANVLEYLHHHCHTSIVHCD 696
           E++P  +L   L                  L  A +    +  VL+ L    +  IVH D
Sbjct: 59  EYVPGRTLREVL------AADGA-------LP-AGETGRLMLQVLDALACAHNQGIVHRD 104

Query: 697 LKPSNVLL---DNEMVAHVGDFGLSRLL---HDNSPDQ-TSTSRVKGSIGYVAPEYGALG 749
           LKP N+++        A V DFG+  LL    D      T T+ V G+  Y APE    G
Sbjct: 105 LKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQ-LRG 163

Query: 750 E-VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK--YAKMGLPDQVAEIIDPAI 804
           E V+ + D Y++G++ LE  TG+R       +G S+ +  Y ++  P  V+  + P I
Sbjct: 164 EPVTPNSDLYAWGLIFLECLTGQRVV-----QGASVAEILYQQLS-PVDVS--LPPWI 213

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 76/241 (31%), Positives = 113/241 (46%), Gaps = 37/241 (15%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITS 624
           IG G YG VYK         +A+K + L+Q   G   + I E   L+ ++H N+V++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ-- 67

Query: 625 CSSIDTRGNEFKA-LVYEFMPNGSLENWLNQKED-EQNQR-PKLNLMQRLS-IAIDVANV 680
               D   +E +  LV+E++ +  L+  ++   D  +N R  K  L Q L  IA      
Sbjct: 68  ----DVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA------ 116

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVA-HVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
             Y H H    ++H DLKP N+L+D    A  + DFGL+R      P +T T  V  ++ 
Sbjct: 117 --YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVV-TLW 168

Query: 740 YVAPEYGALG--EVSTHGDEYSFGILMLEMFTGKR--PTDDMFEEGLSLHK-YAKMGLPD 794
           Y APE   LG    ST  D +S G +  EM   K   P D   +E   L K +  +G P+
Sbjct: 169 YRAPEI-LLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE---LFKIFRILGTPN 224

Query: 795 Q 795
           +
Sbjct: 225 E 225

Length = 294

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 64/230 (27%), Positives = 103/230 (44%), Gaps = 44/230 (19%)

Query: 567 IGIGGYGYVYKGI---LGTEET--NVAVKVLDLQQRGASKSFIAECEALRSI-------- 613
           +G G +G V +     L   +    VAVK+L         +  +E EAL S         
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK------PTAHSSEREALMSELKIMSHLG 96

Query: 614 RHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
            H N+V ++ +C    T G     ++ E+   G L N+L +K +       L L   LS 
Sbjct: 97  NHENIVNLLGAC----TIGGPI-LVITEYCCYGDLLNFLRRKRESF-----LTLEDLLSF 146

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR-LLHDNSPDQTSTS 732
           +  VA  + +L      + +H DL   NVLL +  +  + DFGL+R +++D      S  
Sbjct: 147 SYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND------SNY 197

Query: 733 RVKGS----IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
            VKG+    + ++APE       +   D +S+GIL+ E+F+ G  P   M
Sbjct: 198 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 20/218 (9%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNL 618
           F   N IG G +G V+K +   ++   A+K +DL +  R   +  I E   L  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP-KLNLMQRLSIAIDV 677
           ++   S   +D        +V E+  NG L   L      Q  RP   + + R  I I +
Sbjct: 62  IRYYESF--LD---KGKLNIVMEYAENGDLHKLLKM----QRGRPLPEDQVWRFFIQILL 112

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
              L +LH      I+H D+K  N+ LD      +GD G+++LL DN+      + + G+
Sbjct: 113 G--LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---NFANTIVGT 164

Query: 738 IGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTD 775
             Y++PE       +   D ++ G+++ E  TGK P D
Sbjct: 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 20/213 (9%)

Query: 567 IGIGGYGYVYKGI-LGTEETNVAVKVLDLQ--QRGASKSFIAECEALR---SIRHRNLVK 620
           IG G YG V+K   L      VA+K + +Q  + G   S I E   LR   +  H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
           +   C+   T       LV+E + +  L  +L++  +     P +       +   +   
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-----PGVPTETIKDMMFQLLRG 122

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           L++LH H    +VH DLKP N+L+ +     + DFGL+R+       Q + + V  ++ Y
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVVTLWY 175

Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
            APE       +T  D +S G +  EMF  ++P
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 65.1 bits (158), Expect = 3e-11
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 19/207 (9%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS 626
           IG G  G VY  +       VA++ ++LQQ+   +  I E   +R  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY- 86

Query: 627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH 686
                G+E   +V E++  GSL + + +   ++ Q          ++  +    LE+LH 
Sbjct: 87  ---LVGDEL-WVVMEYLAGGSLTDVVTETCMDEGQIA--------AVCRECLQALEFLHS 134

Query: 687 HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYG 746
           +    ++H D+K  N+LL  +    + DFG    +   +P+Q+  S + G+  ++APE  
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVV 188

Query: 747 ALGEVSTHGDEYSFGILMLEMFTGKRP 773
                    D +S GI+ +EM  G+ P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 3e-11
 Identities = 65/257 (25%), Positives = 100/257 (38%), Gaps = 70/257 (27%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETN---VAVKVL---DLQQRGASKSFIAECEALRS 612
           + F    +IG G +G V+   L  ++      A+KVL   D+ +R       AE + L  
Sbjct: 1   DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57

Query: 613 IRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQR 670
                +VK+    S  D    E   LV E+MP G L N L +K+   E+          R
Sbjct: 58  ADSPWIVKLY--YSFQD---EEHLYLVMEYMPGGDLMNLLIRKDVFPEE--------TAR 104

Query: 671 LSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRLLHDNSPDQ 728
             IA  V   L+ +H       +H D+KP N+L+D +   H+   DFGL + ++     +
Sbjct: 105 FYIAELVL-ALDSVHKLGF---IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDRE 158

Query: 729 TSTSRVK--------------------------GSIGYVAPE------YGALGEVSTHGD 756
              +                             G+  Y+APE      YG   E     D
Sbjct: 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG--LEC----D 212

Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+++ EM  G  P
Sbjct: 213 WWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 17/216 (7%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVK---VLDLQQRGASKSFIAECEALRSIRHRN 617
           F     IG G +  VY+     +   VA+K   + DL    A    I E + L+ + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           ++K   S        NE   +V E    G L   +   + ++   P+  + +     + +
Sbjct: 64  VIKYYASF----IEDNELN-IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF---VQL 115

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
            + LE++H      ++H D+KP+NV +    V  +GD GL R     S   T+   + G+
Sbjct: 116 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGT 169

Query: 738 IGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
             Y++PE       +   D +S G L+ EM   + P
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 65/245 (26%), Positives = 109/245 (44%), Gaps = 31/245 (12%)

Query: 554 LLKATEGFSSANLIGIGGYGYVYKGILGTEETN----VAVKVL-DLQQRGASKSFIAECE 608
           +LK TE      ++G G +G VYKGI   +  N    VA+KVL +     A+K  + E  
Sbjct: 3   ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61

Query: 609 ALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLM 668
            +  +    + +++  C +   +      LV + MP G L +++ + +D    +  LN  
Sbjct: 62  VMAGVGSPYVCRLLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDLLNW- 114

Query: 669 QRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQ 728
                 + +A  + YL       +VH DL   NVL+ +     + DFGL+RLL D    +
Sbjct: 115 -----CVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL-DIDETE 165

Query: 729 TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTD--------DMFE 779
                 K  I ++A E       +   D +S+G+ + E+ T G +P D        D+ E
Sbjct: 166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 225

Query: 780 EGLSL 784
           +G  L
Sbjct: 226 KGERL 230

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 37/232 (15%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIA---ECEALRSIR 614
           ++   ++G G YG VY G+    +  +AVK ++L       A K +     E + L+S++
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQL-IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
           H N+V+ + +C   +T      ++  EF+P GS+ + LN          +   +      
Sbjct: 61  HVNIVQYLGTCLDDNT-----ISIFMEFVPGGSISSILN----------RFGPLPEPVFC 105

Query: 675 IDVANVLE---YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTST 731
                +L+   YLH++C   +VH D+K +NV+L    +  + DFG +R L       T +
Sbjct: 106 KYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHS 162

Query: 732 SRVK---GSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRPTDDM 777
           + +K   G+  ++APE   + E S +G   D +S G  + EM TGK P   M
Sbjct: 163 NMLKSMHGTPYWMAPE--VINE-SGYGRKSDIWSIGCTVFEMATGKPPLASM 211

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 4e-11
 Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 33/216 (15%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVK---I 621
           IG G YG VYK         VA+K + L+    G   + I E   L+ + H N+V+   +
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP--KLNLMQRLSIAIDVAN 679
           + S + +         LV+EF+ +  L+ +++         P  K  L Q L        
Sbjct: 67  VHSENKL--------YLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ------- 110

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            + Y H H    ++H DLKP N+L+D E    + DFGL+R      P +T T  V  ++ 
Sbjct: 111 GIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVV-TLW 164

Query: 740 YVAPEYGALG--EVSTHGDEYSFGILMLEMFTGKRP 773
           Y APE   LG  + ST  D +S G +  EM   +RP
Sbjct: 165 YRAPEI-LLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 68/219 (31%), Positives = 102/219 (46%), Gaps = 38/219 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITS 624
           IG G YG VYKG        VA+K + L+  + G   + I E   L+ ++H N+V +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ-- 65

Query: 625 CSSIDTRGNEFKA-LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
               D    E +  L++EF+ +  L+ +L+     Q    +L              V  Y
Sbjct: 66  ----DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAEL--------------VKSY 106

Query: 684 LHH------HCHT-SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
           L+        CH+  ++H DLKP N+L+DN+ V  + DFGL+R      P +  T  V  
Sbjct: 107 LYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVV- 163

Query: 737 SIGYVAPEYGALGEV--STHGDEYSFGILMLEMFTGKRP 773
           ++ Y APE   LG    ST  D +S G +  EM T K+P
Sbjct: 164 TLWYRAPEV-LLGSPRYSTPVDIWSIGTIFAEMAT-KKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 31/218 (14%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
            +G G YG VYK I       VA+KV+ ++     +  I E   L+      +VK     
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVKYY--- 64

Query: 626 SSIDTRGNEFKA----LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
                 G+ FK     +V E+   GS+ + +            L   +  +I       L
Sbjct: 65  ------GSYFKNTDLWIVMEYCGAGSVSDIMKITNK------TLTEEEIAAILYQTLKGL 112

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           EYLH +     +H D+K  N+LL+ E  A + DFG+S  L D    + +   V G+  ++
Sbjct: 113 EYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIGTPFWM 166

Query: 742 APEYGALGEV--STHGDEYSFGILMLEMFTGKRPTDDM 777
           APE   + E+  +   D +S GI  +EM  GK P  D+
Sbjct: 167 APE--VIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.0 bits (161), Expect = 5e-11
 Identities = 35/90 (38%), Positives = 48/90 (53%)

Query: 42  GLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGS 101
           GLGL      G IP  +S L  LQ ++LS NS+ GNIP  LG +  L +  +S N   GS
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 102 IPIQLFNISSMDYFAVTQNKLVGEIPHYVG 131
           IP  L  ++S+    +  N L G +P  +G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.0 bits (161), Expect = 5e-11
 Identities = 34/80 (42%), Positives = 49/80 (61%)

Query: 238 GTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIF 297
           G IP  +  L++L  I +  N + G+IP S+G +  L+VL L  N  +G IP SLG L  
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 298 LTEVDLQGNSIRGSIPSALG 317
           L  ++L GNS+ G +P+ALG
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 51/187 (27%), Positives = 92/187 (49%), Gaps = 19/187 (10%)

Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK++DL+++   +    E   +R  +H+N+V++  S       G E   L+ EF+  G
Sbjct: 49  VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY----LVGEELWVLM-EFLQGG 103

Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L + ++Q         +LN  Q  ++   V   L YLH      ++H D+K  ++LL  
Sbjct: 104 ALTDIVSQT--------RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTL 152

Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           +    + DFG    +  + P + S   + G+  ++APE  +     T  D +S GI+++E
Sbjct: 153 DGRVKLSDFGFCAQISKDVPKRKS---LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209

Query: 767 MFTGKRP 773
           M  G+ P
Sbjct: 210 MVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 55/223 (24%), Positives = 102/223 (45%), Gaps = 25/223 (11%)

Query: 567 IGIGGYGYVYKGIL---GTEETN-VAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKI 621
           +G   +G +YKG L   G +    VA+K L D+        F  E   +  + H N+V +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQK----------EDEQNQRPKLNLMQRL 671
           +   +       +   +++E++  G L  +L  +          +++   +  L+    L
Sbjct: 73  LGVVTQ-----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 672 SIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTST 731
            IAI +A  +EYL  H     VH DL   N+L+  ++   + D GLSR ++     +   
Sbjct: 128 HIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 732 SRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
             +   I ++ PE    G+ S+  D +SFG+++ E+F+ G +P
Sbjct: 185 KSLL-PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 26/273 (9%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNL 618
           E   S   IG G  G V           VAVK +DL+++   +    E   +R   H N+
Sbjct: 22  EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV 81

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
           V +  S       G+E   +V EF+  G+L + +           ++N  Q  ++ + V 
Sbjct: 82  VDMYNSY----LVGDEL-WVVMEFLEGGALTDIVTHT--------RMNEEQIATVCLSVL 128

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSI 738
             L YLH+     ++H D+K  ++LL ++    + DFG    +    P + S   + G+ 
Sbjct: 129 RALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS---LVGTP 182

Query: 739 GYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE 798
            ++APE  +     T  D +S GI+++EM  G+ P  +  E  L   +  +  LP +V +
Sbjct: 183 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN--EPPLQAMRRIRDNLPPRVKD 240

Query: 799 IID-PAILEEALEIQAGIVKELQPNLRAKFHEI 830
                ++L   L++   +V+E  P+ RA   E+
Sbjct: 241 SHKVSSVLRGFLDLM--LVRE--PSQRATAQEL 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 64.4 bits (157), Expect = 6e-11
 Identities = 69/240 (28%), Positives = 118/240 (49%), Gaps = 36/240 (15%)

Query: 566 LIGIGGYGYVY--KGILGTEETNV-AVKVLD---LQQRGASKSFIAECEALRSIRHRNLV 619
           ++G G +G V+  + I G +   + A+KVL    L+ R   ++ + E + L  + H  +V
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
           K+     +  T G  +  L+ +F+  G L   L+++     +  K  L + L++A+D   
Sbjct: 62  KL---HYAFQTEGKLY--LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-LALALD--- 112

Query: 680 VLEYLHHHCHT-SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSI 738
                  H H+  I++ DLKP N+LLD E    + DFGLS+   D+   +       G++
Sbjct: 113 -------HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH---EKKAYSFCGTV 162

Query: 739 GYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFE-----EGLSLHKYAKMGLP 793
            Y+APE       +   D +SFG+LM EM TG  P    F+     E +++   AK+G+P
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP----FQGKDRKETMTMILKAKLGMP 218

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.0 bits (155), Expect = 7e-11
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 19/207 (9%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS 626
           IG G  G VY  I       VA+K ++LQQ+   +  I E   +R  ++ N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY- 85

Query: 627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH 686
                G+E   +V E++  GSL + + +   ++ Q          ++  +    L++LH 
Sbjct: 86  ---LVGDEL-WVVMEYLAGGSLTDVVTETCMDEGQIA--------AVCRECLQALDFLHS 133

Query: 687 HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYG 746
           +    ++H D+K  N+LL  +    + DFG    +   +P+Q+  S + G+  ++APE  
Sbjct: 134 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVV 187

Query: 747 ALGEVSTHGDEYSFGILMLEMFTGKRP 773
                    D +S GI+ +EM  G+ P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 63.6 bits (155), Expect = 8e-11
 Identities = 73/283 (25%), Positives = 115/283 (40%), Gaps = 50/283 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS-KSFIAECEALRSIRHRNLVKIITSC 625
           +G G YG V K       T +AVK +         K  + + +   S+R  +    +T  
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDI--SMRSVDCPYTVTFY 66

Query: 626 SSIDTRGNEFKALVYEFMP--NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
            ++   G+     V+  M   + SL+ +  +  D+    P+  L +   IA+ +   LEY
Sbjct: 67  GALFREGD-----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK---IAVSIVKALEY 118

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK----GSIG 739
           LH     S++H D+KPSNVL++      + DFG+S  L D        S  K    G   
Sbjct: 119 LHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--------SVAKTIDAGCKP 168

Query: 740 YVAPEY----GALGEVSTHGDEYSFGILMLEMFTGKRPTD---DMFEEGLSLHKYAKMGL 792
           Y+APE               D +S GI M+E+ TG+ P D     F++            
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ------------ 216

Query: 793 PDQVAEIIDPAILEE--ALEIQAGIVKELQ--PNLRAKFHEIQ 831
             QV E   P +  E  + E Q  + K L+     R  + E+ 
Sbjct: 217 LKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELL 259

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 63.1 bits (153), Expect = 9e-11
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 32/226 (14%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNL 618
           E F+    IG G +G V+KGI    +  VA+K++DL++        AE E +  I+    
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AEDE-IEDIQQE-- 52

Query: 619 VKIITSCSS---IDTRGNEFKA----LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRL 671
           + +++ C S       G+  K     ++ E++  GS  + L     ++         Q  
Sbjct: 53  ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDE--------FQIA 104

Query: 672 SIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTST 731
           ++  ++   L+YLH       +H D+K +NVLL  +    + DFG++  L D    Q   
Sbjct: 105 TMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKR 158

Query: 732 SRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
           +   G+  ++APE        +  D +S GI  +E+  G+ P  DM
Sbjct: 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 59/223 (26%), Positives = 90/223 (40%), Gaps = 45/223 (20%)

Query: 566 LIGIGGYGYVYKGILGTEETN--VAVK-VLDLQQRGASKSFIA-ECEALRSIRHRNLVKI 621
           ++G G YG V K     + T   VA+K   + +     K     E + LR +RH N+V +
Sbjct: 8   VVGEGAYGVVLK--CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL 65

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP----KLNLMQRLSIAIDV 677
             +      +G  +  LV+E++        L   E      P    +  + Q L      
Sbjct: 66  KEAFRR---KGRLY--LVFEYVER----TLLELLEASPGGLPPDAVRSYIWQLL------ 110

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
              + Y H H   +I+H D+KP N+L+    V  + DFG +R L    P    T  V  +
Sbjct: 111 -QAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR-PASPLTDYV-AT 164

Query: 738 IGYVAPE-------YGALGEVSTHGDEYSFGILMLEMFTGKRP 773
             Y APE       YG    V    D ++ G +M E+  G  P
Sbjct: 165 RWYRAPELLVGDTNYGK--PV----DVWAIGCIMAELLDG-EP 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 31/226 (13%)

Query: 558 TEGFSSANLIGIGGYGYVYKGILGTEETNVA---VKVLDLQQRGASKSFIAECEALRSIR 614
              F     IG G +  VYK I   +   VA   V++ ++    A +  + E + L+ + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
           H N++K + S   I+   NE   +V E    G L   +   + ++   P+  + +     
Sbjct: 61  HPNVIKYLASF--IEN--NELN-IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF--- 112

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
           + + + LE++H      I+H D+KP+NV +    V  +GD GL R     S   T+   +
Sbjct: 113 VQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSL 166

Query: 735 KGSIGYVAPEYGALGEVSTHGDEYSF-------GILMLEMFTGKRP 773
            G+  Y++PE         H + Y+F       G L+ EM   + P
Sbjct: 167 VGTPYYMSPE-------RIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 29/221 (13%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRN 617
           E +   + +G G Y  V+KG     E  VA+K + L+ + GA  + I E   L++++H N
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN 64

Query: 618 LVK---IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
           +V    II +   +         LV+E+     L++ L Q  D        NLM   ++ 
Sbjct: 65  IVTLHDIIHTERCL--------TLVFEY-----LDSDLKQYLDNCG-----NLMSMHNVK 106

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
           I +  +L  L +     I+H DLKP N+L++ +    + DFGL+R    + P +T ++ V
Sbjct: 107 IFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEV 164

Query: 735 KGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFTGKRP 773
             ++ Y  P+   LG  E ST  D +  G ++ EM TG RP
Sbjct: 165 V-TLWYRPPDV-LLGSTEYSTPIDMWGVGCILYEMATG-RP 202

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 63.2 bits (153), Expect = 1e-10
 Identities = 71/264 (26%), Positives = 123/264 (46%), Gaps = 35/264 (13%)

Query: 567 IGIGGYGYVYKGI---LGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIIT 623
           IG G  G V+  I    G E   VA+K ++LQ++   +  I E   ++ +++ N+V  + 
Sbjct: 27  IGQGASGTVFTAIDVATGQE---VAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLD 83

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
           S       G+E   +V E++  GSL + + +          ++  Q  ++  +    LE+
Sbjct: 84  SF----LVGDEL-FVVMEYLAGGSLTDVVTET--------CMDEAQIAAVCRECLQALEF 130

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
           LH +    ++H D+K  NVLL  +    + DFG    +   +P+Q+  S + G+  ++AP
Sbjct: 131 LHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAP 184

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL-SLHKYAKMGLPD-QVAEIID 801
           E           D +S GI+ +EM  G+ P   + E  L +L+  A  G P+ Q  E + 
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY--LNENPLRALYLIATNGTPELQNPEKLS 242

Query: 802 PA---ILEEALEI---QAGIVKEL 819
           P     L   LE+   + G  KEL
Sbjct: 243 PIFRDFLNRCLEMDVEKRGSAKEL 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 62.6 bits (153), Expect = 2e-10
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 34/215 (15%)

Query: 567 IGIGGYGYVYKGI-LGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
           IG G  G VYK     T +  VA+K + L+++   +  I E   ++  +H N+V      
Sbjct: 27  IGEGASGEVYKATDRATGKE-VAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYY--- 81

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
            S       +  +V E+M  GSL + + Q         ++N  Q   +  +V   LEYLH
Sbjct: 82  DSYLVGDELW--VVMEYMDGGSLTDIITQNF------VRMNEPQIAYVCREVLQGLEYLH 133

Query: 686 -HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
             +     +H D+K  N+LL  +    + DFG +  L          S V G+  ++APE
Sbjct: 134 SQNV----IHRDIKSDNILLSKDGSVKLADFGFAAQL--TKEKSKRNSVV-GTPYWMAPE 186

Query: 745 ------YGALGEVSTHGDEYSFGILMLEMFTGKRP 773
                 YG   +V    D +S GI+ +EM  G+ P
Sbjct: 187 VIKRKDYGP--KV----DIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 3e-10
 Identities = 30/82 (36%), Positives = 42/82 (51%)

Query: 325 LDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEI 384
           L L +  L G IP ++  L     ++LS N + G IP  +G +  ++ LDLS N  +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 385 PTSLASCVGLEYLNFSDNSFQG 406
           P SL     L  LN + NS  G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSG 504

Length = 623

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 61.9 bits (151), Expect = 3e-10
 Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 40/227 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVK-VLDLQQR-GASKSFIAECEALRSIRHRNLVKIITS 624
           +G G +G VYK         VA+K +L   ++ G   + + E + L+ ++H N+V +I  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 625 CSSIDTRGNEFKALVYEFMP------NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
                 +    +  VY   P      +G LEN             KL   Q     + + 
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN----------PSVKLTESQIKCYMLQLL 125

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSI 738
             + YLH +    I+H D+K +N+L+DN+ +  + DFGL+R      P      +  G  
Sbjct: 126 EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPP----NPKGGGGG 178

Query: 739 G------------YVAPEYGALGE--VSTHGDEYSFGILMLEMFTGK 771
           G            Y  PE   LGE   +T  D +  G +  EMFT +
Sbjct: 179 GTRKYTNLVVTRWYRPPEL-LLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 27/223 (12%)

Query: 561 FSSANLIGIGGYGYVY--KGILGTEETNV-AVKVLD----LQQRGASKSFIAECEALRSI 613
           F    ++G G YG V+  + + G +   + A+KVL     +Q+   ++    E + L  I
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 614 RHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
           R    +  +      DT+ +    L+ +++  G L   L+Q+E     R K   +Q  S 
Sbjct: 62  RQSPFLVTLHYAFQTDTKLH----LILDYINGGELFTHLSQRE-----RFKEQEVQIYSG 112

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
            I +A  LE+LH      I++ D+K  N+LLD+     + DFGLS+  H++  ++  +  
Sbjct: 113 EIVLA--LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-- 165

Query: 734 VKGSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP 773
             G+I Y+AP+    G+   H    D +S G+LM E+ TG  P
Sbjct: 166 FCGTIEYMAPDIVRGGD-GGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 61.4 bits (150), Expect = 3e-10
 Identities = 63/226 (27%), Positives = 94/226 (41%), Gaps = 57/226 (25%)

Query: 567 IGIGGYGYVYKGILGTEETN--VAVKVLDLQQRGASKSFIAECEALR---SIR----HRN 617
           +G G +G VY      +ET   VA+K +  +++  S     EC  LR   S+R    H N
Sbjct: 7   LGDGTFGSVYLAR--NKETGELVAIKKM--KKKFYSWE---ECMNLREVKSLRKLNEHPN 59

Query: 618 LVKI---ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
           +VK+            R N+    V+E+M     E  L Q   ++  +P  +     SI 
Sbjct: 60  IVKLKEVF--------RENDELYFVFEYM-----EGNLYQLMKDRKGKP-FSESVIRSII 105

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSP--DQTSTS 732
             +   L ++H H      H DLKP N+L+    V  + DFGL+R +    P  D  ST 
Sbjct: 106 YQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST- 161

Query: 733 RVKGSIGYVAPEYGALGEVSTHGDEYS-------FGILMLEMFTGK 771
           R      Y AP      E+      YS        G +M E++T +
Sbjct: 162 R-----WYRAP------EILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 50/263 (19%)

Query: 561 FSSANL-----IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS-KSFIAECEALRSIR 614
           F++ +L     IG G +G V K +     T +AVK +         K  + + + +  +R
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MR 58

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
             +   I+    ++   G+ +  +  E M + SL+ +     +         ++ +  IA
Sbjct: 59  SSDCPYIVKFYGALFREGDCW--ICMELM-DISLDKFYKYVYEVLKSVIPEEILGK--IA 113

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
           +     L YL       I+H D+KPSN+LLD      + DFG+S  L D S  +T   R 
Sbjct: 114 VATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD-SIAKT---RD 167

Query: 735 KGSIGYVAPE---------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLH 785
            G   Y+APE         Y    +V      +S GI + E+ TGK P            
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDV------WSLGITLYEVATGKFP------------ 209

Query: 786 KYAK-MGLPDQVAEII--DPAIL 805
            Y K   + DQ+ +++  DP IL
Sbjct: 210 -YPKWNSVFDQLTQVVKGDPPIL 231

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 61.6 bits (149), Expect = 4e-10
 Identities = 71/300 (23%), Positives = 131/300 (43%), Gaps = 59/300 (19%)

Query: 565 NLIGIGGYGYVYKGILGTE--ETNVAVKVL-DLQQRGASKSFIAECEAL-RSIRHRNLVK 620
           ++IG G +G V K  +  +    + A+K + +   +   + F  E E L +   H N++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE---------DEQNQRPKLNLMQRL 671
           ++ +C   + RG  +  L  E+ P+G+L ++L +              +    L+  Q L
Sbjct: 73  LLGAC---EHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127

Query: 672 SIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTST 731
             A DVA  ++YL        +H DL   N+L+    VA + DFGLSR            
Sbjct: 128 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---------GQE 175

Query: 732 SRVKGSIGYVAPEYGALGEV-----STHGDEYSFGILMLEMFT-GKRP-----TDDMFEE 780
             VK ++G +   + A+  +     +T+ D +S+G+L+ E+ + G  P       +++E+
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235

Query: 781 ---GLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRV 837
              G  L K   +   D+V +++     E+  E             R  F +I VS+ R+
Sbjct: 236 LPQGYRLEK--PLNCDDEVYDLMRQCWREKPYE-------------RPSFAQILVSLNRM 280

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (148), Expect = 7e-10
 Identities = 72/223 (32%), Positives = 104/223 (46%), Gaps = 43/223 (19%)

Query: 567 IGIGGYGYVYKGILGTEETN--VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
           IG G +G VY+  +  ++T    A+KVL      + K  +A+ E   +I  RN    I  
Sbjct: 1   IGKGTFGQVYQ--VRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERN----ILV 48

Query: 625 CSSIDTR----GNEFK-------ALVYEFMPNGSLENWLNQKEDE-QNQRPKLNLMQRLS 672
            + +D      G +F         LV ++M  G L  W  QKE      R K  + + L 
Sbjct: 49  RTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGEL-FWHLQKEGRFSEDRAKFYIAE-LV 106

Query: 673 IAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS 732
           +A      LE+LH +    IV+ DLKP N+LLD      + DFGLS+    N  D  +T+
Sbjct: 107 LA------LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTN 154

Query: 733 RVKGSIGYVAPEYGALGE--VSTHGDEYSFGILMLEMFTGKRP 773
              G+  Y+APE   L E   + H D +S G+L+ EM  G  P
Sbjct: 155 TFCGTTEYLAPEV-LLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 32/224 (14%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVK 620
           F+    IG G +G VYKGI    +  VA+K++DL++        AE E +  I+    + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54

Query: 621 IITSCSS-IDTR--GNEFKA----LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
           +++ C S   TR  G+  K     ++ E++  GS  + L     E+            +I
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA--------TI 106

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
             ++   L+YLH       +H D+K +NVLL  +    + DFG++  L D    Q   + 
Sbjct: 107 LREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKRNT 160

Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
             G+  ++APE           D +S GI  +E+  G+ P  D+
Sbjct: 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 61.3 bits (149), Expect = 7e-10
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 23/216 (10%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS 626
           +G G  G V+  +    +  VAVK + L    + K  + E + +R + H N+VK+     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 627 SIDTRGN-------EFKAL--VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
              +          E  ++  V E+M    L N L Q      +  +L + Q L      
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGP-LSEEHARLFMYQLL------ 124

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNE-MVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
              L+Y+H     +++H DLKP+NV ++ E +V  +GDFGL+R++  +   +   S    
Sbjct: 125 -RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180

Query: 737 SIGYVAPEYGALGEVSTHG-DEYSFGILMLEMFTGK 771
           +  Y +P         T   D ++ G +  EM TGK
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 60.3 bits (147), Expect = 7e-10
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 34/216 (15%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIIT 623
           +G+GG+G V    + ++    A+K +    + + G  +   +E E L    H  +VK+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQ-RLSIAIDVANVLE 682
           +      +  ++  ++ E+   G L   L         R   +    R  IA  V    E
Sbjct: 61  T-----FKDKKYIYMLMEYCLGGELWTILRD-------RGLFDEYTARFYIAC-VVLAFE 107

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           YLH+     I++ DLKP N+LLD+     + DFG ++ L      +T T    G+  YVA
Sbjct: 108 YLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT--FCGTPEYVA 160

Query: 743 PEYGALGEVSTHG-----DEYSFGILMLEMFTGKRP 773
           PE      +   G     D +S GIL+ E+ TG+ P
Sbjct: 161 PEI-----ILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 60.3 bits (147), Expect = 9e-10
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 25/219 (11%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVL--DLQQRGASKSFIAECEALRSIRHR 616
           + +   N I  G YG VY+         VA+K L  + ++ G   + + E   L  ++H 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64

Query: 617 NLVKI--ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
           N+V +  +   S++D     +  +V E++ +  L++ +   +    Q     LM +L   
Sbjct: 65  NIVTVKEVVVGSNLD---KIY--MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSG 118

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
           +       +LH +    I+H DLK SN+LL+N  +  + DFGL+R     SP +  T  V
Sbjct: 119 VA------HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY--GSPLKPYTQLV 167

Query: 735 KGSIGYVAPEYGALGE--VSTHGDEYSFGILMLEMFTGK 771
             ++ Y APE   LG    ST  D +S G +  E+ T K
Sbjct: 168 V-TLWYRAPEL-LLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 60.4 bits (147), Expect = 1e-09
 Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 29/227 (12%)

Query: 582 TEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
                VAVKVL       A + F+ E + L  +   N+ +++  C       +    ++ 
Sbjct: 44  DAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVC-----TVDPPLCMIM 98

Query: 641 EFMPNGSLENWLNQKEDEQN----QRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           E+M NG L  +L +   E +        L+    L +A  +A+ + YL      + VH D
Sbjct: 99  EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155

Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVS 752
           L   N L+       + DFG+SR L+ +        RV+G     I ++A E   LG+ +
Sbjct: 156 LATRNCLVGKNYTIKIADFGMSRNLYSS-----DYYRVQGRAPLPIRWMAWESVLLGKFT 210

Query: 753 THGDEYSFGILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLP 793
           T  D ++FG+ + E+ T  +       TD    E    H +   G  
Sbjct: 211 TKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAG-HFFRDDGRQ 256

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 24/213 (11%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIA-ECEALRSIRHRNLVKIIT- 623
           LIG G YG VY+G        VA+K+++L       S I  E   L  +R      I   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 624 -SCSSIDTRGNEFKALVYEFMPNGSLENWLN-QKEDEQNQRPKLNLMQRLSIAIDVANVL 681
                   R      ++ E+   GS+   +      E      ++++ R     +V   L
Sbjct: 68  YGSYLKGPR----LWIIMEYAEGGSVRTLMKAGPIAE----KYISVIIR-----EVLVAL 114

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           +Y+H      ++H D+K +N+L+ N     + DFG++ LL+ NS  +++     G+  ++
Sbjct: 115 KYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST---FVGTPYWM 168

Query: 742 APEYGALG-EVSTHGDEYSFGILMLEMFTGKRP 773
           APE    G    T  D +S GI + EM TG  P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 19/207 (9%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS 626
           IG G  G V    + +    VAVK +DL+++   +    E   +R  +H N+V++  S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY- 86

Query: 627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH 686
                G+E   +V EF+  G+L + +           ++N  Q  ++ + V   L  LH 
Sbjct: 87  ---LVGDEL-WVVMEFLEGGALTDIVTHT--------RMNEEQIAAVCLAVLKALSVLHA 134

Query: 687 HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYG 746
                ++H D+K  ++LL ++    + DFG    +    P + S   + G+  ++APE  
Sbjct: 135 Q---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS---LVGTPYWMAPELI 188

Query: 747 ALGEVSTHGDEYSFGILMLEMFTGKRP 773
           +        D +S GI+++EM  G+ P
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 53/210 (25%), Positives = 83/210 (39%), Gaps = 20/210 (9%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIIT 623
           +G GG+G V    +       A K LD   L++R   +  + E + L  +  R +V +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
           +  + D        LV   M  G L+  +    +      +      +  A  +   LE+
Sbjct: 61  AFETKDDL-----CLVMTLMNGGDLKYHIYNVGEPGFPEARA-----IFYAAQIICGLEH 110

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
           LH      IV+ DLKP NVLLD+     + D GL+  L              G+ GY+AP
Sbjct: 111 LHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVEL----KGGKKIKGRAGTPGYMAP 163

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           E           D ++ G  + EM  G+ P
Sbjct: 164 EVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 49/210 (23%), Positives = 93/210 (44%), Gaps = 17/210 (8%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVK---VLDLQQRGASKSFIAECEALRSIRHRNLVKIIT 623
           IG G +  VY+     +   VA+K   + ++    A +  + E + L+ + H N++K + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
           S        NE   +V E    G L   +   + ++   P+  + +     + + + +E+
Sbjct: 70  SF----IEDNELN-IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYF---VQLCSAVEH 121

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
           +H      ++H D+KP+NV +    V  +GD GL R     S   T+   + G+  Y++P
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYMSP 175

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           E       +   D +S G L+ EM   + P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 51/189 (26%), Positives = 91/189 (48%), Gaps = 23/189 (12%)

Query: 587 VAVKVLDL--QQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK +DL  QQR   +    E   +R  +H N+V++ +S       G+E   +V EF+ 
Sbjct: 47  VAVKKMDLRKQQR--RELLFNEVVIMRDYQHPNIVEMYSS----YLVGDEL-WVVMEFLE 99

Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            G+L + +           ++N  Q  ++ + V   L +LH      ++H D+K  ++LL
Sbjct: 100 GGALTDIVTHT--------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILL 148

Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
            ++    + DFG    +    P + S   + G+  ++APE  +     T  D +S GI++
Sbjct: 149 TSDGRVKLSDFGFCAQVSKEVPRRKS---LVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 205

Query: 765 LEMFTGKRP 773
           +EM  G+ P
Sbjct: 206 IEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 32/226 (14%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNL 618
           E F+    IG G +G V+KGI    +  VA+K++DL++        AE E +  I+    
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AEDE-IEDIQQE-- 52

Query: 619 VKIITSCSS---IDTRGNEFKA----LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRL 671
           + +++ C S       G+  K     ++ E++  GS  + L        +   L+  Q  
Sbjct: 53  ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--------EPGPLDETQIA 104

Query: 672 SIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTST 731
           +I  ++   L+YLH       +H D+K +NVLL       + DFG++  L D    Q   
Sbjct: 105 TILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKR 158

Query: 732 SRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
           +   G+  ++APE        +  D +S GI  +E+  G+ P  ++
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 60.1 bits (146), Expect = 2e-09
 Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 11/111 (9%)

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A ++   L++LH      I++ DLK  NVLLD+E    + DFG+ +   +      +TS 
Sbjct: 102 AAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTST 155

Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP-----TDDMFE 779
             G+  Y+APE  +        D ++ G+L+ EM  G+ P      D++F+
Sbjct: 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 33/216 (15%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSC 625
           +G G Y  VYKG        VA+K + L+   GA  + I E   L+ ++H N   I+T  
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHAN---IVTLH 69

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQN-----QRPKLNLMQRLSIAIDVANV 680
             I T+  +   LV+E++     +  L Q  D+          +L L Q L         
Sbjct: 70  DIIHTK--KTLTLVFEYL-----DTDLKQYMDDCGGGLSMHNVRLFLFQLL-------RG 115

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           L Y H      ++H DLKP N+L+       + DFGL+R    + P +T ++ V  ++ Y
Sbjct: 116 LAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARA--KSVPSKTYSNEVV-TLWY 169

Query: 741 VAPEYGALG--EVSTHGDEYSFGILMLEMFTGKRPT 774
             P+   LG  E ST  D +  G +  EM TG RP 
Sbjct: 170 RPPDV-LLGSTEYSTSLDMWGVGCIFYEMATG-RPL 203

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 64/268 (23%), Positives = 106/268 (39%), Gaps = 48/268 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHR-----NLVKI 621
           I  G +G VY     +     A+KVL  +    +K+ +   +A R+I         + K+
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLK-KSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVAN 679
             S  S D     +  LV E++  G   + +       E   +             +V  
Sbjct: 63  YYSFQSKD-----YLYLVMEYLNGGDCASLIKTLGGLPEDWAK---------QYIAEVVL 108

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            +E LH      I+H D+KP N+L+D      + DFGLSR   +N        +  G+  
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPD 158

Query: 740 YVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP-----TDDMFEEGLSLHKYAKMGLPD 794
           Y+APE           D +S G ++ E   G  P      D +F+  LS     ++  P+
Sbjct: 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS----RRINWPE 214

Query: 795 QVAEIIDPAILEEALEIQAGIVKELQPN 822
           +V E   P    EA+++   I + L  +
Sbjct: 215 EVKEFCSP----EAVDL---INRLLCMD 235

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 6/93 (6%)

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           LE+LH      I++ DLKP NVLLDN+    + D GL+  L D    Q+ T    G+ G+
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG---QSKTKGYAGTPGF 163

Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           +APE     E     D ++ G+ + EM   + P
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.6 bits (145), Expect = 2e-09
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 33/219 (15%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVK-------VLDLQQRGASKSFIAECEALRSIRHRNLV 619
           IG G YG V   I       VA+K       V  L +R      + E + LR  +H N++
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT-----LRELKILRHFKHDNII 67

Query: 620 KIITSCSSIDTRGNEFKA--LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
            I      +   G +FK   +V + M +  L + ++  +    +  +  L Q L      
Sbjct: 68  AIRDI---LRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLL------ 117

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTS--TSRVK 735
              L+Y+H      ++H DLKPSN+L++ +    +GDFG++R L  +  +     T  V 
Sbjct: 118 -RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV- 172

Query: 736 GSIGYVAPEYG-ALGEVSTHGDEYSFGILMLEMFTGKRP 773
            +  Y APE   +L E +T  D +S G +  EM  G+R 
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 3e-09
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 34/225 (15%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIA-ECEALRSIRHRNLV 619
           F+    IG G +G VYK I       VA+KV+DL++       I  E + L   R   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLN-QKEDEQNQRPKLNLMQRLSIAI--- 675
           K   S      +G++   ++ E+   GS  + L   K DE              IA    
Sbjct: 63  KYYGSF----LKGSKL-WIIMEYCGGGSCLDLLKPGKLDET------------YIAFILR 105

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           +V   LEYLH       +H D+K +N+LL  E    + DFG+S  L          S+  
Sbjct: 106 EVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM------SKRN 156

Query: 736 GSIG---YVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
             +G   ++APE           D +S GI  +E+  G+ P  D+
Sbjct: 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 58.8 bits (142), Expect = 3e-09
 Identities = 60/241 (24%), Positives = 101/241 (41%), Gaps = 37/241 (15%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIIT 623
           +G GG+G V    +       A K LD   L+++   K  + E E L  +   N   I+ 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV---NSPFIVN 57

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
              + +++ +    LV   M  G L               K ++       +++  V+ Y
Sbjct: 58  LAYAFESKTH--LCLVMSLMNGGDL---------------KYHIYNVGERGLEMERVIHY 100

Query: 684 --------LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
                   LH H    IV+ D+KP NVLLD++    + D GL+  L     D  + ++  
Sbjct: 101 SAQITCGILHLH-SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL----KDGKTITQRA 155

Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ 795
           G+ GY+APE       S   D ++ G  + EM  G+ P  D  +E ++  +  +  L D+
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD-HKEKVAKEELKRRTLEDE 214

Query: 796 V 796
           V
Sbjct: 215 V 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 30/212 (14%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVK---II 622
           +G G Y  V+KG     E  VA+K + L+ + GA  + I E   L+ ++H N+V    I+
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
            +  S+         LV+E+     L+  L Q  D+       N+M   ++ I +  +L 
Sbjct: 74  HTDKSL--------TLVFEY-----LDKDLKQYMDDCG-----NIMSMHNVKIFLYQILR 115

Query: 683 YLHHHCHT-SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
            L + CH   ++H DLKP N+L++      + DFGL+R    + P +T ++ V  ++ Y 
Sbjct: 116 GLAY-CHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVV-TLWYR 171

Query: 742 APEYGALG--EVSTHGDEYSFGILMLEMFTGK 771
            P+   LG  E ST  D +  G +  EM +G+
Sbjct: 172 PPDV-LLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 30/220 (13%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRN 617
           E +   + +G G Y  VYKG     +  VA+K + L+ + GA  + I E   L+ ++H N
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65

Query: 618 LVK---IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
           +V    II +  S+         LV+E+     L+  L Q  D+       N +   ++ 
Sbjct: 66  IVTLHDIIHTEKSL--------TLVFEY-----LDKDLKQYLDDCG-----NSINMHNVK 107

Query: 675 IDVANVLEYLHHHCH-TSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           + +  +L  L++ CH   ++H DLKP N+L++      + DFGL+R    + P +T ++ 
Sbjct: 108 LFLFQLLRGLNY-CHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNE 164

Query: 734 VKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFTGK 771
           V  ++ Y  P+   LG  + ST  D +  G +  EM TG+
Sbjct: 165 VV-TLWYRPPDI-LLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 58.8 bits (142), Expect = 3e-09
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSC 625
           +G G Y  VYKGI       VA+KV+ ++ + G   + I E   L+ ++H N+V +    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLL---H 69

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDE-QNQRPKLNLMQRLSIAIDVANVLEYL 684
             I T+  E    V+E+M +  L  ++ Q          +L + Q L         L Y+
Sbjct: 70  DIIHTK--ETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLL-------RGLAYI 119

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
           H      I+H DLKP N+L+       + DFGL+R    + P QT +S V  ++ Y  P+
Sbjct: 120 HGQ---HILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVV-TLWYRPPD 173

Query: 745 --YGALGEVSTHGDEYSFGILMLEMFTGK 771
              GA  + S+  D +  G + +EM  G+
Sbjct: 174 VLLGAT-DYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 35/226 (15%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVL------DLQQRGASKSFIAECEALRS 612
           E     + +G G  G V K  L       A+K +      DLQ     K  + E E  +S
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ-----KQILRELEINKS 55

Query: 613 IRHRNLVKIITSC-----SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNL 667
            +   +VK   +      SSI         +  E+   GSL++ + +K  ++  R    +
Sbjct: 56  CKSPYIVKYYGAFLDESSSSI--------GIAMEYCEGGSLDS-IYKKVKKRGGRIGEKV 106

Query: 668 MQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD 727
           + +  IA  V   L YLH      I+H D+KPSN+LL  +    + DFG+S  L  NS  
Sbjct: 107 LGK--IAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLA 160

Query: 728 QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
            T T    G+  Y+APE       S   D +S G+ +LE+   + P
Sbjct: 161 GTFT----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.8 bits (142), Expect = 4e-09
 Identities = 47/192 (24%), Positives = 92/192 (47%), Gaps = 22/192 (11%)

Query: 587 VAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           VAVK+L     + A   F+ E + +  ++  N+++++  C + D        ++ E+M N
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPL-----CMITEYMEN 103

Query: 646 GSLENWLN----QKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
           G L  +L+    Q+  E+     ++    + +A  +A+ ++YL      + VH DL   N
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160

Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHGDE 757
            L+       + DFG+SR L+          R++G     I +++ E   LG+ +T  D 
Sbjct: 161 CLVGKNYTIKIADFGMSRNLY-----SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDV 215

Query: 758 YSFGILMLEMFT 769
           ++FG+ + E+ T
Sbjct: 216 WAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 71/250 (28%), Positives = 107/250 (42%), Gaps = 49/250 (19%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSC 625
           +G G  G VYK         +AVKV+ L       K  ++E E            I+  C
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE------------ILYKC 56

Query: 626 SS---IDTRGNEFK----ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
            S   I   G  F     ++  EFM  GSL+ +    E         +++ R  IA+ V 
Sbjct: 57  DSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPE---------HVLGR--IAVAVV 105

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSI 738
             L YL       I+H D+KPSN+L++      + DFG+S  L  NS  +T      G+ 
Sbjct: 106 KGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-NSIAKTYV----GTN 157

Query: 739 GYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE 798
            Y+APE  +  +   H D +S GI  +E+  G+ P   + +   SL       +P Q+ +
Sbjct: 158 AYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-------MPLQLLQ 210

Query: 799 II---DPAIL 805
            I   DP +L
Sbjct: 211 CIVDEDPPVL 220

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 70/247 (28%), Positives = 111/247 (44%), Gaps = 33/247 (13%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVL--DLQQRGASKSFIA-ECEA--LRSIRHRNLVK 620
           L+G G +G VY          +AVK +  D   +  SK   A ECE   L+++RH  +V+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 621 IITSCSSIDTRGNEFKAL--VYEFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAI 675
               C     R  E K L    E+MP GS+++ L       +   +R    ++Q +S   
Sbjct: 69  YY-GC----LRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS--- 120

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
                  YLH +    IVH D+K +N+L D+     +GDFG S+ +       T    V 
Sbjct: 121 -------YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170

Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA----KMG 791
           G+  +++PE  +        D +S    ++EM T K P  + +E   ++ K A    K  
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE-YEAMAAIFKIATQPTKPM 229

Query: 792 LPDQVAE 798
           LPD V++
Sbjct: 230 LPDGVSD 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 58.5 bits (141), Expect = 5e-09
 Identities = 64/256 (25%), Positives = 109/256 (42%), Gaps = 27/256 (10%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVL---DLQQRGASKSFIAECEALRSIRH 615
           E F    +IG G +G V    L   +   A+K+L   ++ +R  +  F  E + L  +  
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VNG 58

Query: 616 RNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI 675
            N  + IT+        N    LV ++   G L   L++ ED   +      +  + IAI
Sbjct: 59  DN--QWITTLHYAFQDENNL-YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI 115

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           D  + L Y+H          D+KP N+L+D      + DFG    L ++   Q+S +   
Sbjct: 116 DSVHQLHYVHR---------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--V 164

Query: 736 GSIGYVAPEY-----GALGEVSTHGDEYSFGILMLEMFTGKRP--TDDMFEE-GLSLHKY 787
           G+  Y++PE         G+     D +S G+ M EM  G+ P   + + E  G  ++  
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 224

Query: 788 AKMGLPDQVAEIIDPA 803
            +   P QV ++ + A
Sbjct: 225 ERFQFPAQVTDVSEDA 240

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 58.3 bits (141), Expect = 6e-09
 Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 11/111 (9%)

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A +V   L +LH H    +++ DLK  N+LLD E    + DFG+ +   +   +  +T+ 
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTT 155

Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP-----TDDMFE 779
             G+  Y+APE     E     D ++ G+LM EM  G+ P      DD+FE
Sbjct: 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 58.2 bits (141), Expect = 6e-09
 Identities = 57/235 (24%), Positives = 96/235 (40%), Gaps = 46/235 (19%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ----RGASKSFIAEC----------EAL 610
             +G G YG V K         VA+K + + +        +  +  C          + +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 611 RSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQR 670
             I+H N++ ++      D     F  LV + M    L+  +++K      + K  L+Q 
Sbjct: 75  NEIKHENIMGLVDVYVEGD-----FINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128

Query: 671 LSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR------LLHDN 724
           L       N L  LH       +H DL P+N+ ++++ +  + DFGL+R           
Sbjct: 129 L-------NGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178

Query: 725 SPDQTS------TSRVKGSIGYVAPEYGALGEVSTHG--DEYSFGILMLEMFTGK 771
           S D+T       TS+V  ++ Y APE   +G    H   D +S G +  E+ TGK
Sbjct: 179 SKDETMQRREEMTSKVV-TLWYRAPEL-LMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 58.0 bits (140), Expect = 6e-09
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 30/199 (15%)

Query: 587 VAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           VAVK+L     + A   F+ E + L  ++  N+++++  C   D        ++ E+M N
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL-----CMITEYMEN 103

Query: 646 GSLENWLN-----QKEDEQN-------QRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIV 693
           G L  +L+      KE+  N         P ++    L +A+ +A+ ++YL      + V
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFV 160

Query: 694 HCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALG 749
           H DL   N L+   +   + DFG+SR L+          R++G     I ++A E   +G
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAG-----DYYRIQGRAVLPIRWMAWECILMG 215

Query: 750 EVSTHGDEYSFGILMLEMF 768
           + +T  D ++FG+ + E+ 
Sbjct: 216 KFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 57.4 bits (138), Expect = 8e-09
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 26/217 (11%)

Query: 566 LIGIGGYGYV---YKGILGTEETNVAVKVLDLQQRGASKSFIA-ECEA--LRSIRHRNLV 619
           L+G G +G V   Y    G E     V+  D +    SK   A ECE   L++++H    
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQ-FDPESPETSKEVSALECEIQLLKNLQHE--- 64

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAID 676
           +I+     +  R  +   +  E+MP GS+++ L       +   ++    +++ +S    
Sbjct: 65  RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS---- 120

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
                 YLH +    IVH D+K +N+L D+     +GDFG S+ L       T    V G
Sbjct: 121 ------YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171

Query: 737 SIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           +  +++PE  +        D +S G  ++EM T K P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 56.9 bits (137), Expect = 9e-09
 Identities = 77/296 (26%), Positives = 124/296 (41%), Gaps = 65/296 (21%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDL-----QQRGASKSFIAECEALRSIRHRNLVKI 621
           IG G +G +Y     ++  +  +K +DL     +++ ASK    E   L  ++H N   I
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPN---I 61

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL-NLMQRLSIAIDVANV 680
           +T  +S    G  F  +V E+   G L   +N+      QR  L +  Q LS  + ++  
Sbjct: 62  VTFFASFQENGRLF--IVMEYCDGGDLMKRINR------QRGVLFSEDQILSWFVQISLG 113

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLD-NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
           L+++H      I+H D+K  N+ L  N MVA +GDFG++R L+D      S       +G
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND------SMELAYTCVG 164

Query: 740 ---YVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV 796
              Y++PE       +   D +S G ++ E+ T K P      EG +LH+          
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-----EGNNLHQL--------- 210

Query: 797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI 852
                       L+I  G    + PN       +   + +V        PRDR  I
Sbjct: 211 -----------VLKICQGYFAPISPNFSRDLRSLISQLFKVS-------PRDRPSI 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 58.7 bits (142), Expect = 1e-08
 Identities = 34/117 (29%), Positives = 58/117 (49%), Gaps = 10/117 (8%)

Query: 63  FLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKL 122
           F+  L L    L G IP+++  L+ L    +S N + G+IP  L +I+S++   ++ N  
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 123 VGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARN 179
            G IP  +G  L ++R+L L  N  +G +P ++          G+L +    NF  N
Sbjct: 479 NGSIPESLG-QLTSLRILNLNGNSLSGRVPAALG---------GRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 59/240 (24%), Positives = 105/240 (43%), Gaps = 26/240 (10%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVK--VLDLQQRGASKSFIAECEALRSIRHRN-LVKIIT 623
           IG G YG VYK         VA+K   L++ + G   + + E   L+ +     +V+++ 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRL--SIAIDVANVL 681
                +  G     LV+E++ +  L+ +++       +      ++     +   VA   
Sbjct: 69  VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA--- 124

Query: 682 EYLHHHCHT-SIVHCDLKPSNVLLDNE-MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
                HCH   ++H DLKP N+L+D +  +  + D GL R    + P ++ T  +  ++ 
Sbjct: 125 -----HCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF--SIPVKSYTHEIV-TLW 176

Query: 740 YVAPEYGALG--EVSTHGDEYSFGILMLEMFTGKR--PTDDMFEEGLSLHKYAKMGLPDQ 795
           Y APE   LG    ST  D +S G +  EM   +   P D   ++ L + K   +G P +
Sbjct: 177 YRAPEV-LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL--LGTPTE 233

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 66/227 (29%), Positives = 99/227 (43%), Gaps = 25/227 (11%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLV 619
           F    ++G G YG VYKG         A+KV+D+ +    +    E   L+    HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIA 76

Query: 620 KIITSCSSIDTRGNEFKA-LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
               +       G++ +  LV EF   GS+ + +        +  K N ++   IA    
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--------KNTKGNALKEDWIAYICR 128

Query: 679 NVLEYLHH-HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR--VK 735
            +L  L H H H  ++H D+K  NVLL       + DFG+S  L     D+T   R    
Sbjct: 129 EILRGLAHLHAH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-----DRTVGRRNTFI 182

Query: 736 GSIGYVAPEYGALGEV--STH---GDEYSFGILMLEMFTGKRPTDDM 777
           G+  ++APE  A  E   +T+    D +S GI  +EM  G  P  DM
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 57.2 bits (139), Expect = 1e-08
 Identities = 68/247 (27%), Positives = 101/247 (40%), Gaps = 93/247 (37%)

Query: 567 IGIGGYGYVYKGI-LGTEETNVAVKVLDLQQRGASKSFIA---ECEALRSIR-------- 614
           +G G YG V+K I   T+E  VA+K          K F A     +A R+ R        
Sbjct: 15  LGKGAYGIVWKAIDRRTKEV-VALK----------KIFDAFRNATDAQRTFREIMFLQEL 63

Query: 615 --HRNLVKIITSCSSIDTRGNEFKA-------LVYEFMPNGSLENWLNQKEDEQNQRPKL 665
             H N+VK++          N  KA       LV+E+M            E + +   + 
Sbjct: 64  GDHPNIVKLL----------NVIKAENDKDIYLVFEYM------------ETDLHAVIRA 101

Query: 666 NLMQRL---SIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH 722
           N+++ +    I   +   L+Y+H     +++H DLKPSN+LL+++    + DFGL+R L 
Sbjct: 102 NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158

Query: 723 DNS-----PDQTSTSRVKGSIGYVA------PEYGALGEVSTHGDEYSFGILML------ 765
           +       P  T          YVA      PE   LG  ST    Y+ G+ M       
Sbjct: 159 ELEENPENPVLTD---------YVATRWYRAPEI-LLG--STR---YTKGVDMWSVGCIL 203

Query: 766 -EMFTGK 771
            EM  GK
Sbjct: 204 GEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 58.0 bits (140), Expect = 1e-08
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 4/97 (4%)

Query: 686 HHCHTS-IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
           HH H+  ++H D+K +N+LL +  +  +GDFG S++      D    +   G+  YVAPE
Sbjct: 157 HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-GTPYYVAPE 215

Query: 745 YGALGEVSTHGDEYSFGILMLEMFTGKRPTD--DMFE 779
                  S   D +S G+L+ E+ T KRP D  +M E
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE 252

Length = 496

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 20/216 (9%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRN 617
           F    ++G GG+G V    +       A K L+   +++R      + E + L  +  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           +V +  +  + D        LV   M  G L+  +    +   +  +      +  A ++
Sbjct: 62  VVSLAYAYETKDAL-----CLVLTLMNGGDLKFHIYHMGEAGFEEGR-----AVFYAAEI 111

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
              LE LH      IV+ DLKP N+LLD+     + D GL+  + +    QT   RV G+
Sbjct: 112 CCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRV-GT 164

Query: 738 IGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           +GY+APE       +   D ++ G L+ EM  G+ P
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 50/222 (22%), Positives = 102/222 (45%), Gaps = 33/222 (14%)

Query: 572 YGYVYKGIL-----GTEETNVAVKVLDLQQRGASKSFIAECEALRS-IRHRNLVKIITSC 625
           +G VYKG L     G +   VA+K L  +  G  +        +RS ++H N+V ++   
Sbjct: 18  FGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV 77

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQK---------EDEQNQRPKLNLMQRLSIAID 676
           +       +  ++++ +  +  L  +L  +         +D++  +  L     + I   
Sbjct: 78  TK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
           +A  +E+L  H    +VH DL   NVL+ +++   + D GL R ++          ++ G
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY-----AADYYKLMG 184

Query: 737 S----IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
           +    I +++PE    G+ S   D +S+G+++ E+F+ G +P
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 34/228 (14%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVL---DLQQRGASKSFIAECEALRSIRH 615
           + F    +IG G +G V    +   E   A+K+L   ++ +R  +  F  E         
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE--------- 51

Query: 616 RNLVKIITSCSSIDTRGNEFKA-----LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQR 670
           RN V +   C  I T    F+      LV ++   G L   L++ ED   +      +  
Sbjct: 52  RN-VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAE 110

Query: 671 LSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTS 730
           + +AI   + L Y         VH D+KP NVLLD      + DFG    ++ +   Q+S
Sbjct: 111 MVLAIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS 161

Query: 731 TSRVKGSIGYVAPEY-----GALGEVSTHGDEYSFGILMLEMFTGKRP 773
            +   G+  Y++PE        +G+     D +S G+ M EM  G+ P
Sbjct: 162 VA--VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 17/207 (8%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEA--LRSIRHRNLVKIITS 624
           +G G YG V      T+     +K L+L+     +   AE EA  L  ++H N+V    S
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
               D        +V  F   G L + L  KE +    P+  +++     + +A  L+YL
Sbjct: 68  WEGEDG----LLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVEWF---VQIAMALQYL 118

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
           H      I+H DLK  NV L    +  VGD G++R+L +N  D  ST  + G+  Y++PE
Sbjct: 119 HEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMAST--LIGTPYYMSPE 172

Query: 745 YGALGEVSTHGDEYSFGILMLEMFTGK 771
             +    +   D ++ G  + EM T K
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 27/223 (12%)

Query: 561 FSSANLIGIGGYGYVY--KGILGTEETNV-AVKVLD----LQQRGASKSFIAECEALRSI 613
           F    ++G G YG V+  + + G +   + A+KVL     +Q+   ++    E + L ++
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 614 RHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
           R    +  +      DT+ +    L+ +++  G L   L Q+E             R+ I
Sbjct: 62  RRCPFLVTLHYAFQTDTKLH----LILDYVNGGELFTHLYQREHFTESE------VRVYI 111

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A ++   L++LH      I++ D+K  N+LLD+E    + DFGLS+       ++  +  
Sbjct: 112 A-EIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-- 165

Query: 734 VKGSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP 773
             G+I Y+APE    G    H    D +S G+L  E+ TG  P
Sbjct: 166 FCGTIEYMAPEVIRGGS-GGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 33/219 (15%)

Query: 566 LIGIGGYGYVY--KGILGTEETNV-AVKVLDLQQRGASKSFIAECEALRSI----RHRNL 618
           ++G GGYG V+  + + G +   + A+KVL       ++   A  +A R+I    +H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
           V +I +     T G  +  L+ E++  G L   L ++           L +     I +A
Sbjct: 63  VDLIYA---FQTGGKLY--LILEYLSGGELFMHLEREGIFMEDTACFYLSE-----ISLA 112

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR-LLHDNSPDQTSTSRVKGS 737
             LE+LH      I++ DLKP N+LLD +    + DFGL +  +H+ +   T      G+
Sbjct: 113 --LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC----GT 163

Query: 738 IGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP 773
           I Y+APE   +   S HG   D +S G LM +M TG  P
Sbjct: 164 IEYMAPE---ILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 6/109 (5%)

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A ++A  L +LH      I++ DLK  NV+LD E    + DFG+ +   +N     +T  
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRT 160

Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL 782
             G+  Y+APE  A        D ++FG+L+ EM  G+ P D   E+ L
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 3e-08
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 26/217 (11%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS 626
           IG G YG VYK         VA+KV+ L+     +    E   L+  RH N+V    S  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-- 68

Query: 627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH 686
                  +   +V E+   GSL++          + P L+ +Q   +  +    L YLH 
Sbjct: 69  ---YLRRDKLWIVMEYCGGGSLQDIYQ-----VTRGP-LSELQIAYVCRETLKGLAYLH- 118

Query: 687 HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YVAP 743
              T  +H D+K +N+LL  +    + DFG+S  L        + ++ K  IG   ++AP
Sbjct: 119 --ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGTPYWMAP 170

Query: 744 EYGAL---GEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
           E  A+   G      D ++ GI  +E+   + P  D+
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 56.2 bits (136), Expect = 3e-08
 Identities = 63/212 (29%), Positives = 89/212 (41%), Gaps = 30/212 (14%)

Query: 271 LLKLQVLSLFGNKISGE----IPSSLGNLIFLTEVDLQGN------SIRGSIPSALGNCL 320
           LL LQVL L GN +  E    + S+L     L E+ L  N          S+   L    
Sbjct: 22  LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81

Query: 321 QLQKLDLSDNNLSGTIPREVIG-LSSFVL--LDLSRNHLS-GPIPLEVGRLKGIQ----Q 372
            LQ+LDLSDN L       +   L S  L  L L+ N L    + L    LK +     +
Sbjct: 82  GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141

Query: 373 LDLSENKLSGEIPTSLASCV----GLEYLNFSDNSFQGP-IHS---GFSSLKGLQDLDLS 424
           L L  N+L G    +LA  +     L+ LN ++N      I +   G  +   L+ LDL+
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN 201

Query: 425 RNNF----SGKIPMFLNTFRFLQKLNLSFNNL 452
            N      +  +   L + + L+ LNL  NNL
Sbjct: 202 NNGLTDEGASALAETLASLKSLEVLNLGDNNL 233

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 40/128 (31%), Positives = 65/128 (50%), Gaps = 9/128 (7%)

Query: 673 IAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS 732
           IA+ V   L YL++     I+H D+KPSN+L+++     + DFG+S  L  NS   T   
Sbjct: 108 IAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTFV- 163

Query: 733 RVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL 792
              G+  Y++PE    G+ +   D +S GI ++E+  GK P    F       +   MG+
Sbjct: 164 ---GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA--FSNIDDDGQDDPMGI 218

Query: 793 PDQVAEII 800
            D + +I+
Sbjct: 219 LDLLQQIV 226

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 56.1 bits (135), Expect = 3e-08
 Identities = 39/120 (32%), Positives = 59/120 (49%), Gaps = 8/120 (6%)

Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
           K +L +    A ++   L++LH      IV+ DLK  N+LLD +    + DFG+ +   +
Sbjct: 92  KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCK---E 145

Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-DEYSFGILMLEMFTGKRPTDDMFEEGL 782
           N      T    G+  Y+APE   LG+      D +SFG+L+ EM  G+ P     EE L
Sbjct: 146 NMLGDAKTCTFCGTPDYIAPEI-LLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 6/109 (5%)

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A ++A  L +LH      I++ DLK  NV+LD+E    + DFG+ +   +N  D  +T  
Sbjct: 107 AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKT 160

Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL 782
             G+  Y+APE  A        D ++FG+L+ EM  G+ P +   E+ L
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 55.9 bits (134), Expect = 3e-08
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 22/207 (10%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSC 625
           +G G Y  VYKG        VA+KV+ LQ+  G   + I E   L+ ++H N+V +    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLL---H 69

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
             I T+  E   LV+E++     +           +  KL L Q L         L Y+H
Sbjct: 70  DIIHTK--ETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLL-------RGLSYIH 120

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY 745
                 I+H DLKP N+L+ +     + DFGL+R    + P  T ++ V  ++ Y  P+ 
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVV-TLWYRPPDV 174

Query: 746 GALG--EVSTHGDEYSFGILMLEMFTG 770
             LG  E ST  D +  G + +EM  G
Sbjct: 175 -LLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 55.5 bits (133), Expect = 4e-08
 Identities = 64/226 (28%), Positives = 93/226 (41%), Gaps = 23/226 (10%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLV 619
           F    L+G G YG VYKG         A+KV+D+      +    E   L+    HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 66

Query: 620 KIITSCSSIDTRGNEFKA-LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
               +    +  G + +  LV EF   GS+ + +        +  K N ++   IA    
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--------KNTKGNTLKEEWIAYICR 118

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR--VKG 736
            +L  L H     ++H D+K  NVLL       + DFG+S  L     D+T   R    G
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-----DRTVGRRNTFIG 173

Query: 737 SIGYVAPEYGALGE-----VSTHGDEYSFGILMLEMFTGKRPTDDM 777
           +  ++APE  A  E          D +S GI  +EM  G  P  DM
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.1 bits (135), Expect = 4e-08
 Identities = 62/217 (28%), Positives = 92/217 (42%), Gaps = 38/217 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVL--DLQQRGASKSFIAECEALRSIRHRN---LVKI 621
           +G G YG V   +       VA+K L    Q    +K    E   L+ ++H N   L+ +
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
            T   S+D R ++F  LV  FM  G+    L + E     R +  + Q L         L
Sbjct: 83  FTPDLSLD-RFHDF-YLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML-------KGL 131

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           +Y+H      I+H DLKP N+ ++ +    + DFGL+R        QT +       GYV
Sbjct: 132 KYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--------QTDSEMT----GYV 176

Query: 742 APEYGALGEV-------STHGDEYSFGILMLEMFTGK 771
              +    EV       +   D +S G +M EM TGK
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 55.6 bits (134), Expect = 4e-08
 Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 13/105 (12%)

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           L++LH      I++ DLK  NVLLD +    + DFG+ +    N   +   S   G+  Y
Sbjct: 109 LQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE---NMNGEGKASTFCGTPDY 162

Query: 741 VAPEYGALGEVSTHG-DEYSFGILMLEMFTGKRP-----TDDMFE 779
           +APE    G+      D +SFG+L+ EM  G+ P      D++F+
Sbjct: 163 IAPEI-LKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.4 bits (133), Expect = 5e-08
 Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 27/227 (11%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEAL-RSIRHRNLVKI 621
           +IG G +G V       EE   AVKVL    + ++   K  ++E   L ++++H  LV +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
             S  + D         V +++  G L   L      Q +R  L    R   A ++A+ L
Sbjct: 62  HFSFQTADKL-----YFVLDYINGGELFYHL------QRERCFLEPRARF-YAAEIASAL 109

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
            YLH     +IV+ DLKP N+LLD++    + DFGL +   +N     +TS   G+  Y+
Sbjct: 110 GYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYL 163

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFTG-----KRPTDDMFEEGLS 783
           APE           D +  G ++ EM  G      R T +M++  L+
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 32/223 (14%)

Query: 566 LIGIGGYGYVYK--------GILGTEETNVAVKVLDLQQRGASKSF---IAECEALR-SI 613
            +G G +G VYK         +L  +E NV        +R   KS    ++E   ++  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 614 RHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSL-ENWLNQKEDEQNQRPKLNLMQRL- 671
           RH N+V+   +        N+   +V + +    L E++ + KE +Q    +     R+ 
Sbjct: 67  RHPNIVRYYKTFLE-----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE-----RIW 116

Query: 672 SIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL-DNEMVAHVGDFGLSRLLHDNSPDQTS 730
           +I + +   L YLH      IVH DL P+N++L +++ V  + DFGL++      P+   
Sbjct: 117 NIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVT-ITDFGLAK---QKQPESKL 170

Query: 731 TSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           TS V G+I Y  PE           D ++FG ++ +M T + P
Sbjct: 171 TSVV-GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 55.4 bits (133), Expect = 7e-08
 Identities = 95/381 (24%), Positives = 142/381 (37%), Gaps = 76/381 (19%)

Query: 1   MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSN 60
                +P++++    L +L            + L NL  L  L L  N    +I   L  
Sbjct: 57  NTLLLLPSSLSRLLSLDLLSPSGISSLDGSEN-LLNLLPLPSLDLNLNRLRSNIS-ELLE 114

Query: 61  LSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
           L+ L  L L  N+++ +IP  +GLLK                                  
Sbjct: 115 LTNLTSLDLDNNNIT-DIPPLIGLLK---------------------------------- 139

Query: 121 KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNN 180
                          N++ L L  N              S+P  L  L NL  L+ + N+
Sbjct: 140 --------------SNLKELDLSDN-----------KIESLPSPLRNLPNLKNLDLSFND 174

Query: 181 LGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTI 240
           L             L N + L  + LS N +S  LP  I    S L  L +S N I   +
Sbjct: 175 L-------SDLPKLLSNLSNLNNLDLSGNKIS-DLPPEI-ELLSALEELDLSNNSII-EL 224

Query: 241 PTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTE 300
            + + NLKNL  + +  N L   +P S+G L  L+ L L  N+IS    SSLG+L  L E
Sbjct: 225 LSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRE 281

Query: 301 VDLQGNSIRGSIPS-ALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGP 359
           +DL GNS+  ++P  AL   L    L+L     +  +    I L++ +L +   +     
Sbjct: 282 LDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEAL 341

Query: 360 IPLEVGRLKGIQQLDLSENKL 380
             LE           L E+ L
Sbjct: 342 SILESLNNLWTLDNALDESNL 362

Length = 394

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 7e-08
 Identities = 67/250 (26%), Positives = 95/250 (38%), Gaps = 68/250 (27%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKII 622
           L+G G  G V+   L       A+KVLD   + +R   K  + E E L ++ H  L  + 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI------AID 676
              +S  T    +  LV ++ P G L   L +       +P     + LS       A +
Sbjct: 68  ---ASFQT--ETYLCLVMDYCPGGELFRLLQR-------QP----GKCLSEEVARFYAAE 111

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLS-------RLLHDNSPD 727
           V   LEYLH      IV+ DLKP N+LL      H+   DF LS         +      
Sbjct: 112 VLLALEYLHL---LGIVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRK 166

Query: 728 QTSTSRVK-------------------GSIGYVAPEYGALGEVSTHG-----DEYSFGIL 763
            +  S V                    G+  Y+APE      +S  G     D ++ GIL
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV-----ISGDGHGSAVDWWTLGIL 221

Query: 764 MLEMFTGKRP 773
           + EM  G  P
Sbjct: 222 LYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 8e-08
 Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 7/93 (7%)

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           LE LH      IV+ DLKP N+LLD+     + D GL+  + +    +T   RV G++GY
Sbjct: 115 LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG---ETIRGRV-GTVGY 167

Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           +APE       +   D +  G L+ EM  GK P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 8e-08
 Identities = 48/189 (25%), Positives = 79/189 (41%), Gaps = 22/189 (11%)

Query: 567 IGIGGYGYVYKGIL--GTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKI 621
           IG G YG VYK     G +    A+K       Q  G S+S   E   LR ++H N+V +
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLE--NWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
           +        +      L++++  +   +   +  Q +        +      S+   + N
Sbjct: 68  VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK-----SLLWQILN 119

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH----VGDFGLSRLLHDNSPDQTSTSRVK 735
            + YLH +    ++H DLKP+N+L+  E        +GD GL+RL +           V 
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176

Query: 736 GSIGYVAPE 744
            +I Y APE
Sbjct: 177 VTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 54.8 bits (132), Expect = 8e-08
 Identities = 59/219 (26%), Positives = 90/219 (41%), Gaps = 30/219 (13%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKS---FIAECEALRSIRHRN 617
           F     +G G +G V            A+K L  ++    K       E   L  + H  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           +V ++  CS  D     F   + EF+  G L   L +     N   K           ++
Sbjct: 80  IVNMM--CSFQDENRVYF---LLEFVVGGELFTHLRKAGRFPNDVAKF-------YHAEL 127

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
               EYLH      I++ DLKP N+LLDN+    V DFG ++ +    PD+T T  + G+
Sbjct: 128 VLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFT--LCGT 178

Query: 738 IGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP 773
             Y+APE   + +   HG   D ++ G+L+ E   G  P
Sbjct: 179 PEYLAPE---VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 54.1 bits (130), Expect = 8e-08
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 29/216 (13%)

Query: 567 IGIGGYGYVYKGI-------LGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLV 619
           +G G +  ++KGI           +T V +KVLD   R  S+SF      +  + H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
                C   D        +V E++  GSL+ +L +       +  +N+  +L +A  +A 
Sbjct: 63  LNYGVCVCGDE-----SIMVQEYVKFGSLDTYLKKN------KNLINISWKLEVAKQLAW 111

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG--- 736
            L +L       + H ++   NVLL  E     G+    +L   + P  + T   K    
Sbjct: 112 ALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKL---SDPGISITVLPKEILL 165

Query: 737 -SIGYVAPE-YGALGEVSTHGDEYSFGILMLEMFTG 770
             I +V PE       +S   D++SFG  + E+F+G
Sbjct: 166 ERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.9 bits (132), Expect = 8e-08
 Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 11/158 (6%)

Query: 653 NQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL-HHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           +++ DE  + P L L   +S +  VA  +E+L    C    +H DL   N+LL    V  
Sbjct: 159 DEEGDELYKEP-LTLEDLISYSFQVARGMEFLASRKC----IHRDLAARNILLSENNVVK 213

Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-- 769
           + DFGL+R ++ + PD       +  + ++APE       +T  D +SFG+L+ E+F+  
Sbjct: 214 ICDFGLARDIYKD-PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 272

Query: 770 -GKRPTDDMFEEGLS-LHKYAKMGLPDQVAEIIDPAIL 805
               P   + EE    L +  +M  P+     I   +L
Sbjct: 273 ASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIML 310

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 54.7 bits (132), Expect = 9e-08
 Identities = 46/192 (23%), Positives = 78/192 (40%), Gaps = 25/192 (13%)

Query: 289 PSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQ---LQKLDLSDNNLSGTIPREVI-GLS 344
              L     L E+DL  N++       L + L+   LQ+L L++N L     R +  GL 
Sbjct: 74  LQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLK 133

Query: 345 SFVL----LDLSRNHLSG----PIPLEVGRLKGIQQLDLSENKLSGE-IPT---SLASCV 392
                   L L RN L G     +   +   + +++L+L+ N +    I      L +  
Sbjct: 134 DLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANC 193

Query: 393 GLEYLNFSDNSFQ----GPIHSGFSSLKGLQDLDLSRNNFSGKI-----PMFLNTFRFLQ 443
            LE L+ ++N         +    +SLK L+ L+L  NN +           L+    L 
Sbjct: 194 NLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLL 253

Query: 444 KLNLSFNNLEGE 455
            L+LS N++  +
Sbjct: 254 TLSLSCNDITDD 265

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 54.3 bits (131), Expect = 9e-08
 Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 12/106 (11%)

Query: 673 IAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS-RLLHDNSPDQTST 731
           + + +   L YL    H  ++H D+KPSN+LLD      + DFG+S RL+     D  + 
Sbjct: 119 MTVAIVKALHYLKEK-H-GVIHRDVKPSNILLDASGNVKLCDFGISGRLV-----DSKAK 171

Query: 732 SRVKGSIGYVAPEY----GALGEVSTHGDEYSFGILMLEMFTGKRP 773
           +R  G   Y+APE         +     D +S GI ++E+ TG+ P
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 35/114 (30%), Positives = 59/114 (51%), Gaps = 6/114 (5%)

Query: 669 QRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQ 728
           Q +  A +++  L +LH      I++ DLK  NV+LD+E    + DFG+ +   ++  D 
Sbjct: 102 QAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDG 155

Query: 729 TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL 782
            +T    G+  Y+APE  A        D +++G+L+ EM  G+ P D   E+ L
Sbjct: 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 28/215 (13%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASK---SFIAECEALRSIRHRNLVKIIT 623
           IG G +G V    + T+     V V +L+   +SK    F+ + +  R ++H N+++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 624 SC-SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
            C  +I         LV+E+   G L+++L+Q E    +  +L L+QR+  A ++A  + 
Sbjct: 63  QCVEAIPY------LLVFEYCELGDLKSYLSQ-EQWHRRNSQLLLLQRM--ACEIAAGVT 113

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL--SRLLHDNSPDQTSTSRVKGSIGY 740
           ++H H   + +H DL   N  L +++   VGD+G+  SR   D      +       + +
Sbjct: 114 HMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI---ETEDDKCVPLRW 167

Query: 741 VAPE-----YGAL--GEVSTHGDEYSFGILMLEMF 768
           +APE     +G L   E +   + ++ G+ + E+F
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 9/178 (5%)

Query: 599 ASKSFIAECEALRSIRHRNLVKIITSCSSIDTR--GNEFKALVYEFMPNGSLENWLNQKE 656
           A + F +     +S + R   + +   S +D R    +   L   F P+ S      Q+ 
Sbjct: 105 AKREFFSPY-REKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163

Query: 657 DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG 716
           D+  + P L +   +  +  VA  +E+L        +H DL   N+LL    V  + DFG
Sbjct: 164 DDLWKSP-LTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFG 219

Query: 717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
           L+R ++ + PD       +  + ++APE       +T  D +SFG+L+ E+F+ G  P
Sbjct: 220 LARDIYKD-PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 43/145 (29%), Positives = 64/145 (44%), Gaps = 27/145 (18%)

Query: 638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
            V EF+  G L   +      Q QR KL        + +++  L +LH      I++ DL
Sbjct: 73  FVIEFVSGGDLMFHM------QRQR-KLPEEHARFYSAEISLALNFLHER---GIIYRDL 122

Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE 757
           K  NVLLD E    + D+G+ +   +      +TS   G+  Y+APE          G++
Sbjct: 123 KLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIAPEI-------LRGED 172

Query: 758 YSF-------GILMLEMFTGKRPTD 775
           Y F       G+LM EM  G+ P D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 36/96 (37%), Positives = 52/96 (54%), Gaps = 10/96 (10%)

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           LE+LH      IV+ D+K  N+LLD+E    + DFGLS+       ++T +    G+I Y
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIEY 172

Query: 741 VAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP 773
           +APE   +     HG   D +S GIL+ E+ TG  P
Sbjct: 173 MAPE--IIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 52/166 (31%), Positives = 82/166 (49%), Gaps = 23/166 (13%)

Query: 660 NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR 719
           N+ P L+ M  +  +  VAN +E+L      + VH DL   NVL+    +  + DFGL+R
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287

Query: 720 -LLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
            ++ D      S    KGS    + ++APE       +T  D +SFGIL+ E+FT G  P
Sbjct: 288 DIMRD------SNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341

Query: 774 TDD--MFEEGLS-LHKYAKMGLP----DQVAEIIDPAILEEALEIQ 812
             +  M E+  + + +  +M  P    D++ EI+     EE  EI+
Sbjct: 342 YPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKC-WEEKFEIR 386

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 19/228 (8%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVL--DLQQRGASKSFIA-ECEA--LRSIRHRNLVK 620
           L+G G +G VY          +AVK +  D +    SK   A ECE   L+++ H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
                     R     ++  E MP GS+++ L             N+ ++ +       +
Sbjct: 69  YYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTE-----NVTRKYT-----RQI 115

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           LE + +     IVH D+K +N+L D+     +GDFG S+ L       T    V G+  +
Sbjct: 116 LEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175

Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA 788
           ++PE  +        D +S G  ++EM T K P  + FE   ++ K A
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE-FEAMAAIFKIA 222

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 49/159 (30%), Positives = 71/159 (44%), Gaps = 21/159 (13%)

Query: 638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           LV E+ P G L + LN+ ED+ ++      +  L +AI   + + Y         VH D+
Sbjct: 78  LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY---------VHRDI 128

Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL---GEVSTH 754
           KP NVL+D      + DFG +  L  N     S   V G+  Y+APE           T+
Sbjct: 129 KPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPV-GTPDYIAPEVLTTMNGDGKGTY 186

Query: 755 G---DEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM 790
           G   D +S G++  EM  G+ P    F EG S   Y  +
Sbjct: 187 GVECDWWSLGVIAYEMIYGRSP----FHEGTSAKTYNNI 221

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 18/147 (12%)

Query: 638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
            V EF+  G L   +  K        + +L +    A ++   L++LH      I++ DL
Sbjct: 73  FVMEFLNGGDLMFHIQDKG-------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDL 122

Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE 757
           K  NV+LD +    + DFG+ +   +N       S   G+  Y+APE     + +   D 
Sbjct: 123 KLDNVMLDRDGHIKIADFGMCK---ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDW 179

Query: 758 YSFGILMLEMFTGKRP-----TDDMFE 779
           +SFG+L+ EM  G+ P      D++FE
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.7 bits (129), Expect = 3e-07
 Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 22/167 (13%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVL---DLQQRGASKSFIAECEALRSIRH 615
           E F     I  G +G VY G         AVKV+   D+  +       AE +AL   + 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 616 RNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSI 673
             +V +  S  S +        LV E++  G +++ L+     DE+        M    I
Sbjct: 64  PFIVHLYYSLQSAN-----NVYLVMEYLIGGDVKSLLHIYGYFDEE--------MAVKYI 110

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL 720
           + +VA  L+YLH H    I+H DLKP N+L+ NE    + DFGLS++
Sbjct: 111 S-EVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.8 bits (125), Expect = 4e-07
 Identities = 43/171 (25%), Positives = 78/171 (45%), Gaps = 23/171 (13%)

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
           + N +K+  S +++         L+ +++ +G L + L +KE       KL+  +   I 
Sbjct: 68  NPNFIKLYYSVTTLKGH-----VLIMDYIKDGDLFDLL-KKEG------KLSEAEVKKII 115

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV-AHVGDFGLSRLLHDNSPDQTSTSR 733
             +   L  LH H   +I+H D+K  NVL D      ++ D+GL +++        + S 
Sbjct: 116 RQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG-------TPSC 165

Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSL 784
             G++ Y +PE           D ++ G+L  E+ TGK P  +  +E L L
Sbjct: 166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216

Length = 267

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 52.3 bits (125), Expect = 5e-07
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 22/212 (10%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEAL-RSIRHRNLVKI 621
           +IG G +G V      ++ +  AVKVL    + ++      +AE   L ++++H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
             S  +      E    V +++  G L  + + + +     P+         A +VA+ +
Sbjct: 62  HYSFQT-----AEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFY-----AAEVASAI 109

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
            YLH     +I++ DLKP N+LLD++    + DFGL +      P++T TS   G+  Y+
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEET-TSTFCGTPEYL 163

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           APE           D +  G ++ EM  G  P
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 5e-07
 Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 25/182 (13%)

Query: 633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSI 692
                LV ++   G L   L++ ED   +      +  + +AID  + L Y         
Sbjct: 73  ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY--------- 123

Query: 693 VHCDLKPSNVLLDNEMVAHV--GDFGLS-RLLHDNSPDQTSTSRVKGSIGYVAPEY---- 745
           VH D+KP NVLLD     H+   DFG   RLL D +     ++   G+  Y++PE     
Sbjct: 124 VHRDIKPDNVLLD--KNGHIRLADFGSCLRLLADGTVQ---SNVAVGTPDYISPEILQAM 178

Query: 746 -GALGEVSTHGDEYSFGILMLEMFTGKRP--TDDMFEE-GLSLHKYAKMGLPDQVAEIID 801
               G      D +S G+ M EM  G+ P   + + E  G  ++       P  V ++ +
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238

Query: 802 PA 803
            A
Sbjct: 239 EA 240

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 52.2 bits (125), Expect = 5e-07
 Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 38/163 (23%)

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A ++ + L +LH      I++ DLK  NVLLD+E    + DFG+ +   +   +  +TS 
Sbjct: 102 AAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTST 155

Query: 734 VKGSIGYVAPE------YGALGEVSTHGDEYSFGILMLEMFTGKRP-----TDDMFEEGL 782
             G+  Y+APE      YG         D ++ G+L+ EM  G  P      DD+FE  L
Sbjct: 156 FCGTPDYIAPEILQEMLYGPS------VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 209

Query: 783 SLHKYAKMGLPDQVAEIIDPAIL-EEALEIQAGIVKELQPNLR 824
           +              E++ P  L ++A++I    + +  P +R
Sbjct: 210 N-------------DEVVYPTWLSQDAVDILKAFMTK-NPTMR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 52.1 bits (125), Expect = 6e-07
 Identities = 74/280 (26%), Positives = 119/280 (42%), Gaps = 48/280 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEAL-RSIRHRNLVKII 622
           IG G +G V       +    AVKVL    + ++   K  +AE   L ++++H  LV + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI-AIDVANVL 681
            S  + D         V +++  G L   L        QR +     R    A ++A+ L
Sbjct: 63  YSFQTADKL-----YFVLDYVNGGELFFHL--------QRERSFPEPRARFYAAEIASAL 109

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
            YLH     +I++ DLKP N+LLD++    + DFGL +   +      +TS   G+  Y+
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYL 163

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFTG-----KRPTDDMFEEGLSLHKYAKMGLPDQV 796
           APE           D +  G ++ EM  G      R T +M++    L+K      P ++
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDN--ILNK------PLRL 215

Query: 797 AEIIDPA---ILEEALEIQAGIVKELQPNLRAK--FHEIQ 831
              I  +   +LE  L+      K+    L AK  F EI+
Sbjct: 216 KPNISVSARHLLEGLLQ------KDRTKRLGAKDDFLEIK 249

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 52.2 bits (125), Expect = 7e-07
 Identities = 40/126 (31%), Positives = 67/126 (53%), Gaps = 16/126 (12%)

Query: 654 QKEDEQNQRPKLNLMQRLSIAIDVANVLEYL-HHHCHTSIVHCDLKPSNVLLDNEMVAHV 712
            +ED ++  P L+L   L  +  VA  +++L   +C    +H D+   NVLL +  VA +
Sbjct: 199 DEEDTEDSWP-LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKI 253

Query: 713 GDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHGDEYSFGILMLEMF 768
            DFGL+R + ++     S   VKG+    + ++APE       +   D +S+GIL+ E+F
Sbjct: 254 CDFGLARDIMND-----SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 308

Query: 769 T-GKRP 773
           + GK P
Sbjct: 309 SLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 51.7 bits (124), Expect = 7e-07
 Identities = 42/133 (31%), Positives = 68/133 (51%), Gaps = 14/133 (10%)

Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           E M  GSL+  L     ++  R   N++ ++SIA  V   L YL       I+H D+KPS
Sbjct: 79  EHMDGGSLDQVL-----KKAGRIPENILGKISIA--VLRGLTYLREK--HKIMHRDVKPS 129

Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+++     + DFG+S  L D+     + S V G+  Y++PE       +   D +S 
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLIDS----MANSFV-GTRSYMSPERLQGTHYTVQSDIWSL 184

Query: 761 GILMLEMFTGKRP 773
           G+ ++EM  G+ P
Sbjct: 185 GLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 51.9 bits (124), Expect = 7e-07
 Identities = 78/277 (28%), Positives = 120/277 (43%), Gaps = 40/277 (14%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEAL-RSIRHRNLVKI 621
           +IG G +G V       +    AVKVL    +  R   K  +AE   L ++++H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
             S  + +         V +F+  G L   L ++      R +         A ++A+ L
Sbjct: 62  HYSFQTTEKL-----YFVLDFVNGGELFFHLQRERSFPEPRARF-------YAAEIASAL 109

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
            YLH     +IV+ DLKP N+LLD++    + DFGL +   +      +T+   G+  Y+
Sbjct: 110 GYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYL 163

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFTG-----KRPTDDMFEEGLSLHKYAKMGLPDQV 796
           APE           D +  G ++ EM  G      R   +M++    LHK   +  P   
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN--ILHKPLVL-RPG-- 218

Query: 797 AEIIDPAILEEALEIQAGIVKELQPNLRAK--FHEIQ 831
           A +   +ILEE LE      K+ Q  L AK  F EIQ
Sbjct: 219 ASLTAWSILEELLE------KDRQRRLGAKEDFLEIQ 249

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 51.5 bits (123), Expect = 8e-07
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 20/216 (9%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRN 617
           F    ++G GG+G V    +       A K L+   +++R      + E + L  +  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           +V +  +  + D        LV   M  G L+  +    +     P     + L  A ++
Sbjct: 62  VVNLAYAYETKDAL-----CLVLTIMNGGDLKFHIYNMGN-----PGFEEERALFYAAEI 111

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
              LE LH     + V+ DLKP N+LLD+     + D GL+  +    P+  S     G+
Sbjct: 112 LCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI----PEGESIRGRVGT 164

Query: 738 IGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           +GY+APE       +   D +  G L+ EM  G+ P
Sbjct: 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 34/212 (16%)

Query: 567 IGIGGYGYVYKGILGTEETNV--AVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
           +G G +G VYK     +ET V  A KV+D +     + ++ E + L S  H N+VK++ +
Sbjct: 13  LGDGAFGKVYKA--QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
                   N    L+ EF   G+++  + + E    + P++ ++ + ++       L YL
Sbjct: 71  F----YYENNLWILI-EFCAGGAVDAVMLELERPLTE-PQIRVVCKQTL-----EALNYL 119

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YV 741
           H      I+H DLK  N+L   +    + DFG+S      + +  +  R    IG   ++
Sbjct: 120 H---ENKIIHRDLKAGNILFTLDGDIKLADFGVS------AKNTRTIQRRDSFIGTPYWM 170

Query: 742 APEYGALGEVST------HGDEYSFGILMLEM 767
           APE   + E S         D +S GI ++EM
Sbjct: 171 APEV-VMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 51.2 bits (123), Expect = 8e-07
 Identities = 57/217 (26%), Positives = 86/217 (39%), Gaps = 41/217 (18%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVL-----DLQQRGASKSFIAECEALRSIRHRNLVKI 621
           IG G YG V+K         VA+K       D   +   K  + E   L+ ++H NLV +
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK---KIALREIRMLKQLKHPNLVNL 65

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
           I        R      LV+E+  +  L       E E+N R  +       I       +
Sbjct: 66  IEV-----FRRKRKLHLVFEYCDHTVLN------ELEKNPR-GVPEHLIKKIIWQTLQAV 113

Query: 682 EYLH-HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
            + H H+C    +H D+KP N+L+  +    + DFG +R+L    P    T  V  +  Y
Sbjct: 114 NFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYV-ATRWY 166

Query: 741 VAPE-------YGALGEVSTHGDEYSFGILMLEMFTG 770
            APE       YG         D ++ G +  E+ TG
Sbjct: 167 RAPELLVGDTQYG------PPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 51.5 bits (124), Expect = 8e-07
 Identities = 59/231 (25%), Positives = 92/231 (39%), Gaps = 54/231 (23%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLD--LQQRGASKSFIAECEALRSIRHRN- 617
           + + + +G G YG V           VA+K L    Q    +K    E   L+ + H N 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76

Query: 618 --LVKIITSCSSIDTRGNEFKA--LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLS- 672
             L+ + T  SS+     +F+   LV   M    L N +                Q+LS 
Sbjct: 77  IGLLDVFTPASSL----EDFQDVYLVTHLM-GADLNNIVKC--------------QKLSD 117

Query: 673 -----IAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD 727
                +   +   L+Y+H      I+H DLKPSN+ ++ +    + DFGL+R   D   +
Sbjct: 118 DHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD---E 171

Query: 728 QTSTSRVKGSIGYVAPEYGALGEV-------STHGDEYSFGILMLEMFTGK 771
            T         GYVA  +    E+       +   D +S G +M E+ TGK
Sbjct: 172 MT---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 38/131 (29%), Positives = 63/131 (48%), Gaps = 11/131 (8%)

Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           Y+   +  ++N L+    E      L  +  LS    VA  +E+L      + VH DL  
Sbjct: 214 YKGSNDSEVKNLLSDDGSE-----GLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAA 265

Query: 700 SNVLLDNEMVAHVGDFGLSR-LLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEY 758
            NVLL    +  + DFGL+R ++HD+  +  S       + ++APE       +T  D +
Sbjct: 266 RNVLLAQGKIVKICDFGLARDIMHDS--NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVW 323

Query: 759 SFGILMLEMFT 769
           S+GIL+ E+F+
Sbjct: 324 SYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 19/212 (8%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLD--LQQRGASKSFIAECEALRSIRHRNLVKIIT 623
           +IG G YG V   I       VA+K ++   +    +   + E + LR +RH ++V+I  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 624 SCSSIDTRGNEFKAL--VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
                  R  EFK +  V+E M    L   +   +D   +  +  L Q L         L
Sbjct: 67  IMLPPSRR--EFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLL-------RAL 116

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           +Y+H     ++ H DLKP N+L + +    + DFGL+R+  +++P     +    +  Y 
Sbjct: 117 KYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 742 APEY-GAL-GEVSTHGDEYSFGILMLEMFTGK 771
           APE  G+   + +   D +S G +  E+ TGK
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 6/100 (6%)

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           +++  L YLH      I++ DLK  NVLLD+E    + D+G+ +      P  T TS   
Sbjct: 104 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDT-TSTFC 157

Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTD 775
           G+  Y+APE     +     D ++ G+LM EM  G+ P D
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 51.1 bits (122), Expect = 1e-06
 Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 16/101 (15%)

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           LE LH     ++++ DLKP N+LLD +    + DFGL +L   N  D   T+   G+  Y
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKL---NMKDDDKTNTFCGTPEY 159

Query: 741 VAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRPTDD 776
           +APE      +  HG     D ++ G+L+ EM TG  P  D
Sbjct: 160 LAPEL-----LLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 51.5 bits (123), Expect = 1e-06
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 38/229 (16%)

Query: 560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLV 619
           GFS       G  G+ +  I      +V +K     QRG +     E   LR+I H +++
Sbjct: 93  GFSILETFTPGAEGFAFACIDNKTCEHVVIKA---GQRGGT---ATEAHILRAINHPSII 146

Query: 620 KIITSCSSIDTRGNEFKALVYEFMP--NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           ++  + +      N+F  L+   +P     L  +L  K         + +   L+I   V
Sbjct: 147 QLKGTFTY-----NKFTCLI---LPRYKTDLYCYLAAKR-------NIAICDILAIERSV 191

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
              ++YLH +    I+H D+K  N+ +++     +GDFG +       P   + ++  G 
Sbjct: 192 LRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF-----PVDINANKYYGW 243

Query: 738 IGYVA---PEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFE-EGL 782
            G +A   PE  A        D +S GI++ EM T     D +FE +GL
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFEKDGL 289

Length = 391

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 30/210 (14%)

Query: 567 IGIGGYGYVYKGILGTEETNV--AVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
           +G G +G VYK     +ET    A KV++ +     + ++ E E L +  H  +VK++  
Sbjct: 20  LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL-- 75

Query: 625 CSSIDTRGNEFK-ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
                    + K  ++ EF P G+++  + +  D     P++ ++ R         +LE 
Sbjct: 76  ----GAFYWDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICR--------QMLEA 122

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
           L +     I+H DLK  NVLL  +    + DFG+S     N           G+  ++AP
Sbjct: 123 LQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA---KNVKTLQRRDSFIGTPYWMAP 179

Query: 744 EYGALGEV------STHGDEYSFGILMLEM 767
           E   + E           D +S GI ++EM
Sbjct: 180 EV-VMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 50.8 bits (122), Expect = 1e-06
 Identities = 60/220 (27%), Positives = 89/220 (40%), Gaps = 32/220 (14%)

Query: 565 NLIGIGGYGYVYKGILGTEETN---VAVKVL---DLQQRGASKSFIAE---CEALRSIRH 615
             + + G G+  K +L   +      A+K L   D+  R   +S + E    E   S RH
Sbjct: 2   RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERH 61

Query: 616 RNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI 675
             LV +  +C   +         V E+   G L   +     +    P+         A 
Sbjct: 62  PFLVNLF-ACFQTEDH----VCFVMEYAAGGDL---MMHIHTDVFSEPRAVFY-----AA 108

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
            V   L+YLH +    IV+ DLK  N+LLD E    + DFGL +           TS   
Sbjct: 109 CVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDR-TSTFC 162

Query: 736 GSIGYVAPEYGALGEVS-THG-DEYSFGILMLEMFTGKRP 773
           G+  ++APE   L E S T   D +  G+L+ EM  G+ P
Sbjct: 163 GTPEFLAPE--VLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 28/220 (12%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRN 617
           F    ++G GG+G V    +       A K L+   +++R      + E   L  +  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLE----NWLNQKEDEQNQRPKLNLMQRLSI 673
           +V +  +  + D        LV   M  G L+    N  N   DEQ         + +  
Sbjct: 62  VVSLAYAYETKDAL-----CLVLTIMNGGDLKFHIYNMGNPGFDEQ---------RAIFY 107

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A ++   LE L       IV+ DLKP N+LLD+     + D GL+  + +    +T   R
Sbjct: 108 AAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ETVRGR 161

Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           V G++GY+APE     + +   D +  G L+ EM  G+ P
Sbjct: 162 V-GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 67/224 (29%), Positives = 94/224 (41%), Gaps = 30/224 (13%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSC 625
           IG G YG VYK     + +  AVK+LD       +   AE   L+S+  H N+VK     
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLS---IAIDVANVLE 682
              D        LV E    GS+   +         +  L   QRL    I+  +   L 
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELV---------KGLLICGQRLDEAMISYILYGALL 139

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS-RVKGSIG-- 739
            L H  +  I+H D+K +N+LL  E    + DFG+S  L       TST  R   S+G  
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL-------TSTRLRRNTSVGTP 192

Query: 740 -YVAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRPTDDM 777
            ++APE  A  +   +      D +S GI  +E+  G  P  DM
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 63/254 (24%), Positives = 108/254 (42%), Gaps = 35/254 (13%)

Query: 532 RRSKALVNSSIEDKYLKI--SYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAV 589
           R++K + N    ++Y KI     +L    E +    +IG G +G V      + +   A+
Sbjct: 16  RKNKNIDN--FLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAM 73

Query: 590 KVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           K+L   ++ +R  S  F  E + +       +V++   C+  D   +++  +V E+MP G
Sbjct: 74  KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF--CAFQD---DKYLYMVMEYMPGG 128

Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
            L N L    D   +  K           +V   L+ +H      ++H D+KP N+LLD 
Sbjct: 129 DLVN-LMSNYDVPEKWAKF-------YTAEVVLALDAIHS---MGLIHRDVKPDNMLLDK 177

Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YVAPEY----GALGEVSTHGDEYS 759
                + DFG    +     D+T   R   ++G   Y++PE     G  G      D +S
Sbjct: 178 HGHLKLADFGTCMKM-----DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 232

Query: 760 FGILMLEMFTGKRP 773
            G+ + EM  G  P
Sbjct: 233 VGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 65/221 (29%), Positives = 99/221 (44%), Gaps = 24/221 (10%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSC 625
           IG G YG V+K +     +  AVK+LD       +   AE   L+++  H N+VK     
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
              D +  +   LV E    GS+ + L +   ++ +R     M+   IA  +   L  L 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTD-LVKGFLKRGER-----MEEPIIAYILHEALMGLQ 138

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS-RVKGSIG---YV 741
           H      +H D+K +N+LL  E    + DFG+S  L       TST  R   S+G   ++
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-------TSTRLRRNTSVGTPFWM 191

Query: 742 APEYGALGEV--STHG---DEYSFGILMLEMFTGKRPTDDM 777
           APE  A  +   ST+    D +S GI  +E+  G  P  D+
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 32/210 (15%)

Query: 570 GGYGYVYKGILGTEETN--VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSS 627
           G  G V+      +E    V VK +        K+   E + L++I HR ++ +I +   
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAYR- 156

Query: 628 IDTRGNEFKALVYEFMP--NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
                  +K+ V   MP     L  ++++          L L Q ++I   +   L YLH
Sbjct: 157 -------WKSTVCMVMPKYKCDLFTYVDRSG-------PLPLEQAITIQRRLLEALAYLH 202

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL--HDNSPDQTSTSRVKGSIGYVAP 743
                 I+H D+K  N+ LD    A +GDFG +  L  H ++P     S   G++   +P
Sbjct: 203 GR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS---GTLETNSP 256

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           E  AL       D +S G+++ EM      
Sbjct: 257 ELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 25/212 (11%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVK--VLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
           IG G YG V+K         VA+K   LD    G   S + E   L+ ++H+N+V++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY-- 65

Query: 625 CSSIDTRGNEFK-ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
               D   ++ K  LV+E+      +  L +  D  N      +++  S    +   L +
Sbjct: 66  ----DVLHSDKKLTLVFEY-----CDQDLKKYFDSCNGDIDPEIVK--SFMFQLLKGLAF 114

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
            H H   +++H DLKP N+L++      + DFGL+R      P +  ++ V  ++ Y  P
Sbjct: 115 CHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAF--GIPVRCYSAEVV-TLWYRPP 168

Query: 744 E--YGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           +  +GA    ST  D +S G +  E+    RP
Sbjct: 169 DVLFGAKL-YSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 58/223 (26%), Positives = 88/223 (39%), Gaps = 37/223 (16%)

Query: 558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVL--DLQQRGASKSFIAECEALRSIRH 615
           T  +     +G+G +G V          NVA+K +         +K    E + L+ +RH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 616 RNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI 675
            N++    S S I     E    V E +  G+  + L      + Q  +  L Q L    
Sbjct: 69  ENII----SLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQIL---- 118

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
                L+Y+H      +VH DLKPSN+L++      + DFGL+R+     P  T      
Sbjct: 119 ---RGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMT------ 163

Query: 736 GSIGYVAPEYGALGEV-------STHGDEYSFGILMLEMFTGK 771
              GYV+  Y    E+           D +S G +  EM  GK
Sbjct: 164 ---GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 4e-06
 Identities = 59/230 (25%), Positives = 89/230 (38%), Gaps = 48/230 (20%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLD------LQQRGASKSFIAECEALRSIR 614
           + + + IG G YG V           VA+K +         QR      + E + LR  +
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-----LREIKILRRFK 61

Query: 615 HRNLVKI--ITSCSSIDTRGNEFKA--LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQR 670
           H N++ I  I    S +     F    +V E M                    KL   Q 
Sbjct: 62  HENIIGILDIIRPPSFE----SFNDVYIVQELMET---------------DLYKLIKTQH 102

Query: 671 LS------IAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
           LS          +   L+Y+H     +++H DLKPSN+LL+      + DFGL+R + D 
Sbjct: 103 LSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLAR-IADP 158

Query: 725 SPDQTS--TSRVKGSIGYVAPEYG-ALGEVSTHGDEYSFGILMLEMFTGK 771
             D T   T  V  +  Y APE        +   D +S G ++ EM + +
Sbjct: 159 EHDHTGFLTEYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 60/275 (21%), Positives = 113/275 (41%), Gaps = 30/275 (10%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS------KSFIAECEALRSIRHRNLV 619
            +G G +   Y+       T +AVK +   +  +S      ++   E   +  + H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
           +++ +     T  +    L  E+M  GS+ + L++    +         Q       +  
Sbjct: 67  RMLGA-----TCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ-------LLR 114

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNE-MVAHVGDFGLS-RLLHDNSPDQTSTSRVKGS 737
            L YLH +    I+H D+K +N+L+D+      + DFG + RL    +       ++ G+
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171

Query: 738 IGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP-TDDMFEEGLSL-HKYAKMGLPDQ 795
           I ++APE     +     D +S G +++EM T K P   +     L+L  K A       
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231

Query: 796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEI 830
           + E + P + +  L        ELQP  R    E+
Sbjct: 232 IPEHLSPGLRDVTLR-----CLELQPEDRPPSREL 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.0 bits (119), Expect = 4e-06
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 26/214 (12%)

Query: 574 YVYKGILGTEETN---VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS--SI 628
           YV   ++G   T    VA +  D +++  +K F+   +  ++   R+ +  + +C    I
Sbjct: 69  YVLTTLVGRNPTTAAFVATRGSDPKEKVVAK-FVMLNDERQAAYARSELHCLAACDHFGI 127

Query: 629 DTRGNEFKA-----LVYEFMPNGSLENWLNQKEDE----QNQRPKLNLMQRLSIAIDVAN 679
               ++FK+     L+ E+   G L   + Q+  E    Q     L L  ++ +A+D   
Sbjct: 128 VKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL-LFYQIVLALD--- 183

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
               +H      ++H DLK +N+ L    +  +GDFG S+   D+     ++S   G+  
Sbjct: 184 ---EVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC-GTPY 236

Query: 740 YVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           Y+APE       S   D +S G+++ E+ T  RP
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 64/252 (25%), Positives = 105/252 (41%), Gaps = 54/252 (21%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETN--VAVKVL---DLQQRGASKSFIAECEALRSI 613
           + F S  +IG G +G V   ++  ++T    A+K+L   D+ ++       AE + L   
Sbjct: 1   DDFESLKVIGRGAFGEVR--LVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA 58

Query: 614 RHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
               +VK+  S    D R N +  L+ EF+P G +   L +K+    +  +  + + + +
Sbjct: 59  DGAWVVKMFYSFQ--DKR-NLY--LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV-L 112

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS------------RLL 721
           AID  + L ++H          D+KP N+LLD +    + DFGL             R L
Sbjct: 113 AIDAIHQLGFIHR---------DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNL 163

Query: 722 HDNSPD----QTSTSRVK----------------GSIGYVAPEYGALGEVSTHGDEYSFG 761
             N P     Q   S+ K                G+  Y+APE       +   D +S G
Sbjct: 164 THNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223

Query: 762 ILMLEMFTGKRP 773
           ++M EM  G  P
Sbjct: 224 VIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 44/138 (31%), Positives = 63/138 (45%), Gaps = 13/138 (9%)

Query: 638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           LV E++  G L   +      Q QR KL        A ++   L +LH      I++ DL
Sbjct: 73  LVIEYVNGGDLMFHM------QRQR-KLPEEHARFYAAEICIALNFLHER---GIIYRDL 122

Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE 757
           K  NVLLD +    + D+G+ +      P  T TS   G+  Y+APE     E     D 
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCK--EGLGPGDT-TSTFCGTPNYIAPEILRGEEYGFSVDW 179

Query: 758 YSFGILMLEMFTGKRPTD 775
           ++ G+LM EM  G+ P D
Sbjct: 180 WALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 49.3 bits (117), Expect = 5e-06
 Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 27/214 (12%)

Query: 566 LIGIGGYGYVYKGILGTEETN---VAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLV 619
           L+G G +G V   IL  E+ +    A+K+L  +    +      + E   L++ RH  L 
Sbjct: 2   LLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
            +  S  + D         V E++  G L   L+++      R +           ++ +
Sbjct: 59  SLKYSFQTKDRL-----CFVMEYVNGGELFFHLSRERVFSEDRTRF-------YGAEIVS 106

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            L+YLH      IV+ DLK  N++LD +    + DFGL +   +   D  +     G+  
Sbjct: 107 ALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPE 160

Query: 740 YVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           Y+APE     +     D +  G++M EM  G+ P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 26/198 (13%)

Query: 583 EETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
            E  V +KVLD   R  + +F      +  + H +L  +   C     RG+E   +V EF
Sbjct: 43  RELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVC----VRGSE-NIMVEEF 97

Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
           + +G L+  L +      ++ ++ +  ++++A  +A+ L YL      ++VH ++   N+
Sbjct: 98  VEHGPLDVCLRK------EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNI 148

Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTS-----RVKGSIGYVAPE-YGALGEVSTHGD 756
           LL    +A     G S  +  + P  + T+     RV+  I ++APE       +ST  D
Sbjct: 149 LLARLGLAE----GTSPFIKLSDPGVSFTALSREERVE-RIPWIAPECVPGGNSLSTAAD 203

Query: 757 EYSFGILMLEM-FTGKRP 773
           ++SFG  +LE+ F G+ P
Sbjct: 204 KWSFGTTLLEICFDGEVP 221

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 49.3 bits (117), Expect = 5e-06
 Identities = 62/252 (24%), Positives = 106/252 (42%), Gaps = 54/252 (21%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETN--VAVKVL---DLQQRGASKSFIAECEALRSI 613
           E F S  +IG G +G V   ++  ++T    A+K+L   D+ ++       AE + L   
Sbjct: 1   EDFESLKVIGRGAFGEVR--LVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA 58

Query: 614 RHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
               +VK+  S      + N +  L+ EF+P G +   L +K+    +  +  + + + +
Sbjct: 59  DSLWVVKMFYS---FQDKLNLY--LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV-L 112

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS------------RLL 721
           AID  + L ++H          D+KP N+LLD++    + DFGL             R L
Sbjct: 113 AIDSIHQLGFIHR---------DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNL 163

Query: 722 HDNSPD----QTSTSRVK----------------GSIGYVAPEYGALGEVSTHGDEYSFG 761
           + + P     Q   S+ K                G+  Y+APE       +   D +S G
Sbjct: 164 NHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223

Query: 762 ILMLEMFTGKRP 773
           ++M EM  G  P
Sbjct: 224 VIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 48.8 bits (116), Expect = 5e-06
 Identities = 28/98 (28%), Positives = 48/98 (48%), Gaps = 6/98 (6%)

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      +V+ D+K  N++LD +    + DFGL +   +   D  +     
Sbjct: 103 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFC 156

Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  Y+APE     +     D +  G++M EM  G+ P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 48.8 bits (116), Expect = 6e-06
 Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 39/226 (17%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETN----VAVKVLD----LQQRGASKSFIAECEAL 610
           E F+    +G G +G V   IL T +      VA+K  +    ++Q+     F +E + L
Sbjct: 30  EDFNFIRTLGTGSFGRV---ILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKIL 85

Query: 611 RSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQR 670
             I H   V +  S      +   +  LV EF+  G    +L + +   N          
Sbjct: 86  NYINHPFCVNLYGS-----FKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF----- 135

Query: 671 LSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTS 730
              A  +  + EYL      +IV+ DLKP N+LLD +    + DFG ++++       T 
Sbjct: 136 --YAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV------DTR 184

Query: 731 TSRVKGSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP 773
           T  + G+  Y+APE   L  V  HG   D ++ GI + E+  G  P
Sbjct: 185 TYTLCGTPEYIAPE--ILLNVG-HGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 48.7 bits (116), Expect = 7e-06
 Identities = 61/225 (27%), Positives = 92/225 (40%), Gaps = 39/225 (17%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLD--LQQRGASKSFIAECEALRSIRHR 616
           E ++S   +G G YG V   I       VA+K L    Q    +K    E   L+ ++H 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 617 N---LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
           N   L+ + TS  S D   + +  LV  +M    L+  +     E   + +  + Q L  
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFY--LVMPYMQT-DLQKIMGHPLSED--KVQYLVYQMLC- 128

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
                  L+Y+H      I+H DLKP N+ ++ +    + DFGL+R       D   T  
Sbjct: 129 ------GLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMT-- 172

Query: 734 VKGSIGYVAPEYGALGEV-------STHGDEYSFGILMLEMFTGK 771
                GYV   +    EV       +   D +S G +M EM TGK
Sbjct: 173 -----GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 48.7 bits (116), Expect = 7e-06
 Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 42/230 (18%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSF---IAECEALRSIRHRN 617
           F+    IG G +G VY          VA+K +    + +++ +   I E   L+ +RH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 618 LVKIITSCSSIDTRGNEFKA----LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
                    +I+ +G   +     LV E+   GS  + L     E +++P    +Q + I
Sbjct: 77  ---------TIEYKGCYLREHTAWLVMEYCL-GSASDIL-----EVHKKP----LQEVEI 117

Query: 674 AI---DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTS 730
           A         L YLH H     +H D+K  N+LL       + DFG + L+   SP  + 
Sbjct: 118 AAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLV---SPANSF 171

Query: 731 TSRVKGSIGYVAPEY-GALGEVSTHG--DEYSFGILMLEMFTGKRPTDDM 777
                G+  ++APE   A+ E    G  D +S GI  +E+   K P  +M
Sbjct: 172 V----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.9 bits (116), Expect = 7e-06
 Identities = 33/124 (26%), Positives = 60/124 (48%), Gaps = 8/124 (6%)

Query: 654 QKEDEQNQ---RPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA 710
           ++E+ + +   +  L L   +  +  VA  +E+L        +H DL   N+LL    V 
Sbjct: 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVV 218

Query: 711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT- 769
            + DFGL+R ++ + PD       +  + ++APE       +   D +SFG+L+ E+F+ 
Sbjct: 219 KICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 277

Query: 770 GKRP 773
           G  P
Sbjct: 278 GASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 48.7 bits (116), Expect = 8e-06
 Identities = 42/179 (23%), Positives = 81/179 (45%), Gaps = 26/179 (14%)

Query: 591 VLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP--NGSL 648
           VL + Q+G +   + E   L+++ H +++++  +  S         A+    +P  +  L
Sbjct: 95  VLKIGQKGTT---LIEAMLLQNVNHPSVIRMKDTLVS--------GAITCMVLPHYSSDL 143

Query: 649 ENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM 708
             +L +       RP L + Q L I   +   L YLH      I+H D+K  N+ +++  
Sbjct: 144 YTYLTK-----RSRP-LPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVD 194

Query: 709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEM 767
              +GD G ++     +P       + G++   APE  A  + ++  D +S GI++ EM
Sbjct: 195 QVCIGDLGAAQ-FPVVAPAFLG---LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.1 bits (114), Expect = 9e-06
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 33/218 (15%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS- 624
           +IG GG+G VY           A+K LD ++R   K    + E L ++  R ++ ++++ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLD-KKRIKMK----QGETL-ALNERIMLSLVSTG 54

Query: 625 -CSSIDTRGNEFKA-----LVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAID 676
            C  I      F        + + M  G L   L+Q     E+  R           A +
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMR---------FYATE 105

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
           +   LE++H+     +V+ DLKP+N+LLD      + D GL+       P  +      G
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----G 157

Query: 737 SIGYVAPEYGALGEV-STHGDEYSFGILMLEMFTGKRP 773
           + GY+APE    G    +  D +S G ++ ++  G  P
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 39/137 (28%), Positives = 68/137 (49%), Gaps = 14/137 (10%)

Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           ++  E M  GSL+  L     ++ +R    ++ ++SIA  V   L YL       I+H D
Sbjct: 79  SICMEHMDGGSLDQVL-----KEAKRIPEEILGKVSIA--VLRGLAYLREK--HQIMHRD 129

Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           +KPSN+L+++     + DFG+S  L D+  +    +R      Y++PE       S   D
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQGTHYSVQSD 184

Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+ ++E+  G+ P
Sbjct: 185 IWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 36/216 (16%)

Query: 567 IGIGGYGYVYKGILG----TEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLV 619
           +G GGYG V+   L     T E  VA+K +    L +    +  + E + L + +   LV
Sbjct: 9   VGQGGYGQVF---LAKKKDTGEI-VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLV 64

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
           K++ +    D    E+  L  E++P G     LN          +   M  +  A+D  +
Sbjct: 65  KLLYAFQ--DD---EYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAEMFEAVDALH 118

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR--LLHDNSPDQTSTSRVKGS 737
            L Y+H          DLKP N L+D      + DFGLS+  + + NS        V GS
Sbjct: 119 ELGYIHR---------DLKPENFLIDASGHIKLTDFGLSKGIVTYANS--------VVGS 161

Query: 738 IGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
             Y+APE           D +S G ++ E   G  P
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 32/226 (14%)

Query: 567 IGIGGYGYVYKGIL-----------GTE-ETNVAVKVLDLQQRGASKSFIAECEALRSIR 614
           +G G    +Y GIL             E E  V +KVLD   R  S +F      +R + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
           H+++V +   C     R  E   +V EF+  G L+ ++++K D       L    +  +A
Sbjct: 63  HKHIVLLYGVC----VRDVE-NIMVEEFVEFGPLDLFMHRKSD------VLTTPWKFKVA 111

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
             +A+ L YL       +VH ++   N+LL  E +   G+ G    L D     T  SR 
Sbjct: 112 KQLASALSYLE---DKDLVHGNVCTKNILLAREGID--GECGPFIKLSDPGIPITVLSRQ 166

Query: 735 K--GSIGYVAPE-YGALGEVSTHGDEYSFGILMLEM-FTGKRPTDD 776
           +    I ++APE       +S   D++SFG  + E+ + G+ P  D
Sbjct: 167 ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 24/221 (10%)

Query: 557 ATEGFSSANLIGIGGYGYVYKGI-LGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRH 615
             + +   N+IG G +G VY+ I + T E     KVL   Q    +  I     ++++ H
Sbjct: 64  PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI-----MKNLNH 118

Query: 616 RNLVKIITSCSSIDTRGNE---FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLS 672
            N++ +     +   + NE   F  +V EF+P  ++  ++       N    L L++  S
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYA-RNNHALPLFLVKLYS 176

Query: 673 IAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD-NEMVAHVGDFGLSRLLHDNSPDQTST 731
             +     L Y+H      I H DLKP N+L+D N     + DFG ++ L      Q S 
Sbjct: 177 YQL--CRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSV 228

Query: 732 SRVKGSIGYVAPEYGALGEV--STHGDEYSFGILMLEMFTG 770
           S +  S  Y APE   LG    +TH D +S G ++ EM  G
Sbjct: 229 SYI-CSRFYRAPEL-MLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 33/218 (15%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS- 624
           +IG GG+G VY           A+K LD ++R   K    + E L ++  R ++ ++++ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLD-KKRIKMK----QGETL-ALNERIMLSLVSTG 54

Query: 625 ------CSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAID 676
                 C S      +  + + + M  G L   L+Q     E   R           A +
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMR---------FYAAE 105

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
           +   LE++H+     +V+ DLKP+N+LLD      + D GL+       P  +      G
Sbjct: 106 IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----G 157

Query: 737 SIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRP 773
           + GY+APE    G    +  D +S G ++ ++  G  P
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 43/227 (18%)

Query: 567 IGIGGYGYVYKGILGTE----------ETNVAVKVLDLQQRGASKSFIAECEALRSIRHR 616
           +G G +  +YKG+L  +          E +V +KVL    R  S +F      +  + H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR-DSLAFFETASLMSQLSHK 61

Query: 617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAID 676
           +LVK+   C   +        +V E++  G L+ +L        ++  ++L  +L +A  
Sbjct: 62  HLVKLYGVCVRDEN------IMVEEYVKFGPLDVFL------HREKNNVSLHWKLDVAKQ 109

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLL-------DNEMVAHVGDFGLSRLLHDNSPDQT 729
           +A+ L YL       +VH ++   N+L+              + D G+           +
Sbjct: 110 LASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI------TVLS 160

Query: 730 STSRVKGSIGYVAPEYGALGEVSTH--GDEYSFGILMLEMFT-GKRP 773
              RV+  I ++APE    G+ S     D++SFG  +LE+ + G+ P
Sbjct: 161 REERVE-RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 60/259 (23%), Positives = 95/259 (36%), Gaps = 69/259 (26%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETN--VAVKVL---DLQQRGASKSFIAECEALRSIRH 615
           F S  +IG G +G V   ++  ++T    A+K L   ++ ++       AE + L    +
Sbjct: 3   FESIKVIGRGAFGEVR--LVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 616 RNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI 675
             +VK+    S  D     +  L+ E++P G +   L  K+D   +      +    +AI
Sbjct: 61  PWVVKLY--YSFQD---ENYLYLIMEYLPGGDMMTLL-MKKDTFTEEETRFYIAETILAI 114

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH------------- 722
           D  + L Y+H          D+KP N+LLD +    + DFGL   L              
Sbjct: 115 DSIHKLGYIHR---------DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165

Query: 723 ---DNSPDQTSTSRVK-------------------GSIGYVAPE------YGALGEVSTH 754
               N  D  S                        G+  Y+APE      Y         
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE------ 219

Query: 755 GDEYSFGILMLEMFTGKRP 773
            D +S G++M EM  G  P
Sbjct: 220 CDWWSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 36/227 (15%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSF---IAECEALRSIRHRN 617
           FS    IG G +G VY          VA+K +    + +++ +   I E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 618 LVKIITSCSSIDTRGNEFKA----LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
                    +I  RG   +     LV E+   GS  + L     E +++P L  ++  ++
Sbjct: 77  ---------TIQYRGCYLREHTAWLVMEYCL-GSASDLL-----EVHKKP-LQEVEIAAV 120

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
                  L YLH H   +++H D+K  N+LL    +  +GDFG + ++   +P       
Sbjct: 121 THGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFV-- 172

Query: 734 VKGSIGYVAPEY-GALGEVSTHG--DEYSFGILMLEMFTGKRPTDDM 777
             G+  ++APE   A+ E    G  D +S GI  +E+   K P  +M
Sbjct: 173 --GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 14/137 (10%)

Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           ++  E M  GSL+  L +      Q     ++ ++SIA  V   L YL       I+H D
Sbjct: 79  SICMEHMDGGSLDQVLKKAGRIPEQ-----ILGKVSIA--VIKGLTYLREK--HKIMHRD 129

Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           +KPSN+L+++     + DFG+S  L D+  +    +R      Y++PE       S   D
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQGTHYSVQSD 184

Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+ ++EM  G+ P
Sbjct: 185 IWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 31/213 (14%)

Query: 574 YVYKGILGTEETNVAVKVLDLQQRGASK---SFIAECEALRSIRHRNLVKI----ITSCS 626
            +YKGI   +E  V ++      +G          E + LR I   N++KI    I    
Sbjct: 35  SIYKGIFNNKE--VIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92

Query: 627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH 686
            +  R     +L+ E+   G L   L++++D       L+   +L +AID    L  L+ 
Sbjct: 93  DL-PRL----SLILEYCTRGYLREVLDKEKD-------LSFKTKLDMAIDCCKGLYNLYK 140

Query: 687 HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY- 745
             +T+  + +L   + L+       +   GL ++L        +       + Y + +  
Sbjct: 141 --YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF------MVYFSYKML 192

Query: 746 -GALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
                E +   D YS G+++ E+FTGK P +++
Sbjct: 193 NDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225

Length = 283

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 46.6 bits (111), Expect = 3e-05
 Identities = 45/157 (28%), Positives = 68/157 (43%), Gaps = 17/157 (10%)

Query: 567 IGIGGYGYVYKGILGTEETN--VAVKVLD--LQQRGASKSFIAECEALRSIRHRNLVKII 622
           IG G YG V        ETN  VA+K +      R  +K  + E + LR + H N++ I 
Sbjct: 13  IGRGAYGIVCSAK--NSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
                          +VYE M +  L   +   +   +   +  L Q L         L+
Sbjct: 71  DIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLL-------RGLK 122

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR 719
           Y+H     +++H DLKPSN+LL+      + DFGL+R
Sbjct: 123 YIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 29/144 (20%), Positives = 66/144 (45%), Gaps = 23/144 (15%)

Query: 579 ILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLV--KIITSCSSIDTRGNEFK 636
           +LGT++ +  +K+   +++GA      E   L+ +  + L   K++ S    ++ G  + 
Sbjct: 16  LLGTKDEDYVLKINPSREKGAD--REREVAILQLLARKGLPVPKVLASG---ESDGWSY- 69

Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
            L+ E++   +L+              +++  ++  IA  +A +L  LH      + H D
Sbjct: 70  -LLMEWIEGETLD--------------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGD 114

Query: 697 LKPSNVLLDNEMVAHVGDFGLSRL 720
           L P N+L+D+  +  + D+  +  
Sbjct: 115 LHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 28/98 (28%), Positives = 49/98 (50%), Gaps = 5/98 (5%)

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + L+YLH     ++V+ DLK  N++LD +    + DFGL +   +   D  +     
Sbjct: 103 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFC 157

Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  Y+APE     +     D +  G++M EM  G+ P
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.6 bits (110), Expect = 4e-05
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 38/216 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD--LQQRGASKSFIAECEALRSIRHRNLVKIITS 624
           IG G  G V          NVAVK L    Q +  +K    E   L+ + H+N++ ++  
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
                            F P  SLE +  Q      +    NL Q + + +D   +   L
Sbjct: 89  -----------------FTPQKSLEEF--QDVYLVMELMDANLCQVIHMELDHERMSYLL 129

Query: 685 HH------HCHTS-IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN---SPDQTSTSRV 734
           +       H H++ I+H DLKPSN+++ ++    + DFGL+R    N   +P   +    
Sbjct: 130 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-- 187

Query: 735 KGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
                Y APE         + D +S G +M E+  G
Sbjct: 188 -----YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.1 bits (112), Expect = 4e-05
 Identities = 62/240 (25%), Positives = 94/240 (39%), Gaps = 50/240 (20%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVL--DLQQRGA-SKSFIAECEALRSIRHRNLVKII 622
           LIG GG G VY          VA+K +  DL +     K F+ E +    + H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 623 TSCSSIDTRGNEFKALVYEFMP---NGSLENWLN---QKE------DEQNQRPKLNLMQR 670
           + CS  D         VY  MP     +L++ L    QKE       E+           
Sbjct: 69  SICSDGD--------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF----- 115

Query: 671 LSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD--NEMVAHVGDFGLSRLLHDNSPDQ 728
           LSI   +   +EY+H      ++H DLKP N+LL    E+V  + D+G +        D 
Sbjct: 116 LSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV--ILDWGAAIFKKLEEEDL 170

Query: 729 TSTS---------------RVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
                              ++ G+  Y+APE       S   D Y+ G+++ +M T   P
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.2 bits (109), Expect = 5e-05
 Identities = 55/217 (25%), Positives = 88/217 (40%), Gaps = 38/217 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD--LQQRGASKSFIAECEALRSIRHRNLVKIITS 624
           IG G  G V        E NVA+K L    Q +  +K    E   ++ + H+N++     
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 86

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
                        L+  F P  SLE +  Q      +    NL Q + + +D   +   L
Sbjct: 87  ------------GLLNVFTPQKSLEEF--QDVYIVMELMDANLCQVIQMELDHERMSYLL 132

Query: 685 HH------HCHTS-IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN---SPDQTSTSRV 734
           +       H H++ I+H DLKPSN+++ ++    + DFGL+R    +   +P   +    
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-- 190

Query: 735 KGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGK 771
                Y APE         + D +S G +M EM  G 
Sbjct: 191 -----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.0 bits (109), Expect = 5e-05
 Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 12/101 (11%)

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + L YLH      +V+ DLK  N++LD +    + DFGL +   +   D  +     
Sbjct: 103 EIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFC 156

Query: 736 GSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP 773
           G+  Y+APE   + E + +G   D +  G++M EM  G+ P
Sbjct: 157 GTPEYLAPE---VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 62/244 (25%), Positives = 99/244 (40%), Gaps = 58/244 (23%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNL 618
           E F +  LI  G YG VY            V+  + +QR A K    +   LR+   +  
Sbjct: 1   EDFETIKLISNGAYGAVY-----------LVRHKETRQRFAMKKINKQNLILRNQIQQVF 49

Query: 619 VK-----------IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNL 667
           V+           +++   S +T+      +V E++  G     L      +N       
Sbjct: 50  VERDILTFAENPFVVSMFCSFETK--RHLCMVMEYVEGGDCATLL------KNIGALPVD 101

Query: 668 MQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL------- 720
           M R+  A  V   LEYLH++    IVH DLKP N+L+ +     + DFGLS++       
Sbjct: 102 MARMYFAETVL-ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157

Query: 721 -LHDNSPD----QTSTSRVKGSIGYVAPE------YGALGEVSTHGDEYSFGILMLEMFT 769
            L++   +    +    +V G+  Y+APE      YG         D ++ GI++ E   
Sbjct: 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG------KPVDWWAMGIILYEFLV 211

Query: 770 GKRP 773
           G  P
Sbjct: 212 GCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 46.2 bits (109), Expect = 6e-05
 Identities = 58/251 (23%), Positives = 105/251 (41%), Gaps = 29/251 (11%)

Query: 532 RRSKALVN--SSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAV 589
           R++K + N  +  +D   KI   +L    E +    +IG G +G V      +     A+
Sbjct: 16  RKNKNIDNFLNRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 73

Query: 590 KVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           K+L   ++ +R  S  F  E + +       +V++  +      + + +  +V E+MP G
Sbjct: 74  KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA-----FQDDRYLYMVMEYMPGG 128

Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
            L N ++  +  +          R   A +V   L+ +H       +H D+KP N+LLD 
Sbjct: 129 DLVNLMSNYDVPEK-------WARFYTA-EVVLALDAIHS---MGFIHRDVKPDNMLLDK 177

Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY----GALGEVSTHGDEYSFGI 762
                + DFG    ++     +  T+   G+  Y++PE     G  G      D +S G+
Sbjct: 178 SGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235

Query: 763 LMLEMFTGKRP 773
            + EM  G  P
Sbjct: 236 FLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 45.4 bits (107), Expect = 6e-05
 Identities = 57/235 (24%), Positives = 102/235 (43%), Gaps = 43/235 (18%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETN--VAVKVLDLQQRG--ASKSFIAECEALRSIRHR 616
           F    ++G G YG V K     +ET   VA+K     +      ++ + E + LR+++  
Sbjct: 3   FEVLGVVGEGAYGVVLK--CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAID 676
           N+V++     +   RG  +  LV+E++                 ++  L L++ +   + 
Sbjct: 61  NIVELK---EAFRRRGKLY--LVFEYV-----------------EKNMLELLEEMPNGVP 98

Query: 677 VANVLEYLH------HHCHTS-IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQT 729
              V  Y++      H CH + IVH D+KP N+L+ +  V  + DFG +R L + S +  
Sbjct: 99  PEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NAN 157

Query: 730 STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE------MFTGKRPTDDMF 778
            T  V  +  Y +PE           D +S G ++ E      +F G+   D +F
Sbjct: 158 YTEYV-ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.0 bits (97), Expect = 6e-05
 Identities = 23/59 (38%), Positives = 28/59 (47%)

Query: 298 LTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHL 356
           L  +DL  N +      A      L+ LDLS NNL+   P    GL S   LDLS N+L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 45.8 bits (108), Expect = 6e-05
 Identities = 63/232 (27%), Positives = 97/232 (41%), Gaps = 42/232 (18%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDL---QQRGASKSFIAECEALRSIRH 615
           E F   + IG G +G VY          VAVK +     Q     +  I E + L+ ++H
Sbjct: 21  EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH 80

Query: 616 RNLVKIITSCSSIDTRGNEFKA----LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRL 671
            N         +I+ +G   K     LV E+   GS  + L     E +++P    +Q +
Sbjct: 81  PN---------TIEYKGCYLKEHTAWLVMEYCL-GSASDLL-----EVHKKP----LQEV 121

Query: 672 SIAIDVANVLE---YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQ 728
            IA      L+   YLH H    ++H D+K  N+LL       + DFG +      SP  
Sbjct: 122 EIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS---SPAN 175

Query: 729 TSTSRVKGSIGYVAPEY-GALGEVSTHG--DEYSFGILMLEMFTGKRPTDDM 777
           +      G+  ++APE   A+ E    G  D +S GI  +E+   K P  +M
Sbjct: 176 SFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 44.8 bits (106), Expect = 9e-05
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 37/221 (16%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS-KSFIAECEALRSIRHRNLVKIITSC 625
           +G G YG VYK +       +A+K + L+   +     I E + L    H+ +   I   
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI--- 61

Query: 626 SSIDTRGNEF-KALVY---EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
             +D  G  F +  VY   E+M  GSL+  L          P+ ++++R++ A+ V  + 
Sbjct: 62  --VDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPE-DVLRRITYAV-VKGLK 116

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG-- 739
                H   +I+H D+KP+NVL++      + DFG+S             S  K +IG  
Sbjct: 117 FLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVS--------GNLVASLAKTNIGCQ 165

Query: 740 -YVAPEY------GALGEVSTHGDEYSFGILMLEMFTGKRP 773
            Y+APE             +   D +S G+ +LEM  G+ P
Sbjct: 166 SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 72/286 (25%), Positives = 102/286 (35%), Gaps = 45/286 (15%)

Query: 158 ASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPN 217
           A ++   L    +L  L  + N  G         L  L     L+ + LS N+L      
Sbjct: 40  AKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCG 99

Query: 218 SIANF--SSHLIYLYMSANRISGTIPTGVG--------NLKNLILIAMEVNLLTGSIPTS 267
            + +   SS L  L ++ N +       +          L+ L+L     N L G+   +
Sbjct: 100 VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVL---GRNRLEGASCEA 156

Query: 268 VGYLL----KLQVLSLFGNKISGE-IPS------SLGNLIFLTEVDLQGNSIRGSIPSAL 316
           +   L     L+ L+L  N I    I +      +  NL  L   DL  N +     SAL
Sbjct: 157 LAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVL---DLNNNGLTDEGASAL 213

Query: 317 GNCL----QLQKLDLSDNNLSGTIPREV-----IGLSSFVLLDLSRNHL--SGPIPL-EV 364
              L     L+ L+L DNNL+      +         S + L LS N +   G   L EV
Sbjct: 214 AETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEV 273

Query: 365 GRLKGIQQ-LDLSENKLSGEIPTSLAS-----CVGLEYLNFSDNSF 404
              K     LDL  NK   E    LA         LE L   D+SF
Sbjct: 274 LAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 58/229 (25%), Positives = 89/229 (38%), Gaps = 42/229 (18%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS 626
           +G G YG V           VAVK L       S+ F +   A R+ R   L+K +   +
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKL-------SRPFQSLIHARRTYRELRLLKHMKHEN 75

Query: 627 SIDTRGNEFKALVYEFMPNGSLENW------LNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
            I         L+  F P  S+EN+       N    + N   K   +    +   +  +
Sbjct: 76  VI--------GLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL 127

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           L  L +     I+H DLKPSNV ++ +    + DFGL+R   D               GY
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE------------MTGY 175

Query: 741 VAPEYGALGEVSTHG-------DEYSFGILMLEMFTGKR--PTDDMFEE 780
           VA  +    E+  +        D +S G +M E+  GK   P +D  ++
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ 224

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 16/213 (7%)

Query: 567 IGIGGYGYVYKGIL--GTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
           +G G YG+VYK     G +E   A+K   ++  G S S   E   LR ++H N++ +   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALK--QIEGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP-KLNLMQRLSIAIDVANVLEY 683
             S   R      L++++  +         +  + N++P +L      S+   + + + Y
Sbjct: 67  FLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMV----AHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
           LH +    ++H DLKP+N+L+  E        + D G +RL +           V  +  
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 740 YVAPEYGALGEVSTHG-DEYSFGILMLEMFTGK 771
           Y APE        T   D ++ G +  E+ T +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 28/162 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD--LQQRGASKSFIAECEALRSIRHRNLVKIITS 624
           IG G  G V        + NVA+K L    Q +  +K    E   ++ + H+N++     
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 79

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
                       +L+  F P  SLE +  Q      +    NL Q + + +D   +   L
Sbjct: 80  ------------SLLNVFTPQKSLEEF--QDVYLVMELMDANLCQVIQMELDHERMSYLL 125

Query: 685 HH------HCHTS-IVHCDLKPSNVLLDNEMVAHVGDFGLSR 719
           +       H H++ I+H DLKPSN+++ ++    + DFGL+R
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 9/98 (9%)

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A ++   L+ LH      IV  DL P+N+LLD+     +  F     + D S D  +   
Sbjct: 91  AAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-SCDGEAVEN 146

Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGK 771
           +     Y APE G + E +   D +S G ++ E+ TGK
Sbjct: 147 M-----YCAPEVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 65/252 (25%), Positives = 106/252 (42%), Gaps = 31/252 (12%)

Query: 532 RRSKALVN--SSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAV 589
           R++K + N  S  E    KI   +L    E F    +IG G +G V      + +   A+
Sbjct: 16  RKNKNIDNFLSRYEKAAEKI--TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAM 73

Query: 590 KVL---DLQQRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           K+L   ++ +R  S  F  E    R I  H N   I+    +   + +++  +V E+MP 
Sbjct: 74  KLLSKFEMIKRSDSAFFWEE----RDIMAHANSEWIVQLHYAF--QDDKYLYMVMEYMPG 127

Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L N ++  +  +          R   A +V   L+ +H       +H D+KP N+LLD
Sbjct: 128 GDLVNLMSNYDIPEK-------WARFYTA-EVVLALDAIHSM---GFIHRDVKPDNMLLD 176

Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY----GALGEVSTHGDEYSFG 761
                 + DFG    +  N   +  T+   G+  Y++PE     G  G      D +S G
Sbjct: 177 KSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234

Query: 762 ILMLEMFTGKRP 773
           + + EM  G  P
Sbjct: 235 VFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 44.3 bits (104), Expect = 2e-04
 Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 42/230 (18%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSF---IAECEALRSIRHRN 617
           F+    IG G +G VY          VA+K +    + +++ +   I E + L+ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 618 LVKIITSCSSIDTRGNEFKA----LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
                    SI+ +G   +     LV E+   GS  + L     E +++P    +Q + I
Sbjct: 87  ---------SIEYKGCYLREHTAWLVMEYCL-GSASDLL-----EVHKKP----LQEVEI 127

Query: 674 AIDVANVLE---YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTS 730
           A      L+   YLH H   +++H D+K  N+LL       + DFG + +    SP  + 
Sbjct: 128 AAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIA---SPANSF 181

Query: 731 TSRVKGSIGYVAPEY-GALGEVSTHG--DEYSFGILMLEMFTGKRPTDDM 777
                G+  ++APE   A+ E    G  D +S GI  +E+   K P  +M
Sbjct: 182 V----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 7/87 (8%)

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           + Y+H      I+H DLK  N+ L N ++  +GDFG+SRLL   S D  +T    G+  Y
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLM-GSCDLATT--FTGTPYY 171

Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEM 767
           ++PE        +  D +S G ++ EM
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 57/236 (24%), Positives = 104/236 (44%), Gaps = 26/236 (11%)

Query: 566 LIGIGGYGYVYKGILGTEE--TNVAV-KVLDLQQRGASKSFIAECEALRSIRHRNLVKII 622
           LIG GG+G VY+    ++    N AV K+ +L+    +++ + E     +I   + + + 
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLE----NETIVMETLVYNNIYDIDKIALW 74

Query: 623 TSCSSIDTRG-------NEFK--ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
            +  +ID  G         FK   + Y F+    L    N KE  +  + K   + + +I
Sbjct: 75  KNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL--VENTKEIFKRIKCKNKKLIK-NI 131

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR--LLHDNSPDQTST 731
             D+   LEY+H H    I H D+KP N+++D     ++ D+G++   ++H    + +  
Sbjct: 132 MKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188

Query: 732 SR--VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLH 785
            +   +G++ Y   +      V+  GD  S G  ML+    K P       G  +H
Sbjct: 189 QKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244

Length = 294

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 16/213 (7%)

Query: 567 IGIGGYGYVYKGIL--GTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
           +G G YG+VYK     G ++ + A+K   ++  G S S   E   LR ++H N++ +   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALK--QIEGTGISMSACREIALLRELKHPNVISLQKV 66

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP-KLNLMQRLSIAIDVANVLEY 683
             S     +    L++++  +         +  + N++P +L      S+   + + + Y
Sbjct: 67  FLS---HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMV----AHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
           LH +    ++H DLKP+N+L+  E        + D G +RL +           V  +  
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 740 YVAPEYGALGEVSTHG-DEYSFGILMLEMFTGK 771
           Y APE        T   D ++ G +  E+ T +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 26/118 (22%), Positives = 56/118 (47%), Gaps = 8/118 (6%)

Query: 657 DEQNQRPKLNLMQRLSIA--IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD 714
           D+  ++      + + +     + + + Y+H      I+H D+K  N+ L    +  +GD
Sbjct: 88  DKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGD 144

Query: 715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKR 772
           FG+S++L     + +    V G+  Y++PE     + +   D ++ G ++ E+ T KR
Sbjct: 145 FGISKILGS---EYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.1 bits (101), Expect = 4e-04
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 42/219 (19%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD--LQQRGASKSFIAECEALRSIRHRN---LVKI 621
           +G G YG V           VAVK L    Q    +K    E   L+ ++H N   L+ +
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLN-QK-EDEQNQRPKLNLMQRLSIAIDVAN 679
            T   S++   + +  LV   M    L N +  QK  D+  Q           +   +  
Sbjct: 85  FTPARSLEEFNDVY--LVTHLM-GADLNNIVKCQKLTDDHVQ----------FLIYQILR 131

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            L+Y+H      I+H DLKPSN+ ++ +    + DFGL+R    ++ D+ +        G
Sbjct: 132 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT--------G 176

Query: 740 YVAPEYGALGEVSTHG-------DEYSFGILMLEMFTGK 771
           YVA  +    E+  +        D +S G +M E+ TG+
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.7 bits (91), Expect = 5e-04
 Identities = 20/60 (33%), Positives = 29/60 (48%)

Query: 273 KLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNL 332
            L+ L L  N+++     +   L  L  +DL GN++    P A      L+ LDLS NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 43.6 bits (102), Expect = 5e-04
 Identities = 48/214 (22%), Positives = 91/214 (42%), Gaps = 44/214 (20%)

Query: 588 AVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGS 647
           A+    L++R  S+  + E   +R ++H+N+V+ I        + N+   ++ EF   G 
Sbjct: 45  AISYRGLKEREKSQ-LVIEVNVMRELKHKNIVRYI---DRFLNKANQKLYILMEFCDAGD 100

Query: 648 LENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHT--------SIVHCDLKP 699
           L        + Q        ++  +I +D+   L +   +CH          ++H DLKP
Sbjct: 101 LS------RNIQKCYKMFGKIEEHAI-VDITRQLLHALAYCHNLKDGPNGERVLHRDLKP 153

Query: 700 SNVLLDNEM-----------------VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
            N+ L   +                 +A +GDFGLS+    N   ++      G+  Y +
Sbjct: 154 QNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK----NIGIESMAHSCVGTPYYWS 209

Query: 743 PEYGALGEVSTHGDE---YSFGILMLEMFTGKRP 773
           PE   L E  ++ D+   ++ G ++ E+ +GK P
Sbjct: 210 PEL-LLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 34/118 (28%), Positives = 58/118 (49%), Gaps = 13/118 (11%)

Query: 665 LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
           L+    LS +  VA  + +L      + +H DL   N+LL +  +  + DFGL+R + ++
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 725 SPDQTSTSRVKGS----IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
                S   VKG+    + ++APE       +   D +S+GIL+ E+F+ G  P   M
Sbjct: 268 -----SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 41.7 bits (98), Expect = 0.001
 Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 16/97 (16%)

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTS--TSRVKGSI 738
           L+YLH      I+H D+KP N+L+++  V  + DFGL+R+     PD++   T  V    
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV---EEPDESKHMTQEVVTQY 169

Query: 739 GYVAPEYGALGEVSTHG----DEYSFGILMLEMFTGK 771
            Y APE   +G  S H     D +S G +  E+   +
Sbjct: 170 -YRAPEI-LMG--SRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 56/225 (24%), Positives = 91/225 (40%), Gaps = 27/225 (12%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNL 618
           E F     IG G YG VYK          A+KV+ L+          E   ++  +H N+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
           V    S    D        +  EF   GSL+       D  +    L+  Q   ++ +  
Sbjct: 69  VAYFGSYLRRDKLW-----ICMEFCGGGSLQ-------DIYHVTGPLSESQIAYVSRETL 116

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSI 738
             L YLH       +H D+K +N+LL +     + DFG+S  +        + ++ K  I
Sbjct: 117 QGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQI------TATIAKRKSFI 167

Query: 739 G---YVAPEYGAL---GEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
           G   ++APE  A+   G  +   D ++ GI  +E+   + P  D+
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 41.6 bits (97), Expect = 0.001
 Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 49/182 (26%)

Query: 606 ECEALRSIRHRNLVKIITSCSSID-----TRGNEFKALVYEFMPNGSLENWLNQKEDEQN 660
           E  AL  + H N++KI     S       T+  +F   +Y FM + + + W ++   +Q 
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFMYDEAFD-WKDRPLLKQT 269

Query: 661 QRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL 720
           +     +M++L  A+      EY+H      ++H D+K  N+ L+ +    +GDFG    
Sbjct: 270 RA----IMKQLLCAV------EYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFG---- 312

Query: 721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH------GDEY-------SFGILMLEM 767
                   T+    K      A +YG +G V+T+      GD Y       S G+++L+M
Sbjct: 313 --------TAMPFEKER---EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361

Query: 768 FT 769
            +
Sbjct: 362 LS 363

Length = 501

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.8 bits (86), Expect = 0.002
 Identities = 20/57 (35%), Positives = 28/57 (49%), Gaps = 2/57 (3%)

Query: 349 LDLSRNHLSGPIPLEV-GRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSF 404
           LDLS N L+  IP      L  ++ LDLS N L+   P + +    L  L+ S N+ 
Sbjct: 5   LDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.8 bits (86), Expect = 0.002
 Identities = 21/57 (36%), Positives = 28/57 (49%), Gaps = 2/57 (3%)

Query: 373 LDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSG-FSSLKGLQDLDLSRNNF 428
           LDLS N+L+     +      L+ L+ S N+    I    FS L  L+ LDLS NN 
Sbjct: 5   LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 41.0 bits (96), Expect = 0.002
 Identities = 42/179 (23%), Positives = 77/179 (43%), Gaps = 26/179 (14%)

Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL 665
           E   L +++H N   I+    S +  GN +  +V ++   G L   +N +          
Sbjct: 49  EVAVLSNMKHPN---IVQYQESFEENGNLY--IVMDYCEGGDLYKKINAQRGVLFPED-- 101

Query: 666 NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNS 725
              Q L   + +   L+++H      I+H D+K  N+ L  +    +GDFG++R+L+   
Sbjct: 102 ---QILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN--- 152

Query: 726 PDQTSTSRVKGSIG---YVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG 781
              ++    +  IG   Y++PE       +   D ++ G ++ EM T K      FE G
Sbjct: 153 ---STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA----FEAG 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 41.2 bits (97), Expect = 0.002
 Identities = 30/108 (27%), Positives = 52/108 (48%), Gaps = 13/108 (12%)

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTS--TSRVKGSI 738
           L+Y+H     +++H DLKP N+L++ +    + DFGL+R   +N  +     T  V  + 
Sbjct: 118 LKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATR 173

Query: 739 GYVAPEYG-ALGEVSTHGDEYSFGILMLE------MFTGKRPTDDMFE 779
            Y APE   +    +   D +S G ++ E      +F GK   D + +
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQ 221

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.8 bits (86), Expect = 0.003
 Identities = 21/60 (35%), Positives = 29/60 (48%)

Query: 393 GLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNL 452
            L+ L+ S+N         F  L  L+ LDLS NN +   P   +    L+ L+LS NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	871
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.84
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.8
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.8
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.78
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.78
PRK10345	210	hypothetical protein; Provisional	99.78
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.74
smart00090	237	RIO RIO-like kinase.	99.74
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.73
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.66
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.66
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.65
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.6
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.57
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.56
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.54
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.53
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.51
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.49
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.48
PLN03150	623	hypothetical protein; Provisional	99.45
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.42
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.4
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.35
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.34
KOG1243	690	consensus Protein kinase [General function predict	99.31
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.29
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.25
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.24
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.22
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.21
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.21
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.19
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.19
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.18
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.18
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.16
PLN03150	623	hypothetical protein; Provisional	99.16
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.16
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.13
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.09
KOG3087	229	consensus Serine/threonine protein kinase [General	99.05
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.05
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.04
COG4248	637	Uncharacterized protein with protein kinase and he	99.03
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.99
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.98
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.97
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.91
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.9
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.89
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.86
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.85
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.83
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.79
PRK09902	216	hypothetical protein; Provisional	98.69
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.61
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.56
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.55
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.52
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.49

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8.9e-97  Score=915.16  Aligned_cols=792  Identities=33%  Similarity=0.519  Sum_probs=580.7

Q ss_pred             CCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCcccccccccccc
Q 002883           12 HCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMF   91 (871)
Q Consensus        12 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L   91 (871)
                      .+++|+.|+|++|.+++.+|..++.+++|++|+|++|.+.+.+|.+|+++++|++|+|++|.+++.+|..|+.+++|++|
T Consensus       138 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L  217 (968)
T PLN00113        138 SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWI  217 (968)
T ss_pred             ccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEE
Confidence            34556666666666655555556666666666666666555555556666666666666666555555556666666666


Q ss_pred             ccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCC-------------
Q 002883           92 QVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNA-------------  158 (871)
Q Consensus        92 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~-------------  158 (871)
                      +|++|.+.+.+|..+.++++|++|++++|.+.+.+|..+. .+++|+.|+|++|.+++.+|.++.++             
T Consensus       218 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l  296 (968)
T PLN00113        218 YLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL  296 (968)
T ss_pred             ECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh-CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCee
Confidence            6666666555555555566666666666655555554443 55556666666665555444433221             


Q ss_pred             -CCCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccC
Q 002883          159 -SSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRIS  237 (871)
Q Consensus       159 -~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~  237 (871)
                       ..+|+.+..+++|+.|++++|.+...      .+..+..+++|+.|+|++|.+++.+|..+..+ .+|+.|++++|+++
T Consensus       297 ~~~~p~~~~~l~~L~~L~l~~n~~~~~------~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~-~~L~~L~Ls~n~l~  369 (968)
T PLN00113        297 SGEIPELVIQLQNLEILHLFSNNFTGK------IPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH-NNLTVLDLSTNNLT  369 (968)
T ss_pred             ccCCChhHcCCCCCcEEECCCCccCCc------CChhHhcCCCCCEEECcCCCCcCcCChHHhCC-CCCcEEECCCCeeE
Confidence             13556677788888888888877642      23456677888888888888887788877776 46888888888888


Q ss_pred             CCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCccccc
Q 002883          238 GTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALG  317 (871)
Q Consensus       238 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~  317 (871)
                      +..|..+..+++|+.|++++|.+.+..|..+..+++|+.|+|++|++++..|..|..+++|+.|++++|++++.++..+.
T Consensus       370 ~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  449 (968)
T PLN00113        370 GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKW  449 (968)
T ss_pred             eeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhc
Confidence            88888888888888888888888888888888888999999999998888888888899999999999999888888888


Q ss_pred             CCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCcee
Q 002883          318 NCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYL  397 (871)
Q Consensus       318 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  397 (871)
                      .+++|+.|++++|++.+.+|..+ +.++|+.|++++|++++..|..+..+++|+.|+|++|++.+.+|..+..+++|++|
T Consensus       450 ~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  528 (968)
T PLN00113        450 DMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSL  528 (968)
T ss_pred             cCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEE
Confidence            88999999999999887777655 56889999999999998999999999999999999999999999999999999999


Q ss_pred             eecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCCcccccccceeccCCCCCc
Q 002883          398 NFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLC  477 (871)
Q Consensus       398 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~C  477 (871)
                      +|++|.+++.+|..|..+++|+.|||++|++++.+|..+..+++|+.|++++|++.+.+|..+.+..+....+.+|+..|
T Consensus       529 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc  608 (968)
T PLN00113        529 DLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLC  608 (968)
T ss_pred             ECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCcccc
Confidence            99999999999999999999999999999999999999999999999999999999999988888888888899999999


Q ss_pred             cCCCcccccccccCCCCcccccceeEEEeeehhhhhhhhHHHHHH-HHHHHHHhhhhhhh-hc-cccccccc------cc
Q 002883          478 GGSPELHLHSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIVF-VFYQRRKRRRRSKA-LV-NSSIEDKY------LK  548 (871)
Q Consensus       478 ~~~~~~~~~~c~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~rr~~~~~~~~-~~-~~~~~~~~------~~  548 (871)
                      +.++......|.....   .  ....++++++++ ++++++++++ ++++|++++.+.+. .. ...+....      ..
T Consensus       609 ~~~~~~~~~~c~~~~~---~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  682 (968)
T PLN00113        609 GGDTTSGLPPCKRVRK---T--PSWWFYITCTLG-AFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKS  682 (968)
T ss_pred             CCccccCCCCCccccc---c--ceeeeehhHHHH-HHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchh
Confidence            9776554555632211   1  111122222222 2222222222 22223222111111 10 01111000      11


Q ss_pred             cCHHHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeeccc
Q 002883          549 ISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSI  628 (871)
Q Consensus       549 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  628 (871)
                      +++++   ....|...+.||+|+||.||+|++..++..||||+++....    ...+|++++++++||||++++++|.+.
T Consensus       683 ~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~  755 (968)
T PLN00113        683 ITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSE  755 (968)
T ss_pred             hhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcC
Confidence            22222   23567888999999999999999988999999999864332    123468899999999999999998765


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM  708 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  708 (871)
                           ...|+||||+++|+|.++++          .++|.++..++.|+|+|++|||..+.++|+||||||+||+++.++
T Consensus       756 -----~~~~lv~Ey~~~g~L~~~l~----------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~  820 (968)
T PLN00113        756 -----KGAYLIHEYIEGKNLSEVLR----------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD  820 (968)
T ss_pred             -----CCCEEEEeCCCCCcHHHHHh----------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC
Confidence                 55799999999999999995          278999999999999999999966556999999999999999988


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA  788 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~  788 (871)
                      ..++. ||.+.....       .....+++.|+|||+..+..++.++|||||||++|||+||+.||............+.
T Consensus       821 ~~~~~-~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~  892 (968)
T PLN00113        821 EPHLR-LSLPGLLCT-------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA  892 (968)
T ss_pred             ceEEE-ecccccccc-------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHH
Confidence            88875 665543221       1123578999999999999999999999999999999999999965433333333333


Q ss_pred             hhCCCc-hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          789 KMGLPD-QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       789 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      ...... ....+.++.+....                ....+...++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       893 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        893 RYCYSDCHLDMWIDPSIRGDV----------------SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             HHhcCccchhheeCccccCCC----------------CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            322111 12223332221100                0112344578899999999999999999999999998865

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.6e-54  Score=531.51  Aligned_cols=475  Identities=35%  Similarity=0.560  Sum_probs=305.5

Q ss_pred             cccccCccCcCCCCCCEEecCCCcccccCCcccc-CCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCc
Q 002883            2 LQGEIPANITHCSELRILDLVVNKLEGNIPSELG-NLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPS   80 (871)
Q Consensus         2 ~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~   80 (871)
                      +.|.+|..|..+++|+.|+|++|++++.+|..+. .+++|++|+|++|++++.+|.  +.+++|++|+|++|.+++.+|.
T Consensus        81 i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~  158 (968)
T PLN00113         81 ISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPN  158 (968)
T ss_pred             ccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCCh
Confidence            4566677777777777777777777766665544 666666666666666554443  2344555555555555544555


Q ss_pred             cccccccccccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCC-
Q 002883           81 ELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNAS-  159 (871)
Q Consensus        81 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~-  159 (871)
                      .|+.+++|++|+|++|.+.+.+|..+.++++|++|++++|.+.+.+|..+. .+++|+.|+|++|.+++.+|..+.++. 
T Consensus       159 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~  237 (968)
T PLN00113        159 DIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELG-QMKSLKWIYLGYNNLSGEIPYEIGGLTS  237 (968)
T ss_pred             HHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHc-CcCCccEEECcCCccCCcCChhHhcCCC
Confidence            555555555555555555444555555555555555555555444444433 444555555555554444444332221 


Q ss_pred             -------------CCCccccCCCcccEEecccccCCCCCCCCc------------------cccccccCCCcccEEEccC
Q 002883          160 -------------SIPEDLGKLKNLIRLNFARNNLGTGKGNDL------------------RFLDSLVNCTFLEVVSLSS  208 (871)
Q Consensus       160 -------------~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~------------------~~~~~l~~l~~L~~L~L~~  208 (871)
                                   .+|..++++++|++|++++|++...-+..+                  ..+..+.++++|++|++++
T Consensus       238 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~  317 (968)
T PLN00113        238 LNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFS  317 (968)
T ss_pred             CCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCC
Confidence                         234445555555555555555542110000                  0112233444455555555


Q ss_pred             CcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCC
Q 002883          209 NSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEI  288 (871)
Q Consensus       209 n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  288 (871)
                      |.+++..|..+..+ ++|+.|++++|.+++..|..++.+++|+.|++++|.+++..|..+..+++|+.|++++|++.+..
T Consensus       318 n~~~~~~~~~~~~l-~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~  396 (968)
T PLN00113        318 NNFTGKIPVALTSL-PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEI  396 (968)
T ss_pred             CccCCcCChhHhcC-CCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccC
Confidence            55544444444444 23555555555555455555555555555555555555555555555555555555555555555


Q ss_pred             CcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCC
Q 002883          289 PSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLK  368 (871)
Q Consensus       289 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~  368 (871)
                      |..+..+++|+.|+|++|++++..|..|..+++|+.|++++|.+++.++..+..+++|+.|++++|++.+..|..+ ..+
T Consensus       397 p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~  475 (968)
T PLN00113        397 PKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSK  475 (968)
T ss_pred             CHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccc
Confidence            6666666677777777777766666667777777777777777776667667777777777777777776666544 357


Q ss_pred             CCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecC
Q 002883          369 GIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLS  448 (871)
Q Consensus       369 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~  448 (871)
                      +|+.|++++|++++..|..|..+++|+.|+|++|++.+.+|..+..+++|++|+|++|++++.+|..+..+++|+.|+|+
T Consensus       476 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  555 (968)
T PLN00113        476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS  555 (968)
T ss_pred             cceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECC
Confidence            88889999999998999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCcccCCCC-cccccccceeccCCCCCccCCC
Q 002883          449 FNNLEGEVPSE-GVFKNVRAVSIIGNNKLCGGSP  481 (871)
Q Consensus       449 ~N~l~~~~~~~-~~~~~l~~l~l~~N~~~C~~~~  481 (871)
                      +|++++..|.. ..+..++.+++.+|+..+..|.
T Consensus       556 ~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~  589 (968)
T PLN00113        556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS  589 (968)
T ss_pred             CCcccccCChhHhcCcccCEEeccCCcceeeCCC
Confidence            99999988764 5567899999999998775553

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-46  Score=376.25  Aligned_cols=253  Identities=26%  Similarity=0.358  Sum_probs=208.6

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc-eee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE-FKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~~  637 (871)
                      +.+..+.||+|..|+||+++++.+++.+|+|++... +....+++.+|+++++..+||+||.+||+|+..     . ..+
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~-----~~~is  154 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN-----GEEIS  154 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC-----CceEE
Confidence            345678899999999999999999999999999433 334567899999999999999999999999876     4 589


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH-HCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||++|+|++++...+       ++++...-+++.+|++||.|||+ +   +||||||||+|||++..|.+||||||
T Consensus       155 I~mEYMDgGSLd~~~k~~g-------~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFG  224 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRVG-------RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFG  224 (364)
T ss_pred             eehhhcCCCCHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEecccc
Confidence            9999999999999998764       69999999999999999999996 5   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      .+..+...     .....+||..|||||.+.+..|+.++||||||++++|+++|+.||.........+.           
T Consensus       225 VS~~lvnS-----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~-----------  288 (364)
T KOG0581|consen  225 VSGILVNS-----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF-----------  288 (364)
T ss_pred             ccHHhhhh-----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHH-----------
Confidence            99887543     44557899999999999999999999999999999999999999986311100000           


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                   +.....+...+|.+...  .+.+++.+++..||+.||.+|||++|+++.
T Consensus       289 -------------~Ll~~Iv~~ppP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  289 -------------ELLCAIVDEPPPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             -------------HHHHHHhcCCCCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                         11111111112222111  356678899999999999999999999874

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-46  Score=375.25  Aligned_cols=205  Identities=27%  Similarity=0.501  Sum_probs=184.4

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ..++|...+.||+|+||+||+|+++.++..||||.+...  .....+.+..|+.+++.++|||||++++++.+.     +
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-----~   82 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-----D   82 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-----C
Confidence            346899999999999999999999999999999999655  444556788999999999999999999998876     7


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC------C
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE------M  708 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~------~  708 (871)
                      ++|+|||||.||+|.+|++..+       .+++..++.++.|||.|+++||++   +||||||||+|||++..      .
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~-------~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~  152 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRG-------RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSP  152 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCc
Confidence            8999999999999999999876       699999999999999999999999   99999999999999764      5


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhh
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEE  780 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  780 (871)
                      .+||+|||+|+.+.+.    ......+|++.|||||++....|+.|+|+||+|+++|+|++|+.||......
T Consensus       153 ~LKIADFGfAR~L~~~----~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  153 VLKIADFGFARFLQPG----SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             eEEecccchhhhCCch----hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            6899999999988743    3344578999999999999999999999999999999999999999865444

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-46  Score=378.09  Aligned_cols=254  Identities=21%  Similarity=0.324  Sum_probs=207.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHHHHHcCCCCccceeeeeecccCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-------GASKSFIAECEALRSIRHRNLVKIITSCSSIDT  630 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  630 (871)
                      ...|.+.+.+|+|+||.|-+|..+.+++.||||++..+..       .....+.+|+++|++++||+||+++++|...  
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~--  248 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP--  248 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC--
Confidence            3568889999999999999999999999999999954321       1223567999999999999999999999877  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC---
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE---  707 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---  707 (871)
                         +..||||||++||+|.+++-.++       .+.+...+.+++|++.|+.|||++   ||+||||||+|||+..+   
T Consensus       249 ---ds~YmVlE~v~GGeLfd~vv~nk-------~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~  315 (475)
T KOG0615|consen  249 ---DSSYMVLEYVEGGELFDKVVANK-------YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAED  315 (475)
T ss_pred             ---CceEEEEEEecCccHHHHHHhcc-------ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcc
Confidence               66799999999999999998766       578888899999999999999999   99999999999999765   


Q ss_pred             CceEEeecccceecCCCCCCccccccccccccccCcccccCCCC---CCccchhhHHHHHHHHHhCCCCCchhhhhhhhH
Q 002883          708 MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV---STHGDEYSFGILMLEMFTGKRPTDDMFEEGLSL  784 (871)
Q Consensus       708 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~  784 (871)
                      ..+||+|||+|+..++.    ......+||+.|.|||++.+..+   ..++|+||+||++|-+++|.+||.+...+....
T Consensus       316 ~llKItDFGlAK~~g~~----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~  391 (475)
T KOG0615|consen  316 CLLKITDFGLAKVSGEG----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK  391 (475)
T ss_pred             eEEEecccchhhccccc----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHH
Confidence            78999999999987643    34455789999999999876543   347899999999999999999998754432122


Q ss_pred             HHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          785 HKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .+.....+..                            ..+.+.++.++..++|.+||..||++|||++|+++.
T Consensus       392 eQI~~G~y~f----------------------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  392 EQILKGRYAF----------------------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             HHHhcCcccc----------------------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            2222211111                            112334667788899999999999999999999874

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-45  Score=389.54  Aligned_cols=249  Identities=23%  Similarity=0.347  Sum_probs=211.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .+|...+.||+|+|+.||++++..+|+.||+|++...   .....+.+.+||++.++++|||||+++++|++.     .+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs-----~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS-----NN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC-----Cc
Confidence            5799999999999999999999889999999999642   344567889999999999999999999999887     88


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      +|+|.|+|+.++|..+++..+       .+++.+++.+.+||+.||.|||++   +|+|||||..|++++++.++||+||
T Consensus        93 VYivLELC~~~sL~el~Krrk-------~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDF  162 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRK-------PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDF  162 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcC-------CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEeccc
Confidence            999999999999999998544       699999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |+|..+..+.   ......+|||.|.|||++.....+..+||||+|||+|.|++|++||+...-.+ .+......     
T Consensus       163 GLAt~le~~~---Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-ty~~Ik~~-----  233 (592)
T KOG0575|consen  163 GLATQLEYDG---ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-TYNKIKLN-----  233 (592)
T ss_pred             ceeeeecCcc---cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-HHHHHHhc-----
Confidence            9999886432   23445789999999999999999999999999999999999999998642221 11111111     


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                        +..-|.                         ....+..+||.++|+.||.+|||+++|+..
T Consensus       234 --~Y~~P~-------------------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  234 --EYSMPS-------------------------HLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             --Cccccc-------------------------ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              000000                         223356699999999999999999999863

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-45  Score=391.65  Aligned_cols=290  Identities=40%  Similarity=0.671  Sum_probs=235.9

Q ss_pred             cccccCHHHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeee
Q 002883          545 KYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS  624 (871)
Q Consensus       545 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~  624 (871)
                      ....|++.++..++++|.....||+|+||.||+|... +++.||||.+........++|.+|++++.+++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            4456899999999999999999999999999999997 458999998865443214569999999999999999999999


Q ss_pred             ecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 002883          625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL  704 (871)
Q Consensus       625 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  704 (871)
                      |.+.+.    ..++|+|||+.|+|.+++......     .++|..+.+||.++|+||+|||..+.+.|+||||||+|||+
T Consensus       140 C~e~~~----~~~LVYEym~nGsL~d~L~~~~~~-----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL  210 (361)
T KOG1187|consen  140 CLEGGE----HRLLVYEYMPNGSLEDHLHGKKGE-----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL  210 (361)
T ss_pred             EecCCc----eEEEEEEccCCCCHHHHhCCCCCC-----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence            987621    589999999999999999875432     58999999999999999999999988899999999999999


Q ss_pred             CCCCceEEeecccceecCCCCCCccccccc-cccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhh-hhhh
Q 002883          705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRV-KGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMF-EEGL  782 (871)
Q Consensus       705 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~-~~~~  782 (871)
                      |+++++||+|||+|+.....   ....... .||.+|+|||+...+..+.++|||||||++.|++||+.|.+... ....
T Consensus       211 D~~~~aKlsDFGLa~~~~~~---~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~  287 (361)
T KOG1187|consen  211 DEDFNAKLSDFGLAKLGPEG---DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGEL  287 (361)
T ss_pred             CCCCCEEccCccCcccCCcc---ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccc
Confidence            99999999999999654431   1111112 79999999999999999999999999999999999999887543 2222


Q ss_pred             hHHHHhhhCCCc-hhhhhcChhHHH-HHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          783 SLHKYAKMGLPD-QVAEIIDPAILE-EALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       783 ~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                      ....|....... .+.+++|+.+.. .+..                 .+...++..++.+|++.+|++||++.||++.|+
T Consensus       288 ~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~-----------------~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~  350 (361)
T KOG1187|consen  288 SLVEWAKPLLEEGKLREIVDPRLKEGEYPD-----------------EKEVKKLAELALRCLRPDPKERPTMSQVVKELE  350 (361)
T ss_pred             cHHHHHHHHHHCcchhheeCCCccCCCCCh-----------------HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence            344544332222 566777766541 1110                 045566899999999999999999999999997


Q ss_pred             HHHH
Q 002883          861 EAQK  864 (871)
Q Consensus       861 ~i~~  864 (871)
                      .+..
T Consensus       351 ~~~~  354 (361)
T KOG1187|consen  351 GILS  354 (361)
T ss_pred             hhcc
Confidence            6654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-46  Score=356.95  Aligned_cols=263  Identities=22%  Similarity=0.313  Sum_probs=210.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ..+|++.++||+|+||+||+|++..+|..||.|.+...  +....+....|+.++++++|||||+++++-...   +...
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~---~~ev   94 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE---DNEV   94 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc---cchh
Confidence            45688999999999999999999999999999998633  233456788999999999999999998842221   2245


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCceeeCCCCceEEee
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCH-TSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      +++|||+|++|+|..+|+..+..   +..+++..+|+++.|++.||.++|...+ ..|+||||||.||+++.+|.+||+|
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~q---kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGD  171 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQ---KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGD  171 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhc---cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeecc
Confidence            89999999999999999876543   4579999999999999999999999432 1399999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh-hhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA-KMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~-~~~~~  793 (871)
                      ||+++.+...   .+.....+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+.  .-..+.+.+ ....|
T Consensus       172 fGL~r~l~s~---~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qgd~~  246 (375)
T KOG0591|consen  172 FGLGRFLSSK---TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQGDYP  246 (375)
T ss_pred             chhHhHhcch---hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcCCCC
Confidence            9999988653   33445578999999999999999999999999999999999999999864  111121111 11111


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                      +-..                              ..++..+..++..|+..||+.||+...+++.+..
T Consensus       247 ~~p~------------------------------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  247 PLPD------------------------------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             CCcH------------------------------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            1111                              1334567789999999999999997666666554

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=382.98  Aligned_cols=258  Identities=32%  Similarity=0.477  Sum_probs=208.4

Q ss_pred             CCCCceeeccccceEEEEEECCCCcE-EEEEEeeccccch--HHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETN-VAVKVLDLQQRGA--SKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ..+.+.+|+|+||+||+|.+.  |+. ||||++.......  .+.|.+|+.++.+++|||||+++|+|.+..    ...+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~~  116 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSLC  116 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----CceE
Confidence            344556999999999999996  455 9999996544322  468999999999999999999999997752    1579


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEecCCCCCceeeCCCC-ceEEeec
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPSNVLLDNEM-VAHVGDF  715 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~Nill~~~~-~~kl~Df  715 (871)
                      +||||+++|+|.+++....     ...+++..+..++.|||+||.|||+.   + ||||||||+|||++.++ ++||+||
T Consensus       117 iVtEy~~~GsL~~~l~~~~-----~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DF  188 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKR-----KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADF  188 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcc-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCC
Confidence            9999999999999998742     12699999999999999999999999   7 99999999999999997 9999999


Q ss_pred             ccceecCCCCCCccccccccccccccCccccc--CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA--LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |+++......   .......||+.|||||++.  ...|+.|+||||||+++|||+||+.||.+.... ............
T Consensus       189 Glsr~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~~~~~v~~~~~R  264 (362)
T KOG0192|consen  189 GLSREKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-QVASAVVVGGLR  264 (362)
T ss_pred             ccceeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhcCCC
Confidence            9998765431   2222357999999999998  569999999999999999999999999976542 222222111111


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      +.+..                              .+...+..++.+||+.||++||+..|++..|+.+....
T Consensus       265 p~~p~------------------------------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  265 PPIPK------------------------------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             CCCCc------------------------------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence            11110                              14456778999999999999999999999999886643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.3e-45  Score=350.72  Aligned_cols=278  Identities=20%  Similarity=0.238  Sum_probs=215.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      +.|+...++|+|+||+||+++++.+|+.||||++...  +....+...+|++++++++|+|+|.++++|...     ...
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-----rkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-----RKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc-----cee
Confidence            4688889999999999999999999999999999432  233456778999999999999999999998765     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++|+|||+. ++.+-++....      .++...+.++++|++.|+.|+|++   +++||||||+|||++.+|.+||||||
T Consensus        77 hLVFE~~dh-TvL~eLe~~p~------G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFG  146 (396)
T KOG0593|consen   77 HLVFEYCDH-TVLHELERYPN------GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFG  146 (396)
T ss_pred             EEEeeecch-HHHHHHHhccC------CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccch
Confidence            999999966 55555555543      489999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hCCCc
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MGLPD  794 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~~  794 (871)
                      +|+.+...   ....+.++.|.+|+|||.+.+ .+|++.+||||+||++.||++|.+.|.+..+-+..+..... ....+
T Consensus       147 FAR~L~~p---gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p  223 (396)
T KOG0593|consen  147 FARTLSAP---GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP  223 (396)
T ss_pred             hhHhhcCC---cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence            99988642   223445779999999998766 78999999999999999999999999876554443332222 22233


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...+++...-.   ...+.-....-...+..+++....-+.+++..|++.||.+|++.+|++.
T Consensus       224 rhq~iF~~N~~---F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  224 RHQSIFSSNPF---FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHHHhccCCc---eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            32222221100   0000000011122345667777778999999999999999999999885

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-44  Score=367.83  Aligned_cols=280  Identities=20%  Similarity=0.261  Sum_probs=221.9

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHH-HHHHHHHHHHcCC-CCccceeeeeecccCcCCCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASK-SFIAECEALRSIR-HRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~  634 (871)
                      ..+||+++++||.|+||.||+|+...++..||||.++..-..+.+ .-.||+..+++++ ||||+++.+.+.+.+    .
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----R   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----c
Confidence            346899999999999999999999999999999999654443333 3468999999998 999999999987652    2


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||| ..+|++.++....      .+++..++.|+.||++||+|+|.+   |+.|||+||+|||+.+...+||+|
T Consensus        84 ~L~fVfE~M-d~NLYqLmK~R~r------~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaD  153 (538)
T KOG0661|consen   84 ILYFVFEFM-DCNLYQLMKDRNR------LFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIAD  153 (538)
T ss_pred             eEeeeHHhh-hhhHHHHHhhcCC------cCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecc
Confidence            789999999 5699999987632      699999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccc-cCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYG-ALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||+|+.+...    ...+.++.|.+|+|||++ ..+.|+.+.||||+|||++|+.+-++.|.+..+-+..+......+.|
T Consensus       154 FGLARev~Sk----pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP  229 (538)
T KOG0661|consen  154 FGLAREVRSK----PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTP  229 (538)
T ss_pred             cccccccccC----CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCC
Confidence            9999987543    345567889999999974 56788999999999999999999999999876666655555555544


Q ss_pred             chhhhhcC-hhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIID-PAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ..- ++.. ..+. ...  .-.+....+..+...+..+..+..+++.+|+.+||.+||||+|+++.
T Consensus       230 ~~~-~~~eg~~La-~~m--nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  230 DKD-SWPEGYNLA-SAM--NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             ccc-cchhHHHHH-HHh--ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            331 1111 0000 000  00011122223445555678889999999999999999999999875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-43  Score=365.23  Aligned_cols=279  Identities=25%  Similarity=0.291  Sum_probs=221.1

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      +.|+.+++||+|+||.||+|++..+|+.||+|.++.+.  .+......+||.||++++||||+++.+...+..   ...+
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~---~~si  193 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL---SGSI  193 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC---CceE
Confidence            45777899999999999999999999999999996554  556677889999999999999999999887652   2678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+|+|||+. +|.-++....      ..+++.++..+++|++.||+|+|++   ||+|||||.+|||||.+|.+||+|||
T Consensus       194 YlVFeYMdh-DL~GLl~~p~------vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFG  263 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPG------VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFG  263 (560)
T ss_pred             EEEEecccc-hhhhhhcCCC------cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccc
Confidence            999999965 8888886643      3699999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      +|+++....  ....+..+.|.+|+|||.+.+ ..|+.++|+||.|||+.||++|++.|.+..+-+..-..+...+.|..
T Consensus       264 LAr~y~~~~--~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e  341 (560)
T KOG0600|consen  264 LARFYTPSG--SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE  341 (560)
T ss_pred             ceeeccCCC--CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence            999886543  223555678999999998665 47999999999999999999999999876554433333333333332


Q ss_pred             -hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 -VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       .+...+-.....     -.......+.+++.+........+|+..+|..||.+|.||.++++
T Consensus       342 ~~W~~~kLP~~~~-----~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  342 DYWPVSKLPHATI-----FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             hccccccCCcccc-----cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence             111111000000     001122234566777788888999999999999999999999886

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.5e-43  Score=332.84  Aligned_cols=276  Identities=23%  Similarity=0.316  Sum_probs=219.4

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .+|...+++|+|.||.||+|++..+|+.||||.++...  .+......+|++.++.++|+||+.++++|...     +..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-----~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-----SNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-----Cce
Confidence            47888999999999999999999999999999996443  33456788999999999999999999998776     668


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      .+|+||+ ..+|+..++....      .++..++..++.++++|++|+|++   .|+||||||.|+|++++|.+||+|||
T Consensus        77 ~lVfEfm-~tdLe~vIkd~~i------~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFG  146 (318)
T KOG0659|consen   77 SLVFEFM-PTDLEVVIKDKNI------ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFG  146 (318)
T ss_pred             EEEEEec-cccHHHHhccccc------ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeeccc
Confidence            8999999 5599999987653      599999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      +|+.+.......   ...+.|..|+|||.+.+ ..|+..+||||.|||+.||+-|.+-|.+..+-+.....+...+.|..
T Consensus       147 LAr~f~~p~~~~---~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~  223 (318)
T KOG0659|consen  147 LARFFGSPNRIQ---THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTP  223 (318)
T ss_pred             chhccCCCCccc---ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCc
Confidence            999887543222   22378999999997665 57899999999999999999998888765554444444444444432


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcC-chhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQ-PNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                       .+|-+-.-..++.++     +..+ +.....+..+.....+++..|+.+||.+|+||+|+++.
T Consensus       224 -~~WP~~~~lpdY~~~-----~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  224 -DQWPEMTSLPDYVKI-----QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             -ccCccccccccHHHH-----hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence             222222222233321     1222 22333566777778999999999999999999999864

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=371.02  Aligned_cols=256  Identities=30%  Similarity=0.472  Sum_probs=210.1

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEE
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      ++..+.||+|.||.||.|.+. ....||+|.++... ...+.|.+|+++|++++|++||+++++|...     ..+||||
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyIVt  280 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYIVT  280 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEEEE
Confidence            455688999999999999997 44589999997643 2457888999999999999999999999876     3589999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      |||+.|+|.+|++...+     ..+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||+|+.
T Consensus       281 E~m~~GsLl~yLr~~~~-----~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREG-----GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             EecccCcHHHHhhhcCC-----CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccc
Confidence            99999999999998432     2699999999999999999999999   999999999999999999999999999996


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhhhh
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEI  799 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  799 (871)
                      ..++.  ........-...|.|||.+..+.++.|||||||||++|||+| |+.||..+...+..-.-......       
T Consensus       353 ~~d~~--Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl-------  423 (468)
T KOG0197|consen  353 IGDDE--YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL-------  423 (468)
T ss_pred             cCCCc--eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC-------
Confidence            55432  222222334678999999999999999999999999999999 99999876544321111111111       


Q ss_pred             cChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          800 IDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                                               +....++.++.++|..||+.+|++|||.+.+...++++...
T Consensus       424 -------------------------p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  424 -------------------------PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence                                     11124567788999999999999999999999999887653

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=375.90  Aligned_cols=375  Identities=24%  Similarity=0.222  Sum_probs=284.4

Q ss_pred             ceeeccCccccCCCCccccccccccccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccC
Q 002883           65 QQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGS  144 (871)
Q Consensus        65 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~  144 (871)
                      +.||+|+|+++...+..|.++++|+++++.+|.++ .+|.......+|+.|+|.+|.|. ++...-...++.|++||||.
T Consensus        81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~-sv~se~L~~l~alrslDLSr  158 (873)
T KOG4194|consen   81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLIS-SVTSEELSALPALRSLDLSR  158 (873)
T ss_pred             eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccc-cccHHHHHhHhhhhhhhhhh
Confidence            34555555555555555555555555555555555 55554444455666666666555 34433344566666666666


Q ss_pred             ccCCCCCCccCcCCCCCCcc-ccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhcc
Q 002883          145 NWFTGEIPPSISNASSIPED-LGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFS  223 (871)
Q Consensus       145 n~i~~~~p~~~~~~~~lp~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~  223 (871)
                      |.|+           .+|.. |..-.++++|+|++|.|+.+..      +.|.++.+|..|.|+.|+++ .+|...++-.
T Consensus       159 N~is-----------~i~~~sfp~~~ni~~L~La~N~It~l~~------~~F~~lnsL~tlkLsrNrit-tLp~r~Fk~L  220 (873)
T KOG4194|consen  159 NLIS-----------EIPKPSFPAKVNIKKLNLASNRITTLET------GHFDSLNSLLTLKLSRNRIT-TLPQRSFKRL  220 (873)
T ss_pred             chhh-----------cccCCCCCCCCCceEEeecccccccccc------ccccccchheeeecccCccc-ccCHHHhhhc
Confidence            6665           33332 5555677777777777777664      34556678888888888888 5666666644


Q ss_pred             ccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEc
Q 002883          224 SHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDL  303 (871)
Q Consensus       224 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  303 (871)
                      ++|+.|+|..|+|...---.|.+|++|+.|.|..|.|.......|..+.++++|+|+.|+++..-.+++.+|++|+.|+|
T Consensus       221 ~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~l  300 (873)
T KOG4194|consen  221 PKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDL  300 (873)
T ss_pred             chhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhcc
Confidence            67999999999888544677888999999999999988888888888999999999999998777888888999999999


Q ss_pred             cCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCC
Q 002883          304 QGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGE  383 (871)
Q Consensus       304 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  383 (871)
                      ++|.|..+.++.....++|++|+|++|+|+...++.|..+..|++|+|++|.+...-...|..+++|++|||++|.|+..
T Consensus       301 S~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~  380 (873)
T KOG4194|consen  301 SYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWC  380 (873)
T ss_pred             chhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEE
Confidence            99999888888888888999999999999888888888888999999999988866667788888999999999988743


Q ss_pred             C---ccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCCc
Q 002883          384 I---PTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEG  460 (871)
Q Consensus       384 ~---~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~  460 (871)
                      +   ...|.++++|+.|+|.||+|..+...+|.++++|++|||.+|.|...-|+.|..+ .|++|-+..-.+-|.|.-.+
T Consensus       381 IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~W  459 (873)
T KOG4194|consen  381 IEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKW  459 (873)
T ss_pred             EecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccHHH
Confidence            3   3457788888899999999888888888889999999999998888888888888 88888887777777765443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-43  Score=357.73  Aligned_cols=262  Identities=27%  Similarity=0.414  Sum_probs=206.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ..+|...+.||+|+||+||++....+|+..|||.+........+.+.+|+.++++++|||||+++|.....+.   ..++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeE
Confidence            3457888999999999999999998899999999976543336778999999999999999999997443311   4689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCceEEeecc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-EMVAHVGDFG  716 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg  716 (871)
                      ++|||+++|+|.+++...++      .+++..++.+++||++||+|||++   |||||||||+|||++. ++.+||+|||
T Consensus        93 i~mEy~~~GsL~~~~~~~g~------~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG  163 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGG------KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFG  163 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCc
Confidence            99999999999999988753      499999999999999999999999   9999999999999999 7999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      .+.................||+.|||||++..+ ...+++||||+||++.||+||+.||...................+.
T Consensus       164 ~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~  243 (313)
T KOG0198|consen  164 LAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPE  243 (313)
T ss_pred             cccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCC
Confidence            998765412122233456799999999998854 3346999999999999999999999863111111111111110001


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                      +.+                              ....+..+++.+|+..||++||||+|+++.-..
T Consensus       244 ip~------------------------------~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  244 IPD------------------------------SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             CCc------------------------------ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence            111                              133456789999999999999999999987654

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=374.41  Aligned_cols=401  Identities=21%  Similarity=0.205  Sum_probs=353.1

Q ss_pred             cceeeccCccccCCCCccccc-c-ccccccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEE
Q 002883           64 LQQLSLSENSLSGNIPSELGL-L-KQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLL  141 (871)
Q Consensus        64 L~~L~Ls~n~l~~~~~~~~~~-l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~  141 (871)
                      -..||.+++.+....-..+.+ + +.-+.|++++|++...-+..|.++++|+++++.+|.+. .||.... ...+|+.|+
T Consensus        54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~-~sghl~~L~  131 (873)
T KOG4194|consen   54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGH-ESGHLEKLD  131 (873)
T ss_pred             ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccc-cccceeEEe
Confidence            346788888776322222322 2 23456999999999888889999999999999999998 8998765 778899999


Q ss_pred             ccCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhh
Q 002883          142 LGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIAN  221 (871)
Q Consensus       142 l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~  221 (871)
                      |.+|.|+.          .-.+.++.++.|+.||||.|.|..++..      ++..-.++++|+|++|+|+..-...|..
T Consensus       132 L~~N~I~s----------v~se~L~~l~alrslDLSrN~is~i~~~------sfp~~~ni~~L~La~N~It~l~~~~F~~  195 (873)
T KOG4194|consen  132 LRHNLISS----------VTSEELSALPALRSLDLSRNLISEIPKP------SFPAKVNIKKLNLASNRITTLETGHFDS  195 (873)
T ss_pred             eecccccc----------ccHHHHHhHhhhhhhhhhhchhhcccCC------CCCCCCCceEEeeccccccccccccccc
Confidence            99999981          2235589999999999999999998864      3445578999999999999877788888


Q ss_pred             ccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEE
Q 002883          222 FSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEV  301 (871)
Q Consensus       222 ~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  301 (871)
                      +. +|..|.|++|+|+...+..|++|++|+.|+|..|+|.-.---+|.+|++|+.|.|..|.|.....+.|..+.++++|
T Consensus       196 ln-sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l  274 (873)
T KOG4194|consen  196 LN-SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHL  274 (873)
T ss_pred             cc-hheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeeccccee
Confidence            75 79999999999998888889999999999999999995557789999999999999999998888999999999999


Q ss_pred             EccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCC
Q 002883          302 DLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLS  381 (871)
Q Consensus       302 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  381 (871)
                      +|..|+++..-..++.++++|+.|+||+|.|..+-++.+.-.++|++|+|++|+|+...+..|..+..|+.|+|++|.++
T Consensus       275 ~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~  354 (873)
T KOG4194|consen  275 NLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID  354 (873)
T ss_pred             ecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH
Confidence            99999999888889999999999999999999888899999999999999999999888899999999999999999999


Q ss_pred             CCCccchhcccCCceeeecCCcccccCc---cccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCC
Q 002883          382 GEIPTSLASCVGLEYLNFSDNSFQGPIH---SGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPS  458 (871)
Q Consensus       382 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~  458 (871)
                      ..-...|..+++|++|||++|.|+..+.   ..|.+|++|+.|+|.+|+|....-..|..+++|+.|||.+|.+....|.
T Consensus       355 ~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~n  434 (873)
T KOG4194|consen  355 HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPN  434 (873)
T ss_pred             HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeeccc
Confidence            7777889999999999999999986654   3589999999999999999987778999999999999999999998887


Q ss_pred             CcccccccceeccCCCCCccCCCcc
Q 002883          459 EGVFKNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       459 ~~~~~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      ...-..++.|.+..-...|+|-..|
T Consensus       435 AFe~m~Lk~Lv~nSssflCDCql~W  459 (873)
T KOG4194|consen  435 AFEPMELKELVMNSSSFLCDCQLKW  459 (873)
T ss_pred             ccccchhhhhhhcccceEEeccHHH
Confidence            6443478899999999999998888

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-43  Score=362.98  Aligned_cols=254  Identities=26%  Similarity=0.381  Sum_probs=210.2

Q ss_pred             HHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCc
Q 002883          555 LKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDT  630 (871)
Q Consensus       555 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  630 (871)
                      .....+|..++.||+|+|++|++|+...+++.||||++...-   ....+-+.+|-++|.++ .||.|++++..|.+.  
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~--  146 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE--  146 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--
Confidence            345678999999999999999999999999999999985331   22335677888899999 899999999999877  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCce
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA  710 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  710 (871)
                         ..+|+|+||+++|+|.++|++.+       .+++..++.++.+|+.|++|||+.   |||||||||+|||+|+|+++
T Consensus       147 ---~sLYFvLe~A~nGdll~~i~K~G-------sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhi  213 (604)
T KOG0592|consen  147 ---ESLYFVLEYAPNGDLLDLIKKYG-------SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHI  213 (604)
T ss_pred             ---cceEEEEEecCCCcHHHHHHHhC-------cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcE
Confidence               66999999999999999999876       699999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCCC--------ccc--cccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhh
Q 002883          711 HVGDFGLSRLLHDNSPD--------QTS--TSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEE  780 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~--------~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  780 (871)
                      ||+|||.|+.+.+....        ...  ...++||..|.+||++.++..++.+|||+||||+|+|+.|.+||.+..+ 
T Consensus       214 kITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-  292 (604)
T KOG0592|consen  214 KITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-  292 (604)
T ss_pred             EEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-
Confidence            99999999998753211        111  1447899999999999999999999999999999999999999986422 


Q ss_pred             hhhHHHHhhh--CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          781 GLSLHKYAKM--GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       781 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      -..+.++...  .+|+                                  ..++.+.+|+.+.|..||.+|+|++|+.+.
T Consensus       293 yliFqkI~~l~y~fp~----------------------------------~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  293 YLIFQKIQALDYEFPE----------------------------------GFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHHHHHHhcccCCC----------------------------------CCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            1122222111  1111                                  122456789999999999999999888764

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-42  Score=349.60  Aligned_cols=266  Identities=23%  Similarity=0.323  Sum_probs=216.7

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG-ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ..+.|+..+.||.|..++||+|+....++.||||++..+.-. ..+.+.+|+..|+.++||||+.++..|...     ..
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-----~~   98 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD-----SE   98 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-----ce
Confidence            456899999999999999999999999999999999655433 358899999999999999999999999876     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||.||.+|++.+.++.....     .+++..+..|.+++++||.|||.+   |.+|||||+.|||++++|.|||+||
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~-----Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadF  170 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPD-----GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADF  170 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccc-----cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCc
Confidence            99999999999999999887644     599999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCcccc-ccccccccccCccccc--CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          716 GLSRLLHDNSPDQTST-SRVKGSIGYVAPEYGA--LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |.+..+.+........ ...+||+.|||||++.  ...|+.|+||||||++..||.+|..||.....-..-+.+.... .
T Consensus       171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~-p  249 (516)
T KOG0582|consen  171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND-P  249 (516)
T ss_pred             eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-C
Confidence            9988776654332222 5578999999999843  3478999999999999999999999999765443333322221 1


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      |.......+.                      .......+.+.+++..||..||++||||++++..
T Consensus       250 p~~~t~~~~~----------------------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  250 PTLLTSGLDK----------------------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CCcccccCCh----------------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            1111111111                      1122344578899999999999999999999863

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=347.64  Aligned_cols=203  Identities=29%  Similarity=0.390  Sum_probs=183.4

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..++|++.++||+|+||.||.++.+.+++.+|+|+++...   ....+...+|..++.+++||.||+++..|.+.     
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~-----   97 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE-----   97 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC-----
Confidence            3568999999999999999999999999999999995442   33457788999999999999999999998877     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+|+||+.||.|...+++.+       .+++..++-++.+|+.||.|||++   ||||||+||+|||++.+|+++|+
T Consensus        98 ~kLylVld~~~GGeLf~hL~~eg-------~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~Lt  167 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQREG-------RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLT  167 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHhcC-------CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEe
Confidence            77999999999999999998765       699999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      |||+|+..-..   ...+...+||+.|||||++.+..|+.++|-||+|+++|||++|.+||...
T Consensus       168 DFgL~k~~~~~---~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~  228 (357)
T KOG0598|consen  168 DFGLCKEDLKD---GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE  228 (357)
T ss_pred             ccccchhcccC---CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence            99999854332   23344578999999999999999999999999999999999999999864

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-42  Score=345.18  Aligned_cols=286  Identities=21%  Similarity=0.262  Sum_probs=229.2

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEee--ccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLD--LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ...+|...+.||+|+||.|+.|.+..+++.||||.+.  .......++..+|+.+++.++|+||+.+.+.+.......-.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3456777899999999999999999999999999985  44555668889999999999999999999998774455557


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      .+|+|+|+| +.+|...++...       .++...+..+++|+++||+|+|+.   +|+|||+||.|++++.+..+||+|
T Consensus       100 DvYiV~elM-etDL~~iik~~~-------~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~D  168 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQ-------DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICD  168 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCc-------cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecc
Confidence            789999999 779999998754       489999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccc-cCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYG-ALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||+|+..... ......+..+.|.+|+|||++ ....|+.+.||||.|||+.||++|++.|.+...-+.........+.|
T Consensus       169 FGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP  247 (359)
T KOG0660|consen  169 FGLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP  247 (359)
T ss_pred             ccceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence            9999988654 334445667899999999974 46689999999999999999999999998654332222222222333


Q ss_pred             ch--hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQ--VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      +.  +..+-...    +...+..+...-+..+...++......++++.+||..||.+|+||+|+++.
T Consensus       248 ~~e~l~~i~s~~----ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  248 SEEDLQKIRSEK----ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             CHHHHHHhccHH----HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            22  22222222    222333344444456677778888899999999999999999999999863

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=362.98  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=212.5

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      ..|+..++||+|+.|.||.|+...+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...     +..|+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeEE
Confidence            4688889999999999999999999999999999877777778889999999999999999999998766     67899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||++||+|.+.+...        .+++.++..|++++++||+|||.+   ||+|||||.+|||++.+|.+||+|||++
T Consensus       348 VMEym~ggsLTDvVt~~--------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFc  416 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKT--------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFC  416 (550)
T ss_pred             EEeecCCCchhhhhhcc--------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeee
Confidence            99999999999999875        389999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE  798 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  798 (871)
                      ..+.....   .....+||++|||||+.....|++++||||||++++||+-|.+||-.... -..+..++..+.|+-   
T Consensus       417 aqi~~~~~---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-lrAlyLIa~ng~P~l---  489 (550)
T KOG0578|consen  417 AQISEEQS---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRALYLIATNGTPKL---  489 (550)
T ss_pred             eccccccC---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-HHHHHHHhhcCCCCc---
Confidence            98765432   34456899999999999999999999999999999999999999974211 111111111111110   


Q ss_pred             hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                                ...+.....+.+++.+||..||++||+|.|+|+.
T Consensus       490 --------------------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  490 --------------------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             --------------------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence                                      0112345567899999999999999999999974

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=4.8e-46  Score=371.78  Aligned_cols=413  Identities=28%  Similarity=0.452  Sum_probs=280.1

Q ss_pred             CccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccc
Q 002883            7 PANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLK   86 (871)
Q Consensus         7 p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~   86 (871)
                      -+.+.+|..|..|++++|+++ .+|.+++.+..++.|+.++|++. .+|+.+..+.+|..|+.++|.+. .+|+.++.+-
T Consensus        61 ~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~  137 (565)
T KOG0472|consen   61 REDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLL  137 (565)
T ss_pred             cHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHh
Confidence            345677777888888888887 77888888888888888888887 77888888888888888888887 7777888888


Q ss_pred             cccccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCcccc
Q 002883           87 QLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLG  166 (871)
Q Consensus        87 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~  166 (871)
                      .|+.|+..+|++. ..|+++.++.+|..+++.+|++. ++|+..- ++..|+.||...|-+.           .+|++++
T Consensus       138 ~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i-~m~~L~~ld~~~N~L~-----------tlP~~lg  203 (565)
T KOG0472|consen  138 DLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHI-AMKRLKHLDCNSNLLE-----------TLPPELG  203 (565)
T ss_pred             hhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHH-HHHHHHhcccchhhhh-----------cCChhhc
Confidence            8888888888887 77777888888888888888877 3443333 4777888888888776           6777777


Q ss_pred             CCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCC
Q 002883          167 KLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGN  246 (871)
Q Consensus       167 ~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~  246 (871)
                      .+.+|+.|+|.+|+|..+|        .|..|+.|++|+++.|.|. .+|.+..+-.+++..|||++|++. ..|+.+.-
T Consensus       204 ~l~~L~~LyL~~Nki~~lP--------ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~cl  273 (565)
T KOG0472|consen  204 GLESLELLYLRRNKIRFLP--------EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICL  273 (565)
T ss_pred             chhhhHHHHhhhcccccCC--------CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHH
Confidence            7777777777777776533        4555555555555555555 555555533344555555555555 45555555


Q ss_pred             ccccceeecccccccccCCccccCCCCCcEEEccCCCCCC----------------------------------------
Q 002883          247 LKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISG----------------------------------------  286 (871)
Q Consensus       247 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~----------------------------------------  286 (871)
                      +++|.+||+++|.|+ ..|-+++++ +|+.|-+.+|.+..                                        
T Consensus       274 LrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~  351 (565)
T KOG0472|consen  274 LRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLP  351 (565)
T ss_pred             hhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCC
Confidence            555555555555555 344555555 55555555555441                                        


Q ss_pred             ------------------------CCCcccCCCcc---ccEEEccCccccccCcccccCCCCCC-EEecCCCcCCCCCcc
Q 002883          287 ------------------------EIPSSLGNLIF---LTEVDLQGNSIRGSIPSALGNCLQLQ-KLDLSDNNLSGTIPR  338 (871)
Q Consensus       287 ------------------------~~~~~~~~l~~---L~~L~L~~N~i~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~  338 (871)
                                              .+|+......+   .+.++++.|++. .+|..+..+..+. .+.+++|.+. .+|.
T Consensus       352 ~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~  429 (565)
T KOG0472|consen  352 SESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPL  429 (565)
T ss_pred             CCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchH
Confidence                                    22222222222   445555555555 4555555444433 3344444444 6677


Q ss_pred             cccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCC
Q 002883          339 EVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGL  418 (871)
Q Consensus       339 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  418 (871)
                      .++.+++|..|+|++|.+. .+|..++.+..|+.|++|+|++. ..|..+..+..|+.+-.++|++..+.++.+.+|.+|
T Consensus       430 ~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL  507 (565)
T KOG0472|consen  430 ELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNL  507 (565)
T ss_pred             HHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhc
Confidence            7777777777777777776 66777777777777777777777 677777777777777777777777777777777777


Q ss_pred             CEEeCCCCcCCCCCcccccccccccEEecCCCcCc
Q 002883          419 QDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLE  453 (871)
Q Consensus       419 ~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~  453 (871)
                      ..|||.+|.+. .+|..+++|.+|++|+++||+|.
T Consensus       508 ~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  508 TTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            77777777777 56777777777777777777777

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.4e-42  Score=356.36  Aligned_cols=248  Identities=28%  Similarity=0.373  Sum_probs=208.9

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG--ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+++..+.  +.+.+.+|+++++.++||||+.++++|+..     .++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~-----~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS-----AHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc-----ceE
Confidence            5788999999999999999999999999999999665543  346789999999999999999999999877     789


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+|+||+.| +|..++...+       .++++.++.++.|++.||.|||+.   +|.|||+||.||++++.+.+|++|||
T Consensus        77 ~vVte~a~g-~L~~il~~d~-------~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg  145 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTILEQDG-------KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFG  145 (808)
T ss_pred             EEEehhhhh-hHHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhh
Confidence            999999966 9999998866       699999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +|+.+..   .......+.|||.|||||...+++|+..+|+||+||++||+++|++||....--  .+.+.+........
T Consensus       146 ~Ar~m~~---~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~--~Lv~~I~~d~v~~p  220 (808)
T KOG0597|consen  146 LARAMST---NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT--QLVKSILKDPVKPP  220 (808)
T ss_pred             hhhhccc---CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH--HHHHHHhcCCCCCc
Confidence            9998765   234455678999999999999999999999999999999999999999853211  12222211100000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                                     ......+.+++...+..||.+|.|..+++..
T Consensus       221 -------------------------------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  221 -------------------------------STASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             -------------------------------ccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                                           0233456788889999999999999988764

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=363.40  Aligned_cols=268  Identities=26%  Similarity=0.411  Sum_probs=214.5

Q ss_pred             CHHHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecc
Q 002883          550 SYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSS  627 (871)
Q Consensus       550 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  627 (871)
                      +..++....+...+.+.||+|+||+||+|+|.++   ||||++.....  +..+.|++|+.++++-+|.||+-+.|+|..
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            3345555566677889999999999999999754   99999965543  356789999999999999999999999876


Q ss_pred             cCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC
Q 002883          628 IDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE  707 (871)
Q Consensus       628 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  707 (871)
                      .     .+ .||+.+|+|-+|+.+++..+.      +++..+.+.||+|||+|+.|||.+   +|+|||||..||++.++
T Consensus       460 p-----~~-AIiTqwCeGsSLY~hlHv~et------kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~  524 (678)
T KOG0193|consen  460 P-----PL-AIITQWCEGSSLYTHLHVQET------KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHED  524 (678)
T ss_pred             C-----ce-eeeehhccCchhhhhccchhh------hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccC
Confidence            4     44 899999999999999987653      599999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccceecCCCCCCccccccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhH
Q 002883          708 MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA---LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSL  784 (871)
Q Consensus       708 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~  784 (871)
                      ++|||+|||++.....-. .........|...|||||++.   ..+|++.+||||||+|+|||+||..||.....+ ..+
T Consensus       525 ~kVkIgDFGLatvk~~w~-g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-qIi  602 (678)
T KOG0193|consen  525 LKVKIGDFGLATVKTRWS-GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-QII  602 (678)
T ss_pred             CcEEEecccceeeeeeec-cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-heE
Confidence            999999999997654321 222233355888999999865   458899999999999999999999999832222 111


Q ss_pred             HHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          785 HKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      ...-..                           .+.++.......+++++.+|+..||.++|++||+..+++..|+++..
T Consensus       603 fmVGrG---------------------------~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  603 FMVGRG---------------------------YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             EEeccc---------------------------ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            111000                           01112222333667789999999999999999999999999998866

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-41  Score=333.06  Aligned_cols=279  Identities=23%  Similarity=0.280  Sum_probs=220.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .+.|+....|++|+||.||+|+++.+++.||+|.++...  .+..-.-.+||.++.+.+|||||.+..+.....-   +.
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~---d~  151 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM---DK  151 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc---ce
Confidence            345888899999999999999999999999999996443  3445567899999999999999999988765433   56


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      +|+|||||+. +|...+.....      ++...++..+..|+++|++|||..   .|+|||+||+|+|+...|.+||+||
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q------~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDF  221 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQ------PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADF  221 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccC------CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEeccc
Confidence            8999999965 99999987653      699999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      |+|+.++..   ....+..+.|..|+|||.+.+ ..|+++.|+||+|||+.||+++++.|.+..+-+.....+...+.|.
T Consensus       222 GLAR~ygsp---~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPt  298 (419)
T KOG0663|consen  222 GLAREYGSP---LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPS  298 (419)
T ss_pred             chhhhhcCC---cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCc
Confidence            999988764   233455678999999998665 4689999999999999999999999987666555444444445443


Q ss_pred             h-hh-hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHH--HHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 Q-VA-EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQ--VSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      . ++ .+.......     .....++....++..|+...  +.-.+++...+.+||.+|.||+|.++
T Consensus       299 e~iwpg~~~lp~~k-----~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  299 EAIWPGYSELPAVK-----KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cccCCCccccchhh-----ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            3 11 111111110     01122233334555555544  77789999999999999999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=356.89  Aligned_cols=252  Identities=22%  Similarity=0.315  Sum_probs=206.2

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc----cc-chHHHHHHHHHHHHcCC-CCccceeeeeecccC
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ----QR-GASKSFIAECEALRSIR-HRNLVKIITSCSSID  629 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  629 (871)
                      ...++|.+.+.||+|+||.|+.|.+..+++.||+|+++..    .. ...+.+.+|+.+++.++ ||||+++++++... 
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-   92 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-   92 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence            3457899999999999999999999999999999987543    11 23456778999999998 99999999998876 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-C
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE-M  708 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~  708 (871)
                          ...|+||||+.||+|.+++...+       ++.+.++..+++|++.|++|+|++   ||+||||||+||+++.+ +
T Consensus        93 ----~~~~ivmEy~~gGdL~~~i~~~g-------~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~  158 (370)
T KOG0583|consen   93 ----TKIYIVMEYCSGGDLFDYIVNKG-------RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEG  158 (370)
T ss_pred             ----CeEEEEEEecCCccHHHHHHHcC-------CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCC
Confidence                56999999999999999998843       588999999999999999999999   99999999999999999 9


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccCCC-CC-CccchhhHHHHHHHHHhCCCCCchhhhhhhhHHH
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE-VS-THGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK  786 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~  786 (871)
                      ++||+|||++.....   ........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||.+..... ....
T Consensus       159 ~~Kl~DFG~s~~~~~---~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-l~~k  234 (370)
T KOG0583|consen  159 NLKLSDFGLSAISPG---EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-LYRK  234 (370)
T ss_pred             CEEEeccccccccCC---CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-HHHH
Confidence            999999999997731   223344578999999999999877 85 88999999999999999999999732221 1111


Q ss_pred             HhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          787 YAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       787 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      +...  .-.+..++.                             ..++..++.+|+..||.+|+|+.|+++
T Consensus       235 i~~~--~~~~p~~~~-----------------------------S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  235 IRKG--EFKIPSYLL-----------------------------SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             HhcC--CccCCCCcC-----------------------------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            1111  011111110                             345678999999999999999999983

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=3e-45  Score=366.16  Aligned_cols=430  Identities=30%  Similarity=0.414  Sum_probs=364.7

Q ss_pred             CCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCcccccccccccccc
Q 002883           14 SELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQV   93 (871)
Q Consensus        14 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l   93 (871)
                      ..|+.|++++|.++ .+-..+.+|..|.+|++++|++. ..|.+++.+..++.|+.|+|.++ .+|..++.+.+|..|++
T Consensus        45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~  121 (565)
T KOG0472|consen   45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDC  121 (565)
T ss_pred             cchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhc
Confidence            35788999999998 77888999999999999999999 89999999999999999999999 99999999999999999


Q ss_pred             ccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccE
Q 002883           94 SANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIR  173 (871)
Q Consensus        94 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~  173 (871)
                      +.|++. .+|+.++.+..|+.++..+|++. .+|...+ .+..|..|++.+|+++           .+|++.-.++.|++
T Consensus       122 s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~-~~~~l~~l~~~~n~l~-----------~l~~~~i~m~~L~~  187 (565)
T KOG0472|consen  122 SSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMV-NLSKLSKLDLEGNKLK-----------ALPENHIAMKRLKH  187 (565)
T ss_pred             ccccee-ecCchHHHHhhhhhhhccccccc-cCchHHH-HHHHHHHhhccccchh-----------hCCHHHHHHHHHHh
Confidence            999999 89999999999999999999998 7777766 7899999999999998           77887666999999


Q ss_pred             EecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCcccccee
Q 002883          174 LNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILI  253 (871)
Q Consensus       174 L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L  253 (871)
                      ||+..|-++.+|       +.++.+.+|+.|+|.+|+|. .+| +|... +-|.+|+++.|+|.....+..+++++|..|
T Consensus       188 ld~~~N~L~tlP-------~~lg~l~~L~~LyL~~Nki~-~lP-ef~gc-s~L~Elh~g~N~i~~lpae~~~~L~~l~vL  257 (565)
T KOG0472|consen  188 LDCNSNLLETLP-------PELGGLESLELLYLRRNKIR-FLP-EFPGC-SLLKELHVGENQIEMLPAEHLKHLNSLLVL  257 (565)
T ss_pred             cccchhhhhcCC-------hhhcchhhhHHHHhhhcccc-cCC-CCCcc-HHHHHHHhcccHHHhhHHHHhcccccceee
Confidence            999999999855       56888999999999999998 667 66665 459999999999994444445699999999


Q ss_pred             ecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCcccccc----------------------
Q 002883          254 AMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGS----------------------  311 (871)
Q Consensus       254 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~----------------------  311 (871)
                      ||..|+++ ..|+.++.+.+|+.||+|+|.|+ ..|..++++ +|+.|-+.||.+..+                      
T Consensus       258 DLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~  334 (565)
T KOG0472|consen  258 DLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKD  334 (565)
T ss_pred             eccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhcc
Confidence            99999999 78999999999999999999999 788899999 899999999988620                      


Q ss_pred             ----------------Cccc---ccCCCCCCEEecCCCcCCC-------------------------CCcccccCCCCCc
Q 002883          312 ----------------IPSA---LGNCLQLQKLDLSDNNLSG-------------------------TIPREVIGLSSFV  347 (871)
Q Consensus       312 ----------------~~~~---~~~l~~L~~L~L~~N~l~~-------------------------~~~~~~~~l~~L~  347 (871)
                                      .+..   ...+.+.+.|++++-+++.                         .+|..+..++.+.
T Consensus       335 dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelv  414 (565)
T KOG0472|consen  335 DGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELV  414 (565)
T ss_pred             CCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHH
Confidence                            0000   1123345556666555552                         3333333333332


Q ss_pred             -EEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCC
Q 002883          348 -LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRN  426 (871)
Q Consensus       348 -~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  426 (871)
                       .+.+++|.++ .+|..++.+++|..|+|++|.+. .+|..+..+..|+.|+++.|++. ..|.....+..++.+-.++|
T Consensus       415 T~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~n  491 (565)
T KOG0472|consen  415 TDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNN  491 (565)
T ss_pred             HHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccc
Confidence             2344555554 77777888899999999999998 78899999999999999999998 67887777888888888889


Q ss_pred             cCCCCCcccccccccccEEecCCCcCcccCCCCcccccccceeccCCCCC
Q 002883          427 NFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKL  476 (871)
Q Consensus       427 ~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~  476 (871)
                      ++....|..+.+|.+|.+|||.+|.+...+|..+.+.+++.+.+.|||+.
T Consensus       492 qi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  492 QIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             cccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            99977777799999999999999999999999999999999999999975

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=319.63  Aligned_cols=274  Identities=19%  Similarity=0.234  Sum_probs=220.7

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ...+||++.+.+|+|||+.||.++...++..||+|.+........+..++|++..++++|||+++++++......++...
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            34679999999999999999999999899999999997776667788999999999999999999999987776667788


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|++++|+..|+|.+.++.....   +..+++.+++.|+.+|++||.+||+.. ++++||||||.||++.+++.+++.||
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~k---g~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIK---GNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhc---CCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence            99999999999999999876543   336999999999999999999999982 25999999999999999999999999


Q ss_pred             ccceecCCCCCCcc------ccccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHH
Q 002883          716 GLSRLLHDNSPDQT------STSRVKGSIGYVAPEYGA---LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK  786 (871)
Q Consensus       716 g~a~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~  786 (871)
                      |.++...-......      .......|..|+|||.+.   +...++++|||||||++|+|+.|..||+.....+.++.-
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL  253 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL  253 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence            99986542211111      122235789999999754   456789999999999999999999999976554333211


Q ss_pred             HhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          787 YAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       787 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      ....      ..+.-                       +....+++.+.+++.+|++.||.+||++.|++..++.+
T Consensus       254 Av~n------~q~s~-----------------------P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  254 AVQN------AQISI-----------------------PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             eeec------ccccc-----------------------CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            1110      00000                       00112456788999999999999999999999998875

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.6e-41  Score=371.73  Aligned_cols=266  Identities=27%  Similarity=0.442  Sum_probs=217.3

Q ss_pred             cCCCCCceeeccccceEEEEEEC-----CCCcEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILG-----TEETNVAVKVLDLQQRG-ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      .+....+.||+|.||.||+|+..     +....||||.++..... ...+|++|++.+..++|||||+++|.|.+.    
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~----  561 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG----  561 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC----
Confidence            34556788999999999999974     24467999999766554 678999999999999999999999999887    


Q ss_pred             CceeeEEEeccCCCCHHHHhhccccccc-------ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQN-------QRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD  705 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  705 (871)
                       +..|+|+|||..|||.+|++.......       ..++++..+.+.||.|||.||.||-++   .+|||||..+|+||.
T Consensus       562 -~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  562 -DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG  637 (774)
T ss_pred             -CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence             558999999999999999987654321       144589999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhH
Q 002883          706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSL  784 (871)
Q Consensus       706 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~  784 (871)
                      ++..|||+|||+++.+...+.. .......-..+|||||.+..+.|+.+|||||||||+||+++ |+.||.+...++.. 
T Consensus       638 e~l~VKIsDfGLsRdiYssDYY-k~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI-  715 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYY-KVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI-  715 (774)
T ss_pred             cceEEEecccccchhhhhhhhh-cccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH-
Confidence            9999999999999977543211 11222335679999999999999999999999999999999 99999876554321 


Q ss_pred             HHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          785 HKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                       ++++.+                              ...+..+.++.++.+||..||+..|++||+++||-..|+...+
T Consensus       716 -e~i~~g------------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  716 -ECIRAG------------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             -HHHHcC------------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence             111110                              0011223567789999999999999999999999999998755


Q ss_pred             H
Q 002883          865 M  865 (871)
Q Consensus       865 ~  865 (871)
                      .
T Consensus       765 ~  765 (774)
T KOG1026|consen  765 A  765 (774)
T ss_pred             c
Confidence            4

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.2e-41  Score=338.55  Aligned_cols=275  Identities=24%  Similarity=0.340  Sum_probs=207.7

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEE
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV  639 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  639 (871)
                      .|+..+++|+|+||.||+|....+++.||||.+-.+.+    --.+|+++|+.++|||||++..+|....+.+.-+..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            57788999999999999999999999999999854433    22469999999999999999999877655434567799


Q ss_pred             EeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-CceEEeecccc
Q 002883          640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE-MVAHVGDFGLS  718 (871)
Q Consensus       640 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a  718 (871)
                      ||||+ .+|.++++.....   ...++...++-+.+||.+|++|||+.   +|+||||||.|+|+|.+ |.+||||||.|
T Consensus       101 leymP-~tL~~~~r~~~~~---~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen  101 LEYMP-ETLYRVIRHYTRA---NQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHhch-HHHHHHHHHHhhc---CCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            99995 4999999864211   23688899999999999999999998   99999999999999976 89999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch--
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ--  795 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--  795 (871)
                      +.+..+++.    .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|.+....+.......-.+.|..  
T Consensus       174 K~L~~~epn----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~  249 (364)
T KOG0658|consen  174 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED  249 (364)
T ss_pred             eeeccCCCc----eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            998765433    345689999999987654 7899999999999999999999999875444332222222333322  


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchh--HHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNL--RAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      +..+-.......+        .++.+..  +-.......+..+++.+++.++|.+|.+|.|+++
T Consensus       250 I~~mn~~y~~~~~--------p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  250 IKSMNPNYTEFKF--------PQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HhhcCcccccccC--------cccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            1111110000000        0000000  0122345567889999999999999999999985

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=345.55  Aligned_cols=251  Identities=23%  Similarity=0.347  Sum_probs=209.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ...|+..+.||+|+||.||+|.+..+++.||+|+++.... .....+++|+.++.+++++||.++|+.|...     ..+
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~~L   86 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----TKL   86 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----ccH
Confidence            4568888999999999999999999999999999976543 3457889999999999999999999998776     778


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |++||||.||++.+.++...       .+++..+..++++++.|+.|||.+   +.+|||||+.||++..+|.+|++|||
T Consensus        87 wiiMey~~gGsv~~lL~~~~-------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~Dfg  156 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKSGN-------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFG  156 (467)
T ss_pred             HHHHHHhcCcchhhhhccCC-------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecc
Confidence            99999999999999998764       457888888999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      .+..+....   ......+||+.|||||++....|+.|+||||||++.+||++|.+|+.+.+....  .    ..+|.. 
T Consensus       157 Va~ql~~~~---~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--l----flIpk~-  226 (467)
T KOG0201|consen  157 VAGQLTNTV---KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--L----FLIPKS-  226 (467)
T ss_pred             eeeeeechh---hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--E----EeccCC-
Confidence            998876532   223557899999999999988999999999999999999999999987543210  0    011111 


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                            .+|.+..   .+.+.+.+++..||+.||+.||+|.++++.
T Consensus       227 ----------------------~PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  227 ----------------------APPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ----------------------CCCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence                                  1111111   334557789999999999999999999864

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-40  Score=354.35  Aligned_cols=249  Identities=22%  Similarity=0.296  Sum_probs=208.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .+-|+.++.||.|+.|.|-.|++..+|+.+|||++....   ......+.+|+-+|+-+.||||+++|++|+..     .
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~-----~   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK-----Q   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC-----c
Confidence            356899999999999999999999999999999995442   22346788999999999999999999998776     8


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ++|+|.||++||-|.+++...+       ++++.++.++++||+.|+.|+|..   +|+|||+||+|+|+|..+++||+|
T Consensus        86 ~lylvlEyv~gGELFdylv~kG-------~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIAD  155 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRKG-------PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIAD  155 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeec
Confidence            8999999999999999998766       699999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV-STHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||+|..-.++    ......+|++.|.|||++.+.+| +.++||||+|||+|.|+||+.||++..-.  .+......+. 
T Consensus       156 FGMAsLe~~g----klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir--~LLlKV~~G~-  228 (786)
T KOG0588|consen  156 FGMASLEVPG----KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR--VLLLKVQRGV-  228 (786)
T ss_pred             cceeecccCC----ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH--HHHHHHHcCc-
Confidence            9999875433    33445689999999999999999 68999999999999999999999953211  1111111110 


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                                    .+....+..+..+|+++|+..||++|.|++||++.
T Consensus       229 ------------------------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  229 ------------------------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             ------------------------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence                                          01112344567799999999999999999999874

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=337.68  Aligned_cols=261  Identities=25%  Similarity=0.313  Sum_probs=203.5

Q ss_pred             HHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--------------cchHHHHHHHHHHHHcCCCCccce
Q 002883          555 LKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--------------RGASKSFIAECEALRSIRHRNLVK  620 (871)
Q Consensus       555 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~  620 (871)
                      .+..++|++.+.||+|.||.|-+|++..+++.||||++....              ....+.+.+||.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            456789999999999999999999999999999999994321              112357899999999999999999


Q ss_pred             eeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 002883          621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS  700 (871)
Q Consensus       621 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  700 (871)
                      ++++..+.   ..+.+|+|+|||..|.+...=..       .+.+++.+++.++++++.||.|||.+   ||+||||||+
T Consensus       173 LiEvLDDP---~s~~~YlVley~s~G~v~w~p~d-------~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPs  239 (576)
T KOG0585|consen  173 LIEVLDDP---ESDKLYLVLEYCSKGEVKWCPPD-------KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPS  239 (576)
T ss_pred             EEEeecCc---ccCceEEEEEeccCCccccCCCC-------cccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchh
Confidence            99987554   44789999999998876533211       22389999999999999999999999   9999999999


Q ss_pred             ceeeCCCCceEEeecccceecCCCC--CCccccccccccccccCcccccCCC---C-CCccchhhHHHHHHHHHhCCCCC
Q 002883          701 NVLLDNEMVAHVGDFGLSRLLHDNS--PDQTSTSRVKGSIGYVAPEYGALGE---V-STHGDEYSFGILMLEMFTGKRPT  774 (871)
Q Consensus       701 Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~---~-~~~~DiwSlG~il~elltG~~pf  774 (871)
                      |+|++++|++||+|||.+.....+.  .........+|||.|+|||...++.   + +.+.||||+||++|+|+.|+.||
T Consensus       240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF  319 (576)
T KOG0585|consen  240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF  319 (576)
T ss_pred             heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence            9999999999999999998764321  1122233468999999999866532   2 67889999999999999999999


Q ss_pred             chhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHH
Q 002883          775 DDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQD  854 (871)
Q Consensus       775 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~e  854 (871)
                      .+...-+ .+.++....                              -..+..+++.+.+.+++.++|+.||++|.+..+
T Consensus       320 ~~~~~~~-l~~KIvn~p------------------------------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~  368 (576)
T KOG0585|consen  320 FDDFELE-LFDKIVNDP------------------------------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPD  368 (576)
T ss_pred             ccchHHH-HHHHHhcCc------------------------------ccCCCcccccHHHHHHHHHHhhcChhheeehhh
Confidence            8643221 111111110                              011222244567889999999999999999998


Q ss_pred             HHHHH
Q 002883          855 AIMEL  859 (871)
Q Consensus       855 vl~~L  859 (871)
                      |....
T Consensus       369 ik~Hp  373 (576)
T KOG0585|consen  369 IKLHP  373 (576)
T ss_pred             heecc
Confidence            86543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=318.58  Aligned_cols=200  Identities=28%  Similarity=0.376  Sum_probs=182.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG---ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|+..+.+|.|+||+|.+++.+.++..+|+|+++...-.   ..+...+|..+++.+.||.++++++.|.+.     .
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~-----~  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN-----S  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC-----C
Confidence            45789999999999999999999999999999999755432   235667899999999999999999998876     7


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      +.|+||||++||-|..++++.+       ++++..++-+|.||+.|++|||+.   +|++||+||+|||+|.+|.+||+|
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~-------rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitD  187 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSG-------RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITD  187 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcC-------CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEe
Confidence            8999999999999999999876       699999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhh
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMF  778 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  778 (871)
                      ||+|+.+..      .+...+|||.|+|||++...+|+.++|-|||||++|||+.|.+||.+..
T Consensus       188 FGFAK~v~~------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~  245 (355)
T KOG0616|consen  188 FGFAKRVSG------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN  245 (355)
T ss_pred             ccceEEecC------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence            999998653      2455789999999999999999999999999999999999999998643

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-39  Score=356.81  Aligned_cols=284  Identities=22%  Similarity=0.302  Sum_probs=209.3

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|++.+.||+|+||.||+|++..+++.||||++...  .......+.+|+++++.++||||+++++++...........|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            588999999999999999999989999999998632  222345688999999999999999999988655444445689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+ +++|.+++....       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        81 lv~e~~-~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          81 VVFELM-ESDLHQVIKAND-------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             EEEecC-CCCHHHHHHhcc-------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcc
Confidence            999999 579999887543       589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc-
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL--GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD-  794 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-  794 (871)
                      ++................||+.|+|||++.+  ..++.++|||||||++|||++|+.||................+.+. 
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  229 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP  229 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9865432222222234568999999998765  6789999999999999999999999975432111100000111111 


Q ss_pred             h-hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          795 Q-VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       795 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      . ...+....    .........+..+......++.....+.+++.+||+.||++|||++|+++.
T Consensus       230 ~~~~~i~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         230 ETISRVRNEK----ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHHhhhhh----HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            1 11111111    111111111222222233333455678899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-39  Score=355.48  Aligned_cols=269  Identities=23%  Similarity=0.362  Sum_probs=205.7

Q ss_pred             hhcCCCCCceeeccccceEEEEEEC-----CCCcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeecccC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILG-----TEETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCSSID  629 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  629 (871)
                      ..++|++.+.||+|+||.||+|.+.     .+++.||+|+++... ....+.+.+|+.+++.+ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-   83 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-   83 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence            4568999999999999999999852     345679999986432 23346788999999999 899999999987543 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccc--------------------------------------------------
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQ--------------------------------------------------  659 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------  659 (871)
                         ....++||||+++|+|.+++.......                                                  
T Consensus        84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence               245799999999999999997542110                                                  


Q ss_pred             -----cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCCCCCCccccccc
Q 002883          660 -----NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV  734 (871)
Q Consensus       660 -----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  734 (871)
                           .....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....... .......
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~  236 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSA  236 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCC
Confidence                 0012478889999999999999999999   999999999999999999999999999986543221 1112223


Q ss_pred             cccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHh
Q 002883          735 KGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQA  813 (871)
Q Consensus       735 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (871)
                      .++..|+|||++.+..++.++|||||||++|||++ |..||........ .............                 
T Consensus       237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~~~~~~~~-----------------  298 (338)
T cd05102         237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLKDGTRMRA-----------------  298 (338)
T ss_pred             CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHhcCCCCCC-----------------
Confidence            46688999999988899999999999999999997 9999975322211 1111110000000                 


Q ss_pred             hhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          814 GIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       814 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                                   ...+...+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       299 -------------~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         299 -------------PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             -------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                         00223457799999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-41  Score=362.74  Aligned_cols=261  Identities=26%  Similarity=0.424  Sum_probs=218.5

Q ss_pred             CCCCCceeeccccceEEEEEECCCC---cEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEE---TNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ...+.++||.|.||.|++|+.+..+   ..||||.++.... ....+|..|+.||.+++||||+++.|+....     ..
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks-----~P  704 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS-----KP  704 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC-----ce
Confidence            4567899999999999999997655   4699999976543 3457899999999999999999999997665     66


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      ++||+|||++|+|+.|++.+.+      ++++.+...+.+.||.||+||.+.   ++|||||.++|||++.+..+|++||
T Consensus       705 vMIiTEyMENGsLDsFLR~~DG------qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDF  775 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDG------QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDF  775 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCC------ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccc
Confidence            8999999999999999999875      499999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      |+++.+.++......+..-.-..+|.|||.+....++.++||||||+|+||.++ |.+||+++.+.+..-........|+
T Consensus       776 GLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp  855 (996)
T KOG0196|consen  776 GLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP  855 (996)
T ss_pred             cceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC
Confidence            999988665433332222234678999999999999999999999999999887 9999998876643322222222222


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      +                                .+++..|.+||..||+.|-.+||+..|++..|.++-..-
T Consensus       856 P--------------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  856 P--------------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             C--------------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            1                                256778899999999999999999999999999886543

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=316.66  Aligned_cols=252  Identities=20%  Similarity=0.315  Sum_probs=205.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .+.|++.+.||+|.|+.||++....+|+.+|+|++...  .....+.+.+|++|.+.++||||+++.+.+.+.     .+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~-----~~   84 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SF   84 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc-----ce
Confidence            45788899999999999999999999999999998422  233567889999999999999999999987665     77


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC---CCCceEE
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD---NEMVAHV  712 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl  712 (871)
                      .|+|+|+|.|++|..-|-+..       .+++..+-..++||++||.|.|.+   +|||||+||+|+++.   ..-.+||
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R~-------~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL  154 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVARE-------FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKL  154 (355)
T ss_pred             eEEEEecccchHHHHHHHHHH-------HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceee
Confidence            899999999999986554432       588999999999999999999999   999999999999994   3346999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      +|||.|..+..    ........|||+|||||++...+|+..+|||+.|||+|-++.|.+||++..... .+..+....+
T Consensus       155 ~~FGvAi~l~~----g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-lye~I~~g~y  229 (355)
T KOG0033|consen  155 ADFGLAIEVND----GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYEQIKAGAY  229 (355)
T ss_pred             cccceEEEeCC----ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-HHHHHhcccc
Confidence            99999998873    334455789999999999999999999999999999999999999999743221 1222211111


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                           ++-.                       +.+..+.++..+++++||..||.+|.||.|++.
T Consensus       230 -----d~~~-----------------------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  230 -----DYPS-----------------------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             -----CCCC-----------------------cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                 0111                       112244556779999999999999999999875

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=361.92  Aligned_cols=266  Identities=19%  Similarity=0.240  Sum_probs=213.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-CCccceeeeeec-ccCcCC-Cc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSCS-SIDTRG-NE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~-~~~~~~-~~  634 (871)
                      ..++++.++|.+|||+.||.|++...+..||+|.+-..+......+.+|+++|+.++ |+|||.+++... .....+ ..
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            456788999999999999999999777999999997767777889999999999995 999999999433 332333 36


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      .+++.||||+||.|-|++.+....     .+++.++++|+.|+++|+++||.. .++|+|||||-+|||++.++..||||
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~-----~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQT-----RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhc-----cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence            789999999999999999876533     599999999999999999999996 55799999999999999999999999


Q ss_pred             cccceecCCCCCCccc------cccccccccccCccc---ccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHH
Q 002883          715 FGLSRLLHDNSPDQTS------TSRVKGSIGYVAPEY---GALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLH  785 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~------~~~~~gt~~y~aPE~---~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~  785 (871)
                      ||.|...-........      .-....|+.|+|||+   +.+.+.++|+|||||||++|-|++...||++...-     
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----  264 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----  264 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----
Confidence            9999754332211100      111346899999996   45678899999999999999999999999853111     


Q ss_pred             HHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          786 KYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                                  .++....                  ..+.++.+...+.+||+.||+.||.+||++.+|++.+.+|.+
T Consensus       265 ------------aIlng~Y------------------~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  265 ------------AILNGNY------------------SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ------------eEEeccc------------------cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                        1111000                  001123455678899999999999999999999999998864

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=328.39  Aligned_cols=273  Identities=22%  Similarity=0.305  Sum_probs=213.5

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC--CCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI--RHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++.+..+.||+|.||.||+|+|+  |+.||||+|...+   .+.+.+|.+|++.+  +|+||..++++-... ...-...
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~TQL  284 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWTQL  284 (513)
T ss_pred             heeEEEEEecCccccceeecccc--CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccC-CCceEEE
Confidence            56788899999999999999996  8899999997544   37788899999885  999999999874332 3344678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCceeeCCCCceE
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHH-----CHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                      |+|++|.+.|||.||+...        .++....++++..+|.||++||..     .++.|+|||||+.||||++++.+.
T Consensus       285 wLvTdYHe~GSL~DyL~r~--------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~  356 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRN--------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  356 (513)
T ss_pred             EEeeecccCCcHHHHHhhc--------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence            9999999999999999875        599999999999999999999953     578999999999999999999999


Q ss_pred             EeecccceecCCCC-CCccccccccccccccCcccccCCC------CCCccchhhHHHHHHHHHhC----------CCCC
Q 002883          712 VGDFGLSRLLHDNS-PDQTSTSRVKGSIGYVAPEYGALGE------VSTHGDEYSFGILMLEMFTG----------KRPT  774 (871)
Q Consensus       712 l~Dfg~a~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~elltG----------~~pf  774 (871)
                      |+|+|+|-...... .-.......+||.+|||||++...-      .-..+||||||.|+||+.-+          +.||
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py  436 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY  436 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence            99999998776542 2223455678999999999865431      13458999999999998753          3577


Q ss_pred             chhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHH
Q 002883          775 DDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQD  854 (871)
Q Consensus       775 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~e  854 (871)
                      .+....+..+..+.....-+.+...++..|.                     ..+....+.++|+.||..+|..|-||--
T Consensus       437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~---------------------s~~~l~~m~klMkeCW~~Np~aRltALr  495 (513)
T KOG2052|consen  437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWK---------------------SDPALRVMAKLMKECWYANPAARLTALR  495 (513)
T ss_pred             ccCCCCCCCHHHHhcceeecccCCCCCcccc---------------------cCHHHHHHHHHHHHhhcCCchhhhHHHH
Confidence            6655554444444433322222222222221                     1245667889999999999999999999


Q ss_pred             HHHHHHHHHHHH
Q 002883          855 AIMELQEAQKMR  866 (871)
Q Consensus       855 vl~~L~~i~~~~  866 (871)
                      +-..|.++.+..
T Consensus       496 iKKtl~~l~~~~  507 (513)
T KOG2052|consen  496 IKKTLAKLSNSD  507 (513)
T ss_pred             HHHHHHHHhcCh
Confidence            999999887543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.2e-40  Score=328.19  Aligned_cols=249  Identities=21%  Similarity=0.312  Sum_probs=207.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ..+|++.+.+|+|.||.|-+|.....|+.||||.++.+.   ..+.-.+.+|++||..++||||+.+|.+|+..     +
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk-----d  126 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK-----D  126 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC-----c
Confidence            357999999999999999999998899999999996443   33445688999999999999999999998776     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ...+||||..+|.|++|+...+       .+++.+++.+++||..|+.|+|.+   ++||||+|.+|||+|.++++||+|
T Consensus       127 KIvivMEYaS~GeLYDYiSer~-------~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIAD  196 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISERG-------SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIAD  196 (668)
T ss_pred             eEEEEEEecCCccHHHHHHHhc-------cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeec
Confidence            6899999999999999998765       699999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV-STHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||++..+.+.    .....++|++-|.+||+..+.+| ++.+|.||+||++|.|+.|..||++.... ....++....+.
T Consensus       197 FGLSNly~~~----kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-~lvrQIs~GaYr  271 (668)
T KOG0611|consen  197 FGLSNLYADK----KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-RLVRQISRGAYR  271 (668)
T ss_pred             cchhhhhccc----cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-HHHHHhhccccc
Confidence            9999887643    33445789999999999999999 69999999999999999999999863222 112222221111


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                             .|.                          -+....-||++||..+|++|.|+.+|....
T Consensus       272 -------EP~--------------------------~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  272 -------EPE--------------------------TPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             -------CCC--------------------------CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                   111                          011234688999999999999999987654

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.9e-39  Score=348.71  Aligned_cols=278  Identities=23%  Similarity=0.285  Sum_probs=213.2

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-C-----CccceeeeeecccCcCCC
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-H-----RNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~  633 (871)
                      +|++.+.||+|+||+|.+|.+.++++.||||+++.... ...+...|+.+|..++ |     -|+|+++++|...     
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr-----  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR-----  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc-----
Confidence            89999999999999999999999999999999976544 4566778999999986 4     4899999999887     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC--CceE
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE--MVAH  711 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~k  711 (871)
                      ++.|||+|.. +.+|.++++.+.-.     .++...++.++.||+.||.+||+.   +|||+||||+|||+...  ..+|
T Consensus       261 ~HlciVfELL-~~NLYellK~n~f~-----Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vK  331 (586)
T KOG0667|consen  261 NHLCIVFELL-STNLYELLKNNKFR-----GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIK  331 (586)
T ss_pred             cceeeeehhh-hhhHHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCcee
Confidence            8899999999 77999999987644     699999999999999999999999   99999999999999643  3799


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      |+|||+|++....      ....+.+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+..+.+.........+
T Consensus       332 VIDFGSSc~~~q~------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG  405 (586)
T KOG0667|consen  332 VIDFGSSCFESQR------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG  405 (586)
T ss_pred             EEecccccccCCc------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC
Confidence            9999999986432      1246789999999999999999999999999999999999888876554443333333333


Q ss_pred             CCch-hh-------hhcCh-hHHH------H---------HHH-HHhhhhhhcCc----hhHHhHH-HHHHHHHhhhccc
Q 002883          792 LPDQ-VA-------EIIDP-AILE------E---------ALE-IQAGIVKELQP----NLRAKFH-EIQVSILRVGILC  841 (871)
Q Consensus       792 ~~~~-~~-------~~~~~-~~~~------~---------~~~-~~~~~~~~~~~----~~~~~~~-~~~~~l~~li~~c  841 (871)
                      .|+. .-       .+++. ....      .         ... ..........|    ....... .....+++++.+|
T Consensus       406 ~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~  485 (586)
T KOG0667|consen  406 LPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC  485 (586)
T ss_pred             CCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence            3332 11       11111 0000      0         000 00001111122    2222233 4456789999999


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 002883          842 SEELPRDRMKIQDAIME  858 (871)
Q Consensus       842 l~~dP~~RPta~evl~~  858 (871)
                      +++||.+|+|+.|+++.
T Consensus       486 L~~dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  486 LEWDPAERITPAQALNH  502 (586)
T ss_pred             hccCchhcCCHHHHhcC
Confidence            99999999999998863

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.7e-39  Score=337.46  Aligned_cols=207  Identities=26%  Similarity=0.353  Sum_probs=181.1

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..++|+.++.||+|+||.||+|+-+.+|..+|+|+++..   ..+..+.+..|-++|...++|.||++|..|.+.     
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~-----  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK-----  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC-----
Confidence            457899999999999999999999999999999999654   234567788999999999999999999999887     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      .++|+||||++||++..++...+       .+++..++.++.+.+.|+..+|+.   |++||||||+|+|||..|++||+
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~~-------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLS  283 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRKD-------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLS  283 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhcC-------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeec
Confidence            78999999999999999998765       699999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCC--------------------CCCcc------c------------------cccccccccccCcccccCC
Q 002883          714 DFGLSRLLHDN--------------------SPDQT------S------------------TSRVKGSIGYVAPEYGALG  749 (871)
Q Consensus       714 Dfg~a~~~~~~--------------------~~~~~------~------------------~~~~~gt~~y~aPE~~~~~  749 (871)
                      |||++.-+...                    .....      .                  ....+|||.|+|||++.+.
T Consensus       284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k  363 (550)
T KOG0605|consen  284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK  363 (550)
T ss_pred             cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence            99998543210                    00000      0                  0124699999999999999


Q ss_pred             CCCCccchhhHHHHHHHHHhCCCCCchhh
Q 002883          750 EVSTHGDEYSFGILMLEMFTGKRPTDDMF  778 (871)
Q Consensus       750 ~~~~~~DiwSlG~il~elltG~~pf~~~~  778 (871)
                      .|+..+|.||+|||+|||+.|.+||....
T Consensus       364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~t  392 (550)
T KOG0605|consen  364 GYGKECDWWSLGCIMYEMLVGYPPFCSET  392 (550)
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999999998643

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-39  Score=305.02  Aligned_cols=252  Identities=22%  Similarity=0.301  Sum_probs=212.6

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      +.++|++++.||+|-||.||.|+.++++-.||+|++...+   .+...++.+|++|-..++||||.++|++|.+.     
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-----   94 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-----   94 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-----
Confidence            4578999999999999999999999999999999995432   33457899999999999999999999999887     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+++||..+|.+...++.....     ++++.....+..|+|.|+.|+|..   +|+||||||+|+|++..+.+|++
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~-----~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiA  166 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMK-----RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIA  166 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccc-----cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeecc
Confidence            6799999999999999999865533     689999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||.+....     .......+||..|.|||...+..++..+|+|++|+..||++.|.+||.... .+..+.+.....+.
T Consensus       167 dfGwsV~~p-----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~~  240 (281)
T KOG0580|consen  167 DFGWSVHAP-----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDLK  240 (281)
T ss_pred             CCCceeecC-----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcccc
Confidence            999997643     222334679999999999999999999999999999999999999999765 33333333332211


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                      .+                                ..+.....++|.+|+..+|.+|.+..|+++.-
T Consensus       241 ~p--------------------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  241 FP--------------------------------STISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             CC--------------------------------cccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence            11                                12334567899999999999999999998753

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-39  Score=341.02  Aligned_cols=254  Identities=20%  Similarity=0.275  Sum_probs=212.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|..++.+|+|+||.++.++++.++..||+|.+.....  ...+...+|+.+++++.|||||.+.+.|.+.    +...
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~----~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED----GQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC----CceE
Confidence            579999999999999999999999999999999964432  2345678999999999999999999998765    2448


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      +|||+||+||++.+.+.+.++.     .++++.+..|+.|++.|+.|||+.   .|+|||||+.||+++.++.|||+|||
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~-----~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfG  151 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGV-----LFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFG  151 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhc-----cccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchh
Confidence            9999999999999999887633     699999999999999999999988   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +|+.+....   ......+||+.||.||.+.+.+|+.|+||||+||++|||++-+++|....-...........  .   
T Consensus       152 laK~l~~~~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~--~---  223 (426)
T KOG0589|consen  152 LAKILNPED---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL--Y---  223 (426)
T ss_pred             hhhhcCCch---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc--C---
Confidence            999887543   23445789999999999999999999999999999999999999998543222211111110  0   


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                                                 .+....+..++..++..|++.+|+.||+|.+++..-
T Consensus       224 ---------------------------~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  224 ---------------------------SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             ---------------------------CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence                                       011112344677899999999999999999999873

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.7e-38  Score=339.09  Aligned_cols=277  Identities=25%  Similarity=0.343  Sum_probs=202.7

Q ss_pred             cCCCCCceeeccccceEEEEEECC-CCcEEEEEEeeccc--cchHHHHHHHHHHHHcC---CCCccceeeeeecccCcCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGT-EETNVAVKVLDLQQ--RGASKSFIAECEALRSI---RHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~  632 (871)
                      ++|++.+.||+|+||.||+|++.. +++.||+|+++...  ......+.+|+.+++.+   +||||+++++++.......
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999854 46889999986433  22234566788777765   6999999999986544444


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                      ....++||||++ ++|.+++......     .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl  151 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEP-----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL  151 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEE
Confidence            567899999995 6999998764322     589999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MG  791 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~  791 (871)
                      +|||.+......    .......|++.|+|||.+.+..++.++||||+||++|||++|++||......+. ...... ..
T Consensus       152 ~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-~~~i~~~~~  226 (290)
T cd07862         152 ADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIG  226 (290)
T ss_pred             ccccceEeccCC----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhC
Confidence            999999876432    222335689999999998888999999999999999999999999986433221 111111 11


Q ss_pred             CCc--hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          792 LPD--QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       792 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .+.  .......  +....      ...................+.+++.+|++.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~--~~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         227 LPGEEDWPRDVA--LPRQA------FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCChhhchhhhc--ccchh------ccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            111  0000000  00000      0000000111111234566789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.8e-39  Score=323.16  Aligned_cols=283  Identities=24%  Similarity=0.319  Sum_probs=216.6

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCc-cceeeeeecccCc-CCCc
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRN-LVKIITSCSSIDT-RGNE  634 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~-~~~~  634 (871)
                      ..|+.+++||+|+||+||+|+...+|+.||+|+++....  +......+|+.+++.++|+| |+++++++..... ....
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            456777889999999999999999999999999965543  45677889999999999999 9999999977632 3335


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+ ..+|..++.......   ..++...++.+++||+.||+|||++   +|+||||||+||+++++|.+||+|
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~---~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKP---QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence            789999999 669999998765321   2467789999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||+|+...-..   ......++|..|+|||++.+. .|++..||||+|||++||++++..|.+..+.+.....+...+.|
T Consensus       164 FGlAra~~ip~---~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP  240 (323)
T KOG0594|consen  164 FGLARAFSIPM---RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP  240 (323)
T ss_pred             cchHHHhcCCc---ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence            99998655321   224456789999999998776 78999999999999999999999998876655555555555544


Q ss_pred             ch--hhhhcC-hhHHHHHHHHHhhhhhhc-CchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQ--VAEIID-PAILEEALEIQAGIVKEL-QPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~--~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ..  +..... +....       ...++. ........+.......+++.+|++++|.+|.||+.+++.
T Consensus       241 ~e~~Wp~v~~~~~~k~-------~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKA-------PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccCCCCccccccccc-------cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            32  111110 00000       000111 111222222222467899999999999999999999986

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-39  Score=328.27  Aligned_cols=281  Identities=25%  Similarity=0.323  Sum_probs=205.1

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHc--CCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRS--IRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ...+..+.||+|.||.||+|...  ++.||||++...   ..+.+..|-+|++.  ++|+||++++++-...+.. ...+
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ey  283 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEY  283 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccce
Confidence            34566788999999999999995  689999999754   34778888888776  4899999999885544333 4578


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeEecCCCCCceeeCCCCce
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC------HTSIVHCDLKPSNVLLDNEMVA  710 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~Nill~~~~~~  710 (871)
                      ++|+||.+.|+|.+|++.+        .++|....+++..+++||+|||+..      +++|+|||||++||||..|+++
T Consensus       284 wLVt~fh~kGsL~dyL~~n--------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc  355 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKAN--------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC  355 (534)
T ss_pred             eEEeeeccCCcHHHHHHhc--------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence            9999999999999999887        4999999999999999999999753      5789999999999999999999


Q ss_pred             EEeecccceecCCCCCCccccccccccccccCcccccCCCC------CCccchhhHHHHHHHHHhCCCCCch-hhhhhhh
Q 002883          711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV------STHGDEYSFGILMLEMFTGKRPTDD-MFEEGLS  783 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DiwSlG~il~elltG~~pf~~-~~~~~~~  783 (871)
                      .|+|||+|..+........ ....+||.+|||||++.+..-      -.+.||||+|.|+|||+++..-+.. ...+-..
T Consensus       356 cIaDFGLAl~~~p~~~~~d-~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql  434 (534)
T KOG3653|consen  356 CIADFGLALRLEPGKPQGD-THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL  434 (534)
T ss_pred             EeeccceeEEecCCCCCcc-hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence            9999999999876553333 333789999999998766432      2357999999999999986544321 1000000


Q ss_pred             HHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHH--HHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          784 LHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFH--EIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                      ..+. ..+.        +|.+ ++..+  ....+..+|.....+.  ....-+.+.+..||+.||+.|.||.=|.+++.+
T Consensus       435 pfe~-evG~--------hPt~-e~mq~--~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~  502 (534)
T KOG3653|consen  435 PFEA-EVGN--------HPTL-EEMQE--LVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAE  502 (534)
T ss_pred             chhH-HhcC--------CCCH-HHHHH--HHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence            0000 0000        0000 00000  0011222232222222  345568899999999999999999999999988


Q ss_pred             HHHHH
Q 002883          862 AQKMR  866 (871)
Q Consensus       862 i~~~~  866 (871)
                      +....
T Consensus       503 l~~~~  507 (534)
T KOG3653|consen  503 LMMLW  507 (534)
T ss_pred             HhccC
Confidence            86554

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-39  Score=340.82  Aligned_cols=246  Identities=24%  Similarity=0.331  Sum_probs=199.7

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.....   ...+.+.+|+++++.++||||+++++++.+.     ..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-----RF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-----Ce
Confidence            378999999999999999999998999999999864321   2345678999999999999999999887654     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++...+       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Df  145 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSG-------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDF  145 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEec
Confidence            899999999999999997654       588999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |++......      .....|++.|+|||++.+..++.++|||||||++|+|++|+.||........ .........  .
T Consensus       146 g~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~--~  216 (291)
T cd05612         146 GFAKKLRDR------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-YEKILAGKL--E  216 (291)
T ss_pred             CcchhccCC------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCc--C
Confidence            999865422      1234689999999999888899999999999999999999999975322111 111100000  0


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC-----HHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK-----IQDAIME  858 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----a~evl~~  858 (871)
                                             .+       ......+.+++.+||+.||.+||+     ++|+++.
T Consensus       217 -----------------------~~-------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         217 -----------------------FP-------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -----------------------CC-------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                                   00       011335679999999999999995     8887754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-39  Score=367.89  Aligned_cols=268  Identities=24%  Similarity=0.380  Sum_probs=217.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCC-----cEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEE-----TNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ...+..+.||+|.||.||.|......     ..||||.++.. +.+...+|.+|+.+|+.++|||||+++|.+.+.    
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~----  767 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS----  767 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC----
Confidence            34566789999999999999985432     34899988543 455678999999999999999999999999875    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                       ...+|++|||++|+|..|++..+....+...++..+.+.++.|||+|+.||+++   ++|||||..+|+|++....|||
T Consensus       768 -~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKI  843 (1025)
T KOG1095|consen  768 -GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKI  843 (1025)
T ss_pred             -CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEE
Confidence             557999999999999999999876666666899999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      +|||+|+.+...+... ......-...|||||.+..+.++.|+|||||||++||++| |..||.+....+....-.....
T Consensus       844 aDFGlArDiy~~~yyr-~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR  922 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYR-KHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR  922 (1025)
T ss_pred             cccchhHhhhhchhee-ccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc
Confidence            9999999654432211 1111234578999999999999999999999999999999 9999987544322111111110


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQ  867 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~~  867 (871)
                      .                                +....++.++.++|..||+.+|++||+...+++++..+.+...
T Consensus       923 L--------------------------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  923 L--------------------------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             c--------------------------------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence            0                                1112466788899999999999999999999999988866543

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.6e-38  Score=338.73  Aligned_cols=278  Identities=20%  Similarity=0.252  Sum_probs=203.7

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++...  ....+.+.+|+++++.++||||+++++++...     +..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR-----GKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC-----CEE
Confidence            47999999999999999999999899999999986432  22346778999999999999999999988654     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||++++.+..+.....       .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg  145 (287)
T cd07848          76 YLVFEYVEKNMLELLEEMPN-------GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFG  145 (287)
T ss_pred             EEEEecCCCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeecc
Confidence            99999999877765543321       589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHH-HHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLH-KYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~-~~~~~~~~~~  795 (871)
                      .+.......  ........|++.|+|||++.+..++.++||||+||++|||++|+.||......+.... .......+..
T Consensus       146 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  223 (287)
T cd07848         146 FARNLSEGS--NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAE  223 (287)
T ss_pred             Ccccccccc--cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHH
Confidence            998764322  1122234689999999999888899999999999999999999999976433221111 1111111111


Q ss_pred             hhhhc--ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEII--DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .....  ++.......    ....................+.+++.+||+.||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         224 QMKLFYSNPRFHGLRF----PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHHhhhccchhccccc----CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11100  000000000    00000000000111234567899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.9e-38  Score=340.51  Aligned_cols=279  Identities=24%  Similarity=0.325  Sum_probs=201.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.     ...
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK-----ETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC-----CeE
Confidence            4689999999999999999999998999999999864332 2234677899999999999999999998765     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+ +++|.+++.....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        79 ~lv~e~~-~~~l~~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  148 (303)
T cd07869          79 TLVFEYV-HTDLCQYMDKHPG------GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFG  148 (303)
T ss_pred             EEEEECC-CcCHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCC
Confidence            9999999 4688888865432      488999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh-CCCc
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM-GLPD  794 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~~~~  794 (871)
                      ++.......   .......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||....+........... ..+.
T Consensus       149 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (303)
T cd07869         149 LARAKSVPS---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN  225 (303)
T ss_pred             cceeccCCC---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCC
Confidence            997543221   11223468999999998765 457899999999999999999999998643322222211111 1110


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHH--HHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFH--EIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      . ..+....-.....  ........+......+.  .....+.+++.+|++.||++|||+.|+++
T Consensus       226 ~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         226 E-DTWPGVHSLPHFK--PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             h-hhccchhhccccc--cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0 0000000000000  00000000011111111  12345779999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.7e-38  Score=343.70  Aligned_cols=242  Identities=21%  Similarity=0.282  Sum_probs=195.1

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEe
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE  641 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  641 (871)
                      +.||+|+||.||+|++..+++.||+|+++...   ......+.+|++++++++||||+++++++...     ...|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-----DRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-----CEEEEEEe
Confidence            46999999999999999899999999996432   22345677899999999999999999988765     67899999


Q ss_pred             ccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceec
Q 002883          642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL  721 (871)
Q Consensus       642 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  721 (871)
                      |+++|+|.+++....       .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 ~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          76 YANGGELFFHLSRER-------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             CCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            999999999997643       589999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcC
Q 002883          722 HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIID  801 (871)
Q Consensus       722 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  801 (871)
                      ...   ........||+.|+|||++.+..++.++||||+||++|||++|+.||.......  .......... .      
T Consensus       146 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~~~~~~~-~------  213 (323)
T cd05571         146 ISD---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILMEEI-R------  213 (323)
T ss_pred             ccC---CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HHHHHHcCCC-C------
Confidence            221   112233569999999999988899999999999999999999999997532211  1111100000 0      


Q ss_pred             hhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHH
Q 002883          802 PAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIM  857 (871)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~  857 (871)
                                       .+       .....++.+++.+||+.||++||     ++.|+++
T Consensus       214 -----------------~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         214 -----------------FP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -----------------CC-------CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                             00       01234567899999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.4e-38  Score=337.01  Aligned_cols=277  Identities=22%  Similarity=0.279  Sum_probs=202.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++...     ...
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~   78 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE-----RCL   78 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC-----CeE
Confidence            357999999999999999999999899999999986432 22345678999999999999999999998654     568


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||++ ++|.+++.....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        79 ~lv~e~~~-~~l~~~l~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG  148 (288)
T cd07871          79 TLVFEYLD-SDLKQYLDNCGN------LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFG  148 (288)
T ss_pred             EEEEeCCC-cCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCc
Confidence            99999996 599998865432      478999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc-
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD-  794 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-  794 (871)
                      ++.......   .......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||..................+. 
T Consensus       149 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (288)
T cd07871         149 LARAKSVPT---KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE  225 (288)
T ss_pred             ceeeccCCC---ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            997653221   11223467899999998765 5689999999999999999999999975433222111111111111 


Q ss_pred             -hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 -QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       ....+.+..   .+....  ..+...............+..+++.+|+++||.+|||++|+++
T Consensus       226 ~~~~~~~~~~---~~~~~~--~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         226 ETWPGITSNE---EFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             HHhhccccch---hhhccc--cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             111111100   000000  0000000000111123456789999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.1e-38  Score=336.83  Aligned_cols=253  Identities=21%  Similarity=0.310  Sum_probs=199.6

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .|+..+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+++++.++|++|+++++++.+.     ...
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-----~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-----DAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-----CeE
Confidence            3778899999999999999999899999999986432   22234577899999999999999999988665     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++|+|.+++.....     ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg  147 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMGN-----PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLG  147 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCC
Confidence            999999999999988865432     2589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      ++.......    ......||..|+|||++.+..++.++||||+||++|+|++|+.||......... ...... .....
T Consensus       148 ~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~~~-~~~~~  221 (285)
T cd05631         148 LAVQIPEGE----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-EEVDRR-VKEDQ  221 (285)
T ss_pred             CcEEcCCCC----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-HHHHHH-hhccc
Confidence            998754321    122346899999999999899999999999999999999999999753221100 000000 00000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC-----HHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK-----IQDAIME  858 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----a~evl~~  858 (871)
                                                 ..........+.+++.+||+.||++||+     ++|+++.
T Consensus       222 ---------------------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         222 ---------------------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ---------------------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence                                       0000123446779999999999999997     7888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.5e-39  Score=306.76  Aligned_cols=256  Identities=25%  Similarity=0.374  Sum_probs=208.8

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--------chHHHHHHHHHHHHcC-CCCccceeeeeec
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--------GASKSFIAECEALRSI-RHRNLVKIITSCS  626 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  626 (871)
                      .....|...+.+|.|..++|.++..+.++..+|+|++.....        ...+.-.+|+.|++++ .||+|+.+.++|.
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            445678889999999999999999999999999999954321        1124556899999998 7999999999988


Q ss_pred             ccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC
Q 002883          627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN  706 (871)
Q Consensus       627 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  706 (871)
                      +.     .++++|+|.|+.|.|.|++...-       .+++...++|++|+.+|++|||..   .|||||+||+|||+++
T Consensus        94 s~-----sF~FlVFdl~prGELFDyLts~V-------tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILldd  158 (411)
T KOG0599|consen   94 SD-----AFVFLVFDLMPRGELFDYLTSKV-------TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDD  158 (411)
T ss_pred             Cc-----chhhhhhhhcccchHHHHhhhhe-------eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecc
Confidence            76     78999999999999999998754       699999999999999999999999   9999999999999999


Q ss_pred             CCceEEeecccceecCCCCCCccccccccccccccCccccc------CCCCCCccchhhHHHHHHHHHhCCCCCchhhhh
Q 002883          707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA------LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEE  780 (871)
Q Consensus       707 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  780 (871)
                      +.++||+|||+|+.+.++.    .....+|||+|.|||.+.      ...|+..+|+||+||++|.++.|.+||+....-
T Consensus       159 n~~i~isDFGFa~~l~~Ge----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm  234 (411)
T KOG0599|consen  159 NMNIKISDFGFACQLEPGE----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM  234 (411)
T ss_pred             ccceEEeccceeeccCCch----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH
Confidence            9999999999999887543    345578999999999643      346788999999999999999999999853211


Q ss_pred             hhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          781 GLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                       ..++.+....     .++-.+.                       +.++.....+++.+||+.||.+|.|++|+++.=
T Consensus       235 -lMLR~ImeGk-----yqF~spe-----------------------Wadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  235 -LMLRMIMEGK-----YQFRSPE-----------------------WADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             -HHHHHHHhcc-----cccCCcc-----------------------hhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence             1111111111     1222222                       235556778999999999999999999998753

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.7e-38  Score=346.24  Aligned_cols=274  Identities=20%  Similarity=0.262  Sum_probs=202.1

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|...      ...+.+|++++++++||||+++++++...     ...+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~  159 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYN-----KFTC  159 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC-----CeeE
Confidence            357999999999999999999999999999999753      24567899999999999999999998654     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +|||++ +++|.+++....       .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       160 lv~e~~-~~~L~~~l~~~~-------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~  228 (391)
T PHA03212        160 LILPRY-KTDLYCYLAAKR-------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGA  228 (391)
T ss_pred             EEEecC-CCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCc
Confidence            999999 578988886543       588999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhh------hhhhHHHHhhh-
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFE------EGLSLHKYAKM-  790 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~------~~~~~~~~~~~-  790 (871)
                      |.......  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....      ........... 
T Consensus       229 a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~  306 (391)
T PHA03212        229 ACFPVDIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRS  306 (391)
T ss_pred             cccccccc--ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHh
Confidence            97543221  1122335699999999999888999999999999999999999988753221      11111111111 


Q ss_pred             CC-CchhhhhcChhHHHHHHHHHhhhhhhcCch---hHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          791 GL-PDQVAEIIDPAILEEALEIQAGIVKELQPN---LRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       791 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      +. +..............+......  ....+.   ........+.++.+++.+||+.||++||||+|+++
T Consensus       307 g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        307 GTHPNEFPIDAQANLDEIYIGLAKK--SSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             cCChhhcCcchhHHHHHHHHHHHhc--cCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            11 1110000000011111000000  000111   11222345668899999999999999999999986

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=337.40  Aligned_cols=241  Identities=25%  Similarity=0.396  Sum_probs=199.5

Q ss_pred             CCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEe
Q 002883          562 SSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE  641 (871)
Q Consensus       562 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  641 (871)
                      ...+.+|.|+.|.||+|+..  ++.||||+++.       .-..+|+-|++++||||+.+.|+|...     ..+|||||
T Consensus       127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiME  192 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIME  192 (904)
T ss_pred             hhhhhhccCcccceeeeecc--CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCC-----ceeEEeee
Confidence            44678999999999999995  78899998752       223478889999999999999999887     77899999


Q ss_pred             ccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceec
Q 002883          642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL  721 (871)
Q Consensus       642 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  721 (871)
                      ||..|-|.+.++...       .++......|..+||.|+.|||.+   .|+|||||.-||||+.+..|||+|||.++..
T Consensus       193 fCa~GqL~~VLka~~-------~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~  262 (904)
T KOG4721|consen  193 FCAQGQLYEVLKAGR-------PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKEL  262 (904)
T ss_pred             ccccccHHHHHhccC-------ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhh
Confidence            999999999998765       688999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcC
Q 002883          722 HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIID  801 (871)
Q Consensus       722 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  801 (871)
                      .+-    .....+.||..|||||++...+.++|+||||||||+|||+||..||.+.......+     . ........  
T Consensus       263 ~~~----STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw-----G-VGsNsL~L--  330 (904)
T KOG4721|consen  263 SDK----STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW-----G-VGSNSLHL--  330 (904)
T ss_pred             hhh----hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE-----e-ccCCcccc--
Confidence            532    33344679999999999999999999999999999999999999998643322111     0 00000000  


Q ss_pred             hhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          802 PAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                                             +....+++-+.-|++.||+-.|..||++.+++..|+-
T Consensus       331 -----------------------pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  331 -----------------------PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             -----------------------cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence                                   0011445567788999999999999999999999873

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.2e-38  Score=338.17  Aligned_cols=270  Identities=22%  Similarity=0.347  Sum_probs=201.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECC----------------CCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGT----------------EETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVK  620 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  620 (871)
                      .++|++.+.||+|+||.||+|++..                ++..||+|++.... ......+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4679999999999999999998642                33479999986543 233467889999999999999999


Q ss_pred             eeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccc------------cccCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 002883          621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ------------NQRPKLNLMQRLSIAIDVANVLEYLHHHC  688 (871)
Q Consensus       621 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~  688 (871)
                      +++++.+.     ...++||||+++|+|.+++.......            .....+++..+..++.||+.||+|||+. 
T Consensus        84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-  157 (304)
T cd05096          84 LLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-  157 (304)
T ss_pred             EEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence            99998765     55899999999999999986542110            1123478889999999999999999999 


Q ss_pred             CCCeEecCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHH
Q 002883          689 HTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMF  768 (871)
Q Consensus       689 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  768 (871)
                        +|+||||||+||+++.++.+||+|||.+........ ........++..|+|||++..+.++.++|||||||++|||+
T Consensus       158 --~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~  234 (304)
T cd05096         158 --NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL  234 (304)
T ss_pred             --CccccCcchhheEEcCCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence              999999999999999999999999999986543321 11222344678899999988889999999999999999998


Q ss_pred             h--CCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCC
Q 002883          769 T--GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELP  846 (871)
Q Consensus       769 t--G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  846 (871)
                      +  |..||.........  .............                    ...   .....++..+.+++.+||+.||
T Consensus       235 ~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~--------------------~~~---~~~~~~~~~~~~li~~cl~~~p  289 (304)
T cd05096         235 MLCKEQPYGELTDEQVI--ENAGEFFRDQGRQ--------------------VYL---FRPPPCPQGLYELMLQCWSRDC  289 (304)
T ss_pred             HccCCCCCCcCCHHHHH--HHHHHHhhhcccc--------------------ccc---cCCCCCCHHHHHHHHHHccCCc
Confidence            7  56777653222110  0000000000000                    000   0001233567899999999999


Q ss_pred             CCCCCHHHHHHHHHH
Q 002883          847 RDRMKIQDAIMELQE  861 (871)
Q Consensus       847 ~~RPta~evl~~L~~  861 (871)
                      ++|||+.||.+.|++
T Consensus       290 ~~RPs~~~i~~~l~~  304 (304)
T cd05096         290 RERPSFSDIHAFLTE  304 (304)
T ss_pred             hhCcCHHHHHHHHhC
Confidence            999999999988863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.5e-38  Score=332.05  Aligned_cols=252  Identities=20%  Similarity=0.271  Sum_probs=199.5

Q ss_pred             CceeeccccceEEEEEECCCCcEEEEEEeeccccch---HHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEE
Q 002883          564 ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGA---SKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      ...||+|++|.||+|.+  +++.||||+++......   .+.+.+|+.++++++||||+++++++.+. ..+....++||
T Consensus        25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~  101 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLIL  101 (283)
T ss_pred             CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEE
Confidence            36799999999999998  58899999996543322   46778999999999999999999998652 12235679999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++|+|.+++....       .+++.....++.|++.|+.|||+..  +++||||||+||+++.++.+||+|||++..
T Consensus       102 Ey~~~g~L~~~l~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~  172 (283)
T PHA02988        102 EYCTRGYLREVLDKEK-------DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKI  172 (283)
T ss_pred             EeCCCCcHHHHHhhCC-------CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence            9999999999997643       5889999999999999999999741  788999999999999999999999999986


Q ss_pred             cCCCCCCccccccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhh
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGAL--GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE  798 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  798 (871)
                      .....      ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||........ .........+...  
T Consensus       173 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-~~~i~~~~~~~~~--  243 (283)
T PHA02988        173 LSSPP------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-YDLIINKNNSLKL--  243 (283)
T ss_pred             hcccc------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhcCCCCCC--
Confidence            54321      12457899999999865  6889999999999999999999999985432211 1111110000000  


Q ss_pred             hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                                               .   ..++..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus       244 -------------------------~---~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        244 -------------------------P---LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             -------------------------C---CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                                     0   0234467899999999999999999999999998754

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.3e-38  Score=343.39  Aligned_cols=246  Identities=21%  Similarity=0.237  Sum_probs=199.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.     .
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-----N   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-----C
Confidence            357999999999999999999999899999999996432   22345688999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||+++|+|.+++....       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~D  161 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAG-------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTD  161 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEee
Confidence            7899999999999999997643       588999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||++.......      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .........  .
T Consensus       162 fg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~--~  232 (329)
T PTZ00263        162 FGFAKKVPDRT------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-IYEKILAGR--L  232 (329)
T ss_pred             ccCceEcCCCc------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-HHHHHhcCC--c
Confidence            99998764321      22468999999999998889999999999999999999999997532111 011100000  0


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC-----HHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK-----IQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----a~evl~  857 (871)
                      ....                              .+...+.+++.+||+.||++||+     ++|+++
T Consensus       233 ~~p~------------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        233 KFPN------------------------------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CCCC------------------------------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            0000                              11234678999999999999997     577664

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.7e-38  Score=345.36  Aligned_cols=267  Identities=23%  Similarity=0.366  Sum_probs=205.1

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCC-----CcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeecccC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTE-----ETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCSSID  629 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  629 (871)
                      ..++|++.+.||+|+||.||+|++...     +..||+|+++... ......+.+|+++++.+ +|+||+++++++... 
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-  114 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG-  114 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-
Confidence            345799999999999999999986433     3579999996433 23345688999999999 899999999998765 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhccccc---------------------------------------------------
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDE---------------------------------------------------  658 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------  658 (871)
                          ...++||||+++|+|.+++......                                                   
T Consensus       115 ----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         115 ----GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             ----CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence                5689999999999999998653210                                                   


Q ss_pred             ------------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCCCCC
Q 002883          659 ------------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSP  726 (871)
Q Consensus       659 ------------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  726 (871)
                                  ......+++.++++++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                        00112478899999999999999999999   999999999999999999999999999986543221


Q ss_pred             CccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHH
Q 002883          727 DQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAIL  805 (871)
Q Consensus       727 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  805 (871)
                       ........++..|+|||++.+..++.++|||||||++|||++ |+.||........ ...............       
T Consensus       268 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~~~~~~~~~~~~-------  338 (374)
T cd05106         268 -YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKMVKRGYQMSRPD-------  338 (374)
T ss_pred             -eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHHHHcccCccCCC-------
Confidence             111222335678999999888899999999999999999997 9999975432211 111111110000000       


Q ss_pred             HHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          806 EEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                                             ..+.++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       339 -----------------------~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         339 -----------------------FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             -----------------------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                                   11345778999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.1e-38  Score=339.56  Aligned_cols=201  Identities=25%  Similarity=0.334  Sum_probs=176.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||.||+|++..++..||+|++.... ......+.+|++++++++||||+++++++...     +..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEE
Confidence            468999999999999999999999999999999997543 23346789999999999999999999998765     568


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++++|.+++....       .+++..+..++.|++.|+.|||+..  +|+||||||+||+++.++.+||+|||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg  149 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAK-------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFG  149 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCc
Confidence            99999999999999997643       5889999999999999999999851  69999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      ++......     ......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       150 ~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         150 VSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             cccccccc-----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            99765332     122346899999999998889999999999999999999999999753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-38  Score=342.77  Aligned_cols=254  Identities=21%  Similarity=0.281  Sum_probs=203.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++...   ......+.+|+++++.++||||+++++++...     ..
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-----EY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC-----CE
Confidence            47999999999999999999999899999999996432   22345678899999999999999999988765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++....       .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Df  145 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLG-------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDF  145 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeC
Confidence            899999999999999997643       588999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |++.....      ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ........  ..
T Consensus       146 g~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~--~~  216 (333)
T cd05600         146 GLSKGIVT------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WENLKYWK--ET  216 (333)
T ss_pred             cCCccccc------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HHHHHhcc--cc
Confidence            99976532      22335689999999999888999999999999999999999999975322211 11100000  00


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                          ...                  +........+..++.+++.+|+..+|++||+++|+++.
T Consensus       217 ----~~~------------------~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         217 ----LQR------------------PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ----ccC------------------CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                000                  00000001234567789999999999999999999865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=9.7e-41  Score=349.77  Aligned_cols=367  Identities=29%  Similarity=0.400  Sum_probs=219.0

Q ss_pred             cCCCCCCEEecCCCccc-ccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCcccccccccc
Q 002883           11 THCSELRILDLVVNKLE-GNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLN   89 (871)
Q Consensus        11 ~~l~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~   89 (871)
                      +-|+..+-.|+++|.++ +-.|.+....+++++|.|...++. .+|+.++.|.+|++|.++||++. .+.++++.|+.|+
T Consensus         4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR   81 (1255)
T KOG0444|consen    4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR   81 (1255)
T ss_pred             cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence            34566778888888887 467888888888888888888887 78888888888888888888887 6667777777777


Q ss_pred             ccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCC
Q 002883           90 MFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLK  169 (871)
Q Consensus        90 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~  169 (871)
                      .+.+.+|+++.                       +-+|..+| .|..|++||||+|+++           ..|..+..-+
T Consensus        82 sv~~R~N~LKn-----------------------sGiP~diF-~l~dLt~lDLShNqL~-----------EvP~~LE~AK  126 (1255)
T KOG0444|consen   82 SVIVRDNNLKN-----------------------SGIPTDIF-RLKDLTILDLSHNQLR-----------EVPTNLEYAK  126 (1255)
T ss_pred             HHhhhcccccc-----------------------CCCCchhc-ccccceeeecchhhhh-----------hcchhhhhhc
Confidence            77777777762                       13555555 6666666666666666           5666666667


Q ss_pred             cccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccc
Q 002883          170 NLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKN  249 (871)
Q Consensus       170 ~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~  249 (871)
                      ++..|+||+|+|.++|..      -+.+++.|-.||||+|++. .+|..+-.+ .+|++|.|++|.+.-.-...+-.|++
T Consensus       127 n~iVLNLS~N~IetIPn~------lfinLtDLLfLDLS~NrLe-~LPPQ~RRL-~~LqtL~Ls~NPL~hfQLrQLPsmts  198 (1255)
T KOG0444|consen  127 NSIVLNLSYNNIETIPNS------LFINLTDLLFLDLSNNRLE-MLPPQIRRL-SMLQTLKLSNNPLNHFQLRQLPSMTS  198 (1255)
T ss_pred             CcEEEEcccCccccCCch------HHHhhHhHhhhccccchhh-hcCHHHHHH-hhhhhhhcCCChhhHHHHhcCccchh
Confidence            777777777777666542      2345555666666666665 555555555 34666666666554333333444455


Q ss_pred             cceeeccccccc-ccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecC
Q 002883          250 LILIAMEVNLLT-GSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLS  328 (871)
Q Consensus       250 L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  328 (871)
                      |..|.+++.+-+ .-+|.++..+.+|..+|||.|.+. ..|+.+.++++|+.|+|++|+|+ .+........+|++|+||
T Consensus       199 L~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlS  276 (1255)
T KOG0444|consen  199 LSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLS  276 (1255)
T ss_pred             hhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccc
Confidence            555555554322 234555555555555555555555 45555555555555555555555 333334444455555555


Q ss_pred             CCcCCCCCcccccCCCCCcEEeccCCCCC-CCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCccccc
Q 002883          329 DNNLSGTIPREVIGLSSFVLLDLSRNHLS-GPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP  407 (871)
Q Consensus       329 ~N~l~~~~~~~~~~l~~L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  407 (871)
                      +|+++ .+|.+++.+++|+.|++.+|+++ .-+|..++.+.+|+.+..++|.+. .+|+.++.|.+|+.|.|+.|++. .
T Consensus       277 rNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-T  353 (1255)
T KOG0444|consen  277 RNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-T  353 (1255)
T ss_pred             cchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-e
Confidence            55555 55555555555555555555543 123445555555555555555554 45555555555555555555544 3


Q ss_pred             CccccCCCCCCCEEeCCCCc
Q 002883          408 IHSGFSSLKGLQDLDLSRNN  427 (871)
Q Consensus       408 ~~~~~~~l~~L~~L~l~~N~  427 (871)
                      .|.++.-|+.|+.|||.+|.
T Consensus       354 LPeaIHlL~~l~vLDlreNp  373 (1255)
T KOG0444|consen  354 LPEAIHLLPDLKVLDLRENP  373 (1255)
T ss_pred             chhhhhhcCCcceeeccCCc
Confidence            44444444445555554443

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.7e-38  Score=343.97  Aligned_cols=266  Identities=23%  Similarity=0.366  Sum_probs=204.3

Q ss_pred             hhcCCCCCceeeccccceEEEEEE-----CCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeecccC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCSSID  629 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  629 (871)
                      ..++|++.+.||+|+||.||+|++     ..++..||||+++... ....+.+.+|+++++.+ +||||+++++++.+. 
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-  111 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG-  111 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC-
Confidence            345799999999999999999975     3356689999986432 23346788999999999 899999999998765 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccc--------------------------------------------------
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQ--------------------------------------------------  659 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------  659 (871)
                          ...++||||+++|+|.++++......                                                  
T Consensus       112 ----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  187 (375)
T cd05104         112 ----GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR  187 (375)
T ss_pred             ----CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence                56899999999999999997543100                                                  


Q ss_pred             ------------------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceec
Q 002883          660 ------------------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL  721 (871)
Q Consensus       660 ------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  721 (871)
                                        .....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~  264 (375)
T cd05104         188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI  264 (375)
T ss_pred             ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceec
Confidence                              0112478899999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhhhhc
Q 002883          722 HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEII  800 (871)
Q Consensus       722 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  800 (871)
                      ...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.....+.. ..+.........     
T Consensus       265 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~-----  337 (375)
T cd05104         265 RNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKMIKEGYRML-----  337 (375)
T ss_pred             cCcccc-cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHHHHHhCccCC-----
Confidence            433211 11222335678999999988999999999999999999998 8999875432211 111111110000     


Q ss_pred             ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                                         .+      ...+.++.+++.+|++.||++|||+.|+++.|++.
T Consensus       338 -------------------~~------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 -------------------SP------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -------------------CC------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                               00      01134577999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8.9e-38  Score=333.20  Aligned_cols=279  Identities=24%  Similarity=0.327  Sum_probs=203.4

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcC---CCCccceeeeeecccCcCCCc
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSI---RHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~  634 (871)
                      +|++.+.||+|+||+||+|++..+++.||+|.++...  ......+.+|+++++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5889999999999999999999999999999986432  22234566777777665   799999999998765454556


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||++ ++|.+++.....     ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~d  151 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP-----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLAD  151 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence            7899999996 589998876432     2589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||.+.......    ......++..|+|||++.+..++.++||||+||++|+|++|++||..................+.
T Consensus       152 fg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~  227 (288)
T cd07863         152 FGLARIYSCQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  227 (288)
T ss_pred             cCccccccCcc----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC
Confidence            99998664321    12234688999999999888999999999999999999999999975433221111111111111


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      . ..+     .......................+.+..++.+++.+|++.||++|||+.|+++
T Consensus       228 ~-~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         228 E-DDW-----PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             h-hhC-----cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0 000     00000000000000011111222244567789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8e-38  Score=338.13  Aligned_cols=242  Identities=20%  Similarity=0.290  Sum_probs=194.2

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEe
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE  641 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  641 (871)
                      +.||+|+||.||+|++..+++.||+|+++...   ......+.+|+++++.++||||+++++++...     ...|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CEEEEEEe
Confidence            46999999999999999899999999996432   22345677899999999999999999988765     67899999


Q ss_pred             ccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceec
Q 002883          642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL  721 (871)
Q Consensus       642 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  721 (871)
                      |+++|+|.+++....       .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        76 ~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          76 YANGGELFFHLSRER-------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             CCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            999999999887643       589999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcC
Q 002883          722 HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIID  801 (871)
Q Consensus       722 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  801 (871)
                      ...   ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ .........  .      
T Consensus       146 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~~~~~~~~--~------  213 (323)
T cd05595         146 ISD---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEEI--R------  213 (323)
T ss_pred             cCC---CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHhcCCC--C------
Confidence            221   1122235689999999999888999999999999999999999999975322211 111000000  0      


Q ss_pred             hhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHH
Q 002883          802 PAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIM  857 (871)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~  857 (871)
                                       .+       ..+..++.+++.+||+.||++||     ++.|+++
T Consensus       214 -----------------~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         214 -----------------FP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             -----------------CC-------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                             00       01234567899999999999998     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=340.58  Aligned_cols=265  Identities=27%  Similarity=0.396  Sum_probs=210.9

Q ss_pred             HHHhhcCCCCCceeeccccceEEEEEECCCC----cEEEEEEeec---cccchHHHHHHHHHHHHcCCCCccceeeeeec
Q 002883          554 LLKATEGFSSANLIGIGGYGYVYKGILGTEE----TNVAVKVLDL---QQRGASKSFIAECEALRSIRHRNLVKIITSCS  626 (871)
Q Consensus       554 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  626 (871)
                      ++...++-...++||+|+||.||+|+....+    ..||||..+.   ........+.+|+++|++++|||||++||++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            3344556667799999999999999986432    2389999875   23456678999999999999999999999987


Q ss_pred             ccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC
Q 002883          627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN  706 (871)
Q Consensus       627 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  706 (871)
                      ..     ..+++|||+|.||+|.+++++...      .++..+...++.+.|.||+|||++   +++||||.++|+|++.
T Consensus       232 ~~-----~Pl~ivmEl~~gGsL~~~L~k~~~------~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~  297 (474)
T KOG0194|consen  232 LE-----EPLMLVMELCNGGSLDDYLKKNKK------SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSK  297 (474)
T ss_pred             CC-----CccEEEEEecCCCcHHHHHHhCCC------CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecC
Confidence            76     558999999999999999998764      499999999999999999999999   9999999999999999


Q ss_pred             CCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHH
Q 002883          707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLH  785 (871)
Q Consensus       707 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~  785 (871)
                      ++.+||+|||+++....   .........-...|+|||.+..+.|++++|||||||++||+++ |..||.+.....  ..
T Consensus       298 ~~~vKISDFGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~--v~  372 (474)
T KOG0194|consen  298 KGVVKISDFGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE--VK  372 (474)
T ss_pred             CCeEEeCccccccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH--HH
Confidence            99999999999875431   1111112235679999999999999999999999999999999 899998754331  11


Q ss_pred             HHh-hhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          786 KYA-KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       786 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      .++ ..+++-....                              ..+..+..++..|+..+|++|||+.++.+.++.+.+
T Consensus       373 ~kI~~~~~r~~~~~------------------------------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  373 AKIVKNGYRMPIPS------------------------------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             HHHHhcCccCCCCC------------------------------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence            111 1111111000                              223456678889999999999999999999998876


Q ss_pred             HHH
Q 002883          865 MRQ  867 (871)
Q Consensus       865 ~~~  867 (871)
                      ...
T Consensus       423 ~~~  425 (474)
T KOG0194|consen  423 KKE  425 (474)
T ss_pred             ccc
Confidence            543

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.6e-38  Score=340.68  Aligned_cols=247  Identities=22%  Similarity=0.271  Sum_probs=198.8

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCC-cEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEE-TNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .++|++.+.||+|+||.||+|.+..++ ..||+|++....   ....+.+.+|+++++.++||||+++++++.+.     
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE-----  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-----
Confidence            457999999999999999999876554 689999985432   22345678899999999999999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||+++|+|.+++....       .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~  173 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNK-------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMT  173 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEe
Confidence            67899999999999999997654       589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||++......      .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... .......... 
T Consensus       174 DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~i~~~~~-  245 (340)
T PTZ00426        174 DFGFAKVVDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-IYQKILEGII-  245 (340)
T ss_pred             cCCCCeecCCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-HHHHHhcCCC-
Confidence            99999875421      123468999999999988889999999999999999999999997532211 1111110000 


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~~  858 (871)
                       ..                       ++       .....+.+++.+|++.||++|+     |++|+++.
T Consensus       246 -~~-----------------------p~-------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 -YF-----------------------PK-------FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -CC-----------------------CC-------CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence             00                       00       1123456899999999999995     88888764

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-38  Score=337.70  Aligned_cols=240  Identities=25%  Similarity=0.303  Sum_probs=191.9

Q ss_pred             eeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEecc
Q 002883          567 IGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM  643 (871)
Q Consensus       567 lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  643 (871)
                      ||+|+||.||+|++..+++.||+|+++..   .......+.+|++++++++||||+++++++...     ...|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-----EKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-----CeEEEEEcCC
Confidence            69999999999999989999999998643   223345678899999999999999999988655     6789999999


Q ss_pred             CCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCC
Q 002883          644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD  723 (871)
Q Consensus       644 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  723 (871)
                      ++|+|.+++....       .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        76 ~~g~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  145 (312)
T cd05585          76 NGGELFHHLQREG-------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMK  145 (312)
T ss_pred             CCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence            9999999997643       589999999999999999999999   999999999999999999999999999975432


Q ss_pred             CCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChh
Q 002883          724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPA  803 (871)
Q Consensus       724 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  803 (871)
                      ..   .......||+.|+|||++.+..++.++||||+||++|+|++|+.||........ .......  +....      
T Consensus       146 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-~~~~~~~--~~~~~------  213 (312)
T cd05585         146 DD---DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-YRKILQE--PLRFP------  213 (312)
T ss_pred             CC---CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH-HHHHHcC--CCCCC------
Confidence            21   122345689999999999988999999999999999999999999975322111 1110000  00000      


Q ss_pred             HHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC---HHHHHH
Q 002883          804 ILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK---IQDAIM  857 (871)
Q Consensus       804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---a~evl~  857 (871)
                                              .....++.+++.+||+.||++||+   +.|++.
T Consensus       214 ------------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         214 ------------------------DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             ------------------------CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence                                    022345678999999999999985   556554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=338.04  Aligned_cols=249  Identities=29%  Similarity=0.398  Sum_probs=202.5

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEeccC
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP  644 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~  644 (871)
                      -++|+|.||+||.|++..+...+|||.+........+-+..|+...++++|.|||+++|.+.+.     ++.-|.||-++
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen-----Gf~kIFMEqVP  655 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN-----GFFKIFMEQVP  655 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCC-----CeEEEEeecCC
Confidence            3699999999999999999999999999776666677889999999999999999999997654     78899999999


Q ss_pred             CCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC-CCCceEEeecccceecCC
Q 002883          645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD-NEMVAHVGDFGLSRLLHD  723 (871)
Q Consensus       645 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~~~~~  723 (871)
                      ||+|.+.++..-+.    -+-++...-.+.+||++||.|||+.   .|||||||-+||||+ -.|.+||+|||.++.+..
T Consensus       656 GGSLSsLLrskWGP----lKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg  728 (1226)
T KOG4279|consen  656 GGSLSSLLRSKWGP----LKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG  728 (1226)
T ss_pred             CCcHHHHHHhccCC----CccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence            99999999876431    1227788889999999999999999   999999999999995 678999999999998764


Q ss_pred             CCCCccccccccccccccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcC
Q 002883          724 NSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIID  801 (871)
Q Consensus       724 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  801 (871)
                      -   ...+..+.||..|||||++..+  .|+.++|||||||++.||.||++||.........+.+               
T Consensus       729 i---nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---------------  790 (1226)
T KOG4279|consen  729 I---NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---------------  790 (1226)
T ss_pred             C---CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---------------
Confidence            2   2344557799999999998765  5789999999999999999999999865333222111               


Q ss_pred             hhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          802 PAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                 .++-+..++.+    .+...+...++.+|+.+||.+||+|+++++.
T Consensus       791 -----------VGmyKvHP~iP----eelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  791 -----------VGMYKVHPPIP----EELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             -----------hcceecCCCCc----HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence                       11111111111    1344566789999999999999999999864

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.5e-37  Score=327.02  Aligned_cols=257  Identities=23%  Similarity=0.342  Sum_probs=201.7

Q ss_pred             hcCCCCCceeeccccceEEEEEEC---CCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILG---TEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..+|++.+.||+|+||.||+|.+.   ..+..||+|.++... ......+.+|+.++++++||||+++++++...     
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   78 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-----   78 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-----
Confidence            356899999999999999999874   346789999986543 23345788999999999999999999998654     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+++|+|.+++.....      .+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.++++
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~------~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~  149 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHEG------QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKIS  149 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEEC
Confidence            668999999999999999976432      589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |||.+.......  ........++..|+|||.+.+..++.++|||||||++||+++ |+.||........  ........
T Consensus       150 dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~--~~~~~~~~  225 (266)
T cd05064         150 GFRRLQEDKSEA--IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV--IKAVEDGF  225 (266)
T ss_pred             CCcccccccccc--hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HHHHHCCC
Confidence            999876532211  111112235678999999888999999999999999999875 9999975432211  11111100


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      ...                              ....++..+.+++.+||+.+|++|||++|+.+.|.++
T Consensus       226 ~~~------------------------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 RLP------------------------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCC------------------------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            000                              0012344577899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=329.07  Aligned_cols=264  Identities=25%  Similarity=0.364  Sum_probs=211.4

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG-ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ....++++||+|-||.|.++... .+..||||.++..... ...+|.+|+++|.+++||||++++|+|...     +.++
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePic  611 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPLC  611 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----CchH
Confidence            34668899999999999999986 4689999999766543 358999999999999999999999999876     5589


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +|+|||+.|+|.+|+..+...     ....+...+|+.||+.|++||.+.   ++||||+.++|+|+++++++||+|||+
T Consensus       612 mI~EYmEnGDLnqFl~aheap-----t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgm  683 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELP-----TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGM  683 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCc-----ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccc
Confidence            999999999999999887532     345667788999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT--GKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--G~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      ++-+..+. ........+-..+|||||.+.-++++.++|||+||+++||+++  ...||.+..++...-...  .-.+.+
T Consensus       684 sR~lysg~-yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~--~~~~~~  760 (807)
T KOG1094|consen  684 SRNLYSGD-YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG--EFFRDQ  760 (807)
T ss_pred             ccccccCC-ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh--hhcCCC
Confidence            98665433 2233344556789999999999999999999999999999876  888999876653221111  111111


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      -...                       ......-++.++.+++.+||..|.++|||.+++...|++.
T Consensus       761 ~~~~-----------------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  761 GRQV-----------------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             Ccce-----------------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            0000                       0011123456788999999999999999999999988765

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.1e-37  Score=337.61  Aligned_cols=243  Identities=21%  Similarity=0.288  Sum_probs=195.0

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEe
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE  641 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  641 (871)
                      +.||+|+||.||+|++..+++.||+|++....   ......+.+|+++++.++||||+++++++...     ...|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK-----DRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----CEEEEEEe
Confidence            46999999999999999999999999996432   22345778899999999999999999988665     67899999


Q ss_pred             ccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceec
Q 002883          642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL  721 (871)
Q Consensus       642 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  721 (871)
                      |+++|+|.+++....       .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        76 y~~~g~L~~~l~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          76 YVNGGELFFHLSRER-------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             CCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            999999999887643       589999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcC
Q 002883          722 HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIID  801 (871)
Q Consensus       722 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  801 (871)
                      ...   ........||+.|+|||++.+..++.++||||+||++|+|++|+.||........  ....... ...      
T Consensus       146 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~--~~~~~~~-~~~------  213 (328)
T cd05593         146 ITD---AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FELILME-DIK------  213 (328)
T ss_pred             CCc---ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH--HHHhccC-Ccc------
Confidence            221   1122335689999999999888999999999999999999999999975322111  0000000 000      


Q ss_pred             hhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHHH
Q 002883          802 PAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIME  858 (871)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~~  858 (871)
                                       .+       .....++.+++.+||+.||++||     ++.|+++.
T Consensus       214 -----------------~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         214 -----------------FP-------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -----------------CC-------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                             00       01234567899999999999997     89998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-40  Score=315.54  Aligned_cols=250  Identities=24%  Similarity=0.316  Sum_probs=209.1

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEE
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV  639 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  639 (871)
                      -|.+++++|+|+||.||+|.++.+|..||||.+....  ..+.+.+|+.+|++.+.|+||++||.|...     ..+|+|
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~-----sDLWIV  106 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKH-----SDLWIV  106 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccC-----CceEee
Confidence            3667899999999999999999999999999987654  467889999999999999999999998765     568999


Q ss_pred             EeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccce
Q 002883          640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR  719 (871)
Q Consensus       640 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  719 (871)
                      ||||..|+..+.++....      ++++.++..++++-++||+|||..   .-+|||||..|||++.+|.+||+|||.|.
T Consensus       107 MEYCGAGSiSDI~R~R~K------~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAG  177 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRARRK------PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAG  177 (502)
T ss_pred             hhhcCCCcHHHHHHHhcC------CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccc
Confidence            999999999999987653      699999999999999999999999   88999999999999999999999999998


Q ss_pred             ecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhh
Q 002883          720 LLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEI  799 (871)
Q Consensus       720 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  799 (871)
                      .+.+   .........||+.|||||++..-.|..++||||+|++..||..|++||.+.......+  +    +|.     
T Consensus       178 QLTD---TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF--M----IPT-----  243 (502)
T KOG0574|consen  178 QLTD---TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF--M----IPT-----  243 (502)
T ss_pred             hhhh---hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE--e----ccC-----
Confidence            7653   2334455789999999999999999999999999999999999999998643221100  0    111     


Q ss_pred             cChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          800 IDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                         .+|....+.+....++.++++.||-..|++|.||.++++.
T Consensus       244 -------------------~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  244 -------------------KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             -------------------CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence                               1111111223445567799999999999999999998875

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=336.71  Aligned_cols=245  Identities=24%  Similarity=0.319  Sum_probs=202.1

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcC
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  631 (871)
                      ...++|...++||+|+||.|++|..+.+++.+|||+++...   +++.+..+.|.+|+... +||.++.++.+|.+.   
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~---  441 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK---  441 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC---
Confidence            34578999999999999999999999999999999997553   45567788899988887 599999999999887   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                        .++|+||||+.||++..+.+..        .+++..+.-++..|+.||+|||++   |||+||||.+|||+|.+|.+|
T Consensus       442 --~~l~fvmey~~Ggdm~~~~~~~--------~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~k  508 (694)
T KOG0694|consen  442 --EHLFFVMEYVAGGDLMHHIHTD--------VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVK  508 (694)
T ss_pred             --CeEEEEEEecCCCcEEEEEecc--------cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEE
Confidence              8899999999999944443322        599999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      |+|||+++.--   .....++..+||+.|||||++.+..|+.++|-|||||++|||+.|..||.+..+++. ...+....
T Consensus       509 iADFGlcKe~m---~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-FdsI~~d~  584 (694)
T KOG0694|consen  509 IADFGLCKEGM---GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-FDSIVNDE  584 (694)
T ss_pred             ecccccccccC---CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHhcCC
Confidence            99999998532   233456678999999999999999999999999999999999999999986443321 11111111


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI  852 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta  852 (871)
                             ..-|.                         ....+.++++++++..+|++|--+
T Consensus       585 -------~~yP~-------------------------~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 -------VRYPR-------------------------FLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -------CCCCC-------------------------cccHHHHHHHHHHhccCcccccCC
Confidence                   00011                         223456789999999999999866

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.5e-37  Score=324.79  Aligned_cols=261  Identities=20%  Similarity=0.297  Sum_probs=207.6

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||.||+|++..+++.||||.++...   ......+.+|+++++.++||||+++++++.+.     ..
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence            57999999999999999999999899999999875422   23345688999999999999999999988654     56


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||+++++|.+++......   ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~  150 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQ---KRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECcc
Confidence            89999999999999988653221   22578999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh-CCCc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM-GLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~~~~  794 (871)
                      |.+.......   .......++..|+|||...+..++.++||||+|+++|+|++|+.||................ ..++
T Consensus       151 g~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  227 (267)
T cd08228         151 GLGRFFSSKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP  227 (267)
T ss_pred             ccceeccchh---HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC
Confidence            9998764321   11223458889999999888889999999999999999999999986432221111111111 0000


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                      .                           .   .......+.+++.+||..+|++||++.|+++.++.++
T Consensus       228 ~---------------------------~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         228 L---------------------------P---TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             C---------------------------C---hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            0                           0   0123356789999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.3e-37  Score=334.63  Aligned_cols=201  Identities=25%  Similarity=0.349  Sum_probs=175.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+++++.++||||++++++|.+.     .+.
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CEE
Confidence            468999999999999999999999899999999986542 23346788999999999999999999998765     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++++|.+++....       .+++..+..++.|++.|+.|||+.  .+|+||||||+||+++.++.+||+|||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg  149 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKAG-------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFG  149 (333)
T ss_pred             EEEEecCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCC
Confidence            99999999999999997643       588899999999999999999974  179999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      ++......     ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       150 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         150 VSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             cchhhhhh-----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            98755322     112346899999999998888999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=331.96  Aligned_cols=252  Identities=23%  Similarity=0.316  Sum_probs=211.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG---ASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  633 (871)
                      ...|++.+.||+|.||.||+++.+.+|+.+|+|++......   ....+.+|+.+|+++. |||||.++++|.+.     
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~-----  108 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP-----  108 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC-----
Confidence            45799999999999999999999999999999999654332   3468899999999998 99999999999887     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC----CCc
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN----EMV  709 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----~~~  709 (871)
                      ..+++|||++.||.|.+.+...        .+++..+..++.|++.|++|||+.   ||||||+||+|+|+..    ++.
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~--------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~  177 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK--------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGR  177 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc--------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCc
Confidence            6799999999999999999774        289999999999999999999999   9999999999999953    357


Q ss_pred             eEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh
Q 002883          710 AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK  789 (871)
Q Consensus       710 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~  789 (871)
                      +|++|||+|.....    .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.......... ....
T Consensus       178 ik~~DFGla~~~~~----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~i~~  252 (382)
T KOG0032|consen  178 IKLIDFGLAKFIKP----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-AILR  252 (382)
T ss_pred             EEEeeCCCceEccC----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-HHHc
Confidence            99999999998764    234556789999999999998999999999999999999999999999765443222 1111


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ..+     ++.+                       +.+..+...+.+++..|+..||.+|+||.++++.
T Consensus       253 ~~~-----~f~~-----------------------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  253 GDF-----DFTS-----------------------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CCC-----CCCC-----------------------CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            111     1111                       2223445567899999999999999999999984

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-37  Score=350.36  Aligned_cols=256  Identities=19%  Similarity=0.251  Sum_probs=203.7

Q ss_pred             cCCCCCceeeccccceEEEEEECCC-CcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTE-ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ..|.+.+.||+|+||.||+|....+ ++.||+|.+..........+.+|+.+++.++||||+++++++...     +..|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----DKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CEEE
Confidence            3489999999999999999998777 788999987655554556778899999999999999999998765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++|+|.+++......   ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgl  215 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKE---HLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGF  215 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcC
Confidence            999999999999988653211   23588999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      ++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .........+ .. 
T Consensus       216 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~-~~~~~~~~~~-~~-  291 (478)
T PTZ00267        216 SKQYSDSVS-LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI-MQQVLYGKYD-PF-  291 (478)
T ss_pred             ceecCCccc-cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCC-CC-
Confidence            987654321 1123345699999999999888999999999999999999999999975322111 1111000000 00 


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                            +       ..+..++.+++.+||+.||++|||+.|+++.
T Consensus       292 ----------------------~-------~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        292 ----------------------P-------CPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             ----------------------C-------ccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                                  0       0123457789999999999999999999753

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.6e-37  Score=334.73  Aligned_cols=245  Identities=24%  Similarity=0.306  Sum_probs=192.9

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHH---HcCCCCccceeeeeecccCcCCCc
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEAL---RSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      |++.+.||+|+||.||+|.+..+++.||||+++...   ....+.+.+|++++   +.++||||+++++++...     .
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-----~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-----D   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-----C
Confidence            678899999999999999999899999999996432   22335566676665   456899999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||+++++|..++...        .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~~--------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~D  144 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHTD--------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIAD  144 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCc
Confidence            789999999999999888642        489999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||++......   ........|++.|+|||.+.+..++.++|||||||++|+|++|+.||........ .........  
T Consensus       145 fg~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-~~~i~~~~~--  218 (324)
T cd05589         145 FGLCKEGMGF---GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-FDSIVNDEV--  218 (324)
T ss_pred             ccCCccCCCC---CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCC--
Confidence            9998753221   1222345689999999999888999999999999999999999999975322211 111100000  


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~  857 (871)
                                             ..+       ......+.+++.+||+.||++||     ++.++++
T Consensus       219 -----------------------~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 -----------------------RYP-------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -----------------------CCC-------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                                   000       01234567899999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=342.78  Aligned_cols=204  Identities=24%  Similarity=0.341  Sum_probs=175.7

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||+||+|++..+++.||||++....   ......+.+|+++++.++||||+++++++.+.     .+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-----NY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----Ce
Confidence            47999999999999999999999899999999996432   23345678899999999999999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++....       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  145 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKD-------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDF  145 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeec
Confidence            899999999999999997643       589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCc-----------------------------------cccccccccccccCcccccCCCCCCccchhhH
Q 002883          716 GLSRLLHDNSPDQ-----------------------------------TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF  760 (871)
Q Consensus       716 g~a~~~~~~~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  760 (871)
                      |++..+.......                                   .......||+.|+|||++.+..++.++|||||
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  225 (364)
T cd05599         146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL  225 (364)
T ss_pred             ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence            9987653211000                                   00112358999999999988899999999999


Q ss_pred             HHHHHHHHhCCCCCchh
Q 002883          761 GILMLEMFTGKRPTDDM  777 (871)
Q Consensus       761 G~il~elltG~~pf~~~  777 (871)
                      ||++|||++|..||...
T Consensus       226 G~il~el~~G~~Pf~~~  242 (364)
T cd05599         226 GVIMYEMLVGYPPFCSD  242 (364)
T ss_pred             hhHHHHhhcCCCCCCCC
Confidence            99999999999999754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-37  Score=342.67  Aligned_cols=203  Identities=23%  Similarity=0.321  Sum_probs=174.0

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .|++++.||+|+||+||+|++..+++.||+|++....   ......+.+|+++++.++||||+++++++.+.     ...
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-----DNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-----CEE
Confidence            5889999999999999999999999999999996432   23345788999999999999999999998765     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||+++|+|.+++....       .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~-------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFG  146 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRME-------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFG  146 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCc
Confidence            99999999999999997643       588999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCC--------------------------------------------ccccccccccccccCcccccCCCCC
Q 002883          717 LSRLLHDNSPD--------------------------------------------QTSTSRVKGSIGYVAPEYGALGEVS  752 (871)
Q Consensus       717 ~a~~~~~~~~~--------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~  752 (871)
                      ++.........                                            ........||+.|+|||++.+..++
T Consensus       147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~  226 (381)
T cd05626         147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT  226 (381)
T ss_pred             CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC
Confidence            97543210000                                            0001234699999999999888899


Q ss_pred             CccchhhHHHHHHHHHhCCCCCchh
Q 002883          753 THGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       753 ~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      .++|||||||++|||++|+.||...
T Consensus       227 ~~~DiwSlG~il~elltG~~Pf~~~  251 (381)
T cd05626         227 QLCDWWSVGVILFEMLVGQPPFLAP  251 (381)
T ss_pred             CccceeehhhHHHHHHhCCCCCcCC
Confidence            9999999999999999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.7e-37  Score=322.80  Aligned_cols=256  Identities=26%  Similarity=0.419  Sum_probs=204.6

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      .+|++.+.||+|+||.||+|.+...++.||+|++..... ..+.+.+|+++++.++||||+++++++...     ...++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYI   79 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch-HHHHHHHHHHHHHhCCCCChhheEEEEcCC-----CCcEE
Confidence            457888999999999999999998899999999864432 346788999999999999999999998665     56799


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||+++++|.+++.....     ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.+
T Consensus        80 v~e~~~~~~L~~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~  151 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS  151 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccc
Confidence            9999999999999976432     2589999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      .......  ........++..|+|||...+..++.++|||||||++|||++ |..||.....+.  .........+..  
T Consensus       152 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~--  225 (263)
T cd05052         152 RLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKGYRME--  225 (263)
T ss_pred             cccccce--eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCCCCCC--
Confidence            8764321  111112234568999999888899999999999999999998 999987532211  111111000000  


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                                               .   ...++.++.+++.+|++.||++|||+.|+++.|+.+
T Consensus       226 -------------------------~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         226 -------------------------R---PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -------------------------C---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                                     0   012235678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.1e-37  Score=345.97  Aligned_cols=281  Identities=21%  Similarity=0.280  Sum_probs=199.0

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCc---CCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT---RGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~  633 (871)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....    ....+|+.+++.++||||+++++++.....   ...
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999998899999999885332    234579999999999999999988754321   223


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEE
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM-VAHV  712 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl  712 (871)
                      .+.++||||++ +++.+++.....   ....+++..++.++.||+.||+|||+.   +|+||||||+||+++.++ .+||
T Consensus       140 ~~l~lvmE~~~-~~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL  212 (440)
T PTZ00036        140 IFLNVVMEFIP-QTVHKYMKHYAR---NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKL  212 (440)
T ss_pred             eEEEEEEecCC-ccHHHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceee
Confidence            46789999996 578877754321   122589999999999999999999999   999999999999998665 7999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      +|||+|+......    ......||+.|+|||++.+ ..++.++||||+||++|||++|.+||................+
T Consensus       213 ~DFGla~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~  288 (440)
T PTZ00036        213 CDFGSAKNLLAGQ----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG  288 (440)
T ss_pred             eccccchhccCCC----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999998664322    1223468999999998765 4689999999999999999999999976433222111111111


Q ss_pred             CCch-hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHH-HHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          792 LPDQ-VAEIIDPAILEEALEIQAGIVKELQPNLRAKFH-EIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       792 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .+.. ......+.....      .............++ ..+.++.+++.+||++||.+|||+.|+++.
T Consensus       289 ~p~~~~~~~~~~~~~~~------~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        289 TPTEDQLKEMNPNYADI------KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CCCHHHHHHhchhhhcc------cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            1111 000011100000      000000001111111 234578899999999999999999999853

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.6e-37  Score=336.45  Aligned_cols=243  Identities=21%  Similarity=0.287  Sum_probs=193.9

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEe
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE  641 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  641 (871)
                      +.||+|+||.||+|++..+++.||+|+++...   ......+.+|+++++.++||||+++++++...     ...|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-----~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----DRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-----CEEEEEEe
Confidence            46999999999999999899999999996432   22345677899999999999999999988665     67899999


Q ss_pred             ccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH-HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       642 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      |+++|+|.+++....       .+++..+..++.||+.||+|||+ .   +|+||||||+||+++.++.+||+|||++..
T Consensus        76 ~~~~~~L~~~l~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~  145 (325)
T cd05594          76 YANGGELFFHLSRER-------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE  145 (325)
T ss_pred             CCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCee
Confidence            999999999887643       58999999999999999999997 6   999999999999999999999999999875


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhc
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII  800 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  800 (871)
                      .....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....+..  ......... .     
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~--~~~i~~~~~-~-----  214 (325)
T cd05594         146 GIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FELILMEEI-R-----  214 (325)
T ss_pred             cCCCC---cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH--HHHHhcCCC-C-----
Confidence            43211   122234699999999999888999999999999999999999999975322211  111000000 0     


Q ss_pred             ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHHH
Q 002883          801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIME  858 (871)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~~  858 (871)
                                        .+       .....++.+++.+||+.||++|+     ++.|+++.
T Consensus       215 ------------------~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         215 ------------------FP-------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             ------------------CC-------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                              00       01234567899999999999997     89998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.5e-37  Score=331.93  Aligned_cols=261  Identities=23%  Similarity=0.375  Sum_probs=204.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCc----EEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEET----NVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ..+|++.+.||+|+||.||+|++..+++    .||+|+++... ....+.+.+|+.+++.++||||+++++++...    
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----   81 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   81 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC----
Confidence            3569999999999999999999865554    48999986433 33456788999999999999999999998643    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                        ..++|+||+++|+|.+++.....      .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        82 --~~~~v~e~~~~g~l~~~l~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl  150 (316)
T cd05108          82 --TVQLITQLMPFGCLLDYVREHKD------NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKI  150 (316)
T ss_pred             --CceeeeecCCCCCHHHHHHhccc------cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEE
Confidence              35799999999999999986542      488899999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      +|||.++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||.......  ........
T Consensus       151 ~DfG~a~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~~~~  227 (316)
T cd05108         151 TDFGLAKLLGADEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKG  227 (316)
T ss_pred             ccccccccccCCCcc-eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhCC
Confidence            999999876543211 11122234678999999988899999999999999999998 999997532221  11111110


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      .....                              ...+..++.+++.+||..+|++|||+.|+++.+..+.+..
T Consensus       228 ~~~~~------------------------------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         228 ERLPQ------------------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             CCCCC------------------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            00000                              0012235678999999999999999999999998886543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.3e-37  Score=329.06  Aligned_cols=274  Identities=24%  Similarity=0.317  Sum_probs=203.8

Q ss_pred             cCC-CCCceeeccccceEEEEEE----CCCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          559 EGF-SSANLIGIGGYGYVYKGIL----GTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       559 ~~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ++| ++.+.||+|+||+||++..    ..++..||+|+++.... .....+.+|+++++.++||||+++++++...   .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~   79 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---G   79 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence            345 8899999999999988653    34678899999865432 3456788999999999999999999987543   2


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                      ....++||||+++++|.+++...        .+++.+++.++.|++.|+.|||+.   +|+||||||+||+++.++.++|
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~~--------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l  148 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPKH--------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKI  148 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEE
Confidence            25679999999999999999653        489999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      +|||.+.................++..|+|||...+..++.++||||||+++|+|++|..||................  
T Consensus       149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--  226 (283)
T cd05080         149 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG--  226 (283)
T ss_pred             eecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc--
Confidence            999999876543211111122345677999999888889999999999999999999999986432211000000000  


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                           ......+.....       ......   ....++.++.+++..|++.+|++|||++++++.|+++.
T Consensus       227 -----~~~~~~~~~~~~-------~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         227 -----QMTVVRLIELLE-------RGMRLP---CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             -----ccchhhhhhhhh-------cCCCCC---CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence                 000000000000       000000   00123457889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.9e-37  Score=333.31  Aligned_cols=242  Identities=22%  Similarity=0.294  Sum_probs=192.3

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCC-ccceeeeeecccCcCCCce
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHR-NLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~  635 (871)
                      +|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+..|++++..+.|+ +|+++++++.+.     +.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----CE
Confidence            5889999999999999999999899999999996432   23445678899999999765 577888877654     66


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++....       .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Df  145 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVG-------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADF  145 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeec
Confidence            899999999999999997643       588999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |++......   ........||+.|+|||++.+..++.++||||+||++|+|+||+.||........ ........  ..
T Consensus       146 g~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-~~~i~~~~--~~  219 (324)
T cd05587         146 GMCKENIFG---GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-FQSIMEHN--VS  219 (324)
T ss_pred             CcceecCCC---CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHcCC--CC
Confidence            998753221   1122335689999999999988999999999999999999999999975332211 11110000  00


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI  852 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta  852 (871)
                      ..                              .....++.+++.+|++.||++|+++
T Consensus       220 ~~------------------------------~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         220 YP------------------------------KSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CC------------------------------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            00                              0123456789999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.4e-37  Score=326.27  Aligned_cols=263  Identities=25%  Similarity=0.434  Sum_probs=205.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCC-----cEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEE-----TNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      .++|++.+.||+|+||.||+|.+...+     ..||+|.++... ......+.+|+++++.++||||+++++++...   
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---   80 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE---   80 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC---
Confidence            357899999999999999999986544     679999986433 23345788999999999999999999998654   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhccccccc---------ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCce
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQN---------QRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV  702 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  702 (871)
                        ...|++|||+++++|.+++........         ....+++..++.++.|++.|++|||+.   +++||||||+||
T Consensus        81 --~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Ni  155 (283)
T cd05048          81 --QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNC  155 (283)
T ss_pred             --CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceE
Confidence              557999999999999999976432100         013588999999999999999999999   999999999999


Q ss_pred             eeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhh
Q 002883          703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEG  781 (871)
Q Consensus       703 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~  781 (871)
                      +++.++.++|+|||++........ ........+++.|+|||.+.++.++.++|||||||++|||++ |..||......+
T Consensus       156 l~~~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~  234 (283)
T cd05048         156 LVGEGLTVKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE  234 (283)
T ss_pred             EEcCCCcEEECCCcceeecccccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999986543221 112223456788999999888899999999999999999998 999997533221


Q ss_pred             hhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          782 LSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                      .  ..........                              .....++.++.+++.+||+.||++|||+.|+++.|++
T Consensus       235 ~--~~~i~~~~~~------------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 V--IEMIRSRQLL------------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             H--HHHHHcCCcC------------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            1  1111100000                              0001344678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.6e-37  Score=338.78  Aligned_cols=248  Identities=26%  Similarity=0.342  Sum_probs=192.5

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .+|+..+.||+|+||.||+|++..+++.||||++..... .....+.+|+++++.++|+||+++++++...     ...+
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~  148 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN-----GEIQ  148 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC-----CeEE
Confidence            456778899999999999999998999999999854432 3346788999999999999999999998665     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+..           ..++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       149 lv~e~~~~~~L~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~  214 (353)
T PLN00034        149 VLLEFMDGGSLEGTH-----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGV  214 (353)
T ss_pred             EEEecCCCCcccccc-----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccccc
Confidence            999999999986532           356778889999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhH-HHHhhhC
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-----GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSL-HKYAKMG  791 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~-~~~~~~~  791 (871)
                      +.......   .......||..|+|||++..     ...+.++|||||||++|||++|+.||.......... .......
T Consensus       215 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  291 (353)
T PLN00034        215 SRILAQTM---DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS  291 (353)
T ss_pred             ceeccccc---ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc
Confidence            98764321   11223468999999998642     234578999999999999999999997321111100 0000000


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .+                           +.   ....+..++.+++.+||+.||++|||+.|+++.
T Consensus       292 ~~---------------------------~~---~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 QP---------------------------PE---APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CC---------------------------CC---CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00                           00   001234467899999999999999999999875

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.2e-37  Score=329.83  Aligned_cols=276  Identities=21%  Similarity=0.296  Sum_probs=203.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++...     ...+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-----KSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-----CeEE
Confidence            57999999999999999999999899999999986443 22335677899999999999999999998765     5689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||++ ++|.+++.....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        81 lv~e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~  150 (309)
T cd07872          81 LVFEYLD-KDLKQYMDDCGN------IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGL  150 (309)
T ss_pred             EEEeCCC-CCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcccc
Confidence            9999996 488888865432      478999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch-
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ-  795 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~-  795 (871)
                      +.......   .......+++.|+|||.+.+ ..++.++||||+||++|+|+||+.||......+...........+.. 
T Consensus       151 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  227 (309)
T cd07872         151 ARAKSVPT---KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE  227 (309)
T ss_pred             ceecCCCc---cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            97643321   11223457899999998754 46789999999999999999999999754332221111111111111 


Q ss_pred             -hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 -VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       ...+....   ....  ....................++.+++.+|++.||++|||+.|+++
T Consensus       228 ~~~~~~~~~---~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         228 TWPGISSND---EFKN--YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             HHhhhcchh---hhhh--hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence             11111100   0000  000000011111222345567889999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8e-37  Score=335.97  Aligned_cols=281  Identities=20%  Similarity=0.209  Sum_probs=202.8

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~  633 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...  .......+.+|+.+++.++||||+++++++..... ...
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            357899999999999999999999989999999998533  22344677899999999999999999998865422 122


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||+++ ++.+.+..         .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~  165 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  165 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEe
Confidence            457999999964 67766643         478889999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh-CC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM-GL  792 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~~  792 (871)
                      |||++......    .......||+.|+|||.+.+..++.++||||+||++|+|++|+.||....... .+...... ..
T Consensus       166 Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~  240 (359)
T cd07876         166 DFGLARTACTN----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGT  240 (359)
T ss_pred             cCCCccccccC----ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCC
Confidence            99999754322    12233468999999999998899999999999999999999999997543221 11111111 11


Q ss_pred             CchhhhhcChhHHHHHHHHHhhh------------hhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGI------------VKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      +.  .++.+... ..........            ..+..+............+.+++.+||+.||++|||+.|+++.
T Consensus       241 ~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         241 PS--AEFMNRLQ-PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             Cc--HHHHHHHH-HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11  01100000 0000000000            0000000001111224567899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.6e-37  Score=332.61  Aligned_cols=237  Identities=24%  Similarity=0.303  Sum_probs=189.6

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||+||+|++..+++.||+|++....   ....+.+..|..++... +||||+++++++...     ...|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-----~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-----DRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-----CEEEEEE
Confidence            46999999999999999899999999986432   23345667888888876 799999999998665     6789999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++|+|.+++....       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        76 Ey~~~g~L~~~i~~~~-------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~  145 (320)
T cd05590          76 EFVNGGDLMFHIQKSR-------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE  145 (320)
T ss_pred             cCCCCchHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence            9999999999987654       589999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhc
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII  800 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  800 (871)
                      ....   ........||+.|+|||++.+..++.++||||+||++|+|++|+.||........ .........  ..    
T Consensus       146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~~i~~~~~--~~----  215 (320)
T cd05590         146 GIFN---GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-FEAILNDEV--VY----  215 (320)
T ss_pred             cCcC---CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-HHHHhcCCC--CC----
Confidence            4321   1122335689999999999888999999999999999999999999975332211 111110000  00    


Q ss_pred             ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCH
Q 002883          801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI  852 (871)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta  852 (871)
                       +                         .....++.+++.+|++.||++||++
T Consensus       216 -~-------------------------~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         216 -P-------------------------TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -C-------------------------CCCCHHHHHHHHHHcccCHHHCCCC
Confidence             0                         0123356789999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=342.28  Aligned_cols=255  Identities=22%  Similarity=0.296  Sum_probs=203.4

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||+||+|++..+++.||+|+++...   ......+.+|++++..++||||+++++++.+.     .+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE-----EH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC-----Ce
Confidence            47999999999999999999999899999999996432   23456788999999999999999999887655     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++++|.+++....       .+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Df  145 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKD-------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADF  145 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecC
Confidence            899999999999999997653       589999999999999999999998   9999999999999999999999999


Q ss_pred             ccceecCCCCC--------------------------CccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh
Q 002883          716 GLSRLLHDNSP--------------------------DQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT  769 (871)
Q Consensus       716 g~a~~~~~~~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt  769 (871)
                      |++........                          .........||+.|+|||++.+..++.++|||||||++|||++
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~  225 (350)
T cd05573         146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY  225 (350)
T ss_pred             CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc
Confidence            99987654320                          0112233568999999999998999999999999999999999


Q ss_pred             CCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCC
Q 002883          770 GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDR  849 (871)
Q Consensus       770 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  849 (871)
                      |+.||........ .......  ....                     ..     +....+..++.+++.+|+. ||++|
T Consensus       226 g~~Pf~~~~~~~~-~~~i~~~--~~~~---------------------~~-----p~~~~~~~~~~~li~~ll~-dp~~R  275 (350)
T cd05573         226 GFPPFYSDTLQET-YNKIINW--KESL---------------------RF-----PPDPPVSPEAIDLICRLLC-DPEDR  275 (350)
T ss_pred             CCCCCCCCCHHHH-HHHHhcc--CCcc---------------------cC-----CCCCCCCHHHHHHHHHHcc-Chhhc
Confidence            9999975432111 1111100  0000                     00     0000134467789999997 99999


Q ss_pred             CC-HHHHHHH
Q 002883          850 MK-IQDAIME  858 (871)
Q Consensus       850 Pt-a~evl~~  858 (871)
                      |+ ++|+++.
T Consensus       276 ~~s~~~ll~h  285 (350)
T cd05573         276 LGSFEEIKSH  285 (350)
T ss_pred             CCCHHHHhcC
Confidence            99 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4e-37  Score=327.44  Aligned_cols=276  Identities=24%  Similarity=0.337  Sum_probs=205.5

Q ss_pred             cCCCCCceeeccccceEEEEEE----CCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          559 EGFSSANLIGIGGYGYVYKGIL----GTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .+|++.+.||+|+||.||+|..    ..+++.||+|++........+.+.+|++++++++||||+++++++...+   ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---CC
Confidence            5789999999999999999984    4468899999987665555678899999999999999999999875432   24


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+++++|.+++.....      .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~------~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~d  151 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRE------RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGD  151 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCc------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECC
Confidence            57999999999999999975432      489999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||++.................++..|+|||+..+..++.++|||||||++|||++|..|+......   ........   
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~---  225 (284)
T cd05081         152 FGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGND---  225 (284)
T ss_pred             CcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccc---
Confidence            999987654322111111222445699999988888999999999999999999998776532111   00000000   


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      .........+....    ...   ...   +....++.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus       226 ~~~~~~~~~~~~~~----~~~---~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         226 KQGQMIVYHLIELL----KNN---GRL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cccccchHHHHHHH----hcC---CcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00000001110000    000   000   00112345688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.5e-37  Score=337.32  Aligned_cols=268  Identities=24%  Similarity=0.367  Sum_probs=206.5

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCC-----CcEEEEEEeecccc-chHHHHHHHHHHHHcCC-CCccceeeeeeccc
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTE-----ETNVAVKVLDLQQR-GASKSFIAECEALRSIR-HRNLVKIITSCSSI  628 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  628 (871)
                      ...++|++.+.||+|+||.||+|++...     +..||||+++.... ...+.+.+|+++++++. ||||+++++++.+.
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            4457899999999999999999987432     34699999964332 33467889999999995 99999999998765


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhcccccc-------------------------------------------------
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDEQ-------------------------------------------------  659 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------------  659 (871)
                           ...|+||||+++|+|.+++.......                                                 
T Consensus       114 -----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         114 -----GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             -----CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence                 56899999999999999987542110                                                 


Q ss_pred             ----------------------------------------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 002883          660 ----------------------------------------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP  699 (871)
Q Consensus       660 ----------------------------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  699 (871)
                                                              .....+++..+..++.|++.|++|||+.   +|+||||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp  265 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAA  265 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCh
Confidence                                                    0112478888999999999999999999   999999999


Q ss_pred             CceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhh
Q 002883          700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMF  778 (871)
Q Consensus       700 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~  778 (871)
                      +||+++.++.+||+|||++........ ........++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus       266 ~Nill~~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~  344 (400)
T cd05105         266 RNVLLAQGKIVKICDFGLARDIMHDSN-YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI  344 (400)
T ss_pred             HhEEEeCCCEEEEEeCCcceecccccc-ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence            999999999999999999986543221 111222346788999999888899999999999999999997 999997543


Q ss_pred             hhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          779 EEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .+......... .....                              ....++.++.+++.+||+.||++|||+.++.+.
T Consensus       345 ~~~~~~~~~~~-~~~~~------------------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  393 (400)
T cd05105         345 VDSTFYNKIKS-GYRMA------------------------------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI  393 (400)
T ss_pred             hhHHHHHHHhc-CCCCC------------------------------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence            22211111110 00000                              001234567899999999999999999999999


Q ss_pred             HHHHH
Q 002883          859 LQEAQ  863 (871)
Q Consensus       859 L~~i~  863 (871)
                      |+++.
T Consensus       394 l~~l~  398 (400)
T cd05105         394 VESLL  398 (400)
T ss_pred             HHHHc
Confidence            98764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.7e-37  Score=349.23  Aligned_cols=266  Identities=22%  Similarity=0.282  Sum_probs=207.3

Q ss_pred             HHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          554 LLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       554 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      .....++|++.+.||+|+||+||+|++..+++.||||+++...  ......+.+|+.++..++|+|++++.+.+...+..
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            3445679999999999999999999999899999999986442  23345678899999999999999998776544321


Q ss_pred             ---CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 002883          632 ---GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM  708 (871)
Q Consensus       632 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  708 (871)
                         .....++||||+++|+|.+++......   ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~---~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKT---NRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNG  180 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCC
Confidence               123478999999999999999754321   23589999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA  788 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~  788 (871)
                      .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....
T Consensus       181 ~vkL~DFGls~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~-~~~~~  258 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVS-DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV-MHKTL  258 (496)
T ss_pred             CEEEEecccCeecccccc-ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHh
Confidence            999999999987643221 1122345699999999999989999999999999999999999999975322110 00000


Q ss_pred             hhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          789 KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ... .                       ...+       ..+..++.+++.+||+.||++||++.|+++.
T Consensus       259 ~~~-~-----------------------~~~~-------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        259 AGR-Y-----------------------DPLP-------PSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             cCC-C-----------------------CCCC-------CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            000 0                       0000       1233467799999999999999999999864

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.6e-37  Score=330.45  Aligned_cols=242  Identities=23%  Similarity=0.314  Sum_probs=189.8

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||.||+|++..+++.||+|+++...   ....+....|..++... +||||+++++++...     ...|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-----EHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEE
Confidence            46999999999999999899999999996432   22334556677777654 899999999987654     6789999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++|+|.+++....       .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        76 e~~~gg~L~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~  145 (316)
T cd05592          76 EYLNGGDLMFHIQSSG-------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE  145 (316)
T ss_pred             cCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence            9999999999987643       589999999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhc
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII  800 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  800 (871)
                      .....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .... ....+ ...   
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~-~~~i-~~~~~-~~~---  216 (316)
T cd05592         146 NMNGE---GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-FDSI-LNDRP-HFP---  216 (316)
T ss_pred             CCCCC---CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH-HHHH-HcCCC-CCC---
Confidence            43221   223345689999999999888999999999999999999999999975332211 1111 00000 000   


Q ss_pred             ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHH-HHHH
Q 002883          801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQ-DAIM  857 (871)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~-evl~  857 (871)
                                                 ..+..++.+++.+||+.||++||++. ++++
T Consensus       217 ---------------------------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         217 ---------------------------RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             ---------------------------CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence                                       01233566899999999999999875 4543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.8e-37  Score=338.60  Aligned_cols=281  Identities=20%  Similarity=0.216  Sum_probs=203.3

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+++++.++||||+++++++...........|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999999889999999998543  222346788999999999999999999998765433334789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+. ++|.+++....       .+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        81 lv~e~~~-~~l~~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-------PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccc
Confidence            9999995 68888886533       589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hCCCch
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MGLPDQ  795 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~~~  795 (871)
                      +.......  ........+++.|+|||.+.+. .++.++||||+||++|||++|+.||........ ...... .+.+..
T Consensus       150 a~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~g~~~~  226 (372)
T cd07853         150 ARVEEPDE--SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-LDLITDLLGTPSL  226 (372)
T ss_pred             eeecccCc--cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCH
Confidence            98654321  1122234578999999987764 578999999999999999999999975432211 111111 111111


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhH---HhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLR---AKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                       .++. ... .......... ....+...   ........++.+++.+|++.||++|||+.|+++.
T Consensus       227 -~~~~-~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         227 -EAMR-SAC-EGARAHILRG-PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             -HHHH-Hhh-HHHHHHHHhC-CCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence             1100 000 0000000000 00001100   0111235678899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.4e-37  Score=325.78  Aligned_cols=262  Identities=28%  Similarity=0.431  Sum_probs=205.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECC-----CCcEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGT-----EETNVAVKVLDLQQRG-ASKSFIAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      .++|.+.+.||+|+||.||+|.+..     +++.||+|+++..... ..+.+.+|+++++.++|+||+++++++...   
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG---   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence            3568899999999999999998743     3578999998654443 457889999999999999999999998765   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhccccc-------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDE-------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL  704 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  704 (871)
                        ...++||||+++++|.+++...+..       ......+++.++..++.|++.|+.|||+.   +++||||||+||++
T Consensus        81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili  155 (280)
T cd05049          81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV  155 (280)
T ss_pred             --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence              6689999999999999999765321       11233588999999999999999999999   99999999999999


Q ss_pred             CCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhh
Q 002883          705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLS  783 (871)
Q Consensus       705 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~  783 (871)
                      +.++.+||+|||.+........ ........+++.|+|||++.++.+++++|||||||++|||++ |+.||........ 
T Consensus       156 ~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~-  233 (280)
T cd05049         156 GYDLVVKIGDFGMSRDVYTTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV-  233 (280)
T ss_pred             cCCCeEEECCcccceecccCcc-eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-
Confidence            9999999999999976533211 111222345788999999999999999999999999999998 9999875332211 


Q ss_pred             HHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          784 LHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                       ............                              ...++..+.+++.+||+.||++|||+.|+++.|+
T Consensus       234 -~~~~~~~~~~~~------------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         234 -IECITQGRLLQR------------------------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -HHHHHcCCcCCC------------------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence             111111000000                              0122346789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.7e-37  Score=324.43  Aligned_cols=256  Identities=30%  Similarity=0.485  Sum_probs=207.0

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ...+|++.+.||.|+||.||+|.+.. ++.||+|++..........+.+|+.+++.++||||+++++++.+.     ...
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   77 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-----EPV   77 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC-----CCe
Confidence            34568999999999999999999986 889999999766554567789999999999999999999988665     568


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++++|.+++......     .+++..++.++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g  149 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEGQ-----VLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFG  149 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEcccc
Confidence            9999999999999999765422     589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      .+.......   .......++..|+|||...+..++.++||||||+++|+|++ |+.||....... ..... .......
T Consensus       150 ~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-~~~~~-~~~~~~~  224 (261)
T cd05148         150 LARLIKEDV---YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-VYDQI-TAGYRMP  224 (261)
T ss_pred             chhhcCCcc---ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-HHHHH-HhCCcCC
Confidence            998764321   11112345678999999888889999999999999999998 899997543211 11111 1100000


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                      .                              ...++..+.+++.+|++.||++|||+.|+++.|+.
T Consensus       225 ~------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         225 C------------------------------PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             C------------------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            0                              01223457799999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=9.2e-37  Score=325.05  Aligned_cols=266  Identities=25%  Similarity=0.383  Sum_probs=208.3

Q ss_pred             cCCCCCceeeccccceEEEEEE-----CCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .+|.+.+.||+|+||.||+|..     ..++..||+|.+........+.+.+|++++++++||||+++++++...     
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-----   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----
Confidence            4688999999999999999986     234567999998765555567889999999999999999999998754     


Q ss_pred             ceeeEEEeccCCCCHHHHhhccccc------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDE------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE  707 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  707 (871)
                      ...++||||+++++|.+++......      ......+++..++.++.|++.||+|||+.   +++||||||+||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence            6689999999999999999754321      01122589999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHH
Q 002883          708 MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHK  786 (871)
Q Consensus       708 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~  786 (871)
                      +.+||+|||.+....... .........++..|+|||++.+..++.++|||||||++|+|++ |..||....... ....
T Consensus       157 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~  234 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIEC  234 (288)
T ss_pred             CcEEeccCCccccccCCc-eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH
Confidence            999999999998654321 1111223345778999999888889999999999999999998 999987543221 1111


Q ss_pred             HhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          787 YAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       787 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      ......+. .                              ......++.+++.+|++.||.+|||+.|+.+.|+++.+.
T Consensus       235 i~~~~~~~-~------------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         235 ITQGRVLQ-R------------------------------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHcCCcCC-C------------------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            11110000 0                              001234578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.4e-37  Score=333.07  Aligned_cols=269  Identities=23%  Similarity=0.345  Sum_probs=205.0

Q ss_pred             hhcCCCCCceeeccccceEEEEEECC-----CCcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeecccC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGT-----EETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCSSID  629 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  629 (871)
                      ..++|++.+.||+|+||.||+|.+..     +++.||+|+++... ....+.+.+|+.+++++ +|+||+++++++... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-   83 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-   83 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence            34689999999999999999997533     35789999986432 22345678899999999 899999999987543 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccc--------------------------------------------------
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQ--------------------------------------------------  659 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------  659 (871)
                         +...+++|||+++++|.+++.......                                                  
T Consensus        84 ---~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          84 ---GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ---CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence               246789999999999999986532100                                                  


Q ss_pred             ----cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCCCCCCcccccccc
Q 002883          660 ----NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK  735 (871)
Q Consensus       660 ----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  735 (871)
                          .....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.++|+|||++..+..... ........
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~~~~~  236 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDAR  236 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhccCCC
Confidence                0012589999999999999999999999   999999999999999999999999999987643221 11122334


Q ss_pred             ccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhh
Q 002883          736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAG  814 (871)
Q Consensus       736 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (871)
                      ++..|+|||++.+..++.++||||+||++|||++ |..||......+. .............                  
T Consensus       237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~------------------  297 (337)
T cd05054         237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRRLKEGTRMRA------------------  297 (337)
T ss_pred             CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHHHhccCCCCC------------------
Confidence            5678999999999999999999999999999998 9999975321111 1111100000000                  


Q ss_pred             hhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          815 IVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       815 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                                  ......++.+++.+|++.+|++||++.|+++.|+++..
T Consensus       298 ------------~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         298 ------------PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             ------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                        00223467899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.1e-37  Score=332.68  Aligned_cols=243  Identities=23%  Similarity=0.308  Sum_probs=193.1

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||.||+|++..+++.||+|+++...   ....+.+..|.++++.+ +||+|+++++++...     ...|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-----~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-----DRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CeEEEEE
Confidence            46899999999999999899999999996432   23345667888888866 899999999998765     6689999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++|+|.+++....       .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        76 E~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~  145 (321)
T cd05591          76 EYVNGGDLMFQIQRSR-------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKE  145 (321)
T ss_pred             eCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeeccccee
Confidence            9999999999987644       588999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhc
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII  800 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  800 (871)
                      .....   .......||+.|+|||++.+..++.++||||+||++|+|++|+.||........ .........       .
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-~~~i~~~~~-------~  214 (321)
T cd05591         146 GILNG---VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-FESILHDDV-------L  214 (321)
T ss_pred             cccCC---ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-HHHHHcCCC-------C
Confidence            43221   122335689999999999888999999999999999999999999975432211 111111000       0


Q ss_pred             ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-------CHHHHHHH
Q 002883          801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-------KIQDAIME  858 (871)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------ta~evl~~  858 (871)
                      .+.                         ....++.+++.+|++.||++||       +++++++.
T Consensus       215 ~p~-------------------------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         215 YPV-------------------------WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCC-------------------------CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            000                         1124567899999999999999       77777653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.9e-37  Score=321.83  Aligned_cols=255  Identities=26%  Similarity=0.451  Sum_probs=202.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.++||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++...     ...+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   77 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKE-----EPIY   77 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CCcE
Confidence            467999999999999999999976 567799998864332 356788999999999999999999887654     5679


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++......     .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~  149 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGG-----KVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGL  149 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCcc
Confidence            999999999999999764322     588899999999999999999998   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +........  .......++..|+|||+...+.++.++|||||||++|+|++ |+.||........  ........+.. 
T Consensus       150 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~--~~~~~~~~~~~-  224 (261)
T cd05072         150 ARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV--MSALQRGYRMP-  224 (261)
T ss_pred             ceecCCCce--eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH--HHHHHcCCCCC-
Confidence            987643221  11222345678999999888889999999999999999998 9999975322211  11111000000 


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                                                   ....++.++.+++.+|++.+|++|||++++.+.|++
T Consensus       225 -----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         225 -----------------------------RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             -----------------------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                                         001233457789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=329.49  Aligned_cols=246  Identities=24%  Similarity=0.329  Sum_probs=202.7

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG---ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .|.-.+.||.|+||.||-|++..+.+.||||.+......   ...++.+|+..+++++|||++.+.|+|...     ...
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-----~Ta  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-----HTA  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-----chH
Confidence            466678999999999999999999999999999655433   346788999999999999999999998765     567


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||| -|+-.|.+...+.      ++.+.++..|+.+.+.||+|||+.   +.+|||||+.|||+++.|.|||+|||
T Consensus       102 WLVMEYC-lGSAsDlleVhkK------plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFG  171 (948)
T KOG0577|consen  102 WLVMEYC-LGSASDLLEVHKK------PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFG  171 (948)
T ss_pred             HHHHHHH-hccHHHHHHHHhc------cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeecccc
Confidence            9999999 6688898877653      689999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccc---cCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYG---ALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      .|....+       ...++|||+|||||++   ..+.|+-++||||+|+++.|+...++|+..+......+. ++....|
T Consensus       172 SAsi~~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH-IAQNesP  243 (948)
T KOG0577|consen  172 SASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESP  243 (948)
T ss_pred             chhhcCc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH-HHhcCCC
Confidence            9987653       3346899999999974   468999999999999999999999999886644332221 1111111


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                       ...   .+                          +....+.+++..||+.-|.+|||+++++..
T Consensus       244 -tLq---s~--------------------------eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  244 -TLQ---SN--------------------------EWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             -CCC---Cc--------------------------hhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence             110   11                          334456789999999999999999998764

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-37  Score=326.37  Aligned_cols=253  Identities=23%  Similarity=0.298  Sum_probs=199.7

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      +|++.+.||+|+||+||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++.+...     ...
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-----CeE
Confidence            4888999999999999999998889999999986432   12234567899999999999999999987655     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++|+|.+++.....     ..+++..+..++.|++.|+.|||+.   +++||||||+||++++++.++|+|||
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg  147 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGN-----PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLG  147 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCC
Confidence            999999999999998865432     2589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      .+.......    ......|+..|+|||++.+..++.++||||+||++|||++|+.||........ ....... ..   
T Consensus       148 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-~~~~~~~-~~---  218 (285)
T cd05605         148 LAVEIPEGE----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-REEVERR-VK---  218 (285)
T ss_pred             CceecCCCC----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-HHHHHHH-hh---
Confidence            998754321    11234689999999999888899999999999999999999999975322110 0000000 00   


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIME  858 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~~  858 (871)
                                           ....   .....+...+.+++.+|++.||++||     +++++++.
T Consensus       219 ---------------------~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         219 ---------------------EDQE---EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ---------------------hccc---ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                                 0000   00012345677999999999999999     88888664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.3e-37  Score=340.28  Aligned_cols=255  Identities=21%  Similarity=0.256  Sum_probs=200.4

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.     
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~-----  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD-----  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----
Confidence            4568999999999999999999999899999999996432   22335577899999999999999999988765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||+++|+|.+++...        .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~  184 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSNY--------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLA  184 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEE
Confidence            6789999999999999998653        378889999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCC----CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG----EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK  789 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~  789 (871)
                      |||.+.......  ........||+.|+|||++.+.    .++.++|||||||++|||++|+.||....... .+.....
T Consensus       185 DfG~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~  261 (370)
T cd05596         185 DFGTCMKMDANG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMD  261 (370)
T ss_pred             eccceeeccCCC--cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHHHHHc
Confidence            999998764321  1122335699999999987543    47899999999999999999999997532211 1111111


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCC--CCCHHHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRD--RMKIQDAIME  858 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPta~evl~~  858 (871)
                      .......                            +....+..++.+++.+|++.+|++  |||++|+++.
T Consensus       262 ~~~~~~~----------------------------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         262 HKNSLTF----------------------------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCCcCCC----------------------------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            0000000                            000123456778999999999988  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.3e-37  Score=322.76  Aligned_cols=256  Identities=21%  Similarity=0.274  Sum_probs=202.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+.++++++||||+++++++...     ...|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----EKLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----CEEE
Confidence            35799999999999999999999889999999999765544556788999999999999999999998665     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++....       .+++..+..++.|++.|+.|||+.   +|+|||++|+||+++.++.++|+|||+
T Consensus        83 iv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~  152 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTG-------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGV  152 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCcc
Confidence            9999999999999986543       589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGA---LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      +.......   .......++..|+|||.+.   ...++.++||||+||++|||++|+.||......... ..........
T Consensus       153 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~  228 (267)
T cd06646         153 AAKITATI---AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSKSNFQP  228 (267)
T ss_pred             ceeecccc---cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeecCCCCC
Confidence            98664321   1122345888999999864   445788999999999999999999998643221110 0000000000


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                             +.+                    .........+.+++.+||+.+|++|||++++++.+
T Consensus       229 -------~~~--------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         229 -------PKL--------------------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             -------CCC--------------------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                   000                    00012335678999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=327.09  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=211.2

Q ss_pred             cCCCCCceeeccccceEEEEEECC----CCcEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGT----EETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      +..+..++||.|-||.||+|....    ..-.||||..+.+ ..+..+.|..|+.+|+.++||||++++|.|.+.     
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-----  463 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-----  463 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-----
Confidence            344556789999999999998732    2345999998763 345578899999999999999999999999774     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                       ..|||||.++-|-|..|++.+..      .++......++.||+.||+|||+.   .+|||||..+|||+.+...+|++
T Consensus       464 -P~WivmEL~~~GELr~yLq~nk~------sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLa  533 (974)
T KOG4257|consen  464 -PMWIVMELAPLGELREYLQQNKD------SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLA  533 (974)
T ss_pred             -ceeEEEecccchhHHHHHHhccc------cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeec
Confidence             47999999999999999998875      489999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |||+++.+.++...  ..+...-...|||||-+....++.++|||-|||++||++. |..||......+.....-..   
T Consensus       534 DFGLSR~~ed~~yY--kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG---  608 (974)
T KOG4257|consen  534 DFGLSRYLEDDAYY--KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG---  608 (974)
T ss_pred             ccchhhhccccchh--hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC---
Confidence            99999998765322  2223334678999999999999999999999999999988 99999875443321111000   


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                                                   +..+..+.++..+..++.+||++||.+||+..|+...|.++..
T Consensus       609 -----------------------------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  609 -----------------------------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             -----------------------------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                                         0111223566778899999999999999999999999998865

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.1e-37  Score=336.51  Aligned_cols=204  Identities=25%  Similarity=0.335  Sum_probs=175.8

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||+||+|++..+++.||+|+++...   ......+.+|+.++..++|++|+++++.+.+.     ..
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-----~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-----LN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----Ce
Confidence            47899999999999999999999899999999996432   22335678899999999999999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++....       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DF  145 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKD-------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDF  145 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeec
Confidence            899999999999999997643       589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCC--------------------------------ccccccccccccccCcccccCCCCCCccchhhHHHH
Q 002883          716 GLSRLLHDNSPD--------------------------------QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL  763 (871)
Q Consensus       716 g~a~~~~~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i  763 (871)
                      |+++........                                ........||+.|+|||++.+..++.++|||||||+
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvi  225 (363)
T cd05628         146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI  225 (363)
T ss_pred             cCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHH
Confidence            998765321100                                000123469999999999988899999999999999


Q ss_pred             HHHHHhCCCCCchh
Q 002883          764 MLEMFTGKRPTDDM  777 (871)
Q Consensus       764 l~elltG~~pf~~~  777 (871)
                      +|||++|+.||...
T Consensus       226 l~ell~G~~Pf~~~  239 (363)
T cd05628         226 MYEMLIGYPPFCSE  239 (363)
T ss_pred             HHHHHhCCCCCCCC
Confidence            99999999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.3e-36  Score=334.96  Aligned_cols=283  Identities=19%  Similarity=0.209  Sum_probs=205.0

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~  633 (871)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++..... ...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            357899999999999999999999989999999998643  23334677889999999999999999998755422 223


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||++ +++.+++..         .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~  168 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQM---------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  168 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHHh---------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEE
Confidence            46799999995 578777743         378889999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MGL  792 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~  792 (871)
                      |||++......    .......+|..|+|||++.+..++.++|||||||++|+|++|+.||........ +..... ...
T Consensus       169 DfG~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~  243 (364)
T cd07875         169 DFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGT  243 (364)
T ss_pred             eCCCccccCCC----CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCC
Confidence            99999865432    122234689999999999988999999999999999999999999975433221 111111 111


Q ss_pred             C-chhhhhcChhHHHHHHHHHhh---------hhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          793 P-DQVAEIIDPAILEEALEIQAG---------IVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       793 ~-~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      + +.....+.+........ ...         ......+...........++.+++.+|++.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         244 PCPEFMKKLQPTVRTYVEN-RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CCHHHHHhhhHHHHHHHhh-CCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            1 11111111111110000 000         00000000001111123567899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-37  Score=341.24  Aligned_cols=204  Identities=24%  Similarity=0.322  Sum_probs=174.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||.||+|++..+++.||||++....   ....+.+.+|+++++.++||||+++++++.+.     .+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-----QY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----Ce
Confidence            47999999999999999999999999999999985432   22345678899999999999999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++....       .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~Df  145 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYD-------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDF  145 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeec
Confidence            899999999999999997643       588999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCC------------c--------------------------------cccccccccccccCcccccCCCC
Q 002883          716 GLSRLLHDNSPD------------Q--------------------------------TSTSRVKGSIGYVAPEYGALGEV  751 (871)
Q Consensus       716 g~a~~~~~~~~~------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~  751 (871)
                      |+++........            .                                .......||+.|+|||++.+..+
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  225 (377)
T cd05629         146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY  225 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC
Confidence            998643211000            0                                00012468999999999988899


Q ss_pred             CCccchhhHHHHHHHHHhCCCCCchh
Q 002883          752 STHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       752 ~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      +.++||||+||++|||++|+.||...
T Consensus       226 ~~~~DiwSlGvil~elltG~~Pf~~~  251 (377)
T cd05629         226 GQECDWWSLGAIMFECLIGWPPFCSE  251 (377)
T ss_pred             CCceeeEecchhhhhhhcCCCCCCCC
Confidence            99999999999999999999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=8.3e-37  Score=335.44  Aligned_cols=284  Identities=19%  Similarity=0.205  Sum_probs=203.8

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~  633 (871)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.+++.++||||+++++++..... ...
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457899999999999999999999889999999998643  22334677889999999999999999998765422 223


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||+++ ++.+++..         .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~  161 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM---------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence            467999999954 67777643         478889999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||+++.....    .......||..|+|||++.+..++.++|||||||++|+|++|+.||..................+
T Consensus       162 Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (355)
T cd07874         162 DFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  237 (355)
T ss_pred             eCcccccCCCc----cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99999865432    12233568999999999988899999999999999999999999997543221111111111111


Q ss_pred             -chhhhhcChhHHHHHHHHHhh---------hhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 -DQVAEIIDPAILEEALEIQAG---------IVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 -~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                       ........+.... .......         ......+...........++.+++.+|++.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         238 CPEFMKKLQPTVRN-YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CHHHHHhhcHHHHH-HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence             1111111111100 0000000         00000000000111224567899999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.5e-37  Score=328.47  Aligned_cols=242  Identities=24%  Similarity=0.327  Sum_probs=191.1

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||.||+|++..+++.||+|+++...   .........|..+++.. +||||+++++++.+.     ...|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-----ENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-----CEEEEEE
Confidence            46999999999999999899999999996542   22345566788888764 999999999998765     6789999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++|+|.+++....       .+++.++..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        76 ey~~~g~L~~~l~~~~-------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05619          76 EYLNGGDLMFHIQSCH-------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKE  145 (316)
T ss_pred             eCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence            9999999999997643       588999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhc
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII  800 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  800 (871)
                      ....   ........||+.|+|||++.+..++.++||||+||++|||++|+.||.......  .........+ ...   
T Consensus       146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~i~~~~~-~~~---  216 (316)
T cd05619         146 NMLG---DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQSIRMDNP-CYP---  216 (316)
T ss_pred             CCCC---CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCC-CCC---
Confidence            3221   112233568999999999988899999999999999999999999997532211  1111110000 000   


Q ss_pred             ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHH-HHHH
Q 002883          801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQ-DAIM  857 (871)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~-evl~  857 (871)
                                                 .....++.+++.+|++.||++||++. ++.+
T Consensus       217 ---------------------------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 ---------------------------RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ---------------------------ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence                                       01223567899999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-36  Score=319.37  Aligned_cols=258  Identities=26%  Similarity=0.417  Sum_probs=204.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCC---CcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTE---ETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .++|++.+.||+|+||.||+|++...   ...||+|+++... ......+.+|+.++++++||||+++++++...     
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   77 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS-----   77 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC-----
Confidence            35799999999999999999998643   4579999986443 33346788999999999999999999987654     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+++++|.+++.....      .+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.++|+
T Consensus        78 ~~~~iv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~  148 (266)
T cd05033          78 RPVMIITEYMENGSLDKFLRENDG------KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVS  148 (266)
T ss_pred             CceEEEEEcCCCCCHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEEC
Confidence            568999999999999999976432      589999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |||.+....... .........++..|+|||...+..++.++||||||+++|+|++ |..||........  ........
T Consensus       149 dfg~~~~~~~~~-~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~--~~~~~~~~  225 (266)
T cd05033         149 DFGLSRRLEDSE-ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV--IKAVEDGY  225 (266)
T ss_pred             ccchhhcccccc-cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH--HHHHHcCC
Confidence            999998775221 1111112235678999999888899999999999999999998 9999975332211  11111100


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      ....                              ...++..+.+++.+|++.+|++||++.|+++.|+++
T Consensus       226 ~~~~------------------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 RLPP------------------------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCC------------------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0000                              012234577999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.4e-37  Score=331.01  Aligned_cols=242  Identities=21%  Similarity=0.303  Sum_probs=192.8

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCce
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      +|++.+.||+|+||.||+|++..+++.||+|+++...   .........|..++... .|++|+++++++.+.     +.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-----DR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-----CE
Confidence            5888999999999999999999899999999996432   22234566788888777 589999999887665     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++....       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~Df  145 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVG-------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADF  145 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccC
Confidence            899999999999999987643       588999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |++......   ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ .........  .
T Consensus       146 G~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-~~~i~~~~~--~  219 (323)
T cd05616         146 GMCKENMWD---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-FQSIMEHNV--A  219 (323)
T ss_pred             CCceecCCC---CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCC--C
Confidence            999754321   1122345689999999999999999999999999999999999999975432211 111111000  0


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI  852 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta  852 (871)
                                             .+       .....++.+++.+|++.||++|+++
T Consensus       220 -----------------------~p-------~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         220 -----------------------YP-------KSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -----------------------CC-------CcCCHHHHHHHHHHcccCHHhcCCC
Confidence                                   00       0123456789999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-37  Score=331.26  Aligned_cols=248  Identities=23%  Similarity=0.401  Sum_probs=209.8

Q ss_pred             CCceeeccccceEEEEEECCCCcEEEEEEeec----cccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          563 SANLIGIGGYGYVYKGILGTEETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       563 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      ...+||+|+|-+||+|.+..+|..||--.++.    ......+++..|+.+++.++||||+++|++|.+...   ...-+
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in~  120 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTINF  120 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceeee
Confidence            34679999999999999998998887544422    223345789999999999999999999999987633   56789


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCceEEeeccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-EMVAHVGDFGL  717 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~  717 (871)
                      |+|.+..|+|..|.++.+       .++...++.|++||++||.|||++ .++|+|||||.+||+|++ .|.|||+|+|+
T Consensus       121 iTEL~TSGtLr~Y~kk~~-------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  121 ITELFTSGTLREYRKKHR-------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             eeecccCCcHHHHHHHhc-------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence            999999999999999887       689999999999999999999997 569999999999999975 58999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      |.....     .....++|||.|||||++. ..|.+.+||||||+++.||+|+..||.........+.+.....-|..+.
T Consensus       193 Atl~r~-----s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~  266 (632)
T KOG0584|consen  193 ATLLRK-----SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS  266 (632)
T ss_pred             HHHhhc-----cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh
Confidence            998753     2333478999999999866 7899999999999999999999999998777666666666655566666


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .+-||.                              +.++|.+|+.. .++||||.|+++.
T Consensus       267 kV~dPe------------------------------vr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  267 KVKDPE------------------------------VREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ccCCHH------------------------------HHHHHHHHhcC-chhccCHHHHhhC
Confidence            666644                              45889999999 9999999999863

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.1e-37  Score=341.14  Aligned_cols=203  Identities=22%  Similarity=0.310  Sum_probs=173.5

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      +|++++.||+|+||+||+|++..+++.||+|++....   ......+.+|++++++++||||+++++++.+.     ...
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-----~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-----CEE
Confidence            6889999999999999999999999999999986432   22345788999999999999999999998765     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||+++|+|.+++....       .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~-------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFG  146 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMG-------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  146 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECC
Confidence            99999999999999997643       588999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCC--------------------------------------------CccccccccccccccCcccccCCCCC
Q 002883          717 LSRLLHDNSP--------------------------------------------DQTSTSRVKGSIGYVAPEYGALGEVS  752 (871)
Q Consensus       717 ~a~~~~~~~~--------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~  752 (871)
                      +|........                                            .........||+.|+|||++.+..++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~  226 (382)
T cd05625         147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT  226 (382)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC
Confidence            9753211000                                            00001124689999999999888999


Q ss_pred             CccchhhHHHHHHHHHhCCCCCchh
Q 002883          753 THGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       753 ~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      .++||||+||++|||++|+.||...
T Consensus       227 ~~~DiwSlGvil~elltG~~Pf~~~  251 (382)
T cd05625         227 QLCDWWSVGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             CeeeEEechHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.4e-37  Score=352.82  Aligned_cols=268  Identities=22%  Similarity=0.299  Sum_probs=206.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++...   ....+++.+|+++++.++||||+++++++.+.     +.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-----~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-----DP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-----CE
Confidence            58999999999999999999999899999999986432   22346788999999999999999999988665     66


Q ss_pred             eeEEEeccCCCCHHHHhhccccc----ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 002883          636 KALVYEFMPNGSLENWLNQKEDE----QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                      .|+||||++||+|.+++......    .......++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence            89999999999999998653211    01122467788899999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCCC---------------ccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCch
Q 002883          712 VGDFGLSRLLHDNSPD---------------QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDD  776 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  776 (871)
                      |+|||++.........               ........||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9999999876211100               0111234699999999999989999999999999999999999999975


Q ss_pred             hhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC-HHHH
Q 002883          777 MFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK-IQDA  855 (871)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-a~ev  855 (871)
                      ..........  ....+..                            ......++..+.+++.+|++.||++||+ ++++
T Consensus       234 ~~~~ki~~~~--~i~~P~~----------------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL  283 (932)
T PRK13184        234 KKGRKISYRD--VILSPIE----------------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQEL  283 (932)
T ss_pred             cchhhhhhhh--hccChhh----------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            2211111000  0000000                            0011234456778999999999999975 7777


Q ss_pred             HHHHHHHHH
Q 002883          856 IMELQEAQK  864 (871)
Q Consensus       856 l~~L~~i~~  864 (871)
                      .+.|+...+
T Consensus       284 l~~Le~~lq  292 (932)
T PRK13184        284 KQDLEPHLQ  292 (932)
T ss_pred             HHHHHHHHh
Confidence            777776643

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.3e-37  Score=336.90  Aligned_cols=204  Identities=23%  Similarity=0.346  Sum_probs=174.9

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.    
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~----  115 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD----  115 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----
Confidence            34578999999999999999999999899999999985421   22345678899999999999999999998765    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                       ...|+||||+++|+|.+++...        .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||
T Consensus       116 -~~~~lv~Ey~~gg~L~~~l~~~--------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL  183 (370)
T cd05621         116 -KYLYMVMEYMPGGDLVNLMSNY--------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKL  183 (370)
T ss_pred             -CEEEEEEcCCCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEE
Confidence             6789999999999999999653        378899999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCC----CCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG----EVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      +|||+|.......  ........||+.|+|||++.+.    .++.++||||+||++|+|++|+.||...
T Consensus       184 ~DFG~a~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~  250 (370)
T cd05621         184 ADFGTCMKMDETG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD  250 (370)
T ss_pred             EecccceecccCC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence            9999998764322  1122345699999999987643    3789999999999999999999999753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.1e-37  Score=329.73  Aligned_cols=242  Identities=23%  Similarity=0.292  Sum_probs=193.4

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||+||+|++..+++.||+|+++...   ......+.+|.++++.+ +||||+++++++...     ...|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-----~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-----DRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEE
Confidence            46999999999999999899999999996432   23345677888998887 799999999988765     6789999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++|+|.+++....       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        76 e~~~~~~L~~~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  145 (318)
T cd05570          76 EYVNGGDLMFHIQRSG-------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKE  145 (318)
T ss_pred             cCCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCee
Confidence            9999999999987653       589999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhc
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII  800 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  800 (871)
                      ....   ........|++.|+|||++.+..++.++||||+||++|+|++|+.||........ ........ . ..    
T Consensus       146 ~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~-~~~i~~~~-~-~~----  215 (318)
T cd05570         146 GILG---GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL-FQSILEDE-V-RY----  215 (318)
T ss_pred             cCcC---CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH-HHHHHcCC-C-CC----
Confidence            3221   1122334689999999999999999999999999999999999999975322111 11000000 0 00    


Q ss_pred             ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCH-----HHHHH
Q 002883          801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI-----QDAIM  857 (871)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta-----~evl~  857 (871)
                                         +       ......+.+++.+||+.||++|||+     .++++
T Consensus       216 -------------------~-------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         216 -------------------P-------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             -------------------C-------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence                               0       0123456799999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.3e-37  Score=330.03  Aligned_cols=243  Identities=26%  Similarity=0.319  Sum_probs=192.3

Q ss_pred             CceeeccccceEEEEEEC---CCCcEEEEEEeeccc----cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          564 ANLIGIGGYGYVYKGILG---TEETNVAVKVLDLQQ----RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .+.||+|+||.||+|+..   .+++.||+|+++...    ......+.+|+++++.++||||+++++++...     +..
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-----GKL   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-----CeE
Confidence            368999999999999873   467899999986432    22335677899999999999999999988665     668


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||+++++|.+++....       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  145 (323)
T cd05584          76 YLILEYLSGGELFMHLEREG-------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFG  145 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCc
Confidence            99999999999999997643       578889999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +++......   .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........    
T Consensus       146 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-~~~~~~~~~~----  217 (323)
T cd05584         146 LCKESIHEG---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-TIDKILKGKL----  217 (323)
T ss_pred             CCeecccCC---CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCC----
Confidence            987543221   12233568999999999988889999999999999999999999997532211 0111100000    


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIM  857 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~  857 (871)
                                           .+++       ....++.+++.+|++.||++||     +++++++
T Consensus       218 ---------------------~~~~-------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 ---------------------NLPP-------YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ---------------------CCCC-------CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                                 0000       1234567999999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=9e-37  Score=328.86  Aligned_cols=241  Identities=24%  Similarity=0.311  Sum_probs=190.8

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||.||+|++..+++.||+|+++...   .........|..++... +||+|+++++++.+.     .+.|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-----EHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-----CEEEEEE
Confidence            46999999999999999999999999996432   22345567788888754 899999999998765     6789999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++|+|.+++....       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        76 E~~~~g~L~~~i~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05620          76 EFLNGGDLMFHIQDKG-------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKE  145 (316)
T ss_pred             CCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence            9999999999987643       588999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhc
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII  800 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  800 (871)
                      ....   ........||+.|+|||++.+..++.++||||+||++|||++|+.||.......  .........+ ....  
T Consensus       146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~~~~~~~~~~-~~~~--  217 (316)
T cd05620         146 NVFG---DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--LFESIRVDTP-HYPR--  217 (316)
T ss_pred             cccC---CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCC-CCCC--
Confidence            3221   112234568999999999998899999999999999999999999997532221  1111111000 0000  


Q ss_pred             ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHH-HHH
Q 002883          801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQ-DAI  856 (871)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~-evl  856 (871)
                                                  ....++.+++.+|++.||++||++. ++.
T Consensus       218 ----------------------------~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         218 ----------------------------WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ----------------------------CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                                        1223567899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-36  Score=332.41  Aligned_cols=280  Identities=22%  Similarity=0.265  Sum_probs=203.8

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~  633 (871)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++....  ....+.+.+|++++++++||||+++++++..... ...
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4578999999999999999999998899999999986432  2234567789999999999999999998754322 222


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+++|++ +++|.+++...        .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKCQ--------KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence            4578999998 88999888642        489999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MG  791 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~  791 (871)
                      |||++......      .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||........ ...... ..
T Consensus       161 Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~  233 (343)
T cd07878         161 DFGLARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ-LKRIMEVVG  233 (343)
T ss_pred             CCccceecCCC------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhC
Confidence            99999865432      123468999999998766 5689999999999999999999999975322211 111111 11


Q ss_pred             CC-chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          792 LP-DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       792 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .+ ......+.......+..   .............+......+.+++.+|++.||++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         234 TPSPEVLKKISSEHARKYIQ---SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCCHHHHHhcchhhHHHHhh---ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11 11111111111111100   000000011111122234457899999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.1e-37  Score=336.68  Aligned_cols=253  Identities=21%  Similarity=0.258  Sum_probs=199.8

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||+||+|++..+++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.     ..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-----~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-----DN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----Ce
Confidence            46899999999999999999999999999999996432   22345678899999999999999999987654     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++.....      .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Df  146 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYED------QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADF  146 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccC
Confidence            8999999999999999977532      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCccccc------CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA------LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK  789 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~  789 (871)
                      |++........  .......||+.|+|||++.      ...++.++|||||||++|+|++|+.||........ +.....
T Consensus       147 g~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~~i~~  223 (330)
T cd05601         147 GSAARLTANKM--VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-YNNIMN  223 (330)
T ss_pred             CCCeECCCCCc--eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-HHHHHc
Confidence            99987654321  1222346899999999875      45678999999999999999999999975322111 111100


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...   ...+                         +....+...+.+++..|+. +|++|||+.++++
T Consensus       224 ~~~---~~~~-------------------------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         224 FQR---FLKF-------------------------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCC---ccCC-------------------------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            000   0000                         0001223456788899998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.2e-36  Score=320.74  Aligned_cols=261  Identities=22%  Similarity=0.303  Sum_probs=207.7

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||.||+|++..+++.||||.+....   ......+.+|+++++.++||||+++++++.+.     ..
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----Ce
Confidence            46889999999999999999998899999999885432   22345788999999999999999999988765     66


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||+++++|.+++.....   ....+++..++.++.|++.|+.|||+.   +++|+||||+||+++.++.++++||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df  150 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKK---QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcc
Confidence            8999999999999999875321   123589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh-CCCc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM-GLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~~~~  794 (871)
                      |.+.......   .......++..|+|||+..+..++.++||||||+++|+|++|..||.....+.....+.... ..++
T Consensus       151 g~~~~~~~~~---~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  227 (267)
T cd08229         151 GLGRFFSSKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP  227 (267)
T ss_pred             hhhhccccCC---cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCC
Confidence            9987654322   11223458899999999888889999999999999999999999996432221111111100 0000


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                      .                              .......++.+++.+|++.||++|||+.+|++.++++.
T Consensus       228 ~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         228 L------------------------------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             C------------------------------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            0                              00123456789999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.5e-37  Score=342.21  Aligned_cols=204  Identities=23%  Similarity=0.305  Sum_probs=173.9

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .+|++.+.||+|+||.||+|++..+++.||+|++....   ......+.+|+++++.++||||+++++.+.+.     +.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-----DN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----CE
Confidence            36999999999999999999999899999999985432   22345678999999999999999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++....       .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~-------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DF  145 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLG-------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  145 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeC
Confidence            899999999999999997643       588899999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCC----------------------------------------CccccccccccccccCcccccCCCCCCcc
Q 002883          716 GLSRLLHDNSP----------------------------------------DQTSTSRVKGSIGYVAPEYGALGEVSTHG  755 (871)
Q Consensus       716 g~a~~~~~~~~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  755 (871)
                      |+|..+.....                                        .........||+.|+|||++.+..++.++
T Consensus       146 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  225 (376)
T cd05598         146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC  225 (376)
T ss_pred             CCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcce
Confidence            99753310000                                        00001124699999999999988999999


Q ss_pred             chhhHHHHHHHHHhCCCCCchh
Q 002883          756 DEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       756 DiwSlG~il~elltG~~pf~~~  777 (871)
                      ||||+||++|||++|+.||...
T Consensus       226 DiwSlGvilyell~G~~Pf~~~  247 (376)
T cd05598         226 DWWSVGVILYEMLVGQPPFLAD  247 (376)
T ss_pred             eeeeccceeeehhhCCCCCCCC
Confidence            9999999999999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-36  Score=317.29  Aligned_cols=249  Identities=26%  Similarity=0.407  Sum_probs=196.0

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEecc
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM  643 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  643 (871)
                      +.||+|+||.||+|++..+++.||+|.+.... ......+.+|+++++.++||||+++++++...     ...++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEeec
Confidence            46899999999999998899999999885432 23346789999999999999999999998665     5689999999


Q ss_pred             CCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCC
Q 002883          644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD  723 (871)
Q Consensus       644 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  723 (871)
                      ++++|.+++.....      .+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||.+.....
T Consensus        76 ~~~~L~~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  146 (252)
T cd05084          76 QGGDFLTFLRTEGP------RLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEED  146 (252)
T ss_pred             cCCcHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccc
Confidence            99999999975432      488999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhhhhcCh
Q 002883          724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDP  802 (871)
Q Consensus       724 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  802 (871)
                      ... .........+..|+|||.+.++.++.++|||||||++|+|++ |..||........  ........+....     
T Consensus       147 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~-----  218 (252)
T cd05084         147 GVY-ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT--REAIEQGVRLPCP-----  218 (252)
T ss_pred             ccc-cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH--HHHHHcCCCCCCc-----
Confidence            211 111111223467999999888889999999999999999998 8999875332211  1111100000000     


Q ss_pred             hHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          803 AILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                                               ...+..+.+++.+|++.+|++|||+.|+.+.|+
T Consensus       219 -------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         219 -------------------------ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             -------------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence                                     012346789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.9e-36  Score=317.83  Aligned_cols=255  Identities=29%  Similarity=0.454  Sum_probs=201.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.++||+|+||.||+|++..+ ..||+|+++.... ..+.+.+|++++++++||||+++++++.+      ...+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY   76 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC------CCcE
Confidence            46799999999999999999998744 5699999864332 34678899999999999999999987643      3468


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++|+|.+++.....     ..+++..+..++.|++.||+|+|+.   +++||||||+||+++.++.++|+|||.
T Consensus        77 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~  148 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMG-----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL  148 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCc
Confidence            99999999999999976432     2578999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +........  .......++..|+|||+..+..++.++|||||||++|+|+| |..||........ .... ....+.  
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~~~~-~~~~~~--  222 (262)
T cd05071         149 ARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQV-ERGYRM--  222 (262)
T ss_pred             eeecccccc--ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-HHHH-hcCCCC--
Confidence            987654321  11122346678999999888889999999999999999999 8889875432211 1100 000000  


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                                                  +.....+..+.+++.+|++.||++|||+.++++.|++.
T Consensus       223 ----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 ----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ----------------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                                        00013345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=9.4e-37  Score=346.44  Aligned_cols=282  Identities=17%  Similarity=0.174  Sum_probs=197.1

Q ss_pred             HHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCC------Cccceeeeeecc
Q 002883          554 LLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRH------RNLVKIITSCSS  627 (871)
Q Consensus       554 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~  627 (871)
                      +....++|++.+.||+|+||+||+|.+..+++.||||+++.... ..+....|+++++.++|      .+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            33456789999999999999999999988999999999964322 23455667777777654      458888888754


Q ss_pred             cCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceeeCC
Q 002883          628 IDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH-HCHTSIVHCDLKPSNVLLDN  706 (871)
Q Consensus       628 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~  706 (871)
                      .    ..+.|+|||++ +++|.+++....       .+++..+..++.||+.||.|||+ .   +||||||||+|||++.
T Consensus       203 ~----~~~~~iv~~~~-g~~l~~~l~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~  267 (467)
T PTZ00284        203 E----TGHMCIVMPKY-GPCLLDWIMKHG-------PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMET  267 (467)
T ss_pred             C----CceEEEEEecc-CCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEec
Confidence            3    25689999998 789999887643       58999999999999999999997 5   9999999999999986


Q ss_pred             CC----------------ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhC
Q 002883          707 EM----------------VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG  770 (871)
Q Consensus       707 ~~----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG  770 (871)
                      ++                .+||+|||.+.....      ......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG  341 (467)
T PTZ00284        268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG  341 (467)
T ss_pred             CCcccccccccccCCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhC
Confidence            65                499999998864321      12335799999999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhh-HHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhH--------HhHHHHHHHHHhhhccc
Q 002883          771 KRPTDDMFEEGLS-LHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLR--------AKFHEIQVSILRVGILC  841 (871)
Q Consensus       771 ~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~c  841 (871)
                      +.||......+.. .........|..+........................+...        .........+.+|+.+|
T Consensus       342 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  421 (467)
T PTZ00284        342 KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL  421 (467)
T ss_pred             CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence            9999754322111 11111111222211110000000000000000000000000        00001134578999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 002883          842 SEELPRDRMKIQDAIM  857 (871)
Q Consensus       842 l~~dP~~RPta~evl~  857 (871)
                      |++||++||||+|+++
T Consensus       422 L~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        422 LHYDRQKRLNARQMTT  437 (467)
T ss_pred             CCcChhhCCCHHHHhc
Confidence            9999999999999986

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-36  Score=323.84  Aligned_cols=252  Identities=21%  Similarity=0.316  Sum_probs=203.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+|+.+++.++|+|++++++.+...     ...|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-----~~~~   93 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW   93 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-----CEEE
Confidence            35899999999999999999999889999999999765555567788999999999999999999988764     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++...        .+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        94 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~  162 (296)
T cd06654          94 VVMEYLAGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF  162 (296)
T ss_pred             EeecccCCCCHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECcccc
Confidence            999999999999998643        378899999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +.......   .......+++.|+|||...+..++.++|||||||++|+|++|+.||.......... .......+.   
T Consensus       163 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~---  235 (296)
T cd06654         163 CAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPE---  235 (296)
T ss_pred             chhccccc---cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH-HHhcCCCCC---
Confidence            87654321   11223458899999999888888999999999999999999999997532211111 111000000   


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                       ..                         ........+.+++.+|+..||++|||+.|+++.
T Consensus       236 -~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         236 -LQ-------------------------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             -CC-------------------------CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence             00                         001233457789999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.6e-36  Score=317.56  Aligned_cols=251  Identities=29%  Similarity=0.460  Sum_probs=198.2

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      .+|++.+.||+|+||.||+|++. ++..+|+|.+..... ..+.+.+|+++++.++||||+++++++...     ...++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-----KPLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccC-----CCEEE
Confidence            45888999999999999999986 556899998864332 346788999999999999999999998665     56899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||+++|+|.+++.....      .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|++|||.+
T Consensus        77 v~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~  147 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQG------KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMT  147 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCc
Confidence            9999999999999975432      488999999999999999999999   9999999999999999999999999998


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      .......  ........++..|+|||...+..++.++||||||+++|+|++ |+.||........  ...........  
T Consensus       148 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~--~~~i~~~~~~~--  221 (256)
T cd05114         148 RYVLDDE--YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV--VEMISRGFRLY--  221 (256)
T ss_pred             cccCCCc--eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHHCCCCCC--
Confidence            7654321  111122235668999999888889999999999999999999 9999975322111  11111100000  


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                         .+                         ......+.+++.+||+.+|++|||++|+++.|
T Consensus       222 ---~~-------------------------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         222 ---RP-------------------------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---CC-------------------------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               00                         01123578999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.7e-36  Score=322.00  Aligned_cols=266  Identities=25%  Similarity=0.393  Sum_probs=208.4

Q ss_pred             cCCCCCceeeccccceEEEEEEC-----CCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILG-----TEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ++|.+.+.||+|+||.||+|.+.     .++..|++|.++.......+.+.+|++++++++||||+++++++...     
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG-----   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-----
Confidence            46888999999999999999863     24556999998765555557889999999999999999999998654     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccc---------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQ---------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL  704 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  704 (871)
                      ...++||||+++++|.+++.......         .....+++..++.++.||+.|++|||++   +|+||||||+||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence            56899999999999999997643210         1122489999999999999999999999   99999999999999


Q ss_pred             CCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhh
Q 002883          705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLS  783 (871)
Q Consensus       705 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~  783 (871)
                      +.++.++|+|||.+....... .........++..|+|||++.+..++.++|||||||++|||+| |+.||.......  
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--  233 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--  233 (291)
T ss_pred             ccCCcEEECCCCcccccCCCc-eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence            999999999999997654322 1112223456788999999888889999999999999999999 999986533221  


Q ss_pred             HHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          784 LHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                      .............                              ...++..+.+++.+|++.||++|||+.++++.|+++.
T Consensus       234 ~~~~~~~~~~~~~------------------------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         234 VIECITQGRVLER------------------------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             HHHHHhCCCCCCC------------------------------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            1111110000000                              0012345779999999999999999999999999986


Q ss_pred             HH
Q 002883          864 KM  865 (871)
Q Consensus       864 ~~  865 (871)
                      +.
T Consensus       284 ~~  285 (291)
T cd05094         284 KA  285 (291)
T ss_pred             hh
Confidence            64

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-36  Score=316.54  Aligned_cols=254  Identities=22%  Similarity=0.300  Sum_probs=202.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-----GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ++|++.+.||+|++|.||.|.+..+++.||+|++.....     ...+.+.+|++++++++||||+++++++.+.     
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-----   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----
Confidence            468999999999999999999988899999999864321     1235688899999999999999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+++++|.+++....       .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~  146 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAYG-------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLG  146 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence            57899999999999999997643       578899999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||.+.................++..|+|||+..+..++.++||||+|+++|+|++|+.||......... .........
T Consensus       147 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~  225 (263)
T cd06625         147 DFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-FKIATQPTN  225 (263)
T ss_pred             ecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-HHHhccCCC
Confidence            9999986543221111112345788999999998888999999999999999999999999753221111 111110000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ....                              ..+...+.+++.+|+..+|++|||+.|+++.
T Consensus       226 ~~~~------------------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 PQLP------------------------------SHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCC------------------------------ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            0000                              1223456789999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.9e-36  Score=319.52  Aligned_cols=258  Identities=24%  Similarity=0.372  Sum_probs=200.4

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCc----EEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEET----NVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ++|++.+.||+|+||.||+|.+..+++    .|++|.+.... ......+..|+.++++++||||+++++++..      
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence            578899999999999999999976665    47777774332 2233567788889999999999999998643      


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++++||+++|+|.+++.....      .+++..+..++.||+.|++|||+.   +++||||||+||+++.++.+||+
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~  151 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRD------SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIA  151 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEc
Confidence            336789999999999999976432      489999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |||.++...... .........++..|+|||...++.++.++|||||||++||+++ |+.||.+.....  .........
T Consensus       152 Dfg~~~~~~~~~-~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~  228 (279)
T cd05111         152 DFGVADLLYPDD-KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLEKGE  228 (279)
T ss_pred             CCccceeccCCC-cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCCC
Confidence            999998764332 1112223456788999999888899999999999999999998 999997542221  111111100


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      ......                              .+...+.+++.+|+..||++|||+.|+++.|..+..
T Consensus       229 ~~~~~~------------------------------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         229 RLAQPQ------------------------------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             cCCCCC------------------------------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            000000                              012345678899999999999999999999988754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-36  Score=317.54  Aligned_cols=255  Identities=28%  Similarity=0.454  Sum_probs=202.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.++.... ..+.+.+|++++++++||||+++++++...     ...|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   77 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-----EPIY   77 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecC-----CCee
Confidence            457899999999999999999986 557899999865432 356788999999999999999999987654     5679


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++.....     ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||.
T Consensus        78 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~  149 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAG-----RALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGL  149 (261)
T ss_pred             eeeecccCCcHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcce
Confidence            99999999999999976442     2589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +........  ........+..|+|||+..+..++.++||||||+++|+|++ |+.||........ .... ....+...
T Consensus       150 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~-~~~~~~~~  225 (261)
T cd05068         150 ARVIKEDIY--EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV-LQQV-DQGYRMPC  225 (261)
T ss_pred             EEEccCCcc--cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHH-HcCCCCCC
Confidence            987653211  11111223457999999888889999999999999999999 9999975322211 1111 11000000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                                                    .......+.+++.+|++.+|++||+++++++.|++
T Consensus       226 ------------------------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         226 ------------------------------PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ------------------------------CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                                          01223467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.5e-36  Score=321.61  Aligned_cols=262  Identities=24%  Similarity=0.375  Sum_probs=203.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECC-----CCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGT-----EETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      .++|++.+.||+|+||.||+|.+..     .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.   
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER---   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence            4678999999999999999999976     67889999886443 22345688999999999999999999987665   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC---
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM---  708 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---  708 (871)
                        ...++||||+++++|.+++............+++..+..++.||+.|++|||+.   +++||||||+||+++.++   
T Consensus        82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~  156 (277)
T cd05036          82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGR  156 (277)
T ss_pred             --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCc
Confidence              457899999999999999977653322233589999999999999999999999   999999999999998654   


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHH
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKY  787 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~  787 (871)
                      .+||+|||.++....... .........+..|+|||++.+..++.++|||||||++|||++ |+.||........  ...
T Consensus       157 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~--~~~  233 (277)
T cd05036         157 VAKIADFGMARDIYRASY-YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV--MEF  233 (277)
T ss_pred             ceEeccCccccccCCccc-eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHH
Confidence            699999999987632211 111112233568999999988899999999999999999997 9999975432211  111


Q ss_pred             hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                      .....+...                              ...++..+.+++.+|++.+|++|||+.|+++.|+
T Consensus       234 ~~~~~~~~~------------------------------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 VTGGGRLDP------------------------------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHcCCcCCC------------------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111000000                              0122346779999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.7e-36  Score=316.18  Aligned_cols=262  Identities=23%  Similarity=0.302  Sum_probs=208.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++..   .....+.+.+|++++++++|++++++++++...     ..
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence            5799999999999999999999989999999988532   223356788999999999999999999998765     56


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||+++++|.+++......   ...+++.+++.++.|++.|+.|||+.   +++||||+|+||+++.++.++++||
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~  150 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQ---KRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhccc---CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEecc
Confidence            89999999999999998654221   23589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |.+.......   .......++..|+|||...+..++.++|||||||++|+|++|+.||...................  
T Consensus       151 ~~~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--  225 (267)
T cd08224         151 GLGRFFSSKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY--  225 (267)
T ss_pred             ceeeeccCCC---cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC--
Confidence            9987654321   11223457889999999888889999999999999999999999986432111111110000000  


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                                              .+..   .......+.+++.+|+..+|++|||+.++++.|+++.
T Consensus       226 ------------------------~~~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         226 ------------------------PPLP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ------------------------CCCC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                                    0000   0123446779999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.6e-36  Score=330.06  Aligned_cols=250  Identities=23%  Similarity=0.253  Sum_probs=193.8

Q ss_pred             CCCCCceeeccccceEEEEEEC---CCCcEEEEEEeeccc----cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcC
Q 002883          560 GFSSANLIGIGGYGYVYKGILG---TEETNVAVKVLDLQQ----RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  631 (871)
                      +|++.+.||+|+||.||+|+..   .+++.||+|++....    ....+.+.+|+.+++.+ +||+|+++++++...   
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~---   77 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE---   77 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC---
Confidence            4889999999999999999874   468899999986432    22335678899999999 599999999887655   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                        ...++||||+++|+|.+++....       .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        78 --~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~k  145 (332)
T cd05614          78 --AKLHLILDYVSGGEMFTHLYQRD-------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVV  145 (332)
T ss_pred             --CEEEEEEeCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEE
Confidence              66899999999999999997643       589999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhh--hHHHHh
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL--SLHKYA  788 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~--~~~~~~  788 (871)
                      |+|||+++.......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........  ......
T Consensus       146 l~DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  223 (332)
T cd05614         146 LTDFGLSKEFLSEEK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI  223 (332)
T ss_pred             EeeCcCCccccccCC--CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH
Confidence            999999986543221  122235699999999987764 478999999999999999999999964221110  000000


Q ss_pred             hhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHH
Q 002883          789 KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIM  857 (871)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~  857 (871)
                      .. ..                           +...   ......+.+++.+|++.||++||     +++|+++
T Consensus       224 ~~-~~---------------------------~~~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         224 LK-CD---------------------------PPFP---SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             hc-CC---------------------------CCCC---CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            00 00                           0000   01234567899999999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.3e-36  Score=322.04  Aligned_cols=264  Identities=23%  Similarity=0.398  Sum_probs=201.8

Q ss_pred             hhcCCCCCceeeccccceEEEEEECC-----CCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGT-----EETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDT  630 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  630 (871)
                      ..++|++.+.||+|+||.||+|.+..     ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.  
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG--   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence            45689999999999999999998742     35679999985332 22345688999999999999999999997654  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhccccccc---ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQN---QRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE  707 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  707 (871)
                         ...++||||+++++|.+++........   ....+++..+..++.|++.|+.|||+.   +++||||||+||+++++
T Consensus        82 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          82 ---QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  155 (277)
T ss_pred             ---CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence               568999999999999999976432110   112467889999999999999999998   99999999999999999


Q ss_pred             CceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHH
Q 002883          708 MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHK  786 (871)
Q Consensus       708 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~  786 (871)
                      +.++++|||++......... .......++..|+|||++.++.++.++|||||||++|||++ |..||........ ...
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~-~~~  233 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV-LRF  233 (277)
T ss_pred             CCEEECCCCCccccCCccee-ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHH
Confidence            99999999998765432211 11112345778999999988889999999999999999999 7889875322211 100


Q ss_pred             HhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          787 YAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       787 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                      ......+..                               ....+..+.+++.+|++.||++|||+.|+++.|++
T Consensus       234 ~~~~~~~~~-------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 VMEGGLLDK-------------------------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHcCCcCCC-------------------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            001000000                               00123457799999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.9e-36  Score=318.96  Aligned_cols=248  Identities=24%  Similarity=0.332  Sum_probs=192.8

Q ss_pred             eeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEecc
Q 002883          567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM  643 (871)
Q Consensus       567 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  643 (871)
                      ||+|+||.||+|+...+++.||+|++....   ....+....|++++++++||||+++++++...     .+.|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK-----THLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC-----CeEEEEEecC
Confidence            699999999999999899999999985322   12234556799999999999999999988654     6789999999


Q ss_pred             CCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCC
Q 002883          644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD  723 (871)
Q Consensus       644 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  723 (871)
                      ++++|.+++......     .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||.+.....
T Consensus        76 ~g~~L~~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~  147 (277)
T cd05607          76 NGGDLKYHIYNVGER-----GLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD  147 (277)
T ss_pred             CCCCHHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence            999999988654322     588999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChh
Q 002883          724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPA  803 (871)
Q Consensus       724 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  803 (871)
                      ..    ......|+..|+|||++.+..++.++||||+||++|||++|+.||......... ...........        
T Consensus       148 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~--------  214 (277)
T cd05607         148 GK----TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-EELKRRTLEDE--------  214 (277)
T ss_pred             Cc----eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-HHHHHHhhccc--------
Confidence            21    122346899999999988888999999999999999999999999743211100 00000000000        


Q ss_pred             HHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          804 ILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                                         .......+..++.+++.+||+.||++||++.|+++..
T Consensus       215 -------------------~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         215 -------------------VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             -------------------cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence                               0000012344678999999999999999997766433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.1e-36  Score=317.73  Aligned_cols=259  Identities=26%  Similarity=0.443  Sum_probs=202.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCc---EEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEET---NVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..+|+..+.||+|+||.||+|++..++.   .||+|.++... ....+.+.+|+++++.++|||++++.+++...     
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   78 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF-----   78 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-----
Confidence            3468889999999999999999865544   79999986442 33456788999999999999999999998665     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+++++|.+++.....      .+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+|++
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~  149 (268)
T cd05063          79 KPAMIITEYMENGALDKYLRDHDG------EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVS  149 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEEC
Confidence            568999999999999999976432      589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |||.+..................+..|+|||+.....++.++|||||||++|||++ |+.||.......  .........
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~~~i~~~~  227 (268)
T cd05063         150 DFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VMKAINDGF  227 (268)
T ss_pred             CCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHHhcCC
Confidence            99999876543211111111223567999999888889999999999999999998 999996532221  111111100


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      +..                              .......++.+++.+|++.+|++||++.++++.|+++
T Consensus       228 ~~~------------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 RLP------------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCC------------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            000                              0012234577999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.9e-37  Score=320.20  Aligned_cols=251  Identities=36%  Similarity=0.551  Sum_probs=191.8

Q ss_pred             CCceeeccccceEEEEEEC----CCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          563 SANLIGIGGYGYVYKGILG----TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       563 ~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +.+.||.|+||.||+|.+.    ..+..|+||+++.... ...+.+.+|++.+++++||||++++|++...     ...+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc-----cccc
Confidence            4578999999999999997    3467899999965332 3367899999999999999999999999844     4489


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++|+|.+++.....     ..+++.++..++.||++||.|||+.   +++|+||+++||+++.++.+||+|||.
T Consensus        78 lv~e~~~~g~L~~~L~~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~  149 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNK-----EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGL  149 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCT-----TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTT
T ss_pred             cccccccccccccccccccc-----ccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence            99999999999999988622     2689999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +....... .............|+|||.+.+..++.++||||||+++||+++ |+.||.+..... ..... ........
T Consensus       150 ~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-~~~~~-~~~~~~~~  226 (259)
T PF07714_consen  150 SRPISEKS-KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-IIEKL-KQGQRLPI  226 (259)
T ss_dssp             GEETTTSS-SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-HHHHH-HTTEETTS
T ss_pred             cccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccc-ccccccee
Confidence            98763221 1122233456789999999888889999999999999999999 789987642221 11111 11000000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                      .                              ..++..+.+++..||+.||++|||+.|+++.|
T Consensus       227 ~------------------------------~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 P------------------------------DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             B------------------------------TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             c------------------------------cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            0                              01234567899999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.6e-36  Score=321.46  Aligned_cols=249  Identities=22%  Similarity=0.284  Sum_probs=193.2

Q ss_pred             eeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEecc
Q 002883          567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM  643 (871)
Q Consensus       567 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  643 (871)
                      ||+|+||+||+|.+..+++.||+|++.....   ...+.+..|+++++.++|+||+++.+++...     ...|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-----TDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-----CeEEEEEeCC
Confidence            6999999999999998999999999864322   2235667899999999999999999887655     6689999999


Q ss_pred             CCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCC
Q 002883          644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD  723 (871)
Q Consensus       644 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  723 (871)
                      ++|+|.+++.....   ....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.++|+|||.+.....
T Consensus        76 ~~g~L~~~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  149 (280)
T cd05608          76 NGGDLRYHIYNVDE---ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD  149 (280)
T ss_pred             CCCCHHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence            99999988754321   123589999999999999999999999   999999999999999999999999999986643


Q ss_pred             CCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChh
Q 002883          724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPA  803 (871)
Q Consensus       724 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  803 (871)
                      ..   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ............       
T Consensus       150 ~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~-------  218 (280)
T cd05608         150 GQ---SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRILNDSV-------  218 (280)
T ss_pred             CC---ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHHhhcccCC-------
Confidence            22   1122346899999999999999999999999999999999999999743211100 000000000000       


Q ss_pred             HHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHHH
Q 002883          804 ILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIME  858 (871)
Q Consensus       804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~~  858 (871)
                                           .....+...+.+++.+|++.||++||     |++|+++.
T Consensus       219 ---------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         219 ---------------------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             ---------------------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence                                 00012345677999999999999999     77777753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.7e-36  Score=327.16  Aligned_cols=194  Identities=26%  Similarity=0.335  Sum_probs=168.1

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|..+++.+ +||||+++++++.+.     ...|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-----~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-----SRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-----CEEEEEE
Confidence            46999999999999999999999999996432   22345678899999888 799999999998765     6789999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++|+|.+++....       .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        76 e~~~~g~L~~~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  145 (329)
T cd05588          76 EFVSGGDLMFHMQRQR-------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  145 (329)
T ss_pred             eCCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccc
Confidence            9999999999887643       589999999999999999999999   999999999999999999999999999874


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCch
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDD  776 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  776 (871)
                      ....   ........||+.|+|||++.+..++.++||||+||++|+|++|+.||..
T Consensus       146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         146 GIRP---GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             cccC---CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            3211   1122335689999999999988999999999999999999999999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-36  Score=316.87  Aligned_cols=265  Identities=24%  Similarity=0.379  Sum_probs=204.0

Q ss_pred             CCCCceeeccccceEEEEEECCC---CcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCCc
Q 002883          561 FSSANLIGIGGYGYVYKGILGTE---ETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGNE  634 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  634 (871)
                      |++.+.||+|+||.||+|.+..+   +..||+|.++....  .....+.+|++.++.++||||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            57789999999999999997543   47899999864432  234578899999999999999999998766533 2334


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+++|+|.+++...... .....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence            579999999999999998654321 1123589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||.++........ .......++..|+|||...+..++.++|||||||++|||++ |..||.......  ..........
T Consensus       157 fg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~~  233 (273)
T cd05035         157 FGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDYLRHGNR  233 (273)
T ss_pred             ccceeeccccccc-cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC
Confidence            9999876543211 11122335678999999888889999999999999999999 889987532221  1111111000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      ..                              ....+..++.+++.+|++.||++|||+.|+++.|+++
T Consensus       234 ~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         234 LK------------------------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CC------------------------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00                              0012344678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.2e-36  Score=329.69  Aligned_cols=193  Identities=27%  Similarity=0.347  Sum_probs=167.1

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+.++.++ +||||+++++++...     ...|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-----CEEEEEE
Confidence            46999999999999999999999999996432   22345677888888776 899999999998765     6789999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++|+|..++....       .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        76 E~~~~~~L~~~~~~~~-------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~  145 (329)
T cd05618          76 EYVNGGDLMFHMQRQR-------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  145 (329)
T ss_pred             eCCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence            9999999999886643       589999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTD  775 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~  775 (871)
                      ....   ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~  197 (329)
T cd05618         146 GLRP---GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             ccCC---CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence            3221   112233568999999999999999999999999999999999999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.7e-36  Score=321.79  Aligned_cols=266  Identities=24%  Similarity=0.395  Sum_probs=204.2

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCc--EEEEEEeecc-ccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCc
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEET--NVAVKVLDLQ-QRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++...     .
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-----G   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-----C
Confidence            578999999999999999999876654  4788888632 233446788999999999 799999999988654     5


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccc---------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQ---------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD  705 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  705 (871)
                      ..|+||||+++++|.+++.......         .....+++..++.++.|++.|++|||+.   +|+||||||+||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence            6899999999999999997643110         0112488999999999999999999998   999999999999999


Q ss_pred             CCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhH
Q 002883          706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSL  784 (871)
Q Consensus       706 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~  784 (871)
                      .++.+||+|||++......    ........+..|+|||+..+..++.++|||||||++|||++ |..||........ .
T Consensus       154 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-~  228 (297)
T cd05089         154 ENLASKIADFGLSRGEEVY----VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-Y  228 (297)
T ss_pred             CCCeEEECCcCCCccccce----eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-H
Confidence            9999999999998643211    11111223567999999888889999999999999999997 9999975432211 1


Q ss_pred             HHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          785 HKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      ... ........                              ...+..++.+++.+|++.+|.+|||++++++.|+.+..
T Consensus       229 ~~~-~~~~~~~~------------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         229 EKL-PQGYRMEK------------------------------PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             HHH-hcCCCCCC------------------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            000 00000000                              01223457799999999999999999999999999877


Q ss_pred             HHHh
Q 002883          865 MRQA  868 (871)
Q Consensus       865 ~~~~  868 (871)
                      .+++
T Consensus       278 ~~~~  281 (297)
T cd05089         278 ARKA  281 (297)
T ss_pred             hhcc
Confidence            6654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6e-36  Score=313.26  Aligned_cols=251  Identities=24%  Similarity=0.340  Sum_probs=203.5

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|++.+.||+|++|.||+|.+..+++.|++|.+...  .....+.+.+|+++++.++|||++++++++.+.     ...|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEE
Confidence            478889999999999999999989999999998643  233456788999999999999999999998765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++.....     ..+++..++.++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||.
T Consensus        76 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~  147 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRG-----RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGV  147 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEccccc
Confidence            99999999999999986532     2589999999999999999999998   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +.......   .......|++.|+|||+..+..++.++|||||||++|+|++|+.||....... .......... +...
T Consensus       148 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~~~  222 (256)
T cd08529         148 AKLLSDNT---NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-LILKIIRGVF-PPVS  222 (256)
T ss_pred             ceeccCcc---chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCC-CCCc
Confidence            98765432   11223457889999999988889999999999999999999999997543211 1111111000 0000


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                                    ..+...+.+++.+|++.+|++||++.|+++.
T Consensus       223 ------------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         223 ------------------------------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ------------------------------cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                                          0233467899999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.3e-36  Score=334.35  Aligned_cols=207  Identities=23%  Similarity=0.333  Sum_probs=176.2

Q ss_pred             HHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccC
Q 002883          553 ELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSID  629 (871)
Q Consensus       553 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  629 (871)
                      ++....++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+. 
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-  115 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-  115 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-
Confidence            34445689999999999999999999999999999999985422   22335577899999999999999999988654 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV  709 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  709 (871)
                          ...|+||||+++|+|.+++...        .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.
T Consensus       116 ----~~~~lv~Ey~~gg~L~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~  180 (371)
T cd05622         116 ----RYLYMVMEYMPGGDLVNLMSNY--------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH  180 (371)
T ss_pred             ----CEEEEEEcCCCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCC
Confidence                6789999999999999998653        378889999999999999999999   9999999999999999999


Q ss_pred             eEEeecccceecCCCCCCccccccccccccccCcccccCC----CCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          710 AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG----EVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       710 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      +||+|||++.......  ........||+.|+|||++...    .++.++||||+||++|||++|+.||...
T Consensus       181 ikL~DfG~a~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  250 (371)
T cd05622         181 LKLADFGTCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (371)
T ss_pred             EEEEeCCceeEcCcCC--cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence            9999999998764321  1122345699999999987643    3789999999999999999999999753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.6e-36  Score=328.45  Aligned_cols=238  Identities=26%  Similarity=0.330  Sum_probs=187.1

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHH-HHHcCCCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECE-ALRSIRHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||+||+|++..+++.||+|++....   ......+.+|.. +++.++||||+++++++...     ...|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-----~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-----DKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-----CEEEEEE
Confidence            46999999999999999999999999996432   122334455544 46778999999999988665     6789999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++|+|.+++....       .+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        76 e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~  145 (323)
T cd05575          76 DYVNGGELFFHLQRER-------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (323)
T ss_pred             cCCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence            9999999999987643       588999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhc
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII  800 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  800 (871)
                      ....   ........||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .......  +.      
T Consensus       146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~--~~------  213 (323)
T cd05575         146 GIEH---SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-YDNILNK--PL------  213 (323)
T ss_pred             cccC---CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH-HHHHHcC--CC------
Confidence            3221   1122345689999999999988999999999999999999999999975322110 0000000  00      


Q ss_pred             ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHH
Q 002883          801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQ  853 (871)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~  853 (871)
                                       ...+       ....++.+++.+|++.||++||++.
T Consensus       214 -----------------~~~~-------~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 -----------------RLKP-------NISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -----------------CCCC-------CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                             0000       1234567899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.8e-36  Score=319.30  Aligned_cols=252  Identities=23%  Similarity=0.288  Sum_probs=200.8

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++...     ...|+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-----~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-----DKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEEEE
Confidence            5788889999999999999999989999999999766554556788899999999999999999987665     67899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||+++++|.+++...+       .+++.++..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||.+
T Consensus        84 v~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTG-------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVS  153 (267)
T ss_pred             EEeccCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceee
Confidence            999999999999987643       589999999999999999999999   9999999999999999999999999998


Q ss_pred             eecCCCCCCccccccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC-Cc
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGA---LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL-PD  794 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~-~~  794 (871)
                      .......   .......|+..|+|||++.   ...++.++||||+||++|+|++|+.||.......... ....... ++
T Consensus       154 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~-~~~~~~~~~~  229 (267)
T cd06645         154 AQITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMTKSNFQPP  229 (267)
T ss_pred             eEccCcc---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH-hhhccCCCCC
Confidence            7654321   1223346899999999864   4568899999999999999999999986432211111 1100000 00


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ....                            ...+...+.+++.+|++.+|++|||++++++
T Consensus       230 ~~~~----------------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         230 KLKD----------------------------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cccc----------------------------cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0000                            0012335678999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.4e-36  Score=315.87  Aligned_cols=252  Identities=26%  Similarity=0.427  Sum_probs=198.9

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      ++|++.+.||+|+||.||.|.+. .+..||+|.+..... ..+.+.+|+.++++++||||+++++++.+.     ...++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   76 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RPIYI   76 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CCcEE
Confidence            46889999999999999999886 455699998864332 346788999999999999999999998654     45799


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||+.+|+|.+++.....      .+++..++.++.||+.|++|||+.   +++|+||||+||+++.++.+||+|||.+
T Consensus        77 v~e~~~~~~l~~~i~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~  147 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGK------RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLS  147 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccc
Confidence            9999999999999976432      489999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      ........  .......++..|+|||...+..++.++|||||||++|+|++ |+.||........ ....... ......
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~-~~~~~~~-~~~~~~  223 (256)
T cd05113         148 RYVLDDEY--TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET-VEKVSQG-LRLYRP  223 (256)
T ss_pred             eecCCCce--eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH-HHHHhcC-CCCCCC
Confidence            86643221  11112335678999999888889999999999999999999 9999875332211 1111110 000000


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                                                    ......+.+++.+||+.+|++|||+.++++.++
T Consensus       224 ------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 ------------------------------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ------------------------------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                                          012346779999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.8e-39  Score=340.20  Aligned_cols=373  Identities=26%  Similarity=0.400  Sum_probs=307.6

Q ss_pred             CCcCceeeCCCCccc-ccCCccccCCcccceeeccCccccCCCCccccccccccccccccccccCCCCccccccCCCcee
Q 002883           37 LFKLVGLGLTGNNYT-GSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYF  115 (871)
Q Consensus        37 l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  115 (871)
                      |+-.+-.++++|.++ +..|..+..+++++.|-|...++. .+|++++.|.+|++|.+++|++.                
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~----------------   68 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI----------------   68 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH----------------
Confidence            334445555666555 445555555556666666555555 55555555555555555555554                


Q ss_pred             eeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCccccccc
Q 002883          116 AVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSL  195 (871)
Q Consensus       116 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l  195 (871)
                               .+-..+ ..||.||.+++..|.++.         +-+|.+|-++..|+.||||+|+++.+|       ..+
T Consensus        69 ---------~vhGEL-s~Lp~LRsv~~R~N~LKn---------sGiP~diF~l~dLt~lDLShNqL~EvP-------~~L  122 (1255)
T KOG0444|consen   69 ---------SVHGEL-SDLPRLRSVIVRDNNLKN---------SGIPTDIFRLKDLTILDLSHNQLREVP-------TNL  122 (1255)
T ss_pred             ---------hhhhhh-ccchhhHHHhhhcccccc---------CCCCchhcccccceeeecchhhhhhcc-------hhh
Confidence                     222222 268889999999999873         368999999999999999999999865       456


Q ss_pred             cCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCc
Q 002883          196 VNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQ  275 (871)
Q Consensus       196 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  275 (871)
                      ..-+++-+|+||+|+|. .+|..++--...|-+||||+|++. ..|+.+..|..|++|.|++|.+...-...+..+++|+
T Consensus       123 E~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~  200 (1255)
T KOG0444|consen  123 EYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLS  200 (1255)
T ss_pred             hhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhh
Confidence            77789999999999998 678777766667999999999998 8899999999999999999998755555566788899


Q ss_pred             EEEccCCCCC-CCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCC
Q 002883          276 VLSLFGNKIS-GEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRN  354 (871)
Q Consensus       276 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N  354 (871)
                      +|.+++.+-+ ..+|..+..+.+|..+||+.|.+. .+|+.+.++++|+.|+||+|+|+ .+......+.+|++|+||.|
T Consensus       201 vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrN  278 (1255)
T KOG0444|consen  201 VLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRN  278 (1255)
T ss_pred             hhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccc
Confidence            9999987754 257889999999999999999998 89999999999999999999998 66667778889999999999


Q ss_pred             CCCCCCccccCCCCCCCEEeCCCCcCC-CCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCc
Q 002883          355 HLSGPIPLEVGRLKGIQQLDLSENKLS-GEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP  433 (871)
Q Consensus       355 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  433 (871)
                      +++ .+|.+++.++.|+.|++.+|+++ .-+|..++.+.+|+.+..++|.+. ..|..++.+..|+.|.|++|+|- .+|
T Consensus       279 QLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLP  355 (1255)
T KOG0444|consen  279 QLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLP  355 (1255)
T ss_pred             hhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-ech
Confidence            999 89999999999999999999987 347899999999999999999998 88999999999999999999998 789


Q ss_pred             ccccccccccEEecCCCcCcccCCCC
Q 002883          434 MFLNTFRFLQKLNLSFNNLEGEVPSE  459 (871)
Q Consensus       434 ~~~~~~~~L~~L~l~~N~l~~~~~~~  459 (871)
                      +.+.-++.|+.|||..|+--..+|+.
T Consensus       356 eaIHlL~~l~vLDlreNpnLVMPPKP  381 (1255)
T KOG0444|consen  356 EAIHLLPDLKVLDLRENPNLVMPPKP  381 (1255)
T ss_pred             hhhhhcCCcceeeccCCcCccCCCCc
Confidence            99999999999999999977666654

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.9e-36  Score=316.96  Aligned_cols=265  Identities=25%  Similarity=0.382  Sum_probs=201.4

Q ss_pred             CCCCceeeccccceEEEEEECCCCc--EEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCCce
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEET--NVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGNEF  635 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  635 (871)
                      |.+.+.||+|+||.||+|++...+.  .||+|.++..  .....+.+.+|+++++.++||||+++++++..... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4567899999999999999876664  6999988643  23345678899999999999999999998754322 22345


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||+++|+|.+++...... .....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLG-DCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhccc-CCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence            78999999999999988543211 1123589999999999999999999998   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      |.+......... .......+++.|+|||...+..++.++|||||||++|||++ |+.||.......  ...........
T Consensus       157 g~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~~~  233 (272)
T cd05075         157 GLSKKIYNGDYY-RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--IYDYLRQGNRL  233 (272)
T ss_pred             CcccccCcccce-ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCCCC
Confidence            999876533211 11122345678999999888889999999999999999999 889987532211  11111110000


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      .                       ..       ..+...+.+++.+||+.||++|||+.|+++.|+++
T Consensus       234 ~-----------------------~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         234 K-----------------------QP-------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             C-----------------------CC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0                       00       01234567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-36  Score=329.35  Aligned_cols=242  Identities=26%  Similarity=0.324  Sum_probs=188.5

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHH-HHHcCCCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECE-ALRSIRHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||+||+|++..+++.||+|++....   ......+..|.. +++.++||||+++++++...     +..|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-----~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-----CeEEEEE
Confidence            46999999999999999899999999996432   112234444444 56778999999999988665     6689999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++|+|.+++....       .+++..+..++.||+.||.|||+.   ||+||||||+||+++.++.+||+|||++..
T Consensus        76 e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~  145 (325)
T cd05602          76 DYINGGELFYHLQRER-------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE  145 (325)
T ss_pred             eCCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence            9999999999997643       478889999999999999999999   999999999999999999999999999975


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhc
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII  800 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  800 (871)
                      ....   ........||+.|+|||++.+..++.++||||+||++|+|++|+.||........ .......  +..     
T Consensus       146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~--~~~-----  214 (325)
T cd05602         146 NIEH---NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-YDNILNK--PLQ-----  214 (325)
T ss_pred             cccC---CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH-HHHHHhC--CcC-----
Confidence            4321   1122345699999999999988999999999999999999999999975322211 1110000  000     


Q ss_pred             ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                        ..       ......+.+++.+|++.||.+||++.+.+.
T Consensus       215 ------------------~~-------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         215 ------------------LK-------PNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             ------------------CC-------CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence                              00       122345678999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.1e-36  Score=318.67  Aligned_cols=260  Identities=22%  Similarity=0.372  Sum_probs=203.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCc----EEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEET----NVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ..+|++.+.||+|+||+||+|++..+++    .||+|++.... ......+.+|+.+++.++||||+++++++..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-----   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence            4578999999999999999999866665    48999986433 2335678899999999999999999998764     


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                       ...+++|||+++|+|.+++.....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL  150 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENKD------RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKI  150 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEE
Confidence             235799999999999999976432      489999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      +|||+++........ .......++..|+|||...+..++.++|||||||++|||++ |..||.......  ........
T Consensus       151 ~dfG~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~  227 (279)
T cd05109         151 TDFGLARLLDIDETE-YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDLLEKG  227 (279)
T ss_pred             CCCCceeecccccce-eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCC
Confidence            999999876432211 11112235678999999888889999999999999999998 999987532221  11111110


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      .....                              ...+..++.+++.+||+.||++||++.|+++.|+++.+.
T Consensus       228 ~~~~~------------------------------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         228 ERLPQ------------------------------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             CcCCC------------------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            00000                              012234577899999999999999999999999887554

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.7e-36  Score=318.97  Aligned_cols=259  Identities=24%  Similarity=0.318  Sum_probs=203.1

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCC-C
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRG-N  633 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~-~  633 (871)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ +|+|++++++++......+ .
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            356789999999999999999999998999999999965433 346788899999998 7999999999987653322 3


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||+++++|.+++......     .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~  153 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGN-----TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV  153 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence            5689999999999999999764322     588999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA-----LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA  788 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~  788 (871)
                      |||++.......   .......|+..|+|||++.     +..++.++||||+||++|||++|+.||............ .
T Consensus       154 Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~-~  229 (272)
T cd06637         154 DFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-P  229 (272)
T ss_pred             cCCCceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-h
Confidence            999998654321   1223356889999999875     346788999999999999999999999743221111000 0


Q ss_pred             hhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          789 KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ..  +  .....+                          ..++.++.+++.+||..+|.+|||+.|+++
T Consensus       230 ~~--~--~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 RN--P--APRLKS--------------------------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             cC--C--CCCCCC--------------------------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            00  0  000000                          012345779999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.8e-36  Score=326.19  Aligned_cols=205  Identities=21%  Similarity=0.298  Sum_probs=165.0

Q ss_pred             CceeeccccceEEEEEEC--CCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEe
Q 002883          564 ANLIGIGGYGYVYKGILG--TEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE  641 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  641 (871)
                      .++||+|+||+||+|++.  .+++.||+|++....  ....+.+|++++++++||||+++++++....   ....|+|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEEEe
Confidence            468999999999999975  366889999986432  2356788999999999999999999875432   256899999


Q ss_pred             ccCCCCHHHHhhcccccc--cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee----CCCCceEEeec
Q 002883          642 FMPNGSLENWLNQKEDEQ--NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL----DNEMVAHVGDF  715 (871)
Q Consensus       642 ~~~~gsL~~~l~~~~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Df  715 (871)
                      |+ +++|.+++.......  .....+++..++.++.||+.||+|||+.   +|+||||||+||++    +.++.+||+||
T Consensus        81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            99 468988876432211  1122589999999999999999999999   99999999999999    45678999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      |+|.................||+.|+|||++.+ ..++.++||||+||++|+|++|++||...
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            999876543222223334578999999998766 45899999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.1e-36  Score=316.46  Aligned_cols=259  Identities=25%  Similarity=0.420  Sum_probs=202.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCC---cEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEE---TNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .++|++.+.||+|+||.||+|++..++   ..||+|.++... ....+.+.+|+.++++++||||+++++++...     
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   77 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-----   77 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----
Confidence            357899999999999999999985433   479999986433 23346788999999999999999999998654     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||+++++|.+++.....      .+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~  148 (267)
T cd05066          78 KPVMIVTEYMENGSLDAFLRKHDG------QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVS  148 (267)
T ss_pred             CccEEEEEcCCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeC
Confidence            568999999999999999976432      489999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |||.+.................++..|+|||...+..++.++|||||||++||+++ |..||......+  .........
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~~~  226 (267)
T cd05066         149 DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIEEGY  226 (267)
T ss_pred             CCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHhCCC
Confidence            99999876543211111122223568999999988889999999999999999887 999997532211  111111100


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      ...                              .....+..+.+++.+|++.+|++||++.++++.|+++
T Consensus       227 ~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 RLP------------------------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             cCC------------------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            000                              0012234567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.5e-36  Score=314.75  Aligned_cols=251  Identities=19%  Similarity=0.240  Sum_probs=201.8

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      +|++.+.||+|+||.||++.+..+++.||+|.++.. .....+.+.+|+.+++.++|+|++++++++.+.     ...|+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-----GHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEE
Confidence            588899999999999999999989999999998643 233456788899999999999999999998665     67899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||+++++|.+++......     .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++++|||.+
T Consensus        76 v~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~  147 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRGK-----LFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSA  147 (255)
T ss_pred             EEeeCCCCcHHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcc
Confidence            99999999999998754322     578999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE  798 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  798 (871)
                      .......   .......++..|+|||+..+..++.++|+||||+++|+|++|+.||......... ...... ...... 
T Consensus       148 ~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~-~~~~~~-~~~~~~-  221 (255)
T cd08219         148 RLLTSPG---AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI-LKVCQG-SYKPLP-  221 (255)
T ss_pred             eeecccc---cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH-HHHhcC-CCCCCC-
Confidence            7664321   1122346889999999988888999999999999999999999999753211110 000000 000000 


Q ss_pred             hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                                   ......+.+++.+||+.||++|||+.|++..
T Consensus       222 -----------------------------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         222 -----------------------------SHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -----------------------------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                                         0123356789999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.5e-36  Score=322.77  Aligned_cols=266  Identities=24%  Similarity=0.377  Sum_probs=203.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcE--EEEEEeecc-ccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETN--VAVKVLDLQ-QRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  633 (871)
                      .++|++.+.||+|+||.||+|.+..++..  +|+|.++.. .....+.+.+|++++.++ +||||+++++++.+.     
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-----   80 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----   80 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-----
Confidence            35789999999999999999998766654  577776532 223346788999999999 899999999998665     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccc---------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQ---------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL  704 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  704 (871)
                      ...|+||||+++++|.+++.......         .....+++.+++.++.|++.|++|||+.   +++||||||+||++
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili  157 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV  157 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence            56899999999999999997653211         1123588999999999999999999999   99999999999999


Q ss_pred             CCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhh
Q 002883          705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLS  783 (871)
Q Consensus       705 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~  783 (871)
                      +.++.+||+|||++......    .......++..|+|||+..+..++.++|||||||++|||+| |..||.......  
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--  231 (303)
T cd05088         158 GENYVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--  231 (303)
T ss_pred             cCCCcEEeCccccCcccchh----hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--
Confidence            99999999999998642211    11111224567999999888889999999999999999998 999996432221  


Q ss_pred             HHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          784 LHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                      ............                              ........+.+++.+|++.+|++||+++++++.++++.
T Consensus       232 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         232 LYEKLPQGYRLE------------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             HHHHHhcCCcCC------------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111110000000                              00012345678999999999999999999999999887


Q ss_pred             HHHH
Q 002883          864 KMRQ  867 (871)
Q Consensus       864 ~~~~  867 (871)
                      ..+.
T Consensus       282 ~~~~  285 (303)
T cd05088         282 EERK  285 (303)
T ss_pred             Hhhh
Confidence            6654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6e-37  Score=331.10  Aligned_cols=239  Identities=24%  Similarity=0.293  Sum_probs=190.1

Q ss_pred             ceeeccccceEEEEEE---CCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEE
Q 002883          565 NLIGIGGYGYVYKGIL---GTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV  639 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  639 (871)
                      +.||+|+||.||++++   ..+++.||+|+++....  .....+.+|++++++++||||+++++++.+.     ...|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-----GKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----CEEEEE
Confidence            6799999999999986   35788999999964332  2234567899999999999999999998765     678999


Q ss_pred             EeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccce
Q 002883          640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR  719 (871)
Q Consensus       640 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  719 (871)
                      |||+++|+|.+++....       .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        77 ~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  146 (318)
T cd05582          77 LDFLRGGDLFTRLSKEV-------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK  146 (318)
T ss_pred             EcCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCc
Confidence            99999999999986543       589999999999999999999999   99999999999999999999999999997


Q ss_pred             ecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhh
Q 002883          720 LLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEI  799 (871)
Q Consensus       720 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  799 (871)
                      ......   .......|++.|+|||.+.+..++.++|||||||++|||++|+.||........ .........  ..   
T Consensus       147 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~i~~~~~--~~---  217 (318)
T cd05582         147 ESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET-MTMILKAKL--GM---  217 (318)
T ss_pred             ccCCCC---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH-HHHHHcCCC--CC---
Confidence            654321   122335689999999998888899999999999999999999999975322111 111100000  00   


Q ss_pred             cChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHH
Q 002883          800 IDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQD  854 (871)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~e  854 (871)
                                          +       ......+.+++.+||+.||++|||+.+
T Consensus       218 --------------------p-------~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 --------------------P-------QFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --------------------C-------CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                                0       012345678999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.9e-36  Score=314.54  Aligned_cols=254  Identities=29%  Similarity=0.476  Sum_probs=200.8

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.++.... ..+.+.+|+.++++++|++++++++++..      ...+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIY   76 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcE
Confidence            457999999999999999999886 566799999865433 34678999999999999999999988632      3468


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++.....     ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||.
T Consensus        77 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~  148 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEG-----RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGL  148 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCcee
Confidence            99999999999999976432     2589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +........  .......++..|+|||...+..++.++||||||+++|+|++ |..||.......  .........+...
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~~~  224 (260)
T cd05070         149 ARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLEQVERGYRMPC  224 (260)
T ss_pred             eeeccCccc--ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCCCCC
Confidence            987643221  11112235678999999888889999999999999999999 899997532211  1111110000000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                                                    ....+..+.+++.+|+..+|++|||+.++.+.|++
T Consensus       225 ------------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         225 ------------------------------PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ------------------------------CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                                          01223467899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-36  Score=313.54  Aligned_cols=251  Identities=27%  Similarity=0.424  Sum_probs=197.9

Q ss_pred             ceeeccccceEEEEEECCCC---cEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTEE---TNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||.||+|.+...+   ..||+|.+..... ...+.+.+|+++++.++|||++++++++..      ...++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEEE
Confidence            46999999999999875544   7899999864433 245678899999999999999999998643      3468999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++++|.+++....       .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+..
T Consensus        75 e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~  144 (257)
T cd05060          75 ELAPLGPLLKYLKKRR-------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRA  144 (257)
T ss_pred             EeCCCCcHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccce
Confidence            9999999999997654       589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhhhh
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEI  799 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  799 (871)
                      ...............++..|+|||...+..++.++|||||||++|+|++ |..||......  ..........+...   
T Consensus       145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~~~---  219 (257)
T cd05060         145 LGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAMLESGERLPR---  219 (257)
T ss_pred             eecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCCcCCC---
Confidence            6543322111112224568999999888889999999999999999998 99999754322  11111111110000   


Q ss_pred             cChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          800 IDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                                                 ...++.++.+++.+|+..+|++|||+.++++.|+++.
T Consensus       220 ---------------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         220 ---------------------------PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             ---------------------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                                       0122346779999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.5e-36  Score=320.87  Aligned_cols=261  Identities=23%  Similarity=0.367  Sum_probs=203.9

Q ss_pred             hhcCCCCCceeeccccceEEEEEE-----CCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeecccC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCSSID  629 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  629 (871)
                      ..++|.+.+.||+|+||.||+|.+     ..++..||+|.++... ....+.+.+|+++++++ +||||+++++++... 
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-  111 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-  111 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-
Confidence            345799999999999999999986     2345679999986443 23346788999999999 799999999998665 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV  709 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  709 (871)
                          +..|+||||+++|+|.++++.....     .+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.
T Consensus       112 ----~~~~lv~e~~~~~~L~~~i~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~  179 (302)
T cd05055         112 ----GPILVITEYCCYGDLLNFLRRKRES-----FLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKI  179 (302)
T ss_pred             ----CceEEEEEcCCCCcHHHHHHhCCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCe
Confidence                5689999999999999999764321     389999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHh
Q 002883          710 AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYA  788 (871)
Q Consensus       710 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~  788 (871)
                      ++++|||.+........ ........++..|+|||.+.+..++.++||||+||++|+|++ |..||......... ....
T Consensus       180 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~-~~~~  257 (302)
T cd05055         180 VKICDFGLARDIMNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF-YKLI  257 (302)
T ss_pred             EEECCCcccccccCCCc-eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH-HHHH
Confidence            99999999986543221 111222345778999999888889999999999999999998 99998754322111 1111


Q ss_pred             hhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          789 KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      ....+....                              .....++.+++.+|++.+|++|||+.|+++.|+++
T Consensus       258 ~~~~~~~~~------------------------------~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         258 KEGYRMAQP------------------------------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HcCCcCCCC------------------------------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            110000000                              01234577999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=312.91  Aligned_cols=248  Identities=20%  Similarity=0.291  Sum_probs=205.5

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      +-|...+.||+|.|+.|-+|++.-+|+.||||+++...-  .....+.+|++.|+.++|||||++|++....     ...
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ-----TKl   92 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-----TKL   92 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc-----ceE
Confidence            458888999999999999999999999999999965433  2345788999999999999999999997665     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee-CCCCceEEeec
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL-DNEMVAHVGDF  715 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~Df  715 (871)
                      |+|+|.-++|+|.+||-++..      .+.+..+.+++.||+.|+.|+|+.   .+||||+||+||.+ .+-|-+||.||
T Consensus        93 yLiLELGD~GDl~DyImKHe~------Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDF  163 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEE------GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDF  163 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhc------cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeec
Confidence            999999999999999988764      499999999999999999999999   99999999999877 67789999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVS-THGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      |++-.+.++.    .....+|+..|-|||++.+..|+ +++||||+|||+|-|++|+.||+...+.+. +..+..  +..
T Consensus       164 GFSNkf~PG~----kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-LTmImD--CKY  236 (864)
T KOG4717|consen  164 GFSNKFQPGK----KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-LTMIMD--CKY  236 (864)
T ss_pred             cccccCCCcc----hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-hhhhhc--ccc
Confidence            9998776543    33446899999999999999996 889999999999999999999987543322 111111  000


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .+.                              .....+..+||..||..||.+|.+.+||..
T Consensus       237 tvP------------------------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  237 TVP------------------------------SHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             cCc------------------------------hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            000                              123456679999999999999999999874

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.3e-36  Score=325.51  Aligned_cols=242  Identities=22%  Similarity=0.313  Sum_probs=191.5

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCce
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  635 (871)
                      +|+..+.||+|+||+||+|++..+++.||+|++....   ....+.+..|.++++.+. |++|+++++++.+.     +.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV-----DR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC-----CE
Confidence            4778899999999999999999899999999996432   223456778888888885 57788888887654     56


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++....       .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~-------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Df  145 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVG-------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADF  145 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEecc
Confidence            899999999999999997643       589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |++.......   .......||+.|+|||++.+..++.++||||+||++|+|++|+.||........ .........  .
T Consensus       146 g~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-~~~i~~~~~--~  219 (323)
T cd05615         146 GMCKEHMVDG---VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-FQSIMEHNV--S  219 (323)
T ss_pred             ccccccCCCC---ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCC--C
Confidence            9987543211   122334689999999999888999999999999999999999999975432211 111110000  0


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI  852 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta  852 (871)
                                             .+       .....++.+++.+|++.+|.+|+++
T Consensus       220 -----------------------~p-------~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 -----------------------YP-------KSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -----------------------CC-------ccCCHHHHHHHHHHcccCHhhCCCC
Confidence                                   00       0123356789999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.6e-36  Score=350.29  Aligned_cols=260  Identities=20%  Similarity=0.293  Sum_probs=200.4

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ...++|++.+.||+|+||+||+|++..++..||+|++....  ......+..|+.++++++||||++++++|....   .
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~---~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA---N   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC---C
Confidence            34568999999999999999999999999999999986432  234567889999999999999999999886432   2


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC----CCCeEecCCCCCceeeCC---
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC----HTSIVHCDLKPSNVLLDN---  706 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~ivH~Dlkp~Nill~~---  706 (871)
                      ..+|+||||+++|+|.+++......   ...+++..++.|+.||+.||+|||+..    ..+||||||||+|||++.   
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~---~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKM---FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence            5689999999999999999764221   125899999999999999999999852    125999999999999964   


Q ss_pred             --------------CCceEEeecccceecCCCCCCccccccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhC
Q 002883          707 --------------EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL--GEVSTHGDEYSFGILMLEMFTG  770 (871)
Q Consensus       707 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG  770 (871)
                                    .+.+||+|||++.......    ......||+.|+|||++.+  ..++.++||||||||+|+|+||
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG  239 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG  239 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence                          3358999999998654321    2233568999999998753  4588999999999999999999


Q ss_pred             CCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC
Q 002883          771 KRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM  850 (871)
Q Consensus       771 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  850 (871)
                      +.||............. ... +..                              .......++.++|..||+.+|.+||
T Consensus       240 k~PF~~~~~~~qli~~l-k~~-p~l------------------------------pi~~~S~eL~dLI~~~L~~dPeeRP  287 (1021)
T PTZ00266        240 KTPFHKANNFSQLISEL-KRG-PDL------------------------------PIKGKSKELNILIKNLLNLSAKERP  287 (1021)
T ss_pred             CCCCCcCCcHHHHHHHH-hcC-CCC------------------------------CcCCCCHHHHHHHHHHhcCChhHCc
Confidence            99997432211111110 000 000                              0001234577899999999999999


Q ss_pred             CHHHHHH
Q 002883          851 KIQDAIM  857 (871)
Q Consensus       851 ta~evl~  857 (871)
                      |+.|+++
T Consensus       288 Sa~QlL~  294 (1021)
T PTZ00266        288 SALQCLG  294 (1021)
T ss_pred             CHHHHhc
Confidence            9999984

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3e-36  Score=322.24  Aligned_cols=267  Identities=25%  Similarity=0.389  Sum_probs=205.3

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCC-----CcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeeccc
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTE-----ETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCSSI  628 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  628 (871)
                      ...++|++.+.||+|+||.||+|.+...     ...||+|.+.... ......+.+|+++++++ +|+||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            4456799999999999999999998643     3689999986432 22345688999999999 899999999988654


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhccccc---------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDE---------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP  699 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  699 (871)
                           ...++||||+++|+|.++++.....         ......+++..++.++.|++.|++|||+.   +|+||||||
T Consensus        89 -----~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp  160 (293)
T cd05053          89 -----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAA  160 (293)
T ss_pred             -----CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccce
Confidence                 5689999999999999999753210         01123689999999999999999999998   999999999


Q ss_pred             CceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhh
Q 002883          700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMF  778 (871)
Q Consensus       700 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~  778 (871)
                      +||+++.++.+||+|||.++.+..... ........++..|+|||+..+..++.++|||||||++|||++ |..||....
T Consensus       161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         161 RNVLVTEDHVMKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             eeEEEcCCCeEEeCccccccccccccc-eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence            999999999999999999987654221 111122235678999999888889999999999999999998 999987532


Q ss_pred             hhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          779 EEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ....  ...........                              ....+...+.+++.+|++.||++|||+.|+++.
T Consensus       240 ~~~~--~~~~~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         240 VEEL--FKLLKEGYRME------------------------------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHH--HHHHHcCCcCC------------------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            2111  11100000000                              001223467799999999999999999999999


Q ss_pred             HHHHH
Q 002883          859 LQEAQ  863 (871)
Q Consensus       859 L~~i~  863 (871)
                      |+++.
T Consensus       288 l~~~~  292 (293)
T cd05053         288 LDRML  292 (293)
T ss_pred             HHHhh
Confidence            99874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-36  Score=305.35  Aligned_cols=255  Identities=25%  Similarity=0.298  Sum_probs=206.4

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|+..+.||.|.-|+||+|+..+++..+|+|+++...   +....+...|-+||+.++||.++.+|..|...     .+
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~-----~~  151 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD-----KY  151 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc-----ce
Confidence            45777899999999999999999999999999996543   33345777899999999999999999999877     78


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+|||||+||+|....+++...     .+++..++-++.+++-||+|||..   |||.|||||+||||.++|++.|+||
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~-----~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDF  223 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGK-----RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDF  223 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCC-----ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeec
Confidence            99999999999999999887654     799999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCC----------------------------------C-------------------CCccccccccccccccC
Q 002883          716 GLSRLLHDN----------------------------------S-------------------PDQTSTSRVKGSIGYVA  742 (871)
Q Consensus       716 g~a~~~~~~----------------------------------~-------------------~~~~~~~~~~gt~~y~a  742 (871)
                      .++......                                  .                   +........+||-.|.|
T Consensus       224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA  303 (459)
T KOG0610|consen  224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA  303 (459)
T ss_pred             cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence            987543210                                  0                   00011223579999999


Q ss_pred             cccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCch
Q 002883          743 PEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPN  822 (871)
Q Consensus       743 PE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  822 (871)
                      ||++.+...+.++|-|+||+.+|||++|..||.+...+.. +........  .                           
T Consensus       304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-l~NIv~~~l--~---------------------------  353 (459)
T KOG0610|consen  304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-LRNIVGQPL--K---------------------------  353 (459)
T ss_pred             ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-HHHHhcCCC--c---------------------------
Confidence            9999999999999999999999999999999987544322 222111100  0                           


Q ss_pred             hHHhHHHHHHHHHhhhcccccCCCCCCCC----HHHHHH
Q 002883          823 LRAKFHEIQVSILRVGILCSEELPRDRMK----IQDAIM  857 (871)
Q Consensus       823 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt----a~evl~  857 (871)
                       .+..+.+...+.+||++.|..||++|..    |.||-+
T Consensus       354 -Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  354 -FPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             -CCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence             0111133456789999999999999998    777654

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.6e-36  Score=319.67  Aligned_cols=268  Identities=23%  Similarity=0.288  Sum_probs=206.5

Q ss_pred             HHHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccC
Q 002883          551 YAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSID  629 (871)
Q Consensus       551 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  629 (871)
                      ++.+....++|++.+.||+|+||.||+|.+..+++.||+|+++.... ....+.+|+.+++.+ +||||+++++++....
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            34455677899999999999999999999998999999999864322 335678899999999 7999999999886554


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV  709 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  709 (871)
                      ...+...++||||+++++|.+++......   ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKR---GERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhcc---CccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence            44557789999999999999988643211   22588999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccceecCCCCCCccccccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhH
Q 002883          710 AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA-----LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSL  784 (871)
Q Consensus       710 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~  784 (871)
                      ++|+|||.+.......   .......|+..|+|||++.     ...++.++||||+||++|+|++|+.||........ .
T Consensus       163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~  238 (286)
T cd06638         163 VKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-L  238 (286)
T ss_pred             EEEccCCceeecccCC---CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-H
Confidence            9999999998664321   1122346899999999864     34578999999999999999999999975322111 0


Q ss_pred             HHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          785 HKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ...... .+.   ....+                         ..+..++.+++.+|++.||++|||+.|+++.
T Consensus       239 ~~~~~~-~~~---~~~~~-------------------------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         239 FKIPRN-PPP---TLHQP-------------------------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             hhcccc-CCC---cccCC-------------------------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            000000 000   00000                         0122357789999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9.6e-36  Score=320.12  Aligned_cols=277  Identities=22%  Similarity=0.289  Sum_probs=205.2

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|++++++++||||+++++++.+.     +..+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-----GEIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEEE
Confidence            36899999999999999999999899999999986442 22345688999999999999999999998765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++....       .+++..+..++.|+++||.|||+.  .+++||||||+||+++.++.+||+|||.
T Consensus        76 lv~ey~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~  146 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKAG-------RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGV  146 (308)
T ss_pred             EEeeccCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCC
Confidence            9999999999999997653       588999999999999999999973  1899999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh-
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV-  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-  796 (871)
                      +......     ......++..|+|||...+..++.++|||||||++|+|++|+.||.......  ............. 
T Consensus       147 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~  219 (308)
T cd06615         147 SGQLIDS-----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRPVSEGEA  219 (308)
T ss_pred             ccccccc-----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCccccccc
Confidence            8755322     1223468899999999888889999999999999999999999996432211  1111110000000 


Q ss_pred             ---------hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          797 ---------AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       797 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                               ....++... ...+..........+....  .....++.+++.+|+..+|++|||+.|+++.-
T Consensus       220 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         220 KESHRPVSGHPPDSPRPM-AIFELLDYIVNEPPPKLPS--GAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             cCCcccccCCCCCccchh-hHHHHHHHHhcCCCccCcC--cccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                     000000000 0000001111111111100  12445688999999999999999999998864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.3e-36  Score=316.05  Aligned_cols=251  Identities=28%  Similarity=0.432  Sum_probs=200.2

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHH--HHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      |++++.||+|+||+||+|++..+++.||+|++.........  ...+|+.++++++||||+++++++...     ...++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD-----NYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES-----SEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc-----ccccc
Confidence            67889999999999999999999999999999766543322  335699999999999999999998774     67899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||+++++|.+++....       .+++..+..++.|+++||++||+.   +++|+||||+||+++.++.++|+|||.+
T Consensus        76 v~~~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~  145 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKNK-------PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSS  145 (260)
T ss_dssp             EEEEETTEBHHHHHHHHS-------SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred             cccccccccccccccccc-------cccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence            999999999999998332       589999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhh--hHHHHhhhCCCch
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGA-LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL--SLHKYAKMGLPDQ  795 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~  795 (871)
                      .....   .........++..|+|||+.. +..++.++||||+|+++|+|++|..||........  ........     
T Consensus       146 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-----  217 (260)
T PF00069_consen  146 VKLSE---NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR-----  217 (260)
T ss_dssp             EESTS---TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT-----
T ss_pred             ccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc-----
Confidence            86521   223344456899999999987 78889999999999999999999999986411110  00000000     


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                 ....            ..........++.+++.+||+.||++|||+.|+++
T Consensus       218 -----------~~~~------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  218 -----------PLPS------------SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -----------HHHH------------HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -----------cccc------------cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                       0000            00000011267889999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.9e-36  Score=312.08  Aligned_cols=250  Identities=26%  Similarity=0.409  Sum_probs=194.3

Q ss_pred             eeeccccceEEEEEEC--CCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEec
Q 002883          566 LIGIGGYGYVYKGILG--TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF  642 (871)
Q Consensus       566 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  642 (871)
                      .||+|+||.||+|.+.  ..+..||+|++..... ...+.+.+|+.++++++||||+++++++..      ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence            3899999999999874  3456799999865432 234678899999999999999999998743      357899999


Q ss_pred             cCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecC
Q 002883          643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH  722 (871)
Q Consensus       643 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  722 (871)
                      +++++|.+++.....      .+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+....
T Consensus        76 ~~~~~L~~~l~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  146 (257)
T cd05115          76 ASGGPLNKFLSGKKD------EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALG  146 (257)
T ss_pred             CCCCCHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCcccccc
Confidence            999999999875432      589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhhhhcC
Q 002883          723 DNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIID  801 (871)
Q Consensus       723 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  801 (871)
                      .............++..|+|||......++.++|||||||++|++++ |..||........  ........+...    +
T Consensus       147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~~~~~----~  220 (257)
T cd05115         147 ADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV--MSFIEQGKRLDC----P  220 (257)
T ss_pred             CCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH--HHHHHCCCCCCC----C
Confidence            33221111111223578999999888889999999999999999996 9999975432211  111111100000    0


Q ss_pred             hhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          802 PAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                                                ..+..++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       221 --------------------------~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 --------------------------AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             --------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                                      02235677899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.4e-36  Score=313.01  Aligned_cols=248  Identities=25%  Similarity=0.395  Sum_probs=194.5

Q ss_pred             eeeccccceEEEEEE--CCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEe
Q 002883          566 LIGIGGYGYVYKGIL--GTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE  641 (871)
Q Consensus       566 ~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  641 (871)
                      .||+|+||.||+|.+  ..++..||+|+++....  ...+.+.+|+.+++.++||||+++++++..      ...++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence            589999999999975  45678899999864432  234678899999999999999999998743      34689999


Q ss_pred             ccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceec
Q 002883          642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL  721 (871)
Q Consensus       642 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  721 (871)
                      |+++++|.+++....       .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+...
T Consensus        76 ~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~  145 (257)
T cd05116          76 LAELGPLNKFLQKNK-------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  145 (257)
T ss_pred             cCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCcccccc
Confidence            999999999997543       588999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhhhhc
Q 002883          722 HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEII  800 (871)
Q Consensus       722 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  800 (871)
                      ..............++..|+|||......++.++|||||||++|||++ |+.||.......  ..............   
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~i~~~~~~~~~---  220 (257)
T cd05116         146 GADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--VTQMIESGERMECP---  220 (257)
T ss_pred             CCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHCCCCCCCC---
Confidence            543221111222234678999999888889999999999999999998 999997542221  11111110000000   


Q ss_pred             ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                                                 ..++.++.+++.+|++.||++||++.+|.+.|+.
T Consensus       221 ---------------------------~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         221 ---------------------------QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             ---------------------------CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence                                       0223457799999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.2e-36  Score=317.60  Aligned_cols=278  Identities=24%  Similarity=0.280  Sum_probs=202.6

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|++.+.||+|++|.||+|++..+++.||+|+++...  ....+.+.+|+.++++++|||++++++++.+.     ...|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-----SRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-----CeEE
Confidence            4888999999999999999998899999999986432  22346788999999999999999999998765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||++ ++|.+++.....    ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  147 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSLPK----GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGL  147 (285)
T ss_pred             EEEecCC-CCHHHHHhcCCC----CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccc
Confidence            9999996 689988865432    12589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +.......   .......+++.|+|||++.+. .++.++||||+||++|+|+||+.||..................+.. 
T Consensus       148 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~-  223 (285)
T cd07861         148 ARAFGIPV---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTE-  223 (285)
T ss_pred             eeecCCCc---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCh-
Confidence            97654321   112223568899999987654 5789999999999999999999999754332222211111111100 


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ..+-.......+.   .................+..++.+++.+||+.||++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         224 DVWPGVTSLPDYK---NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhhhcchhhHHHH---hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000000000000   000011111111222235567789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.7e-36  Score=328.42  Aligned_cols=242  Identities=26%  Similarity=0.315  Sum_probs=188.5

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHH-HHHcCCCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECE-ALRSIRHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||+||+|++..+++.||+|++....   ......+..|.. +++.++||||+++++++...     +..|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-----~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-----EKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-----CEEEEEE
Confidence            46999999999999999899999999996432   222344555554 46778999999999988665     6789999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++|+|..++....       .+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||++..
T Consensus        76 e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~  145 (325)
T cd05604          76 DFVNGGELFFHLQRER-------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKE  145 (325)
T ss_pred             cCCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence            9999999999887643       589999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhc
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII  800 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  800 (871)
                      ....   ........||+.|+|||++.+..++.++||||+||++|+|++|+.||........ .........        
T Consensus       146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-~~~~~~~~~--------  213 (325)
T cd05604         146 GIAQ---SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-YDNILHKPL--------  213 (325)
T ss_pred             CCCC---CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH-HHHHHcCCc--------
Confidence            3221   1122345689999999999999999999999999999999999999975322111 111000000        


Q ss_pred             ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                       ...+       .....+.+++.+|++.+|++||++.+.++
T Consensus       214 -----------------~~~~-------~~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         214 -----------------VLRP-------GASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             -----------------cCCC-------CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence                             0000       12335668999999999999999864433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-36  Score=333.38  Aligned_cols=279  Identities=16%  Similarity=0.188  Sum_probs=200.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||...      ...+.+|++++++++|+||+++++++...     ...+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVG-----GLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEE
Confidence            457999999999999999999999899999999642      23456899999999999999999987665     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +|||++ .++|.+++.....      .+++.+++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       237 lv~e~~-~~~L~~~l~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGl  306 (461)
T PHA03211        237 LVLPKY-RSDLYTYLGARLR------PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGA  306 (461)
T ss_pred             EEEEcc-CCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCC
Confidence            999999 5789988865432      589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhh------hhhHHHHhhh-
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEE------GLSLHKYAKM-  790 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~------~~~~~~~~~~-  790 (871)
                      ++...... .........||..|+|||++.+..++.++|||||||++|||++|..|+......      .......... 
T Consensus       307 a~~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~  385 (461)
T PHA03211        307 ACFARGSW-STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA  385 (461)
T ss_pred             ceeccccc-ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence            98764321 111122356999999999999999999999999999999999988765332111      0111111111 


Q ss_pred             CCC-chhhhhcChhHHHHHHHHHhhh-hhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          791 GLP-DQVAEIIDPAILEEALEIQAGI-VKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       791 ~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ... ..........+...+....... ...........+......+.+++.+||+.||++|||+.|+++.
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        386 QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            110 0111111111111111100000 0000001112222334567899999999999999999999874

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1e-35  Score=312.09  Aligned_cols=254  Identities=29%  Similarity=0.468  Sum_probs=200.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|.+.+.||+|+||.||+|.+..+ ..||+|.+..... ..+.+.+|++++++++|+|++++++++..      ...+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~   76 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EPIY   76 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CCcE
Confidence            35789999999999999999998644 5699998864332 34678899999999999999999988642      3468


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++.....     ..+++..+..++.|++.|+.|||+.   +++||||||+||++++++.++|+|||.
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~  148 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDG-----KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGL  148 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCcc
Confidence            99999999999999976432     2478999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +........  .......++..|+|||...+..++.++||||||+++|+|++ |+.||........ .... ....+.. 
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~-~~~~~~~-  223 (260)
T cd05069         149 ARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-LEQV-ERGYRMP-  223 (260)
T ss_pred             ceEccCCcc--cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHH-HcCCCCC-
Confidence            987643221  11122345678999999888889999999999999999999 9999975432211 1111 1110000 


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                                                   .....+..+.+++.+|+..||++||+++++++.|++
T Consensus       224 -----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 -----------------------------CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -----------------------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                                         001234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.5e-36  Score=321.12  Aligned_cols=274  Identities=24%  Similarity=0.358  Sum_probs=203.8

Q ss_pred             CCCCCceeeccccceEEEEEE----CCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          560 GFSSANLIGIGGYGYVYKGIL----GTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      -|++.+.||+|+||.||.|+.    ..++..||+|.++... ......+.+|+++++.++|||++++++++...   +..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence            478899999999999999985    3467889999986443 33446789999999999999999999987653   225


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+++++|.+++.....      .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~------~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~d  152 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKN------KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD  152 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECC
Confidence            57999999999999999965432      489999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||.+.................++..|+|||+..+..++.++|||||||++|+|++++.|+.......      .....+.
T Consensus       153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~------~~~~~~~  226 (284)
T cd05079         153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF------LKMIGPT  226 (284)
T ss_pred             CccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh------hhhcccc
Confidence            9999876543222122223456778999999888889999999999999999999887754321110      0000000


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      . .+......    ......   ....   +....+..++.+++.+|++.+|++|||++|+++.++++
T Consensus       227 ~-~~~~~~~~----~~~~~~---~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         227 H-GQMTVTRL----VRVLEE---GKRL---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             c-ccccHHHH----HHHHHc---CccC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0 00000000    000000   0000   00112456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=322.07  Aligned_cols=262  Identities=25%  Similarity=0.398  Sum_probs=215.1

Q ss_pred             HHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          553 ELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       553 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      +++-.-.+.+..++||-|.||.||.|.|++-.-.||||.++.+ .....+|.+|+.+|+.++|||+|+++|+|...    
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E----  335 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE----  335 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccC----
Confidence            3333334567788999999999999999988899999999744 34678999999999999999999999999776    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                       ..+|||+|||..|+|.+|++.....     .++....+.++.||+.|+.||..+   .++||||..+|+|+.++..+|+
T Consensus       336 -pPFYIiTEfM~yGNLLdYLRecnr~-----ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKv  406 (1157)
T KOG4278|consen  336 -PPFYIITEFMCYGNLLDYLRECNRS-----EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKV  406 (1157)
T ss_pred             -CCeEEEEecccCccHHHHHHHhchh-----hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEe
Confidence             4579999999999999999987644     578888899999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      +|||+++++..+.  .+......-...|.|||-+....++.|+|||+|||++||+.| |..||.+..-.           
T Consensus       407 ADFGLsRlMtgDT--YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----------  473 (1157)
T KOG4278|consen  407 ADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------  473 (1157)
T ss_pred             eccchhhhhcCCc--eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----------
Confidence            9999999986542  222333334678999999999999999999999999999999 99999853211           


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                         ++.+.+....+            .      ...+.|++++.+||+.||++.|.+||+..|+-+.++.|
T Consensus       474 ---qVY~LLEkgyR------------M------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  474 ---QVYGLLEKGYR------------M------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             ---HHHHHHhcccc------------c------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence               01111111100            0      11125678899999999999999999999999999866

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-36  Score=313.00  Aligned_cols=251  Identities=27%  Similarity=0.449  Sum_probs=197.8

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|+++++.++||||+++++++...     ...|+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l   76 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----RPIFI   76 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----CceEE
Confidence            35888999999999999999986 567899999854322 345688899999999999999999987655     56899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||+++++|.+++.....      .+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+
T Consensus        77 v~e~~~~~~L~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~  147 (256)
T cd05059          77 VTEYMANGCLLNYLRERKG------KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLA  147 (256)
T ss_pred             EEecCCCCCHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccc
Confidence            9999999999999976432      489999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      ....+...  .......++..|+|||...+..++.++||||||+++|+|++ |+.||........ .. .......... 
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~-~~~~~~~~~~-  222 (256)
T cd05059         148 RYVLDDQY--TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-VE-SVSAGYRLYR-  222 (256)
T ss_pred             eecccccc--cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-HH-HHHcCCcCCC-
Confidence            76543211  11111224467999999888899999999999999999999 8999974322211 11 1110000000 


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                                                   ...++.++.+++.+|+..+|++|||+.|+++.|
T Consensus       223 -----------------------------~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 -----------------------------PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -----------------------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                                         001344678999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.5e-36  Score=317.10  Aligned_cols=261  Identities=26%  Similarity=0.403  Sum_probs=203.0

Q ss_pred             cCCCCCceeeccccceEEEEEEC-----CCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILG-----TEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .+|...+.||+|+||.||+|...     .++..||+|.+..........+.+|+++++.++|+||+++++++...     
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG-----   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-----
Confidence            46888999999999999999752     34668999998765555567899999999999999999999987665     


Q ss_pred             ceeeEEEeccCCCCHHHHhhccccc--------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDE--------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD  705 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~--------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  705 (871)
                      ...++||||+++++|.+++......        ......+++..+..++.|++.|++|||+.   +++||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~  156 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG  156 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence            5579999999999999999765321        01112578999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhH
Q 002883          706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSL  784 (871)
Q Consensus       706 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~  784 (871)
                      +++.+||+|||++....... .........+++.|+|||...+..++.++|||||||++|||++ |+.||........ .
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~  234 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTD-YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-I  234 (280)
T ss_pred             CCCCEEECCCCceeEcCCCc-eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-H
Confidence            99999999999997654321 1111222335678999999888889999999999999999998 9999865332211 0


Q ss_pred             HHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          785 HKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                       .......+..                              ....++..+.+++.+||+.||++||++.|+++.|+
T Consensus       235 -~~~~~~~~~~------------------------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 -ECITQGRELE------------------------------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -HHHHcCccCC------------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence             0000000000                              00122345779999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9.2e-36  Score=318.16  Aligned_cols=251  Identities=22%  Similarity=0.319  Sum_probs=203.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      .+|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|||++++++++...     ...|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG-----DELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC-----ceEEE
Confidence            4699999999999999999999889999999999765555567788999999999999999999998765     67899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      |+||+++++|.+++...        .+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||.+
T Consensus        94 v~e~~~~~~L~~~~~~~--------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~  162 (296)
T cd06655          94 VMEYLAGGSLTDVVTET--------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFC  162 (296)
T ss_pred             EEEecCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccc
Confidence            99999999999998643        489999999999999999999999   9999999999999999999999999998


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE  798 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  798 (871)
                      ........   ......++..|+|||.+.+..++.++|||||||++|+|++|+.||......... ........+ ..  
T Consensus       163 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-~~~~~~~~~-~~--  235 (296)
T cd06655         163 AQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTP-EL--  235 (296)
T ss_pred             hhcccccc---cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCc-cc--
Confidence            76543221   122345888999999988888999999999999999999999999754322111 111100000 00  


Q ss_pred             hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                                .....+...+.+++.+||..||++|||+.++++.
T Consensus       236 --------------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         236 --------------------------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             --------------------------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                                      0001223456789999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-36  Score=319.77  Aligned_cols=269  Identities=24%  Similarity=0.363  Sum_probs=200.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCC--------------CcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTE--------------ETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKII  622 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~  622 (871)
                      .++|++.+.||+|+||.||+|++...              ...||+|+++... ......+.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            35899999999999999999987532              2358999986542 23345788999999999999999999


Q ss_pred             eeecccCcCCCceeeEEEeccCCCCHHHHhhccccc-----ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 002883          623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDE-----QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL  697 (871)
Q Consensus       623 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  697 (871)
                      +++...     ...++||||+++++|.+++......     ......+++..+..++.|++.|++|||+.   +++||||
T Consensus        84 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dl  155 (295)
T cd05097          84 GVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDL  155 (295)
T ss_pred             EEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence            998655     5689999999999999999653211     01122478899999999999999999999   9999999


Q ss_pred             CCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCc
Q 002883          698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT--GKRPTD  775 (871)
Q Consensus       698 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--G~~pf~  775 (871)
                      ||+||+++.++.+||+|||.+........ ........++..|+|||+..++.++.++|||||||++|+|++  |..||.
T Consensus       156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~  234 (295)
T cd05097         156 ATRNCLVGNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS  234 (295)
T ss_pred             ChhhEEEcCCCcEEecccccccccccCcc-eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence            99999999999999999999976543221 111222345778999999888889999999999999999998  667876


Q ss_pred             hhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHH
Q 002883          776 DMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDA  855 (871)
Q Consensus       776 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~ev  855 (871)
                      ....... .................                        ......+..+.+++.+|++.||++|||+++|
T Consensus       235 ~~~~~~~-~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i  289 (295)
T cd05097         235 LLSDEQV-IENTGEFFRNQGRQIYL------------------------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI  289 (295)
T ss_pred             ccChHHH-HHHHHHhhhhccccccC------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            4322211 00000000000000000                        0000123468899999999999999999999


Q ss_pred             HHHHH
Q 002883          856 IMELQ  860 (871)
Q Consensus       856 l~~L~  860 (871)
                      ++.|+
T Consensus       290 ~~~l~  294 (295)
T cd05097         290 HHFLR  294 (295)
T ss_pred             HHHHh
Confidence            99886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-36  Score=317.50  Aligned_cols=262  Identities=23%  Similarity=0.394  Sum_probs=203.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCC-----CcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTE-----ETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      .++|++.+.||+|+||.||+|.+...     +..||+|.+.... ......+.+|+.+++.++||||+++++++...   
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---   81 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG---   81 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC---
Confidence            45789999999999999999998643     3789999986443 23345788999999999999999999998765   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccc---cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQ---NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM  708 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  708 (871)
                        ...++||||+++|+|.+++.......   .....+++..++.++.|++.|+.|||+.   +++||||||+||+++.++
T Consensus        82 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~  156 (277)
T cd05032          82 --QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             --CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence              66899999999999999997643221   1122478899999999999999999998   999999999999999999


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHH
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKY  787 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~  787 (871)
                      .+||+|||.++....... ........++..|+|||...++.++.++|||||||++||+++ |..||.......  ....
T Consensus       157 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~  233 (277)
T cd05032         157 TVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLKF  233 (277)
T ss_pred             CEEECCcccchhhccCcc-cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHHH
Confidence            999999999976543321 111223346788999999888889999999999999999998 999986432221  1111


Q ss_pred             hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                      ..........                              ..++.++.+++.+|++.+|++|||+.|+++.|+
T Consensus       234 ~~~~~~~~~~------------------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         234 VIDGGHLDLP------------------------------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HhcCCCCCCC------------------------------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1110000000                              012346789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.8e-36  Score=317.68  Aligned_cols=262  Identities=23%  Similarity=0.365  Sum_probs=200.8

Q ss_pred             cCCCCCceeeccccceEEEEEE----CCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGIL----GTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .+|++.+.||+|+||.||+|.+    ...+..||+|.+.... ......+.+|+++++.++||||+++++++...     
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-----   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----
Confidence            4688899999999999999985    3356789999986432 23346788999999999999999999987655     


Q ss_pred             ceeeEEEeccCCCCHHHHhhccccc----------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcee
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDE----------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL  703 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  703 (871)
                      ...|+||||+++++|.+++......          ......+++.++..++.|++.|++|||+.   +++||||||+||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil  156 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL  156 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence            5689999999999999998643210          00122478899999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhh
Q 002883          704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGL  782 (871)
Q Consensus       704 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~  782 (871)
                      ++.++.+||+|||++........ ........++..|+|||+..+..++.++|||||||++|||++ |..||......  
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--  233 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADY-YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--  233 (283)
T ss_pred             EcCCCcEEeccccccccccCCcc-eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence            99999999999999986543221 111222345678999999888889999999999999999999 99998653221  


Q ss_pred             hHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          783 SLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       783 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                      ...............                              ..+..++.+++.+|++.||++||++.++.+.|+.
T Consensus       234 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         234 EVIEMVRKRQLLPCS------------------------------EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHcCCcCCCC------------------------------CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            111111111000000                              0123456789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.1e-36  Score=314.61  Aligned_cols=258  Identities=26%  Similarity=0.429  Sum_probs=201.7

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCc---EEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEET---NVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .+|++.+.||+|+||.||+|.+..+++   .||+|+++.. .......+..|+.+++.++||||+++++++...     .
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-----R   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-----C
Confidence            458889999999999999999876554   6999998644 233456889999999999999999999987654     5


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+++++|.+++.....      .+++.+++.++.|++.|+.|||+.   +++||||||+||+++.++.+|++|
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~d  149 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDG------QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSD  149 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECC
Confidence            67999999999999999976432      489999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCcccccccc--ccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVK--GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      ||.+.................  .+..|+|||+..+..++.++||||+||++||+++ |..||.......  ........
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--~~~~i~~~  227 (269)
T cd05065         150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VINAIEQD  227 (269)
T ss_pred             CccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--HHHHHHcC
Confidence            999876643321111111111  2457999999988899999999999999999987 999997532221  11111110


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      .+..                              ....++..+.+++.+|++.+|++||++.++++.|+++
T Consensus       228 ~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 YRLP------------------------------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CcCC------------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0000                              0012234567899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.4e-36  Score=312.43  Aligned_cols=254  Identities=27%  Similarity=0.468  Sum_probs=201.8

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.++||+|+||.||+|... +++.||+|.+..... ....+.+|+.++++++|+|++++++++..      ...+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~   76 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIY   76 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CCcE
Confidence            467999999999999999999976 678899999864433 34678899999999999999999987632      4579


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++......     .+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~  148 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGI-----KLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGL  148 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcc
Confidence            999999999999998764422     589999999999999999999998   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +.......  ........++..|+|||+.....++.++||||||+++||+++ |+.||........  ........+...
T Consensus       149 ~~~~~~~~--~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~~~~~  224 (260)
T cd05067         149 ARLIEDNE--YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV--IQNLERGYRMPR  224 (260)
T ss_pred             eeecCCCC--cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH--HHHHHcCCCCCC
Confidence            98765321  111122345678999999888889999999999999999999 9999975432211  111111100000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                      .                              ...+.++.+++.+|++.+|++|||++++.+.|+.
T Consensus       225 ~------------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 P------------------------------DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             C------------------------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            0                              0123467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.7e-36  Score=316.84  Aligned_cols=253  Identities=26%  Similarity=0.333  Sum_probs=198.1

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   75 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRIS   75 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEE
Confidence            36888999999999999999998899999999986442 23346788999999999999999999998765     5678


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|..+.           .+++..+..++.|++.|+.|||+.   +|+|+||||+||+++.++.++|+|||.
T Consensus        76 lv~e~~~~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~  141 (279)
T cd06619          76 ICTEFMDGGSLDVYR-----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGV  141 (279)
T ss_pred             EEEecCCCCChHHhh-----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCc
Confidence            999999999997652           367888999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +......     ......++..|+|||++.+..++.++|||||||++|+|++|+.||............       ....
T Consensus       142 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~-------~~~~  209 (279)
T cd06619         142 STQLVNS-----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP-------LQLL  209 (279)
T ss_pred             ceecccc-----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch-------HHHH
Confidence            9765432     122346899999999998888999999999999999999999999753221110000       0000


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                      ..               ......+..  .......++.+++.+|++.+|++||+++|+++.-
T Consensus       210 ~~---------------~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         210 QC---------------IVDEDPPVL--PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             HH---------------HhccCCCCC--CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence            00               000000000  0011234577999999999999999999998763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-36  Score=323.78  Aligned_cols=202  Identities=25%  Similarity=0.347  Sum_probs=173.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||+||+|++..+++.||+|++...   .....+.+.+|+.+++.++|++|+++++++.+.     .+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-----NN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-----Ce
Confidence            4799999999999999999999989999999999642   222345678899999999999999999988765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++.....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Df  146 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFED------RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADF  146 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEEC
Confidence            8999999999999999976432      489999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-----GEVSTHGDEYSFGILMLEMFTGKRPTDD  776 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltG~~pf~~  776 (871)
                      |.+........  .......||+.|+|||++..     ..++.++||||+||++|+|++|+.||..
T Consensus       147 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         147 GSCLRLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CceeecCCCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            99976543221  11223468999999998752     4578899999999999999999999975

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1e-35  Score=317.43  Aligned_cols=264  Identities=24%  Similarity=0.353  Sum_probs=202.6

Q ss_pred             CCCCCceeeccccceEEEEEECC-----CCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          560 GFSSANLIGIGGYGYVYKGILGT-----EETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      +|++.+.||+|+||.||+|++..     ....+|+|.+.... ......+.+|+.+++.++||||+++++.+...     
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD-----   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----
Confidence            47889999999999999998743     23568999886433 23346788999999999999999999987654     


Q ss_pred             ceeeEEEeccCCCCHHHHhhccccc-----------------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDE-----------------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD  696 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  696 (871)
                      ...++||||+.+++|.+++......                 ......+++..++.++.|++.|++|||+.   +++|||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d  152 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD  152 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence            5579999999999999998753211                 01123588999999999999999999998   999999


Q ss_pred             CCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCc
Q 002883          697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTD  775 (871)
Q Consensus       697 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~  775 (871)
                      |||+||++++++.+||+|||.+......... .......++..|+|||...+..++.++||||||+++|||++ |..||.
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  231 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  231 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence            9999999999999999999999765432211 11222345678999999888889999999999999999998 999997


Q ss_pred             hhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHH
Q 002883          776 DMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDA  855 (871)
Q Consensus       776 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~ev  855 (871)
                      ......  ............                           .   ...+..++.+++.+|++.+|++||++.|+
T Consensus       232 ~~~~~~--~~~~~~~~~~~~---------------------------~---~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i  279 (290)
T cd05045         232 GIAPER--LFNLLKTGYRME---------------------------R---PENCSEEMYNLMLTCWKQEPDKRPTFADI  279 (290)
T ss_pred             CCCHHH--HHHHHhCCCCCC---------------------------C---CCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            532211  111111100000                           0   01223467789999999999999999999


Q ss_pred             HHHHHHHHH
Q 002883          856 IMELQEAQK  864 (871)
Q Consensus       856 l~~L~~i~~  864 (871)
                      ++.|+++..
T Consensus       280 ~~~l~~~~~  288 (290)
T cd05045         280 SKELEKMMV  288 (290)
T ss_pred             HHHHHHHHh
Confidence            999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-36  Score=325.22  Aligned_cols=284  Identities=19%  Similarity=0.220  Sum_probs=207.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++...........
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999999899999999986432 2344667889999999999999999998766544445678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+|+||++ +++.+++...        .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--------~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg  151 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ--------HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFG  151 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccc
Confidence            99999995 5888877543        489999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh---hCC
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK---MGL  792 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~---~~~  792 (871)
                      ++.................|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||........ ......   ...
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-~~~~~~~~~~~~  230 (336)
T cd07849         152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-LNLILGVLGTPS  230 (336)
T ss_pred             ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCC
Confidence            99876543222222233568899999997644 5688999999999999999999999975322211 111111   011


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ++....+.+.......    ...............+....++.+++.+||+.||++|||+.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         231 QEDLNCIISLRARNYI----KSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHHhhchhhhhHH----hhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1111111111111000    0000000001111122345678899999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.5e-36  Score=321.28  Aligned_cols=277  Identities=22%  Similarity=0.298  Sum_probs=201.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|.++... ......+.+|+.+++.++||||+++++++...     ...
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC-----CeE
Confidence            357999999999999999999999899999999986433 22345677899999999999999999998765     668


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||++ ++|.+++.....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~------~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  149 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCGN------SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFG  149 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCc
Confidence            99999996 699998876432      488999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc-
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD-  794 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-  794 (871)
                      .+.......   .......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||..................+. 
T Consensus       150 ~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  226 (301)
T cd07873         150 LARAKSIPT---KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE  226 (301)
T ss_pred             chhccCCCC---CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            997643221   11222357889999998654 4578899999999999999999999975433221111111111110 


Q ss_pred             -hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 -QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       ....+.+.......     ....................+.+++.+|++.||.+|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         227 ETWPGILSNEEFKSY-----NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             hhchhhhcccccccc-----ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             01111100000000     00000000001111133456789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1e-35  Score=324.69  Aligned_cols=269  Identities=22%  Similarity=0.340  Sum_probs=203.1

Q ss_pred             hhcCCCCCceeeccccceEEEEEEC-----CCCcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeecccC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILG-----TEETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCSSID  629 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  629 (871)
                      ..++|++.+.||+|+||.||+|.+.     .+++.||||+++... ......+.+|+.++.++ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-   83 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-   83 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence            3468999999999999999999853     356789999996533 22345788999999999 689999999987543 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccc--------------------------------------------------
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQ--------------------------------------------------  659 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------  659 (871)
                         +...++||||+++|+|.+++.......                                                  
T Consensus        84 ---~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          84 ---GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ---CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence               245789999999999999987532100                                                  


Q ss_pred             ----------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCCCCCCcc
Q 002883          660 ----------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQT  729 (871)
Q Consensus       660 ----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  729 (871)
                                .....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++........ ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~  236 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YV  236 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcc-hh
Confidence                      0012468888999999999999999999   999999999999999999999999999986533211 11


Q ss_pred             ccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHH
Q 002883          730 STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEA  808 (871)
Q Consensus       730 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  808 (871)
                      ......++..|+|||...+..++.++||||||+++|+|++ |..||......... ..............          
T Consensus       237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~----------  305 (343)
T cd05103         237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-CRRLKEGTRMRAPD----------  305 (343)
T ss_pred             hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH-HHHHhccCCCCCCC----------
Confidence            1222345678999999888889999999999999999997 99998753221111 11110000000000          


Q ss_pred             HHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          809 LEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       809 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                                          ....++.+++..||+.||++|||+.|+++.|+.+.+
T Consensus       306 --------------------~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         306 --------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             --------------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                                112356788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7e-36  Score=319.40  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=203.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|+||+++++++...     ...|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CEEE
Confidence            36899999999999999999999889999999999765555557788999999999999999999998765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++...        .+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||.
T Consensus        93 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~  161 (297)
T cd06656          93 VVMEYLAGGSLTDVVTET--------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF  161 (297)
T ss_pred             EeecccCCCCHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCcc
Confidence            999999999999998643        478899999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +.......   .......+++.|+|||...+..++.++|||||||++|+|++|+.||.......... .......+.   
T Consensus       162 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-~~~~~~~~~---  234 (297)
T cd06656         162 CAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPE---  234 (297)
T ss_pred             ceEccCCc---cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-eeccCCCCC---
Confidence            97654322   11223458889999999888889999999999999999999999997532211100 000000000   


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       ...                         .......+.+++.+|++.+|++||++.|+++
T Consensus       235 -~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         235 -LQN-------------------------PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             -CCC-------------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             000                         0122345678999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1e-35  Score=316.04  Aligned_cols=252  Identities=21%  Similarity=0.312  Sum_probs=198.5

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+....   ....+.+.+|+.++++++|++++.+++.+.+.     ...
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-----DAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-----CEE
Confidence            3778899999999999999999999999999985432   22234567899999999999999999988665     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||+++++|.+++......     .+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg  147 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEA-----GFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLG  147 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeecc
Confidence            9999999999999998654322     589999999999999999999998   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      .+.......    ......|+..|+|||++.+..++.++||||+||++|+|++|+.||........ ....         
T Consensus       148 ~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~---------  213 (285)
T cd05630         148 LAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEV---------  213 (285)
T ss_pred             ceeecCCCc----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHH---------
Confidence            997654321    11234689999999999888999999999999999999999999975321100 0000         


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC-----HHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK-----IQDAIM  857 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----a~evl~  857 (871)
                      ..... ..               ..   .....+...+.+++.+||+.||++|||     ++|+++
T Consensus       214 ~~~~~-~~---------------~~---~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         214 ERLVK-EV---------------QE---EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             Hhhhh-hh---------------hh---hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            00000 00               00   000122345679999999999999999     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-36  Score=331.89  Aligned_cols=277  Identities=19%  Similarity=0.206  Sum_probs=199.5

Q ss_pred             hcCCCCCceeeccccceEEEEEEC--CCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILG--TEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ..+|++.+.||+|+||.||+|...  ..++.||+|.+...     +...+|++++++++||||+++++++...     ..
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWK-----ST  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeC-----CE
Confidence            357999999999999999999864  34678999987532     2346799999999999999999987654     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+|||++ +++|.+++....       .+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.++|+||
T Consensus       161 ~~lv~e~~-~~~l~~~l~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~Df  229 (392)
T PHA03207        161 VCMVMPKY-KCDLFTYVDRSG-------PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDF  229 (392)
T ss_pred             EEEEehhc-CCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccC
Confidence            89999999 468998885432       589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhh--hhhHHHHhhh-C-
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEE--GLSLHKYAKM-G-  791 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~--~~~~~~~~~~-~-  791 (871)
                      |++....... .........||+.|+|||++.+..++.++||||+||++|||++|+.||......  ...+...... . 
T Consensus       230 G~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~  308 (392)
T PHA03207        230 GAACKLDAHP-DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV  308 (392)
T ss_pred             ccccccCccc-ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhcc
Confidence            9998665432 112223456999999999999889999999999999999999999999754321  1111111111 0 


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhH--HHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKF--HEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .+..........+...+...........  .....+  .....++.+++.+|+..||++||||.|++..
T Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        309 HPLEFPQNGSTNLCKHFKQYAIVLRPPY--TIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CccccCCccchhHHHHHHhhcccccCCc--cccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0101100001111111111000000000  000000  1224567789999999999999999999875

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.7e-35  Score=316.14  Aligned_cols=253  Identities=23%  Similarity=0.284  Sum_probs=201.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .+.|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|+.+++.++||||+++++++...     ...|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   85 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GKLW   85 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----CeEE
Confidence            36799999999999999999999988999999999766655667888999999999999999999988654     5689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|..++.....      .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||.
T Consensus        86 lv~e~~~~~~l~~~~~~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~  156 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELDR------GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGV  156 (292)
T ss_pred             EEEecCCCCcHHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCcc
Confidence            99999999999988865432      489999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGA-----LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      +......   ........++..|+|||++.     ...++.++|||||||++|+|++|+.||....... ..........
T Consensus       157 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~  232 (292)
T cd06644         157 SAKNVKT---LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEP  232 (292)
T ss_pred             ceecccc---ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-HHHHHhcCCC
Confidence            8754322   11122345788999999874     3457889999999999999999999997532211 1111111100


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      +.    ..                         ....+..++.+++.+||+.+|++||+++|+++
T Consensus       233 ~~----~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         233 PT----LS-------------------------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             cc----CC-------------------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00    00                         00122345678999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.5e-36  Score=316.49  Aligned_cols=253  Identities=21%  Similarity=0.292  Sum_probs=198.1

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .|+..+.||+|+||+||+|.+..+++.||+|++....   ......+.+|+++++.++|++++++.+++...     +..
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-----DAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-----CEE
Confidence            3677889999999999999999899999999986432   22234577899999999999999999887665     668


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++++|.+++.....     ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg  147 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGN-----PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLG  147 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCC
Confidence            999999999999998865432     2589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      .+.......    ......|+..|+|||++.+..++.++||||+||++|+|++|+.||......... ... ........
T Consensus       148 ~~~~~~~~~----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-~~~-~~~~~~~~  221 (285)
T cd05632         148 LAVKIPEGE----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-EEV-DRRVLETE  221 (285)
T ss_pred             cceecCCCC----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHH-HHhhhccc
Confidence            997654221    122346899999999998889999999999999999999999999753222110 000 00000000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC-----HHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK-----IQDAIME  858 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----a~evl~~  858 (871)
                      ..                           ........+.+++..|++.||++|||     +.|+++.
T Consensus       222 ~~---------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         222 EV---------------------------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             cc---------------------------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            00                           00122345678999999999999999     6676663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-35  Score=318.51  Aligned_cols=272  Identities=23%  Similarity=0.358  Sum_probs=208.9

Q ss_pred             HhhcCCCCCceeeccccceEEEEEEC-------CCCcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeec
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILG-------TEETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCS  626 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  626 (871)
                      ...++|++.+.||+|+||.||+|++.       .++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34567899999999999999999752       234579999986432 23346788999999999 8999999999986


Q ss_pred             ccCcCCCceeeEEEeccCCCCHHHHhhcccccc---------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 002883          627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ---------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL  697 (871)
Q Consensus       627 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  697 (871)
                      ..     ...|+||||+++|+|.+++.......         .....+++.++..++.|++.|+.|||+.   +++||||
T Consensus        92 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dl  163 (304)
T cd05101          92 QD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDL  163 (304)
T ss_pred             cC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccc
Confidence            65     56899999999999999997643210         0123578899999999999999999999   9999999


Q ss_pred             CCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCch
Q 002883          698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDD  776 (871)
Q Consensus       698 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~  776 (871)
                      ||+||+++.++.+||+|||.+......... .......++..|+|||+..+..++.++||||||+++|+|++ |..||..
T Consensus       164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  242 (304)
T cd05101         164 AARNVLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  242 (304)
T ss_pred             ccceEEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999876543211 11222345678999999888889999999999999999998 8888864


Q ss_pred             hhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHH
Q 002883          777 MFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAI  856 (871)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl  856 (871)
                      .....  ............                              ....+...+.+++.+||+.+|++|||+.|++
T Consensus       243 ~~~~~--~~~~~~~~~~~~------------------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l  290 (304)
T cd05101         243 IPVEE--LFKLLKEGHRMD------------------------------KPANCTNELYMMMRDCWHAIPSHRPTFKQLV  290 (304)
T ss_pred             CCHHH--HHHHHHcCCcCC------------------------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence            32211  111111000000                              0012345677899999999999999999999


Q ss_pred             HHHHHHHHHHHh
Q 002883          857 MELQEAQKMRQA  868 (871)
Q Consensus       857 ~~L~~i~~~~~~  868 (871)
                      +.|+++.....+
T Consensus       291 ~~l~~~~~~~~~  302 (304)
T cd05101         291 EDLDRILTLTTN  302 (304)
T ss_pred             HHHHHHHHhhhc
Confidence            999998876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.4e-36  Score=327.66  Aligned_cols=193  Identities=21%  Similarity=0.342  Sum_probs=165.0

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ...+|++.+.||+|+||.||+|++..+++.||+|+....      ....|+.++++++||||+++++++...     ...
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~  132 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSG-----AIT  132 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeC-----Cee
Confidence            345799999999999999999999988999999985322      234699999999999999999998765     668


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++|||++ .++|.+++.....      .+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       133 ~lv~e~~-~~~l~~~l~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  202 (357)
T PHA03209        133 CMVLPHY-SSDLYTYLTKRSR------PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLG  202 (357)
T ss_pred             EEEEEcc-CCcHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCc
Confidence            9999999 5688888865432      589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCC
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPT  774 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf  774 (871)
                      .+......    .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       203 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        203 AAQFPVVA----PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccC----cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            99753321    1122346899999999998889999999999999999999855544

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-35  Score=318.60  Aligned_cols=269  Identities=23%  Similarity=0.357  Sum_probs=203.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCC----------------cEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEE----------------TNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVK  620 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  620 (871)
                      .++|++.+.||+|+||.||+|.+...+                ..||+|.+.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            457999999999999999999875433                558999986443 234567889999999999999999


Q ss_pred             eeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccc----cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 002883          621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ----NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD  696 (871)
Q Consensus       621 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  696 (871)
                      +++++...     ...++||||+++++|.+++.......    .....+++..++.++.|++.|++|||+.   +++|||
T Consensus        84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d  155 (296)
T cd05051          84 LLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD  155 (296)
T ss_pred             EEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence            99998665     56899999999999999997654210    0112589999999999999999999999   999999


Q ss_pred             CCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCC
Q 002883          697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT--GKRPT  774 (871)
Q Consensus       697 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--G~~pf  774 (871)
                      |||+||+++.++.++|+|||.+....... .........++..|+|||...++.++.++|||||||++|||++  |..||
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  234 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSD-YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY  234 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCc-ceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence            99999999999999999999997654322 1112223456788999999888889999999999999999998  77788


Q ss_pred             chhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHH
Q 002883          775 DDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQD  854 (871)
Q Consensus       775 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~e  854 (871)
                      ........ +...... .......                       ...+....++.++.+++.+|++.||++|||+.|
T Consensus       235 ~~~~~~~~-~~~~~~~-~~~~~~~-----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e  289 (296)
T cd05051         235 EHLTDQQV-IENAGHF-FRDDGRQ-----------------------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFRE  289 (296)
T ss_pred             CCcChHHH-HHHHHhc-ccccccc-----------------------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHH
Confidence            64322111 1100000 0000000                       000000123356889999999999999999999


Q ss_pred             HHHHHH
Q 002883          855 AIMELQ  860 (871)
Q Consensus       855 vl~~L~  860 (871)
                      +++.|+
T Consensus       290 l~~~L~  295 (296)
T cd05051         290 IHLFLQ  295 (296)
T ss_pred             HHHHhc
Confidence            999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.5e-35  Score=312.86  Aligned_cols=259  Identities=24%  Similarity=0.373  Sum_probs=203.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCC---CcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTE---ETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..+|++.+.||+|+||.||+|.+...   ...||+|...... ....+.+.+|+.++++++||||+++++++.+      
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------   78 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------   78 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------
Confidence            35688999999999999999987533   3569999986544 3445688999999999999999999998754      


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||+++++|.+++.....      .+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+|++
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~  149 (270)
T cd05056          79 NPVWIVMELAPLGELRSYLQVNKY------SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLG  149 (270)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEc
Confidence            346899999999999999976432      489999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |||.+........  .......++..|+|||.+....++.++||||||+++||+++ |..||......... ........
T Consensus       150 d~g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~~~~~~~  226 (270)
T cd05056         150 DFGLSRYLEDESY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GRIENGER  226 (270)
T ss_pred             cCceeeecccccc--eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHcCCc
Confidence            9999987644311  11112234568999999888889999999999999999996 99999754332211 11111000


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      . .                              ....++..+.+++.+|+..+|++|||+.|+++.|+++...
T Consensus       227 ~-~------------------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         227 L-P------------------------------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             C-C------------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            0 0                              0012234677899999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-35  Score=327.82  Aligned_cols=268  Identities=24%  Similarity=0.340  Sum_probs=204.9

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECC-----CCcEEEEEEeecccc-chHHHHHHHHHHHHcCC-CCccceeeeeeccc
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGT-----EETNVAVKVLDLQQR-GASKSFIAECEALRSIR-HRNLVKIITSCSSI  628 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  628 (871)
                      ...++|.+.+.||+|+||.||+|++..     .++.||+|+++.... ...+.+.+|++++.++. ||||+++++++...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            344568889999999999999999642     456899999964432 23457889999999997 99999999998765


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhcccccc-------------------------------------------------
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDEQ-------------------------------------------------  659 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------------  659 (871)
                           ...++||||+++|+|.++++..+...                                                 
T Consensus       114 -----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (401)
T cd05107         114 -----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD  188 (401)
T ss_pred             -----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence                 56899999999999999997643210                                                 


Q ss_pred             ------------------------------------------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 002883          660 ------------------------------------------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL  697 (871)
Q Consensus       660 ------------------------------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  697 (871)
                                                                ...+.+++..+..++.|++.||+|||+.   +++||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdl  265 (401)
T cd05107         189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDL  265 (401)
T ss_pred             ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccC
Confidence                                                      1123477888999999999999999998   9999999


Q ss_pred             CCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCch
Q 002883          698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDD  776 (871)
Q Consensus       698 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~  776 (871)
                      ||+||+++.++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus       266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~  344 (401)
T cd05107         266 AARNVLICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE  344 (401)
T ss_pred             CcceEEEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999999999865432111 11122346788999999888889999999999999999998 8999865


Q ss_pred             hhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHH
Q 002883          777 MFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAI  856 (871)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl  856 (871)
                      ........ .......+...                              ...+..++.+++.+||..+|++||+++|++
T Consensus       345 ~~~~~~~~-~~~~~~~~~~~------------------------------p~~~~~~l~~li~~cl~~~P~~RPs~~ell  393 (401)
T cd05107         345 LPMNEQFY-NAIKRGYRMAK------------------------------PAHASDEIYEIMQKCWEEKFEIRPDFSQLV  393 (401)
T ss_pred             CCchHHHH-HHHHcCCCCCC------------------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            32221111 11110000000                              001234678999999999999999999999


Q ss_pred             HHHHHHH
Q 002883          857 MELQEAQ  863 (871)
Q Consensus       857 ~~L~~i~  863 (871)
                      +.|+.+.
T Consensus       394 ~~L~~~~  400 (401)
T cd05107         394 HLVGDLL  400 (401)
T ss_pred             HHHHHHh
Confidence            9998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=310.94  Aligned_cols=254  Identities=23%  Similarity=0.295  Sum_probs=204.7

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|++........+.+.+|++++++++||||+++++++...     ...|+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-----DKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-----CEEEE
Confidence            5799999999999999999999888999999999766555667899999999999999999999987665     67899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      +|||+++++|.+++.....      .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||.+
T Consensus        78 ~~e~~~~~~l~~~~~~~~~------~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~  148 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRG------PLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVS  148 (262)
T ss_pred             EEeCCCCCcHHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccc
Confidence            9999999999999876522      589999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCC---CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALG---EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      .......   .......++..|+|||.....   .++.++||||||+++|+|++|+.||.......... .......+..
T Consensus       149 ~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-~~~~~~~~~~  224 (262)
T cd06613         149 AQLTATI---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LISKSNFPPP  224 (262)
T ss_pred             hhhhhhh---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCCCc
Confidence            7654321   112234578899999998766   78999999999999999999999997533221111 1111000000


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                                 ..........++.+++.+|+..+|.+|||++|++.
T Consensus       225 ---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 ---------------------------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ---------------------------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                                       00001133456789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-36  Score=314.84  Aligned_cols=252  Identities=22%  Similarity=0.324  Sum_probs=194.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEe--eccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~--~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ...|++.+.||+||.+.||++... +.+.||+|.+  ...+......+.+|+..|.++ .|.+||++++|-...     +
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d-----~  433 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD-----G  433 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC-----c
Confidence            456999999999999999999986 4455666655  233444567899999999999 699999999996654     8


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      +.|+||||- ..+|..++++....      .+...++.+..|++.|+.++|.+   ||||.||||.|+++-+ |.+||+|
T Consensus       434 ~lYmvmE~G-d~DL~kiL~k~~~~------~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLID  502 (677)
T KOG0596|consen  434 YLYMVMECG-DIDLNKILKKKKSI------DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLID  502 (677)
T ss_pred             eEEEEeecc-cccHHHHHHhccCC------CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeee
Confidence            899999976 77999999987643      33338889999999999999999   9999999999999954 7999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCC-----------CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhh
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-----------EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLS  783 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~  783 (871)
                      ||.|..+..+. ........+||+.|||||.+...           ..+.++||||+|||+|+|+.|+.||......-..
T Consensus       503 FGIA~aI~~DT-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aK  581 (677)
T KOG0596|consen  503 FGIANAIQPDT-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAK  581 (677)
T ss_pred             echhcccCccc-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHH
Confidence            99999887654 22334446799999999975432           2578899999999999999999999863322111


Q ss_pred             HHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHH--HHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          784 LHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEI--QVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      +.            .+.+|.-                   ...|++.  ..+++++|..||..||.+|||+.|+++.
T Consensus       582 l~------------aI~~P~~-------------------~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  582 LH------------AITDPNH-------------------EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             HH------------hhcCCCc-------------------cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            11            1122111                   0011110  1127899999999999999999999874

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.1e-35  Score=321.96  Aligned_cols=194  Identities=26%  Similarity=0.333  Sum_probs=168.0

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+.++.++ +||+|+++++++...     ...|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-----SRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-----CEEEEEE
Confidence            46999999999999999899999999996432   22345678899999888 699999999988665     6789999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++|+|.+++....       .+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        76 e~~~~~~L~~~~~~~~-------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~  145 (327)
T cd05617          76 EYVNGGDLMFHMQRQR-------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKE  145 (327)
T ss_pred             eCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecccccee
Confidence            9999999999887543       589999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCch
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDD  776 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  776 (871)
                      ....   ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~  198 (327)
T cd05617         146 GLGP---GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             ccCC---CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence            3221   1122335689999999999889999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1e-35  Score=317.01  Aligned_cols=264  Identities=23%  Similarity=0.400  Sum_probs=202.5

Q ss_pred             hhcCCCCCceeeccccceEEEEEECC-----CCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGT-----EETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDT  630 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  630 (871)
                      ..++|++.+.||+|+||.||+|.+..     .+..||+|.++.... .....+.+|+.+++.++||||+++++++.+.  
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG--   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence            45789999999999999999997642     355799998854332 2334678899999999999999999987654  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccc---cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQ---NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE  707 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  707 (871)
                         ...++||||+++|+|.+++.......   ...+..++..+..++.|++.|++|||+.   +|+||||||+||+++.+
T Consensus        82 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~  155 (288)
T cd05061          82 ---QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD  155 (288)
T ss_pred             ---CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence               56799999999999999997643211   1123567788999999999999999999   99999999999999999


Q ss_pred             CceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHH
Q 002883          708 MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHK  786 (871)
Q Consensus       708 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~  786 (871)
                      +.++|+|||.++........ .......++..|+|||...++.++.++|||||||++|||++ |..||.....++  ...
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~  232 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLK  232 (288)
T ss_pred             CcEEECcCCccccccccccc-cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH
Confidence            99999999999765432211 11122235678999999888889999999999999999999 788987532221  111


Q ss_pred             Hhhh-CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          787 YAKM-GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       787 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      .... ..+.                               ....+...+.+++.+|++.||++|||+.|+++.+++.
T Consensus       233 ~~~~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         233 FVMDGGYLD-------------------------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHHcCCCCC-------------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            1110 0000                               0001234678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.4e-36  Score=330.93  Aligned_cols=204  Identities=25%  Similarity=0.337  Sum_probs=175.2

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||+||+|++..+++.||+|+++...   ......+.+|+.++..++||+|+++++++.+.     ..
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-----RN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CE
Confidence            36889999999999999999999899999999996432   23345778899999999999999999988665     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++....       .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~-------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~Df  145 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKD-------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDF  145 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeec
Confidence            899999999999999997643       589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCC--------------------------------ccccccccccccccCcccccCCCCCCccchhhHHHH
Q 002883          716 GLSRLLHDNSPD--------------------------------QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL  763 (871)
Q Consensus       716 g~a~~~~~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i  763 (871)
                      |++.........                                ........||+.|+|||++.+..++.++||||+||+
T Consensus       146 G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi  225 (360)
T cd05627         146 GLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI  225 (360)
T ss_pred             cCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccce
Confidence            998754321100                                000112469999999999999999999999999999


Q ss_pred             HHHHHhCCCCCchh
Q 002883          764 MLEMFTGKRPTDDM  777 (871)
Q Consensus       764 l~elltG~~pf~~~  777 (871)
                      +|||++|+.||...
T Consensus       226 lyel~tG~~Pf~~~  239 (360)
T cd05627         226 MYEMLIGYPPFCSE  239 (360)
T ss_pred             eeecccCCCCCCCC
Confidence            99999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.7e-35  Score=310.08  Aligned_cols=254  Identities=22%  Similarity=0.299  Sum_probs=196.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-----RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++....     ......+.+|+.++++++||||+++++++.+.   .+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence            46899999999999999999998899999999885432     12335688899999999999999999987543   12


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...+++|||+++++|.+++....       .+++..++.++.|++.||+|||+.   +|+||||+|+||+++.++.+||+
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~  148 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAYG-------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLG  148 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence            56789999999999999997643       478899999999999999999998   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||.+.................++..|+|||.+.+..++.++||||+||++|+|++|+.||........ ..........
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-~~~~~~~~~~  227 (266)
T cd06651         149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-IFKIATQPTN  227 (266)
T ss_pred             cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-HHHHhcCCCC
Confidence            999987654321111122234578899999998888899999999999999999999999975321111 1111000000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...                           .   ....+.+.+++ +|+..+|++|||++|+++
T Consensus       228 ~~~---------------------------~---~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         228 PQL---------------------------P---SHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCC---------------------------c---hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            000                           0   01223345566 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.2e-35  Score=319.49  Aligned_cols=205  Identities=22%  Similarity=0.298  Sum_probs=164.1

Q ss_pred             CceeeccccceEEEEEECC--CCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEe
Q 002883          564 ANLIGIGGYGYVYKGILGT--EETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE  641 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  641 (871)
                      ..+||+|+||+||+|+...  ++..||+|.+....  ....+.+|+++++.++||||+++++++....   ....++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEEEe
Confidence            3689999999999999753  56789999986433  2356788999999999999999999885432   256799999


Q ss_pred             ccCCCCHHHHhhcccccc--cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee----CCCCceEEeec
Q 002883          642 FMPNGSLENWLNQKEDEQ--NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL----DNEMVAHVGDF  715 (871)
Q Consensus       642 ~~~~gsL~~~l~~~~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Df  715 (871)
                      |++ ++|.+++.......  .....+++..++.++.|++.||.|||+.   +|+||||||+||++    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            985 58888875432211  1122588999999999999999999999   99999999999999    56679999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      |+++................+|+.|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            999876543322222334568999999998766 45799999999999999999999999743

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-35  Score=314.51  Aligned_cols=251  Identities=23%  Similarity=0.294  Sum_probs=199.1

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEE
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      |++.+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++|||++++++++...     ...|+||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEEEE
Confidence            67889999999999999999988999999999765555567788999999999999999999998665     6689999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++++|.+++.....      .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+|++|||++..
T Consensus        82 e~~~~~~l~~~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~  152 (282)
T cd06643          82 EFCAGGAVDAVMLELER------PLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK  152 (282)
T ss_pred             EecCCCcHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccc
Confidence            99999999998865321      589999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCCCccccccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGA-----LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      .....   .......++..|+|||++.     +..++.++||||+||++|+|++|+.||........ .........+ .
T Consensus       153 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~~-~  227 (282)
T cd06643         153 NTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSEPP-T  227 (282)
T ss_pred             ccccc---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHHHhhcCCC-C
Confidence            53221   1223346889999999863     45678899999999999999999999975322211 1111110000 0


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                         ...                         ...+..++.+++.+||+.||.+|||+.++++.
T Consensus       228 ---~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         228 ---LAQ-------------------------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ---CCC-------------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               000                         00123457799999999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.9e-36  Score=324.45  Aligned_cols=238  Identities=25%  Similarity=0.307  Sum_probs=185.7

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHH-HHHcCCCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECE-ALRSIRHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||.||+|++..+++.||+|++....   ......+.+|.. +++.++||||+++++++.+.     ...|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-----EKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----CEEEEEE
Confidence            46999999999999999899999999986432   122334555554 57888999999999887665     6789999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++++|.+++....       .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        76 e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  145 (321)
T cd05603          76 DYVNGGELFFHLQRER-------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (321)
T ss_pred             cCCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence            9999999998886543       588899999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhc
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII  800 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  800 (871)
                      ....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......  +..     
T Consensus       146 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~--~~~-----  214 (321)
T cd05603         146 GVEP---EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-YDNILHK--PLQ-----  214 (321)
T ss_pred             CCCC---CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-HHHHhcC--CCC-----
Confidence            3221   1122345689999999999888999999999999999999999999975321111 0000000  000     


Q ss_pred             ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHH
Q 002883          801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQ  853 (871)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~  853 (871)
                                        .+       ......+.+++.+|++.||++||++.
T Consensus       215 ------------------~~-------~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 ------------------LP-------GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ------------------CC-------CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                              00       01223567899999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-36  Score=316.22  Aligned_cols=254  Identities=22%  Similarity=0.295  Sum_probs=202.8

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||.|+||.||+|.+..++..||+|+++.......+.+.+|++++++++||||+++++++...     ...|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-----NKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-----CeEE
Confidence            45799999999999999999999888999999999766655567888999999999999999999998764     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++.....      .+++..+..++.|++.|+.|||+.   +|+|+||||+||+++.++.++|+|||.
T Consensus        79 lv~e~~~~~~L~~~~~~~~~------~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~  149 (280)
T cd06611          79 ILIEFCDGGALDSIMLELER------GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGV  149 (280)
T ss_pred             EEeeccCCCcHHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCcc
Confidence            99999999999999876432      489999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGA-----LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      +.......   .......++..|+|||.+.     ...++.++||||+|+++|+|++|+.||....... ..........
T Consensus       150 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~  225 (280)
T cd06611         150 SAKNKSTL---QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILKSEP  225 (280)
T ss_pred             chhhcccc---cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhcCCC
Confidence            87653321   1122345889999999864     3457889999999999999999999997542211 1111111000


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      + ..   ..                         ...+..++.+++.+||+.+|++||++.++++.
T Consensus       226 ~-~~---~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 P-TL---DQ-------------------------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             C-Cc---CC-------------------------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0 00   00                         00123456789999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-37  Score=295.48  Aligned_cols=257  Identities=22%  Similarity=0.272  Sum_probs=205.6

Q ss_pred             cCCCCC-ceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSA-NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++. ++||-|-.|.|..+..+.+++++|+|++..     ....++|++..-.. .|||||.++++|... ..+....
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rkcL  134 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENS-YQGRKCL  134 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCceee
Confidence            455543 679999999999999999999999999852     24456788876555 799999999998664 5556788


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC---CCCceEEe
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD---NEMVAHVG  713 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~  713 (871)
                      .+|||.++||.|.+.++..+..     .+++.++-.|++||+.|+.|||+.   +|.||||||+|+|.+   .+..+||+
T Consensus       135 LiVmE~meGGeLfsriq~~g~~-----afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQ-----AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             EeeeecccchHHHHHHHHcccc-----cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence            9999999999999999987744     699999999999999999999999   999999999999996   45579999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||+|+.....    ......+-|+.|.|||++....|+..+|+||+||++|-|++|.+||.........  .-.+..+.
T Consensus       207 DfGFAK~t~~~----~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais--pgMk~rI~  280 (400)
T KOG0604|consen  207 DFGFAKETQEP----GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKRRIR  280 (400)
T ss_pred             ccccccccCCC----ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC--hhHHhHhh
Confidence            99999875432    2233456899999999999999999999999999999999999999865432111  11111111


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ....++-+                       +.+.++++...++|+.+|..+|.+|.|++|+++.
T Consensus       281 ~gqy~FP~-----------------------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  281 TGQYEFPE-----------------------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ccCccCCC-----------------------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            12223333                       3344677788999999999999999999998753

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.8e-36  Score=316.86  Aligned_cols=275  Identities=26%  Similarity=0.391  Sum_probs=207.5

Q ss_pred             cCCCCCceeeccccceEEEEEECC----CCcEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGT----EETNVAVKVLDLQQRG-ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ++|++.+.||+|+||.||+|++..    ++..||+|++...... ..+.+.+|+++++.+.|+||+++++++...   ++
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CC
Confidence            468888999999999999999643    4788999999755443 457899999999999999999999987553   23


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+++++|.+++.....      .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~------~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~  151 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRD------QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKIS  151 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCcc------ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEc
Confidence            568999999999999999976542      489999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||.+.................++..|+|||...+..++.++||||||+++|||++|+.||.............      
T Consensus       152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~------  225 (284)
T cd05038         152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI------  225 (284)
T ss_pred             ccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc------
Confidence            99999877533222122222345667999999888889999999999999999999999986532221110000      


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      ..     +..............   ..   .+....++.++.+++.+|++.+|++|||+.|++++|+.+
T Consensus       226 ~~-----~~~~~~~~~~~~~~~---~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         226 AQ-----GQMIVTRLLELLKEG---ER---LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cc-----ccccHHHHHHHHHcC---Cc---CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            00     000000000000000   00   000112346788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.2e-35  Score=317.06  Aligned_cols=267  Identities=25%  Similarity=0.254  Sum_probs=206.3

Q ss_pred             HHHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccC
Q 002883          551 YAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSID  629 (871)
Q Consensus       551 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  629 (871)
                      ..++....++|++.+.||+|+||.||+|....+++.+|+|++..... ....+.+|+.+++++ +|||++++++++...+
T Consensus        14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            34555567889999999999999999999998999999999864322 345677899999998 8999999999987654


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV  709 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  709 (871)
                      .......|+||||+++++|.++++.....   ...+++..++.++.|++.|+.|||+.   +++||||||+||+++.++.
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLIC---GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence            44446789999999999999988643211   22589999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccceecCCCCCCccccccccccccccCcccccCC-----CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhH
Q 002883          710 AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-----EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSL  784 (871)
Q Consensus       710 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~  784 (871)
                      +||+|||.+........   ......|+..|+|||.+...     .++.++|||||||++|+|++|+.||........ .
T Consensus       167 ~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~  242 (291)
T cd06639         167 VKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-L  242 (291)
T ss_pred             EEEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-H
Confidence            99999999886543211   11224578899999986543     368999999999999999999999975432111 1


Q ss_pred             HHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          785 HKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ....... +..   +.+                         .......+.+++.+|++.+|++||++.|+++
T Consensus       243 ~~~~~~~-~~~---~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         243 FKIPRNP-PPT---LLH-------------------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHhcCC-CCC---CCc-------------------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1111100 000   000                         0122345789999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.8e-35  Score=319.02  Aligned_cols=268  Identities=25%  Similarity=0.382  Sum_probs=204.5

Q ss_pred             hhcCCCCCceeeccccceEEEEEEC-------CCCcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeecc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILG-------TEETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCSS  627 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  627 (871)
                      ..++|.+.+.||+|+||.||+|++.       .....||+|.++... ......+.+|+++++++ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3468899999999999999999863       234579999986432 23346788999999999 69999999998865


Q ss_pred             cCcCCCceeeEEEeccCCCCHHHHhhccccc---------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 002883          628 IDTRGNEFKALVYEFMPNGSLENWLNQKEDE---------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK  698 (871)
Q Consensus       628 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  698 (871)
                      .     ...|+||||+++|+|.+++......         ......+++.++..++.|++.|+.|||+.   |++|||||
T Consensus        90 ~-----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlk  161 (314)
T cd05099          90 E-----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLA  161 (314)
T ss_pred             C-----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence            4     5689999999999999999764321         01123588999999999999999999999   99999999


Q ss_pred             CCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchh
Q 002883          699 PSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM  777 (871)
Q Consensus       699 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~  777 (871)
                      |+||+++.++.+||+|||.++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus       162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         162 ARNVLVTEDNVMKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             ceeEEEcCCCcEEEccccccccccccccc-cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999865432111 11111234567999999888889999999999999999999 89998653


Q ss_pred             hhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          778 FEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ....  ...........   +                           ....+..++.+++.+|+..+|++|||+.|+++
T Consensus       241 ~~~~--~~~~~~~~~~~---~---------------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         241 PVEE--LFKLLREGHRM---D---------------------------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CHHH--HHHHHHcCCCC---C---------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            2211  11111100000   0                           00122346778999999999999999999999


Q ss_pred             HHHHHHHH
Q 002883          858 ELQEAQKM  865 (871)
Q Consensus       858 ~L~~i~~~  865 (871)
                      .|+++...
T Consensus       289 ~l~~~~~~  296 (314)
T cd05099         289 ALDKVLAA  296 (314)
T ss_pred             HHHHHHHH
Confidence            99988653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.7e-35  Score=309.92  Aligned_cols=254  Identities=21%  Similarity=0.273  Sum_probs=197.2

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-----RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .+|++.+.||+|+||.||.|.+..+++.||+|++....     ....+.+.+|++++++++||||+++++++.+..   .
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence            47899999999999999999999899999999885322     122457788999999999999999999875432   2


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+++++|.+++....       .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~  148 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSYG-------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLG  148 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEEC
Confidence            46789999999999999987543       478889999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||.+.................++..|+|||...+..++.++|||||||++|+|++|+.||........ ......... 
T Consensus       149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~-  226 (265)
T cd06652         149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-IFKIATQPT-  226 (265)
T ss_pred             cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-HHHHhcCCC-
Confidence            999998654321111122234588899999998888899999999999999999999999975321111 111110000 


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                             .+..                      .......+.+++.+|+. +|++||+++|+++
T Consensus       227 -------~~~~----------------------~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         227 -------NPVL----------------------PPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -------CCCC----------------------chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                   0000                      01223456678888884 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-35  Score=309.23  Aligned_cols=250  Identities=29%  Similarity=0.422  Sum_probs=202.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||.|+||.||+|...  ++.||+|.++.... ..+++.+|+.+++.++|+||+++++++.+.     ...+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   76 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG-----NPLY   76 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC-----CCeE
Confidence            457899999999999999999984  78899999975544 457889999999999999999999998654     5689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++......     .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||.
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~  148 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRA-----VITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGL  148 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccc
Confidence            999999999999999765422     589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +........      ....+..|+|||+...+.++.++||||||+++|+|++ |+.||........  ........+...
T Consensus       149 ~~~~~~~~~------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~~~~~~~  220 (256)
T cd05039         149 AKEASQGQD------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPHVEKGYRMEA  220 (256)
T ss_pred             ccccccccc------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHhcCCCCCC
Confidence            987632211      1234568999999888889999999999999999997 9999875322211  111111000000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                                                    ....+..+.+++.+|+..+|++|||+.|+++.|+.
T Consensus       221 ------------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         221 ------------------------------PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ------------------------------ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence                                          01223567799999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-35  Score=316.93  Aligned_cols=270  Identities=22%  Similarity=0.363  Sum_probs=201.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECC----------------CCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGT----------------EETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVK  620 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  620 (871)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|++.... ......+.+|+++++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3579999999999999999986532                34569999986443 334567889999999999999999


Q ss_pred             eeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccc----cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 002883          621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ----NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD  696 (871)
Q Consensus       621 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  696 (871)
                      +++++...     ...++||||+++++|.+++.......    .....+++..+..++.|++.|++|||+.   +++|||
T Consensus        84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~d  155 (296)
T cd05095          84 LLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRD  155 (296)
T ss_pred             EEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence            99998665     55799999999999999997643211    1122478889999999999999999999   999999


Q ss_pred             CCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCC
Q 002883          697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT--GKRPT  774 (871)
Q Consensus       697 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--G~~pf  774 (871)
                      |||+||+++.++.++|+|||.+..+...... .......++..|+|||....+.++.++|||||||++|||++  |..||
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~  234 (296)
T cd05095         156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY  234 (296)
T ss_pred             CChheEEEcCCCCEEeccCcccccccCCcce-eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence            9999999999999999999999865432211 11222334678999998888889999999999999999998  77888


Q ss_pred             chhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHH
Q 002883          775 DDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQD  854 (871)
Q Consensus       775 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~e  854 (871)
                      ......... ....         +.....          .  .   ....+....++..+.+++.+||+.||++|||+.|
T Consensus       235 ~~~~~~~~~-~~~~---------~~~~~~----------~--~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~  289 (296)
T cd05095         235 SQLSDEQVI-ENTG---------EFFRDQ----------G--R---QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQE  289 (296)
T ss_pred             cccChHHHH-HHHH---------HHHhhc----------c--c---cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence            643222110 0000         000000          0  0   0000000123356789999999999999999999


Q ss_pred             HHHHHHH
Q 002883          855 AIMELQE  861 (871)
Q Consensus       855 vl~~L~~  861 (871)
                      +++.|++
T Consensus       290 i~~~l~~  296 (296)
T cd05095         290 IHATLLE  296 (296)
T ss_pred             HHHHHhC
Confidence            9999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.7e-35  Score=309.84  Aligned_cols=251  Identities=25%  Similarity=0.320  Sum_probs=203.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+.....  .+.+.+|+++++.++||||+++++++.+.     ...|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~   74 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDLW   74 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcEE
Confidence            3679999999999999999999988889999999865433  67899999999999999999999998765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +++||+++++|.+++.....      .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.
T Consensus        75 l~~e~~~~~~L~~~l~~~~~------~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~  145 (256)
T cd06612          75 IVMEYCGAGSVSDIMKITNK------TLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGV  145 (256)
T ss_pred             EEEecCCCCcHHHHHHhCcc------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEccccc
Confidence            99999999999999975432      589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +........   ......++..|+|||++.+..++.++||||||+++|+|++|+.||............  ....+..  
T Consensus       146 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~--  218 (256)
T cd06612         146 SGQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--PNKPPPT--  218 (256)
T ss_pred             chhcccCcc---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh--ccCCCCC--
Confidence            987653321   122345788999999988888999999999999999999999999753222110000  0000000  


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       .                         .....+...+.+++.+|++.||++|||+.|+++
T Consensus       219 -~-------------------------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         219 -L-------------------------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -C-------------------------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence             0                         000123346788999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.9e-35  Score=310.24  Aligned_cols=256  Identities=27%  Similarity=0.376  Sum_probs=197.2

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      +.+.......||+|+||.||+|++..+++.||+|.+........+.+.+|+.+++.++|+||+++++++...     ...
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~   80 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-----GFF   80 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-----CEE
Confidence            344455567899999999999999888999999998765555567889999999999999999999998665     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCceEEeec
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-EMVAHVGDF  715 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Df  715 (871)
                      ++|+||+++++|.+++......    ...++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.++|+||
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~df  153 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKWGP----LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDF  153 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhccc----CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecc
Confidence            9999999999999999764211    0127888899999999999999999   9999999999999976 679999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE--VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |.+........   ......++..|+|||+.....  ++.++||||+|+++|+|++|+.||...................
T Consensus       154 g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  230 (268)
T cd06624         154 GTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH  230 (268)
T ss_pred             hhheecccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccC
Confidence            99976543221   122235789999999876543  7899999999999999999999997432111111000000000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                                 +..   ......++.+++.+|++.+|++|||+.|+++
T Consensus       231 ---------------------------~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         231 ---------------------------PEI---PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ---------------------------CCC---CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                                       000   0122345778999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.7e-35  Score=314.25  Aligned_cols=268  Identities=24%  Similarity=0.335  Sum_probs=207.4

Q ss_pred             hhcCCCCCceeeccccceEEEEEECC----CCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGT----EETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      ..++|++.+.||+|+||.||+|.+..    .+..||+|++.... ......+.+|+.+++.++||||+++++++...   
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---   80 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---   80 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence            35689999999999999999999875    25789999886432 23356788999999999999999999987543   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhccccc-ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCce
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDE-QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA  710 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  710 (871)
                       +...++++||+++++|.+++...... ......+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+
T Consensus        81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~  156 (280)
T cd05043          81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQV  156 (280)
T ss_pred             -CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcE
Confidence             25578999999999999999764321 01123589999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhh
Q 002883          711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAK  789 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~  789 (871)
                      |++|||+++.+.... .........++..|+|||++.+..++.++|||||||++||+++ |+.||......  ....+..
T Consensus       157 kl~d~g~~~~~~~~~-~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~  233 (280)
T cd05043         157 KITDNALSRDLFPMD-YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--EMAAYLK  233 (280)
T ss_pred             EECCCCCcccccCCc-eEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--HHHHHHH
Confidence            999999998654322 1111122345678999999888889999999999999999999 99999753221  1111111


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      ...+...                              ...++.++.+++.+|++.||++|||+.|+++.|+++.+
T Consensus       234 ~~~~~~~------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         234 DGYRLAQ------------------------------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             cCCCCCC------------------------------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1110000                              00123457789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.8e-35  Score=308.09  Aligned_cols=250  Identities=26%  Similarity=0.372  Sum_probs=198.8

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      .+|++.+.||+|+||.||+|...  +..||+|.++...  ..+.+.+|+.++++++|++++++++++...    +...++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEE
Confidence            47899999999999999999874  7789999986433  346788999999999999999999876432    245799


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||+++++|.+++.....     ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.+
T Consensus        78 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~  149 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  149 (256)
T ss_pred             EEECCCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccc
Confidence            9999999999999976542     2588999999999999999999999   9999999999999999999999999998


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      .......      ....++..|+|||+..+..++.++|||||||++|+|++ |+.||.......  .........+... 
T Consensus       150 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~~~-  220 (256)
T cd05082         150 KEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYKMDA-  220 (256)
T ss_pred             eeccccC------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcCCCCCC-
Confidence            7643221      12234568999999888889999999999999999998 999987432111  1111111100000 


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                                                   ...++..+.+++.+|++.+|++|||+.++++.|+++
T Consensus       221 -----------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         221 -----------------------------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -----------------------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                                         012344677899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-35  Score=310.19  Aligned_cols=256  Identities=29%  Similarity=0.485  Sum_probs=203.0

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ..++|++.+.||+|+||.||+|.+. +++.||||.+..... ..+.+.+|+.++++++|+|++++++++...     ...
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   76 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE-----EPI   76 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecC-----Cce
Confidence            3468999999999999999999986 567899999864433 346789999999999999999999987654     557


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++++|.+++......     .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.+|++|||
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~-----~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g  148 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGK-----KLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFG  148 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccc
Confidence            9999999999999999765422     589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      .+.......  ........++..|+|||...+..++.++||||+|+++|++++ |+.||....... ..... .......
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~-~~~~~~~  224 (261)
T cd05034         149 LARLIEDDE--YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQV-ERGYRMP  224 (261)
T ss_pred             cceeccchh--hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH-HcCCCCC
Confidence            998764321  111112234568999999888889999999999999999999 999996532221 11111 1110000


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                      .                              ....+.++.+++.+|++.+|++||+++|+.+.|+.
T Consensus       225 ~------------------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 R------------------------------PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             C------------------------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            0                              00113457789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.6e-35  Score=310.51  Aligned_cols=251  Identities=25%  Similarity=0.387  Sum_probs=199.7

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc---------hHHHHHHHHHHHHcCCCCccceeeeeecccCc
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG---------ASKSFIAECEALRSIRHRNLVKIITSCSSIDT  630 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  630 (871)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+......         ..+.+.+|++++++++||||+++++++.+.  
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   78 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--   78 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence            588899999999999999999888999999988543221         125678899999999999999999997665  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCce
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA  710 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  710 (871)
                         ...++||||+++++|.+++....       .+++..+..++.|++.|++|||+.   +++||||+|+||++++++.+
T Consensus        79 ---~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~  145 (267)
T cd06628          79 ---DHLNIFLEYVPGGSVAALLNNYG-------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGI  145 (267)
T ss_pred             ---CccEEEEEecCCCCHHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCE
Confidence               66899999999999999997653       588899999999999999999998   99999999999999999999


Q ss_pred             EEeecccceecCCCCCCc---cccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHH
Q 002883          711 HVGDFGLSRLLHDNSPDQ---TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKY  787 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~  787 (871)
                      +|+|||.++.........   .......|+..|+|||.+.+..++.++||||+||++|+|++|+.||....... .....
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~  224 (267)
T cd06628         146 KISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFKI  224 (267)
T ss_pred             EecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHHH
Confidence            999999998765321111   11122457889999999888889999999999999999999999997532211 11100


Q ss_pred             hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ... .....                              .......+.+++.+||+.||.+||++.|+++
T Consensus       225 ~~~-~~~~~------------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 GEN-ASPEI------------------------------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             hcc-CCCcC------------------------------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            000 00000                              0123346778999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.6e-35  Score=318.47  Aligned_cols=268  Identities=25%  Similarity=0.368  Sum_probs=205.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECC-------CCcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeeccc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGT-------EETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCSSI  628 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  628 (871)
                      .++|.+.+.||+|+||.||+|++..       ....||+|.++... ......+.+|+++++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4679999999999999999998743       23569999997542 23345688899999999 799999999998665


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhcccccc---------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDEQ---------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP  699 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  699 (871)
                           ...|+||||+++|+|.+++.......         .....+++.++..++.|++.||+|||+.   +++||||||
T Consensus        97 -----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  168 (307)
T cd05098          97 -----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA  168 (307)
T ss_pred             -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence                 56899999999999999997653210         0122588999999999999999999998   999999999


Q ss_pred             CceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhh
Q 002883          700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMF  778 (871)
Q Consensus       700 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~  778 (871)
                      +||+++.++.+||+|||.+......... .......++..|+|||+..+..++.++|||||||++|+|++ |..||....
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            9999999999999999998765432111 11111234568999999888889999999999999999998 888986432


Q ss_pred             hhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          779 EEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .+.  ...........                              +.......++.+++.+|+..+|++|||+.|+++.
T Consensus       248 ~~~--~~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         248 VEE--LFKLLKEGHRM------------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHH--HHHHHHcCCCC------------------------------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            211  11111110000                              0001223467789999999999999999999999


Q ss_pred             HHHHHHHH
Q 002883          859 LQEAQKMR  866 (871)
Q Consensus       859 L~~i~~~~  866 (871)
                      |+++.+..
T Consensus       296 l~~~~~~~  303 (307)
T cd05098         296 LDRILALT  303 (307)
T ss_pred             HHHHHHHh
Confidence            99987664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1e-35  Score=316.41  Aligned_cols=261  Identities=21%  Similarity=0.335  Sum_probs=200.3

Q ss_pred             cCCCCCceeeccccceEEEEEECC-----CCcEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGT-----EETNVAVKVLDLQQRG-ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      .+|++.+.||+|+||.||+|.+..     .+..||+|+++..... ....+.+|+.+++.++||||+++++++.+.    
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~----   80 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE----   80 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC----
Confidence            357788999999999999998753     3578999999644332 345688999999999999999999998765    


Q ss_pred             CceeeEEEeccCCCCHHHHhhccccc---------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcee
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDE---------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL  703 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  703 (871)
                       ...++++||+++++|.+++......         ......+++..+..++.|++.||+|+|+.   +|+||||||+||+
T Consensus        81 -~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil  156 (283)
T cd05091          81 -QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL  156 (283)
T ss_pred             -CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence             5579999999999999998532110         01123588899999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhh
Q 002883          704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGL  782 (871)
Q Consensus       704 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~  782 (871)
                      +++++.+||+|||+++....... ........+++.|+|||...++.++.++||||+||++|||++ |..||....... 
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-  234 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-  234 (283)
T ss_pred             ecCCCceEecccccccccccchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence            99999999999999886543221 112223346789999999888889999999999999999998 888887532221 


Q ss_pred             hHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          783 SLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       783 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                       .............                              ...++..+.+++..|++.+|++||++.|+++.|+
T Consensus       235 -~~~~i~~~~~~~~------------------------------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         235 -VIEMIRNRQVLPC------------------------------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             -HHHHHHcCCcCCC------------------------------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence             1111111000000                              0123345779999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.9e-36  Score=291.36  Aligned_cols=291  Identities=22%  Similarity=0.285  Sum_probs=211.0

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCC----cEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEE----TNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT  630 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  630 (871)
                      ....|+....||+|.||.||+|....+.    +.+|+|.++..  ..+......+|+..++.++|||++.+..+|...  
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~--   99 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH--   99 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc--
Confidence            3457999999999999999999654332    36899999644  334567788999999999999999999988664  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC---
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE---  707 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---  707 (871)
                        +..+|+++||.+. +|.+.|+-++....  ..++...+.+|+.||+.|+.|||++   =|+|||+||.|||+..+   
T Consensus       100 --d~~v~l~fdYAEh-DL~~II~fHr~~~~--~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgpe  171 (438)
T KOG0666|consen  100 --DKKVWLLFDYAEH-DLWHIIKFHRASKA--KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPE  171 (438)
T ss_pred             --CceEEEEehhhhh-hHHHHHHHhccchh--ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCc
Confidence              3678999999965 99999987765433  3689999999999999999999999   89999999999999887   


Q ss_pred             -CceEEeecccceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhh---
Q 002883          708 -MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL---  782 (871)
Q Consensus       708 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~---  782 (871)
                       |.|||+|||+|+.+...-........++.|..|+|||.+.+. .|+++.||||.|||+.||+|-++.|....++..   
T Consensus       172 rG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~  251 (438)
T KOG0666|consen  172 RGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKN  251 (438)
T ss_pred             cCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCC
Confidence             899999999999987655444455667889999999987664 689999999999999999999998875433211   


Q ss_pred             -----hHHH-HhhhCCCchhhhhcChhHHHHHHHHHhhhh-hhcCc-hhHHhHHH---HHHHHHhhhcccccCCCCCCCC
Q 002883          783 -----SLHK-YAKMGLPDQVAEIIDPAILEEALEIQAGIV-KELQP-NLRAKFHE---IQVSILRVGILCSEELPRDRMK  851 (871)
Q Consensus       783 -----~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~---~~~~l~~li~~cl~~dP~~RPt  851 (871)
                           .+.+ +...+.|.. .+|-+-.-.++....+.... +...+ .+...++.   -.+...+++.++|++||-+|.|
T Consensus       252 Pfq~dQl~rIf~vLG~Pt~-~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIt  330 (438)
T KOG0666|consen  252 PFQHDQLDRIFEVLGTPTD-KDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRIT  330 (438)
T ss_pred             CchHHHHHHHHHHcCCCcc-ccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhcc
Confidence                 1111 111222221 11111000011111111111 11111 12222221   1234678999999999999999


Q ss_pred             HHHHHHH
Q 002883          852 IQDAIME  858 (871)
Q Consensus       852 a~evl~~  858 (871)
                      |+++++.
T Consensus       331 a~qAleh  337 (438)
T KOG0666|consen  331 AEQALEH  337 (438)
T ss_pred             HHHHhcc
Confidence            9999874

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2e-35  Score=314.02  Aligned_cols=265  Identities=24%  Similarity=0.298  Sum_probs=205.9

Q ss_pred             CHHHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeeccc
Q 002883          550 SYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSI  628 (871)
Q Consensus       550 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  628 (871)
                      +..++....+.|++.+.||+|+||.||+|++..+++.||+|++..... ....+..|+.+++++ +|+|++++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            445555667899999999999999999999998999999999865433 345678899999998 799999999998653


Q ss_pred             Cc-CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC
Q 002883          629 DT-RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE  707 (871)
Q Consensus       629 ~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  707 (871)
                      .. ......|+||||+++|+|.+++......     .+++..+..++.|++.|++|||+.   +|+||||+|+||+++.+
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~  157 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-----ALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN  157 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence            22 2346789999999999999999764422     578888999999999999999999   99999999999999999


Q ss_pred             CceEEeecccceecCCCCCCccccccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhh
Q 002883          708 MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA-----LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL  782 (871)
Q Consensus       708 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~  782 (871)
                      +.++|+|||.+.......   .......|+..|+|||.+.     ...++.++|||||||++|+|++|+.||........
T Consensus       158 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~  234 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA  234 (282)
T ss_pred             CCEEEeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence            999999999987553211   1122346889999999865     35678899999999999999999999975321111


Q ss_pred             hHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          783 SLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       783 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      . ....... +                           +.  .....+...+.+++.+||+.||.+|||+.|+++
T Consensus       235 ~-~~~~~~~-~---------------------------~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 L-FLIPRNP-P---------------------------PK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             h-hhHhhCC-C---------------------------CC--CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            0 0000000 0                           00  000123456789999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.3e-35  Score=310.42  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=202.2

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ..|+..+.||.|+||.||+|.+..++..||+|+++... ......+.+|+++++.+.||||+++++++.+.     ...|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   78 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-----TKLW   78 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEE
Confidence            45888899999999999999998889999999986443 33456788999999999999999999998765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++...        .+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.
T Consensus        79 lv~e~~~~~~L~~~i~~~--------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~  147 (277)
T cd06640          79 IIMEYLGGGSALDLLRAG--------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGV  147 (277)
T ss_pred             EEEecCCCCcHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEccccc
Confidence            999999999999998653        478889999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +.......   .......++..|+|||+..+..++.++|+|||||++|||++|..||..........  ......+    
T Consensus       148 ~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~~~~~~~----  218 (277)
T cd06640         148 AGQLTDTQ---IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF--LIPKNNP----  218 (277)
T ss_pred             ceeccCCc---cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh--hhhcCCC----
Confidence            97654322   11223457889999999888889999999999999999999999997542221100  0000000    


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                             +.   ....++..+.+++.+||+.+|++||++.|+++.
T Consensus       219 -----------------------~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 -----------------------PT---LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -----------------------CC---CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                                   00   011234567799999999999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8.1e-36  Score=317.43  Aligned_cols=274  Identities=21%  Similarity=0.280  Sum_probs=198.6

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|++.+.||+|+||.||+|++..+|+.||+|+++...  ......+.+|++++++++||||+++++++.+.     ...+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-----KKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-----CceE
Confidence            5889999999999999999999899999999986432  22235677899999999999999999998655     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +|+||++ ++|.+++.....      .+++..++.++.||++||.|||+.   +++||||||+||+++.++.+||+|||.
T Consensus        76 lv~e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~  145 (284)
T cd07839          76 LVFEYCD-QDLKKYFDSCNG------DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGL  145 (284)
T ss_pred             EEEecCC-CCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccch
Confidence            9999996 588888765332      589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh-CCCch
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM-GLPDQ  795 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~~~~~  795 (871)
                      +.......   .......++..|+|||.+.+. .++.++||||+||++|+|+||..||................ ..+..
T Consensus       146 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  222 (284)
T cd07839         146 ARAFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  222 (284)
T ss_pred             hhccCCCC---CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence            97654321   112234578899999987654 46899999999999999999999875432222222111111 11100


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCc--hhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQP--NLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       ..+  +.+... ...  ........  ...+.......++.+++.+||+.||++|||++|+++
T Consensus       223 -~~~--~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         223 -ESW--PGVSKL-PDY--KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             -HHh--HHhhhc-ccc--cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence             000  000000 000  00000000  001112234567789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2e-35  Score=314.92  Aligned_cols=262  Identities=25%  Similarity=0.386  Sum_probs=201.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECC-----CCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGT-----EETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|++..... ...+.+.+|+.+++.++|||++++++++...   
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~---   80 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG---   80 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC---
Confidence            4679999999999999999999743     578899999864432 3346788999999999999999999988664   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccc---------------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQ---------------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD  696 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  696 (871)
                        ...++||||+++|+|.+++.......               .....+++..++.++.|++.||+|||+.   +++|||
T Consensus        81 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d  155 (288)
T cd05050          81 --KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD  155 (288)
T ss_pred             --CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence              56799999999999999997543210               1123578899999999999999999999   999999


Q ss_pred             CCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCc
Q 002883          697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTD  775 (871)
Q Consensus       697 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~  775 (871)
                      |||+||+++.++.++|+|||.+........ .........+..|+|||...+..++.++|||||||++|||++ |..||.
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADY-YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCcc-ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999876543211 111112234667999999888899999999999999999998 888986


Q ss_pred             hhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHH
Q 002883          776 DMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDA  855 (871)
Q Consensus       776 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~ev  855 (871)
                      ....... ...........                               .....+.++.+++.+|++.||++|||+.|+
T Consensus       235 ~~~~~~~-~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el  282 (288)
T cd05050         235 GMAHEEV-IYYVRDGNVLS-------------------------------CPDNCPLELYNLMRLCWSKLPSDRPSFASI  282 (288)
T ss_pred             CCCHHHH-HHHHhcCCCCC-------------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence            4322211 11000000000                               000123467889999999999999999999


Q ss_pred             HHHHH
Q 002883          856 IMELQ  860 (871)
Q Consensus       856 l~~L~  860 (871)
                      ++.|+
T Consensus       283 ~~~l~  287 (288)
T cd05050         283 NRILQ  287 (288)
T ss_pred             HHHhh
Confidence            99986

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-35  Score=322.07  Aligned_cols=202  Identities=25%  Similarity=0.355  Sum_probs=173.5

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||+||+|++..+++.||+|++...   .......+.+|+.++..++|++|+++++++.+.     ..
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-----~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-----NY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CE
Confidence            4799999999999999999999989999999998642   222345578899999999999999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++.....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~Df  146 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFED------RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADF  146 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEec
Confidence            8999999999999999976432      488999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-----GEVSTHGDEYSFGILMLEMFTGKRPTDD  776 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltG~~pf~~  776 (871)
                      |++........  .......||+.|+|||++.+     +.++.++||||+||++|+|++|+.||..
T Consensus       147 G~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         147 GSCLKMNQDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             cceeeccCCCc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence            99987643321  11223469999999998765     5678999999999999999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.9e-35  Score=308.28  Aligned_cols=251  Identities=27%  Similarity=0.402  Sum_probs=198.1

Q ss_pred             ceeeccccceEEEEEECC-CC--cEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGT-EE--TNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|++|.||+|.+.. .+  ..||+|.+..... ...+.+.+|+.++++++||||+++++++..      ...++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            468999999999999864 33  3699999976554 456788999999999999999999998754      4579999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++++|.+++.....     ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.+..
T Consensus        75 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~  146 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL-----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRA  146 (257)
T ss_pred             EecCCCcHHHHHHhccc-----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccc
Confidence            99999999999977542     2589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhhhh
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEI  799 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  799 (871)
                      ...............++..|+|||+..+..++.++|||||||++|+|++ |+.||........ ........  ...   
T Consensus       147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~--~~~---  220 (257)
T cd05040         147 LPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI-LKKIDKEG--ERL---  220 (257)
T ss_pred             ccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHhcC--CcC---
Confidence            7543222222223457789999999888889999999999999999998 9999964322211 11110000  000   


Q ss_pred             cChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          800 IDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                                               ......+..+.+++.+|++.+|++|||+.|+++.|.
T Consensus       221 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 -------------------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -------------------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                                     000122346778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.2e-35  Score=308.47  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=198.1

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR------GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      +|++.+.||+|+||+||+|... +++.+|+|.++....      .....+.+|++++++++|+||+++++++.+.     
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-----   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-----
Confidence            5889999999999999999875 788999999864321      1235688999999999999999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+++++|.+++....       .+++..+..++.|++.|++|||+.   +|+|+||+|+||+++.++.++|+
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~  144 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFG-------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLI  144 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEec
Confidence            67899999999999999997643       478999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCC---CccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh
Q 002883          714 DFGLSRLLHDNSP---DQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM  790 (871)
Q Consensus       714 Dfg~a~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~  790 (871)
                      |||.+........   .........++..|+|||+..+..++.++||||+||++|+|++|+.||................
T Consensus       145 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~  224 (265)
T cd06631         145 DFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR  224 (265)
T ss_pred             cchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc
Confidence            9999876532111   1111223458899999999888889999999999999999999999997532211110000000


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...+..                           .   ..+..++.+++++|++.+|++|||+.|+++
T Consensus       225 ~~~~~~---------------------------~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 GLMPRL---------------------------P---DSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCCC---------------------------C---CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000                           0   022345778999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.7e-35  Score=306.68  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=201.1

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|++.+.||+|++|.||.|.+..+++.||+|.+....  ....+.+.+|++++++++|+|++++++.+...    ....|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE----DGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC----CCEEE
Confidence            5899999999999999999999889999999986432  23346788999999999999999998876432    24579


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++......     .+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.
T Consensus        77 lv~e~~~~~~l~~~l~~~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~  148 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKGK-----LLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGI  148 (257)
T ss_pred             EEecccCCCcHHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccc
Confidence            999999999999999764322     589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +.......   .......+++.|+|||+..+..++.++||||+|+++|+|++|+.||........ .........+. ..
T Consensus       149 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~-~~  223 (257)
T cd08223         149 ARVLENQC---DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-VYRIIEGKLPP-MP  223 (257)
T ss_pred             eEEecccC---CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHhcCCCC-Cc
Confidence            98764321   122334588999999999888899999999999999999999999974322111 11111110000 00


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                                    ......+.+++.+|++.+|++|||+.|+++.
T Consensus       224 ------------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         224 ------------------------------KDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ------------------------------cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                                          1233457799999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-35  Score=311.60  Aligned_cols=263  Identities=24%  Similarity=0.377  Sum_probs=205.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCc----EEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEET----NVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ..+|++.+.||+|+||.||+|.+..+++    .||+|...... ......+.+|+.+++.++|||++++++++..     
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-----   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence            3578899999999999999999865554    58999886443 2334678899999999999999999998864     


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                       ...++||||+++|+|.+++.....      .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL  150 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRNHKD------NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKI  150 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEE
Confidence             457899999999999999976532      489999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      +|||.+......... .......++..|+|||......++.++||||||+++||+++ |+.||........  .......
T Consensus       151 ~dfg~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~  227 (279)
T cd05057         151 TDFGLAKLLDVDEKE-YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI--PDLLEKG  227 (279)
T ss_pred             CCCcccccccCcccc-eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH--HHHHhCC
Confidence            999999876532211 11111224568999999888889999999999999999999 9999975432211  1111110


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHHHh
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQA  868 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~~~  868 (871)
                      ......                              ..+...+.+++.+||..||++|||+.++++.|+++.+...|
T Consensus       228 ~~~~~~------------------------------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~  274 (279)
T cd05057         228 ERLPQP------------------------------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQR  274 (279)
T ss_pred             CCCCCC------------------------------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcc
Confidence            000000                              01123467889999999999999999999999998765544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.6e-35  Score=306.48  Aligned_cols=251  Identities=18%  Similarity=0.269  Sum_probs=203.8

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|+..+.||.|+||.||.++...+++.|++|.+....  ....+.+.+|++++++++|+||+++++++.+.     ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-----NTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-----CeEE
Confidence            6899999999999999999999899999999986432  33456788999999999999999999998765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++.....     ..+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.+||+|||.
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~  147 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKG-----QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGI  147 (256)
T ss_pred             EEEEecCCCcHHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcc
Confidence            99999999999999976532     2589999999999999999999998   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +........   ......+++.|+|||...+..++.++||||+|+++|+|++|..||........ .........+.   
T Consensus       148 ~~~~~~~~~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~---  220 (256)
T cd08221         148 SKILGSEYS---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL-VVKIVQGNYTP---  220 (256)
T ss_pred             eEEcccccc---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHcCCCCC---
Confidence            987644321   22334689999999998888889999999999999999999999974321111 11111100000   


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                                  ....+..++.+++.+|++.+|++||++.|+++.
T Consensus       221 ----------------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         221 ----------------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ----------------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                                        001234467789999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.7e-36  Score=311.77  Aligned_cols=240  Identities=24%  Similarity=0.374  Sum_probs=186.9

Q ss_pred             ceeeccccceEEEEEECCCCc-------EEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          565 NLIGIGGYGYVYKGILGTEET-------NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +.||+|+||.||+|.+...+.       .||+|.+........+.+.+|+.+++.++|||++++++++...     ...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcE
Confidence            468999999999999865443       4888888655554556788999999999999999999998764     5579


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc--------
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV--------  709 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------  709 (871)
                      +||||+++|+|.+++.....      .+++..+..++.||+.|++|||+.   +|+||||||+||+++.++.        
T Consensus        76 lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~  146 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKN------LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPF  146 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCce
Confidence            99999999999999976542      488999999999999999999999   9999999999999987765        


Q ss_pred             eEEeecccceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCC-CCCchhhhhhhhHHHH
Q 002883          710 AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGK-RPTDDMFEEGLSLHKY  787 (871)
Q Consensus       710 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~-~pf~~~~~~~~~~~~~  787 (871)
                      ++++|||.+.....       .....++..|+|||++.+. .++.++|||||||++|+|++|. .||........  ...
T Consensus       147 ~~l~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--~~~  217 (258)
T cd05078         147 IKLSDPGISITVLP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--LQF  217 (258)
T ss_pred             EEecccccccccCC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--HHH
Confidence            68999998865432       1224578899999988764 5789999999999999999985 55543221110  000


Q ss_pred             hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                      ....                         ...+.       ....++.+++.+||+.||++|||++|+++.|
T Consensus       218 ~~~~-------------------------~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         218 YEDR-------------------------HQLPA-------PKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             HHcc-------------------------ccCCC-------CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            0000                         00000       1123567999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-35  Score=310.47  Aligned_cols=250  Identities=25%  Similarity=0.337  Sum_probs=202.7

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ++|++.+.||.|+||.||+|++..+++.||+|++.... ......+.+|+++++.++|+|++++++++.+.     ...|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEE
Confidence            46889999999999999999999899999999986543 33456788999999999999999999988765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +|+||+++++|.+++...        .+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++++|||.
T Consensus        76 ~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~  144 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG--------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGV  144 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccccc
Confidence            999999999999999753        489999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +.......   .......++..|+|||+..+..++.++||||||+++|+|+||+.||.......  .........++...
T Consensus       145 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~  219 (274)
T cd06609         145 SGQLTSTM---SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIPKNNPPSLE  219 (274)
T ss_pred             ceeecccc---cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhhhcCCCCCc
Confidence            98775432   12233467889999999888889999999999999999999999997432111  00000000000000


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                                 .  ..+...+.+++.+|+..+|++|||++++++.
T Consensus       220 ---------------------------~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         220 ---------------------------G--NKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             ---------------------------c--cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                                       0  0023457789999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.1e-35  Score=312.02  Aligned_cols=277  Identities=24%  Similarity=0.321  Sum_probs=202.2

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|+..+.||.|++|.||+|++..+++.||||+++...  ......+.+|++++++++||||+++++++.+.     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-----CcEE
Confidence            4888999999999999999999899999999986432  22335788999999999999999999997654     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+. ++|.+++.....     ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||.
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~  146 (284)
T cd07860          76 LVFEFLH-QDLKKFMDASPL-----SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL  146 (284)
T ss_pred             EEeeccc-cCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999995 689998876432     2589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE-VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +.......   .......++..|+|||...+.. ++.++|||||||++|+|+||+.||....+.............+...
T Consensus       147 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  223 (284)
T cd07860         147 ARAFGVPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV  223 (284)
T ss_pred             hhhcccCc---cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            87654321   1122234688999999876544 5889999999999999999999997543332222222222211110


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                         ..+.... .........................++.+++.+|++.||++|||++|+++
T Consensus       224 ---~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         224 ---VWPGVTS-LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             ---hhhhhhH-HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence               0000000 00000001111111111222234556789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3e-35  Score=313.48  Aligned_cols=278  Identities=21%  Similarity=0.250  Sum_probs=203.4

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|++++++++|||++++++++...     ...
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-----RKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-----CEE
Confidence            47899999999999999999999889999999985432  22335678999999999999999999998765     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||++++++..++....       .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||
T Consensus        76 ~~v~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  145 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNPR-------GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFG  145 (286)
T ss_pred             EEEEeccCccHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccc
Confidence            99999999998888775432       489999999999999999999998   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hCCCc
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MGLPD  794 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~~  794 (871)
                      .+........   ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||......+........ .....
T Consensus       146 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  222 (286)
T cd07847         146 FARILTGPGD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP  222 (286)
T ss_pred             cceecCCCcc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            9987654321   1223457889999998765 55789999999999999999999999754332211111100 00001


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...+..+...   +..................+......+.+++.+|++.+|++|||+.|++.
T Consensus       223 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         223 RHQQIFSTNQ---FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HHhhhccccc---ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            1001100000   00000000000000111223344667889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=350.25  Aligned_cols=257  Identities=27%  Similarity=0.329  Sum_probs=207.8

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..+-+|.....||.|.||.||-|....+|+..|+|.++.+..  ...+.+.+|..++..++|||+|++||+-...     
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR----- 1306 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR----- 1306 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-----
Confidence            345678889999999999999999999999999999865433  3346788999999999999999999986554     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      +.++|.||||++|+|.+.++..+       ..++.....+..|++.|++|||++   |||||||||.||+++.+|.+|++
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~gr-------i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~ 1376 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGR-------IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYG 1376 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHhcc-------hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEee
Confidence            66899999999999999998765       467788888999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCC-CCccccccccccccccCcccccCC---CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh
Q 002883          714 DFGLSRLLHDNS-PDQTSTSRVKGSIGYVAPEYGALG---EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK  789 (871)
Q Consensus       714 Dfg~a~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~  789 (871)
                      |||.|..+.... ..........||+.|||||++.+.   .-.-++||||+|||+.||+||+.||.....+-..+.+...
T Consensus      1377 DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~ 1456 (1509)
T KOG4645|consen 1377 DFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA 1456 (1509)
T ss_pred             cccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc
Confidence            999999887553 222334457899999999987654   3467899999999999999999999876544333333222


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ...|+-..                               ....+-.+++..|++.||++|++|.|+++.
T Consensus      1457 gh~Pq~P~-------------------------------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 GHKPQIPE-------------------------------RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             cCCCCCch-------------------------------hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            22221111                               122344588899999999999999988764

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3e-35  Score=315.64  Aligned_cols=262  Identities=25%  Similarity=0.411  Sum_probs=203.1

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCc----EEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEET----NVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      .++|+..+.||+|+||.||+|.+..++.    .||+|.+..... .....+.+|+.+++.++||||+++++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence            4578889999999999999999876665    578888854332 2234688999999999999999999988642    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                        ..++++||+++|+|.+++.....      .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||
T Consensus        82 --~~~~v~e~~~~g~l~~~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL  150 (303)
T cd05110          82 --TIQLVTQLMPHGCLLDYVHEHKD------NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKI  150 (303)
T ss_pred             --CceeeehhcCCCCHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEE
Confidence              35799999999999999976432      478999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      +|||.+......... .......++..|+|||...+..++.++|||||||++|||++ |..||.......  ........
T Consensus       151 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~  227 (303)
T cd05110         151 TDFGLARLLEGDEKE-YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IPDLLEKG  227 (303)
T ss_pred             ccccccccccCcccc-cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHCC
Confidence            999999876432211 11222345678999999888889999999999999999997 999997532211  11111110


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQ  867 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~~  867 (871)
                      ......                              ..+...+.+++..|+..+|++||++.|+++.++++.+...
T Consensus       228 ~~~~~~------------------------------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         228 ERLPQP------------------------------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             CCCCCC------------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence            000000                              0112356789999999999999999999999998865544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=325.94  Aligned_cols=257  Identities=25%  Similarity=0.403  Sum_probs=207.5

Q ss_pred             CCCceeeccccceEEEEEECCCCc----EEEEEEeec-cccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          562 SSANLIGIGGYGYVYKGILGTEET----NVAVKVLDL-QQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       562 ~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ...++||+|+||+||+|.|-..++    +||+|++.. .......++..|+-+|.+++|||+++++++|...      ..
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~~  772 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------TL  772 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------hH
Confidence            446889999999999999955553    589998843 3444568899999999999999999999999765      26


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      .+|++|++.|+|.+|++.++.      .+.....+.|..|||+||.|||.+   ++|||||..+||||+....+|+.|||
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~------~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfg  843 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRD------NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFG  843 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhc------cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecc
Confidence            799999999999999998765      588899999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      +|+....+..... .....-.+.|||=|.+....|+.++|||||||++||++| |..|++....++..            
T Consensus       844 la~ll~~d~~ey~-~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~------------  910 (1177)
T KOG1025|consen  844 LAKLLAPDEKEYS-APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP------------  910 (1177)
T ss_pred             hhhccCccccccc-ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh------------
Confidence            9998876543322 222334678999999999999999999999999999999 99999865433211            


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                        +.+....                  ..+..+.+...+..++.+||..|+..||+++++.+.+.++.+.-
T Consensus       911 --dlle~ge------------------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  911 --DLLEKGE------------------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             --HHHhccc------------------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence              0000000                  00011134456778899999999999999999999999886543

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-35  Score=307.11  Aligned_cols=255  Identities=31%  Similarity=0.489  Sum_probs=201.2

Q ss_pred             ceeeccccceEEEEEECCC---CcEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTE---ETNVAVKVLDLQQRG-ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||.||+|.+...   +..||+|++...... ..+.+.+|++.++.++|+|++++++++...     ...++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE-----EPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCC-----CceEEEE
Confidence            4689999999999999865   889999999655433 257888999999999999999999998763     6789999


Q ss_pred             eccCCCCHHHHhhcccccc--cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          641 EFMPNGSLENWLNQKEDEQ--NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||+++++|.+++.......  .....+++..++.++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||.+
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence            9999999999998752100  0012689999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      ........ ........++..|+|||......++.++||||+|+++|+|++ |..||.......  ...........   
T Consensus       153 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~---  226 (262)
T cd00192         153 RDVYDDDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VLEYLRKGYRL---  226 (262)
T ss_pred             cccccccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCCC---
Confidence            87754321 122233457889999999888889999999999999999999 699997642211  11111100000   


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                                                 .....++.++.+++.+|++.+|++|||+.|+++.|+
T Consensus       227 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 ---------------------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---------------------------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                                       000122456789999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-35  Score=311.63  Aligned_cols=262  Identities=23%  Similarity=0.307  Sum_probs=205.0

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCc-CCC
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDT-RGN  633 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~  633 (871)
                      .+.++|++.+.||+|+||.||+|.+..+++.|++|++..... ..+.+.+|+++++++ +|+||+++++++..... ..+
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            356899999999999999999999988899999999875543 346788999999999 79999999999876543 335


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||+++++|.+++......   ...+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKK---GKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEEC
Confidence            6789999999999999998754311   12589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-----GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA  788 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~  788 (871)
                      |||.+.......   .......++..|+|||++..     ..++.++||||+||++|+|++|+.||....... ......
T Consensus       156 d~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~  231 (275)
T cd06608         156 DFGVSAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIP  231 (275)
T ss_pred             CCccceecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhh
Confidence            999998654321   12233458899999997643     346789999999999999999999997432211 111111


Q ss_pred             hhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          789 KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .. .+.   .+.                         ........+.+++.+|+..||++|||+.|+++
T Consensus       232 ~~-~~~---~~~-------------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 RN-PPP---TLK-------------------------SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             cc-CCC---CCC-------------------------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            10 000   000                         00123456779999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.5e-35  Score=319.79  Aligned_cols=280  Identities=17%  Similarity=0.175  Sum_probs=197.5

Q ss_pred             CCceeecc--ccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          563 SANLIGIG--GYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       563 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      +.++||+|  +|++||++++..+++.||+|+++...  ....+.+.+|+++++.++||||+++++++...     ...|+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence            46789999  68899999999999999999996542  23345677899999999999999999998765     66899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||+++|+|.+++......     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+
T Consensus        77 v~e~~~~~~l~~~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~  148 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFMD-----GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN  148 (327)
T ss_pred             EEeccCCCcHHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchh
Confidence            99999999999999764322     488999999999999999999999   9999999999999999999999999875


Q ss_pred             eecCCCCCCc----cccccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          719 RLLHDNSPDQ----TSTSRVKGSIGYVAPEYGAL--GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       719 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      ..........    .......++..|+|||++.+  ..++.++|||||||++|||++|+.||............ .....
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~  227 (327)
T cd08227         149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTV  227 (327)
T ss_pred             hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCc
Confidence            4432111000    01122346778999998765  46899999999999999999999999754332211111 11111


Q ss_pred             Cchhh-------hh--------cChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          793 PDQVA-------EI--------IDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       793 ~~~~~-------~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      +....       +.        .+......... .............+........+.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTV-STPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccccccchhhhhcccCCcccCCcCCCCccccc-CCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            10000       00        00000000000 0000000000001112234567889999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.2e-35  Score=320.65  Aligned_cols=203  Identities=25%  Similarity=0.348  Sum_probs=173.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||+||+|++..+++.||+|++....   ......+.+|+.++..++|++|+++++++.+.     ..
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-----NN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----CE
Confidence            47899999999999999999999899999999985321   22334578899999999999999999988665     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++.....      .+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~Df  146 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFED------RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF  146 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeec
Confidence            8999999999999999976432      489999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA-----LGEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      |++.......  ........||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       147 G~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         147 GSCLKLMEDG--TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             chheecccCC--cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            9997653321  11223356999999999875     346789999999999999999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.3e-35  Score=307.23  Aligned_cols=255  Identities=24%  Similarity=0.392  Sum_probs=192.7

Q ss_pred             ceeeccccceEEEEEECC---CCcEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGT---EETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||.||+|.+..   ....||+|.+... .....+.+.+|+.+++.++|||++++++++...    +...++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence            468999999999998743   3457999988532 233456788999999999999999999976533    14468999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+.+|+|.+++.....      ..++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||.+..
T Consensus        77 e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~  147 (262)
T cd05058          77 PYMKHGDLRNFIRSETH------NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARD  147 (262)
T ss_pred             ecCCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcccccc
Confidence            99999999999976432      367788899999999999999998   999999999999999999999999999976


Q ss_pred             cCCCCCCc-cccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhC-CCCCchhhhhhhhHHHHhhhCCCchhhh
Q 002883          721 LHDNSPDQ-TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG-KRPTDDMFEEGLSLHKYAKMGLPDQVAE  798 (871)
Q Consensus       721 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~  798 (871)
                      ........ .......++..|+|||...+..++.++|||||||++|||++| .+||.......  .........+...  
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~--~~~~~~~~~~~~~--  223 (262)
T cd05058         148 IYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD--ITVYLLQGRRLLQ--  223 (262)
T ss_pred             ccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhcCCCCCC--
Confidence            54321111 111123456789999998888899999999999999999995 55665322111  1111110000000  


Q ss_pred             hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                                            +      ...+..+.+++.+||+.+|++||++.|+++.|+++.+
T Consensus       224 ----------------------~------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         224 ----------------------P------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             ----------------------C------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                                  0      0123457799999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.6e-35  Score=308.84  Aligned_cols=257  Identities=23%  Similarity=0.369  Sum_probs=188.7

Q ss_pred             ceeeccccceEEEEEECC--CCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEe
Q 002883          565 NLIGIGGYGYVYKGILGT--EETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE  641 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  641 (871)
                      +.||+|+||.||+|.+..  ++..+|+|.++.... .....+.+|+.++++++||||+++++++.+.     ...++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEEE
Confidence            358999999999998643  456799998865432 2345788899999999999999999988665     55799999


Q ss_pred             ccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceec
Q 002883          642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL  721 (871)
Q Consensus       642 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  721 (871)
                      |+++|+|.+++......  .....++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+...
T Consensus        76 ~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  150 (269)
T cd05087          76 FCPLGDLKGYLRSCRKA--ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNK  150 (269)
T ss_pred             CCCCCcHHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccc
Confidence            99999999999764321  122467778889999999999999999   9999999999999999999999999999754


Q ss_pred             CCCCCCccccccccccccccCcccccCC-------CCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCC
Q 002883          722 HDNSPDQTSTSRVKGSIGYVAPEYGALG-------EVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       722 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ..... ........++..|+|||++.+.       .++.++||||||+++|||++ |+.||.................  
T Consensus       151 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--  227 (269)
T cd05087         151 YKEDY-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ--  227 (269)
T ss_pred             cCcce-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc--
Confidence            33211 1112234567889999986532       35789999999999999996 9999975432221111110000  


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                         ....++...                   .   ...+.+.+++..|+ .+|++|||++||++.|+
T Consensus       228 ---~~~~~~~~~-------------------~---~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         228 ---LKLPKPRLK-------------------L---PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ---CCCCCCccC-------------------C---CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence               000011000                   0   11234567888898 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.9e-35  Score=307.28  Aligned_cols=254  Identities=28%  Similarity=0.383  Sum_probs=202.0

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG--ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|++.+.||+|+||.||+|.+..+++.||+|+++.....  ..+.+.+|+++++.++|+||+++++++...     ...+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-----EKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-----CEEE
Confidence            688999999999999999999888999999999655442  567889999999999999999999987554     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +|+||+++++|.+++....       .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.+||+|||.
T Consensus        76 lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~  145 (264)
T cd06626          76 IFMEYCSGGTLEELLEHGR-------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGC  145 (264)
T ss_pred             EEEecCCCCcHHHHHhhcC-------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccccc
Confidence            9999999999999997643       478899999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccc-cccccccccccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          718 SRLLHDNSPDQTS-TSRVKGSIGYVAPEYGALGE---VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       718 a~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      +............ .....++..|+|||++.+..   ++.++||||||+++|++++|+.||........... .......
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~  224 (264)
T cd06626         146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF-HVGAGHK  224 (264)
T ss_pred             ccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH-HHhcCCC
Confidence            9876543322211 22345788999999987665   78999999999999999999999975321111111 0110000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...                            +....+...+.+++.+|++.+|++|||+.|++.
T Consensus       225 ~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PPI----------------------------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCC----------------------------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000                            001122345678999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.7e-35  Score=311.94  Aligned_cols=276  Identities=23%  Similarity=0.285  Sum_probs=204.5

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....  ......+.+|+.++++++|||++++++++...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-----SGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-----CeeE
Confidence            5889999999999999999998899999999996543  33456788999999999999999999998764     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+ +++|.+++.....      .+++.+++.++.||+.||+|||+.   +++|+||||+||+++.++.++++|||.
T Consensus        76 ~v~e~~-~~~L~~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~  145 (286)
T cd07832          76 LVMEYM-PSDLSEVLRDEER------PLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGL  145 (286)
T ss_pred             EEeccc-CCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeee
Confidence            999999 9999999875432      589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hCCCch
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MGLPDQ  795 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~~~  795 (871)
                      +........  .......++..|+|||.+.+. .++.++||||+||++|+|++|.+||....... ....... ...+..
T Consensus       146 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~  222 (286)
T cd07832         146 ARLFSEEEP--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAIVFRTLGTPNE  222 (286)
T ss_pred             cccccCCCC--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHHHHHHcCCCCh
Confidence            987654321  122334688999999987544 46899999999999999999988886433221 1111111 111100


Q ss_pred             --hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          796 --VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       796 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                        ..+..+......     ..............+.+....+.+++.+|++.+|++|||++++++.
T Consensus       223 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         223 ETWPGLTSLPDYNK-----ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             HHHhhccCcchhhc-----ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              101000000000     0000000001112223445788999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-35  Score=312.41  Aligned_cols=264  Identities=23%  Similarity=0.287  Sum_probs=204.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+++++.++||||+++++++...     ...
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~   78 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNI   78 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEE
Confidence            357888999999999999999999889999999986443 23456788999999999999999999998765     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++++|.+++...+       .+++..+..++.+++.|+.|||+.  .+++||||+|+||+++.++.++|+|||
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~g  149 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKGG-------PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFG  149 (284)
T ss_pred             EEEEecCCCCCHHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCC
Confidence            99999999999999987643       589999999999999999999973  189999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      ++......     ......|+..|+|||++.+..++.++|||||||++|++++|+.||..........      ..+...
T Consensus       150 l~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~------~~~~~~  218 (284)
T cd06620         150 VSGELINS-----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ------DDPMGI  218 (284)
T ss_pred             cccchhhh-----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh------hhhhHH
Confidence            98654321     1123468999999999888889999999999999999999999998543221100      000000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                      .+...            .......+...  ...+..++.+++.+|++.||++|||+.|+++...
T Consensus       219 ~~~~~------------~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         219 LDLLQ------------QIVQEPPPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             HHHHH------------HHhhccCCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            00000            00000000000  0124456889999999999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-35  Score=308.20  Aligned_cols=255  Identities=24%  Similarity=0.395  Sum_probs=194.9

Q ss_pred             ceeeccccceEEEEEECCCCc--EEEEEEeecc-ccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTEET--NVAVKVLDLQ-QRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||.||+|++..++.  .+|+|.++.. .......+.+|+++++++ +||||+++++++...     ...|+||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEEE
Confidence            368999999999999977665  4688887632 233446788999999999 899999999998665     5679999


Q ss_pred             eccCCCCHHHHhhcccccc---------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 002883          641 EFMPNGSLENWLNQKEDEQ---------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                      ||+++|+|.+++.......         .....+++.++..++.|++.|++|||+.   +++||||||+||++++++.+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence            9999999999997643210         1122578999999999999999999998   999999999999999999999


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhh
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKM  790 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~  790 (871)
                      ++|||++......    ........+..|+|||+.....++.++|||||||++|||++ |..||........  ......
T Consensus       153 l~dfgl~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~~~~~  226 (270)
T cd05047         153 IADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YEKLPQ  226 (270)
T ss_pred             ECCCCCccccchh----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH--HHHHhC
Confidence            9999998532211    11111223567999999888889999999999999999997 9999975322110  000000


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                      .....                              .......++.+++.+|+..+|.+|||+.|+++.|+++.
T Consensus       227 ~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         227 GYRLE------------------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCCCC------------------------------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            00000                              00012345779999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.7e-35  Score=306.42  Aligned_cols=240  Identities=23%  Similarity=0.381  Sum_probs=186.6

Q ss_pred             ceeeccccceEEEEEECCC------------CcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          565 NLIGIGGYGYVYKGILGTE------------ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      +.||+|+||.||+|+....            ...||+|++..........+.+|+.+++.++||||+++++++...    
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~----   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD----   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence            4689999999999986422            235899998765555566788899999999999999999998655    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc---
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV---  709 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---  709 (871)
                       ...++||||+++++|..++.....      .+++..++.++.||+.|++|||+.   +|+||||||+||+++.++.   
T Consensus        77 -~~~~lv~e~~~~~~l~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~  146 (262)
T cd05077          77 -VENIMVEEFVEFGPLDLFMHRKSD------VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGE  146 (262)
T ss_pred             -CCCEEEEecccCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCC
Confidence             557899999999999998865432      589999999999999999999999   9999999999999986654   


Q ss_pred             ----eEEeecccceecCCCCCCccccccccccccccCccccc-CCCCCCccchhhHHHHHHHHH-hCCCCCchhhhhhhh
Q 002883          710 ----AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA-LGEVSTHGDEYSFGILMLEMF-TGKRPTDDMFEEGLS  783 (871)
Q Consensus       710 ----~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell-tG~~pf~~~~~~~~~  783 (871)
                          ++++|||.+.....       .....++..|+|||.+. +..++.++|||||||++|||+ +|+.||........ 
T Consensus       147 ~~~~~~l~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-  218 (262)
T cd05077         147 CGPFIKLSDPGIPITVLS-------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-  218 (262)
T ss_pred             CCceeEeCCCCCCccccC-------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-
Confidence                89999999875432       12245788999999876 467899999999999999998 58888864321110 


Q ss_pred             HHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          784 LHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                       ........     ....                           ....++.+++.+||+.||++||++.|+++.+
T Consensus       219 -~~~~~~~~-----~~~~---------------------------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         219 -ERFYEGQC-----MLVT---------------------------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -HHHHhcCc-----cCCC---------------------------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence             00000000     0000                           1123567899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.9e-35  Score=309.71  Aligned_cols=239  Identities=23%  Similarity=0.358  Sum_probs=184.5

Q ss_pred             eeeccccceEEEEEECC------------------------CCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccee
Q 002883          566 LIGIGGYGYVYKGILGT------------------------EETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKI  621 (871)
Q Consensus       566 ~lg~G~~g~V~~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~  621 (871)
                      .||+|+||.||+|....                        ....||+|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999998532                        124589999865544445678889999999999999999


Q ss_pred             eeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 002883          622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN  701 (871)
Q Consensus       622 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  701 (871)
                      ++++.+.     ...++||||+++|+|..++.....      .+++..+..++.|+++||+|||+.   +|+||||||+|
T Consensus        82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~N  147 (274)
T cd05076          82 HGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKG------RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKN  147 (274)
T ss_pred             EEEEEeC-----CceEEEEecCCCCcHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCccc
Confidence            9998765     567999999999999999875432      588999999999999999999999   99999999999


Q ss_pred             eeeCCCC-------ceEEeecccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHH-hCCC
Q 002883          702 VLLDNEM-------VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMF-TGKR  772 (871)
Q Consensus       702 ill~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell-tG~~  772 (871)
                      |+++..+       .+|++|||.+......       ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.
T Consensus       148 ill~~~~~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~  220 (274)
T cd05076         148 ILLARLGLAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEV  220 (274)
T ss_pred             EEEeccCcccCccceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9997643       4899999988643221       12347788999998765 56899999999999999995 6999


Q ss_pred             CCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCH
Q 002883          773 PTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI  852 (871)
Q Consensus       773 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta  852 (871)
                      ||........  .......                         ...+.       .....+.+++.+||+.+|++|||+
T Consensus       221 p~~~~~~~~~--~~~~~~~-------------------------~~~~~-------~~~~~~~~li~~cl~~~p~~Rps~  266 (274)
T cd05076         221 PLKERTPSEK--ERFYEKK-------------------------HRLPE-------PSCKELATLISQCLTYEPTQRPSF  266 (274)
T ss_pred             CccccChHHH--HHHHHhc-------------------------cCCCC-------CCChHHHHHHHHHcccChhhCcCH
Confidence            9875322111  0000000                         00000       011346789999999999999999


Q ss_pred             HHHHHHH
Q 002883          853 QDAIMEL  859 (871)
Q Consensus       853 ~evl~~L  859 (871)
                      .|+++.|
T Consensus       267 ~~il~~L  273 (274)
T cd05076         267 RTILRDL  273 (274)
T ss_pred             HHHHHhh
Confidence            9999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.1e-35  Score=313.43  Aligned_cols=250  Identities=24%  Similarity=0.334  Sum_probs=199.1

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEE
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV  639 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  639 (871)
                      .|.....||+|+||.||+|.+..++..||||.+........+.+.+|+.+++.++|+|++++++.+...     +..|+|
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~lv   97 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-----DELWVV   97 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-----CeEEEE
Confidence            344457799999999999999888999999998765555567788999999999999999999987654     678999


Q ss_pred             EeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccce
Q 002883          640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR  719 (871)
Q Consensus       640 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  719 (871)
                      |||+++++|.+++...        .+++.++..++.||+.|+.|||+.   +|+||||||+||+++.++.++|+|||.+.
T Consensus        98 ~e~~~~~~L~~~~~~~--------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~  166 (292)
T cd06658          98 MEFLEGGALTDIVTHT--------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCA  166 (292)
T ss_pred             EeCCCCCcHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchh
Confidence            9999999999988542        478999999999999999999999   99999999999999999999999999987


Q ss_pred             ecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhh
Q 002883          720 LLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEI  799 (871)
Q Consensus       720 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  799 (871)
                      ......   .......|+..|+|||...+..++.++||||||+++|||++|+.||........ .. ......+....  
T Consensus       167 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~-~~~~~~~~~~~--  239 (292)
T cd06658         167 QVSKEV---PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-MR-RIRDNLPPRVK--  239 (292)
T ss_pred             hccccc---ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHhcCCCccc--
Confidence            653321   112234688999999998888899999999999999999999999974322110 00 00000000000  


Q ss_pred             cChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          800 IDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                                ........+.+++.+|+..||++|||++|+++.
T Consensus       240 --------------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         240 --------------------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             --------------------------cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                                      001223456788999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.4e-35  Score=318.18  Aligned_cols=267  Identities=24%  Similarity=0.365  Sum_probs=204.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCC-------CcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeeccc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTE-------ETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCSSI  628 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  628 (871)
                      ..+|++.+.||+|+||.||+|++...       +..||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            45799999999999999999986432       2368999886432 22346788999999999 899999999998664


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhcccccc---------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDEQ---------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP  699 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  699 (871)
                           ...++||||+++|+|.+++.......         .....+++.++..++.|++.|++|||+.   +++||||||
T Consensus        91 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp  162 (334)
T cd05100          91 -----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAA  162 (334)
T ss_pred             -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccccc
Confidence                 56899999999999999997643210         1123588899999999999999999999   999999999


Q ss_pred             CceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhh
Q 002883          700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMF  778 (871)
Q Consensus       700 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~  778 (871)
                      +||+++.++.+||+|||.++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  241 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  241 (334)
T ss_pred             ceEEEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999999866432211 11112234567999999988899999999999999999998 889987532


Q ss_pred             hhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          779 EEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .+..  ...........                              ....+..++.+++.+|++.+|++|||+.|+++.
T Consensus       242 ~~~~--~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         242 VEEL--FKLLKEGHRMD------------------------------KPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHH--HHHHHcCCCCC------------------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            2211  11111000000                              000223467799999999999999999999999


Q ss_pred             HHHHHHH
Q 002883          859 LQEAQKM  865 (871)
Q Consensus       859 L~~i~~~  865 (871)
                      |+++...
T Consensus       290 l~~~~~~  296 (334)
T cd05100         290 LDRVLTV  296 (334)
T ss_pred             HHHHhhh
Confidence            9988743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.9e-36  Score=337.72  Aligned_cols=260  Identities=23%  Similarity=0.344  Sum_probs=200.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC----
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG----  632 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~----  632 (871)
                      ..+|+..+.||+||||.||+++.+-+|+.||||.+... .......+.+|+..+.+++|||||+++..+.+.....    
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            45678889999999999999999999999999999644 3334567889999999999999999986553211100    


Q ss_pred             --------------------------------------------------------------------------------
Q 002883          633 --------------------------------------------------------------------------------  632 (871)
Q Consensus       633 --------------------------------------------------------------------------------  632 (871)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ------------------------------CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHH
Q 002883          633 ------------------------------NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE  682 (871)
Q Consensus       633 ------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~  682 (871)
                                                    ....||-||||+..++.++++.+.-.      -.....|+++++|++||+
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~------~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN------SQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc------hhhHHHHHHHHHHHHHHH
Confidence                                          02468999999998888888776421      147789999999999999


Q ss_pred             HHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecC---C------------CCCCccccccccccccccCccccc
Q 002883          683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH---D------------NSPDQTSTSRVKGSIGYVAPEYGA  747 (871)
Q Consensus       683 ~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~---~------------~~~~~~~~~~~~gt~~y~aPE~~~  747 (871)
                      |+|++   |||||||||.||+++++..|||+|||+|+...   .            ........+..+||.-|+|||++.
T Consensus       712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            99999   99999999999999999999999999998822   0            011122344568999999999876


Q ss_pred             CC---CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhH
Q 002883          748 LG---EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLR  824 (871)
Q Consensus       748 ~~---~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  824 (871)
                      +.   .|+.|+|+||+|+|++||+.   ||...-+....+.......+|.. ..+.++...                   
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~~~-------------------  845 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPEHP-------------------  845 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccccch-------------------
Confidence            54   49999999999999999995   57754444444444434444444 333443322                   


Q ss_pred             HhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          825 AKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       825 ~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                              .=..+|++|++.||.+||||.|++.
T Consensus       846 --------~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  846 --------EEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             --------HHHHHHHHHhcCCCccCCCHHHHhh
Confidence                    2247889999999999999999985

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.1e-35  Score=303.91  Aligned_cols=247  Identities=30%  Similarity=0.461  Sum_probs=194.1

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEecc
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM  643 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  643 (871)
                      +.||+|+||.||+|... +++.||+|.++.... .....+.+|+++++.++||||+++++++...     ...++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEECC
Confidence            46899999999999875 688999999864432 2335688999999999999999999998665     5679999999


Q ss_pred             CCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCC
Q 002883          644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD  723 (871)
Q Consensus       644 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  723 (871)
                      ++++|.+++.....      .+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.+|++|||.+.....
T Consensus        75 ~~~~L~~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  145 (250)
T cd05085          75 PGGDFLSFLRKKKD------ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDD  145 (250)
T ss_pred             CCCcHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccc
Confidence            99999999865432      478999999999999999999998   999999999999999999999999999976443


Q ss_pred             CCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhhhhcCh
Q 002883          724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDP  802 (871)
Q Consensus       724 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  802 (871)
                      ...  .......++..|+|||+..++.++.++||||||+++|++++ |..||.........  ...........      
T Consensus       146 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~--~~~~~~~~~~~------  215 (250)
T cd05085         146 GIY--SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR--EQVEKGYRMSC------  215 (250)
T ss_pred             ccc--ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH--HHHHcCCCCCC------
Confidence            211  11112234677999999888889999999999999999998 99999754322111  11111000000      


Q ss_pred             hHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          803 AILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                                              ...++..+.+++.+|+..+|++|||+.|+++.|.
T Consensus       216 ------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         216 ------------------------PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             ------------------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                                    0012346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-35  Score=313.34  Aligned_cols=277  Identities=23%  Similarity=0.304  Sum_probs=199.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+|++++++++|+||+++++++.+.     ...
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~   78 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK-----KTL   78 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC-----CeE
Confidence            3679999999999999999999988899999999864332 2234567899999999999999999998655     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||++ ++|.+++.....      .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        79 ~lv~e~~~-~~L~~~~~~~~~------~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  148 (291)
T cd07844          79 TLVFEYLD-TDLKQYMDDCGG------GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFG  148 (291)
T ss_pred             EEEEecCC-CCHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccc
Confidence            99999997 599998876432      488999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hCCCc
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MGLPD  794 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~~  794 (871)
                      .+.......   .......++..|+|||+..+ ..++.++||||+|+++|+|++|+.||............... ...+.
T Consensus       149 ~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  225 (291)
T cd07844         149 LARAKSVPS---KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPT  225 (291)
T ss_pred             cccccCCCC---ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCC
Confidence            987543211   11112346789999998765 45789999999999999999999999754322111111111 11110


Q ss_pred             --hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHH--HHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 --QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQ--VSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                        ........   .....  ...................  ..+.+++.+|++.+|++|||+.|+++
T Consensus       226 ~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         226 EETWPGVSSN---PEFKP--YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhhhhhhc---ccccc--ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence              00000000   00000  0000000011111111222  56789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=7.4e-35  Score=304.93  Aligned_cols=250  Identities=19%  Similarity=0.281  Sum_probs=201.4

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|++.+.||+|+||.||.+++..+++.||+|.+....  ....+.+.+|++++++++||||+++++++.+.     .+.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-----GNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC-----CeEE
Confidence            5889999999999999999999899999999986432  23346788999999999999999999988654     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++......     .+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||.
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~  147 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRGV-----LFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGI  147 (256)
T ss_pred             EEEecCCCCcHHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccc
Confidence            999999999999999764322     478999999999999999999998   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +.......   .......|+..|+|||+..+..++.++|+|||||++|+|++|+.||........ .........+.   
T Consensus       148 ~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~---  220 (256)
T cd08218         148 ARVLNSTV---ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL-VLKIIRGSYPP---  220 (256)
T ss_pred             eeecCcch---hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH-HHHHhcCCCCC---
Confidence            98654321   112234578899999998888899999999999999999999999974321111 11111110000   


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                                  .......++.+++.+|++.+|++||++.|+++
T Consensus       221 ----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 ----------------------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ----------------------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                                        00122345789999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-35  Score=304.03  Aligned_cols=248  Identities=30%  Similarity=0.466  Sum_probs=195.7

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEecc
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG-ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM  643 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  643 (871)
                      +.||+|+||.||+|.+.. ++.||+|.+...... ....+.+|++++++++|+||+++++++...     ...++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEcC
Confidence            468999999999999986 999999998654332 456789999999999999999999988765     5689999999


Q ss_pred             CCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCC
Q 002883          644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD  723 (871)
Q Consensus       644 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  723 (871)
                      ++++|.+++.....      .+++..+..++.+++.|++|||++   +++||||||+||+++.++.+||+|||.+.....
T Consensus        75 ~~~~l~~~l~~~~~------~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  145 (251)
T cd05041          75 PGGSLLTFLRKKKN------RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEG  145 (251)
T ss_pred             CCCcHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccC
Confidence            99999999976432      478999999999999999999999   999999999999999999999999999986542


Q ss_pred             CCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhhhhcCh
Q 002883          724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDP  802 (871)
Q Consensus       724 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  802 (871)
                      .. ..........+..|+|||...++.++.++|||||||++|+|++ |..||........  ............      
T Consensus       146 ~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~--~~~~~~~~~~~~------  216 (251)
T cd05041         146 GI-YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT--RERIESGYRMPA------  216 (251)
T ss_pred             Cc-ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH--HHHHhcCCCCCC------
Confidence            21 1111111224567999999888889999999999999999999 8889865322211  111110000000      


Q ss_pred             hHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          803 AILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                                              ....+.++.+++.+|+..+|++|||+.|+++.|+
T Consensus       217 ------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         217 ------------------------PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ------------------------CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence                                    0012346789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.4e-35  Score=309.12  Aligned_cols=256  Identities=28%  Similarity=0.414  Sum_probs=196.7

Q ss_pred             ceeeccccceEEEEEECCCC------cEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          565 NLIGIGGYGYVYKGILGTEE------TNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +.||+|+||.||+|++....      +.||+|.+.... ......+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCeE
Confidence            36899999999999985433      679999885432 23456788999999999999999999988654     5589


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-----ceEE
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM-----VAHV  712 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~~kl  712 (871)
                      +||||+++++|.+++............+++.++..++.|++.|++|||+.   +++|+||||+||+++.++     .+++
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence            99999999999999976432211233578999999999999999999998   999999999999999877     8999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      +|||++........ ........++..|+|||++.++.++.++|||||||++|+|++ |+.||.......  ........
T Consensus       153 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~  229 (269)
T cd05044         153 GDFGLARDIYKSDY-YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQHVTAG  229 (269)
T ss_pred             CCcccccccccccc-cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHHHHhcC
Confidence            99999976543211 111122345678999999988899999999999999999998 999997432221  11111100


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                      ...                              ......+..+.+++.+||..+|++||+++++++.|++
T Consensus       230 ~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         230 GRL------------------------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             Ccc------------------------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            000                              0001234567899999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-34  Score=303.67  Aligned_cols=248  Identities=25%  Similarity=0.331  Sum_probs=199.0

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-----RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      +|+..+.||+|+||.||+|.+..+++.||+|.+....     ....+.+.+|+++++.++|+||+++++++...     .
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-----D   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-----C
Confidence            5888899999999999999998889999999986433     22446788999999999999999999987655     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+++++|.+++....       .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d  145 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYG-------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLAD  145 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcc
Confidence            6899999999999999997643       488999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE-VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||.+.......    ......++..|+|||...... ++.++|+|||||++|+|++|+.||......... .........
T Consensus       146 ~~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~  220 (258)
T cd06632         146 FGMAKQVVEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV-FKIGRSKEL  220 (258)
T ss_pred             Cccceeccccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH-HHHHhcccC
Confidence            99988754322    123345889999999877665 899999999999999999999999754311111 111000000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...                              ...+...+.+++.+|++.+|++|||+.|+++
T Consensus       221 ~~~------------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 PPI------------------------------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCc------------------------------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            000                              0112345678999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7e-35  Score=307.49  Aligned_cols=257  Identities=23%  Similarity=0.323  Sum_probs=186.2

Q ss_pred             ceeeccccceEEEEEECC--CCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEe
Q 002883          565 NLIGIGGYGYVYKGILGT--EETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE  641 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  641 (871)
                      +.||+|+||.||+|....  ....+|+|.+.... ......+.+|+++++.++||||+++++++...     ...|+|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEEE
Confidence            358999999999997532  34578889875432 22345678999999999999999999988765     56899999


Q ss_pred             ccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceec
Q 002883          642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL  721 (871)
Q Consensus       642 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  721 (871)
                      |+++|+|.+++.......  ....++..+..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||.+...
T Consensus        76 ~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMV--AQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             eCCCCcHHHHHHhccccc--cccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccccccc
Confidence            999999999997754321  11356788899999999999999999   9999999999999999999999999998654


Q ss_pred             CCCCCCccccccccccccccCccccc-------CCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCC
Q 002883          722 HDNSPDQTSTSRVKGSIGYVAPEYGA-------LGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       722 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ...... .......++..|+|||+..       ...++.++|||||||++|||++ |..||........ ..........
T Consensus       151 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~~~  228 (269)
T cd05042         151 YPEDYY-ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LKQVVREQDI  228 (269)
T ss_pred             ccchhe-eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-HHHHhhccCc
Confidence            322111 1112234567899999753       3456889999999999999999 7888875432221 1111111100


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                          .+..+.+                      .......+.+++..|+ .||++|||++||++.|.
T Consensus       229 ----~~~~~~~----------------------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         229 ----KLPKPQL----------------------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ----cCCCCcc----------------------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence                0000000                      0012234556777788 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=9.9e-35  Score=305.70  Aligned_cols=255  Identities=22%  Similarity=0.280  Sum_probs=202.6

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....  ....+.+..|+++++.++|||++++++++...   .+...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence            5888999999999999999999899999999986432  23346788899999999999999999877543   225679


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH-----HHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                      ++|||+++++|.+++......   ...+++..++.++.|++.|+.|||     +.   +++|+||+|+||+++.++.+|+
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl  151 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKE---RKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKL  151 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEE
Confidence            999999999999999764321   236899999999999999999999     66   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      +|||.+........   ......++..|+|||...+..++.++||||||+++|+|++|+.||......  ..........
T Consensus       152 ~d~g~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~  226 (265)
T cd08217         152 GDFGLAKILGHDSS---FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--QLASKIKEGK  226 (265)
T ss_pred             ecccccccccCCcc---cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--HHHHHHhcCC
Confidence            99999987654321   122346899999999998888999999999999999999999999754311  1111111100


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ...                              ........+.+++.+|++.+|++|||+.||++.
T Consensus       227 ~~~------------------------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         227 FRR------------------------------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CCC------------------------------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            000                              001233567899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.5e-35  Score=305.96  Aligned_cols=255  Identities=25%  Similarity=0.459  Sum_probs=201.4

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ..++|++.+.||+|+||.||+|.+. .+..||+|.+.... ...+.+.+|+++++.++|+||+++++++..      ...
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~   75 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPI   75 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCe
Confidence            3568999999999999999999876 55679999886432 234678899999999999999999988754      346


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      +++|||+++++|.+++......     ..++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~  147 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGS-----KQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFG  147 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCcc-----ccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCc
Confidence            8999999999999999764322     578899999999999999999998   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      .+........  .......++..|+|||++..+.++.++|||||||++|++++ |+.||........  ........+..
T Consensus       148 ~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~--~~~~~~~~~~~  223 (260)
T cd05073         148 LARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--IRALERGYRMP  223 (260)
T ss_pred             ceeeccCCCc--ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHhCCCCCC
Confidence            9976543221  11222345678999999888889999999999999999999 9999975322211  11111110000


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                                                    .....+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus       224 ------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 ------------------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ------------------------------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                                          001233467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=317.56  Aligned_cols=253  Identities=23%  Similarity=0.321  Sum_probs=207.8

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      +.|.++..+|.|+||.||+|..+.++...|.|++.........++.-||+|+...+||+||++++.|+..     +.+||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----nkLwi  106 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----NKLWI  106 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----CceEE
Confidence            4578888999999999999999988888899999888888889999999999999999999999998776     77899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      +.|||.||..+..+-.-+.      .+.+.++..+++|++.||.|||++   .|+|||+|+.|||++-+|.++|+|||.+
T Consensus       107 liEFC~GGAVDaimlEL~r------~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVS  177 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGR------VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVS  177 (1187)
T ss_pred             EEeecCCchHhHHHHHhcc------ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccccc
Confidence            9999999999998866542      599999999999999999999999   9999999999999999999999999998


Q ss_pred             eecCCCCCCccccccccccccccCccc-----ccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEY-----GALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      .....   .......++|||+|||||+     +...+|+.++||||||+++.||..+.+|..+..... .+.+......|
T Consensus       178 AKn~~---t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-VllKiaKSePP  253 (1187)
T KOG0579|consen  178 AKNKS---TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPP  253 (1187)
T ss_pred             ccchh---HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-HHHHHhhcCCC
Confidence            64322   2233445789999999996     457799999999999999999999999987532221 11122222111


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .    .+.|.                         .....+.+++.+||..||..||+|.++++.
T Consensus       254 T----LlqPS-------------------------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  254 T----LLQPS-------------------------HWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             c----ccCcc-------------------------hhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            1    11111                         223456789999999999999999999863

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-34  Score=308.80  Aligned_cols=261  Identities=23%  Similarity=0.248  Sum_probs=201.8

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ++|+..+.||.|++|.||+|.+..+++.||+|.+..... .....+.+|++++++++||||++++++|.+..   ....|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeEE
Confidence            368889999999999999999988999999999864432 34567889999999999999999999886542   25679


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++......   ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~  151 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKR---GGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGV  151 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccc
Confidence            999999999999987643221   22588999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhh---hhhHHHHhhhCCCc
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEE---GLSLHKYAKMGLPD  794 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~---~~~~~~~~~~~~~~  794 (871)
                      +.......     .....++..|+|||...+..++.++||||+||++|+|++|+.||......   ......+.......
T Consensus       152 ~~~~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  226 (287)
T cd06621         152 SGELVNSL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP  226 (287)
T ss_pred             cccccccc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch
Confidence            87653221     11235788999999988889999999999999999999999999754210   01111111100000


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ....                       .. .........+.+++.+|++.+|++|||+.|+++
T Consensus       227 ~~~~-----------------------~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         227 ELKD-----------------------EP-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             hhcc-----------------------CC-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0000                       00 000012456789999999999999999999998

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.6e-35  Score=317.03  Aligned_cols=286  Identities=20%  Similarity=0.267  Sum_probs=207.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++.... .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence            368999999999999999999999899999999986432  233466788999999999999999999876543 33467


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||+. ++|.+++....       .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~df  151 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQ-------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDF  151 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccc
Confidence            899999995 68999886543       589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCC-ccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          716 GLSRLLHDNSPD-QTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       716 g~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |.+......... ........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||................+.+
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~  231 (334)
T cd07855         152 GMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP  231 (334)
T ss_pred             ccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC
Confidence            999765432211 111223468899999998655 468899999999999999999999997543221111111111111


Q ss_pred             -chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 -DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                       ....+....   ...........................++.+++.+|++.+|++|||++|+++.
T Consensus       232 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         232 SEEVLNRIGS---DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhHhhhhhch---hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence             111111111   11100000000001111112223456788999999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-36  Score=317.90  Aligned_cols=258  Identities=26%  Similarity=0.364  Sum_probs=212.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCC---CcEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTE---ETNVAVKVLDLQQRG-ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ++....++||+|+||.||+|.|...   ...||||.++..... ...+|.+|+.+|.+++|+|++++||...+      .
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------q  183 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------Q  183 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------c
Confidence            3445668899999999999999543   345999999766544 56899999999999999999999999765      3


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ...+|||.++.|+|.+.+++..     +..+.......++.|||.||.||.++   ++||||+..+|+++-....+||+|
T Consensus       184 p~mMV~ELaplGSLldrLrka~-----~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~D  255 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRKAK-----KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICD  255 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhhcc-----ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeec
Confidence            3679999999999999998833     23688899999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||+.+-++.++............+.|+|||.+....++.++|||+|||++|||+| |..||.+....             
T Consensus       256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-------------  322 (1039)
T KOG0199|consen  256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-------------  322 (1039)
T ss_pred             ccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-------------
Confidence            9999999887766655555667889999999999999999999999999999999 89999753221             


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                       .+.+.+|.                  .+..++-+.+.+.+.+++..||..+|++|||+..+.+.+-..
T Consensus       323 -qIL~~iD~------------------~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  323 -QILKNIDA------------------GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             -HHHHhccc------------------cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence             11111110                  011122335778899999999999999999999998665444

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8e-35  Score=312.06  Aligned_cols=275  Identities=23%  Similarity=0.274  Sum_probs=202.1

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc-----hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG-----ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      +|++.+.||+|+||.||+|.+..+++.||+|+++.....     ....+..|+++++.++|+||+++++++.+.     .
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK-----S   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC-----C
Confidence            588899999999999999999888999999999644322     235667899999999999999999998764     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+ +++|.+++....      ..+++..+..++.||++||+|||+.   +++||||+|+||+++.++.++|+|
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~d  145 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKS------IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLAD  145 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEcc
Confidence            789999999 999999997643      1489999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MGL  792 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~  792 (871)
                      ||.+.......   .......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||........ ...... ...
T Consensus       146 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~-~~~~~~~~~~  221 (298)
T cd07841         146 FGLARSFGSPN---RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ-LGKIFEALGT  221 (298)
T ss_pred             ceeeeeccCCC---ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH-HHHHHHHcCC
Confidence            99998765432   11222346788999998754 4678999999999999999999887764322111 111111 011


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      +.. ..+.+.......    ..............+.....++.+++.+|++.||++|||+.|+++.
T Consensus       222 ~~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         222 PTE-ENWPGVTSLPDY----VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             Cch-hhhhhccccccc----ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            100 000000000000    0000001111222233456778999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=322.34  Aligned_cols=241  Identities=24%  Similarity=0.237  Sum_probs=184.5

Q ss_pred             eeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHHcC---CCCccceeeeeecccCcCCCceeeEEE
Q 002883          567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEALRSI---RHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       567 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      ||+|+||+||+|++..+++.||||++.....   ........|..++...   +||+|+++++++...     ...|+||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-----~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-----SDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-----CeEEEEE
Confidence            6999999999999998999999999854321   1223445566666655   699999999988765     6789999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++|+|.+++....       .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        76 e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~  145 (330)
T cd05586          76 DYMSGGELFWHLQKEG-------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKA  145 (330)
T ss_pred             cCCCCChHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence            9999999999987643       589999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhh
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEI  799 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  799 (871)
                      .....   .......||..|+|||++.+. .++.++||||+||++|+|++|+.||........ ..........     +
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~~-----~  216 (330)
T cd05586         146 NLTDN---KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-YRNIAFGKVR-----F  216 (330)
T ss_pred             CCCCC---CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-HHHHHcCCCC-----C
Confidence            43221   122335699999999987654 479999999999999999999999975322111 1111000000     0


Q ss_pred             cChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC----HHHHHH
Q 002883          800 IDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK----IQDAIM  857 (871)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----a~evl~  857 (871)
                      ..                          ......+.+++.+||+.||++||+    +.|+++
T Consensus       217 ~~--------------------------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         217 PK--------------------------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CC--------------------------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            00                          012345678999999999999994    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.6e-35  Score=318.34  Aligned_cols=284  Identities=20%  Similarity=0.210  Sum_probs=208.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|.+.+.||+|+||+||+|++..+++.||||.++..  .......+.+|+.+++.++|+||+++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35799999999999999999999989999999998642  2233456778999999999999999999876554333456


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+. ++|.+++....       .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+||
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Df  152 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDF  152 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcC
Confidence            899999995 78999887643       589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh-hhCCC
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA-KMGLP  793 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~-~~~~~  793 (871)
                      |++.......   .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.............. ....+
T Consensus       153 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  229 (337)
T cd07858         153 GLARTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS  229 (337)
T ss_pred             ccccccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9998664321   11223457889999998654 4688999999999999999999999975322111100000 01111


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      +.....+.......+.   ........+........+..++.+++.+|++.+|++|||++|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         230 EEDLGFIRNEKARRYI---RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hHHhhhcCchhhhHHH---HhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            1111111111111111   1111111122223334566788999999999999999999999876

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.6e-35  Score=311.44  Aligned_cols=277  Identities=24%  Similarity=0.343  Sum_probs=198.2

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+++++.++|+||+++++++...     ..
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~   77 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK-----ET   77 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC-----Ce
Confidence            35689999999999999999999988999999999864432 2334677899999999999999999997654     56


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+. +++.+++.....      .+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+||
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Df  147 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHPG------GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADF  147 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecc
Confidence            899999995 788777754321      477888999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh-hhCCC
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA-KMGLP  793 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~-~~~~~  793 (871)
                      |.+.......   .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||.............. ..+.|
T Consensus       148 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~  224 (291)
T cd07870         148 GLARAKSIPS---QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVP  224 (291)
T ss_pred             ccccccCCCC---CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCC
Confidence            9987543221   112223578899999987653 578899999999999999999999975433222221111 11111


Q ss_pred             chh--hhhcC-hhHHHHHHHHHhhhhhhcCchhHHhHH--HHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQV--AEIID-PAILEEALEIQAGIVKELQPNLRAKFH--EIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...  ..... +......      ......+.......  .....+.+++.+|+..||++|||++|++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         225 TEDTWPGVSKLPNYKPEW------FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             Chhhhhhhhhcccccchh------ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            110  00000 0000000      00000000000000  11346778999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.7e-35  Score=311.69  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=198.5

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEE
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      |.....||+|+||.||+|.+..+++.||+|+++.......+.+.+|+.+++.++|||++++++++...     ...|+||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-----EELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-----CeEEEEE
Confidence            33456799999999999999888999999999655544556788999999999999999999987665     6689999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++++|.+++...        .+++..++.++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||.+..
T Consensus        98 e~~~~~~L~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~  166 (297)
T cd06659          98 EFLQGGALTDIVSQT--------RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ  166 (297)
T ss_pred             ecCCCCCHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhh
Confidence            999999999987542        488999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhc
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII  800 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  800 (871)
                      .....   .......++..|+|||++.+..++.++|||||||++|||++|+.||........ .... ....+...    
T Consensus       167 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~-~~~~~~~~----  237 (297)
T cd06659         167 ISKDV---PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKRL-RDSPPPKL----  237 (297)
T ss_pred             ccccc---ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-hccCCCCc----
Confidence            54321   112235688999999998888899999999999999999999999974322111 1111 00000000    


Q ss_pred             ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                              .........+.+++.+|++.+|++||+++|+++.
T Consensus       238 ------------------------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         238 ------------------------KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ------------------------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                                    0001223456789999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.8e-35  Score=310.57  Aligned_cols=254  Identities=22%  Similarity=0.286  Sum_probs=198.2

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++.. .......+.+|++++++++||||+++++++...     ...|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-----GAVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-----CeEE
Confidence            3688999999999999999999989999999998653 223346788999999999999999999987664     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++.....    ...+++..+..++.|++.|+.|||+.  .+|+||||||+||+++.++.++|+|||.
T Consensus        76 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~  149 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVA----TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGV  149 (286)
T ss_pred             EEEeecCCCCHHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence            99999999999999876421    12589999999999999999999963  1899999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCC------CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhh-HHHHhhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG------EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLS-LHKYAKM  790 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~-~~~~~~~  790 (871)
                      +......     ......++..|+|||.+.+.      .++.++||||+||++|+|++|+.||......... .......
T Consensus       150 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  224 (286)
T cd06622         150 SGNLVAS-----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD  224 (286)
T ss_pred             cccccCC-----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh
Confidence            8765322     11223578899999987543      3588999999999999999999999643211100 0000000


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ..+.                           ..   ...+..++.+++.+|++.+|++||++.|+++.
T Consensus       225 ~~~~---------------------------~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         225 GDPP---------------------------TL---PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             cCCC---------------------------CC---CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            0000                           00   01234567789999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.9e-35  Score=306.94  Aligned_cols=255  Identities=26%  Similarity=0.389  Sum_probs=197.7

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc----------chHHHHHHHHHHHHcCCCCccceeeeeecccC
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR----------GASKSFIAECEALRSIRHRNLVKIITSCSSID  629 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  629 (871)
                      +|.+.+.||.|+||.||+|....+++.||+|.++....          ...+.+.+|+.+++.++|||++++++++... 
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE-   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence            57889999999999999999988899999998853211          1124678899999999999999999987654 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV  709 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  709 (871)
                          ...++||||+++++|.+++....       .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.
T Consensus        81 ----~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~  146 (272)
T cd06629          81 ----EYLSIFLEYVPGGSIGSCLRTYG-------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGI  146 (272)
T ss_pred             ----CceEEEEecCCCCcHHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCe
Confidence                66899999999999999997653       588999999999999999999998   9999999999999999999


Q ss_pred             eEEeecccceecCCCCCCccccccccccccccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHH
Q 002883          710 AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE--VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKY  787 (871)
Q Consensus       710 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~  787 (871)
                      ++++|||.+....... .........++..|+|||......  ++.++|+||+|+++|++++|..||........ ....
T Consensus       147 ~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~  224 (272)
T cd06629         147 CKISDFGISKKSDDIY-DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-MFKL  224 (272)
T ss_pred             EEEeeccccccccccc-cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH-HHHh
Confidence            9999999997653221 111122345788999999876554  78999999999999999999999964322111 1110


Q ss_pred             hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...........                          .....+..++.+++.+|+..+|++|||+.|+++
T Consensus       225 ~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         225 GNKRSAPPIPP--------------------------DVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             hccccCCcCCc--------------------------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            00000000000                          001133456789999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-35  Score=314.05  Aligned_cols=255  Identities=25%  Similarity=0.304  Sum_probs=201.7

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||+||+|.+..+++.||+|.+.....   ...+.+.+|+++++.++||||+++++.+.+.     ..
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE-----TY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC-----CE
Confidence            368899999999999999999998899999999965432   2446788999999999999999999987654     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+.+++|.+++.....     ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+||
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~df  147 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQPG-----KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDF  147 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCCC-----CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeec
Confidence            8999999999999999875432     2589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCc--------------------------cccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh
Q 002883          716 GLSRLLHDNSPDQ--------------------------TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT  769 (871)
Q Consensus       716 g~a~~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt  769 (871)
                      |.+..........                          .......|+..|+|||+..+..++.++||||||+++|+|++
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~  227 (316)
T cd05574         148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY  227 (316)
T ss_pred             chhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh
Confidence            9987653321110                          01122467889999999888889999999999999999999


Q ss_pred             CCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCC
Q 002883          770 GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDR  849 (871)
Q Consensus       770 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  849 (871)
                      |+.||........ +.........  .                            +........+.+++.+|+..||++|
T Consensus       228 g~~pf~~~~~~~~-~~~~~~~~~~--~----------------------------~~~~~~~~~~~~li~~~l~~~p~~R  276 (316)
T cd05574         228 GTTPFKGSNRDET-FSNILKKEVT--F----------------------------PGSPPVSSSARDLIRKLLVKDPSKR  276 (316)
T ss_pred             CCCCCCCCchHHH-HHHHhcCCcc--C----------------------------CCccccCHHHHHHHHHHccCCHhHC
Confidence            9999975432211 1111100000  0                            0001134568899999999999999


Q ss_pred             CC----HHHHHH
Q 002883          850 MK----IQDAIM  857 (871)
Q Consensus       850 Pt----a~evl~  857 (871)
                      ||    ++|+++
T Consensus       277 ~s~~~~~~~ll~  288 (316)
T cd05574         277 LGSKRGAAEIKQ  288 (316)
T ss_pred             CCchhhHHHHHc
Confidence            99    777766

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=9.9e-35  Score=303.99  Aligned_cols=251  Identities=27%  Similarity=0.485  Sum_probs=198.1

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      .+|++.+.||+|+||.||+|.+. .+..+|+|++..... ....+.+|++++++++||+++++++++...     ...++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~   76 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SPICL   76 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccC-----CceEE
Confidence            46888999999999999999986 467899998864332 346788999999999999999999987655     56899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||+++++|.+++.....      .+++..++.++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+
T Consensus        77 v~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~  147 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRG------KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMT  147 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcce
Confidence            9999999999999876432      478999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      ........  .......++..|+|||...++.++.++||||+|+++|||++ |+.||........  ..........   
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~~~---  220 (256)
T cd05112         148 RFVLDDQY--TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV--VETINAGFRL---  220 (256)
T ss_pred             eecccCcc--cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--HHHHhCCCCC---
Confidence            86543211  11112234678999999888889999999999999999998 9999975322211  1100000000   


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                        ..                   +.      .....+.+++.+||+.+|++|||+.|+++.|
T Consensus       221 --~~-------------------~~------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         221 --YK-------------------PR------LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             --CC-------------------CC------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence              00                   00      0124577899999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.8e-35  Score=310.14  Aligned_cols=248  Identities=23%  Similarity=0.333  Sum_probs=199.2

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      .|+..+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|+++++.++||||+++++++...     ...|+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-----TKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC-----CceEE
Confidence            4667788999999999999998889999999986433 33456788999999999999999999988654     66899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||+++++|.+++...        .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||.+
T Consensus        80 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~  148 (277)
T cd06642          80 IMEYLGGGSALDLLKPG--------PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA  148 (277)
T ss_pred             EEEccCCCcHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccccc
Confidence            99999999999998642        488999999999999999999998   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE  798 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  798 (871)
                      .......   .......++..|+|||++.+..++.++|||||||++|||++|+.||.........  .......+..   
T Consensus       149 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~---  220 (277)
T cd06642         149 GQLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL--FLIPKNSPPT---  220 (277)
T ss_pred             ccccCcc---hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH--hhhhcCCCCC---
Confidence            7654321   1122245788999999988888999999999999999999999998753221110  0000000000   


Q ss_pred             hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                              ..   ..+...+.+++.+|++.+|++|||+.|+++.
T Consensus       221 ------------------------~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         221 ------------------------LE---GQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ------------------------CC---cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                                    00   0223457799999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-36  Score=300.74  Aligned_cols=279  Identities=20%  Similarity=0.253  Sum_probs=207.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-C-C----ccceeeeeecccCcC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-H-R----NLVKIITSCSSIDTR  631 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~~~~~~~~~~~~  631 (871)
                      .++|++...+|+|.||.|-++.+..++..||||+++...+ ..+...-|+++++++. + |    -+|.+.++|...   
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr---  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR---  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc---
Confidence            6899999999999999999999998999999999975544 3455677999999983 2 2    367777777554   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-----
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-----  706 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----  706 (871)
                        ++.|+|+|.+ |.|+.+++..+...     +++...++.+++|++++++|||+.   +++|.|+||+||++.+     
T Consensus       164 --ghiCivfell-G~S~~dFlk~N~y~-----~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  164 --GHICIVFELL-GLSTFDFLKENNYI-----PFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             --CceEEEEecc-ChhHHHHhccCCcc-----ccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEE
Confidence              7899999998 77999999987654     799999999999999999999999   9999999999999931     


Q ss_pred             ---------------CCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCC
Q 002883          707 ---------------EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGK  771 (871)
Q Consensus       707 ---------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~  771 (871)
                                     +..++++|||.|.+..+.      ....+.|..|+|||++.+-.++.++||||+|||++|+.||.
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~  306 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE  306 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccC------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence                           336899999999875432      34567899999999999999999999999999999999999


Q ss_pred             CCCchhhh-hhhhHHHHhhhCCCchhhhhcC------hh---HHHHHH----HHHhhhhhhcCchhHHhHHHHHHHHHhh
Q 002883          772 RPTDDMFE-EGLSLHKYAKMGLPDQVAEIID------PA---ILEEAL----EIQAGIVKELQPNLRAKFHEIQVSILRV  837 (871)
Q Consensus       772 ~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~------~~---~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~l  837 (871)
                      ..|+.-.+ +...+.+.+...+|.....-.+      ..   |.+...    ......++.+...... .......+.+|
T Consensus       307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~-~d~e~~~LfDL  385 (415)
T KOG0671|consen  307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQ-DDLEHVQLFDL  385 (415)
T ss_pred             eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhcc-CcHHHhHHHHH
Confidence            99975432 2333334444444433221110      00   000000    0000001111111111 11334569999


Q ss_pred             hcccccCCCCCCCCHHHHHHH
Q 002883          838 GILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       838 i~~cl~~dP~~RPta~evl~~  858 (871)
                      +++||.+||.+|+|+.|+++.
T Consensus       386 l~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  386 LRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HHHHHccCccccccHHHHhcC
Confidence            999999999999999999863

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.3e-34  Score=315.61  Aligned_cols=284  Identities=20%  Similarity=0.214  Sum_probs=204.8

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~  633 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...  .......+.+|+.+++.++||||+++++++..... .+.
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            357899999999999999999999989999999998532  22334567789999999999999999998764422 223


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||+. ++|.+++..         .++...+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~---------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~  160 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM---------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  160 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence            46799999995 588888753         378889999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MGL  792 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~  792 (871)
                      |||.+.......    ......++..|+|||.+.+..++.++||||+||++|+|++|+.||....... .+..... ...
T Consensus       161 Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~  235 (353)
T cd07850         161 DFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGT  235 (353)
T ss_pred             cCccceeCCCCC----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCC
Confidence            999998764321    1223457889999999988899999999999999999999999997542221 1111111 111


Q ss_pred             C-chhhhhcChhHHHHHHHH--------HhhhhhhcCchh-HHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          793 P-DQVAEIIDPAILEEALEI--------QAGIVKELQPNL-RAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       793 ~-~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      + ....+..+..........        .........+.. .........++.+++.+||+.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1 111121111111000000        000000000000 00011235567899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.5e-34  Score=310.60  Aligned_cols=257  Identities=23%  Similarity=0.261  Sum_probs=199.1

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+++++.++||||+++++.+...     .+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-----RH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC-----CE
Confidence            36889999999999999999999999999999986443   22345678899999999999999999987654     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||+++++|.+++....       .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~df  145 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIG-------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDF  145 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeC
Confidence            899999999999999997643       589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCC------------ccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhh
Q 002883          716 GLSRLLHDNSPD------------QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLS  783 (871)
Q Consensus       716 g~a~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~  783 (871)
                      |.++........            ........++..|+|||.+....++.++|||||||++|||++|..||........ 
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~-  224 (305)
T cd05609         146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-  224 (305)
T ss_pred             CCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence            998642111000            0011123578899999998888899999999999999999999999974322111 


Q ss_pred             HHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          784 LHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                      .........+..                          ..   ....+..+.+++.+|++.||++||++.++.+.++
T Consensus       225 ~~~~~~~~~~~~--------------------------~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         225 FGQVISDDIEWP--------------------------EG---DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHHHHhcccCCC--------------------------Cc---cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            111100000000                          00   0022345679999999999999999766666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.6e-34  Score=302.41  Aligned_cols=249  Identities=21%  Similarity=0.359  Sum_probs=199.5

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|+..+.||+|+||.||+|.+..+++.||+|.+....  ......+.+|+++++.++|||++++++.+...     ...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-----KALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC-----CEEE
Confidence            5889999999999999999998899999999986432  23356788999999999999999999987654     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-CceEEeecc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE-MVAHVGDFG  716 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg  716 (871)
                      +||||+++++|.+++......     .+++..+..++.|++.|++|||++   +++||||+|+||+++.+ +.+|++|||
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~  147 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCNS-----LLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFG  147 (256)
T ss_pred             EEEecCCCCCHHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCC
Confidence            999999999999999765422     589999999999999999999999   99999999999999854 468999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      .+.......    ......++..|+|||...+..++.++||||||+++|+|++|+.||........  ............
T Consensus       148 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~  221 (256)
T cd08220         148 ISKILSSKS----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL--VLKIMSGTFAPI  221 (256)
T ss_pred             CceecCCCc----cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH--HHHHHhcCCCCC
Confidence            998765432    12234588899999998888889999999999999999999999975322111  111000000000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .                              ......+.+++..||+.+|++|||+.|+++
T Consensus       222 ~------------------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 S------------------------------DRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             C------------------------------CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            0                              012345779999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.6e-34  Score=304.56  Aligned_cols=260  Identities=25%  Similarity=0.351  Sum_probs=204.4

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ++|++.+.||.|+||+||+|.+..++..||+|++.... ....+.+.+|+++++.++|+|++++++.+...     ...|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG-----DELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-----CEEE
Confidence            47999999999999999999998889999999986432 22457789999999999999999999987664     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +|||++++++|.++++....    ...+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||.
T Consensus        76 iv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~  148 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYP----RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGV  148 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccch
Confidence            99999999999999976432    12589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCc-cccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          718 SRLLHDNSPDQ-TSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       718 a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      +.......... .......|+..|+|||++... .++.++|+|||||++|+|++|+.||....... ........ .+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~-~~~~  226 (267)
T cd06610         149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQN-DPPS  226 (267)
T ss_pred             HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcC-CCCC
Confidence            98765432221 122334688999999987766 78999999999999999999999997542221 11111111 0000


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ....                         .....+...+.+++.+|++.||++|||+.|+++
T Consensus       227 ~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         227 LETG-------------------------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cCCc-------------------------cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0000                         001233456789999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=9e-35  Score=303.82  Aligned_cols=248  Identities=26%  Similarity=0.434  Sum_probs=197.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||.||+|..  +++.||+|.++...  ....+.+|+.+++.++|||++++++++...      ..+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~   74 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN------GLY   74 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------CcE
Confidence            35689999999999999999975  67889999986432  346788999999999999999999987542      368


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++......     .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||.
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~  146 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRA-----LVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGL  146 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCcc
Confidence            999999999999999765422     588999999999999999999998   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +.......      .....+..|+|||.+.++.++.++|||||||++|+|++ |+.||........  ..........  
T Consensus       147 ~~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~~~--  216 (254)
T cd05083         147 ARVGSMGV------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV--KECVEKGYRM--  216 (254)
T ss_pred             ceeccccC------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH--HHHHhCCCCC--
Confidence            97643221      11234568999999888899999999999999999998 9999975422211  1111100000  


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                                               ..   ...++.++.+++.+|++.+|++||+++++++.|++
T Consensus       217 -------------------------~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 -------------------------EP---PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -------------------------CC---CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                                     00   01234567799999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=320.26  Aligned_cols=288  Identities=24%  Similarity=0.297  Sum_probs=209.6

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccC-cCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSID-TRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~  637 (871)
                      -|...+.||+|+||.||+|+.+.+|+.||||.++... ....+...+|++++++++|+|||++++.-.+.. .--.....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3566788999999999999999999999999996432 334578889999999999999999998744332 01135568


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC----CCCceEEe
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD----NEMVAHVG  713 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~----~~~~~kl~  713 (871)
                      +|||||.||||...+++-.+.    ..+++.+.+.+..+++.||.|||++   |||||||||.||++-    +.-..||+
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~----~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENA----YGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccc----cCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeee
Confidence            999999999999999875542    3599999999999999999999999   999999999999993    23358999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhh----hhHHHHh
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG----LSLHKYA  788 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~----~~~~~~~  788 (871)
                      |||.|+.++++.    .....+||..|.+||.+.. +.|+..+|.|||||++|+++||..||.......    ..+....
T Consensus       167 DfG~Arel~d~s----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t  242 (732)
T KOG4250|consen  167 DFGAARELDDNS----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT  242 (732)
T ss_pred             cccccccCCCCC----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence            999999887543    4556789999999999884 888999999999999999999999997543321    2222111


Q ss_pred             hhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC--CHHHHHHHHHHHHHHH
Q 002883          789 KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM--KIQDAIMELQEAQKMR  866 (871)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--ta~evl~~L~~i~~~~  866 (871)
                        .-|..+.-...+...+...     ....++. ...........+...+..++..+|++|.  ...+....+..|....
T Consensus       243 --kkp~~v~i~~~~~eNgpv~-----~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  243 --KKPSGVAIGAQEEENGPVE-----WSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             --cCCCceeEeeecccCCcee-----eeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence              1122211111111100000     0001111 1122223334455677778889999999  7777777777775543

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.8e-34  Score=300.99  Aligned_cols=252  Identities=32%  Similarity=0.515  Sum_probs=200.3

Q ss_pred             CCCCceeeccccceEEEEEECCCC----cEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEE----TNVAVKVLDLQQRG-ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      +++.+.||.|+||.||+|++...+    ..||+|++...... ..+.+..|+++++.++|+||+++++++.+.     ..
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Ce
Confidence            457789999999999999998665    88999999654432 567889999999999999999999998765     56


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .+++|||+++++|.+++......     .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+||
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~df  147 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPK-----ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDF  147 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhc-----cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEccc
Confidence            89999999999999999765421     289999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      |.+...........  ....+++.|+|||...+..++.++||||+|+++|+|++ |+.||.......  ...........
T Consensus       148 g~~~~~~~~~~~~~--~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~  223 (258)
T smart00219      148 GLSRDLYDDDYYKK--KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE--VLEYLKKGYRL  223 (258)
T ss_pred             CCceeccccccccc--ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcCCCC
Confidence            99987654421111  12236789999999888889999999999999999998 888887422111  11111100000


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                      .                              .....+.++.+++.+|+..||++|||+.|+++.|
T Consensus       224 ~------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 P------------------------------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             C------------------------------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0                              0001344678899999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1e-34  Score=309.70  Aligned_cols=252  Identities=23%  Similarity=0.317  Sum_probs=202.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++|||++++++++...     ...|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----CcEE
Confidence            36899999999999999999999888999999998655554557788999999999999999999988665     5689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +|+||+++++|.+++...        .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.
T Consensus        93 lv~e~~~~~~L~~~~~~~--------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~  161 (293)
T cd06647          93 VVMEYLAGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF  161 (293)
T ss_pred             EEEecCCCCcHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcc
Confidence            999999999999999753        378889999999999999999999   999999999999999999999999998


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +.......   .......+++.|+|||......++.++|||||||++|++++|+.||.......... ...... ...  
T Consensus       162 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-~~~~~~-~~~--  234 (293)
T cd06647         162 CAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNG-TPE--  234 (293)
T ss_pred             eecccccc---cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-ehhcCC-CCC--
Confidence            87654322   11223458889999999888889999999999999999999999997532211100 000000 000  


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                       +                         .........+.+++.+||+.+|++||++.|++..
T Consensus       235 -~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         235 -L-------------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             -C-------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0                         0001223457789999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.6e-35  Score=310.31  Aligned_cols=278  Identities=23%  Similarity=0.283  Sum_probs=202.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....  ...+.+.+|+++++.++||||+++++++...     ...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-----KRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC-----CeE
Confidence            468999999999999999999988899999999853322  2346788999999999999999999998654     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||++++++.++.....       .+++.++..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg  145 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYPN-------GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG  145 (286)
T ss_pred             EEEEecCCccHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeee
Confidence            99999999999988775432       489999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh-hhCCCc
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA-KMGLPD  794 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~-~~~~~~  794 (871)
                      .+.......   .......++..|+|||+..+ ..++.++||||||+++|+|++|+.||.............. ......
T Consensus       146 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  222 (286)
T cd07846         146 FARTLAAPG---EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP  222 (286)
T ss_pred             eeeeccCCc---cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCch
Confidence            998754332   11223457889999998765 4568899999999999999999999964322111111000 011111


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ......+.........   ..............+.+...+.+++.+||+.+|++|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         223 RHQEIFQKNPLFAGMR---LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hhHHHhccchHhhccc---cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            1111111000000000   00000001111222345677899999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.4e-34  Score=308.59  Aligned_cols=245  Identities=25%  Similarity=0.275  Sum_probs=198.9

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|++++++++||||+++++++...     ..
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-----SN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----Ce
Confidence            46899999999999999999999899999999986432   22346788999999999999999999998665     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++++|.+++....       .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+||
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~-------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~df  145 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDF  145 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeC
Confidence            899999999999999997653       589999999999999999999998   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |.+......      .....+++.|+|||...+..++.++||||||+++|+|++|+.||....... .........  ..
T Consensus       146 g~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~--~~  216 (290)
T cd05580         146 GFAKRVKGR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-IYEKILEGK--VR  216 (290)
T ss_pred             CCccccCCC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcCC--cc
Confidence            999876432      223458899999999888888999999999999999999999997533111 111111000  00


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~  857 (871)
                      ...                              .....+.+++.+||+.||.+||     +++|+++
T Consensus       217 ~~~------------------------------~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         217 FPS------------------------------FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             CCc------------------------------cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            000                              1134567899999999999999     6777664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2e-34  Score=304.83  Aligned_cols=265  Identities=24%  Similarity=0.363  Sum_probs=200.5

Q ss_pred             CCCCceeeccccceEEEEEEC---CCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC-Cc
Q 002883          561 FSSANLIGIGGYGYVYKGILG---TEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG-NE  634 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~-~~  634 (871)
                      |++.+.||+|+||.||+|.+.   .+++.||||++....  ....+.+.+|+++++.++||||+++++++......+ ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            677889999999999999864   356889999986432  234567889999999999999999999876543222 13


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++++||+.+|+|.+++....... ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGE-EPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence            4578999999999998875432110 112478899999999999999999998   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||.++........ .......++..|++||......++.++|||||||++|+|++ |+.||.......  ..........
T Consensus       157 fg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~~  233 (273)
T cd05074         157 FGLSKKIYSGDYY-RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--IYNYLIKGNR  233 (273)
T ss_pred             ccccccccCCcce-ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--HHHHHHcCCc
Confidence            9999866432211 11122345678999999888889999999999999999999 889987532211  1111110000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      ...                       .       ......+.+++.+|++.+|++|||+.|+++.|+++
T Consensus       234 ~~~-----------------------~-------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 LKQ-----------------------P-------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCC-----------------------C-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            000                       0       01234678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.7e-35  Score=307.53  Aligned_cols=255  Identities=25%  Similarity=0.354  Sum_probs=202.4

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+++++.++||||+++++++...     ...+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~   75 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDIS   75 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEE
Confidence            36888899999999999999999899999999986543 23456788999999999999999999988765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH-HCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      +|+||+++++|.+++....      ..+++..+..++.|++.|++|||+ .   +++||||||+||+++.++.++|+|||
T Consensus        76 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g  146 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQ------GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFG  146 (265)
T ss_pred             EEEEecCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence            9999999999999997653      258999999999999999999999 7   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      .+.......     .....++..|+|||...+..++.++||||+|+++|+|++|+.||................      
T Consensus       147 ~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------  215 (265)
T cd06605         147 VSGQLVNSL-----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY------  215 (265)
T ss_pred             cchhhHHHH-----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH------
Confidence            987653221     111568889999999888899999999999999999999999997542111100000000      


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                        ......+....  ..+...+.+++.+|+..||++|||+.|++..
T Consensus       216 ------------------~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         216 ------------------IVNEPPPRLPS--GKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ------------------HhcCCCCCCCh--hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence                              00000000000  0144567899999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.3e-34  Score=303.50  Aligned_cols=253  Identities=20%  Similarity=0.299  Sum_probs=199.6

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ------RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      +|+..+.||+|+||.||+|.+..+++.||+|++....      ....+.+.+|++++++++|+|++++++++.+.     
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED-----   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-----
Confidence            4888999999999999999998899999999986433      11346788999999999999999999998665     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEE
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM-VAHV  712 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl  712 (871)
                      +..++||||+++++|.+++....       .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++ .++|
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l  145 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYG-------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRI  145 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEE
Confidence            67899999999999999997643       588999999999999999999999   999999999999998775 6999


Q ss_pred             eecccceecCCCCCCcc-ccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHH--HHhh
Q 002883          713 GDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLH--KYAK  789 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~--~~~~  789 (871)
                      +|||.+........... ......++..|+|||...+..++.++||||+|+++|+|++|+.||...........  ....
T Consensus       146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  225 (268)
T cd06630         146 ADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS  225 (268)
T ss_pred             cccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc
Confidence            99999987654321111 12234578899999998888899999999999999999999999964211100000  0000


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .....                              .........+.+++.+|++.+|++|||+.|+++
T Consensus       226 ~~~~~------------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 ATTAP------------------------------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             cCCCC------------------------------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            00000                              000123456778999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.5e-34  Score=307.74  Aligned_cols=285  Identities=21%  Similarity=0.256  Sum_probs=203.6

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++...  ......+.+|+++++.+ +||||+++++++...+..+...
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46899999999999999999999899999999985432  22345778899999999 4699999999887664444456


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCceEEee
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-EMVAHVGD  714 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~D  714 (871)
                      .|+||||+++ ++.+++......  ....+++..++.++.||+.||.|||+.   +|+||||+|+||+++. ++.+||+|
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d  154 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRG--PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD  154 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhccc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence            8999999975 899888654321  122589999999999999999999999   9999999999999998 88999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||.+.......   .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||..................+
T Consensus       155 fg~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  231 (295)
T cd07837         155 LGLGRAFSIPV---KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP  231 (295)
T ss_pred             cccceecCCCc---cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99998653321   11122346888999998754 457899999999999999999999997543222111111111111


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...  .. +........  .......+.......+....++.+++.+|+..||++|||+.|++.
T Consensus       232 ~~~--~~-~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQ--VW-PGVSKLRDW--HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             Chh--hC-cchhhccch--hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            100  00 000000000  000000111122222345677889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-34  Score=314.77  Aligned_cols=285  Identities=20%  Similarity=0.234  Sum_probs=211.4

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|+++++.++||||+++++++...........|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            6889999999999999999998889999999986433  33456788999999999999999999998776433345789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||++ ++|.+++....       .+++..++.++.|++.|++|||+.   ||+||||||+||+++.++.++|+|||.
T Consensus        81 lv~e~~~-~~l~~~l~~~~-------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCc
Confidence            9999996 58998887543       589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc-h
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD-Q  795 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-~  795 (871)
                      +.................++..|+|||++.+. .++.++||||+|+++|+|++|+.||..................+. .
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence            98775432111223334578899999998877 789999999999999999999999976543222111111111111 1


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ............+.   .....................+.+++.+||+.+|++|||++++++.
T Consensus       230 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         230 DLKFITSEKARNYL---KSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             HhhhccccchhhHH---hhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            11111111111110   0000111111222223356678999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-34  Score=315.94  Aligned_cols=285  Identities=22%  Similarity=0.277  Sum_probs=202.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC-----
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG-----  632 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~-----  632 (871)
                      ..+|++.+.||.|+||.||+|.+..+++.||+|++........+.+.+|+++++.++||||+++++++.......     
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            368999999999999999999999899999999997665555677889999999999999999998775542211     


Q ss_pred             ----CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC-CC
Q 002883          633 ----NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD-NE  707 (871)
Q Consensus       633 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~  707 (871)
                          ....|+||||++ ++|.+++...        .+++..++.++.||+.|+.|||+.   +|+||||||+||+++ .+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~  151 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG--------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTED  151 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCC
Confidence                135799999996 5898888542        488999999999999999999999   999999999999997 45


Q ss_pred             CceEEeecccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHH
Q 002883          708 MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK  786 (871)
Q Consensus       708 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~  786 (871)
                      +.+|++|||.+.................++..|+|||.+.. ..++.++|||||||++|+|++|+.||........... 
T Consensus       152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~-  230 (342)
T cd07854         152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL-  230 (342)
T ss_pred             ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence            67899999999875432211112223457889999997544 5678999999999999999999999975433221111 


Q ss_pred             HhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          787 YAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       787 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .... .+....+... .........................+....++.+++.+|++.||++|||++|+++
T Consensus       231 ~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         231 ILES-VPVVREEDRN-ELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHh-cCCCChHHhh-hhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            1110 1100000000 0000000000000000001111122234567889999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.7e-34  Score=307.11  Aligned_cols=254  Identities=24%  Similarity=0.300  Sum_probs=193.1

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHH-HHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEA-LRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++.... .....+..|+.+ ++..+|||++++++++...     ...
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcE
Confidence            368999999999999999999998999999999865432 223455566665 5667999999999998654     568


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||++ |+|.+++......   ...+++..++.++.|++.|++|||+++  +++||||||+||+++.++.+||+|||
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg  149 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVYDK---GLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFG  149 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecc
Confidence            99999995 7898888653221   236899999999999999999999852  89999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccC----CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL----GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      .+.......    ......++..|+|||.+.+    ..++.++|+||+||++|+|++|+.||..................
T Consensus       150 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  225 (283)
T cd06617         150 ISGYLVDSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS  225 (283)
T ss_pred             ccccccccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC
Confidence            998654321    1122457889999998654    45688999999999999999999999642211111111110000


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      + .                           .  ....++.++.+++.+||..+|++|||+.|+++
T Consensus       226 ~-~---------------------------~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 P-Q---------------------------L--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             C-C---------------------------C--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0 0                           0  00123456789999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=345.03  Aligned_cols=409  Identities=28%  Similarity=0.338  Sum_probs=268.9

Q ss_pred             CCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccccc
Q 002883           15 ELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVS   94 (871)
Q Consensus        15 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~   94 (871)
                      .|+.||+++|++. ..|..+..+.+|+.|+++.|.|. ..|.+.+++.+|++|.|.+|++. .+|..+..+++|+.|++|
T Consensus        46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS  122 (1081)
T KOG0618|consen   46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS  122 (1081)
T ss_pred             eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence            3888899998887 78888888889999999999888 78888888889999999988887 888888889999999999


Q ss_pred             cccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCC---------CCccc
Q 002883           95 ANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASS---------IPEDL  165 (871)
Q Consensus        95 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~---------lp~~~  165 (871)
                      +|.+. .+|..+..+..++.+..++|.....++..      .++.+++..|.+.+.++..+.++..         .--.+
T Consensus       123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~------~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~dl  195 (1081)
T KOG0618|consen  123 FNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQT------SIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVLDL  195 (1081)
T ss_pred             hhccC-CCchhHHhhhHHHHHhhhcchhhhhhccc------cchhhhhhhhhcccchhcchhhhheeeecccchhhhhhh
Confidence            98888 78887877777777777777222122211      1444555555554433333322211         01124


Q ss_pred             cCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCC
Q 002883          166 GKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVG  245 (871)
Q Consensus       166 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~  245 (871)
                      ..+.+|+.|.++.|++..+..          ..++|+.|+.++|.++...+..   ...+|+++++++|+++ ..|++++
T Consensus       196 s~~~~l~~l~c~rn~ls~l~~----------~g~~l~~L~a~~n~l~~~~~~p---~p~nl~~~dis~n~l~-~lp~wi~  261 (1081)
T KOG0618|consen  196 SNLANLEVLHCERNQLSELEI----------SGPSLTALYADHNPLTTLDVHP---VPLNLQYLDISHNNLS-NLPEWIG  261 (1081)
T ss_pred             hhccchhhhhhhhcccceEEe----------cCcchheeeeccCcceeecccc---ccccceeeecchhhhh-cchHHHH
Confidence            455555566666655544221          2245566666666655222111   1235666666666666 3446666


Q ss_pred             CccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccc---------
Q 002883          246 NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSAL---------  316 (871)
Q Consensus       246 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~---------  316 (871)
                      .+.+|+.+...+|.++ ..|..+....+|+.|...+|.+. -+|....+++.|++|+|..|+|...++..|         
T Consensus       262 ~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~  339 (1081)
T KOG0618|consen  262 ACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNT  339 (1081)
T ss_pred             hcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHH
Confidence            6666666666666664 55555666666666666666666 455555556666666666666652222111         


Q ss_pred             ----------------cCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcC
Q 002883          317 ----------------GNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKL  380 (871)
Q Consensus       317 ----------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  380 (871)
                                      ..++.|+.|++.+|.+++..-..+.+++.|+.|+|++|+|.......+.++..|+.|+||+|++
T Consensus       340 ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL  419 (1081)
T KOG0618|consen  340 LNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKL  419 (1081)
T ss_pred             HhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchh
Confidence                            1234467777777777766666777777788888888877744455677777788888888888


Q ss_pred             CCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcC
Q 002883          381 SGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNL  452 (871)
Q Consensus       381 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l  452 (871)
                      + .+|+.+..++.|++|...+|+|. ..| .+..++.|+.+|+|.|+|+...-......++|++|||+||..
T Consensus       420 ~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  420 T-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             h-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            7 67777777788888888888777 444 677777888888888877753333333337788888888875

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=306.37  Aligned_cols=276  Identities=24%  Similarity=0.318  Sum_probs=201.3

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      |++.+.||.|++|.||+|.+..+++.||+|++....  ......+.+|+++++.++|||++++++++.+.     ...|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-----~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-----NKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-----CeEEE
Confidence            678899999999999999998899999999986443  22345688899999999999999999998655     67899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||+ +++|.+++.....     ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||.+
T Consensus        76 v~e~~-~~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~  146 (283)
T cd07835          76 VFEFL-DLDLKKYMDSSPL-----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA  146 (283)
T ss_pred             EEecc-CcCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccc
Confidence            99999 5699999876542     2589999999999999999999998   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      .......   .......++..|+|||++.+. .++.++||||||+++|+|++|+.||..................+....
T Consensus       147 ~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (283)
T cd07835         147 RAFGVPV---RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV  223 (283)
T ss_pred             cccCCCc---cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence            7653221   111223468899999987654 568999999999999999999999975433222111111111111100


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       +  +... ..........+...+............+.+++.+|++.||++|||++|+++
T Consensus       224 -~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         224 -W--PGVT-SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             -h--hhhh-hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence             0  0000 000000000011111111222234467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.4e-34  Score=309.20  Aligned_cols=278  Identities=23%  Similarity=0.270  Sum_probs=202.4

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++....  .....+.+|++++++++||||+++++++...+   ....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence            578999999999999999999998899999999964432  22345678999999999999999999876542   2678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||++ ++|.+++.....      .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g  151 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMKQ------PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFG  151 (293)
T ss_pred             EEEehhcC-cCHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecC
Confidence            99999996 599998876432      489999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      .+.......   .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||..................+..
T Consensus       152 ~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  228 (293)
T cd07843         152 LAREYGSPL---KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE  228 (293)
T ss_pred             ceeeccCCc---cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence            998765432   112234578899999987654 4689999999999999999999999754332211111111111100


Q ss_pred             --hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHH--HHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 --VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHE--IQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                        ...+..-.   ...  ...............++.  ..+.+.+++.+|++.+|++|||+.|+++
T Consensus       229 ~~~~~~~~~~---~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         229 KIWPGFSELP---GAK--KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHHHHhhccc---hhc--ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence              00000000   000  000000001111222222  2567889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.8e-34  Score=305.45  Aligned_cols=261  Identities=23%  Similarity=0.364  Sum_probs=202.0

Q ss_pred             cCCCCCceeeccccceEEEEEECC-----CCcEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGT-----EETNVAVKVLDLQQRG-ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ++|++.+.||+|+||.||+|+...     ..+.||+|.+...... ..+.+.+|++++++++|+|++++++++.+.    
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA----   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC----
Confidence            578999999999999999999753     3467999998654433 456789999999999999999999988664    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccc--cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCce
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQ--NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA  710 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  710 (871)
                       ...|+||||+++|+|.+++.......  .....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          81 -EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             -CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence             56799999999999999997654211  0112589999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhh
Q 002883          711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAK  789 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~  789 (871)
                      +++|||.+.......  ........++..|+|||...+..++.++||||||+++|+|++ |..||........ ......
T Consensus       157 ~l~~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~-~~~~~~  233 (275)
T cd05046         157 KVSLLSLSKDVYNSE--YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV-LNRLQA  233 (275)
T ss_pred             EEcccccccccCccc--ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH-HHHHHc
Confidence            999999987543221  112223346778999999888888999999999999999999 8889865322211 111100


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                      ...+     +..                         ...++..+.+++.+|++.+|++|||+.|+++.|.
T Consensus       234 ~~~~-----~~~-------------------------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKLE-----LPV-------------------------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcC-----CCC-------------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            0000     000                         0022346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.1e-34  Score=300.85  Aligned_cols=252  Identities=25%  Similarity=0.344  Sum_probs=205.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+.+|++++++++|+|++++++++...     ...+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEIS   75 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEE
Confidence            368899999999999999999998899999999865543 3457889999999999999999999998765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH-HCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      +||||+++++|.+++....       .+++..++.++.|+++|++|||+ .   +++||||+|+||+++.++.++|+|||
T Consensus        76 lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~  145 (264)
T cd06623          76 IVLEYMDGGSLADLLKKVG-------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFG  145 (264)
T ss_pred             EEEEecCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCc
Confidence            9999999999999997653       58999999999999999999999 8   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhh-hhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFE-EGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~-~~~~~~~~~~~~~~~~  795 (871)
                      .+.........   .....++..|+|||...+..++.++||||||+++|+|++|+.||..... ..............  
T Consensus       146 ~~~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--  220 (264)
T cd06623         146 ISKVLENTLDQ---CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP--  220 (264)
T ss_pred             cceecccCCCc---ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC--
Confidence            99876543211   1234578899999998888899999999999999999999999975431 10111111110000  


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHH-HHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHE-IQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                               +..   ... ++..+.+++.+|++.+|++|||+.|+++.
T Consensus       221 -------------------------~~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 -------------------------PSL---PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -------------------------CCC---CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                                     000   001 34568899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=311.50  Aligned_cols=209  Identities=24%  Similarity=0.347  Sum_probs=172.1

Q ss_pred             CCCCCceeeccccceEEEEEECC--CCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          560 GFSSANLIGIGGYGYVYKGILGT--EETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      +|++.+.||+|+||.||+|.+..  +++.||+|.+....   ......+.+|+++++.++||||+++++++.+.   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            58889999999999999999987  78999999997532   33456778899999999999999999998654   235


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC----CCce
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN----EMVA  710 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~  710 (871)
                      ..++||||++ +++.+++......  ....+++..++.++.|++.|+.|||+.   +|+||||||+||+++.    ++.+
T Consensus        78 ~~~lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~  151 (316)
T cd07842          78 SVYLLFDYAE-HDLWQIIKFHRQA--KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVV  151 (316)
T ss_pred             eEEEEEeCCC-cCHHHHHHhhccC--CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceE
Confidence            6899999996 5777777544321  112588999999999999999999999   9999999999999999    9999


Q ss_pred             EEeecccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      ||+|||.+.................++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus       152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  219 (316)
T cd07842         152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR  219 (316)
T ss_pred             EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence            99999999876543222222333567899999997665 45789999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.1e-34  Score=310.28  Aligned_cols=280  Identities=24%  Similarity=0.287  Sum_probs=201.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++....  .....+.+|++++++++|+|++++++++....   ...
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence            4679999999999999999999998999999999864332  22345668999999999999999999876432   245


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||++ ++|.+++.....      .+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+||
T Consensus        83 ~~lv~e~~~-~~l~~~l~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~df  152 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDNMPT------PFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADF  152 (309)
T ss_pred             EEEEEecCC-CCHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence            799999995 589888876432      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      |.+.......   .......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||..................+.
T Consensus       153 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  229 (309)
T cd07845         153 GLARTYGLPA---KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN  229 (309)
T ss_pred             ceeeecCCcc---CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9998765322   11222345788999998765 4578999999999999999999999975433221111111111110


Q ss_pred             h-hh-hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          795 Q-VA-EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       795 ~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      . .. .+........+.     ............+....+++.+++.+|++.||++|||++|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         230 ESIWPGFSDLPLVGKFT-----LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhchhhhccccccccc-----ccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0 00 000000000000     00000011112222345677899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.8e-34  Score=301.92  Aligned_cols=255  Identities=20%  Similarity=0.315  Sum_probs=198.9

Q ss_pred             CCCCCceeeccccceEEEEEECC-CCcEEEEEEeeccc----------cchHHHHHHHHHHHHc-CCCCccceeeeeecc
Q 002883          560 GFSSANLIGIGGYGYVYKGILGT-EETNVAVKVLDLQQ----------RGASKSFIAECEALRS-IRHRNLVKIITSCSS  627 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~  627 (871)
                      +|++.+.||+|+||.||+|.+.. .++.+|+|.+....          ......+.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48889999999999999999987 67889999885321          2223456778888765 799999999999876


Q ss_pred             cCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceeeCC
Q 002883          628 IDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH-HCHTSIVHCDLKPSNVLLDN  706 (871)
Q Consensus       628 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~  706 (871)
                      .     ...++||||+++++|.+++......   ...+++..++.++.|++.|+.|||+ .   +++|+||+|+||+++.
T Consensus        81 ~-----~~~~lv~e~~~~~~l~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~  149 (269)
T cd08528          81 N-----DRLYIVMDLIEGAPLGEHFNSLKEK---KQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGE  149 (269)
T ss_pred             C-----CeEEEEEecCCCCcHHHHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECC
Confidence            5     6789999999999999988643211   2258999999999999999999996 5   8999999999999999


Q ss_pred             CCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHH
Q 002883          707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK  786 (871)
Q Consensus       707 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~  786 (871)
                      ++.+||+|||.+.......    ......++..|+|||...+..++.++||||||+++|+|++|+.||........ ...
T Consensus       150 ~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~-~~~  224 (269)
T cd08528         150 DDKVTITDFGLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL-ATK  224 (269)
T ss_pred             CCcEEEecccceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH-HHH
Confidence            9999999999998754332    22335688999999999888899999999999999999999999874321111 000


Q ss_pred             HhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          787 YAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       787 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                      .......+.                           .   ......++.+++.+|++.||++||++.|+.++++
T Consensus       225 ~~~~~~~~~---------------------------~---~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         225 IVEAVYEPL---------------------------P---EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HhhccCCcC---------------------------C---cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            000000000                           0   0012345778999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-34  Score=302.63  Aligned_cols=277  Identities=24%  Similarity=0.311  Sum_probs=203.2

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcC---CCCccceeeeeecccCcCCCce
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSI---RHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      |++.+.||+|+||.||+|++..+++.||+|+++....  .....+.+|+.+++++   +|||++++++++...+..+...
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6788999999999999999988899999999964322  2234566788877666   5999999999988765444456


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .+++|||+. ++|.+++......     .+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.+||+||
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKP-----GLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEecc
Confidence            899999996 5899988764321     589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hCCCc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MGLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~~  794 (871)
                      |.+.......    ......++..|+|||+..+..++.++|||||||++|+|++|+.||........ ...+.. ...+.
T Consensus       152 g~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~  226 (287)
T cd07838         152 GLARIYSFEM----ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ-LDKIFDVIGLPS  226 (287)
T ss_pred             CcceeccCCc----ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH-HHHHHHHcCCCC
Confidence            9998764332    11223478899999999888899999999999999999999999975433221 111111 11111


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .............      ....................+.+++.+||+.||++||++.|+++
T Consensus       227 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         227 EEEWPRNVSLPRS------SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hHhcCCCcccchh------hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            1000000000000      00000111112223355677889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-34  Score=306.56  Aligned_cols=276  Identities=22%  Similarity=0.311  Sum_probs=203.2

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++..  .....+.+.+|++++++++|+||+++++++...     +..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-----GRL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-----CEE
Confidence            3689999999999999999999988999999998643  233346789999999999999999999998764     668


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||++++.+..+.....       .+++.++..++.|++.|+.|||+.   +++|||++|+||++++++.+||+|||
T Consensus        76 ~iv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g  145 (288)
T cd07833          76 YLVFEYVERTLLELLEASPG-------GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFG  145 (288)
T ss_pred             EEEEecCCCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeee
Confidence            99999998877766654432       489999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh-hhCCCc
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA-KMGLPD  794 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~-~~~~~~  794 (871)
                      .+........  .......++..|+|||+..+. .++.++||||+|+++|+|++|+.||......+....... ....++
T Consensus       146 ~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  223 (288)
T cd07833         146 FARALRARPA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP  223 (288)
T ss_pred             cccccCCCcc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9987654321  122334678899999998877 789999999999999999999999975432211111110 111111


Q ss_pred             hhhhhcC--hhHHHHHHHHHhhhhhhcCc-hhHHhHH-HHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIID--PAILEEALEIQAGIVKELQP-NLRAKFH-EIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .......  +.....      .......+ .....+. .+..++.+++++||..+|++|||++++++
T Consensus       224 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         224 SHQELFSSNPRFAGV------AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HHhhhcccCcccccc------ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            1000000  000000      00000000 0111111 23677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-34  Score=299.37  Aligned_cols=254  Identities=20%  Similarity=0.259  Sum_probs=198.4

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ-----QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .+|++.+.||+|+||.||+|++..+++.||+|++...     .......+.+|++++++++|+||+++++++.+..   .
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence            4789999999999999999999989999999987432     1223457889999999999999999999875432   2


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+++++|.+++....       .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~~-------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~  148 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAYG-------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLG  148 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEC
Confidence            56789999999999999987543       478899999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||.+.................++..|+|||...+..++.++|||||||++|+|++|+.||........ .........+
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~  227 (264)
T cd06653         149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-IFKIATQPTK  227 (264)
T ss_pred             ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-HHHHHcCCCC
Confidence            999998654221111112234588999999998888889999999999999999999999975322111 1111110000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      +..                              .....+.+.+++.+|+. +|.+|||+.+++.
T Consensus       228 ~~~------------------------------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         228 PML------------------------------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCC------------------------------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            000                              01233457789999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.9e-34  Score=300.01  Aligned_cols=256  Identities=21%  Similarity=0.347  Sum_probs=184.7

Q ss_pred             ceeeccccceEEEEEECCC--CcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEe
Q 002883          565 NLIGIGGYGYVYKGILGTE--ETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE  641 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  641 (871)
                      +.||+|+||.||+|.....  ...+++|.++... ....+.+.+|+.+++.++||||+++++++...     ...|+|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEEe
Confidence            3589999999999976432  3456777765433 23456889999999999999999999998765     56799999


Q ss_pred             ccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceec
Q 002883          642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL  721 (871)
Q Consensus       642 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  721 (871)
                      |+++|+|.+++......   ....++..+..++.||+.||+|||+.   +++||||||+||+++.++.++|+|||.+...
T Consensus        76 ~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~  149 (268)
T cd05086          76 YCELGDLKSYLSQEQWH---RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSR  149 (268)
T ss_pred             cCCCCcHHHHHHhhhcc---cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEeccccccccc
Confidence            99999999999764321   12467778889999999999999998   9999999999999999999999999998643


Q ss_pred             CCCCCCccccccccccccccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCC
Q 002883          722 HDNSPDQTSTSRVKGSIGYVAPEYGAL-------GEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       722 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      .... .........++..|+|||+...       ..++.++|||||||++|||++ |..||....... .......... 
T Consensus       150 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~-  226 (268)
T cd05086         150 YKED-YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-VLNHVIKDQQ-  226 (268)
T ss_pred             Ccch-hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhhcc-
Confidence            2111 1111223457889999998642       345789999999999999997 577886432211 1111111100 


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                         ....++.+.                   .   .....+.+++..|+ .+|++|||++|+++.|.
T Consensus       227 ---~~~~~~~~~-------------------~---~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         227 ---VKLFKPQLE-------------------L---PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ---cccCCCccC-------------------C---CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence               011111110                   0   12234567888899 67999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6.5e-34  Score=302.39  Aligned_cols=249  Identities=22%  Similarity=0.324  Sum_probs=199.1

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEE
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV  639 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  639 (871)
                      +|...+.||+|++|.||+|.+..+++.||+|+++.......+.+.+|+.+++.++|||++++++++...     ...++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeEEEE
Confidence            355567999999999999999888999999998655544556788999999999999999999987654     668999


Q ss_pred             EeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccce
Q 002883          640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR  719 (871)
Q Consensus       640 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  719 (871)
                      +||+++++|.+++...        .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.+.
T Consensus        95 ~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~  163 (285)
T cd06648          95 MEFLEGGALTDIVTHT--------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCA  163 (285)
T ss_pred             EeccCCCCHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccch
Confidence            9999999999998762        488999999999999999999999   99999999999999999999999999887


Q ss_pred             ecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhh
Q 002883          720 LLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEI  799 (871)
Q Consensus       720 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  799 (871)
                      ......   .......|+..|+|||...+..++.++||||+||++|+|++|+.||....... ... ......+....  
T Consensus       164 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~-~~~-~~~~~~~~~~~--  236 (285)
T cd06648         164 QVSKEV---PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-AMK-RIRDNLPPKLK--  236 (285)
T ss_pred             hhccCC---cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH-HHH-HHHhcCCCCCc--
Confidence            554321   11223458899999999888889999999999999999999999986422111 010 01100000000  


Q ss_pred             cChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          800 IDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                                ....+...+.+++.+|++.+|++|||+.|+++
T Consensus       237 --------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 --------------------------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             --------------------------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence                                      00113346789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.8e-34  Score=300.20  Aligned_cols=238  Identities=23%  Similarity=0.419  Sum_probs=187.7

Q ss_pred             ceeeccccceEEEEEECCCC----------cEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          565 NLIGIGGYGYVYKGILGTEE----------TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      +.||+|+||.||+|.+..++          ..|++|++...... ...+.+|+.+++.++||||+++++++..      .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence            46899999999999997665          35888887654433 5788899999999999999999998755      2


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC------
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM------  708 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~------  708 (871)
                      ..++||||+++|+|.+++.....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++      
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~  144 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKN------NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYV  144 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCc
Confidence            35899999999999999986542      488999999999999999999998   999999999999999887      


Q ss_pred             -ceEEeecccceecCCCCCCccccccccccccccCcccccCC--CCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhH
Q 002883          709 -VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSL  784 (871)
Q Consensus       709 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~  784 (871)
                       .+|++|||.+.....       .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||........ .
T Consensus       145 ~~~kl~Dfg~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-~  216 (259)
T cd05037         145 PFIKLSDPGIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-E  216 (259)
T ss_pred             eeEEeCCCCccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-H
Confidence             799999999986543       1123467789999998766  78999999999999999999 5777765321110 0


Q ss_pred             HHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          785 HKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                      ..+....   .   .                     +.  +    ....+.+++.+|+..+|.+|||+.|+++.|
T Consensus       217 ~~~~~~~---~---~---------------------~~--~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         217 RFYQDQH---R---L---------------------PM--P----DCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             HHHhcCC---C---C---------------------CC--C----CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            0000000   0   0                     00  0    014577999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.2e-34  Score=311.74  Aligned_cols=283  Identities=22%  Similarity=0.278  Sum_probs=203.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++++ +||||+++++++...+   +.
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~---~~   82 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN---DK   82 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC---Cc
Confidence            46799999999999999999999888999999988432  222335677899999999 9999999999875432   25


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||++ ++|.+++...        .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d  150 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN--------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD  150 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence            6799999996 5999988653        378889999999999999999998   999999999999999999999999


Q ss_pred             cccceecCCCCCC--ccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          715 FGLSRLLHDNSPD--QTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       715 fg~a~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      ||.+.........  ........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.................
T Consensus       151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~  230 (337)
T cd07852         151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG  230 (337)
T ss_pred             ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999876543211  112233568899999997654 4578999999999999999999999975432221111111111


Q ss_pred             CCc-hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          792 LPD-QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       792 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .+. .....+........   ..................+..++.+++.+|++.||++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         231 PPSAEDIESIKSPFAATM---LDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CCCHHHHHHHHhhhHHHh---hhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            111 10000000110000   00000111111222223356678999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.9e-34  Score=300.80  Aligned_cols=247  Identities=26%  Similarity=0.324  Sum_probs=199.3

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      +|++.+.||.|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++.+.     ...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE-----ENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC-----CeE
Confidence            5889999999999999999998889999999996432   23457889999999999999999999887654     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++|+||+++++|.+++....       .+++..+..++.|+++|+.|||+.   +++|+||+|+||++++++.++|+|||
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~  145 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKV-------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFN  145 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcC-------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecc
Confidence            99999999999999997652       588999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhh-hHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL-SLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~-~~~~~~~~~~~~~  795 (871)
                      .+.......    ......|+..|+|||...+..++.++|+||+|+++|+|++|+.||........ ......... .. 
T Consensus       146 ~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~-  219 (258)
T cd05578         146 IATKVTPDT----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA-DV-  219 (258)
T ss_pred             cccccCCCc----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc-cc-
Confidence            998664321    22234578899999998888899999999999999999999999985432100 000000000 00 


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCH--HHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI--QDAI  856 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta--~evl  856 (871)
                                                   ......+..+.+++.+|++.||.+||++  +|++
T Consensus       220 -----------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 -----------------------------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -----------------------------cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                                         0001223567799999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-34  Score=302.20  Aligned_cols=249  Identities=25%  Similarity=0.368  Sum_probs=197.9

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCC---CCccceeeeeecccCcCCCce
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIR---HRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.+++.++   |||++++++++...     ..
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-----~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-----PR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-----CE
Confidence            4788899999999999999998899999999986432 334567889999999986   99999999988654     66


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++++|.++++..        .+++..++.++.|++.|+.|||+.   +++||||+|+||+++.++.++++||
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~df  145 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKAG--------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDF  145 (277)
T ss_pred             EEEEEecCCCCcHHHHHHcc--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccC
Confidence            89999999999999998653        488999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      |.+.......   .......|+..|+|||...++ .++.++|||||||++|+|++|+.||.........  .......+.
T Consensus       146 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~  220 (277)
T cd06917         146 GVAALLNQNS---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM--MLIPKSKPP  220 (277)
T ss_pred             CceeecCCCc---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh--hccccCCCC
Confidence            9998765432   112234688999999987654 5689999999999999999999999753211100  000000000


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .        +                   ..  .....++.+++.+|++.||++|||+.|+++.
T Consensus       221 ~--------~-------------------~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         221 R--------L-------------------ED--NGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             C--------C-------------------Cc--ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            0        0                   00  0123467789999999999999999999764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.6e-34  Score=308.19  Aligned_cols=282  Identities=22%  Similarity=0.273  Sum_probs=200.7

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcC---
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTR---  631 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---  631 (871)
                      ..++|++.+.||+|+||.||+|.+..+++.||||.+....  ......+.+|++++++++||||+++++++......   
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3467999999999999999999999899999999985432  22234567899999999999999999988664321   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                      .....++||||+. +++.+++.....      .+++.+++.++.|++.|+.|||+.   +++|+||||+||+++.++.+|
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~k  159 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNKNV------KFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILK  159 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEE
Confidence            2346699999995 588888765432      489999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCCCc-cccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhh-hHHHHh
Q 002883          712 VGDFGLSRLLHDNSPDQ-TSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL-SLHKYA  788 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~-~~~~~~  788 (871)
                      |+|||.+.......... .......++..|+|||...+. .++.++||||||+++|+|++|+.||........ ......
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~  239 (310)
T cd07865         160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL  239 (310)
T ss_pred             ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            99999998764332111 112234578899999986554 468899999999999999999999975432211 111111


Q ss_pred             hhCCCchhh-hhcChhHHHHHHHHHhhhhhhcCchhHHhHH------HHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          789 KMGLPDQVA-EIIDPAILEEALEIQAGIVKELQPNLRAKFH------EIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       789 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ....++... ...+......         ...+........      .....+.+++.+|+..||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         240 CGSITPEVWPGVDKLELFKK---------MELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hCCCChhhcccccchhhhhh---------ccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            111111111 0000000000         000000000000      01245678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.1e-34  Score=304.50  Aligned_cols=276  Identities=22%  Similarity=0.298  Sum_probs=199.8

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++.+.||+|++|+||+|.+..+++.||+|.+.....  ...+.+.+|++++++++||||+++++++...     ...
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-----CeE
Confidence            579999999999999999999988999999999854322  2345788899999999999999999998765     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCceEEeec
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-EMVAHVGDF  715 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Df  715 (871)
                      |+||||++ +++.+++......     ..++..+..++.||+.||+|||+.   +++||||+|+||+++. ++.+||+||
T Consensus        77 ~lv~e~~~-~~l~~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~df  147 (294)
T PLN00009         77 YLVFEYLD-LDLKKHMDSSPDF-----AKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADF  147 (294)
T ss_pred             EEEEeccc-ccHHHHHHhCCCC-----CcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccc
Confidence            99999995 5888887654321     467888999999999999999999   9999999999999985 567999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      |.+.......   .......+++.|+|||++.+ ..++.++||||+||++|+|+||+.||......+...........+.
T Consensus       148 g~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  224 (294)
T PLN00009        148 GLARAFGIPV---RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN  224 (294)
T ss_pred             ccccccCCCc---cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9997654321   11122357889999998755 4578999999999999999999999975433222221111111111


Q ss_pred             -hh-hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 -QV-AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 -~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       .. ....+  + ....   ...............+....++.+++.+|++.+|++||++.|+++
T Consensus       225 ~~~~~~~~~--~-~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        225 EETWPGVTS--L-PDYK---SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhcccccc--c-hhhh---hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00 00000  0 0000   000000111111222334566889999999999999999999986

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.2e-33  Score=299.20  Aligned_cols=248  Identities=23%  Similarity=0.332  Sum_probs=199.3

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      -|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...     ...|+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-----CeEEE
Confidence            3778899999999999999998889999999985432 23446788999999999999999999998765     67899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||+++++|.+++...        .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||.+
T Consensus        80 v~e~~~~~~l~~~i~~~--------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~  148 (277)
T cd06641          80 IMEYLGGGSALDLLEPG--------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA  148 (277)
T ss_pred             EEEeCCCCcHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccc
Confidence            99999999999998643        488999999999999999999998   9999999999999999999999999998


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE  798 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  798 (871)
                      .......   .......++..|+|||...+..++.++|+||+||++|+|++|..||........  ........++... 
T Consensus       149 ~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~-  222 (277)
T cd06641         149 GQLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV--LFLIPKNNPPTLE-  222 (277)
T ss_pred             eecccch---hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH--HHHHhcCCCCCCC-
Confidence            7654321   112224578899999998888889999999999999999999999974322110  0000000000000 


Q ss_pred             hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                                   ..+...+.+++.+|++.+|++||++.|+++.
T Consensus       223 -----------------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         223 -----------------------------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             -----------------------------cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                                         0223456789999999999999999999994

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-35  Score=285.58  Aligned_cols=255  Identities=21%  Similarity=0.287  Sum_probs=199.5

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCceeeEEEecc
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYEFM  643 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  643 (871)
                      +.+|+|+|+.|--+....++..||||+++........++.+|++++.+. .|+||++++++|++.     ...|+|||-|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd-----~~FYLVfEKm  158 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD-----TRFYLVFEKM  158 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc-----ceEEEEEecc
Confidence            6799999999999999999999999999888777778999999999998 699999999999876     6689999999


Q ss_pred             CCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC---ceEEeeccccee
Q 002883          644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM---VAHVGDFGLSRL  720 (871)
Q Consensus       644 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~a~~  720 (871)
                      .||+|...|++..       -+++.++.++.++|+.||.|||.+   ||.|||+||+|||-....   -+||+||.++.-
T Consensus       159 ~GGplLshI~~~~-------~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  159 RGGPLLSHIQKRK-------HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             cCchHHHHHHHhh-------hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccc
Confidence            9999999998865       599999999999999999999999   999999999999996544   589999988765


Q ss_pred             cCCCCCC----ccccccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhH------H
Q 002883          721 LHDNSPD----QTSTSRVKGSIGYVAPEYGA-----LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSL------H  785 (871)
Q Consensus       721 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~------~  785 (871)
                      +....+-    .......+|+..|||||+..     .-.|+.++|.||+|||+|-|++|.+||.+.-..+.-+      .
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr  308 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR  308 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence            4332211    12233467999999999632     2357899999999999999999999998653322111      1


Q ss_pred             HHhhh---CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          786 KYAKM---GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       786 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .....   .+.+...++-|.                       .+..+..+..+++...+-.||.+|-+|.++++
T Consensus       309 ~CQ~~LFesIQEGkYeFPdk-----------------------dWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  309 VCQNKLFESIQEGKYEFPDK-----------------------DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHHHhccCCcCChh-----------------------hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            11100   111122222232                       23355566677888888888888888888776

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7.5e-34  Score=298.66  Aligned_cols=250  Identities=21%  Similarity=0.267  Sum_probs=193.3

Q ss_pred             HHHHHhhcCCCCCcee--eccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeeccc
Q 002883          552 AELLKATEGFSSANLI--GIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSI  628 (871)
Q Consensus       552 ~~~~~~~~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  628 (871)
                      .+.....++|++.+.+  |+|+||.||+++...+++.+|+|++........     |+.....+ +|||++++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence            3444445677887777  999999999999998999999999864322111     22222222 799999999998765


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM  708 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  708 (871)
                           ...|+||||+++++|.+++....       .+++.++..++.|+++|+.|||+.   +++||||||+||+++.++
T Consensus        82 -----~~~~iv~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~  146 (267)
T PHA03390         82 -----KGHVLIMDYIKDGDLFDLLKKEG-------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAK  146 (267)
T ss_pred             -----CeeEEEEEcCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCC
Confidence                 57899999999999999997653       589999999999999999999999   999999999999999988


Q ss_pred             -ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHH
Q 002883          709 -VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKY  787 (871)
Q Consensus       709 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~  787 (871)
                       .++|+|||.+......       ....++..|+|||++.+..++.++||||+|+++|+|++|+.||.....+......+
T Consensus       147 ~~~~l~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~  219 (267)
T PHA03390        147 DRIYLCDYGLCKIIGTP-------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL  219 (267)
T ss_pred             CeEEEecCccceecCCC-------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH
Confidence             9999999998765422       12357899999999988899999999999999999999999998543322111111


Q ss_pred             hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC-HHHHHH
Q 002883          788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK-IQDAIM  857 (871)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-a~evl~  857 (871)
                      .... ..                            ...........+.+++.+||+.+|.+||+ ++|+++
T Consensus       220 ~~~~-~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        220 LKRQ-QK----------------------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHhh-cc----------------------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            1110 00                            00011134456789999999999999997 588874

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9.9e-34  Score=304.60  Aligned_cols=248  Identities=24%  Similarity=0.312  Sum_probs=196.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ..+|++.+.||+|+||+||+|.+..+++.||+|++....   ....+.+.+|+++++.++|||++++++++...     .
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~   88 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----H   88 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----C
Confidence            356899999999999999999998889999999985432   22335688999999999999999999998765     5


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||++ |++.+++.....      .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|
T Consensus        89 ~~~lv~e~~~-g~l~~~~~~~~~------~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~d  158 (307)
T cd06607          89 TAWLVMEYCL-GSASDILEVHKK------PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLAD  158 (307)
T ss_pred             eEEEEHHhhC-CCHHHHHHHccc------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEee
Confidence            6899999996 678777754332      489999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA---LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      ||.+......       ....++..|+|||++.   .+.++.++||||||+++|||++|+.||.......... ......
T Consensus       159 fg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-~~~~~~  230 (307)
T cd06607         159 FGSASLVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQND  230 (307)
T ss_pred             cCcceecCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-HHhcCC
Confidence            9998765322       1245788999999863   4568899999999999999999999997543221111 000000


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .+ .                           .  ....+...+.+++.+||+.+|++||++.++++.
T Consensus       231 ~~-~---------------------------~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 SP-T---------------------------L--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CC-C---------------------------C--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00 0                           0  001234467899999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-34  Score=326.13  Aligned_cols=284  Identities=17%  Similarity=0.161  Sum_probs=190.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCC-cEEEEE------------------EeeccccchHHHHHHHHHHHHcCCCCcc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEE-TNVAVK------------------VLDLQQRGASKSFIAECEALRSIRHRNL  618 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~ni  618 (871)
                      .++|++.+.||+|+||+||+|..+... ..++.|                  .+.. .......+.+|++++++++||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCc
Confidence            468999999999999999998764322 222222                  1111 11233567899999999999999


Q ss_pred             ceeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 002883          619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK  698 (871)
Q Consensus       619 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  698 (871)
                      +++++++...     ...|+|+|++ ++++.+++.......  ........+..++.|++.||+|||+.   +|||||||
T Consensus       226 v~l~~~~~~~-----~~~~lv~e~~-~~~l~~~l~~~~~~~--~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLK  294 (501)
T PHA03210        226 LKIEEILRSE-----ANTYMITQKY-DFDLYSFMYDEAFDW--KDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIK  294 (501)
T ss_pred             CcEeEEEEEC-----CeeEEEEecc-ccCHHHHHhhccccc--cccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            9999998765     5679999999 567888775432111  11244667889999999999999999   99999999


Q ss_pred             CCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCC-Cchh
Q 002883          699 PSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP-TDDM  777 (871)
Q Consensus       699 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~p-f~~~  777 (871)
                      |+|||++.++.+||+|||++..+....  ........||..|+|||++.+..++.++|||||||++|||++|..+ |...
T Consensus       295 P~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~  372 (501)
T PHA03210        295 LENIFLNCDGKIVLGDFGTAMPFEKER--EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDG  372 (501)
T ss_pred             HHHEEECCCCCEEEEeCCCceecCccc--ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence            999999999999999999998765322  1122235699999999999999999999999999999999998754 4322


Q ss_pred             hh-hhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhh-hhhcCchhHHhHH--HHHHHHHhhhcccccCCCCCCCCHH
Q 002883          778 FE-EGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGI-VKELQPNLRAKFH--EIQVSILRVGILCSEELPRDRMKIQ  853 (871)
Q Consensus       778 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPta~  853 (871)
                      .. ....+.+..... .....++.+..  .......... ...........+.  .....+.+++.+||++||++||||.
T Consensus       373 ~~~~~~~~~~~~~~~-~~~~~~~p~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~  449 (501)
T PHA03210        373 GGKPGKQLLKIIDSL-SVCDEEFPDPP--CKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAA  449 (501)
T ss_pred             CCCHHHHHHHHHHhc-ccChhhcCCcH--HHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHH
Confidence            11 111222221110 00001111100  0000000000 0000011111111  1234567889999999999999999


Q ss_pred             HHHHH
Q 002883          854 DAIME  858 (871)
Q Consensus       854 evl~~  858 (871)
                      |+++.
T Consensus       450 elL~h  454 (501)
T PHA03210        450 ELLAL  454 (501)
T ss_pred             HHhhC
Confidence            99874

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=9.6e-34  Score=301.19  Aligned_cols=274  Identities=19%  Similarity=0.215  Sum_probs=195.8

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCceeeE
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      |++.+.||+|+||.||+|.+..+++.||+|+++... ........+|+.++.++. |+|++++++++.+..   .+..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEEE
Confidence            678899999999999999998899999999986432 222234457888898884 999999999986542   246799


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||++ +++.+++.....      .+++.++..++.|++.||+|||+.   +++||||+|+||+++. +.+||+|||.+
T Consensus        78 v~e~~~-~~l~~~l~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~  146 (282)
T cd07831          78 VFELMD-MNLYELIKGRKR------PLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSC  146 (282)
T ss_pred             EEecCC-ccHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccc
Confidence            999996 588888765431      589999999999999999999999   9999999999999999 99999999999


Q ss_pred             eecCCCCCCccccccccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC-CCchh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGA-LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG-LPDQV  796 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~  796 (871)
                      ........    .....++..|+|||+.. ++.++.++||||+||++|||++|..||......+.........+ .++..
T Consensus       147 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
T cd07831         147 RGIYSKPP----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV  222 (282)
T ss_pred             cccccCCC----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            86643221    12245788999999754 45678999999999999999999999975432211111000000 11111


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ............     .................+.++.+++.+|++.+|++|||++|+++
T Consensus       223 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         223 LKKFRKSRHMNY-----NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HHhhcccccccc-----cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000000000000     00000001111222345678999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-33  Score=300.74  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=204.5

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ..+.|++.+.||+|+||.||+|.+..++..||+|+++.... ..+.+.+|+++++.++|+|++++++++...     ...
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG-----DEL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEE
Confidence            44678899999999999999999988899999999976544 456788999999999999999999998765     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+|+||+++++|.+++....      ..+++..+..++.|++.|+.|||+.   |++|+||+|+||+++.++.++|+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~  161 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNF------VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFG  161 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccc
Confidence            99999999999999998754      1589999999999999999999998   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      .+.......   .......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .........+ . 
T Consensus       162 ~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-~~~~~~~~~~-~-  235 (286)
T cd06614         162 FAAQLTKEK---SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-LFLITTKGIP-P-  235 (286)
T ss_pred             hhhhhccch---hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCC-C-
Confidence            987654321   111223478899999998888899999999999999999999999975322211 1111110000 0 


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                        .                         .....+...+.+++.+|++.+|.+|||+.|+++.
T Consensus       236 --~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         236 --L-------------------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             --C-------------------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence              0                         0011234567799999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.7e-34  Score=301.83  Aligned_cols=275  Identities=24%  Similarity=0.330  Sum_probs=201.5

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      +|++.+.||.|++|.||+|++..+++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.     +..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEE
Confidence            58899999999999999999998999999999865432 2346677899999999999999999998765     56899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||++ ++|.+++.....    ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.++++|||.+
T Consensus        76 v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~  147 (284)
T cd07836          76 VFEYMD-KDLKKYMDTHGV----RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA  147 (284)
T ss_pred             EEecCC-ccHHHHHHhcCC----CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchh
Confidence            999997 489998865432    12589999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch--
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ--  795 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--  795 (871)
                      .......   .......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||..................+..  
T Consensus       148 ~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (284)
T cd07836         148 RAFGIPV---NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTEST  224 (284)
T ss_pred             hhhcCCc---cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence            7653321   11122357889999998655 35689999999999999999999999754332211111111111100  


Q ss_pred             hhhhcC-hhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIID-PAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...+.. +.+..       ..............+.....+.+++.+|++.||.+||++.|+++
T Consensus       225 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         225 WPGISQLPEYKP-------TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HHHHhcCchhcc-------cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000 00000       00000000111122234567889999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.4e-34  Score=298.67  Aligned_cols=250  Identities=23%  Similarity=0.329  Sum_probs=199.2

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|++.+.||+|+||.||+|.+..++..||+|.+....  ....+.+.+|+++++.++|+|++++++.+...     ...+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~-----~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN-----GRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC-----CeEE
Confidence            5888999999999999999999899999999986532  12345778999999999999999999987655     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEEeecc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM-VAHVGDFG  716 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg  716 (871)
                      +|+||+++++|.+++......     .+++..+..++.|++.|+.|||+.   +++|+||||+||++++++ .+|++|||
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~  147 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRGV-----LFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFG  147 (257)
T ss_pred             EEEecCCCCcHHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccc
Confidence            999999999999999764422     579999999999999999999999   999999999999998875 56999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      .+.......   .......|++.|+|||+..+..++.++|+||||+++|+|++|..||.......... .......+ . 
T Consensus       148 ~~~~~~~~~---~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~-~-  221 (257)
T cd08225         148 IARQLNDSM---ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL-KICQGYFA-P-  221 (257)
T ss_pred             cchhccCCc---ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH-HHhcccCC-C-
Confidence            998664322   11222458899999999888889999999999999999999999997432211110 00000000 0 


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                            ..       .....++.+++.+|+..+|++|||+.|+++
T Consensus       222 ----------------------~~-------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         222 ----------------------IS-------PNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ----------------------CC-------CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                                  00       112345778999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.5e-34  Score=309.52  Aligned_cols=284  Identities=20%  Similarity=0.241  Sum_probs=203.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  634 (871)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++....  ......+.+|+++++.++||||+++++++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368999999999999999999998889999999985422  2234567899999999999999999998865422 1224


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+|+||+. .++.++...         .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~d  160 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMGH---------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILD  160 (342)
T ss_pred             eEEEEecccc-cCHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEee
Confidence            5699999995 477766531         488999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||.+......      .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............+...+.+
T Consensus       161 fg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (342)
T cd07879         161 FGLARHADAE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  234 (342)
T ss_pred             CCCCcCCCCC------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9998754321      122457889999998765 468899999999999999999999997543222111111111111


Q ss_pred             c-hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH--HHHHH
Q 002883          794 D-QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME--LQEAQ  863 (871)
Q Consensus       794 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~--L~~i~  863 (871)
                      . ...+...........   ..............++....++.+++.+|++.||++||+++|+++.  ++..+
T Consensus       235 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         235 GPEFVQKLEDKAAKSYI---KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             CHHHHHHhcccchHHHH---hhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            1 111111110000000   0000111112222233445678899999999999999999999854  55443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=301.32  Aligned_cols=276  Identities=26%  Similarity=0.336  Sum_probs=202.8

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      |++.+.||+|+||.||+|++..+++.||+|++....  ......+.+|+++++.++|+|++++++++...+   ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            678899999999999999999889999999997553  334467889999999999999999999986542   356899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||++ ++|.+++....      ..+++..++.++.|++.|++|||+.   +++|+||+|+||++++++.+||+|||.+
T Consensus        78 v~e~~~-~~l~~~~~~~~------~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~  147 (287)
T cd07840          78 VFEYMD-HDLTGLLDSPE------VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLA  147 (287)
T ss_pred             Eecccc-ccHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccce
Confidence            999996 58998886542      1589999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hCCCc--
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MGLPD--  794 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~~--  794 (871)
                      ........  .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ...... ...+.  
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~  224 (287)
T cd07840         148 RPYTKRNS--ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDE  224 (287)
T ss_pred             eeccCCCc--ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchh
Confidence            87654321  11223456788999997654 4578999999999999999999999975433211 111111 11110  


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHH-HHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEI-QVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ....+.+-......     .............+... ..++.+++.+|++.+|++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         225 NWPGVSKLPWFENL-----KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hccccccchhhhhc-----cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00000000000000     00011111122222332 678899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.4e-34  Score=303.61  Aligned_cols=265  Identities=20%  Similarity=0.254  Sum_probs=189.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCC---CcEEEEEEeeccccchH-----------HHHHHHHHHHHcCCCCccceeee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTE---ETNVAVKVLDLQQRGAS-----------KSFIAECEALRSIRHRNLVKIIT  623 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~  623 (871)
                      .++|++.+.||+|+||.||+|.+..+   +..+|+|+.........           .....+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            46899999999999999999999766   66778886543222110           11223334456678999999998


Q ss_pred             eecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcee
Q 002883          624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL  703 (871)
Q Consensus       624 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  703 (871)
                      ++..... .....++++|++ ..++.+.+....       ..++..+..++.|++.|++|||+.   +|+||||||+||+
T Consensus        91 ~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nil  158 (294)
T PHA02882         91 CGSFKRC-RMYYRFILLEKL-VENTKEIFKRIK-------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIM  158 (294)
T ss_pred             eeeEecC-CceEEEEEEehh-ccCHHHHHHhhc-------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence            7544321 123557888887 446777665432       357788899999999999999999   9999999999999


Q ss_pred             eCCCCceEEeecccceecCCCCCCc----cccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhh
Q 002883          704 LDNEMVAHVGDFGLSRLLHDNSPDQ----TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFE  779 (871)
Q Consensus       704 l~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  779 (871)
                      ++.++.++|+|||+|+.........    .......||+.|+|||+..+..++.++||||+||++|||++|+.||.....
T Consensus       159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            9999999999999998764322111    112234699999999999989999999999999999999999999985422


Q ss_pred             hhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          780 EGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       780 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                      ........ ..       +++     ..           +.. ........++.+.+++..|++.+|++||++.++.+.+
T Consensus       239 ~~~~~~~~-~~-------~~~-----~~-----------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        239 NGNLIHAA-KC-------DFI-----KR-----------LHE-GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             chHHHHHh-HH-------HHH-----HH-----------hhh-hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            21111100 00       000     00           000 0001123356688999999999999999999999876

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-35  Score=279.84  Aligned_cols=283  Identities=21%  Similarity=0.294  Sum_probs=207.1

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEe--eccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcC---CC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVL--DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTR---GN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~--~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---~~  633 (871)
                      +.|+...+||+|.||.||+|+.+.+++.||+|++  .....+......+|+++++.++|+|++.+++.|.....+   ..
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4567778999999999999999999999999876  334445567788999999999999999999988665433   33


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||++|+. +|.-.+....      .+++..++.+++.++..||.|+|..   .|+|||+||+|++|+++|.+||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~------vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRK------VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCcc------ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEee
Confidence            568999999965 8888886543      2699999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCC-CCccccccccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh---
Q 002883          714 DFGLSRLLHDNS-PDQTSTSRVKGSIGYVAPEYGA-LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA---  788 (871)
Q Consensus       714 Dfg~a~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~---  788 (871)
                      |||+|+.+.... ......+..+.|..|++||.+. ...|+++.|||+.|||+.||+||.+.+....+... +..+.   
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq-l~~Is~Lc  245 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ-LHLISQLC  245 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH-HHHHHHHh
Confidence            999997654322 2223345567899999999754 56899999999999999999999999886544322 11111   


Q ss_pred             hhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHH------HHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          789 KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQV------SILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ....++.+.....-.+.+...      ...++.......++..+      +..+++..++..||.+||++++++..
T Consensus       246 Gs~tkevWP~~d~lpL~~sie------~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  246 GSITKEVWPNVDNLPLYQSIE------LEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccCCcccCCCcccchHHHhcc------CCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            111111111111111111100      00011111112222222      56789999999999999999999854

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=299.20  Aligned_cols=274  Identities=24%  Similarity=0.305  Sum_probs=204.3

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      |++.+.||+|++|.||+|.+..+++.+|+|+++....  .....+.+|++++++++|++|+++++++...     ...++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence            6788999999999999999988999999999864432  2456788899999999999999999987665     67899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||+++ ++.+++.....      .+++..+..++.|++.|+.|||+.   +|+|+||||+||+++.++.++|+|||.+
T Consensus        76 v~e~~~~-~l~~~l~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~  145 (283)
T cd05118          76 VFEFMDT-DLYKLIKDRQR------GLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLA  145 (283)
T ss_pred             EEeccCC-CHHHHHHhhcc------cCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeee
Confidence            9999965 88888876432      589999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC--ch
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP--DQ  795 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~--~~  795 (871)
                      .......   .......++..|+|||...+. .++.++||||+|+++|+|++|+.||......+...........+  ..
T Consensus       146 ~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (283)
T cd05118         146 RSFGSPV---RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEV  222 (283)
T ss_pred             EecCCCc---ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHh
Confidence            8765432   112224578899999987766 78999999999999999999999997543322111111111111  00


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .....+...     .......................++.+++.+|++.||.+||++.|++.
T Consensus       223 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         223 WPKFTSLAR-----NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             cccchhhhh-----hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            111111000     000001111111222233456778999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.3e-33  Score=292.90  Aligned_cols=250  Identities=27%  Similarity=0.381  Sum_probs=203.3

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEE
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV  639 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  639 (871)
                      +|+..+.||+|++|.||+|.+..+++.|++|++........+.+.+|+++++.++|++++++++++...     ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence            478889999999999999999888999999999765544567889999999999999999999988665     568999


Q ss_pred             EeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccce
Q 002883          640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR  719 (871)
Q Consensus       640 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  719 (871)
                      +||+++++|.+++....      ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+.
T Consensus        76 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~  146 (253)
T cd05122          76 MEFCSGGSLKDLLKSTN------QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSA  146 (253)
T ss_pred             EecCCCCcHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccc
Confidence            99999999999997653      2589999999999999999999998   99999999999999999999999999998


Q ss_pred             ecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhh
Q 002883          720 LLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEI  799 (871)
Q Consensus       720 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  799 (871)
                      .......    .....++..|+|||...+..++.++||||||+++|+|++|+.||........... ......+ .   .
T Consensus       147 ~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~-~---~  217 (253)
T cd05122         147 QLSDTKA----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-IATNGPP-G---L  217 (253)
T ss_pred             ccccccc----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-HHhcCCC-C---c
Confidence            7654321    2335688999999998888889999999999999999999999975421111110 0000000 0   0


Q ss_pred             cChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          800 IDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ..                         ...+...+.+++.+|++.||++|||+.|+++
T Consensus       218 ~~-------------------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         218 RN-------------------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             Cc-------------------------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00                         0012346789999999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-33  Score=299.53  Aligned_cols=243  Identities=20%  Similarity=0.242  Sum_probs=184.8

Q ss_pred             eeeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHH---cCCCCccceeeeeecccCcCCCceeeEE
Q 002883          566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEALR---SIRHRNLVKIITSCSSIDTRGNEFKALV  639 (871)
Q Consensus       566 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~~~~~~lv  639 (871)
                      .||+|+||.||+|.+..+++.||+|.+.....   .....+.+|..+++   ..+||+++.+++++...     +..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEE
Confidence            48999999999999988999999999854321   11233344544433   34799999999888665     568999


Q ss_pred             EeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccce
Q 002883          640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR  719 (871)
Q Consensus       640 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  719 (871)
                      |||+++++|.+++....       .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||.+.
T Consensus        76 ~e~~~~~~L~~~i~~~~-------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~  145 (279)
T cd05633          76 LDLMNGGDLHYHLSQHG-------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  145 (279)
T ss_pred             EecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcce
Confidence            99999999999987643       589999999999999999999999   99999999999999999999999999987


Q ss_pred             ecCCCCCCccccccccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhh
Q 002883          720 LLHDNSPDQTSTSRVKGSIGYVAPEYGA-LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE  798 (871)
Q Consensus       720 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  798 (871)
                      ......     .....|+..|+|||... +..++.++||||+||++|+|++|+.||..................+.    
T Consensus       146 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----  216 (279)
T cd05633         146 DFSKKK-----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV----  216 (279)
T ss_pred             eccccC-----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCc----
Confidence            553321     12245899999999876 45678999999999999999999999974322111100000000000    


Q ss_pred             hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHHH
Q 002883          799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIME  858 (871)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~~  858 (871)
                                             ..   ......++.+++.+|+..||++||     |++|+++.
T Consensus       217 -----------------------~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         217 -----------------------EL---PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -----------------------CC---ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                                   00   012344677899999999999999     59988874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.2e-34  Score=307.30  Aligned_cols=287  Identities=21%  Similarity=0.268  Sum_probs=203.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCc---CC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDT---RG  632 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  632 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.....  .....+.+|+++++.++||||+++++++.+...   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4789999999999999999999998999999999854322  223466789999999999999999988755432   22


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                      ....++||||+. +++.+.+....      ..+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++|
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~------~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l  156 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPS------VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKI  156 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            356799999995 47777765432      2589999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCcc--------ccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhh
Q 002883          713 GDFGLSRLLHDNSPDQT--------STSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLS  783 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~  783 (871)
                      +|||++...........        ......+++.|+|||...+ ..++.++|||||||++|+|++|++||.........
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~  236 (311)
T cd07866         157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL  236 (311)
T ss_pred             CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999986543221111        1123456888999997654 45789999999999999999999999754332111


Q ss_pred             HHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          784 LHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...+.....+.. ..+.+.........  .......++.....+......+.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         237 HLIFKLCGTPTE-ETWPGWRSLPGCEG--VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHhCCCCh-hhchhhhhcccccc--cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            111111111100 00000000000000  000111122233333444567889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.3e-34  Score=304.71  Aligned_cols=258  Identities=24%  Similarity=0.268  Sum_probs=192.8

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|+..+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++.++. |+||+++++++...     ...+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcEE
Confidence            5667788999999999999999999999999986433 234467889999999995 99999999987654     5678


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      ++|||+. +++.++.......  ....+++..+..++.|++.|++|||+.  .+++||||||+||+++.++.+||+|||+
T Consensus        80 ~~~e~~~-~~l~~l~~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~  154 (288)
T cd06616          80 ICMELMD-ISLDKFYKYVYEV--LKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGI  154 (288)
T ss_pred             EEEeccc-CCHHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecch
Confidence            9999985 4665544321100  012589999999999999999999973  2899999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCC---CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG---EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      +.......    ......|+..|+|||++.+.   .++.++||||+||++|+|++|+.||................. +.
T Consensus       155 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~  229 (288)
T cd06616         155 SGQLVDSI----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD-PP  229 (288)
T ss_pred             hHHhccCC----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCC-CC
Confidence            97654321    11223578899999987765   689999999999999999999999975321111111110000 00


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ...                       .   .....+..++.+++.+|++.||++|||++|+++.
T Consensus       230 ~~~-----------------------~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         230 ILS-----------------------N---SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             cCC-----------------------C---cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000                       0   0001244568899999999999999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.2e-33  Score=306.70  Aligned_cols=290  Identities=19%  Similarity=0.221  Sum_probs=199.7

Q ss_pred             ceeecc--ccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIG--GYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      ..||+|  +||+||+|++..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++...     ...++||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-----SWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-----CceEEEE
Confidence            346666  89999999998899999999986432  23346788999999999999999999998765     6689999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+.++++.+++......     .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+..
T Consensus        79 e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~  150 (328)
T cd08226          79 PFMAYGSANSLLKTYFPE-----GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYS  150 (328)
T ss_pred             ecccCCCHHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence            999999999999875422     588999999999999999999998   999999999999999999999999986543


Q ss_pred             cCCCCCCcc----ccccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          721 LHDNSPDQT----STSRVKGSIGYVAPEYGAL--GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       721 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      .........    ......++..|+|||++.+  ..++.++||||+||++|+|++|+.||...................+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  230 (328)
T cd08226         151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP  230 (328)
T ss_pred             hhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCC
Confidence            322111110    0111234567999999765  3478999999999999999999999976543322221111111000


Q ss_pred             --------hhhhhcChhHHHH--HHH-HHhhhh-hhcC--chhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH--H
Q 002883          795 --------QVAEIIDPAILEE--ALE-IQAGIV-KELQ--PNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM--E  858 (871)
Q Consensus       795 --------~~~~~~~~~~~~~--~~~-~~~~~~-~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~--~  858 (871)
                              ....+.+......  ..+ ...... ....  .-..+....+...+.+++++||+.||++|||+.|+++  .
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~  310 (328)
T cd08226         231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF  310 (328)
T ss_pred             ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence                    0000000000000  000 000000 0000  0001112345678899999999999999999999975  4


Q ss_pred             HHHHHHHHH
Q 002883          859 LQEAQKMRQ  867 (871)
Q Consensus       859 L~~i~~~~~  867 (871)
                      ++.+.+..+
T Consensus       311 ~~~~~~~~~  319 (328)
T cd08226         311 FKQVKEQTQ  319 (328)
T ss_pred             HHHHHHhcc
Confidence            455554443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-35  Score=277.64  Aligned_cols=253  Identities=21%  Similarity=0.276  Sum_probs=196.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ-QRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++.+.+..+|.|+.|+||+++.+.++...|||.+... ..++.+++...++++..- ++|.||+.+|+|...     ..+
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~dV  166 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TDV  166 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----chH
Confidence            3445667899999999999999999999999999544 345567888888877665 599999999999876     557


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++.||.| ..-++..++.-..      ++++.-+-++...+++||.||.++  ++|+|||+||+|||+|+.|++|+||||
T Consensus       167 ~IcMelM-s~C~ekLlkrik~------piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  167 FICMELM-STCAEKLLKRIKG------PIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             HHHHHHH-HHHHHHHHHHhcC------CchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeeccc
Confidence            8999988 4345555544332      588888889999999999999987  499999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL---GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      .+.++-+.    ...+...|-+.|||||.+..   ..|+.++||||||++++||.||+.||.....+-..+.+... ..|
T Consensus       238 IsGrlvdS----kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~eP  312 (391)
T KOG0983|consen  238 ISGRLVDS----KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEP  312 (391)
T ss_pred             ccceeecc----cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCC
Confidence            99887643    33445569999999997653   46889999999999999999999999864333222322222 112


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      +....                            ...+...+.+++..||+.|+.+||...++++.
T Consensus       313 P~L~~----------------------------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  313 PLLPG----------------------------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCCc----------------------------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            11110                            01134567789999999999999999988763

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-34  Score=306.23  Aligned_cols=248  Identities=23%  Similarity=0.304  Sum_probs=204.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccch--HHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGA--SKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .+.|.+.+.||+|.|+.|.+|++.-++..||||+++...-..  ...+.+|+++|+.++|||||+++.+....     ..
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~-----~~  129 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE-----AT  129 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-----ce
Confidence            467999999999999999999999999999999997654332  34588999999999999999999998776     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      +|+||||+.+|.+.+|+..++       ...+..+..++.|+.+|++|+|++   .|||||||++||+++.+.++||+||
T Consensus       130 lylV~eya~~ge~~~yl~~~g-------r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDf  199 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHG-------RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADF  199 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcc-------cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecc
Confidence            999999999999999999876       466689999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHH-hhhCCC
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV-STHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKY-AKMGLP  793 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~-~~~~~~  793 (871)
                      |++.++....    .....+|++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||++..-....-+.. .+..++
T Consensus       200 gfS~~~~~~~----~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp  275 (596)
T KOG0586|consen  200 GFSTFFDYGL----MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP  275 (596)
T ss_pred             ccceeecccc----cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc
Confidence            9999887433    3344679999999999988887 699999999999999999999998632211100000 000000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                          -                              -...+..+++++++-.+|.+|++.+++...
T Consensus       276 ----~------------------------------~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  276 ----F------------------------------YMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ----c------------------------------eeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                0                              011234578888999999999999998764

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.5e-33  Score=306.59  Aligned_cols=283  Identities=20%  Similarity=0.237  Sum_probs=200.7

Q ss_pred             CCCCCceeeccccceEEEEEECCC--CcEEEEEEeecc--ccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCc
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTE--ETNVAVKVLDLQ--QRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  634 (871)
                      +|++.+.||+|+||.||+|++..+  +..||+|++...  .....+.+.+|+++++++ +||||+++++.+... .....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence            588899999999999999999877  889999998542  222345678899999999 599999999875432 12235


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+++||+. ++|.+++....       .+++..++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~D  148 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQ-------PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICD  148 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCc
Confidence            6789999985 68999886543       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCC-ccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          715 FGLSRLLHDNSPD-QTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       715 fg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      ||.+......... ........|+..|+|||+..+ ..++.++||||+||++|+|++|+.||................+.
T Consensus       149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  228 (332)
T cd07857         149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT  228 (332)
T ss_pred             CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC
Confidence            9999876532211 111233468999999997655 46899999999999999999999999753322111111111111


Q ss_pred             Cch--hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          793 PDQ--VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       793 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      +..  ...+..+..    .........................+.+++.+|++.||++|||+.|+++.
T Consensus       229 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         229 PDEETLSRIGSPKA----QNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             CCHHHHHhhhhhhH----HHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            111  111111100    00000000000011111112235678899999999999999999998753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-33  Score=307.26  Aligned_cols=280  Identities=19%  Similarity=0.204  Sum_probs=203.6

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcC-CC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTR-GN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~  633 (871)
                      ..++|++.+.||+|+||.||+|.+..++..||||++....  ......+.+|+++++.++||||+++++++...... ..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4578999999999999999999999899999999985322  22345678999999999999999999988654221 12


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+ +++|.+++...        .+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.++++
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~--------~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHE--------KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence            3568999999 78999888642        489999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh-C
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM-G  791 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~  791 (871)
                      |||.+......      .....+++.|+|||.+.+ ..++.++|+||+||++|++++|+.||................ .
T Consensus       161 dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~  234 (343)
T cd07880         161 DFGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT  234 (343)
T ss_pred             ecccccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999765322      122357889999998765 457899999999999999999999997543221111111111 1


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .+....+.+.......+   ........+.............+.+++.+|++.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         235 PSKEFVQKLQSEDAKNY---VKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CCHHHHHhhcchhHHHH---HHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11111111111110000   1111111111111222344556889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.3e-34  Score=309.76  Aligned_cols=279  Identities=21%  Similarity=0.274  Sum_probs=204.9

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~  633 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...  .....+.+.+|+.++++++|||++++.+++...+. ...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            356899999999999999999999989999999998543  22234567789999999999999999987755432 223


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++|+||+ +++|.+++...        .+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~  160 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ--------KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKIL  160 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEc
Confidence            4589999999 77999998752        489999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MG  791 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~  791 (871)
                      |||.+......      .....++..|+|||...+ ..++.++||||+||++|+|++|+.||........ ...... ..
T Consensus       161 dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~i~~~~~  233 (343)
T cd07851         161 DFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-LKRIMNLVG  233 (343)
T ss_pred             ccccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcC
Confidence            99999865432      222457889999998654 3678999999999999999999999975432211 111111 11


Q ss_pred             C-CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          792 L-PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       792 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      . ++....-+...   .............++.....+.....++.+++.+|++.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         234 TPDEELLQKISSE---SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CCCHHHHhhccch---hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            1 11111111100   011111111111112222223344678899999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-33  Score=306.21  Aligned_cols=277  Identities=22%  Similarity=0.253  Sum_probs=202.0

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ...++|++.+.||.|+||.||+|.+..+++.||+|++...  .....+.+.+|+++++.++|||++++++++...    .
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~   82 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----L   82 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----C
Confidence            4567899999999999999999999999999999987532  222346778899999999999999999987542    2


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||+ +++|.+++...        .+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.++|+
T Consensus        83 ~~~~lv~e~~-~~~L~~~~~~~--------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~  150 (328)
T cd07856          83 EDIYFVTELL-GTDLHRLLTSR--------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKIC  150 (328)
T ss_pred             CcEEEEeehh-ccCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeC
Confidence            4578999999 67899888643        478888899999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh-hhC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA-KMG  791 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~-~~~  791 (871)
                      |||.+......      .....++..|+|||.+.+ ..++.++||||+||++|+|++|+.||.............. ...
T Consensus       151 dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~  224 (328)
T cd07856         151 DFGLARIQDPQ------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT  224 (328)
T ss_pred             ccccccccCCC------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99998754321      122356889999998655 5689999999999999999999999975432111111001 111


Q ss_pred             CCchhh-hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          792 LPDQVA-EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       792 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .++... .+.+...    ...................+....++.+++.+|++.+|++|||++|++..
T Consensus       225 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         225 PPDDVINTICSENT----LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCHHHHHhccchhh----HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            111111 1111110    00000000000111112222345678899999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.7e-33  Score=299.85  Aligned_cols=246  Identities=22%  Similarity=0.321  Sum_probs=196.8

Q ss_pred             CCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEec
Q 002883          563 SANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF  642 (871)
Q Consensus       563 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  642 (871)
                      ....||+|+||.||+|....+++.||+|++..........+.+|+.+++.++|+|++++++++...     +..++||||
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~   98 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVMEF   98 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-----CEEEEEEec
Confidence            346799999999999999889999999998655444556788999999999999999999998765     678999999


Q ss_pred             cCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecC
Q 002883          643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH  722 (871)
Q Consensus       643 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  722 (871)
                      +++++|.+++...        .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+....
T Consensus        99 ~~~~~L~~~~~~~--------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~  167 (292)
T cd06657          99 LEGGALTDIVTHT--------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  167 (292)
T ss_pred             CCCCcHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecc
Confidence            9999999987542        478999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcCh
Q 002883          723 DNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDP  802 (871)
Q Consensus       723 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  802 (871)
                      ...   .......++..|+|||...+..++.++||||+|+++|+|++|..||.......  .........+....     
T Consensus       168 ~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~-----  237 (292)
T cd06657         168 KEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRDNLPPKLK-----  237 (292)
T ss_pred             ccc---ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhhCCcccC-----
Confidence            321   11223457899999999888888999999999999999999999997432111  11111111111100     


Q ss_pred             hHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          803 AILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                             ........+.+++.+|++.+|.+||++.|+++
T Consensus       238 -----------------------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         238 -----------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             -----------------------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence                                   01122345678899999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.8e-33  Score=302.31  Aligned_cols=247  Identities=24%  Similarity=0.315  Sum_probs=194.8

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .|+..+.||+|+||.||+|++..++..||+|++....   ......+.+|+++++.++|||++++++++.+.     ...
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CeE
Confidence            3778899999999999999998889999999986432   22345788899999999999999999998765     567


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+. |++.+++.....      .+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||
T Consensus       101 ~lv~e~~~-g~l~~~~~~~~~------~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg  170 (317)
T cd06635         101 WLVMEYCL-GSASDLLEVHKK------PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG  170 (317)
T ss_pred             EEEEeCCC-CCHHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCC
Confidence            99999996 588877754332      589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA---LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      .+......       ....++..|+|||++.   .+.++.++|||||||++|+|++|+.||........ .........+
T Consensus       171 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~~  242 (317)
T cd06635         171 SASIASPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESP  242 (317)
T ss_pred             CccccCCc-------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhccCC
Confidence            98754321       2235788999999863   45689999999999999999999999875321111 1111111100


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                      ..                              ........+.+++.+|++.+|++||++.|+++..
T Consensus       243 ~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         243 TL------------------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             CC------------------------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            00                              0012234577899999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.4e-33  Score=302.98  Aligned_cols=284  Identities=24%  Similarity=0.301  Sum_probs=203.4

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCc---
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDT---  630 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---  630 (871)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|+++...  ......+.+|++++++++|||++++++++.+...   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34578999999999999999999999889999999996432  2234567789999999999999999998866531   


Q ss_pred             --CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 002883          631 --RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM  708 (871)
Q Consensus       631 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  708 (871)
                        ......++|+||+++ ++.+++....      ..+++..++.++.|++.||+|||+.   +|+||||||+||++++++
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~  153 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL------VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKG  153 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence              122478999999975 7777776532      1589999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHH
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKY  787 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~  787 (871)
                      .+||+|||.+........  .......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||....... .....
T Consensus       154 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~~~  230 (302)
T cd07864         154 QIKLADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLELI  230 (302)
T ss_pred             cEEeCcccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Confidence            999999999987654321  11122346788999997654 456899999999999999999999997532211 11111


Q ss_pred             hh---hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          788 AK---MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       788 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ..   ...+.....+.........     .............+...+..+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         231 SRLCGSPCPAVWPDVIKLPYFNTM-----KPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHhCCCChhhccccccccccccc-----ccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11   1111111111000000000     00000111112222234567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-33  Score=305.87  Aligned_cols=285  Identities=20%  Similarity=0.240  Sum_probs=205.6

Q ss_pred             HHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccC
Q 002883          552 AELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSID  629 (871)
Q Consensus       552 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  629 (871)
                      .++....++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|++++++++||||+++++++....
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            344556789999999999999999999998899999999986432  223456778999999999999999999875432


Q ss_pred             c-CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 002883          630 T-RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM  708 (871)
Q Consensus       630 ~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  708 (871)
                      . ......|++++++ +++|.+++...        .+++..++.++.|++.|++|||+.   +|+||||||+||+++.++
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQ--------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence            2 1224568888887 88999888643        488999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHH
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKY  787 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~  787 (871)
                      .+||+|||.+......      .....++..|+|||...+ ..++.++||||+||++|+|++|+.||........ ....
T Consensus       158 ~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~  230 (345)
T cd07877         158 ELKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI  230 (345)
T ss_pred             CEEEeccccccccccc------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence            9999999998764321      123457889999998755 5678999999999999999999999964322211 1111


Q ss_pred             hh-hC-CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          788 AK-MG-LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       788 ~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .. .. .++.....+.......+..   ...................++.+++.+|++.||.+|||+.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQ---SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHH---HhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            11 11 1111111111111111110   000000111111111235568899999999999999999998864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.3e-33  Score=291.23  Aligned_cols=252  Identities=22%  Similarity=0.333  Sum_probs=203.4

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|++.+.||+|+||.||+|.+..++..||+|++.....  ...+.+.+|+++++.++|||++++.+.+...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence            58889999999999999999988899999999965433  4556788999999999999999999987665     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +|+||+++++|.+++......   ...+++..+..++.+++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~  149 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKE---GKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGI  149 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhcc---CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccc
Confidence            999999999999999775311   12689999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +.......   .......|++.|+|||...+..++.++||||+|+++|+|++|+.||.......  ............. 
T Consensus       150 ~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~-  223 (258)
T cd08215         150 SKVLSSTV---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE--LALKILKGQYPPI-  223 (258)
T ss_pred             eeecccCc---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH--HHHHHhcCCCCCC-
Confidence            98765432   12223468889999999888889999999999999999999999997532111  1111000000000 


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                            +       ......+.+++.+|+..+|++|||+.|+++
T Consensus       224 ----------------------~-------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 ----------------------P-------SQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ----------------------C-------CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                                  0       022345778999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-33  Score=297.36  Aligned_cols=276  Identities=21%  Similarity=0.252  Sum_probs=198.9

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCceeeE
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      |++.+.||+|++|+||+|+...+++.||||.+..... .......+|+..+++++ |+|++++++++.+.     ...++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-----~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN-----DELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC-----CcEEE
Confidence            6788999999999999999988899999999854322 22234567999999998 99999999998764     67899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||+ +|+|.+++.....     ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        76 v~e~~-~~~l~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~  146 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRKG-----KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLA  146 (283)
T ss_pred             EEecC-CCCHHHHHHhccc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccc
Confidence            99999 8899998876542     2589999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGA-LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      .......    ......++..|+|||++. ...++.++|+||||+++|+|++|+.||......+...........+.. .
T Consensus       147 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~  221 (283)
T cd07830         147 REIRSRP----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTK-Q  221 (283)
T ss_pred             eeccCCC----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCCh-h
Confidence            8664321    122345788999999764 455789999999999999999999999654322211111111111100 0


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .+.+........  ...............+......+.+++++|++.||++|||++|++.
T Consensus       222 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         222 DWPEGYKLASKL--GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhhhHhhhhccc--cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000000000000  0000000011111222223467889999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.6e-33  Score=296.79  Aligned_cols=245  Identities=23%  Similarity=0.290  Sum_probs=190.9

Q ss_pred             eeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEecc
Q 002883          567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM  643 (871)
Q Consensus       567 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  643 (871)
                      ||+|+||+||+|.+..+++.||+|++....   ......+.+|+++++.++||||+++++++...     +..|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-----DDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-----CeEEEEEecC
Confidence            689999999999999899999999985432   22334567899999999999999999988654     6689999999


Q ss_pred             CCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCC
Q 002883          644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD  723 (871)
Q Consensus       644 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  723 (871)
                      ++++|.+++.....     ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.+.....
T Consensus        76 ~~~~L~~~l~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~  147 (277)
T cd05577          76 NGGDLKYHIYNVGE-----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG  147 (277)
T ss_pred             CCCcHHHHHHHcCc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence            99999999976542     2589999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChh
Q 002883          724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPA  803 (871)
Q Consensus       724 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  803 (871)
                      .    .......++..|+|||...+..++.++||||+||++|+|++|+.||........ ......... ..        
T Consensus       148 ~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-~~--------  213 (277)
T cd05577         148 G----KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRRTL-EM--------  213 (277)
T ss_pred             C----CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhccc-cc--------
Confidence            2    112234578899999998888899999999999999999999999974322100 000000000 00        


Q ss_pred             HHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHH
Q 002883          804 ILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIM  857 (871)
Q Consensus       804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~  857 (871)
                                      ..   .........+.+++.+||+.||++||     ++.++++
T Consensus       214 ----------------~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         214 ----------------AV---EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ----------------cc---cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence                            00   00012244677999999999999999     6666764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-33  Score=290.69  Aligned_cols=248  Identities=27%  Similarity=0.421  Sum_probs=201.6

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|++.+.||+|++|.||+|++..+++.||+|.+.....  ...+.+.+|++++++++|||++++++++.+.     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-----DSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEEE
Confidence            58889999999999999999988899999999965543  3456789999999999999999999987654     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++....       .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.
T Consensus        76 ~v~e~~~~~~L~~~~~~~~-------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~  145 (254)
T cd06627          76 IILEYAENGSLRQIIKKFG-------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGV  145 (254)
T ss_pred             EEEecCCCCcHHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEecccc
Confidence            9999999999999997653       589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +.........   .....++..|+|||...+..++.++||||+|+++|+|++|+.||........ .........+ .. 
T Consensus       146 ~~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~-~~-  219 (254)
T cd06627         146 ATKLNDVSKD---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-LFRIVQDDHP-PL-  219 (254)
T ss_pred             ceecCCCccc---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHhccCCC-CC-
Confidence            9877543221   2234578899999998777789999999999999999999999975321111 1110000000 00 


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                                   .......+.+++.+|+..+|++|||+.|++.
T Consensus       220 -----------------------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 -----------------------------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -----------------------------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                                         0022345778999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.3e-33  Score=300.94  Aligned_cols=274  Identities=20%  Similarity=0.208  Sum_probs=190.3

Q ss_pred             ccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEeccCCCCH
Q 002883          571 GYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSL  648 (871)
Q Consensus       571 ~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL  648 (871)
                      ++|.||.++...+++.||+|++...  .....+.+.+|+++++.++|+||+++++++...     ...+++|||+++++|
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEEEeccCCCCH
Confidence            4455666666668999999998654  333456889999999999999999999988665     668999999999999


Q ss_pred             HHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCCCCCC-
Q 002883          649 ENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD-  727 (871)
Q Consensus       649 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  727 (871)
                      .+++......     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||.+......... 
T Consensus        87 ~~~l~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          87 EDLLKTHFPE-----GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             HHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            9999865322     588999999999999999999999   9999999999999999999999999998765432111 


Q ss_pred             ---ccccccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcCh
Q 002883          728 ---QTSTSRVKGSIGYVAPEYGAL--GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDP  802 (871)
Q Consensus       728 ---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  802 (871)
                         ........++..|+|||++..  ..++.++||||+||++|||++|+.||............ .....+.......-+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~  237 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKSTYP  237 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccCchh
Confidence               111223456788999998765  35789999999999999999999999864332221111 111111000000000


Q ss_pred             hHHHHHHHHH--hhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          803 AILEEALEIQ--AGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       803 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ..........  ....................++.+++.+||+.||++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            0000000000  0000000000111122345678899999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.1e-33  Score=290.98  Aligned_cols=254  Identities=26%  Similarity=0.365  Sum_probs=203.7

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|+..+.||+|++|.||+|.+..+++.|++|++.....  ...+.+.+|++++++++||||+++++.+.+..   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            47888999999999999999998899999999965542  34578899999999999999999999876542   25689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +|+||+++++|.+++....       .+++..++.++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.
T Consensus        78 lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~  147 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFG-------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGC  147 (260)
T ss_pred             EEEEecCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccccc
Confidence            9999999999999997654       589999999999999999999998   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +......... .......++..|+|||...+..++.++||||||+++|+|++|..||...................... 
T Consensus       148 ~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  225 (260)
T cd06606         148 AKRLGDIETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEI-  225 (260)
T ss_pred             EEeccccccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCC-
Confidence            9877654321 11233468899999999888889999999999999999999999997543111111110000000000 


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                                   .......+.+++.+|++.+|++||++.|+++
T Consensus       226 -----------------------------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         226 -----------------------------PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -----------------------------CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                                         0012456788999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3e-33  Score=292.78  Aligned_cols=250  Identities=24%  Similarity=0.306  Sum_probs=201.7

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+....  ......+.+|+++++.++|+||+++.+++.+.     ...|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence            5888999999999999999999899999999986432  23345678899999999999999999887665     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++.....   ....+++..++.++.|++.|++|||+.   +++|+||+|+||+++.++.+|++|||.
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~  149 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKK---KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGI  149 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccc
Confidence            99999999999999876331   123589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +......     ......++..|+|||...+..++.++|+||+|+++|+|++|+.||........  ...........  
T Consensus       150 ~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~--  220 (256)
T cd08530         150 SKVLKKN-----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL--RYKVQRGKYPP--  220 (256)
T ss_pred             hhhhccC-----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHhcCCCCC--
Confidence            9876543     11223578899999999888899999999999999999999999975332211  11111000000  


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                               .   ......++.+++.+|++.+|++|||+.|+++
T Consensus       221 -------------------------~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         221 -------------------------I---PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             -------------------------C---chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                                     0   0123456789999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-33  Score=294.22  Aligned_cols=244  Identities=20%  Similarity=0.204  Sum_probs=187.6

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHH-HcCCCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEAL-RSIRHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||.||+|.+..+++.||+|+++....   .....+..|..++ ...+|+|++++++++...     ...|+||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-----DYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-----CeEEEEE
Confidence            568999999999999988899999999864322   1123344555444 445899999999998654     6789999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++++|.+++....       .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||.+..
T Consensus        77 e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  146 (260)
T cd05611          77 EYLNGGDCASLIKTLG-------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRN  146 (260)
T ss_pred             eccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeeccccee
Confidence            9999999999997643       588999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhc
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII  800 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  800 (871)
                      ...       .....++..|+|||...+..++.++||||+|+++|+|++|..||....... ...........       
T Consensus       147 ~~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-------  211 (260)
T cd05611         147 GLE-------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILSRRIN-------  211 (260)
T ss_pred             ccc-------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhcccC-------
Confidence            432       122457889999999888888999999999999999999999997532211 11111000000       


Q ss_pred             ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                                        .++   .....+...+.+++.+|++.+|++|||+.++.+.+
T Consensus       212 ------------------~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         212 ------------------WPE---EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ------------------CCC---cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence                              000   00012345678999999999999999886665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.1e-33  Score=292.77  Aligned_cols=242  Identities=24%  Similarity=0.330  Sum_probs=193.7

Q ss_pred             eeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEecc
Q 002883          567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM  643 (871)
Q Consensus       567 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  643 (871)
                      ||.|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.     ...++||||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-----KYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-----CccEEEEecC
Confidence            689999999999999889999999986432   23446788999999999999999999987654     6689999999


Q ss_pred             CCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCC
Q 002883          644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD  723 (871)
Q Consensus       644 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  723 (871)
                      ++++|.+++....       .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        76 ~~~~L~~~l~~~~-------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~  145 (262)
T cd05572          76 LGGELWTILRDRG-------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS  145 (262)
T ss_pred             CCCcHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence            9999999997643       488999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh-CCCchhhhhcCh
Q 002883          724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM-GLPDQVAEIIDP  802 (871)
Q Consensus       724 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  802 (871)
                      ..    ......++..|+|||...+..++.++|+||+|+++|+|++|..||.....+.......... .....       
T Consensus       146 ~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------  214 (262)
T cd05572         146 GQ----KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE-------  214 (262)
T ss_pred             cc----ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC-------
Confidence            32    1223467889999999888889999999999999999999999997543211111111000 00000       


Q ss_pred             hHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC-----HHHHHH
Q 002883          803 AILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK-----IQDAIM  857 (871)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----a~evl~  857 (871)
                                          ...   ....++.+++.+||+.+|++|||     ++|+++
T Consensus       215 --------------------~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         215 --------------------FPN---YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             --------------------CCc---ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence                                000   11346789999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=281.17  Aligned_cols=203  Identities=25%  Similarity=0.328  Sum_probs=180.1

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..++|...+++|+|.||.|.+++.+.+++.+|+|+++..-   +.....-..|-++++..+||.+..+...|...     
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~-----  240 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ-----  240 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC-----
Confidence            4467889999999999999999999999999999996542   33445667899999999999999998887766     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      +..|+||||+.||.|.-.+...+       .+++...+.+...|+.||.|||++   +||.||+|.+|.|+|++|++||+
T Consensus       241 drlCFVMeyanGGeLf~HLsrer-------~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKit  310 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSRER-------VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKIT  310 (516)
T ss_pred             ceEEEEEEEccCceEeeehhhhh-------cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEee
Confidence            77999999999999998887654       689999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      |||+++.-   ......+...+|||.|.|||++....|+.++|-|.+|||+|||++|+.||...
T Consensus       311 DFGLCKE~---I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~  371 (516)
T KOG0690|consen  311 DFGLCKEE---IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK  371 (516)
T ss_pred             ecccchhc---ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence            99999742   22444556689999999999999999999999999999999999999999854

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-34  Score=254.70  Aligned_cols=272  Identities=21%  Similarity=0.265  Sum_probs=203.5

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .|...++||+|.||+||+|+...+++.||+|.++.+  +.+......+|+-+++.++|.|||++++.....     ....
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-----kklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-----ceeE
Confidence            466678999999999999999999999999998644  345567889999999999999999999987654     6788


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +|+||| ..+|..|.....+      .++.+.+++++.|+++|+.+.|++   .+.|||+||.|.+++.+|.+|++|||+
T Consensus        78 lvfe~c-dqdlkkyfdslng------~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgl  147 (292)
T KOG0662|consen   78 LVFEFC-DQDLKKYFDSLNG------DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGL  147 (292)
T ss_pred             EeHHHh-hHHHHHHHHhcCC------cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccch
Confidence            999999 5689988877654      489999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |+-++-.   -...+..+.|..|++|.++.+. -|+...|+||.||++.|+.. |++.|.+...++...+.+...+.|.+
T Consensus       148 arafgip---vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~e  224 (292)
T KOG0662|consen  148 ARAFGIP---VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  224 (292)
T ss_pred             hhhcCCc---eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcc
Confidence            9866432   1223334679999999987765 57899999999999999988 77777765544444444444333322


Q ss_pred             --hh---hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          796 --VA---EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       796 --~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                        +.   ...|-...+.+..    .     .......+.....=.+++++.+.-+|.+|.+|+++++.
T Consensus       225 d~wps~t~lpdyk~yp~ypa----t-----tswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  225 DQWPSMTKLPDYKPYPIYPA----T-----TSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             ccCCccccCCCCcccCCccc----c-----chHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence              11   1111000000000    0     00011111222233577778888899999999998863

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3e-33  Score=304.88  Aligned_cols=278  Identities=21%  Similarity=0.274  Sum_probs=198.3

Q ss_pred             cCCC-CCceeeccccceEEEEEECCCCcEEEEEEeeccccch--------------HHHHHHHHHHHHcCCCCccceeee
Q 002883          559 EGFS-SANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGA--------------SKSFIAECEALRSIRHRNLVKIIT  623 (871)
Q Consensus       559 ~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~  623 (871)
                      ++|. +.+.||+|+||+||+|.+..+++.||+|+++......              ...+.+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            5665 4577999999999999998899999999985432211              125778999999999999999999


Q ss_pred             eecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcee
Q 002883          624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL  703 (871)
Q Consensus       624 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  703 (871)
                      ++...     .+.++||||+. |+|.+++....       .+++..+..++.|++.|++|||+.   +++||||+|+||+
T Consensus        88 ~~~~~-----~~~~lv~e~~~-~~l~~~l~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nil  151 (335)
T PTZ00024         88 VYVEG-----DFINLVMDIMA-SDLKKVVDRKI-------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIF  151 (335)
T ss_pred             EEecC-----CcEEEEEeccc-cCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeE
Confidence            98655     67899999996 69999986533       589999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeecccceecCCCCC-----------CccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCC
Q 002883          704 LDNEMVAHVGDFGLSRLLHDNSP-----------DQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGK  771 (871)
Q Consensus       704 l~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~  771 (871)
                      ++.++.++|+|||.+........           .........++..|+|||.+.+. .++.++||||+||++|+|++|+
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~  231 (335)
T PTZ00024        152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK  231 (335)
T ss_pred             ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999999987651110           01111223467889999987654 4689999999999999999999


Q ss_pred             CCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC
Q 002883          772 RPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK  851 (871)
Q Consensus       772 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt  851 (871)
                      .||......+...........+.. ..+..........    ......++...........++.+++.+|++.+|++|||
T Consensus       232 ~p~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s  306 (335)
T PTZ00024        232 PLFPGENEIDQLGRIFELLGTPNE-DNWPQAKKLPLYT----EFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS  306 (335)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCch-hhCcchhhccccc----ccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC
Confidence            999754332211111111111100 0000000000000    00001111122222234567889999999999999999


Q ss_pred             HHHHHH
Q 002883          852 IQDAIM  857 (871)
Q Consensus       852 a~evl~  857 (871)
                      ++|++.
T Consensus       307 ~~~~l~  312 (335)
T PTZ00024        307 AKEALK  312 (335)
T ss_pred             HHHHhc
Confidence            999986

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6e-33  Score=293.82  Aligned_cols=243  Identities=20%  Similarity=0.258  Sum_probs=184.7

Q ss_pred             eeeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHH---HHHcCCCCccceeeeeecccCcCCCceeeEE
Q 002883          566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECE---ALRSIRHRNLVKIITSCSSIDTRGNEFKALV  639 (871)
Q Consensus       566 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  639 (871)
                      .||+|+||.||+|.+..+++.||+|++.....   .....+..|..   .++...||+|+++++++.+.     +..++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----DKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CEEEEE
Confidence            48999999999999988899999999864321   11122333433   34445799999999888765     668999


Q ss_pred             EeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccce
Q 002883          640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR  719 (871)
Q Consensus       640 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  719 (871)
                      |||+.|++|.+++....       .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||.+.
T Consensus        76 ~e~~~g~~L~~~l~~~~-------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~  145 (278)
T cd05606          76 LDLMNGGDLHYHLSQHG-------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  145 (278)
T ss_pred             EecCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence            99999999999886543       589999999999999999999998   99999999999999999999999999987


Q ss_pred             ecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhh
Q 002883          720 LLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE  798 (871)
Q Consensus       720 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  798 (871)
                      ......     .....|+..|+|||.+.++ .++.++||||+||++|+|++|+.||..................+.    
T Consensus       146 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----  216 (278)
T cd05606         146 DFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV----  216 (278)
T ss_pred             ccCccC-----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCC----
Confidence            553221     1234689999999997654 689999999999999999999999975321111000000000000    


Q ss_pred             hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHHH
Q 002883          799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIME  858 (871)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~~  858 (871)
                                             ...   .....++.+++.+|+..+|++||     ++.|+++.
T Consensus       217 -----------------------~~~---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         217 -----------------------ELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             -----------------------CCC---CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence                                   000   01234677899999999999999     99999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.8e-33  Score=294.59  Aligned_cols=247  Identities=23%  Similarity=0.289  Sum_probs=193.5

Q ss_pred             eeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEecc
Q 002883          567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM  643 (871)
Q Consensus       567 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  643 (871)
                      ||.|+||.||+|++..+++.||+|++.....   ...+.+.+|++++++++|||++++++.+...     ...|+||||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK-----KNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC-----cEEEEEEecC
Confidence            5899999999999998899999999864432   3456788999999999999999999887554     6789999999


Q ss_pred             CCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCC
Q 002883          644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD  723 (871)
Q Consensus       644 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  723 (871)
                      ++++|.+++....       .+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        76 ~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~  145 (265)
T cd05579          76 PGGDLASLLENVG-------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV  145 (265)
T ss_pred             CCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence            9999999997643       589999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCC-----ccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhh
Q 002883          724 NSPD-----QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE  798 (871)
Q Consensus       724 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  798 (871)
                      ....     ........++..|+|||......++.++||||||+++|++++|+.||........ .........+.    
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~----  220 (265)
T cd05579         146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-FQNILNGKIEW----  220 (265)
T ss_pred             CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhcCCcCC----
Confidence            2110     1122334578899999998888889999999999999999999999975432211 10000000000    


Q ss_pred             hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                                                +........+.+++.+|++.+|++|||+.++.+.|
T Consensus       221 --------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         221 --------------------------PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             --------------------------CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence                                      00001245677999999999999999995555444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.4e-33  Score=299.99  Aligned_cols=255  Identities=23%  Similarity=0.302  Sum_probs=194.6

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ..++|++.+.||+|+||.||+|.+..+++.||||+++... ......+.+|+.++... .||||+++++++.+.     .
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~   87 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD-----S   87 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC-----C
Confidence            3467899999999999999999998889999999996433 22345566777767666 599999999998765     5


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH-HCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ..|+||||+ ++++.+++.....      .+++..+..++.|++.|++|||+ .   +|+||||+|+||+++.++.+||+
T Consensus        88 ~~~~v~e~~-~~~l~~l~~~~~~------~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~  157 (296)
T cd06618          88 DVFICMELM-STCLDKLLKRIQG------PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLC  157 (296)
T ss_pred             eEEEEeecc-CcCHHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEEC
Confidence            689999998 4578777755332      58999999999999999999997 5   89999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCC----CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG----EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK  789 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~  789 (871)
                      |||.+.......    ......++..|+|||.+.+.    .++.++||||||+++|+|++|+.||.....+.........
T Consensus       158 dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  233 (296)
T cd06618         158 DFGISGRLVDSK----AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ  233 (296)
T ss_pred             ccccchhccCCC----cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc
Confidence            999987654321    11223478899999987654    3789999999999999999999999753222111111111


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                      ...+ ...   .                         ...+..++.+++.+|++.||++||++.++++.-
T Consensus       234 ~~~~-~~~---~-------------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         234 EEPP-SLP---P-------------------------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CCCC-CCC---C-------------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            1000 000   0                         001234678999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.2e-32  Score=296.68  Aligned_cols=245  Identities=24%  Similarity=0.315  Sum_probs=192.6

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      |...+.||+|+||+||+|++..+++.||+|++.....   .....+.+|+++++.++|||++++++++.+.     ...|
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEE
Confidence            6667889999999999999988999999999864322   2335678899999999999999999998765     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+. |++.+++.....      .+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.+||+|||.
T Consensus        98 lv~e~~~-~~l~~~l~~~~~------~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~  167 (313)
T cd06633          98 LVMEYCL-GSASDLLEVHKK------PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS  167 (313)
T ss_pred             EEEecCC-CCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCC
Confidence            9999995 688887765332      489999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGA---LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      +.....       .....|+..|+|||++.   .+.++.++|||||||++|+|++|..||.......... .......+.
T Consensus       168 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~  239 (313)
T cd06633         168 ASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPT  239 (313)
T ss_pred             CcccCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCC
Confidence            864321       12345888999999863   4568899999999999999999999987542211111 111111110


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ..                              ...+...+.+++.+|++.+|++||++.|+++.
T Consensus       240 ~~------------------------------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 LQ------------------------------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CC------------------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00                              00122356789999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.8e-33  Score=296.23  Aligned_cols=251  Identities=25%  Similarity=0.380  Sum_probs=200.8

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCc
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~  634 (871)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+++++++. ||||+++++++...     .
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-----E   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-----c
Confidence            4789999999999999999999989999999998642   2223467888999999998 99999999987654     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+++++|.+++....       .+++..++.++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~d  145 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYG-------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITD  145 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecC
Confidence            6899999999999999997653       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCC-----------------ccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          715 FGLSRLLHDNSPD-----------------QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       715 fg~a~~~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      ||.+.........                 ........++..|+|||......++.++||||+|+++|++++|+.||...
T Consensus       146 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (280)
T cd05581         146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS  225 (280)
T ss_pred             CccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence            9999876543211                 01222345788999999988888999999999999999999999999854


Q ss_pred             hhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCH----H
Q 002883          778 FEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI----Q  853 (871)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta----~  853 (871)
                      .... ..........                         ..+       ....+.+.+++.+||+.+|++|||+    +
T Consensus       226 ~~~~-~~~~~~~~~~-------------------------~~~-------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  272 (280)
T cd05581         226 NEYL-TFQKILKLEY-------------------------SFP-------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYD  272 (280)
T ss_pred             cHHH-HHHHHHhcCC-------------------------CCC-------CccCHHHHHHHHHHhcCCHhhCCCcccCHH
Confidence            2111 0111000000                         000       0123457799999999999999999    7


Q ss_pred             HHHH
Q 002883          854 DAIM  857 (871)
Q Consensus       854 evl~  857 (871)
                      |+++
T Consensus       273 ~ll~  276 (280)
T cd05581         273 ELKA  276 (280)
T ss_pred             HHhc
Confidence            7764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.6e-33  Score=298.09  Aligned_cols=249  Identities=23%  Similarity=0.297  Sum_probs=195.1

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ..|+..+.||+|+||.||+|++..+++.||+|.+...   ......++.+|+++++.++|+|++++++++...     ..
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   89 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT   89 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----Ce
Confidence            4477788999999999999999888999999998532   222345678899999999999999999998765     66


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||+. |++.+++.....      .+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.++++||
T Consensus        90 ~~lv~e~~~-~~l~~~~~~~~~------~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~df  159 (308)
T cd06634          90 AWLVMEYCL-GSASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF  159 (308)
T ss_pred             eEEEEEccC-CCHHHHHHHcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCc
Confidence            899999996 688887754331      488999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA---LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |.+......       ....++..|+|||.+.   .+.++.++|||||||++|+|++|+.||......... ........
T Consensus       160 g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~  231 (308)
T cd06634         160 GSASIMAPA-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNES  231 (308)
T ss_pred             ccceeecCc-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH-HHHhhcCC
Confidence            998765422       2235788999999863   356789999999999999999999998753221111 11111100


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                      +...                              ...+...+.+++.+||+.+|++||+++++++.-.
T Consensus       232 ~~~~------------------------------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         232 PALQ------------------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             CCcC------------------------------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence            0000                              0123345779999999999999999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-34  Score=289.13  Aligned_cols=203  Identities=26%  Similarity=0.379  Sum_probs=179.5

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..+.|+.-++||+|+||.||-++.+.+|+-+|+|.+...+   +.......+|-.++++++.+.||.+-.+|++.     
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk-----  257 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK-----  257 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC-----
Confidence            3456788899999999999999999999999999884332   22335667899999999999999999888877     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      +..|+|+..|.||+|.-+|-..+.     +.+++..++-++.+|+.||.+||+.   +||.||+||+|||+|+.|+++|+
T Consensus       258 d~LClVLtlMNGGDLkfHiyn~g~-----~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRIS  329 (591)
T KOG0986|consen  258 DALCLVLTLMNGGDLKFHIYNHGN-----PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRIS  329 (591)
T ss_pred             CceEEEEEeecCCceeEEeeccCC-----CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEee
Confidence            779999999999999988877653     3799999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCch
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDD  776 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  776 (871)
                      |.|+|..+.+..    .....+||.+|||||++..+.|+...|-||+||++|||+.|+.||..
T Consensus       330 DLGLAvei~~g~----~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~  388 (591)
T KOG0986|consen  330 DLGLAVEIPEGK----PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ  388 (591)
T ss_pred             ccceEEecCCCC----ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence            999999887543    23334799999999999999999999999999999999999999975

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7e-33  Score=294.55  Aligned_cols=273  Identities=24%  Similarity=0.320  Sum_probs=202.1

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      |+..+.||+|+||.||+|+...+++.||+|++....  ....+.+..|+++++.++|+|++++++++.+.     ...++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence            667789999999999999999889999999996542  33346778899999999999999999998765     67899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||++ ++|.+++....      ..+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.++|+|||.+
T Consensus        76 v~e~~~-~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~  145 (282)
T cd07829          76 VFEYCD-MDLKKYLDKRP------GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLA  145 (282)
T ss_pred             EecCcC-cCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcc
Confidence            999997 59999998753      1589999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch--
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ--  795 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--  795 (871)
                      ........   ......++..|+|||...+. .++.++|||||||++||+++|+.||..................+..  
T Consensus       146 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
T cd07829         146 RAFGIPLR---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES  222 (282)
T ss_pred             cccCCCcc---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHH
Confidence            87643221   12223457789999987666 7899999999999999999999999754322211111111111110  


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...+.+-...      ...............++.....+.+++.+|++.||++||++.|++.
T Consensus       223 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         223 WPGVTKLPDY------KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HHhhcccccc------cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0000000000      0000000111111222334567899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-34  Score=320.10  Aligned_cols=209  Identities=27%  Similarity=0.367  Sum_probs=185.0

Q ss_pred             HHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeec---cccchHHHHHHHHHHHHcCCCCccceeeeeeccc
Q 002883          552 AELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDL---QQRGASKSFIAECEALRSIRHRNLVKIITSCSSI  628 (871)
Q Consensus       552 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  628 (871)
                      .++.-..++|.++++||+|+||.|..++.+.+++.||+|++..   -.+.....|..|-++|..-+.+=|+.+..+|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            3444456789999999999999999999999999999999964   2344567899999999998999999999888776


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM  708 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  708 (871)
                           .+.|+|||||+||+|-..+.+..       ++++..++.++..|+-||.-+|+.   |+|||||||+|||+|..|
T Consensus       148 -----~~LYlVMdY~pGGDlltLlSk~~-------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~G  212 (1317)
T KOG0612|consen  148 -----RYLYLVMDYMPGGDLLTLLSKFD-------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSG  212 (1317)
T ss_pred             -----cceEEEEecccCchHHHHHhhcC-------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccC
Confidence                 88999999999999999998875       599999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCccccc----C-CCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA----L-GEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      ++||+|||.+..+..+  ........+|||.|.+||++.    + +.|++.+|-||+||++|||++|..||...
T Consensus       213 HikLADFGsClkm~~d--G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad  284 (1317)
T KOG0612|consen  213 HIKLADFGSCLKMDAD--GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD  284 (1317)
T ss_pred             cEeeccchhHHhcCCC--CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence            9999999999888754  334455678999999999753    3 68999999999999999999999999853

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=288.79  Aligned_cols=260  Identities=25%  Similarity=0.377  Sum_probs=200.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHHHHcCCCCccceeeeeecccCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-------RGASKSFIAECEALRSIRHRNLVKIITSCSSIDT  630 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  630 (871)
                      .++|-..+++|+|+|+.||+|.+....++||||+-....       ....+...+|.+|.+.++||.||++|++|.-.  
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD--  539 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD--  539 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec--
Confidence            467899999999999999999999899999999873221       12335678999999999999999999998543  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC---CC
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD---NE  707 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~  707 (871)
                        .+.+|-|+|||+|.+|+-|+++++       .+++.+++.|+.||+.||.||.+. +++|+|-|+||.|||+.   .-
T Consensus       540 --tdsFCTVLEYceGNDLDFYLKQhk-------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gtac  609 (775)
T KOG1151|consen  540 --TDSFCTVLEYCEGNDLDFYLKQHK-------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTAC  609 (775)
T ss_pred             --cccceeeeeecCCCchhHHHHhhh-------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccc
Confidence              255799999999999999999876       689999999999999999999986 56899999999999994   45


Q ss_pred             CceEEeecccceecCCCCCCc----cccccccccccccCcccccC----CCCCCccchhhHHHHHHHHHhCCCCCchhhh
Q 002883          708 MVAHVGDFGLSRLLHDNSPDQ----TSTSRVKGSIGYVAPEYGAL----GEVSTHGDEYSFGILMLEMFTGKRPTDDMFE  779 (871)
Q Consensus       708 ~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltG~~pf~~~~~  779 (871)
                      |.+||.|||++++++++....    ..++...||.+|.+||.+.-    ...+.++||||+|||+|..++|+.||.....
T Consensus       610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs  689 (775)
T KOG1151|consen  610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS  689 (775)
T ss_pred             ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence            789999999999998654332    23445679999999996432    3468999999999999999999999985322


Q ss_pred             hhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHH
Q 002883          780 EGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAI  856 (871)
Q Consensus       780 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl  856 (871)
                      ....+..-.                      ++.+....+++.     +.+..+...+|++||++.-++|....++.
T Consensus       690 QQdILqeNT----------------------IlkAtEVqFP~K-----PvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  690 QQDILQENT----------------------ILKATEVQFPPK-----PVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             HHHHHhhhc----------------------hhcceeccCCCC-----CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            211111000                      000000111110     12334556889999999999998877764

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-36  Score=329.96  Aligned_cols=441  Identities=26%  Similarity=0.334  Sum_probs=365.4

Q ss_pred             ccCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccc
Q 002883            5 EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGL   84 (871)
Q Consensus         5 ~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~   84 (871)
                      -||..|-.-..++.|++++|-+-.-+-+.+.+--+|+.|+|++|++. ..|..+..+.+|+.|+++.|.|. ..|.+.++
T Consensus        12 ~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~   89 (1081)
T KOG0618|consen   12 LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSN   89 (1081)
T ss_pred             ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhh
Confidence            36777777677999999999886333344455667999999999998 89999999999999999999998 89999999


Q ss_pred             cccccccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccC------c--
Q 002883           85 LKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSI------S--  156 (871)
Q Consensus        85 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~------~--  156 (871)
                      +.+|++|+|.+|++. ..|.++..+.+|++|+++.|++. .+|..+. .+..+..++.++|.-...++...      .  
T Consensus        90 ~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~-~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n  166 (1081)
T KOG0618|consen   90 MRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIE-VLTAEEELAASNNEKIQRLGQTSIKKLDLRLN  166 (1081)
T ss_pred             hhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHH-hhhHHHHHhhhcchhhhhhccccchhhhhhhh
Confidence            999999999999999 99999999999999999999997 8888776 88999999999993222222211      0  


Q ss_pred             -CCCCCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCc
Q 002883          157 -NASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANR  235 (871)
Q Consensus       157 -~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~  235 (871)
                       ....++.++..+++  .|+|++|.+..         -.+.++.+|+.|.++.|++...   .+.  ..+|+.|+.++|.
T Consensus       167 ~l~~~~~~~i~~l~~--~ldLr~N~~~~---------~dls~~~~l~~l~c~rn~ls~l---~~~--g~~l~~L~a~~n~  230 (1081)
T KOG0618|consen  167 VLGGSFLIDIYNLTH--QLDLRYNEMEV---------LDLSNLANLEVLHCERNQLSEL---EIS--GPSLTALYADHNP  230 (1081)
T ss_pred             hcccchhcchhhhhe--eeecccchhhh---------hhhhhccchhhhhhhhcccceE---Eec--CcchheeeeccCc
Confidence             01235555666666  69999998874         3467788999999999998732   112  2469999999999


Q ss_pred             cCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCccc
Q 002883          236 ISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSA  315 (871)
Q Consensus       236 i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~  315 (871)
                      ++...+.  ..-.+|+++++++|+++ ..|++++.+.+|+.|+..+|++. ..|..+..+.+|+.|++..|.+. -+|..
T Consensus       231 l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~  305 (1081)
T KOG0618|consen  231 LTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPF  305 (1081)
T ss_pred             ceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCc
Confidence            9843332  23468999999999999 56799999999999999999997 78999999999999999999999 67777


Q ss_pred             ccCCCCCCEEecCCCcCCCCCccccc--------------------------CCCCCcEEeccCCCCCCCCccccCCCCC
Q 002883          316 LGNCLQLQKLDLSDNNLSGTIPREVI--------------------------GLSSFVLLDLSRNHLSGPIPLEVGRLKG  369 (871)
Q Consensus       316 ~~~l~~L~~L~L~~N~l~~~~~~~~~--------------------------~l~~L~~L~ls~N~l~~~~~~~~~~l~~  369 (871)
                      ...++.|+.|+|..|+|. .+|+.+.                          .++.|+.|++.+|.+++..-..+.+.++
T Consensus       306 le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~h  384 (1081)
T KOG0618|consen  306 LEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKH  384 (1081)
T ss_pred             ccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccc
Confidence            888999999999999998 5554332                          1345778889999998777778889999


Q ss_pred             CCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCC
Q 002883          370 IQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSF  449 (871)
Q Consensus       370 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~  449 (871)
                      |+.|+|++|+|.......+.++..|++|+||||+++ .+|.....++.|++|...+|+|. ..| .+..++.|+.+|++.
T Consensus       385 LKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~  461 (1081)
T KOG0618|consen  385 LKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSC  461 (1081)
T ss_pred             eeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEeccc
Confidence            999999999999666667889999999999999999 56788999999999999999999 677 889999999999999


Q ss_pred             CcCcccCCC-CcccccccceeccCCCC
Q 002883          450 NNLEGEVPS-EGVFKNVRAVSIIGNNK  475 (871)
Q Consensus       450 N~l~~~~~~-~~~~~~l~~l~l~~N~~  475 (871)
                      |.|+...-. ....++++++++.||.|
T Consensus       462 N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  462 NNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             chhhhhhhhhhCCCcccceeeccCCcc
Confidence            999875433 33348999999999997

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-33  Score=284.87  Aligned_cols=137  Identities=25%  Similarity=0.407  Sum_probs=121.8

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-----C---CccceeeeeecccC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-----H---RNLVKIITSCSSID  629 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~~~  629 (871)
                      .+||.+.++||-|.|++||+|.+....+.||+|+.+.... ..+....||+++++++     |   ..||++++.|... 
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs-  154 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS-  154 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec-
Confidence            3789999999999999999999999999999999976543 4567788999999983     2   4799999998775 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL  704 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  704 (871)
                      ++++.++|||+|+. |-+|..+|......     .++...++.|++||+.||.|||..|  ||+|.||||+|||+
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~Yr-----Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYR-----GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCCC-----CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            67789999999999 88999999877644     6999999999999999999999997  99999999999999

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.7e-32  Score=287.70  Aligned_cols=251  Identities=20%  Similarity=0.247  Sum_probs=194.4

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ-----QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      +|.+.+.||+|+||.||+|++...+..+++|+.+..     .......+.+|+.+++.++||||+++++++.+.     .
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----D   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----C
Confidence            688999999999999999999877777777776421     122334567899999999999999999987654     5


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+++++|.+++......   ...+++..++.++.|++.|+.|||+.   +++|+||+|+||+++. +.++++|
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d  148 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHT---GKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGD  148 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecc
Confidence            689999999999999998753221   23689999999999999999999999   9999999999999975 5699999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||.+.......   .......++..|+|||...+..++.++|+||+|+++|+|++|..||....... ..........+ 
T Consensus       149 ~g~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~-  223 (260)
T cd08222         149 FGVSRLLMGSC---DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS-VVLRIVEGPTP-  223 (260)
T ss_pred             cCceeecCCCc---ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHcCCCC-
Confidence            99998764322   11223457889999999888888999999999999999999999996422111 01110000000 


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                                 ..   ...+..++.+++.+|++.+|++||++.|+++
T Consensus       224 ---------------------------~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 ---------------------------SL---PETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ---------------------------CC---cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                                       00   0123446778999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.1e-32  Score=291.69  Aligned_cols=255  Identities=24%  Similarity=0.286  Sum_probs=194.2

Q ss_pred             CCCCCceeeccccceEEEEEEC---CCCcEEEEEEeeccc----cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcC
Q 002883          560 GFSSANLIGIGGYGYVYKGILG---TEETNVAVKVLDLQQ----RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  631 (871)
                      +|++.+.||+|+||.||+|++.   .+++.||||+++...    ....+.+.+|+++++++ +||+|+++++.+...   
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~---   77 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD---   77 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC---
Confidence            4788999999999999999864   356889999986432    22345678899999999 699999999887554   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                        ...++||||+++++|.+++....       .+++..+..++.|+++||.|||+.   +++||||+|+||+++.++.++
T Consensus        78 --~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~  145 (288)
T cd05583          78 --TKLHLILDYVNGGELFTHLYQRE-------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVV  145 (288)
T ss_pred             --CEEEEEEecCCCCcHHHHHhhcC-------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEE
Confidence              56899999999999999987543       588999999999999999999998   999999999999999999999


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE--VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK  789 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~  789 (871)
                      ++|||++........  .......|+..|+|||...+..  .+.++||||+|+++|+|++|..||....... .......
T Consensus       146 l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~  222 (288)
T cd05583         146 LTDFGLSKEFLAEEE--ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISR  222 (288)
T ss_pred             EEECccccccccccc--cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHH
Confidence            999999876543221  1122345789999999876654  6889999999999999999999996321110 0000000


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                      .        .                .....+ .   .......+.+++.+|++.||++|||+.++.+.|+
T Consensus       223 ~--------~----------------~~~~~~-~---~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         223 R--------I----------------LKSKPP-F---PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             H--------H----------------HccCCC-C---CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            0        0                000000 0   0112345678999999999999999888877665

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-33  Score=303.31  Aligned_cols=265  Identities=23%  Similarity=0.294  Sum_probs=217.2

Q ss_pred             HHHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccC
Q 002883          551 YAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSID  629 (871)
Q Consensus       551 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  629 (871)
                      ++.+...++-|++.+.||.|.+|.||+++..++++.+|+|+...... ..+++..|..+++.. .|||++.+||+|.-.+
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            34444556779999999999999999999999999999999876544 346778899999988 7999999999998888


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV  709 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  709 (871)
                      ...++.+|+|||||.+||..|+++...+.     .+.|..+..|++.++.|+.+||..   .++|||||=.|||++.++.
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~-----rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGN-----RLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhccc-----chhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence            88889999999999999999999877643     799999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccceecCCCCCCccccccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhH
Q 002883          710 AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA-----LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSL  784 (871)
Q Consensus       710 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~  784 (871)
                      ||++|||.+.....   ........+||+.|||||++.     ...|+..+|+||+|++..||.-|.+|+.++......+
T Consensus       162 VKLvDFGvSaQlds---T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF  238 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDS---TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF  238 (953)
T ss_pred             EEEeeeeeeeeeec---ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc
Confidence            99999999987754   223344568999999999864     3457788999999999999999999998764331111


Q ss_pred             HHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          785 HKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                            .+|..                        +|.-........+++.++|..|+..|-++||+..++++
T Consensus       239 ------~IpRN------------------------PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  239 ------LIPRN------------------------PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ------cCCCC------------------------CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                  11110                        00001112245667889999999999999999998875

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.7e-32  Score=289.28  Aligned_cols=200  Identities=27%  Similarity=0.367  Sum_probs=168.0

Q ss_pred             CCCCCceeeccccceEEEEEEC---CCCcEEEEEEeeccc----cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcC
Q 002883          560 GFSSANLIGIGGYGYVYKGILG---TEETNVAVKVLDLQQ----RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  631 (871)
                      +|++.+.||+|+||.||.|++.   .+++.||+|++....    ....+.+.+|+++++++ +|++|+++++++...   
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~---   77 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD---   77 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC---
Confidence            4888999999999999999984   368899999986432    22345678899999999 699999999887654   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                        ...|+||||+++++|.+++....       .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+|
T Consensus        78 --~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~k  145 (290)
T cd05613          78 --TKLHLILDYINGGELFTHLSQRE-------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV  145 (290)
T ss_pred             --CeEEEEEecCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEE
Confidence              56899999999999999997643       578999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCch
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFTGKRPTDD  776 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~  776 (871)
                      |+|||.+........  .......|+..|+|||.....  .++.++||||||+++|+|++|+.||..
T Consensus       146 l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         146 LTDFGLSKEFHEDEV--ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             EeeCccceecccccc--cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence            999999986543221  112234588999999987643  467899999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.2e-32  Score=318.52  Aligned_cols=147  Identities=31%  Similarity=0.425  Sum_probs=131.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|.+.+.||+|+||.||+|.+..+++.||||+++...   ......+.+|+.+++.++||||+++++++...     .
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA-----N   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-----C
Confidence            367999999999999999999999899999999996432   22346788899999999999999999887655     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      +.|+||||+.+++|.+++....       .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~~-------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~D  147 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIYG-------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTD  147 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEe
Confidence            7899999999999999997643       478899999999999999999998   999999999999999999999999


Q ss_pred             cccce
Q 002883          715 FGLSR  719 (871)
Q Consensus       715 fg~a~  719 (871)
                      ||+++
T Consensus       148 FGls~  152 (669)
T cd05610         148 FGLSK  152 (669)
T ss_pred             CCCCc
Confidence            99986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=273.36  Aligned_cols=258  Identities=24%  Similarity=0.249  Sum_probs=194.4

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHc-CCCCccceeeeeecccCcCCCceeeE
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRS-IRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      .+-...||.|+||+|++..++.+|+..|||.++.... ...+++..|.+...+ -++||||++||++...     +..|+
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E-----GdcWi  140 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-----GDCWI  140 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----Cceee
Confidence            3345679999999999999999999999999975543 345678888886544 4899999999998776     66899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      -||.| ..|++.+-+....  .+...+++.-.-.|+...+.||.||...  ..|+|||+||+|||++..|.+||||||.+
T Consensus       141 CMELM-d~SlDklYk~vy~--vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIc  215 (361)
T KOG1006|consen  141 CMELM-DISLDKLYKRVYS--VQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGIC  215 (361)
T ss_pred             eHHHH-hhhHHHHHHHHHH--HHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccch
Confidence            99999 6687765433221  1233688888888999999999999876  38999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGAL--GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      ..+.++    ...+.-.|-..|||||.+..  ..|+-+|||||+|+++||+.||+.||.....--.++........|.-.
T Consensus       216 GqLv~S----iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~  291 (361)
T KOG1006|consen  216 GQLVDS----IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL  291 (361)
T ss_pred             HhHHHH----HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec
Confidence            766432    23334568899999997653  358899999999999999999999998643322222222221111110


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ..                          ....+....+..++..|+..|-.+||...++...
T Consensus       292 ~~--------------------------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  292 FD--------------------------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             Cc--------------------------ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            00                          0011345578899999999999999999988653

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-33  Score=297.55  Aligned_cols=240  Identities=23%  Similarity=0.263  Sum_probs=195.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .+.|+....+|.|+|+.|-.+.+..+++..++|++....    .+..+|+.++... +||||+++.+.+.+.     .+.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~-----~~~  391 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDG-----KEI  391 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCC-----cee
Confidence            467888888999999999999999999999999996542    2334577666655 799999999998766     789


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee-CCCCceEEeec
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL-DNEMVAHVGDF  715 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~Df  715 (871)
                      |+|||.+.|+-+.+.+...+        .....+..|+.+|+.|+.|||++   |+||||+||+|||+ +..++++|+||
T Consensus       392 ~~v~e~l~g~ell~ri~~~~--------~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyF  460 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKP--------EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYF  460 (612)
T ss_pred             eeeehhccccHHHHHHHhcc--------hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEe
Confidence            99999999999888887654        22367778999999999999999   99999999999999 58999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |.++.....      ....+-|..|.|||+.....|++++|+||||+++|+|++|+.||.....+ ..+.......   .
T Consensus       461 G~a~~~~~~------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~~---~  530 (612)
T KOG0603|consen  461 GFWSELERS------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQMP---K  530 (612)
T ss_pred             chhhhCchh------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcCC---c
Confidence            999876543      22335688999999999999999999999999999999999999865444 1111111110   0


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ..                              ..++....+|+..||+.||.+||++.|+..
T Consensus       531 ~s------------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  531 FS------------------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             cc------------------------------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            00                              234556779999999999999999999865

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=3.7e-33  Score=287.68  Aligned_cols=244  Identities=25%  Similarity=0.368  Sum_probs=192.7

Q ss_pred             CceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEe
Q 002883          564 ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE  641 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  641 (871)
                      .+++|+|.||+||-|+++++|+.||||+++.-+  ......+++|+.|++.+.||.||.+..-|+..     +.+++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~-----ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP-----ERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC-----ceEEEEeh
Confidence            478999999999999999999999999995432  23347889999999999999999999888776     67999999


Q ss_pred             ccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEEeecccc
Q 002883          642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN---EMVAHVGDFGLS  718 (871)
Q Consensus       642 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~a  718 (871)
                      -+ .|+..++|-....     .++++.....++.||+.||.|||.+   +|||+|+||+|||+.+   -.++||||||+|
T Consensus       644 Kl-~GDMLEMILSsEk-----gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfA  714 (888)
T KOG4236|consen  644 KL-HGDMLEMILSSEK-----GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFA  714 (888)
T ss_pred             hh-cchHHHHHHHhhc-----ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccce
Confidence            99 4566665544332     2699999999999999999999999   9999999999999954   358999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE  798 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  798 (871)
                      +++++..    .....+||+.|.|||++....|...-|+||.|||+|--++|..||.+..+-..+.....-+ +|+..  
T Consensus       715 RiIgEks----FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM-yPp~P--  787 (888)
T KOG4236|consen  715 RIIGEKS----FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM-YPPNP--  787 (888)
T ss_pred             eecchhh----hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc-cCCCc--
Confidence            9997643    2334689999999999999999999999999999999999999998543222222111111 11111  


Q ss_pred             hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHH
Q 002883          799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAI  856 (871)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl  856 (871)
                                                  +.++....+++|...|+..-++|-|.++.+
T Consensus       788 ----------------------------W~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  788 ----------------------------WSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             ----------------------------hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence                                        123444556777777778888888777654

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=9.5e-32  Score=280.33  Aligned_cols=237  Identities=27%  Similarity=0.307  Sum_probs=190.0

Q ss_pred             eeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEecc
Q 002883          567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM  643 (871)
Q Consensus       567 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  643 (871)
                      ||+|+||.||+|.+..+++.||+|+++....   ...+.+..|++++++++|||++++++.+...     ...++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE-----EKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC-----CeeEEEEecC
Confidence            6899999999999988899999999864432   2345788999999999999999999887654     6789999999


Q ss_pred             CCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCC
Q 002883          644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD  723 (871)
Q Consensus       644 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  723 (871)
                      ++++|.+++....       .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        76 ~~~~L~~~l~~~~-------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          76 PGGELFSHLSKEG-------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             CCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            9999999997653       489999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChh
Q 002883          724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPA  803 (871)
Q Consensus       724 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  803 (871)
                      ..   .......++..|+|||...+...+.++|+||||+++|++++|+.||....... .........  .....     
T Consensus       146 ~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~~--~~~~~-----  214 (250)
T cd05123         146 EG---SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-IYEKILKDP--LRFPE-----  214 (250)
T ss_pred             CC---CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHhcCC--CCCCC-----
Confidence            21   12233457889999999888888999999999999999999999997432211 011100000  00000     


Q ss_pred             HHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHH
Q 002883          804 ILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQD  854 (871)
Q Consensus       804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~e  854 (871)
                                               .....+.+++.+|+..||++|||+.+
T Consensus       215 -------------------------~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 -------------------------FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             -------------------------CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence                                     11345678999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=7.8e-32  Score=310.98  Aligned_cols=272  Identities=26%  Similarity=0.368  Sum_probs=208.4

Q ss_pred             HHHHhhcCCCCCceeeccccceEEEEEECC-------CCcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeee
Q 002883          553 ELLKATEGFSSANLIGIGGYGYVYKGILGT-------EETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIIT  623 (871)
Q Consensus       553 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~  623 (871)
                      .++...++..+.+.+|+|.||.||+|....       ....||||..+... ....+.+..|+++|+.+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            334444555677799999999999998531       14579999986433 24567889999999999 6999999999


Q ss_pred             eecccCcCCCceeeEEEeccCCCCHHHHhhccc---c------cccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 002883          624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE---D------EQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVH  694 (871)
Q Consensus       624 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  694 (871)
                      +|...     +..++|+||+..|+|.+|++..+   .      ...+...++..+.+.++.|||.|++||++.   ++||
T Consensus       370 ~~t~~-----~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vH  441 (609)
T KOG0200|consen  370 ACTQD-----GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVH  441 (609)
T ss_pred             eeccC-----CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccc
Confidence            99873     66899999999999999999877   1      111112489999999999999999999999   9999


Q ss_pred             cCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCC
Q 002883          695 CDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP  773 (871)
Q Consensus       695 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~p  773 (871)
                      ||+..+|||++++..+||+|||+|+...+............-...|||||.+....|+.++||||||+++||++| |..|
T Consensus       442 RDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~P  521 (609)
T KOG0200|consen  442 RDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTP  521 (609)
T ss_pred             hhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCC
Confidence            999999999999999999999999965543322211111012456999999999999999999999999999999 9999


Q ss_pred             CchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHH
Q 002883          774 TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQ  853 (871)
Q Consensus       774 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~  853 (871)
                      |.+....... .++...+..-.                              ....+..++.++|+.||+.+|++||+..
T Consensus       522 Yp~~~~~~~l-~~~l~~G~r~~------------------------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~  570 (609)
T KOG0200|consen  522 YPGIPPTEEL-LEFLKEGNRME------------------------------QPEHCSDEIYDLMKSCWNADPEDRPTFS  570 (609)
T ss_pred             CCCCCcHHHH-HHHHhcCCCCC------------------------------CCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence            9863211111 11222211100                              1113355678999999999999999999


Q ss_pred             HHHHHHHHHH
Q 002883          854 DAIMELQEAQ  863 (871)
Q Consensus       854 evl~~L~~i~  863 (871)
                      |+.+.++.+.
T Consensus       571 ~~~~~~~~~l  580 (609)
T KOG0200|consen  571 ECVEFFEKHL  580 (609)
T ss_pred             HHHHHHHHHH
Confidence            9999999853

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-32  Score=275.47  Aligned_cols=205  Identities=26%  Similarity=0.361  Sum_probs=176.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..+|..+.+||+|+||.|.+|..+++.+.+|||+++.+-   ....+--+.|-+++... +-|.++++..+|...     
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm-----  422 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM-----  422 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh-----
Confidence            457889999999999999999999999999999986442   22333445576777665 578888888888776     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      +.+|+||||+.||+|--.|++.+       ++-+..+.-+|.+||-||-+||++   ||+.||+|.+|||++.+|.+||+
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ~G-------kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~  492 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQVG-------KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIA  492 (683)
T ss_pred             hheeeEEEEecCchhhhHHHHhc-------ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEee
Confidence            66899999999999999998876       578888999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhh
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEE  780 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  780 (871)
                      |||+++.   .......+...+||+.|+|||++...+|+.++|-||+||++|||+.|++||++..++
T Consensus       493 DFGmcKE---ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~  556 (683)
T KOG0696|consen  493 DFGMCKE---NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED  556 (683)
T ss_pred             ecccccc---cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence            9999974   222334455688999999999999999999999999999999999999999975444

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1e-32  Score=256.36  Aligned_cols=277  Identities=19%  Similarity=0.256  Sum_probs=209.7

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCce
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ..++|++.+++|+|.|+.||.|....+.++++||++++..   .+.+.+|+.+++.+. ||||+.+++...+...   ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S---kt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPES---KT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccc---cC
Confidence            3468999999999999999999998899999999997544   478899999999995 9999999999876544   55


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCceEEee
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-EMVAHVGD  714 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~D  714 (871)
                      ..+|+||+.+.+....-.          .++...++.++.+++.||.|+|+.   ||.|||+||.|+|++. ...++|+|
T Consensus       110 paLiFE~v~n~Dfk~ly~----------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlID  176 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYP----------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLID  176 (338)
T ss_pred             chhHhhhhccccHHHHhh----------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeee
Confidence            679999998887776554          477888999999999999999999   9999999999999985 45799999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      +|+|.++.+..    .....+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||....+...++.+++.....
T Consensus       177 WGLAEFYHp~~----eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt  252 (338)
T KOG0668|consen  177 WGLAEFYHPGK----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGT  252 (338)
T ss_pred             cchHhhcCCCc----eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhCh
Confidence            99999887543    2334567889999997654 457888999999999999999999998877776667666654333


Q ss_pred             chhhhh-------cChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEI-------IDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      +.....       +++.............+...-.  ...-.-...+.++++.+.|.+|-++|+||+|+++.
T Consensus       253 ~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~--~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  253 DELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFIN--SENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHHHHHHccCCChhHhhHhhccccccHHHhCC--ccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            332222       2222211100000000000000  00001123577899999999999999999999863

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.1e-31  Score=277.00  Aligned_cols=221  Identities=19%  Similarity=0.155  Sum_probs=174.9

Q ss_pred             cccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEeccCCCCHH
Q 002883          570 GGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLE  649 (871)
Q Consensus       570 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~  649 (871)
                      |.+|.||+|++..+++.||+|+++...     ...+|...+....|||++++++++.+.     ...++||||+++|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSE-----DSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecC-----CeEEEEEecCCCCCHH
Confidence            899999999999999999999986443     223455555556799999999987654     6789999999999999


Q ss_pred             HHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCCCCCCcc
Q 002883          650 NWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQT  729 (871)
Q Consensus       650 ~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  729 (871)
                      +++....       .+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.++++|||.+......     
T Consensus        74 ~~l~~~~-------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----  138 (237)
T cd05576          74 SHISKFL-------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----  138 (237)
T ss_pred             HHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----
Confidence            9987643       489999999999999999999999   9999999999999999999999999988655332     


Q ss_pred             ccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHH
Q 002883          730 STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEAL  809 (871)
Q Consensus       730 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (871)
                       .....++..|+|||...+..++.++||||+|+++|||++|+.|+.......               .......      
T Consensus       139 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~~~~------  196 (237)
T cd05576         139 -CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHTTLN------  196 (237)
T ss_pred             -cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------ccccccC------
Confidence             112345678999999888889999999999999999999998875321100               0000000      


Q ss_pred             HHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHH
Q 002883          810 EIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQ  853 (871)
Q Consensus       810 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~  853 (871)
                               .+       ..+...+.+++.+|++.||++|||+.
T Consensus       197 ---------~~-------~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         197 ---------IP-------EWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             ---------Cc-------ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence                     00       01234567899999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-31  Score=265.24  Aligned_cols=277  Identities=22%  Similarity=0.310  Sum_probs=212.5

Q ss_pred             HHHHHhhcCCCCCceeeccccceEEEEEECCCC-----cEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeee
Q 002883          552 AELLKATEGFSSANLIGIGGYGYVYKGILGTEE-----TNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSC  625 (871)
Q Consensus       552 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  625 (871)
                      .++.....|++....+.+|.||.||.|.|...+     +.|.+|.++.. ..-....+..|.-.+....|||+..+.+.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            344455567888888999999999999886543     34666766432 222345677888888889999999999987


Q ss_pred             cccCcCCCceeeEEEeccCCCCHHHHhhccccc-ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 002883          626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDE-QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL  704 (871)
Q Consensus       626 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  704 (871)
                      .+.    ....++++.++.-|+|..|++..++. ......++..+...++.|++.|++|||++   +|||.||..+|++|
T Consensus       357 ie~----~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvI  429 (563)
T KOG1024|consen  357 IED----YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVI  429 (563)
T ss_pred             eec----cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhccee
Confidence            653    35678999999999999999854432 12233577888899999999999999999   99999999999999


Q ss_pred             CCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhh
Q 002883          705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLS  783 (871)
Q Consensus       705 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~  783 (871)
                      ++..++||+|=.+++...+.+ ...-.........||+||.+....|+.++|||||||++|||+| |+.||.+.+..+  
T Consensus       430 dd~LqVkltDsaLSRDLFP~D-YhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--  506 (563)
T KOG1024|consen  430 DDQLQVKLTDSALSRDLFPGD-YHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--  506 (563)
T ss_pred             hhheeEEeccchhccccCccc-ccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--
Confidence            999999999999998876543 2222222335678999999999999999999999999999999 999998643332  


Q ss_pred             HHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          784 LHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                      +..+.+.+..-                              +..-+++.++..+|.-||..+|++||+.+|+.+-|.+..
T Consensus       507 m~~ylkdGyRl------------------------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  507 MEHYLKDGYRL------------------------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             HHHHHhcccee------------------------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            22222221110                              001156778999999999999999999999999999876


Q ss_pred             HHHHh
Q 002883          864 KMRQA  868 (871)
Q Consensus       864 ~~~~~  868 (871)
                      ....+
T Consensus       557 ~qlt~  561 (563)
T KOG1024|consen  557 TQLTR  561 (563)
T ss_pred             HHHhh
Confidence            65543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=7.5e-31  Score=299.73  Aligned_cols=275  Identities=19%  Similarity=0.213  Sum_probs=174.7

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCC----CcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccC-cC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTE----ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSID-TR  631 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~  631 (871)
                      ..++|++.+.||+|+||.||+|++..+    +..||+|++.....  .+....|  .+....+.++..++..+.... ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            457899999999999999999999888    89999998753322  1111111  122222333333332222211 13


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccc-------------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQ-------------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK  698 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  698 (871)
                      .....++||||+++++|.+++.......             ..........+..++.|++.||.|||+.   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            3467899999999999999987542100             0011122345678999999999999999   99999999


Q ss_pred             CCceeeCC-CCceEEeecccceecCCCCCCccccccccccccccCcccccCC----------------------CCCCcc
Q 002883          699 PSNVLLDN-EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG----------------------EVSTHG  755 (871)
Q Consensus       699 p~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~  755 (871)
                      |+|||++. ++.+||+|||+|+......  ........+++.|+|||.+...                      .++.++
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~--~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI--NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc--ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            99999985 5799999999998654321  1222345689999999954322                      234567


Q ss_pred             chhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hCCCc-hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhH---HHH
Q 002883          756 DEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MGLPD-QVAEIIDPAILEEALEIQAGIVKELQPNLRAKF---HEI  830 (871)
Q Consensus       756 DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  830 (871)
                      ||||+||++|||+++..|+......   +..... ..... .......+.               ..+.....+   ...
T Consensus       361 DVwSlGviL~el~~~~~~~~~~~~~---~~~~l~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~d~~  422 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSNLIQ---FNRQLKRNDYDLVAWRKLVEPR---------------ASPDLRRGFEVLDLD  422 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchHHHH---HHHHHHhcCCcHHHHHHhhccc---------------cchhhhhhhhhcccc
Confidence            9999999999999987776532111   111110 00000 000000000               000000000   011


Q ss_pred             HHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          831 QVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       831 ~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .....+++.+||+.||++|||+.|+++.
T Consensus       423 ~~~~~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        423 GGAGWELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             chHHHHHHHHHccCCcccCCCHHHHhCC
Confidence            2235589999999999999999999874

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-31  Score=242.82  Aligned_cols=214  Identities=24%  Similarity=0.288  Sum_probs=171.6

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ..+....+..||+|+||.|-+.++..+|...|+|.++..-. ...++..+|+++..+- .+|.+|.+||.+...     .
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re-----g  118 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE-----G  118 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc-----c
Confidence            33445556789999999999999999999999999964432 2346777888876654 899999999987665     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      .+|+.||.| ..||+.+-++.-.   ....+++..+-+||..+.+||.|||++  ..++|||+||+|||++.+|++|+||
T Consensus       119 dvwIcME~M-~tSldkfy~~v~~---~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCD  192 (282)
T KOG0984|consen  119 DVWICMELM-DTSLDKFYRKVLK---KGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICD  192 (282)
T ss_pred             cEEEeHHHh-hhhHHHHHHHHHh---cCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcc
Confidence            689999999 6688876654322   133688999999999999999999998  4899999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCccccc----CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHH
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA----LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLH  785 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~  785 (871)
                      ||.+..+.++.    ..+...|...|||||.+.    ...|+-++||||+|+++.||.+++.||+.....-..+.
T Consensus       193 FGIsG~L~dSi----Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLk  263 (282)
T KOG0984|consen  193 FGISGYLVDSI----AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLK  263 (282)
T ss_pred             cccceeehhhh----HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHH
Confidence            99998875432    222245788999999754    34789999999999999999999999986544433333

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-32  Score=258.99  Aligned_cols=203  Identities=22%  Similarity=0.302  Sum_probs=167.1

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      .+..+.||.|+||.||.+++..+|+.||+|++....  -...+++-+|++++..++|.|+...++........--...|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            445688999999999999999999999999984322  234578889999999999999998887653321111134688


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ++|.+ ..+|...|-.-.       .++...++-+.+||++||+|||+.   +|.||||||.|.+++++..+||||||+|
T Consensus       135 ~TELm-QSDLHKIIVSPQ-------~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLA  203 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIVSPQ-------ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLA  203 (449)
T ss_pred             HHHHH-HhhhhheeccCC-------CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccc
Confidence            99998 568888775432       588899999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCch
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDD  776 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~  776 (871)
                      +....+  .....+..+.|..|+|||++.+. .|+.+.||||.||++.|++.++..|..
T Consensus       204 Rvee~d--~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA  260 (449)
T KOG0664|consen  204 RTWDQR--DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA  260 (449)
T ss_pred             cccchh--hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence            876543  23334445679999999987765 689999999999999999999888864

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.3e-29  Score=262.82  Aligned_cols=239  Identities=26%  Similarity=0.338  Sum_probs=192.0

Q ss_pred             ccceEEEEEECCCCcEEEEEEeeccccch-HHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEeccCCCCHH
Q 002883          571 GYGYVYKGILGTEETNVAVKVLDLQQRGA-SKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLE  649 (871)
Q Consensus       571 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~  649 (871)
                      +||.||+|.+..+++.||+|++....... .+.+.+|++.+++++|++++++++++...     ...+++|||+++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHH
Confidence            58999999998889999999997554433 67899999999999999999999988765     5689999999999999


Q ss_pred             HHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCCCCCCcc
Q 002883          650 NWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQT  729 (871)
Q Consensus       650 ~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  729 (871)
                      +++....       .+++..++.++.+++.++.|||+.   +++|+||+|+||+++.++.++++|||.+.......    
T Consensus        76 ~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----  141 (244)
T smart00220       76 DLLKKRG-------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----  141 (244)
T ss_pred             HHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc----
Confidence            9997643       378999999999999999999999   99999999999999999999999999998765432    


Q ss_pred             ccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHH
Q 002883          730 STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEAL  809 (871)
Q Consensus       730 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (871)
                      ......++..|+|||......++.++||||+|+++|++++|..||........ .............             
T Consensus       142 ~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~~~-------------  207 (244)
T smart00220      142 LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-LFKKIGKPKPPFP-------------  207 (244)
T ss_pred             ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHhccCCCCc-------------
Confidence            22334578899999998888889999999999999999999999975211111 1111111000000             


Q ss_pred             HHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          810 EIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       810 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                     .....+..++.+++.+|+..+|++||++.++++
T Consensus       208 ---------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      208 ---------------PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ---------------cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence                           000003356788999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-31  Score=288.75  Aligned_cols=247  Identities=25%  Similarity=0.323  Sum_probs=188.4

Q ss_pred             CCCceeeccccce-EEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCceeeEE
Q 002883          562 SSANLIGIGGYGY-VYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALV  639 (871)
Q Consensus       562 ~~~~~lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  639 (871)
                      .-.+++|.|+.|+ ||+|..  +++.||||.+-.   +..+...+|++.++.- +|||||++++.-.+     +.+.||.
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d-----~qF~YIa  581 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQD-----RQFLYIA  581 (903)
T ss_pred             ccHHHcccCCCCcEEEEEee--CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccC-----CceEEEE
Confidence            3346788999875 799999  588999998742   2345678999999988 79999999987433     3889999


Q ss_pred             EeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---C--CceEEee
Q 002883          640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN---E--MVAHVGD  714 (871)
Q Consensus       640 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~--~~~kl~D  714 (871)
                      .|.| ..+|.+++......   .........+.+..|+++||++||+.   +||||||||.||||+.   +  ..++|+|
T Consensus       582 lELC-~~sL~dlie~~~~d---~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSD  654 (903)
T KOG1027|consen  582 LELC-ACSLQDLIESSGLD---VEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISD  654 (903)
T ss_pred             ehHh-hhhHHHHHhccccc---hhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecc
Confidence            9999 56999999885111   00112145678899999999999998   9999999999999965   2  4799999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||+++.++.+...........||.+|+|||++....-+.++||||+||++|+.++ |.+||++..+.+..+..-..    
T Consensus       655 fglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~----  730 (903)
T KOG1027|consen  655 FGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNY----  730 (903)
T ss_pred             cccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcc----
Confidence            9999998876555555666789999999999998888899999999999999999 59999975433221110000    


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       ..                    ..+.+..     ++  +..+||.+|+.+||..||+|.+|+.
T Consensus       731 -~L--------------------~~L~~~~-----d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  731 -TL--------------------VHLEPLP-----DC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             -ce--------------------eeeccCc-----hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence             00                    0000000     11  4569999999999999999999974

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=275.02  Aligned_cols=200  Identities=24%  Similarity=0.374  Sum_probs=177.1

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .+++++..+|-|+||.|=+++.......+|+|+++..   +....+.+..|-.+|...+.|.||++|..|.+.     .+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~-----ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS-----KY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc-----hh
Confidence            4566778899999999999999866666899988533   233345677899999999999999999988766     88


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      +|+.||.|-||.++..++..+       .++...++.++.-+++|++|||++   +||.||+||+|.+++.+|-+||.||
T Consensus       495 vYmLmEaClGGElWTiLrdRg-------~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDF  564 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDRG-------SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDF  564 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhcC-------CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeeh
Confidence            999999999999999998765       689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      |+|+.+..+    ..+..++||+.|.|||++.....+.++|.||+|+.+|||++|.+||...
T Consensus       565 GFAKki~~g----~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~  622 (732)
T KOG0614|consen  565 GFAKKIGSG----RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV  622 (732)
T ss_pred             hhHHHhccC----CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence            999998754    3455678999999999999999999999999999999999999999853

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.1e-29  Score=281.92  Aligned_cols=276  Identities=18%  Similarity=0.250  Sum_probs=182.1

Q ss_pred             hhcCCCCCceeeccccceEEEEEEC----------------CCCcEEEEEEeeccccchHHHH--------------HHH
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILG----------------TEETNVAVKVLDLQQRGASKSF--------------IAE  606 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E  606 (871)
                      ..++|++.++||+|+||+||+|.+.                ..++.||||.+........+.+              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3568999999999999999999752                2456799999865433322333              346


Q ss_pred             HHHHHcCCCCc-----cceeeeeecccCcC---CCceeeEEEeccCCCCHHHHhhcccccc-----------------cc
Q 002883          607 CEALRSIRHRN-----LVKIITSCSSIDTR---GNEFKALVYEFMPNGSLENWLNQKEDEQ-----------------NQ  661 (871)
Q Consensus       607 ~~~l~~l~h~n-----iv~~~~~~~~~~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------~~  661 (871)
                      +.++.+++|.+     +++++++|......   .....|+||||+++++|.+++.......                 ..
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            66667776554     46777776543111   1245799999999999999987532110                 01


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCCCCCCcccccccccccccc
Q 002883          662 RPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV  741 (871)
Q Consensus       662 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~  741 (871)
                      ....++..++.++.|++.||.|+|+.   +|+||||||+||+++.++.+||+|||++........  .......+++.|+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~g~~tp~Y~  377 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN--FNPLYGMLDPRYS  377 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc--cCccccCCCccee
Confidence            12357788999999999999999999   999999999999999999999999999976543211  1111223578999


Q ss_pred             CcccccCCC--------------------C--CCccchhhHHHHHHHHHhCCC-CCchhhhhhhhHHHHhhhCCCchhhh
Q 002883          742 APEYGALGE--------------------V--STHGDEYSFGILMLEMFTGKR-PTDDMFEEGLSLHKYAKMGLPDQVAE  798 (871)
Q Consensus       742 aPE~~~~~~--------------------~--~~~~DiwSlG~il~elltG~~-pf~~~~~~~~~~~~~~~~~~~~~~~~  798 (871)
                      |||.+....                    +  ..+.||||+||++|+|++|.. ||............+..     ....
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~-----~~~~  452 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDN-----DLNR  452 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccc-----hHHH
Confidence            999764322                    1  134799999999999999875 77542111111100000     0000


Q ss_pred             hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCC---CCCCCHHHHHH
Q 002883          799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELP---RDRMKIQDAIM  857 (871)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPta~evl~  857 (871)
                           |..         .+...... ..+........+++.+|+..+|   .+|+|++|+++
T Consensus       453 -----~r~---------~~~~~~~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        453 -----WRM---------YKGQKYDF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             -----HHh---------hcccCCCc-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence                 000         00000000 0122334567789999998766   78999999986

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=5.4e-31  Score=271.88  Aligned_cols=293  Identities=18%  Similarity=0.235  Sum_probs=217.0

Q ss_pred             cccccCHHHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC------CCcc
Q 002883          545 KYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR------HRNL  618 (871)
Q Consensus       545 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~ni  618 (871)
                      .|..+...++  -..+|.+....|+|-|++|.+|.+...+..||||++..... ..+.=.+|+++|+++.      --|+
T Consensus       420 GYYrv~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hc  496 (752)
T KOG0670|consen  420 GYYRVRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHC  496 (752)
T ss_pred             ceEEEehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHH
Confidence            4444555554  35689999999999999999999999999999999975543 3355578999999994      3478


Q ss_pred             ceeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 002883          619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK  698 (871)
Q Consensus       619 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  698 (871)
                      ++++..|...     .++|+|+|.. ..+|.+++++.+.    ...+....+..++.|+.-||..|...   +|+|.|||
T Consensus       497 lrl~r~F~hk-----nHLClVFE~L-slNLRevLKKyG~----nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIK  563 (752)
T KOG0670|consen  497 LRLFRHFKHK-----NHLCLVFEPL-SLNLREVLKKYGR----NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIK  563 (752)
T ss_pred             HHHHHHhhhc-----ceeEEEehhh-hchHHHHHHHhCc----ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccC
Confidence            8888887765     8899999988 6799999988764    34688999999999999999999998   99999999


Q ss_pred             CCceeeCC-CCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          699 PSNVLLDN-EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       699 p~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      |+||||.+ ...+||||||.|....++.     .+.+..+..|+|||++.+-+|+...|+||.||++||+.||+..|.+.
T Consensus       564 PDNiLVNE~k~iLKLCDfGSA~~~~ene-----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~  638 (752)
T KOG0670|consen  564 PDNILVNESKNILKLCDFGSASFASENE-----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR  638 (752)
T ss_pred             ccceEeccCcceeeeccCcccccccccc-----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence            99999975 4578999999999876543     22345677899999999999999999999999999999999999887


Q ss_pred             hhhhhhHH-HHhhhCCCchh---hhhcChhHHHHHHHH-----------HhhhhhhcCc------------hhHHhHHHH
Q 002883          778 FEEGLSLH-KYAKMGLPDQV---AEIIDPAILEEALEI-----------QAGIVKELQP------------NLRAKFHEI  830 (871)
Q Consensus       778 ~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~~~~-----------~~~~~~~~~~------------~~~~~~~~~  830 (871)
                      ....+... .-....+|..+   ..+.|..+-.++...           ....+..+.|            .+...-...
T Consensus       639 TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~  718 (752)
T KOG0670|consen  639 TNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKI  718 (752)
T ss_pred             CcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHH
Confidence            65543222 11222233221   112222211110000           0000011111            112222355


Q ss_pred             HHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          831 QVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       831 ~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ..++.+|+..|+..||++|.|..++++.
T Consensus       719 ~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  719 VQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             HHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence            6688999999999999999999998863

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-30  Score=252.62  Aligned_cols=202  Identities=25%  Similarity=0.321  Sum_probs=177.2

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  632 (871)
                      ..++|...++||+|+|+.|..++..++.+.+|+|+++..   ..+..+-++.|-.+..+. +||.+|.+..+|...    
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte----  323 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE----  323 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc----
Confidence            346899999999999999999999999999999999643   333445566777777776 799999999888776    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                       ...++|.||++||+|--.+++.+       +++++.++.+...|.-||.|||++   ||+.||+|.+|++++..|.+|+
T Consensus       324 -srlffvieyv~ggdlmfhmqrqr-------klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikl  392 (593)
T KOG0695|consen  324 -SRLFFVIEYVNGGDLMFHMQRQR-------KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKL  392 (593)
T ss_pred             -ceEEEEEEEecCcceeeehhhhh-------cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceee
Confidence             66899999999999988887655       699999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCch
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDD  776 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  776 (871)
                      .|+|+++.--   .....++..+||+.|.|||++.+..|+..+|-|++||+++||+.|+.||+-
T Consensus       393 tdygmcke~l---~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  393 TDYGMCKEGL---GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             cccchhhcCC---CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            9999997532   233445668899999999999999999999999999999999999999973

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=4.2e-30  Score=251.65  Aligned_cols=280  Identities=20%  Similarity=0.215  Sum_probs=202.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  634 (871)
                      ..||...+.+|.|.- .|..|.+.-.++.||+|.....  .....++..+|...+..+.|+||++++.+|.-... ..-.
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            467888899999988 7888888888999999988322  23345778899999999999999999998844322 1224


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      .+|+|||+| ..+|.+.+.-         .++-+.+..+..|++.|++|||+.   ||+||||||+||++..+..+||.|
T Consensus        95 e~y~v~e~m-~~nl~~vi~~---------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~d  161 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM---------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILD  161 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH---------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeecc
Confidence            679999999 6799998873         478889999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~  793 (871)
                      ||+|...+..    -..+.++.|..|+|||++.+..|.+.+||||.||++.||++|+..|.+...- .++.+... .+.|
T Consensus       162 fg~ar~e~~~----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~i-dQ~~ki~~~lgtp  236 (369)
T KOG0665|consen  162 FGLARTEDTD----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHI-DQWNKIIEQLGTP  236 (369)
T ss_pred             chhhcccCcc----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHH-HHHHHHHHHhcCC
Confidence            9999865432    3455678999999999988888999999999999999999999999843221 12222221 1222


Q ss_pred             ch-hhhhcChhHHHHHHH---------HHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQ-VAEIIDPAILEEALE---------IQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~-~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      +. ..+-+.+. ...+.+         +........-+...+..+-......+++.+||-.||++|.+++++++
T Consensus       237 d~~F~~qL~~~-~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  237 DPSFMKQLQPT-VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             CHHHHHHhhHH-HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            21 11100000 000000         00000000000000111122334678999999999999999999986

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-30  Score=269.81  Aligned_cols=198  Identities=21%  Similarity=0.316  Sum_probs=173.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--------chHHHHHHHHHHHHcCC---CCccceeeeeec
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--------GASKSFIAECEALRSIR---HRNLVKIITSCS  626 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~~~~~~~  626 (871)
                      ..+|+..+.+|.|+||.|+.|.++.....|+||.+...+-        ...-.+..|++||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3579999999999999999999998989999998854321        11124667999999996   999999999998


Q ss_pred             ccCcCCCceeeEEEecc-CCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC
Q 002883          627 SIDTRGNEFKALVYEFM-PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD  705 (871)
Q Consensus       627 ~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  705 (871)
                      +.     +++|++||.. +|.+|.++|....       .+++.++..|++||+.|+++||++   ||||||||-+|+.++
T Consensus       640 dd-----d~yyl~te~hg~gIDLFd~IE~kp-------~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd  704 (772)
T KOG1152|consen  640 DD-----DYYYLETEVHGEGIDLFDFIEFKP-------RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVD  704 (772)
T ss_pred             cC-----CeeEEEecCCCCCcchhhhhhccC-------ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEe
Confidence            77     7899999986 4579999998754       699999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCc
Q 002883          706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV-STHGDEYSFGILMLEMFTGKRPTD  775 (871)
Q Consensus       706 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~  775 (871)
                      ++|-+||+|||.|.....+     .....+||..|.|||++.+.+| +..-|||++|+++|.++....||.
T Consensus       705 ~~g~~klidfgsaa~~ksg-----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  705 SNGFVKLIDFGSAAYTKSG-----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cCCeEEEeeccchhhhcCC-----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999999999876433     3445789999999999999888 677899999999999999999986

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.7e-29  Score=266.12  Aligned_cols=207  Identities=22%  Similarity=0.290  Sum_probs=176.1

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .-|..++.||-|+||.|.+++...+...||+|.++..+   +.....+..|-+||...+.+=||++|..|.+.     +.
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk-----dn  703 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DN  703 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC-----Cc
Confidence            34788899999999999999998888899999986443   33446678899999999999999999998877     77


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      +|+||||++||++-.++-+.+       .+.+..++.++.++..|+++.|..   |++||||||+|||||.+|.+||.||
T Consensus       704 LYFVMdYIPGGDmMSLLIrmg-------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDF  773 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRMG-------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  773 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHhc-------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeec
Confidence            999999999999999887765       689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCC---------CCC-----Cc-------------------------cccccccccccccCcccccCCCCCCccc
Q 002883          716 GLSRLLHD---------NSP-----DQ-------------------------TSTSRVKGSIGYVAPEYGALGEVSTHGD  756 (871)
Q Consensus       716 g~a~~~~~---------~~~-----~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D  756 (871)
                      |++.-+..         +..     ..                         ......+||+.|+|||++....|+..+|
T Consensus       774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd  853 (1034)
T KOG0608|consen  774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD  853 (1034)
T ss_pred             cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence            99854321         000     00                         0001245999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCchhhhh
Q 002883          757 EYSFGILMLEMFTGKRPTDDMFEE  780 (871)
Q Consensus       757 iwSlG~il~elltG~~pf~~~~~~  780 (871)
                      -||.|||+|||+.|++||.+....
T Consensus       854 wws~gvil~em~~g~~pf~~~tp~  877 (1034)
T KOG0608|consen  854 WWSVGVILYEMLVGQPPFLADTPG  877 (1034)
T ss_pred             hhHhhHHHHHHhhCCCCccCCCCC
Confidence            999999999999999999765443

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-29  Score=238.92  Aligned_cols=260  Identities=21%  Similarity=0.296  Sum_probs=196.8

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .+.|.+.+.+|+|.||.+-+++++++.+.+|+|.+..... ..++|.+|...--.+ .|.||+..|+...+.    .+.+
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt----~d~Y   97 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQT----SDAY   97 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhc----CceE
Confidence            3569999999999999999999999999999999865433 457888887655455 589999988764332    2578


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC--CCCceEEee
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD--NEMVAHVGD  714 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~D  714 (871)
                      .+++||++.|+|.+-+...+        +.+.....++.|+++|+.|||+.   .+||||||.+||||-  +...+|+||
T Consensus        98 vF~qE~aP~gdL~snv~~~G--------igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcD  166 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAAG--------IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCD  166 (378)
T ss_pred             EEeeccCccchhhhhcCccc--------ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeee
Confidence            89999999999999887653        78888999999999999999999   999999999999992  345899999


Q ss_pred             cccceecCCCCCCccccccccccccccCccccc---CC--CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA---LG--EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK  789 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~--~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~  789 (871)
                      ||.+...+..      .....-+..|.|||...   .+  ...+.+|||.||+++|.++||..||+.....+..+..|..
T Consensus       167 FG~t~k~g~t------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~  240 (378)
T KOG1345|consen  167 FGLTRKVGTT------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ  240 (378)
T ss_pred             cccccccCce------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH
Confidence            9999865421      12233567799999633   22  3478899999999999999999999865544444433322


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      -                         .+...+.....|....+.+.++.++-+..+|++|=...++....+..+.
T Consensus       241 w-------------------------~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  241 W-------------------------LKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             H-------------------------hcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            1                         1111222233444556677788889999999999666666666555543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-29  Score=269.97  Aligned_cols=255  Identities=23%  Similarity=0.289  Sum_probs=205.7

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ..++|+.+..+|.|+||.||+|++..+++..|+|+++.......+..++|+-+++..+||||+.+++.|...     +..
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~-----dkl   87 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR-----DKL   87 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh-----cCc
Confidence            346799999999999999999999999999999999988887888889999999999999999999998665     568


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+.||||.||+|.+.-+..+       ++++.++..+.+..++|++|||+.   |=+|||||-.||++++.|.+|++|||
T Consensus        88 wicMEycgggslQdiy~~Tg-------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfg  157 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVTG-------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFG  157 (829)
T ss_pred             EEEEEecCCCcccceeeecc-------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccC
Confidence            99999999999999776654       689999999999999999999999   98999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccc---cCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYG---ALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      .+..+..   .-.......||++|||||+.   ..+.|...+|||+.|++..|+-.-++|..+..... ...-+.+..+.
T Consensus       158 vsaqita---ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-~l~LmTkS~~q  233 (829)
T KOG0576|consen  158 VSAQITA---TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-ALFLMTKSGFQ  233 (829)
T ss_pred             chhhhhh---hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-HHHHhhccCCC
Confidence            9876643   22233456899999999963   45688999999999999999998888865432221 11111122211


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      +.  ..-|+.-                         ..+.+-++++.|+..+|++||||+.+++
T Consensus       234 pp--~lkDk~k-------------------------ws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  234 PP--TLKDKTK-------------------------WSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CC--cccCCcc-------------------------chHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11  1112111                         1233558889999999999999998876

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=1.1e-28  Score=251.28  Aligned_cols=283  Identities=22%  Similarity=0.292  Sum_probs=204.8

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECC---CCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcC
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGT---EETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  631 (871)
                      ...+.|..+++||.|+|++||+|.+..   ..+.||+|.+....  ...++.+|++++..+ .+.||+++.+++...   
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn---  107 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNN---  107 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccC---
Confidence            344678999999999999999999976   78899999986443  346789999999999 699999999987554   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCce
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-EMVA  710 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~  710 (871)
                        +.+.+|+||++.....++...          ++..++..+++.+..||+++|..   |||||||||.|++.+. .+.-
T Consensus       108 --d~v~ivlp~~~H~~f~~l~~~----------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg  172 (418)
T KOG1167|consen  108 --DQVAIVLPYFEHDRFRDLYRS----------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRG  172 (418)
T ss_pred             --CeeEEEecccCccCHHHHHhc----------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCc
Confidence              778999999999999988864          77889999999999999999999   9999999999999974 4678


Q ss_pred             EEeecccceecCCCC--------------C---------------------------CccccccccccccccCcccccCC
Q 002883          711 HVGDFGLSRLLHDNS--------------P---------------------------DQTSTSRVKGSIGYVAPEYGALG  749 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~--------------~---------------------------~~~~~~~~~gt~~y~aPE~~~~~  749 (871)
                      .|+|||+|.......              .                           .........||++|+|||++...
T Consensus       173 ~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~  252 (418)
T KOG1167|consen  173 VLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC  252 (418)
T ss_pred             eEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc
Confidence            899999998321100              0                           00011224599999999987654


Q ss_pred             -CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh---h------hc-------ChhHHHHHHHH-
Q 002883          750 -EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA---E------II-------DPAILEEALEI-  811 (871)
Q Consensus       750 -~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~---~------~~-------~~~~~~~~~~~-  811 (871)
                       ..++++||||.|||+..+++++.||....++...+.+.........+.   .      +.       .++....+... 
T Consensus       253 ~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~  332 (418)
T KOG1167|consen  253 PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLH  332 (418)
T ss_pred             cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccC
Confidence             458999999999999999999999987666544444333221111100   0      00       11111111111 


Q ss_pred             HhhhhhhcCc--hhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          812 QAGIVKELQP--NLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       812 ~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .+...+.-++  .........+..+.+++.+|++.||.+|.||+|++..
T Consensus       333 ~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  333 IESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             hhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            0111111111  2222223344578999999999999999999999863

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-30  Score=260.46  Aligned_cols=417  Identities=21%  Similarity=0.218  Sum_probs=267.0

Q ss_pred             ccCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccC-ccccCCCCcccc
Q 002883            5 EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSE-NSLSGNIPSELG   83 (871)
Q Consensus         5 ~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-n~l~~~~~~~~~   83 (871)
                      |+|.++.  ++-.+++|..|+|+.+.|.+|+.+++|++|+||+|.|+.+.|++|..|.+|..|-+-+ |+|+..-.+.|+
T Consensus        60 eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~  137 (498)
T KOG4237|consen   60 EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFG  137 (498)
T ss_pred             cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhh
Confidence            6777777  3678999999999988899999999999999999999999999999999988877766 999955556899


Q ss_pred             ccccccccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCC----
Q 002883           84 LLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNAS----  159 (871)
Q Consensus        84 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~----  159 (871)
                      +|..|+.|.+.-|++.-...+.|..+++|..|.+-+|.+. .++...+..+..++.+.+..|.+-     ..+++.    
T Consensus       138 gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~wla~  211 (498)
T KOG4237|consen  138 GLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFI-----CDCNLPWLAD  211 (498)
T ss_pred             hHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccc-----cccccchhhh
Confidence            9999999999999999777788999999999999999997 888888889999999999999853     222221    


Q ss_pred             ---CCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCcc
Q 002883          160 ---SIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRI  236 (871)
Q Consensus       160 ---~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i  236 (871)
                         ..|..+++.+-..-..+.++++.++....+.  .   .+..+..=-.+.+......|..-+.-.++|+.|+|++|+|
T Consensus       212 ~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~--c---~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i  286 (498)
T KOG4237|consen  212 DLAMNPIETSGARCVSPYRLYYKRINQEDARKFL--C---SLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKI  286 (498)
T ss_pred             HHhhchhhcccceecchHHHHHHHhcccchhhhh--h---hHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCcc
Confidence               2444566666666666666666665543322  1   1111111112222233344544444445566666666666


Q ss_pred             CCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccC-ccc
Q 002883          237 SGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSI-PSA  315 (871)
Q Consensus       237 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~-~~~  315 (871)
                      +.+-+.+|.++..+++|.|..|+|.......|.++..|+.|+|++|+|+...|..|..+..|.+|+|-.|.+.--- -.+
T Consensus       287 ~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~w  366 (498)
T KOG4237|consen  287 TRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAW  366 (498)
T ss_pred             chhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHH
Confidence            6666666666666666666666666555555666666666666666666555666666666666666555543100 000


Q ss_pred             ccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCC---CCccc---------cCCCCCCCEEe-CCCCcCCC
Q 002883          316 LGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSG---PIPLE---------VGRLKGIQQLD-LSENKLSG  382 (871)
Q Consensus       316 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~---~~~~~---------~~~l~~L~~L~-L~~N~l~~  382 (871)
                      +..       .|..+.-.+. |. -..-..++.+.++++.+..   ..|++         -..++.+.+.. .|+..++ 
T Consensus       367 l~~-------Wlr~~~~~~~-~~-Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-  436 (498)
T KOG4237|consen  367 LGE-------WLRKKSVVGN-PR-CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-  436 (498)
T ss_pred             HHH-------HHhhCCCCCC-CC-CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-
Confidence            000       0111110000 00 0111234444444443321   11111         12233444433 3444444 


Q ss_pred             CCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCC
Q 002883          383 EIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFN  450 (871)
Q Consensus       383 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N  450 (871)
                      .+|..+.  ....+|++.+|.++.++..   .+.+| .+|+++|+++......|.++.+|.+|-|+.|
T Consensus       437 ~lp~~iP--~d~telyl~gn~~~~vp~~---~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  437 LLPRGIP--VDVTELYLDGNAITSVPDE---LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             hcCCCCC--chhHHHhcccchhcccCHH---HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            5665554  2567888888888854443   45566 7888888888777778888888888887765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=1.2e-26  Score=234.76  Aligned_cols=211  Identities=29%  Similarity=0.466  Sum_probs=181.5

Q ss_pred             eeccccceEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEeccCC
Q 002883          567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRG-ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN  645 (871)
Q Consensus       567 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  645 (871)
                      ||+|++|.||++....+++.+++|++...... ..+.+.+|++.++.++|++++++++++...     ...+++||++++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence            68999999999999878999999999755432 346789999999999999999999998664     568999999999


Q ss_pred             CCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCceEEeecccceecCCC
Q 002883          646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-EMVAHVGDFGLSRLLHDN  724 (871)
Q Consensus       646 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~  724 (871)
                      ++|.+++....      ..+++..++.++.++++++.+||+.   +++|+||+|.||+++. ++.++|+|||.+......
T Consensus        76 ~~l~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~  146 (215)
T cd00180          76 GSLKDLLKENE------GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD  146 (215)
T ss_pred             CcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence            99999997652      1488999999999999999999999   9999999999999999 899999999999876543


Q ss_pred             CCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChh
Q 002883          725 SPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPA  803 (871)
Q Consensus       725 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  803 (871)
                      ..   ......+...|++||..... .++.++|+|++|+++|++                                    
T Consensus       147 ~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------  187 (215)
T cd00180         147 KS---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------  187 (215)
T ss_pred             cc---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------
Confidence            21   12334578899999988776 788999999999999999                                    


Q ss_pred             HHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          804 ILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                                  ..+.+++..|++.+|++||++.++++.
T Consensus       188 ----------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ----------------------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ----------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                                        135588889999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=2.7e-26  Score=234.89  Aligned_cols=200  Identities=31%  Similarity=0.466  Sum_probs=173.3

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEE
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG-ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV  639 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  639 (871)
                      |.+.+.||.|++|.||+|....+++.+|+|.+...... ..+.+.+|++.++.++|+|++++++++...     ...+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence            56788999999999999999888899999999765544 567889999999999999999999987654     568999


Q ss_pred             EeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccce
Q 002883          640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR  719 (871)
Q Consensus       640 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  719 (871)
                      +||+++++|.+++.....      .+++..+..++.+++.++.+||+.   +++|+|++|.||+++.++.++|+|||.+.
T Consensus        76 ~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~  146 (225)
T smart00221       76 MEYCEGGDLFDYLRKKGG------KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLAR  146 (225)
T ss_pred             EeccCCCCHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceee
Confidence            999999999999976541      178999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCCCccccccccccccccCcccc-cCCCCCCccchhhHHHHHHHHHhCCCCCch
Q 002883          720 LLHDNSPDQTSTSRVKGSIGYVAPEYG-ALGEVSTHGDEYSFGILMLEMFTGKRPTDD  776 (871)
Q Consensus       720 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltG~~pf~~  776 (871)
                      .......  .......++..|++||.. ....++.++|||+||+++|+|++|+.||..
T Consensus       147 ~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      147 FIHRDLA--ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             EecCccc--ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            7754321  122334578899999987 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN03210 Resistant to P

Probab=99.93  E-value=1.4e-24  Score=269.49  Aligned_cols=346  Identities=21%  Similarity=0.234  Sum_probs=210.1

Q ss_pred             cCCccccCCCcCceeeCCCCc------ccccCCccccCCc-ccceeeccCccccCCCCccccccccccccccccccccCC
Q 002883           29 NIPSELGNLFKLVGLGLTGNN------YTGSIPQSLSNLS-FLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGS  101 (871)
Q Consensus        29 ~~~~~~~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  101 (871)
                      ..+.+|.++.+|+.|.+..+.      +...+|+.|..++ +|+.|++.+|.+. .+|..| ...+|+.|++++|++. .
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~  625 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-K  625 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-c
Confidence            345678888888888886653      3335677777765 5888888888887 788877 4688888888888887 6


Q ss_pred             CCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccc-c
Q 002883          102 IPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARN-N  180 (871)
Q Consensus       102 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n-~  180 (871)
                      ++..+..+++|+.|+|++|.....+|.  ...+++|+.|+|++|...          ..+|..++.+++|+.|++++| .
T Consensus       626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L----------~~lp~si~~L~~L~~L~L~~c~~  693 (1153)
T PLN03210        626 LWDGVHSLTGLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSL----------VELPSSIQYLNKLEDLDMSRCEN  693 (1153)
T ss_pred             cccccccCCCCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCc----------cccchhhhccCCCCEEeCCCCCC
Confidence            777888888888888888765557775  236888999999887543          256677788888999999886 4


Q ss_pred             CCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccc
Q 002883          181 LGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLL  260 (871)
Q Consensus       181 l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l  260 (871)
                      ++.++.       . .++++|+.|++++|.....+|..    ..+|++|++++|.|. .+|..+ .+++|+.|++.++..
T Consensus       694 L~~Lp~-------~-i~l~sL~~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~  759 (1153)
T PLN03210        694 LEILPT-------G-INLKSLYRLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKS  759 (1153)
T ss_pred             cCccCC-------c-CCCCCCCEEeCCCCCCccccccc----cCCcCeeecCCCccc-cccccc-cccccccccccccch
Confidence            555432       1 25778888888888655455532    346888888888876 455544 567777777765432


Q ss_pred             cccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccc
Q 002883          261 TGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREV  340 (871)
Q Consensus       261 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  340 (871)
                      .. ....+..                ..+..+...++|+.|+|++|.....+|..++++++|+.|++++|..-+.+|..+
T Consensus       760 ~~-l~~~~~~----------------l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~  822 (1153)
T PLN03210        760 EK-LWERVQP----------------LTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI  822 (1153)
T ss_pred             hh-ccccccc----------------cchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC
Confidence            21 1110000                011111122344455555444433444445555555555555443222334333


Q ss_pred             cCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCC-cccccCccccCCCCCCC
Q 002883          341 IGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDN-SFQGPIHSGFSSLKGLQ  419 (871)
Q Consensus       341 ~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~  419 (871)
                       .+++|+.|++++|.....+|..   ..+|+.|+|++|.++ .+|..+..+++|+.|+|++| ++. .++..+..+++|+
T Consensus       823 -~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~  896 (1153)
T PLN03210        823 -NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLE  896 (1153)
T ss_pred             -CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCC
Confidence             4455555555554332233321   245555555555555 45555555556666666553 333 2344455555666


Q ss_pred             EEeCCCC
Q 002883          420 DLDLSRN  426 (871)
Q Consensus       420 ~L~l~~N  426 (871)
                      .+++++|
T Consensus       897 ~L~l~~C  903 (1153)
T PLN03210        897 TVDFSDC  903 (1153)
T ss_pred             eeecCCC
Confidence            6666555

syringae 6; Provisional

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=1.8e-27  Score=238.88  Aligned_cols=388  Identities=21%  Similarity=0.219  Sum_probs=270.4

Q ss_pred             cccCc-cCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCC-CcccccCCccccCCcccceeeccCccccCCCCcc
Q 002883            4 GEIPA-NITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTG-NNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSE   81 (871)
Q Consensus         4 ~~~p~-~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~   81 (871)
                      ..||+ +|++++.||.||||+|+|+.+-|++|.+|..|..|-+.+ |+|+....+.|..|..|+.|.+.-|++.-...+.
T Consensus        80 ~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~a  159 (498)
T KOG4237|consen   80 SSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDA  159 (498)
T ss_pred             ccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHH
Confidence            35664 699999999999999999999999999999999999888 9999666678999999999999999999888899


Q ss_pred             ccccccccccccccccccCCCCc-cccccCCCceeeeecccccc------------ccccccccCCCCccEEEccCccCC
Q 002883           82 LGLLKQLNMFQVSANYLTGSIPI-QLFNISSMDYFAVTQNKLVG------------EIPHYVGFTLPNIRVLLLGSNWFT  148 (871)
Q Consensus        82 ~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~------------~~~~~~~~~l~~L~~L~l~~n~i~  148 (871)
                      |..|++|..|.+-.|.+. .++. .|.++.+++.+.+..|.+..            ..|...+ .........+.++++.
T Consensus       160 l~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~iets-garc~~p~rl~~~Ri~  237 (498)
T KOG4237|consen  160 LRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETS-GARCVSPYRLYYKRIN  237 (498)
T ss_pred             HHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcc-cceecchHHHHHHHhc
Confidence            999999999999999999 5554 89999999999999987431            1111111 2222223333333333


Q ss_pred             CCCCccCcCCCCCCcc-c-cCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccc
Q 002883          149 GEIPPSISNASSIPED-L-GKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHL  226 (871)
Q Consensus       149 ~~~p~~~~~~~~lp~~-~-~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L  226 (871)
                                 +++.. | ..+..+..=-.+.+....+.+     ...|..+++|+.|+|++|+|+.+-+.+|... +.+
T Consensus       238 -----------q~~a~kf~c~~esl~s~~~~~d~~d~~cP-----~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~-a~l  300 (498)
T KOG4237|consen  238 -----------QEDARKFLCSLESLPSRLSSEDFPDSICP-----AKCFKKLPNLRKLNLSNNKITRIEDGAFEGA-AEL  300 (498)
T ss_pred             -----------ccchhhhhhhHHhHHHhhccccCcCCcCh-----HHHHhhcccceEeccCCCccchhhhhhhcch-hhh
Confidence                       12211 1 122222222222332333222     2458899999999999999997777777776 579


Q ss_pred             cEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCC-CcccCCCccccEEEccC
Q 002883          227 IYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEI-PSSLGNLIFLTEVDLQG  305 (871)
Q Consensus       227 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~  305 (871)
                      ++|+|..|+|..+....|.++..|+.|+|.+|+|+...|.+|..+..|.+|+|-.|.+-..- -.+++.       .|..
T Consensus       301 ~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~-------Wlr~  373 (498)
T KOG4237|consen  301 QELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE-------WLRK  373 (498)
T ss_pred             hhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH-------HHhh
Confidence            99999999999888888999999999999999999999999999999999999988775210 001110       0111


Q ss_pred             ccccccCcccccCCCCCCEEecCCCcCCC---CCccccc---------CCCCCcE-EeccCCCCCCCCccccCCCCCCCE
Q 002883          306 NSIRGSIPSALGNCLQLQKLDLSDNNLSG---TIPREVI---------GLSSFVL-LDLSRNHLSGPIPLEVGRLKGIQQ  372 (871)
Q Consensus       306 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~---~~~~~~~---------~l~~L~~-L~ls~N~l~~~~~~~~~~l~~L~~  372 (871)
                      +.-.+..|  -+.-..++.+.++++.+.+   ..|+...         ..+-+.+ ...|++.++ .+|..+  .....+
T Consensus       374 ~~~~~~~~--Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~i--P~d~te  448 (498)
T KOG4237|consen  374 KSVVGNPR--CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGI--PVDVTE  448 (498)
T ss_pred             CCCCCCCC--CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCC--CchhHH
Confidence            11111111  0011123344444433321   1111111         1122222 234455555 555433  245678


Q ss_pred             EeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCC
Q 002883          373 LDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRN  426 (871)
Q Consensus       373 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  426 (871)
                      |++.+|.++ .+|..  .+.+| .+++++|+|.......|.+|.+|.+|-|++|
T Consensus       449 lyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  449 LYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             Hhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            899999998 67776  56678 8999999999888888999999999998876

>PLN03210 Resistant to P

Probab=99.92  E-value=3.9e-24  Score=265.54  Aligned_cols=338  Identities=20%  Similarity=0.223  Sum_probs=222.4

Q ss_pred             Ccccccccccccccccccc------ccCCCCccccccC-CCceeeeeccccccccccccccCCCCccEEEccCccCCCCC
Q 002883           79 PSELGLLKQLNMFQVSANY------LTGSIPIQLFNIS-SMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEI  151 (871)
Q Consensus        79 ~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~  151 (871)
                      +.+|.++++|+.|.+..+.      +...+|..+..++ +|+.|.+.+|.+. .+|..+  ...+|+.|++++|.+.   
T Consensus       551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~---  624 (1153)
T PLN03210        551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLE---  624 (1153)
T ss_pred             HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--CccCCcEEECcCcccc---
Confidence            3456677777777775543      2234566666554 5777777777765 666554  4677778888877776   


Q ss_pred             CccCcCCCCCCccccCCCcccEEeccccc-CCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEE
Q 002883          152 PPSISNASSIPEDLGKLKNLIRLNFARNN-LGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLY  230 (871)
Q Consensus       152 p~~~~~~~~lp~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~  230 (871)
                              .+|+.+..+++|+.|+|++|+ ++.+        +.+..+++|++|+|++|.....+|..+..+ .+|+.|+
T Consensus       625 --------~L~~~~~~l~~Lk~L~Ls~~~~l~~i--------p~ls~l~~Le~L~L~~c~~L~~lp~si~~L-~~L~~L~  687 (1153)
T PLN03210        625 --------KLWDGVHSLTGLRNIDLRGSKNLKEI--------PDLSMATNLETLKLSDCSSLVELPSSIQYL-NKLEDLD  687 (1153)
T ss_pred             --------ccccccccCCCCCEEECCCCCCcCcC--------CccccCCcccEEEecCCCCccccchhhhcc-CCCCEEe
Confidence                    566667777788888887664 4332        335667778888888776555677777766 3588888


Q ss_pred             ccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCcccc-
Q 002883          231 MSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIR-  309 (871)
Q Consensus       231 L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~-  309 (871)
                      +++|.....+|..+ ++++|+.|++++|......|..   ..+|+.|+|++|.+. .+|..+ .+++|++|++.++... 
T Consensus       688 L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~  761 (1153)
T PLN03210        688 MSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEK  761 (1153)
T ss_pred             CCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhh
Confidence            88764433556554 6778888888877654444432   356778888888876 455544 5677777777664322 


Q ss_pred             ------ccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCC
Q 002883          310 ------GSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGE  383 (871)
Q Consensus       310 ------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  383 (871)
                            ...+..+...++|+.|+|++|.....+|..+.++++|+.|++++|.....+|..+ .+++|+.|++++|.....
T Consensus       762 l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~  840 (1153)
T PLN03210        762 LWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRT  840 (1153)
T ss_pred             ccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccc
Confidence                  1112222334677888888876666777777788888888887765433566555 577788888887654434


Q ss_pred             CccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCC-cCCCCCcccccccccccEEecCCCc
Q 002883          384 IPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRN-NFSGKIPMFLNTFRFLQKLNLSFNN  451 (871)
Q Consensus       384 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~~~~L~~L~l~~N~  451 (871)
                      +|..   ..+|++|+|++|.|+ ..|..+..+++|+.|+|++| +++ .+|..+..+++|+.+++++|.
T Consensus       841 ~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        841 FPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             cccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            4443   256777888888777 45666777778888888773 444 566667777777777777764

syringae 6; Provisional

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=1.5e-24  Score=212.63  Aligned_cols=170  Identities=19%  Similarity=0.224  Sum_probs=128.6

Q ss_pred             CCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCCCC
Q 002883          646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNS  725 (871)
Q Consensus       646 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  725 (871)
                      |+|.+++...+.      .+++.+++.++.|++.||+|||+.   +      ||+||+++.++.+|+  ||.+.......
T Consensus         1 GsL~~~l~~~~~------~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~   63 (176)
T smart00750        1 VSLADILEVRGR------PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ   63 (176)
T ss_pred             CcHHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc
Confidence            689999976432      599999999999999999999998   5      999999999999999  99998764321


Q ss_pred             CCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHH
Q 002883          726 PDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAIL  805 (871)
Q Consensus       726 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  805 (871)
                              ..||+.|+|||++.+..+++++|||||||++|||+||+.||..................+..          
T Consensus        64 --------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  125 (176)
T smart00750       64 --------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD----------  125 (176)
T ss_pred             --------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC----------
Confidence                    25889999999999999999999999999999999999999753222111111111100000          


Q ss_pred             HHHHHHHhhhhhhcCchhHHhHHHHH--HHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          806 EEALEIQAGIVKELQPNLRAKFHEIQ--VSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       806 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                                     +..........  .++.+++.+|+..+|++|||+.|+++.+..+...
T Consensus       126 ---------------~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      126 ---------------PRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             ---------------ccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence                           00000111222  2588999999999999999999999999877544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=4.5e-25  Score=266.18  Aligned_cols=202  Identities=15%  Similarity=0.199  Sum_probs=139.1

Q ss_pred             cCCC-CccceeeeeecccCcC--CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 002883          612 SIRH-RNLVKIITSCSSIDTR--GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC  688 (871)
Q Consensus       612 ~l~h-~niv~~~~~~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~  688 (871)
                      .++| +||++++++|......  ....++.++|++ +++|.+++....      ..+++.+++.++.||++||+|||++ 
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~-   99 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD------RSVDAFECFHVFRQIVEIVNAAHSQ-   99 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc------ccccHHHHHHHHHHHHHHHHHHHhC-
Confidence            3455 6888888887433221  224567888987 679999997532      2589999999999999999999999 


Q ss_pred             CCCeEecCCCCCceeeCCCC-------------------ceEEeecccceecCCCCC-------------Cccccccccc
Q 002883          689 HTSIVHCDLKPSNVLLDNEM-------------------VAHVGDFGLSRLLHDNSP-------------DQTSTSRVKG  736 (871)
Q Consensus       689 ~~~ivH~Dlkp~Nill~~~~-------------------~~kl~Dfg~a~~~~~~~~-------------~~~~~~~~~g  736 (871)
                        ||+||||||+|||++..+                   .+|++|||+++.......             .........|
T Consensus       100 --gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  177 (793)
T PLN00181        100 --GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME  177 (793)
T ss_pred             --CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence              999999999999996544                   455666666543211000             0000112357


Q ss_pred             cccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhh
Q 002883          737 SIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIV  816 (871)
Q Consensus       737 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (871)
                      |+.|||||++.+..++.++|||||||++|||++|..|+......   .........++        ..            
T Consensus       178 t~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~---~~~~~~~~~~~--------~~------------  234 (793)
T PLN00181        178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT---MSSLRHRVLPP--------QI------------  234 (793)
T ss_pred             CcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH---HHHHHHhhcCh--------hh------------
Confidence            88999999999999999999999999999999999887632111   00000000000        00            


Q ss_pred             hhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          817 KELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       817 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                 .....+..+++.+||+.+|.+|||+.|+++
T Consensus       235 -----------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        235 -----------LLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             -----------hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence                       001122346778899999999999999976

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.91  E-value=2.1e-24  Score=247.66  Aligned_cols=265  Identities=26%  Similarity=0.297  Sum_probs=157.8

Q ss_pred             CCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCcccccccccccccccc
Q 002883           16 LRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSA   95 (871)
Q Consensus        16 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~   95 (871)
                      -..|||+.|+++ .+|..+..  +|+.|+|++|+++ .+|..   .++|++|+|++|+|+ .+|..   .++|+.|+|++
T Consensus       203 ~~~LdLs~~~Lt-sLP~~l~~--~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~  271 (788)
T PRK15387        203 NAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS  271 (788)
T ss_pred             CcEEEcCCCCCC-cCCcchhc--CCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence            445666666666 45555542  5666666666666 44432   355666666666665 44432   24455555555


Q ss_pred             ccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEe
Q 002883           96 NYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLN  175 (871)
Q Consensus        96 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~  175 (871)
                      |.++ .+|..                            ..+|+.|++++|+|+           .+|..   +++|+.|+
T Consensus       272 N~L~-~Lp~l----------------------------p~~L~~L~Ls~N~Lt-----------~LP~~---p~~L~~Ld  308 (788)
T PRK15387        272 NPLT-HLPAL----------------------------PSGLCKLWIFGNQLT-----------SLPVL---PPGLQELS  308 (788)
T ss_pred             Cchh-hhhhc----------------------------hhhcCEEECcCCccc-----------ccccc---ccccceeE
Confidence            5555 33321                            134455555555554           22221   23455555


Q ss_pred             cccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeec
Q 002883          176 FARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAM  255 (871)
Q Consensus       176 l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l  255 (871)
                      +++|+|+.++..          ..+|+.|++++|.++ .+|.    +..+|+.|+|++|+|+. +|..   .++|+.|++
T Consensus       309 LS~N~L~~Lp~l----------p~~L~~L~Ls~N~L~-~LP~----lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~L  369 (788)
T PRK15387        309 VSDNQLASLPAL----------PSELCKLWAYNNQLT-SLPT----LPSGLQELSVSDNQLAS-LPTL---PSELYKLWA  369 (788)
T ss_pred             CCCCccccCCCC----------cccccccccccCccc-cccc----cccccceEecCCCccCC-CCCC---Ccccceehh
Confidence            555555543320          123555666666665 3342    22356667777766663 3432   245666677


Q ss_pred             ccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCC
Q 002883          256 EVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGT  335 (871)
Q Consensus       256 ~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~  335 (871)
                      ++|+|+. +|..   ..+|+.|+|++|+|+ .+|..   .++|+.|++++|+|+. +|..+   .+|+.|++++|+|+ .
T Consensus       370 s~N~L~~-LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~  436 (788)
T PRK15387        370 YNNRLTS-LPAL---PSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-R  436 (788)
T ss_pred             hcccccc-Cccc---ccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-c
Confidence            7777763 4432   246788888888887 35543   2568888888888884 55432   46788899999998 7


Q ss_pred             CcccccCCCCCcEEeccCCCCCCCCccccCC
Q 002883          336 IPREVIGLSSFVLLDLSRNHLSGPIPLEVGR  366 (871)
Q Consensus       336 ~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~  366 (871)
                      +|..+..+++|+.|+|++|+|++..+..+..
T Consensus       437 LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~  467 (788)
T PRK15387        437 LPESLIHLSSETTVNLEGNPLSERTLQALRE  467 (788)
T ss_pred             cChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence            7888888999999999999998766665533

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.91  E-value=2.6e-24  Score=246.92  Aligned_cols=264  Identities=26%  Similarity=0.349  Sum_probs=192.1

Q ss_pred             eeeccCccccCCCCccccccccccccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCc
Q 002883           66 QLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSN  145 (871)
Q Consensus        66 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n  145 (871)
                      .|+|++|.++ .+|..+.  ++|+.|++++|+++ .+|.   ..++|++|++++|+++ .+|..    .++|+.|+|++|
T Consensus       205 ~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l----p~sL~~L~Ls~N  272 (788)
T PRK15387        205 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL----PPGLLELSIFSN  272 (788)
T ss_pred             EEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCc----ccccceeeccCC
Confidence            3444444444 3444332  23444444444444 2332   1345666666666665 45542    367889999999


Q ss_pred             cCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhcccc
Q 002883          146 WFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSH  225 (871)
Q Consensus       146 ~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~  225 (871)
                      .|+           .+|..   .++|+.|++++|+++.++.          ..++|+.|+|++|++++ +|.    +..+
T Consensus       273 ~L~-----------~Lp~l---p~~L~~L~Ls~N~Lt~LP~----------~p~~L~~LdLS~N~L~~-Lp~----lp~~  323 (788)
T PRK15387        273 PLT-----------HLPAL---PSGLCKLWIFGNQLTSLPV----------LPPGLQELSVSDNQLAS-LPA----LPSE  323 (788)
T ss_pred             chh-----------hhhhc---hhhcCEEECcCCccccccc----------cccccceeECCCCcccc-CCC----Cccc
Confidence            887           44442   2568899999999998653          13679999999999984 554    2346


Q ss_pred             ccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccC
Q 002883          226 LIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQG  305 (871)
Q Consensus       226 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  305 (871)
                      |+.|++++|+|+. +|..   ..+|+.|+|++|+|++ +|..   ..+|+.|++++|+|+ .+|..   ..+|+.|+|++
T Consensus       324 L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~  391 (788)
T PRK15387        324 LCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSG  391 (788)
T ss_pred             ccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc---ccccceEEecC
Confidence            9999999999984 5542   2589999999999994 5543   357899999999999 46653   35799999999


Q ss_pred             ccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCc
Q 002883          306 NSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIP  385 (871)
Q Consensus       306 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  385 (871)
                      |+|++ +|..   .++|+.|++++|+|+ .+|..   ..+|+.|++++|+|+ .+|..+..+++|+.|+|++|++++..+
T Consensus       392 N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~  462 (788)
T PRK15387        392 NRLTS-LPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL  462 (788)
T ss_pred             CcccC-CCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHH
Confidence            99994 5543   368999999999998 56653   357889999999999 789999999999999999999998777


Q ss_pred             cchhcc
Q 002883          386 TSLASC  391 (871)
Q Consensus       386 ~~~~~l  391 (871)
                      ..+..+
T Consensus       463 ~~L~~l  468 (788)
T PRK15387        463 QALREI  468 (788)
T ss_pred             HHHHHH
Confidence            766443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=1.7e-23  Score=222.72  Aligned_cols=172  Identities=19%  Similarity=0.159  Sum_probs=132.4

Q ss_pred             HHHHhhcCCCCCceeeccccceEEEEEECC-CCcEEEEEEeecc-----ccchHHHHHHHHHHHHcCCCCccceeeeeec
Q 002883          553 ELLKATEGFSSANLIGIGGYGYVYKGILGT-EETNVAVKVLDLQ-----QRGASKSFIAECEALRSIRHRNLVKIITSCS  626 (871)
Q Consensus       553 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  626 (871)
                      ......++|++.+.||+|+||+||+|++.. +++.||||+....     .......+.+|++++++++|+++++.+..+ 
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-   90 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-   90 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence            344456789999999999999999999875 6777899987432     122346789999999999999998543321 


Q ss_pred             ccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCceeeC
Q 002883          627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL-KPSNVLLD  705 (871)
Q Consensus       627 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~Nill~  705 (871)
                             ...|+||||++|++|.. +..          ..   ...++.|+++||.|||+.   ||+|||| ||+||+++
T Consensus        91 -------~~~~LVmE~~~G~~L~~-~~~----------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~  146 (365)
T PRK09188         91 -------GKDGLVRGWTEGVPLHL-ARP----------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMG  146 (365)
T ss_pred             -------CCcEEEEEccCCCCHHH-hCc----------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEc
Confidence                   23699999999999973 211          11   146788999999999999   9999999 99999999


Q ss_pred             CCCceEEeecccceecCCCCCCccc-----cccccccccccCcccccCC
Q 002883          706 NEMVAHVGDFGLSRLLHDNSPDQTS-----TSRVKGSIGYVAPEYGALG  749 (871)
Q Consensus       706 ~~~~~kl~Dfg~a~~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~  749 (871)
                      .++.+||+|||+|+.+.........     .....+++.|+|||++...
T Consensus       147 ~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        147 PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999999999999987654322111     1345688899999986543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=7.1e-22  Score=212.34  Aligned_cols=205  Identities=23%  Similarity=0.345  Sum_probs=166.0

Q ss_pred             CCCCCceeeccccceEEEEEECCCC-cEEEEEEeeccccchHHHHHHHHHHHHcCCC----CccceeeeeecccCcCCCc
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEE-TNVAVKVLDLQQRGASKSFIAECEALRSIRH----RNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~  634 (871)
                      +|.+.+.||+|+||.||.|.+..++ ..+|+|+...........+..|+.++..+..    +++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            8999999999999999999997664 6789998865433322367889999988862    57888887753    2236


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-----Cc
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE-----MV  709 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~  709 (871)
                      +.|+||+.+ |.+|.++.......     .++...+..++.|++.+|+++|+.   |++||||||+|+++...     ..
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~~~-----~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~  165 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNPPG-----RFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRT  165 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCCCC-----CcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccce
Confidence            789999988 88999988665422     699999999999999999999999   99999999999999754     46


Q ss_pred             eEEeecccce--ecCCCCCC-----ccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          710 AHVGDFGLSR--LLHDNSPD-----QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       710 ~kl~Dfg~a~--~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      +.+.|||+|+  .+......     ........||..|+++....+...+.+.|+||++.++.++..|..||...
T Consensus       166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~  240 (322)
T KOG1164|consen  166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL  240 (322)
T ss_pred             EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence            9999999998  33222111     11123356999999999999999999999999999999999999999653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=3.3e-22  Score=188.21  Aligned_cols=206  Identities=22%  Similarity=0.331  Sum_probs=169.0

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCC-CccceeeeeecccCcCCCce
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRH-RNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~  635 (871)
                      ..+.|.++++||.|+||.+|.|..-.+|+.||||+-+....  ..++..|..+.+.+++ ..|..+..+..+.     .+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~-----~y   85 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEK-----DY   85 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhcccc-----cc
Confidence            34689999999999999999999999999999999754433  3567789999999864 5566665554433     56


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEE
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN---EMVAHV  712 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl  712 (871)
                      -.+|||.. |.+|++...-...      .++..+++-++-|++.-++|+|.+   +++||||||+|+|..-   ...+.+
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~R------~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~L  155 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCSR------RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYL  155 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHhh------hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEE
Confidence            78999998 8899998876543      599999999999999999999999   9999999999999963   346899


Q ss_pred             eecccceecCCCCCCcc----ccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhh
Q 002883          713 GDFGLSRLLHDNSPDQT----STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFE  779 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  779 (871)
                      +|||+|+.+.+......    ......||..|.+-....+...+.+.|+-|+|.++.+..-|..||++...
T Consensus       156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            99999998765432221    22345699999998887777788999999999999999999999997543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.1e-21  Score=193.35  Aligned_cols=203  Identities=19%  Similarity=0.329  Sum_probs=172.1

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      -+|.++++||+|+||.+|.|+.--+++.||||.-....  ...++..|.+.++.+ ..+.|..+|.+-.     .+.+-.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGq-----eG~~Ni  100 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQ-----EGKYNI  100 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeecc-----ccchhh
Confidence            47999999999999999999998899999999864332  346788899999998 5789998886633     336678


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-----CceEE
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE-----MVAHV  712 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~kl  712 (871)
                      +|+|.. |.+|+|...-.+.      .++...+..+|.|++.-++|+|++   .+|.|||||+|+||...     ..+.+
T Consensus       101 LVidLL-GPSLEDLFD~CgR------~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihi  170 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGR------RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHI  170 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcC------cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEE
Confidence            999999 8899999877654      599999999999999999999999   99999999999999644     36899


Q ss_pred             eecccceecCCCCCCcc----ccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhh
Q 002883          713 GDFGLSRLLHDNSPDQT----STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMF  778 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  778 (871)
                      +|||+|+.+.+......    ......||.+||+-....+.+.+.+.|+-|+|-|+++.+-|..||.+..
T Consensus       171 iDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  171 IDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             EeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            99999998876543322    1233469999999999999999999999999999999999999998753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=7.1e-23  Score=232.90  Aligned_cols=257  Identities=19%  Similarity=0.239  Sum_probs=189.6

Q ss_pred             CCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccc----hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          562 SSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRG----ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       562 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ...+++|.|++|.|+.+......+.++.|.+...  ...    ....+..|+-+-..+.|||++..+..+.+...     
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence            3567899999998888888766666666655311  111    11225567777778899999888877666522     


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .+-+||||++ +|..++....       .+...++..++.|++.|++|+|+.   ||.|||+|++|++++.+|.+||+||
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~~-------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Df  464 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSNG-------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDF  464 (601)
T ss_pred             chhhhhcccH-HHHHHHhccc-------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeec
Confidence            3344999999 9999998753       488899999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCC-CCccccccccccccccCcccccCCCCCC-ccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          716 GLSRLLHDNS-PDQTSTSRVKGSIGYVAPEYGALGEVST-HGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       716 g~a~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |.+....-.. .........+|+..|+|||++.+..|.+ ..||||.|++++.|.+|+.||......+....   .....
T Consensus       465 g~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---~~~~~  541 (601)
T KOG0590|consen  465 GAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---TNNYS  541 (601)
T ss_pred             CcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---hhccc
Confidence            9997654321 1224455678999999999999999975 47999999999999999999986543332220   00000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .+.                     ........-....+.+-..++.+|+++||.+|.|+++|++.
T Consensus       542 ~~~---------------------~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  542 DQR---------------------NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ccc---------------------ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            000                     00011112223455567789999999999999999999863

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=5.9e-23  Score=196.15  Aligned_cols=248  Identities=22%  Similarity=0.333  Sum_probs=185.5

Q ss_pred             CCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEE
Q 002883          562 SSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV  639 (871)
Q Consensus       562 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  639 (871)
                      ....+|.+...|..|+|+|.  |..+++|++....-  ...++|..|.-.++.+.||||..+++.|.+.     .+..++
T Consensus       193 nl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~i  265 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVII  265 (448)
T ss_pred             hhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEe
Confidence            34556888999999999996  55677888754432  2346889999999999999999999999876     668899


Q ss_pred             EeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe--eccc
Q 002883          640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG--DFGL  717 (871)
Q Consensus       640 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~--Dfg~  717 (871)
                      ..||+.|+|+..+......     ..+..++.+++.++|+|++|||+.. +-|.---+.+..+++|++.+++|+  |--+
T Consensus       266 sq~mp~gslynvlhe~t~v-----vvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kf  339 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTSV-----VVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKF  339 (448)
T ss_pred             eeeccchHHHHHHhcCccE-----EEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheeccccee
Confidence            9999999999999876543     6788899999999999999999973 123334688999999999988874  3222


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCC---CCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV---STHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      +-          ......-.+.||+||.+...+-   -.++|+|||++++||+.|...||.+....+.-+...       
T Consensus       340 sf----------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-------  402 (448)
T KOG0195|consen  340 SF----------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-------  402 (448)
T ss_pred             ee----------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-------
Confidence            21          1111234689999998876654   467899999999999999999998754332211110       


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                                       .+++...++|.       +...+.+++.-|+..||.+||..+.++-.|+++.
T Consensus       403 -----------------leglrv~ippg-------is~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  403 -----------------LEGLRVHIPPG-------ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -----------------hccccccCCCC-------ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                             11122222222       2334567888899999999999999999998764

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.87  E-value=1.7e-22  Score=233.88  Aligned_cols=246  Identities=23%  Similarity=0.359  Sum_probs=136.6

Q ss_pred             CCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccccc
Q 002883           15 ELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVS   94 (871)
Q Consensus        15 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~   94 (871)
                      +.+.|++++++++ .+|..+.  .+|+.|+|++|+|+ .+|..+.  .+|++|+|++|+++ .+|..+.  .+|+.|+|+
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls  249 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS  249 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence            4566777777776 4565553  35677777777776 4555443  46777777777766 5555442  356666666


Q ss_pred             cccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEE
Q 002883           95 ANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRL  174 (871)
Q Consensus        95 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L  174 (871)
                      +|.+. .+|..+.  ++|+.|++++|++. .+|..+.   ++                                  |+.|
T Consensus       250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~---~s----------------------------------L~~L  288 (754)
T PRK15370        250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP---EE----------------------------------LRYL  288 (754)
T ss_pred             CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC---CC----------------------------------CcEE
Confidence            66665 4444332  24555555555544 3443322   24                                  4455


Q ss_pred             ecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceee
Q 002883          175 NFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIA  254 (871)
Q Consensus       175 ~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~  254 (871)
                      ++++|+|+.++..       +  .++|+.|++++|+++ .+|..+.   ++|+.|++++|.++. +|..+.  ++|+.|+
T Consensus       289 ~Ls~N~Lt~LP~~-------l--p~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~  352 (754)
T PRK15370        289 SVYDNSIRTLPAH-------L--PSGITHLNVQSNSLT-ALPETLP---PGLKTLEAGENALTS-LPASLP--PELQVLD  352 (754)
T ss_pred             ECCCCccccCccc-------c--hhhHHHHHhcCCccc-cCCcccc---ccceeccccCCcccc-CChhhc--CcccEEE
Confidence            5555544443311       1  024555555555555 3343322   345666666666553 343332  4566666


Q ss_pred             cccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccc----cCCCCCCEEecCCC
Q 002883          255 MEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSAL----GNCLQLQKLDLSDN  330 (871)
Q Consensus       255 l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~----~~l~~L~~L~L~~N  330 (871)
                      +++|+|+ .+|..+  .++|+.|+|++|+|+ .+|..+.  ..|+.|++++|+|+ .+|..+    ..++++..|++.+|
T Consensus       353 Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~N  425 (754)
T PRK15370        353 VSKNQIT-VLPETL--PPTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYN  425 (754)
T ss_pred             CCCCCCC-cCChhh--cCCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCC
Confidence            6666665 344433  246777777777776 3444433  25777777777776 444433    34467778888888


Q ss_pred             cCC
Q 002883          331 NLS  333 (871)
Q Consensus       331 ~l~  333 (871)
                      .++
T Consensus       426 pls  428 (754)
T PRK15370        426 PFS  428 (754)
T ss_pred             Ccc
Confidence            876

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.86  E-value=4.4e-22  Score=230.48  Aligned_cols=266  Identities=24%  Similarity=0.364  Sum_probs=162.6

Q ss_pred             CccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccC
Q 002883          136 NIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVL  215 (871)
Q Consensus       136 ~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~  215 (871)
                      +.+.|+++++.++           .+|..+.  ++|+.|+|++|+|+.++..       +  .++|++|+|++|+++ .+
T Consensus       179 ~~~~L~L~~~~Lt-----------sLP~~Ip--~~L~~L~Ls~N~LtsLP~~-------l--~~nL~~L~Ls~N~Lt-sL  235 (754)
T PRK15370        179 NKTELRLKILGLT-----------TIPACIP--EQITTLILDNNELKSLPEN-------L--QGNIKTLYANSNQLT-SI  235 (754)
T ss_pred             CceEEEeCCCCcC-----------cCCcccc--cCCcEEEecCCCCCcCChh-------h--ccCCCEEECCCCccc-cC
Confidence            4455666665555           3333332  3456666666666654421       1  135666666666665 44


Q ss_pred             ChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCC
Q 002883          216 PNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNL  295 (871)
Q Consensus       216 ~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  295 (871)
                      |..+.   .+|+.|+|++|++. .+|..+.  ++|+.|++++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.  
T Consensus       236 P~~l~---~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--  303 (754)
T PRK15370        236 PATLP---DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--  303 (754)
T ss_pred             Chhhh---ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--
Confidence            55443   24666666666666 4444443  35666777777666 3455443  46777777777777 3444332  


Q ss_pred             ccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeC
Q 002883          296 IFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDL  375 (871)
Q Consensus       296 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L  375 (871)
                      ++|+.|++++|+++. +|..+.  ++|+.|++++|.++ .+|..+.  ++|+.|++++|+|+ .+|..+  .++|+.|+|
T Consensus       304 ~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdL  374 (754)
T PRK15370        304 SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT-VLPETL--PPTITTLDV  374 (754)
T ss_pred             hhHHHHHhcCCcccc-CCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCC-cCChhh--cCCcCEEEC
Confidence            367777788887773 444332  57788888888887 4565553  67888888888887 456544  357888888


Q ss_pred             CCCcCCCCCccchhcccCCceeeecCCcccccC---ccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcC
Q 002883          376 SENKLSGEIPTSLASCVGLEYLNFSDNSFQGPI---HSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNL  452 (871)
Q Consensus       376 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l  452 (871)
                      ++|+|+ .+|..+.  .+|+.|++++|+|++.+   +..+..++++..|++.+|.++.      ..+++|+.| ++.+.+
T Consensus       375 s~N~Lt-~LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~  444 (754)
T PRK15370        375 SRNALT-NLPENLP--AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGY  444 (754)
T ss_pred             CCCcCC-CCCHhHH--HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccc
Confidence            888888 4565554  36888888888887432   2233445778888888888872      344455555 444555


Q ss_pred             ccc
Q 002883          453 EGE  455 (871)
Q Consensus       453 ~~~  455 (871)
                      .|.
T Consensus       445 ~gp  447 (754)
T PRK15370        445 QGP  447 (754)
T ss_pred             cCC
Confidence            543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=7.1e-20  Score=200.25  Aligned_cols=261  Identities=28%  Similarity=0.374  Sum_probs=194.2

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHcCCCC-ccceeeeeecccCcCCCcee
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG---ASKSFIAECEALRSIRHR-NLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~  636 (871)
                      |.+.+.+|.|+||.||++.+.   ..+++|.+......   ....+.+|+.+++.+.|+ +++++++.+...     ...
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEE
Confidence            678899999999999999997   77999998544332   357789999999999888 799999998443     337


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEEeec
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM-VAHVGDF  715 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Df  715 (871)
                      +++++++.++++.+++......    ..++......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++||
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~df  146 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK----GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDF  146 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEecc
Confidence            9999999999999777654311    2488999999999999999999999   999999999999999988 7999999


Q ss_pred             ccceecCCCCCCcc---ccccccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCchhhhh--hhhHHHH
Q 002883          716 GLSRLLHDNSPDQT---STSRVKGSIGYVAPEYGAL---GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEE--GLSLHKY  787 (871)
Q Consensus       716 g~a~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltG~~pf~~~~~~--~~~~~~~  787 (871)
                      |.+...........   ......|+..|+|||...+   ..++...|+||+|++++++++|..||......  .......
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~  226 (384)
T COG0515         147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI  226 (384)
T ss_pred             CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence            99986554322211   2355679999999999877   57889999999999999999999997654321  1111111


Q ss_pred             hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ..............                   ....   ......+.+++..|+..+|..|.++.+....
T Consensus       227 ~~~~~~~~~~~~~~-------------------~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         227 ILELPTPSLASPLS-------------------PSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHhcCCcccccccC-------------------cccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            11110000000000                   0000   1223456688888888999999998887664

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=3.1e-21  Score=190.27  Aligned_cols=175  Identities=11%  Similarity=0.098  Sum_probs=133.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHH---H------HHHHHHHHHcCCCCccceeeeeeccc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASK---S------FIAECEALRSIRHRNLVKIITSCSSI  628 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~~~~~~~~~  628 (871)
                      .++|.+.+.+|.|+||.||++..  ++..+|+|+++.......+   .      +.+|+..+.++.|++|..+.+++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            57899999999999999999766  4668999999654332222   2      67899999999999999999886543


Q ss_pred             CcC---CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC
Q 002883          629 DTR---GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD  705 (871)
Q Consensus       629 ~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  705 (871)
                      ...   .....++||||++|.+|.++..           .+.    ....+++.++..+|+.   |++|||++|+||+++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~  169 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS  169 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence            221   1245789999999999988732           222    2456999999999999   999999999999999


Q ss_pred             CCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHH
Q 002883          706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMF  768 (871)
Q Consensus       706 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  768 (871)
                      .++ ++++|||......+...    .           ..+.....+..++|+||||+++....
T Consensus       170 ~~g-i~liDfg~~~~~~e~~a----~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        170 KNG-LRIIDLSGKRCTAQRKA----K-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCC-EEEEECCCcccccchhh----H-----------HHHHHHhHhcccccccceeEeehHHH
Confidence            988 99999998875432110    0           01334455677899999999876654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.84  E-value=5.1e-21  Score=194.50  Aligned_cols=242  Identities=19%  Similarity=0.259  Sum_probs=150.2

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCC----------Cccceeeeeecc
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRH----------RNLVKIITSCSS  627 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~~  627 (871)
                      +...+.||.|+++.||.+++..+++.+|+|++....   ....+.+.+|.-....+.+          -.++..++....
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            456789999999999999999999999999984332   2234566666644444321          122222221110


Q ss_pred             c-------CcCCCc-----eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 002883          628 I-------DTRGNE-----FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC  695 (871)
Q Consensus       628 ~-------~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  695 (871)
                      .       ...+..     ..+++|+-+ .++|.+++..-.................+..|+++.+++||+.   |+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence            0       001011     236788877 6799888754222111111234455567779999999999999   99999


Q ss_pred             CCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccC--------CCCCCccchhhHHHHHHHH
Q 002883          696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL--------GEVSTHGDEYSFGILMLEM  767 (871)
Q Consensus       696 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el  767 (871)
                      ||+|+|++++.+|.++|+||+.....+..      ......+..|.+||....        -.++.+.|.|++|+++|.|
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEE------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCce------eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            99999999999999999999988765321      111345678999996432        2578899999999999999


Q ss_pred             HhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCC
Q 002883          768 FTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPR  847 (871)
Q Consensus       768 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  847 (871)
                      ++|+.||...........            + +                        ....+.++.+..||+.+|+.+|+
T Consensus       244 WC~~lPf~~~~~~~~~~~------------~-f------------------------~~C~~~Pe~v~~LI~~lL~~~~~  286 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW------------D-F------------------------SRCRDMPEPVQFLIRGLLQRNPE  286 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG------------G-G------------------------TTSS---HHHHHHHHHHT-SSGG
T ss_pred             HHccCCCCCCCccccccc------------c-c------------------------hhcCCcCHHHHHHHHHHccCCcc
Confidence            999999985432211100            0 0                        01114556788999999999999


Q ss_pred             CC
Q 002883          848 DR  849 (871)
Q Consensus       848 ~R  849 (871)
                      +|
T Consensus       287 ~R  288 (288)
T PF14531_consen  287 DR  288 (288)
T ss_dssp             GS
T ss_pred             cC
Confidence            88

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=1.2e-21  Score=220.29  Aligned_cols=248  Identities=20%  Similarity=0.224  Sum_probs=179.3

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chH---HHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GAS---KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .|...+.+|++.|=.|.+|++. .|. |+||++-...+ -..   .+..+|++ ...++|||++++.-+....     ..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~-----kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD-----KA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh-----HH
Confidence            5777889999999999999997 454 99999954432 222   33334444 4556899999987664443     55


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+|-+|+ .-+|.|.+...       |-+...+.+.|+.|++.|+..+|..   ||+|||||.+|||++.-.-+.|+||
T Consensus        96 AylvRqyv-khnLyDRlSTR-------PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDF  164 (1431)
T KOG1240|consen   96 AYLVRQYV-KHNLYDRLSTR-------PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDF  164 (1431)
T ss_pred             HHHHHHHH-hhhhhhhhccc-------hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcc
Confidence            68888988 44899988763       4688889999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccc----cccccccccccCcccccC----------CC-CCCccchhhHHHHHHHHHh-CCCCCchhhh
Q 002883          716 GLSRLLHDNSPDQTS----TSRVKGSIGYVAPEYGAL----------GE-VSTHGDEYSFGILMLEMFT-GKRPTDDMFE  779 (871)
Q Consensus       716 g~a~~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~----------~~-~~~~~DiwSlG~il~ellt-G~~pf~~~~~  779 (871)
                      ..-+...-..+....    ......-..|.|||.+..          .+ .+++.||||+||++.|+++ |++||.-.  
T Consensus       165 AsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--  242 (1431)
T KOG1240|consen  165 ASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--  242 (1431)
T ss_pred             cccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--
Confidence            887654321111111    122223457999996433          12 5788999999999999999 89998732  


Q ss_pred             hhhhHHHHhhhC--CCch-hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHH
Q 002883          780 EGLSLHKYAKMG--LPDQ-VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAI  856 (871)
Q Consensus       780 ~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl  856 (871)
                         ++..|....  .++. ..++-|                              ..+.+++..|++.||++|.+|++.+
T Consensus       243 ---QL~aYr~~~~~~~e~~Le~Ied------------------------------~~~Rnlil~Mi~rdPs~RlSAedyL  289 (1431)
T KOG1240|consen  243 ---QLLAYRSGNADDPEQLLEKIED------------------------------VSLRNLILSMIQRDPSKRLSAEDYL  289 (1431)
T ss_pred             ---HHHhHhccCccCHHHHHHhCcC------------------------------ccHHHHHHHHHccCchhccCHHHHH
Confidence               222222221  1111 111111                              1466899999999999999999999


Q ss_pred             HHHHH
Q 002883          857 MELQE  861 (871)
Q Consensus       857 ~~L~~  861 (871)
                      +..+.
T Consensus       290 ~~yrG  294 (1431)
T KOG1240|consen  290 QKYRG  294 (1431)
T ss_pred             Hhhhc
Confidence            98553

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=2.1e-20  Score=183.45  Aligned_cols=140  Identities=16%  Similarity=0.133  Sum_probs=108.4

Q ss_pred             CceeeccccceEEEEEECCCCcEEEEEEeeccccc--h------------------------HHHHHHHHHHHHcCCCCc
Q 002883          564 ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG--A------------------------SKSFIAECEALRSIRHRN  617 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~n  617 (871)
                      ...||+|+||.||+|.+. +|+.||||+++.....  .                        .....+|++.++++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999997 8999999999654211  0                        012245999999998777


Q ss_pred             cceeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEecC
Q 002883          618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL-HHHCHTSIVHCD  696 (871)
Q Consensus       618 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~D  696 (871)
                      +.....+..       ...++||||++|+++........       .++...+..++.|++.+|.|+ |+.   ||+|||
T Consensus        81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~-------~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrD  143 (190)
T cd05147          81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDA-------PLSESKARELYLQVIQIMRILYQDC---RLVHAD  143 (190)
T ss_pred             CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            644332211       12379999999887765433222       588999999999999999999 688   999999


Q ss_pred             CCCCceeeCCCCceEEeecccceecC
Q 002883          697 LKPSNVLLDNEMVAHVGDFGLSRLLH  722 (871)
Q Consensus       697 lkp~Nill~~~~~~kl~Dfg~a~~~~  722 (871)
                      |||+||+++ ++.++|+|||+|....
T Consensus       144 lkP~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         144 LSEYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCHHHEEEE-CCcEEEEEccccccCC
Confidence            999999998 4789999999997643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=3.1e-20  Score=187.01  Aligned_cols=204  Identities=22%  Similarity=0.248  Sum_probs=142.6

Q ss_pred             CCCccceeeeeecccCc----------------------CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHH
Q 002883          614 RHRNLVKIITSCSSIDT----------------------RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRL  671 (871)
Q Consensus       614 ~h~niv~~~~~~~~~~~----------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~  671 (871)
                      +|||||++.++|.+.-.                      ..+...|+||..+ ..+|.+|+....        .+.....
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~--------~s~r~~~  344 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH--------RSYRTGR  344 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC--------CchHHHH
Confidence            59999999988744211                      2235679999988 559999997654        5666778


Q ss_pred             HHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC--CC--CceEEeecccceecCC---CCCCccccccccccccccCcc
Q 002883          672 SIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD--NE--MVAHVGDFGLSRLLHD---NSPDQTSTSRVKGSIGYVAPE  744 (871)
Q Consensus       672 ~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~--~~~kl~Dfg~a~~~~~---~~~~~~~~~~~~gt~~y~aPE  744 (871)
                      -++.|+++|+.|||.+   ||.|||+|++||++.  +|  ..+.++|||++---..   .-+.........|.-.-||||
T Consensus       345 ~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPE  421 (598)
T KOG4158|consen  345 VILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPE  421 (598)
T ss_pred             HHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchh
Confidence            8999999999999999   999999999999993  33  3678999999743221   111222223345777899999


Q ss_pred             cccCC--C----CCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhh
Q 002883          745 YGALG--E----VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKE  818 (871)
Q Consensus       745 ~~~~~--~----~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  818 (871)
                      +....  +    --.++|.|+.|.+.||+++...||...-+...+...+.....|.                        
T Consensus       422 i~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPa------------------------  477 (598)
T KOG4158|consen  422 IATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPA------------------------  477 (598)
T ss_pred             hhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCC------------------------
Confidence            75432  1    14678999999999999999999986322222222222211111                        


Q ss_pred             cCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          819 LQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       819 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                             ....++..+.+++...++.||++|+++.-+...|.
T Consensus       478 -------lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  478 -------LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             -------CcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence                   11133445678888899999999999876666664

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=2.4e-19  Score=176.94  Aligned_cols=140  Identities=19%  Similarity=0.148  Sum_probs=110.5

Q ss_pred             CCceeeccccceEEEEEECCCCcEEEEEEeeccccch--------------------------HHHHHHHHHHHHcCCCC
Q 002883          563 SANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGA--------------------------SKSFIAECEALRSIRHR  616 (871)
Q Consensus       563 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~  616 (871)
                      +.+.||+|+||+||+|++. +|+.||||+++......                          .....+|++.+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 89999999986542110                          11235789999999998


Q ss_pred             ccceeeeeecccCcCCCceeeEEEeccCCCCHHHH-hhcccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEe
Q 002883          617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW-LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH-HCHTSIVH  694 (871)
Q Consensus       617 niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH  694 (871)
                      ++.....+...       ..++||||++|+++... +...        .++..++..++.|++.++.++|+ .   ||+|
T Consensus        80 ~i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~--------~~~~~~~~~i~~~l~~~l~~lH~~~---givH  141 (190)
T cd05145          80 GVPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDV--------PLEEEEAEELYEQVVEQMRRLYQEA---GLVH  141 (190)
T ss_pred             CCCCceEEEec-------CCEEEEEEecCCCchhhhhhhc--------cCCHHHHHHHHHHHHHHHHHHHHhC---CEec
Confidence            87544433221       13799999988865443 3221        47788999999999999999999 8   9999


Q ss_pred             cCCCCCceeeCCCCceEEeecccceecC
Q 002883          695 CDLKPSNVLLDNEMVAHVGDFGLSRLLH  722 (871)
Q Consensus       695 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  722 (871)
                      |||||+||+++ ++.++|+|||+|....
T Consensus       142 rDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         142 GDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCChhhEEEE-CCCEEEEEcccceecC
Confidence            99999999998 8899999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=4e-19  Score=170.98  Aligned_cols=188  Identities=14%  Similarity=0.070  Sum_probs=139.3

Q ss_pred             CCCceeeccccceEEEEEECCCCcEEEEEEeeccccc----hHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCcee
Q 002883          562 SSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG----ASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       562 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .+...+++|+||+||.+..  .+.+++.+.+.....-    ....+.+|+++++++. |+++++++++         ...
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence            3568899999999997776  6788887777544331    1225789999999995 5889999886         225


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCceeeCCCCceEEeec
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL-KPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~Df  715 (871)
                      +++|||+.|.+|.+....              ....++.|++.++.++|+.   ||+|||| ||+||+++.++.++|+||
T Consensus        74 ~lvmeyI~G~~L~~~~~~--------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDF  136 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR--------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDF  136 (218)
T ss_pred             EEEEeeecCccHHhhhhh--------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEEC
Confidence            899999999998754321              1134778999999999999   9999999 799999999999999999


Q ss_pred             ccceecCCCCCC----cc------ccccccccccccCcccccC-CCCC-CccchhhHHHHHHHHHhCCCCCchh
Q 002883          716 GLSRLLHDNSPD----QT------STSRVKGSIGYVAPEYGAL-GEVS-THGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       716 g~a~~~~~~~~~----~~------~~~~~~gt~~y~aPE~~~~-~~~~-~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      |+|........-    ..      .......++.|++|+...- ...+ .+.+-++-|+.+|.++||..|+...
T Consensus       137 G~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        137 QLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             CCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            999865543210    00      0112336777888874221 1223 5668889999999999999987643

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.80  E-value=1.6e-21  Score=173.98  Aligned_cols=180  Identities=24%  Similarity=0.386  Sum_probs=143.1

Q ss_pred             cCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCC
Q 002883          292 LGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQ  371 (871)
Q Consensus       292 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~  371 (871)
                      +.++.+++.|-|++|+++ .+|..++.+.+|+.|++++|+|+ .+|..+..+++|+.|+++-|++. ..|..|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            344556666777777776 55556777777777777777776 66777777777777777777777 7777788888888


Q ss_pred             EEeCCCCcCC-CCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCC
Q 002883          372 QLDLSENKLS-GEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFN  450 (871)
Q Consensus       372 ~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N  450 (871)
                      .|||.+|++. ..+|..|..+..|+.|+|++|.+. +.|...+.+++|+.|.+.+|.+- .+|..++.+.+|++|.+.||
T Consensus       106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn  183 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN  183 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence            8888887776 357888999999999999999998 77888999999999999999998 78999999999999999999


Q ss_pred             cCcccCCCCcccc---cccceeccCCCCC
Q 002883          451 NLEGEVPSEGVFK---NVRAVSIIGNNKL  476 (871)
Q Consensus       451 ~l~~~~~~~~~~~---~l~~l~l~~N~~~  476 (871)
                      +++-.+|..+.+.   +-+...+..|||.
T Consensus       184 rl~vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  184 RLTVLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             eeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            9998887654443   3345678888884

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.80  E-value=1.8e-21  Score=173.59  Aligned_cols=165  Identities=28%  Similarity=0.482  Sum_probs=141.5

Q ss_pred             CCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCC
Q 002883          243 GVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQL  322 (871)
Q Consensus       243 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  322 (871)
                      .+.++.+.+.|.|++|+++ .+|..++.+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. ..|..|+.++.|
T Consensus        28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l  104 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL  104 (264)
T ss_pred             cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence            3556677777888888888 66777888889999999999998 78888999999999999999998 889999999999


Q ss_pred             CEEecCCCcCC-CCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecC
Q 002883          323 QKLDLSDNNLS-GTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSD  401 (871)
Q Consensus       323 ~~L~L~~N~l~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  401 (871)
                      +.|||++|++. ..+|..|+.++.|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|..++.+..|++|++.+
T Consensus       105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg  182 (264)
T KOG0617|consen  105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG  182 (264)
T ss_pred             hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence            99999999886 467888999999999999999998 88889999999999999999988 7899999999999999999


Q ss_pred             CcccccCccccC
Q 002883          402 NSFQGPIHSGFS  413 (871)
Q Consensus       402 N~l~~~~~~~~~  413 (871)
                      |+++ +.|..++
T Consensus       183 nrl~-vlppel~  193 (264)
T KOG0617|consen  183 NRLT-VLPPELA  193 (264)
T ss_pred             ceee-ecChhhh
Confidence            9998 4444443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=7.2e-19  Score=203.18  Aligned_cols=199  Identities=23%  Similarity=0.253  Sum_probs=156.7

Q ss_pred             HHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC---CCccceeeeeecccCc
Q 002883          554 LLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR---HRNLVKIITSCSSIDT  630 (871)
Q Consensus       554 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~  630 (871)
                      .....+.|.|.+.||+|+||+||+|.... |+.||+|+-+....   -+|.--.+++.+++   -+.|..+..++...  
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~--  766 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQ--  766 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccC--
Confidence            33455779999999999999999999985 99999999765433   22222233444454   23344444444333  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC-----
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD-----  705 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-----  705 (871)
                         +.-++|+||.+.|+|.+++...+       .+++.-+..++.|+++.+++||..   +||||||||+|+|+.     
T Consensus       767 ---~~S~lv~ey~~~Gtlld~~N~~~-------~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~  833 (974)
T KOG1166|consen  767 ---NASVLVSEYSPYGTLLDLINTNK-------VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICA  833 (974)
T ss_pred             ---CcceeeeeccccccHHHhhccCC-------CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCC
Confidence               33579999999999999998544       689999999999999999999999   999999999999994     


Q ss_pred             --CCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCC
Q 002883          706 --NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKR  772 (871)
Q Consensus       706 --~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~  772 (871)
                        ....++|+|||.+..+.--. +........+|-.+-.+|+..+.+++..+|.|.++.+++.|+.|+.
T Consensus       834 ~~~~~~l~lIDfG~siDm~lfp-~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  834 DSDSKGLYLIDFGRSIDMKLFP-DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             CCcccceEEEecccceeeeEcC-CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence              23469999999998765332 2234555678999999999999999999999999999999999865

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.78  E-value=1.2e-20  Score=204.26  Aligned_cols=209  Identities=23%  Similarity=0.286  Sum_probs=109.4

Q ss_pred             CCCccccceeecccccccccCCccccCCCC---CcEEEccCCCCCC----CCCcccCCC-ccccEEEccCcccccc----
Q 002883          244 VGNLKNLILIAMEVNLLTGSIPTSVGYLLK---LQVLSLFGNKISG----EIPSSLGNL-IFLTEVDLQGNSIRGS----  311 (871)
Q Consensus       244 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~---L~~L~L~~n~l~~----~~~~~~~~l-~~L~~L~L~~N~i~~~----  311 (871)
                      +..+++|+.|++++|.+....+..+..+.+   |++|++++|++..    .+...+..+ ++|++|+|++|.+++.    
T Consensus        77 l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~  156 (319)
T cd00116          77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEA  156 (319)
T ss_pred             HHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHH
Confidence            344455555555555554333333433333   6666666666552    112233444 5666666666666521    


Q ss_pred             CcccccCCCCCCEEecCCCcCCCC----CcccccCCCCCcEEeccCCCCCCCC----ccccCCCCCCCEEeCCCCcCCCC
Q 002883          312 IPSALGNCLQLQKLDLSDNNLSGT----IPREVIGLSSFVLLDLSRNHLSGPI----PLEVGRLKGIQQLDLSENKLSGE  383 (871)
Q Consensus       312 ~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~  383 (871)
                      .+..+..+++|+.|++++|.+++.    ++..+..+++|++|++++|.+++..    +..+..+++|++|++++|.+++.
T Consensus       157 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~  236 (319)
T cd00116         157 LAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDA  236 (319)
T ss_pred             HHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchH
Confidence            223445556666666666666531    2223344456666666666665322    23344566677777777766642


Q ss_pred             Cccchhc-----ccCCceeeecCCcccc----cCccccCCCCCCCEEeCCCCcCCCC----Cccccccc-ccccEEecCC
Q 002883          384 IPTSLAS-----CVGLEYLNFSDNSFQG----PIHSGFSSLKGLQDLDLSRNNFSGK----IPMFLNTF-RFLQKLNLSF  449 (871)
Q Consensus       384 ~~~~~~~-----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~~-~~L~~L~l~~  449 (871)
                      ....+..     .++|++|++++|.++.    .....+..+++|+++++++|.++..    ....+... +.|++|++.+
T Consensus       237 ~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (319)
T cd00116         237 GAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKD  316 (319)
T ss_pred             HHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCC
Confidence            2222221     2566666666666652    1223344456666666666666633    33333333 4566666666


Q ss_pred             CcC
Q 002883          450 NNL  452 (871)
Q Consensus       450 N~l  452 (871)
                      |+|
T Consensus       317 ~~~  319 (319)
T cd00116         317 DSF  319 (319)
T ss_pred             CCC
Confidence            654

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=2.3e-18  Score=170.12  Aligned_cols=140  Identities=19%  Similarity=0.275  Sum_probs=108.7

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-----CCCccceeeeeecccCcCCCce
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-----RHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      +.-.+.||+|+||.||.  +..++.. +||++........+.+.+|+.+++.+     .||||+++++++.+..  +.+.
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~   78 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGY   78 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeE
Confidence            34568899999999995  5555555 79998765444567899999999999     5799999999987642  2234


Q ss_pred             -eeEEEec--cCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeEecCCCCCceeeCC----C
Q 002883          636 -KALVYEF--MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL-EYLHHHCHTSIVHCDLKPSNVLLDN----E  707 (871)
Q Consensus       636 -~~lv~e~--~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlkp~Nill~~----~  707 (871)
                       +.+|+||  +.+|+|.+++.+.        .+++.  ..++.|++.++ +|||++   +|+||||||+||+++.    +
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~--------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~  145 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC--------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESE  145 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc--------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCC
Confidence             4489999  5579999999653        24444  35677888777 999999   9999999999999974    3


Q ss_pred             CceEEeecccc
Q 002883          708 MVAHVGDFGLS  718 (871)
Q Consensus       708 ~~~kl~Dfg~a  718 (871)
                      +.++|+||+.+
T Consensus       146 ~~~~LiDg~G~  156 (210)
T PRK10345        146 VIPVVCDNIGE  156 (210)
T ss_pred             CcEEEEECCCC
Confidence            48999995443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=8.7e-19  Score=189.55  Aligned_cols=217  Identities=29%  Similarity=0.402  Sum_probs=162.2

Q ss_pred             HHcCCCCccceeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 002883          610 LRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCH  689 (871)
Q Consensus       610 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  689 (871)
                      |+.+.|.|+.+++|.+.+.     ...++|.+||..|+|.|.+.....      .+++.....+.++|+.||.|+|+.  
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~------~~d~~F~~s~~rdi~~Gl~ylh~s--   67 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDI------KLDYFFILSFIRDISKGLAYLHNS--   67 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhcccc------CccHHHHHHHHHHHHHHHHHHhcC--
Confidence            3567899999999998876     668999999999999999987432      599999999999999999999998  


Q ss_pred             CCe-EecCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCC-------CCCCccchhhHH
Q 002883          690 TSI-VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-------EVSTHGDEYSFG  761 (871)
Q Consensus       690 ~~i-vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG  761 (871)
                       .| .|+.+++.|++++..+.+|++|||+.....+.. .........-..-|.|||.+...       ..+.++||||||
T Consensus        68 -~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~-~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~  145 (484)
T KOG1023|consen   68 -PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETA-EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFG  145 (484)
T ss_pred             -cceeeeeeccccceeeeeEEEEechhhhcccccccc-cccccchhHHHHhccCHHHhcccccccccccccccCCeehHH
Confidence             44 999999999999999999999999998764311 11111222345679999986653       246779999999


Q ss_pred             HHHHHHHhCCCCCchhhhhhh--hHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhc
Q 002883          762 ILMLEMFTGKRPTDDMFEEGL--SLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGI  839 (871)
Q Consensus       762 ~il~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  839 (871)
                      ++++|+++.+.||........  ....+...    .                   ......|...... +..+.+..+++
T Consensus       146 ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~----~-------------------~~~~~rP~i~~~~-e~~~~l~~l~~  201 (484)
T KOG1023|consen  146 IIMYEILFRSGPFDLRNLVEDPDEIILRVKK----G-------------------GSNPFRPSIELLN-ELPPELLLLVA  201 (484)
T ss_pred             HHHHHHHhccCccccccccCChHHHHHHHHh----c-------------------CCCCcCcchhhhh-hcchHHHHHHH
Confidence            999999999999986432211  11111111    0                   0011112211111 44457889999


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          840 LCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       840 ~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      .||..+|++||+++++-..++.+.+.
T Consensus       202 ~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  202 RCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             HhcccChhhCccHHHHHhhhhhhccc
Confidence            99999999999999999988877553

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=2.4e-20  Score=201.91  Aligned_cols=231  Identities=22%  Similarity=0.233  Sum_probs=168.0

Q ss_pred             CCccccceeeccccccc------ccCCccccCCCCCcEEEccCCCCCCCCCcccCCCcc---ccEEEccCccccc----c
Q 002883          245 GNLKNLILIAMEVNLLT------GSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIF---LTEVDLQGNSIRG----S  311 (871)
Q Consensus       245 ~~l~~L~~L~l~~N~l~------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~N~i~~----~  311 (871)
                      ...++|+.|+++++.+.      ...+..+..+++|+.|++++|.+....+..+..+.+   |++|++++|++.+    .
T Consensus        48 ~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~  127 (319)
T cd00116          48 RPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRL  127 (319)
T ss_pred             hhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHH
Confidence            33444555555554443      133456777899999999999998666666666655   9999999999873    2


Q ss_pred             CcccccCC-CCCCEEecCCCcCCCC----CcccccCCCCCcEEeccCCCCCCC----CccccCCCCCCCEEeCCCCcCCC
Q 002883          312 IPSALGNC-LQLQKLDLSDNNLSGT----IPREVIGLSSFVLLDLSRNHLSGP----IPLEVGRLKGIQQLDLSENKLSG  382 (871)
Q Consensus       312 ~~~~~~~l-~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~  382 (871)
                      +...+..+ ++|+.|++++|.+++.    ++..+..+++|++|++++|.+++.    ++..+..+++|+.|++++|.+++
T Consensus       128 l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~  207 (319)
T cd00116         128 LAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTD  207 (319)
T ss_pred             HHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccCh
Confidence            33455667 8999999999999842    344567788999999999999843    23345566799999999999974


Q ss_pred             CC----ccchhcccCCceeeecCCcccccCccccC-----CCCCCCEEeCCCCcCCC----CCcccccccccccEEecCC
Q 002883          383 EI----PTSLASCVGLEYLNFSDNSFQGPIHSGFS-----SLKGLQDLDLSRNNFSG----KIPMFLNTFRFLQKLNLSF  449 (871)
Q Consensus       383 ~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~----~~~~~~~~~~~L~~L~l~~  449 (871)
                      ..    +..+..+++|++|++++|++++.....+.     ..+.|+.|++++|.++.    .+...+..+++|+++++++
T Consensus       208 ~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~  287 (319)
T cd00116         208 EGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRG  287 (319)
T ss_pred             HHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCC
Confidence            43    34456788999999999999863333222     24799999999999972    3345566778999999999


Q ss_pred             CcCcccCCC-----Cccc-ccccceeccCCCC
Q 002883          450 NNLEGEVPS-----EGVF-KNVRAVSIIGNNK  475 (871)
Q Consensus       450 N~l~~~~~~-----~~~~-~~l~~l~l~~N~~  475 (871)
                      |.++.....     ...+ ..++.+++.+|||
T Consensus       288 N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         288 NKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             CCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            999965221     1223 4677788877775

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.74  E-value=1.2e-18  Score=184.17  Aligned_cols=199  Identities=21%  Similarity=0.299  Sum_probs=136.8

Q ss_pred             CCCCCceeeccccceEEEEEECCC---CcEEEEEEeeccccchHHHHHHHHHHHHcCC-CCccceeee-------eeccc
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTE---ETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIIT-------SCSSI  628 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~-------~~~~~  628 (871)
                      .+.+.+..+.++++.++..+....   .+.++.|..+...........+++-.+.... |+..+. .+       .+...
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~-~d~~~s~~~~~~~~  323 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSIL-EDLRPSLFESSKRN  323 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccc-cCCCCchhhhcccc
Confidence            345556666666776666554322   2334444433332112222233333333333 333322 22       11111


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM  708 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  708 (871)
                      ......+.||.|++|+..+|.+|+......    ...++.....++.|++.|++|   +   +.+|+|+||.||+...+.
T Consensus       324 ~v~~~~~lyI~Mn~c~~~tledWl~rr~~~----e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~  393 (516)
T KOG1033|consen  324 KVGKKVYLYIQMNLCEKETLEDWLRRRRTG----EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDD  393 (516)
T ss_pred             ccccccchhhhhhhhhhhhHHHHhhCCCcc----cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccch
Confidence            111124689999999999999999754422    257888899999999999999   5   999999999999999999


Q ss_pred             ceEEeecccceecCCCCC---CccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh
Q 002883          709 VAHVGDFGLSRLLHDNSP---DQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT  769 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt  769 (871)
                      .+||.|||+.........   .....+...||..||+||.+.+..|+.++||||+|++++|+++
T Consensus       394 q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  394 QLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            999999999987765431   1223445679999999999999999999999999999999997

>smart00090 RIO RIO-like kinase

Probab=99.74  E-value=1.4e-17  Score=169.21  Aligned_cols=144  Identities=19%  Similarity=0.143  Sum_probs=112.5

Q ss_pred             cCCCCCceeeccccceEEEEE-ECCCCcEEEEEEeeccccc------------------------hHHHHHHHHHHHHcC
Q 002883          559 EGFSSANLIGIGGYGYVYKGI-LGTEETNVAVKVLDLQQRG------------------------ASKSFIAECEALRSI  613 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  613 (871)
                      ..|.+.+.||+|+||.||+|. +..+|+.||+|+++.....                        ....+.+|++.++++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            358899999999999999999 6668999999998643210                        012356899999999


Q ss_pred             CCC--ccceeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 002883          614 RHR--NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS  691 (871)
Q Consensus       614 ~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  691 (871)
                      .+.  .+.+++++         ...++||||++++++..+.....       ......+..++.|++.++.+||+.   +
T Consensus       108 ~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~---g  168 (237)
T smart00090      108 YEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDV-------EPEEEEEFELYDDILEEMRKLYKE---G  168 (237)
T ss_pred             HhcCCCCCeeeEe---------cCceEEEEEecCCcccccccccC-------CcchHHHHHHHHHHHHHHHHHHhc---C
Confidence            653  34444432         12479999999988876653221       355667789999999999999999   9


Q ss_pred             -eEecCCCCCceeeCCCCceEEeecccceecC
Q 002883          692 -IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH  722 (871)
Q Consensus       692 -ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  722 (871)
                       ++||||||+||+++ ++.++++|||.|....
T Consensus       169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence             99999999999999 8899999999987543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.73  E-value=3.6e-19  Score=191.67  Aligned_cols=186  Identities=27%  Similarity=0.292  Sum_probs=153.5

Q ss_pred             eeccccceEEEEEE---CCCCcEEEEEEeeccccc--hHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCceeeEEE
Q 002883          567 IGIGGYGYVYKGIL---GTEETNVAVKVLDLQQRG--ASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       567 lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +|+|+||.|++++.   ...+..+|+|+.+.....  .......|..++...+ ||.++++...+...     ...++++
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~-----~kl~l~l   76 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD-----GKLYLIL   76 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc-----cchhHhh
Confidence            68999999998764   334677899887433211  1114456777888885 99999999887765     6688999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      +|..||.+...+....       .+++.....+...++-|++++|+.   +++|||+|++||+++.+|.+++.|||.++.
T Consensus        77 d~~rgg~lft~l~~~~-------~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske  146 (612)
T KOG0603|consen   77 DFLRGGDLFTRLSKEV-------MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKE  146 (612)
T ss_pred             hhcccchhhhccccCC-------chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhH
Confidence            9999999998887654       578888888999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCch
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDD  776 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  776 (871)
                      .-+...       .+||..|||||+..  ....++|-||||++++||+||..||..
T Consensus       147 ~v~~~~-------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  147 AVKEKI-------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             hHhhhh-------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            543321       17999999999977  567899999999999999999999986

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=1.4e-16  Score=160.94  Aligned_cols=134  Identities=20%  Similarity=0.268  Sum_probs=109.9

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeecccc--------chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--------GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      +.||+|++|.||+|.+  .+..|++|+......        .....+.+|++++..+.|+++.....++...     ...
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence            5799999999999998  577899998643221        1124577899999999998887666655443     346


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||++|++|.+++....          . ....++.+++.++.++|+.   +++|||++|.||+++ ++.++++|||
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~----------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~  139 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNG----------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFG  139 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhcc----------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECC
Confidence            89999999999999986421          2 7889999999999999999   999999999999999 7899999999


Q ss_pred             ccee
Q 002883          717 LSRL  720 (871)
Q Consensus       717 ~a~~  720 (871)
                      .+..
T Consensus       140 ~a~~  143 (211)
T PRK14879        140 LAEF  143 (211)
T ss_pred             cccC
Confidence            9864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.66  E-value=6.2e-16  Score=154.14  Aligned_cols=143  Identities=22%  Similarity=0.195  Sum_probs=110.4

Q ss_pred             HHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc----------------------hHHHHHHHHHHHH
Q 002883          554 LLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG----------------------ASKSFIAECEALR  611 (871)
Q Consensus       554 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~  611 (871)
                      +......|.+.+.||+|+||.||+|... +++.||||+++.....                      ......+|+.++.
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            3334445888999999999999999885 7999999987543210                      1123567888888


Q ss_pred             cCCCC--ccceeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 002883          612 SIRHR--NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCH  689 (871)
Q Consensus       612 ~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  689 (871)
                      .+.|+  .++..++.         ...++||||++|++|.+....             .....++.+++.++.++|+.  
T Consensus        89 ~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~-------------~~~~~~~~~i~~~l~~lh~~--  144 (198)
T cd05144          89 ALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL-------------EDPEEVLDEILEEIVKAYKH--  144 (198)
T ss_pred             HHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc-------------ccHHHHHHHHHHHHHHHHHC--
Confidence            88776  34444432         234899999999998765421             23457889999999999998  


Q ss_pred             CCeEecCCCCCceeeCCCCceEEeecccceecC
Q 002883          690 TSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH  722 (871)
Q Consensus       690 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  722 (871)
                       +|+||||||+||++++++.++|+|||.+....
T Consensus       145 -gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         145 -GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             -CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence             99999999999999999999999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.66  E-value=6.9e-17  Score=182.56  Aligned_cols=170  Identities=26%  Similarity=0.331  Sum_probs=124.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ..+|..++.|..|+||.||.++++.+.+.+|+|+-+..      .+.+-  ++.....|                    +
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~np--------------------f  133 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNP--------------------F  133 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCc--------------------c
Confidence            35788999999999999999999988999999653211      11111  11111222                    2


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      .|      |+-...++..+       .++...        +.+++|+|+.   ||||||+||+|.+|+.-|.+|+.|||+
T Consensus       134 vv------gDc~tllk~~g-------~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgL  189 (1205)
T KOG0606|consen  134 VV------GDCATLLKNIG-------PLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGL  189 (1205)
T ss_pred             ee------chhhhhcccCC-------CCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhh
Confidence            23      34344443322       233322        7799999999   999999999999999999999999999


Q ss_pred             ceecCCCCCC------------ccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhh
Q 002883          718 SRLLHDNSPD------------QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFE  779 (871)
Q Consensus       718 a~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  779 (871)
                      ++........            .-.....+||+.|+|||++....|+..+|-|++|+++||.+.|..||.....
T Consensus       190 sk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp  263 (1205)
T KOG0606|consen  190 SKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP  263 (1205)
T ss_pred             hhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence            8764321111            1112335799999999999999999999999999999999999999986543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.65  E-value=8.5e-16  Score=176.72  Aligned_cols=145  Identities=22%  Similarity=0.257  Sum_probs=112.4

Q ss_pred             CHHHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEe--eccc------cchHHHHHHHHHHHHcCCCCcccee
Q 002883          550 SYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVL--DLQQ------RGASKSFIAECEALRSIRHRNLVKI  621 (871)
Q Consensus       550 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~--~~~~------~~~~~~~~~E~~~l~~l~h~niv~~  621 (871)
                      ++.........|...+.||+|+||+||+|.+..  ..+++|+.  +...      ....+.+.+|+++++.++|++++..
T Consensus       324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p  401 (535)
T PRK09605        324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP  401 (535)
T ss_pred             eeccccccccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence            333333445567788999999999999999853  34444443  1111      1123567899999999999999887


Q ss_pred             eeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 002883          622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN  701 (871)
Q Consensus       622 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  701 (871)
                      ..++...     ...++||||+++++|.+++.               ....++.+++.++.|||+.   +++|||+||+|
T Consensus       402 ~~~~~~~-----~~~~lv~E~~~g~~L~~~l~---------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~N  458 (535)
T PRK09605        402 VIYDVDP-----EEKTIVMEYIGGKDLKDVLE---------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSN  458 (535)
T ss_pred             EEEEEeC-----CCCEEEEEecCCCcHHHHHH---------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHH
Confidence            6665443     34689999999999998874               2456899999999999999   99999999999


Q ss_pred             eeeCCCCceEEeeccccee
Q 002883          702 VLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       702 ill~~~~~~kl~Dfg~a~~  720 (871)
                      |++ .++.++|+|||+++.
T Consensus       459 ILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        459 FIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEE-ECCcEEEEeCccccc
Confidence            999 678999999999975

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=4.6e-16  Score=155.59  Aligned_cols=130  Identities=20%  Similarity=0.271  Sum_probs=102.5

Q ss_pred             eeeccccceEEEEEECCCCcEEEEEEeecccc--------chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--------GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       566 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .||+|+||.||+|.+  .+..|++|+......        ....++.+|++++..+.|+++.....++...     ...+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence            379999999999996  567899998643211        1125677899999999887654443333322     3458


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||++|++|.+++....        .      .++.+++.++.++|+.   +++|||++|.||+++ ++.++++|||.
T Consensus        74 lv~e~~~g~~l~~~~~~~~--------~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~  135 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGN--------D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGL  135 (199)
T ss_pred             EEEEEECCccHHHHHhhcH--------H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCC
Confidence            9999999999998875421        1      7899999999999999   999999999999999 78999999999


Q ss_pred             cee
Q 002883          718 SRL  720 (871)
Q Consensus       718 a~~  720 (871)
                      +..
T Consensus       136 a~~  138 (199)
T TIGR03724       136 GKY  138 (199)
T ss_pred             CcC
Confidence            865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.60  E-value=1.3e-16  Score=182.00  Aligned_cols=257  Identities=22%  Similarity=0.249  Sum_probs=191.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECC-CCcEEEEEEeeccc--cchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGT-EETNVAVKVLDLQQ--RGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  633 (871)
                      ...|.+.+.||+|+|+.|-.+.... ....+|+|.+....  .........|..+-+.+. |+|++++++.....     
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~-----   93 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP-----   93 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC-----
Confidence            4568889999999999999887743 34457777764433  333445566887777776 99999999876554     


Q ss_pred             ceeeEEEeccCCCCHHHHh-hcccccccccCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEecCCCCCceeeCCCC-ce
Q 002883          634 EFKALVYEFMPNGSLENWL-NQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH-HHCHTSIVHCDLKPSNVLLDNEM-VA  710 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l-~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlkp~Nill~~~~-~~  710 (871)
                      ...+++++|..|+++.+.+ .....      ..+...+..++.|+..++.|+| ..   +++|+|+||+|.+++..+ ..
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~~------~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l  164 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDST------GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSAL  164 (601)
T ss_pred             cccccccCcccccccccccccCCcc------CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcc
Confidence            6789999999999999988 33321      3566778889999999999999 77   999999999999999999 99


Q ss_pred             EEeecccceecCCCCCCccccccccc-cccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh
Q 002883          711 HVGDFGLSRLLHDNSPDQTSTSRVKG-SIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA  788 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~  788 (871)
                      +++|||+|..+..-..........+| ++.|+|||...+. -..+..|+||.|+++.-+++|..|+............+.
T Consensus       165 ~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~  244 (601)
T KOG0590|consen  165 KIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK  244 (601)
T ss_pred             cCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec
Confidence            99999999987762223344445678 9999999987774 447889999999999999999999986544443332222


Q ss_pred             hhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHH
Q 002883          789 KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAI  856 (871)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl  856 (871)
                      ........                            ..+........++..+++..+|..|.+.+++-
T Consensus       245 ~~~~~~~~----------------------------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  245 SNKGRFTQ----------------------------LPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             cccccccc----------------------------CccccCChhhhhcccccccCCchhcccccccc
Confidence            22100000                            01112233456788888889999999988764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.57  E-value=1.3e-14  Score=143.47  Aligned_cols=136  Identities=22%  Similarity=0.240  Sum_probs=97.0

Q ss_pred             CceeeccccceEEEEEECCCCcEEEEEEeeccccchH--HH----------------------HHHHHHHHHcCCCC--c
Q 002883          564 ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KS----------------------FIAECEALRSIRHR--N  617 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~----------------------~~~E~~~l~~l~h~--n  617 (871)
                      .+.||+|+||+||+|.+. +++.||||++........  ..                      ...|.+.+..+.+.  .
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            568999999999999987 789999999864322111  11                      13455555555332  2


Q ss_pred             cceeeeeecccCcCCCceeeEEEeccCCCCHHHH-hhcccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEec
Q 002883          618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW-LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH-HCHTSIVHC  695 (871)
Q Consensus       618 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~  695 (871)
                      +.+.+++         ...++||||++++++... +....        .. .++..++.+++.++.++|. .   +|+||
T Consensus        81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~--------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~  139 (187)
T cd05119          81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR--------LL-EDPEELYDQILELMRKLYREA---GLVHG  139 (187)
T ss_pred             CCceEec---------CCCEEEEEEeCCCCccChhhhhhh--------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcC
Confidence            3444432         225899999998553311 11100        11 5678899999999999999 7   99999


Q ss_pred             CCCCCceeeCCCCceEEeecccceecC
Q 002883          696 DLKPSNVLLDNEMVAHVGDFGLSRLLH  722 (871)
Q Consensus       696 Dlkp~Nill~~~~~~kl~Dfg~a~~~~  722 (871)
                      ||||+||+++ ++.++++|||.+....
T Consensus       140 Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         140 DLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCChhhEEEE-CCcEEEEECccccccc
Confidence            9999999999 8999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.56  E-value=1.7e-14  Score=137.48  Aligned_cols=135  Identities=21%  Similarity=0.252  Sum_probs=110.6

Q ss_pred             CCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCC--CccceeeeeecccCcCCCceeeEEE
Q 002883          563 SANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRH--RNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       563 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.+.||+|.++.||++...+  ..+++|.......  ...+.+|+.+++.++|  ..++++++++...     +..+++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESD-----GWSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEEEE
Confidence            46789999999999999853  7899999865433  4678899999999976  5888888776543     5579999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||++++.+..+              +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.+..
T Consensus        73 e~~~g~~~~~~--------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          73 EWIEGETLDEV--------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EecCCeecccC--------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99988766543              3455677899999999999986444799999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.54  E-value=7.1e-14  Score=142.39  Aligned_cols=139  Identities=18%  Similarity=0.156  Sum_probs=105.4

Q ss_pred             Cceee-ccccceEEEEEECCCCcEEEEEEeeccc-------------cchHHHHHHHHHHHHcCCCCcc--ceeeeeecc
Q 002883          564 ANLIG-IGGYGYVYKGILGTEETNVAVKVLDLQQ-------------RGASKSFIAECEALRSIRHRNL--VKIITSCSS  627 (871)
Q Consensus       564 ~~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~  627 (871)
                      ...|| .|+.|+||.+...  +..+|||.+....             ......+.+|++++..+.|+++  ++.+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            35687 8999999999884  6789999884311             1223567889999999988774  666665433


Q ss_pred             cCcCCCceeeEEEeccCC-CCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC
Q 002883          628 IDTRGNEFKALVYEFMPN-GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN  706 (871)
Q Consensus       628 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  706 (871)
                      . .......++|||+++| .+|.+++...        .++..    .+.+++.++.+||+.   ||+||||||+|||++.
T Consensus       114 ~-~~~~~~~~lV~e~l~G~~~L~~~l~~~--------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~  177 (239)
T PRK01723        114 R-HGLFYRADILIERIEGARDLVALLQEA--------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDP  177 (239)
T ss_pred             e-cCcceeeeEEEEecCCCCCHHHHHhcC--------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcC
Confidence            2 1111223699999997 6999988642        24443    356899999999999   9999999999999999


Q ss_pred             CCceEEeeccccee
Q 002883          707 EMVAHVGDFGLSRL  720 (871)
Q Consensus       707 ~~~~kl~Dfg~a~~  720 (871)
                      ++.++|+|||.+..
T Consensus       178 ~~~v~LIDfg~~~~  191 (239)
T PRK01723        178 DGKFWLIDFDRGEL  191 (239)
T ss_pred             CCCEEEEECCCccc
Confidence            89999999999875

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.53  E-value=7.7e-16  Score=162.68  Aligned_cols=213  Identities=26%  Similarity=0.419  Sum_probs=142.9

Q ss_pred             eeeCCCCcccccCCcc-cc-CCcccceeeccCccccCCCCccccccccccccccccccccCCCCccccccCCCceeeeec
Q 002883           42 GLGLTGNNYTGSIPQS-LS-NLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQ  119 (871)
Q Consensus        42 ~L~L~~n~l~~~~p~~-~~-~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  119 (871)
                      +|.|++-+++ ..|.. +. .|.--...||+.|++. .+|..++.+..|+.+.|.+|.+. .+|..++++..|++++|+.
T Consensus        54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~  130 (722)
T KOG0532|consen   54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS  130 (722)
T ss_pred             ccccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence            3445555555 33321 11 2344445666666666 66666666666666666666666 6666666666666666666


Q ss_pred             cccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCccccccccCCC
Q 002883          120 NKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCT  199 (871)
Q Consensus       120 n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~  199 (871)
                      |++. .+|..++ . --|+.|.+++|+++           .+|+.++.+..|..||.+.|++.+       .+..+..+.
T Consensus       131 NqlS-~lp~~lC-~-lpLkvli~sNNkl~-----------~lp~~ig~~~tl~~ld~s~nei~s-------lpsql~~l~  189 (722)
T KOG0532|consen  131 NQLS-HLPDGLC-D-LPLKVLIVSNNKLT-----------SLPEEIGLLPTLAHLDVSKNEIQS-------LPSQLGYLT  189 (722)
T ss_pred             chhh-cCChhhh-c-CcceeEEEecCccc-----------cCCcccccchhHHHhhhhhhhhhh-------chHHhhhHH
Confidence            6665 5555543 2 33777777777776           777777777788888888887776       345677777


Q ss_pred             cccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCC---CcE
Q 002883          200 FLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLK---LQV  276 (871)
Q Consensus       200 ~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~---L~~  276 (871)
                      +|+.|.+..|++. .+|..+..+ + |..||+|+|+|+ .+|-.|.+|+.|++|-|.+|.++ ..|..++..-+   -++
T Consensus       190 slr~l~vrRn~l~-~lp~El~~L-p-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKy  264 (722)
T KOG0532|consen  190 SLRDLNVRRNHLE-DLPEELCSL-P-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKY  264 (722)
T ss_pred             HHHHHHHhhhhhh-hCCHHHhCC-c-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeee
Confidence            8888888888887 677888866 3 899999999998 78888888888888888888888 55655543322   355


Q ss_pred             EEccCCC
Q 002883          277 LSLFGNK  283 (871)
Q Consensus       277 L~L~~n~  283 (871)
                      |+..-++
T Consensus       265 L~~qA~q  271 (722)
T KOG0532|consen  265 LSTQACQ  271 (722)
T ss_pred             ecchhcc
Confidence            6665553

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.51  E-value=1.1e-15  Score=161.42  Aligned_cols=202  Identities=31%  Similarity=0.472  Sum_probs=140.0

Q ss_pred             EEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccce
Q 002883          173 RLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLIL  252 (871)
Q Consensus       173 ~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~  252 (871)
                      +|.|++-+++.++.+...     ..++--...||+.|++. .+|..+..+.. |+.+.|.+|.|. .+|..++++..|+.
T Consensus        54 ~l~Ls~rrlk~fpr~a~~-----~~ltdt~~aDlsrNR~~-elp~~~~~f~~-Le~liLy~n~~r-~ip~~i~~L~~lt~  125 (722)
T KOG0532|consen   54 RLLLSGRRLKEFPRGAAS-----YDLTDTVFADLSRNRFS-ELPEEACAFVS-LESLILYHNCIR-TIPEAICNLEALTF  125 (722)
T ss_pred             ccccccchhhcCCCcccc-----ccccchhhhhccccccc-cCchHHHHHHH-HHHHHHHhccce-ecchhhhhhhHHHH
Confidence            455666666665544322     23455567788888887 67777777754 778888888877 67777777777777


Q ss_pred             eecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcC
Q 002883          253 IAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNL  332 (871)
Q Consensus       253 L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  332 (871)
                      |+|+.|++. ..|..++.|+ |+.|.+++|+++ .+|..++.+.+|..||.+.|.|. .+|..++++.+|+.|.+..|++
T Consensus       126 l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l  201 (722)
T KOG0532|consen  126 LDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHL  201 (722)
T ss_pred             hhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhh
Confidence            777777777 5666666654 777777777777 66777777777777777777776 5666677777777777777777


Q ss_pred             CCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhc
Q 002883          333 SGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLAS  390 (871)
Q Consensus       333 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  390 (871)
                      . .+|..+..|+ |..||+|.|+++ .+|-.|.+|+.|++|-|.+|.++ ..|..++-
T Consensus       202 ~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~  255 (722)
T KOG0532|consen  202 E-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICE  255 (722)
T ss_pred             h-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHh
Confidence            6 5565666444 667777777776 66777777777777777777776 55555543

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.49  E-value=3.5e-14  Score=158.12  Aligned_cols=242  Identities=32%  Similarity=0.387  Sum_probs=121.3

Q ss_pred             CCccEEEccCccCCCCCCccCcCCCCCCccccCCC-cccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcc
Q 002883          135 PNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLK-NLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSG  213 (871)
Q Consensus       135 ~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~  213 (871)
                      +.++.|++.+|.++           ++|.....++ +|+.|++++|++..++       ..+..+++|+.|++++|+++ 
T Consensus       116 ~~l~~L~l~~n~i~-----------~i~~~~~~~~~nL~~L~l~~N~i~~l~-------~~~~~l~~L~~L~l~~N~l~-  176 (394)
T COG4886         116 TNLTSLDLDNNNIT-----------DIPPLIGLLKSNLKELDLSDNKIESLP-------SPLRNLPNLKNLDLSFNDLS-  176 (394)
T ss_pred             cceeEEecCCcccc-----------cCccccccchhhcccccccccchhhhh-------hhhhccccccccccCCchhh-
Confidence            44555555555554           4444444443 5555555555554421       23444555555555555555 


Q ss_pred             cCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccC
Q 002883          214 VLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLG  293 (871)
Q Consensus       214 ~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  293 (871)
                      .+|...... ++|+.|++++|+++ .+|.....+..|++|.+++|.+. ..+..+..+.++..|.+.+|++. ..+..++
T Consensus       177 ~l~~~~~~~-~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~  252 (394)
T COG4886         177 DLPKLLSNL-SNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIG  252 (394)
T ss_pred             hhhhhhhhh-hhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhc
Confidence            333333222 24555555555555 34443344444556666665433 24455556666666666666665 3355566


Q ss_pred             CCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEE
Q 002883          294 NLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQL  373 (871)
Q Consensus       294 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L  373 (871)
                      .++++++|++++|+++.. +. ++.+.+++.|++++|.+....+........... ... +.+. ..+........+...
T Consensus       253 ~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~~~~~~~-~~~-~~~~-~~~~~~~~~~~~~~~  327 (394)
T COG4886         253 NLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPLIALLLLLLEL-LLN-LLLT-LKALELKLNSILLNN  327 (394)
T ss_pred             cccccceecccccccccc-cc-ccccCccCEEeccCccccccchhhhccchhHHh-hhh-hhhh-ccccccccccccccc
Confidence            666666666666666633 22 666666666666666666444433332221111 111 2222 222233334444444


Q ss_pred             eCCCCcCCCCCccchhcccCCceeeecCCccc
Q 002883          374 DLSENKLSGEIPTSLASCVGLEYLNFSDNSFQ  405 (871)
Q Consensus       374 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  405 (871)
                      ++..+... ..+..+.....+..++...+...
T Consensus       328 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  358 (394)
T COG4886         328 NILSNGET-SSPEALSILESLNNLWTLDNALD  358 (394)
T ss_pred             cccccccc-ccchhhcccccccCceecccccc
Confidence            55555554 45555555555566666555554

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.48  E-value=4.4e-14  Score=157.35  Aligned_cols=261  Identities=27%  Similarity=0.322  Sum_probs=126.3

Q ss_pred             eeeccCccccCCCCccccccccccccccccccccCCCCccccccC-CCceeeeeccccccccccccccCCCCccEEEccC
Q 002883           66 QLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNIS-SMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGS  144 (871)
Q Consensus        66 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~  144 (871)
                      .|+++.|++. ..+..+..++.++.|++.+|.++ .++.....+. +|+.|++++|.+. .+|..+. .+++|+.|++++
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~-~l~~L~~L~l~~  172 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLR-NLPNLKNLDLSF  172 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhh-ccccccccccCC
Confidence            3444444443 22233333344444444444444 3444344442 4445555554444 3332222 455555555555


Q ss_pred             ccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccc
Q 002883          145 NWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSS  224 (871)
Q Consensus       145 n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~  224 (871)
                      |+++           ++|...+.+++|+.|++++|++..++.       .......|++|.+++|++. ..+..+..+ .
T Consensus       173 N~l~-----------~l~~~~~~~~~L~~L~ls~N~i~~l~~-------~~~~~~~L~~l~~~~N~~~-~~~~~~~~~-~  232 (394)
T COG4886         173 NDLS-----------DLPKLLSNLSNLNNLDLSGNKISDLPP-------EIELLSALEELDLSNNSII-ELLSSLSNL-K  232 (394)
T ss_pred             chhh-----------hhhhhhhhhhhhhheeccCCccccCch-------hhhhhhhhhhhhhcCCcce-ecchhhhhc-c
Confidence            5554           444444455555555555555555432       1122334666666666433 334444444 2


Q ss_pred             cccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEcc
Q 002883          225 HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQ  304 (871)
Q Consensus       225 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  304 (871)
                      ++..|.+.+|++. ..+..++.+++++.|++++|.++....  ++.+.+++.|++++|.+....+....... +......
T Consensus       233 ~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~~~-~~~~~~~  308 (394)
T COG4886         233 NLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALLLL-LLELLLN  308 (394)
T ss_pred             cccccccCCceee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhccch-hHHhhhh
Confidence            4666666666665 335666667777777777777773322  66777777777777777644443332221 1111111


Q ss_pred             CccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCC
Q 002883          305 GNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLS  357 (871)
Q Consensus       305 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~  357 (871)
                       +.+. ..+..+.....+....+..+... ..+..+.....+..++...+...
T Consensus       309 -~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  358 (394)
T COG4886         309 -LLLT-LKALELKLNSILLNNNILSNGET-SSPEALSILESLNNLWTLDNALD  358 (394)
T ss_pred             -hhhh-ccccccccccccccccccccccc-ccchhhcccccccCceecccccc
Confidence             2222 22222233333444444455544 44445555555555555554443

>PLN03150 hypothetical protein; Provisional

Probab=99.45  E-value=2.5e-13  Score=157.81  Aligned_cols=113  Identities=35%  Similarity=0.486  Sum_probs=99.2

Q ss_pred             CCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecC
Q 002883          369 GIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLS  448 (871)
Q Consensus       369 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~  448 (871)
                      .++.|+|++|.+++.+|..+..+++|+.|+|++|.+.+.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37889999999999999999999999999999999998899899999999999999999999999999999999999999


Q ss_pred             CCcCcccCCCCc--ccccccceeccCCCCCccCCC
Q 002883          449 FNNLEGEVPSEG--VFKNVRAVSIIGNNKLCGGSP  481 (871)
Q Consensus       449 ~N~l~~~~~~~~--~~~~l~~l~l~~N~~~C~~~~  481 (871)
                      +|++++.+|..-  .+..+..+++.+|+..|+.+.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~  533 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG  533 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence            999999888641  223456788999999998654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.42  E-value=6.5e-14  Score=138.74  Aligned_cols=161  Identities=22%  Similarity=0.339  Sum_probs=122.2

Q ss_pred             HHHHcCCCCccceeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhc
Q 002883          608 EALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHH  687 (871)
Q Consensus       608 ~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~  687 (871)
                      .-+-++.|.|++++..|+.+....+.....+++|||..|++..++++....   ...+......+|+.||..||.|||+.
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~---~~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN---QKALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh---hhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            334556799999999998877665667788999999999999999876543   23577888899999999999999994


Q ss_pred             CCCCeEecCCCCCceeeCCCCceEEeecccceecCCC--CCCccccccccccccccCcccccCCCCCCccchhhHHHHHH
Q 002883          688 CHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN--SPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML  765 (871)
Q Consensus       688 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  765 (871)
                       .+.|+|+++..+-|++..+|-+|+.- +.-......  ...........+-++|.|||.-..-..+.++|||+||....
T Consensus       196 -~PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl  273 (458)
T KOG1266|consen  196 -DPPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL  273 (458)
T ss_pred             -CCccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence             67999999999999999998888742 111111000  00111122334678999999866667788999999999999


Q ss_pred             HHHhCCCC
Q 002883          766 EMFTGKRP  773 (871)
Q Consensus       766 elltG~~p  773 (871)
                      +|..|..-
T Consensus       274 emailEiq  281 (458)
T KOG1266|consen  274 EMAILEIQ  281 (458)
T ss_pred             HHHHheec
Confidence            99887653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=2.6e-13  Score=147.14  Aligned_cols=202  Identities=24%  Similarity=0.277  Sum_probs=159.8

Q ss_pred             cCCCCCceeec--cccceEEEEEE--CCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcC
Q 002883          559 EGFSSANLIGI--GGYGYVYKGIL--GTEETNVAVKVLDLQQ--RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       559 ~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  631 (871)
                      ..+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+...  .....+-.+|+...+.+ .|++.++.+..+.+.   
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~---  190 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS---  190 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC---
Confidence            34667788999  99999999999  8889999999853322  23334455677777777 599999966665544   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeEecCCCCCceeeCCC
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN----VLEYLHHHCHTSIVHCDLKPSNVLLDNE  707 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlkp~Nill~~~  707 (871)
                        +..++-+|++ +.++.++......      -++....+....+...    |+.++|..   .++|-|+||.||+...+
T Consensus       191 --~~lfiqtE~~-~~sl~~~~~~~~~------~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~  258 (524)
T KOG0601|consen  191 --GILFIQTELC-GESLQSYCHTPCN------FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSD  258 (524)
T ss_pred             --Ccceeeeccc-cchhHHhhhcccc------cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccc
Confidence              7789999999 5788888876543      3778888888888888    99999999   99999999999999999


Q ss_pred             -CceEEeecccceecCCCCCCccc--cccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCch
Q 002883          708 -MVAHVGDFGLSRLLHDNSPDQTS--TSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDD  776 (871)
Q Consensus       708 -~~~kl~Dfg~a~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  776 (871)
                       ...+++|||....+.+.......  .....|...|++||. ..+.++.++||||+|.++.+..+|..+...
T Consensus       259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSV  329 (524)
T ss_pred             cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccC
Confidence             88999999999988765422221  122357888999997 456789999999999999999998776653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.35  E-value=3.8e-12  Score=141.19  Aligned_cols=142  Identities=20%  Similarity=0.218  Sum_probs=98.8

Q ss_pred             CceeeccccceEEEEEECCCCcEEEEEEeeccccchH----------------------------------------HHH
Q 002883          564 ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS----------------------------------------KSF  603 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~  603 (871)
                      .+.||.|++|+||+|+.. +|+.||||+.++......                                        -++
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            468999999999999986 789999999854321000                                        024


Q ss_pred             HHHHHHHHcC----CCCccceeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHH
Q 002883          604 IAECEALRSI----RHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN  679 (871)
Q Consensus       604 ~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~  679 (871)
                      .+|++.+.++    +|.+-+.+-..|.+..    ...++||||++|++|.++......      ..   ....++.+++.
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~------~~---~~~~ia~~~~~  267 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEA------GL---DRKALAENLAR  267 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhc------CC---CHHHHHHHHHH
Confidence            4455555554    2333333333332221    235899999999999987653211      12   23456666665


Q ss_pred             -HHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecC
Q 002883          680 -VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH  722 (871)
Q Consensus       680 -~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  722 (871)
                       .+..+|..   |++|+|++|.||+++.++.++++|||++..+.
T Consensus       268 ~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       268 SFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             47788988   99999999999999999999999999998765

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.34  E-value=2.7e-13  Score=132.39  Aligned_cols=208  Identities=25%  Similarity=0.260  Sum_probs=139.6

Q ss_pred             CCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCc-cccccCcccccCC
Q 002883          241 PTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGN-SIRGSIPSALGNC  319 (871)
Q Consensus       241 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l  319 (871)
                      |-.+.-+++|+.+.++.+.-.. +.+....-+.|+++...+.-++. .| .+-.+..+....-+.- -.+|..-..+...
T Consensus       207 ~f~l~~f~~l~~~~~s~~~~~~-i~~~~~~kptl~t~~v~~s~~~~-~~-~l~pe~~~~D~~~~E~~t~~G~~~~~~dTW  283 (490)
T KOG1259|consen  207 SFNLNAFRNLKTLKFSALSTEN-IVDIELLKPTLQTICVHNTTIQD-VP-SLLPETILADPSGSEPSTSNGSALVSADTW  283 (490)
T ss_pred             ccchHHhhhhheeeeeccchhh-eeceeecCchhheeeeecccccc-cc-cccchhhhcCccCCCCCccCCceEEecchH
Confidence            3334444556666665554331 11222223567777777666652 22 2222222222211111 1122222334445


Q ss_pred             CCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeee
Q 002883          320 LQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNF  399 (871)
Q Consensus       320 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  399 (871)
                      ..|++||||+|.|+ .+.++..-++.++.|++|+|.|. .+. .++.+++|+.||||+|.++ ....+-..+.+.+.|.|
T Consensus       284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L  359 (490)
T KOG1259|consen  284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL  359 (490)
T ss_pred             hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence            67889999999998 77778888899999999999997 333 3888999999999999998 66667777889999999


Q ss_pred             cCCcccccCccccCCCCCCCEEeCCCCcCCCCC-cccccccccccEEecCCCcCcccCC
Q 002883          400 SDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKI-PMFLNTFRFLQKLNLSFNNLEGEVP  457 (871)
Q Consensus       400 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~~~~L~~L~l~~N~l~~~~~  457 (871)
                      ++|.|.+  -+.+..+-+|..||+++|+|.... ...++++|-|+.+.|.+||+.+.+.
T Consensus       360 a~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  360 AQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             hhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            9999874  345778888999999999987422 2467888999999999999987654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.31  E-value=1.7e-11  Score=134.10  Aligned_cols=180  Identities=18%  Similarity=0.240  Sum_probs=136.0

Q ss_pred             eeccccceEE-EEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEeccCC
Q 002883          567 IGIGGYGYVY-KGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN  645 (871)
Q Consensus       567 lg~G~~g~V~-~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  645 (871)
                      .+-++.+ +| .|..+.++.+|.|.+.+...........+.++.++.++||+|+++++.+...     +..|+|+|.+  
T Consensus        20 ~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~-----~~~ylvTErV--   91 (690)
T KOG1243|consen   20 TAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEE-----GTLYLVTERV--   91 (690)
T ss_pred             ccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhccc-----CceEEEeecc--
Confidence            3334443 44 4666778899999998766655556778889999999999999999988776     5789999998  


Q ss_pred             CCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCCCC
Q 002883          646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNS  725 (871)
Q Consensus       646 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  725 (871)
                      ..|..+++.          +....+..-+.||+.||.|||+.+  +++|+++..+-|+|+..|..||++|..+.......
T Consensus        92 ~Pl~~~lk~----------l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~  159 (690)
T KOG1243|consen   92 RPLETVLKE----------LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN  159 (690)
T ss_pred             ccHHHHHHH----------hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC
Confidence            367777765          335567778899999999999764  89999999999999999999999999887543322


Q ss_pred             CCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCC
Q 002883          726 PDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGK  771 (871)
Q Consensus       726 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~  771 (871)
                      .   ......--..|..|+.+....  -..|.|-|||++||++.|.
T Consensus       160 ~---~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  160 A---PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             c---ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence            1   111112233466777543322  4569999999999999993

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.29  E-value=4.6e-11  Score=115.73  Aligned_cols=138  Identities=20%  Similarity=0.198  Sum_probs=100.1

Q ss_pred             CceeeccccceEEEEEECC------CCcEEEEEEeeccc----------------------cchHHHHH----HHHHHHH
Q 002883          564 ANLIGIGGYGYVYKGILGT------EETNVAVKVLDLQQ----------------------RGASKSFI----AECEALR  611 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~  611 (871)
                      ...||.|--+.||.|....      .+..+|||+++...                      ....+.+.    +|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998753      35789999974221                      01122333    8999999


Q ss_pred             cCC--CCccceeeeeecccCcCCCceeeEEEeccCCCCHHH-HhhcccccccccCCCCHHHHHHHHHHHHHHHHHH-hhc
Q 002883          612 SIR--HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLEN-WLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL-HHH  687 (871)
Q Consensus       612 ~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~  687 (871)
                      ++.  .-+++.++++         ...++||||+.+..+.. .++..        .++..+...+..+++.++..+ |+.
T Consensus        82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd~--------~~~~~~~~~i~~~i~~~l~~l~H~~  144 (197)
T cd05146          82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKDA--------KLNDEEMKNAYYQVLSMMKQLYKEC  144 (197)
T ss_pred             HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhcc--------ccCHHHHHHHHHHHHHHHHHHHHhC
Confidence            984  3567777765         22479999997654321 22211        245556777889999999999 787


Q ss_pred             CCCCeEecCCCCCceeeCCCCceEEeecccceecC
Q 002883          688 CHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH  722 (871)
Q Consensus       688 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  722 (871)
                         ++||||+++.||+++ ++.++++|||.|....
T Consensus       145 ---glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         145 ---NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             ---CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence               999999999999997 4689999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.25  E-value=8e-12  Score=139.79  Aligned_cols=149  Identities=15%  Similarity=0.146  Sum_probs=95.2

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc----------------------------------hHH---
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG----------------------------------ASK---  601 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------------------~~~---  601 (871)
                      ..|+. +.||+|++|+||+|+...+|+.||||+.++.-..                                  ..+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34666 7899999999999999877999999999643210                                  011   


Q ss_pred             ---HHHHHHHHHHcC----CCCccceeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHH
Q 002883          602 ---SFIAECEALRSI----RHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA  674 (871)
Q Consensus       602 ---~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~  674 (871)
                         ++.+|+..+.++    .+...+.+-..|.+.    ....++||||++|+.+.++-.-.... .....+....+..++
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~la~~~v~~~~  273 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAG-TDMKLLAERGVEVFF  273 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcC-CCHHHHHHHHHHHHH
Confidence               133444444443    233333333333221    13357999999999998753211100 000123333344444


Q ss_pred             HHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC----ceEEeecccceecCC
Q 002883          675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM----VAHVGDFGLSRLLHD  723 (871)
Q Consensus       675 ~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfg~a~~~~~  723 (871)
                      .|+.       ..   |++|+|+||.||+++.++    .++++|||++..+.+
T Consensus       274 ~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        274 TQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            4443       45   999999999999999888    999999999988754

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.24  E-value=1.9e-13  Score=137.02  Aligned_cols=232  Identities=22%  Similarity=0.271  Sum_probs=107.2

Q ss_pred             CCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCC----CCCCCccccccccCCCcccEEEccC
Q 002883          133 TLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGT----GKGNDLRFLDSLVNCTFLEVVSLSS  208 (871)
Q Consensus       133 ~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~~~~l~~l~~L~~L~L~~  208 (871)
                      .+..++.++|++|.+.....+      .+.+.+.+.++|++.++|+=-..-    ++....-+.+.+..+++|++||||+
T Consensus        28 ~~~s~~~l~lsgnt~G~EAa~------~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSD  101 (382)
T KOG1909|consen   28 PMDSLTKLDLSGNTFGTEAAR------AIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSD  101 (382)
T ss_pred             ccCceEEEeccCCchhHHHHH------HHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccc
Confidence            456677777777766422211      233445556666666665432111    1111111112333444555555555


Q ss_pred             CcCcccCChhhhhcc---ccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCC
Q 002883          209 NSLSGVLPNSIANFS---SHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKIS  285 (871)
Q Consensus       209 n~l~~~~~~~~~~~~---~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  285 (871)
                      |.+....+..+..+.   ..|++|+|.+|.+....-..++.  -|..|.  .|       .....-++|++++..+|++.
T Consensus       102 NA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~-------kk~~~~~~Lrv~i~~rNrle  170 (382)
T KOG1909|consen  102 NAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VN-------KKAASKPKLRVFICGRNRLE  170 (382)
T ss_pred             cccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HH-------hccCCCcceEEEEeeccccc
Confidence            555433333333221   12444444444443111111100  011111  11       11223356777777777765


Q ss_pred             CCC----CcccCCCccccEEEccCcccccc----CcccccCCCCCCEEecCCCcCCCC----CcccccCCCCCcEEeccC
Q 002883          286 GEI----PSSLGNLIFLTEVDLQGNSIRGS----IPSALGNCLQLQKLDLSDNNLSGT----IPREVIGLSSFVLLDLSR  353 (871)
Q Consensus       286 ~~~----~~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~ls~  353 (871)
                      ...    ...|...+.|+.+.++.|.|...    ...+|..+++|+.|||.+|-++..    +...+..+++|+.|++++
T Consensus       171 n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~d  250 (382)
T KOG1909|consen  171 NGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGD  250 (382)
T ss_pred             cccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccc
Confidence            322    22345556677777777766521    223456667777777777766521    223445555666666666


Q ss_pred             CCCCCCCccccC-----CCCCCCEEeCCCCcCC
Q 002883          354 NHLSGPIPLEVG-----RLKGIQQLDLSENKLS  381 (871)
Q Consensus       354 N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~  381 (871)
                      |.+......+|.     ..++|+.|.|.+|.|+
T Consensus       251 cll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt  283 (382)
T KOG1909|consen  251 CLLENEGAIAFVDALKESAPSLEVLELAGNEIT  283 (382)
T ss_pred             cccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence            666543333322     1345555555555554

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.22  E-value=9.8e-13  Score=135.52  Aligned_cols=40  Identities=18%  Similarity=0.273  Sum_probs=23.4

Q ss_pred             CCCCCcEEeccCCCCCCC-CccccCCCCCCCEEeCCCCcCC
Q 002883          342 GLSSFVLLDLSRNHLSGP-IPLEVGRLKGIQQLDLSENKLS  381 (871)
Q Consensus       342 ~l~~L~~L~ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~  381 (871)
                      .+++|++|+++.|+|... .-..+..+++|+.|....|.++
T Consensus       299 ~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  299 TFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             ccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence            345666666666666421 1123455667777777777776

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.21  E-value=9.6e-12  Score=117.97  Aligned_cols=104  Identities=32%  Similarity=0.435  Sum_probs=21.5

Q ss_pred             CCCEEecCCCcCCCCCccccc-CCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccch-hcccCCceee
Q 002883          321 QLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSL-ASCVGLEYLN  398 (871)
Q Consensus       321 ~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~  398 (871)
                      ++++|+|++|+|+ .+. .+. .+.+|+.|+|++|.|+. +. .+..++.|+.|++++|+|+. +.+.+ ..+++|++|+
T Consensus        20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~   94 (175)
T PF14580_consen   20 KLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY   94 (175)
T ss_dssp             ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred             ccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence            3444555555544 221 222 23444444444444441 11 24444555555555555542 22222 2344555555


Q ss_pred             ecCCcccccCc-cccCCCCCCCEEeCCCCcCC
Q 002883          399 FSDNSFQGPIH-SGFSSLKGLQDLDLSRNNFS  429 (871)
Q Consensus       399 L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~  429 (871)
                      |++|+|..... ..+..+++|+.|+|.+|.++
T Consensus        95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             -TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             CcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            55555543211 22333444444444444443

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.21  E-value=1.9e-12  Score=133.41  Aligned_cols=133  Identities=23%  Similarity=0.249  Sum_probs=76.0

Q ss_pred             ccccEEEccCCccCCC-CCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCC--cccCCCccccE
Q 002883          224 SHLIYLYMSANRISGT-IPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIP--SSLGNLIFLTE  300 (871)
Q Consensus       224 ~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~  300 (871)
                      ++|+.|.|+.|.++.. +-..+..+++|+.|+|+.|...........-+..|+.|||++|++. ..+  ...+.++.|+.
T Consensus       197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~  275 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQ  275 (505)
T ss_pred             hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhh
Confidence            3455555555554411 1112234556666666666422233334445566777777777766 233  34566777777


Q ss_pred             EEccCccccccC-ccc-----ccCCCCCCEEecCCCcCCCCC-cccccCCCCCcEEeccCCCCC
Q 002883          301 VDLQGNSIRGSI-PSA-----LGNCLQLQKLDLSDNNLSGTI-PREVIGLSSFVLLDLSRNHLS  357 (871)
Q Consensus       301 L~L~~N~i~~~~-~~~-----~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~ls~N~l~  357 (871)
                      |+++.|.|..+- |+.     ...+++|++|+++.|+|.+.. -..+..+++|+.|....|.++
T Consensus       276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence            777777776432 222     235677888888888885221 134556677788888888876

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.19  E-value=5.6e-11  Score=115.46  Aligned_cols=131  Identities=18%  Similarity=0.137  Sum_probs=95.6

Q ss_pred             CceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCcc-ceeeeeecccCcCCCceeeEEEec
Q 002883          564 ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNL-VKIITSCSSIDTRGNEFKALVYEF  642 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~  642 (871)
                      .+.++.|.++.||+++..  +..|++|+...... ....+.+|+.+++.+.+..+ .+++.+..       ...++||||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-------~~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP-------ETGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC-------CCCeEEEEe
Confidence            356889999999999974  77899999854432 12346789999998855443 44544321       124799999


Q ss_pred             cCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC--HTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       643 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ++|.++.+.    .       ..    ...++.+++++++.||+..  +.+++|||++|.||+++ ++.++++|||.+..
T Consensus        73 i~G~~l~~~----~-------~~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          73 IEGSELLTE----D-------FS----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cCCCccccc----c-------cc----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            999877643    0       01    1235678999999999982  22369999999999999 66899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.19  E-value=5.4e-12  Score=123.44  Aligned_cols=204  Identities=21%  Similarity=0.203  Sum_probs=146.4

Q ss_pred             cCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCC-CcCCCCCccccc
Q 002883          263 SIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSD-NNLSGTIPREVI  341 (871)
Q Consensus       263 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~  341 (871)
                      ..|-.+.-..+|+.+.+|++.-. .+.+....=+.|.++...+..+. ..|. +-.+..+..+.-+. .-.+|..-..+.
T Consensus       205 ~l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~-~~~~-l~pe~~~~D~~~~E~~t~~G~~~~~~d  281 (490)
T KOG1259|consen  205 RLSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQ-DVPS-LLPETILADPSGSEPSTSNGSALVSAD  281 (490)
T ss_pred             ccccchHHhhhhheeeeeccchh-heeceeecCchhheeeeeccccc-cccc-ccchhhhcCccCCCCCccCCceEEecc
Confidence            44555566678888888887655 23333334467888888777665 2222 21222222222211 112233334555


Q ss_pred             CCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEE
Q 002883          342 GLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDL  421 (871)
Q Consensus       342 ~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  421 (871)
                      .++.|++||||+|.|+ .+.....-.+.++.|++|+|.|. .+. .+..+++|+.||||+|.++.. ...-..+-+++.|
T Consensus       282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~~-~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAEC-VGWHLKLGNIKTL  357 (490)
T ss_pred             hHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHhh-hhhHhhhcCEeee
Confidence            6788999999999999 77778888999999999999998 333 388999999999999999853 4445568899999


Q ss_pred             eCCCCcCCCCCcccccccccccEEecCCCcCccc--CCCCcccccccceeccCCCC
Q 002883          422 DLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGE--VPSEGVFKNVRAVSIIGNNK  475 (871)
Q Consensus       422 ~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~--~~~~~~~~~l~~l~l~~N~~  475 (871)
                      .|+.|.|..  -..+..+-+|..||+++|++...  +...+.++.+..+.+.+||.
T Consensus       358 ~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl  411 (490)
T KOG1259|consen  358 KLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL  411 (490)
T ss_pred             ehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence            999999873  34567788899999999999864  44567889999999999985

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.18  E-value=3.4e-13  Score=135.34  Aligned_cols=90  Identities=23%  Similarity=0.236  Sum_probs=52.9

Q ss_pred             CcCCCCCCEEecCCCcccc----cCCccccCCCcCceeeCCCC---cccccCCccc-------cCCcccceeeccCcccc
Q 002883           10 ITHCSELRILDLVVNKLEG----NIPSELGNLFKLVGLGLTGN---NYTGSIPQSL-------SNLSFLQQLSLSENSLS   75 (871)
Q Consensus        10 ~~~l~~L~~L~l~~n~i~~----~~~~~~~~l~~L~~L~L~~n---~l~~~~p~~~-------~~l~~L~~L~Ls~n~l~   75 (871)
                      +..+..++.|+||+|.+..    .+-..+...++|+.-++|+-   ++...+|+++       -..++|++||||+|.+.
T Consensus        26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G  105 (382)
T KOG1909|consen   26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG  105 (382)
T ss_pred             hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence            3455667788888888743    33445556667777777765   3334444432       23456777777777665


Q ss_pred             CCCCcc----cccccccccccccccccc
Q 002883           76 GNIPSE----LGLLKQLNMFQVSANYLT   99 (871)
Q Consensus        76 ~~~~~~----~~~l~~L~~L~l~~n~l~   99 (871)
                      ...+..    +..+..|++|.|++|.+.
T Consensus       106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg  133 (382)
T KOG1909|consen  106 PKGIRGLEELLSSCTDLEELYLNNCGLG  133 (382)
T ss_pred             ccchHHHHHHHHhccCHHHHhhhcCCCC
Confidence            433333    334556666666666554

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.18  E-value=2.1e-11  Score=115.69  Aligned_cols=84  Identities=30%  Similarity=0.326  Sum_probs=19.9

Q ss_pred             CccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccc-cCCCCCcEEeccCCCCCCCC-ccccCCCCCCCE
Q 002883          295 LIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREV-IGLSSFVLLDLSRNHLSGPI-PLEVGRLKGIQQ  372 (871)
Q Consensus       295 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~ls~N~l~~~~-~~~~~~l~~L~~  372 (871)
                      +.+|+.|+|++|.|+..  +.+..+++|++|++++|+|+. +...+ ..+++|++|++++|+|.... -..++.+++|+.
T Consensus        41 l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~  117 (175)
T PF14580_consen   41 LDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRV  117 (175)
T ss_dssp             -TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--E
T ss_pred             hcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcce
Confidence            34444444444444421  123344444444444444442 21112 12344444444444443211 123334444444


Q ss_pred             EeCCCCcCC
Q 002883          373 LDLSENKLS  381 (871)
Q Consensus       373 L~L~~N~l~  381 (871)
                      |+|.+|+++
T Consensus       118 L~L~~NPv~  126 (175)
T PF14580_consen  118 LSLEGNPVC  126 (175)
T ss_dssp             EE-TT-GGG
T ss_pred             eeccCCccc
Confidence            444444444

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.16  E-value=4.2e-12  Score=141.44  Aligned_cols=155  Identities=26%  Similarity=0.302  Sum_probs=74.7

Q ss_pred             CccccEEEccCccccccCc-ccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCC--CCC
Q 002883          295 LIFLTEVDLQGNSIRGSIP-SALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLK--GIQ  371 (871)
Q Consensus       295 l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~--~L~  371 (871)
                      ++.|+.+++++|++....+ . ...+.+++.+++.+|.+..  ...+..+..+..+++..|.++..-  .+..+.  .|+
T Consensus       161 l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~--~l~~~~~~~L~  235 (414)
T KOG0531|consen  161 LKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLE--GLNELVMLHLR  235 (414)
T ss_pred             chhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceecc--CcccchhHHHH
Confidence            4444444444444442222 1 2344445555555555431  122233333333455555544111  112222  256


Q ss_pred             EEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCC---CCccc-ccccccccEEec
Q 002883          372 QLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSG---KIPMF-LNTFRFLQKLNL  447 (871)
Q Consensus       372 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~---~~~~~-~~~~~~L~~L~l  447 (871)
                      .+++++|++. ..+..+..+..+..|++.+|++...  ..+.....+..+.+..|++..   ..... ....+.+..+.+
T Consensus       236 ~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (414)
T KOG0531|consen  236 ELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTL  312 (414)
T ss_pred             HHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhcccccccccccccccc
Confidence            6666666665 3334555566666666666666532  224444556666666666552   11111 445566777777


Q ss_pred             CCCcCcccCC
Q 002883          448 SFNNLEGEVP  457 (871)
Q Consensus       448 ~~N~l~~~~~  457 (871)
                      .+|+.....+
T Consensus       313 ~~~~~~~~~~  322 (414)
T KOG0531|consen  313 ELNPIRKISS  322 (414)
T ss_pred             ccCccccccc
Confidence            7777766444

>PLN03150 hypothetical protein; Provisional

Probab=99.16  E-value=7.3e-11  Score=137.31  Aligned_cols=113  Identities=34%  Similarity=0.491  Sum_probs=103.9

Q ss_pred             CCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCC
Q 002883          345 SFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLS  424 (871)
Q Consensus       345 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  424 (871)
                      .++.|+|++|.+.+.+|..++.+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..++.+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCCCCCccccccc-ccccEEecCCCcCcccCC
Q 002883          425 RNNFSGKIPMFLNTF-RFLQKLNLSFNNLEGEVP  457 (871)
Q Consensus       425 ~N~l~~~~~~~~~~~-~~L~~L~l~~N~l~~~~~  457 (871)
                      +|++++.+|..+... .++..+++.+|+..|..|
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            999999999988763 467889999999777554

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.16  E-value=3.8e-12  Score=141.73  Aligned_cols=236  Identities=30%  Similarity=0.285  Sum_probs=151.4

Q ss_pred             cccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEcc
Q 002883          225 HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQ  304 (871)
Q Consensus       225 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  304 (871)
                      .+..++++.|.|. ..-..+..+++|+.|++..|.|.. +...+..+++|++|+|++|+|+..  ..+..++.|+.|+++
T Consensus        73 ~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~  148 (414)
T KOG0531|consen   73 SLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLS  148 (414)
T ss_pred             hHHhhccchhhhh-hhhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccc--cchhhccchhhheec
Confidence            3555566666665 233446667777777777777773 222266777888888888888733  336666778888888


Q ss_pred             CccccccCcccccCCCCCCEEecCCCcCCCCCc-ccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCC
Q 002883          305 GNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIP-REVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGE  383 (871)
Q Consensus       305 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  383 (871)
                      +|.|+.+  ..+..+++|+.+++++|+++...+ . ...+.+++.+++++|.+.  ....+..+..+..+++..|.++..
T Consensus       149 ~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~  223 (414)
T KOG0531|consen  149 GNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKL  223 (414)
T ss_pred             cCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceec
Confidence            8888732  345667888888888888874433 1 467778888888888886  233455566666668888887732


Q ss_pred             Cccchhccc--CCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCccc---CCC
Q 002883          384 IPTSLASCV--GLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGE---VPS  458 (871)
Q Consensus       384 ~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~---~~~  458 (871)
                      .+  +..+.  .|+.+++++|++... +..+..+..+..|++.+|++...  ..+...+.+..+.+..|++...   ...
T Consensus       224 ~~--l~~~~~~~L~~l~l~~n~i~~~-~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (414)
T KOG0531|consen  224 EG--LNELVMLHLRELYLSGNRISRS-PEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQE  298 (414)
T ss_pred             cC--cccchhHHHHHHhcccCccccc-cccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhcc
Confidence            22  22223  378888888888743 25566777888888888888732  3355566677777777776632   111


Q ss_pred             --CcccccccceeccCCC
Q 002883          459 --EGVFKNVRAVSIIGNN  474 (871)
Q Consensus       459 --~~~~~~l~~l~l~~N~  474 (871)
                        ....+.+....+.+||
T Consensus       299 ~~~~~~~~~~~~~~~~~~  316 (414)
T KOG0531|consen  299 YITSAAPTLVTLTLELNP  316 (414)
T ss_pred             ccccccccccccccccCc
Confidence              2233445555565554

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.13  E-value=3e-11  Score=131.30  Aligned_cols=251  Identities=19%  Similarity=0.160  Sum_probs=173.6

Q ss_pred             hhcCCCCCceeeccccceEEEEEEC-CCCcEEEEEEeeccccchHHH--HHHHHHHHHcC-CCCccceeeeeecccCcCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILG-TEETNVAVKVLDLQQRGASKS--FIAECEALRSI-RHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  632 (871)
                      ...+|..+..||.|.|+.|+..... .++..|++|...........+  -..|+.+...+ .|.++++.+..+...    
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~----  338 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL----  338 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc----
Confidence            3457888999999999999998765 577889999874433322222  23455555555 588888877666554    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-CceE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE-MVAH  711 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~k  711 (871)
                       ...|+--|||++++....+....       .+++...+++..|++.++.++|+.   .++|+|+||+||++..+ +..+
T Consensus       339 -r~~~ip~e~~~~~s~~l~~~~~~-------~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~  407 (524)
T KOG0601|consen  339 -RQGYIPLEFCEGGSSSLRSVTSQ-------MLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSK  407 (524)
T ss_pred             -ccccCchhhhcCcchhhhhHHHH-------hcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhh
Confidence             44679999999999887763322       478888999999999999999998   99999999999999876 7889


Q ss_pred             EeecccceecCCCCCCccccccccccccc-cCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGY-VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM  790 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~  790 (871)
                      +.|||++..+.-.     ......++..| .+|+......+..++|+||||..+.+..+|..--....    .+......
T Consensus       408 ~~~~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~  478 (524)
T KOG0601|consen  408 LGDFGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSG  478 (524)
T ss_pred             cccccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecc
Confidence            9999998743211     11111233444 36666667788899999999999999999876433210    00000000


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                      ..+.                                .......+..+...+...++..||.+.+.....+...
T Consensus       479 ~~p~--------------------------------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  479 DTPN--------------------------------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             cccC--------------------------------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            0000                                0011123456667788899999999988876655443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.09  E-value=7.7e-10  Score=102.68  Aligned_cols=129  Identities=22%  Similarity=0.270  Sum_probs=95.7

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccc--------cchHHHHHHHHHHHHcCCCC--ccceeeeeecccCcCCCc
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--------RGASKSFIAECEALRSIRHR--NLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~  634 (871)
                      ..+++|+-+.+|.+.+.  |..+++|.-.+..        .-...+..+|+.++.+++--  +++.++++  +.     .
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~-----~   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DP-----D   72 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cC-----C
Confidence            45789999999999774  5557777652211        11124567899999887533  33444444  22     3


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ...|+|||++|..|.+++...              ...++..+-.-+.-||..   ||||+|+.++||++.++. +.++|
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~--------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~ID  134 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEA--------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFID  134 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhc--------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEE
Confidence            457999999999999888753              134677788888899999   999999999999998764 99999


Q ss_pred             ccccee
Q 002883          715 FGLSRL  720 (871)
Q Consensus       715 fg~a~~  720 (871)
                      ||++.+
T Consensus       135 fGLg~~  140 (204)
T COG3642         135 FGLGEF  140 (204)
T ss_pred             CCcccc
Confidence            999974

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.05  E-value=1.7e-09  Score=99.58  Aligned_cols=143  Identities=20%  Similarity=0.234  Sum_probs=101.6

Q ss_pred             CCceeeccccceEEEEEECCCCcEEEEEEeeccc--------cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          563 SANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--------RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       563 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ....+-+|+-+.|+++.+  .|+..+||.-....        .-..++..+|++.+.++.--.|....-++.+.     .
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-----~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-----Y   83 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-----C
Confidence            567899999999999999  57888888652211        11235677899998887432222222222222     2


Q ss_pred             eeeEEEeccCC-CCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC---ce
Q 002883          635 FKALVYEFMPN-GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM---VA  710 (871)
Q Consensus       635 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~  710 (871)
                      .-.++|||++| .++.+++......     .........++.+|-+.+.-||..   +|+||||..+||++.+++   .+
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~-----~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~  155 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMED-----ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITP  155 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccC-----cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCce
Confidence            23699999976 4888888765432     223333368899999999999999   999999999999997655   45


Q ss_pred             EEeeccccee
Q 002883          711 HVGDFGLSRL  720 (871)
Q Consensus       711 kl~Dfg~a~~  720 (871)
                      .++|||++..
T Consensus       156 ~lIdfgls~~  165 (229)
T KOG3087|consen  156 ILIDFGLSSV  165 (229)
T ss_pred             EEEeecchhc
Confidence            8999999864

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.05  E-value=9.9e-11  Score=138.77  Aligned_cols=131  Identities=27%  Similarity=0.329  Sum_probs=100.3

Q ss_pred             CCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCc--ccccCCccccCCcccceeeccCccccCCCCcccccccccc
Q 002883           12 HCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNN--YTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLN   89 (871)
Q Consensus        12 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~   89 (871)
                      +....+...+-+|.+. .++.+..+- +|++|-+.+|.  +....++.|..++.|++||||+|.=-+.+|..++.|-+|+
T Consensus       521 ~~~~~rr~s~~~~~~~-~~~~~~~~~-~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr  598 (889)
T KOG4658|consen  521 SWNSVRRMSLMNNKIE-HIAGSSENP-KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR  598 (889)
T ss_pred             chhheeEEEEeccchh-hccCCCCCC-ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence            3356788888888886 455554333 78899999986  5534445588899999999998866568999999999999


Q ss_pred             ccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCcc
Q 002883           90 MFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNW  146 (871)
Q Consensus        90 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~  146 (871)
                      +|+++++.++ .+|.++.+|..|.+|++..+.-...+ ..+...|++|++|.+-...
T Consensus       599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~-~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESI-PGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             cccccCCCcc-ccchHHHHHHhhheeccccccccccc-cchhhhcccccEEEeeccc
Confidence            9999999998 88999999999999998887655334 4444468888888776654

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.04  E-value=1.4e-10  Score=137.63  Aligned_cols=108  Identities=30%  Similarity=0.360  Sum_probs=95.5

Q ss_pred             CCCCCEEecCCCc--ccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccc
Q 002883           13 CSELRILDLVVNK--LEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNM   90 (871)
Q Consensus        13 l~~L~~L~l~~n~--i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~   90 (871)
                      .++|+.|-+..|.  +....++.|..++.|++|||++|.=-+.+|.+++.|-+|++|+|++..++ .+|..+++|++|.+
T Consensus       544 ~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~  622 (889)
T KOG4658|consen  544 NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIY  622 (889)
T ss_pred             CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhe
Confidence            3479999999997  55455566889999999999999777799999999999999999999999 99999999999999


Q ss_pred             cccccccccCCCCccccccCCCceeeeeccc
Q 002883           91 FQVSANYLTGSIPIQLFNISSMDYFAVTQNK  121 (871)
Q Consensus        91 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  121 (871)
                      |++..+.-...+|.....|++|++|.+....
T Consensus       623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  623 LNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             eccccccccccccchhhhcccccEEEeeccc
Confidence            9999998776777777889999999997654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.03  E-value=4e-09  Score=108.84  Aligned_cols=274  Identities=13%  Similarity=0.116  Sum_probs=162.9

Q ss_pred             CCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecc--cCcCCCceeeE
Q 002883          562 SSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSS--IDTRGNEFKAL  638 (871)
Q Consensus       562 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~~~~~~l  638 (871)
                      ...+.+|+|+-+.+|-.-.   -...+.|++.........+   .++.|... .||-+..-+.+=..  ...++.....+
T Consensus        14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecch---hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            4568899999999996432   2334668875444322222   22333333 56654431211100  01122233677


Q ss_pred             EEeccCCC-CHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          639 VYEFMPNG-SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       639 v~e~~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      .|..+.+. ...++..... .....+..+|...++.++.++.+.+.||+.   |.+-||+.++|+|+++++.+.|.|-..
T Consensus        88 lmP~v~g~~pI~~~y~p~t-RRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPAT-RRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             ecccCCCccchhhhcCchh-hcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence            88887664 2222222211 112244689999999999999999999999   999999999999999999999998655


Q ss_pred             ceecCCCCCCccccccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhC-CCCCchhhhhhh---hHH-HH
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGA-----LGEVSTHGDEYSFGILMLEMFTG-KRPTDDMFEEGL---SLH-KY  787 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG-~~pf~~~~~~~~---~~~-~~  787 (871)
                      -.....    .......+|...|.+||...     +..-+...|-|.+|+++++++.| ++||.+......   ... .+
T Consensus       164 fqi~~n----g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I  239 (637)
T COG4248         164 FQINAN----GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI  239 (637)
T ss_pred             eeeccC----CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence            444322    22333457899999999633     34457788999999999999885 999986432110   000 00


Q ss_pred             hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccC--CCCCCCCHHHHHHHHHHHHHH
Q 002883          788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEE--LPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPta~evl~~L~~i~~~  865 (871)
                      ....+-..                ...-....++....-+.-.+..+..+...|+..  .|.-|||++.++..|.++.+.
T Consensus       240 a~g~f~ya----------------~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         240 AHGRFAYA----------------SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             hcceeeec----------------hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            00000000                000000001111111222233444555666654  367899999999999888654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.99  E-value=3.2e-09  Score=108.23  Aligned_cols=145  Identities=21%  Similarity=0.224  Sum_probs=108.0

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCC--CccceeeeeecccCcCCCceeeEEEe
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRH--RNLVKIITSCSSIDTRGNEFKALVYE  641 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e  641 (871)
                      +.++.|.++.||++... +|+.+++|+...... .....+.+|+++++.+.+  ..+.+++.+.....  ..+..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence            56899999999999885 367899999754332 134577899999999965  34566776654321  1134689999


Q ss_pred             ccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------
Q 002883          642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC---------------------------------  688 (871)
Q Consensus       642 ~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------  688 (871)
                      |++|.++.+.+.. .       .++..+...++.++++++.+||+..                                 
T Consensus        81 ~i~G~~l~~~~~~-~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (223)
T cd05154          81 RVDGRVLRDRLLR-P-------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTD  152 (223)
T ss_pred             EeCCEecCCCCCC-C-------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccc
Confidence            9999888775532 1       3667777788888888888888521                                 


Q ss_pred             --------------------CCCeEecCCCCCceeeCC--CCceEEeeccccee
Q 002883          689 --------------------HTSIVHCDLKPSNVLLDN--EMVAHVGDFGLSRL  720 (871)
Q Consensus       689 --------------------~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~  720 (871)
                                          ...++|+|++|.||+++.  ++.+.++||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         153 EPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             ccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                246899999999999998  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.98  E-value=3.5e-09  Score=102.41  Aligned_cols=126  Identities=21%  Similarity=0.219  Sum_probs=83.0

Q ss_pred             eEEEEEECCCCcEEEEEEeecccc--------------------------chHHHHHHHHHHHHcCCCC--ccceeeeee
Q 002883          574 YVYKGILGTEETNVAVKVLDLQQR--------------------------GASKSFIAECEALRSIRHR--NLVKIITSC  625 (871)
Q Consensus       574 ~V~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~h~--niv~~~~~~  625 (871)
                      .||.|... ++..+|+|+.+....                          .......+|++.|.++..-  ++++++++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38999985 788999999743210                          0113567899999999654  567777552


Q ss_pred             cccCcCCCceeeEEEeccC--CCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCeEecCCCCCce
Q 002883          626 SSIDTRGNEFKALVYEFMP--NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY-LHHHCHTSIVHCDLKPSNV  702 (871)
Q Consensus       626 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlkp~Ni  702 (871)
                               ...+||||++  |..+..+....         ++......++.+++..+.. +|..   ||+|||+.+.||
T Consensus        80 ---------~~~ivME~I~~~G~~~~~l~~~~---------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NI  138 (188)
T PF01163_consen   80 ---------RNVIVMEYIGEDGVPLPRLKDVD---------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNI  138 (188)
T ss_dssp             ---------TTEEEEE--EETTEEGGCHHHCG---------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSE
T ss_pred             ---------CCEEEEEecCCCccchhhHHhcc---------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhE
Confidence                     2379999998  65554433321         2234456677888886665 4677   999999999999


Q ss_pred             eeCCCCceEEeecccceecC
Q 002883          703 LLDNEMVAHVGDFGLSRLLH  722 (871)
Q Consensus       703 ll~~~~~~kl~Dfg~a~~~~  722 (871)
                      +++++ .+.++|||.|....
T Consensus       139 lv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  139 LVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             EEETT-CEEE--GTTEEETT
T ss_pred             Eeecc-eEEEEecCcceecC
Confidence            99887 99999999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.97  E-value=1.7e-10  Score=131.59  Aligned_cols=208  Identities=21%  Similarity=0.237  Sum_probs=149.5

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ...+.+.+.+-+.+|+++.++.+.-..++...++|+......   ...+....+-.+.-...+|.++.....+.     .
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-----~  875 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-----C  875 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-----C
Confidence            355677888899999999999998877776666665532211   11122222222222233455554443321     2


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                      ....++|++|..+++|...++...       ..+.+.++.....+..+..|||..   .+.|+|++|.|.+...++..++
T Consensus       876 rsP~~L~~~~~~~~~~~Skl~~~~-------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l  945 (1205)
T KOG0606|consen  876 RSPLPLVGHYLNGGDLPSKLHNSG-------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPL  945 (1205)
T ss_pred             CCCcchhhHHhccCCchhhhhcCC-------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCccc
Confidence            255789999999999999987754       356666777788889999999998   7999999999999999999999


Q ss_pred             eecccceecCCC---------------------CC-------CccccccccccccccCcccccCCCCCCccchhhHHHHH
Q 002883          713 GDFGLSRLLHDN---------------------SP-------DQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM  764 (871)
Q Consensus       713 ~Dfg~a~~~~~~---------------------~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il  764 (871)
                      .|||.....+.-                     ..       .........||+.|.|||...+......+|.|+.|+++
T Consensus       946 ~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l 1025 (1205)
T KOG0606|consen  946 TDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCL 1025 (1205)
T ss_pred             CccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhh
Confidence            999844332210                     00       00112235689999999999999999999999999999


Q ss_pred             HHHHhCCCCCchhh
Q 002883          765 LEMFTGKRPTDDMF  778 (871)
Q Consensus       765 ~elltG~~pf~~~~  778 (871)
                      +|.++|.+||....
T Consensus      1026 ~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 1026 FEVLTGIPPFNAET 1039 (1205)
T ss_pred             hhhhcCCCCCCCcc
Confidence            99999999998643

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.91  E-value=4e-08  Score=104.49  Aligned_cols=179  Identities=18%  Similarity=0.211  Sum_probs=136.7

Q ss_pred             ccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEeccCC-CCHH
Q 002883          571 GYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN-GSLE  649 (871)
Q Consensus       571 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~  649 (871)
                      .-.+.|++....+|..|++|.++..+.........-+++++++.|+|+|++.+++... .-++...++|++|+++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~-tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTY-TFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhh-ccCcceEEEEEecCCCCchHH
Confidence            3468999999999999999999544443333344567889999999999999988743 4455678999999986 6777


Q ss_pred             HHhhccccc--------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceec
Q 002883          650 NWLNQKEDE--------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL  721 (871)
Q Consensus       650 ~~l~~~~~~--------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  721 (871)
                      ++--.....        ..+....++...|.++.|+..||.++|+.   |+.-+-+.|.+|+++++.+++|+..|....+
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence            754332211        23455688999999999999999999999   9999999999999999989999888877665


Q ss_pred             CCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCC
Q 002883          722 HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP  773 (871)
Q Consensus       722 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~p  773 (871)
                      ..+.               .  |.+.   --.+-|.=.||.++..|.||..-
T Consensus       444 ~~d~---------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  444 QEDP---------------T--EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             cCCC---------------C--cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            4332               0  1111   12456888999999999999654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.90  E-value=3e-08  Score=102.04  Aligned_cols=147  Identities=13%  Similarity=0.047  Sum_probs=101.9

Q ss_pred             CceeeccccceEEEEEECCCCcEEEEEEeeccccc-----------hHHHHHHHHHHHHcCCC--CccceeeeeecccCc
Q 002883          564 ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG-----------ASKSFIAECEALRSIRH--RNLVKIITSCSSIDT  630 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~  630 (871)
                      .+.+-......|+++..  .|+.|.||........           ....+.+|...+.++..  -.++..+++......
T Consensus        27 ~e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~  104 (268)
T PRK15123         27 GEVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSN  104 (268)
T ss_pred             CcEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCC
Confidence            34555555556777766  5778999977432211           11146788888887732  233344444432212


Q ss_pred             CCCceeeEEEeccCCC-CHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---
Q 002883          631 RGNEFKALVYEFMPNG-SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN---  706 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---  706 (871)
                      ......++|||++++. +|.+++......     ..+......++.+++..+.-||..   ||+|+|++++|||++.   
T Consensus       105 ~~~~~s~LVte~l~~~~sL~~~~~~~~~~-----~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~  176 (268)
T PRK15123        105 PATRTSFIITEDLAPTISLEDYCADWATN-----PPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFP  176 (268)
T ss_pred             CccceeEEEEeeCCCCccHHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEecccc
Confidence            2124468999999875 899998643211     356677889999999999999999   9999999999999975   


Q ss_pred             ----CCceEEeeccccee
Q 002883          707 ----EMVAHVGDFGLSRL  720 (871)
Q Consensus       707 ----~~~~kl~Dfg~a~~  720 (871)
                          ++.+.++||+.+..
T Consensus       177 ~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        177 GREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCCCceEEEEECCcccc
Confidence                46899999998864

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.89  E-value=1.1e-09  Score=85.28  Aligned_cols=61  Identities=43%  Similarity=0.513  Sum_probs=49.6

Q ss_pred             CCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccc
Q 002883           14 SELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSL   74 (871)
Q Consensus        14 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l   74 (871)
                      ++|+.|++++|+|+...+++|.++++|++|++++|+++...|++|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4678888888888866667888888888888888888877777888888888888888865

...

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.86  E-value=1.6e-08  Score=99.74  Aligned_cols=136  Identities=24%  Similarity=0.201  Sum_probs=100.8

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeecccc----------------------chHHHHHHHHHHHHcCCCC--
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR----------------------GASKSFIAECEALRSIRHR--  616 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--  616 (871)
                      +.++..||-|--|.||.|.+. .|.++|||.-+....                      ......++|.++|+.+...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            557789999999999999997 789999997532110                      0123567899999999544  


Q ss_pred             ccceeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 002883          617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD  696 (871)
Q Consensus       617 niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  696 (871)
                      .|.+.+++         +...+|||+++|-.|...-            ++.+....++..|+.-+..+-..   ||||||
T Consensus       172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~r------------~~~en~~~il~~il~~~~~~~~~---GiVHGD  227 (304)
T COG0478         172 KVPKPIAW---------NRHAVVMEYIEGVELYRLR------------LDVENPDEILDKILEEVRKAYRR---GIVHGD  227 (304)
T ss_pred             CCCCcccc---------ccceeeeehcccceeeccc------------CcccCHHHHHHHHHHHHHHHHHc---CccccC
Confidence            77777765         4468999999886655322            22334445555666655555566   999999


Q ss_pred             CCCCceeeCCCCceEEeecccceec
Q 002883          697 LKPSNVLLDNEMVAHVGDFGLSRLL  721 (871)
Q Consensus       697 lkp~Nill~~~~~~kl~Dfg~a~~~  721 (871)
                      +++-||+++++|.+.++||--+...
T Consensus       228 lSefNIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         228 LSEFNILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             CchheEEEecCCCEEEEeCcccccC
Confidence            9999999999999999999766543

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.85  E-value=3.3e-11  Score=131.26  Aligned_cols=129  Identities=31%  Similarity=0.367  Sum_probs=97.2

Q ss_pred             CCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCcc-chhcccCCceeee
Q 002883          321 QLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPT-SLASCVGLEYLNF  399 (871)
Q Consensus       321 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L  399 (871)
                      .|...+.++|.+. ....++.-++.|+.|+|++|+++. .. .+..++.|++|||++|.++ .+|. ...++. |..|.+
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l  239 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL  239 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhh-hH-HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence            4777788888887 667777778888888888888873 22 6788888888888888888 4443 333444 888899


Q ss_pred             cCCcccccCccccCCCCCCCEEeCCCCcCCCCC-cccccccccccEEecCCCcCcccC
Q 002883          400 SDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKI-PMFLNTFRFLQKLNLSFNNLEGEV  456 (871)
Q Consensus       400 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~~~~L~~L~l~~N~l~~~~  456 (871)
                      ++|.++..  ..+.+|++|+.||+++|-|.+.- -..++.+..|+.|+|.|||+.|.+
T Consensus       240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            99988743  34678888999999999887522 234677888999999999988753

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.83  E-value=1.8e-09  Score=84.18  Aligned_cols=59  Identities=37%  Similarity=0.475  Sum_probs=28.7

Q ss_pred             CCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCc
Q 002883          393 GLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNN  451 (871)
Q Consensus       393 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~  451 (871)
                      +|++|++++|+|+.+.+..|.++++|++|++++|+++...|..|..+++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            34444444444444444444444555555555555544444444555555555555544

...

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.79  E-value=1.4e-10  Score=126.56  Aligned_cols=131  Identities=22%  Similarity=0.247  Sum_probs=109.1

Q ss_pred             CCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEe
Q 002883          343 LSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLD  422 (871)
Q Consensus       343 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  422 (871)
                      +..|...+.++|.+. .....+.-++.|+.|||++|+++..  ..+..|++|++|||+.|.++.++--...+.. |+.|.
T Consensus       163 Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~  238 (1096)
T KOG1859|consen  163 WNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLN  238 (1096)
T ss_pred             hhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeee
Confidence            357888999999998 6777888899999999999999844  3789999999999999999966555555555 99999


Q ss_pred             CCCCcCCCCCcccccccccccEEecCCCcCcccCC--CCcccccccceeccCCCCCccC
Q 002883          423 LSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVP--SEGVFKNVRAVSIIGNNKLCGG  479 (871)
Q Consensus       423 l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~--~~~~~~~l~~l~l~~N~~~C~~  479 (871)
                      +++|.+++.  ..+.++++|+.|||+.|-|.+.-.  ..+.+..+..|.+.|||..|..
T Consensus       239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            999999843  357889999999999999987433  3466778899999999987763

>PRK09902 hypothetical protein; Provisional

Probab=98.69  E-value=2.7e-07  Score=89.46  Aligned_cols=143  Identities=17%  Similarity=0.111  Sum_probs=105.1

Q ss_pred             eeccccceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHHHHcCCC--CccceeeeeecccCcCCCceeeE
Q 002883          567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQ------RGASKSFIAECEALRSIRH--RNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       567 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      -|+||.+.|+.....  |..+-+|.-....      +.....|.+|...++++..  -.+.+++ ++........-..++
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            357999999998874  4468888763111      2235789999999998842  2355555 332222333345689


Q ss_pred             EEeccCC-CCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc--eEEeec
Q 002883          639 VYEFMPN-GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV--AHVGDF  715 (871)
Q Consensus       639 v~e~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Df  715 (871)
                      |+|-+++ .+|.+++......     +.+......+..+++..++-||+.   |+.|+|+.+.||+++.++.  ++++||
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~-----~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDl  174 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVS-----PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDL  174 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcC-----CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEh
Confidence            9997753 6899988664321     467788889999999999999999   9999999999999986666  999999


Q ss_pred             cccee
Q 002883          716 GLSRL  720 (871)
Q Consensus       716 g~a~~  720 (871)
                      .-++.
T Consensus       175 Ek~r~  179 (216)
T PRK09902        175 EKSRR  179 (216)
T ss_pred             hccch
Confidence            87764

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.61  E-value=5e-09  Score=103.05  Aligned_cols=216  Identities=22%  Similarity=0.220  Sum_probs=98.1

Q ss_pred             ccccCCCceeeeeccccccccc-cccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCC
Q 002883          106 LFNISSMDYFAVTQNKLVGEIP-HYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTG  184 (871)
Q Consensus       106 ~~~l~~L~~L~l~~n~l~~~~~-~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~  184 (871)
                      ++.+.-++.|.+.++.|-.... ..++.....++.|||.+|.|+        ..+.+-.-+.+++.|+.|+|+.|.+.+ 
T Consensus        41 v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iS--------dWseI~~ile~lP~l~~LNls~N~L~s-  111 (418)
T KOG2982|consen   41 VSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLIS--------DWSEIGAILEQLPALTTLNLSCNSLSS-  111 (418)
T ss_pred             eccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhc--------cHHHHHHHHhcCccceEeeccCCcCCC-
Confidence            3334444555555555532211 122334566777777777775        112222235566667777777776654 


Q ss_pred             CCCCccccccc-cCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeeccccccccc
Q 002883          185 KGNDLRFLDSL-VNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGS  263 (871)
Q Consensus       185 ~~~~~~~~~~l-~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~  263 (871)
                            ..+.+ ..+.+|++|.|.+..+...-...+..-.+.++.|.+|.|.+.              .+++..|.+...
T Consensus       112 ------~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~r--------------q~n~Dd~c~e~~  171 (418)
T KOG2982|consen  112 ------DIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLR--------------QLNLDDNCIEDW  171 (418)
T ss_pred             ------ccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhh--------------hhcccccccccc
Confidence                  12222 234556666666655553322222222234455555544322              222333333311


Q ss_pred             CCc--cccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccC-cccccCCCCCCEEecCCCcCCCCCc-cc
Q 002883          264 IPT--SVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSI-PSALGNCLQLQKLDLSDNNLSGTIP-RE  339 (871)
Q Consensus       264 ~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~-~~  339 (871)
                      .+.  .+..++.+..++++-|++...       ++++..+.+..|.|...- ...+..++.+..|+|+.|+|.+... +.
T Consensus       172 s~~v~tlh~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~  244 (418)
T KOG2982|consen  172 STEVLTLHQLPCLEQLWLNKNKLSRI-------FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDA  244 (418)
T ss_pred             chhhhhhhcCCcHHHHHHHHHhHHhh-------cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHH
Confidence            111  112222333333333333322       234555555555554221 2234444555556666666552211 24


Q ss_pred             ccCCCCCcEEeccCCCCC
Q 002883          340 VIGLSSFVLLDLSRNHLS  357 (871)
Q Consensus       340 ~~~l~~L~~L~ls~N~l~  357 (871)
                      +.++++|..|.+++|.+.
T Consensus       245 Ln~f~~l~dlRv~~~Pl~  262 (418)
T KOG2982|consen  245 LNGFPQLVDLRVSENPLS  262 (418)
T ss_pred             HcCCchhheeeccCCccc
Confidence            445555555555555554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.56  E-value=6.3e-07  Score=89.44  Aligned_cols=110  Identities=25%  Similarity=0.280  Sum_probs=84.7

Q ss_pred             HHHHHHHHHHHcCC--CCccceeeeeecccCcCCCceeeEEEeccCC-CCHHHHhhcccccccccCCCCHHHHHHHHHHH
Q 002883          601 KSFIAECEALRSIR--HRNLVKIITSCSSIDTRGNEFKALVYEFMPN-GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV  677 (871)
Q Consensus       601 ~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i  677 (871)
                      ....+|...+..+.  .=.+++.+++........ ...++|+|++++ .+|.+++....       ..+......++.++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~-------~~~~~~~~~ll~~l  127 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWE-------QLDPSQRRELLRAL  127 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhc-------ccchhhHHHHHHHH
Confidence            46777888777773  333555566554432222 456899999987 48999987643       25566778899999


Q ss_pred             HHHHHHHhhcCCCCeEecCCCCCceeeCCCC---ceEEeecccceec
Q 002883          678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM---VAHVGDFGLSRLL  721 (871)
Q Consensus       678 ~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~a~~~  721 (871)
                      +..++-||+.   ||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       128 ~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  128 ARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999   999999999999998877   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.55  E-value=1.7e-08  Score=111.53  Aligned_cols=98  Identities=20%  Similarity=0.405  Sum_probs=76.3

Q ss_pred             HHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCCCCC------CccccccccccccccCcccccCC
Q 002883          676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSP------DQTSTSRVKGSIGYVAPEYGALG  749 (871)
Q Consensus       676 ~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~  749 (871)
                      +++.|+.|+|..  .++||++|.|++|.++..+..||+.|+++........      +............|.|||++.+.
T Consensus       107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            445899999987  5999999999999999999999999998865543211      00111112345679999999888


Q ss_pred             CCCCccchhhHHHHHHHHH-hCCCCCc
Q 002883          750 EVSTHGDEYSFGILMLEMF-TGKRPTD  775 (871)
Q Consensus       750 ~~~~~~DiwSlG~il~ell-tG~~pf~  775 (871)
                      ..++++|+||+||.+|.+. .|+.-+.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~  211 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIA  211 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhh
Confidence            8899999999999999999 4665554

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.52  E-value=5.5e-09  Score=90.94  Aligned_cols=87  Identities=24%  Similarity=0.258  Sum_probs=38.3

Q ss_pred             CCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecC
Q 002883          369 GIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLS  448 (871)
Q Consensus       369 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~  448 (871)
                      .++.|+|++|.|+ .+|..++.++.|+.|+++.|++. ..|..+..|.+|-.||..+|.+. .+|..+-.-......++.
T Consensus        78 t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lg  154 (177)
T KOG4579|consen   78 TATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLG  154 (177)
T ss_pred             hhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhc
Confidence            4444444444444 34444444444444444444444 23333333444445555555444 222222122222333445


Q ss_pred             CCcCcccCCC
Q 002883          449 FNNLEGEVPS  458 (871)
Q Consensus       449 ~N~l~~~~~~  458 (871)
                      +++|.+.++.
T Consensus       155 nepl~~~~~~  164 (177)
T KOG4579|consen  155 NEPLGDETKK  164 (177)
T ss_pred             CCcccccCcc
Confidence            5666655543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.49  E-value=1.4e-06  Score=85.43  Aligned_cols=156  Identities=21%  Similarity=0.201  Sum_probs=105.6

Q ss_pred             ccccCHHHHHHhhcCCCCCceee---ccccceEEEEEECCCCcEEEEEEeeccccch-------------------H---
Q 002883          546 YLKISYAELLKATEGFSSANLIG---IGGYGYVYKGILGTEETNVAVKVLDLQQRGA-------------------S---  600 (871)
Q Consensus       546 ~~~~~~~~~~~~~~~y~~~~~lg---~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------~---  600 (871)
                      .-..+...+..-..+..+....|   +|--+.||+|... ++..||+|+++......                   .   
T Consensus        32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~l  110 (268)
T COG1718          32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKL  110 (268)
T ss_pred             hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHH
Confidence            33455566666667777766655   5566789999874 78899999985432110                   0   


Q ss_pred             --HHHHHHHHHHHcC--CCCccceeeeeecccCcCCCceeeEEEeccCCCC-HHHHhhcccccccccCCCCHHHHHHHHH
Q 002883          601 --KSFIAECEALRSI--RHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGS-LENWLNQKEDEQNQRPKLNLMQRLSIAI  675 (871)
Q Consensus       601 --~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~l~~~~~~~i~~  675 (871)
                        .-..+|+.-|+++  .+=.+.+.+++.         .-.+||||+.... -.-.++.        ..+...++..+..
T Consensus       111 v~~W~~kEf~NL~R~~eAGVrvP~Pi~~~---------~nVLvMEfIg~~g~pAP~LkD--------v~~e~~e~~~~~~  173 (268)
T COG1718         111 VFAWARKEFRNLKRAYEAGVRVPEPIAFR---------NNVLVMEFIGDDGLPAPRLKD--------VPLELEEAEGLYE  173 (268)
T ss_pred             HHHHHHHHHHHHHHHHHcCCCCCCceeec---------CCeEEEEeccCCCCCCCCccc--------CCcCchhHHHHHH
Confidence              1245677777777  345566666653         2469999995531 1111111        1233336778888


Q ss_pred             HHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecC
Q 002883          676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH  722 (871)
Q Consensus       676 ~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  722 (871)
                      ++++.+.-|-..  .++||+||+.-|||+. ++.+.++|||.|....
T Consensus       174 ~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         174 DVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHHHHHHh--cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            888888888773  2999999999999999 8899999999997654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	871
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		6e-31
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		8e-05
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-30
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-30
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		8e-05
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-30
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-22
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-20
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-19
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-19
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-19
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-18
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-16
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		9e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-09
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		6e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-07
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		9e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-06
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-06
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-06
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		7e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		8e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-05
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-05
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-05
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-05
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-05
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-05
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-05
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		9e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		9e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-05
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-05
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-04
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-04
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-04
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-04
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-04
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-04
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-04
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-04
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-04
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-04
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-04
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-04
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-04
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-04
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-04
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-04
2v9t_B	220	Complex Between The Second Lrr Domain Of Slit2 And		3e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-04
2v9s_A	220	Second Lrr Domain Of Human Slit2 Length = 220		3e-04
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-04
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-04
3zyn_A	321	Crystal Structure Of The N-Terminal Leucine Rich Re		5e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-04
4fho_A	231	Crystal Structure Of An Internalin C2 (Inlc2) From		6e-04
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-04
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-04
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-04
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-04
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-04
3kj4_A	286	Structure Of Rat Nogo Receptor Bound To 1d9 Antagon		7e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		7e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-04
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-04
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  132 bits (333), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 152/573 (26%), Positives = 227/573 (39%), Gaps = 121/573 (21%)
Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPXXXXXX 61
           L G+    I+ C+EL++L++  N+  G IP     L  L  L L  N +TG IP      
Sbjct: 232 LSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGA 289
Query: 62  XXXXXXXXXXXXX-XXXIPSELGLLKQLNMFQVSANYLTGSIPIQ-LFNISSMDYFAVTQ 119
                            +P   G    L    +S+N  +G +P+  L  +  +    ++ 
Sbjct: 290 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 349
Query: 120 NKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEXXXXXXXXXXXXEDLGKLKNLIRLNFARN 179
           N+  GE+P  +     ++  L L SN F+G                   KN ++  + +N
Sbjct: 350 NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNP---------KNTLQELYLQN 400
Query: 180 NLGTGKGNDLRFLDSLVNCTFLEXXXXXXXXXXXXXXXXIANFSSHLIYLYMSANRISGT 239
           N  TGK        +L NC                         S L+ L++S N +SGT
Sbjct: 401 NGFTGK-----IPPTLSNC-------------------------SELVSLHLSFNYLSGT 430
Query: 240 IPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVL---------------------- 277
           IP+ +G+L  L  + + +N+L G IP  + Y+  L+ L                      
Sbjct: 431 IPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLN 490
Query: 278 --SLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGT 335
             SL  N+++GEIP  +G L  L  + L  NS  G+IP+ LG+C  L  LDL+ N  +GT
Sbjct: 491 WISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT 550
Query: 336 IP-----------------------------REVIGLSSFVLLDLSR----NHLSGPIPL 362
           IP                             +E  G  + +     R    N LS   P 
Sbjct: 551 IPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC 610
Query: 363 EV-GRLKG------------IQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIH 409
            +  R+ G            +  LD+S N LSG IP  + S   L  LN   N   G I 
Sbjct: 611 NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIP 670
Query: 410 SGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVS 469
                L+GL  LDLS N   G+IP  ++    L +++LS NNL G +P  G F+      
Sbjct: 671 DEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAK 730
Query: 470 IIGNNKLCG--------GSPELHLHSCRSRGSR 494
            + N  LCG         + + + H  RS G R
Sbjct: 731 FLNNPGLCGYPLPRCDPSNADGYAHHQRSHGRR 763

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/87 (42%), Positives = 48/87 (55%), Gaps = 12/87 (13%)
Query: 351 LSRNHLSGPIPLEVGRLK---GIQQLDLSENKLSGEIPT--SLASCVGLEYLNFSDNS-- 403
           LS +H++G     V   K    +  LDLS N LSG + T  SL SC GL++LN S N+  
Sbjct: 81  LSNSHING----SVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLD 136
Query: 404 FQGPIHSGFSSLKGLQDLDLSRNNFSG 430
           F G +  G   L  L+ LDLS N+ SG
Sbjct: 137 FPGKVSGGL-KLNSLEVLDLSANSISG 162

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  132 bits (331), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 99/316 (31%), Positives = 167/316 (52%), Gaps = 30/316 (9%)
Query: 548 KISYAELLKATEGFSSANLXXXXXXXXXXXXXXXTEETNVAVKVLDLQQ-RGASKSFIAE 606
           + S  EL  A++ FS+ N+                + T VAVK L  ++ +G    F  E
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 607 CEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLN 666
            E +    HRNL+++   C +   R      LVY +M NGS+ + L ++ + Q   P L+
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTER-----LLVYPYMANGSVASCLRERPESQ---PPLD 137
Query: 667 LMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSP 726
             +R  IA+  A  L YLH HC   I+H D+K +N+LLD E  A VGDFGL++L+  +  
Sbjct: 138 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYK 195
Query: 727 DQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK 786
           D      V+G+IG++APEY + G+ S   D + +G+++LE+ TG+R  D           
Sbjct: 196 DXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD----------- 244
Query: 787 YAKMGLPDQVAEIID--PAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEE 844
            A++   D V  ++D    +L+E  +++A +  +LQ N   K  E++  +++V +LC++ 
Sbjct: 245 LARLANDDDVM-LLDWVKGLLKEK-KLEALVDVDLQGNY--KDEEVE-QLIQVALLCTQS 299
Query: 845 LPRDRMKIQDAIMELQ 860
            P +R K+ + +  L+
Sbjct: 300 SPMERPKMSEVVRMLE 315

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  131 bits (330), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 142/530 (26%), Positives = 220/530 (41%), Gaps = 115/530 (21%)
Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPXXXXXX 61
           L G+    I+ C+EL++L++  N+  G IP     L  L  L L  N +TG IP      
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLS-- 290
Query: 62  XXXXXXXXXXXXXXXXIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
                                G    L    +S N+  G++P    + S ++  A++ N 
Sbjct: 291 ---------------------GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329
Query: 122 LVGEIPHYVGFTLPNIRVLLLGSNWFTGEXXXXXXXXXXXXEDLGKLK-NLIRLNFARNN 180
             GE+P      +  ++VL L  N F+GE            E L  L  +L+ L+ + NN
Sbjct: 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELP----------ESLTNLSASLLTLDLSSNN 379
Query: 181 LGTGKGNDLRFLDSLVNCTFLEXXXXXXXXXXXXXXXXIANFSSHLIYLYMSANRISGTI 240
                      L +L                         N  + L  LY+  N  +G I
Sbjct: 380 FSG------PILPNLC-----------------------QNPKNTLQELYLQNNGFTGKI 410
Query: 241 PTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTE 300
           P  + N   L+ + +  N L+G+IP+S+G L KL+ L L+ N + GEIP  L  +  L  
Sbjct: 411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET 470
Query: 301 VDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPI 360
           + L  N + G IPS L NC  L  + LS+N L+G IP+ +  L +  +L LS N  SG I
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530
Query: 361 PLEVGRLKGIQQLDLSENKLSGEIPTSL--------------------------ASCVG- 393
           P E+G  + +  LDL+ N  +G IP ++                            C G 
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGA 590
Query: 394 ---LEY----------------LNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPM 434
              LE+                 N +   + G     F +   +  LD+S N  SG IP 
Sbjct: 591 GNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650
Query: 435 FLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSI--IGNNKLCGGSPE 482
            + +  +L  LNL  N++ G +P E    ++R ++I  + +NKL G  P+
Sbjct: 651 EIGSMPYLFILNLGHNDISGSIPDE--VGDLRGLNILDLSSNKLDGRIPQ 698

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/87 (42%), Positives = 48/87 (55%), Gaps = 12/87 (13%)
Query: 351 LSRNHLSGPIPLEVGRLK---GIQQLDLSENKLSGEIPT--SLASCVGLEYLNFSDNS-- 403
           LS +H++G     V   K    +  LDLS N LSG + T  SL SC GL++LN S N+  
Sbjct: 84  LSNSHING----SVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLD 139
Query: 404 FQGPIHSGFSSLKGLQDLDLSRNNFSG 430
           F G +  G   L  L+ LDLS N+ SG
Sbjct: 140 FPGKVSGGL-KLNSLEVLDLSANSISG 165

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  130 bits (328), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 91/277 (32%), Positives = 152/277 (54%), Gaps = 29/277 (10%)
Query: 587 VAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           VAVK L  ++ +G    F  E E +    HRNL+++   C +   R      LVY +M N
Sbjct: 57  VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER-----LLVYPYMAN 111
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           GS+ + L ++ + Q   P L+  +R  IA+  A  L YLH HC   I+H D+K +N+LLD
Sbjct: 112 GSVASCLRERPESQ---PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
            E  A VGDFGL++L+  +  D      V+G IG++APEY + G+ S   D + +G+++L
Sbjct: 169 EEFEAVVGDFGLAKLM--DYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLL 226
Query: 766 EMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIID--PAILEEALEIQAGIVKELQPNL 823
           E+ TG+R  D            A++   D V  ++D    +L+E  +++A +  +LQ N 
Sbjct: 227 ELITGQRAFD-----------LARLANDDDVM-LLDWVKGLLKEK-KLEALVDVDLQGNY 273
Query: 824 RAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ 860
             K  E++  +++V +LC++  P +R K+ + +  L+
Sbjct: 274 --KDEEVE-QLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 116/245 (47%), Gaps = 7/245 (2%)
Query: 240 IPTGVGNLKNL-ILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFL 298
           IP+ + NL  L  L    +N L G IP ++  L +L  L +    +SG IP  L  +  L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 299 TEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSS-FVLLDLSRNHLS 357
             +D   N++ G++P ++ +   L  +    N +SG IP      S  F  + +SRN L+
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 358 GPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHS-GFSSLK 416
           G IP     L  +  +DLS N L G+      S    + ++ + NS    +   G S  K
Sbjct: 188 GKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS--K 244
Query: 417 GLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKL 476
            L  LDL  N   G +P  L   +FL  LN+SFNNL GE+P  G  +    VS   NNK 
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFD-VSAYANNKC 303
Query: 477 CGGSP 481
             GSP
Sbjct: 304 LCGSP 308

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 105/204 (51%), Gaps = 18/204 (8%)
Query: 585 TNVAVKVL----DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           T VAVK L    D+      + F  E + +   +H NLV+++       + G++   LVY
Sbjct: 55  TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVY 109
Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
            +MPNGSL + L+      +  P L+   R  IA   AN + +LH + H   +H D+K +
Sbjct: 110 VYMPNGSLLDRLSC----LDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSA 162
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+LLD    A + DFGL+R   +        SR+ G+  Y+APE    GE++   D YSF
Sbjct: 163 NILLDEAFTAKISDFGLAR-ASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSF 220
Query: 761 GILMLEMFTGKRPTDDMFEEGLSL 784
           G+++LE+ TG    D+  E  L L
Sbjct: 221 GVVLLEIITGLPAVDEHREPQLLL 244

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 585 TNVAVK----VLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           T VAVK    ++D+      + F  E + +   +H NLV+++   S  D        LVY
Sbjct: 55  TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL-----CLVY 109
Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
            +MPNGSL + L+      +  P L+   R  IA   AN + +LH + H   +H D+K +
Sbjct: 110 VYMPNGSLLDRLSC----LDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSA 162
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+LLD    A + DFGL+R   +         R+ G+  Y+APE    GE++   D YSF
Sbjct: 163 NILLDEAFTAKISDFGLAR-ASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSF 220
Query: 761 GILMLEMFTGKRPTDDMFEEGLSL 784
           G+++LE+ TG    D+  E  L L
Sbjct: 221 GVVLLEIITGLPAVDEHREPQLLL 244

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 18/204 (8%)
Query: 585 TNVAVK----VLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           T VAVK    ++D+      + F  E + +   +H NLV+++       + G++   LVY
Sbjct: 49  TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVY 103
Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
            +MPNGSL + L+      +  P L+   R  IA   AN + +LH + H   +H D+K +
Sbjct: 104 VYMPNGSLLDRLSC----LDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSA 156
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+LLD    A + DFGL+R   +         R+ G+  Y+APE    GE++   D YSF
Sbjct: 157 NILLDEAFTAKISDFGLAR-ASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSF 214
Query: 761 GILMLEMFTGKRPTDDMFEEGLSL 784
           G+++LE+ TG    D+  E  L L
Sbjct: 215 GVVLLEIITGLPAVDEHREPQLLL 238

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 585 TNVAVKVL----DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           T VAVK L    D+      + F  E +     +H NLV+++   S  D        LVY
Sbjct: 46  TTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDL-----CLVY 100
Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
            + PNGSL + L+      +  P L+   R  IA   AN + +LH + H   +H D+K +
Sbjct: 101 VYXPNGSLLDRLSC----LDGTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSA 153
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+LLD    A + DFGL+R   +        SR+ G+  Y APE    GE++   D YSF
Sbjct: 154 NILLDEAFTAKISDFGLAR-ASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSF 211
Query: 761 GILMLEMFTGKRPTDDMFEEGLSL 784
           G+++LE+ TG    D+  E  L L
Sbjct: 212 GVVLLEIITGLPAVDEHREPQLLL 235

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 131/261 (50%), Gaps = 38/261 (14%)
Query: 614 RHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLM--QRL 671
           RH +LV +I  C   D R NE   L+Y++M NG+L+  L   +      P +++   QRL
Sbjct: 93  RHPHLVSLIGFC---DER-NEM-ILIYKYMENGNLKRHLYGSD-----LPTMSMSWEQRL 142
Query: 672 SIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTST 731
            I I  A  L YLH     +I+H D+K  N+LLD   V  + DFG+S+       DQT  
Sbjct: 143 EICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK--KGTELDQTHL 197
Query: 732 SRV-KGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP-TDDMFEEGLSLHKYAK 789
             V KG++GY+ PEY   G ++   D YSFG+++ E+   +      +  E ++L ++A 
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 790 MGLPD-QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRD 848
               + Q+ +I+DP            +  +++P    KF +  V  L    L SE    D
Sbjct: 258 ESHNNGQLEQIVDP-----------NLADKIRPESLRKFGDTAVKCL---ALSSE----D 299
Query: 849 RMKIQDAIMELQEAQKMRQAI 869
           R  + D + +L+ A ++++++
Sbjct: 300 RPSMGDVLWKLEYALRLQESV 320

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 130/261 (49%), Gaps = 38/261 (14%)
Query: 614 RHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLM--QRL 671
           RH +LV +I  C   D R NE   L+Y++M NG+L+  L   +      P +++   QRL
Sbjct: 93  RHPHLVSLIGFC---DER-NEM-ILIYKYMENGNLKRHLYGSD-----LPTMSMSWEQRL 142
Query: 672 SIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTST 731
            I I  A  L YLH     +I+H D+K  N+LLD   V  + DFG+S+        QT  
Sbjct: 143 EICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK--KGTELGQTHL 197
Query: 732 SRV-KGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP-TDDMFEEGLSLHKYAK 789
             V KG++GY+ PEY   G ++   D YSFG+++ E+   +      +  E ++L ++A 
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 790 MGLPD-QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRD 848
               + Q+ +I+DP            +  +++P    KF +  V  L    L SE    D
Sbjct: 258 ESHNNGQLEQIVDP-----------NLADKIRPESLRKFGDTAVKCL---ALSSE----D 299
Query: 849 RMKIQDAIMELQEAQKMRQAI 869
           R  + D + +L+ A ++++++
Sbjct: 300 RPSMGDVLWKLEYALRLQESV 320

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 109/205 (53%), Gaps = 30/205 (14%)
Query: 583 EETNVAVKVLD----LQQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           +E+ VA+K L      +QR   + F++E   +    H N+++   ++T+   +       
Sbjct: 43  KESCVAIKTLKGGYTERQR---REFLSEASIMGQFEHPNIIRLEGVVTNSMPV------- 92
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             ++ EFM NG+L+++L   + +        ++Q + +   +A+ + YL      S VH 
Sbjct: 93  -MILTEFMENGALDSFLRLNDGQ------FTVIQLVGMLRGIASGMRYL---AEMSYVHR 142
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG--YVAPEYGALGEVST 753
           DL   N+L+++ +V  V DFGLSR L +NS D T TS + G I   + APE  A  + ++
Sbjct: 143 DLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTS 202
Query: 754 HGDEYSFGILMLEMFT-GKRPTDDM 777
             D +S+GI+M E+ + G+RP  DM
Sbjct: 203 ASDAWSYGIVMWEVMSFGERPYWDM 227

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 109/205 (53%), Gaps = 30/205 (14%)
Query: 583 EETNVAVKVLD----LQQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           +E+ VA+K L      +QR   + F++E   +    H N+++   ++T+   +       
Sbjct: 41  KESCVAIKTLKGGYTERQR---REFLSEASIMGQFEHPNIIRLEGVVTNSMPV------- 90
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             ++ EFM NG+L+++L   + +        ++Q + +   +A+ + YL      S VH 
Sbjct: 91  -MILTEFMENGALDSFLRLNDGQ------FTVIQLVGMLRGIASGMRYL---AEMSYVHR 140
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG--YVAPEYGALGEVST 753
           DL   N+L+++ +V  V DFGLSR L +NS D T TS + G I   + APE  A  + ++
Sbjct: 141 DLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTS 200
Query: 754 HGDEYSFGILMLEMFT-GKRPTDDM 777
             D +S+GI+M E+ + G+RP  DM
Sbjct: 201 ASDAWSYGIVMWEVMSFGERPYWDM 225

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 111/231 (48%), Gaps = 32/231 (13%)
Query: 583 EETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL 638
            +  VA+K L      +QR   + F++E   +    H N++++      + TRG     +
Sbjct: 76  RDVPVAIKALKAGYTERQR---RDFLSEASIMGQFDHPNIIRL----EGVVTRGR-LAMI 127
Query: 639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK 698
           V E+M NGSL+ +L   + +        +MQ + +   V   + YL        VH DL 
Sbjct: 128 VTEYMENGSLDTFLRTHDGQ------FTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLA 178
Query: 699 PSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEY 758
             NVL+D+ +V  V DFGLSR+L D+     +T+  K  I + APE  A    S+  D +
Sbjct: 179 ARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVW 238
Query: 759 SFGILMLEMFT-GKRPTDDM--------FEEGLSLHKYAKMGLPDQVAEII 800
           SFG++M E+   G+RP  +M         EEG  L   A MG P  + +++
Sbjct: 239 SFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP--APMGCPHALHQLM 287

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 111/231 (48%), Gaps = 32/231 (13%)
Query: 583 EETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL 638
            +  VA+K L      +QR   + F++E   +    H N++++      + TRG     +
Sbjct: 76  RDVPVAIKALKAGYTERQR---RDFLSEASIMGQFDHPNIIRL----EGVVTRGR-LAMI 127
Query: 639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK 698
           V E+M NGSL+ +L   + +        +MQ + +   V   + YL        VH DL 
Sbjct: 128 VTEYMENGSLDTFLRTHDGQ------FTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLA 178
Query: 699 PSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEY 758
             NVL+D+ +V  V DFGLSR+L D+     +T+  K  I + APE  A    S+  D +
Sbjct: 179 ARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVW 238
Query: 759 SFGILMLEMFT-GKRPTDDM--------FEEGLSLHKYAKMGLPDQVAEII 800
           SFG++M E+   G+RP  +M         EEG  L   A MG P  + +++
Sbjct: 239 SFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP--APMGCPHALHQLM 287

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 33  TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIXIVTEYMS 85
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 86  KGSLLDFLKGETGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 137
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 138 GENLVCKVADFGLARLIEDN--EXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 195
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 196 TELTTKGRVPYPGM 209

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 61/194 (31%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ IRH  LV++    S       E   +V E+M 
Sbjct: 43  TRVAIKTLKPGTM-SPEAFLQEAQVMKKIRHEKLVQLYAVVSE------EPIYIVTEYMS 95
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 96  KGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 147
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 148 GENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 205
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 206 TELTTKGRVPYPGM 219

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + +SF+ E + ++ ++H  LV++    S       E   +V E+M 
Sbjct: 34  TKVAIKTLKPGTM-SPESFLEEAQIMKKLKHDKLVQLYAVVSE------EPIYIVTEYMN 86
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L   E    + P L     + +A  VA  + Y+      + +H DL+ +N+L+
Sbjct: 87  KGSLLDFLKDGEGRALKLPNL-----VDMAAQVAAGMAYIER---MNYIHRDLRSANILV 138
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
            N ++  + DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 139 GNGLICKIADFGLARLIEDN--EXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 196
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 197 TELVTKGRVPYPGM 210

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 61/219 (27%), Positives = 111/219 (50%), Gaps = 20/219 (9%)
Query: 583 EETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + T VAVK +        ++F+AE   +++++H  LVK+     ++ T+  E   ++ EF
Sbjct: 38  KHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKL----HAVVTK--EPIYIITEF 90
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
           M  GSL ++L   E  +   PKL     +  +  +A  + ++      + +H DL+ +N+
Sbjct: 91  MAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQR---NYIHRDLRAANI 142
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGI 762
           L+   +V  + DFGL+R++ DN  + T+    K  I + APE    G  +   D +SFGI
Sbjct: 143 LVSASLVCKIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 200
Query: 763 LMLEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQVAE 798
           L++E+ T G+ P   M    +  +L +  +M  P+   E
Sbjct: 201 LLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE 239

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 209 TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIVTEYMS 261
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 262 KGSLLDFLKGETGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 313
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 314 GENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 372 TELTTKGRVPYPGM 385

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 209 TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIVTEYMS 261
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 262 KGSLLDFLKGETGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 313
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 314 GENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 372 TELTTKGRVPYPGM 385

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 96/188 (51%), Gaps = 17/188 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 292 TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIVTEYMS 344
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 345 KGSLLDFLKGETGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 396
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 397 GENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 454
Query: 765 LEMFTGKR 772
            E+ T  R
Sbjct: 455 TELTTKGR 462

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 43  TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVIEYMS 95
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 96  KGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 147
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 148 GENLVCKVADFGLARLIEDN--EXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 205
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 206 TELTTKGRVPYPGM 219

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 36  TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMS 88
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 89  KGSLLDFLKGETGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 140
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 141 GENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 198
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 199 TELTTKGRVPYPGM 212

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 43  TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVIEYMS 95
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 96  KGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 147
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 148 GENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 205
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 206 TELTTKGRVPYPGM 219

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 209 TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIVGEYMS 261
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 262 KGSLLDFLKGETGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 313
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 314 GENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 372 TELTTKGRVPYPGM 385

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 32  TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMS 84
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 85  KGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 136
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 137 GENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 194
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 195 TELTTKGRVPYPGM 208

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 34  TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMS 86
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 87  KGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 138
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 139 GENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 196
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 197 TELTTKGRVPYPGM 210

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 43  TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMS 95
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 96  KGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 147
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 148 GENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 205
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 206 TELTTKGRVPYPGM 219

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 106/204 (51%), Gaps = 30/204 (14%)
Query: 584 ETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEFK 636
           E  VA+K L      +QR   + F++E   +    H N++    ++T  + +        
Sbjct: 61  EIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHPNVIHLEGVVTKSTPV-------- 109
Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
            ++ EFM NGSL+++L Q + +        ++Q + +   +A  ++YL      + VH D
Sbjct: 110 MIITEFMENGSLDSFLRQNDGQ------FTVIQLVGMLRGIAAGMKYL---ADMNYVHRD 160
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG--YVAPEYGALGEVSTH 754
           L   N+L+++ +V  V DFGLSR L D++ D T TS + G I   + APE     + ++ 
Sbjct: 161 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA 220
Query: 755 GDEYSFGILMLEMFT-GKRPTDDM 777
            D +S+GI+M E+ + G+RP  DM
Sbjct: 221 SDVWSYGIVMWEVMSYGERPYWDM 244

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 43  TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVCEYMS 95
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 96  KGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 147
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 148 GENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 205
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 206 TELTTKGRVPYPGM 219

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 210 TRVAIKTLKPGNM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIVTEYMS 262
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 263 KGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 314
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 315 GENLVCKVADFGLGRLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 372
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 373 TELTTKGRVPYPGM 386

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 88/183 (48%), Gaps = 12/183 (6%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L        + F  E E L+S++H N+VK    C S   R      L+ EF+P G
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEFLPYG 101
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL  +L      Q  + +++ ++ L     +   +EYL        +H DL   N+L++N
Sbjct: 102 SLREYL------QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVEN 152
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           E    +GDFGL+++L  +          +  I + APE     + S   D +SFG+++ E
Sbjct: 153 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 212
Query: 767 MFT 769
           +FT
Sbjct: 213 LFT 215

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 98/194 (50%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK +        ++F+AE   +++++H  LVK+    +       E   ++ EFM 
Sbjct: 213 TKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVT------KEPIYIITEFMA 265
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L   E  +   PKL     +  +  +A  + ++    +   +H DL+ +N+L+
Sbjct: 266 KGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQRNY---IHRDLRAANILV 317
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  + DFGL+R++ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 318 SASLVCKIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375
Query: 765 LEMFT-GKRPTDDM 777
           +E+ T G+ P   M
Sbjct: 376 MEIVTYGRIPYPGM 389

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK L  Q   +  +F+AE   ++ ++H+ LV++    +       E   ++ E+M 
Sbjct: 46  TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYME 98
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           NGSL ++L           KL + + L +A  +A  + ++      + +H DL+ +N+L+
Sbjct: 99  NGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILV 150
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
            + +   + DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 151 SDTLSCKIADFGLARLIEDN--EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 208
Query: 765 LEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQVAE 798
            E+ T G+ P   M    +  +L +  +M  PD   E
Sbjct: 209 TEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 245

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 12/183 (6%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L        + F  E E L+S++H N+VK    C S   R      L+ E++P G
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYG 116
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL ++L      Q  + +++ ++ L     +   +EYL        +H DL   N+L++N
Sbjct: 117 SLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVEN 167
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           E    +GDFGL+++L  +          +  I + APE     + S   D +SFG+++ E
Sbjct: 168 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 227
Query: 767 MFT 769
           +FT
Sbjct: 228 LFT 230

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK L  Q   +  +F+AE   ++ ++H+ LV++    +       E   ++ E+M 
Sbjct: 44  TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYME 96
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           NGSL ++L           KL + + L +A  +A  + ++      + +H DL+ +N+L+
Sbjct: 97  NGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILV 148
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
            + +   + DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 149 SDTLSCKIADFGLARLIEDN--EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 206
Query: 765 LEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQVAE 798
            E+ T G+ P   M    +  +L +  +M  PD   E
Sbjct: 207 TEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 243

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK L  Q   +  +F+AE   ++ ++H+ LV++    +       E   ++ E+M 
Sbjct: 38  TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYME 90
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           NGSL ++L           KL + + L +A  +A  + ++      + +H DL+ +N+L+
Sbjct: 91  NGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILV 142
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
            + +   + DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 143 SDTLSCKIADFGLARLIEDN--EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 765 LEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQVAE 798
            E+ T G+ P   M    +  +L +  +M  PD   E
Sbjct: 201 TEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK L  Q   +  +F+AE   ++ ++H+ LV++    +       E   ++ E+M 
Sbjct: 47  TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYME 99
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           NGSL ++L           KL + + L +A  +A  + ++      + +H DL+ +N+L+
Sbjct: 100 NGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILV 151
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
            + +   + DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 152 SDTLSCKIADFGLARLIEDN--EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 209
Query: 765 LEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQVAE 798
            E+ T G+ P   M    +  +L +  +M  PD   E
Sbjct: 210 TEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 246

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK L  Q   +  +F+AE   ++ ++H+ LV++    +       E   ++ E+M 
Sbjct: 38  TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYME 90
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           NGSL ++L           KL + + L +A  +A  + ++      + +H DL+ +N+L+
Sbjct: 91  NGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILV 142
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
            + +   + DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 143 SDTLSCKIADFGLARLIEDN--EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 765 LEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQVAE 798
            E+ T G+ P   M    +  +L +  +M  PD   E
Sbjct: 201 TEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK L  Q   +  +F+AE   ++ ++H+ LV++    +       E   ++ E+M 
Sbjct: 39  TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYME 91
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           NGSL ++L           KL + + L +A  +A  + ++      + +H DL+ +N+L+
Sbjct: 92  NGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILV 143
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
            + +   + DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 144 SDTLSCKIADFGLARLIEDN--EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 201
Query: 765 LEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQVAE 798
            E+ T G+ P   M    +  +L +  +M  PD   E
Sbjct: 202 TEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 238

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK L  Q   +  +F+AE   ++ ++H+ LV++    +       E   ++ E+M 
Sbjct: 40  TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYME 92
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           NGSL ++L           KL + + L +A  +A  + ++      + +H DL+ +N+L+
Sbjct: 93  NGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILV 144
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
            + +   + DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 145 SDTLSCKIADFGLARLIEDN--EXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 202
Query: 765 LEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQVAE 798
            E+ T G+ P   M    +  +L +  +M  PD   E
Sbjct: 203 TEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 239

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 12/183 (6%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L        + F  E E L+S++H N+VK    C S   R      L+ E++P G
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYG 116
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL ++L      Q  + +++ ++ L     +   +EYL        +H DL   N+L++N
Sbjct: 117 SLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVEN 167
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           E    +GDFGL+++L  +          +  I + APE     + S   D +SFG+++ E
Sbjct: 168 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 227
Query: 767 MFT 769
           +FT
Sbjct: 228 LFT 230

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 12/183 (6%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L        + F  E E L+S++H N+VK    C S   R      L+ E++P G
Sbjct: 48  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYG 104
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL ++L      Q  + +++ ++ L     +   +EYL        +H DL   N+L++N
Sbjct: 105 SLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVEN 155
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           E    +GDFGL+++L  +          +  I + APE     + S   D +SFG+++ E
Sbjct: 156 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 215
Query: 767 MFT 769
           +FT
Sbjct: 216 LFT 218

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 59/194 (30%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 40  TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMN 92
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + ++  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 93  KGSLLDFLKGETGKY-----LRLPQLVDMSAQIASGMAYVER---MNYVHRDLRAANILV 144
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 145 GENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 202
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 203 TELTTKGRVPYPGM 216

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 43  TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMS 95
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL  +N+L+
Sbjct: 96  KGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLAAANILV 147
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 148 GENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 205
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 206 TELTTKGRVPYPGM 219

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 12/183 (6%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L        + F  E E L+S++H N+VK    C S   R      L+ E++P G
Sbjct: 73  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYG 129
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL ++L      Q  + +++ ++ L     +   +EYL        +H DL   N+L++N
Sbjct: 130 SLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVEN 180
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           E    +GDFGL+++L  +          +  I + APE     + S   D +SFG+++ E
Sbjct: 181 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 240
Query: 767 MFT 769
           +FT
Sbjct: 241 LFT 243

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 12/183 (6%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L        + F  E E L+S++H N+VK    C S   R      L+ E++P G
Sbjct: 47  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYG 103
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL ++L      Q  + +++ ++ L     +   +EYL        +H DL   N+L++N
Sbjct: 104 SLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVEN 154
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           E    +GDFGL+++L  +          +  I + APE     + S   D +SFG+++ E
Sbjct: 155 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 214
Query: 767 MFT 769
           +FT
Sbjct: 215 LFT 217

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 100/191 (52%), Gaps = 15/191 (7%)
Query: 585 TNVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           ++VAVK+L  Q   A +   F+ E   ++ +RH N+V  + + +          ++V E+
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL-----SIVTEY 115
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
           +  GSL   L++       R +L+  +RLS+A DVA  + YLH+  +  IVH DLK  N+
Sbjct: 116 LSRGSLYRLLHK----SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNL 170
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGI 762
           L+D +    V DFGLSRL    +     +    G+  ++APE       +   D YSFG+
Sbjct: 171 LVDKKYTVKVCDFGLSRL---KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGV 227
Query: 763 LMLEMFTGKRP 773
           ++ E+ T ++P
Sbjct: 228 ILWELATLQQP 238

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 12/183 (6%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L        + F  E E L+S++H N+VK    C S   R      L+ E++P G
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYG 101
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL ++L      Q  + +++ ++ L     +   +EYL        +H DL   N+L++N
Sbjct: 102 SLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVEN 152
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           E    +GDFGL+++L  +          +  I + APE     + S   D +SFG+++ E
Sbjct: 153 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 212
Query: 767 MFT 769
           +FT
Sbjct: 213 LFT 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 12/183 (6%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L        + F  E E L+S++H N+VK    C S   R      L+ E++P G
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYG 98
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL ++L      Q  + +++ ++ L     +   +EYL        +H DL   N+L++N
Sbjct: 99  SLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVEN 149
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           E    +GDFGL+++L  +          +  I + APE     + S   D +SFG+++ E
Sbjct: 150 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 209
Query: 767 MFT 769
           +FT
Sbjct: 210 LFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 12/183 (6%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L        + F  E E L+S++H N+VK    C S   R      L+ E++P G
Sbjct: 40  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYG 96
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL ++L      Q  + +++ ++ L     +   +EYL        +H DL   N+L++N
Sbjct: 97  SLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVEN 147
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           E    +GDFGL+++L  +          +  I + APE     + S   D +SFG+++ E
Sbjct: 148 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 207
Query: 767 MFT 769
           +FT
Sbjct: 208 LFT 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 12/183 (6%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L        + F  E E L+S++H N+VK    C S   R      L+ E++P G
Sbjct: 49  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYG 105
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL ++L      Q  + +++ ++ L     +   +EYL        +H DL   N+L++N
Sbjct: 106 SLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVEN 156
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           E    +GDFGL+++L  +          +  I + APE     + S   D +SFG+++ E
Sbjct: 157 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 216
Query: 767 MFT 769
           +FT
Sbjct: 217 LFT 219

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 12/183 (6%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L        + F  E E L+S++H N+VK    C S   R      L+ E++P G
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYG 98
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL ++L      Q  + +++ ++ L     +   +EYL        +H DL   N+L++N
Sbjct: 99  SLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVEN 149
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           E    +GDFGL+++L  +          +  I + APE     + S   D +SFG+++ E
Sbjct: 150 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 209
Query: 767 MFT 769
           +FT
Sbjct: 210 LFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 12/183 (6%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L        + F  E E L+S++H N+VK    C S   R      L+ E++P G
Sbjct: 46  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYG 102
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL ++L      Q  + +++ ++ L     +   +EYL        +H DL   N+L++N
Sbjct: 103 SLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVEN 153
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           E    +GDFGL+++L  +          +  I + APE     + S   D +SFG+++ E
Sbjct: 154 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 213
Query: 767 MFT 769
           +FT
Sbjct: 214 LFT 216

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK L  Q   +  +F+AE   ++ ++H+ LV++    +       E   ++ E+M 
Sbjct: 44  TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYME 96
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           NGSL ++L           KL + + L +A  +A  + ++      + +H DL+ +N+L+
Sbjct: 97  NGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILV 148
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
            + +   + DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 149 SDTLSCKIADFGLARLIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 206
Query: 765 LEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQVAE 798
            E+ T G+ P   M    +  +L +  +M  PD   E
Sbjct: 207 TEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 243

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK L  Q   +  +F+AE   ++ ++H+ LV++    +       E   ++ E+M 
Sbjct: 48  TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYME 100
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           NGSL ++L           KL + + L +A  +A  + ++      + +H DL+ +N+L+
Sbjct: 101 NGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILV 152
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
            + +   + DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 153 SDTLSCKIADFGLARLIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 210
Query: 765 LEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQVAE 798
            E+ T G+ P   M    +  +L +  +M  PD   E
Sbjct: 211 TEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 247

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK L  Q   +  +F+AE   ++ ++H+ LV++    +       E   ++ E+M 
Sbjct: 38  TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYME 90
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           NGSL ++L           KL + + L +A  +A  + ++      + +H DL+ +N+L+
Sbjct: 91  NGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILV 142
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
            + +   + DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 143 SDTLSCKIADFGLARLIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 765 LEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQVAE 798
            E+ T G+ P   M    +  +L +  +M  PD   E
Sbjct: 201 TEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK L  Q   +  +F+AE   ++ ++H+ LV++    +       E   ++ E+M 
Sbjct: 43  TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYME 95
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           NGSL ++L           KL + + L +A  +A  + ++      + +H DL+ +N+L+
Sbjct: 96  NGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILV 147
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
            + +   + DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 148 SDTLSCKIADFGLARLIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 205
Query: 765 LEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQVAE 798
            E+ T G+ P   M    +  +L +  +M  PD   E
Sbjct: 206 TEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 242

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 59/194 (30%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 40  TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMN 92
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L  +  +      L L Q + ++  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 93  KGSLLDFLKGETGKY-----LRLPQLVDMSAQIASGMAYVER---MNYVHRDLRAANILV 144
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 145 GENLVCKVADFGLARLIEDN--EWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 202
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 203 TELTTKGRVPYPGM 216

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 12/183 (6%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L        + F  E E L+S++H N+VK    C S   R      L+ E++P G
Sbjct: 41  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYG 97
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL ++L      Q  + +++ ++ L     +   +EYL        +H DL   N+L++N
Sbjct: 98  SLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVEN 148
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           E    +GDFGL+++L  +          +  I + APE     + S   D +SFG+++ E
Sbjct: 149 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 208
Query: 767 MFT 769
           +FT
Sbjct: 209 LFT 211

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 22/194 (11%)
Query: 586 NVAVKVLDLQQRGA--SKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
            VA+K +   + GA   + FI E E +  + H  LV++   C            LV+EFM
Sbjct: 33  KVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLVFEFM 84
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
            +G L ++L      + QR        L + +DV   + YL   C   ++H DL   N L
Sbjct: 85  EHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCL 135
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
           +    V  V DFG++R + D+    TS++  K  + + +PE  +    S+  D +SFG+L
Sbjct: 136 VGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 193
Query: 764 MLEMFT-GKRPTDD 776
           M E+F+ GK P ++
Sbjct: 194 MWEVFSEGKIPYEN 207

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 22/194 (11%)
Query: 586 NVAVKVLDLQQRGA--SKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
            VA+K +   + GA   + FI E E +  + H  LV++   C            LV+EFM
Sbjct: 31  KVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLVFEFM 82
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
            +G L ++L      + QR        L + +DV   + YL   C   ++H DL   N L
Sbjct: 83  EHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCL 133
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
           +    V  V DFG++R + D+    TS++  K  + + +PE  +    S+  D +SFG+L
Sbjct: 134 VGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 191
Query: 764 MLEMFT-GKRPTDD 776
           M E+F+ GK P ++
Sbjct: 192 MWEVFSEGKIPYEN 205

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 22/194 (11%)
Query: 586 NVAVKVLDLQQRGA--SKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
            VA+K +   + GA   + FI E E +  + H  LV++   C            LV+EFM
Sbjct: 36  KVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLVFEFM 87
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
            +G L ++L      + QR        L + +DV   + YL   C   ++H DL   N L
Sbjct: 88  EHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCL 138
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
           +    V  V DFG++R + D+    TS++  K  + + +PE  +    S+  D +SFG+L
Sbjct: 139 VGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 196
Query: 764 MLEMFT-GKRPTDD 776
           M E+F+ GK P ++
Sbjct: 197 MWEVFSEGKIPYEN 210

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 103/195 (52%), Gaps = 20/195 (10%)
Query: 583 EETNVAVKVLDLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL--V 639
           +E  VA+K L        +  F+ E   +    H N++++    S       ++K +  +
Sbjct: 72  KEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-------KYKPMMII 124
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            E+M NG+L+ +L +K+ E       +++Q + +   +A  ++YL    + + VH DL  
Sbjct: 125 TEYMENGALDKFLREKDGE------FSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAA 175
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYS 759
            N+L+++ +V  V DFGLSR+L D+     +TS  K  I + APE  +  + ++  D +S
Sbjct: 176 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWS 235
Query: 760 FGILMLEMFT-GKRP 773
           FGI+M E+ T G+RP
Sbjct: 236 FGIVMWEVMTYGERP 250

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 38/218 (17%)
Query: 584 ETNVAVKVL-----DLQQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           E  VA+K L     D Q+R     F++E   +    H N++    ++T C  +       
Sbjct: 42  EICVAIKTLKAGYTDKQRR----DFLSEASIMGQFDHPNIIHLEGVVTKCKPV------- 90
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             ++ E+M NGSL+ +L + +       +  ++Q + +   + + ++YL      S VH 
Sbjct: 91  -MIITEYMENGSLDAFLRKNDG------RFTVIQLVGMLRGIGSGMKYLSD---MSYVHR 140
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+L+++ +V  V DFG+SR+L D+     +T   K  I + APE  A  + ++  
Sbjct: 141 DLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 200
Query: 756 DEYSFGILMLEMFT-GKRPTDDM--------FEEGLSL 784
           D +S+GI+M E+ + G+RP  DM         EEG  L
Sbjct: 201 DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRL 238

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 43  TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVMEYMS 95
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            G L ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 96  KGCLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 147
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 148 GENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 205
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 206 TELTTKGRVPYPGM 219

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 38/219 (17%)
Query: 583 EETNVAVKVL-----DLQQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNE 634
            E  VA+K L     D Q+R     F++E   +    H N++    ++T C  +      
Sbjct: 35  REICVAIKTLKAGYTDKQRR----DFLSEASIMGQFDHPNIIHLEGVVTKCKPV------ 84
Query: 635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVH 694
              ++ E+M NGSL+ +L + +       +  ++Q + +   + + ++YL      S VH
Sbjct: 85  --MIITEYMENGSLDAFLRKNDG------RFTVIQLVGMLRGIGSGMKYLSD---MSYVH 133
Query: 695 CDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH 754
            DL   N+L+++ +V  V DFG+SR+L D+     +T   K  I + APE  A  + ++ 
Sbjct: 134 RDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA 193
Query: 755 GDEYSFGILMLEMFT-GKRPTDDM--------FEEGLSL 784
            D +S+GI+M E+ + G+RP  DM         EEG  L
Sbjct: 194 SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRL 232

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 101/191 (52%), Gaps = 15/191 (7%)
Query: 585 TNVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           ++VAVK+L  Q   A +   F+ E   ++ +RH N+V  + + +          ++V E+
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL-----SIVTEY 115
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
           +  GSL   L++       R +L+  +RLS+A DVA  + YLH+  +  IVH +LK  N+
Sbjct: 116 LSRGSLYRLLHK----SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNL 170
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGI 762
           L+D +    V DFGLSRL    +    S+    G+  ++APE       +   D YSFG+
Sbjct: 171 LVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGV 227
Query: 763 LMLEMFTGKRP 773
           ++ E+ T ++P
Sbjct: 228 ILWELATLQQP 238

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 30/203 (14%)
Query: 584 ETNVAVKVL-----DLQQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           E  VA+K L     D Q+R     F++E   +    H N++    ++T C  +       
Sbjct: 57  EICVAIKTLKAGYTDKQRR----DFLSEASIMGQFDHPNIIHLEGVVTKCKPV------- 105
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             ++ E+M NGSL+ +L + +       +  ++Q + +   + + ++YL      S VH 
Sbjct: 106 -MIITEYMENGSLDAFLRKNDG------RFTVIQLVGMLRGIGSGMKYLSD---MSAVHR 155
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+L+++ +V  V DFG+SR+L D+     +T   K  I + APE  A  + ++  
Sbjct: 156 DLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 215
Query: 756 DEYSFGILMLEMFT-GKRPTDDM 777
           D +S+GI+M E+ + G+RP  DM
Sbjct: 216 DVWSYGIVMWEVMSYGERPYWDM 238

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 18/194 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VA+K L      + ++F+ E + ++ +RH  LV++    S       E   +V E+M 
Sbjct: 43  TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMS 95
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            G L ++L  +  +      L L Q + +A  +A+ + Y+      + VH DL+ +N+L+
Sbjct: 96  KGCLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILV 147
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  V DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 148 GENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 205
Query: 765 LEMFT-GKRPTDDM 777
            E+ T G+ P   M
Sbjct: 206 TELTTKGRVPYPGM 219

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK L  Q   +  +F+AE   ++ ++H+ LV++    +       E   ++ E+M 
Sbjct: 33  TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYME 85
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           NGSL ++L           KL + + L +A  +A  + ++    +   +H DL+ +N+L+
Sbjct: 86  NGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILV 137
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
            + +   + DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 138 SDTLSCKIADFGLARLIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 195
Query: 765 LEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQVAE 798
            E+ T G+ P   M    +  +L +  +M  PD   E
Sbjct: 196 TEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 232

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 18/192 (9%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
            VA+K +  +   +   FI E E +  + H  LV++   C            LV+EFM +
Sbjct: 53  KVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLVFEFMEH 106
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L ++L      + QR        L + +DV   + YL   C   ++H DL   N L+ 
Sbjct: 107 GCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVG 157
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
              V  V DFG++R + D+    TS++  K  + + +PE  +    S+  D +SFG+LM 
Sbjct: 158 ENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMW 215
Query: 766 EMFT-GKRPTDD 776
           E+F+ GK P ++
Sbjct: 216 EVFSEGKIPYEN 227

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 91/187 (48%), Gaps = 20/187 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L        + F  E E L+S++H N+VK    C S   R      L+ E++P G
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYG 98
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL ++L      Q  + +++ ++ L     +   +EYL        +H DL   N+L++N
Sbjct: 99  SLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVEN 149
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVK----GSIGYVAPEYGALGEVSTHGDEYSFGI 762
           E    +GDFGL+++L    P      +VK      I + APE     + S   D +SFG+
Sbjct: 150 ENRVKIGDFGLTKVL----PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 205
Query: 763 LMLEMFT 769
           ++ E+FT
Sbjct: 206 VLYELFT 212

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 22/194 (11%)
Query: 586 NVAVKVLDLQQRGA--SKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
            VA+K +   + GA   + FI E E +  + H  LV++   C            LV+EFM
Sbjct: 33  KVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLVFEFM 84
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
            +G L ++L      + QR        L + +DV   + YL      S++H DL   N L
Sbjct: 85  EHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEE---ASVIHRDLAARNCL 135
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
           +    V  V DFG++R + D+    TS++  K  + + +PE  +    S+  D +SFG+L
Sbjct: 136 VGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 193
Query: 764 MLEMFT-GKRPTDD 776
           M E+F+ GK P ++
Sbjct: 194 MWEVFSEGKIPYEN 207

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 30/205 (14%)
Query: 583 EETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
            E  VA+K L      +QR   + F++E   +    H N++    ++T  + +       
Sbjct: 34  REIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHPNVIHLEGVVTKSTPV------- 83
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             ++ EFM NGSL+++L Q + +        ++Q + +   +A  ++YL      + VH 
Sbjct: 84  -MIITEFMENGSLDSFLRQNDGQ------FTVIQLVGMLRGIAAGMKYL---ADMNYVHR 133
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG--YVAPEYGALGEVST 753
            L   N+L+++ +V  V DFGLSR L D++ D T TS + G I   + APE     + ++
Sbjct: 134 ALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTS 193
Query: 754 HGDEYSFGILMLEMFT-GKRPTDDM 777
             D +S+GI+M E+ + G+RP  DM
Sbjct: 194 ASDVWSYGIVMWEVMSYGERPYWDM 218

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 92/185 (49%), Gaps = 13/185 (7%)
Query: 586 NVAVKVLDLQQRGAS-KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
            VAVK L  +  G        E E LR++ H N+VK    C+  +  GN  K L+ EF+P
Sbjct: 52  QVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT--EDGGNGIK-LIMEFLP 108
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           +GSL+ +L + ++      K+NL Q+L  A+ +   ++YL        VH DL   NVL+
Sbjct: 109 SGSLKEYLPKNKN------KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLV 159
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
           ++E    +GDFGL++ +  +    T        + + APE     +     D +SFG+ +
Sbjct: 160 ESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 219
Query: 765 LEMFT 769
            E+ T
Sbjct: 220 HELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 92/185 (49%), Gaps = 13/185 (7%)
Query: 586 NVAVKVLDLQQRGAS-KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
            VAVK L  +  G        E E LR++ H N+VK    C+  +  GN  K L+ EF+P
Sbjct: 40  QVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT--EDGGNGIK-LIMEFLP 96
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           +GSL+ +L + ++      K+NL Q+L  A+ +   ++YL        VH DL   NVL+
Sbjct: 97  SGSLKEYLPKNKN------KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLV 147
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
           ++E    +GDFGL++ +  +    T        + + APE     +     D +SFG+ +
Sbjct: 148 ESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 207
Query: 765 LEMFT 769
            E+ T
Sbjct: 208 HELLT 212

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 88/183 (48%), Gaps = 12/183 (6%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L        + F  E E L+S++H N+VK    C S   R      L+ E++P G
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYG 101
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL ++L      Q    +++ ++ L     +   +EYL        +H DL   N+L++N
Sbjct: 102 SLRDYL------QAHAERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVEN 152
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           E    +GDFGL+++L  +          +  I + APE     + S   D +SFG+++ E
Sbjct: 153 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 212
Query: 767 MFT 769
           +FT
Sbjct: 213 LFT 215

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 93/194 (47%), Gaps = 22/194 (11%)
Query: 586 NVAVKVLDLQQRGA--SKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
            VA+K +   + GA   + FI E E +  + H  LV++   C            LV EFM
Sbjct: 34  KVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLVTEFM 85
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
            +G L ++L      + QR        L + +DV   + YL   C   ++H DL   N L
Sbjct: 86  EHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCL 136
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
           +    V  V DFG++R + D+    TS++  K  + + +PE  +    S+  D +SFG+L
Sbjct: 137 VGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 194
Query: 764 MLEMFT-GKRPTDD 776
           M E+F+ GK P ++
Sbjct: 195 MWEVFSEGKIPYEN 208

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 42  VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIIIEFMTYG 95
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L      +  R ++N +  L +A  +++ +EYL      + +H DL   N L+  
Sbjct: 96  NLLDYL-----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGE 147
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 148 NHLVKVADFGLSRLMTGDT--XTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 205
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 206 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 246

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK L  Q   +  +F+AE   ++ ++H+ LV++    +       E   ++ E+M 
Sbjct: 34  TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYME 86
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           NGSL ++L           KL + + L +A  +A  + ++    +   +H +L+ +N+L+
Sbjct: 87  NGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEERNY---IHRNLRAANILV 138
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
            + +   + DFGL+RL+ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 139 SDTLSCKIADFGLARLIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 196
Query: 765 LEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQVAE 798
            E+ T G+ P   M    +  +L +  +M  PD   E
Sbjct: 197 TEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 233

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 46  VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYG 99
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L      +  R ++N +  L +A  +++ +EYL      + +H DL   N L+  
Sbjct: 100 NLLDYL-----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGE 151
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 152 NHLVKVADFGLSRLMTGDT--XTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 209
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 210 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 250

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK L  Q   +  +F+AE   ++ ++H+ LV++    +       E   ++ E+M 
Sbjct: 38  TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYIITEYME 90
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           NGSL ++L           KL + + L +A  +A  + ++      + +H DL+ +N+L+
Sbjct: 91  NGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILV 142
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
            + +   + DFGL+RL+ D   + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 143 SDTLSCKIADFGLARLIED--AEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 765 LEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQVAE 798
            E+ T G+ P   M    +  +L +  +M  PD   E
Sbjct: 201 TEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 42  VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYG 95
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L      +  R ++N +  L +A  +++ +EYL      + +H DL   N L+  
Sbjct: 96  NLLDYL-----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGE 147
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 148 NHLVKVADFGLSRLMTGDT--YTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 205
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 206 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 246

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 43  VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYG 96
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L      +  R ++N +  L +A  +++ +EYL      + +H DL   N L+  
Sbjct: 97  NLLDYL-----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGE 148
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 149 NHLVKVADFGLSRLMTGDT--YTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 206
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 207 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 247

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 91/187 (48%), Gaps = 20/187 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L        + F  E E L+S++H N+VK    C S   R      L+ E++P G
Sbjct: 43  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYG 99
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL ++L      Q  + +++ ++ L     +   +EYL        +H +L   N+L++N
Sbjct: 100 SLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVEN 150
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVK----GSIGYVAPEYGALGEVSTHGDEYSFGI 762
           E    +GDFGL+++L    P      +VK      I + APE     + S   D +SFG+
Sbjct: 151 ENRVKIGDFGLTKVL----PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 206
Query: 763 LMLEMFT 769
           ++ E+FT
Sbjct: 207 VLYELFT 213

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 108/203 (53%), Gaps = 28/203 (13%)
Query: 583 EETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           +E +VA+K L +    +QR   + F+ E   +    H N+++   ++T    +       
Sbjct: 60  KEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV------- 109
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             +V E+M NGSL+++L +K D Q       ++Q + +   +A+ ++YL    +   VH 
Sbjct: 110 -MIVTEYMENGSLDSFL-RKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMGY---VHR 159
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+L+++ +V  V DFGLSR+L D+     +T   K  I + +PE  A  + ++  
Sbjct: 160 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 219
Query: 756 DEYSFGILMLEMFT-GKRPTDDM 777
           D +S+GI++ E+ + G+RP  +M
Sbjct: 220 DVWSYGIVLWEVMSYGERPYWEM 242

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 46  VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIIIEFMTYG 99
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L      +  R ++N +  L +A  +++ +EYL      + +H DL   N L+  
Sbjct: 100 NLLDYL-----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGE 151
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 152 NHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 209
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 210 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 250

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 46  VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYG 99
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L      +  R ++N +  L +A  +++ +EYL      + +H DL   N L+  
Sbjct: 100 NLLDYL-----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGE 151
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 152 NHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 209
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 210 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 250

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 41  VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYG 94
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L      +  R ++N +  L +A  +++ +EYL      + +H DL   N L+  
Sbjct: 95  NLLDYL-----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGE 146
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 147 NHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 205 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 245

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 45  VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYG 98
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L      +  R ++N +  L +A  +++ +EYL      + +H DL   N L+  
Sbjct: 99  NLLDYL-----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGE 150
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 151 NHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 208
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 209 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 249

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 41  VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYG 94
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L      +  R ++N +  L +A  +++ +EYL      + +H DL   N L+  
Sbjct: 95  NLLDYL-----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGE 146
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 147 NHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 205 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 245

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 43  VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYG 96
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L      +  R ++N +  L +A  +++ +EYL      + +H DL   N L+  
Sbjct: 97  NLLDYL-----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGE 148
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 149 NHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 206
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 207 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 247

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 43  VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYG 96
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L      +  R ++N +  L +A  +++ +EYL      + +H DL   N L+  
Sbjct: 97  NLLDYL-----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGE 148
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 149 NHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 206
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 207 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 247

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 108/203 (53%), Gaps = 28/203 (13%)
Query: 583 EETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           +E +VA+K L +    +QR   + F+ E   +    H N+++   ++T    +       
Sbjct: 43  KEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV------- 92
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             +V E+M NGSL+++L +K D Q       ++Q + +   +A+ ++YL    +   VH 
Sbjct: 93  -MIVTEYMENGSLDSFL-RKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMGY---VHR 142
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+L+++ +V  V DFGLSR+L D+     +T   K  I + +PE  A  + ++  
Sbjct: 143 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 202
Query: 756 DEYSFGILMLEMFT-GKRPTDDM 777
           D +S+GI++ E+ + G+RP  +M
Sbjct: 203 DVWSYGIVLWEVMSYGERPYWEM 225

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 111/222 (50%), Gaps = 23/222 (10%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
            VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  
Sbjct: 53  TVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTY 106
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G+L ++L +       R ++N +  L +A  +++ +EYL      + +H DL   N L+ 
Sbjct: 107 GNLLDYLRE-----CNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG 158
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
              +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ 
Sbjct: 159 ENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLW 216
Query: 766 EMFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           E+ T      P  D+ +    L K  +M    G P++V E++
Sbjct: 217 EIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 258

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           + +VA+K++  +   +   FI E + + ++ H  LV++   C+           ++ E+M
Sbjct: 48  QYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFIITEYM 101
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
            NG L N+L +       R +    Q L +  DV   +EYL        +H DL   N L
Sbjct: 102 ANGCLLNYLRE------MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCL 152
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
           ++++ V  V DFGLSR + D+  ++TS+   K  + +  PE     + S+  D ++FG+L
Sbjct: 153 VNDQGVVKVSDFGLSRYVLDD--EETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 210
Query: 764 MLEMFT-GKRP--------TDDMFEEGLSLHK 786
           M E+++ GK P        T +   +GL L++
Sbjct: 211 MWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 242

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 111/222 (50%), Gaps = 23/222 (10%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
            VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  
Sbjct: 45  TVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTY 98
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G+L ++L +       R ++N +  L +A  +++ +EYL      + +H DL   N L+ 
Sbjct: 99  GNLLDYLRE-----CNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG 150
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
              +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ 
Sbjct: 151 ENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLW 208
Query: 766 EMFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           E+ T      P  D+ +    L K  +M    G P++V E++
Sbjct: 209 EIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 250

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 28/203 (13%)
Query: 583 EETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           +E +VA+K L +    +QR   + F+ E   +    H N+++   ++T    +       
Sbjct: 72  KEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV------- 121
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             +V E+M NGSL+++L +K D Q       ++Q + +   +A+ ++YL        VH 
Sbjct: 122 -MIVTEYMENGSLDSFL-RKHDAQ-----FTVIQLVGMLRGIASGMKYL---SDMGFVHR 171
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+L+++ +V  V DFGLSR+L D+     +T   K  I + +PE  A  + ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 756 DEYSFGILMLEMFT-GKRPTDDM 777
           D +S+GI++ E+ + G+RP  +M
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEM 254

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 27/224 (12%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
            VAVK L  +     + F+ E   ++ I+H NLV+++  C    T    F  +V E+MP 
Sbjct: 59  TVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TLEPPF-YIVTEYMPY 112
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G+L ++L +       R ++  +  L +A  +++ +EYL      + +H DL   N L+ 
Sbjct: 113 GNLLDYLRE-----CNREEVTAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG 164
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
              V  V DFGLSRL+  ++   T+ +  K  I + APE  A    S   D ++FG+L+ 
Sbjct: 165 ENHVVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLW 222
Query: 766 EMFT-GKRPTD--------DMFEEGLSLHKYAKMGLPDQVAEII 800
           E+ T G  P          D+ E+G  + +    G P +V E++
Sbjct: 223 EIATYGMSPYPGIDLSQVYDLLEKGYRMEQ--PEGCPPKVYELM 264

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 108/203 (53%), Gaps = 28/203 (13%)
Query: 583 EETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           +E +VA+K L +    +QR   + F+ E   +    H N+++   ++T    +       
Sbjct: 72  KEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV------- 121
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             +V E+M NGSL+++L +K D Q       ++Q + +   +A+ ++YL    +   VH 
Sbjct: 122 -MIVTEYMENGSLDSFL-RKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMGY---VHR 171
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+L+++ +V  V DFGLSR+L D+     +T   K  I + +PE  A  + ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 756 DEYSFGILMLEMFT-GKRPTDDM 777
           D +S+GI++ E+ + G+RP  +M
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 108/203 (53%), Gaps = 28/203 (13%)
Query: 583 EETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           +E +VA+K L +    +QR   + F+ E   +    H N+++   ++T    +       
Sbjct: 72  KEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV------- 121
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             +V E+M NGSL+++L +K D Q       ++Q + +   +A+ ++YL    +   VH 
Sbjct: 122 -MIVTEYMENGSLDSFL-RKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMGY---VHR 171
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+L+++ +V  V DFGLSR+L D+     +T   K  I + +PE  A  + ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 756 DEYSFGILMLEMFT-GKRPTDDM 777
           D +S+GI++ E+ + G+RP  +M
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 108/203 (53%), Gaps = 28/203 (13%)
Query: 583 EETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           +E +VA+K L +    +QR   + F+ E   +    H N+++   ++T    +       
Sbjct: 72  KEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV------- 121
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             +V E+M NGSL+++L +K D Q       ++Q + +   +A+ ++YL    +   VH 
Sbjct: 122 -MIVTEYMENGSLDSFL-RKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMGY---VHR 171
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+L+++ +V  V DFGLSR+L D+     +T   K  I + +PE  A  + ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 756 DEYSFGILMLEMFT-GKRPTDDM 777
           D +S+GI++ E+ + G+RP  +M
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 108/203 (53%), Gaps = 28/203 (13%)
Query: 583 EETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           +E +VA+K L +    +QR   + F+ E   +    H N+++   ++T    +       
Sbjct: 72  KEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV------- 121
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             +V E+M NGSL+++L +K D Q       ++Q + +   +A+ ++YL    +   VH 
Sbjct: 122 -MIVTEYMENGSLDSFL-RKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMGY---VHR 171
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+L+++ +V  V DFGLSR+L D+     +T   K  I + +PE  A  + ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 756 DEYSFGILMLEMFT-GKRPTDDM 777
           D +S+GI++ E+ + G+RP  +M
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEM 254

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 108/203 (53%), Gaps = 28/203 (13%)
Query: 583 EETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           +E +VA+K L +    +QR   + F+ E   +    H N+++   ++T    +       
Sbjct: 70  KEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV------- 119
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             +V E+M NGSL+++L +K D Q       ++Q + +   +A+ ++YL    +   VH 
Sbjct: 120 -MIVTEYMENGSLDSFL-RKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMGY---VHR 169
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+L+++ +V  V DFGLSR+L D+     +T   K  I + +PE  A  + ++  
Sbjct: 170 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 229
Query: 756 DEYSFGILMLEMFT-GKRPTDDM 777
           D +S+GI++ E+ + G+RP  +M
Sbjct: 230 DVWSYGIVLWEVMSYGERPYWEM 252

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           + +VA+K++  +   +   FI E + + ++ H  LV++   C+           ++ E+M
Sbjct: 33  QYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFIITEYM 86
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
            NG L N+L +       R +    Q L +  DV   +EYL        +H DL   N L
Sbjct: 87  ANGCLLNYLRE------MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCL 137
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
           ++++ V  V DFGLSR + D+  + TS+   K  + +  PE     + S+  D ++FG+L
Sbjct: 138 VNDQGVVKVSDFGLSRYVLDD--EYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 195
Query: 764 MLEMFT-GKRP--------TDDMFEEGLSLHK 786
           M E+++ GK P        T +   +GL L++
Sbjct: 196 MWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 227

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 27/201 (13%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L      A K F  E E L +++H ++VK    C   D        +V+E+M +G
Sbjct: 48  VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL-----IMVFEYMKHG 102
Query: 647 SLENWLNQKE-------DEQNQRPK--LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
            L  +L           D Q ++ K  L L Q L IA  +A+ + YL        VH DL
Sbjct: 103 DLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDL 159
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVST 753
              N L+   ++  +GDFG+SR ++      T   RV G     I ++ PE     + +T
Sbjct: 160 ATRNCLVGANLLVKIGDFGMSRDVYS-----TDYYRVGGHTMLPIRWMPPESIMYRKFTT 214
Query: 754 HGDEYSFGILMLEMFT-GKRP 773
             D +SFG+++ E+FT GK+P
Sbjct: 215 ESDVWSFGVILWEIFTYGKQP 235

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           + +VA+K++  +   +   FI E + + ++ H  LV++   C+           ++ E+M
Sbjct: 28  QYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFIITEYM 81
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
            NG L N+L +       R +    Q L +  DV   +EYL        +H DL   N L
Sbjct: 82  ANGCLLNYLRE------MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCL 132
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
           ++++ V  V DFGLSR + D+  + TS+   K  + +  PE     + S+  D ++FG+L
Sbjct: 133 VNDQGVVKVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 190
Query: 764 MLEMFT-GKRP--------TDDMFEEGLSLHK 786
           M E+++ GK P        T +   +GL L++
Sbjct: 191 MWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 222

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           + +VA+K++  +   +   FI E + + ++ H  LV++   C+           ++ E+M
Sbjct: 48  QYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFIITEYM 101
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
            NG L N+L +       R +    Q L +  DV   +EYL        +H DL   N L
Sbjct: 102 ANGCLLNYLRE------MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCL 152
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
           ++++ V  V DFGLSR + D+  + TS+   K  + +  PE     + S+  D ++FG+L
Sbjct: 153 VNDQGVVKVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 210
Query: 764 MLEMFT-GKRP--------TDDMFEEGLSLHK 786
           M E+++ GK P        T +   +GL L++
Sbjct: 211 MWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 242

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           + +VA+K++  +   +   FI E + + ++ H  LV++   C+           ++ E+M
Sbjct: 33  QYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFIITEYM 86
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
            NG L N+L +       R +    Q L +  DV   +EYL        +H DL   N L
Sbjct: 87  ANGCLLNYLRE------MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCL 137
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
           ++++ V  V DFGLSR + D+  + TS+   K  + +  PE     + S+  D ++FG+L
Sbjct: 138 VNDQGVVKVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 195
Query: 764 MLEMFT-GKRP--------TDDMFEEGLSLHK 786
           M E+++ GK P        T +   +GL L++
Sbjct: 196 MWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 227

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           + +VA+K++  +   +   FI E + + ++ H  LV++   C+           ++ E+M
Sbjct: 32  QYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFIITEYM 85
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
            NG L N+L +       R +    Q L +  DV   +EYL        +H DL   N L
Sbjct: 86  ANGCLLNYLRE------MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCL 136
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
           ++++ V  V DFGLSR + D+  + TS+   K  + +  PE     + S+  D ++FG+L
Sbjct: 137 VNDQGVVKVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 194
Query: 764 MLEMFT-GKRP--------TDDMFEEGLSLHK 786
           M E+++ GK P        T +   +GL L++
Sbjct: 195 MWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 226

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 108/203 (53%), Gaps = 28/203 (13%)
Query: 583 EETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           +E +VA+K L +    +QR   + F+ E   +    H N+++   ++T    +       
Sbjct: 72  KEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV------- 121
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             +V E+M NGSL+++L +K D Q       ++Q + +   +A+ ++YL    +   VH 
Sbjct: 122 -MIVTEYMENGSLDSFL-RKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMGY---VHR 171
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+L+++ +V  V DFGL+R+L D+     +T   K  I + +PE  A  + ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 756 DEYSFGILMLEMFT-GKRPTDDM 777
           D +S+GI++ E+ + G+RP  +M
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEM 254

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 57/190 (30%), Positives = 98/190 (51%), Gaps = 17/190 (8%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK L        ++F+ E   +++++H  LV++     ++ TR  E   ++ E+M 
Sbjct: 38  TKVAVKTLKPGTMSV-QAFLEEANLMKTLQHDKLVRLY----AVVTR-EEPIYIITEYMA 91
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L   E  +   PKL     +  +  +A  + Y+      + +H DL+ +NVL+
Sbjct: 92  KGSLLDFLKSDEGGKVLLPKL-----IDFSAQIAEGMAYIER---KNYIHRDLRAANVLV 143
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              ++  + DFGL+R++ DN  + T+    K  I + APE    G  +   D +SFGIL+
Sbjct: 144 SESLMCKIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILL 201
Query: 765 LEMFT-GKRP 773
            E+ T GK P
Sbjct: 202 YEIVTYGKIP 211

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           + +VA+K++  +   +   FI E + + ++ H  LV++   C+           ++ E+M
Sbjct: 39  QYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFIITEYM 92
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
            NG L N+L +       R +    Q L +  DV   +EYL        +H DL   N L
Sbjct: 93  ANGCLLNYLRE------MRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCL 143
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
           ++++ V  V DFGLSR + D+  + TS+   K  + +  PE     + S+  D ++FG+L
Sbjct: 144 VNDQGVVKVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 201
Query: 764 MLEMFT-GKRP--------TDDMFEEGLSLHK 786
           M E+++ GK P        T +   +GL L++
Sbjct: 202 MWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 233

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 22/199 (11%)
Query: 584 ETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           +  VA+K L +    +QR   + F+ E   +    H N+V +      + TRG     +V
Sbjct: 71  DVAVAIKTLKVGYTEKQR---RDFLCEASIMGQFDHPNVVHL----EGVVTRGKPV-MIV 122
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            EFM NG+L+ +L +K D Q       ++Q + +   +A  + YL        VH DL  
Sbjct: 123 IEFMENGALDAFL-RKHDGQ-----FTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAA 173
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYS 759
            N+L+++ +V  V DFGLSR++ D+     +T+  K  + + APE     + ++  D +S
Sbjct: 174 RNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWS 233
Query: 760 FGILMLEMFT-GKRPTDDM 777
           +GI+M E+ + G+RP  DM
Sbjct: 234 YGIVMWEVMSYGERPYWDM 252

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 41  VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIIIEFMTYG 94
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L      +  R +++ +  L +A  +++ +EYL      + +H DL   N L+  
Sbjct: 95  NLLDYL-----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGE 146
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 147 NHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 205 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 245

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 41  VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIIIEFMTYG 94
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L      +  R +++ +  L +A  +++ +EYL      + +H DL   N L+  
Sbjct: 95  NLLDYL-----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGE 146
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 147 NHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 205 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 245

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 41  VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYG 94
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L      +  R +++ +  L +A  +++ +EYL      + +H DL   N L+  
Sbjct: 95  NLLDYL-----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGE 146
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 147 NHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 205 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 245

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 28/203 (13%)
Query: 583 EETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           +E +VA+K L +    +QR   + F+ E   +    H N+++   ++T    +       
Sbjct: 43  KEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV------- 92
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             +V E M NGSL+++L +K D Q       ++Q + +   +A+ ++YL    +   VH 
Sbjct: 93  -MIVTEXMENGSLDSFL-RKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMGY---VHR 142
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+L+++ +V  V DFGLSR+L D+     +T   K  I + +PE  A  + ++  
Sbjct: 143 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 202
Query: 756 DEYSFGILMLEMFT-GKRPTDDM 777
           D +S+GI++ E+ + G+RP  +M
Sbjct: 203 DVWSYGIVLWEVMSYGERPYWEM 225

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 41  VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYG 94
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L      +  R +++ +  L +A  +++ +EYL      + +H DL   N L+  
Sbjct: 95  NLLDYL-----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGE 146
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 147 NHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 205 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 245

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 37/229 (16%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
            VAVK +  +    +++F+AE   +  +RH NLV+++     ++ +G  +  +V E+M  
Sbjct: 37  KVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI--VEEKGGLY--IVTEYMAK 90
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           GSL ++L  +      R  L     L  ++DV   +EYL  +   + VH DL   NVL+ 
Sbjct: 91  GSLVDYLRSR-----GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVS 142
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS--IGYVAPEYGALGEVSTHGDEYSFGIL 763
            + VA V DFGL++        + S+++  G   + + APE       ST  D +SFGIL
Sbjct: 143 EDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFGIL 194
Query: 764 MLEMFTGKR------PTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILE 806
           + E+++  R      P  D+      + K  KM  PD       PA+ E
Sbjct: 195 LWEIYSFGRVPYPRIPLKDVVPR---VEKGYKMDAPDGCP----PAVYE 236

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 111/229 (48%), Gaps = 37/229 (16%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
            VAVK +  +    +++F+AE   +  +RH NLV+++     ++ +G  +  +V E+M  
Sbjct: 46  KVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI--VEEKGGLY--IVTEYMAK 99
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           GSL ++L  +      R  L     L  ++DV   +EYL  +   + VH DL   NVL+ 
Sbjct: 100 GSLVDYLRSR-----GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVS 151
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS--IGYVAPEYGALGEVSTHGDEYSFGIL 763
            + VA V DFGL++        + S+++  G   + + APE     + ST  D +SFGIL
Sbjct: 152 EDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 203
Query: 764 MLEMFTGKR------PTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILE 806
           + E+++  R      P  D+      + K  KM  PD       PA+ E
Sbjct: 204 LWEIYSFGRVPYPRIPLKDVVPR---VEKGYKMDAPDGCP----PAVYE 245

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 107/203 (52%), Gaps = 28/203 (13%)
Query: 583 EETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           +E +VA+K L +    +QR   + F+ E   +    H N+++   ++T    +       
Sbjct: 72  KEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV------- 121
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             +V E+M NGSL+++L +K D Q       ++Q + +   +A+ ++YL    +   VH 
Sbjct: 122 -MIVTEYMENGSLDSFL-RKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMGY---VHR 171
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+L+++ +V  V DFGL R+L D+     +T   K  I + +PE  A  + ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 756 DEYSFGILMLEMFT-GKRPTDDM 777
           D +S+GI++ E+ + G+RP  +M
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEM 254

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 111/229 (48%), Gaps = 37/229 (16%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
            VAVK +  +    +++F+AE   +  +RH NLV+++     ++ +G  +  +V E+M  
Sbjct: 31  KVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI--VEEKGGLY--IVTEYMAK 84
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           GSL ++L  +      R  L     L  ++DV   +EYL  +   + VH DL   NVL+ 
Sbjct: 85  GSLVDYLRSR-----GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVS 136
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS--IGYVAPEYGALGEVSTHGDEYSFGIL 763
            + VA V DFGL++        + S+++  G   + + APE     + ST  D +SFGIL
Sbjct: 137 EDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 188
Query: 764 MLEMFTGKR------PTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILE 806
           + E+++  R      P  D+      + K  KM  PD       PA+ E
Sbjct: 189 LWEIYSFGRVPYPRIPLKDVVPR---VEKGYKMDAPDGCP----PAVYE 230

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 23/222 (10%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
            VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  
Sbjct: 45  TVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTY 98
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G+L ++L +       R +++ +  L +A  +++ +EYL      + +H DL   N L+ 
Sbjct: 99  GNLLDYLRE-----CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG 150
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
              +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ 
Sbjct: 151 ENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLW 208
Query: 766 EMFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           E+ T      P  D+ +    L K  +M    G P++V E++
Sbjct: 209 EIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 250

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 28/203 (13%)
Query: 583 EETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           +E +VA+K L +    +QR   + F+ E   +    H N+++   ++T    +       
Sbjct: 72  KEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV------- 121
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             +V E M NGSL+++L +K D Q       ++Q + +   +A+ ++YL        VH 
Sbjct: 122 -MIVTEXMENGSLDSFL-RKHDAQ-----FTVIQLVGMLRGIASGMKYL---SDMGAVHR 171
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+L+++ +V  V DFGLSR+L D+     +T   K  I + +PE  A  + ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 756 DEYSFGILMLEMFT-GKRPTDDM 777
           D +S+GI++ E+ + G+RP  +M
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 28/203 (13%)
Query: 583 EETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEF 635
           +E +VA+K L +    +QR   + F+ E   +    H N+++   ++T    +       
Sbjct: 72  KEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKSKPV------- 121
Query: 636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
             +V E M NGSL+++L +K D Q       ++Q + +   +A+ ++YL    +   VH 
Sbjct: 122 -MIVTEXMENGSLDSFL-RKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMGY---VHR 171
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+L+++ +V  V DFGLSR+L D+     +T   K  I + +PE  A  + ++  
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 756 DEYSFGILMLEMFT-GKRPTDDM 777
           D +S+GI++ E+ + G+RP  +M
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 55/190 (28%), Positives = 95/190 (50%), Gaps = 17/190 (8%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK L        ++F+ E   +++++H  LV++    +       E   ++ EFM 
Sbjct: 37  TKVAVKTLKPGTMSV-QAFLEEANLMKTLQHDKLVRLYAVVTK-----EEPIYIITEFMA 90
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L   E  +   PKL     +  +  +A  + Y+      + +H DL+ +NVL+
Sbjct: 91  KGSLLDFLKSDEGGKVLLPKL-----IDFSAQIAEGMAYIER---KNYIHRDLRAANVLV 142
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              ++  + DFGL+R++ DN  + T+    K  I + APE    G  +   + +SFGIL+
Sbjct: 143 SESLMCKIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAINFGCFTIKSNVWSFGILL 200
Query: 765 LEMFT-GKRP 773
            E+ T GK P
Sbjct: 201 YEIVTYGKIP 210

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 62/223 (27%), Positives = 112/223 (50%), Gaps = 27/223 (12%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 39  VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIIIEFMTYG 92
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L      +  R +++ +  L +A  +++ +EYL      + +H DL   N L+  
Sbjct: 93  NLLDYL-----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGE 144
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 145 NHLVKVADFGLSRLMTGDT--XTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 202
Query: 767 MFT-------GKRPTD--DMFEEGLSLHKYAKMGLPDQVAEII 800
           + T       G  P+   ++ E+   + +    G P++V E++
Sbjct: 203 IATYGMSPYPGIDPSQVYELLEKDYRMER--PEGCPEKVYELM 243

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 95/184 (51%), Gaps = 16/184 (8%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
            VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  
Sbjct: 38  TVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTY 91
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G+L ++L +       R +++ +  L +A  +++ +EYL      + +H DL   N L+ 
Sbjct: 92  GNLLDYLRE-----CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG 143
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
              +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ 
Sbjct: 144 ENHLVKVADFGLSRLMTGDT--XTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLW 201
Query: 766 EMFT 769
           E+ T
Sbjct: 202 EIAT 205

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 28/202 (13%)
Query: 584 ETNVAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEFK 636
           E  VA+K L +    +QR   + F+ E   +    H N++    ++T    +        
Sbjct: 50  ELPVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNIIHLEGVVTKSKPV-------- 98
Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
            +V E+M NGSL+ +L +K D Q       ++Q + +   ++  ++YL    +   VH D
Sbjct: 99  MIVTEYMENGSLDTFL-KKNDGQ-----FTVIQLVGMLRGISAGMKYLSDMGY---VHRD 149
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           L   N+L+++ +V  V DFGLSR+L D+     +T   K  I + APE  A  + ++  D
Sbjct: 150 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASD 209
Query: 757 EYSFGILMLEMFT-GKRPTDDM 777
            +S+GI+M E+ + G+RP  +M
Sbjct: 210 VWSYGIVMWEVVSYGERPYWEM 231

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 33/217 (15%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
            VAVK +  +    +++F+AE   +  +RH NLV+++     ++ +G  +  +V E+M  
Sbjct: 218 KVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI--VEEKGGLY--IVTEYMAK 271
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           GSL ++L  +      R  L     L  ++DV   +EYL  +   + VH DL   NVL+ 
Sbjct: 272 GSLVDYLRSR-----GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVS 323
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS--IGYVAPEYGALGEVSTHGDEYSFGIL 763
            + VA V DFGL++        + S+++  G   + + APE     + ST  D +SFGIL
Sbjct: 324 EDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 375
Query: 764 MLEMFTGKR------PTDDMFEEGLSLHKYAKMGLPD 794
           + E+++  R      P  D+      + K  KM  PD
Sbjct: 376 LWEIYSFGRVPYPRIPLKDVVPR---VEKGYKMDAPD 409

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 287 VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYG 340
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L +       R ++N +  L +A  +++ +EYL      + +H +L   N L+  
Sbjct: 341 NLLDYLRE-----CNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGE 392
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 393 NHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 450
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 451 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 491

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 112/224 (50%), Gaps = 27/224 (12%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
            VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  
Sbjct: 38  TVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTY 91
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G+L ++L +       R +++ +  L +A  +++ +EYL      + +H DL   N L+ 
Sbjct: 92  GNLLDYLRE-----CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG 143
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
              +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ 
Sbjct: 144 ENHLVKVADFGLSRLMTGDT--FTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLW 201
Query: 766 EMFT-------GKRPTD--DMFEEGLSLHKYAKMGLPDQVAEII 800
           E+ T       G  P+   ++ E+   + +    G P++V E++
Sbjct: 202 EIATYGMSPYPGIDPSQVYELLEKDYRMER--PEGCPEKVYELM 243

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 20/194 (10%)
Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA-LVYEF 642
           + +VAVK++  +   +   F  E + +  + H  LVK    CS       E+   +V E+
Sbjct: 32  QYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS------KEYPIYIVTEY 84
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
           + NG L N+L      ++    L   Q L +  DV   + +L  H     +H DL   N 
Sbjct: 85  ISNGCLLNYL------RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNC 135
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGI 762
           L+D ++   V DFG++R + D+     S+   K  + + APE     + S+  D ++FGI
Sbjct: 136 LVDRDLCVKVSDFGMTRYVLDDQ--YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGI 193
Query: 763 LMLEMFT-GKRPTD 775
           LM E+F+ GK P D
Sbjct: 194 LMWEVFSLGKMPYD 207

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 26/200 (13%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L      A + F  E E L  ++H+++V+    C    T G     +V+E+M +G
Sbjct: 74  VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC----TEGRPL-LMVFEYMRHG 128
Query: 647 SLENWLNQKEDE-------QNQRP-KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK 698
            L  +L     +       ++  P  L L Q L++A  VA  + YL        VH DL 
Sbjct: 129 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLA 185
Query: 699 PSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTH 754
             N L+   +V  +GDFG+SR ++      T   RV G     I ++ PE     + +T 
Sbjct: 186 TRNCLVGQGLVVKIGDFGMSRDIYS-----TDYYRVGGRTMLPIRWMPPESILYRKFTTE 240
Query: 755 GDEYSFGILMLEMFT-GKRP 773
            D +SFG+++ E+FT GK+P
Sbjct: 241 SDVWSFGVVLWEIFTYGKQP 260

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L  +     + F+ E   ++ I+H NLV+++  C    TR   F  ++ EFM  G
Sbjct: 248 VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYG 301
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L ++L +       R +++ +  L +A  +++ +EYL      + +H +L   N L+  
Sbjct: 302 NLLDYLRE-----CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGE 353
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
             +  V DFGLSRL+  ++   T+ +  K  I + APE  A  + S   D ++FG+L+ E
Sbjct: 354 NHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 411
Query: 767 MFT---GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEII 800
           + T      P  D+ +    L K  +M    G P++V E++
Sbjct: 412 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 452

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 91/198 (45%), Gaps = 24/198 (12%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L      A K F  E E L +++H ++VK    C   D        +V+E+M +G
Sbjct: 46  VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL-----IMVFEYMKHG 100
Query: 647 SLENWLNQKED------EQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
            L  +L           E N   +L   Q L IA  +A  + YL        VH DL   
Sbjct: 101 DLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATR 157
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHGD 756
           N L+   ++  +GDFG+SR ++      T   RV G     I ++ PE     + +T  D
Sbjct: 158 NCLVGENLLVKIGDFGMSRDVYS-----TDYYRVGGHTMLPIRWMPPESIMYRKFTTESD 212
Query: 757 EYSFGILMLEMFT-GKRP 773
            +S G+++ E+FT GK+P
Sbjct: 213 VWSLGVVLWEIFTYGKQP 230

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 26/200 (13%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L      A + F  E E L  ++H+++V+    C    T G     +V+E+M +G
Sbjct: 45  VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC----TEGRPL-LMVFEYMRHG 99
Query: 647 SLENWLNQKEDE-------QNQRP-KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK 698
            L  +L     +       ++  P  L L Q L++A  VA  + YL        VH DL 
Sbjct: 100 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLA 156
Query: 699 PSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTH 754
             N L+   +V  +GDFG+SR ++      T   RV G     I ++ PE     + +T 
Sbjct: 157 TRNCLVGQGLVVKIGDFGMSRDIYS-----TDYYRVGGRTMLPIRWMPPESILYRKFTTE 211
Query: 755 GDEYSFGILMLEMFT-GKRP 773
            D +SFG+++ E+FT GK+P
Sbjct: 212 SDVWSFGVVLWEIFTYGKQP 231

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 26/200 (13%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK L      A + F  E E L  ++H+++V+    C    T G     +V+E+M +G
Sbjct: 51  VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC----TEGRPL-LMVFEYMRHG 105
Query: 647 SLENWLNQKEDE-------QNQRP-KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK 698
            L  +L     +       ++  P  L L Q L++A  VA  + YL        VH DL 
Sbjct: 106 DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLA 162
Query: 699 PSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTH 754
             N L+   +V  +GDFG+SR ++      T   RV G     I ++ PE     + +T 
Sbjct: 163 TRNCLVGQGLVVKIGDFGMSRDIYS-----TDYYRVGGRTMLPIRWMPPESILYRKFTTE 217
Query: 755 GDEYSFGILMLEMFT-GKRP 773
            D +SFG+++ E+FT GK+P
Sbjct: 218 SDVWSFGVVLWEIFTYGKQP 237

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 91/193 (47%), Gaps = 20/193 (10%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           +VA+K   ++     K+FI E   L  + H N+VK+  +C +          LV E+   
Sbjct: 34  DVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP-------VCLVMEYAEG 84
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL- 704
           GSL N L+  E      P       +S  +  +  + YLH     +++H DLKP N+LL 
Sbjct: 85  GSLYNVLHGAEP----LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV 140
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
               V  + DFG +  +      QT  +  KGS  ++APE       S   D +S+GI++
Sbjct: 141 AGGTVLKICDFGTACDI------QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIIL 194
Query: 765 LEMFTGKRPTDDM 777
            E+ T ++P D++
Sbjct: 195 WEVITRRKPFDEI 207

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 91/193 (47%), Gaps = 20/193 (10%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           +VA+K   ++     K+FI E   L  + H N+VK+  +C +          LV E+   
Sbjct: 33  DVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP-------VCLVMEYAEG 83
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL- 704
           GSL N L+  E      P       +S  +  +  + YLH     +++H DLKP N+LL 
Sbjct: 84  GSLYNVLHGAEP----LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV 139
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
               V  + DFG +  +      QT  +  KGS  ++APE       S   D +S+GI++
Sbjct: 140 AGGTVLKICDFGTACDI------QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIIL 193
Query: 765 LEMFTGKRPTDDM 777
            E+ T ++P D++
Sbjct: 194 WEVITRRKPFDEI 206

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 92/194 (47%), Gaps = 28/194 (14%)
Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           T VAVK +        ++F+AE   +++++H  LVK+    +       E   ++ EFM 
Sbjct: 207 TKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVT------KEPIYIITEFMA 259
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            GSL ++L   E  +   PKL     +  +  +A  + ++    +   +H DL+ +N+L+
Sbjct: 260 KGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQRNY---IHRDLRAANILV 311
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
              +V  + DFGL+R+              K  I + APE    G  +   D +SFGIL+
Sbjct: 312 SASLVCKIADFGLARV------------GAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 359
Query: 765 LEMFT-GKRPTDDM 777
           +E+ T G+ P   M
Sbjct: 360 MEIVTYGRIPYPGM 373

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 26/199 (13%)
Query: 585 TNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYE 641
           T VAVK+L  D  ++  S   I+E E ++ I +H+N++ ++ +C    T+      +V E
Sbjct: 61  TKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV-E 114
Query: 642 FMPNGSLENWLNQKED---EQNQRPKLNLMQRLS------IAIDVANVLEYLHHHCHTSI 692
           +   G+L  +L  +E    E +  P  N  ++LS       A  VA  +EYL        
Sbjct: 115 YASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKC 171
Query: 693 VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALGEV 751
           +H DL   NVL+  + V  + DFGL+R +H  +   +T+  R+   + ++APE      +
Sbjct: 172 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL--PVKWMAPE-ALFDRI 228
Query: 752 STH-GDEYSFGILMLEMFT 769
            TH  D +SFG+L+ E+FT
Sbjct: 229 YTHQSDVWSFGVLLWEIFT 247

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 26/199 (13%)
Query: 585 TNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYE 641
           T VAVK+L  D  ++  S   I+E E ++ I +H+N++ ++ +C    T+      +V E
Sbjct: 102 TKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV-E 155
Query: 642 FMPNGSLENWLNQKED---EQNQRPKLNLMQRLS------IAIDVANVLEYLHHHCHTSI 692
           +   G+L  +L  +     E +  P  N  ++LS       A  VA  +EYL        
Sbjct: 156 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKC 212
Query: 693 VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALGEV 751
           +H DL   NVL+  + V  + DFGL+R +H  +   +T+  R+   + ++APE      +
Sbjct: 213 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL--PVKWMAPE-ALFDRI 269
Query: 752 STH-GDEYSFGILMLEMFT 769
            TH  D +SFG+L+ E+FT
Sbjct: 270 YTHQSDVWSFGVLLWEIFT 288

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 26/199 (13%)
Query: 585 TNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYE 641
           T VAVK+L  D  ++  S   I+E E ++ I +H+N++ ++ +C    T+      +V E
Sbjct: 61  TKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV-E 114
Query: 642 FMPNGSLENWLNQKED---------EQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSI 692
           +   G+L  +L  +             N   +L+    +S A  VA  +EYL        
Sbjct: 115 YASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKC 171
Query: 693 VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALGEV 751
           +H DL   NVL+  + V  + DFGL+R +H  +   +T+  R+   + ++APE      +
Sbjct: 172 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRL--PVKWMAPE-ALFDRI 228
Query: 752 STH-GDEYSFGILMLEMFT 769
            TH  D +SFG+L+ E+FT
Sbjct: 229 YTHQSDVWSFGVLLWEIFT 247

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 26/199 (13%)
Query: 585 TNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYE 641
           T VAVK+L  D  ++  S   I+E E ++ I +H+N++ ++ +C    T+      +V E
Sbjct: 50  TKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV-E 103
Query: 642 FMPNGSLENWLNQKED---EQNQRPKLNLMQRLS------IAIDVANVLEYLHHHCHTSI 692
           +   G+L  +L  +     E +  P  N  ++LS       A  VA  +EYL        
Sbjct: 104 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKC 160
Query: 693 VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALGEV 751
           +H DL   NVL+  + V  + DFGL+R +H  +   +T+  R+   + ++APE      +
Sbjct: 161 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL--PVKWMAPE-ALFDRI 217
Query: 752 STH-GDEYSFGILMLEMFT 769
            TH  D +SFG+L+ E+FT
Sbjct: 218 YTHQSDVWSFGVLLWEIFT 236

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 26/199 (13%)
Query: 585 TNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYE 641
           T VAVK+L  D  ++  S   I+E E ++ I +H+N++ ++ +C    T+      +V E
Sbjct: 61  TKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV-E 114
Query: 642 FMPNGSLENWLNQKED---EQNQRPKLNLMQRLS------IAIDVANVLEYLHHHCHTSI 692
           +   G+L  +L  +     E +  P  N  ++LS       A  VA  +EYL        
Sbjct: 115 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKC 171
Query: 693 VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALGEV 751
           +H DL   NVL+  + V  + DFGL+R +H  +   +T+  R+   + ++APE      +
Sbjct: 172 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL--PVKWMAPE-ALFDRI 228
Query: 752 STH-GDEYSFGILMLEMFT 769
            TH  D +SFG+L+ E+FT
Sbjct: 229 YTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 26/199 (13%)
Query: 585 TNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYE 641
           T VAVK+L  D  ++  S   I+E E ++ I +H+N++ ++ +C    T+      +V E
Sbjct: 54  TKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV-E 107
Query: 642 FMPNGSLENWLNQKED---EQNQRPKLNLMQRLS------IAIDVANVLEYLHHHCHTSI 692
           +   G+L  +L  +     E +  P  N  ++LS       A  VA  +EYL        
Sbjct: 108 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKC 164
Query: 693 VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALGEV 751
           +H DL   NVL+  + V  + DFGL+R +H  +   +T+  R+   + ++APE      +
Sbjct: 165 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL--PVKWMAPE-ALFDRI 221
Query: 752 STH-GDEYSFGILMLEMFT 769
            TH  D +SFG+L+ E+FT
Sbjct: 222 YTHQSDVWSFGVLLWEIFT 240

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 26/199 (13%)
Query: 585 TNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYE 641
           T VAVK+L  D  ++  S   I+E E ++ I +H+N++ ++ +C    T+      +V E
Sbjct: 53  TKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV-E 106
Query: 642 FMPNGSLENWLNQKED---EQNQRPKLNLMQRLS------IAIDVANVLEYLHHHCHTSI 692
           +   G+L  +L  +     E +  P  N  ++LS       A  VA  +EYL        
Sbjct: 107 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKC 163
Query: 693 VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALGEV 751
           +H DL   NVL+  + V  + DFGL+R +H  +   +T+  R+   + ++APE      +
Sbjct: 164 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL--PVKWMAPE-ALFDRI 220
Query: 752 STH-GDEYSFGILMLEMFT 769
            TH  D +SFG+L+ E+FT
Sbjct: 221 YTHQSDVWSFGVLLWEIFT 239

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 26/199 (13%)
Query: 585 TNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYE 641
           T VAVK+L  D  ++  S   I+E E ++ I +H+N++ ++ +C    T+      +V E
Sbjct: 61  TKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV-E 114
Query: 642 FMPNGSLENWLNQKED---------EQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSI 692
           +   G+L  +L  +             N   +L+    +S A  VA  +EYL        
Sbjct: 115 YASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKC 171
Query: 693 VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALGEV 751
           +H DL   NVL+  + V  + DFGL+R +H  +   +T+  R+   + ++APE      +
Sbjct: 172 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL--PVKWMAPE-ALFDRI 228
Query: 752 STH-GDEYSFGILMLEMFT 769
            TH  D +SFG+L+ E+FT
Sbjct: 229 YTHQSDVWSFGVLLWEIFT 247

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 23/188 (12%)
Query: 587 VAVKVLDLQQRGASKS-FIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           VAVK L        +S +  E + LR++ H +++K    C   +  G     LV E++P 
Sbjct: 63  VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCC---EDAGAASLQLVMEYVPL 119
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           GSL ++L         R  + L Q L  A  +   + YLH       +H DL   NVLLD
Sbjct: 120 GSLRDYLP--------RHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLD 168
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVK----GSIGYVAPEYGALGEVSTHGDEYSFG 761
           N+ +  +GDFGL++ +    P+     RV+      + + APE     +     D +SFG
Sbjct: 169 NDRLVKIGDFGLAKAV----PEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFG 224
Query: 762 ILMLEMFT 769
           + + E+ T
Sbjct: 225 VTLYELLT 232

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 90/187 (48%), Gaps = 9/187 (4%)
Query: 586 NVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
            VAVK + L      +   F++E   ++   H N+++++  C  + ++G     ++  FM
Sbjct: 64  KVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             G L  +L     E   +  + L   L   +D+A  +EYL +    + +H DL   N +
Sbjct: 124 KYGDLHTYLLYSRLETGPK-HIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCM 179
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV-KGSIGYVAPEYGALGEVSTHGDEYSFGI 762
           L ++M   V DFGLS+ ++  S D     R+ K  + ++A E  A    ++  D ++FG+
Sbjct: 180 LRDDMTVCVADFGLSKKIY--SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 237
Query: 763 LMLEMFT 769
            M E+ T
Sbjct: 238 TMWEIAT 244

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 21/197 (10%)
Query: 586 NVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +VAVK+L++      +  +F  E   LR  RH N++  +   ++         A+V ++ 
Sbjct: 32  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL------AIVTQWC 85
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
              SL + L+  E       K  +++ + IA   A  ++YLH     SI+H DLK +N+ 
Sbjct: 86  EGSSLYHHLHIIET------KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 136
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE---VSTHGDEYSF 760
           L  ++   +GDFGL+ +    S       ++ GSI ++APE   + +    S   D Y+F
Sbjct: 137 LHEDLTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF 195
Query: 761 GILMLEMFTGKRPTDDM 777
           GI++ E+ TG+ P  ++
Sbjct: 196 GIVLYELMTGQLPYSNI 212

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 26/199 (13%)
Query: 585 TNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYE 641
           T VAVK+L  D  ++  S   I+E E ++ I +H+N++ ++ +C    T+      +V E
Sbjct: 46  TKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV-E 99
Query: 642 FMPNGSLENWLNQKED---------EQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSI 692
           +   G+L  +L  +             N   +L+    +S A  VA  +EYL        
Sbjct: 100 YASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKC 156
Query: 693 VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALGEV 751
           +H DL   NVL+  + V  + DFGL+R +H  +   +T+  R+   + ++APE      +
Sbjct: 157 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL--PVKWMAPE-ALFDRI 213
Query: 752 STH-GDEYSFGILMLEMFT 769
            TH  D +SFG+L+ E+FT
Sbjct: 214 YTHQSDVWSFGVLLWEIFT 232

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 60/193 (31%), Positives = 84/193 (43%), Gaps = 21/193 (10%)
Query: 586 NVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           +VAVK L    L Q  A   FI E  A+ S+ HRNL+++     +   +      +V E 
Sbjct: 38  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTEL 91
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLS-IAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            P GSL + L + +          L+  LS  A+ VA  + YL        +H DL   N
Sbjct: 92  APLGSLLDRLRKHQGH-------FLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARN 141
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +LL    +  +GDFGL R L  N          K    + APE       S   D + FG
Sbjct: 142 LLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 201
Query: 762 ILMLEMFT-GKRP 773
           + + EMFT G+ P
Sbjct: 202 VTLWEMFTYGQEP 214

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 98/199 (49%), Gaps = 31/199 (15%)
Query: 586 NVAVKVLDLQQRGASKSFIA----ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
            VAVK+L+ +Q+  S   +     E + L+  RH +++K+      I T  + F  +V E
Sbjct: 38  KVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY---QVISTPTDFF--MVME 91
Query: 642 FMPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           ++  G L +++ +  + +E   R    L Q++  A+D      Y H H    +VH DLKP
Sbjct: 92  YVSGGELFDYICKHGRVEEMEAR---RLFQQILSAVD------YCHRHM---VVHRDLKP 139
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY--GALGEVSTHGDE 757
            NVLLD  M A + DFGLS ++ D    +TS     GS  Y APE   G L       D 
Sbjct: 140 ENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPEVISGRL-YAGPEVDI 194
Query: 758 YSFGILMLEMFTGKRPTDD 776
           +S G+++  +  G  P DD
Sbjct: 195 WSCGVILYALLCGTLPFDD 213

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 84/193 (43%), Gaps = 21/193 (10%)
Query: 586 NVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           +VAVK L    L Q  A   FI E  A+ S+ HRNL+++     +   +      +V E 
Sbjct: 48  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTEL 101
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLS-IAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            P GSL + L + +          L+  LS  A+ VA  + YL        +H DL   N
Sbjct: 102 APLGSLLDRLRKHQGH-------FLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARN 151
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +LL    +  +GDFGL R L  N          K    + APE       S   D + FG
Sbjct: 152 LLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 211
Query: 762 ILMLEMFT-GKRP 773
           + + EMFT G+ P
Sbjct: 212 VTLWEMFTYGQEP 224

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 60/193 (31%), Positives = 84/193 (43%), Gaps = 21/193 (10%)
Query: 586 NVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           +VAVK L    L Q  A   FI E  A+ S+ HRNL+++     +   +      +V E 
Sbjct: 42  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTEL 95
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLS-IAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            P GSL + L + +          L+  LS  A+ VA  + YL        +H DL   N
Sbjct: 96  APLGSLLDRLRKHQGH-------FLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARN 145
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +LL    +  +GDFGL R L  N          K    + APE       S   D + FG
Sbjct: 146 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 205
Query: 762 ILMLEMFT-GKRP 773
           + + EMFT G+ P
Sbjct: 206 VTLWEMFTYGQEP 218

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 60/193 (31%), Positives = 84/193 (43%), Gaps = 21/193 (10%)
Query: 586 NVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           +VAVK L    L Q  A   FI E  A+ S+ HRNL+++     +   +      +V E 
Sbjct: 38  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTEL 91
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLS-IAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            P GSL + L + +          L+  LS  A+ VA  + YL        +H DL   N
Sbjct: 92  APLGSLLDRLRKHQGH-------FLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARN 141
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +LL    +  +GDFGL R L  N          K    + APE       S   D + FG
Sbjct: 142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 201
Query: 762 ILMLEMFT-GKRP 773
           + + EMFT G+ P
Sbjct: 202 VTLWEMFTYGQEP 214

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 89/191 (46%), Gaps = 29/191 (15%)
Query: 587 VAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           VAVK L      Q R   K    E + LR++ H +++K    C   + +G +   LV E+
Sbjct: 46  VAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCC---EDQGEKSLQLVMEY 99
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
           +P GSL ++L         R  + L Q L  A  +   + YLH       +H +L   NV
Sbjct: 100 VPLGSLRDYL--------PRHSIGLAQLLLFAQQICEGMAYLHSQ---HYIHRNLAARNV 148
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK----GSIGYVAPEYGALGEVSTHGDEY 758
           LLDN+ +  +GDFGL++ +    P+     RV+      + + APE     +     D +
Sbjct: 149 LLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVW 204
Query: 759 SFGILMLEMFT 769
           SFG+ + E+ T
Sbjct: 205 SFGVTLYELLT 215

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 60/193 (31%), Positives = 84/193 (43%), Gaps = 21/193 (10%)
Query: 586 NVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           +VAVK L    L Q  A   FI E  A+ S+ HRNL+++     +   +      +V E 
Sbjct: 38  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTEL 91
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLS-IAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            P GSL + L + +          L+  LS  A+ VA  + YL        +H DL   N
Sbjct: 92  APLGSLLDRLRKHQGH-------FLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARN 141
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +LL    +  +GDFGL R L  N          K    + APE       S   D + FG
Sbjct: 142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 201
Query: 762 ILMLEMFT-GKRP 773
           + + EMFT G+ P
Sbjct: 202 VTLWEMFTYGQEP 214

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 84/193 (43%), Gaps = 21/193 (10%)
Query: 586 NVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           +VAVK L    L Q  A   FI E  A+ S+ HRNL+++     +   +      +V E 
Sbjct: 48  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTEL 101
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLS-IAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            P GSL + L + +          L+  LS  A+ VA  + YL        +H DL   N
Sbjct: 102 APLGSLLDRLRKHQGH-------FLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARN 151
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +LL    +  +GDFGL R L  N          K    + APE       S   D + FG
Sbjct: 152 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 211
Query: 762 ILMLEMFT-GKRP 773
           + + EMFT G+ P
Sbjct: 212 VTLWEMFTYGQEP 224

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 89/191 (46%), Gaps = 29/191 (15%)
Query: 587 VAVKVLDL----QQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           VAVK L      Q R   K    E + LR++ H +++K    C   + +G +   LV E+
Sbjct: 46  VAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHIIKYKGCC---EDQGEKSLQLVMEY 99
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
           +P GSL ++L         R  + L Q L  A  +   + YLH       +H +L   NV
Sbjct: 100 VPLGSLRDYL--------PRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRNLAARNV 148
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK----GSIGYVAPEYGALGEVSTHGDEY 758
           LLDN+ +  +GDFGL++ +    P+     RV+      + + APE     +     D +
Sbjct: 149 LLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVW 204
Query: 759 SFGILMLEMFT 769
           SFG+ + E+ T
Sbjct: 205 SFGVTLYELLT 215

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 21/197 (10%)
Query: 586 NVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +VAVK+L++      +  +F  E   LR  RH N++  +   +          A+V ++ 
Sbjct: 32  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL------AIVTQWC 85
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
              SL + L+  E       K  +++ + IA   A  ++YLH     SI+H DLK +N+ 
Sbjct: 86  EGSSLYHHLHIIET------KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 136
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE---VSTHGDEYSF 760
           L  ++   +GDFGL+ +    S       ++ GSI ++APE   + +    S   D Y+F
Sbjct: 137 LHEDLTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF 195
Query: 761 GILMLEMFTGKRPTDDM 777
           GI++ E+ TG+ P  ++
Sbjct: 196 GIVLYELMTGQLPYSNI 212

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 21/197 (10%)
Query: 586 NVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +VAVK+L++      +  +F  E   LR  RH N++  +   +          A+V ++ 
Sbjct: 34  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL------AIVTQWC 87
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
              SL + L+  E       K  +++ + IA   A  ++YLH     SI+H DLK +N+ 
Sbjct: 88  EGSSLYHHLHIIET------KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 138
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE---VSTHGDEYSF 760
           L  ++   +GDFGL+ +    S       ++ GSI ++APE   + +    S   D Y+F
Sbjct: 139 LHEDLTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF 197
Query: 761 GILMLEMFTGKRPTDDM 777
           GI++ E+ TG+ P  ++
Sbjct: 198 GIVLYELMTGQLPYSNI 214

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 93/193 (48%), Gaps = 21/193 (10%)
Query: 586 NVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +VAVK+L +      +  +F  E   LR  RH N++  +   +  +       A+V ++ 
Sbjct: 60  DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNL------AIVTQWC 113
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
              SL   L+ +E       K  + Q + IA   A  ++YLH     +I+H D+K +N+ 
Sbjct: 114 EGSSLYKHLHVQET------KFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIF 164
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE---VSTHGDEYSF 760
           L   +   +GDFGL+ +    S  Q    +  GS+ ++APE   + +    S   D YS+
Sbjct: 165 LHEGLTVKIGDFGLATVKSRWSGSQ-QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSY 223
Query: 761 GILMLEMFTGKRP 773
           GI++ E+ TG+ P
Sbjct: 224 GIVLYELMTGELP 236

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 95/193 (49%), Gaps = 21/193 (10%)
Query: 586 NVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +VAVK+L++      +  +F  E   LR  RH N++  +   +          A+V ++ 
Sbjct: 37  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL------AIVTQWC 90
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
              SL + L+  E       K  +++ + IA   A  ++YLH     SI+H DLK +N+ 
Sbjct: 91  EGSSLYHHLHIIET------KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 141
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE---VSTHGDEYSF 760
           L  ++   +GDFGL+ +    S       ++ GSI ++APE   + +    S   D Y+F
Sbjct: 142 LHEDLTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF 200
Query: 761 GILMLEMFTGKRP 773
           GI++ E+ TG+ P
Sbjct: 201 GIVLYELMTGQLP 213

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 84/193 (43%), Gaps = 21/193 (10%)
Query: 586 NVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           +VAVK L    L Q  A   FI E  A+ S+ HRNL+++     +   +      +V E 
Sbjct: 42  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTEL 95
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLS-IAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            P GSL + L + +          L+  LS  A+ VA  + YL        +H DL   N
Sbjct: 96  APLGSLLDRLRKHQGH-------FLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARN 145
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +LL    +  +GDFGL R L  N          K    + APE       S   D + FG
Sbjct: 146 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 205
Query: 762 ILMLEMFT-GKRP 773
           + + EMFT G+ P
Sbjct: 206 VTLWEMFTYGQEP 218

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 95/193 (49%), Gaps = 21/193 (10%)
Query: 586 NVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +VAVK+L++      +  +F  E   LR  RH N++  +   +          A+V ++ 
Sbjct: 37  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL------AIVTQWC 90
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
              SL + L+  E       K  +++ + IA   A  ++YLH     SI+H DLK +N+ 
Sbjct: 91  EGSSLYHHLHIIET------KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 141
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE---VSTHGDEYSF 760
           L  ++   +GDFGL+ +    S       ++ GSI ++APE   + +    S   D Y+F
Sbjct: 142 LHEDLTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF 200
Query: 761 GILMLEMFTGKRP 773
           GI++ E+ TG+ P
Sbjct: 201 GIVLYELMTGQLP 213

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 29/201 (14%)
Query: 586 NVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +VAVK+L++      +  +F  E   LR  RH N++  +   +          A+V ++ 
Sbjct: 32  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL------AIVTQWC 85
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
              SL + L+  E       K  +++ + IA   A  ++YLH     SI+H DLK +N+ 
Sbjct: 86  EGSSLYHHLHIIET------KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 136
Query: 704 LDNEMVAHVGDFGL----SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE---VSTHGD 756
           L  ++   +GDFGL    SR    +  +Q S     GSI ++APE   + +    S   D
Sbjct: 137 LHEDLTVKIGDFGLATEKSRWSGSHQFEQLS-----GSILWMAPEVIRMQDKNPYSFQSD 191
Query: 757 EYSFGILMLEMFTGKRPTDDM 777
            Y+FGI++ E+ TG+ P  ++
Sbjct: 192 VYAFGIVLYELMTGQLPYSNI 212

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 95/193 (49%), Gaps = 21/193 (10%)
Query: 586 NVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +VAVK+L++      +  +F  E   LR  RH N++  +   +          A+V ++ 
Sbjct: 59  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL------AIVTQWC 112
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
              SL + L+  E       K  +++ + IA   A  ++YLH     SI+H DLK +N+ 
Sbjct: 113 EGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 163
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE---VSTHGDEYSF 760
           L  ++   +GDFGL+ +    S       ++ GSI ++APE   + +    S   D Y+F
Sbjct: 164 LHEDLTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF 222
Query: 761 GILMLEMFTGKRP 773
           GI++ E+ TG+ P
Sbjct: 223 GIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 95/193 (49%), Gaps = 21/193 (10%)
Query: 586 NVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +VAVK+L++      +  +F  E   LR  RH N++  +   +          A+V ++ 
Sbjct: 60  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL------AIVTQWC 113
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
              SL + L+  E       K  +++ + IA   A  ++YLH     SI+H DLK +N+ 
Sbjct: 114 EGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 164
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE---VSTHGDEYSF 760
           L  ++   +GDFGL+ +    S       ++ GSI ++APE   + +    S   D Y+F
Sbjct: 165 LHEDLTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF 223
Query: 761 GILMLEMFTGKRP 773
           GI++ E+ TG+ P
Sbjct: 224 GIVLYELMTGQLP 236

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 97/199 (48%), Gaps = 31/199 (15%)
Query: 586 NVAVKVLDLQQRGASKSFIA----ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
            VAVK+L+ +Q+  S   +     E + L+  RH +++K+      I T  + F  +V E
Sbjct: 43  KVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY---QVISTPSDIF--MVME 96
Query: 642 FMPNGSLENWL--NQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           ++  G L +++  N + DE+  R    L Q++   +D      Y H H    +VH DLKP
Sbjct: 97  YVSGGELFDYICKNGRLDEKESR---RLFQQILSGVD------YCHRHM---VVHRDLKP 144
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY--GALGEVSTHGDE 757
            NVLLD  M A + DFGLS ++ D    + S     GS  Y APE   G L       D 
Sbjct: 145 ENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC----GSPNYAAPEVISGRL-YAGPEVDI 199
Query: 758 YSFGILMLEMFTGKRPTDD 776
           +S G+++  +  G  P DD
Sbjct: 200 WSSGVILYALLCGTLPFDD 218

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/182 (32%), Positives = 89/182 (48%), Gaps = 37/182 (20%)
Query: 606 ECEALRSIRHRNLVK---IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQK----EDE 658
           E   L+ +RH +++K   +IT+ + I         +V E+   G L +++ +K    EDE
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDI--------VMVIEYA-GGELFDYIVEKKRMTEDE 109
Query: 659 QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS 718
             +       Q++  AI      EY H H    IVH DLKP N+LLD+ +   + DFGLS
Sbjct: 110 GRR-----FFQQIICAI------EYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLS 155
Query: 719 RLLHDNSPDQTSTSRVKGSIGYVAPEY--GALGEVSTHGDEYSFGILMLEMFTGKRPTDD 776
            ++ D +  +TS     GS  Y APE   G L       D +S GI++  M  G+ P DD
Sbjct: 156 NIMTDGNFLKTSC----GSPNYAAPEVINGKL-YAGPEVDVWSCGIVLYVMLVGRLPFDD 210
Query: 777 MF 778
            F
Sbjct: 211 EF 212

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 29/197 (14%)
Query: 586 NVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +VAVK+L++      +  +F  E   LR  RH N++  +   +          A+V ++ 
Sbjct: 52  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL------AIVTQWC 105
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
              SL + L+  E       K  +++ + IA   A  ++YLH     SI+H DLK +N+ 
Sbjct: 106 EGSSLYHHLHIIET------KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 156
Query: 704 LDNEMVAHVGDFGL----SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE---VSTHGD 756
           L  ++   +GDFGL    SR    +  +Q S     GSI ++APE   + +    S   D
Sbjct: 157 LHEDLTVKIGDFGLATEKSRWSGSHQFEQLS-----GSILWMAPEVIRMQDKNPYSFQSD 211
Query: 757 EYSFGILMLEMFTGKRP 773
            Y+FGI++ E+ TG+ P
Sbjct: 212 VYAFGIVLYELMTGQLP 228

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 124/280 (44%), Gaps = 41/280 (14%)
Query: 583 EETNVAVKVL--DLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           +  +VAVKVL  DL +  +    F  E +   ++ H  +V +  +  + +T       +V
Sbjct: 36  DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIV 94
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            E++   +L + ++    E    PK    + + +  D    L + H +    I+H D+KP
Sbjct: 95  MEYVDGVTLRDIVHT---EGPMTPK----RAIEVIADACQALNFSHQN---GIIHRDVKP 144
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYS 759
           +N+++       V DFG++R + D+    T T+ V G+  Y++PE      V    D YS
Sbjct: 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 760 FGILMLEMFTGKRP-TDDMFEEGLSLHKYAKMGLPDQVA------EIIDPAILEEAL--E 810
            G ++ E+ TG+ P T D                PD VA      + I P+   E L  +
Sbjct: 205 LGCVLYEVLTGEPPFTGDS---------------PDSVAYQHVREDPIPPSARHEGLSAD 249
Query: 811 IQAGIVKELQPNLRAKFH---EIQVSILRVGILCSEELPR 847
           + A ++K L  N   ++    E++  ++RV      E P+
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK 289

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 29/197 (14%)
Query: 586 NVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +VAVK+L++      +  +F  E   LR  RH N++  +   +          A+V ++ 
Sbjct: 60  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL------AIVTQWC 113
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
              SL + L+  E       K  +++ + IA   A  ++YLH     SI+H DLK +N+ 
Sbjct: 114 EGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 164
Query: 704 LDNEMVAHVGDFGL----SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE---VSTHGD 756
           L  ++   +GDFGL    SR    +  +Q S     GSI ++APE   + +    S   D
Sbjct: 165 LHEDLTVKIGDFGLATEKSRWSGSHQFEQLS-----GSILWMAPEVIRMQDKNPYSFQSD 219
Query: 757 EYSFGILMLEMFTGKRP 773
            Y+FGI++ E+ TG+ P
Sbjct: 220 VYAFGIVLYELMTGQLP 236

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 31/204 (15%)
Query: 583 EETNVAVKVLDL-QQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ +VA+KVL    ++  ++  + E + +  + +  +V++I  C +      E   LV E
Sbjct: 36  KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVME 89
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC-------HTSIVH 694
               G L  +L  K +E                I V+NV E LH            + VH
Sbjct: 90  MAGGGPLHKFLVGKREE----------------IPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 695 CDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH 754
            DL   NVLL N   A + DFGLS+ L  +    T+ S  K  + + APE     + S+ 
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 755 GDEYSFGILMLEMFT-GKRPTDDM 777
            D +S+G+ M E  + G++P   M
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKM 217

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 34/220 (15%)
Query: 586 NVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +VAVK+L++      +  +F  E   LR  RH N++  +   +          A+V ++ 
Sbjct: 36  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL------AIVTQWC 89
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
              SL + L+  E       K  + + + IA   A  ++YLH     SI+H DLK +N+ 
Sbjct: 90  EGSSLYHHLHASE------TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIF 140
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE---VSTHGDEYSF 760
           L  +    +GDFGL+ +    S       ++ GSI ++APE   + +    S   D Y+F
Sbjct: 141 LHEDNTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAF 199
Query: 761 GILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII 800
           GI++ E+ TG+ P             Y+ +   DQ+ E++
Sbjct: 200 GIVLYELMTGQLP-------------YSNINNRDQIIEMV 226

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 22/168 (13%)
Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL 665
           E E LR++ H ++VK    C   + +G +   LV E++P GSL ++L         R  +
Sbjct: 61  EIEILRTLYHEHIVKYKGCC---EDQGEKSVQLVMEYVPLGSLRDYLP--------RHCV 109
Query: 666 NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNS 725
            L Q L  A  +   + YLH       +H  L   NVLLDN+ +  +GDFGL++ +    
Sbjct: 110 GLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAV---- 162
Query: 726 PDQTSTSRVK----GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT 769
           P+     RV+      + + APE     +     D +SFG+ + E+ T
Sbjct: 163 PEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 42/224 (18%)
Query: 586 NVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +VAVK+L++      +  +F  E   LR  RH N++  +   ++         A+V ++ 
Sbjct: 48  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL------AIVTQWC 101
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
              SL + L+  E       K  + + + IA   A  ++YLH     SI+H DLK +N+ 
Sbjct: 102 EGSSLYHHLHASE------TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIF 152
Query: 704 LDNEMVAHVGDFGL----SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE---VSTHGD 756
           L  +    +GDFGL    SR    +  +Q S     GSI ++APE   + +    S   D
Sbjct: 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLS-----GSILWMAPEVIRMQDSNPYSFQSD 207
Query: 757 EYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII 800
            Y+FGI++ E+ TG+ P             Y+ +   DQ+ E++
Sbjct: 208 VYAFGIVLYELMTGQLP-------------YSNINNRDQIIEMV 238

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 26/200 (13%)
Query: 582 TEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL 638
           T    VA+K+++   L +         E   LR +RH +++K+     S D        +
Sbjct: 31  TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE-----IIM 85
Query: 639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK 698
           V E+  N  L +++ Q++    Q  +    Q +S        +EY H H    IVH DLK
Sbjct: 86  VIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIIS-------AVEYCHRH---KIVHRDLK 134
Query: 699 PSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY--GALGEVSTHGD 756
           P N+LLD  +   + DFGLS ++ D +  +TS     GS  Y APE   G L       D
Sbjct: 135 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKL-YAGPEVD 189
Query: 757 EYSFGILMLEMFTGKRPTDD 776
            +S G+++  M   + P DD
Sbjct: 190 VWSCGVILYVMLCRRLPFDD 209

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 26/200 (13%)
Query: 582 TEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL 638
           T    VA+K+++   L +         E   LR +RH +++K+     S D        +
Sbjct: 27  TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE-----IIM 81
Query: 639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK 698
           V E+  N  L +++ Q++    Q  +    Q +S        +EY H H    IVH DLK
Sbjct: 82  VIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIIS-------AVEYCHRH---KIVHRDLK 130
Query: 699 PSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY--GALGEVSTHGD 756
           P N+LLD  +   + DFGLS ++ D +  +TS     GS  Y APE   G L       D
Sbjct: 131 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKL-YAGPEVD 185
Query: 757 EYSFGILMLEMFTGKRPTDD 776
            +S G+++  M   + P DD
Sbjct: 186 VWSCGVILYVMLCRRLPFDD 205

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 31/199 (15%)
Query: 586 NVAVKVLDLQQRGASKSFIA----ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
            VAVK+L+ +Q+  S   +     E + L+  RH +++K+      I T  + F  +V E
Sbjct: 38  KVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY---QVISTPTDFF--MVME 91
Query: 642 FMPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           ++  G L +++ +  + +E   R    L Q++  A+D      Y H H    +VH DLKP
Sbjct: 92  YVSGGELFDYICKHGRVEEMEAR---RLFQQILSAVD------YCHRHM---VVHRDLKP 139
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY--GALGEVSTHGDE 757
            NVLLD  M A + DFGLS ++ D    + S     GS  Y APE   G L       D 
Sbjct: 140 ENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC----GSPNYAAPEVISGRL-YAGPEVDI 194
Query: 758 YSFGILMLEMFTGKRPTDD 776
           +S G+++  +  G  P DD
Sbjct: 195 WSCGVILYALLCGTLPFDD 213

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 26/200 (13%)
Query: 582 TEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL 638
           T    VA+K+++   L +         E   LR +RH +++K+     S D        +
Sbjct: 37  TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE-----IIM 91
Query: 639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK 698
           V E+  N  L +++ Q++    Q  +    Q +S        +EY H H    IVH DLK
Sbjct: 92  VIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIIS-------AVEYCHRH---KIVHRDLK 140
Query: 699 PSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY--GALGEVSTHGD 756
           P N+LLD  +   + DFGLS ++ D +  +TS     GS  Y APE   G L       D
Sbjct: 141 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKL-YAGPEVD 195
Query: 757 EYSFGILMLEMFTGKRPTDD 776
            +S G+++  M   + P DD
Sbjct: 196 VWSCGVILYVMLCRRLPFDD 215

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 26/200 (13%)
Query: 582 TEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL 638
           T    VA+K+++   L +         E   LR +RH +++K+     S D        +
Sbjct: 36  TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE-----IIM 90
Query: 639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK 698
           V E+  N  L +++ Q++    Q  +    Q +S        +EY H H    IVH DLK
Sbjct: 91  VIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIIS-------AVEYCHRH---KIVHRDLK 139
Query: 699 PSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY--GALGEVSTHGD 756
           P N+LLD  +   + DFGLS ++ D +  +TS     GS  Y APE   G L       D
Sbjct: 140 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKL-YAGPEVD 194
Query: 757 EYSFGILMLEMFTGKRPTDD 776
            +S G+++  M   + P DD
Sbjct: 195 VWSCGVILYVMLCRRLPFDD 214

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 50/168 (29%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL 665
           E E LR++ H ++VK    C   + +G +   LV E++P GSL ++L         R  +
Sbjct: 60  EIEILRTLYHEHIVKYKGCC---EDQGEKSVQLVMEYVPLGSLRDYL--------PRHCV 108
Query: 666 NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNS 725
            L Q L  A  +   + YLH   +   +H  L   NVLLDN+ +  +GDFGL++ +    
Sbjct: 109 GLAQLLLFAQQICEGMAYLHAQHY---IHRALAARNVLLDNDRLVKIGDFGLAKAV---- 161
Query: 726 PDQTSTSRVK----GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT 769
           P+     RV+      + + APE     +     D +SFG+ + E+ T
Sbjct: 162 PEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 91/191 (47%), Gaps = 14/191 (7%)
Query: 586 NVAVKVL--DLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           +VAVKVL  DL +  +    F  E +   ++ H  +V +  +  + +T       +V E+
Sbjct: 39  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEA-ETPAGPLPYIVMEY 97
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
           +   +L + ++    E    PK    + + +  D    L + H +    I+H D+KP+N+
Sbjct: 98  VDGVTLRDIVHT---EGPMTPK----RAIEVIADACQALNFSHQN---GIIHRDVKPANI 147
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGI 762
           ++       V DFG++R + D+    T T+ V G+  Y++PE      V    D YS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 763 LMLEMFTGKRP 773
           ++ E+ TG+ P
Sbjct: 208 VLYEVLTGEPP 218

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 42/224 (18%)
Query: 586 NVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +VAVK+L++      +  +F  E   LR  RH N++  +   +          A+V ++ 
Sbjct: 48  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL------AIVTQWC 101
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
              SL + L+  E       K  + + + IA   A  ++YLH     SI+H DLK +N+ 
Sbjct: 102 EGSSLYHHLHASE------TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIF 152
Query: 704 LDNEMVAHVGDFGL----SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE---VSTHGD 756
           L  +    +GDFGL    SR    +  +Q S     GSI ++APE   + +    S   D
Sbjct: 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLS-----GSILWMAPEVIRMQDSNPYSFQSD 207
Query: 757 EYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII 800
            Y+FGI++ E+ TG+ P             Y+ +   DQ+ E++
Sbjct: 208 VYAFGIVLYELMTGQLP-------------YSNINNRDQIIEMV 238

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 91/191 (47%), Gaps = 14/191 (7%)
Query: 586 NVAVKVL--DLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           +VAVKVL  DL +  +    F  E +   ++ H  +V +  +  + +T       +V E+
Sbjct: 56  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEY 114
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
           +   +L + ++    E    PK    + + +  D    L + H +    I+H D+KP+N+
Sbjct: 115 VDGVTLRDIVHT---EGPMTPK----RAIEVIADACQALNFSHQN---GIIHRDVKPANI 164
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGI 762
           ++       V DFG++R + D+    T T+ V G+  Y++PE      V    D YS G 
Sbjct: 165 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 224
Query: 763 LMLEMFTGKRP 773
           ++ E+ TG+ P
Sbjct: 225 VLYEVLTGEPP 235

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 19/194 (9%)
Query: 603 FIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQR 662
            +AE   ++ + +  +V++I  C +      E   LV E    G L  +L Q    +++ 
Sbjct: 59  LLAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDKN 112
Query: 663 PKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH 722
             + L+ ++S+       ++YL     ++ VH DL   NVLL  +  A + DFGLS+ L 
Sbjct: 113 -IIELVHQVSMG------MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 162
Query: 723 DNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM--FE 779
            +     + +  K  + + APE     + S+  D +SFG+LM E F+ G++P   M   E
Sbjct: 163 ADENXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 222
Query: 780 EGLSLHKYAKMGLP 793
               L K  +MG P
Sbjct: 223 VTAMLEKGERMGCP 236

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 24/192 (12%)
Query: 587 VAVKVLDLQQRGAS---KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           VA+K + +  R      K F  E      + H+N+V +I     +D   + +  LV E++
Sbjct: 39  VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI----DVDEEDDCY-YLVMEYI 93
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN-VLEYLHHHCHTSIVHCDLKPSNV 702
              +L  ++      ++  P       +  AI+  N +L+ + H     IVH D+KP N+
Sbjct: 94  EGPTLSEYI------ESHGP-----LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI 142
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEYSFG 761
           L+D+     + DFG+++ L + S   T T+ V G++ Y +PE  A GE +    D YS G
Sbjct: 143 LIDSNKTLKIFDFGIAKALSETS--LTQTNHVLGTVQYFSPE-QAKGEATDECTDIYSIG 199
Query: 762 ILMLEMFTGKRP 773
           I++ EM  G+ P
Sbjct: 200 IVLYEMLVGEPP 211

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 91/191 (47%), Gaps = 14/191 (7%)
Query: 586 NVAVKVL--DLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           +VAVKVL  DL +  +    F  E +   ++ H  +V +  +  + +T       +V E+
Sbjct: 39  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEY 97
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
           +   +L + ++    E    PK    + + +  D    L + H +    I+H D+KP+N+
Sbjct: 98  VDGVTLRDIVHT---EGPMTPK----RAIEVIADACQALNFSHQN---GIIHRDVKPANI 147
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGI 762
           ++       V DFG++R + D+    T T+ V G+  Y++PE      V    D YS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 763 LMLEMFTGKRP 773
           ++ E+ TG+ P
Sbjct: 208 VLYEVLTGEPP 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 92/194 (47%), Gaps = 14/194 (7%)
Query: 583 EETNVAVKVL--DLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           +  +VAVKVL  DL +  +    F  E +   ++ H  +V +  +  + +T       +V
Sbjct: 36  DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIV 94
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            E++   +L + ++    E    PK    + + +  D    L + H +    I+H D+KP
Sbjct: 95  MEYVDGVTLRDIVHT---EGPMTPK----RAIEVIADACQALNFSHQN---GIIHRDVKP 144
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYS 759
           +N+++       V DFG++R + D+    T T+ V G+  Y++PE      V    D YS
Sbjct: 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 760 FGILMLEMFTGKRP 773
            G ++ E+ TG+ P
Sbjct: 205 LGCVLYEVLTGEPP 218

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 19/194 (9%)
Query: 603 FIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQR 662
            +AE   ++ + +  +V++I  C +      E   LV E    G L  +L Q    +++ 
Sbjct: 53  LLAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDKN 106
Query: 663 PKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH 722
             + L+ ++S+       ++YL     ++ VH DL   NVLL  +  A + DFGLS+ L 
Sbjct: 107 -IIELVHQVSMG------MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 156
Query: 723 DNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM--FE 779
            +     + +  K  + + APE     + S+  D +SFG+LM E F+ G++P   M   E
Sbjct: 157 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 216
Query: 780 EGLSLHKYAKMGLP 793
               L K  +MG P
Sbjct: 217 VTAMLEKGERMGCP 230

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 19/194 (9%)
Query: 603 FIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQR 662
            +AE   ++ + +  +V++I  C +      E   LV E    G L  +L Q    +++ 
Sbjct: 55  LLAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDKN 108
Query: 663 PKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH 722
             + L+ ++S+       ++YL     ++ VH DL   NVLL  +  A + DFGLS+ L 
Sbjct: 109 -IIELVHQVSMG------MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 158
Query: 723 DNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM--FE 779
            +     + +  K  + + APE     + S+  D +SFG+LM E F+ G++P   M   E
Sbjct: 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
Query: 780 EGLSLHKYAKMGLP 793
               L K  +MG P
Sbjct: 219 VTAMLEKGERMGCP 232

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 19/194 (9%)
Query: 603 FIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQR 662
            +AE   ++ + +  +V++I  C +      E   LV E    G L  +L Q    +++ 
Sbjct: 59  LLAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDKN 112
Query: 663 PKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH 722
             + L+ ++S+       ++YL     ++ VH DL   NVLL  +  A + DFGLS+ L 
Sbjct: 113 -IIELVHQVSMG------MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 162
Query: 723 DNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM--FE 779
            +     + +  K  + + APE     + S+  D +SFG+LM E F+ G++P   M   E
Sbjct: 163 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 222
Query: 780 EGLSLHKYAKMGLP 793
               L K  +MG P
Sbjct: 223 VTAMLEKGERMGCP 236

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 93/190 (48%), Gaps = 21/190 (11%)
Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL 665
           E + L  + H  +VK+     +  T G  +  L+ +F+  G L   L+++     +  K 
Sbjct: 76  ERDILVEVNHPFIVKL---HYAFQTEGKLY--LILDFLRGGDLFTRLSKEVMFTEEDVKF 130
Query: 666 NLMQRLSIAIDVANVLEYLHHHCHT-SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
            L + L++A+D          H H+  I++ DLKP N+LLD E    + DFGLS+   D+
Sbjct: 131 YLAE-LALALD----------HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179
Query: 725 SPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM-FEEGLS 783
                S     G++ Y+APE       +   D +SFG+LM EM TG  P      +E ++
Sbjct: 180 EKKAYSFC---GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236
Query: 784 LHKYAKMGLP 793
           +   AK+G+P
Sbjct: 237 MILKAKLGMP 246

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 93/190 (48%), Gaps = 21/190 (11%)
Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL 665
           E + L  + H  +VK+     +  T G  +  L+ +F+  G L   L+++     +  K 
Sbjct: 77  ERDILVEVNHPFIVKL---HYAFQTEGKLY--LILDFLRGGDLFTRLSKEVMFTEEDVKF 131
Query: 666 NLMQRLSIAIDVANVLEYLHHHCHT-SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
            L + L++A+D          H H+  I++ DLKP N+LLD E    + DFGLS+   D+
Sbjct: 132 YLAE-LALALD----------HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 180
Query: 725 SPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM-FEEGLS 783
                S     G++ Y+APE       +   D +SFG+LM EM TG  P      +E ++
Sbjct: 181 EKKAYSFC---GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 237
Query: 784 LHKYAKMGLP 793
           +   AK+G+P
Sbjct: 238 MILKAKLGMP 247

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 121/263 (46%), Gaps = 43/263 (16%)
Query: 584 ETNVAVKVLD----LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           ET VAVK ++    L++R     F+ E   ++     ++V+++   S       +   +V
Sbjct: 47  ETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHHVVRLLGVVSK-----GQPTLVV 98
Query: 640 YEFMPNGSLENWLN--QKEDEQNQ-RPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
            E M +G L+++L   + E E N  RP   L + + +A ++A+ + YL+       VH D
Sbjct: 99  MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRD 155
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVS 752
           L   N ++ ++    +GDFG++R +      +T   R  G     + ++APE    G  +
Sbjct: 156 LAARNCMVAHDFTVKIGDFGMTRDIX-----ETDXXRKGGKGLLPVRWMAPESLKDGVFT 210
Query: 753 THGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEIIDPAILEE 807
           T  D +SFG+++ E+ +  ++P      +GLS  +  K     G  DQ      P    E
Sbjct: 211 TSSDMWSFGVVLWEITSLAEQPY-----QGLSNEQVLKFVMDGGYLDQ------PDNCPE 259
Query: 808 ALEIQAGIVKELQPNLRAKFHEI 830
            +     +  +  PN+R  F EI
Sbjct: 260 RVTDLMRMCWQFNPNMRPTFLEI 282

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 123/263 (46%), Gaps = 36/263 (13%)
Query: 584 ETNVAVKVLDLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           ET VA+K ++       +  F+ E   ++     ++V+++   S       +   ++ E 
Sbjct: 77  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMEL 131
Query: 643 MPNGSLENWLNQKEDEQNQRPKL---NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           M  G L+++L     E    P L   +L + + +A ++A+ + YL+ +     VH DL  
Sbjct: 132 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 188
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHG 755
            N ++  +    +GDFG++R ++     +T   R  G     + +++PE    G  +T+ 
Sbjct: 189 RNCMVAEDFTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 243
Query: 756 DEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL-------PDQVAEII------D 801
           D +SFG+++ E+ T  ++P   +  E + L    + GL       PD + E++      +
Sbjct: 244 DVWSFGVVLWEIATLAEQPYQGLSNEQV-LRFVMEGGLLDKPDNCPDMLFELMRMCWQYN 302
Query: 802 PAILEEALEIQAGIVKELQPNLR 824
           P +    LEI + I +E++P  R
Sbjct: 303 PKMRPSFLEIISSIKEEMEPGFR 325

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 98/195 (50%), Gaps = 27/195 (13%)
Query: 584 ETNVAVKVLD----LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           ET VAVK ++    L++R     F+ E   ++     ++V+++   S       +   +V
Sbjct: 47  ETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHHVVRLLGVVSK-----GQPTLVV 98
Query: 640 YEFMPNGSLENWLN--QKEDEQNQ-RPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
            E M +G L+++L   + E E N  RP   L + + +A ++A+ + YL+       VH D
Sbjct: 99  MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRD 155
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVS 752
           L   N ++ ++    +GDFG++R ++     +T+  R  G     + ++APE    G  +
Sbjct: 156 LAARNCMVAHDFTVKIGDFGMTRDIY-----ETAYYRKGGKGLLPVRWMAPESLKDGVFT 210
Query: 753 THGDEYSFGILMLEM 767
           T  D +SFG+++ E+
Sbjct: 211 TSSDMWSFGVVLWEI 225

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 109/249 (43%), Gaps = 35/249 (14%)
Query: 582 TEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           + +  +A+K +  +    S+    E    + ++H+N+V+ + S S      N F  +  E
Sbjct: 31  SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFME 85
Query: 642 FMPNGSLE-----NWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
            +P GSL       W   K++EQ            +I      +LE L +     IVH D
Sbjct: 86  QVPGGSLSALLRSKWGPLKDNEQ------------TIGFYTKQILEGLKYLHDNQIVHRD 133
Query: 697 LKPSNVLLDN-EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE--VST 753
           +K  NVL++    V  + DFG S+ L   +P    T    G++ Y+APE    G      
Sbjct: 134 IKGDNVLINTYSGVLKISDFGTSKRLAGINP---CTETFTGTLQYMAPEIIDKGPRGYGK 190
Query: 754 HGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQA 813
             D +S G  ++EM TGK P  ++ E   ++ K     +  ++ E +       + E +A
Sbjct: 191 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESM-------SAEAKA 243
Query: 814 GIVKELQPN 822
            I+K  +P+
Sbjct: 244 FILKCFEPD 252

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 19/195 (9%)
Query: 602 SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQ 661
             +AE   ++ + +  +V++I  C +      E   LV E    G L  +L Q    +++
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDK 117
Query: 662 RPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL 721
              + L+ ++S+       ++YL     ++ VH DL   NVLL  +  A + DFGLS+ L
Sbjct: 118 NI-IELVHQVSMG------MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167
Query: 722 HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM--F 778
             +     + +  K  + + APE     + S+  D +SFG+LM E F+ G++P   M   
Sbjct: 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 227
Query: 779 EEGLSLHKYAKMGLP 793
           E    L K  +MG P
Sbjct: 228 EVTAMLEKGERMGCP 242

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 123/263 (46%), Gaps = 36/263 (13%)
Query: 584 ETNVAVKVLDLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           ET VA+K ++       +  F+ E   ++     ++V+++   S       +   ++ E 
Sbjct: 42  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMEL 96
Query: 643 MPNGSLENWLNQKEDEQNQRPKL---NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           M  G L+++L     E    P L   +L + + +A ++A+ + YL+ +     VH DL  
Sbjct: 97  MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 153
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHG 755
            N ++  +    +GDFG++R ++     +T   R  G     + +++PE    G  +T+ 
Sbjct: 154 RNCMVAEDFTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 208
Query: 756 DEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL-------PDQVAEII------D 801
           D +SFG+++ E+ T  ++P   +  E + L    + GL       PD + E++      +
Sbjct: 209 DVWSFGVVLWEIATLAEQPYQGLSNEQV-LRFVMEGGLLDKPDNCPDMLFELMRMCWQYN 267
Query: 802 PAILEEALEIQAGIVKELQPNLR 824
           P +    LEI + I +E++P  R
Sbjct: 268 PKMRPSFLEIISSIKEEMEPGFR 290

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 93/190 (48%), Gaps = 21/190 (11%)
Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL 665
           E + L  + H  +VK+     +  T G  +  L+ +F+  G L   L+++     +  K 
Sbjct: 76  ERDILVEVNHPFIVKL---HYAFQTEGKLY--LILDFLRGGDLFTRLSKEVMFTEEDVKF 130
Query: 666 NLMQRLSIAIDVANVLEYLHHHCHT-SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
            L + L++A+D          H H+  I++ DLKP N+LLD E    + DFGLS+   D+
Sbjct: 131 YLAE-LALALD----------HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179
Query: 725 SPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM-FEEGLS 783
                S     G++ Y+APE       +   D +SFG+LM EM TG  P      +E ++
Sbjct: 180 EKKAYSFC---GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236
Query: 784 LHKYAKMGLP 793
           +   AK+G+P
Sbjct: 237 MILKAKLGMP 246

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 123/263 (46%), Gaps = 36/263 (13%)
Query: 584 ETNVAVKVLDLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           ET VA+K ++       +  F+ E   ++     ++V+++   S       +   ++ E 
Sbjct: 49  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMEL 103
Query: 643 MPNGSLENWLNQKEDEQNQRPKL---NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           M  G L+++L     E    P L   +L + + +A ++A+ + YL+ +     VH DL  
Sbjct: 104 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 160
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHG 755
            N ++  +    +GDFG++R ++     +T   R  G     + +++PE    G  +T+ 
Sbjct: 161 RNCMVAEDFTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 215
Query: 756 DEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL-------PDQVAEII------D 801
           D +SFG+++ E+ T  ++P   +  E + L    + GL       PD + E++      +
Sbjct: 216 DVWSFGVVLWEIATLAEQPYQGLSNEQV-LRFVMEGGLLDKPDNCPDMLFELMRMCWQYN 274
Query: 802 PAILEEALEIQAGIVKELQPNLR 824
           P +    LEI + I +E++P  R
Sbjct: 275 PKMRPSFLEIISSIKEEMEPGFR 297

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 123/263 (46%), Gaps = 36/263 (13%)
Query: 584 ETNVAVKVLDLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           ET VA+K ++       +  F+ E   ++     ++V+++   S       +   ++ E 
Sbjct: 46  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMEL 100
Query: 643 MPNGSLENWLNQKEDEQNQRPKL---NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           M  G L+++L     E    P L   +L + + +A ++A+ + YL+ +     VH DL  
Sbjct: 101 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 157
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHG 755
            N ++  +    +GDFG++R ++     +T   R  G     + +++PE    G  +T+ 
Sbjct: 158 RNCMVAEDFTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 212
Query: 756 DEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL-------PDQVAEII------D 801
           D +SFG+++ E+ T  ++P   +  E + L    + GL       PD + E++      +
Sbjct: 213 DVWSFGVVLWEIATLAEQPYQGLSNEQV-LRFVMEGGLLDKPDNCPDMLFELMRMCWQYN 271
Query: 802 PAILEEALEIQAGIVKELQPNLR 824
           P +    LEI + I +E++P  R
Sbjct: 272 PKMRPSFLEIISSIKEEMEPGFR 294

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 116/251 (46%), Gaps = 23/251 (9%)
Query: 587 VAVKVLDLQQRGASK-SFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK+L        K + ++E + +  + +H N+V ++ +C    T G     ++ E+  
Sbjct: 71  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC----THGGPV-LVITEYCC 125
Query: 645 NGSLENWLNQKE----DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
            G L N+L +K     D+++ RP L L   L  +  VA  + +L      + +H D+   
Sbjct: 126 YGDLLNFLRRKAEADLDKEDGRP-LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAAR 181
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           NVLL N  VA +GDFGL+R + ++S +       +  + ++APE       +   D +S+
Sbjct: 182 NVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 240
Query: 761 GILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKEL 819
           GIL+ E+F+ G  P   +       +K  K G      ++  PA   + +         L
Sbjct: 241 GILLWEIFSLGLNPYPGILVNS-KFYKLVKDGY-----QMAQPAFAPKNIYSIMQACWAL 294
Query: 820 QPNLRAKFHEI 830
           +P  R  F +I
Sbjct: 295 EPTHRPTFQQI 305

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 123/263 (46%), Gaps = 36/263 (13%)
Query: 584 ETNVAVKVLDLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           ET VA+K ++       +  F+ E   ++     ++V+++   S       +   ++ E 
Sbjct: 48  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMEL 102
Query: 643 MPNGSLENWLNQKEDEQNQRPKL---NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           M  G L+++L     E    P L   +L + + +A ++A+ + YL+ +     VH DL  
Sbjct: 103 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 159
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHG 755
            N ++  +    +GDFG++R ++     +T   R  G     + +++PE    G  +T+ 
Sbjct: 160 RNCMVAEDFTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 214
Query: 756 DEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL-------PDQVAEII------D 801
           D +SFG+++ E+ T  ++P   +  E + L    + GL       PD + E++      +
Sbjct: 215 DVWSFGVVLWEIATLAEQPYQGLSNEQV-LRFVMEGGLLDKPDNCPDMLFELMRMCWQYN 273
Query: 802 PAILEEALEIQAGIVKELQPNLR 824
           P +    LEI + I +E++P  R
Sbjct: 274 PKMRPSFLEIISSIKEEMEPGFR 296

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 123/263 (46%), Gaps = 36/263 (13%)
Query: 584 ETNVAVKVLDLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           ET VA+K ++       +  F+ E   ++     ++V+++   S       +   ++ E 
Sbjct: 48  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMEL 102
Query: 643 MPNGSLENWLNQKEDEQNQRPKL---NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           M  G L+++L     E    P L   +L + + +A ++A+ + YL+ +     VH DL  
Sbjct: 103 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 159
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHG 755
            N ++  +    +GDFG++R ++     +T   R  G     + +++PE    G  +T+ 
Sbjct: 160 RNCMVAEDFTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 214
Query: 756 DEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL-------PDQVAEII------D 801
           D +SFG+++ E+ T  ++P   +  E + L    + GL       PD + E++      +
Sbjct: 215 DVWSFGVVLWEIATLAEQPYQGLSNEQV-LRFVMEGGLLDKPDNCPDMLFELMRMCWQYN 273
Query: 802 PAILEEALEIQAGIVKELQPNLR 824
           P +    LEI + I +E++P  R
Sbjct: 274 PKMRPSFLEIISSIKEEMEPGFR 296

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 31/204 (15%)
Query: 583 EETNVAVKVLDL-QQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ +VA+KVL    ++  ++  + E + +  + +  +V++I  C +      E   LV E
Sbjct: 362 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVME 415
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC-------HTSIVH 694
               G L  +L  K +E                I V+NV E LH            + VH
Sbjct: 416 MAGGGPLHKFLVGKREE----------------IPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 695 CDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH 754
            +L   NVLL N   A + DFGLS+ L  +    T+ S  K  + + APE     + S+ 
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 755 GDEYSFGILMLEMFT-GKRPTDDM 777
            D +S+G+ M E  + G++P   M
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKM 543

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 37/250 (14%)
Query: 582 TEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           + +  +A+K +  +    S+    E    + ++H+N+V+ + S S      N F  +  E
Sbjct: 45  SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFME 99
Query: 642 FMPNGSLE-----NWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
            +P GSL       W   K++EQ            +I      +LE L +     IVH D
Sbjct: 100 QVPGGSLSALLRSKWGPLKDNEQ------------TIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 697 LKPSNVLLDN-EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE---YGALGEVS 752
           +K  NVL++    V  + DFG S+ L   +P    T    G++ Y+APE    G  G   
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLAGINP---CTETFTGTLQYMAPEIIDKGPRG-YG 203
Query: 753 THGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQ 812
              D +S G  ++EM TGK P  ++ E   ++ K     +  ++ E +       + E +
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESM-------SAEAK 256
Query: 813 AGIVKELQPN 822
           A I+K  +P+
Sbjct: 257 AFILKCFEPD 266

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 91/218 (41%), Gaps = 43/218 (19%)
Query: 583 EETNVAVKVLDLQQRGASKSFIAECEALRS--IRHRNLVKIITSCSSIDTRGNEFKALVY 640
           +E  VAVKV     R   ++FI E    R   + H N+ + I     +   G     LV 
Sbjct: 35  DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91
Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH------HHCHTSIVH 694
           E+ PNGSL  +L+            + +    +A  V   L YLH       H   +I H
Sbjct: 92  EYYPNGSLXKYLSLHTS--------DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISH 143
Query: 695 CDLKPSNVLLDNEMVAHVGDFGLSRLLHDN------SPDQTSTSRVKGSIGYVAPEY--- 745
            DL   NVL+ N+    + DFGLS  L  N        D  + S V G+I Y+APE    
Sbjct: 144 RDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV-GTIRYMAPEVLEG 202
Query: 746 --------GALGEVSTHGDEYSFGILMLEMFTGKRPTD 775
                    AL +V    D Y+ G++  E+F   R TD
Sbjct: 203 AVNLRDXESALKQV----DMYALGLIYWEIFM--RCTD 234

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 97/195 (49%), Gaps = 27/195 (13%)
Query: 584 ETNVAVKVLD----LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           ET VAVK ++    L++R     F+ E   ++     ++V+++   S       +   +V
Sbjct: 46  ETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHHVVRLLGVVSK-----GQPTLVV 97
Query: 640 YEFMPNGSLENWLN--QKEDEQNQ-RPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
            E M +G L+++L   + E E N  RP   L + + +A ++A+ + YL+       VH D
Sbjct: 98  MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRD 154
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVS 752
           L   N ++ ++    +GDFG++R ++     +T   R  G     + ++APE    G  +
Sbjct: 155 LAARNCMVAHDFTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPVRWMAPESLKDGVFT 209
Query: 753 THGDEYSFGILMLEM 767
           T  D +SFG+++ E+
Sbjct: 210 TSSDMWSFGVVLWEI 224

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 97/195 (49%), Gaps = 27/195 (13%)
Query: 584 ETNVAVKVLD----LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           ET VAVK ++    L++R     F+ E   ++     ++V+++   S       +   +V
Sbjct: 47  ETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHHVVRLLGVVSK-----GQPTLVV 98
Query: 640 YEFMPNGSLENWLN--QKEDEQNQ-RPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
            E M +G L+++L   + E E N  RP   L + + +A ++A+ + YL+       VH D
Sbjct: 99  MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRD 155
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVS 752
           L   N ++ ++    +GDFG++R ++     +T   R  G     + ++APE    G  +
Sbjct: 156 LAARNCMVAHDFTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPVRWMAPESLKDGVFT 210
Query: 753 THGDEYSFGILMLEM 767
           T  D +SFG+++ E+
Sbjct: 211 TSSDMWSFGVVLWEI 225

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 25/180 (13%)
Query: 599 ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDE 658
             ++F+ E + +R + H N++K I      D R N     + E++  G+L   +   +  
Sbjct: 50  TQRTFLKEVKVMRCLEHPNVLKFIGVLYK-DKRLN----FITEYIKGGTLRGIIKSMD-- 102
Query: 659 QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS 718
            +Q P     QR+S A D+A+ + YLH     +I+H DL   N L+       V DFGL+
Sbjct: 103 -SQYP---WSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLA 155
Query: 719 RLLHD-----------NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEM 767
           RL+ D             PD+     V G+  ++APE           D +SFGI++ E+
Sbjct: 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 14/194 (7%)
Query: 583 EETNVAVKVL--DLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           +  +VAVKVL  DL +  +    F  E +   ++ H  +V +  +  + +T       +V
Sbjct: 36  DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIV 94
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            E++   +L + ++    E    PK    + + +  D    L + H +    I+H D+KP
Sbjct: 95  MEYVDGVTLRDIVHT---EGPMTPK----RAIEVIADACQALNFSHQN---GIIHRDVKP 144
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYS 759
           +N+L+       V DFG++R + D+      T+ V G+  Y++PE      V    D YS
Sbjct: 145 ANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 760 FGILMLEMFTGKRP 773
            G ++ E+ TG+ P
Sbjct: 205 LGCVLYEVLTGEPP 218

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 19/195 (9%)
Query: 602 SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQ 661
             +AE   ++ + +  +V++I  C +      E   LV E    G L  +L Q    +++
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDK 127
Query: 662 RPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL 721
              + L+ ++S+       ++YL     ++ VH DL   NVLL  +  A + DFGLS+ L
Sbjct: 128 NI-IELVHQVSMG------MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 177
Query: 722 HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM--F 778
             +     + +  K  + + APE     + S+  D +SFG+LM E F+ G++P   M   
Sbjct: 178 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 237
Query: 779 EEGLSLHKYAKMGLP 793
           E    L K  +MG P
Sbjct: 238 EVTAMLEKGERMGCP 252

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 19/195 (9%)
Query: 602 SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQ 661
             +AE   ++ + +  +V++I  C +      E   LV E    G L  +L Q    +++
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDK 127
Query: 662 RPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL 721
              + L+ ++S+       ++YL     ++ VH DL   NVLL  +  A + DFGLS+ L
Sbjct: 128 NI-IELVHQVSMG------MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 177
Query: 722 HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM--F 778
             +     + +  K  + + APE     + S+  D +SFG+LM E F+ G++P   M   
Sbjct: 178 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 237
Query: 779 EEGLSLHKYAKMGLP 793
           E    L K  +MG P
Sbjct: 238 EVTAMLEKGERMGCP 252

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 122/263 (46%), Gaps = 36/263 (13%)
Query: 584 ETNVAVKVLDLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           ET VA+K ++       +  F+ E   ++     ++V+++   S       +   ++ E 
Sbjct: 40  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMEL 94
Query: 643 MPNGSLENWLNQKEDEQNQRPKL---NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           M  G L+++L     E    P L   +L + + +A ++A+ + YL+ +     VH DL  
Sbjct: 95  MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 151
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHG 755
            N ++  +    +GDFG++R +      +T   R  G     + +++PE    G  +T+ 
Sbjct: 152 RNCMVAEDFTVKIGDFGMTRDIX-----ETDXXRKGGKGLLPVRWMSPESLKDGVFTTYS 206
Query: 756 DEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL-------PDQVAEII------D 801
           D +SFG+++ E+ T  ++P   +  E + L    + GL       PD + E++      +
Sbjct: 207 DVWSFGVVLWEIATLAEQPYQGLSNEQV-LRFVMEGGLLDKPDNCPDMLLELMRMCWQYN 265
Query: 802 PAILEEALEIQAGIVKELQPNLR 824
           P +    LEI + I +E++P  R
Sbjct: 266 PKMRPSFLEIISSIKEEMEPGFR 288

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 19/195 (9%)
Query: 602 SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQ 661
             +AE   ++ + +  +V++I  C +      E   LV E    G L  +L Q    +++
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDK 125
Query: 662 RPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL 721
              + L+ ++S+       ++YL     ++ VH DL   NVLL  +  A + DFGLS+ L
Sbjct: 126 NI-IELVHQVSMG------MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 175
Query: 722 HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM--F 778
             +     + +  K  + + APE     + S+  D +SFG+LM E F+ G++P   M   
Sbjct: 176 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 235
Query: 779 EEGLSLHKYAKMGLP 793
           E    L K  +MG P
Sbjct: 236 EVTAMLEKGERMGCP 250

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 122/263 (46%), Gaps = 36/263 (13%)
Query: 584 ETNVAVKVLDLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           ET VA+K ++       +  F+ E   ++     ++V+++   S       +   ++ E 
Sbjct: 49  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMEL 103
Query: 643 MPNGSLENWLNQKEDEQNQRPKL---NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           M  G L+++L     E    P L   +L + + +A ++A+ + YL+ +     VH DL  
Sbjct: 104 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 160
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHG 755
            N ++  +    +GDFG++R +      +T   R  G     + +++PE    G  +T+ 
Sbjct: 161 RNCMVAEDFTVKIGDFGMTRDIX-----ETDXXRKGGKGLLPVRWMSPESLKDGVFTTYS 215
Query: 756 DEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL-------PDQVAEII------D 801
           D +SFG+++ E+ T  ++P   +  E + L    + GL       PD + E++      +
Sbjct: 216 DVWSFGVVLWEIATLAEQPYQGLSNEQV-LRFVMEGGLLDKPDNCPDMLFELMRMCWQYN 274
Query: 802 PAILEEALEIQAGIVKELQPNLR 824
           P +    LEI + I +E++P  R
Sbjct: 275 PKMRPSFLEIISSIKEEMEPGFR 297

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 123/263 (46%), Gaps = 36/263 (13%)
Query: 584 ETNVAVKVLDLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           ET VA+K ++       +  F+ E   ++     ++V+++   S       +   ++ E 
Sbjct: 55  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMEL 109
Query: 643 MPNGSLENWLNQKEDEQNQRPKL---NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           M  G L+++L     E    P L   +L + + +A ++A+ + YL+ +     VH DL  
Sbjct: 110 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 166
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHG 755
            N ++  +    +GDFG++R ++     +T   R  G     + +++PE    G  +T+ 
Sbjct: 167 RNCMVAEDFTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 221
Query: 756 DEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL-------PDQVAEII------D 801
           D +SFG+++ E+ T  ++P   +  E + L    + GL       PD + E++      +
Sbjct: 222 DVWSFGVVLWEIATLAEQPYQGLSNEQV-LRFVMEGGLLDKPDNCPDMLFELMRMCWQYN 280
Query: 802 PAILEEALEIQAGIVKELQPNLR 824
           P +    LEI + I +E++P  R
Sbjct: 281 PKMRPSFLEIISSIKEEMEPGFR 303

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 26/201 (12%)
Query: 583 EETNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALV 639
           E   VAVK+L  D  ++  S   ++E E ++ I +H+N++ ++ +C    T+      +V
Sbjct: 66  EAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV 120
Query: 640 YEFMPNGSLENWLNQKED-------EQNQRP--KLNLMQRLSIAIDVANVLEYLHHHCHT 690
            E+   G+L  +L  +         + N+ P  ++     +S    +A  +EYL      
Sbjct: 121 -EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALG 749
             +H DL   NVL+    V  + DFGL+R +++ +   +T+  R+   + ++APE     
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRL--PVKWMAPE-ALFD 233
Query: 750 EVSTH-GDEYSFGILMLEMFT 769
            V TH  D +SFG+LM E+FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 19/193 (9%)
Query: 604 IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP 663
           +AE   ++ + +  +V++I  C +      E   LV E    G L  +L Q    +++  
Sbjct: 418 LAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDKN- 470
Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
            + L+ ++S+       ++YL     ++ VH DL   NVLL  +  A + DFGLS+ L  
Sbjct: 471 IIELVHQVSMG------MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521
Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM--FEE 780
           +     + +  K  + + APE     + S+  D +SFG+LM E F+ G++P   M   E 
Sbjct: 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 581
Query: 781 GLSLHKYAKMGLP 793
              L K  +MG P
Sbjct: 582 TAMLEKGERMGCP 594

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 26/201 (12%)
Query: 583 EETNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALV 639
           E   VAVK+L  D  ++  S   ++E E ++ I +H+N++ ++ +C    T+      +V
Sbjct: 66  EAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV 120
Query: 640 YEFMPNGSLENWLNQKED-------EQNQRP--KLNLMQRLSIAIDVANVLEYLHHHCHT 690
            E+   G+L  +L  +         + N+ P  ++     +S    +A  +EYL      
Sbjct: 121 -EYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALG 749
             +H DL   NVL+    V  + DFGL+R +++ +   +T+  R+   + ++APE     
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRL--PVKWMAPE-ALFD 233
Query: 750 EVSTH-GDEYSFGILMLEMFT 769
            V TH  D +SFG+LM E+FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 19/194 (9%)
Query: 603 FIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQR 662
            +AE   ++ + +  +V++I  C +      E   LV E    G L  +L Q    +++ 
Sbjct: 418 LLAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDKN 471
Query: 663 PKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH 722
             + L+ ++S+       ++YL     ++ VH DL   NVLL  +  A + DFGLS+ L 
Sbjct: 472 -IIELVHQVSMG------MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 521
Query: 723 DNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM--FE 779
            +     + +  K  + + APE     + S+  D +SFG+LM E F+ G++P   M   E
Sbjct: 522 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 581
Query: 780 EGLSLHKYAKMGLP 793
               L K  +MG P
Sbjct: 582 VTAMLEKGERMGCP 595

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 15/167 (8%)
Query: 603 FIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQR 662
           F+ E   L+   H N+V++I  C+       +   +V E +  G    +L      + + 
Sbjct: 159 FLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELVQGGDFLTFL------RTEG 207
Query: 663 PKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH 722
            +L +   L +  D A  +EYL   C    +H DL   N L+  + V  + DFG+SR   
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264
Query: 723 DNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT 769
           D     +   R +  + + APE    G  S+  D +SFGIL+ E F+
Sbjct: 265 DGVXAASGGLR-QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 91/188 (48%), Gaps = 19/188 (10%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
            VAVK++DL+++   +    E   +R  +H N+V++  S       G E   L+ EF+  
Sbjct: 72  QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY----LVGEELWVLM-EFLQG 126
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G+L + ++Q         +LN  Q  ++   V   L YLH      ++H D+K  ++LL 
Sbjct: 127 GALTDIVSQV--------RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT 175
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
            +    + DFG    +  + P +     + G+  ++APE  +    +T  D +S GI+++
Sbjct: 176 LDGRVKLSDFGFCAQISKDVPKRKX---LVGTPYWMAPEVISRSLYATEVDIWSLGIMVI 232
Query: 766 EMFTGKRP 773
           EM  G+ P
Sbjct: 233 EMVDGEPP 240

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 96/195 (49%), Gaps = 27/195 (13%)
Query: 584 ETNVAVKVLD----LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           ET VAVK ++    L++R     F+ E   ++     ++V+++   S       +   +V
Sbjct: 47  ETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHHVVRLLGVVSK-----GQPTLVV 98
Query: 640 YEFMPNGSLENWLN--QKEDEQNQ-RPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
            E M +G L+++L   + E E N  RP   L + + +A ++A+ + YL+       VH D
Sbjct: 99  MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRD 155
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVS 752
           L   N ++ ++    +GDFG++R +      +T   R  G     + ++APE    G  +
Sbjct: 156 LAARNCMVAHDFTVKIGDFGMTRDIX-----ETDXXRKGGKGLLPVRWMAPESLKDGVFT 210
Query: 753 THGDEYSFGILMLEM 767
           T  D +SFG+++ E+
Sbjct: 211 TSSDMWSFGVVLWEI 225

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 122/263 (46%), Gaps = 43/263 (16%)
Query: 584 ETNVAVKVLD----LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           ET VAVK ++    L++R     F+ E   ++     ++V+++   S       +   +V
Sbjct: 48  ETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHHVVRLLGVVSK-----GQPTLVV 99
Query: 640 YEFMPNGSLENWLN--QKEDEQNQ-RPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
            E M +G L+++L   + E E N  RP   L + + +A ++A+ + YL+       VH +
Sbjct: 100 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRN 156
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVS 752
           L   N ++ ++    +GDFG++R ++     +T   R  G     + ++APE    G  +
Sbjct: 157 LAARNCMVAHDFTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPVRWMAPESLKDGVFT 211
Query: 753 THGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEIIDPAILEE 807
           T  D +SFG+++ E+ +  ++P      +GLS  +  K     G  DQ      P    E
Sbjct: 212 TSSDMWSFGVVLWEITSLAEQPY-----QGLSNEQVLKFVMDGGYLDQ------PDNCPE 260
Query: 808 ALEIQAGIVKELQPNLRAKFHEI 830
            +     +  +  PN+R  F EI
Sbjct: 261 RVTDLMRMCWQFNPNMRPTFLEI 283

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 122/263 (46%), Gaps = 43/263 (16%)
Query: 584 ETNVAVKVLD----LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           ET VAVK ++    L++R     F+ E   ++     ++V+++   S       +   +V
Sbjct: 47  ETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHHVVRLLGVVSK-----GQPTLVV 98
Query: 640 YEFMPNGSLENWLN--QKEDEQNQ-RPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
            E M +G L+++L   + E E N  RP   L + + +A ++A+ + YL+       VH +
Sbjct: 99  MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRN 155
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVS 752
           L   N ++ ++    +GDFG++R ++     +T   R  G     + ++APE    G  +
Sbjct: 156 LAARNCMVAHDFTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPVRWMAPESLKDGVFT 210
Query: 753 THGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKM----GLPDQVAEIIDPAILEE 807
           T  D +SFG+++ E+ +  ++P      +GLS  +  K     G  DQ      P    E
Sbjct: 211 TSSDMWSFGVVLWEITSLAEQPY-----QGLSNEQVLKFVMDGGYLDQ------PDNCPE 259
Query: 808 ALEIQAGIVKELQPNLRAKFHEI 830
            +     +  +  PN+R  F EI
Sbjct: 260 RVTDLMRMCWQFNPNMRPTFLEI 282

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 21/190 (11%)
Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL 665
           E + L  + H  +VK+     +  T G  +  L+ +F+  G L   L+++     +  K 
Sbjct: 80  ERDILADVNHPFVVKL---HYAFQTEGKLY--LILDFLRGGDLFTRLSKEVMFTEEDVKF 134
Query: 666 NLMQRLSIAIDVANVLEYLHHHCHT-SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
            L + L++ +D          H H+  I++ DLKP N+LLD E    + DFGLS+   D+
Sbjct: 135 YLAE-LALGLD----------HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDH 183
Query: 725 SPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM-FEEGLS 783
                S     G++ Y+APE       S   D +S+G+LM EM TG  P      +E ++
Sbjct: 184 EKKAYSFC---GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMT 240
Query: 784 LHKYAKMGLP 793
           L   AK+G+P
Sbjct: 241 LILKAKLGMP 250

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 116/252 (46%), Gaps = 23/252 (9%)
Query: 586 NVAVKVLDLQQRGASK-SFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
            VAVK+L        K + ++E + +  + +H N+V ++ +C    T G     ++ E+ 
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC----THGGPV-LVITEYC 132
Query: 644 PNGSLENWLNQKE----DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
             G L N+L +K     D+++ RP L L   L  +  VA  + +L      + +H D+  
Sbjct: 133 CYGDLLNFLRRKAEADLDKEDGRP-LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 188
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYS 759
            NVLL N  VA +GDFGL+R + ++S +       +  + ++APE       +   D +S
Sbjct: 189 RNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 247
Query: 760 FGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKE 818
           +GIL+ E+F+ G  P   +       +K  K G      ++  PA   + +         
Sbjct: 248 YGILLWEIFSLGLNPYPGILVNS-KFYKLVKDGY-----QMAQPAFAPKNIYSIMQACWA 301
Query: 819 LQPNLRAKFHEI 830
           L+P  R  F +I
Sbjct: 302 LEPTHRPTFQQI 313

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
            VAVK +DL+++   +    E   +R   H N+V + +S       G+E   +V EF+  
Sbjct: 72  QVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLV----GDEL-WVVMEFLEG 126
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G+L + +           ++N  Q  ++ + V   L YLH+     ++H D+K  ++LL 
Sbjct: 127 GALTDIVTHT--------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLT 175
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
           ++    + DFG    +    P +     + G+  ++APE  +     T  D +S GI+++
Sbjct: 176 SDGRIKLSDFGFCAQVSKEVPKRKX---LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 232
Query: 766 EMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEI 799
           EM  G+ P  +  E  L   +  +  LP +V ++
Sbjct: 233 EMIDGEPPYFN--EPPLQAMRRIRDSLPPRVKDL 264

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 26/201 (12%)
Query: 583 EETNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALV 639
           E   VAVK+L  D  ++  S   ++E E ++ I +H+N++ ++ +C    T+      +V
Sbjct: 66  EAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV 120
Query: 640 YEFMPNGSLENWLNQKED-------EQNQRP--KLNLMQRLSIAIDVANVLEYLHHHCHT 690
            E+   G+L  +L  +         + N+ P  ++     +S    +A  +EYL      
Sbjct: 121 -EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALG 749
             +H DL   NVL+    V  + DFGL+R +++ +   +T+  R+   + ++APE     
Sbjct: 177 KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRL--PVKWMAPE-ALFD 233
Query: 750 EVSTH-GDEYSFGILMLEMFT 769
            V TH  D +SFG+LM E+FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 96/195 (49%), Gaps = 27/195 (13%)
Query: 584 ETNVAVKVLD----LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           ET VAVK ++    L++R     F+ E   ++     ++V+++   S       +   +V
Sbjct: 44  ETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHHVVRLLGVVSK-----GQPTLVV 95
Query: 640 YEFMPNGSLENWLN--QKEDEQNQ-RPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
            E M +G L+++L   + E E N  RP   L + + +A ++A+ + YL+       VH D
Sbjct: 96  MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRD 152
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVS 752
           L   N ++ ++    +GDFG++R +      +T   R  G     + ++APE    G  +
Sbjct: 153 LAARNCMVAHDFTVKIGDFGMTRDIX-----ETDXXRKGGKGLLPVRWMAPESLKDGVFT 207
Query: 753 THGDEYSFGILMLEM 767
           T  D +SFG+++ E+
Sbjct: 208 TSSDMWSFGVVLWEI 222

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 15/167 (8%)
Query: 603 FIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQR 662
           F+ E   L+   H N+V++I  C+       +   +V E +  G    +L      + + 
Sbjct: 159 FLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELVQGGDFLTFL------RTEG 207
Query: 663 PKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH 722
            +L +   L +  D A  +EYL   C    +H DL   N L+  + V  + DFG+SR   
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264
Query: 723 DNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT 769
           D     +   R +  + + APE    G  S+  D +SFGIL+ E F+
Sbjct: 265 DGVYAASGGLR-QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 26/201 (12%)
Query: 583 EETNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALV 639
           E   VAVK+L  D  ++  S   ++E E ++ I +H+N++ ++ +C    T+      +V
Sbjct: 53  EAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV 107
Query: 640 YEFMPNGSLENWLNQKED-------EQNQRP--KLNLMQRLSIAIDVANVLEYLHHHCHT 690
            E+   G+L  +L  +         + N+ P  ++     +S    +A  +EYL      
Sbjct: 108 -EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--- 163
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALG 749
             +H DL   NVL+    V  + DFGL+R +++ +   +T+  R+   + ++APE     
Sbjct: 164 KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL--PVKWMAPE-ALFD 220
Query: 750 EVSTH-GDEYSFGILMLEMFT 769
            V TH  D +SFG+LM E+FT
Sbjct: 221 RVYTHQSDVWSFGVLMWEIFT 241

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 26/201 (12%)
Query: 583 EETNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALV 639
           E   VAVK+L  D  ++  S   ++E E ++ I +H+N++ ++ +C    T+      +V
Sbjct: 58  EAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV 112
Query: 640 YEFMPNGSLENWLNQKED-------EQNQRP--KLNLMQRLSIAIDVANVLEYLHHHCHT 690
            E+   G+L  +L  +         + N+ P  ++     +S    +A  +EYL      
Sbjct: 113 -EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--- 168
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALG 749
             +H DL   NVL+    V  + DFGL+R +++ +   +T+  R+   + ++APE     
Sbjct: 169 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL--PVKWMAPE-ALFD 225
Query: 750 EVSTH-GDEYSFGILMLEMFT 769
            V TH  D +SFG+LM E+FT
Sbjct: 226 RVYTHQSDVWSFGVLMWEIFT 246

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 26/201 (12%)
Query: 583 EETNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALV 639
           E   VAVK+L  D  ++  S   ++E E ++ I +H+N++ ++ +C    T+      +V
Sbjct: 66  EAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIITLLGAC----TQDGPLYVIV 120
Query: 640 YEFMPNGSLENWLNQKED-------EQNQRP--KLNLMQRLSIAIDVANVLEYLHHHCHT 690
            E+   G+L  +L  +         + N+ P  ++     +S    +A  +EYL      
Sbjct: 121 -EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALG 749
             +H DL   NVL+    V  + DFGL+R +++ +   +T+  R+   + ++APE     
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL--PVKWMAPE-ALFD 233
Query: 750 EVSTH-GDEYSFGILMLEMFT 769
            V TH  D +SFG+LM E+FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 26/201 (12%)
Query: 583 EETNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALV 639
           E   VAVK+L  D  ++  S   ++E E ++ I +H+N++ ++ +C    T+      +V
Sbjct: 55  EAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV 109
Query: 640 YEFMPNGSLENWLNQKED-------EQNQRP--KLNLMQRLSIAIDVANVLEYLHHHCHT 690
            E+   G+L  +L  +         + N+ P  ++     +S    +A  +EYL      
Sbjct: 110 -EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--- 165
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALG 749
             +H DL   NVL+    V  + DFGL+R +++ +   +T+  R+   + ++APE     
Sbjct: 166 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL--PVKWMAPE-ALFD 222
Query: 750 EVSTH-GDEYSFGILMLEMFT 769
            V TH  D +SFG+LM E+FT
Sbjct: 223 RVYTHQSDVWSFGVLMWEIFT 243

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 122/263 (46%), Gaps = 36/263 (13%)
Query: 584 ETNVAVKVLDLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           ET VA+K ++       +  F+ E   ++     ++V+++   S       +   ++ E 
Sbjct: 42  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMEL 96
Query: 643 MPNGSLENWLNQKEDEQNQRPKL---NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           M  G L+++L     E    P L   +L + + +A ++A+ + YL+ +     VH DL  
Sbjct: 97  MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 153
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHG 755
            N  +  +    +GDFG++R ++     +T   R  G     + +++PE    G  +T+ 
Sbjct: 154 RNCXVAEDFTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 208
Query: 756 DEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL-------PDQVAEII------D 801
           D +SFG+++ E+ T  ++P   +  E + L    + GL       PD + E++      +
Sbjct: 209 DVWSFGVVLWEIATLAEQPYQGLSNEQV-LRFVMEGGLLDKPDNCPDMLLELMRMCWQYN 267
Query: 802 PAILEEALEIQAGIVKELQPNLR 824
           P +    LEI + I +E++P  R
Sbjct: 268 PKMRPSFLEIISSIKEEMEPGFR 290

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 26/201 (12%)
Query: 583 EETNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALV 639
           E   VAVK+L  D  ++  S   ++E E ++ I +H+N++ ++ +C    T+      +V
Sbjct: 112 EAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV 166
Query: 640 YEFMPNGSLENWLNQKED-------EQNQRP--KLNLMQRLSIAIDVANVLEYLHHHCHT 690
            E+   G+L  +L  +         + N+ P  ++     +S    +A  +EYL      
Sbjct: 167 -EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--- 222
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALG 749
             +H DL   NVL+    V  + DFGL+R +++ +   +T+  R+   + ++APE     
Sbjct: 223 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL--PVKWMAPE-ALFD 279
Query: 750 EVSTH-GDEYSFGILMLEMFT 769
            V TH  D +SFG+LM E+FT
Sbjct: 280 RVYTHQSDVWSFGVLMWEIFT 300

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 28/196 (14%)
Query: 583 EETNVAVKVLDLQQRGA--SKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA--- 637
           + T   V V  LQ  G    + F  E + L+++    +VK          RG  +     
Sbjct: 33  DNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY---------RGVSYGPGRP 83
Query: 638 ---LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL-HHHCHTSIV 693
              LV E++P+G L ++L      Q  R +L+  + L  +  +   +EYL    C    V
Sbjct: 84  ELRLVMEYLPSGCLRDFL------QRHRARLDASRLLLYSSQICKGMEYLGSRRC----V 133
Query: 694 HCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVST 753
           H DL   N+L+++E    + DFGL++LL  +          +  I + APE  +    S 
Sbjct: 134 HRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSR 193
Query: 754 HGDEYSFGILMLEMFT 769
             D +SFG+++ E+FT
Sbjct: 194 QSDVWSFGVVLYELFT 209

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 12/127 (9%)
Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           EF   G+LE W+ ++  E     KL+ +  L +   +   ++Y+H      ++H DLKPS
Sbjct: 114 EFCDKGTLEQWIEKRRGE-----KLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPS 165
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+ L +     +GDFGL   L ++       +R KG++ Y++PE  +  +     D Y+ 
Sbjct: 166 NIFLVDTKQVKIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISSQDYGKEVDLYAL 221
Query: 761 GILMLEM 767
           G+++ E+
Sbjct: 222 GLILAEL 228

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 84/175 (48%), Gaps = 27/175 (15%)
Query: 603 FIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ--- 659
            ++E   LR ++H N+V+       I  R N    +V E+   G L + + +   E+   
Sbjct: 52  LVSEVNLLRELKHPNIVRYY---DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 660 NQRPKLNLMQRLSIAIDVANVLEYLHHHCHT------SIVHCDLKPSNVLLDNEMVAHVG 713
           ++   L +M +L++A+            CH       +++H DLKP+NV LD +    +G
Sbjct: 109 DEEFVLRVMTQLTLAL----------KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158
Query: 714 DFGLSRLL-HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEM 767
           DFGL+R+L HD S  +T      G+  Y++PE       +   D +S G L+ E+
Sbjct: 159 DFGLARILNHDTSFAKTFV----GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 24/200 (12%)
Query: 583 EETNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALV 639
           E   VAVK+L  D  ++  S   ++E E ++ I +H+N++ ++ +C    T+      +V
Sbjct: 66  EAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV 120
Query: 640 YEFMPNGSLENWLNQKED-------EQNQRP--KLNLMQRLSIAIDVANVLEYLHHHCHT 690
            E+   G+L  +L  +         + N+ P  ++     +S    +A  +EYL      
Sbjct: 121 -EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE 750
             +H DL   NVL+    V  + DFGL+R ++ N     +T+  +  + ++APE      
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDIN-NIDYYKNTTNGRLPVKWMAPE-ALFDR 234
Query: 751 VSTH-GDEYSFGILMLEMFT 769
           V TH  D +SFG+LM E+FT
Sbjct: 235 VYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 26/201 (12%)
Query: 583 EETNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALV 639
           E   VAVK+L  D  ++  S   ++E E ++ I +H+N++ ++ +C    T+      +V
Sbjct: 66  EAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIIHLLGAC----TQDGPLYVIV 120
Query: 640 YEFMPNGSLENWLNQKED-------EQNQRP--KLNLMQRLSIAIDVANVLEYLHHHCHT 690
            E+   G+L  +L  +         + N+ P  ++     +S    +A  +EYL      
Sbjct: 121 -EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALG 749
             +H DL   NVL+    V  + DFGL+R +++ +   +T+  R+   + ++APE     
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL--PVKWMAPE-ALFD 233
Query: 750 EVSTH-GDEYSFGILMLEMFT 769
            V TH  D +SFG+LM E+FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C  + + G+    L Y 
Sbjct: 116 KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--LRSEGSPLVVLPY- 172
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            M +G L N++      +N+     +   +   + VA  +++L        VH DL   N
Sbjct: 173 -MKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARN 222
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R ++D   D   + +  K  + ++A E     + +T  D +SF
Sbjct: 223 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 282
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 283 GVLLWELMTRGAPPYPDV 300

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 92/193 (47%), Gaps = 23/193 (11%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII-TSCSSIDTRGNEFKALVYEFM 643
            VAVK L ++        F+ E   +  + H+N+V+ I  S  S+       + ++ E M
Sbjct: 77  QVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLP------RFILLELM 130
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             G L+++L +     +Q   L ++  L +A D+A   +YL  +     +H D+   N L
Sbjct: 131 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 187
Query: 704 LDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPEYGALGEVSTHGD 756
           L       VA +GDFG++R ++     + S  R  G     + ++ PE    G  ++  D
Sbjct: 188 LTCPGPGRVAKIGDFGMARDIY-----RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 242
Query: 757 EYSFGILMLEMFT 769
            +SFG+L+ E+F+
Sbjct: 243 TWSFGVLLWEIFS 255

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 23/193 (11%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII-TSCSSIDTRGNEFKALVYEFM 643
            VAVK L ++        F+ E   +    H+N+V+ I  S  S+       + ++ E M
Sbjct: 77  QVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP------RFILLELM 130
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             G L+++L +     +Q   L ++  L +A D+A   +YL  +     +H D+   N L
Sbjct: 131 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 187
Query: 704 LDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPEYGALGEVSTHGD 756
           L       VA +GDFG++R ++     + S  R  G     + ++ PE    G  ++  D
Sbjct: 188 LTCPGPGRVAKIGDFGMARDIY-----RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 242
Query: 757 EYSFGILMLEMFT 769
            +SFG+L+ E+F+
Sbjct: 243 TWSFGVLLWEIFS 255

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 92/193 (47%), Gaps = 23/193 (11%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII-TSCSSIDTRGNEFKALVYEFM 643
            VAVK L ++        F+ E   +  + H+N+V+ I  S  S+       + ++ E M
Sbjct: 63  QVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLP------RFILLELM 116
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             G L+++L +     +Q   L ++  L +A D+A   +YL  +     +H D+   N L
Sbjct: 117 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 173
Query: 704 LDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPEYGALGEVSTHGD 756
           L       VA +GDFG++R ++     + S  R  G     + ++ PE    G  ++  D
Sbjct: 174 LTCPGPGRVAKIGDFGMARDIY-----RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 228
Query: 757 EYSFGILMLEMFT 769
            +SFG+L+ E+F+
Sbjct: 229 TWSFGVLLWEIFS 241

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 117/261 (44%), Gaps = 38/261 (14%)
Query: 586 NVAVKVLDLQQRGAS----KSFIAECEALRSIRHR-NLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L   + GA+    ++ ++E + L  I H  N+V ++ +C+     G     +V 
Sbjct: 59  TVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIV- 111
Query: 641 EFMPNGSLENWLNQKEDE-----QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
           EF   G+L  +L  K +E        +  L L   +  +  VA  +E+L        +H 
Sbjct: 112 EFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHR 168
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+LL  + V  + DFGL+R ++ + PD       +  + ++APE       +   
Sbjct: 169 DLAARNILLSEKNVVKIXDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVYTIQS 227
Query: 756 DEYSFGILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEAL 809
           D +SFG+L+ E+F+ G  P      D+ F     L +  +M  PD       P + +  L
Sbjct: 228 DVWSFGVLLWEIFSLGASPYPGVKIDEEFXR--RLKEGTRMRAPDYTT----PEMYQTML 281
Query: 810 EIQAGIVKELQPNLRAKFHEI 830
           +   G     +P+ R  F E+
Sbjct: 282 DCWHG-----EPSQRPTFSEL 297

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 23/193 (11%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII-TSCSSIDTRGNEFKALVYEFM 643
            VAVK L ++        F+ E   +    H+N+V+ I  S  S+       + ++ E M
Sbjct: 54  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP------RFILLELM 107
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             G L+++L +     +Q   L ++  L +A D+A   +YL  +     +H D+   N L
Sbjct: 108 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 164
Query: 704 LDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPEYGALGEVSTHGD 756
           L       VA +GDFG++R ++     + S  R  G     + ++ PE    G  ++  D
Sbjct: 165 LTCPGPGRVAKIGDFGMARDIY-----RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 219
Query: 757 EYSFGILMLEMFT 769
            +SFG+L+ E+F+
Sbjct: 220 TWSFGVLLWEIFS 232

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 26/201 (12%)
Query: 583 EETNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCS---------SIDT 630
           E   VAVK+L  D  ++  S   ++E E ++ I +H+N++ ++ +C+         +  +
Sbjct: 66  EAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYAS 124
Query: 631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHT 690
           +GN  + L     P       +N+  +EQ     +     +S    +A  +EYL      
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQ-----MTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALG 749
             +H DL   NVL+    V  + DFGL+R +++ +   +T+  R+   + ++APE     
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL--PVKWMAPE-ALFD 233
Query: 750 EVSTH-GDEYSFGILMLEMFT 769
            V TH  D +SFG+LM E+FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C  + + G+    L Y 
Sbjct: 58  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--LRSEGSPLVVLPY- 114
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            M +G L N++      +N+     +   +   + VA  +++L        VH DL   N
Sbjct: 115 -MKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARN 164
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R ++D   D   + +  K  + ++A E     + +T  D +SF
Sbjct: 165 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 224
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 225 GVLLWELMTRGAPPYPDV 242

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C  + + G+    L Y 
Sbjct: 57  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--LRSEGSPLVVLPY- 113
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            M +G L N++      +N+     +   +   + VA  +++L        VH DL   N
Sbjct: 114 -MKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARN 163
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R ++D   D   + +  K  + ++A E     + +T  D +SF
Sbjct: 164 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 223
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 224 GVLLWELMTRGAPPYPDV 241

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C     R      +V  
Sbjct: 55  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC----LRSEGSPLVVLP 110
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
           +M +G L N++      +N+     +   +   + VA  +++L        VH DL   N
Sbjct: 111 YMKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARN 161
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R ++D   D   + +  K  + ++A E     + +T  D +SF
Sbjct: 162 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 221
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 222 GVLLWELMTRGAPPYPDV 239

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C  + + G+    L Y 
Sbjct: 57  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--LRSEGSPLVVLPY- 113
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            M +G L N++      +N+     +   +   + VA  +++L        VH DL   N
Sbjct: 114 -MKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARN 163
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R ++D   D   + +  K  + ++A E     + +T  D +SF
Sbjct: 164 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 223
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 224 GVLLWELMTRGAPPYPDV 241

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 23/193 (11%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII-TSCSSIDTRGNEFKALVYEFM 643
            VAVK L ++        F+ E   +    H+N+V+ I  S  S+       + ++ E M
Sbjct: 62  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP------RFILMELM 115
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             G L+++L +     +Q   L ++  L +A D+A   +YL  +     +H D+   N L
Sbjct: 116 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 172
Query: 704 LDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPEYGALGEVSTHGD 756
           L       VA +GDFG++R ++     + S  R  G     + ++ PE    G  ++  D
Sbjct: 173 LTCPGPGRVAKIGDFGMARDIY-----RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 227
Query: 757 EYSFGILMLEMFT 769
            +SFG+L+ E+F+
Sbjct: 228 TWSFGVLLWEIFS 240

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 23/193 (11%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII-TSCSSIDTRGNEFKALVYEFM 643
            VAVK L ++        F+ E   +    H+N+V+ I  S  S+       + ++ E M
Sbjct: 79  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP------RFILLELM 132
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             G L+++L +     +Q   L ++  L +A D+A   +YL  +     +H D+   N L
Sbjct: 133 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 189
Query: 704 LDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPEYGALGEVSTHGD 756
           L       VA +GDFG++R ++     + S  R  G     + ++ PE    G  ++  D
Sbjct: 190 LTCPGPGRVAKIGDFGMARDIY-----RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 244
Query: 757 EYSFGILMLEMFT 769
            +SFG+L+ E+F+
Sbjct: 245 TWSFGVLLWEIFS 257

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 111/269 (41%), Gaps = 31/269 (11%)
Query: 583 EETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           + T   V V  LQ  G    + F  E + L+++    +VK           G +   LV 
Sbjct: 37  DNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---GRQSLRLVM 93
Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           E++P+G L ++L      Q  R +L+  + L  +  +   +EYL        VH DL   
Sbjct: 94  EYLPSGCLRDFL------QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAAR 144
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+++E    + DFGL++LL  +          +  I + APE  +    S   D +SF
Sbjct: 145 NILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 204
Query: 761 GILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQ 820
           G+++ E+FT    +     E L +     MG    V     PA+      ++ G      
Sbjct: 205 GVVLYELFTYCDKSCSPSAEFLRM-----MGCERDV-----PALCRLLELLEEGQRLPAP 254
Query: 821 PNLRAKFHEIQVSILRVGILCSEELPRDR 849
           P   A+ HE+         LC    P+DR
Sbjct: 255 PACPAEVHELMK-------LCWAPSPQDR 276

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C  + + G+    L Y 
Sbjct: 62  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--LRSEGSPLVVLPY- 118
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            M +G L N++      +N+     +   +   + VA  +++L        VH DL   N
Sbjct: 119 -MKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARN 168
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R ++D   D   + +  K  + ++A E     + +T  D +SF
Sbjct: 169 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 228
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 229 GVLLWELMTRGAPPYPDV 246

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 23/193 (11%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII-TSCSSIDTRGNEFKALVYEFM 643
            VAVK L ++        F+ E   +    H+N+V+ I  S  S+       + ++ E M
Sbjct: 69  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP------RFILLELM 122
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             G L+++L +     +Q   L ++  L +A D+A   +YL  +     +H D+   N L
Sbjct: 123 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 179
Query: 704 LDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPEYGALGEVSTHGD 756
           L       VA +GDFG++R ++     + S  R  G     + ++ PE    G  ++  D
Sbjct: 180 LTCPGPGRVAKIGDFGMARDIY-----RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 234
Query: 757 EYSFGILMLEMFT 769
            +SFG+L+ E+F+
Sbjct: 235 TWSFGVLLWEIFS 247

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 23/193 (11%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII-TSCSSIDTRGNEFKALVYEFM 643
            VAVK L ++        F+ E   +    H+N+V+ I  S  S+       + ++ E M
Sbjct: 62  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP------RFILLELM 115
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             G L+++L +     +Q   L ++  L +A D+A   +YL  +     +H D+   N L
Sbjct: 116 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 172
Query: 704 LDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPEYGALGEVSTHGD 756
           L       VA +GDFG++R ++     + S  R  G     + ++ PE    G  ++  D
Sbjct: 173 LTCPGPGRVAKIGDFGMARDIY-----RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 227
Query: 757 EYSFGILMLEMFT 769
            +SFG+L+ E+F+
Sbjct: 228 TWSFGVLLWEIFS 240

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 23/193 (11%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII-TSCSSIDTRGNEFKALVYEFM 643
            VAVK L ++        F+ E   +    H+N+V+ I  S  S+       + ++ E M
Sbjct: 77  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP------RFILMELM 130
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             G L+++L +     +Q   L ++  L +A D+A   +YL  +     +H D+   N L
Sbjct: 131 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 187
Query: 704 LDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPEYGALGEVSTHGD 756
           L       VA +GDFG++R ++     + S  R  G     + ++ PE    G  ++  D
Sbjct: 188 LTCPGPGRVAKIGDFGMARDIY-----RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 242
Query: 757 EYSFGILMLEMFT 769
            +SFG+L+ E+F+
Sbjct: 243 TWSFGVLLWEIFS 255

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 23/193 (11%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII-TSCSSIDTRGNEFKALVYEFM 643
            VAVK L ++        F+ E   +    H+N+V+ I  S  S+       + ++ E M
Sbjct: 63  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP------RFILLELM 116
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             G L+++L +     +Q   L ++  L +A D+A   +YL  +     +H D+   N L
Sbjct: 117 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 173
Query: 704 LDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPEYGALGEVSTHGD 756
           L       VA +GDFG++R ++     + S  R  G     + ++ PE    G  ++  D
Sbjct: 174 LTCPGPGRVAKIGDFGMARDIY-----RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 228
Query: 757 EYSFGILMLEMFT 769
            +SFG+L+ E+F+
Sbjct: 229 TWSFGVLLWEIFS 241

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 113/254 (44%), Gaps = 26/254 (10%)
Query: 583 EETNVAVKVLDLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           E+ NVAVK         +K  F++E   ++++ H ++VK+I           E   ++ E
Sbjct: 51  EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE------EPTWIIME 104
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
             P G L ++L     E+N+   L ++  +  ++ +   + YL      + VH D+   N
Sbjct: 105 LYPYGELGHYL-----ERNKN-SLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRN 155
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +L+ +     +GDFGLSR + D    + S +R+   I +++PE       +T  D + F 
Sbjct: 156 ILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRFTTASDVWMFA 213
Query: 762 ILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQ 820
           + M E+ + GK+P          L     +G+ ++   +  P +    L        +  
Sbjct: 214 VCMWEILSFGKQPF-------FWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYD 266
Query: 821 PNLRAKFHEIQVSI 834
           P+ R +F E+  S+
Sbjct: 267 PSDRPRFTELVCSL 280

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 14/189 (7%)
Query: 583 EETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           + T   V V  LQ  G    + F  E + L+++    +VK           G +   LV 
Sbjct: 49  DNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---GRQSLRLVM 105
Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           E++P+G L ++L      Q  R +L+  + L  +  +   +EYL        VH DL   
Sbjct: 106 EYLPSGCLRDFL------QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAAR 156
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+++E    + DFGL++LL  +          +  I + APE  +    S   D +SF
Sbjct: 157 NILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 216
Query: 761 GILMLEMFT 769
           G+++ E+FT
Sbjct: 217 GVVLYELFT 225

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 26/201 (12%)
Query: 583 EETNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALV 639
           E   VAVK+L  D  +   S   ++E E ++ I +H+N++ ++ +C    T+      +V
Sbjct: 66  EAVTVAVKMLKDDATEEDLS-DLVSEMEMMKMIGKHKNIINLLGAC----TQDGPLYVIV 120
Query: 640 YEFMPNGSLENWLNQKED-------EQNQRP--KLNLMQRLSIAIDVANVLEYLHHHCHT 690
            E+   G+L  +L  +         + N+ P  ++     +S    +A  +EYL      
Sbjct: 121 -EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALG 749
             +H DL   NVL+    V  + DFGL+R +++ +   +T+  R+   + ++APE     
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL--PVKWMAPE-ALFD 233
Query: 750 EVSTH-GDEYSFGILMLEMFT 769
            V TH  D +SFG+LM E+FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 26/201 (12%)
Query: 583 EETNVAVKVL--DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSS---------IDT 630
           E   VAVK+L  D  ++  S   ++E E ++ I +H+N++ ++ +C+            +
Sbjct: 66  EAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYAS 124
Query: 631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHT 690
           +GN  + L     P       +N+  +EQ     +     +S    +A  +EYL      
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQ-----MTFKDLVSCTYQLARGMEYL---ASQ 176
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD-NSPDQTSTSRVKGSIGYVAPEYGALG 749
             +H DL   NVL+    V  + DFGL+R +++ +   +T+  R+   + ++APE     
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL--PVKWMAPE-ALFD 233
Query: 750 EVSTH-GDEYSFGILMLEMFT 769
            V TH  D +SFG+LM E+FT
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C  + + G+    L Y 
Sbjct: 56  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--LRSEGSPLVVLPY- 112
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            M +G L N++      +N+     +   +   + VA  ++YL        VH DL   N
Sbjct: 113 -MKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARN 162
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R ++D       + +  K  + ++A E     + +T  D +SF
Sbjct: 163 CMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 222
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 223 GVLLWELMTRGAPPYPDV 240

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 14/189 (7%)
Query: 583 EETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           + T   V V  LQ  G    + F  E + L+++    +VK           G +   LV 
Sbjct: 36  DNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---GRQSLRLVM 92
Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           E++P+G L ++L      Q  R +L+  + L  +  +   +EYL        VH DL   
Sbjct: 93  EYLPSGCLRDFL------QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAAR 143
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+++E    + DFGL++LL  +          +  I + APE  +    S   D +SF
Sbjct: 144 NILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 203
Query: 761 GILMLEMFT 769
           G+++ E+FT
Sbjct: 204 GVVLYELFT 212

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 23/193 (11%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII-TSCSSIDTRGNEFKALVYEFM 643
            VAVK L ++        F+ E   +    H+N+V+ I  S  S+       + ++ E M
Sbjct: 89  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP------RFILLELM 142
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             G L+++L +     +Q   L ++  L +A D+A   +YL  +     +H D+   N L
Sbjct: 143 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 199
Query: 704 LDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPEYGALGEVSTHGD 756
           L       VA +GDFG++R ++     + S  R  G     + ++ PE    G  ++  D
Sbjct: 200 LTCPGPGRVAKIGDFGMARDIY-----RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 254
Query: 757 EYSFGILMLEMFT 769
            +SFG+L+ E+F+
Sbjct: 255 TWSFGVLLWEIFS 267

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 13/108 (12%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM--------VAHVGDFGLSRLLHDNS 725
           A+ +A  + YLH      I+H DLK SN+L+  ++        +  + DFGL+R  H   
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--- 167
Query: 726 PDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
             +T+     G+  ++APE       S   D +S+G+L+ E+ TG+ P
Sbjct: 168 --RTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VA++ ++LQQ+   +  I E   +R  ++ N+V  + S       G+E   +V E++  G
Sbjct: 48  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY----LVGDEL-WVVMEYLAGG 102
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL + + +   ++ Q          ++  +    LE+LH +    ++H D+K  N+LL  
Sbjct: 103 SLTDVVTETCMDEGQIA--------AVCRECLQALEFLHSN---QVIHRDIKSDNILLGM 151
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           +    + DFG    +   +P+Q+  S + G+  ++APE           D +S GI+ +E
Sbjct: 152 DGSVKLTDFGFCAQI---TPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
Query: 767 MFTGKRP 773
           M  G+ P
Sbjct: 209 MIEGEPP 215

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 122/263 (46%), Gaps = 36/263 (13%)
Query: 584 ETNVAVKVLDLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           ET VA+K ++       +  F+ E   ++     ++V+++   S       +   ++ E 
Sbjct: 45  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMEL 99
Query: 643 MPNGSLENWLNQKEDEQNQRPKL---NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           M  G L+++L          P L   +L + + +A ++A+ + YL+ +     VH DL  
Sbjct: 100 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 156
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHG 755
            N ++  +    +GDFG++R ++     +T   R  G     + +++PE    G  +T+ 
Sbjct: 157 RNCMVAEDFTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 211
Query: 756 DEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL-------PDQVAEII------D 801
           D +SFG+++ E+ T  ++P   +  E + L    + GL       PD + E++      +
Sbjct: 212 DVWSFGVVLWEIATLAEQPYQGLSNEQV-LRFVMEGGLLDKPDNCPDMLFELMRMCWQYN 270
Query: 802 PAILEEALEIQAGIVKELQPNLR 824
           P +    LEI + I +E++P  R
Sbjct: 271 PKMRPSFLEIISSIKEEMEPGFR 293

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 13/117 (11%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A +V   LEYLH      I++ DLKP N+LLD      + DFG ++ + D       T  
Sbjct: 112 AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYX 162
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM 790
           + G+  Y+APE  +    +   D +SFGIL+ EM  G  P    F +  ++  Y K+
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEKI 215

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 119/265 (44%), Gaps = 42/265 (15%)
Query: 586 NVAVKVLDLQQRGAS----KSFIAECEALRSIRHR-NLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L   + GA+    ++ ++E + L  I H  N+V ++ +C+     G     +V 
Sbjct: 61  TVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIV- 113
Query: 641 EFMPNGSLENWLNQKEDE---QNQRPK------LNLMQRLSIAIDVANVLEYLHHHCHTS 691
           EF   G+L  +L  K +E     + P+      L L   +  +  VA  +E+L       
Sbjct: 114 EFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRK 170
Query: 692 IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV 751
            +H DL   N+LL  + V  + DFGL+R ++ + PD       +  + ++APE       
Sbjct: 171 CIHRDLAARNILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVY 229
Query: 752 STHGDEYSFGILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAIL 805
           +   D +SFG+L+ E+F+ G  P      D+ F     L +  +M  PD       P + 
Sbjct: 230 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTRMRAPDYTT----PEMY 283
Query: 806 EEALEIQAGIVKELQPNLRAKFHEI 830
           +  L+   G     +P+ R  F E+
Sbjct: 284 QTMLDCWHG-----EPSQRPTFSEL 303

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 117/261 (44%), Gaps = 38/261 (14%)
Query: 586 NVAVKVLDLQQRGAS----KSFIAECEALRSIRHR-NLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L   + GA+    ++ ++E + L  I H  N+V ++ +C+     G     +V 
Sbjct: 59  TVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIV- 111
Query: 641 EFMPNGSLENWLNQKEDE-----QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
           EF   G+L  +L  K +E        +  L L   +  +  VA  +E+L        +H 
Sbjct: 112 EFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHR 168
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DL   N+LL  + V  + DFGL+R ++ + PD       +  + ++APE       +   
Sbjct: 169 DLAARNILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVYTIQS 227
Query: 756 DEYSFGILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEAL 809
           D +SFG+L+ E+F+ G  P      D+ F     L +  +M  PD       P + +  L
Sbjct: 228 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCR--RLKEGTRMRAPDYTT----PEMYQTML 281
Query: 810 EIQAGIVKELQPNLRAKFHEI 830
           +   G     +P+ R  F E+
Sbjct: 282 DCWHG-----EPSQRPTFSEL 297

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 122/263 (46%), Gaps = 36/263 (13%)
Query: 584 ETNVAVKVLDLQQRGASK-SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           ET VA+K ++       +  F+ E   ++     ++V+++   S       +   ++ E 
Sbjct: 55  ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMEL 109
Query: 643 MPNGSLENWLNQKEDEQNQRPKL---NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           M  G L+++L          P L   +L + + +A ++A+ + YL+ +     VH DL  
Sbjct: 110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 166
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHG 755
            N ++  +    +GDFG++R ++     +T   R  G     + +++PE    G  +T+ 
Sbjct: 167 RNCMVAEDFTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 221
Query: 756 DEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL-------PDQVAEII------D 801
           D +SFG+++ E+ T  ++P   +  E + L    + GL       PD + E++      +
Sbjct: 222 DVWSFGVVLWEIATLAEQPYQGLSNEQV-LRFVMEGGLLDKPDNCPDMLFELMRMCWQYN 280
Query: 802 PAILEEALEIQAGIVKELQPNLR 824
           P +    LEI + I +E++P  R
Sbjct: 281 PKMRPSFLEIISSIKEEMEPGFR 303

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 33/178 (18%)
Query: 603 FIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ--- 659
            ++E   LR ++H N+V+       I  R N    +V E+   G L + + +   E+   
Sbjct: 52  LVSEVNLLRELKHPNIVRYY---DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 660 NQRPKLNLMQRLSIAIDVANVLEYLHHHCHT------SIVHCDLKPSNVLLDNEMVAHVG 713
           ++   L +M +L++A+            CH       +++H DLKP+NV LD +    +G
Sbjct: 109 DEEFVLRVMTQLTLAL----------KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158
Query: 714 DFGLSRLL-HDNSPDQTSTSRVKGSIG---YVAPEYGALGEVSTHGDEYSFGILMLEM 767
           DFGL+R+L HD       TS  K  +G   Y++PE       +   D +S G L+ E+
Sbjct: 159 DFGLARILNHD-------TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VA++ ++LQQ+   +  I E   +R  ++ N+V  + S       G+E   +V E++  G
Sbjct: 48  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY----LVGDEL-WVVMEYLAGG 102
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL + + +   ++ Q          ++  +    LE+LH +    ++H D+K  N+LL  
Sbjct: 103 SLTDVVTETCMDEGQIA--------AVCRECLQALEFLHSN---QVIHRDIKSDNILLGM 151
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           +    + DFG    +   +P+Q+  S + G+  ++APE           D +S GI+ +E
Sbjct: 152 DGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
Query: 767 MFTGKRP 773
           M  G+ P
Sbjct: 209 MIEGEPP 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VA++ ++LQQ+   +  I E   +R  ++ N+V  + S       G+E   +V E++  G
Sbjct: 48  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY----LVGDEL-WVVMEYLAGG 102
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL + + +   ++ Q          ++  +    LE+LH +    ++H D+K  N+LL  
Sbjct: 103 SLTDVVTETCMDEGQIA--------AVCRECLQALEFLHSN---QVIHRDIKSDNILLGM 151
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           +    + DFG    +   +P+Q+  S + G+  ++APE           D +S GI+ +E
Sbjct: 152 DGSVKLTDFGFCAQI---TPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
Query: 767 MFTGKRP 773
           M  G+ P
Sbjct: 209 MIEGEPP 215

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C  + + G+    L Y 
Sbjct: 76  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--LRSEGSPLVVLPY- 132
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            M +G L N++      +N+     +   +   + VA  ++YL        VH DL   N
Sbjct: 133 -MKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARN 182
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R ++D       + +  K  + ++A E     + +T  D +SF
Sbjct: 183 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 242
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 243 GVLLWELMTRGAPPYPDV 260

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VA++ ++LQQ+   +  I E   +R  ++ N+V  + S       G+E   +V E++  G
Sbjct: 49  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY----LVGDEL-WVVMEYLAGG 103
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL + + +   ++ Q          ++  +    LE+LH +    ++H D+K  N+LL  
Sbjct: 104 SLTDVVTETCMDEGQIA--------AVCRECLQALEFLHSN---QVIHRDIKSDNILLGM 152
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           +    + DFG    +   +P+Q+  S + G+  ++APE           D +S GI+ +E
Sbjct: 153 DGSVKLTDFGFCAQI---TPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 209
Query: 767 MFTGKRP 773
           M  G+ P
Sbjct: 210 MIEGEPP 216

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 26/203 (12%)
Query: 583 EETNVAVKVLDLQQRG-ASKSFIAECEALRSIRHRNLVKIITSCSSIDT----RGNEFKA 637
           ++ N A+K + L  R  A +  + E +AL  + H  +V+   +    +T    + +  K 
Sbjct: 29  DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88
Query: 638 LVY---EFMPNGSLENWLNQK-EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIV 693
            +Y   +     +L++W+N +   E+ +R        L I + +A  +E+LH      ++
Sbjct: 89  YLYIQMQLCRKENLKDWMNGRCTIEERERSVC-----LHIFLQIAEAVEFLHS---KGLM 140
Query: 694 HCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQT------STSRVKGSIG---YVAPE 744
           H DLKPSN+    + V  VGDFGL   +  +  +QT      + +R  G +G   Y++PE
Sbjct: 141 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE 200
Query: 745 YGALGEVSTHGDEYSFGILMLEM 767
                  S   D +S G+++ E+
Sbjct: 201 QIHGNSYSHKVDIFSLGLILFEL 223

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 25/174 (14%)
Query: 603 FIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ--- 659
            ++E   LR ++H N+V+       I  R N    +V E+   G L + + +   E+   
Sbjct: 52  LVSEVNLLRELKHPNIVRYY---DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 660 NQRPKLNLMQRLSIAIDVANVLEYLHHHCHT------SIVHCDLKPSNVLLDNEMVAHVG 713
           ++   L +M +L++A+            CH       +++H DLKP+NV LD +    +G
Sbjct: 109 DEEFVLRVMTQLTLAL----------KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158
Query: 714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEM 767
           DFGL+R+L+    D+       G+  Y++PE       +   D +S G L+ E+
Sbjct: 159 DFGLARILNH---DEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C  + + G+    L Y 
Sbjct: 49  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--LRSEGSPLVVLPY- 105
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            M +G L N++      +N+     +   +   + VA  ++YL        VH DL   N
Sbjct: 106 -MKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARN 155
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R ++D       + +  K  + ++A E     + +T  D +SF
Sbjct: 156 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 215
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 216 GVLLWELMTRGAPPYPDV 233

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C  + + G+    L Y 
Sbjct: 55  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--LRSEGSPLVVLPY- 111
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            M +G L N++      +N+     +   +   + VA  ++YL        VH DL   N
Sbjct: 112 -MKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARN 161
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R ++D       + +  K  + ++A E     + +T  D +SF
Sbjct: 162 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 221
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 222 GVLLWELMTRGAPPYPDV 239

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C     R      +V  
Sbjct: 75  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC----LRSEGSPLVVLP 130
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
           +M +G L N++      +N+     +   +   + VA  ++YL        VH DL   N
Sbjct: 131 YMKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARN 181
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R ++D       + +  K  + ++A E     + +T  D +SF
Sbjct: 182 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 241
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 242 GVLLWELMTRGAPPYPDV 259

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 49/198 (24%), Positives = 95/198 (47%), Gaps = 29/198 (14%)
Query: 583 EETNVAVKV------LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK 636
           E+ NVAVK       LD +++     F++E   ++++ H ++VK+I           E  
Sbjct: 35  EKINVAVKTCKKDCTLDNKEK-----FMSEAVIMKNLDHPHIVKLIGIIEE------EPT 83
Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
            ++ E  P G L ++L + ++       L ++  +  ++ +   + YL      + VH D
Sbjct: 84  WIIMELYPYGELGHYLERNKNS------LKVLTLVLYSLQICKAMAYLES---INCVHRD 134
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           +   N+L+ +     +GDFGLSR + D    + S +R+   I +++PE       +T  D
Sbjct: 135 IAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRFTTASD 192
Query: 757 EYSFGILMLEMFT-GKRP 773
            + F + M E+ + GK+P
Sbjct: 193 VWMFAVCMWEILSFGKQP 210

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 49/198 (24%), Positives = 95/198 (47%), Gaps = 29/198 (14%)
Query: 583 EETNVAVKV------LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK 636
           E+ NVAVK       LD +++     F++E   ++++ H ++VK+I           E  
Sbjct: 39  EKINVAVKTCKKDCTLDNKEK-----FMSEAVIMKNLDHPHIVKLIGIIEE------EPT 87
Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
            ++ E  P G L ++L + ++       L ++  +  ++ +   + YL      + VH D
Sbjct: 88  WIIMELYPYGELGHYLERNKNS------LKVLTLVLYSLQICKAMAYLES---INCVHRD 138
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           +   N+L+ +     +GDFGLSR + D    + S +R+   I +++PE       +T  D
Sbjct: 139 IAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRFTTASD 196
Query: 757 EYSFGILMLEMFT-GKRP 773
            + F + M E+ + GK+P
Sbjct: 197 VWMFAVCMWEILSFGKQP 214

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C  + + G+    L Y 
Sbjct: 57  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--LRSEGSPLVVLPY- 113
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            M +G L N++      +N+     +   +   + VA  ++YL        VH DL   N
Sbjct: 114 -MKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARN 163
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R ++D       + +  K  + ++A E     + +T  D +SF
Sbjct: 164 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 223
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 224 GVLLWELMTRGAPPYPDV 241

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C  + + G+    L Y 
Sbjct: 54  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--LRSEGSPLVVLPY- 110
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            M +G L N++      +N+     +   +   + VA  ++YL        VH DL   N
Sbjct: 111 -MKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARN 160
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R ++D       + +  K  + ++A E     + +T  D +SF
Sbjct: 161 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 220
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 221 GVLLWELMTRGAPPYPDV 238

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C  + + G+    L Y 
Sbjct: 56  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--LRSEGSPLVVLPY- 112
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            M +G L N++      +N+     +   +   + VA  ++YL        VH DL   N
Sbjct: 113 -MKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARN 162
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R ++D       + +  K  + ++A E     + +T  D +SF
Sbjct: 163 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 222
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 223 GVLLWELMTRGAPPYPDV 240

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C  + + G+    L Y 
Sbjct: 52  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--LRSEGSPLVVLPY- 108
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            M +G L N++      +N+     +   +   + VA  ++YL        VH DL   N
Sbjct: 109 -MKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARN 158
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R ++D       + +  K  + ++A E     + +T  D +SF
Sbjct: 159 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 218
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 219 GVLLWELMTRGAPPYPDV 236

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C  + + G+    L Y 
Sbjct: 57  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--LRSEGSPLVVLPY- 113
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            M +G L N++      +N+     +   +   + VA  ++YL        VH DL   N
Sbjct: 114 -MKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARN 163
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R ++D       + +  K  + ++A E     + +T  D +SF
Sbjct: 164 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 223
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 224 GVLLWELMTRGAPPYPDV 241

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 582 TEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           T +  VA+K+L +     A+  F+ E   + S+ H +LV+++  C S   +      LV 
Sbjct: 65  TVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ------LVT 118
Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           + MP+G L  ++++ +D    +  LN        + +A  + YL       +VH DL   
Sbjct: 119 QLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEER---RLVHRDLAAR 169
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           NVL+ +     + DFGL+RLL  +  +  +    K  I ++A E     + +   D +S+
Sbjct: 170 NVLVKSPNHVKITDFGLARLLEGDEKEYNADGG-KMPIKWMALECIHYRKFTHQSDVWSY 228
Query: 761 GILMLEMFT-GKRPTD--------DMFEEGLSL 784
           G+ + E+ T G +P D        D+ E+G  L
Sbjct: 229 GVTIWELMTFGGKPYDGIPTREIPDLLEKGERL 261

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 90/193 (46%), Gaps = 23/193 (11%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII-TSCSSIDTRGNEFKALVYEFM 643
            VAVK L ++        F+ E   +    H+N+V+ I  S  S+       + ++ E M
Sbjct: 103 QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP------RFILLELM 156
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             G L+++L +     +Q   L ++  L +A D+A   +YL  +     +H D+   N L
Sbjct: 157 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 213
Query: 704 LDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPEYGALGEVSTHGD 756
           L       VA +GDFG++R ++     +    R  G     + ++ PE    G  ++  D
Sbjct: 214 LTCPGPGRVAKIGDFGMARDIY-----RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 268
Query: 757 EYSFGILMLEMFT 769
            +SFG+L+ E+F+
Sbjct: 269 TWSFGVLLWEIFS 281

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 90/193 (46%), Gaps = 23/193 (11%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII-TSCSSIDTRGNEFKALVYEFM 643
            VAVK L ++        F+ E   +    H+N+V+ I  S  S+       + ++ E M
Sbjct: 80  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP------RFILLELM 133
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             G L+++L +     +Q   L ++  L +A D+A   +YL  +     +H D+   N L
Sbjct: 134 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 190
Query: 704 LDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPEYGALGEVSTHGD 756
           L       VA +GDFG++R ++     +    R  G     + ++ PE    G  ++  D
Sbjct: 191 LTCPGPGRVAKIGDFGMARDIY-----RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 245
Query: 757 EYSFGILMLEMFT 769
            +SFG+L+ E+F+
Sbjct: 246 TWSFGVLLWEIFS 258

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 87/183 (47%), Gaps = 23/183 (12%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+V +I    S          LV+EFM    L+  
Sbjct: 55  LDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-----ERCLTLVFEFM-EKDLKKV 108
Query: 652 LNQ-KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHT-SIVHCDLKPSNVLLDNEMV 709
           L++ K   Q+ + K+ L Q L     VA        HCH   I+H DLKP N+L++++  
Sbjct: 109 LDENKTGLQDSQIKIYLYQLLR---GVA--------HCHQHRILHRDLKPQNLLINSDGA 157
Query: 710 AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY-GALGEVSTHGDEYSFGILMLEMF 768
             + DFGL+R      P ++ T  V  ++ Y AP+      + ST  D +S G +  EM 
Sbjct: 158 LKLADFGLARAF--GIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214
Query: 769 TGK 771
           TGK
Sbjct: 215 TGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 87/183 (47%), Gaps = 23/183 (12%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+V +I    S          LV+EFM    L+  
Sbjct: 55  LDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-----ERCLTLVFEFM-EKDLKKV 108
Query: 652 LNQ-KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHT-SIVHCDLKPSNVLLDNEMV 709
           L++ K   Q+ + K+ L Q L     VA        HCH   I+H DLKP N+L++++  
Sbjct: 109 LDENKTGLQDSQIKIYLYQLLR---GVA--------HCHQHRILHRDLKPQNLLINSDGA 157
Query: 710 AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY-GALGEVSTHGDEYSFGILMLEMF 768
             + DFGL+R      P ++ T  V  ++ Y AP+      + ST  D +S G +  EM 
Sbjct: 158 LKLADFGLARAF--GIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214
Query: 769 TGK 771
           TGK
Sbjct: 215 TGK 217

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 46/175 (26%), Positives = 83/175 (47%), Gaps = 25/175 (14%)
Query: 606 ECEALRSIRHRNLVKIITSC----------SSIDTRGNEFKALV--YEFMPNGSLENWLN 653
           E +AL  + H N+V     C          SS ++  ++ K L    EF   G+LE W+ 
Sbjct: 54  EVKALAKLDHVNIVHY-NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112
Query: 654 QKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG 713
           ++  E     KL+ +  L +   +   ++Y+H      +++ DLKPSN+ L +     +G
Sbjct: 113 KRRGE-----KLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIG 164
Query: 714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMF 768
           DFGL   L ++        R KG++ Y++PE  +  +     D Y+ G+++ E+ 
Sbjct: 165 DFGLVTSLKNDG----KRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 583 EETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++ + AVK L+ +   G    F+ E   ++   H N++ ++  C  + + G+    L Y 
Sbjct: 58  KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--LRSEGSPLVVLPY- 114
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            M +G L N++      +N+     +   +   + VA  +++L        VH DL   N
Sbjct: 115 -MKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARN 164
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
            +LD +    V DFGL+R + D   D   + +  K  + ++A E     + +T  D +SF
Sbjct: 165 CMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 224
Query: 761 GILMLEMFT-GKRPTDDM 777
           G+L+ E+ T G  P  D+
Sbjct: 225 GVLLWELMTRGAPPYPDV 242

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 118/265 (44%), Gaps = 42/265 (15%)
Query: 586 NVAVKVLDLQQRGAS----KSFIAECEALRSIRHR-NLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L   + GA+    ++ ++E + L  I H  N+V ++ +C+     G     +V 
Sbjct: 96  TVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIV- 148
Query: 641 EFMPNGSLENWLNQKEDE---QNQRPK------LNLMQRLSIAIDVANVLEYLHHHCHTS 691
           EF   G+L  +L  K +E       P+      L L   +  +  VA  +E+L       
Sbjct: 149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRK 205
Query: 692 IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV 751
            +H DL   N+LL  + V  + DFGL+R ++ + PD       +  + ++APE       
Sbjct: 206 CIHRDLAARNILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVY 264
Query: 752 STHGDEYSFGILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAIL 805
           +   D +SFG+L+ E+F+ G  P      D+ F     L +  +M  PD       P + 
Sbjct: 265 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR--RLKEGTRMRAPDYTT----PEMY 318
Query: 806 EEALEIQAGIVKELQPNLRAKFHEI 830
           +  L+   G     +P+ R  F E+
Sbjct: 319 QTMLDCWHG-----EPSQRPTFSEL 338

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 23/193 (11%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII-TSCSSIDTRGNEFKALVYEFM 643
            VAVK L ++        F+ E   +    H+N+V+ I  S  S+       + ++ E M
Sbjct: 63  QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP------RFILLELM 116
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             G L+++L +     +Q   L ++  L +A D+A   +YL  +     +H D+   N L
Sbjct: 117 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 173
Query: 704 LDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPEYGALGEVSTHGD 756
           L       VA +GDFG+++ ++     + S  R  G     + ++ PE    G  ++  D
Sbjct: 174 LTCPGPGRVAKIGDFGMAQDIY-----RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 228
Query: 757 EYSFGILMLEMFT 769
            +SFG+L+ E+F+
Sbjct: 229 TWSFGVLLWEIFS 241

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 118/265 (44%), Gaps = 42/265 (15%)
Query: 586 NVAVKVLDLQQRGAS----KSFIAECEALRSIRHR-NLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L   + GA+    ++ ++E + L  I H  N+V ++ +C+     G     +V 
Sbjct: 59  TVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIV- 111
Query: 641 EFMPNGSLENWLNQKEDE---QNQRPK------LNLMQRLSIAIDVANVLEYLHHHCHTS 691
           EF   G+L  +L  K +E       P+      L L   +  +  VA  +E+L       
Sbjct: 112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRK 168
Query: 692 IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV 751
            +H DL   N+LL  + V  + DFGL+R ++ + PD       +  + ++APE       
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKD-PDXVRKGDARLPLKWMAPETIFDRVY 227
Query: 752 STHGDEYSFGILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAIL 805
           +   D +SFG+L+ E+F+ G  P      D+ F     L +  +M  PD       P + 
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTRMRAPDYTT----PEMY 281
Query: 806 EEALEIQAGIVKELQPNLRAKFHEI 830
           +  L+   G     +P+ R  F E+
Sbjct: 282 QTMLDCWHG-----EPSQRPTFSEL 301

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 118/265 (44%), Gaps = 42/265 (15%)
Query: 586 NVAVKVLDLQQRGAS----KSFIAECEALRSIRHR-NLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L   + GA+    ++ ++E + L  I H  N+V ++ +C+     G     +V 
Sbjct: 59  TVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIV- 111
Query: 641 EFMPNGSLENWLNQKEDE---QNQRPK------LNLMQRLSIAIDVANVLEYLHHHCHTS 691
           EF   G+L  +L  K +E       P+      L L   +  +  VA  +E+L       
Sbjct: 112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRK 168
Query: 692 IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV 751
            +H DL   N+LL  + V  + DFGL+R ++ + PD       +  + ++APE       
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVY 227
Query: 752 STHGDEYSFGILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAIL 805
           +   D +SFG+L+ E+F+ G  P      D+ F     L +  +M  PD       P + 
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTRMRAPDYTT----PEMY 281
Query: 806 EEALEIQAGIVKELQPNLRAKFHEI 830
           +  L+   G     +P+ R  F E+
Sbjct: 282 QTMLDCWHG-----EPSQRPTFSEL 301

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 32/216 (14%)
Query: 583 EETNVAVKVLDLQQRGASKSFIAECE---ALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E   + V +  ++ +   +SF A  +   A+ S+ H ++V+++  C      G+  + LV
Sbjct: 39  ESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----GSSLQ-LV 92
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            +++P GSL + + Q       R  L     L+  + +A  + YL  H    +VH +L  
Sbjct: 93  TQYLPLGSLLDHVRQ------HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAA 143
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPD--QTSTSRVKGSIGYVAPEYGALGEVSTHGDE 757
            NVLL +     V DFG++ LL    PD  Q   S  K  I ++A E    G+ +   D 
Sbjct: 144 RNVLLKSPSQVQVADFGVADLL---PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDV 200
Query: 758 YSFGILMLEMFT-GKRP--------TDDMFEEGLSL 784
           +S+G+ + E+ T G  P          D+ E+G  L
Sbjct: 201 WSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL 236

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 582 TEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           T +  VA+K+L +     A+  F+ E   + S+ H +LV+++  C S   +      LV 
Sbjct: 42  TVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ------LVT 95
Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           + MP+G L  ++++ +D    +  LN        + +A  + YL       +VH DL   
Sbjct: 96  QLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEER---RLVHRDLAAR 146
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           NVL+ +     + DFGL+RLL  +  +  +    K  I ++A E     + +   D +S+
Sbjct: 147 NVLVKSPNHVKITDFGLARLLEGDEKEYNADGG-KMPIKWMALECIHYRKFTHQSDVWSY 205
Query: 761 GILMLEMFT-GKRPTD--------DMFEEGLSL 784
           G+ + E+ T G +P D        D+ E+G  L
Sbjct: 206 GVTIWELMTFGGKPYDGIPTREIPDLLEKGERL 238

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 118/263 (44%), Gaps = 40/263 (15%)
Query: 586 NVAVKVLDLQQRGAS----KSFIAECEALRSIRHR-NLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L   + GA+    ++ ++E + L  I H  N+V ++ +C+     G     +V 
Sbjct: 61  TVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIV- 113
Query: 641 EFMPNGSLENWLNQKEDE-QNQRPK------LNLMQRLSIAIDVANVLEYLHHHCHTSIV 693
           EF   G+L  +L  K +E    +P+      L L   +  +  VA  +E+L        +
Sbjct: 114 EFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXI 170
Query: 694 HCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVST 753
           H DL   N+LL  + V  + DFGL+R +  + PD       +  + ++APE       + 
Sbjct: 171 HRDLAARNILLSEKNVVKICDFGLARDIXKD-PDXVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 754 HGDEYSFGILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEE 807
             D +SFG+L+ E+F+ G  P      D+ F     L +  +M  PD       P + + 
Sbjct: 230 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTRMRAPDYTT----PEMYQT 283
Query: 808 ALEIQAGIVKELQPNLRAKFHEI 830
            L+   G     +P+ R  F E+
Sbjct: 284 MLDCWHG-----EPSQRPTFSEL 301

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 118/264 (44%), Gaps = 41/264 (15%)
Query: 586 NVAVKVLDLQQRGAS----KSFIAECEALRSIRHR-NLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L   + GA+    ++ ++E + L  I H  N+V ++ +C+     G     +V 
Sbjct: 60  TVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIV- 112
Query: 641 EFMPNGSLENWLNQKEDE--QNQRPK------LNLMQRLSIAIDVANVLEYLHHHCHTSI 692
           EF   G+L  +L  K +E    + P+      L L   +  +  VA  +E+L        
Sbjct: 113 EFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKC 169
Query: 693 VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVS 752
           +H DL   N+LL  + V  + DFGL+R +  + PD       +  + ++APE       +
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIXKD-PDXVRKGDARLPLKWMAPETIFDRVYT 228
Query: 753 THGDEYSFGILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILE 806
              D +SFG+L+ E+F+ G  P      D+ F     L +  +M  PD       P + +
Sbjct: 229 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTRMRAPDYTT----PEMYQ 282
Query: 807 EALEIQAGIVKELQPNLRAKFHEI 830
             L+   G     +P+ R  F E+
Sbjct: 283 TMLDCWHG-----EPSQRPTFSEL 301

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 42/265 (15%)
Query: 586 NVAVKVLDLQQRGAS----KSFIAECEALRSIRHR-NLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L   + GA+    ++ ++E + L  I H  N+V ++ +C    T+      ++ 
Sbjct: 50  TVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC----TKPGGPLMVIT 102
Query: 641 EFMPNGSLENWLNQKEDE---QNQRPK------LNLMQRLSIAIDVANVLEYLHHHCHTS 691
           EF   G+L  +L  K +E       P+      L L   +  +  VA  +E+L       
Sbjct: 103 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRK 159
Query: 692 IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV 751
            +H DL   N+LL  + V  + DFGL+R ++ + PD       +  + ++APE       
Sbjct: 160 CIHRDLAARNILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVY 218
Query: 752 STHGDEYSFGILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAIL 805
           +   D +SFG+L+ E+F+ G  P      D+ F     L +  +M  PD       P + 
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTRMRAPDYTT----PEMY 272
Query: 806 EEALEIQAGIVKELQPNLRAKFHEI 830
           +  L+   G     +P+ R  F E+
Sbjct: 273 QTMLDCWHG-----EPSQRPTFSEL 292

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 32/216 (14%)
Query: 583 EETNVAVKVLDLQQRGASKSFIAECE---ALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E   + V +  ++ +   +SF A  +   A+ S+ H ++V+++  C      G+  + LV
Sbjct: 57  ESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----GSSLQ-LV 110
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            +++P GSL + + Q       R  L     L+  + +A  + YL  H    +VH +L  
Sbjct: 111 TQYLPLGSLLDHVRQ------HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAA 161
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPD--QTSTSRVKGSIGYVAPEYGALGEVSTHGDE 757
            NVLL +     V DFG++ LL    PD  Q   S  K  I ++A E    G+ +   D 
Sbjct: 162 RNVLLKSPSQVQVADFGVADLL---PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDV 218
Query: 758 YSFGILMLEMFT-GKRP--------TDDMFEEGLSL 784
           +S+G+ + E+ T G  P          D+ E+G  L
Sbjct: 219 WSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL 254

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 116/264 (43%), Gaps = 36/264 (13%)
Query: 587 VAVKVLDLQQRGASK-SFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK+L        K + ++E + +  + +H N+V ++ +C    T G     ++ E+  
Sbjct: 64  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC----THGGPV-LVITEYCC 118
Query: 645 NGSLENWLNQKE-----------------DEQNQRPKLNLMQRLSIAIDVANVLEYLHHH 687
            G L N+L +K                  D+++ RP L L   L  +  VA  + +L   
Sbjct: 119 YGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP-LELRDLLHFSSQVAQGMAFL--- 174
Query: 688 CHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA 747
              + +H D+   NVLL N  VA +GDFGL+R + ++S +       +  + ++APE   
Sbjct: 175 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNARLPVKWMAPESIF 233
Query: 748 LGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILE 806
               +   D +S+GIL+ E+F+ G  P   +       +K  K G      ++  PA   
Sbjct: 234 DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KFYKLVKDGY-----QMAQPAFAP 287
Query: 807 EALEIQAGIVKELQPNLRAKFHEI 830
           + +         L+P  R  F +I
Sbjct: 288 KNIYSIMQACWALEPTHRPTFQQI 311

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 42/265 (15%)
Query: 586 NVAVKVLDLQQRGAS----KSFIAECEALRSIRHR-NLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L   + GA+    ++ ++E + L  I H  N+V ++ +C    T+      ++ 
Sbjct: 50  TVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC----TKPGGPLMVIT 102
Query: 641 EFMPNGSLENWLNQKEDE---QNQRPK------LNLMQRLSIAIDVANVLEYLHHHCHTS 691
           EF   G+L  +L  K +E       P+      L L   +  +  VA  +E+L       
Sbjct: 103 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRK 159
Query: 692 IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV 751
            +H DL   N+LL  + V  + DFGL+R ++ + PD       +  + ++APE       
Sbjct: 160 CIHRDLAARNILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVY 218
Query: 752 STHGDEYSFGILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAIL 805
           +   D +SFG+L+ E+F+ G  P      D+ F     L +  +M  PD       P + 
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTRMRAPDYTT----PEMY 272
Query: 806 EEALEIQAGIVKELQPNLRAKFHEI 830
           +  L+   G     +P+ R  F E+
Sbjct: 273 QTMLDCWHG-----EPSQRPTFSEL 292

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 87/193 (45%), Gaps = 9/193 (4%)
Query: 585 TNVAVKVL--DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN-EFKALVYE 641
             VAVK+L  D+      + F+ E   ++   H ++ K++        +G      ++  
Sbjct: 52  VKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILP 111
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
           FM +G L  +L      +N    L L   +   +D+A  +EYL      + +H DL   N
Sbjct: 112 FMKHGDLHAFLLASRIGENPF-NLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARN 167
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
            +L  +M   V DFGLSR ++     +   +  K  + ++A E  A    + H D ++FG
Sbjct: 168 CMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS-KLPVKWLALESLADNLYTVHSDVWAFG 226
Query: 762 ILMLEMFT-GKRP 773
           + M E+ T G+ P
Sbjct: 227 VTMWEIMTRGQTP 239

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 27/202 (13%)
Query: 586 NVAVKVLDLQQRGASK-SFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
            VAVK+L  +   + + + ++E + +  +  H N+V ++ +C+     G  +  L++E+ 
Sbjct: 77  QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT---LSGPIY--LIFEYC 131
Query: 644 PNGSLENWLNQK-----EDE---QNQR-----PKLNLM---QRLSIAIDVANVLEYLHHH 687
             G L N+L  K     EDE   +NQ+       LN++     L  A  VA  +E+L   
Sbjct: 132 CYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 191
Query: 688 CHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA 747
              S VH DL   NVL+ +  V  + DFGL+R +  +S +       +  + ++APE   
Sbjct: 192 ---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLF 247
Query: 748 LGEVSTHGDEYSFGILMLEMFT 769
            G  +   D +S+GIL+ E+F+
Sbjct: 248 EGIYTIKSDVWSYGILLWEIFS 269

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VA++ ++LQQ+   +  I E   +R  ++ N+V  + S       G+E   +V E++  G
Sbjct: 49  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY----LVGDEL-WVVMEYLAGG 103
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           SL + + +   ++ Q          ++  +    LE+LH +    ++H ++K  N+LL  
Sbjct: 104 SLTDVVTETCMDEGQIA--------AVCRECLQALEFLHSN---QVIHRNIKSDNILLGM 152
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           +    + DFG    +   +P+Q+  S + G+  ++APE           D +S GI+ +E
Sbjct: 153 DGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 209
Query: 767 MFTGKRP 773
           M  G+ P
Sbjct: 210 MIEGEPP 216

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 37  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 91
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 92  PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 138
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + DFG S   H  S  +T+ S   G++ Y+ PE   + E   H ++   
Sbjct: 139 NLLLGSAGELKIADFGWS--CHAPSSRRTTLS---GTLDYLPPE---MIEGRMHDEKVDL 190
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 232

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 41  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 95
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G +   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 96  PRGEVYKELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 142
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + DFG S  +H  S  +T+     G++ Y+ PE   + E   H ++   
Sbjct: 143 NLLLGSAGELKIADFGWS--VHAPSSRRTTLC---GTLDYLPPE---MIEGRMHDEKVDL 194
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 236

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 106/241 (43%), Gaps = 42/241 (17%)
Query: 585 TNVAVKVLDLQQRGAS-KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           T VAVK+L      +  +  ++E   L+ + H +++K+  +CS      +    L+ E+ 
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-----DGPLLLIVEYA 108
Query: 644 PNGSLENWLNQKE------------------DEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
             GSL  +L +                    D  ++R  L +   +S A  ++  ++YL 
Sbjct: 109 KYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER-ALTMGDLISFAWQISQGMQYL- 166
Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY 745
                S+VH DL   N+L+       + DFGLSR +++        S VK S G +  ++
Sbjct: 167 --AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED------SXVKRSQGRIPVKW 218
Query: 746 GALGEV-----STHGDEYSFGILMLEMFT-GKRPTDDMFEEGLS--LHKYAKMGLPDQVA 797
            A+  +     +T  D +SFG+L+ E+ T G  P   +  E L   L    +M  PD  +
Sbjct: 219 MAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCS 278
Query: 798 E 798
           E
Sbjct: 279 E 279

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 33  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TR----VYLILEYA 87
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ            +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 88  PLGTVYRELQKLSKFDEQRT---------ATYITELANALSY----CHSKRVIHRDIKPE 134
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DE 757
           N+LL +     + DFG S  +H  S  +T+     G++ Y+ PE   + E   H    D 
Sbjct: 135 NLLLGSAGELKIADFGWS--VHAPSSRRTTLC---GTLDYLPPE---MIEGRMHDEKVDL 186
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 187 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 228

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 40  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TR----VYLILEYA 94
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ            +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 95  PLGTVYRELQKLSKFDEQRT---------ATYITELANALSY----CHSKRVIHRDIKPE 141
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DE 757
           N+LL +     + DFG S  +H  S  +T+     G++ Y+ PE   + E   H    D 
Sbjct: 142 NLLLGSAGELKIADFGWS--VHAPSSRRTTLC---GTLDYLPPE---MIEGRMHDEKVDL 193
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 194 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 235

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 42/265 (15%)
Query: 586 NVAVKVLDLQQRGAS----KSFIAECEALRSIRHR-NLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L   + GA+    ++ ++E + L  I H  N+V ++ +C+     G     +V 
Sbjct: 59  TVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIV- 111
Query: 641 EFMPNGSLENWLNQKEDE---QNQRPK------LNLMQRLSIAIDVANVLEYLHHHCHTS 691
           EF   G+L  +L  K +E       P+      L L   +  +  VA  +E+L       
Sbjct: 112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRK 168
Query: 692 IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV 751
            +H DL   N+LL  + V  + DFGL+R +  + PD       +  + ++APE       
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGLARDIXKD-PDXVRKGDARLPLKWMAPETIFDRVY 227
Query: 752 STHGDEYSFGILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAIL 805
           +   D +SFG+L+ E+F+ G  P      D+ F     L +  +M  PD       P + 
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTRMRAPDYTT----PEMY 281
Query: 806 EEALEIQAGIVKELQPNLRAKFHEI 830
           +  L+   G     +P+ R  F E+
Sbjct: 282 QTMLDCWHG-----EPSQRPTFSEL 301

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 35  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TR----VYLILEYA 89
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ            +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 90  PLGTVYRELQKLSKFDEQRT---------ATYITELANALSY----CHSKRVIHRDIKPE 136
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DE 757
           N+LL +     + DFG S  +H  S  +T+     G++ Y+ PE   + E   H    D 
Sbjct: 137 NLLLGSAGELKIADFGWS--VHAPSSRRTTLC---GTLDYLPPE---MIEGRMHDEKVDL 188
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 189 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 230

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 93
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ            +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 94  PLGTVYRELQKLSKFDEQRT---------ATYITELANALSY----CHSKRVIHRDIKPE 140
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DE 757
           N+LL +     + DFG S  +H  S  +T+     G++ Y+ PE   + E   H    D 
Sbjct: 141 NLLLGSAGELKIADFGWS--VHAPSSRRTTLC---GTLDYLPPE---MIEGRMHDEKVDL 192
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 42/265 (15%)
Query: 586 NVAVKVLDLQQRGAS----KSFIAECEALRSIRHR-NLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L   + GA+    ++ ++E + L  I H  N+V ++ +C+     G     +V 
Sbjct: 50  TVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---GGPLMVIV- 102
Query: 641 EFMPNGSLENWLNQKEDE---QNQRPK------LNLMQRLSIAIDVANVLEYLHHHCHTS 691
           EF   G+L  +L  K +E       P+      L L   +  +  VA  +E+L       
Sbjct: 103 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRK 159
Query: 692 IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV 751
            +H DL   N+LL  + V  + DFGL+R +  + PD       +  + ++APE       
Sbjct: 160 CIHRDLAARNILLSEKNVVKICDFGLARDIXKD-PDXVRKGDARLPLKWMAPETIFDRVY 218
Query: 752 STHGDEYSFGILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAIL 805
           +   D +SFG+L+ E+F+ G  P      D+ F     L +  +M  PD       P + 
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTRMRAPDYTT----PEMY 272
Query: 806 EEALEIQAGIVKELQPNLRAKFHEI 830
           +  L+   G     +P+ R  F E+
Sbjct: 273 QTMLDCWHG-----EPSQRPTFSEL 292

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 42/265 (15%)
Query: 586 NVAVKVLDLQQRGAS----KSFIAECEALRSIRHR-NLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L   + GA+    ++ ++E + L  I H  N+V ++ +C    T+      ++ 
Sbjct: 50  TVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC----TKPGGPLMVIT 102
Query: 641 EFMPNGSLENWLNQKEDE---QNQRPK------LNLMQRLSIAIDVANVLEYLHHHCHTS 691
           EF   G+L  +L  K +E       P+      L L   +  +  VA  +E+L       
Sbjct: 103 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRK 159
Query: 692 IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV 751
            +H DL   N+LL  + V  + DFGL+R +  + PD       +  + ++APE       
Sbjct: 160 CIHRDLAARNILLSEKNVVKICDFGLARDIXKD-PDXVRKGDARLPLKWMAPETIFDRVY 218
Query: 752 STHGDEYSFGILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAIL 805
           +   D +SFG+L+ E+F+ G  P      D+ F     L +  +M  PD       P + 
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTRMRAPDYTT----PEMY 272
Query: 806 EEALEIQAGIVKELQPNLRAKFHEI 830
           +  L+   G     +P+ R  F E+
Sbjct: 273 QTMLDCWHG-----EPSQRPTFSEL 292

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 45  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 98
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 99  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 150
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE--VSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T T  V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 151 LADFGLARAF--GVPVRTYTHEVV-TLWYRAPEI-LLGXKYYSTAVDIWSLGCIFAEMVT 206
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 207 RRALFPGDSEIDQLFRI--FRTLGTPDEV 233

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 115/256 (44%), Gaps = 27/256 (10%)
Query: 587 VAVKVLDLQQRGASK-SFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK+L        K + ++E + +  + +H N+V ++ +C    T G     ++ E+  
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC----THGGPV-LVITEYCC 133
Query: 645 NGSLENWLNQKED---EQNQRPKLNLMQRLS------IAIDVANVLEYLHHHCHTSIVHC 695
            G L N+L +K     E +  P  N  ++LS       +  VA  + +L      + +H 
Sbjct: 134 YGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHR 190
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           D+   NVLL N  VA +GDFGL+R + ++S +       +  + ++APE       +   
Sbjct: 191 DVAARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNARLPVKWMAPESIFDCVYTVQS 249
Query: 756 DEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAG 814
           D +S+GIL+ E+F+ G  P   +       +K  K G      ++  PA   + +     
Sbjct: 250 DVWSYGILLWEIFSLGLNPYPGILVNS-KFYKLVKDGY-----QMAQPAFAPKNIYSIMQ 303
Query: 815 IVKELQPNLRAKFHEI 830
               L+P  R  F +I
Sbjct: 304 ACWALEPTHRPTFQQI 319

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 45  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 98
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 99  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 150
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T T  V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 151 LADFGLARAF--GVPVRTYTHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 206
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 207 RRALFPGDSEIDQLFRI--FRTLGTPDEV 233

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 38  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 91
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 92  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 143
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE--VSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T T  V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 144 LADFGLARAF--GVPVRTYTHEVV-TLWYRAPEI-LLGXKYYSTAVDIWSLGCIFAEMVT 199
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 200 RRALFPGDSEIDQLFRI--FRTLGTPDEV 226

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 39  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 92
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 93  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 144
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T T  V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 145 LADFGLARAF--GVPVRTYTHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 200
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 201 RRALFPGDSEIDQLFRI--FRTLGTPDEV 227

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 81/185 (43%), Gaps = 14/185 (7%)
Query: 589 VKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSL 648
           V++ DL    A    I E + L+ + H N++K   S        NE   +V E    G L
Sbjct: 65  VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF----IEDNELN-IVLELADAGDL 119
Query: 649 ENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM 708
              +   + ++   P+  + +     + + + LE++H      ++H D+KP+NV +    
Sbjct: 120 SRMIKHFKKQKRLIPERTVWKYF---VQLCSALEHMHSR---RVMHRDIKPANVFITATG 173
Query: 709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMF 768
           V  +GD GL R     S   T+   + G+  Y++PE       +   D +S G L+ EM 
Sbjct: 174 VVKLGDLGLGRFF---SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 230
Query: 769 TGKRP 773
             + P
Sbjct: 231 ALQSP 235

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 13/168 (7%)
Query: 604 IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP 663
           +A    L +  H N+V+++  C++  T       LV+E + +  L  +L++        P
Sbjct: 62  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPP-----P 115
Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
            L       +       L++LH +C   IVH DLKP N+L+ +     + DFGL+R+   
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS- 171
Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGK 771
               Q + + V  ++ Y APE       +T  D +S G +  EMF  K
Sbjct: 172 ---YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 38  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 91
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 92  MDASALTGIPLPLIK-----SYLFQLLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIK 143
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T T  V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 144 LADFGLARAF--GVPVRTYTHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 199
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQVA 797
            +   P D   ++   +  +  +G PD+V 
Sbjct: 200 RRALFPGDSEIDQLFRI--FRTLGTPDEVV 227

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 38  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 91
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 92  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 143
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T T  V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 144 LADFGLARAF--GVPVRTYTHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 199
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 200 RRALFPGDSEIDQLFRI--FRTLGTPDEV 226

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 37  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 90
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 91  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 142
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T T  V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 143 LADFGLARAF--GVPVRTYTHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 198
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 199 RRALFPGDSEIDQLFRI--FRTLGTPDEV 225

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TR----VYLILEYA 90
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 91  PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 137
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + DFG S  +H  S  +T+     G++ Y+ PE   + E   H ++   
Sbjct: 138 NLLLGSAGELKIADFGWS--VHAPSSRRTTLC---GTLDYLPPE---MIEGRMHDEKVDL 189
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 38  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 91
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 92  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 143
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T T  V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 144 LADFGLARAF--GVPVRTYTHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 199
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 200 RRALFPGDSEIDQLFRI--FRTLGTPDEV 226

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 37  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 90
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 91  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 142
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T T  V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 143 LADFGLARAF--GVPVRTYTHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 198
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 199 RRALFPGDSEIDQLFRI--FRTLGTPDEV 225

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 38  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 91
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 92  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 143
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T T  V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 144 LADFGLARAF--GVPVRTYTHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 199
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 200 RRALFPGDSEIDQLFRI--FRTLGTPDEV 226

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 37  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 90
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 91  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 142
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T T  V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 143 LADFGLARAF--GVPVRTYTHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 198
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 199 RRALFPGDSEIDQLFRI--FRTLGTPDEV 225

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S    + S V 
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV- 195
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE       S   D ++ G ++ ++  G  P
Sbjct: 196 GTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 13/168 (7%)
Query: 604 IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP 663
           +A    L +  H N+V+++  C++  T       LV+E + +  L  +L++        P
Sbjct: 54  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPP-----P 107
Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
            L       +       L++LH +C   IVH DLKP N+L+ +     + DFGL+R+   
Sbjct: 108 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS- 163
Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGK 771
               Q + + V  ++ Y APE       +T  D +S G +  EMF  K
Sbjct: 164 ---YQMALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 93
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 94  PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 140
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + DFG S  +H  S  +T+     G++ Y+ PE   + E   H ++   
Sbjct: 141 NLLLGSAGELKIADFGWS--VHAPSSRRTTLC---GTLDYLPPE---MIEGRMHDEKVDL 192
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TR----VYLILEYA 90
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ            +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 91  PLGTVYRELQKLSKFDEQRT---------ATYITELANALSY----CHSKRVIHRDIKPE 137
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DE 757
           N+LL +     + DFG S  +H  S  +T      G++ Y+ PE   + E   H    D 
Sbjct: 138 NLLLGSAGELKIADFGWS--VHAPSSRRTXLC---GTLDYLPPE---MIEGRMHDEKVDL 189
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 41  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 95
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 96  PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 142
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + DFG S  +H  S  +T+     G++ Y+ PE   + E   H ++   
Sbjct: 143 NLLLGSAGELKIADFGWS--VHAPSSRRTTLC---GTLDYLPPE---MIEGRMHDEKVDL 194
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 236

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 67/240 (27%), Positives = 102/240 (42%), Gaps = 40/240 (16%)
Query: 584 ETNVAVKVLDLQQRGASKS----FIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           ET V V   +LQ R  +KS    F  E E L+ ++H N+V+   S  S   +G +   LV
Sbjct: 49  ETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 107
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRL-SIAIDVANVLEYLHHHCHTSIVHCDLK 698
            E   +G+L+ +L        +R K+  ++ L S    +   L++LH      I+H DLK
Sbjct: 108 TELXTSGTLKTYL--------KRFKVXKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLK 158
Query: 699 PSNVLLDNEM-VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE 757
             N+ +        +GD GL+ L           S  K  IG   PE+ A        DE
Sbjct: 159 CDNIFITGPTGSVKIGDLGLATL--------KRASFAKAVIG--TPEFXAPEXYEEKYDE 208
Query: 758 ----YSFGILMLEMFTGKRPTDD---------MFEEGLSLHKYAKMGLPDQVAEIIDPAI 804
               Y+FG   LE  T + P  +             G+    + K+ +P +V EII+  I
Sbjct: 209 SVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP-EVKEIIEGCI 267

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 95/190 (50%), Gaps = 21/190 (11%)
Query: 587 VAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK-ALVYEFMP 644
           VA+K + L  + G   + I E   ++ ++H N+V++       D    E K  LV+EFM 
Sbjct: 33  VALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLY------DVIHTENKLTLVFEFMD 86
Query: 645 NGSLENWLNQKEDEQNQRP-KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
           N  L+ +++ +      R  +LNL++     +     L + H +    I+H DLKP N+L
Sbjct: 87  N-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL--LQGLAFCHEN---KILHRDLKPQNLL 140
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE--VSTHGDEYSFG 761
           ++      +GDFGL+R      P  T +S V  ++ Y AP+   +G    ST  D +S G
Sbjct: 141 INKRGQLKLGDFGLARAF--GIPVNTFSSEVV-TLWYRAPDV-LMGSRTYSTSIDIWSCG 196
Query: 762 ILMLEMFTGK 771
            ++ EM TGK
Sbjct: 197 CILAEMITGK 206

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 41  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TR----VYLILEYA 95
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPSNV 702
           P G++   L +      QR         +   ++AN L Y    CH+  ++H D+KP N+
Sbjct: 96  PLGTVYRELQKLSKFDEQRTA-------TYITELANALSY----CHSKRVIHRDIKPENL 144
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGI 762
           LL +     + DFG S  +H  S  +T+     G++ Y+ PE           D +S G+
Sbjct: 145 LLGSAGELKIADFGWS--VHAPSSRRTTLC---GTLDYLPPEXIEGRXHDEKVDLWSLGV 199
Query: 763 LMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           L  E   GK P + + ++E        +   PD V E
Sbjct: 200 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 236

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 90
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 91  PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 137
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DE 757
           N+LL +     + DFG S  +H  S  +T      G++ Y+ PE   + E   H    D 
Sbjct: 138 NLLLGSAGELKIADFGWS--VHAPSSRRTDLC---GTLDYLPPE---MIEGRMHDEKVDL 189
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 42  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 95
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 96  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 147
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T T  V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 148 LADFGLARAF--GVPVRTYTHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 203
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 204 RRALFPGDSEIDQLFRI--FRTLGTPDEV 230

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 583 EETNVAVKVLDLQQRGASKS---FIAECEALRSIRHRNLVKIITSCSSIDTRG-NEFKAL 638
           ++T   V +   +Q  + K+   +  E + ++ + H N+V        +     N+   L
Sbjct: 36  QDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL 95
Query: 639 VYEFMPNGSLENWLNQKED--EQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
             E+   G L  +LNQ E+     + P   L+       D+++ L YLH +    I+H D
Sbjct: 96  AMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS------DISSALRYLHEN---RIIHRD 146
Query: 697 LKPSNVLLD---NEMVAHVGDFGLSRLLHDNSPDQTS-TSRVKGSIGYVAPEYGALGEVS 752
           LKP N++L      ++  + D G ++ L     DQ    +   G++ Y+APE     + +
Sbjct: 147 LKPENIVLQPGPQRLIHKIIDLGYAKEL-----DQGELCTEFVGTLQYLAPELLEQKKYT 201
Query: 753 THGDEYSFGILMLEMFTGKRP 773
              D +SFG L  E  TG RP
Sbjct: 202 VTVDYWSFGTLAFECITGFRP 222

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TR----VYLILEYA 90
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 91  PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 137
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + DFG S  +H  S  +T      G++ Y+ PE   + E   H ++   
Sbjct: 138 NLLLGSAGELKIADFGWS--VHAPSSRRTELC---GTLDYLPPE---MIEGRMHDEKVDL 189
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 62  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 116
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 117 PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 163
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + DFG S  +H  S  +T+     G++ Y+ PE   + E   H ++   
Sbjct: 164 NLLLGSAGELKIADFGWS--VHAPSSRRTTLC---GTLDYLPPE---MIEGRMHDEKVDL 215
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 216 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 257

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 53  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 107
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 108 PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 154
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + DFG S  +H  S  +T+     G++ Y+ PE   + E   H ++   
Sbjct: 155 NLLLGSAGELKIADFGWS--VHAPSSRRTTLC---GTLDYLPPE---MIEGRMHDEKVDL 206
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 207 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 248

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 21/180 (11%)
Query: 601 KSFIAECEALRSIRHRNLVKIITSCSSIDTRG-NEFKALVYEFMPNGSLENWLNQKED-- 657
           + +  E + ++ + H N+V        +     N+   L  E+   G L  +LNQ E+  
Sbjct: 58  ERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC 117
Query: 658 EQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD---NEMVAHVGD 714
              + P   L+       D+++ L YLH +    I+H DLKP N++L      ++  + D
Sbjct: 118 GLKEGPIRTLLS------DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID 168
Query: 715 FGLSRLLHDNSPDQTS-TSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
            G ++ L     DQ    +   G++ Y+APE     + +   D +SFG L  E  TG RP
Sbjct: 169 LGYAKEL-----DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 18/190 (9%)
Query: 587 VAVKVLDLQ--QRGASKSFIAECEALR---SIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           VA+K + +Q  + G   S I E   LR   +  H N+V++   C+   T       LV+E
Sbjct: 40  VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE 99
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            + +  L  +L++  +     P +       +   +   L++LH H    +VH DLKP N
Sbjct: 100 HV-DQDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQN 150
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +L+ +     + DFGL+R+       Q + + V  ++ Y APE       +T  D +S G
Sbjct: 151 ILVTSSGQIKLADFGLARIYS----FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 206
Query: 762 ILMLEMFTGK 771
            +  EMF  K
Sbjct: 207 CIFAEMFRRK 216

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 90
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 91  PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 137
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DE 757
           N+LL +     + DFG S  +H  S  +T      G++ Y+ PE   + E   H    D 
Sbjct: 138 NLLLGSAGELKIADFGWS--VHAPSSRRTDLC---GTLDYLPPE---MIEGRMHDEKVDL 189
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 41  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 95
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G +   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 96  PRGEVYKELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 142
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + DFG S  +H  S   +    + G++ Y+ PE   + E   H ++   
Sbjct: 143 NLLLGSAGELKIADFGWS--VHAPS---SRRXXLXGTLDYLPPE---MIEGRMHDEKVDL 194
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 236

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 18/190 (9%)
Query: 587 VAVKVLDLQ--QRGASKSFIAECEALR---SIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           VA+K + +Q  + G   S I E   LR   +  H N+V++   C+   T       LV+E
Sbjct: 40  VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE 99
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            + +  L  +L++  +     P +       +   +   L++LH H    +VH DLKP N
Sbjct: 100 HV-DQDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQN 150
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +L+ +     + DFGL+R+       Q + + V  ++ Y APE       +T  D +S G
Sbjct: 151 ILVTSSGQIKLADFGLARIYS----FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 206
Query: 762 ILMLEMFTGK 771
            +  EMF  K
Sbjct: 207 CIFAEMFRRK 216

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 37  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 91
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 92  PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 138
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + DFG S  +H  S  +T      G++ Y+ PE   + E   H ++   
Sbjct: 139 NLLLGSAGELKIADFGWS--VHAPSSRRTDLC---GTLDYLPPE---MIEGRMHDEKVDL 190
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 232

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 13/168 (7%)
Query: 604 IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP 663
           +A    L +  H N+V+++  C++  T       LV+E + +  L  +L++        P
Sbjct: 54  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPP-----P 107
Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
            L       +       L++LH +C   IVH DLKP N+L+ +     + DFGL+R+   
Sbjct: 108 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS- 163
Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGK 771
               Q +   V  ++ Y APE       +T  D +S G +  EMF  K
Sbjct: 164 ---YQMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 18/190 (9%)
Query: 587 VAVKVLDLQ--QRGASKSFIAECEALR---SIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           VA+K + +Q  + G   S I E   LR   +  H N+V++   C+   T       LV+E
Sbjct: 40  VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE 99
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            + +  L  +L++  +     P +       +   +   L++LH H    +VH DLKP N
Sbjct: 100 HV-DQDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQN 150
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +L+ +     + DFGL+R+       Q + + V  ++ Y APE       +T  D +S G
Sbjct: 151 ILVTSSGQIKLADFGLARIYS----FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 206
Query: 762 ILMLEMFTGK 771
            +  EMF  K
Sbjct: 207 CIFAEMFRRK 216

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 110/257 (42%), Gaps = 31/257 (12%)
Query: 587 VAVKVLDLQQRGASK-SFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK+L        K + ++E + +  + +H N+V ++ +C    T G     ++ E+  
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC----THGGPV-LVITEYCC 133
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS----------IVH 694
            G L N+L +K       P        +IA   A+  + LH     +           +H
Sbjct: 134 YGDLLNFLRRKSRVLETDPAF------AIANSTASTRDLLHFSSQVAQGMAFLASKNCIH 187
Query: 695 CDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH 754
            D+   NVLL N  VA +GDFGL+R + ++S +       +  + ++APE       +  
Sbjct: 188 RDVAARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNARLPVKWMAPESIFDCVYTVQ 246
Query: 755 GDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQA 813
            D +S+GIL+ E+F+ G  P   +       +K  K G      ++  PA   + +    
Sbjct: 247 SDVWSYGILLWEIFSLGLNPYPGILVNS-KFYKLVKDGY-----QMAQPAFAPKNIYSIM 300
Query: 814 GIVKELQPNLRAKFHEI 830
                L+P  R  F +I
Sbjct: 301 QACWALEPTHRPTFQQI 317

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 41  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 95
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 96  PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 142
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + DFG S  +H  S  +T      G++ Y+ PE   + E   H ++   
Sbjct: 143 NLLLGSAGELKIADFGWS--VHAPSSRRTDLC---GTLDYLPPE---MIEGRMHDEKVDL 194
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 236

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 91/192 (47%), Gaps = 25/192 (13%)
Query: 588 AVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           A+K ++ Q   +R   ++   E + ++ + H  LV +  S      +  E   +V + + 
Sbjct: 44  AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEEDMFMVVDLLL 98
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            G L   L Q    + +  KL + + L +A+D      YL +     I+H D+KP N+LL
Sbjct: 99  GGDLRYHLQQNVHFKEETVKLFICE-LVMALD------YLQNQ---RIIHRDMKPDNILL 148
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DEYSFG 761
           D     H+ DF ++ +L    P +T  + + G+  Y+APE  +  + + +    D +S G
Sbjct: 149 DEHGHVHITDFNIAAML----PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG 204
Query: 762 ILMLEMFTGKRP 773
           +   E+  G+RP
Sbjct: 205 VTAYELLRGRRP 216

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 61/120 (50%), Gaps = 8/120 (6%)
Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
           K +L +    A ++   L++LH      IV+ DLK  N+LLD +    + DFG+ +   +
Sbjct: 115 KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK---E 168
Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-DEYSFGILMLEMFTGKRPTDDMFEEGL 782
           N      T+   G+  Y+APE   LG+   H  D +SFG+L+ EM  G+ P     EE L
Sbjct: 169 NMLGDAKTNEFCGTPDYIAPEI-LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 227

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 105/241 (43%), Gaps = 42/241 (17%)
Query: 585 TNVAVKVLDLQQRGAS-KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           T VAVK+L      +  +  ++E   L+ + H +++K+  +CS      +    L+ E+ 
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-----DGPLLLIVEYA 108
Query: 644 PNGSLENWLNQKE------------------DEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
             GSL  +L +                    D  ++R  L +   +S A  ++  ++YL 
Sbjct: 109 KYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER-ALTMGDLISFAWQISQGMQYL- 166
Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY 745
                 +VH DL   N+L+       + DFGLSR +++        S VK S G +  ++
Sbjct: 167 --AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED------SXVKRSQGRIPVKW 218
Query: 746 GALGEV-----STHGDEYSFGILMLEMFT-GKRPTDDMFEEGLS--LHKYAKMGLPDQVA 797
            A+  +     +T  D +SFG+L+ E+ T G  P   +  E L   L    +M  PD  +
Sbjct: 219 MAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCS 278
Query: 798 E 798
           E
Sbjct: 279 E 279

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 87/187 (46%), Gaps = 19/187 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK +DL+++   +    E   +R  +H N+V++  S       G+E   +V EF+  G
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDEL-WVVMEFLEGG 102
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L + +           ++N  Q  ++ + V   L  LH      ++H D+K  ++LL +
Sbjct: 103 ALTDIVTHT--------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTH 151
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           +    + DFG    +    P +     + G+  ++APE  +        D +S GI+++E
Sbjct: 152 DGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 208
Query: 767 MFTGKRP 773
           M  G+ P
Sbjct: 209 MVDGEPP 215

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 87/187 (46%), Gaps = 19/187 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK +DL+++   +    E   +R  +H N+V++  S       G+E   +V EF+  G
Sbjct: 57  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDEL-WVVMEFLEGG 111
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L + +           ++N  Q  ++ + V   L  LH      ++H D+K  ++LL +
Sbjct: 112 ALTDIVTHT--------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTH 160
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           +    + DFG    +    P +     + G+  ++APE  +        D +S GI+++E
Sbjct: 161 DGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 217
Query: 767 MFTGKRP 773
           M  G+ P
Sbjct: 218 MVDGEPP 224

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 85/186 (45%), Gaps = 33/186 (17%)
Query: 601 KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQN 660
           + F  E   + ++ H N+VK+     +          +V EF+P G L + L  K     
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPR-------MVMEFVPCGDLYHRLLDKAHPIK 120
Query: 661 QRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-----EMVAHVGDF 715
              KL LM      +D+A  +EY+ +  +  IVH DL+  N+ L +      + A V DF
Sbjct: 121 WSVKLRLM------LDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 716 GLSRLLHDNSPDQTSTSRVKGSIG---YVAPE-YGALGEVSTH-GDEYSFGILMLEMFTG 770
           GLS         Q S   V G +G   ++APE  GA  E  T   D YSF +++  + TG
Sbjct: 174 GLS---------QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224
Query: 771 KRPTDD 776
           + P D+
Sbjct: 225 EGPFDE 230

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 87/187 (46%), Gaps = 19/187 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK +DL+++   +    E   +R  +H N+V++  S       G+E   +V EF+  G
Sbjct: 59  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDEL-WVVMEFLEGG 113
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L + +           ++N  Q  ++ + V   L  LH      ++H D+K  ++LL +
Sbjct: 114 ALTDIVTHT--------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTH 162
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           +    + DFG    +    P +     + G+  ++APE  +        D +S GI+++E
Sbjct: 163 DGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 219
Query: 767 MFTGKRP 773
           M  G+ P
Sbjct: 220 MVDGEPP 226

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 61/120 (50%), Gaps = 8/120 (6%)
Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
           K +L +    A ++   L++LH      IV+ DLK  N+LLD +    + DFG+ +   +
Sbjct: 114 KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK---E 167
Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-DEYSFGILMLEMFTGKRPTDDMFEEGL 782
           N      T+   G+  Y+APE   LG+   H  D +SFG+L+ EM  G+ P     EE L
Sbjct: 168 NMLGDAKTNXFCGTPDYIAPEI-LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 226

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 87/187 (46%), Gaps = 19/187 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK +DL+++   +    E   +R  +H N+V++  S       G+E   +V EF+  G
Sbjct: 52  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY----LVGDEL-WVVMEFLEGG 106
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L + +           ++N  Q  ++ + V   L  LH      ++H D+K  ++LL +
Sbjct: 107 ALTDIVTHT--------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTH 155
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           +    + DFG    +    P +     + G+  ++APE  +        D +S GI+++E
Sbjct: 156 DGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 212
Query: 767 MFTGKRP 773
           M  G+ P
Sbjct: 213 MVDGEPP 219

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 105/241 (43%), Gaps = 42/241 (17%)
Query: 585 TNVAVKVLDLQQRGAS-KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           T VAVK+L      +  +  ++E   L+ + H +++K+  +CS      +    L+ E+ 
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-----DGPLLLIVEYA 108
Query: 644 PNGSLENWLNQKE------------------DEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
             GSL  +L +                    D  ++R  L +   +S A  ++  ++YL 
Sbjct: 109 KYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER-ALTMGDLISFAWQISQGMQYL- 166
Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY 745
                 +VH DL   N+L+       + DFGLSR +++        S VK S G +  ++
Sbjct: 167 --AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED------SYVKRSQGRIPVKW 218
Query: 746 GALGEV-----STHGDEYSFGILMLEMFT-GKRPTDDMFEEGLS--LHKYAKMGLPDQVA 797
            A+  +     +T  D +SFG+L+ E+ T G  P   +  E L   L    +M  PD  +
Sbjct: 219 MAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCS 278
Query: 798 E 798
           E
Sbjct: 279 E 279

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 19/174 (10%)
Query: 638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           LV ++   G L   L++ ED   +      +  + IAID  + L Y+H          D+
Sbjct: 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHR---------DI 201
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY-----GALGEVS 752
           KP N+L+D      + DFG    L ++   Q+S +   G+  Y++PE      G  G   
Sbjct: 202 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEGGKGRYG 259
Query: 753 THGDEYSFGILMLEMFTGKRP--TDDMFEE-GLSLHKYAKMGLPDQVAEIIDPA 803
              D +S G+ M EM  G+ P   + + E  G  ++   +   P QV ++ + A
Sbjct: 260 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 93
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 94  PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 140
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + +FG S  +H  S  +T+     G++ Y+ PE   + E   H ++   
Sbjct: 141 NLLLGSAGELKIANFGWS--VHAPSSRRTTLC---GTLDYLPPE---MIEGRMHDEKVDL 192
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 87/187 (46%), Gaps = 19/187 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK +DL+++   +    E   +R  +H N+V++  S       G+E   +V EF+  G
Sbjct: 102 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDEL-WVVMEFLEGG 156
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L + +           ++N  Q  ++ + V   L  LH      ++H D+K  ++LL +
Sbjct: 157 ALTDIVTHT--------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTH 205
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           +    + DFG    +    P +     + G+  ++APE  +        D +S GI+++E
Sbjct: 206 DGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 262
Query: 767 MFTGKRP 773
           M  G+ P
Sbjct: 263 MVDGEPP 269

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TR----VYLILEYA 90
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ            +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 91  PLGTVYRELQKLSKFDEQRT---------ATYITELANALSY----CHSKRVIHRDIKPE 137
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DE 757
           N+LL +     + DFG S  +H  S  + +     G++ Y+ PE   + E   H    D 
Sbjct: 138 NLLLGSAGELKIADFGWS--VHAPSSRRAALC---GTLDYLPPE---MIEGRMHDEKVDL 189
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 25/254 (9%)
Query: 587 VAVKVLDLQQRGASK-SFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK+L        K + ++E + +  + +H N+V ++ +C    T G     ++ E+  
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC----THGGPV-LVITEYCC 133
Query: 645 NGSLENWLNQKEDEQNQRPK-------LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
            G L N+L +K       P        L+    L  +  VA  + +L      + +H D+
Sbjct: 134 YGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDV 190
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE 757
              NVLL N  VA +GDFGL+R + ++S +       +  + ++APE       +   D 
Sbjct: 191 AARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249
Query: 758 YSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIV 816
           +S+GIL+ E+F+ G  P   +       +K  K G      ++  PA   + +       
Sbjct: 250 WSYGILLWEIFSLGLNPYPGILVNS-KFYKLVKDGY-----QMAQPAFAPKNIYSIMQAC 303
Query: 817 KELQPNLRAKFHEI 830
             L+P  R  F +I
Sbjct: 304 WALEPTHRPTFQQI 317

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 13/168 (7%)
Query: 604 IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP 663
           +A    L +  H N+V+++  C++  T       LV+E + +  L  +L++        P
Sbjct: 54  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPP-----P 107
Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
            L       +       L++LH +C   IVH DLKP N+L+ +     + DFGL+R+   
Sbjct: 108 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS- 163
Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGK 771
               Q +   V  ++ Y APE       +T  D +S G +  EMF  K
Sbjct: 164 ---YQMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 83/200 (41%), Gaps = 38/200 (19%)
Query: 587 VAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK++D  Q  +S  +    E   ++ + H N+VK+      I+T    +  LV E+  
Sbjct: 35  VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF---EVIETEKTLY--LVMEYAS 89
Query: 645 NGSL------ENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDL 697
            G +        W+ +KE     R  ++ +Q                 +CH   IVH DL
Sbjct: 90  GGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ-----------------YCHQKFIVHRDL 132
Query: 698 KPSNVLLDNEMVAHVGDFGLS-RLLHDNSPDQTSTSRVKGSIGYVAPE-YGALGEVSTHG 755
           K  N+LLD +M   + DFG S      N  D        GS  Y APE +          
Sbjct: 133 KAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC-----GSPPYAAPELFQGKKYDGPEV 187
Query: 756 DEYSFGILMLEMFTGKRPTD 775
           D +S G+++  + +G  P D
Sbjct: 188 DVWSLGVILYTLVSGSLPFD 207

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+++
Sbjct: 41  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-SMDLKDF 94
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 95  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 146
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 147 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 202
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 203 RRALFPGDSEIDQLFRI--FRTLGTPDEV 229

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+++
Sbjct: 38  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKDF 91
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 92  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIK 143
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 144 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 199
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 200 RRALFPGDSEIDQLFRI--FRTLGTPDEV 226

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S    + S V 
Sbjct: 137 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV- 192
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 193 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 60/119 (50%), Gaps = 6/119 (5%)
Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
           K    Q +  A +++  L +LH      I++ DLK  NV+LD+E    + DFG+ +   +
Sbjct: 116 KFKEPQAVFYAAEISIGLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---E 169
Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL 782
           +  D  +T    G+  Y+APE  A        D +++G+L+ EM  G+ P D   E+ L
Sbjct: 170 HMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 228

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 39/204 (19%)
Query: 588 AVKVLDLQQRGA---------SKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFKA 637
           AVK++D+   G+          ++ + E + LR +  H N++++  +  +     N F  
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-----NTFFF 100
Query: 638 LVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
           LV++ M  G L ++L +K    E+  R  +  +  +  A+   N            IVH 
Sbjct: 101 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN------------IVHR 148
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DLKP N+LLD++M   + DFG S  L    P +   S V G+  Y+APE         H 
Sbjct: 149 DLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLRS-VCGTPSYLAPEIIECSMNDNHP 204
Query: 756 ------DEYSFGILMLEMFTGKRP 773
                 D +S G++M  +  G  P
Sbjct: 205 GYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+++
Sbjct: 40  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-SMDLKDF 93
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 94  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 145
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 146 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 201
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 202 RRALFPGDSEIDQLFRI--FRTLGTPDEV 228

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 28/198 (14%)
Query: 588 AVKVLDLQQRGASKSFIAEC-EALRSIRH--RNLV---KIITSCSSIDTRGNEFKALVYE 641
           AVK++++     S   + E  EA R   H  R +     IIT   S ++  + F  LV++
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES--SSFMFLVFD 180
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            M  G L ++L +K         L+  +  SI   +   + +LH +   +IVH DLKP N
Sbjct: 181 LMRKGELFDYLTEK-------VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPEN 230
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG------ 755
           +LLD+ M   + DFG S  L            + G+ GY+APE        TH       
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEV 286
Query: 756 DEYSFGILMLEMFTGKRP 773
           D ++ G+++  +  G  P
Sbjct: 287 DLWACGVILFTLLAGSPP 304

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 42  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 95
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 96  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 147
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 148 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 203
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 204 RRALFPGDSEIDQLFRI--FRTLGTPDEV 230

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 39  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 92
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 93  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 144
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 145 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 200
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 201 RRALFPGDSEIDQLFRI--FRTLGTPDEV 227

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S    + S V 
Sbjct: 141 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV- 196
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 197 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TR----VYLILEYA 93
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 94  PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 140
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + DFG S  +H  S  + +     G++ Y+ PE   + E   H ++   
Sbjct: 141 NLLLGSAGELKIADFGWS--VHAPSSRRAALC---GTLDYLPPE---MIEGRMHDEKVDL 192
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 41  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 94
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 95  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 146
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 147 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 202
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 203 RRALFPGDSEIDQLFRI--FRTLGTPDEV 229

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 40  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 93
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 94  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 145
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 146 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 201
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 202 RRALFPGDSEIDQLFRI--FRTLGTPDEV 228

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 39/204 (19%)
Query: 588 AVKVLDLQQRGA---------SKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFKA 637
           AVK++D+   G+          ++ + E + LR +  H N++++  +  +     N F  
Sbjct: 33  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-----NTFFF 87
Query: 638 LVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
           LV++ M  G L ++L +K    E+  R  +  +  +  A+   N            IVH 
Sbjct: 88  LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN------------IVHR 135
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DLKP N+LLD++M   + DFG S  L            V G+  Y+APE         H 
Sbjct: 136 DLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHP 191
Query: 756 ------DEYSFGILMLEMFTGKRP 773
                 D +S G++M  +  G  P
Sbjct: 192 GYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 87/187 (46%), Gaps = 19/187 (10%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           VAVK +DL+++   +    E   +R  +H N+V++  S       G+E   +V EF+  G
Sbjct: 179 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDEL-WVVMEFLEGG 233
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L + +           ++N  Q  ++ + V   L  LH      ++H D+K  ++LL +
Sbjct: 234 ALTDIVTHT--------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTH 282
Query: 707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
           +    + DFG    +    P +     + G+  ++APE  +        D +S GI+++E
Sbjct: 283 DGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 339
Query: 767 MFTGKRP 773
           M  G+ P
Sbjct: 340 MVDGEPP 346

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TR----VYLILEYA 90
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ            +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 91  PLGTVYRELQKLSKFDEQRT---------ATYITELANALSY----CHSKRVIHRDIKPE 137
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DE 757
           N+LL +     + DFG S  +H  S   +    + G++ Y+ PE   + E   H    D 
Sbjct: 138 NLLLGSAGELKIADFGWS--VHAPS---SRRXXLCGTLDYLPPE---MIEGRMHDEKVDL 189
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 231

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 41  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKTF 94
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 95  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 146
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 147 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 202
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 203 RRALFPGDSEIDQLFRI--FRTLGTPDEV 229

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 38  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 92
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 93  PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 139
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + +FG S  +H  S  +T+     G++ Y+ PE   + E   H ++   
Sbjct: 140 NLLLGSAGELKIANFGWS--VHAPSSRRTTLC---GTLDYLPPE---MIEGRMHDEKVDL 191
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 192 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 233

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 37  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 90
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 91  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 142
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 143 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 198
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 199 RRALFPGDSEIDQLFRI--FRTLGTPDEV 225

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 118 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 173
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 174 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 41  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 94
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 95  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 146
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 147 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 202
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 203 RRALFPGDSEIDQLFRI--FRTLGTPDEV 229

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 38  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 91
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 92  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 143
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 144 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 199
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 200 RRALFPGDSEIDQLFRI--FRTLGTPDEV 226

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 38  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 91
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 92  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 143
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 144 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 199
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 200 RRALFPGDSEIDQLFRI--FRTLGTPDEV 226

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 38  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 91
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 92  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 143
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 144 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 199
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 200 RRALFPGDSEIDQLFRI--FRTLGTPDEV 226

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 117 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 172
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 173 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 40  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 93
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 94  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 145
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 146 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 201
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 202 RRALFPGDSEIDQLFRI--FRTLGTPDEV 228

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 116 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 171
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 39  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 92
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 93  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIK 144
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 145 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 200
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 201 RRALFPGDSEIDQLFRI--FRTLGTPDEV 227

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 38  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 91
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 92  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 143
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 144 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 199
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 200 RRALFPGDSEIDQLFRI--FRTLGTPDEV 226

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 115 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 170
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 171 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 585 TNVAVKVLDLQQRGASKS-FIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           T VAVK+L  +     ++ F  E   +    + N+VK++  C+       +   L++E+M
Sbjct: 78  TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-----GKPMCLLFEYM 132
Query: 644 PNGSLENWLNQ---------KEDEQNQR--------PKLNLMQRLSIAIDVANVLEYLHH 686
             G L  +L              + + R        P L+  ++L IA  VA  + YL  
Sbjct: 133 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 192
Query: 687 HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG-SIGYVAPEY 745
                 VH DL   N L+   MV  + DFGLSR ++  S D           I ++ PE 
Sbjct: 193 R---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY--SADYYKADGNDAIPIRWMPPES 247
Query: 746 GALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEE 780
                 +T  D +++G+++ E+F+ G +P   M  E
Sbjct: 248 IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 28/195 (14%)
Query: 587 VAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK++D  Q  +S  +    E   ++ + H N+VK+      I+T    +  LV E+  
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF---EVIETEKTLY--LVMEYAS 96
Query: 645 NGSLENWL--NQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
            G + ++L  + +  E+  R K            + + ++Y H      IVH DLK  N+
Sbjct: 97  GGEVFDYLVAHGRMKEKEARAKFR---------QIVSAVQYCHQKF---IVHRDLKAENL 144
Query: 703 LLDNEMVAHVGDFGLS-RLLHDNSPDQTSTSRVKGSIGYVAPE-YGALGEVSTHGDEYSF 760
           LLD +M   + DFG S      N  D        GS  Y APE +          D +S 
Sbjct: 145 LLDADMNIKIADFGFSNEFTFGNKLDTFC-----GSPPYAAPELFQGKKYDGPEVDVWSL 199
Query: 761 GILMLEMFTGKRPTD 775
           G+++  + +G  P D
Sbjct: 200 GVILYTLVSGSLPFD 214

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 86/189 (45%), Gaps = 19/189 (10%)
Query: 587 VAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           VA+K   +       + F+ E   +R   H ++VK+I     + T    +  ++ E    
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI----GVITENPVW--IIMELCTL 94
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L ++L      Q ++  L+L   +  A  ++  L YL        VH D+   NVL+ 
Sbjct: 95  GELRSFL------QVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVS 145
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
           +     +GDFGLSR + D++  + S  ++   I ++APE       ++  D + FG+ M 
Sbjct: 146 SNDCVKLGDFGLSRYMEDSTXXKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMW 203
Query: 766 EMFT-GKRP 773
           E+   G +P
Sbjct: 204 EILMHGVKP 212

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 37  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 90
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 91  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 142
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 143 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 198
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 199 RRALFPGDSEIDQLFRI--FRTLGTPDEV 225

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 40  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 93
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 94  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIK 145
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 146 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 201
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 202 RRALFPGDSEIDQLFRI--FRTLGTPDEV 228

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 39  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-HQDLKKF 92
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 93  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 144
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 145 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 200
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 201 RRALFPGDSEIDQLFRI--FRTLGTPDEV 227

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 22/196 (11%)
Query: 582 TEETNVAVKVLDLQ---QRGASKSFIAECEAL-RSIRHRNLVKIITSCSSIDTRGNEFKA 637
            EE   AVKVL  +   ++   K  ++E   L ++++H  LV +  S  + D        
Sbjct: 61  AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL-----Y 115
Query: 638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
            V +++  G L   L      Q +R  L    R   A ++A+ L YLH     +IV+ DL
Sbjct: 116 FVLDYINGGELFYHL------QRERCFLEPRARF-YAAEIASALGYLHS---LNIVYRDL 165
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE 757
           KP N+LLD++    + DFGL +   +N    ++TS   G+  Y+APE           D 
Sbjct: 166 KPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 758 YSFGILMLEMFTGKRP 773
           +  G ++ EM  G  P
Sbjct: 223 WCLGAVLYEMLYGLPP 238

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 93
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ            +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 94  PLGTVYRELQKLSKFDEQRT---------ATYITELANALSY----CHSKRVIHRDIKPE 140
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DE 757
           N+LL +     + DFG S  +H  S   +    + G++ Y+ PE   + E   H    D 
Sbjct: 141 NLLLGSAGELKIADFGWS--VHAPS---SRRXXLCGTLDYLPPE---MIEGRMHDEKVDL 192
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A ++   LE LH      IV+ DLKP N+LLD+     + D GL+  + +    QT   R
Sbjct: 292 AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGR 345
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           V G++GY+APE       +   D ++ G L+ EM  G+ P
Sbjct: 346 V-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A ++   LE LH      IV+ DLKP N+LLD+     + D GL+  + +    QT   R
Sbjct: 292 AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGR 345
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           V G++GY+APE       +   D ++ G L+ EM  G+ P
Sbjct: 346 V-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 28/195 (14%)
Query: 587 VAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK++D  Q  +S  +    E   ++ + H N+VK+      I+T    +  LV E+  
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF---EVIETEKTLY--LVMEYAS 96
Query: 645 NGSLENWL--NQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
            G + ++L  + +  E+  R K            + + ++Y H      IVH DLK  N+
Sbjct: 97  GGEVFDYLVAHGRMKEKEARAKFR---------QIVSAVQYCHQKF---IVHRDLKAENL 144
Query: 703 LLDNEMVAHVGDFGLS-RLLHDNSPDQTSTSRVKGSIGYVAPE-YGALGEVSTHGDEYSF 760
           LLD +M   + DFG S      N  D        GS  Y APE +          D +S 
Sbjct: 145 LLDADMNIKIADFGFSNEFTFGNKLDTFC-----GSPPYAAPELFQGKKYDGPEVDVWSL 199
Query: 761 GILMLEMFTGKRPTD 775
           G+++  + +G  P D
Sbjct: 200 GVILYTLVSGSLPFD 214

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 39  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-SMDLKKF 92
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 93  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIK 144
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 145 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 200
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 201 RRALFPGDSEIDQLFRI--FRTLGTPDEV 227

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 86/195 (44%), Gaps = 28/195 (14%)
Query: 587 VAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAV+++D  Q  +S  +    E   ++ + H N+VK+      I+T    +  LV E+  
Sbjct: 42  VAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF---EVIETEKTLY--LVMEYAS 96
Query: 645 NGSLENWL--NQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
            G + ++L  + +  E+  R K            + + ++Y H      IVH DLK  N+
Sbjct: 97  GGEVFDYLVAHGRMKEKEARAKFR---------QIVSAVQYCHQKF---IVHRDLKAENL 144
Query: 703 LLDNEMVAHVGDFGLS-RLLHDNSPDQTSTSRVKGSIGYVAPE-YGALGEVSTHGDEYSF 760
           LLD +M   + DFG S      N  D+       GS  Y APE +          D +S 
Sbjct: 145 LLDADMNIKIADFGFSNEFTFGNKLDEFC-----GSPPYAAPELFQGKKYDGPEVDVWSL 199
Query: 761 GILMLEMFTGKRPTD 775
           G+++  + +G  P D
Sbjct: 200 GVILYTLVSGSLPFD 214

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 37  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 91
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 92  PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 138
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + DFG S  +H  S  + +     G++ Y+ PE   + E   H ++   
Sbjct: 139 NLLLGSAGELKIADFGWS--VHAPSSRRDTLC---GTLDYLPPE---MIEGRMHDEKVDL 190
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 232

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 39/204 (19%)
Query: 588 AVKVLDLQQRGA---------SKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFKA 637
           AVK++D+   G+          ++ + E + LR +  H N++++  +  +     N F  
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-----NTFFF 100
Query: 638 LVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC 695
           LV++ M  G L ++L +K    E+  R  +  +  +  A+   N            IVH 
Sbjct: 101 LVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN------------IVHR 148
Query: 696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           DLKP N+LLD++M   + DFG S  L    P +     V G+  Y+APE         H 
Sbjct: 149 DLKPENILLDDDMNIKLTDFGFSCQL---DPGE-KLREVCGTPSYLAPEIIECSMNDNHP 204
Query: 756 ------DEYSFGILMLEMFTGKRP 773
                 D +S G++M  +  G  P
Sbjct: 205 GYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TR----VYLILEYA 93
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ            +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 94  PLGTVYRELQKLSKFDEQRT---------ATYITELANALSY----CHSKRVIHRDIKPE 140
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DE 757
           N+LL +     + DFG S  +H  S   +    + G++ Y+ PE   + E   H    D 
Sbjct: 141 NLLLGSAGELKIADFGWS--VHAPS---SRRDDLCGTLDYLPPE---MIEGRMHDEKVDL 192
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 234

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+EF+ +  L+ +
Sbjct: 41  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEFL-SMDLKKF 94
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 95  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIK 146
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 147 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 202
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 203 RRALFPGDSEIDQLFRI--FRTLGTPDEV 229

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 193
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 195
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 193
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 195
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 196 GTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 195
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 122 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 177
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 178 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 145 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 200
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 201 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 195
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 193
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 141 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 196
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 197 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 195
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-STR----VYLILEYA 90
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 91  PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKKVIHRDIKPE 137
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DE 757
           N+LL +     + DFG S  +H  S  + +     G++ Y+ PE   + E   H    D 
Sbjct: 138 NLLLGSAGELKIADFGWS--VHAPSSRRAALC---GTLDYLPPE---MIEGRMHDEKVDL 189
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + +++        +   PD V E
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTE 231

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 38  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 92
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 93  PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 139
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + DFG S  +H  S   +    + G++ Y+ PE   + E   H ++   
Sbjct: 140 NLLLGSAGELKIADFGWS--VHAPS---SRRXXLCGTLDYLPPE---MIEGRMHDEKVDL 191
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 192 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 233

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/82 (35%), Positives = 45/82 (54%), Gaps = 3/82 (3%)
Query: 692 IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV 751
           I++ DLK  NV+LD+E    + DFG+ +   +N  D  +T    G+  Y+APE  A    
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYIAPEIIAYQPY 198
Query: 752 STHGDEYSFGILMLEMFTGKRP 773
               D ++FG+L+ EM  G+ P
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAP 220

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANAFV 193
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 137 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 192
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 193 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +   
Sbjct: 143 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANXFV 198
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  YV+PE           D ++ G ++ ++  G  P
Sbjct: 199 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 19/189 (10%)
Query: 587 VAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           VA+K   +       + F+ E   +R   H ++VK+I     + T    +  ++ E    
Sbjct: 69  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI----GVITENPVW--IIMELCTL 122
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L ++L      Q ++  L+L   +  A  ++  L YL        VH D+   NVL+ 
Sbjct: 123 GELRSFL------QVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVS 173
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
           +     +GDFGLSR + D++      S+ K  I ++APE       ++  D + FG+ M 
Sbjct: 174 SNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 231
Query: 766 EMFT-GKRP 773
           E+   G +P
Sbjct: 232 EILMHGVKP 240

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 66/141 (46%), Gaps = 16/141 (11%)
Query: 638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           LV ++   G L   L++ ED+  +      +  + +AID  + L Y         VH D+
Sbjct: 151 LVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY---------VHRDI 201
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY-----GALGEVS 752
           KP NVLLD      + DFG    ++D+   Q+S +   G+  Y++PE        +G+  
Sbjct: 202 KPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA--VGTPDYISPEILQAMEDGMGKYG 259
Query: 753 THGDEYSFGILMLEMFTGKRP 773
              D +S G+ M EM  G+ P
Sbjct: 260 PECDWWSLGVCMYEMLYGETP 280

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 19/189 (10%)
Query: 587 VAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           VA+K   +       + F+ E   +R   H ++VK+I     + T    +  ++ E    
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI----GVITENPVW--IIMELCTL 94
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L ++L      Q ++  L+L   +  A  ++  L YL        VH D+   NVL+ 
Sbjct: 95  GELRSFL------QVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVS 145
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
           +     +GDFGLSR + D++      S+ K  I ++APE       ++  D + FG+ M 
Sbjct: 146 SNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 203
Query: 766 EMFT-GKRP 773
           E+   G +P
Sbjct: 204 EILMHGVKP 212

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 63/128 (49%), Gaps = 4/128 (3%)
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
           F  + SL +   +++ +   +  + +   +S +  VA  +E+L        +H DL   N
Sbjct: 173 FQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVARGMEFLSSR---KCIHRDLAARN 229
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +LL    V  + DFGL+R ++ N PD       +  + ++APE       ST  D +S+G
Sbjct: 230 ILLSENNVVKICDFGLARDIYKN-PDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYG 288
Query: 762 ILMLEMFT 769
           +L+ E+F+
Sbjct: 289 VLLWEIFS 296

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 86/189 (45%), Gaps = 19/189 (10%)
Query: 587 VAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           VA+K   +       + F+ E   +R   H ++VK+I     + T    +  ++ E    
Sbjct: 46  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI----GVITENPVW--IIMELCTL 99
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L ++L      Q ++  L+L   +  A  ++  L YL        VH D+   NVL+ 
Sbjct: 100 GELRSFL------QVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVS 150
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
           +     +GDFGLSR + D++  + S  ++   I ++APE       ++  D + FG+ M 
Sbjct: 151 SNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMW 208
Query: 766 EMFT-GKRP 773
           E+   G +P
Sbjct: 209 EILMHGVKP 217

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 66/141 (46%), Gaps = 16/141 (11%)
Query: 638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           LV ++   G L   L++ ED+  +      +  + +AID  + L Y         VH D+
Sbjct: 167 LVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY---------VHRDI 217
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY-----GALGEVS 752
           KP NVLLD      + DFG    ++D+   Q+S +   G+  Y++PE        +G+  
Sbjct: 218 KPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA--VGTPDYISPEILQAMEDGMGKYG 275
Query: 753 THGDEYSFGILMLEMFTGKRP 773
              D +S G+ M EM  G+ P
Sbjct: 276 PECDWWSLGVCMYEMLYGETP 296

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 19/189 (10%)
Query: 587 VAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           VA+K   +       + F+ E   +R   H ++VK+I     + T    +  ++ E    
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI----GVITENPVW--IIMELCTL 94
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L ++L      Q ++  L+L   +  A  ++  L YL        VH D+   NVL+ 
Sbjct: 95  GELRSFL------QVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVS 145
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
           +     +GDFGLSR + D++      S+ K  I ++APE       ++  D + FG+ M 
Sbjct: 146 SNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 203
Query: 766 EMFT-GKRP 773
           E+   G +P
Sbjct: 204 EILMHGVKP 212

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 84/186 (45%), Gaps = 33/186 (17%)
Query: 601 KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQN 660
           + F  E   + ++ H N+VK+     +          +V EF+P G L + L  K     
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIK 120
Query: 661 QRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-----EMVAHVGDF 715
              KL LM      +D+A  +EY+ +  +  IVH DL+  N+ L +      + A V DF
Sbjct: 121 WSVKLRLM------LDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 716 GLSRLLHDNSPDQTSTSRVKGSIG---YVAPE-YGALGEVSTH-GDEYSFGILMLEMFTG 770
           G S         Q S   V G +G   ++APE  GA  E  T   D YSF +++  + TG
Sbjct: 174 GTS---------QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224
Query: 771 KRPTDD 776
           + P D+
Sbjct: 225 EGPFDE 230

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 19/189 (10%)
Query: 587 VAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           VA+K   +       + F+ E   +R   H ++VK+I     + T    +  ++ E    
Sbjct: 38  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI----GVITENPVW--IIMELCTL 91
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L ++L      Q ++  L+L   +  A  ++  L YL        VH D+   NVL+ 
Sbjct: 92  GELRSFL------QVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVS 142
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
           +     +GDFGLSR + D++      S+ K  I ++APE       ++  D + FG+ M 
Sbjct: 143 SNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 200
Query: 766 EMFT-GKRP 773
           E+   G +P
Sbjct: 201 EILMHGVKP 209

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 692 IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV 751
           I++ DLK  NV+LD+E    + DFG+ +   +N  D  +T    G+  Y+APE  A    
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYIAPEIIAYQPY 519
Query: 752 STHGDEYSFGILMLEMFTGKRP-----TDDMFE 779
               D ++FG+L+ EM  G+ P      D++F+
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 62  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRV----YLILEYA 116
Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPS 700
           P G++   L +  K DEQ         +  +   ++AN L Y    CH+  ++H D+KP 
Sbjct: 117 PLGTVYRELQKLSKFDEQ---------RTATYITELANALSY----CHSKRVIHRDIKPE 163
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE--- 757
           N+LL +     + DFG S  +H  S   +    + G++ Y+ PE   + E   H ++   
Sbjct: 164 NLLLGSAGELKIADFGWS--VHAPS---SRRDDLCGTLDYLPPE---MIEGRMHDEKVDL 215
Query: 758 YSFGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
           +S G+L  E   GK P + + ++E        +   PD V E
Sbjct: 216 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 257

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 19/189 (10%)
Query: 587 VAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           VA+K   +       + F+ E   +R   H ++VK+I     + T    +  ++ E    
Sbjct: 43  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI----GVITENPVW--IIMELCTL 96
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L ++L      Q ++  L+L   +  A  ++  L YL        VH D+   NVL+ 
Sbjct: 97  GELRSFL------QVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVS 147
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
           +     +GDFGLSR + D++      S+ K  I ++APE       ++  D + FG+ M 
Sbjct: 148 SNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 205
Query: 766 EMFT-GKRP 773
           E+   G +P
Sbjct: 206 EILMHGVKP 214

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 86/189 (45%), Gaps = 19/189 (10%)
Query: 587 VAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           VA+K   +       + F+ E   +R   H ++VK+I     + T    +  ++ E    
Sbjct: 44  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI----GVITENPVW--IIMELCTL 97
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L ++L      Q ++  L+L   +  A  ++  L YL        VH D+   NVL+ 
Sbjct: 98  GELRSFL------QVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVS 148
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
           +     +GDFGLSR + D++  + S  ++   I ++APE       ++  D + FG+ M 
Sbjct: 149 SNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMW 206
Query: 766 EMFT-GKRP 773
           E+   G +P
Sbjct: 207 EILMHGVKP 215

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 85/195 (43%), Gaps = 28/195 (14%)
Query: 587 VAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK++D  Q  +S  +    E   ++ + H N+VK+      I+T    +  LV E+  
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF---EVIETEKTLY--LVMEYAS 96
Query: 645 NGSLENWL--NQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
            G + ++L  + +  E+  R K            + + ++Y H      IVH DLK  N+
Sbjct: 97  GGEVFDYLVAHGRMKEKEARAKFR---------QIVSAVQYCHQKF---IVHRDLKAENL 144
Query: 703 LLDNEMVAHVGDFGLS-RLLHDNSPDQTSTSRVKGSIGYVAPE-YGALGEVSTHGDEYSF 760
           LLD +M   + DFG S      N  D        G+  Y APE +          D +S 
Sbjct: 145 LLDADMNIKIADFGFSNEFTFGNKLDAFC-----GAPPYAAPELFQGKKYDGPEVDVWSL 199
Query: 761 GILMLEMFTGKRPTD 775
           G+++  + +G  P D
Sbjct: 200 GVILYTLVSGSLPFD 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 85/195 (43%), Gaps = 28/195 (14%)
Query: 587 VAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAV+++D  Q  +S  +    E   ++ + H N+VK+      I+T    +  LV E+  
Sbjct: 42  VAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF---EVIETEKTLY--LVMEYAS 96
Query: 645 NGSLENWL--NQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
            G + ++L  + +  E+  R K            + + ++Y H      IVH DLK  N+
Sbjct: 97  GGEVFDYLVAHGRMKEKEARAKFR---------QIVSAVQYCHQKF---IVHRDLKAENL 144
Query: 703 LLDNEMVAHVGDFGLS-RLLHDNSPDQTSTSRVKGSIGYVAPE-YGALGEVSTHGDEYSF 760
           LLD +M   + DFG S      N  D        GS  Y APE +          D +S 
Sbjct: 145 LLDADMNIKIADFGFSNEFTFGNKLDTFC-----GSPPYAAPELFQGKKYDGPEVDVWSL 199
Query: 761 GILMLEMFTGKRPTD 775
           G+++  + +G  P D
Sbjct: 200 GVILYTLVSGSLPFD 214

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 84/186 (45%), Gaps = 33/186 (17%)
Query: 601 KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQN 660
           + F  E   + ++ H N+VK+     +          +V EF+P G L + L  K     
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPR-------MVMEFVPCGDLYHRLLDKAHPIK 120
Query: 661 QRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-----EMVAHVGDF 715
              KL LM      +D+A  +EY+ +  +  IVH DL+  N+ L +      + A V DF
Sbjct: 121 WSVKLRLM------LDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 716 GLSRLLHDNSPDQTSTSRVKGSIG---YVAPE-YGALGEVSTH-GDEYSFGILMLEMFTG 770
            LS         Q S   V G +G   ++APE  GA  E  T   D YSF +++  + TG
Sbjct: 174 SLS---------QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224
Query: 771 KRPTDD 776
           + P D+
Sbjct: 225 EGPFDE 230

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 32/220 (14%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 40  LALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TR----VYLILEYA 94
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPSNV 702
           P G++   L +      QR         +   ++AN L Y    CH+  ++H D+KP N+
Sbjct: 95  PLGTVYRELQKLSRFDEQRTA-------TYITELANALSY----CHSKRVIHRDIKPENL 143
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DEYS 759
           LL +     + DFG S  +H  S  +T+     G++ Y+ PE   + E   H    D +S
Sbjct: 144 LLGSNGELKIADFGWS--VHAPSSRRTTLC---GTLDYLPPE---MIEGRMHDEKVDLWS 195
Query: 760 FGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
            G+L  E   G  P +   ++E        +   PD V E
Sbjct: 196 LGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTE 235

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+E + +  L+ +
Sbjct: 37  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEHV-HQDLKTF 90
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 91  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 142
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T T  V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 143 LADFGLARAF--GVPVRTYTHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 198
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 199 RRALFPGDSEIDQLFRI--FRTLGTPDEV 225

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 56/117 (47%), Gaps = 8/117 (6%)
Query: 657 DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG 716
           DE N  P     + +     + + LE+LH     +I++ DLKP NVLLD++    + D G
Sbjct: 280 DEDN--PGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLG 334
Query: 717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           L+  L      QT T    G+ G++APE     E     D ++ G+ + EM   + P
Sbjct: 335 LAVELKAG---QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 56/117 (47%), Gaps = 8/117 (6%)
Query: 657 DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG 716
           DE N  P     + +     + + LE+LH     +I++ DLKP NVLLD++    + D G
Sbjct: 280 DEDN--PGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLG 334
Query: 717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           L+  L      QT T    G+ G++APE     E     D ++ G+ + EM   + P
Sbjct: 335 LAVELKAG---QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 56/117 (47%), Gaps = 8/117 (6%)
Query: 657 DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG 716
           DE N  P     + +     + + LE+LH     +I++ DLKP NVLLD++    + D G
Sbjct: 280 DEDN--PGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLG 334
Query: 717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           L+  L      QT T    G+ G++APE     E     D ++ G+ + EM   + P
Sbjct: 335 LAVELKAG---QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 56/117 (47%), Gaps = 8/117 (6%)
Query: 657 DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG 716
           DE N  P     + +     + + LE+LH     +I++ DLKP NVLLD++    + D G
Sbjct: 280 DEDN--PGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLG 334
Query: 717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           L+  L      QT T    G+ G++APE     E     D ++ G+ + EM   + P
Sbjct: 335 LAVELKAG---QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 82/182 (45%), Gaps = 35/182 (19%)
Query: 599 ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDE 658
             K  + E + L+ +RH NLV ++  C     +  +   LV+EF+ +  L++        
Sbjct: 67  VKKIAMREIKLLKQLRHENLVNLLEVC-----KKKKRWYLVFEFVDHTILDD-------- 113
Query: 659 QNQRPKLNLMQRLSIAIDVANVLEYLHH------HCHT-SIVHCDLKPSNVLLDNEMVAH 711
                    ++     +D   V +YL         CH+ +I+H D+KP N+L+    V  
Sbjct: 114 ---------LELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVK 164
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG--DEYSFGILMLEMFT 769
           + DFG +R L   +P +     V  +  Y APE   +G+V      D ++ G L+ EMF 
Sbjct: 165 LCDFGFARTL--AAPGEVYDDEV-ATRWYRAPEL-LVGDVKYGKAVDVWAIGCLVTEMFM 220
Query: 770 GK 771
           G+
Sbjct: 221 GE 222

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 18/174 (10%)
Query: 601 KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQN 660
           + F+ E   +R   H ++VK+I   +           ++ E    G L ++L      Q 
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENPV------WIIMELCTLGELRSFL------QV 483
Query: 661 QRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL 720
           ++  L+L   +  A  ++  L YL        VH D+   NVL+ +     +GDFGLSR 
Sbjct: 484 RKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540
Query: 721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
           + D++      S+ K  I ++APE       ++  D + FG+ M E+   G +P
Sbjct: 541 MEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 84/189 (44%), Gaps = 19/189 (10%)
Query: 587 VAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           VA+K   +       + F+ E   +R   H ++VK+I     + T    +  ++ E    
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI----GVITENPVW--IIMELCTL 94
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L ++L      Q ++  L+L   +  A  ++  L YL        VH D+   NVL+ 
Sbjct: 95  GELRSFL------QVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVS 145
Query: 706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILML 765
                 +GDFGLSR + D++      S+ K  I ++APE       ++  D + FG+ M 
Sbjct: 146 ATDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 203
Query: 766 EMFT-GKRP 773
           E+   G +P
Sbjct: 204 EILMHGVKP 212

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 85/195 (43%), Gaps = 21/195 (10%)
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
           F+   SL +   ++  E   +  L L   +  +  VA  +E+L        +H DL   N
Sbjct: 165 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARN 221
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +LL  + V  + DFGL+R ++ + PD       +  + ++APE       +   D +SFG
Sbjct: 222 ILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 280
Query: 762 ILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGI 815
           +L+ E+F+ G  P      D+ F     L +  +M  PD       P + +  L+   G 
Sbjct: 281 VLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTRMRAPDYTT----PEMYQTMLDCWHG- 333
Query: 816 VKELQPNLRAKFHEI 830
               +P+ R  F E+
Sbjct: 334 ----EPSQRPTFSEL 344

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 92/200 (46%), Gaps = 33/200 (16%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           + A+K + +   +   + F  E E L  +  H N++ ++ +C   + RG  + A+  E+ 
Sbjct: 54  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYLAI--EYA 108
Query: 644 PNGSLENWLNQKED---------EQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVH 694
           P+G+L ++L +              +    L+  Q L  A DVA  ++YL        +H
Sbjct: 109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIH 165
Query: 695 CDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV--- 751
            DL   N+L+    VA + DFGLSR              VK ++G +   + A+  +   
Sbjct: 166 RDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTMGRLPVRWMAIESLNYS 216
Query: 752 --STHGDEYSFGILMLEMFT 769
             +T+ D +S+G+L+ E+ +
Sbjct: 217 VYTTNSDVWSYGVLLWEIVS 236

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 41/224 (18%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRS--IRHRNLVKIITSCSSIDTRGNEFKA---LVYE 641
           VAVK+  LQ +   +S+ +E E   +  ++H NL++ I +    + RG+  +    L+  
Sbjct: 41  VAVKIFPLQDK---QSWQSEREIFSTPGMKHENLLQFIAA----EKRGSNLEVELWLITA 93
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH---HCH-----TSIV 693
           F   GSL ++L       N+           +A  ++  L YLH     C       SI 
Sbjct: 94  FHDKGSLTDYLKGNIITWNEL--------CHVAETMSRGLSYLHEDVPWCRGEGHKPSIA 145
Query: 694 HCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY--GALG-- 749
           H D K  NVLL +++ A + DFGL+       P   +  +V G+  Y+APE   GA+   
Sbjct: 146 HRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV-GTRRYMAPEVLEGAINFQ 204
Query: 750 -EVSTHGDEYSFGILMLEMFTGKR----PTDDM---FEEGLSLH 785
            +     D Y+ G+++ E+ +  +    P D+    FEE +  H
Sbjct: 205 RDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQH 248

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 92/200 (46%), Gaps = 33/200 (16%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           + A+K + +   +   + F  E E L  +  H N++ ++ +C   + RG  + A+  E+ 
Sbjct: 44  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYLAI--EYA 98
Query: 644 PNGSLENWLNQKED---------EQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVH 694
           P+G+L ++L +              +    L+  Q L  A DVA  ++YL        +H
Sbjct: 99  PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIH 155
Query: 695 CDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV--- 751
            DL   N+L+    VA + DFGLSR              VK ++G +   + A+  +   
Sbjct: 156 RDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTMGRLPVRWMAIESLNYS 206
Query: 752 --STHGDEYSFGILMLEMFT 769
             +T+ D +S+G+L+ E+ +
Sbjct: 207 VYTTNSDVWSYGVLLWEIVS 226

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 85/195 (43%), Gaps = 21/195 (10%)
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
           F+   SL +   ++  E   +  L L   +  +  VA  +E+L        +H DL   N
Sbjct: 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARN 223
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +LL  + V  + DFGL+R ++ + PD       +  + ++APE       +   D +SFG
Sbjct: 224 ILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 282
Query: 762 ILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGI 815
           +L+ E+F+ G  P      D+ F     L +  +M  PD       P + +  L+   G 
Sbjct: 283 VLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTRMRAPDYTT----PEMYQTMLDCWHG- 335
Query: 816 VKELQPNLRAKFHEI 830
               +P+ R  F E+
Sbjct: 336 ----EPSQRPTFSEL 346

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 31/196 (15%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++    +    R   +  L+ EF 
Sbjct: 42  MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY---NYFHDRKRIY--LMLEFA 96
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHT-SIVHCDLKPSNV 702
           P G L   L QK    +++     M+ L+ A+          H+CH   ++H D+KP N+
Sbjct: 97  PRGELYKEL-QKHGRFDEQRSATFMEELADAL----------HYCHERKVIHRDIKPENL 145
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DEYS 759
           L+  +    + DFG S  +H  S  +       G++ Y+ PE   + E  TH    D + 
Sbjct: 146 LMGYKGELKIADFGWS--VHAPSLRRRXMC---GTLDYLPPE---MIEGKTHDEKVDLWC 197
Query: 760 FGILMLEMFTGKRPTD 775
            G+L  E   G  P D
Sbjct: 198 AGVLCYEFLVGMPPFD 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 31/196 (15%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++    +    R   +  L+ EF 
Sbjct: 43  MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY---NYFHDRKRIY--LMLEFA 97
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHT-SIVHCDLKPSNV 702
           P G L   L QK    +++     M+ L+ A+          H+CH   ++H D+KP N+
Sbjct: 98  PRGELYKEL-QKHGRFDEQRSATFMEELADAL----------HYCHERKVIHRDIKPENL 146
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DEYS 759
           L+  +    + DFG S  +H  S  +       G++ Y+ PE   + E  TH    D + 
Sbjct: 147 LMGYKGELKIADFGWS--VHAPSLRRRXMC---GTLDYLPPE---MIEGKTHDEKVDLWC 198
Query: 760 FGILMLEMFTGKRPTD 775
            G+L  E   G  P D
Sbjct: 199 AGVLCYEFLVGMPPFD 214

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 118/279 (42%), Gaps = 52/279 (18%)
Query: 605 AECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPK 664
            E E L+ + H  ++KI     + D        +V E M  G L + +   +  +    K
Sbjct: 203 TEIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCK 256
Query: 665 LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAHVGDFGLSRLL 721
           L   Q L         ++YLH +    I+H DLKP NVLL   + + +  + DFG S++L
Sbjct: 257 LYFYQMLL-------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 306
Query: 722 HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRPTDD 776
            + S  +T    + G+  Y+APE   L  V T G     D +S G+++    +G  P   
Sbjct: 307 GETSLMRT----LCGTPTYLAPE--VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--- 357
Query: 777 MFEEGLSLHKYAKMGLPDQVAE---IIDPAILEEALEIQAGIVKEL---QPNLRAKFHEI 830
                 S H+  ++ L DQ+        P +  E  E    +VK+L    P  R    E 
Sbjct: 358 -----FSEHR-TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE- 410
Query: 831 QVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQAI 869
               LR   L  E++ R   K QD + E  E+  + Q +
Sbjct: 411 ---ALRHPWLQDEDMKR---KFQDLLSEENESTALPQVL 443

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 59/114 (51%), Gaps = 15/114 (13%)
Query: 666 NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS-RLLHDN 724
            ++ ++++AI     L YL       ++H D+KPSN+LLD      + DFG+S RL+ D 
Sbjct: 124 RILGKMTVAI--VKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179
Query: 725 SPDQTSTSRVKGSIGYVAPEY-----GALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + D+++     G   Y+APE          +     D +S GI ++E+ TG+ P
Sbjct: 180 AKDRSA-----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 85/195 (43%), Gaps = 21/195 (10%)
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
           F+   SL +   ++  E   +  L L   +  +  VA  +E+L        +H DL   N
Sbjct: 172 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARN 228
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +LL  + V  + DFGL+R ++ + PD       +  + ++APE       +   D +SFG
Sbjct: 229 ILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 287
Query: 762 ILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGI 815
           +L+ E+F+ G  P      D+ F     L +  +M  PD       P + +  L+   G 
Sbjct: 288 VLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTRMRAPDYTT----PEMYQTMLDCWHG- 340
Query: 816 VKELQPNLRAKFHEI 830
               +P+ R  F E+
Sbjct: 341 ----EPSQRPTFSEL 351

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 77/174 (44%), Gaps = 18/174 (10%)
Query: 601 KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQN 660
           + F+ E   +R   H ++VK+I   +           ++ E    G L ++L      Q 
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENPV------WIIMELCTLGELRSFL------QV 483
Query: 661 QRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL 720
           ++  L+L   +  A  ++  L YL        VH D+   NVL+       +GDFGLSR 
Sbjct: 484 RKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRY 540
Query: 721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
           + D++      S+ K  I ++APE       ++  D + FG+ M E+   G +P
Sbjct: 541 MEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 85/195 (43%), Gaps = 21/195 (10%)
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
           F+   SL +   ++  E   +  L L   +  +  VA  +E+L        +H DL   N
Sbjct: 174 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARN 230
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +LL  + V  + DFGL+R ++ + PD       +  + ++APE       +   D +SFG
Sbjct: 231 ILLSEKNVVKICDFGLARDIYKD-PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 289
Query: 762 ILMLEMFT-GKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGI 815
           +L+ E+F+ G  P      D+ F     L +  +M  PD       P + +  L+   G 
Sbjct: 290 VLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTRMRAPDYTT----PEMYQTMLDCWHG- 342
Query: 816 VKELQPNLRAKFHEI 830
               +P+ R  F E+
Sbjct: 343 ----EPSQRPTFSEL 353

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 582 TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           TEE  VAVK++D+++     ++   E    + + H N+VK          R    + L  
Sbjct: 30  TEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH-----RREGNIQYLFL 83
Query: 641 EFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           E+   G L + +       +   QR    LM         A V+ YLH      I H D+
Sbjct: 84  EYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVV-YLHG---IGITHRDI 130
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-D 756
           KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVAPE     E      D
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMXGTLPYVAPELLKRREFHAEPVD 189
Query: 757 EYSFGILMLEMFTGKRPTD 775
            +S GI++  M  G+ P D
Sbjct: 190 VWSCGIVLTAMLAGELPWD 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 582 TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           TEE  VAVK++D+++     ++   E    + + H N+VK          R    + L  
Sbjct: 31  TEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH-----RREGNIQYLFL 84
Query: 641 EFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           E+   G L + +       +   QR    LM         A V+ YLH      I H D+
Sbjct: 85  EYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVV-YLHG---IGITHRDI 131
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-D 756
           KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVAPE     E      D
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMXGTLPYVAPELLKRREFHAEPVD 190
Query: 757 EYSFGILMLEMFTGKRPTD 775
            +S GI++  M  G+ P D
Sbjct: 191 VWSCGIVLTAMLAGELPWD 209

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 26/194 (13%)
Query: 587 VAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK++D  Q   +  +    E   ++ + H N+VK+      I+T    +  LV E+  
Sbjct: 43  VAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF---EVIETEKTLY--LVMEYAS 97
Query: 645 NGSLENWL--NQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
            G + ++L  + +  E+  R K            + + ++Y H      IVH DLK  N+
Sbjct: 98  GGEVFDYLVAHGRMKEKEARAKFR---------QIVSAVQYCHQKY---IVHRDLKAENL 145
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE-YGALGEVSTHGDEYSFG 761
           LLD +M   + DFG S      +   T      GS  Y APE +          D +S G
Sbjct: 146 LLDGDMNIKIADFGFSNEFTVGNKLDTFC----GSPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 762 ILMLEMFTGKRPTD 775
           +++  + +G  P D
Sbjct: 202 VILYTLVSGSLPFD 215

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 93/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V +++L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 75  EKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 128
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 129 TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 179
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 180 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 237
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 238 SYGVTVWELMTFGSKPYD 255

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 24/192 (12%)
Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKA-LVYEFMPNGSLENWLNQKEDEQNQRPK 664
           E +  R   H N+++++  C  +  RG + +A L+  F   G+L N + + +D+ N    
Sbjct: 76  EADMHRLFNHPNILRLVAYC--LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN---F 130
Query: 665 LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL--SRLLH 722
           L   Q L + + +   LE +H        H DLKP+N+LL +E    + D G      +H
Sbjct: 131 LTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187
Query: 723 DNSPDQTST----SRVKGSIGYVAPEYGALGEVSTH------GDEYSFGILMLEMFTGKR 772
                Q  T    +  + +I Y APE   L  V +H       D +S G ++  M  G+ 
Sbjct: 188 VEGSRQALTLQDWAAQRCTISYRAPE---LFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
Query: 773 PTDDMFEEGLSL 784
           P D +F++G S+
Sbjct: 245 PYDMVFQKGDSV 256

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 73/167 (43%), Gaps = 26/167 (15%)
Query: 613 IRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLS 672
           +  RN VK +T+     T       +  E+  NG+L + ++ +   Q +     L ++  
Sbjct: 72  LERRNFVKPMTAVKKKSTL-----FIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ-- 124
Query: 673 IAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH--------DN 724
               +   L Y+H      I+H DLKP N+ +D      +GDFGL++ +H        D+
Sbjct: 125 ----ILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 725 SPDQTSTSRVKGSIG---YVAPEY-GALGEVSTHGDEYSFGILMLEM 767
                S+  +  +IG   YVA E     G  +   D YS GI+  EM
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 25/172 (14%)
Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSL-ENWLNQKEDEQNQRPK 664
           E   L+S+ H N++K+            ++  LV EF   G L E  +N        R K
Sbjct: 96  EISLLKSLDHPNIIKLFDVFED-----KKYFYLVTEFYEGGELFEQIIN--------RHK 142
Query: 665 LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE---MVAHVGDFGLSRLL 721
            +     +I   + + + YLH H   +IVH D+KP N+LL+N+   +   + DFGLS   
Sbjct: 143 FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
Query: 722 HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
              S D     R+ G+  Y+APE     + +   D +S G++M  +  G  P
Sbjct: 200 ---SKDYKLRDRL-GTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           LD +  G   + I E   L+ + H N+VK++     I T    +  LV+E + +  L+ +
Sbjct: 41  LDTETEGVPSTAIREISLLKELNHPNIVKLL---DVIHTENKLY--LVFEHV-DQDLKKF 94
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           ++         P +      S    +   L + H H    ++H DLKP N+L++ E    
Sbjct: 95  MDASALTGIPLPLIK-----SYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 146
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFT 769
           + DFGL+R      P +T    V  ++ Y APE   LG    ST  D +S G +  EM T
Sbjct: 147 LADFGLARAF--GVPVRTYXHEVV-TLWYRAPEI-LLGCKYYSTAVDIWSLGCIFAEMVT 202
Query: 770 GKR--PTDDMFEEGLSLHKYAKMGLPDQV 796
            +   P D   ++   +  +  +G PD+V
Sbjct: 203 RRALFPGDSEIDQLFRI--FRTLGTPDEV 229

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 83/194 (42%), Gaps = 26/194 (13%)
Query: 587 VAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VA+K++D  Q   +  +    E   ++ + H N+VK+      I+T    +  L+ E+  
Sbjct: 40  VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF---EVIETEKTLY--LIMEYAS 94
Query: 645 NGSLENWL--NQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
            G + ++L  + +  E+  R K            + + ++Y H      IVH DLK  N+
Sbjct: 95  GGEVFDYLVAHGRMKEKEARSKFR---------QIVSAVQYCHQ---KRIVHRDLKAENL 142
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE-YGALGEVSTHGDEYSFG 761
           LLD +M   + DFG S          T      GS  Y APE +          D +S G
Sbjct: 143 LLDADMNIKIADFGFSNEFTVGGKLDTFC----GSPPYAAPELFQGKKYDGPEVDVWSLG 198
Query: 762 ILMLEMFTGKRPTD 775
           +++  + +G  P D
Sbjct: 199 VILYTLVSGSLPFD 212

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 124/255 (48%), Gaps = 32/255 (12%)
Query: 586 NVAVK--VLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA---LVY 640
            VA+K  +++ ++ G   + + E + L+ ++H N+V +I  C +  +  N  KA   LV+
Sbjct: 45  KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVF 104
Query: 641 EFMPN---GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           +F  +   G L N L +    + +R    +MQ L       N L Y+H +    I+H D+
Sbjct: 105 DFCEHDLAGLLSNVLVKFTLSEIKR----VMQML------LNGLYYIHRN---KILHRDM 151
Query: 698 KPSNVLLDNEMVAHVGDFGLSRL--LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           K +NVL+  + V  + DFGL+R   L  NS      +RV  ++ Y  PE   LGE   +G
Sbjct: 152 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV-VTLWYRPPEL-LLGE-RDYG 208
Query: 756 ---DEYSFGILMLEMFTGKRP--TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALE 810
              D +  G +M EM+T + P    +  +  L+L       +  +V   +D   L E LE
Sbjct: 209 PPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE 267
Query: 811 IQAGIVKELQPNLRA 825
           +  G  ++++  L+A
Sbjct: 268 LVKGQKRKVKDRLKA 282

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 66/130 (50%), Gaps = 16/130 (12%)
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           +L++W+N++   +++   + L     I I +A  +E+LH      ++H DLKPSN+    
Sbjct: 147 NLKDWMNRRCSLEDREHGVCL----HIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTM 199
Query: 707 EMVAHVGDFGLSRLLHDNSPDQT------STSRVKGSIG---YVAPEYGALGEVSTHGDE 757
           + V  VGDFGL   +  +  +QT      + +   G +G   Y++PE       S   D 
Sbjct: 200 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDI 259
Query: 758 YSFGILMLEM 767
           +S G+++ E+
Sbjct: 260 FSLGLILFEL 269

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 80/183 (43%), Gaps = 24/183 (13%)
Query: 596 QRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           +RG S+  I  E   LR + H N   +IT     + R +    L+ E +  G L ++L Q
Sbjct: 54  RRGVSREEIEREVSILRQVLHHN---VITLHDVYENRTD--VVLILELVSGGELFDFLAQ 108
Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL--DNEMVAHV 712
           KE        L+  +  S    + + + YLH      I H DLKP N++L   N  + H+
Sbjct: 109 KE-------SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 713 G--DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
              DFGL+  + D          + G+  +VAPE      +    D +S G++   + +G
Sbjct: 159 KLIDFGLAHEIEDG----VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
Query: 771 KRP 773
             P
Sbjct: 215 ASP 217

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 18/169 (10%)
Query: 605 AECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPK 664
           AE   L  ++H  +V +I +     T G  +  L+ E++  G L     Q E E      
Sbjct: 70  AERNILEEVKHPFIVDLIYA---FQTGGKLY--LILEYLSGGEL---FMQLERE------ 115
Query: 665 LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
             +    +    +A +   L H     I++ DLKP N++L+++    + DFGL +   ++
Sbjct: 116 -GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK---ES 171
Query: 725 SPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
             D T T    G+I Y+APE       +   D +S G LM +M TG  P
Sbjct: 172 IHDGTVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 18/169 (10%)
Query: 605 AECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPK 664
           AE   L  ++H  +V +I    +  T G  +  L+ E++  G L     Q E E      
Sbjct: 70  AERNILEEVKHPFIVDLI---YAFQTGGKLY--LILEYLSGGEL---FMQLERE------ 115
Query: 665 LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
             +    +    +A +   L H     I++ DLKP N++L+++    + DFGL +   ++
Sbjct: 116 -GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK---ES 171
Query: 725 SPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
             D T T    G+I Y+APE       +   D +S G LM +M TG  P
Sbjct: 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 582 TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           TEE  VAVK++D+++     ++   E    + + H N+VK          R    + L  
Sbjct: 30  TEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH-----RREGNIQYLFL 83
Query: 641 EFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           E+   G L + +       +   QR    LM         A V+ YLH      I H D+
Sbjct: 84  EYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVV-YLHG---IGITHRDI 130
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-D 756
           KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVAPE     E      D
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 757 EYSFGILMLEMFTGKRPTD 775
            +S GI++  M  G+ P D
Sbjct: 190 VWSCGIVLTAMLAGELPWD 208

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 32/220 (14%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           +A+KVL    L++ G       E E    +RH N++++        TR      L+ E+ 
Sbjct: 40  LALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TR----VYLILEYA 94
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPSNV 702
           P G++   L +      QR         +   ++AN L Y    CH+  ++H D+KP N+
Sbjct: 95  PLGTVYRELQKLSRFDEQRTA-------TYITELANALSY----CHSKRVIHRDIKPENL 143
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DEYS 759
           LL +     + DFG S  +H  S  + +     G++ Y+ PE   + E   H    D +S
Sbjct: 144 LLGSNGELKIADFGWS--VHAPSSRRDTLC---GTLDYLPPE---MIEGRMHDEKVDLWS 195
Query: 760 FGILMLEMFTGKRPTD-DMFEEGLSLHKYAKMGLPDQVAE 798
            G+L  E   G  P +   ++E        +   PD V E
Sbjct: 196 LGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTE 235

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 586 NVAVKVLDLQQRGASKS--FIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           ++ VKVL ++     KS  F  EC  LR   H N++ ++ +C S          L+  +M
Sbjct: 35  DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA---PHPTLITHWM 91
Query: 644 PNGSLENWLNQKED---EQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           P GSL N L++  +   +Q+Q  K         A+D+A  + +L H     I    L   
Sbjct: 92  PYGSLYNVLHEGTNFVVDQSQAVKF--------ALDMARGMAFL-HTLEPLIPRHALNSR 142
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH---GDE 757
           +V++D +M A +        + D      S  R+     +VAPE        T+    D 
Sbjct: 143 SVMIDEDMTARIS-------MADVKFSFQSPGRMYAP-AWVAPEALQKKPEDTNRRSADM 194
Query: 758 YSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAI 804
           +SF +L+ E+ T + P  D+    + + K A  GL   +   I P +
Sbjct: 195 WSFAVLLWELVTREVPFADLSNMEIGM-KVALEGLRPTIPPGISPHV 240

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 80/183 (43%), Gaps = 24/183 (13%)
Query: 596 QRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           +RG S+  I  E   LR + H N   +IT     + R +    L+ E +  G L ++L Q
Sbjct: 54  RRGVSREEIEREVSILRQVLHHN---VITLHDVYENRTD--VVLILELVSGGELFDFLAQ 108
Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL--DNEMVAHV 712
           KE        L+  +  S    + + + YLH      I H DLKP N++L   N  + H+
Sbjct: 109 KES-------LSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 713 G--DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
              DFGL+  + D          + G+  +VAPE      +    D +S G++   + +G
Sbjct: 159 KLIDFGLAHEIEDG----VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
Query: 771 KRP 773
             P
Sbjct: 215 ASP 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 80/183 (43%), Gaps = 24/183 (13%)
Query: 596 QRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           +RG S+  I  E   LR + H N   +IT     + R +    L+ E +  G L ++L Q
Sbjct: 54  RRGVSREEIEREVSILRQVLHHN---VITLHDVYENRTD--VVLILELVSGGELFDFLAQ 108
Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL--DNEMVAHV 712
           KE        L+  +  S    + + + YLH      I H DLKP N++L   N  + H+
Sbjct: 109 KES-------LSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 713 G--DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
              DFGL+  + D          + G+  +VAPE      +    D +S G++   + +G
Sbjct: 159 KLIDFGLAHEIEDG----VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
Query: 771 KRP 773
             P
Sbjct: 215 ASP 217

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 582 TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           TEE  VAVK++D+++     ++   E    + + H N+VK          R    + L  
Sbjct: 30  TEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-----RREGNIQYLFL 83
Query: 641 EFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           E+   G L + +       +   QR    LM         A V+ YLH      I H D+
Sbjct: 84  EYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVV-YLHG---IGITHRDI 130
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-D 756
           KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVAPE     E      D
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMXGTLPYVAPELLKRREFHAEPVD 189
Query: 757 EYSFGILMLEMFTGKRPTD 775
            +S GI++  M  G+ P D
Sbjct: 190 VWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 582 TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           TEE  VAVK++D+++     ++   E    + + H N+VK          R    + L  
Sbjct: 30  TEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-----RREGNIQYLFL 83
Query: 641 EFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           E+   G L + +       +   QR    LM         A V+ YLH      I H D+
Sbjct: 84  EYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVV-YLHG---IGITHRDI 130
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-D 756
           KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVAPE     E      D
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMXGTLPYVAPELLKRREFHAEPVD 189
Query: 757 EYSFGILMLEMFTGKRPTD 775
            +S GI++  M  G+ P D
Sbjct: 190 VWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 582 TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           TEE  VAVK++D+++     ++   E    + + H N+VK          R    + L  
Sbjct: 30  TEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-----RREGNIQYLFL 83
Query: 641 EFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           E+   G L + +       +   QR    LM         A V+ YLH      I H D+
Sbjct: 84  EYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVV-YLHG---IGITHRDI 130
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-D 756
           KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVAPE     E      D
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMXGTLPYVAPELLKRREFHAEPVD 189
Query: 757 EYSFGILMLEMFTGKRPTD 775
            +S GI++  M  G+ P D
Sbjct: 190 VWSCGIVLTAMLAGELPWD 208

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 81/185 (43%), Gaps = 17/185 (9%)
Query: 590 KVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLE 649
           ++ ++QQ    ++F+ E   +R + H N++ +I     I         ++  +M +G L 
Sbjct: 59  RITEMQQ---VEAFLREGLLMRGLNHPNVLALI----GIMLPPEGLPHVLLPYMCHGDLL 111
Query: 650 NWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV 709
            ++   +    + P +  +  +S  + VA  +EYL        VH DL   N +LD    
Sbjct: 112 QFIRSPQ----RNPTVKDL--ISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFT 162
Query: 710 AHVGDFGLSRLLHDNSPDQTSTSR-VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMF 768
             V DFGL+R + D         R  +  + + A E       +T  D +SFG+L+ E+ 
Sbjct: 163 VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
Query: 769 TGKRP 773
           T   P
Sbjct: 223 TRGAP 227

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 80/183 (43%), Gaps = 24/183 (13%)
Query: 596 QRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           +RG S+  I  E   LR + H N   +IT     + R +    L+ E +  G L ++L Q
Sbjct: 54  RRGVSREEIEREVSILRQVLHHN---VITLHDVYENRTD--VVLILELVSGGELFDFLAQ 108
Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL--DNEMVAHV 712
           KE        L+  +  S    + + + YLH      I H DLKP N++L   N  + H+
Sbjct: 109 KES-------LSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 713 G--DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
              DFGL+  + D          + G+  +VAPE      +    D +S G++   + +G
Sbjct: 159 KLIDFGLAHEIEDG----VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
Query: 771 KRP 773
             P
Sbjct: 215 ASP 217

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 57/117 (48%), Gaps = 7/117 (5%)
Query: 659 QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS 718
           Q QR KL        + +++  L YLH      I++ DLK  NVLLD+E    + D+G+ 
Sbjct: 113 QRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMC 168
Query: 719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTD 775
           +      P  T TS   G+  Y+APE     +     D ++ G+LM EM  G+ P D
Sbjct: 169 K--EGLRPGDT-TSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 80/183 (43%), Gaps = 24/183 (13%)
Query: 596 QRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           +RG S+  I  E   LR + H N   +IT     + R +    L+ E +  G L ++L Q
Sbjct: 54  RRGVSREEIEREVSILRQVLHHN---VITLHDVYENRTD--VVLILELVSGGELFDFLAQ 108
Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL--DNEMVAHV 712
           KE        L+  +  S    + + + YLH      I H DLKP N++L   N  + H+
Sbjct: 109 KES-------LSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 713 G--DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
              DFGL+  + D          + G+  +VAPE      +    D +S G++   + +G
Sbjct: 159 KLIDFGLAHEIEDG----VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
Query: 771 KRP 773
             P
Sbjct: 215 ASP 217

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 41  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 94
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 95  TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 145
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 203
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 204 SYGVTVWELMTFGSKPYD 221

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 33/200 (16%)
Query: 586 NVAVKVL-DLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           + A+K + +   +   + F  E E L  +  H N++ ++ +C   + RG  + A+  E+ 
Sbjct: 51  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYLAI--EYA 105
Query: 644 PNGSLENWLNQKED---------EQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVH 694
           P+G+L ++L +              +    L+  Q L  A DVA  ++YL        +H
Sbjct: 106 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIH 162
Query: 695 CDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV--- 751
            +L   N+L+    VA + DFGLSR              VK ++G +   + A+  +   
Sbjct: 163 RNLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTMGRLPVRWMAIESLNYS 213
Query: 752 --STHGDEYSFGILMLEMFT 769
             +T+ D +S+G+L+ E+ +
Sbjct: 214 VYTTNSDVWSYGVLLWEIVS 233

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 57/117 (48%), Gaps = 7/117 (5%)
Query: 659 QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS 718
           Q QR KL        + +++  L YLH      I++ DLK  NVLLD+E    + D+G+ 
Sbjct: 145 QRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMC 200
Query: 719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTD 775
           +      P  T TS   G+  Y+APE     +     D ++ G+LM EM  G+ P D
Sbjct: 201 K--EGLRPGDT-TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 57/117 (48%), Gaps = 7/117 (5%)
Query: 659 QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS 718
           Q QR KL        + +++  L YLH      I++ DLK  NVLLD+E    + D+G+ 
Sbjct: 98  QRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMC 153
Query: 719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTD 775
           +      P  T TS   G+  Y+APE     +     D ++ G+LM EM  G+ P D
Sbjct: 154 K--EGLRPGDT-TSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 44  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 97
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 98  MQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 148
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 149 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 206
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 207 SYGVTVWELMTFGSKPYD 224

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 48  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 101
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 102 MQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 152
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 153 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 210
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 211 SYGVTVWELMTFGSKPYD 228

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 42  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 95
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 96  MQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 146
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 147 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 204
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 205 SYGVTVWELMTFGSKPYD 222

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 43  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 96
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 97  MQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 147
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 148 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 205
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 206 SYGVTVWELMTFGSKPYD 223

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 42  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 95
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 96  MQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 146
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 147 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 204
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 205 SYGVTVWELMTFGSKPYD 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 41  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 94
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 95  MQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 145
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 203
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 204 SYGVTVWELMTFGSKPYD 221

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 27/215 (12%)
Query: 583 EETNVAVKVLDLQQRGAS-KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++  VA+K ++L++   S    + E +A+    H N+V   TS    D        LV +
Sbjct: 34  KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW-----LVMK 88
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            +  GS+ + +  K        K  ++   +IA  +  VLE L +      +H D+K  N
Sbjct: 89  LLSGGSVLDII--KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGN 146
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YVAPEYGALGEVSTH---G 755
           +LL  +    + DFG+S  L     D T     K  +G   ++APE   + +V  +    
Sbjct: 147 ILLGEDGSVQIADFGVSAFLATGG-DITRNKVRKTFVGTPCWMAPE--VMEQVRGYDFKA 203
Query: 756 DEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM 790
           D +SFGI  +E+ TG  P           HKY  M
Sbjct: 204 DIWSFGITAIELATGAAP----------YHKYPPM 228

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 45  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 98
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 99  MQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 149
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 150 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 207
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 208 SYGVTVWELMTFGSKPYD 225

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 118/278 (42%), Gaps = 52/278 (18%)
Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL 665
           E E L+ + H  ++KI     + D        +V E M  G L + +   +  +    KL
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 666 NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAHVGDFGLSRLLH 722
              Q L         ++YLH +    I+H DLKP NVLL   + + +  + DFG S++L 
Sbjct: 119 YFYQMLL-------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 723 DNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRPTDDM 777
           + S  +T    + G+  Y+APE   L  V T G     D +S G+++    +G  P    
Sbjct: 169 ETSLMRT----LCGTPTYLAPE--VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---- 218
Query: 778 FEEGLSLHKYAKMGLPDQVAE---IIDPAILEEALEIQAGIVKEL---QPNLRAKFHEIQ 831
                S H+  ++ L DQ+        P +  E  E    +VK+L    P  R    E  
Sbjct: 219 ----FSEHR-TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE-- 271
Query: 832 VSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQAI 869
              LR   L  E++ R   K QD + E  E+  + Q +
Sbjct: 272 --ALRHPWLQDEDMKR---KFQDLLSEENESTALPQVL 304

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 57/117 (48%), Gaps = 7/117 (5%)
Query: 659 QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS 718
           Q QR KL        + +++  L YLH      I++ DLK  NVLLD+E    + D+G+ 
Sbjct: 102 QRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
Query: 719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTD 775
           +      P  T TS   G+  Y+APE     +     D ++ G+LM EM  G+ P D
Sbjct: 158 K--EGLRPGDT-TSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 48  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 101
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 102 TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 152
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 153 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 210
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 211 SYGVTVWELMTFGSKPYD 228

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 118/278 (42%), Gaps = 52/278 (18%)
Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL 665
           E E L+ + H  ++KI     + D        +V E M  G L + +   +  +    KL
Sbjct: 71  EIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKL 124
Query: 666 NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAHVGDFGLSRLLH 722
              Q L         ++YLH +    I+H DLKP NVLL   + + +  + DFG S++L 
Sbjct: 125 YFYQMLL-------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 174
Query: 723 DNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRPTDDM 777
           + S  +T    + G+  Y+APE   L  V T G     D +S G+++    +G  P    
Sbjct: 175 ETSLMRT----LCGTPTYLAPE--VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---- 224
Query: 778 FEEGLSLHKYAKMGLPDQVAE---IIDPAILEEALEIQAGIVKEL---QPNLRAKFHEIQ 831
                S H+  ++ L DQ+        P +  E  E    +VK+L    P  R    E  
Sbjct: 225 ----FSEHR-TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE-- 277
Query: 832 VSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQAI 869
              LR   L  E++ R   K QD + E  E+  + Q +
Sbjct: 278 --ALRHPWLQDEDMKR---KFQDLLSEENESTALPQVL 310

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 79/183 (43%), Gaps = 22/183 (12%)
Query: 597 RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE 656
           +G   S   E   LR I+H N+V +      I    N    LV + +  G L + + +K 
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVAL----EDIYESPNHL-YLVMQLVSGGELFDRIVEKG 115
Query: 657 DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAHVG 713
               +     + Q       V + + YLH      IVH DLKP N+L    D E    + 
Sbjct: 116 FYTEKDASTLIRQ-------VLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMIS 165
Query: 714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           DFGLS++  +   D  ST+   G+ GYVAPE  A    S   D +S G++   +  G  P
Sbjct: 166 DFGLSKM--EGKGDVMSTAC--GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221
Query: 774 TDD 776
             D
Sbjct: 222 FYD 224

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 41  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 94
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 95  TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 145
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 203
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 204 SYGVTVWELMTFGSKPYD 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 118/278 (42%), Gaps = 52/278 (18%)
Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL 665
           E E L+ + H  ++KI     + D        +V E M  G L + +   +  +    KL
Sbjct: 64  EIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKL 117
Query: 666 NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAHVGDFGLSRLLH 722
              Q L         ++YLH +    I+H DLKP NVLL   + + +  + DFG S++L 
Sbjct: 118 YFYQMLL-------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 167
Query: 723 DNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRPTDDM 777
           + S  +T    + G+  Y+APE   L  V T G     D +S G+++    +G  P    
Sbjct: 168 ETSLMRT----LCGTPTYLAPE--VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---- 217
Query: 778 FEEGLSLHKYAKMGLPDQVAE---IIDPAILEEALEIQAGIVKEL---QPNLRAKFHEIQ 831
                S H+  ++ L DQ+        P +  E  E    +VK+L    P  R    E  
Sbjct: 218 ----FSEHR-TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE-- 270
Query: 832 VSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQAI 869
              LR   L  E++ R   K QD + E  E+  + Q +
Sbjct: 271 --ALRHPWLQDEDMKR---KFQDLLSEENESTALPQVL 303

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 48  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 101
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 102 TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 152
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 153 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 210
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 211 SYGVTVWELMTFGSKPYD 228

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 38  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 91
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 92  TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEGMNYLEDR---RLVHRDLAA 142
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 143 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 200
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 201 SYGVTVWELMTFGSKPYD 218

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 41  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 94
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 95  TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 145
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 203
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 204 SYGVTVWELMTFGSKPYD 221

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 41  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 94
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 95  TQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 145
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 203
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 204 SYGVTVWELMTFGSKPYD 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 118/278 (42%), Gaps = 52/278 (18%)
Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL 665
           E E L+ + H  ++KI     + D        +V E M  G L + +   +  +    KL
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 666 NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAHVGDFGLSRLLH 722
              Q L         ++YLH +    I+H DLKP NVLL   + + +  + DFG S++L 
Sbjct: 119 YFYQMLL-------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 723 DNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRPTDDM 777
           + S  +T    + G+  Y+APE   L  V T G     D +S G+++    +G  P    
Sbjct: 169 ETSLMRT----LCGTPTYLAPE--VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---- 218
Query: 778 FEEGLSLHKYAKMGLPDQVAE---IIDPAILEEALEIQAGIVKEL---QPNLRAKFHEIQ 831
                S H+  ++ L DQ+        P +  E  E    +VK+L    P  R    E  
Sbjct: 219 ----FSEHR-TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE-- 271
Query: 832 VSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQAI 869
              LR   L  E++ R   K QD + E  E+  + Q +
Sbjct: 272 --ALRHPWLQDEDMKR---KFQDLLSEENESTALPQVL 304

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 44  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 97
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 98  TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 148
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 149 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 206
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 207 SYGVTVWELMTFGSKPYD 224

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 43  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 96
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 97  TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 147
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 148 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 205
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 206 SYGVTVWELMTFGSKPYD 223

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 44  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 97
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 98  TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 148
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 149 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 206
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 207 SYGVTVWELMTFGSKPYD 224

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 44  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 97
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 98  TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 148
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 149 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 206
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 207 SYGVTVWELMTFGSKPYD 224

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 35  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 88
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 89  TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 139
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 140 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 197
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 198 SYGVTVWELMTFGSKPYD 215

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 51  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 104
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 105 TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 155
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 156 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 213
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 214 SYGVTVWELMTFGSKPYD 231

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 27/215 (12%)
Query: 583 EETNVAVKVLDLQQRGAS-KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           ++  VA+K ++L++   S    + E +A+    H N+V   TS    D        LV +
Sbjct: 39  KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW-----LVMK 93
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            +  GS+ + +  K        K  ++   +IA  +  VLE L +      +H D+K  N
Sbjct: 94  LLSGGSVLDII--KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGN 151
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YVAPEYGALGEVSTH---G 755
           +LL  +    + DFG+S  L     D T     K  +G   ++APE   + +V  +    
Sbjct: 152 ILLGEDGSVQIADFGVSAFLATGG-DITRNKVRKTFVGTPCWMAPE--VMEQVRGYDFKA 208
Query: 756 DEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM 790
           D +SFGI  +E+ TG  P           HKY  M
Sbjct: 209 DIWSFGITAIELATGAAP----------YHKYPPM 233

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 47  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 100
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 101 TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 151
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 152 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 209
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 210 SYGVTVWELMTFGSKPYD 227

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 66  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 119
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 120 TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 170
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFGL++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 171 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 228
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 229 SYGVTVWELMTFGSKPYD 246

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 28/195 (14%)
Query: 587 VAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK++D  Q  +S  +    E    + + H N+VK+      I+T    +  LV E+  
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF---EVIETEKTLY--LVXEYAS 96
Query: 645 NGSLENWL--NQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
            G + ++L  + +  E+  R K            + + ++Y H      IVH DLK  N+
Sbjct: 97  GGEVFDYLVAHGRXKEKEARAKFR---------QIVSAVQYCHQKF---IVHRDLKAENL 144
Query: 703 LLDNEMVAHVGDFGLS-RLLHDNSPDQTSTSRVKGSIGYVAPE-YGALGEVSTHGDEYSF 760
           LLD +    + DFG S      N  D        G+  Y APE +          D +S 
Sbjct: 145 LLDADXNIKIADFGFSNEFTFGNKLDAFC-----GAPPYAAPELFQGKKYDGPEVDVWSL 199
Query: 761 GILMLEMFTGKRPTD 775
           G+++  + +G  P D
Sbjct: 200 GVILYTLVSGSLPFD 214

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 582 TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           TEE  VAVK++D+++     ++   E    + + H N+VK          R    + L  
Sbjct: 30  TEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-----RREGNIQYLFL 83
Query: 641 EFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           E+   G L + +       +   QR    LM         A V+ YLH      I H D+
Sbjct: 84  EYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVV-YLHG---IGITHRDI 130
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-D 756
           KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVAPE     E      D
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 757 EYSFGILMLEMFTGKRPTD 775
            +S GI++  M  G+ P D
Sbjct: 190 VWSCGIVLTAMLAGELPWD 208

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 582 TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           TEE  VAVK++D+++     ++   E    + + H N+VK          R    + L  
Sbjct: 29  TEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-----RREGNIQYLFL 82
Query: 641 EFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           E+   G L + +       +   QR    LM         A V+ YLH      I H D+
Sbjct: 83  EYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVV-YLHG---IGITHRDI 129
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-D 756
           KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVAPE     E      D
Sbjct: 130 KPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELLKRREFHAEPVD 188
Query: 757 EYSFGILMLEMFTGKRPTD 775
            +S GI++  M  G+ P D
Sbjct: 189 VWSCGIVLTAMLAGELPWD 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 582 TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           TEE  VAVK++D+++     ++   E    + + H N+VK          R    + L  
Sbjct: 30  TEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-----RREGNIQYLFL 83
Query: 641 EFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           E+   G L + +       +   QR    LM         A V+ YLH      I H D+
Sbjct: 84  EYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVV-YLHG---IGITHRDI 130
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-D 756
           KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVAPE     E      D
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 757 EYSFGILMLEMFTGKRPTD 775
            +S GI++  M  G+ P D
Sbjct: 190 VWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 582 TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           TEE  VAVK++D+++     ++   E    + + H N+VK          R    + L  
Sbjct: 30  TEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-----RREGNIQYLFL 83
Query: 641 EFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           E+   G L + +       +   QR    LM         A V+ YLH      I H D+
Sbjct: 84  EYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVV-YLHG---IGITHRDI 130
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-D 756
           KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVAPE     E      D
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 757 EYSFGILMLEMFTGKRPTD 775
            +S GI++  M  G+ P D
Sbjct: 190 VWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 582 TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           TEE  VAVK++D+++     ++   E    + + H N+VK          R    + L  
Sbjct: 31  TEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-----RREGNIQYLFL 84
Query: 641 EFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           E+   G L + +       +   QR    LM         A V+ YLH      I H D+
Sbjct: 85  EYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVV-YLHG---IGITHRDI 131
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-D 756
           KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVAPE     E      D
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 757 EYSFGILMLEMFTGKRPTD 775
            +S GI++  M  G+ P D
Sbjct: 191 VWSCGIVLTAMLAGELPWD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 582 TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           TEE  VAVK++D+++     ++   E    + + H N+VK          R    + L  
Sbjct: 30  TEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-----RREGNIQYLFL 83
Query: 641 EFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           E+   G L + +       +   QR    LM         A V+ YLH      I H D+
Sbjct: 84  EYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVV-YLHG---IGITHRDI 130
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-D 756
           KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVAPE     E      D
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 757 EYSFGILMLEMFTGKRPTD 775
            +S GI++  M  G+ P D
Sbjct: 190 VWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 582 TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           TEE  VAVK++D+++     ++   E    + + H N+VK          R    + L  
Sbjct: 30  TEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-----RREGNIQYLFL 83
Query: 641 EFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           E+   G L + +       +   QR    LM         A V+ YLH      I H D+
Sbjct: 84  EYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVV-YLHG---IGITHRDI 130
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-D 756
           KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVAPE     E      D
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 757 EYSFGILMLEMFTGKRPTD 775
            +S GI++  M  G+ P D
Sbjct: 190 VWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 582 TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           TEE  VAVK++D+++     ++   E    + + H N+VK          R    + L  
Sbjct: 30  TEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-----RREGNIQYLFL 83
Query: 641 EFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           E+   G L + +       +   QR    LM         A V+ YLH      I H D+
Sbjct: 84  EYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVV-YLHG---IGITHRDI 130
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-D 756
           KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVAPE     E      D
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 757 EYSFGILMLEMFTGKRPTD 775
            +S GI++  M  G+ P D
Sbjct: 190 VWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 582 TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           TEE  VAVK++D+++     ++   E    + + H N+VK          R    + L  
Sbjct: 31  TEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-----RREGNIQYLFL 84
Query: 641 EFMPNGSLENWLNQK---EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           E+   G L + +       +   QR    LM         A V+ YLH      I H D+
Sbjct: 85  EYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVV-YLHG---IGITHRDI 131
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-D 756
           KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVAPE     E      D
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 757 EYSFGILMLEMFTGKRPTD 775
            +S GI++  M  G+ P D
Sbjct: 191 VWSCGIVLTAMLAGELPWD 209

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 22/192 (11%)
Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           ET V +KVLD   R  S+SF      +  + H++LV     C      G+E   LV EF+
Sbjct: 40  ETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC----GDE-NILVQEFV 94
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             GSL+ +L + ++       +N++ +L +A  +A  + +L  +   +++H ++   N+L
Sbjct: 95  KFGSLDTYLKKNKN------CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNIL 145
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPE-YGALGEVSTHGDEY 758
           L  E     G+    +L   + P  + T   K      I +V PE       ++   D++
Sbjct: 146 LIREEDRKTGNPPFIKL---SDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKW 202
Query: 759 SFGILMLEMFTG 770
           SFG  + E+ +G
Sbjct: 203 SFGTTLWEICSG 214

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 123/255 (48%), Gaps = 32/255 (12%)
Query: 586 NVAVK--VLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA---LVY 640
            VA+K  +++ ++ G   + + E + L+ ++H N+V +I  C +  +  N  K    LV+
Sbjct: 45  KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 104
Query: 641 EFMPN---GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           +F  +   G L N L +    + +R    +MQ L       N L Y+H +    I+H D+
Sbjct: 105 DFCEHDLAGLLSNVLVKFTLSEIKR----VMQML------LNGLYYIHRN---KILHRDM 151
Query: 698 KPSNVLLDNEMVAHVGDFGLSRL--LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           K +NVL+  + V  + DFGL+R   L  NS      +RV  ++ Y  PE   LGE   +G
Sbjct: 152 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV-VTLWYRPPEL-LLGE-RDYG 208
Query: 756 ---DEYSFGILMLEMFTGKRP--TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALE 810
              D +  G +M EM+T + P    +  +  L+L       +  +V   +D   L E LE
Sbjct: 209 PPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE 267
Query: 811 IQAGIVKELQPNLRA 825
           +  G  ++++  L+A
Sbjct: 268 LVKGQKRKVKDRLKA 282

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA---LVYEFM 643
           VAVK+  +Q + + ++   E  +L  ++H N+++ I +    + RG        L+  F 
Sbjct: 50  VAVKIFPIQDKQSWQNEY-EVYSLPGMKHENILQFIGA----EKRGTSVDVDLWLITAFH 104
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC-------HTSIVHCD 696
             GSL ++L       N+           IA  +A  L YLH            +I H D
Sbjct: 105 EKGSLSDFLKANVVSWNEL--------CHIAETMARGLAYLHEDIPGLKDGHKPAISHRD 156
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY--GALG---EV 751
           +K  NVLL N + A + DFGL+ L  +       T    G+  Y+APE   GA+    + 
Sbjct: 157 IKSKNVLLKNNLTACIADFGLA-LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDA 215
Query: 752 STHGDEYSFGILMLEMFT----GKRPTDDM---FEEGLSLH 785
               D Y+ G+++ E+ +       P D+    FEE +  H
Sbjct: 216 FLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 87/187 (46%), Gaps = 34/187 (18%)
Query: 639 VYEFMPNGSLE--NWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           +Y  M  G+++  +WL +K+        ++  +R S   ++   +  +H H    IVH D
Sbjct: 84  IYMVMECGNIDLNSWLKKKKS-------IDPWERKSYWKNMLEAVHTIHQH---GIVHSD 133
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVST--- 753
           LKP+N L+ + M+  + DFG++  +  ++      S+V G++ Y+ PE  A+ ++S+   
Sbjct: 134 LKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV-GTVNYMPPE--AIKDMSSSRE 189
Query: 754 ----------HGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPA 803
                       D +S G ++  M  GK P   +  +   LH      + D   EI  P 
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-----AIIDPNHEIEFPD 244
Query: 804 ILEEALE 810
           I E+ L+
Sbjct: 245 IPEKDLQ 251

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 37/197 (18%)
Query: 588 AVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEFKALVYEF 642
           AVKV++    +   + + + E E L+ + H N++K   I+   SS          +V E 
Sbjct: 51  AVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF--------YIVGEL 102
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
              G L        DE  +R + +      I   V + + Y+H H   +IVH DLKP N+
Sbjct: 103 YTGGELF-------DEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENI 152
Query: 703 LLDN---EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YVAPEYGALGEVSTHGD 756
           LL++   +    + DFGLS     N       +++K  IG   Y+APE    G      D
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQN-------TKMKDRIGTAYYIAPEV-LRGTYDEKCD 204
Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+++  + +G  P
Sbjct: 205 VWSAGVILYILLSGTPP 221

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 87/187 (46%), Gaps = 34/187 (18%)
Query: 639 VYEFMPNGSLE--NWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           +Y  M  G+++  +WL +K+        ++  +R S   ++   +  +H H    IVH D
Sbjct: 87  IYMVMECGNIDLNSWLKKKK-------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSD 136
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVST--- 753
           LKP+N L+ + M+  + DFG++  +  ++      S+V G++ Y+ PE  A+ ++S+   
Sbjct: 137 LKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV-GTVNYMPPE--AIKDMSSSRE 192
Query: 754 ----------HGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPA 803
                       D +S G ++  M  GK P   +  +   LH      + D   EI  P 
Sbjct: 193 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-----AIIDPNHEIEFPD 247
Query: 804 ILEEALE 810
           I E+ L+
Sbjct: 248 IPEKDLQ 254

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 87/187 (46%), Gaps = 34/187 (18%)
Query: 639 VYEFMPNGSLE--NWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           +Y  M  G+++  +WL +K+        ++  +R S   ++   +  +H H    IVH D
Sbjct: 83  IYMVMECGNIDLNSWLKKKK-------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSD 132
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVST--- 753
           LKP+N L+ + M+  + DFG++  +  ++      S+V G++ Y+ PE  A+ ++S+   
Sbjct: 133 LKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV-GTVNYMPPE--AIKDMSSSRE 188
Query: 754 ----------HGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPA 803
                       D +S G ++  M  GK P   +  +   LH      + D   EI  P 
Sbjct: 189 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-----AIIDPNHEIEFPD 243
Query: 804 ILEEALE 810
           I E+ L+
Sbjct: 244 IPEKDLQ 250

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 37/178 (20%)
Query: 616 RNLVKIIT--------SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDE------QNQ 661
           +N ++IIT        +C  I T  +E   ++YE+M N S+      K DE      +N 
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDEV-YIIYEYMENDSI-----LKFDEYFFVLDKNY 144
Query: 662 RPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL 721
              + +     I   V N   Y+H+    +I H D+KPSN+L+D      + DFG S  +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 722 HDNSPDQTSTSRVKGSIG---YVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP 773
            D         ++KGS G   ++ PE+ +  E S +G   D +S GI +  MF    P
Sbjct: 203 VD--------KKIKGSRGTYEFMPPEFFS-NESSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 88/192 (45%), Gaps = 22/192 (11%)
Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           ET V +KVLD   R  S+SF      +  + H++LV     C   D        LV EF+
Sbjct: 40  ETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDE-----NILVQEFV 94
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             GSL+ +L + ++       +N++ +L +A  +A  + +L  +   +++H ++   N+L
Sbjct: 95  KFGSLDTYLKKNKN------CINILWKLEVAKQLAWAMHFLEEN---TLIHGNVCAKNIL 145
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG----SIGYVAPE-YGALGEVSTHGDEY 758
           L  E     G+    +L   + P  + T   K      I +V PE       ++   D++
Sbjct: 146 LIREEDRKTGNPPFIKL---SDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKW 202
Query: 759 SFGILMLEMFTG 770
           SFG  + E+ +G
Sbjct: 203 SFGTTLWEICSG 214

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 85/197 (43%), Gaps = 32/197 (16%)
Query: 587 VAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VA+K++D  Q   +  +    E   ++ + H N+VK+      I+T    +  L+ E+  
Sbjct: 43  VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF---EVIETEKTLY--LIMEYAS 97
Query: 645 NGSLENWL--NQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
            G + ++L  + +  E+  R K            + + ++Y H      IVH DLK  N+
Sbjct: 98  GGEVFDYLVAHGRMKEKEARSKFR---------QIVSAVQYCHQ---KRIVHRDLKAENL 145
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YVAPE-YGALGEVSTHGDEY 758
           LLD +M   + DFG S        + T   ++    G   Y APE +          D +
Sbjct: 146 LLDADMNIKIADFGFSN-------EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVW 198
Query: 759 SFGILMLEMFTGKRPTD 775
           S G+++  + +G  P D
Sbjct: 199 SLGVILYTLVSGSLPFD 215

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 37/201 (18%)
Query: 584 ETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEFKAL 638
           +   AVKV++    +   + + + E E L+ + H N++K   I+   SS          +
Sbjct: 47  QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF--------YI 98
Query: 639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK 698
           V E    G L        DE  +R + +      I   V + + Y+H H   +IVH DLK
Sbjct: 99  VGELYTGGELF-------DEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLK 148
Query: 699 PSNVLLDN---EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YVAPEYGALGEVS 752
           P N+LL++   +    + DFGLS     N       +++K  IG   Y+APE    G   
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQN-------TKMKDRIGTAYYIAPEV-LRGTYD 200
Query: 753 THGDEYSFGILMLEMFTGKRP 773
              D +S G+++  + +G  P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 37/201 (18%)
Query: 584 ETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVK---IITSCSSIDTRGNEFKAL 638
           +   AVKV++    +   + + + E E L+ + H N++K   I+   SS          +
Sbjct: 47  QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF--------YI 98
Query: 639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK 698
           V E    G L        DE  +R + +      I   V + + Y+H H   +IVH DLK
Sbjct: 99  VGELYTGGELF-------DEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLK 148
Query: 699 PSNVLLDN---EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YVAPEYGALGEVS 752
           P N+LL++   +    + DFGLS     N       +++K  IG   Y+APE    G   
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQN-------TKMKDRIGTAYYIAPEV-LRGTYD 200
Query: 753 THGDEYSFGILMLEMFTGKRP 773
              D +S G+++  + +G  P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 123/255 (48%), Gaps = 32/255 (12%)
Query: 586 NVAVK--VLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA---LVY 640
            VA+K  +++ ++ G   + + E + L+ ++H N+V +I  C +  +  N  K    LV+
Sbjct: 45  KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 104
Query: 641 EFMPN---GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           +F  +   G L N L +    + +R    +MQ L       N L Y+H +    I+H D+
Sbjct: 105 DFCEHDLAGLLSNVLVKFTLSEIKR----VMQML------LNGLYYIHRN---KILHRDM 151
Query: 698 KPSNVLLDNEMVAHVGDFGLSRL--LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           K +NVL+  + V  + DFGL+R   L  NS      +RV  ++ Y  PE   LGE   +G
Sbjct: 152 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV-VTLWYRPPEL-LLGE-RDYG 208
Query: 756 ---DEYSFGILMLEMFTGKRP--TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALE 810
              D +  G +M EM+T + P    +  +  L+L       +  +V   +D   L E LE
Sbjct: 209 PPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE 267
Query: 811 IQAGIVKELQPNLRA 825
           +  G  ++++  L+A
Sbjct: 268 LVKGQKRKVKDRLKA 282

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 122
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           MP G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 123 MPGGDMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 171 NLLIDQQGYIKVADFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 586 NVAVK--VLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA---LVY 640
            VA+K  +++ ++ G   + + E + L+ ++H N+V +I  C +  +  N  K    LV+
Sbjct: 44  KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 103
Query: 641 EFMPN---GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           +F  +   G L N L +    + +R    +MQ L       N L Y+H +    I+H D+
Sbjct: 104 DFCEHDLAGLLSNVLVKFTLSEIKR----VMQML------LNGLYYIHRN---KILHRDM 150
Query: 698 KPSNVLLDNEMVAHVGDFGLSRL--LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           K +NVL+  + V  + DFGL+R   L  NS      +RV  ++ Y  PE   LGE   +G
Sbjct: 151 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV-VTLWYRPPEL-LLGE-RDYG 207
Query: 756 ---DEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM-----GLPDQVAEIIDPAILEE 807
              D +  G +M EM+T + P   + +     H+ A +      +  +V   +D   L E
Sbjct: 208 PPIDLWGAGCIMAEMWT-RSP---IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 263
Query: 808 ALEIQAGIVKELQPNLRA 825
            LE+  G  ++++  L+A
Sbjct: 264 KLELVKGQKRKVKDRLKA 281

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 122
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           MP G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 123 MPGGDMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 171 NLLIDQQGYIKVADFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVL---LDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           V + ++YLH      IVH DLKP N+L   LD +    + DFGLS++    S   T+   
Sbjct: 125 VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC-- 179
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDD 776
             G+ GYVAPE  A    S   D +S G++   +  G  P  D
Sbjct: 180 --GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 220

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 32/179 (17%)
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           N  L +WL +K+        ++  +R S   ++   +  +H H    IVH DLKP+N L+
Sbjct: 111 NIDLNSWLKKKK-------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLI 160
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVST----------- 753
            + M+  + DFG++  +  ++      S+V G++ Y+ PE  A+ ++S+           
Sbjct: 161 VDGMLKLI-DFGIANQMQPDTTSVVKDSQV-GTVNYMPPE--AIKDMSSSRENGKSKSKI 216
Query: 754 --HGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALE 810
               D +S G ++  M  GK P   +  +   LH      + D   EI  P I E+ L+
Sbjct: 217 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-----AIIDPNHEIEFPDIPEKDLQ 270

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           YLH      I H D+KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVA
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVA 175
Query: 743 PEYGALGEVSTHG-DEYSFGILMLEMFTGKRPTD 775
           PE     E      D +S GI++  M  G+ P D
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 117/278 (42%), Gaps = 52/278 (18%)
Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL 665
           E E L+ + H  ++KI     + D        +V E M  G L + +   +  +    KL
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 666 NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAHVGDFGLSRLLH 722
              Q L         ++YLH +    I+H DLKP NVLL   + + +  + DFG S++L 
Sbjct: 119 YFYQMLL-------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 723 DNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRPTDDM 777
           + S  +T    + G+  Y+APE   L  V T G     D +S G+++    +G  P    
Sbjct: 169 ETSLMRT----LCGTPTYLAPE--VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---- 218
Query: 778 FEEGLSLHKYAKMGLPDQVAE---IIDPAILEEALEIQAGIVKEL---QPNLRAKFHEIQ 831
                S H+  ++ L DQ+        P +  E  E    +VK+L    P  R    E  
Sbjct: 219 ----FSEHR-TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE-- 271
Query: 832 VSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQAI 869
              LR   L  E++ R   K QD + E  E+    Q +
Sbjct: 272 --ALRHPWLQDEDMKR---KFQDLLSEENESTAKPQVL 304

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           YLH      I H D+KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVA
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVA 175
Query: 743 PEYGALGEVSTHG-DEYSFGILMLEMFTGKRPTD 775
           PE     E      D +S GI++  M  G+ P D
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           YLH      I H D+KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVA
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVA 175
Query: 743 PEYGALGEVSTHG-DEYSFGILMLEMFTGKRPTD 775
           PE     E      D +S GI++  M  G+ P D
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           YLH      I H D+KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVA
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVA 175
Query: 743 PEYGALGEVSTHG-DEYSFGILMLEMFTGKRPTD 775
           PE     E      D +S GI++  M  G+ P D
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 38/209 (18%)
Query: 589 VKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSL 648
           ++ +D+Q R        E E L+ + H+N+VK+        TR    K L+ EF P GSL
Sbjct: 48  LRPVDVQMR--------EFEVLKKLNHKNIVKLFAIEEETTTR---HKVLIMEFCPCGSL 96
Query: 649 ENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---- 704
              L +  +          +      I + +V+  ++H     IVH ++KP N++     
Sbjct: 97  YTVLEEPSNAYG-------LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
           D + V  + DFG +R L D   D+   S       Y   EY        H D Y   +L 
Sbjct: 150 DGQSVYKLTDFGAARELED---DEQFVSL------YGTEEY-------LHPDMYERAVLR 193
Query: 765 LEMFTGKRPTDDMFEEGLSLHKYAKMGLP 793
            +       T D++  G++ +  A   LP
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 11/111 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A ++ + L +LH      I++ DLK  NVLLD+E    + DFG+ +   +   +  +T+ 
Sbjct: 130 AAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTAT 183
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP-----TDDMFE 779
             G+  Y+APE           D ++ G+L+ EM  G  P      DD+FE
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 234

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVL---LDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           V + ++YLH      IVH DLKP N+L   LD +    + DFGLS++    S   T+   
Sbjct: 125 VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC-- 179
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDD 776
             G+ GYVAPE  A    S   D +S G++   +  G  P  D
Sbjct: 180 --GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 220

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 113/268 (42%), Gaps = 52/268 (19%)
Query: 605 AECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPK 664
            E E L+ + H  ++KI     + D        +V E M  G L + +   +  +    K
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCK 242
Query: 665 LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAHVGDFGLSRLL 721
           L   Q L         ++YLH +    I+H DLKP NVLL   + + +  + DFG S++L
Sbjct: 243 LYFYQMLL-------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292
Query: 722 HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRPTDD 776
            + S  +T    + G+  Y+APE   L  V T G     D +S G+++    +G  P   
Sbjct: 293 GETSLMRT----LCGTPTYLAPE--VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--- 343
Query: 777 MFEEGLSLHKYAKMGLPDQVAE---IIDPAILEEALEIQAGIVKEL---QPNLRAKFHEI 830
                 S H+  ++ L DQ+        P +  E  E    +VK+L    P  R    E 
Sbjct: 344 -----FSEHR-TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE- 396
Query: 831 QVSILRVGILCSEELPRDRMKIQDAIME 858
               LR   L  E++ R   K QD + E
Sbjct: 397 ---ALRHPWLQDEDMKR---KFQDLLSE 418

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           L+YLH       +H D+K +NVLL  +    + DFG++  L D    Q   +   G+  +
Sbjct: 133 LDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKRNTFVGTPFW 186
Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
           +APE        +  D +S GI  +E+  G+ P  DM
Sbjct: 187 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 55/107 (51%), Gaps = 10/107 (9%)
Query: 673 IAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS 732
           IA+ +   LE+LH     S++H D+KPSNVL++      + DFG+S  L D+     + +
Sbjct: 158 IAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDS----VAKT 211
Query: 733 RVKGSIGYVAPEY--GALGE--VSTHGDEYSFGILMLEMFTGKRPTD 775
              G   Y+APE     L +   S   D +S GI M+E+   + P D
Sbjct: 212 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 258

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 66/132 (50%), Gaps = 7/132 (5%)
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           + SL+ +  Q  D+    P+  L +   IA+ +   LE+LH     S++H D+KPSNVL+
Sbjct: 89  DTSLDKFYKQVIDKGQTIPEDILGK---IAVSIVKALEHLHSKL--SVIHRDVKPSNVLI 143
Query: 705 DNEMVAHVGDFGLS-RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
           +      + DFG+S  L+ D + D  +  +   +   + PE    G  S   D +S GI 
Sbjct: 144 NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKG-YSVKSDIWSLGIT 202
Query: 764 MLEMFTGKRPTD 775
           M+E+   + P D
Sbjct: 203 MIELAILRFPYD 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVL---LDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           V + ++YLH      IVH DLKP N+L   LD +    + DFGLS++    S   T+   
Sbjct: 125 VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC-- 179
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDD 776
             G+ GYVAPE  A    S   D +S G++   +  G  P  D
Sbjct: 180 --GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 220

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 8/103 (7%)
Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
           I +A V    H   +  I+H D+KPSN+LLD      + DFG+S  L D+     + +R 
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS----IAKTRD 185
Query: 735 KGSIGYVAPEY----GALGEVSTHGDEYSFGILMLEMFTGKRP 773
            G   Y+APE      +        D +S GI + E+ TG+ P
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVL---LDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           V + ++YLH      IVH DLKP N+L   LD +    + DFGLS++    S   T+   
Sbjct: 125 VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC-- 179
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDD 776
             G+ GYVAPE  A    S   D +S G++   +  G  P  D
Sbjct: 180 --GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 72/167 (43%), Gaps = 26/167 (15%)
Query: 613 IRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLS 672
           +  RN VK +T+     T       +  E+  N +L + ++ +   Q +     L ++  
Sbjct: 72  LERRNFVKPMTAVKKKSTL-----FIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQ-- 124
Query: 673 IAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH--------DN 724
               +   L Y+H      I+H DLKP N+ +D      +GDFGL++ +H        D+
Sbjct: 125 ----ILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 725 SPDQTSTSRVKGSIG---YVAPEY-GALGEVSTHGDEYSFGILMLEM 767
                S+  +  +IG   YVA E     G  +   D YS GI+  EM
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 87/187 (46%), Gaps = 34/187 (18%)
Query: 639 VYEFMPNGSLE--NWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           +Y  M  G+++  +WL +K+        ++  +R S   ++   +  +H H    IVH D
Sbjct: 131 IYMVMECGNIDLNSWLKKKK-------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSD 180
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVST--- 753
           LKP+N L+ + M+  + DFG++  +  ++      S+V G++ Y+ PE  A+ ++S+   
Sbjct: 181 LKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV-GTVNYMPPE--AIKDMSSSRE 236
Query: 754 ----------HGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPA 803
                       D +S G ++  M  GK P   +  +   LH      + D   EI  P 
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-----AIIDPNHEIEFPD 291
Query: 804 ILEEALE 810
           I E+ L+
Sbjct: 292 IPEKDLQ 298

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           YLH      I H D+KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVA
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVA 175
Query: 743 PEYGALGEVSTHG-DEYSFGILMLEMFTGKRPTD 775
           PE     E      D +S GI++  M  G+ P D
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 67/141 (47%), Gaps = 14/141 (9%)
Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           ++  E M  GSL+  L +       R    ++ ++SIA  V   L YL       I+H D
Sbjct: 83  SICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIA--VIKGLTYLREK--HKIMHRD 133
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           +KPSN+L+++     + DFG+S  L D   ++   +R      Y++PE       S   D
Sbjct: 134 VKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTR-----SYMSPERLQGTHYSVQSD 188
Query: 757 EYSFGILMLEMFTGKRPTDDM 777
            +S G+ ++EM  G+ P   M
Sbjct: 189 IWSMGLSLVEMAVGRYPRPPM 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           YLH      I H D+KP N+LLD      + DFGL+ +   N+ ++   +++ G++ YVA
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVA 174
Query: 743 PEYGALGEVSTHG-DEYSFGILMLEMFTGKRPTD 775
           PE     E      D +S GI++  M  G+ P D
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 38/209 (18%)
Query: 589 VKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSL 648
           ++ +D+Q R        E E L+ + H+N+VK+        TR    K L+ EF P GSL
Sbjct: 48  LRPVDVQMR--------EFEVLKKLNHKNIVKLFAIEEETTTR---HKVLIMEFCPCGSL 96
Query: 649 ENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---- 704
              L +  +          +      I + +V+  ++H     IVH ++KP N++     
Sbjct: 97  YTVLEEPSNAYG-------LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
           D + V  + DFG +R L D+                    YG   E   H D Y   +L 
Sbjct: 150 DGQSVYKLTDFGAARELEDDEQ--------------FVXLYGT--EEYLHPDMYERAVLR 193
Query: 765 LEMFTGKRPTDDMFEEGLSLHKYAKMGLP 793
            +       T D++  G++ +  A   LP
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 87/187 (46%), Gaps = 34/187 (18%)
Query: 639 VYEFMPNGSLE--NWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           +Y  M  G+++  +WL +K+        ++  +R S   ++   +  +H H    IVH D
Sbjct: 131 IYMVMECGNIDLNSWLKKKK-------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSD 180
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVST--- 753
           LKP+N L+ + M+  + DFG++  +  ++      S+V G++ Y+ PE  A+ ++S+   
Sbjct: 181 LKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV-GAVNYMPPE--AIKDMSSSRE 236
Query: 754 ----------HGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPA 803
                       D +S G ++  M  GK P   +  +   LH      + D   EI  P 
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-----AIIDPNHEIEFPD 291
Query: 804 ILEEALE 810
           I E+ L+
Sbjct: 292 IPEKDLQ 298

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 87/187 (46%), Gaps = 34/187 (18%)
Query: 639 VYEFMPNGSLE--NWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           +Y  M  G+++  +WL +K+        ++  +R S   ++   +  +H H    IVH D
Sbjct: 131 IYMVMECGNIDLNSWLKKKK-------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSD 180
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVST--- 753
           LKP+N L+ + M+  + DFG++  +  ++      S+V G++ Y+ PE  A+ ++S+   
Sbjct: 181 LKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV-GTVNYMPPE--AIKDMSSSRE 236
Query: 754 ----------HGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPA 803
                       D +S G ++  M  GK P   +  +   LH      + D   EI  P 
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-----AIIDPNHEIEFPD 291
Query: 804 ILEEALE 810
           I E+ L+
Sbjct: 292 IPEKDLQ 298

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 67/137 (48%), Gaps = 14/137 (10%)
Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           ++  E M  GSL+  L     ++  R    ++ ++SIA  V   L YL       I+H D
Sbjct: 99  SICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIA--VIKGLTYLREK--HKIMHRD 149
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           +KPSN+L+++     + DFG+S  L D+  +    +R      Y++PE       S   D
Sbjct: 150 VKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQGTHYSVQSD 204
Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+ ++EM  G+ P
Sbjct: 205 IWSMGLSLVEMAVGRYP 221

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 91/198 (45%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 45  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 98
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 99  MQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 149
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFG ++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 150 RNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 207
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 208 SYGVTVWELMTFGSKPYD 225

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 91/198 (45%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 43  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 96
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 97  MQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 147
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFG ++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 148 RNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 205
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 206 SYGVTVWELMTFGSKPYD 223

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           N A K +        ++   E + +  +RH  LV +  +        NE   ++YEFM  
Sbjct: 184 NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED----DNEM-VMIYEFMSG 238
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L     +  DE N   K++  + +     V   L ++H +   + VH DLKP N++  
Sbjct: 239 GEL---FEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFT 289
Query: 706 NEMVAHVG--DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
            +    +   DFGL+  L    P Q S     G+  + APE      V  + D +S G+L
Sbjct: 290 TKRSNELKLIDFGLTAHL---DPKQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345
Query: 764 MLEMFTGKRP 773
              + +G  P
Sbjct: 346 SYILLSGLSP 355

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 91/198 (45%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 43  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 96
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 97  MQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 147
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFG ++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 148 RNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 205
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 206 SYGVTVWELMTFGSKPYD 223

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 18/170 (10%)
Query: 604 IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP 663
           + E   L++ RH  L  +  +  + D         V E+   G L   L+++     +R 
Sbjct: 53  VTESRVLQNTRHPFLTALKYAFQTHDRL-----CFVMEYANGGELFFHLSRERVFTEERA 107
Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
           +           ++ + LEYLH      +V+ D+K  N++LD +    + DFGL +   +
Sbjct: 108 RF-------YGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---E 154
Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
              D  +     G+  Y+APE     +     D +  G++M EM  G+ P
Sbjct: 155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 18/170 (10%)
Query: 604 IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP 663
           + E   L++ RH  L  +  +  + D         V E+   G L   L+++     +R 
Sbjct: 53  VTESRVLQNTRHPFLTALKYAFQTHDRL-----CFVMEYANGGELFFHLSRERVFTEERA 107
Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
           +           ++ + LEYLH      +V+ D+K  N++LD +    + DFGL +   +
Sbjct: 108 RF-------YGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---E 154
Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
              D  +     G+  Y+APE     +     D +  G++M EM  G+ P
Sbjct: 155 GISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 18/170 (10%)
Query: 604 IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP 663
           + E   L++ RH  L  +  +  + D         V E+   G L   L+++     +R 
Sbjct: 53  VTESRVLQNTRHPFLTALKYAFQTHDRL-----CFVMEYANGGELFFHLSRERVFTEERA 107
Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
           +           ++ + LEYLH      +V+ D+K  N++LD +    + DFGL +   +
Sbjct: 108 RF-------YGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---E 154
Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
              D  +     G+  Y+APE     +     D +  G++M EM  G+ P
Sbjct: 155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 91/198 (45%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 48  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 101
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 102 TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 152
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFG ++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 153 RNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 210
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 211 SYGVTVWELMTFGSKPYD 228

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 91/198 (45%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 41  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 94
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 95  TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 145
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFG ++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 146 RNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 203
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 204 SYGVTVWELMTFGSKPYD 221

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 9/92 (9%)
Query: 690 TSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTS-TSRVKGSIGYVAPEYGAL 748
           ++++H DLKPSN+L+++     V DFGL+R++ +++ D +  T +  G   YVA  +   
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRA 190
Query: 749 GEV-------STHGDEYSFGILMLEMFTGKRP 773
            EV       S   D +S G ++ E+F  +RP
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFL-RRP 221

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 81/179 (45%), Gaps = 32/179 (17%)
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           N  L +WL +K+        ++  +R S   ++   +  +H H    IVH DLKP+N L+
Sbjct: 111 NIDLNSWLKKKK-------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLI 160
Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVST----------- 753
            + M+  + DFG++  +  +       S+V G++ Y+ PE  A+ ++S+           
Sbjct: 161 VDGMLKLI-DFGIANQMQPDXXXVVKDSQV-GTVNYMPPE--AIKDMSSSRENGKSKSKI 216
Query: 754 --HGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALE 810
               D +S G ++  M  GK P   +  +   LH      + D   EI  P I E+ L+
Sbjct: 217 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-----AIIDPNHEIEFPDIPEKDLQ 270

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 18/170 (10%)
Query: 604 IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP 663
           + E   L++ RH  L  +  +  + D         V E+   G L   L+++     +R 
Sbjct: 53  VTESRVLQNTRHPFLTALKYAFQTHDRL-----CFVMEYANGGELFFHLSRERVFTEERA 107
Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
           +           ++ + LEYLH      +V+ D+K  N++LD +    + DFGL +   +
Sbjct: 108 RF-------YGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---E 154
Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
              D  +     G+  Y+APE     +     D +  G++M EM  G+ P
Sbjct: 155 GISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 67/137 (48%), Gaps = 14/137 (10%)
Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           ++  E M  GSL+  L +      +R    ++ ++SIA  V   L YL       I+H D
Sbjct: 90  SICMEHMDGGSLDQVLKEA-----KRIPEEILGKVSIA--VLRGLAYLREK--HQIMHRD 140
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           +KPSN+L+++     + DFG+S  L D     +  +   G+  Y+APE       S   D
Sbjct: 141 VKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMAPERLQGTHYSVQSD 195
Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+ ++E+  G+ P
Sbjct: 196 IWSMGLSLVELAVGRYP 212

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 88/194 (45%), Gaps = 26/194 (13%)
Query: 588 AVKVLD----LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           A+KVL     +Q+   ++    E + L  IR    +  +      +T+ +    L+ +++
Sbjct: 86  AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH----LILDYI 141
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
             G L   L+Q+E                + I V  ++  L H     I++ D+K  N+L
Sbjct: 142 NGGELFTHLSQRER----------FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTS-RVKGSIGYVAPEYGALGEVSTHG---DEYS 759
           LD+     + DFGLS+   +   D+T  +    G+I Y+AP+    G+ S H    D +S
Sbjct: 192 LDSNGHVVLTDFGLSK---EFVADETERAYDFCGTIEYMAPDIVRGGD-SGHDKAVDWWS 247
Query: 760 FGILMLEMFTGKRP 773
            G+LM E+ TG  P
Sbjct: 248 LGVLMYELLTGASP 261

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 83/196 (42%), Gaps = 29/196 (14%)
Query: 588 AVKVLDLQQRGASKSFIA------ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
           A K +  +Q  AS+  +       E   LR + H N   IIT     + R +    L+ E
Sbjct: 41  AAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN---IITLHDVYENRTD--VVLILE 95
Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
            +  G L ++L QKE        L+  +  S    + + + YLH      I H DLKP N
Sbjct: 96  LVSGGELFDFLAQKES-------LSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPEN 145
Query: 702 VLL--DNEMVAHVG--DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE 757
           ++L   N  + H+   DFGL+  + D          + G+  +VAPE      +    D 
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 758 YSFGILMLEMFTGKRP 773
           +S G++   + +G  P
Sbjct: 202 WSIGVITYILLSGASP 217

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 91/198 (45%), Gaps = 22/198 (11%)
Query: 583 EETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           E+  + V + +L++     A+K  + E   + S+ + ++ +++  C +   +      L+
Sbjct: 43  EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LI 96
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
            + MP G L +++ + +D    +  LN        + +A  + YL       +VH DL  
Sbjct: 97  TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAA 147
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEY 758
            NVL+       + DFG ++LL     +  +    K  I ++A E   L  + TH  D +
Sbjct: 148 RNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPIKWMALE-SILHRIYTHQSDVW 205
Query: 759 SFGILMLEMFT-GKRPTD 775
           S+G+ + E+ T G +P D
Sbjct: 206 SYGVTVWELMTFGSKPYD 223

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 18/170 (10%)
Query: 604 IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP 663
           + E   L++ RH  L  +  +  + D         V E+   G L   L+++     +R 
Sbjct: 56  VTESRVLQNTRHPFLTALKYAFQTHDRL-----CFVMEYANGGELFFHLSRERVFTEERA 110
Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
           +           ++ + LEYLH      +V+ D+K  N++LD +    + DFGL +   +
Sbjct: 111 RF-------YGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---E 157
Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
              D  +     G+  Y+APE     +     D +  G++M EM  G+ P
Sbjct: 158 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 18/170 (10%)
Query: 604 IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP 663
           + E   L++ RH  L  +  +  + D         V E+   G L   L+++     +R 
Sbjct: 58  VTESRVLQNTRHPFLTALKYAFQTHDRL-----CFVMEYANGGELFFHLSRERVFTEERA 112
Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
           +           ++ + LEYLH      +V+ D+K  N++LD +    + DFGL +   +
Sbjct: 113 RF-------YGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---E 159
Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
              D  +     G+  Y+APE     +     D +  G++M EM  G+ P
Sbjct: 160 GISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 18/170 (10%)
Query: 604 IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP 663
           + E   L++ RH  L  +  +  + D         V E+   G L   L+++     +R 
Sbjct: 53  VTESRVLQNTRHPFLTALKYAFQTHDRL-----CFVMEYANGGELFFHLSRERVFTEERA 107
Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
           +           ++ + LEYLH      +V+ D+K  N++LD +    + DFGL +   +
Sbjct: 108 RF-------YGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---E 154
Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
              D  +     G+  Y+APE     +     D +  G++M EM  G+ P
Sbjct: 155 GISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           N A K +        ++   E + +  +RH  LV +  +        NE   ++YEFM  
Sbjct: 78  NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED----DNEM-VMIYEFMSG 132
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L     +  DE N   K++  + +     V   L ++H +   + VH DLKP N++  
Sbjct: 133 GEL---FEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFT 183
Query: 706 NEMVAHVG--DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
            +    +   DFGL+  L    P Q S     G+  + APE      V  + D +S G+L
Sbjct: 184 TKRSNELKLIDFGLTAHL---DPKQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 239
Query: 764 MLEMFTGKRP 773
              + +G  P
Sbjct: 240 SYILLSGLSP 249

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 29/210 (13%)
Query: 594 LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLN 653
           +Q RG  +    E   L+ + H N+VK++     +D    +   +V+E +  G +     
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLV---EVLDDPNEDHLYMVFELVNQGPVMEVPT 130
Query: 654 QKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG 713
            K   ++Q        R     D+   +EYLH+     I+H D+KPSN+L+  +    + 
Sbjct: 131 LKPLSEDQ-------ARFYFQ-DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIA 179
Query: 714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV-----STHGDEYSFGILMLEMF 768
           DFG+S     +       S   G+  ++APE  +L E          D ++ G+ +    
Sbjct: 180 DFGVSNEFKGSD---ALLSNTVGTPAFMAPE--SLSETRKIFSGKALDVWAMGVTLYCFV 234
Query: 769 TGKRPTDDMFEEGLSLH---KYAKMGLPDQ 795
            G+ P   M E  + LH   K   +  PDQ
Sbjct: 235 FGQCPF--MDERIMCLHSKIKSQALEFPDQ 262

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 63/150 (42%), Gaps = 23/150 (15%)
Query: 631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHT 690
           + +++  +V E+MP G L N L    D   +  K           +V   L+ +H     
Sbjct: 145 QDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-------YTAEVVLALDAIHS---M 193
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YVAPEY-- 745
            ++H D+KP N+LLD      + DFG    +     D+T       ++G   Y++PE   
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-----DETGMVHCDTAVGTPDYISPEVLK 248
Query: 746 --GALGEVSTHGDEYSFGILMLEMFTGKRP 773
             G  G      D +S G+ + EM  G  P
Sbjct: 249 SQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 690 TSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTS-TSRVKGSIGYVAPEYGAL 748
           ++++H DLKPSN+L+++     V DFGL+R++ +++ D +  T +  G + +VA  +   
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190
Query: 749 GEV-------STHGDEYSFGILMLEMFTGKRP 773
            EV       S   D +S G ++ E+F  +RP
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFL-RRP 221

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 198 LXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 57/120 (47%), Gaps = 11/120 (9%)
Query: 657 DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN---EMVAHVG 713
           DE   R K N +    I   V + + YLH H   +IVH DLKP N+LL++   + +  + 
Sbjct: 125 DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV 181
Query: 714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           DFGLS +      +Q       G+  Y+APE     +     D +S G+++  +  G  P
Sbjct: 182 DFGLSAVFE----NQKKMKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 23/199 (11%)
Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKII-----TSCSSIDTRGN--EFK 636
           +  VA+K + L    + K  + E + +R + H N+VK+      +     D  G+  E  
Sbjct: 36  DKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95
Query: 637 A--LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVH 694
           +  +V E+M    L N L Q        P L    RL     +   L+Y+H     +++H
Sbjct: 96  SVYIVQEYM-ETDLANVLEQG-------PLLEEHARL-FMYQLLRGLKYIH---SANVLH 143
Query: 695 CDLKPSNVLLDNE-MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVST 753
            DLKP+N+ ++ E +V  +GDFGL+R++  +   +   S    +  Y +P         T
Sbjct: 144 RDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT 203
Query: 754 HG-DEYSFGILMLEMFTGK 771
              D ++ G +  EM TGK
Sbjct: 204 KAIDMWAAGCIFAEMLTGK 222

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 14/137 (10%)
Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           ++  E M  GSL+  L +       R    ++ ++SIA  V   L YL       I+H D
Sbjct: 107 SICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIA--VIKGLTYLREK--HKIMHRD 157
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           +KPSN+L+++     + DFG+S  L D     +  +   G+  Y++PE       S   D
Sbjct: 158 VKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTHYSVQSD 212
Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+ ++EM  G+ P
Sbjct: 213 IWSMGLSLVEMAVGRYP 229

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 198 LAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 47/207 (22%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 583 EETN-VAVKVLDLQQRGASKSFIAECEALRS-IRHRNLVKIITSCSSIDTRGNEFKALVY 640
           E+T  VA+K L  +  G  +        LR+ ++H N+V ++   +      ++  ++++
Sbjct: 37  EQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-----DQPLSMIF 91
Query: 641 EFMPNGSLENWLNQK---------EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS 691
            +  +G L  +L  +         +D++  +  L     + +   +A  +EYL  H    
Sbjct: 92  SYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---H 148
Query: 692 IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGA 747
           +VH DL   NVL+ +++   + D GL R ++          ++ G+    I ++APE   
Sbjct: 149 VVHKDLATRNVLVYDKLNVKISDLGLFREVY-----AADYYKLLGNSLLPIRWMAPEAIM 203
Query: 748 LGEVSTHGDEYSFGILMLEMFT-GKRP 773
            G+ S   D +S+G+++ E+F+ G +P
Sbjct: 204 YGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 10/99 (10%)
Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           LEYLH       +H D+K  N+LL+ E  A + DFG++  L D        + V G+  +
Sbjct: 138 LEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDX---MAKRNXVIGTPFW 191
Query: 741 VAPEYGALGEVSTH--GDEYSFGILMLEMFTGKRPTDDM 777
           +APE   + E+  +   D +S GI  +EM  GK P  D+
Sbjct: 192 MAPE--VIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 54  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 108
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 109 VPGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 156
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 157 NLLIDQQGYIQVTDFGFAKRV------KGRTWTLCGTPEYLAPEIILSKGYNKAVDWWAL 210
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 211 GVLIYEMAAGYPP 223

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 68  HFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSF-----KDNSNLYMVMEY 122
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 122
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 171 NLLIDQQGYIKVADFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/202 (22%), Positives = 95/202 (47%), Gaps = 28/202 (13%)
Query: 583 EETN-VAVKVLDLQQRGASKSFIAECEALRS-IRHRNLVKIITSCSSIDTRGNEFKALVY 640
           E+T  VA+K L  +  G  +        LR+ ++H N+V ++   +      ++  ++++
Sbjct: 54  EQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-----DQPLSMIF 108
Query: 641 EFMPNGSLENWLNQK---------EDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS 691
            +  +G L  +L  +         +D++  +  L     + +   +A  +EYL  H    
Sbjct: 109 SYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---H 165
Query: 692 IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS----IGYVAPEYGA 747
           +VH DL   NVL+ +++   + D GL R ++          ++ G+    I ++APE   
Sbjct: 166 VVHKDLATRNVLVYDKLNVKISDLGLFREVY-----AADYYKLLGNSLLPIRWMAPEAIM 220
Query: 748 LGEVSTHGDEYSFGILMLEMFT 769
            G+ S   D +S+G+++ E+F+
Sbjct: 221 YGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 14/137 (10%)
Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           ++  E M  GSL+  L +       R    ++ ++SIA  V   L YL       I+H D
Sbjct: 80  SICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIA--VIKGLTYLREK--HKIMHRD 130
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           +KPSN+L+++     + DFG+S  L D     +  +   G+  Y++PE       S   D
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+ ++EM  G+ P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 14/137 (10%)
Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           ++  E M  GSL+  L +       R    ++ ++SIA  V   L YL       I+H D
Sbjct: 80  SICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIA--VIKGLTYLREK--HKIMHRD 130
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           +KPSN+L+++     + DFG+S  L D     +  +   G+  Y++PE       S   D
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+ ++EM  G+ P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 61  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 115
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 116 VPGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 163
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 164 NLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 217
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 218 GVLIYEMAAGYPP 230

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 68  HFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSF-----KDNSNLYMVMEY 122
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 122
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 89  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 143
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 144 VPGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 191
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 192 NLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 246 GVLIYEMAAGYPP 258

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 68  HFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSF-----KDNSNLYMVMEY 122
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 67/137 (48%), Gaps = 14/137 (10%)
Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           ++  E M  GSL+  L     ++  R    ++ ++SIA  V   L YL       I+H D
Sbjct: 80  SICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIA--VIKGLTYLREK--HKIMHRD 130
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           +KPSN+L+++     + DFG+S  L D     +  +   G+  Y++PE       S   D
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+ ++EM  G+ P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 67/137 (48%), Gaps = 14/137 (10%)
Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           ++  E M  GSL+  L     ++  R    ++ ++SIA  V   L YL       I+H D
Sbjct: 142 SICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIA--VIKGLTYLREK--HKIMHRD 192
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           +KPSN+L+++     + DFG+S  L D     +  +   G+  Y++PE       S   D
Sbjct: 193 VKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTHYSVQSD 247
Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+ ++EM  G+ P
Sbjct: 248 IWSMGLSLVEMAVGRYP 264

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 69  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 123
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 124 VPGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 171
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 226 GVLIYEMAAGYPP 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 69  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 123
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 124 VPGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 171
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 226 GVLIYEMAAGYPP 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 122
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 69  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 123
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 124 VPGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 171
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 226 GVLIYEMAAGYPP 238

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 61  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 115
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 116 VPGGEMFSHLRRIGRFXEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 163
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 164 NLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 217
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 218 GVLIYEMAAGYPP 230

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 14/137 (10%)
Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           ++  E M  GSL+  L +       R    ++ ++SIA  V   L YL       I+H D
Sbjct: 80  SICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIA--VIKGLTYLREK--HKIMHRD 130
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           +KPSN+L+++     + DFG+S  L D     +  +   G+  Y++PE       S   D
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+ ++EM  G+ P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 122
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + L+YLH     ++V+ DLK  N++LD +    + DFGL +   +   D  +     
Sbjct: 256 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFC 310
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  Y+APE     +     D +  G++M EM  G+ P
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 69  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 123
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 124 VPGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 171
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 226 GVLIYEMAAGYPP 238

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 84/192 (43%), Gaps = 20/192 (10%)
Query: 587 VAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           VA+K++D   + + G  +    E +    ++H +++++           + +  LV E  
Sbjct: 39  VAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----SNYVYLVLEMC 93
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
            NG +  +L  +    ++    + M ++     +  +L YLH H    I+H DL  SN+L
Sbjct: 94  HNGEMNRYLKNRVKPFSENEARHFMHQI-----ITGML-YLHSH---GILHRDLTLSNLL 144
Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
           L   M   + DFGL+  L    P +   + + G+  Y++PE           D +S G +
Sbjct: 145 LTRNMNIKIADFGLATQL--KMPHEKHYT-LCGTPNYISPEIATRSAHGLESDVWSLGCM 201
Query: 764 MLEMFTGKRPTD 775
              +  G+ P D
Sbjct: 202 FYTLLIGRPPFD 213

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 69  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 123
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 124 VPGGEMFSHLRRIGRFXEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 171
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 226 GVLIYEMAAGYPP 238

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 67/137 (48%), Gaps = 14/137 (10%)
Query: 637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCD 696
           ++  E M  GSL+  L     ++  R    ++ ++SIA  V   L YL       I+H D
Sbjct: 80  SICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIA--VIKGLTYLREK--HKIMHRD 130
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
           +KPSN+L+++     + DFG+S  L D     +  +   G+  Y++PE       S   D
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+ ++EM  G+ P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 122
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 123 VPGGEMFSHLRRIGRFXEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 69  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 123
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 124 VPGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 171
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRV------KGRTWTLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 226 GVLIYEMAAGYPP 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 122
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           +P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 123 VPGGEMFSHLRRIGRFXEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+L+D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + L+YLH     ++V+ DLK  N++LD +    + DFGL +   +   D  +     
Sbjct: 259 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFC 313
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  Y+APE     +     D +  G++M EM  G+ P
Sbjct: 314 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 49/100 (49%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      + +T  
Sbjct: 168 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGATWT 218
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 219 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL-SRLLHDNSPDQTSTSRVKGSIGY 740
           +YLH +    ++H DLK  N+ L+ ++   +GDFGL +++ +D    +T    + G+  Y
Sbjct: 131 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT----LCGTPNY 183
Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           +APE  +    S   D +S G +M  +  GK P
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL-SRLLHDNSPDQTSTSRVKGSIGY 740
           +YLH +    ++H DLK  N+ L+ ++   +GDFGL +++ +D    +T    + G+  Y
Sbjct: 135 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT----LCGTPNY 187
Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           +APE  +    S   D +S G +M  +  GK P
Sbjct: 188 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 220

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 68  HYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 122
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
            P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 123 APGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+++D +    V DFGL++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 171 NLMIDQQGYIQVTDFGLAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 148 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV------KGRTWX 198
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL-SRLLHDNSPDQTSTSRVKGSIGY 740
           +YLH +    ++H DLK  N+ L+ ++   +GDFGL +++ +D    +T    + G+  Y
Sbjct: 131 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT----LCGTPNY 183
Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           +APE  +    S   D +S G +M  +  GK P
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 28/199 (14%)
Query: 588 AVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           AVK+++ Q          E E L   + HRN++++I      D        LV+E M  G
Sbjct: 42  AVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF-----YLVFEKMRGG 96
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           S+ + +++       R   N ++   +  DVA+ L++LH+     I H DLKP N+L ++
Sbjct: 97  SILSHIHK-------RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEH 146
Query: 707 E---MVAHVGDFGLS---RLLHDNSPDQTSTSRVK-GSIGYVAPE-YGALGEVST----H 754
                   + DFGL    +L  D SP  T       GS  Y+APE   A  E ++     
Sbjct: 147 PNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 755 GDEYSFGILMLEMFTGKRP 773
            D +S G+++  + +G  P
Sbjct: 207 CDLWSLGVILYILLSGYPP 225

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + L+YLH     ++V+ DLK  N++LD +    + DFGL +   +   D  +     
Sbjct: 116 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFC 170
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  Y+APE     +     D +  G++M EM  G+ P
Sbjct: 171 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 30/192 (15%)
Query: 587 VAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLV---KIITSCSSIDTRGNEFKALVYEF 642
           VA+K + L+ + GA  + I E   L+ ++H N+V    II +  S+         LV+E+
Sbjct: 30  VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL--------TLVFEY 81
Query: 643 MPNGSLENWLNQKEDEQN-QRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
           + +  L+ +L+   +  N    KL L Q L         L Y H      ++H DLKP N
Sbjct: 82  L-DKDLKQYLDDCGNIINMHNVKLFLFQLL-------RGLAYCHRQ---KVLHRDLKPQN 130
Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYS 759
           +L++      + DFGL+R    + P +T  + V  ++ Y  P+   LG  + ST  D + 
Sbjct: 131 LLINERGELKLADFGLARA--KSIPTKTYDNEVV-TLWYRPPDI-LLGSTDYSTQIDMWG 186
Query: 760 FGILMLEMFTGK 771
            G +  EM TG+
Sbjct: 187 VGCIFYEMATGR 198

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 142 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 192
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 193 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + L+YLH     ++V+ DLK  N++LD +    + DFGL +   +   D  +     
Sbjct: 117 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFC 171
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  Y+APE     +     D +  G++M EM  G+ P
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++ + L+YLH     ++V+ DLK  N++LD +    + DFGL +   +   D  +     
Sbjct: 118 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFC 172
Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  Y+APE     +     D +  G++M EM  G+ P
Sbjct: 173 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 587 VAVKVLDLQQRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           +  + L   +RG S+  I  E   LR IRH N   IIT     + + +    L+ E +  
Sbjct: 45  IKKRRLSSSRRGVSREEIEREVNILREIRHPN---IITLHDIFENKTD--VVLILELVSG 99
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L ++L +KE          L Q          +L+ +H+     I H DLKP N++L 
Sbjct: 100 GELFDFLAEKESLTEDEATQFLKQ----------ILDGVHYLHSKRIAHFDLKPENIMLL 149
Query: 706 NEMVAH----VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           ++ V +    + DFG++  +   +        + G+  +VAPE      +    D +S G
Sbjct: 150 DKNVPNPRIKLIDFGIAHKIEAGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG 205
Query: 762 ILMLEMFTGKRP 773
           ++   + +G  P
Sbjct: 206 VITYILLSGASP 217

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 88/210 (41%), Gaps = 41/210 (19%)
Query: 588 AVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGS 647
           AVK++D  +R  ++    E E L  +R+     IIT     D    ++  +V E M  G 
Sbjct: 51  AVKIIDKSKRDPTE----EIEIL--LRYGQHPNIITLKDVYD--DGKYVYVVTELMKGGE 102
Query: 648 L-ENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           L +  L QK   + +          ++   +   +EYLH      +VH DLKPSN+L  +
Sbjct: 103 LLDKILRQKFFSEREAS--------AVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVD 151
Query: 707 EM----VAHVGDFGLSRLLHDN-----SPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE 757
           E        + DFG ++ L        +P  T+         +VAPE           D 
Sbjct: 152 ESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN--------FVAPEVLERQGYDAACDI 203
Query: 758 YSFGILMLEMFTGKRP----TDDMFEEGLS 783
           +S G+L+  M TG  P     DD  EE L+
Sbjct: 204 WSLGVLLYTMLTGYTPFANGPDDTPEEILA 233

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 148 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 198
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 134 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV------KGRTWX 184
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 185 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 68  HYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 122
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
            P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 123 APGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+++D +    V DFGL++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 171 NLMIDQQGYIKVTDFGLAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 20/194 (10%)
Query: 582 TEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS-CSSIDTRGNEFKALVY 640
            E   VA+K +   +R  ++    E + +R ++H N+V +     S+ D +   F  LV 
Sbjct: 62  VESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117
Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           E++P        +  + +Q        M  L I + +  +L  L +     I H D+KP 
Sbjct: 118 EYVPETVYRASRHYAKLKQT-------MPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQ 170
Query: 701 NVLLDNEM-VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE--YGALGEVSTHGDE 757
           N+LLD    V  + DFG +++L    P+ +       S  Y APE  +GA    +T+ D 
Sbjct: 171 NLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC----SRYYRAPELIFGATN-YTTNIDI 225
Query: 758 YSFGILMLEMFTGK 771
           +S G +M E+  G+
Sbjct: 226 WSTGCVMAELMQGQ 239

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 15/93 (16%)
Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           LEYLH H    I+H DLKP+N+LLD   V  + DFGL++     SP++    +V  +  Y
Sbjct: 125 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYXHQVV-TRWY 178
Query: 741 VAPE--YGALGEVSTHG---DEYSFGILMLEMF 768
            APE  +GA      +G   D ++ G ++ E+ 
Sbjct: 179 RAPELLFGA----RMYGVGVDMWAVGCILAELL 207

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 168 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 218
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 219 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 80/183 (43%), Gaps = 24/183 (13%)
Query: 596 QRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           +RG S+  I  E   LR IRH N   IIT     + + +    L+ E +  G L ++L +
Sbjct: 68  RRGVSREEIEREVNILREIRHPN---IITLHDIFENKTD--VVLILELVSGGELFDFLAE 122
Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH--- 711
           KE          L Q          +L+ +H+     I H DLKP N++L ++ V +   
Sbjct: 123 KESLTEDEATQFLKQ----------ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRI 172
Query: 712 -VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
            + DFG++  +   +        + G+  +VAPE      +    D +S G++   + +G
Sbjct: 173 KLIDFGIAHKIEAGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228
Query: 771 KRP 773
             P
Sbjct: 229 ASP 231

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 4/104 (3%)
Query: 673 IAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS-RLLHDNSPDQTST 731
           IA+ +   LE+LH     S++H D+KPSNVL++        DFG+S  L+ D + D  + 
Sbjct: 141 IAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAG 198
Query: 732 SRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTD 775
            +   +   + PE    G  S   D +S GI  +E+   + P D
Sbjct: 199 CKPYXAPERINPELNQKG-YSVKSDIWSLGITXIELAILRFPYD 241

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 588 AVKVLDLQQRGASKSFIAECEA--LRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           A K+++ ++  A      E EA   R ++H N+V++  S S        F  LV++ +  
Sbjct: 33  AAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-----EGFHYLVFDLVTG 87
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCH-TSIVHCDLKPSNVLL 704
           G L   +  +E                 +  +  +LE ++H CH   IVH DLKP N+LL
Sbjct: 88  GELFEDIVARE----------YYSEADASHCIQQILESVNH-CHLNGIVHRDLKPENLLL 136
Query: 705 DNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
            ++       + DFGL+  +     DQ +     G+ GY++PE           D ++ G
Sbjct: 137 ASKSKGAAVKLADFGLAIEVQG---DQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACG 193
Query: 762 ILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD 794
           +++  +  G  P  D  E+   L++  K G  D
Sbjct: 194 VILYILLVGYPPFWD--EDQHRLYQQIKAGAYD 224

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 81/168 (48%), Gaps = 24/168 (14%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSI--RHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK+   ++    +S+  E E  +++  RH N++  I + +  +    +   LV ++  
Sbjct: 68  VAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL-WLVSDYHE 123
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC-----HTSIVHCDLKP 699
           +GSL ++LN        R  + +   + +A+  A+ L +LH          +I H DLK 
Sbjct: 124 HGSLFDYLN--------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 175
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS---RVKGSIGYVAPE 744
            N+L+       + D GL+ + HD++ D    +   RV G+  Y+APE
Sbjct: 176 KNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV-GTKRYMAPE 221

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 32/195 (16%)
Query: 588 AVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           AVKV+    ++Q+   +S + E + L+ + H N++K+       + +G  +  LV E   
Sbjct: 61  AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY---EFFEDKG--YFYLVGEVYT 115
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            G L        DE   R + + +    I   V + + Y+H +    IVH DLKP N+LL
Sbjct: 116 GGELF-------DEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLL 165
Query: 705 DN---EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YVAPEYGALGEVSTHGDEY 758
           ++   +    + DFGLS           ++ ++K  IG   Y+APE    G      D +
Sbjct: 166 ESKSKDANIRIIDFGLSTHFE-------ASKKMKDKIGTAYYIAPEV-LHGTYDEKCDVW 217
Query: 759 SFGILMLEMFTGKRP 773
           S G+++  + +G  P
Sbjct: 218 STGVILYILLSGCPP 232

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 81/168 (48%), Gaps = 24/168 (14%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSI--RHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK+   ++    +S+  E E  +++  RH N++  I + +  +    +   LV ++  
Sbjct: 55  VAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL-WLVSDYHE 110
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC-----HTSIVHCDLKP 699
           +GSL ++LN        R  + +   + +A+  A+ L +LH          +I H DLK 
Sbjct: 111 HGSLFDYLN--------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 162
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS---RVKGSIGYVAPE 744
            N+L+       + D GL+ + HD++ D    +   RV G+  Y+APE
Sbjct: 163 KNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV-GTKRYMAPE 208

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 587 VAVKVLDLQQRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           +  + L   +RG S+  I  E   LR IRH N   IIT     + + +    L+ E +  
Sbjct: 38  IKKRRLSSSRRGVSREEIEREVNILREIRHPN---IITLHDIFENKTD--VVLILELVSG 92
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L ++L +KE          L Q          +L+ +H+     I H DLKP N++L 
Sbjct: 93  GELFDFLAEKESLTEDEATQFLKQ----------ILDGVHYLHSKRIAHFDLKPENIMLL 142
Query: 706 NEMVAH----VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           ++ V +    + DFG++  +   +        + G+  +VAPE      +    D +S G
Sbjct: 143 DKNVPNPRIKLIDFGIAHKIEAGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG 198
Query: 762 ILMLEMFTGKRP 773
           ++   + +G  P
Sbjct: 199 VITYILLSGASP 210

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 21/173 (12%)
Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP-- 663
           E + LR +RH+N+++++      D   NE K  +Y  M     E  +   ++  +  P  
Sbjct: 56  EIQLLRRLRHKNVIQLV------DVLYNEEKQKMYMVM-----EYCVCGMQEMLDSVPEK 104
Query: 664 KLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD 723
           +  + Q       + + LEYLH      IVH D+KP N+LL       +   G++  LH 
Sbjct: 105 RFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161
Query: 724 NSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP 773
            + D T  +  +GS  +  PE  A G  +  G   D +S G+ +  + TG  P
Sbjct: 162 FAADDTCRTS-QGSPAFQPPEI-ANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 81/168 (48%), Gaps = 24/168 (14%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSI--RHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK+   ++    +S+  E E  +++  RH N++  I + +  +    +   LV ++  
Sbjct: 32  VAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL-WLVSDYHE 87
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC-----HTSIVHCDLKP 699
           +GSL ++LN        R  + +   + +A+  A+ L +LH          +I H DLK 
Sbjct: 88  HGSLFDYLN--------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 139
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS---RVKGSIGYVAPE 744
            N+L+       + D GL+ + HD++ D    +   RV G+  Y+APE
Sbjct: 140 KNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV-GTKRYMAPE 185

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 588 AVKVLDLQQRGASKSFIAECEA--LRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           A K+++ ++  A      E EA   R ++H N+V++  S S        F  LV++ +  
Sbjct: 33  AAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-----EGFHYLVFDLVTG 87
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCH-TSIVHCDLKPSNVLL 704
           G L   +  +E                 +  +  +LE ++H CH   IVH DLKP N+LL
Sbjct: 88  GELFEDIVARE----------YYSEADASHCIQQILESVNH-CHLNGIVHRDLKPENLLL 136
Query: 705 DNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
            ++       + DFGL+  +     DQ +     G+ GY++PE           D ++ G
Sbjct: 137 ASKSKGAAVKLADFGLAIEVQG---DQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACG 193
Query: 762 ILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD 794
           +++  +  G  P  D  E+   L++  K G  D
Sbjct: 194 VILYILLVGYPPFWD--EDQHRLYQQIKAGAYD 224

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 81/168 (48%), Gaps = 24/168 (14%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSI--RHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK+   ++    +S+  E E  +++  RH N++  I + +  +    +   LV ++  
Sbjct: 35  VAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL-WLVSDYHE 90
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC-----HTSIVHCDLKP 699
           +GSL ++LN        R  + +   + +A+  A+ L +LH          +I H DLK 
Sbjct: 91  HGSLFDYLN--------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 142
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS---RVKGSIGYVAPE 744
            N+L+       + D GL+ + HD++ D    +   RV G+  Y+APE
Sbjct: 143 KNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV-GTKRYMAPE 188

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 6/98 (6%)
Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
            A ++  L H  +  +V+ DLKP+N+LLD      + D GL+       P  +      G
Sbjct: 297 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----G 351
Query: 737 SIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRP 773
           + GY+APE    G    +  D +S G ++ ++  G  P
Sbjct: 352 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 36/197 (18%)
Query: 588 AVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           AVKV+    ++Q+   +S + E + L+ + H N++K+       + +G  +  LV E   
Sbjct: 55  AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY---EFFEDKG--YFYLVGEVYT 109
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            G L        DE   R + + +    I   V + + Y+H +    IVH DLKP N+LL
Sbjct: 110 GGELF-------DEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLL 159
Query: 705 DN---EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YVAPE--YGALGEVSTHGD 756
           ++   +    + DFGLS           ++ ++K  IG   Y+APE  +G   E     D
Sbjct: 160 ESKSKDANIRIIDFGLSTHFE-------ASKKMKDKIGTAYYIAPEVLHGTYDEKC---D 209
Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+++  + +G  P
Sbjct: 210 VWSTGVILYILLSGCPP 226

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 19/156 (12%)
Query: 638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           LV + MP G L + + +       R +L     L+  + +A  + YL       +VH DL
Sbjct: 95  LVTQLMPYGCLLDHVRE------NRGRLGSQDLLNWCMQIAKGMSYLED---VRLVHRDL 145
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDE 757
              NVL+ +     + DFGL+RLL D    +      K  I ++A E       +   D 
Sbjct: 146 AARNVLVKSPNHVKITDFGLARLL-DIDETEYHADGGKVPIKWMALESILRRRFTHQSDV 204
Query: 758 YSFGILMLEMFT-GKRPTD--------DMFEEGLSL 784
           +S+G+ + E+ T G +P D        D+ E+G  L
Sbjct: 205 WSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL 240

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 6/98 (6%)
Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
            A ++  L H  +  +V+ DLKP+N+LLD      + D GL+       P  +      G
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----G 352
Query: 737 SIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRP 773
           + GY+APE    G    +  D +S G ++ ++  G  P
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 6/98 (6%)
Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
            A ++  L H  +  +V+ DLKP+N+LLD      + D GL+       P  +      G
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----G 352
Query: 737 SIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRP 773
           + GY+APE    G    +  D +S G ++ ++  G  P
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 6/98 (6%)
Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
            A ++  L H  +  +V+ DLKP+N+LLD      + D GL+       P  +      G
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----G 352
Query: 737 SIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRP 773
           + GY+APE    G    +  D +S G ++ ++  G  P
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 60/147 (40%), Gaps = 17/147 (11%)
Query: 631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHT 690
           + + +  +V E+MP G L N ++  +  +          R   A +V   L+ +H     
Sbjct: 144 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-------WARFYTA-EVVLALDAIHS---M 192
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY----G 746
             +H D+KP N+LLD      + DFG    +  N           G+  Y++PE     G
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM--NKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 747 ALGEVSTHGDEYSFGILMLEMFTGKRP 773
             G      D +S G+ + EM  G  P
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 77/172 (44%), Gaps = 19/172 (11%)
Query: 605 AECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPK 664
           AE E L+S+ H N++KI       +   N +  +V E    G L   L +    Q +   
Sbjct: 69  AEIEVLKSLDHPNIIKIF---EVFEDYHNMY--IVMETCEGGEL---LERIVSAQARGKA 120
Query: 665 LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN---EMVAHVGDFGLSRLL 721
           L+      +   + N L Y H      +VH DLKP N+L  +        + DFGL+ L 
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177
Query: 722 HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
                D+ ST+   G+  Y+APE     +V+   D +S G++M  + TG  P
Sbjct: 178 ---KSDEHSTN-AAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 81/168 (48%), Gaps = 24/168 (14%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSI--RHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK+   ++    +S+  E E  +++  RH N++  I + +  +    +   LV ++  
Sbjct: 29  VAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL-WLVSDYHE 84
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC-----HTSIVHCDLKP 699
           +GSL ++LN        R  + +   + +A+  A+ L +LH          +I H DLK 
Sbjct: 85  HGSLFDYLN--------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS---RVKGSIGYVAPE 744
            N+L+       + D GL+ + HD++ D    +   RV G+  Y+APE
Sbjct: 137 KNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV-GTKRYMAPE 182

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 81/168 (48%), Gaps = 24/168 (14%)
Query: 587 VAVKVLDLQQRGASKSFIAECEALRSI--RHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           VAVK+   ++    +S+  E E  +++  RH N++  I + +  +    +   LV ++  
Sbjct: 30  VAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL-WLVSDYHE 85
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC-----HTSIVHCDLKP 699
           +GSL ++LN        R  + +   + +A+  A+ L +LH          +I H DLK 
Sbjct: 86  HGSLFDYLN--------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 137
Query: 700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS---RVKGSIGYVAPE 744
            N+L+       + D GL+ + HD++ D    +   RV G+  Y+APE
Sbjct: 138 KNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV-GTKRYMAPE 183

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+++D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+++D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 60/147 (40%), Gaps = 17/147 (11%)
Query: 631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHT 690
           + + +  +V E+MP G L N ++  +  +          R   A +V   L+ +H     
Sbjct: 139 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-------WARFYTA-EVVLALDAIHS---M 187
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY----G 746
             +H D+KP N+LLD      + DFG    +  N           G+  Y++PE     G
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM--NKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 747 ALGEVSTHGDEYSFGILMLEMFTGKRP 773
             G      D +S G+ + EM  G  P
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 53/113 (46%), Gaps = 6/113 (5%)
Query: 665 LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
           L+  Q  +I  ++   L+YLH       +H D+K +NVLL       + DFG++  L D 
Sbjct: 121 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 177
Query: 725 SPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
              Q   +   G+  ++APE        +  D +S GI  +E+  G+ P  ++
Sbjct: 178 ---QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 60/147 (40%), Gaps = 17/147 (11%)
Query: 631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHT 690
           + + +  +V E+MP G L N ++  +  +          R   A +V   L+ +H     
Sbjct: 144 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-------WARFYTA-EVVLALDAIHS---M 192
Query: 691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY----G 746
             +H D+KP N+LLD      + DFG    +  N           G+  Y++PE     G
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM--NKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 747 ALGEVSTHGDEYSFGILMLEMFTGKRP 773
             G      D +S G+ + EM  G  P
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 53/113 (46%), Gaps = 6/113 (5%)
Query: 665 LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
           L+  Q  +I  ++   L+YLH       +H D+K +NVLL       + DFG++  L D 
Sbjct: 101 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157
Query: 725 SPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
              Q   +   G+  ++APE        +  D +S GI  +E+  G+ P  ++
Sbjct: 158 ---QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 76/172 (44%), Gaps = 25/172 (14%)
Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL 665
           E   L+ I+H N+V +      I      +  LV + +  G L + + ++     +   L
Sbjct: 56  EIAVLKKIKHENIVTL----EDIYESTTHY-YLVMQLVSGGELFDRILERGVYTEKDASL 110
Query: 666 NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL----DNEMVAHVGDFGLSRLL 721
            + Q LS        ++YLH +    IVH DLKP N+L     +N  +  + DFGLS++ 
Sbjct: 111 VIQQVLS-------AVKYLHEN---GIVHRDLKPENLLYLTPEENSKIM-ITDFGLSKME 159
Query: 722 HDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
            +        S   G+ GYVAPE  A    S   D +S G++   +  G  P
Sbjct: 160 QNGI-----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 53/113 (46%), Gaps = 6/113 (5%)
Query: 665 LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
           L+  Q  +I  ++   L+YLH       +H D+K +NVLL       + DFG++  L D 
Sbjct: 101 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157
Query: 725 SPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
              Q   +   G+  ++APE        +  D +S GI  +E+  G+ P  ++
Sbjct: 158 ---QIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 586 NVAVKVLD----LQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L     L +R A    ++E + L  +  H N+V ++ +C    T G     ++ 
Sbjct: 78  TVAVKMLKPSAHLTEREA---LMSELKVLSYLGNHMNIVNLLGAC----TIGGP-TLVIT 129
Query: 641 EFMPNGSLENWLNQKEDE---QNQRPKL--------NLMQRLSIAIDVANVLEYLHHHCH 689
           E+   G L N+L +K D        P +        +L   LS +  VA  + +L     
Sbjct: 130 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---AS 186
Query: 690 TSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG 749
            + +H DL   N+LL +  +  + DFGL+R + ++S +       +  + ++APE     
Sbjct: 187 KNCIHRDLAARNILLTHGRITKICDFGLARHIKNDS-NYVVKGNARLPVKWMAPESIFNC 245
Query: 750 EVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
             +   D +S+GI + E+F+ G  P   M
Sbjct: 246 VYTFESDVWSYGIFLWELFSLGSSPYPGM 274

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 586 NVAVKVLD----LQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L     L +R A    ++E + L  +  H N+V ++ +C    T G     ++ 
Sbjct: 55  TVAVKMLKPSAHLTEREA---LMSELKVLSYLGNHMNIVNLLGAC----TIGGP-TLVIT 106
Query: 641 EFMPNGSLENWLNQKEDE---QNQRPKL--------NLMQRLSIAIDVANVLEYLHHHCH 689
           E+   G L N+L +K D        P +        +L   LS +  VA  + +L     
Sbjct: 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---AS 163
Query: 690 TSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG 749
            + +H DL   N+LL +  +  + DFGL+R + ++S +       +  + ++APE     
Sbjct: 164 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFNC 222
Query: 750 EVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
             +   D +S+GI + E+F+ G  P   M
Sbjct: 223 VYTFESDVWSYGIFLWELFSLGSSPYPGM 251

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 48/107 (44%), Gaps = 23/107 (21%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++             R
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-------------R 190
Query: 734 VKGSIGYV--APEYGALGEVSTHG-----DEYSFGILMLEMFTGKRP 773
           VKG    +   PEY A   + + G     D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 40/200 (20%)
Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           E NVA+K L       S+ F  +  A R+ R   L+K++   + I         L+  F 
Sbjct: 49  ERNVAIKKL-------SRPFQNQTHAKRAYRELVLMKVVNHKNII--------GLLNVFT 93
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH------HCHTS-IVHCD 696
           P  SLE +  Q      +    NL Q + + +D   +   L+       H H++ I+H D
Sbjct: 94  PQKSLEEF--QDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRD 151
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV----- 751
           LKPSN+++ ++    + DFGL+R           TS +     YV   Y    EV     
Sbjct: 152 LKPSNIVVKSDATLKILDFGLAR--------TAGTSFMMTP--YVVTRYYRAPEVILGMG 201
Query: 752 -STHGDEYSFGILMLEMFTG 770
              + D +S G++M EM  G
Sbjct: 202 YKENVDIWSVGVIMGEMIKG 221

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 36/197 (18%)
Query: 588 AVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           AVKV+    ++Q+   +S + E + L+ + H N++K+       + +G  +  LV E   
Sbjct: 78  AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY---EFFEDKG--YFYLVGEVYT 132
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            G L        DE   R + + +    I   V + + Y+H +    IVH DLKP N+LL
Sbjct: 133 GGELF-------DEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLL 182
Query: 705 DN---EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YVAPE--YGALGEVSTHGD 756
           ++   +    + DFGLS           ++ ++K  IG   Y+APE  +G   E     D
Sbjct: 183 ESKSKDANIRIIDFGLSTHFE-------ASKKMKDKIGTAYYIAPEVLHGTYDEKC---D 232
Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+++  + +G  P
Sbjct: 233 VWSTGVILYILLSGCPP 249

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 36/197 (18%)
Query: 588 AVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           AVKV+    ++Q+   +S + E + L+ + H N++K+       + +G  +  LV E   
Sbjct: 79  AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY---EFFEDKG--YFYLVGEVYT 133
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            G L        DE   R + + +    I   V + + Y+H +    IVH DLKP N+LL
Sbjct: 134 GGELF-------DEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLL 183
Query: 705 DN---EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YVAPE--YGALGEVSTHGD 756
           ++   +    + DFGLS           ++ ++K  IG   Y+APE  +G   E     D
Sbjct: 184 ESKSKDANIRIIDFGLSTHFE-------ASKKMKDKIGTAYYIAPEVLHGTYDEKC---D 233
Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+++  + +G  P
Sbjct: 234 VWSTGVILYILLSGCPP 250

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 6/106 (5%)
Query: 672 SIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTST 731
           +I  ++   L+YLH       +H D+K +NVLL  +    + DFG++  L D    Q   
Sbjct: 120 TILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKR 173
Query: 732 SRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
           +   G+  ++APE           D +S GI  +E+  G+ P  D+
Sbjct: 174 NXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 219

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 85/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 69  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 123
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
            P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 124 APGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 171
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+++D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 226 GVLIYEMAAGYPP 238

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+++D +    V DFG ++ +      +  T  
Sbjct: 148 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV------KGRTWX 198
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 586 NVAVKVLD----LQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L     L +R A    ++E + L  +  H N+V ++ +C    T G     ++ 
Sbjct: 78  TVAVKMLKPSAHLTEREA---LMSELKVLSYLGNHMNIVNLLGAC----TIGGP-TLVIT 129
Query: 641 EFMPNGSLENWLNQKEDE---QNQRPKL--------NLMQRLSIAIDVANVLEYLHHHCH 689
           E+   G L N+L +K D        P +        +L   LS +  VA  + +L     
Sbjct: 130 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---AS 186
Query: 690 TSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG 749
            + +H DL   N+LL +  +  + DFGL+R + ++S +       +  + ++APE     
Sbjct: 187 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFNC 245
Query: 750 EVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
             +   D +S+GI + E+F+ G  P   M
Sbjct: 246 VYTFESDVWSYGIFLWELFSLGSSPYPGM 274

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+++D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 85/193 (44%), Gaps = 28/193 (14%)
Query: 586 NVAVKVLDLQQRGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
           + A+K+LD Q+    K     + E   L+++    LVK+  S      + N    +V E+
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSNLYMVMEY 122
Query: 643 MPNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
            P G + + L +  +  E + R           A  +    EYLH      +++ DLKP 
Sbjct: 123 APGGEMFSHLRRIGRFSEPHAR---------FYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSF 760
           N+++D +    V DFG ++ +      +  T  + G+  Y+APE       +   D ++ 
Sbjct: 171 NLMIDQQGYIKVTDFGFAKRV------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 761 GILMLEMFTGKRP 773
           G+L+ EM  G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 586 NVAVKVLD----LQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L     L +R A    ++E + L  +  H N+V ++ +C    T G     ++ 
Sbjct: 73  TVAVKMLKPSAHLTEREA---LMSELKVLSYLGNHMNIVNLLGAC----TIGGP-TLVIT 124
Query: 641 EFMPNGSLENWLNQKEDE---QNQRPKL--------NLMQRLSIAIDVANVLEYLHHHCH 689
           E+   G L N+L +K D        P +        +L   LS +  VA  + +L     
Sbjct: 125 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---AS 181
Query: 690 TSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG 749
            + +H DL   N+LL +  +  + DFGL+R + ++S +       +  + ++APE     
Sbjct: 182 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFNC 240
Query: 750 EVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
             +   D +S+GI + E+F+ G  P   M
Sbjct: 241 VYTFESDVWSYGIFLWELFSLGSSPYPGM 269

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+++D +    V DFG ++ +      +  T  
Sbjct: 148 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV------KGRTWX 198
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+++D +    V DFG ++ +      +  T  
Sbjct: 148 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV------KGRTWX 198
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ EM  G  P
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 40/200 (20%)
Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           E NVA+K L       S+ F  +  A R+ R   L+K++   + I         L+  F 
Sbjct: 49  ERNVAIKKL-------SRPFQNQTHAKRAYRELVLMKVVNHKNII--------GLLNVFT 93
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH------HCHTS-IVHCD 696
           P  SLE +  Q      +    NL Q + + +D   +   L+       H H++ I+H D
Sbjct: 94  PQKSLEEF--QDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRD 151
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV----- 751
           LKPSN+++ ++    + DFGL+R           TS +     YV   Y    EV     
Sbjct: 152 LKPSNIVVKSDATLKILDFGLAR--------TAGTSFMMTP--YVVTRYYRAPEVILGMG 201
Query: 752 -STHGDEYSFGILMLEMFTG 770
              + D +S G++M EM  G
Sbjct: 202 YKENVDIWSVGVIMGEMIKG 221

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 53/113 (46%), Gaps = 6/113 (5%)
Query: 665 LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
           L+  Q  +I  ++   L+YLH       +H D+K +NVLL       + DFG++  L D 
Sbjct: 116 LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172
Query: 725 SPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
              Q   +   G+  ++APE        +  D +S GI  +E+  G+ P  ++
Sbjct: 173 ---QIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 690 TSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD-------QTSTSRVKGSIGYVA 742
           ++++H DLKPSN+L+++     V DFGL+R++ +++ D       Q+  +    +  Y A
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRA 190
Query: 743 PEYG-ALGEVSTHGDEYSFGILMLEMFTGKRP 773
           PE      + S   D +S G ++ E+F  +RP
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFL-RRP 221

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+  Y+APE       +   D ++ G+L+ +M  G  P
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           +YLH +    ++H DLK  N+ L+ ++   +GDFGL+  +     D      + G+  Y+
Sbjct: 155 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY---DGERKKVLCGTPNYI 208
Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           APE  +    S   D +S G +M  +  GK P
Sbjct: 209 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           +YLH +    ++H DLK  N+ L+ ++   +GDFGL+  +     D      + G+  Y+
Sbjct: 153 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY---DGERKKVLCGTPNYI 206
Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           APE  +    S   D +S G +M  +  GK P
Sbjct: 207 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 586 NVAVKVLD----LQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVY 640
            VAVK+L     L +R A    ++E + L  +  H N+V ++ +C    T G     ++ 
Sbjct: 71  TVAVKMLKPSAHLTEREA---LMSELKVLSYLGNHMNIVNLLGAC----TIGGP-TLVIT 122
Query: 641 EFMPNGSLENWLNQKEDE---QNQRPKL--------NLMQRLSIAIDVANVLEYLHHHCH 689
           E+   G L N+L +K D        P +        +L   LS +  VA  + +L     
Sbjct: 123 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---AS 179
Query: 690 TSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG 749
            + +H DL   N+LL +  +  + DFGL+R + ++S +       +  + ++APE     
Sbjct: 180 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFNC 238
Query: 750 EVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
             +   D +S+GI + E+F+ G  P   M
Sbjct: 239 VYTFESDVWSYGIFLWELFSLGSSPYPGM 267

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL-SRLLHDNSPDQTSTSRVKGSIG 739
           ++YLH++    ++H DLK  N+ L+++M   +GDFGL +++  D    +T    + G+  
Sbjct: 155 VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT----LCGTPN 207
Query: 740 YVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           Y+APE       S   D +S G ++  +  GK P
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           +YLH +    ++H DLK  N+ L+ ++   +GDFGL+  +     D      + G+  Y+
Sbjct: 129 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY---DGERKKVLCGTPNYI 182
Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           APE  +    S   D +S G +M  +  GK P
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 44/232 (18%)
Query: 582 TEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           T ET VA+K + L+  + G   + I E   L+ ++HRN++++ +         N    L+
Sbjct: 58  TNET-VAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----NHRLHLI 111
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHT-SIVHCDLK 698
           +E+  N  L+ ++++  D   +  K  L Q     I+  N        CH+   +H DLK
Sbjct: 112 FEYAEN-DLKKYMDKNPDVSMRVIKSFLYQ----LINGVNF-------CHSRRCLHRDLK 159
Query: 699 PSNVLL-----DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EV 751
           P N+LL         V  +GDFGL+R      P +  T  +  ++ Y  PE   LG    
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEII-TLWYRPPEI-LLGSRHY 215
Query: 752 STHGDEYSFGILMLEM------FTGKRPTDDMFEEGLSLHKYAKMGLPDQVA 797
           ST  D +S   +  EM      F G    D +F+       +  +GLPD   
Sbjct: 216 STSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK------IFEVLGLPDDTT 261

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           ++YLH++    ++H DLK  N+ L+++M   +GDFGL+  +     D      + G+  Y
Sbjct: 155 VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF---DGERKKXLCGTPNY 208
Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           +APE       S   D +S G ++  +  GK P
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           ++YLH++    ++H DLK  N+ L+++M   +GDFGL+  +     D      + G+  Y
Sbjct: 139 VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF---DGERKKDLCGTPNY 192
Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           +APE       S   D +S G ++  +  GK P
Sbjct: 193 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 27/213 (12%)
Query: 588 AVKVLDLQQRGASKSFIAECEA--LRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           A K+++ ++  A      E EA   R ++H N+V++  S S        F  LV++ +  
Sbjct: 33  AAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISE-----EGFHYLVFDLVTG 87
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHT-SIVHCDLKPSNVLL 704
           G L   +  +E          + Q L   +           HCH   +VH DLKP N+LL
Sbjct: 88  GELFEDIVAREYYSEADASHCIQQILEAVL-----------HCHQMGVVHRDLKPENLLL 136
Query: 705 DNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
            ++       + DFGL+    +   DQ +     G+ GY++PE           D ++ G
Sbjct: 137 ASKCKGAAVKLADFGLAI---EVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACG 193
Query: 762 ILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD 794
           +++  +  G  P  D  E+   L++  K G  D
Sbjct: 194 VILYILLVGYPPFWD--EDQHKLYQQIKAGAYD 224

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 36/201 (17%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSI--RHRNLVKIITSCSSIDTRGNEFK-ALVYEF 642
           NVAVK+   +     KS+  E E   ++  RH N++  I S   + +R +  +  L+  +
Sbjct: 62  NVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIAS--DMTSRHSSTQLWLITHY 116
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH-----HHCHTSIVHCDL 697
              GSL ++L        Q   L+ +  L I + +A+ L +LH          +I H DL
Sbjct: 117 HEMGSLYDYL--------QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDL 168
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS---RVKGSIGYVAPEYGALGEV--- 751
           K  N+L+       + D GL+ ++H  S +Q       RV G+  Y+APE   L E    
Sbjct: 169 KSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRV-GTKRYMAPE--VLDETIQV 224
Query: 752 -----STHGDEYSFGILMLEM 767
                    D ++FG+++ E+
Sbjct: 225 DCFDSYKRVDIWAFGLVLWEV 245

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 14/100 (14%)
Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH----------DNSPDQT 729
           +LE L +     I+H +LKP N+ +D      +GDFGL++ +H           N P  +
Sbjct: 125 ILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 730 S--TSRVKGSIGYVAPEY-GALGEVSTHGDEYSFGILMLE 766
              TS + G+  YVA E     G  +   D YS GI+  E
Sbjct: 185 DNLTSAI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           ++YLH++    ++H DLK  N+ L+++M   +GDFGL+  +     D      + G+  Y
Sbjct: 155 VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF---DGERKKDLCGTPNY 208
Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           +APE       S   D +S G ++  +  GK P
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 19/180 (10%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           L+ +  G   + I E   L+ ++H N+VK+      I T+      LV+E + +  L+  
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLY---DVIHTKKR--LVLVFEHL-DQDLKKL 89
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           L+  E        L  +   S  + + N + Y H      ++H DLKP N+L++ E    
Sbjct: 90  LDVCEG------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELK 140
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY-GALGEVSTHGDEYSFGILMLEMFTG 770
           + DFGL+R      P +  T  V  ++ Y AP+      + ST  D +S G +  EM  G
Sbjct: 141 IADFGLARAF--GIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 19/180 (10%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           L+ +  G   + I E   L+ ++H N+VK+      I T+      LV+E + +  L+  
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLY---DVIHTKKR--LVLVFEHL-DQDLKKL 89
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           L+  E        L  +   S  + + N + Y H      ++H DLKP N+L++ E    
Sbjct: 90  LDVCEG------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELK 140
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY-GALGEVSTHGDEYSFGILMLEMFTG 770
           + DFGL+R      P +  T  V  ++ Y AP+      + ST  D +S G +  EM  G
Sbjct: 141 IADFGLARAF--GIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 69/138 (50%), Gaps = 15/138 (10%)
Query: 638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           L+ EF+  G L + +  ++ + ++   +N M++          L+++H H   SIVH D+
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ------ACEGLKHMHEH---SIVHLDI 175
Query: 698 KPSNVLLDNEMVAHVG--DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG 755
           KP N++ + +  + V   DFGL+  L+ +   + +T+  +    + APE      V  + 
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE----FAAPEIVDREPVGFYT 231
Query: 756 DEYSFGILMLEMFTGKRP 773
           D ++ G+L   + +G  P
Sbjct: 232 DMWAIGVLGYVLLSGLSP 249

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 36/201 (17%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSI--RHRNLVKIITSCSSIDTRGNEFK-ALVYEF 642
           NVAVK+   +     KS+  E E   ++  RH N++  I S   + +R +  +  L+  +
Sbjct: 33  NVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIAS--DMTSRHSSTQLWLITHY 87
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH-----HHCHTSIVHCDL 697
              GSL ++L        Q   L+ +  L I + +A+ L +LH          +I H DL
Sbjct: 88  HEMGSLYDYL--------QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDL 139
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS---RVKGSIGYVAPEYGALGEV--- 751
           K  N+L+       + D GL+ ++H  S +Q       RV G+  Y+APE   L E    
Sbjct: 140 KSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRV-GTKRYMAPE--VLDETIQV 195
Query: 752 -----STHGDEYSFGILMLEM 767
                    D ++FG+++ E+
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEV 216

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 36/170 (21%)
Query: 614 RHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
           RHRN++ +  S  S++        +++EF+    +   +N    E N+R  ++ + +   
Sbjct: 59  RHRNILHLHESFESMEEL-----VMIFEFISGLDIFERINTSAFELNEREIVSYVHQ--- 110
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG--DFGLSRLLH--DN----- 724
              V   L++LH H   +I H D++P N++      + +   +FG +R L   DN     
Sbjct: 111 ---VCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164
Query: 725 -SPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
            +P+            Y APE      VST  D +S G L+  + +G  P
Sbjct: 165 TAPE------------YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 36/201 (17%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSI--RHRNLVKIITSCSSIDTRGNEFK-ALVYEF 642
           NVAVK+   +     KS+  E E   ++  RH N++  I S   + +R +  +  L+  +
Sbjct: 33  NVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIAS--DMTSRHSSTQLWLITHY 87
Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH-----HHCHTSIVHCDL 697
              GSL ++L        Q   L+ +  L I + +A+ L +LH          +I H DL
Sbjct: 88  HEMGSLYDYL--------QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDL 139
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS---RVKGSIGYVAPEYGALGEV--- 751
           K  N+L+       + D GL+ ++H  S +Q       RV G+  Y+APE   L E    
Sbjct: 140 KSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRV-GTKRYMAPE--VLDETIQV 195
Query: 752 -----STHGDEYSFGILMLEM 767
                    D ++FG+++ E+
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEV 216

>pdb|2V9T|B Chain B, Complex Between The Second Lrr Domain Of Slit2 And The First Ig Domain From Robo1 Length = 220

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 71/143 (49%), Gaps = 4/143 (2%)
Query: 287 EIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSF 346
           EIP++L   I  TE+ L+ N+I+   P A     +L+++DLS+N +S   P    GL S 
Sbjct: 25  EIPTNLPETI--TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82
Query: 347 VLLDLSRNHLSG-PIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQ 405
             L L  N ++  P  L  G L  +Q L L+ NK++     +      L  L+  DN  Q
Sbjct: 83  NSLVLYGNKITELPKSLFEG-LFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
Query: 406 GPIHSGFSSLKGLQDLDLSRNNF 428
                 FS L+ +Q + L++N F
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQNPF 164

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 28/199 (14%)
Query: 588 AVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFKALVYEFMPNG 646
           AVK+++ Q          E E L   + HRN++++I      D        LV+E M  G
Sbjct: 42  AVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF-----YLVFEKMRGG 96
Query: 647 SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN 706
           S+ + +++       R   N ++   +  DVA+ L++LH+     I H DLKP N+L ++
Sbjct: 97  SILSHIHK-------RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEH 146
Query: 707 E---MVAHVGDFGLS---RLLHDNSPDQTSTSRVK-GSIGYVAPE-YGALGEVST----H 754
                   + DF L    +L  D SP  T       GS  Y+APE   A  E ++     
Sbjct: 147 PNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 755 GDEYSFGILMLEMFTGKRP 773
            D +S G+++  + +G  P
Sbjct: 207 CDLWSLGVILYILLSGYPP 225

>pdb|2V9S|A Chain A, Second Lrr Domain Of Human Slit2 Length = 220

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 71/143 (49%), Gaps = 4/143 (2%)
Query: 287 EIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSF 346
           EIP++L   I  TE+ L+ N+I+   P A     +L+++DLS+N +S   P    GL S 
Sbjct: 25  EIPTNLPETI--TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82
Query: 347 VLLDLSRNHLSG-PIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQ 405
             L L  N ++  P  L  G L  +Q L L+ NK++     +      L  L+  DN  Q
Sbjct: 83  NSLVLYGNKITELPKSLFEG-LFSLQLLLLNANKINXLRVDAFQDLHNLNLLSLYDNKLQ 141
Query: 406 GPIHSGFSSLKGLQDLDLSRNNF 428
                 FS L+ +Q + L++N F
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQNPF 164

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 19/180 (10%)
Query: 592 LDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENW 651
           L+ +  G   + I E   L+ ++H N+VK+      I T+      LV+E + +  L+  
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLY---DVIHTKKR--LVLVFEHL-DQDLKKL 89
Query: 652 LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           L+  E        L  +   S  + + N + Y H      ++H DLKP N+L++ E    
Sbjct: 90  LDVCEG------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELK 140
Query: 712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY-GALGEVSTHGDEYSFGILMLEMFTG 770
           + DFGL+R      P +  T  +  ++ Y AP+      + ST  D +S G +  EM  G
Sbjct: 141 IADFGLARAF--GIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 54/130 (41%), Gaps = 13/130 (10%)
Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDN---EMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           V  +LE + +     IVH DLKP N+L      +    + DFGLS+++      Q     
Sbjct: 154 VKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE----HQVLMKT 209
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDD------MFEEGLSLHKY 787
           V G+ GY APE           D +S GI+   +  G  P  D      MF   L+   Y
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY 269
Query: 788 AKMGLPDQVA 797
                 D+V+
Sbjct: 270 FISPWWDEVS 279

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 51/111 (45%), Gaps = 22/111 (19%)
Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS------RLLHDNSP------- 726
           V++YLH      ++H D+KPSN+LL+ E    V DFGLS      R + +N P       
Sbjct: 121 VIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 727 -----DQTSTSRVKGSIGYVAPEYGALGEVSTHG-DEYSFGILMLEMFTGK 771
                DQ   +    +  Y APE        T G D +S G ++ E+  GK
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 588 AVKVLDLQQRGASKSFIAECEA--LRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           A K+++ ++  A      E EA   R ++H N+V++     SI   G+ +  L+++ +  
Sbjct: 51  AAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH---DSISEEGHHY--LIFDLVTG 105
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHT-SIVHCDLKPSNVLL 704
           G L   +  +E          + Q L   +           HCH   +VH DLKP N+LL
Sbjct: 106 GELFEDIVAREYYSEADASHCIQQILEAVL-----------HCHQMGVVHRDLKPENLLL 154
Query: 705 DNEM---VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
            +++      + DFGL+    +   +Q +     G+ GY++PE           D ++ G
Sbjct: 155 ASKLKGAAVKLADFGLAI---EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACG 211
Query: 762 ILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD 794
           +++  +  G  P  D  E+   L++  K G  D
Sbjct: 212 VILYILLVGYPPFWD--EDQHRLYQQIKAGAYD 242

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 44/96 (45%), Gaps = 18/96 (18%)
Query: 686 HHCHT-SIVHCDLKPSNVLLD-NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
            HCH+  +VH D+K  N+L+D     A + DFG   LLHD        +RV     Y  P
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRV-----YSPP 207
Query: 744 EYGALGEVSTH------GDEYSFGILMLEMFTGKRP 773
           E+     +S H         +S GIL+ +M  G  P
Sbjct: 208 EW-----ISRHQYHALPATVWSLGILLYDMVCGDIP 238

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 25/218 (11%)
Query: 582 TEETNVAVKVLDLQQRGASKSFIAECEA--LRSIRHRNLVKIITSCSSIDTRGNEFKALV 639
           T     A K+++ ++  A      E EA   R ++H N+V++  S S        F  LV
Sbjct: 54  TPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-----EGFHYLV 108
Query: 640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP 699
           ++ +  G L   +  +E                 +  +  +LE ++H     IVH DLKP
Sbjct: 109 FDLVTGGELFEDIVARE----------YYSEADASHCIHQILESVNHIHQHDIVHRDLKP 158
Query: 700 SNVLLDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGD 756
            N+LL ++       + DFGL+  +     +Q +     G+ GY++PE           D
Sbjct: 159 ENLLLASKCKGAAVKLADFGLAIEVQG---EQQAWFGFAGTPGYLSPEVLRKDPYGKPVD 215
Query: 757 EYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD 794
            ++ G+++  +  G  P  D  E+   L++  K G  D
Sbjct: 216 IWACGVILYILLVGYPPFWD--EDQHKLYQQIKAGAYD 251

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 24/183 (13%)
Query: 596 QRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           +RG S+  I  E   L+ I+H N   +IT     + + +    L+ E +  G L ++L +
Sbjct: 53  RRGVSREDIEREVSILKEIQHPN---VITLHEVYENKTDVI--LILELVAGGELFDFLAE 107
Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA---- 710
           KE    +     L Q       + N + YLH      I H DLKP N++L +  V     
Sbjct: 108 KESLTEEEATEFLKQ-------ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRI 157
Query: 711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
            + DFGL+  +   +        + G+  +VAPE      +    D +S G++   + +G
Sbjct: 158 KIIDFGLAHKIDFGN----EFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 771 KRP 773
             P
Sbjct: 214 ASP 216

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 85/200 (42%), Gaps = 40/200 (20%)
Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           E NVA+K L       S+ F  +  A R+ R   L+K++   + I         L+  F 
Sbjct: 49  ERNVAIKKL-------SRPFQNQTHAKRAYRELVLMKVVNHKNII--------GLLNVFT 93
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH------HCHTS-IVHCD 696
           P  SLE +  Q      +    NL Q + + +D   +   L+       H H++ I+H D
Sbjct: 94  PQKSLEEF--QDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRD 151
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV----- 751
           LKPSN+++ ++    + DFGL+R           TS +     YV   Y    EV     
Sbjct: 152 LKPSNIVVKSDATLKILDFGLAR--------TAGTSFMMTP--YVVTRYYRAPEVILGMG 201
Query: 752 -STHGDEYSFGILMLEMFTG 770
              + D +S G +M EM  G
Sbjct: 202 YKENVDIWSVGCIMGEMIKG 221

>pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 5/225 (2%)
Query: 228 YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
           YL +  N I         +L++L ++ +  NL+      +   L  L  L LF N+++  
Sbjct: 39  YLNLQENSIQVIRTDTFKHLRHLEILQLSKNLVRKIEVGAFNGLPSLNTLELFDNRLTTV 98
Query: 288 IPSSLGNLIFLTEVDLQGNSIRGSIPS-ALGNCLQLQKLDLSDNNLSGTIPREVI-GLSS 345
              +   L  L E+ L+ N I  SIPS A      L++LDL +      I      GL +
Sbjct: 99  PTQAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLRRLDLGELKRLEYISEAAFEGLVN 157
Query: 346 FVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQ 405
              L+L   +L   IP  +  L  +++L+LS N+L    P S      L  L        
Sbjct: 158 LRYLNLGMCNLKD-IP-NLTALVRLEELELSGNRLDLIRPGSFQGLTSLRKLWLMHAQVA 215
Query: 406 GPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFN 450
               + F  LK L++L+LS NN              L++++L+ N
Sbjct: 216 TIERNAFDDLKSLEELNLSHNNLMSLPHDLFTPLHRLERVHLNHN 260

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 30/200 (15%)
Query: 588 AVKVLDLQQRGASKSFI-AECEALRSIR-HRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           AVK+++ +Q G S+S +  E E L   + ++N++++I      DTR      LV+E +  
Sbjct: 42  AVKIIE-KQAGHSRSRVFREVETLYQCQGNKNILELIEFFED-DTRFY----LVFEKLQG 95
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           GS+   + QK+   N+R    +++      DVA  L++LH      I H DLKP N+L +
Sbjct: 96  GSILAHI-QKQKHFNEREASRVVR------DVAAALDFLHT---KGIAHRDLKPENILCE 145
Query: 706 N-EMVAHVG--DFGL-SRLLHDNSPDQTSTSRVK---GSIGYVAPE-YGALGEVSTHGDE 757
           + E V+ V   DF L S +  +NS    +T  +    GS  Y+APE      + +T  D+
Sbjct: 146 SPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDK 205
Query: 758 ----YSFGILMLEMFTGKRP 773
               +S G+++  M +G  P
Sbjct: 206 RCDLWSLGVVLYIMLSGYPP 225

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 24/183 (13%)
Query: 596 QRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           +RG S+  I  E   L+ I+H N   +IT     + + +    L+ E +  G L ++L +
Sbjct: 53  RRGVSREDIEREVSILKEIQHPN---VITLHEVYENKTDVI--LILELVAGGELFDFLAE 107
Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA---- 710
           KE    +     L Q       + N + YLH      I H DLKP N++L +  V     
Sbjct: 108 KESLTEEEATEFLKQ-------ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRI 157
Query: 711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
            + DFGL+  +   +        + G+  +VAPE      +    D +S G++   + +G
Sbjct: 158 KIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 771 KRP 773
             P
Sbjct: 214 ASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 24/183 (13%)
Query: 596 QRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           +RG S+  I  E   L+ I+H N   +IT     + + +    L+ E +  G L ++L +
Sbjct: 53  RRGVSREDIEREVSILKEIQHPN---VITLHEVYENKTDVI--LILELVAGGELFDFLAE 107
Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA---- 710
           KE    +     L Q       + N + YLH      I H DLKP N++L +  V     
Sbjct: 108 KESLTEEEATEFLKQ-------ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRI 157
Query: 711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
            + DFGL+  +   +        + G+  +VAPE      +    D +S G++   + +G
Sbjct: 158 KIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 771 KRP 773
             P
Sbjct: 214 ASP 216

>pdb|4FHO|A Chain A, Crystal Structure Of An Internalin C2 (Inlc2) From Listeria Monocytogenes Str. 4b F2365 At 1.90 A Resolution Length = 231

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 12/167 (7%)
Query: 268 VGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDL 327
           + YL  L  L L  N+I+   P  L NL  +TE++L GN ++    SA+     ++ LDL
Sbjct: 65  IQYLNNLIGLELKDNQITDLTP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDL 120
Query: 328 SDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTS 387
           +   ++   P  + GLS+  +L L  N ++   PL    L  +Q L +  N+++   P  
Sbjct: 121 TSTQITDVTP--LAGLSNLQVLYLDLNQITNISPL--AGLTNLQYLSIGNNQVNDLTP-- 174
Query: 388 LASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPM 434
           LA+   L  L   DN       S  +SL  L ++ L  N  S   P+
Sbjct: 175 LANLSKLTTLRADDNKISD--ISPLASLPNLIEVHLKDNQISDVSPL 219

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 32/202 (15%)
Query: 583 EETNV--AVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           +ET+V  A KV+D +     + ++ E + L S  H N+VK++ +        N    L+ 
Sbjct: 59  KETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF----YYENNLWILI- 113
Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           EF   G+++  + + E     RP L   Q   +     + L YLH +    I+H DLK  
Sbjct: 114 EFCAGGAVDAVMLELE-----RP-LTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAG 164
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YVAPEYGALGEVST---- 753
           N+L   +    + DFG+S      + +  +  R    IG   ++APE   + E S     
Sbjct: 165 NILFTLDGDIKLADFGVS------AKNTRTIQRRDSFIGTPYWMAPEV-VMCETSKDRPY 217
Query: 754 --HGDEYSFGILMLEMFTGKRP 773
               D +S GI ++EM   + P
Sbjct: 218 DYKADVWSLGITLIEMAEIEPP 239

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 85/200 (42%), Gaps = 40/200 (20%)
Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           E NVA+K L       S+ F  +  A R+ R   L+K++   + I         L+  F 
Sbjct: 49  ERNVAIKKL-------SRPFQNQTHAKRAYRELVLMKVVNHKNII--------GLLNVFT 93
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH------HCHTS-IVHCD 696
           P  SLE +  Q      +    NL Q + + +D   +   L+       H H++ I+H D
Sbjct: 94  PQKSLEEF--QDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151
Query: 697 LKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV----- 751
           LKPSN+++ ++    + DFGL+R           TS +     YV   Y    EV     
Sbjct: 152 LKPSNIVVKSDATLKILDFGLAR--------TAGTSFMMTP--YVVTRYYRAPEVILGMG 201
Query: 752 -STHGDEYSFGILMLEMFTG 770
              + D +S G +M EM  G
Sbjct: 202 YKENVDIWSVGCIMGEMIKG 221

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 24/183 (13%)
Query: 596 QRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           +RG S+  I  E   L+ I+H N   +IT     + + +    L+ E +  G L ++L +
Sbjct: 53  RRGVSREDIEREVSILKEIQHPN---VITLHEVYENKTDVI--LILELVAGGELFDFLAE 107
Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA---- 710
           KE    +     L Q       + N + YLH      I H DLKP N++L +  V     
Sbjct: 108 KESLTEEEATEFLKQ-------ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRI 157
Query: 711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
            + DFGL+  +   +        + G+  +VAPE      +    D +S G++   + +G
Sbjct: 158 KIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 771 KRP 773
             P
Sbjct: 214 ASP 216

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 26/199 (13%)
Query: 583 EETNV--AVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           +ET+V  A KV+D +     + ++ E + L S  H N+VK++ +        N    L+ 
Sbjct: 59  KETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF----YYENNLWILI- 113
Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           EF   G+++  + + E     RP L   Q   +     + L YLH +    I+H DLK  
Sbjct: 114 EFCAGGAVDAVMLELE-----RP-LTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAG 164
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVST------H 754
           N+L   +    + DFG+S     N+          G+  ++APE   + E S        
Sbjct: 165 NILFTLDGDIKLADFGVSA---KNTRXIQRRDXFIGTPYWMAPEV-VMCETSKDRPYDYK 220
Query: 755 GDEYSFGILMLEMFTGKRP 773
            D +S GI ++EM   + P
Sbjct: 221 ADVWSLGITLIEMAEIEPP 239

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 62/147 (42%), Gaps = 20/147 (13%)
Query: 638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           LV EF   GS+ + +        +  K N ++   IA     +L  L H     ++H D+
Sbjct: 104 LVMEFCGAGSVTDLI--------KNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDI 155
Query: 698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK--GSIGYVAPEYGALGE----- 750
           K  NVLL       + DFG+S  L     D+T   R    G+  ++APE  A  E     
Sbjct: 156 KGQNVLLTENAEVKLVDFGVSAQL-----DRTVGRRNTFIGTPYWMAPEVIACDENPDAT 210
Query: 751 VSTHGDEYSFGILMLEMFTGKRPTDDM 777
                D +S GI  +EM  G  P  DM
Sbjct: 211 YDFKSDLWSLGITAIEMAEGAPPLCDM 237

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 120/286 (41%), Gaps = 34/286 (11%)
Query: 588 AVKVLDLQQRGASKSFIAECEA--LRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           A K+++ ++  A      E EA   R ++H N+V++  S          F  LV++ +  
Sbjct: 58  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESFHYLVFDLVTG 112
Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-IVHCDLKPSNVLL 704
           G L   +  +E                 +  +  +LE + + CH++ IVH +LKP N+LL
Sbjct: 113 GELFEDIVARE----------FYSEADASHCIQQILESIAY-CHSNGIVHRNLKPENLLL 161
Query: 705 DNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
            ++       + DFGL+  ++D+     +     G+ GY++PE       S   D ++ G
Sbjct: 162 ASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 217
Query: 762 ILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQP 821
           +++  +  G  P  D  E+   L+   K G  D  +   D    E    I + +   + P
Sbjct: 218 VILYILLVGYPPFWD--EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLT--VNP 273
Query: 822 NLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQ 867
             R    +     L+V  +C+ E     +  QD +  L++    R+
Sbjct: 274 KKRITADQ----ALKVPWICNRERVASAIHRQDTVDCLKKFNARRK 315

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 36/197 (18%)
Query: 588 AVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
           AVKV+    ++Q+   +S + E + L+ + H N+ K+       + +G  +  LV E   
Sbjct: 55  AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY---EFFEDKG--YFYLVGEVYT 109
Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
            G L        DE   R + + +    I   V + + Y H +    IVH DLKP N+LL
Sbjct: 110 GGELF-------DEIISRKRFSEVDAARIIRQVLSGITYXHKN---KIVHRDLKPENLLL 159
Query: 705 DN---EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YVAPE--YGALGEVSTHGD 756
           ++   +    + DFGLS           ++ + K  IG   Y+APE  +G   E     D
Sbjct: 160 ESKSKDANIRIIDFGLSTHFE-------ASKKXKDKIGTAYYIAPEVLHGTYDEKC---D 209
Query: 757 EYSFGILMLEMFTGKRP 773
            +S G+++  + +G  P
Sbjct: 210 VWSTGVILYILLSGCPP 226

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 26/199 (13%)
Query: 583 EETNV--AVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY 640
           +ET+V  A KV+D +     + ++ E + L S  H N+VK++ +        N    L+ 
Sbjct: 59  KETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF----YYENNLWILI- 113
Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           EF   G+++  + + E     RP L   Q   +     + L YLH +    I+H DLK  
Sbjct: 114 EFCAGGAVDAVMLELE-----RP-LTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAG 164
Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVST------H 754
           N+L   +    + DFG+S     N+          G+  ++APE   + E S        
Sbjct: 165 NILFTLDGDIKLADFGVSA---KNTRXIQRRDSFIGTPYWMAPEV-VMCETSKDRPYDYK 220
Query: 755 GDEYSFGILMLEMFTGKRP 773
            D +S GI ++EM   + P
Sbjct: 221 ADVWSLGITLIEMAEIEPP 239

>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 56/198 (28%), Positives = 77/198 (38%), Gaps = 4/198 (2%)
Query: 263 SIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQL 322
           ++PT  G     Q + L GN+IS    +S  +   LT + L  N++ G   +A      L
Sbjct: 24  AVPT--GIPASSQRIFLHGNRISYVPAASFQSCRNLTILWLHSNALAGIDAAAFTGLTLL 81
Query: 323 QKLDLSDN-NLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLS 381
           ++LDLSDN  L    P    GL     L L R  L    P     L  +Q L L +N L 
Sbjct: 82  EQLDLSDNAQLRVVDPTTFRGLGHLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNNLQ 141
Query: 382 GEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRF 441
                +      L +L    N         F  L  L  L L +N+ +   P        
Sbjct: 142 ALPDNTFRDLGNLTHLFLHGNRIPSVPEHAFRGLHSLDRLLLHQNHVARVHPHAFRDLGR 201
Query: 442 LQKLNLSFNNLEGEVPSE 459
           L  L L  NNL   +P+E
Sbjct: 202 LMTLYLFANNLS-MLPAE 218

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR-LLHDNSPDQTSTSRVKGSIG 739
           L+Y+H      ++H DLKPSN+L++      +GDFG++R L    +  Q   +    +  
Sbjct: 171 LKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 227
Query: 740 YVAPEYG-ALGEVSTHGDEYSFGILMLEMFTGKR 772
           Y APE   +L E +   D +S G +  EM   ++
Sbjct: 228 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 24/183 (13%)
Query: 596 QRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           +RG S+  I  E   L+ I+H N   +IT     + + +    L+ E +  G L ++L +
Sbjct: 53  RRGVSREDIEREVSILKEIQHPN---VITLHEVYENKTDVI--LILELVAGGELFDFLAE 107
Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA---- 710
           KE    +     L Q       + N + YLH      I H DLKP N++L +  V     
Sbjct: 108 KESLTEEEATEFLKQ-------ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRI 157
Query: 711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
            + DFGL+  +   +        + G+  +VAPE      +    D +S G++   + +G
Sbjct: 158 KIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 771 KRP 773
             P
Sbjct: 214 ASP 216

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR-LLHDNSPDQTSTSRVKGSIG 739
           L+Y+H      ++H DLKPSN+L++      +GDFG++R L    +  Q   +    +  
Sbjct: 172 LKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 228
Query: 740 YVAPEYG-ALGEVSTHGDEYSFGILMLEMFTGKR 772
           Y APE   +L E +   D +S G +  EM   ++
Sbjct: 229 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 85/200 (42%), Gaps = 34/200 (17%)
Query: 586 NVAVKVLDLQQRGASKSFIAECEALRSI--RHRNLVKIITSCSSIDTRGNEFKALVY--- 640
            VAVKV    +     S+  E E  +++  RH N++  I +    D +G      +Y   
Sbjct: 62  KVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIAA----DIKGTGSWTQLYLIT 114
Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-----IVHC 695
           ++  NGSL ++L            L+    L +A    + L +LH    ++     I H 
Sbjct: 115 DYHENGSLYDYLKST--------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166
Query: 696 DLKPSNVLLDNEMVAHVGDFGLS-RLLHD-NSPDQTSTSRVKGSIGYVAPEYGALGEVST 753
           DLK  N+L+       + D GL+ + + D N  D    +RV G+  Y+ PE         
Sbjct: 167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYMPPEVLDESLNRN 225
Query: 754 H------GDEYSFGILMLEM 767
           H       D YSFG+++ E+
Sbjct: 226 HFQSYIMADMYSFGLILWEV 245

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 24/183 (13%)
Query: 596 QRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           +RG S+  I  E   L+ I+H N   +IT     + + +    L+ E +  G L ++L +
Sbjct: 53  RRGVSREDIEREVSILKEIQHPN---VITLHEVYENKTDVI--LILELVAGGELFDFLAE 107
Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA---- 710
           KE    +     L Q       + N + YLH      I H DLKP N++L +  V     
Sbjct: 108 KESLTEEEATEFLKQ-------ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRI 157
Query: 711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
            + DFGL+  +   +        + G+  +VAPE      +    D +S G++   + +G
Sbjct: 158 KIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 771 KRP 773
             P
Sbjct: 214 ASP 216

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +  T  
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWX 197
Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+   +APE       +   D ++ G+L+ EM  G  P
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 81/191 (42%), Gaps = 25/191 (13%)
Query: 587 VAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
           VA+KVL    +++ G       E E    + H N++++       D R      L+ E+ 
Sbjct: 51  VALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYF--YDRRR---IYLILEYA 105
Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCH-TSIVHCDLKPSNV 702
           P G L   L +      QR         +I  ++A+ L Y    CH   ++H D+KP N+
Sbjct: 106 PRGELYKELQKSCTFDEQRTA-------TIMEELADALMY----CHGKKVIHRDIKPENL 154
Query: 703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGI 762
           LL  +    + DFG S  +H  S  + +     G++ Y+ PE       +   D +  G+
Sbjct: 155 LLGLKGELKIADFGWS--VHAPSLRRKTMC---GTLDYLPPEMIEGRMHNEKVDLWCIGV 209
Query: 763 LMLEMFTGKRP 773
           L  E+  G  P
Sbjct: 210 LCYELLVGNPP 220

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 11/102 (10%)
Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG-----DFGLSRLLHDNSPDQTST 731
           +  +LE +++    +IVH DLKP N+LL +  +  +G     DFG+SR +          
Sbjct: 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSS--IYPLGDIKIVDFGMSRKI----GHACEL 190
Query: 732 SRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
             + G+  Y+APE      ++T  D ++ GI+   + T   P
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/176 (23%), Positives = 83/176 (47%), Gaps = 20/176 (11%)
Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKL 665
           E   L +++H N+V+      S +  G+ +  +V ++   G L   +N ++    Q  ++
Sbjct: 73  EVAVLANMKHPNIVQYR---ESFEENGSLY--IVMDYCEGGDLFKRINAQKGVLFQEDQI 127
Query: 666 NLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNS 725
                L   + +   L+++H      I+H D+K  N+ L  +    +GDFG++R+L  NS
Sbjct: 128 -----LDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NS 177
Query: 726 PDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG 781
             + + + + G+  Y++PE       +   D ++ G ++ E+ T K      FE G
Sbjct: 178 TVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH----AFEAG 228

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 24/183 (13%)
Query: 596 QRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           +RG S+  I  E   L+ I+H N   +IT     + + +    L+ E +  G L ++L +
Sbjct: 53  RRGVSREDIEREVSILKEIQHPN---VITLHEVYENKTDVI--LILELVAGGELFDFLAE 107
Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA---- 710
           KE    +     L Q       + N + YLH      I H DLKP N++L +  V     
Sbjct: 108 KESLTEEEATEFLKQ-------ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRI 157
Query: 711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
            + DFGL+  +   +        + G+  +VAPE      +    D +S G++   + +G
Sbjct: 158 KIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 771 KRP 773
             P
Sbjct: 214 ASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 24/183 (13%)
Query: 596 QRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           +RG S+  I  E   L+ I+H N   +IT     + + +    L+ E +  G L ++L +
Sbjct: 52  RRGVSREDIEREVSILKEIQHPN---VITLHEVYENKTDVI--LILELVAGGELFDFLAE 106
Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA---- 710
           KE    +     L Q       + N + YLH      I H DLKP N++L +  V     
Sbjct: 107 KESLTEEEATEFLKQ-------ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRI 156
Query: 711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
            + DFGL+  +   +        + G+  +VAPE      +    D +S G++   + +G
Sbjct: 157 KIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212
Query: 771 KRP 773
             P
Sbjct: 213 ASP 215

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 24/183 (13%)
Query: 596 QRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           +RG S+  I  E   L+ I+H N   +IT     + + +    L+ E +  G L ++L +
Sbjct: 53  RRGVSREDIEREVSILKEIQHPN---VITLHEVYENKTDVI--LILELVAGGELFDFLAE 107
Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA---- 710
           KE    +     L Q       + N + YLH      I H DLKP N++L +  V     
Sbjct: 108 KESLTEEEATEFLKQ-------ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRI 157
Query: 711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
            + DFGL+  +   +        + G+  +VAPE      +    D +S G++   + +G
Sbjct: 158 KIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 771 KRP 773
             P
Sbjct: 214 ASP 216

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 42/91 (46%), Gaps = 7/91 (7%)
Query: 687 HCH-TSIVHCDLKPSNVLLDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           H H   +VH DLKP N+L  +E   +   + DFG +RL     PD         ++ Y A
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL---KPPDNQPLKTPCFTLHYAA 177
Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           PE           D +S G+++  M +G+ P
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 24/183 (13%)
Query: 596 QRGASKSFIA-ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           +RG S+  I  E   L+ I+H N   +IT     + + +    L+ E +  G L ++L +
Sbjct: 53  RRGVSREDIEREVSILKEIQHPN---VITLHEVYENKTDVI--LILELVAGGELFDFLAE 107
Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA---- 710
           KE    +     L Q       + N + YLH      I H DLKP N++L +  V     
Sbjct: 108 KESLTEEEATEFLKQ-------ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRI 157
Query: 711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
            + DFGL+  +   +        + G+  +VAPE      +    D +S G++   + +G
Sbjct: 158 KIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
Query: 771 KRP 773
             P
Sbjct: 214 ASP 216

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	871
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-145
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-124
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-122
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-115
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-106
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-85
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-49
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-18
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-102
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-70
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-67
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-61
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-39
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-84
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-81
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-78
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-77
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-76
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-63
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-56
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-79
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-63
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-63
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-59
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-49
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-41
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-38
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-78
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-73
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-66
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-58
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-46
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-12
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-69
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-65
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-63
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-61
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-53
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-42
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-04
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-63
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-63
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-62
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-53
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-48
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-28
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-61
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-55
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-51
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-40
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-33
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-31
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-58
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-52
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-51
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-51
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-49
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-49
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-49
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-48
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-47
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-47
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-46
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-33
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-16
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-47
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-46
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-46
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-45
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-44
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-44
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-43
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-41
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-27
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-25
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-44
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-43
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-43
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-42
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-40
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-29
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-43
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-35
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-34
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-41
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-37
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-30
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-26
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-25
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-21
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-41
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-39
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-31
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-19
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-40
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-39
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-25
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-36
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-30
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-32
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-28
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-22
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-11
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-35
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-34
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-34
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-34
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-32
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-34
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-34
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-34
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-34
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-33
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-33
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-33
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-32
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-24
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-24
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-30
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-23
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-05
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-32
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-32
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-11
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-32
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-32
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-32
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-31
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-31
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-30
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-23
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-09
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-31
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-31
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-31
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-29
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-21
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-30
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-20
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-05
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-30
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-29
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-23
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-28
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-28
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-28
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-27
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-27
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-27
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-27
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-18
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-26
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-25
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-24
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-23
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-17
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-05
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-26
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-26
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-26
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-26
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-26
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-26
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-26
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-26
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-26
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-26
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-25
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-06
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-20
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-15
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-11
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-25
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-25
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-25
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-25
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-08
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-25
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-24
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-24
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-21
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-15
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-09
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-05
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-24
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-12
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-19
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-18
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-24
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-12
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-24
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-24
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-23
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-23
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-23
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-16
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-04
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-21
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-10
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-05
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-07
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-19
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-18
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-18
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-18
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-18
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-18
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-07
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-17
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-17
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-17
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-17
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-08
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-04
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-17
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-17
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-17
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-10
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-16
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-16
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-16
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-16
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-16
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-16
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	9e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-10
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-16
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-16
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-16
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-16
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-16
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-16
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-15
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	8e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	5e-06
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-05
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-07
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-06
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-05
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-15
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-15
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	8e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-05
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-05
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-15
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-14
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-07
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-14
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-14
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-14
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-14
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-13
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-13
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-13
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-04
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-13
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-13
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-12
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-05
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	7e-04
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-04
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-10
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-10
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	6e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-10
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-10
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-09
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	9e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-09
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	9e-09
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-08
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	8e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	9e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	9e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-08
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	6e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	4e-05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	9e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  448 bits (1154), Expect = e-145
 Identities = 150/519 (28%), Positives = 231/519 (44%), Gaps = 37/519 (7%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSEL-GNLFKLVGLGLTGNNYTGSIPQSLSN 60
             G IP        L+ L L  NK  G IP  L G    L GL L+GN++ G++P    +
Sbjct: 259 FVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316

Query: 61  LSFLQQLSLSENSLSGNIPSE-LGLLKQLNMFQVSANYLTGSIPIQLFNIS-SMDYFAVT 118
            S L+ L+LS N+ SG +P + L  ++ L +  +S N  +G +P  L N+S S+    ++
Sbjct: 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLS 376

Query: 119 QNKLVGEIPHYVG-FTLPNIRVLLLGSNWFTGEIPPSISNASS--------------IPE 163
            N   G I   +       ++ L L +N FTG+IPP++SN S               IP 
Sbjct: 377 SNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS 436

Query: 164 DLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFS 223
            LG L  L  L    N L  G+         L+    LE + L  N L+G +P+ ++N +
Sbjct: 437 SLGSLSKLRDLKLWLNML-EGE-----IPQELMYVKTLETLILDFNDLTGEIPSGLSNCT 490

Query: 224 SHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNK 283
           + L ++ +S NR++G IP  +G L+NL ++ +  N  +G+IP  +G    L  L L  N 
Sbjct: 491 N-LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL 549

Query: 284 ISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDN--NLSGTIPREVI 341
            +G IP+++          +  N I G     + N    ++   + N     G    ++ 
Sbjct: 550 FNGTIPAAMFKQSG----KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLN 605

Query: 342 GLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSD 401
            LS+    +++     G           +  LD+S N LSG IP  + S   L  LN   
Sbjct: 606 RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGH 665

Query: 402 NSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGV 461
           N   G I      L+GL  LDLS N   G+IP  ++    L +++LS NNL G +P  G 
Sbjct: 666 NDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQ 725

Query: 462 FKNVRAVSIIGNNKLCGGSPELHLHSCRSRGSRKLWQHS 500
           F+       + N  LCG      L  C    +     H 
Sbjct: 726 FETFPPAKFLNNPGLCG----YPLPRCDPSNADGYAHHQ 760

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  391 bits (1006), Expect = e-124
 Identities = 136/483 (28%), Positives = 221/483 (45%), Gaps = 46/483 (9%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           + G++   ++ C  L  LD+  N     IP  LG+   L  L ++GN  +G   +++S  
Sbjct: 190 ISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTC 246

Query: 62  SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLF-NISSMDYFAVTQN 120
           + L+ L++S N   G IP     LK L    ++ N  TG IP  L     ++    ++ N
Sbjct: 247 TELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304

Query: 121 KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNN 180
              G +P + G +   +  L L SN F+GE+P            L K++ L  L+ + N 
Sbjct: 305 HFYGAVPPFFG-SCSLLESLALSSNNFSGELPMDT---------LLKMRGLKVLDLSFNE 354

Query: 181 LGTGKGNDLRFLDSLVNCTF-LEVVSLSSNSLSGVLPNSIANFS-SHLIYLYMSANRISG 238
             +G        +SL N +  L  + LSSN+ SG +  ++     + L  LY+  N  +G
Sbjct: 355 F-SG-----ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG 408

Query: 239 TIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFL 298
            IP  + N   L+ + +  N L+G+IP+S+G L KL+ L L+ N + GEIP  L  +  L
Sbjct: 409 KIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTL 468

Query: 299 TEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSG 358
             + L  N + G IPS L NC  L  + LS+N L+G IP+ +  L +  +L LS N  SG
Sbjct: 469 ETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 528

Query: 359 PIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLE----------------------Y 396
            IP E+G  + +  LDL+ N  +G IP ++    G                        +
Sbjct: 529 NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECH 588

Query: 397 LNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEV 456
              +   FQG      + L      +++   + G      +    +  L++S+N L G +
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648

Query: 457 PSE 459
           P E
Sbjct: 649 PKE 651

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  385 bits (991), Expect = e-122
 Identities = 148/469 (31%), Positives = 219/469 (46%), Gaps = 34/469 (7%)

Query: 2   LQGEIPA--NITHCSELRILDLVVNKLEGNIP-SELGNLFKLVGLGLTGNNYTGSIPQSL 58
           L G +    ++  CS L+ L++  N L+     S    L  L  L L+ N+ +G+     
Sbjct: 112 LSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGW 171

Query: 59  ---SNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYF 115
                   L+ L++S N +SG++   +     L    VS+N  +  IP  L + S++ + 
Sbjct: 172 VLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHL 228

Query: 116 AVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLN 175
            ++ NKL G+    +  T   +++L + SN F G IPP              LK+L  L+
Sbjct: 229 DISGNKLSGDFSRAIS-TCTELKLLNISSNQFVGPIPPLP------------LKSLQYLS 275

Query: 176 FARNNLGTGKGNDLRFLDSLV-NCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSAN 234
            A N   TG+       D L   C  L  + LS N   G +P    + S  L  L +S+N
Sbjct: 276 LAENKF-TGE-----IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL-LESLALSSN 328

Query: 235 RISGTIPTGV-GNLKNLILIAMEVNLLTGSIPTSVGYLL-KLQVLSLFGNKISGEIPSSL 292
             SG +P      ++ L ++ +  N  +G +P S+  L   L  L L  N  SG I  +L
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388

Query: 293 GN--LIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLD 350
                  L E+ LQ N   G IP  L NC +L  L LS N LSGTIP  +  LS    L 
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448

Query: 351 LSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHS 410
           L  N L G IP E+  +K ++ L L  N L+GEIP+ L++C  L +++ S+N   G I  
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508

Query: 411 GFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE 459
               L+ L  L LS N+FSG IP  L   R L  L+L+ N   G +P+ 
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  367 bits (945), Expect = e-115
 Identities = 137/487 (28%), Positives = 220/487 (45%), Gaps = 37/487 (7%)

Query: 4   GEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIP--QSLSNL 61
             + +++   + L  L L  + + G++         L  L L+ N+ +G +    SL + 
Sbjct: 67  SAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSC 125

Query: 62  SFLQQLSLSENSLSGNIPSELGL-LKQLNMFQVSANYLTGSIPIQLF---NISSMDYFAV 117
           S L+ L++S N+L        GL L  L +  +SAN ++G+  +          + + A+
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI 185

Query: 118 TQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFA 177
           + NK+ G++         N+  L + SN F+  IP            LG    L  L+ +
Sbjct: 186 SGNKISGDVDV---SRCVNLEFLDVSSNNFSTGIP-----------FLGDCSALQHLDIS 231

Query: 178 RNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRIS 237
            N L +G      F  ++  CT L+++++SSN   G +P         L YL ++ N+ +
Sbjct: 232 GNKL-SGD-----FSRAISTCTELKLLNISSNQFVGPIPPLP---LKSLQYLSLAENKFT 282

Query: 238 GTIPTGV-GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIP-SSLGNL 295
           G IP  + G    L  + +  N   G++P   G    L+ L+L  N  SGE+P  +L  +
Sbjct: 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKM 342

Query: 296 IFLTEVDLQGNSIRGSIPSALGNCL-QLQKLDLSDNNLSGTIPREVIG--LSSFVLLDLS 352
             L  +DL  N   G +P +L N    L  LDLS NN SG I   +     ++   L L 
Sbjct: 343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402

Query: 353 RNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGF 412
            N  +G IP  +     +  L LS N LSG IP+SL S   L  L    N  +G I    
Sbjct: 403 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462

Query: 413 SSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE-GVFKNVRAVSII 471
             +K L+ L L  N+ +G+IP  L+    L  ++LS N L GE+P   G  +N+  +  +
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL-KL 521

Query: 472 GNNKLCG 478
            NN   G
Sbjct: 522 SNNSFSG 528

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  344 bits (885), Expect = e-106
 Identities = 135/454 (29%), Positives = 201/454 (44%), Gaps = 32/454 (7%)

Query: 40  LVGLGLTGNNYT---GSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSAN 96
           +  + L+         ++  SL +L+ L+ L LS + ++G++         L    +S N
Sbjct: 52  VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRN 110

Query: 97  YLTGSIP--IQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPS 154
            L+G +     L + S + +  V+ N L        G  L ++ VL L +N  +G     
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170

Query: 155 ISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGV 214
                           L  L  + N + +G          +  C  LE + +SSN+ S  
Sbjct: 171 WVL-------SDGCGELKHLAISGNKI-SGD-------VDVSRCVNLEFLDVSSNNFSTG 215

Query: 215 LPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKL 274
           +P  + + S+ L +L +S N++SG     +     L L+ +  N   G IP     L  L
Sbjct: 216 IP-FLGDCSA-LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSL 271

Query: 275 QVLSLFGNKISGEIPSSL-GNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLS 333
           Q LSL  NK +GEIP  L G    LT +DL GN   G++P   G+C  L+ L LS NN S
Sbjct: 272 QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS 331

Query: 334 GTIPREVIG-LSSFVLLDLSRNHLSGPIPLEVGRLKG-IQQLDLSENKLSGEIPTSLASC 391
           G +P + +  +    +LDLS N  SG +P  +  L   +  LDLS N  SG I  +L   
Sbjct: 332 GELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN 391

Query: 392 --VGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSF 449
               L+ L   +N F G I    S+   L  L LS N  SG IP  L +   L+ L L  
Sbjct: 392 PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 451

Query: 450 NNLEGEVPSE-GVFKNVRAVSIIGNNKLCGGSPE 482
           N LEGE+P E    K +  + I+  N L G  P 
Sbjct: 452 NMLEGEIPQELMYVKTLETL-ILDFNDLTGEIPS 484

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  287 bits (738), Expect = 3e-85
 Identities = 117/431 (27%), Positives = 173/431 (40%), Gaps = 58/431 (13%)

Query: 60  NLSFLQQLSLSENSLS---GNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFA 116
               +  + LS   L+     + S L  L  L    +S +++ GS+              
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS----GFKC----- 98

Query: 117 VTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNF 176
                              ++  L L  N  +G +    S        LG    L  LN 
Sbjct: 99  -----------------SASLTSLDLSRNSLSGPVTTLTS--------LGSCSGLKFLNV 133

Query: 177 ARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFS--SHLIYLYMSAN 234
           + N L    G     +   +    LEV+ LS+NS+SG              L +L +S N
Sbjct: 134 SSNTL-DFPGK----VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188

Query: 235 RISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGN 294
           +ISG +   V    NL  + +  N  +  IP  +G    LQ L + GNK+SG+   ++  
Sbjct: 189 KISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAIST 245

Query: 295 LIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIG-LSSFVLLDLSR 353
              L  +++  N   G IP        LQ L L++N  +G IP  + G   +   LDLS 
Sbjct: 246 CTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSG 303

Query: 354 NHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPT-SLASCVGLEYLNFSDNSFQGPIHSGF 412
           NH  G +P   G    ++ L LS N  SGE+P  +L    GL+ L+ S N F G +    
Sbjct: 304 NHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363

Query: 413 SSLKG-LQDLDLSRNNFSGKIP--MFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVS 469
           ++L   L  LDLS NNFSG I   +  N    LQ+L L  N   G++P      N   + 
Sbjct: 364 TNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT--LSNCSELV 421

Query: 470 II--GNNKLCG 478
            +    N L G
Sbjct: 422 SLHLSFNYLSG 432

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  185 bits (472), Expect = 4e-49
 Identities = 71/252 (28%), Positives = 123/252 (48%), Gaps = 12/252 (4%)

Query: 245 GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQ 304
             + ++ L +  +N+   ++ +S+  L  L+ L L  + I+G +         LT +DL 
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108

Query: 305 GNSIRGSIPSA--LGNCLQLQKLDLSDNNLSGTIPRE-VIGLSSFVLLDLSRNHLSGPIP 361
            NS+ G + +   LG+C  L+ L++S N L         + L+S  +LDLS N +SG   
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168

Query: 362 LEV---GRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGL 418
           +          ++ L +S NK+SG++   ++ CV LE+L+ S N+F   I         L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSAL 225

Query: 419 QDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCG 478
           Q LD+S N  SG     ++T   L+ LN+S N   G +P     K+++ +S +  NK  G
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP-LKSLQYLS-LAENKFTG 283

Query: 479 GSPELHLHSCRS 490
             P+    +C +
Sbjct: 284 EIPDFLSGACDT 295

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 90.0 bits (224), Expect = 1e-18
 Identities = 36/80 (45%), Positives = 48/80 (60%)

Query: 1   MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSN 60
           ML G IP  I     L IL+L  N + G+IP E+G+L  L  L L+ N   G IPQ++S 
Sbjct: 643 MLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA 702

Query: 61  LSFLQQLSLSENSLSGNIPS 80
           L+ L ++ LS N+LSG IP 
Sbjct: 703 LTMLTEIDLSNNNLSGPIPE 722

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  317 bits (816), Expect = e-102
 Identities = 86/308 (27%), Positives = 134/308 (43%), Gaps = 15/308 (4%)

Query: 189 LRFLDSLVNCTFL----EVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGT--IPT 242
           L+    L N T L          + +  GVL ++    +  +  L +S   +     IP+
Sbjct: 12  LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPS 70

Query: 243 GVGNLKNLILIAM-EVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEV 301
            + NL  L  + +  +N L G IP ++  L +L  L +    +SG IP  L  +  L  +
Sbjct: 71  SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130

Query: 302 DLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSS-FVLLDLSRNHLSGPI 360
           D   N++ G++P ++ +   L  +    N +SG IP      S  F  + +SRN L+G I
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190

Query: 361 PLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQD 420
           P     L  +  +DLS N L G+      S    + ++ + NS    +       K L  
Sbjct: 191 PPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNG 248

Query: 421 LDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGS 480
           LDL  N   G +P  L   +FL  LN+SFNNL GE+P  G  +     +   N  LCG  
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS- 307

Query: 481 PELHLHSC 488
               L +C
Sbjct: 308 ---PLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  233 bits (598), Expect = 3e-70
 Identities = 86/394 (21%), Positives = 143/394 (36%), Gaps = 101/394 (25%)

Query: 5   EIPANITHCSELR----ILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGS--IPQSL 58
           +I  ++ + + L       D       G +       +++  L L+G N      IP SL
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 59  SNLSFLQQLSLS-ENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAV 117
           +NL +L  L +   N+L G IP  +  L QL+   ++   ++G+IP  L           
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ--------- 123

Query: 118 TQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFA 177
                           +  +  L    N  +G +PPSIS+          L NL+ +   
Sbjct: 124 ----------------IKTLVTLDFSYNALSGTLPPSISS----------LPNLVGIT-- 155

Query: 178 RNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRIS 237
                                          N +SG +P+S  +FS     + +S NR++
Sbjct: 156 ----------------------------FDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187

Query: 238 GTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIF 297
           G IP    N                         L L  + L  N + G+     G+   
Sbjct: 188 GKIPPTFAN-------------------------LNLAFVDLSRNMLEGDASVLFGSDKN 222

Query: 298 LTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLS 357
             ++ L  NS+   +   +G    L  LDL +N + GT+P+ +  L     L++S N+L 
Sbjct: 223 TQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281

Query: 358 GPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASC 391
           G IP + G L+       + NK     P  L +C
Sbjct: 282 GEIP-QGGNLQRFDVSAYANNKCLCGSP--LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  224 bits (573), Expect = 9e-67
 Identities = 81/337 (24%), Positives = 127/337 (37%), Gaps = 71/337 (21%)

Query: 4   GEIPANITHCSELRILDLVVNKLEG--NIPSELGNLFKLVGLGLTGNNY-TGSIPQSLSN 60
           G +    T    +  LDL    L     IPS L NL  L  L + G N   G IP +++ 
Sbjct: 40  GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99

Query: 61  LSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
           L+ L  L ++  ++SG IP  L  +K L     S N L+G++P  + +            
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS------------ 147

Query: 121 KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNN 180
                        LPN+  +    N  +G IP S  + S +   +               
Sbjct: 148 -------------LPNLVGITFDGNRISGAIPDSYGSFSKLFTSM--------------- 179

Query: 181 LGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTI 240
                                   ++S N L+G +P + AN +  L ++ +S N + G  
Sbjct: 180 ------------------------TISRNRLTGKIPPTFANLN--LAFVDLSRNMLEGDA 213

Query: 241 PTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTE 300
               G+ KN   I +  N L   +   VG    L  L L  N+I G +P  L  L FL  
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272

Query: 301 VDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIP 337
           +++  N++ G IP   GN  +      ++N      P
Sbjct: 273 LNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  208 bits (533), Expect = 4e-61
 Identities = 73/318 (22%), Positives = 118/318 (37%), Gaps = 71/318 (22%)

Query: 3   QGEIPANITHCSELRILDLV-VNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
              IP+++ +   L  L +  +N L G IP  +  L +L  L +T  N +G+IP  LS +
Sbjct: 65  PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124

Query: 62  SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
             L  L  S N+LSG +P  +  L  L       N ++G+IP    + S +         
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL--------- 175

Query: 122 LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNL 181
                             + +  N  TG+IPP+ +N +                      
Sbjct: 176 ---------------FTSMTISRNRLTGKIPPTFANLN---------------------- 198

Query: 182 GTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIP 241
                  L F+D            LS N L G       +  +    ++++ N ++  + 
Sbjct: 199 -------LAFVD------------LSRNMLEGDASVLFGSDKN-TQKIHLAKNSLAFDLG 238

Query: 242 TGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEV 301
             VG  KNL  + +  N + G++P  +  L  L  L++  N + GEIP   GNL      
Sbjct: 239 K-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVS 296

Query: 302 DLQGNSIRGSIPSALGNC 319
               N      P  L  C
Sbjct: 297 AYANNKCLCGSP--LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  146 bits (372), Expect = 3e-39
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 15/181 (8%)

Query: 1   MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLV-GLGLTGNNYTGSIPQSLS 59
            L G +P +I+    L  +    N++ G IP   G+  KL   + ++ N  TG IP + +
Sbjct: 136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA 195

Query: 60  NLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQ 119
           NL+ L  + LS N L G+     G  K      ++ N L   +  ++    +++   +  
Sbjct: 196 NLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRN 253

Query: 120 NKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARN 179
           N++ G +P  +   L  +  L +  N   GEIP             G L+      +A N
Sbjct: 254 NRIYGTLPQGLT-QLKFLHSLNVSFNNLCGEIPQG-----------GNLQRFDVSAYANN 301

Query: 180 N 180
            
Sbjct: 302 K 302

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  270 bits (694), Expect = 5e-84
 Identities = 101/310 (32%), Positives = 164/310 (52%), Gaps = 44/310 (14%)

Query: 550 SYAELLKATEGFSSANLIGIGGYGYVYKGIL--GTEETNVAVKVLDLQQR-GASKSFIAE 606
           S  EL  A++ FS+ N++G GG+G VYKG L  GT    VAVK L  ++  G    F  E
Sbjct: 21  SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL---VAVKRLKEERTQGGELQFQTE 77

Query: 607 CEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLN 666
            E +    HRNL+++   C +   R      LVY +M NGS+ + L    +    +P L+
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTER-----LLVYPYMANGSVASCLR---ERPESQPPLD 129

Query: 667 LMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSP 726
             +R  IA+  A  L YLH HC   I+H D+K +N+LLD E  A VGDFGL++L+     
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY--- 186

Query: 727 DQT--STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMF---EEG 781
             T  +T  V+G+IG++APEY + G+ S   D + +G+++LE+ TG+R  D      ++ 
Sbjct: 187 KDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245

Query: 782 LSLHKYAKMGLPD-QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVS-ILRVGI 839
           + L  + K  L + ++  ++D                    +L+  + + +V  +++V +
Sbjct: 246 VMLLDWVKGLLKEKKLEALVD-------------------VDLQGNYKDEEVEQLIQVAL 286

Query: 840 LCSEELPRDR 849
           LC++  P +R
Sbjct: 287 LCTQSSPMER 296

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  272 bits (698), Expect = 7e-81
 Identities = 72/507 (14%), Positives = 166/507 (32%), Gaps = 54/507 (10%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELG--NLFKLVGLGLTGNNYTGSIPQSLSNLS 62
             P  I+          +    +          +   L+   +  +    SI +S     
Sbjct: 124 FGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183

Query: 63  FLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKL 122
              Q+    N+++  +   +  L +L  F +  +        + +   + +Y      + 
Sbjct: 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQ 237

Query: 123 VGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLG 182
                      L ++  + + +     ++P  +            L  +  +N A N   
Sbjct: 238 YKTEDLKWD-NLKDLTDVEVYNCPNLTKLPTFL----------KALPEMQLINVACNRGI 286

Query: 183 TGK--GNDLRFLDSLVNCTFLEVVSLSSNSL-SGVLPNSIANFSSHLIYLYMSANRISGT 239
           +G+   +D + L        ++++ +  N+L +  +  S+      L  L    N++ G 
Sbjct: 287 SGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKK-LGMLECLYNQLEGK 345

Query: 240 IPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSL--GNLIF 297
           +P   G+   L  + +  N +T       G+  +++ LS   NK+   IP+     ++  
Sbjct: 346 LPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSV 403

Query: 298 LTEVDLQGNSIRG-------SIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLD 350
           ++ +D   N I          +       + +  ++LS+N +S          S    ++
Sbjct: 404 MSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSIN 463

Query: 351 LSRNHLSG-------PIPLEVGRLKGIQQLDLSENKLSGEIPTSLA--SCVGLEYLNFSD 401
           L  N L+                   +  +DL  NKL+  +       +   L  ++ S 
Sbjct: 464 LMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSY 522

Query: 402 NSFQGPIHSGFSSLKGLQDL------DLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGE 455
           NSF     +   +   L+        D   N    + P  +     L +L +  N++   
Sbjct: 523 NSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK- 580

Query: 456 VPSEGVFKNVRAVSIIGNNKLCGGSPE 482
           V  + +  N+  +  I +N        
Sbjct: 581 VNEK-ITPNISVLD-IKDNPNISIDLS 605

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  266 bits (681), Expect = 2e-78
 Identities = 71/495 (14%), Positives = 153/495 (30%), Gaps = 63/495 (12%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGN----IPSELGNLFKLVGLGLTGNNYTGSIPQS 57
             G +P  I   +EL +L L  +  + N     P  +              +Y  +    
Sbjct: 93  ASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDY 152

Query: 58  LSNLSF--LQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYF 115
                F  L +  ++ +    +I     +  +       +N +T  +   +  ++ +  F
Sbjct: 153 DPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQF 211

Query: 116 AVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLN 175
            +  +  V E                               N          LK+L  + 
Sbjct: 212 YMGNSPFVAENI------CEAWENENSEYAQQYKTEDLKWDN----------LKDLTDVE 255

Query: 176 FARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGV--LPNSIANFSS-----HLIY 228
                  T      +    L     +++++++ N       L +     +       +  
Sbjct: 256 VYNCPNLT------KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309

Query: 229 LYMSANRI-SGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
           +Y+  N + +  + T +  +K L ++    N L G +P + G  +KL  L+L  N+I+  
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEI 368

Query: 288 IPSSLGNLIFLTEVDLQGNSIRGSIPSAL--GNCLQLQKLDLSDNNLSG-------TIPR 338
             +  G    +  +    N ++  IP+     +   +  +D S N +          +  
Sbjct: 369 PANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427

Query: 339 EVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSG-------EIPTSLASC 391
                 +   ++LS N +S            +  ++L  N L+        +   +  + 
Sbjct: 428 TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT 487

Query: 392 VGLEYLNFSDNSFQG-PIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKL----- 445
             L  ++   N           ++L  L  +DLS N+FS   P        L+       
Sbjct: 488 YLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546

Query: 446 -NLSFNNLEGEVPSE 459
            +   N    E P  
Sbjct: 547 RDAQGNRTLREWPEG 561

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  262 bits (671), Expect = 5e-77
 Identities = 67/475 (14%), Positives = 140/475 (29%), Gaps = 73/475 (15%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
            +   +   ++LR   +  +        E                   +      NL  L
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDL 251

Query: 65  QQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTG--SIPIQLFNISSMDYFAVTQNKL 122
             + +        +P+ L  L ++ +  V+ N       +      ++            
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADA---------- 301

Query: 123 VGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLG 182
                         I+++ +G N               +   L K+K L  L    N L 
Sbjct: 302 ---------PVGEKIQIIYIGYNNLKT---------FPVETSLQKMKKLGMLECLYNQL- 342

Query: 183 TGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIP- 241
            G       L +  +   L  ++L+ N ++  +P +   F+  +  L  + N++   IP 
Sbjct: 343 EG------KLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPN 394

Query: 242 -TGVGNLKNLILIAMEVNLLTG-------SIPTSVGYLLKLQVLSLFGNKISGEIPSSLG 293
                ++  +  I    N +          +  +    + +  ++L  N+IS        
Sbjct: 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454

Query: 294 NLIFLTEVDLQGNSIRG-------SIPSALGNCLQLQKLDLSDNNLSGTIPREVI--GLS 344
               L+ ++L GN +                N   L  +DL  N L+  +  +     L 
Sbjct: 455 TGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLP 513

Query: 345 SFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSE------NKLSGEIPTSLASCVGLEYLN 398
             V +DLS N  S   P +      ++   +        N+   E P  +  C  L  L 
Sbjct: 514 YLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572

Query: 399 FSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLE 453
              N  +            +  LD+  N        ++  +       L ++  +
Sbjct: 573 IGSNDIRKVNE---KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  261 bits (669), Expect = 1e-76
 Identities = 67/462 (14%), Positives = 143/462 (30%), Gaps = 56/462 (12%)

Query: 33  ELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGN----IPSELGLLKQL 88
            L +  ++ GL L G   +G +P ++  L+ L+ L+L  +    N     P  +      
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 89  NMFQVSANYLTGSIP--IQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNW 146
              Q    +   +        + S +    +  +     I      TL     +   SN 
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL-KDTQIGQLSN- 193

Query: 147 FTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSL 206
                     N + + + + +L  L +     +              +   C   E  + 
Sbjct: 194 ----------NITFVSKAVMRLTKLRQFYMGNSP-----------FVAENICEAWENENS 232

Query: 207 SSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLT----- 261
                         N    L  + +        +PT +  L  + LI +  N        
Sbjct: 233 EYAQQYKTEDLKWDNLKD-LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL 291

Query: 262 ---GSIPTSVGYLLKLQVLSLFGNKI-SGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALG 317
                         K+Q++ +  N + +  + +SL  +  L  ++   N + G +P+  G
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FG 350

Query: 318 NCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSG-PIPLEVGRLKGIQQLDLS 376
           + ++L  L+L+ N ++               L  + N L   P   +   +  +  +D S
Sbjct: 351 SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFS 410

Query: 377 ENKLSG-------EIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFS 429
            N++          +  +    + +  +N S+N         FS+   L  ++L  N  +
Sbjct: 411 YNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470

Query: 430 G-------KIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKN 464
                              L  ++L FN L   +  +     
Sbjct: 471 EIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATT 511

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  223 bits (571), Expect = 4e-63
 Identities = 61/438 (13%), Positives = 128/438 (29%), Gaps = 64/438 (14%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYT--------GS 53
                     +  +L  +++        +P+ L  L ++  + +  N             
Sbjct: 237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ 296

Query: 54  IPQSLSNLSFLQQLSLSENSL-SGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSM 112
                     +Q + +  N+L +  + + L  +K+L M +   N L G +P    +   +
Sbjct: 297 ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKL 355

Query: 113 DYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLI 172
               +  N++   IP         +  L    N     IP               +  + 
Sbjct: 356 ASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFD--------AKSVSVMS 405

Query: 173 RLNFARNNLGTGKGNDLRFL-DSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYM 231
            ++F+ N +G+  G +   L  +      +  ++LS+N +S       +  S  L  + +
Sbjct: 406 AIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP-LSSINL 464

Query: 232 SANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSS 291
             N ++  IP                         +      L  + L  NK++  +   
Sbjct: 465 MGNMLTE-IPKNSL----------------KDENENFKNTYLLTSIDLRFNKLTK-LSDD 506

Query: 292 L--GNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLL 349
                L +L  +DL  NS     P+   N   L+   + +                    
Sbjct: 507 FRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ------------------R 547

Query: 350 DLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIH 409
           D   N      P  +     + QL +  N +   +   +     +  L+  DN       
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDL 604

Query: 410 SGFSSLKGLQDLDLSRNN 427
           S            L  + 
Sbjct: 605 SYVCPYIEAGMYMLFYDK 622

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  204 bits (522), Expect = 2e-56
 Identities = 56/418 (13%), Positives = 127/418 (30%), Gaps = 79/418 (18%)

Query: 48  NNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLF 107
           + +      SL++   +  LSL     SG +P  +G L +L                   
Sbjct: 67  DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTEL------------------- 107

Query: 108 NISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGK 167
                                          VL LGS+                P+ +  
Sbjct: 108 ------------------------------EVLALGSHGEKVNERLFG------PKGISA 131

Query: 168 LKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLI 227
             +  +    R +    +   + +     + + L    ++S+     +  S         
Sbjct: 132 NMSDEQKQKMRMHY---QKTFVDYDPRE-DFSDLIKDCINSDPQQKSIKKSSRITLK-DT 186

Query: 228 YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
            +   +N I+  +   V  L  L    M  +                +    +       
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT----- 240

Query: 288 IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNL--------SGTIPRE 339
                 NL  LT+V++        +P+ L    ++Q ++++ N                +
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD 300

Query: 340 VIGLSSFVLLDLSRNHL-SGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLN 398
                   ++ +  N+L + P+   + ++K +  L+   N+L G++P +  S + L  LN
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN 359

Query: 399 FSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP--MFLNTFRFLQKLNLSFNNLEG 454
            + N       +     + +++L  + N     IP      +   +  ++ S+N +  
Sbjct: 360 LAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGS 416

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  268 bits (687), Expect = 1e-79
 Identities = 94/502 (18%), Positives = 163/502 (32%), Gaps = 40/502 (7%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           +Q          S L  L L  N ++         L  L  L     N        + +L
Sbjct: 64  IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123

Query: 62  SFLQQLSLSENSL-SGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVT-- 118
             L++L+++ N + S  +P     L  L    +S+N +       L  +  M    ++  
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183

Query: 119 --QNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASS---------------- 160
              N +    P    F    +  L L +N+ +  +  +     +                
Sbjct: 184 LSLNPMNFIQPG--AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241

Query: 161 --IPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNS 218
                D   L+ L  L      L          +D     T +   SL S ++  V   S
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS 301

Query: 219 IANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLS 278
              ++    +L +   +        + +LK L           G    S   L  L+ L 
Sbjct: 302 ---YNFGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLD 353

Query: 279 LFGNKIS--GEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTI 336
           L  N +S  G    S      L  +DL  N +   + S      QL+ LD   +NL    
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMS 412

Query: 337 PREVI-GLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEI-PTSLASCVGL 394
              V   L + + LD+S  H           L  ++ L ++ N       P        L
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472

Query: 395 EYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEG 454
            +L+ S    +    + F+SL  LQ L++S NNF             LQ L+ S N++  
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 532

Query: 455 EVPS--EGVFKNVRAVSIIGNN 474
                 +    ++  +++  N+
Sbjct: 533 SKKQELQHFPSSLAFLNLTQND 554

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  224 bits (572), Expect = 2e-63
 Identities = 98/513 (19%), Positives = 165/513 (32%), Gaps = 72/513 (14%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           L+     +     EL++LDL   +++        +L  L  L LTGN        + S L
Sbjct: 40  LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99

Query: 62  SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
           S LQ+L   E +L+      +G LK L    V+ N +      + F+             
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS------------- 146

Query: 122 LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNL 181
                       L N+  L L SN         +     +P         + L+ + N +
Sbjct: 147 -----------NLTNLEHLDLSSNKIQSIYCTDLRVLHQMP------LLNLSLDLSLNPM 189

Query: 182 GTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGT-- 239
                              L  ++L +N  S  +  +     + L    +          
Sbjct: 190 NF-------IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242

Query: 240 ----IPTGVGNLKNLILIAME---VNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSS- 291
                 + +  L NL +       ++     I      L  +   SL    I      S 
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY 302

Query: 292 ----------------LGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLS-- 333
                              L   +   L   S +G    +  +   L+ LDLS N LS  
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFK 362

Query: 334 GTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTS-LASCV 392
           G   +   G +S   LDLS N +   +      L+ ++ LD   + L      S   S  
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421

Query: 393 GLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKI-PMFLNTFRFLQKLNLSFNN 451
            L YL+ S    +   +  F+ L  L+ L ++ N+F     P      R L  L+LS   
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481

Query: 452 LEGEVPSEGVFKNVRAVSI--IGNNKLCGGSPE 482
           LE   P+   F ++ ++ +  + +N        
Sbjct: 482 LEQLSPT--AFNSLSSLQVLNMSHNNFFSLDTF 512

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  223 bits (570), Expect = 3e-63
 Identities = 85/486 (17%), Positives = 154/486 (31%), Gaps = 38/486 (7%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
           +IP N+      + LDL  N L         +  +L  L L+          +  +LS L
Sbjct: 21  KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 65  QQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVG 124
             L L+ N +          L  L         L       + ++ ++    V  N +  
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 125 EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTG 184
                    L N+  L L SN         +     +P         + L+ + N +   
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP------LLNLSLDLSLNPMNF- 191

Query: 185 KGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGT----- 239
                           L  ++L +N  S  +  +     + L    +             
Sbjct: 192 ------IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245

Query: 240 -IPTGVGNLKNLILIAME---VNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNL 295
              + +  L NL +       ++     I      L  +   SL    I      S    
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YN 303

Query: 296 IFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNH 355
                ++L            L +   L++L  + N          + L S   LDLSRN 
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKS---LKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNG 358

Query: 356 LS--GPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPI-HSGF 412
           LS  G           ++ LDLS N +   + ++      LE+L+F  ++ +     S F
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417

Query: 413 SSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSI-- 470
            SL+ L  LD+S  +         N    L+ L ++ N+ +     + +F  +R ++   
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD-IFTELRNLTFLD 476

Query: 471 IGNNKL 476
           +   +L
Sbjct: 477 LSQCQL 482

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  211 bits (539), Expect = 5e-59
 Identities = 91/478 (19%), Positives = 155/478 (32%), Gaps = 49/478 (10%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEG-NIPSELGNLFKLVGLGLTGNNYTGSIPQSLSN 60
           L       I H   L+ L++  N ++   +P    NL  L  L L+ N         L  
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171

Query: 61  LSFLQ----QLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLF-NISSMDYF 115
           L  +      L LS N ++   P     ++ L+   +  N+ + ++       ++ ++  
Sbjct: 172 LHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVH 230

Query: 116 AVTQNKLVGE--IPHYVGFTLPNIRVLLLGSN------WFTGEIPPSISNASSI------ 161
            +   +   E  +  +    L  +  L +         ++  +I    +  +++      
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290

Query: 162 ------PEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSL-------------VNCTFLE 202
                  +D         L       G      L+ L  L             V+   LE
Sbjct: 291 SVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLE 350

Query: 203 VVSLSSNSLS--GVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLL 260
            + LS N LS  G    S    +S L YL +S N +  T+ +    L+ L  +  + + L
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTS-LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL 408

Query: 261 TGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSI-PSALGN 318
                 SV   L  L  L +               L  L  + + GNS + +  P     
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468

Query: 319 CLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSEN 378
              L  LDLS   L    P     LSS  +L++S N+           L  +Q LD S N
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528

Query: 379 KLSGEIPTSLASCVG-LEYLNFSDNSFQGPIHSG--FSSLKGLQDLDLSRNNFSGKIP 433
            +       L      L +LN + N F            +K  + L +         P
Sbjct: 529 HIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 586

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  182 bits (464), Expect = 6e-49
 Identities = 64/404 (15%), Positives = 133/404 (32%), Gaps = 39/404 (9%)

Query: 1   MLQGEIPAN-ITHCSELRILDLVVNKLEGN------IPSELGNLFKLVGLGL---TGNNY 50
                +    I   + L +  LV+ +            S L  L  L          + Y
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270

Query: 51  TGSIPQSLSNLSFLQQLSLSENSLSGNIP-SELGLLKQLNMFQVSANYLTGSIPIQLFNI 109
              I    + L+ +   SL   ++      S     + L +             ++L ++
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLEL---VNCKFGQFPTLKLKSL 327

Query: 110 SSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLK 169
             + + +        E+       LP++  L L  N         +S      +      
Sbjct: 328 KRLTFTSNKGGNAFSEVD------LPSLEFLDLSRN--------GLSFKGCCSQSDFGTT 373

Query: 170 NLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYL 229
           +L  L+ + N + T          + +    LE +    ++L  +   S+     +LIYL
Sbjct: 374 SLKYLDLSFNGVIT-------MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426

Query: 230 YMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSV-GYLLKLQVLSLFGNKISGEI 288
            +S              L +L ++ M  N    +    +   L  L  L L   ++    
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486

Query: 289 PSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGL-SSFV 347
           P++  +L  L  +++  N+              LQ LD S N++  +  +E+    SS  
Sbjct: 487 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA 546

Query: 348 LLDLSRNHLSGPIPLE--VGRLKGIQQLDLSENKLSGEIPTSLA 389
            L+L++N  +     +  +  +K  +QL +   ++    P+   
Sbjct: 547 FLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 590

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  158 bits (401), Expect = 8e-41
 Identities = 44/259 (16%), Positives = 84/259 (32%), Gaps = 14/259 (5%)

Query: 203 VVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTG 262
                  +   +      N       L +S N +         +   L ++ +    +  
Sbjct: 11  TYQCMELNFYKI----PDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66

Query: 263 SIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQL 322
               +   L  L  L L GN I      +   L  L ++     ++       +G+   L
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126

Query: 323 QKLDLSDNNL-SGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQ----QLDLSE 377
           ++L+++ N + S  +P     L++   LDLS N +      ++  L  +      LDLS 
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186

Query: 378 NKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSG-FSSLKGLQDLDLSRNNFSGKIPM-- 434
           N ++   P +      L  L   +N     +       L GL+   L    F  +  +  
Sbjct: 187 NPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245

Query: 435 -FLNTFRFLQKLNLSFNNL 452
              +    L  L +    L
Sbjct: 246 FDKSALEGLCNLTIEEFRL 264

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  150 bits (380), Expect = 4e-38
 Identities = 52/219 (23%), Positives = 84/219 (38%), Gaps = 10/219 (4%)

Query: 246 NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQG 305
            + N+    ME+N     IP ++      + L L  N +      S  +   L  +DL  
Sbjct: 6   VVPNITYQCMELNFY--KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61

Query: 306 NSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVG 365
             I+     A  +   L  L L+ N +         GLSS   L     +L+      +G
Sbjct: 62  CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121

Query: 366 RLKGIQQLDLSENKL-SGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQ----D 420
            LK +++L+++ N + S ++P   ++   LE+L+ S N  Q    +    L  +      
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181

Query: 421 LDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE 459
           LDLS N  +   P      R L KL L  N     V   
Sbjct: 182 LDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKT 219

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  257 bits (658), Expect = 1e-78
 Identities = 89/349 (25%), Positives = 153/349 (43%), Gaps = 37/349 (10%)

Query: 525 YQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEE 584
           Y +           +  +  +  ++   +L +AT  F    LIG G +G VYKG+L  + 
Sbjct: 5   YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDG 63

Query: 585 TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMP 644
             VA+K    +     + F  E E L   RH +LV +I  C   +        L+Y++M 
Sbjct: 64  AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM-----ILIYKYME 118

Query: 645 NGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL 704
           NG+L+  L            ++  QRL I I  A  L YLH      I+H D+K  N+LL
Sbjct: 119 NGNLKRHLY---GSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILL 172

Query: 705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM 764
           D   V  + DFG+S+   +      ST  VKG++GY+ PEY   G ++   D YSFG+++
Sbjct: 173 DENFVPKITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVL 231

Query: 765 LEMFTGKRPTDDMFEEG-LSLHKYAKMGLPD-QVAEIIDPAILEEALEIQAGIVKELQPN 822
            E+   +           ++L ++A     + Q+ +I+DP +               +  
Sbjct: 232 FEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL-------------ADKIR 278

Query: 823 LRA--KFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQAI 869
             +  KF +         + C      DR  + D + +L+ A ++++++
Sbjct: 279 PESLRKFGDT-------AVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  254 bits (650), Expect = 1e-73
 Identities = 98/495 (19%), Positives = 175/495 (35%), Gaps = 35/495 (7%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           L+    AN T  S+L  LD+  N +    P     L  L  L L  N  +    ++ +  
Sbjct: 37  LRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFC 96

Query: 62  SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
           + L +L L  NS+     +     K L    +S N L+ +       + ++    ++ NK
Sbjct: 97  TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156

Query: 122 LVGEIPHYVG-FTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNN 180
           +       +  F   +++ L L SN      P               +  L  L      
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHA----------IGRLFGLFLNNVQ 206

Query: 181 LGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFS-SHLIYLYMSANRISGT 239
           LG    +    L   +  T +  +SLS++ LS     +      ++L  L +S N ++  
Sbjct: 207 LG---PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263

Query: 240 IPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEI---------PS 290
                  L  L    +E N +      S+  L  ++ L+L  +     I           
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323

Query: 291 SLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI--GLSSFVL 348
           S   L  L  ++++ N I G   +     + L+ L LS++  S           L+   L
Sbjct: 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPL 383

Query: 349 LDL--SRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIP-TSLASCVGLEYLNFSDNSFQ 405
             L  ++N +S         L  ++ LDL  N++  E+          +  +  S N + 
Sbjct: 384 HILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYL 443

Query: 406 GPIHSGFSSLKGLQDLDLSRNNFSG--KIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFK 463
               + F+ +  LQ L L R         P      R L  L+LS NN+        + +
Sbjct: 444 QLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIND--DMLE 501

Query: 464 NVRAVSI--IGNNKL 476
            +  + I  + +N L
Sbjct: 502 GLEKLEILDLQHNNL 516

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  234 bits (600), Expect = 1e-66
 Identities = 82/495 (16%), Positives = 160/495 (32%), Gaps = 65/495 (13%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
           ++P ++   + + +L+L  N+L     +      +L  L +  N  +   P+    L  L
Sbjct: 18  QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75

Query: 65  QQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVG 124
           + L+L  N LS            L    + +N +                          
Sbjct: 76  KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK---------------- 119

Query: 125 EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTG 184
                      N+  L L  N  +     +             L+NL  L  + N +   
Sbjct: 120 ---------QKNLITLDLSHNGLSSTKLGTQVQ----------LENLQELLLSNNKIQAL 160

Query: 185 KGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV 244
           K  +L         + L+ + LSSN +    P         L  L+++  ++  ++   +
Sbjct: 161 KSEELDIF----ANSSLKKLELSSNQIKEFSPGCFHAI-GRLFGLFLNNVQLGPSLTEKL 215

Query: 245 G---NLKNLILIAMEVNLLTGSIPTSVGYL--LKLQVLSLFGNKISGEIPSSLGNLIFLT 299
                  ++  +++  + L+ +  T+   L    L +L L  N ++     S   L  L 
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275

Query: 300 EVDLQGNSIRGSIPSALGNCLQLQKLDLSDN---------NLSGTIPREVIGLSSFVLLD 350
              L+ N+I+     +L     ++ L+L  +         +L          L     L+
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335

Query: 351 LSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLA----SCVGLEYLNFSDNSFQG 406
           +  N + G        L  ++ L LS +  S    T+      +   L  LN + N    
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395

Query: 407 PIHSGFSSLKGLQDLDLSRNNFSGKIP-MFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNV 465
                FS L  L+ LDL  N    ++          + ++ LS+N           F  V
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR--NSFALV 453

Query: 466 RAVSII--GNNKLCG 478
            ++  +      L  
Sbjct: 454 PSLQRLMLRRVALKN 468

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  210 bits (536), Expect = 4e-58
 Identities = 79/500 (15%), Positives = 150/500 (30%), Gaps = 78/500 (15%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELG---NLFKLVGLGLTGNNYTGSIPQSL 58
           ++   P        L  L L   +L  ++  +L        +  L L+ +  + +   + 
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242

Query: 59  SNLSF--LQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFA 116
             L +  L  L LS N+L+         L QL  F +  N +       L  + ++ Y  
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302

Query: 117 VTQNKLVG--------EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKL 168
           + ++            +I  +    L  +  L +  N   G      +           L
Sbjct: 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTG----------L 352

Query: 169 KNLIRLNFARNNLGTG----------KGNDLRFLD------------SLVNCTFLEVVSL 206
            NL  L+ + +                 + L  L+            +      LEV+ L
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL 412

Query: 207 SSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTG--SI 264
             N +   L         ++  +Y+S N+           + +L  + +    L    S 
Sbjct: 413 GLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSS 472

Query: 265 PTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSI--------RGSIPSAL 316
           P+    L  L +L L  N I+      L  L  L  +DLQ N++         G     L
Sbjct: 473 PSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFL 532

Query: 317 GNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLS 376
                L  L+L  N            L    ++DL  N+L+            ++ L+L 
Sbjct: 533 KGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQ 592

Query: 377 ENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFL 436
           +N ++                                + + L +LD+  N F        
Sbjct: 593 KNLITSVEKKVFG-----------------------PAFRNLTELDMRFNPFDCTCESIA 629

Query: 437 NTFRFLQKLNLSFNNLEGEV 456
               ++ + + +   L    
Sbjct: 630 WFVNWINETHTNIPELSSHY 649

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  176 bits (448), Expect = 2e-46
 Identities = 61/294 (20%), Positives = 110/294 (37%), Gaps = 16/294 (5%)

Query: 198 CT-FLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAME 256
           CT   EV   S   L+ V      +  +++  L ++ N++             L  + + 
Sbjct: 2   CTVSHEVADCSHLKLTQV----PDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVG 57

Query: 257 VNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSAL 316
            N ++   P     L  L+VL+L  N++S     +      LTE+ L  NSI+    +  
Sbjct: 58  FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117

Query: 317 GNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSG--PIPLEVGRLKGIQQLD 374
                L  LDLS N LS T     + L +   L LS N +       L++     +++L+
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177

Query: 375 LSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFS---SLKGLQDLDLSRNNFSGK 431
           LS N++    P    +   L  L  ++      +        +   +++L LS +  S  
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237

Query: 432 IPMFLNTFRF--LQKLNLSFNNLEGEVPSEGVFKNVRAVSI--IGNNKLCGGSP 481
                   ++  L  L+LS+NNL         F  +  +    +  N +     
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNV--VGNDSFAWLPQLEYFFLEYNNIQHLFS 289

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 69.6 bits (171), Expect = 2e-12
 Identities = 22/127 (17%), Positives = 43/127 (33%), Gaps = 1/127 (0%)

Query: 1   MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSN 60
              G     +   S L IL+L  N  +        +LF+L  + L  NN         +N
Sbjct: 523 ANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNN 582

Query: 61  LSFLQQLSLSENSLSGNIPSELG-LLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQ 119
              L+ L+L +N ++       G   + L    +  N    +     + ++ ++      
Sbjct: 583 QVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNI 642

Query: 120 NKLVGEI 126
            +L    
Sbjct: 643 PELSSHY 649

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  231 bits (592), Expect = 2e-69
 Identities = 82/267 (30%), Positives = 127/267 (47%), Gaps = 29/267 (10%)

Query: 550 SYAELLKATEGFSS------ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--- 600
           S+ EL   T  F         N +G GG+G VYKG +    T VAVK L       +   
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEEL 73

Query: 601 -KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ 659
            + F  E + +   +H NLV+++   S  D        LVY +MPNGSL + L+  +   
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDL-----CLVYVYMPNGSLLDRLSCLDG-- 126

Query: 660 NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR 719
              P L+   R  IA   AN + +LH +     +H D+K +N+LLD    A + DFGL+R
Sbjct: 127 --TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181

Query: 720 LLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFE 779
                +    ++ R+ G+  Y+APE    GE++   D YSFG+++LE+ TG    D+  E
Sbjct: 182 ASEKFAQTVMTS-RIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

Query: 780 EGLSLHKYAKMGLPDQ--VAEIIDPAI 804
               L    +    ++  + + ID  +
Sbjct: 240 PQ-LLLDIKEEIEDEEKTIEDYIDKKM 265

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  232 bits (594), Expect = 9e-65
 Identities = 74/519 (14%), Positives = 154/519 (29%), Gaps = 61/519 (11%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQ-SLSN 60
            +G +P  I   +EL++L    +    +                  +       +  L  
Sbjct: 335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDY 394

Query: 61  LSFLQQLSLSENSLSGN-----IPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYF 115
              L    L +++++ N     I  +  +  +        N +T  I   +  ++ +   
Sbjct: 395 DQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQII 453

Query: 116 AVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISN--------------ASSI 161
               +    +          +                 S SN               + +
Sbjct: 454 YFANSPFTYDNI------AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507

Query: 162 PEDLGKLKNLIRLNFARNNL---GTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNS 218
           P+ L  L  L  LN A N        K +  R  D       +++  +  N+L     ++
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASA 567

Query: 219 IANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLK-LQVL 277
                  L  L    N++   +    G    L  + ++ N +   IP         ++ L
Sbjct: 568 SLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGL 624

Query: 278 SLFGNKISGEIPS--SLGNLIFLTEVDLQGNSIRGSIPSALG-----NCLQLQKLDLSDN 330
               NK+   IP+  +  ++  +  VD   N I     +          +    + LS N
Sbjct: 625 GFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYN 683

Query: 331 NLSGTIPREVIGLSSFVLLDLSRNHLS-------GPIPLEVGRLKGIQQLDLSENKLSGE 383
            +           S    + LS N ++        P          +  +DL  NKL+  
Sbjct: 684 EIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-S 742

Query: 384 IPTSLASC--VGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSR------NNFSGKIPMF 435
           +     +     L  ++ S N F     +   +   L+   +        N    + P  
Sbjct: 743 LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801

Query: 436 LNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNN 474
           + T   L +L +  N++  +V  + +   +  + I  N 
Sbjct: 802 ITTCPSLIQLQIGSNDIR-KVDEK-LTPQLYILDIADNP 838

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  229 bits (585), Expect = 1e-63
 Identities = 72/503 (14%), Positives = 153/503 (30%), Gaps = 56/503 (11%)

Query: 10  ITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTG------NNYTGSIPQSLSNLSF 63
           + +   L + DL+ + +  N   E+  + K   + L         N    I +++  L+ 
Sbjct: 392 LDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTK 449

Query: 64  LQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLV 123
           LQ +  + +  + +  +        +           +  +   N+  +    +     +
Sbjct: 450 LQIIYFANSPFTYDNIAVDWEDANSDY-----AKQYENEELSWSNLKDLTDVELYNCPNM 504

Query: 124 GEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGT 183
            ++P ++   LP ++ L +  N          ++ + + +D      +       NNL  
Sbjct: 505 TQLPDFLY-DLPELQSLNIACNRGIS-AAQLKADWTRLADDEDTGPKIQIFYMGYNNL-- 560

Query: 184 GKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTG 243
               +     SL     L ++    N +  +   +       L  L +  N+I   IP  
Sbjct: 561 ---EEFPASASLQKMVKLGLLDCVHNKVRHL--EAFGTNVK-LTDLKLDYNQIE-EIPED 613

Query: 244 VG-NLKNLILIAMEVNLLTGSIP--TSVGYLLKLQVLSLFGNKISGEIPS-----SLGNL 295
                  +  +    N L   IP   +   +  +  +    NKI  E  +          
Sbjct: 614 FCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG 672

Query: 296 IFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLS-------GTIPREVIGLSSFVL 348
           I  + V L  N I+            +  + LS+N ++                      
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732

Query: 349 LDLSRNHLSG-PIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLN------FSD 401
           +DL  N L+          L  +  +D+S N  S   PT   +   L+            
Sbjct: 733 IDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEG 791

Query: 402 NSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGV 461
           N       +G ++   L  L +  N+   K+         L  L+++ N     +    V
Sbjct: 792 NRILRQWPTGITTCPSLIQLQIGSNDIR-KVDE--KLTPQLYILDIADNPNI-SIDVTSV 847

Query: 462 FKNVRAVSII----GNNKLCGGS 480
              + A   +        + G  
Sbjct: 848 CPYIEAGMYVLLYDKTQDIRGCD 870

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  223 bits (571), Expect = 1e-61
 Identities = 80/487 (16%), Positives = 153/487 (31%), Gaps = 62/487 (12%)

Query: 23  VNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSEL 82
           ++        +L N  ++ GL L G    G +P ++  L+ L+ LS   +S + +     
Sbjct: 308 LDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFG 367

Query: 83  GLLKQLNMFQVSANYLTGSIP------IQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPN 136
                 +M +   + +            Q  N+S +   A+ +N  +  I      +L +
Sbjct: 368 DEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKD 427

Query: 137 IRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLV 196
            ++  L +N  T            I + + +L  L  + FA +                 
Sbjct: 428 TQIGNL-TNRIT-----------FISKAIQRLTKLQIIYFANSPFT-----------YDN 464

Query: 197 NCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAME 256
                E  +            S +N    L  + +        +P  + +L  L  + + 
Sbjct: 465 IAVDWEDANSDYAKQYENEELSWSNLKD-LTDVELYNCPNMTQLPDFLYDLPELQSLNIA 523

Query: 257 VNLLTG---------SIPTSVGYLLKLQVLSLFGNKISGEIPSS--LGNLIFLTEVDLQG 305
            N              +        K+Q+  +  N +  E P+S  L  ++ L  +D   
Sbjct: 524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVH 582

Query: 306 NSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREV-IGLSSFVLLDLSRNHLSG-PIPLE 363
           N +      A G  ++L  L L  N +   IP +          L  S N L   P    
Sbjct: 583 NKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFN 639

Query: 364 VGRLKGIQQLDLSENKLSGEIPTSLAS-----CVGLEYLNFSDNSFQGPIHSGFSSLKGL 418
              +  +  +D S NK+  E      S      +    +  S N  Q      F++   +
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI 699

Query: 419 QDLDLSRNNFS-------GKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSI- 470
             + LS N  +                   L  ++L FN L   +  +     +  +S  
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNM 758

Query: 471 -IGNNKL 476
            +  N  
Sbjct: 759 DVSYNCF 765

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  197 bits (503), Expect = 7e-53
 Identities = 65/441 (14%), Positives = 133/441 (30%), Gaps = 70/441 (15%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTG--------- 52
                  + ++  +L  ++L        +P  L +L +L  L +  N             
Sbjct: 479 QYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT 538

Query: 53  SIPQSLSNLSFLQQLSLSENSLSGNIPSELGL--LKQLNMFQVSANYLTGSIPIQLFNIS 110
            +         +Q   +  N+L    P+   L  + +L +     N +   +        
Sbjct: 539 RLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNV 595

Query: 111 SMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKN 170
            +    +  N++  EIP         +  L    N     IP   +           +  
Sbjct: 596 KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFN--------AKSVYV 645

Query: 171 LIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLY 230
           +  ++F+ N +G+   N    +D          V+LS N +        A  S  +  + 
Sbjct: 646 MGSVDFSYNKIGSEGRNISCSMDDY-KGINASTVTLSYNEIQKFPTELFATGSP-ISTII 703

Query: 231 MSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPS 290
           +S N ++ +IP                         +      L  + L  NK++  +  
Sbjct: 704 LSNNLMT-SIPENSL----------------KPKDGNYKNTYLLTTIDLRFNKLT-SLSD 745

Query: 291 SL--GNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVL 348
                 L +L+ +D+  N    S P+   N  QL+   +                     
Sbjct: 746 DFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQ------------------ 786

Query: 349 LDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSF-QGP 407
            D   N +    P  +     + QL +  N +  ++   L     L  L+ +DN      
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTP--QLYILDIADNPNISID 843

Query: 408 IHSGFSSLK-GLQDLDLSRNN 427
           + S    ++ G+  L   +  
Sbjct: 844 VTSVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  164 bits (416), Expect = 7e-42
 Identities = 60/363 (16%), Positives = 113/363 (31%), Gaps = 34/363 (9%)

Query: 134 LPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLD 193
              +  L L      G +P +I          G+L  L  L+F  ++  T  G      +
Sbjct: 322 NGRVTGLSLAGFGAKGRVPDAI----------GQLTELKVLSFGTHSE-TVSGRLFGDEE 370

Query: 194 SLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILI 253
              + +      +  +     L        S L+   ++ N     I            I
Sbjct: 371 LTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQI 430

Query: 254 AMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIP 313
               N +T  I  ++  L KLQ++    +  + +  +     +   + +        +  
Sbjct: 431 GNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAKQYENEE 484

Query: 314 SALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGP---------IPLEV 364
            +  N   L  ++L +      +P  +  L     L+++ N              +  + 
Sbjct: 485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDE 544

Query: 365 GRLKGIQQLDLSENKLSGEIPTS--LASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLD 422
                IQ   +  N L  E P S  L   V L  L+   N  +      F +   L DL 
Sbjct: 545 DTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRHL--EAFGTNVKLTDLK 601

Query: 423 LSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSII--GNNKLCGGS 480
           L  N        F      ++ L  S N L+  +P+    K+V  +  +    NK+    
Sbjct: 602 LDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEG 660

Query: 481 PEL 483
             +
Sbjct: 661 RNI 663

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 43.7 bits (103), Expect = 3e-04
 Identities = 12/120 (10%), Positives = 36/120 (30%), Gaps = 1/120 (0%)

Query: 371 QQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSG 430
           + LD    +       +    +     N   + +         +   +  L L+     G
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337

Query: 431 KIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPELHLHSCRS 490
           ++P  +     L+ L+   ++        G  +    +S    +++     ++ L   + 
Sbjct: 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  224 bits (573), Expect = 1e-63
 Identities = 93/492 (18%), Positives = 163/492 (33%), Gaps = 28/492 (5%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           +             L  L L  N L     + L     L  L       +      L N 
Sbjct: 69  IYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQ 128

Query: 62  SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISS--MDYFAVTQ 119
             L+ L L  N +S     +    ++L +     N +       + ++         +  
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG 188

Query: 120 NKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARN 179
           N +   I     F     + L  G       I   + N++        +++L    F   
Sbjct: 189 NDI-AGIEPGA-FDSAVFQSLNFGGTQNLLVIFKGLKNST--------IQSLWLGTFEDM 238

Query: 180 NLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGT 239
           +    +       + L   + +E ++L  +    +  N+   FS  L  L ++A  +S  
Sbjct: 239 DD---EDISPAVFEGLCEMS-VESINLQKHYFFNISSNTFHCFSG-LQELDLTATHLS-E 292

Query: 240 IPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPS-SLGNLIFL 298
           +P+G+  L  L  + +  N        S      L  LS+ GN    E+ +  L NL  L
Sbjct: 293 LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352

Query: 299 TEVDLQGNSIRGS--IPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHL 356
            E+DL  + I  S      L N   LQ L+LS N                 LLDL+   L
Sbjct: 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412

Query: 357 SGPIPLEV-GRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIH---SGF 412
                      L  ++ L+LS + L             L++LN   N F        +  
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472

Query: 413 SSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSI-I 471
            +L  L+ L LS  + S        + + +  ++LS N L           +++ + + +
Sbjct: 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE--ALSHLKGIYLNL 530

Query: 472 GNNKLCGGSPEL 483
            +N +    P L
Sbjct: 531 ASNHISIILPSL 542

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  224 bits (572), Expect = 1e-63
 Identities = 89/482 (18%), Positives = 157/482 (32%), Gaps = 29/482 (6%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
           EIP  +   +    L+   N L     +    L  L  L LT          +  +   L
Sbjct: 26  EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83

Query: 65  QQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVG 124
             L L+ N L     + L   K L         ++    I L N  +++   +  N +  
Sbjct: 84  DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143

Query: 125 EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTG 184
                 GF    ++VL   +N         +S+       L +  NL  LN   N++   
Sbjct: 144 IKLP-KGFPTEKLKVLDFQNNAIHYLSKEDMSS-------LQQATNL-SLNLNGNDIAG- 193

Query: 185 KGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFS-SHLIYLYMSANRISGTIPTG 243
                       +    + ++        V+   + N +   L              P  
Sbjct: 194 ------IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247

Query: 244 VGNLKNLILIA--MEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEV 301
              L  + + +  ++ +        +      LQ L L    +S E+PS L  L  L ++
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKL 306

Query: 302 DLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHL--SG 358
            L  N        +  N   L  L +  N     +    +  L +   LDLS + +  S 
Sbjct: 307 VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSD 366

Query: 359 PIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQG-PIHSGFSSLKG 417
              L++  L  +Q L+LS N+       +   C  LE L+ +    +     S F +L  
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL 426

Query: 418 LQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE-GVFKNVRAVSI--IGNN 474
           L+ L+LS +          +    LQ LNL  N+       +    + +  + I  +   
Sbjct: 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC 486

Query: 475 KL 476
            L
Sbjct: 487 DL 488

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  221 bits (565), Expect = 1e-62
 Identities = 96/494 (19%), Positives = 166/494 (33%), Gaps = 33/494 (6%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           L        +    L  LDL   ++         +  +L  L LT N        +LS  
Sbjct: 45  LPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP 104

Query: 62  SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
             L+ L   +  +S      L   K L    + +N+++     + F    +       N 
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164

Query: 122 LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNA-SSIPEDLGKLKNLIRLNFARNN 180
           +       +   L     L L  N           N  + I            LNF    
Sbjct: 165 IHYLSKEDMSS-LQQATNLSLNLN----------GNDIAGIEPGAFDSAVFQSLNFGGTQ 213

Query: 181 LGTGKGNDLRFLDSLVNCTF--LEVVSLSSNSLSGVLPNSIANFS-SHLIYLYMSANRIS 237
                 N L     L N T   L + +        + P          +  + +  +   
Sbjct: 214 ------NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF 267

Query: 238 GTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIF 297
                       L  + +    L+  +P+ +  L  L+ L L  NK       S  N   
Sbjct: 268 NISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPS 326

Query: 298 LTEVDLQGNSIRGSIPS-ALGNCLQLQKLDLSDNNL--SGTIPREVIGLSSFVLLDLSRN 354
           LT + ++GN+ R  + +  L N   L++LDLS +++  S     ++  LS    L+LS N
Sbjct: 327 LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYN 386

Query: 355 HLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTS-LASCVGLEYLNFSDNSFQGPIHSGFS 413
                          ++ LDL+  +L  +   S   +   L+ LN S +         F 
Sbjct: 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446

Query: 414 SLKGLQDLDLSRNNFSGKIPMFLNTFRF---LQKLNLSFNNLEGEVPSEGVFKNVRAVSI 470
            L  LQ L+L  N+F        N+ +    L+ L LSF +L      +  F +++ ++ 
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS--IDQHAFTSLKMMNH 504

Query: 471 I--GNNKLCGGSPE 482
           +   +N+L   S E
Sbjct: 505 VDLSHNRLTSSSIE 518

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  194 bits (494), Expect = 6e-53
 Identities = 86/479 (17%), Positives = 150/479 (31%), Gaps = 36/479 (7%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           +       + +   L  L L  N +      +     KL  L    N       + +S+L
Sbjct: 117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSL 176

Query: 62  SFLQQ--LSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFN--ISSMDYFAV 117
                  L+L+ N ++G I                       I   L N  I S+     
Sbjct: 177 QQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235

Query: 118 TQNKLVGEIPHY-VGFTLPNIRVLLLGSNWFTGEIPPSISNA-------------SSIPE 163
                    P    G    ++  + L  ++F      +                 S +P 
Sbjct: 236 EDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPS 295

Query: 164 DLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFS 223
            L  L  L +L  + N              S  N   L  +S+  N+    L        
Sbjct: 296 GLVGLSTLKKLVLSANKFENLCQI------SASNFPSLTHLSIKGNTKRLELGTGCLENL 349

Query: 224 SHLIYLYMSANRISGTIPTGV--GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFG 281
            +L  L +S + I  +    +   NL +L  + +  N        +     +L++L L  
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409

Query: 282 NKISG-EIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREV 340
            ++   +  S   NL  L  ++L  + +  S          LQ L+L  N+      ++ 
Sbjct: 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469

Query: 341 ---IGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYL 397
                L    +L LS   LS         LK +  +DLS N+L+     +L+   G+ YL
Sbjct: 470 NSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YL 528

Query: 398 NFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEV 456
           N + N     + S    L   + ++L +N              FL+    +   LE   
Sbjct: 529 NLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN----IYFLEWYKENMQKLEDTE 583

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  180 bits (458), Expect = 4e-48
 Identities = 77/434 (17%), Positives = 152/434 (35%), Gaps = 29/434 (6%)

Query: 4   GEIPANITHCSELRILDLVVNKLEGNIPSELGN--LFKLVGLGLTGNNYTGSIPQSLSNL 61
             I       +  + L+    +    I   L N  +  L        +     P     L
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251

Query: 62  SF--LQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQ 119
               ++ ++L ++       +       L    ++A +L+  +P  L  +S++    ++ 
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310

Query: 120 NKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARN 179
           NK    +        P++  L +  N    E+             L  L+NL  L+ + +
Sbjct: 311 NKF-ENLCQISASNFPSLTHLSIKGNTKRLELGTGC---------LENLENLRELDLSHD 360

Query: 180 NLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGT 239
           ++ T    +      L N + L+ ++LS N    +   +       L  L ++  R+   
Sbjct: 361 DIETSDCCN----LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ-LELLDLAFTRLKVK 415

Query: 240 IPTGV-GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEI---PSSLGNL 295
                  NL  L ++ +  +LL  S       L  LQ L+L GN          +SL  L
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475

Query: 296 IFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNH 355
             L  + L    +      A  +   +  +DLS N L+ +   E +     + L+L+ NH
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT-SSSIEALSHLKGIYLNLASNH 534

Query: 356 LSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSL 415
           +S  +P  +  L   + ++L +N L             LE+   +    +    +   + 
Sbjct: 535 ISIILPSLLPILSQQRTINLRQNPLDCTCSNIYF----LEWYKENMQKLEDTEDTLCENP 590

Query: 416 KGLQDLDLSRNNFS 429
             L+ + LS    S
Sbjct: 591 PLLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  119 bits (301), Expect = 3e-28
 Identities = 38/232 (16%), Positives = 72/232 (31%), Gaps = 5/232 (2%)

Query: 261 TGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCL 320
           T S           +  +     ++ EIP +L N      ++   N +     +     +
Sbjct: 1   TTSSDQKCIEKEVNKTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLI 57

Query: 321 QLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKL 380
            L  LDL+   +                L L+ N L       +   K ++ L   +  +
Sbjct: 58  NLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGI 117

Query: 381 SGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFR 440
           S      L +   LE L    N             + L+ LD   N         +++ +
Sbjct: 118 SSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQ 177

Query: 441 FLQ--KLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPELHLHSCRS 490
                 LNL+ N++ G  P        ++++  G   L      L   + +S
Sbjct: 178 QATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  217 bits (554), Expect = 5e-61
 Identities = 96/482 (19%), Positives = 166/482 (34%), Gaps = 47/482 (9%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTG-SIPQSLSN 60
           +Q   P + +  + L  L  V  KL       +G L  L  L +  N      +P   SN
Sbjct: 92  IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151

Query: 61  LSFLQQLSLSENSLSGNIPSELGLLKQLNMFQV----SANYLTGSIPIQLFNISSMDYFA 116
           L+ L  + LS N +     ++L  L++     +    S N +   I  Q F    +    
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELT 210

Query: 117 VTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSI--------------- 161
           +  N     I       L  + V  L    F  E    I   S +               
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270

Query: 162 -------PEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGV 214
                        L N+  ++ A  ++        ++L+ +      + +S+    L   
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVSI--------KYLEDVPKHFKWQSLSIIRCQLKQF 322

Query: 215 LPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYL--L 272
               +      L  L ++ N+ S  I      L +L  + +  N L+ S   S   L   
Sbjct: 323 PTLDL----PFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376

Query: 273 KLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIP-SALGNCLQLQKLDLSDNN 331
            L+ L L  N     + ++   L  L  +D Q ++++     SA  +  +L  LD+S  N
Sbjct: 377 SLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTN 435

Query: 332 LSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLDLSENKLSGEIPTSLAS 390
                    +GL+S   L ++ N         V      +  LDLS+ +L         +
Sbjct: 436 TKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDT 495

Query: 391 CVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFN 450
              L+ LN S N+      S ++ L  L  LD S N       +  +  + L   NL+ N
Sbjct: 496 LHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555

Query: 451 NL 452
           ++
Sbjct: 556 SV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  200 bits (510), Expect = 5e-55
 Identities = 83/503 (16%), Positives = 152/503 (30%), Gaps = 41/503 (8%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           ++            L  L L  N ++   P     L  L  L              +  L
Sbjct: 68  IETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQL 127

Query: 62  SFLQQLSLSENSLSG-NIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVT-- 118
             L++L+++ N +    +P+    L  L    +S NY+       L  +       ++  
Sbjct: 128 ITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLD 187

Query: 119 --QNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNF 176
              N +   I     F    +  L L  N+ +  I  +     +       +    +   
Sbjct: 188 MSLNPI-DFIQDQA-FQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER 245

Query: 177 ARNNLGTGKGNDLRFL-----------------DSLVNCTFLEVVSLSSNSLSGVLPNSI 219
                       L  +                         +  +SL+  S+  +     
Sbjct: 246 NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVP- 304

Query: 220 ANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSL 279
                    L +   ++       +  LK+L L      +  GSI      L  L  L L
Sbjct: 305 --KHFKWQSLSIIRCQLKQFPTLDLPFLKSLTL-----TMNKGSISFKKVALPSLSYLDL 357

Query: 280 FGNKISGEIPSSLGNLIF--LTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIP 337
             N +S     S  +L    L  +DL  N     + +      +LQ LD   + L     
Sbjct: 358 SRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTE 416

Query: 338 REVI-GLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTS-LASCVGLE 395
                 L   + LD+S  +           L  +  L ++ N       ++  A+   L 
Sbjct: 417 FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLT 476

Query: 396 YLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGE 455
           +L+ S    +      F +L  LQ L++S NN         N    L  L+ SFN +E  
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET- 535

Query: 456 VPSEGVFKNVRAVSI--IGNNKL 476
                +    ++++   + NN +
Sbjct: 536 -SKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  189 bits (483), Expect = 2e-51
 Identities = 84/486 (17%), Positives = 155/486 (31%), Gaps = 39/486 (8%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
           ++P +I   S  + +DL  N L+        N  +L  L L+         ++   L  L
Sbjct: 25  KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82

Query: 65  QQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVG 124
             L L+ N +    P     L  L         L       +  + ++    V  N +  
Sbjct: 83  SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142

Query: 125 EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTG 184
                    L N+  + L  N+        +      P      +  + L+ + N +   
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENP------QVNLSLDMSLNPIDFI 196

Query: 185 KGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISG------ 238
           +    + +        L  ++L  N  S  +  +     + L    +             
Sbjct: 197 QDQAFQGIK-------LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249

Query: 239 ---TIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNL 295
              +I  G+ ++       +               L  +  +SL G  I       +   
Sbjct: 250 FEPSIMEGLCDVTIDEF-RLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKH 306

Query: 296 IFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNH 355
                + +    ++      L     L+ L L+ N  S  I  + + L S   LDLSRN 
Sbjct: 307 FKWQSLSIIRCQLKQFPTLDLPF---LKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNA 361

Query: 356 LS--GPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQG-PIHSGF 412
           LS  G           ++ LDLS N     +  +      L++L+F  ++ +     S F
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAF 420

Query: 413 SSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSI-- 470
            SL+ L  LD+S  N              L  L ++ N+ +    S  VF N   ++   
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS-NVFANTTNLTFLD 479

Query: 471 IGNNKL 476
           +   +L
Sbjct: 480 LSKCQL 485

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  157 bits (400), Expect = 1e-40
 Identities = 68/389 (17%), Positives = 121/389 (31%), Gaps = 37/389 (9%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSE-LGNLFKLVGLGLTGNNYTG---------SI 54
            I        +L  L L  N    NI    L NL  L    L    +           SI
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254

Query: 55  PQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDY 114
            + L +++  +   L+  +   +   +   L  ++   ++   +       +        
Sbjct: 255 MEGLCDVTIDE-FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED--VPKHFKWQS 311

Query: 115 FAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRL 174
            ++ + +L  + P      LP ++ L L  N              SI      L +L  L
Sbjct: 312 LSIIRCQL-KQFP---TLDLPFLKSLTLTMNKG------------SISFKKVALPSLSYL 355

Query: 175 NFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSAN 234
           + +RN L          L        L  + LS N    ++  +       L +L    +
Sbjct: 356 DLSRNALSFSGCCSYSDL----GTNSLRHLDLSFNGAI-IMSANFMGLEE-LQHLDFQHS 409

Query: 235 RISGTIPTGV-GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSS-L 292
            +          +L+ L+ + +               L  L  L + GN       S+  
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469

Query: 293 GNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLS 352
            N   LT +DL    +            +LQ L++S NNL          L S   LD S
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529

Query: 353 RNHLSGPIPLEVGRLKGIQQLDLSENKLS 381
            N +     +     K +   +L+ N ++
Sbjct: 530 FNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  134 bits (340), Expect = 4e-33
 Identities = 51/274 (18%), Positives = 84/274 (30%), Gaps = 17/274 (6%)

Query: 203 VVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTG 262
                   LS V P+ I    S    + +S N +         N   L  + +    +  
Sbjct: 15  TYQCMDQKLSKV-PDDI---PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70

Query: 263 SIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQL 322
               +   L  L  L L GN I    P S   L  L  +      +       +G  + L
Sbjct: 71  IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130

Query: 323 QKLDLSDNNLSG-TIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQ----LDLSE 377
           +KL+++ N +    +P     L++ V +DLS N++      ++  L+   Q    LD+S 
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190

Query: 378 NKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSG-FSSLKGLQDLDLSRNNFSGKI---- 432
           N +   I       + L  L    N     I      +L GL    L    F  +     
Sbjct: 191 NPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249

Query: 433 --PMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKN 464
             P  +     +                   F  
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHC 283

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  127 bits (322), Expect = 8e-31
 Identities = 42/227 (18%), Positives = 80/227 (35%), Gaps = 10/227 (4%)

Query: 238 GTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIF 297
           G++   +  + N+    M+  L    +P  +      + + L  N +      S  N   
Sbjct: 2   GSLNPCIEVVPNITYQCMDQKLS--KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57

Query: 298 LTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLS 357
           L  +DL    I      A      L  L L+ N +    P    GL+S   L      L+
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 358 GPIPLEVGRLKGIQQLDLSENKLSG-EIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLK 416
                 +G+L  +++L+++ N +   ++P   ++   L +++ S N  Q    +    L+
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177

Query: 417 GL----QDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE 459
                   LD+S N             + L +L L  N     +   
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKT 223

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  200 bits (511), Expect = 4e-58
 Identities = 70/337 (20%), Positives = 133/337 (39%), Gaps = 44/337 (13%)

Query: 547 LKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAE 606
           + +    L   +       +   G +G V+K  L  E   VAVK+  +Q +  S     E
Sbjct: 12  VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFPIQDK-QSWQNEYE 68

Query: 607 CEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLN 666
             +L  ++H N+++ I +     +   +   L+  F   GSL ++L        +   ++
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFL--------KANVVS 119

Query: 667 LMQRLSIAIDVANVLEYLHHHCHTS-------IVHCDLKPSNVLLDNEMVAHVGDFGLSR 719
             +   IA  +A  L YLH             I H D+K  NVLL N + A + DFGL+ 
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179

Query: 720 LLHDNSPDQTSTSRVKGSIGYVAPEY--GAL---GEVSTHGDEYSFGILMLEMFTGKRPT 774
                     +  +V G+  Y+APE   GA+    +     D Y+ G+++ E+ +     
Sbjct: 180 KFEAGKSAGDTHGQV-GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238

Query: 775 DDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQ-PNLRAKF--HEIQ 831
           D   +E         +   +++ +   P++     ++Q  +V + + P LR  +  H   
Sbjct: 239 DGPVDEY-------MLPFEEEIGQ--HPSL----EDMQEVVVHKKKRPVLRDYWQKHAGM 285

Query: 832 VSILRVGILCSEELPRDR---MKIQDAIMELQEAQKM 865
             +      C +     R     + + I ++Q    +
Sbjct: 286 AMLCETIEECWDHDAEARLSAGCVGERITQMQRLTNI 322

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  185 bits (470), Expect = 3e-52
 Identities = 80/349 (22%), Positives = 129/349 (36%), Gaps = 50/349 (14%)

Query: 547 LKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAE 606
           ++ + +E     +      LIG G YG VYKG L      VAVKV     R   ++FI E
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP--VAVKVFSFANR---QNFINE 55

Query: 607 CE--ALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPK 664
                +  + H N+ + I     +   G     LV E+ PNGSL  +L            
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--------SLHT 107

Query: 665 LNLMQRLSIAIDVANVLEYLH------HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS 718
            + +    +A  V   L YLH       H   +I H DL   NVL+ N+    + DFGLS
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

Query: 719 RLLHDNS-----PDQTSTSRVKGSIGYVAPEY-------GALGEVSTHGDEYSFGILMLE 766
             L  N       +  +     G+I Y+APE                  D Y+ G++  E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227

Query: 767 MFTGKRPTDDMFEEGLSLHK--YAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLR 824
           +F   R TD    E +  ++  +          E +   +            ++ +P   
Sbjct: 228 IFM--RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSR----------EKQRPKFP 275

Query: 825 AKFHEIQVSILRVGIL---CSEELPRDRMKIQDAIMELQEAQKMRQAIK 870
             + E  +++  +      C ++    R+  Q A   + E   + +  K
Sbjct: 276 EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  181 bits (462), Expect = 2e-51
 Identities = 67/214 (31%), Positives = 110/214 (51%), Gaps = 19/214 (8%)

Query: 567 IGIGGYGYVYKGIL-GTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIIT 623
           IG G +G V++    G++   VAVK+L  Q   A     F+ E   ++ +RH N+V  + 
Sbjct: 45  IGAGSFGTVHRAEWHGSD---VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
           +     T+     ++V E++  GSL   L++       R +L+  +RLS+A DVA  + Y
Sbjct: 102 AV----TQPPNL-SIVTEYLSRGSLYRLLHKSG----AREQLDERRRLSMAYDVAKGMNY 152

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
           LH+  +  IVH +LK  N+L+D +    V DFGLSRL         S     G+  ++AP
Sbjct: 153 LHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA---AGTPEWMAP 208

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
           E       +   D YSFG+++ E+ T ++P  ++
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  181 bits (461), Expect = 3e-51
 Identities = 73/309 (23%), Positives = 119/309 (38%), Gaps = 38/309 (12%)

Query: 567 IGIGGYGYVYKGIL-GTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
           +G G +G V K      +   VA+K ++ +     K+FI E   L  + H N+VK+  +C
Sbjct: 16  VGRGAFGVVCKAKWRAKD---VAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
                  N    LV E+   GSL N L+  E      P       +S  +  +  + YLH
Sbjct: 71  L------NPV-CLVMEYAEGGSLYNVLHGAE----PLPYYTAAHAMSWCLQCSQGVAYLH 119

Query: 686 HHCHTSIVHCDLKPSNVLLDNEM-VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
                +++H DLKP N+LL     V  + DFG +  +       T  +  KGS  ++APE
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ------THMTNNKGSAAWMAPE 173

Query: 745 YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAI 804
                  S   D +S+GI++ E+ T ++P D++      +      G    + + +   I
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233

Query: 805 LEEALEIQAGIVKE---LQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE 861
                     ++       P+ R    EI V I+    L       D          L  
Sbjct: 234 ES--------LMTRCWSKDPSQRPSMEEI-VKIMT--HLMRYFPGADEPLQYPCQHSLPP 282

Query: 862 AQKMRQAIK 870
            +  R    
Sbjct: 283 GEDGRVEPY 291

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  175 bits (445), Expect = 3e-49
 Identities = 76/298 (25%), Positives = 123/298 (41%), Gaps = 56/298 (18%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITS 624
           IG G +G VYKG    +   VAVK+L++        ++F  E   LR  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
            +          A+V ++    SL + L           K  + + + IA   A  ++YL
Sbjct: 89  ST------APQLAIVTQWCEGSSLYHHL------HASETKFEMKKLIDIARQTARGMDYL 136

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
           H     SI+H DLK +N+ L  +    +GDFGL+      S          GSI ++APE
Sbjct: 137 HAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL-SGSILWMAPE 192

Query: 745 ---YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIID 801
                     S   D Y+FGI++ E+ TG+ P             Y+ +   DQ+ E++ 
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-------------YSNINNRDQIIEMVG 239

Query: 802 PAIL-EEALEIQAGIVKEL----------QPNLRAKFHEIQVSILRVGILCSEELPRD 848
              L  +  ++++   K +          + + R  F  I   I        EEL R+
Sbjct: 240 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI--------EELARE 289

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  173 bits (442), Expect = 4e-49
 Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 32/223 (14%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVL----DLQQRGASKSFIAECEALRSIRHRNLVKII 622
           IGIGG+G VY+         VAVK      D       ++   E +    ++H N++ + 
Sbjct: 15  IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
             C     +      LV EF   G L   L           ++     ++ A+ +A  + 
Sbjct: 73  GVC----LKEPNL-CLVMEFARGGPLNRVL--------SGKRIPPDILVNWAVQIARGMN 119

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAH--------VGDFGLSRLLHDNSPDQTSTSRV 734
           YLH      I+H DLK SN+L+  ++           + DFGL+R  H     +T+    
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-----RTTKMSA 174

Query: 735 KGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
            G+  ++APE       S   D +S+G+L+ E+ TG+ P   +
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  173 bits (441), Expect = 9e-49
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 34/225 (15%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS-------KSFIAECEALRSIRHRNLV 619
           IG GG+G V+KG L  +++ VA+K L L             + F  E   + ++ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
           K+     +          +V EF+P G L + L       ++   +    +L + +D+A 
Sbjct: 87  KLYGLMHNP-------PRMVMEFVPCGDLYHRL------LDKAHPIKWSVKLRLMLDIAL 133

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDN-----EMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
            +EY+  + +  IVH DL+  N+ L +      + A V DFGLS+         + +  +
Sbjct: 134 GIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-----HSVSGLL 187

Query: 735 KGSIGYVAPE--YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
            G+  ++APE         +   D YSF +++  + TG+ P D+ 
Sbjct: 188 -GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  174 bits (443), Expect = 4e-47
 Identities = 100/444 (22%), Positives = 172/444 (38%), Gaps = 51/444 (11%)

Query: 9   NITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLS 68
             T  +E     L    +   +     +L ++  L              +  L+ L Q++
Sbjct: 19  TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG--IKSIDGVEYLNNLTQIN 74

Query: 69  LSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPH 128
            S N L+    + L  L +L    ++ N +    P+   N++++    +  N++    P 
Sbjct: 75  FSNNQLTD--ITPLKNLTKLVDILMNNNQIADITPLA--NLTNLTGLTLFNNQITDIDP- 129

Query: 129 YVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGND 188
                L N+  L L SN  +                L  L +L +L+F         GN 
Sbjct: 130 --LKNLTNLNRLELSSNTISD------------ISALSGLTSLQQLSF---------GNQ 166

Query: 189 LRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLK 248
           +  L  L N T LE + +SSN +S    + +A  ++ L  L  + N+IS   P  +G L 
Sbjct: 167 VTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTN-LESLIATNNQISDITP--LGILT 221

Query: 249 NLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSI 308
           NL  +++  N L      ++  L  L  L L  N+IS   P  L  L  LTE+ L  N I
Sbjct: 222 NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 277

Query: 309 RGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLK 368
               P  L     L  L+L++N L    P  +  L +   L L  N++S   P+    L 
Sbjct: 278 SNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPV--SSLT 331

Query: 369 GIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNF 428
            +Q+L    NK+S    +SLA+   + +L+   N       +  ++L  +  L L+   +
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDL--TPLANLTRITQLGLNDQAW 387

Query: 429 SGKIPMFLNTFRFLQKLNLSFNNL 452
           +     +         +      L
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGAL 411

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  173 bits (440), Expect = 8e-47
 Identities = 103/443 (23%), Positives = 173/443 (39%), Gaps = 53/443 (11%)

Query: 32  SELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMF 91
                L + +   L   N T ++    ++L  +  L      +       +  L  L   
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73

Query: 92  QVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEI 151
             S N LT   P++  N++ +    +  N++    P      L N+  L L +N  T   
Sbjct: 74  NFSNNQLTDITPLK--NLTKLVDILMNNNQIADITPL---ANLTNLTGLTLFNNQITDID 128

Query: 152 PPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSL 211
           P            L  L NL RL  + N +     +D+  L  L +   L       N +
Sbjct: 129 P------------LKNLTNLNRLELSSNTI-----SDISALSGLTSLQQLSF----GNQV 167

Query: 212 SGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYL 271
           + + P  +AN ++ L  L +S+N++S    + +  L NL  +    N ++   P  +G L
Sbjct: 168 TDLKP--LANLTT-LERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGIL 220

Query: 272 LKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNN 331
             L  LSL GN++      +L +L  LT++DL  N I    P  L    +L +L L  N 
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 276

Query: 332 LSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASC 391
           +S   P  + GL++   L+L+ N L    P+    LK +  L L  N +S   P  ++S 
Sbjct: 277 ISNISP--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP--VSSL 330

Query: 392 VGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNN 451
             L+ L F +N       S  ++L  +  L    N  S   P  L     + +L L+   
Sbjct: 331 TKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 386

Query: 452 LEGEVPSEGVFKNVRAVSIIGNN 474
                 +     NV   + + N 
Sbjct: 387 WTNAPVN--YKANVSIPNTVKNV 407

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  171 bits (436), Expect = 3e-46
 Identities = 96/456 (21%), Positives = 171/456 (37%), Gaps = 52/456 (11%)

Query: 3   QGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLS 62
             +    + + + L  ++   N+L     + L NL KLV + +  N      P  L+NL+
Sbjct: 57  GIKSIDGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLT 112

Query: 63  FLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPI-QLFNISSMDYFAVTQNK 121
            L  L+L  N ++      L  L  LN  ++S+N ++    +  L ++  + +     N+
Sbjct: 113 NLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSF----GNQ 166

Query: 122 LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNL 181
           +    P      L  +  L + SN  +                L KL NL  L    N +
Sbjct: 167 VTDLKP---LANLTTLERLDISSNKVSD------------ISVLAKLTNLESLIATNNQI 211

Query: 182 GTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIP 241
                     +  L   T L+ +SL+ N L  +   ++A+ ++ L  L ++ N+IS   P
Sbjct: 212 SD--------ITPLGILTNLDELSLNGNQLKDI--GTLASLTN-LTDLDLANNQISNLAP 260

Query: 242 TGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEV 301
             +  L  L  + +  N ++   P  +  L  L  L L  N++     S + NL  LT +
Sbjct: 261 --LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYL 314

Query: 302 DLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIP 361
            L  N+I    P  + +  +LQ+L   +N +S      +  L++   L    N +S   P
Sbjct: 315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP 370

Query: 362 LEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDL 421
           L    L  I QL L++   +       A+      +     +   P     S      + 
Sbjct: 371 L--ANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPAT--ISDGGSYTEP 426

Query: 422 DLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVP 457
           D++ N  S        TF     +        G V 
Sbjct: 427 DITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  134 bits (339), Expect = 2e-33
 Identities = 85/380 (22%), Positives = 140/380 (36%), Gaps = 44/380 (11%)

Query: 9   NITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLS 68
            + + + L  L+L  N +     S L  L  L  L   GN  T   P  L+NL+ L++L 
Sbjct: 129 PLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLD 183

Query: 69  LSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPH 128
           +S N +S    S L  L  L     + N ++   P+    ++++D  ++  N+L  +I  
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLK-DIGT 238

Query: 129 YVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGND 188
                L N+  L L +N  +   P            L  L  L  L    N +       
Sbjct: 239 LAS--LTNLTDLDLANNQISNLAP------------LSGLTKLTELKLGANQISN----- 279

Query: 189 LRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLK 248
              +  L   T L  + L+ N L  + P  I+N  + L YL +  N IS   P  V +L 
Sbjct: 280 ---ISPLAGLTALTNLELNENQLEDISP--ISNLKN-LTYLTLYFNNISDISP--VSSLT 331

Query: 249 NLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSI 308
            L  +    N ++    +S+  L  +  LS   N+IS   P  L NL  +T++ L   + 
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387

Query: 309 RGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLK 368
             +  +   N      +      L    P  +    S+   D++ N  S           
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPSY-TNEVSYTFS 444

Query: 369 GIQQLDLSENKLSGEIPTSL 388
               +       SG +   L
Sbjct: 445 QPVTIGKGTTTFSGTVTQPL 464

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 81.2 bits (201), Expect = 4e-16
 Identities = 31/156 (19%), Positives = 54/156 (34%), Gaps = 12/156 (7%)

Query: 299 TEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSG 358
           +    Q   I            +  K  L   N++ T+ +    L     L   R  +  
Sbjct: 5   SATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS 60

Query: 359 PIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGL 418
              +E   L  + Q++ S N+L+   P  L +   L  +  ++N       +  ++L  L
Sbjct: 61  IDGVE--YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI--TPLANLTNL 114

Query: 419 QDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEG 454
             L L  N  +   P  L     L +L LS N +  
Sbjct: 115 TGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD 148

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  168 bits (427), Expect = 5e-47
 Identities = 54/243 (22%), Positives = 99/243 (40%), Gaps = 39/243 (16%)

Query: 544 DKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGIL-GTEETNVAVKVLDLQQRGA--S 600
           +K+  I + +L   T+       +     G ++KG   G +   + VKVL ++      S
Sbjct: 2   NKHSGIDFKQLNFLTK-------LNENHSGELWKGRWQGND---IVVKVLKVRDWSTRKS 51

Query: 601 KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK-ALVYEFMPNGSLENWLNQKEDEQ 659
           + F  EC  LR   H N++ ++ +C             L+  +MP GSL N L++  +  
Sbjct: 52  RDFNEECPRLRIFSHPNVLPVLGAC----QSPPAPHPTLITHWMPYGSLYNVLHEGTN-- 105

Query: 660 NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR 719
                ++  Q +  A+D+A  + +LH      I    L   +V++D +M A +    +  
Sbjct: 106 ---FVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF 161

Query: 720 LLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDE----YSFGILMLEMFTGKRPT 774
                            +  +VAPE  AL  +           +SF +L+ E+ T + P 
Sbjct: 162 SFQSPG--------RMYAPAWVAPE--ALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211

Query: 775 DDM 777
            D+
Sbjct: 212 ADL 214

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  167 bits (424), Expect = 3e-46
 Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 31/226 (13%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKII 622
            LIG G +G VY G    E   VA++++D+++      K+F  E  A R  RH N+V  +
Sbjct: 39  ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
            +C           A++       +L + +      ++ +  L++ +   IA ++   + 
Sbjct: 96  GAC----MSPPHL-AIITSLCKGRTLYSVV------RDAKIVLDVNKTRQIAQEIVKGMG 144

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTST--SRVKGSIGY 740
           YLH      I+H DLK  NV  DN  V  + DFGL  +       +         G + +
Sbjct: 145 YLHAK---GILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200

Query: 741 VAPE---------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
           +APE                S H D ++ G +  E+   + P    
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  165 bits (421), Expect = 9e-46
 Identities = 61/284 (21%), Positives = 108/284 (38%), Gaps = 46/284 (16%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS 626
           +G G +G   K         + +K L        ++F+ E + +R + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL- 76

Query: 627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH 686
               +       + E++  G+L   +      ++   +    QR+S A D+A+ + YLH 
Sbjct: 77  ---YKDKRL-NFITEYIKGGTLRGII------KSMDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 687 HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK----------- 735
               +I+H DL   N L+       V DFGL+RL+ D          +K           
Sbjct: 127 M---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 736 GSIGYVAPEYGALGEVSTH-GDEYSFGILMLEMFTGKRPTDDMF----EEGLSLHKYAKM 790
           G+  ++APE    G       D +SFGI++ E+        D      + GL++  +   
Sbjct: 184 GNPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242

Query: 791 GLPDQVAEIIDPAILEEALEIQAGIVK---ELQPNLRAKFHEIQ 831
             P        P+           I     +L P  R  F +++
Sbjct: 243 YCPPNC----PPSFFP--------ITVRCCDLDPEKRPSFVKLE 274

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  164 bits (417), Expect = 2e-45
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 30/230 (13%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECE--ALRSIRHRNLVKII 622
             +G G YG V++G       NVAVK+   +     KS+  E E      +RH N++  I
Sbjct: 14  ECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFI 68

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
            S  +      +   L+  +   GSL ++L        Q   L+ +  L I + +A+ L 
Sbjct: 69  ASDMTSRHSSTQL-WLITHYHEMGSLYDYL--------QLTTLDTVSCLRIVLSIASGLA 119

Query: 683 YLH-----HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH--DNSPDQTSTSRVK 735
           +LH          +I H DLK  N+L+       + D GL+ +     N  D  +  RV 
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV- 178

Query: 736 GSIGYVAPE------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFE 779
           G+  Y+APE           +     D ++FG+++ E+         + +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  168 bits (427), Expect = 2e-44
 Identities = 97/498 (19%), Positives = 166/498 (33%), Gaps = 64/498 (12%)

Query: 7   PANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQ 66
             +     EL++LDL   +++        +L  L  L LTGN        + S LS LQ+
Sbjct: 45  SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQK 104

Query: 67  LSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPI------------------QLFN 108
           L   E +L+      +G LK L    V+ N +  S  +                  ++ +
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQS 163

Query: 109 ISSMDYFAVTQ------------NKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSI- 155
           I   D   + Q            N +   I     F    +  L L +N+ +  +  +  
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGA-FKEIRLHKLTLRNNFDSLNVMKTCI 221

Query: 156 -----------------SNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNC 198
                            +  +    D   L+ L  L      L          +D     
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281

Query: 199 TFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVN 258
           T +   SL S ++  V   S   ++    +L +   +        + +LK L       +
Sbjct: 282 TNVSSFSLVSVTIERVKDFS---YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFT----S 334

Query: 259 LLTGSIPTSVGYLLKLQVLSLFGNKIS--GEIPSSLGNLIFLTEVDLQGNSIRGSIPSAL 316
              G+  + V  L  L+ L L  N +S  G    S      L  +DL  N +  ++ S  
Sbjct: 335 NKGGNAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF 392

Query: 317 GNCLQLQKLDLSDNNLSGTIPREV-IGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDL 375
               QL+ LD   +NL       V + L + + LD+S  H           L  ++ L +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452

Query: 376 SENKLSGEIPT-SLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPM 434
           + N                L +L+ S    +    + F+SL  LQ L+++ N        
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDG 512

Query: 435 FLNTFRFLQKLNLSFNNL 452
             +    LQK+ L  N  
Sbjct: 513 IFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  165 bits (420), Expect = 2e-43
 Identities = 92/445 (20%), Positives = 156/445 (35%), Gaps = 38/445 (8%)

Query: 12  HCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYT-GSIPQSLSNLSFLQQLSLS 70
             S L+ L  V   L       +G+L  L  L +  N      +P+  SNL+ L+ L LS
Sbjct: 98  GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157

Query: 71  ENSLSGNIPSELGLLKQLNMFQV----SANYLTGSIPIQLFNISSMDYFAVTQNKLVGEI 126
            N +     ++L +L Q+ +  +    S N +   I    F    +    +  N     +
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNV 216

Query: 127 PHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKG 186
                  L  + V  L    F      +  N     +    L+ L  L      L     
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEF-----RNEGNLEKFDKSA--LEGLCNLTIEEFRLAYLDY 269

Query: 187 NDLRFLDSLVNCTFLEVVSLSSNSLSGVLP--------------NSIANFSS----HLIY 228
                +D     T +   SL S ++  V                     F +     L  
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR 329

Query: 229 LYMSANRISGTIPTGVGNLKNLILIAMEVNLLT--GSIPTSVGYLLKLQVLSLFGNKISG 286
           L  ++N+      + V +L +L  + +  N L+  G    S      L+ L L  N +  
Sbjct: 330 LTFTSNKGG-NAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 386

Query: 287 EIPSSLGNLIFLTEVDLQGNSIRGSIP-SALGNCLQLQKLDLSDNNLSGTIPREVIGLSS 345
            + S+   L  L  +D Q ++++     S   +   L  LD+S  +          GLSS
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446

Query: 346 FVLLDLSRNHLSGPIPLEV-GRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSF 404
             +L ++ N        ++   L+ +  LDLS+ +L    PT+  S   L+ LN + N  
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506

Query: 405 QGPIHSGFSSLKGLQDLDLSRNNFS 429
           +      F  L  LQ + L  N + 
Sbjct: 507 KSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  159 bits (404), Expect = 2e-41
 Identities = 86/486 (17%), Positives = 159/486 (32%), Gaps = 38/486 (7%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
           +IP N+      + LDL  N L         +  +L  L L+          +  +LS L
Sbjct: 21  KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 65  QQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVG 124
             L L+ N +          L  L         L       + ++ ++    V  N +  
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 125 EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTG 184
                    L N+  L L SN         +     +P         + L+ + N +   
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP------LLNLSLDLSLNPMNFI 192

Query: 185 KGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYL------YMSANRISG 238
           +    + +        L  ++L +N  S  +  +     + L         + +   +  
Sbjct: 193 QPGAFKEIR-------LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245

Query: 239 TIPTGVGNLKNLILIAMEVNLLTGS---IPTSVGYLLKLQVLSLFGNKISGEIPSSLGNL 295
              + +  L NL +    +  L      I      L  +   SL    I   +     N 
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF 304

Query: 296 IFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNH 355
                ++L            L +   L++L  + N          + L S   LDLSRN 
Sbjct: 305 -GWQHLELVNCKFGQFPTLKLKS---LKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNG 358

Query: 356 LS--GPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQG-PIHSGF 412
           LS  G           ++ LDLS N +   + ++      LE+L+F  ++ +     S F
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417

Query: 413 SSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSI-- 470
            SL+ L  LD+S  +         N    L+ L ++ N+ +       +F  +R ++   
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP-DIFTELRNLTFLD 476

Query: 471 IGNNKL 476
           +   +L
Sbjct: 477 LSQCQL 482

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  117 bits (295), Expect = 2e-27
 Identities = 46/259 (17%), Positives = 88/259 (33%), Gaps = 14/259 (5%)

Query: 203 VVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTG 262
                  +   + P+++         L +S N +         +   L ++ +    +  
Sbjct: 11  TYQCMELNFYKI-PDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66

Query: 263 SIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQL 322
               +   L  L  L L GN I      +   L  L ++     ++       +G+   L
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126

Query: 323 QKLDLSDNNL-SGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQ----QLDLSE 377
           ++L+++ N + S  +P     L++   LDLS N +      ++  L  +      LDLS 
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186

Query: 378 NKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSG-FSSLKGLQDLDLSRNNF--SGKIPM 434
           N ++  I       + L  L   +N     +       L GL+   L    F   G +  
Sbjct: 187 NPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245

Query: 435 F-LNTFRFLQKLNLSFNNL 452
           F  +    L  L +    L
Sbjct: 246 FDKSALEGLCNLTIEEFRL 264

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  109 bits (274), Expect = 5e-25
 Identities = 56/336 (16%), Positives = 108/336 (32%), Gaps = 35/336 (10%)

Query: 14  SELRILDLVV------NKLEGNIPSELGNLFKLVGLGLTGNNYTGS---IPQSLSNLSFL 64
           + L +  LV+        LE    S L  L  L                I    + L+ +
Sbjct: 225 AGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNV 284

Query: 65  QQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVG 124
              SL   ++   +             ++          ++L ++  +     T NK   
Sbjct: 285 SSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFPTLKLKSLKRLT---FTSNKGGN 339

Query: 125 EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTG 184
               +    LP++  L L  N         +S      +      +L  L+ + N + T 
Sbjct: 340 ---AFSEVDLPSLEFLDLSRN--------GLSFKGCCSQSDFGTTSLKYLDLSFNGVIT- 387

Query: 185 KGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV 244
                    + +    LE +    ++L  +   S+     +LIYL +S          G+
Sbjct: 388 ------MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI 440

Query: 245 -GNLKNLILIAMEVNLLTGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVD 302
              L +L ++ M  N    +    +   L  L  L L   ++    P++  +L  L  ++
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500

Query: 303 LQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPR 338
           +  N ++            LQK+ L  N    + PR
Sbjct: 501 MASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  161 bits (408), Expect = 7e-44
 Identities = 57/230 (24%), Positives = 90/230 (39%), Gaps = 30/230 (13%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECE--ALRSIRHRNLVKII 622
             IG G YG V+ G        VAVKV    +     S+  E E      +RH N++  I
Sbjct: 43  KQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFI 97

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
            +         +   L+ ++  NGSL ++L        +   L+    L +A    + L 
Sbjct: 98  AADIKGTGSWTQL-YLITDYHENGSLYDYL--------KSTTLDAKSMLKLAYSSVSGLC 148

Query: 683 YLH-----HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD--NSPDQTSTSRVK 735
           +LH          +I H DLK  N+L+       + D GL+       N  D    +RV 
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV- 207

Query: 736 GSIGYVAPE--YGAL----GEVSTHGDEYSFGILMLEMFTGKRPTDDMFE 779
           G+  Y+ PE    +L     +     D YSFG+++ E+         + E
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  160 bits (407), Expect = 1e-43
 Identities = 54/228 (23%), Positives = 94/228 (41%), Gaps = 30/228 (13%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECE--ALRSIRHRNLVKII 622
             IG G +G V++G    EE  VAVK+   ++    +S+  E E      +RH N++  I
Sbjct: 48  ESIGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
            + +  +    +   LV ++  +GSL ++L         R  + +   + +A+  A+ L 
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYL--------NRYTVTVEGMIKLALSTASGLA 153

Query: 683 YLH-----HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHD--NSPDQTSTSRVK 735
           +LH          +I H DLK  N+L+       + D GL+       ++ D     RV 
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV- 212

Query: 736 GSIGYVAPE------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
           G+  Y+APE           E     D Y+ G++  E+          
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  160 bits (407), Expect = 2e-43
 Identities = 73/390 (18%), Positives = 144/390 (36%), Gaps = 45/390 (11%)

Query: 40  LVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLT 99
              L           P   ++L+   +  L + S++         L+ +    V+   + 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57

Query: 100 GSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNAS 159
               I+   +++++Y  +  N++    P      L  +  L +G+N  T           
Sbjct: 58  SIQGIE--YLTNLEYLNLNGNQITDISP---LSNLVKLTNLYIGTNKIT----------- 101

Query: 160 SIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSI 219
                L  L NL  L    +N+     +D+  L +L     +  ++L +N       + +
Sbjct: 102 -DISALQNLTNLRELYLNEDNI-----SDISPLANLTK---MYSLNLGANHNLS-DLSPL 151

Query: 220 ANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSL 279
           +N +  L YL ++ +++    P  + NL +L  +++  N +    P  +  L  L   + 
Sbjct: 152 SNMTG-LNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTA 206

Query: 280 FGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPRE 339
           + N+I+   P  + N+  L  + +  N I    P  L N  QL  L++  N +S      
Sbjct: 207 YVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INA 260

Query: 340 VIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNF 399
           V  L+   +L++  N +S    L    L  +  L L+ N+L  E    +     L  L  
Sbjct: 261 VKDLTKLKMLNVGSNQISDISVL--NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318

Query: 400 SDNSFQGPIHSGFSSLKGLQDLDLSRNNFS 429
           S N          +SL  +   D +     
Sbjct: 319 SQNHITDI--RPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  156 bits (396), Expect = 5e-42
 Identities = 82/373 (21%), Positives = 137/373 (36%), Gaps = 65/373 (17%)

Query: 9   NITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLS 68
                  +  L +   K+       +  L  L  L L GN  T   P  LSNL  L  L 
Sbjct: 39  TQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLY 94

Query: 69  LSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPH 128
           +  N ++    S L  L  L    ++ + ++   P+                        
Sbjct: 95  IGTNKIT--DISALQNLTNLRELYLNEDNISDISPLA----------------------- 129

Query: 129 YVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGND 188
                L  +  L LG+N              S    L  +  L  L    + +       
Sbjct: 130 ----NLTKMYSLNLGANHNL-----------SDLSPLSNMTGLNYLTVTESKVKD----- 169

Query: 189 LRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLK 248
              +  + N T L  +SL+ N +  + P  +A+ +S L Y     N+I+   P  V N+ 
Sbjct: 170 ---VTPIANLTDLYSLSLNYNQIEDISP--LASLTS-LHYFTAYVNQITDITP--VANMT 221

Query: 249 NLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSI 308
            L  + +  N +T   P  +  L +L  L +  N+IS    +++ +L  L  +++  N I
Sbjct: 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI 277

Query: 309 RGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLK 368
             S  S L N  QL  L L++N L       + GL++   L LS+NH++   PL    L 
Sbjct: 278 --SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPL--ASLS 333

Query: 369 GIQQLDLSENKLS 381
            +   D +   + 
Sbjct: 334 KMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  151 bits (383), Expect = 3e-40
 Identities = 67/391 (17%), Positives = 131/391 (33%), Gaps = 67/391 (17%)

Query: 64  LQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLV 123
              L+     ++   P     L +     +    +T  +  +                  
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE------------------ 41

Query: 124 GEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGT 183
                     L +I  L++                    + +  L NL  LN   N +  
Sbjct: 42  ---------ELESITKLVVAGEKVAS------------IQGIEYLTNLEYLNLNGNQITD 80

Query: 184 GKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTG 243
                   +  L N   L  + + +N ++    +++ N ++ L  LY++ + IS   P  
Sbjct: 81  --------ISPLSNLVKLTNLYIGTNKITD--ISALQNLTN-LRELYLNEDNISDISP-- 127

Query: 244 VGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDL 303
           + NL  +  + +  N    S  + +  +  L  L++  +K+    P  + NL  L  + L
Sbjct: 128 LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL 184

Query: 304 QGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLE 363
             N I    P  L +   L       N ++   P  V  ++    L +  N ++   PL 
Sbjct: 185 NYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPL- 239

Query: 364 VGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDL 423
              L  +  L++  N++S     ++     L+ LN   N       S  ++L  L  L L
Sbjct: 240 -ANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFL 294

Query: 424 SRNNFSGKIPMFLNTFRFLQKLNLSFNNLEG 454
           + N    +    +     L  L LS N++  
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  118 bits (297), Expect = 6e-29
 Identities = 60/329 (18%), Positives = 111/329 (33%), Gaps = 83/329 (25%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
              + + + + LR L L  + +     S L NL K+  L L  N+   S    LSN++ L
Sbjct: 101 TDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGL 157

Query: 65  QQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVG 124
             L+++E+ +    P  +  L  L    ++ N +    P+                    
Sbjct: 158 NYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLA------------------- 196

Query: 125 EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTG 184
                   +L ++       N  T   P            +  +  L  L    N +   
Sbjct: 197 --------SLTSLHYFTAYVNQITDITP------------VANMTRLNSLKIGNNKITD- 235

Query: 185 KGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV 244
                  L  L N + L  + + +N +S +  N++ + +  L  L + +N+IS    + +
Sbjct: 236 -------LSPLANLSQLTWLEIGTNQISDI--NAVKDLTK-LKMLNVGSNQISD--ISVL 283

Query: 245 GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQ 304
            NL                          L  L L  N++  E    +G L  LT + L 
Sbjct: 284 NNLSQ------------------------LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS 319

Query: 305 GNSIRGSIPSALGNCLQLQKLDLSDNNLS 333
            N I    P  L +  ++   D ++  + 
Sbjct: 320 QNHITDIRP--LASLSKMDSADFANQVIK 346

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  167 bits (425), Expect = 5e-43
 Identities = 101/485 (20%), Positives = 183/485 (37%), Gaps = 40/485 (8%)

Query: 12  HCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSI--PQSLSNLSFLQQLSL 69
           +   LRILDL  +K+    P     LF L  L L     + ++       NL  L +L L
Sbjct: 71  NLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDL 130

Query: 70  SENSLSG-NIPSELGLLKQLNMFQVSANYLT----------GSIPIQLFNISSMDYFAVT 118
           S+N +    +    G L  L     S+N +               +  F++++   ++  
Sbjct: 131 SKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRV 190

Query: 119 QNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNA--SSIPEDLGKLKNLIRLNF 176
                  +     F    + +L +  N +T +I  + SNA   S    L    +++   F
Sbjct: 191 SVDWGKCMNP---FRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGF 247

Query: 177 ARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRI 236
             +N+   K  D      L   + +  + LS   +  +           L  L ++ N+I
Sbjct: 248 GFHNI---KDPDQNTFAGLAR-SSVRHLDLSHGFVFSLNSRVFETLKD-LKVLNLAYNKI 302

Query: 237 SGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLI 296
           +         L NL ++ +  NLL     ++   L K+  + L  N I+     +   L 
Sbjct: 303 NKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLE 362

Query: 297 FLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHL 356
            L  +DL+ N++     + +     +  + LS N L  T+P+  +  +    + LS N L
Sbjct: 363 KLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-TLPKINLTANL---IHLSENRL 413

Query: 357 SG-PIPLEVGRLKGIQQLDLSENKLSG-EIPTSLASCVGLEYLNFSDNSFQGPIHSG--- 411
               I   + R+  +Q L L++N+ S      + +    LE L   +N  Q    +    
Sbjct: 414 ENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCW 473

Query: 412 --FSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVS 469
             F  L  LQ L L+ N  +   P   +    L+ L+L+ N L   +    +  N+  + 
Sbjct: 474 DVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILD 532

Query: 470 IIGNN 474
           I  N 
Sbjct: 533 ISRNQ 537

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  142 bits (359), Expect = 6e-35
 Identities = 79/489 (16%), Positives = 146/489 (29%), Gaps = 82/489 (16%)

Query: 7   PANITHCSELRILDLVVNKLEGNIPSE-LGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQ 65
            ++     +L++L+L        I  E   NL  L  L L  +      P +   L  L 
Sbjct: 41  ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLF 100

Query: 66  QLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGE 125
           +L L    LS  +              +   Y                            
Sbjct: 101 ELRLYFCGLSDAV--------------LKDGYFRN------------------------- 121

Query: 126 IPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGK 185
                   L  +  L L  N     +              GKL +L  ++F+ N +    
Sbjct: 122 --------LKALTRLDLSKNQIR-SLYL--------HPSFGKLNSLKSIDFSSNQIFLVC 164

Query: 186 GNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVG 245
            ++L  L        L   SL++NSL   +        +    + +    +S       G
Sbjct: 165 EHELEPLQGKT----LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS-------G 213

Query: 246 NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNL--IFLTEVDL 303
           N   + +     N ++ S   S+     +       + I     ++   L    +  +DL
Sbjct: 214 NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDL 273

Query: 304 QGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLE 363
               +             L+ L+L+ N ++        GL +  +L+LS N L       
Sbjct: 274 SHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN 333

Query: 364 VGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDL 423
              L  +  +DL +N ++     +      L+ L+  DN+      +    +  + D+ L
Sbjct: 334 FYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFL 388

Query: 424 SRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSI--IGNNKLCGGSP 481
           S N                  ++LS N LE  +        V  + I  +  N+    S 
Sbjct: 389 SGNKLVT----LPKINLTANLIHLSENRLEN-LDILYFLLRVPHLQILILNQNRFSSCSG 443

Query: 482 ELHLHSCRS 490
           +       S
Sbjct: 444 DQTPSENPS 452

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  141 bits (356), Expect = 2e-34
 Identities = 80/412 (19%), Positives = 145/412 (35%), Gaps = 54/412 (13%)

Query: 47  GNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQL 106
             N T  +PQ L+     ++L LS N +     S    L+QL + ++ + Y   +I  + 
Sbjct: 13  FCNLT-QVPQVLNTT---ERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEA 68

Query: 107 F-NISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDL 165
           F N+ ++    +  +K+   +       L ++  L L            +S+A       
Sbjct: 69  FRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFC--------GLSDAVLKDGYF 119

Query: 166 GKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSS- 224
             LK L RL+ ++N + +     L    S      L+ +  SSN +  V  + +      
Sbjct: 120 RNLKALTRLDLSKNQIRS-----LYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGK 174

Query: 225 HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKI 284
            L +  ++AN +   +    G   N                      + L++L + GN  
Sbjct: 175 TLSFFSLAANSLYSRVSVDWGKCMNPF------------------RNMVLEILDVSGNGW 216

Query: 285 SGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIG-- 342
           + +I                 N+I  S   +L     +       +N+     +      
Sbjct: 217 TVDIT------------GNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGL 263

Query: 343 -LSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSD 401
             SS   LDLS   +          LK ++ L+L+ NK++     +      L+ LN S 
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323

Query: 402 NSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLE 453
           N       S F  L  +  +DL +N+ +            LQ L+L  N L 
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 85.6 bits (212), Expect = 3e-17
 Identities = 61/352 (17%), Positives = 109/352 (30%), Gaps = 73/352 (20%)

Query: 12  HCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSE 71
              +L++L+L  NK+          L  L  L L+ N        +   L  +  + L +
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347

Query: 72  NSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVG 131
           N ++         L++L    +  N LT                          I     
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALT-------------------------TIHF--- 379

Query: 132 FTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRF 191
             +P+I  + L  N        ++   +              ++ + N L      +L  
Sbjct: 380 --IPSIPDIFLSGNKLV-----TLPKINL---------TANLIHLSENRL-----ENLDI 418

Query: 192 LDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLI 251
           L  L+    L+++ L+ N  S    +   + +  L  L++  N +     T +       
Sbjct: 419 LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELC------ 472

Query: 252 LIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGS 311
                              L  LQVL L  N ++   P    +L  L  + L  N +   
Sbjct: 473 -------------WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVL 519

Query: 312 IPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLE 363
             + L     L+ LD+S N L    P   + LS     D++ N       L 
Sbjct: 520 SHNDLPA--NLEILDISRNQLLAPNPDVFVSLSVL---DITHNKFICECELS 566

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  160 bits (406), Expect = 1e-41
 Identities = 77/429 (17%), Positives = 151/429 (35%), Gaps = 23/429 (5%)

Query: 10  ITHCSELRILDLVVNKL-EGNIPSELGNLFKLVGLGLTGNNYTGSIP-QSLSNLSFLQQL 67
               S L+ L+L+ N      + S   NL  L  L +        I     + L+ L +L
Sbjct: 94  FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNEL 153

Query: 68  SLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIP 127
            +   SL       L  ++ ++   +  +     + I    +SS+ Y  +    L     
Sbjct: 154 EIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL-ARFQ 212

Query: 128 HYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGN 187
                       +   +   +     S +    +   + +L  +   +   N LG    +
Sbjct: 213 FSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPS 272

Query: 188 DLRFLDSL--VNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVG 245
           +   +  L  V    +  + +    L   L    +     +  + +  +++   +P    
Sbjct: 273 ESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK-VKRITVENSKVF-LVPCSFS 330

Query: 246 -NLKNLILIAMEVNLLTGSI---PTSVGYLLKLQVLSLFGNKIS--GEIPSSLGNLIFLT 299
            +LK+L  + +  NL+           G    LQ L L  N +    +    L  L  LT
Sbjct: 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLT 390

Query: 300 EVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGP 359
            +D+  N+    +P +     +++ L+LS   +   +   +    +  +LD+S N+L   
Sbjct: 391 SLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDS- 445

Query: 360 IPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQ 419
             L + RL   Q+L +S NKL   +P   +    L  +  S N  +      F  L  LQ
Sbjct: 446 FSLFLPRL---QELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQ 500

Query: 420 DLDLSRNNF 428
            + L  N +
Sbjct: 501 KIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  146 bits (371), Expect = 3e-37
 Identities = 82/457 (17%), Positives = 163/457 (35%), Gaps = 39/457 (8%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
            IP+ +T  + ++ LDL  NK+      +L     L  L L  +        +  +L  L
Sbjct: 19  SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76

Query: 65  QQLSLSENSLSGNIPSE-LGLLKQLNMFQVSANYLTGSIPIQLF-NISSMDYFAVTQNKL 122
           + L LS+N LS ++ S   G L  L    +  N         LF N++++    +   + 
Sbjct: 77  EHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135

Query: 123 VGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLG 182
             EI       L ++  L + +                  + L  ++++  L    +   
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLR-NYQ---------SQSLKSIRDIHHLTLHLSESA 185

Query: 183 TGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPT 242
                   F D L +  +LE+   +        P  +   SS +  L    + ++     
Sbjct: 186 F---LLEIFADILSSVRYLELRDTNLARFQ-FSPLPVDEVSSPMKKLAFRGSVLTDESFN 241

Query: 243 GVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVD 302
            +  L   IL   EV     +       L  L   +   + +  E+       + +  + 
Sbjct: 242 ELLKLLRYILELSEVEFDDCT-------LNGLGDFNPSESDVVSELGKV--ETVTIRRLH 292

Query: 303 LQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLS---G 358
           +    +   + +      +++++ + ++ +   +P      L S   LDLS N +     
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYL 351

Query: 359 PIPLEVGRLKGIQQLDLSENKLS--GEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLK 416
                 G    +Q L LS+N L    +    L +   L  L+ S N+F  P+       +
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPE 410

Query: 417 GLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLE 453
            ++ L+LS         +     + L+ L++S NNL+
Sbjct: 411 KMRFLNLSSTGIRV---VKTCIPQTLEVLDVSNNNLD 444

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  126 bits (318), Expect = 2e-30
 Identities = 62/423 (14%), Positives = 134/423 (31%), Gaps = 52/423 (12%)

Query: 45  LTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPI 104
               ++T SIP  L+  + ++ L LS N ++     +L     L +  + ++ +  +I  
Sbjct: 12  GRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEG 67

Query: 105 QLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPED 164
             F                         +L ++  L L  N  +  +  S          
Sbjct: 68  DAFY------------------------SLGSLEHLDLSDNHLS-SLSSSW--------- 93

Query: 165 LGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSS 224
            G L +L  LN   N         L       N T L+ + + +      +        +
Sbjct: 94  FGPLSSLKYLNLMGNPY-----QTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT 148

Query: 225 HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKI 284
            L  L + A  +       + +++++  + + ++     +      L  ++ L L    +
Sbjct: 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208

Query: 285 SGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLS 344
           +    S L      + +             +    L+L +  L  + +           +
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE------FDDCT 262

Query: 345 SFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSF 404
              L D + +       L       I++L + +  L  ++ T  +    ++ +   ++  
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322

Query: 405 QGPIHSGFSSLKGLQDLDLSRNNFSGKI---PMFLNTFRFLQKLNLSFNNLEGEVPSEGV 461
                S    LK L+ LDLS N    +          +  LQ L LS N+L     +  +
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382

Query: 462 FKN 464
              
Sbjct: 383 LLT 385

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  112 bits (283), Expect = 3e-26
 Identities = 48/260 (18%), Positives = 92/260 (35%), Gaps = 6/260 (2%)

Query: 196 VNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAM 255
           ++C    V    S S + + P   +  ++ +  L +S N+I+      +    NL ++ +
Sbjct: 2   LSCDASGVCDGRSRSFTSI-P---SGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57

Query: 256 EVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRG-SIPS 314
           + + +      +   L  L+ L L  N +S    S  G L  L  ++L GN  +   + S
Sbjct: 58  KSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117

Query: 315 ALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQL 373
              N   LQ L + +      I R    GL+S   L++    L       +  ++ I  L
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177

Query: 374 DLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP 433
            L  ++ +  +         + YL   D +      S     +    +       S    
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237

Query: 434 MFLNTFRFLQKLNLSFNNLE 453
              N    L +  L  + +E
Sbjct: 238 ESFNELLKLLRYILELSEVE 257

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  110 bits (277), Expect = 2e-25
 Identities = 53/341 (15%), Positives = 124/341 (36%), Gaps = 35/341 (10%)

Query: 159 SSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNS 218
           +SIP  L     +  L+ + N +      DLR       C  L+V+ L S+ ++ +  ++
Sbjct: 18  TSIPSGL--TAAMKSLDLSFNKITYIGHGDLR------ACANLQVLILKSSRINTIEGDA 69

Query: 219 IANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEVNLLTG-SIPTSVGYLLKLQV 276
             +    L +L +S N +S ++ +   G L +L  + +  N      + +    L  LQ 
Sbjct: 70  FYSLG-SLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127

Query: 277 LSLFGNKISGEIP-SSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGT 335
           L +   +   EI       L  L E++++  S+R     +L +   +  L L  +  +  
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187

Query: 336 IPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLS-------GEIPTSL 388
           +      LSS   L+L   +L+      +   +    +     + S        E+   L
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247

Query: 389 ASCVGLEYLNFSDNSFQG-----------PIHSGFSSLKGLQDLDLSRNNFSGKIPMFLN 437
              + L  + F D +  G               G      ++ L + +      +    +
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307

Query: 438 TFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSII--GNNKL 476
               ++++ +  + +   +      ++++++  +    N +
Sbjct: 308 LLEKVKRITVENSKV--FLVPCSFSQHLKSLEFLDLSENLM 346

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 98.3 bits (245), Expect = 2e-21
 Identities = 46/366 (12%), Positives = 100/366 (27%), Gaps = 61/366 (16%)

Query: 7   PANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQ 66
             ++    ++  L L +++    +      L  +  L L   N        L        
Sbjct: 165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSP 224

Query: 67  LSLSENSLS-------GNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFA--- 116
           +       S         +   L  + +L+  +     L G           +       
Sbjct: 225 MKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVE 284

Query: 117 --------VTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGK- 167
                   + Q  L       V   L  ++ + + ++               +P    + 
Sbjct: 285 TVTIRRLHIPQFYL-FYDLSTVYSLLEKVKRITVENS-----------KVFLVPCSFSQH 332

Query: 168 LKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSS--H 225
           LK+L  L+ + N +      +     +  +   L+ + LS N L   +  +     +  +
Sbjct: 333 LKSLEFLDLSENLMVEEYLKNSACKGAWPS---LQTLVLSQNHLR-SMQKTGEILLTLKN 388

Query: 226 LIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKIS 285
           L  L +S N     +P      + +  + +    +   + T       L+VL +  N + 
Sbjct: 389 LTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD 444

Query: 286 GEIPSSLGNLIF-------------------LTEVDLQGNSIRGSIPSALGNCLQLQKLD 326
                 L  L                     L  + +  N ++            LQK+ 
Sbjct: 445 -SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW 503

Query: 327 LSDNNL 332
           L  N  
Sbjct: 504 LHTNPW 509

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  156 bits (396), Expect = 4e-41
 Identities = 91/469 (19%), Positives = 169/469 (36%), Gaps = 93/469 (19%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTG------------ 52
           E+P    +           ++ E N P   G   ++    L                   
Sbjct: 25  EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84

Query: 53  SIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSM 112
           S+P+   +   L+ L  S NSL+  +P     LK L +   +   L+   P     +  +
Sbjct: 85  SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP----LLEYL 136

Query: 113 DYFAVTQNKL--VGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKN 170
               V+ N+L  + E+ +        ++++ + +N               +P+    L+ 
Sbjct: 137 G---VSNNQLEKLPELQN-----SSFLKIIDVDNNSLK-----------KLPDLPPSLEF 177

Query: 171 LIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLY 230
           +          G    N L  L  L N  FL  +   +NSL   LP+   +    L  + 
Sbjct: 178 I--------AAG---NNQLEELPELQNLPFLTAIYADNNSLK-KLPDLPLS----LESIV 221

Query: 231 MSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPS 290
              N +       + NL  L  I  + NLL  ++P        L+ L++  N ++ ++P 
Sbjct: 222 AGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLPE 274

Query: 291 SLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLD 350
              +L FL   +   + +    P+       L  L+ S N +  ++      L     L+
Sbjct: 275 LPQSLTFLDVSENIFSGLSELPPN-------LYYLNASSNEIR-SLCDLPPSLEE---LN 323

Query: 351 LSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHS 410
           +S N L   +P    RL   ++L  S N L+ E+P    +   L+ L+   N  +     
Sbjct: 324 VSNNKLIE-LPALPPRL---ERLIASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPD 374

Query: 411 GFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE 459
              S++     DL  N+   ++P        L++L++  N L  E P  
Sbjct: 375 IPESVE-----DLRMNSHLAEVPELPQN---LKQLHVETNPLR-EFPDI 414

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  150 bits (382), Expect = 3e-39
 Identities = 89/438 (20%), Positives = 163/438 (37%), Gaps = 76/438 (17%)

Query: 31  PSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNM 90
           P  + N F    L    +N T  +P    N+    +   + +    N P   G  +++ +
Sbjct: 5   PRNVSNTFLQEPL-RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 91  FQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGE 150
            ++       +  ++L N             L   +P       P++  L+   N  T  
Sbjct: 63  SRLRDCLDRQAHELELNN-----------LGLS-SLPE----LPPHLESLVASCNSLT-- 104

Query: 151 IPPSISNASSIPEDLGKLKNLIRLNFARNNLGTG---------KGNDLRFLDSLVNCTFL 201
                     +PE    LK+L+  N     L              N L  L  L N +FL
Sbjct: 105 ---------ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFL 155

Query: 202 EVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLT 261
           +++ + +NSL   LP+   +    L ++    N++   +P  + NL  L  I  + N L 
Sbjct: 156 KIIDVDNNSLK-KLPDLPPS----LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK 208

Query: 262 GSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQ 321
             +P      L L+ +    N +       L NL FLT +    N ++ ++P    +   
Sbjct: 209 -KLPDL---PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPS--- 258

Query: 322 LQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLS 381
           L+ L++ DN L+  +P     L+   + +   + LS            +  L+ S N++ 
Sbjct: 259 LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-------ELPPNLYYLNASSNEIR 310

Query: 382 GEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRF 441
             +     S   LE LN S+N          +    L+ L  S N+ + ++P        
Sbjct: 311 -SLCDLPPS---LEELNVSNNKLI----ELPALPPRLERLIASFNHLA-EVPELPQN--- 358

Query: 442 LQKLNLSFNNLEGEVPSE 459
           L++L++ +N L  E P  
Sbjct: 359 LKQLHVEYNPLR-EFPDI 375

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  126 bits (319), Expect = 4e-31
 Identities = 60/329 (18%), Positives = 116/329 (35%), Gaps = 54/329 (16%)

Query: 151 IPPSIS-------------NASSIPEDLGKLKNLIRLNFARNNL--------GTGKGNDL 189
           I P                N + +P +   +K+      A +          G  +   +
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 190 RFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKN 249
             L   ++      + L++  LS  LP        HL  L  S N ++  +P    +LK+
Sbjct: 63  SRLRDCLD-RQAHELELNNLGLS-SLPELP----PHLESLVASCNSLT-ELPELPQSLKS 115

Query: 250 LILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIR 309
           L++    +  L+   P        L+ L +  N++  ++P  L N  FL  +D+  NS++
Sbjct: 116 LLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK 166

Query: 310 GSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKG 369
             +P    +   L+ +   +N L   +P E+  L     +    N L   +P     L  
Sbjct: 167 -KLPDLPPS---LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKK-LPDLPLSL-- 217

Query: 370 IQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFS 429
            + +    N L       L +   L  +   +N     + +       L+ L++  N  +
Sbjct: 218 -ESIVAGNNILE--ELPELQNLPFLTTIYADNNL----LKTLPDLPPSLEALNVRDNYLT 270

Query: 430 GKIPMFLNTFRFLQKLNLSFNNLEGEVPS 458
             +P    +  FL      F+ L    P+
Sbjct: 271 -DLPELPQSLTFLDVSENIFSGLSELPPN 298

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 91.2 bits (227), Expect = 2e-19
 Identities = 46/217 (21%), Positives = 79/217 (36%), Gaps = 33/217 (15%)

Query: 271 LLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGN------------ 318
              LQ      + ++ E+P    N+   TE     +    + P   G             
Sbjct: 10  NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68

Query: 319 -CLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSE 377
              Q  +L+L++  LS ++P     L S   L  S N L+  +P     LK +   + + 
Sbjct: 69  LDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNL 123

Query: 378 NKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLN 437
             LS   P        LEYL  S+N  +        +   L+ +D+  N+   K+P    
Sbjct: 124 KALSDLPP-------LLEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK-KLPDLPP 173

Query: 438 TFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNN 474
           +   L+ +    N LE E+P       + A+    N+
Sbjct: 174 S---LEFIAAGNNQLE-ELPELQNLPFLTAIYADNNS 206

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  151 bits (384), Expect = 1e-40
 Identities = 47/321 (14%), Positives = 108/321 (33%), Gaps = 33/321 (10%)

Query: 156 SNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVL 215
           +      + L + +     +  R +                N    ++ + +  +L    
Sbjct: 23  TALRPYHDVLSQWQRHYNADRNRWHS----------AWRQANSNNPQIETRTGRALK-AT 71

Query: 216 PNSIANFSS-HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKL 274
            + + + +    + L + +  +    P     L +L  + ++   L   +P ++     L
Sbjct: 72  ADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGL 129

Query: 275 QVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCL---------QLQKL 325
           + L+L  N +   +P+S+ +L  L E+ ++       +P  L +            LQ L
Sbjct: 130 ETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188

Query: 326 DLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIP 385
            L    +  ++P  +  L +   L +  + LS  +   +  L  +++LDL         P
Sbjct: 189 RLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYP 246

Query: 386 TSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKL 445
                   L+ L   D S    +      L  L+ LDL       ++P  +        +
Sbjct: 247 PIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCII 306

Query: 446 NLSFN-------NLEGEVPSE 459
            +  +       +     P+E
Sbjct: 307 LVPPHLQAQLDQHRPVARPAE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  146 bits (371), Expect = 6e-39
 Identities = 65/351 (18%), Positives = 123/351 (35%), Gaps = 38/351 (10%)

Query: 52  GSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISS 111
           GS      + S  + L    ++        L   ++      +  +          N ++
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57

Query: 112 MDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNL 171
                 T   L          T P    L L S                 P+   +L +L
Sbjct: 58  PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-----------QFPDQAFRLSHL 106

Query: 172 IRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYM 231
             +      L           D++     LE ++L+ N L   LP SIA+ +  L  L +
Sbjct: 107 QHMTIDAAGLME-------LPDTMQQFAGLETLTLARNPLR-ALPASIASLNR-LRELSI 157

Query: 232 SANRISGTIPTGVGN---------LKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGN 282
            A      +P  + +         L NL  + +E   +  S+P S+  L  L+ L +  +
Sbjct: 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216

Query: 283 KISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIG 342
            +S  +  ++ +L  L E+DL+G +   + P   G    L++L L D +   T+P ++  
Sbjct: 217 PLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHR 275

Query: 343 LSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSEN---KLSGEIPTSLAS 390
           L+    LDL        +P  + +L     + +  +   +L    P +  +
Sbjct: 276 LTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPA 326

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  106 bits (267), Expect = 4e-25
 Identities = 42/293 (14%), Positives = 87/293 (29%), Gaps = 66/293 (22%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
           + P      S L+ + +    L   +P  +     L  L L  N    ++P S+++L+ L
Sbjct: 95  QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRL 152

Query: 65  QQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVG 124
           ++LS+        +P  L         Q                                
Sbjct: 153 RELSIRACPELTELPEPLASTDASGEHQ-------------------------------- 180

Query: 125 EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTG 184
                    L N++ L L                 S+P  +  L+NL  L    + L   
Sbjct: 181 --------GLVNLQSLRLEWTGIR-----------SLPASIANLQNLKSLKIRNSPLSA- 220

Query: 185 KGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMS-ANRISGTIPTG 243
                    ++ +   LE + L   +     P      +  L  L +   + +  T+P  
Sbjct: 221 ------LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAP-LKRLILKDCSNLL-TLPLD 272

Query: 244 VGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISG---EIPSSLG 293
           +  L  L  + +   +    +P+ +  L    ++ +  +  +      P +  
Sbjct: 273 IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 70.7 bits (174), Expect = 3e-13
 Identities = 22/144 (15%), Positives = 58/144 (40%), Gaps = 5/144 (3%)

Query: 3   QGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLS 62
             +          L+ L L    +  ++P+ + NL  L  L +  +  + ++  ++ +L 
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLP 229

Query: 63  FLQQLSLSENSLSGNIPSELGLLKQLNMFQVS-ANYLTGSIPIQLFNISSMDYFAVTQNK 121
            L++L L   +   N P   G    L    +   + L  ++P+ +  ++ ++   +    
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCV 288

Query: 122 LVGEIPHYVGFTLPNIRVLLLGSN 145
            +  +P  +   LP   ++L+  +
Sbjct: 289 NLSRLPSLIA-QLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 21/109 (19%), Positives = 36/109 (33%), Gaps = 2/109 (1%)

Query: 5   EIPANITHCSELRILDLV-VNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSF 63
            +   I H  +L  LDL     L    P   G    L  L L   +   ++P  +  L+ 
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRN-YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ 278

Query: 64  LQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSM 112
           L++L L        +PS +  L    +  V  +        +     + 
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  143 bits (363), Expect = 1e-36
 Identities = 59/429 (13%), Positives = 134/429 (31%), Gaps = 62/429 (14%)

Query: 30  IPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLN 89
           I     N  +     +T ++   ++     +   +++L LS N LS    ++L    +L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 90  MFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTG 149
           +  +S+N L  ++ ++                           +L  +R L L +N+   
Sbjct: 62  LLNLSSNVLYETLDLE---------------------------SLSTLRTLDLNNNYVQ- 93

Query: 150 EIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSN 209
                         +L    ++  L+ A NN+     +  +   ++          L++N
Sbjct: 94  --------------ELLVGPSIETLHAANNNISRVSCSRGQGKKNI---------YLANN 130

Query: 210 SLSGVLPNSIANFSSHLIYLYMSANRISG-TIPTGVGNLKNLILIAMEVNLLTGSIPTSV 268
            ++ +        S  + YL +  N I          +   L  + ++ N +   +   V
Sbjct: 131 KITMLRDLDEGCRSR-VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV 188

Query: 269 GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLS 328
               KL+ L L  NK++  +     +   +T + L+ N +   I  AL     L+  DL 
Sbjct: 189 -VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLR 245

Query: 329 DNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSL 388
            N       R+    +   +  +++  +                                
Sbjct: 246 GNGFHCGTLRDFFSKNQR-VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304

Query: 389 ASCVGLEYLNFSDNSFQG----PIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQK 444
              + L+    +  S QG     +     +    +++D  +  +   I       +    
Sbjct: 305 DRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKIT 364

Query: 445 LNLSFNNLE 453
           L      L+
Sbjct: 365 LEQKKKALD 373

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  125 bits (316), Expect = 1e-30
 Identities = 60/456 (13%), Positives = 134/456 (29%), Gaps = 41/456 (8%)

Query: 5   EIPANI-THCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSF 63
           +  A++      ++ LDL  N L     ++L    KL  L L+ N         L +LS 
Sbjct: 24  QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLST 81

Query: 64  LQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLV 123
           L+ L L+ N +      EL +   +     + N ++  +              +  NK+ 
Sbjct: 82  LRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKIT 133

Query: 124 GEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGT 183
             +          ++ L L  N     +           E       L  LN   N    
Sbjct: 134 -MLRDLDEGCRSRVQYLDLKLNEID-TVNF--------AELAASSDTLEHLNLQYNF--- 180

Query: 184 GKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTG 243
                +  +   V    L+ + LSSN L+  +     + +  + ++ +  N++   I   
Sbjct: 181 -----IYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAG-VTWISLRNNKLV-LIEKA 232

Query: 244 VGNLKNLILIAMEVN-LLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVD 302
           +   +NL    +  N    G++        ++Q ++     +      +       T   
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVPTLGH 290

Query: 303 LQGNSIRGSIPSALGNCLQLQKLDLSDNNLSG----TIPREVIGLSSFVLLDLSRNHLSG 358
                            + L++ + +  +  G     +  E    +    +D  +     
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT 350

Query: 359 PIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGL 418
            I     R +    L+  +  L  ++     +   L+         Q  +         L
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPL 409

Query: 419 QDLDLSRNNFSGK-IPMFLNTFRFLQKLNLSFNNLE 453
           Q L      +    +         ++  ++  +   
Sbjct: 410 QLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  111 bits (278), Expect = 8e-26
 Identities = 42/213 (19%), Positives = 84/213 (39%), Gaps = 12/213 (5%)

Query: 263 SIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQL 322
           +I        + ++  +  + +   + S   +   + E+DL GN +     + L    +L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 323 QKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSG 382
           + L+LS N L      ++  LS+   LDL+ N++      E+     I+ L  + N +S 
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 383 EIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSG-KIPMFLNTFRF 441
            +  S     G + +  ++N               +Q LDL  N            +   
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 442 LQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNN 474
           L+ LNL +N +  +V  + VF  ++ + +  N 
Sbjct: 171 LEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNK 202

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  139 bits (353), Expect = 1e-36
 Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 24/218 (11%)

Query: 567 IGIGGYGYVYKGIL----GTEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKI 621
           +G G +G VYKG+        +  VA+K L +     A+K  + E   + S+ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
           +  C +          L+ + MP G L +++      +  +  +     L+  + +A  +
Sbjct: 83  LGICLT------STVQLITQLMPFGCLLDYV------REHKDNIGSQYLLNWCVQIAKGM 130

Query: 682 EYL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
            YL         VH DL   NVL+       + DFGL++LL      +      K  I +
Sbjct: 131 NYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 185

Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           +A E       +   D +S+G+ + E+ T G +P D +
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  136 bits (346), Expect = 5e-36
 Identities = 63/218 (28%), Positives = 90/218 (41%), Gaps = 22/218 (10%)

Query: 567 IGIGGYGYVYKGIL---GTEETNVAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVK 620
           +G G +G V +G       +  +VAVK L    L Q  A   FI E  A+ S+ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
           +     +          +V E  P GSL + L      +  +    L      A+ VA  
Sbjct: 86  LYGVVLT------PPMKMVTELAPLGSLLDRL------RKHQGHFLLGTLSRYAVQVAEG 133

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           + YL        +H DL   N+LL    +  +GDFGL R L  N          K    +
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190

Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
            APE       S   D + FG+ + EMFT G+ P   +
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  141 bits (356), Expect = 1e-35
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 21/216 (9%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKII 622
           + +G G YG VY+G+       VAVK L   +      + F+ E   ++ I+H NLV+++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
             C    TR   F  ++ EFM  G+L ++L +       R +++ +  L +A  +++ +E
Sbjct: 283 GVC----TREPPFY-IITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAME 332

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           YL      + +H +L   N L+    +  V DFGLSRL+  ++   T+ +  K  I + A
Sbjct: 333 YLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA 387

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           PE  A  + S   D ++FG+L+ E+ T G  P   +
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  138 bits (349), Expect = 2e-35
 Identities = 77/425 (18%), Positives = 153/425 (36%), Gaps = 66/425 (15%)

Query: 30  IPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSE-LGLLKQL 88
           I S L        + +               L+  + ++   +++   +P+  L   +Q+
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 89  NMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFT 148
            +  ++   +   I    F                             I+ L +G N   
Sbjct: 72  ELLNLNDLQIE-EIDTYAFA------------------------YAHTIQKLYMGFNAIR 106

Query: 149 GEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSS 208
             +PP +            +  L  L   RN+L +                 L  +S+S+
Sbjct: 107 -YLPPHV---------FQNVPLLTVLVLERNDLSSLPRGIFHNTPK------LTTLSMSN 150

Query: 209 NSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSV 268
           N+L  +  ++    +S L  L +S+NR++  +   +  + +L    +  NLL     +++
Sbjct: 151 NNLERIEDDTFQATTS-LQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STL 201

Query: 269 GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLS 328
              + ++ L    N I+  +   +   + LT + LQ N++     + L N   L ++DLS
Sbjct: 202 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLS 256

Query: 329 DNNLSGTIPREV-IGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTS 387
            N L   I     + +     L +S N L   + L    +  ++ LDLS N L   +  +
Sbjct: 257 YNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERN 313

Query: 388 LASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNL 447
                 LE L    NS    +    S+   L++L LS N++       L  FR + +  +
Sbjct: 314 QPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAV 368

Query: 448 SFNNL 452
              + 
Sbjct: 369 DDADQ 373

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  128 bits (324), Expect = 3e-32
 Identities = 60/379 (15%), Positives = 133/379 (35%), Gaps = 46/379 (12%)

Query: 14  SELRILDLVVNKLEGNIPSE-LGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSEN 72
           +  +I+    + +   +P+  L +  ++  L L           + +    +Q+L +  N
Sbjct: 45  NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 103

Query: 73  SLSGNIPSELGL-LKQLNMFQVSANYLTGSIPIQLF-NISSMDYFAVTQNKLVGEIPHYV 130
           ++   +P  +   +  L +  +  N L+ S+P  +F N   +   +++ N L   I    
Sbjct: 104 AIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDT 160

Query: 131 GFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLR 190
                +++ L L SN             + +   L  + +L   N + N           
Sbjct: 161 FQATTSLQNLQLSSN-----------RLTHVD--LSLIPSLFHANVSYNL---------- 197

Query: 191 FLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNL 250
            L +L     +E +  S NS++ V           L  L +  N ++      + N   L
Sbjct: 198 -LSTLAIPIAVEELDASHNSINVVRGPVNVE----LTILKLQHNNLT-DTAW-LLNYPGL 250

Query: 251 ILIAMEVNLLTGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIR 309
           + + +  N L   I       + +L+ L +  N++   +      +  L  +DL  N + 
Sbjct: 251 VEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308

Query: 310 GSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKG 369
             +        +L+ L L  N++  T+        +   L LS N         +   + 
Sbjct: 309 -HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWDCNSLRAL--FRN 362

Query: 370 IQQLDLSENKLSGEIPTSL 388
           + +  + +     +I   L
Sbjct: 363 VARPAVDDADQHCKIDYQL 381

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  116 bits (292), Expect = 4e-28
 Identities = 54/276 (19%), Positives = 104/276 (37%), Gaps = 25/276 (9%)

Query: 196 VNCTFLEVVSLSSNSLSGVLPNSIANFS----SHLIYLYMSANRISGTIPTGV-GNLKNL 250
           ++             +     +    F     ++   +    + +   +P  +  + + +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 251 ILIAMEVNLLTGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIR 309
            L+ +    +   I T    Y   +Q L +  N I    P    N+  LT + L+ N + 
Sbjct: 72  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130

Query: 310 GSIPSALGNCLQLQKLDLSDNNLSGTIPREV-IGLSSFVLLDLSRNHLSGPIPLEVGRLK 368
                   N  +L  L +S+NNL   I  +     +S   L LS N L+    +++  + 
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIP 186

Query: 369 GIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNF 428
            +   ++S N L     ++LA  + +E L+ S NS    +         L  L L  NN 
Sbjct: 187 SLFHANVSYNLL-----STLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNL 238

Query: 429 SGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKN 464
           +      LN +  L +++LS+N LE ++     F  
Sbjct: 239 T-DTAWLLN-YPGLVEVDLSYNELE-KIM-YHPFVK 270

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  100 bits (250), Expect = 1e-22
 Identities = 41/238 (17%), Positives = 83/238 (34%), Gaps = 14/238 (5%)

Query: 239 TIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFL 298
            I + +        + +++             L   ++++   + +     + L +   +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 299 TEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLS 357
             ++L    I      A      +QKL +  N +   +P  V   +    +L L RN LS
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130

Query: 358 GPIPLEV-GRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLK 416
             +P  +      +  L +S N L      +  +   L+ L  S N      H   S + 
Sbjct: 131 S-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIP 186

Query: 417 GLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNN 474
            L   ++S N  S      L     +++L+ S N++   V    V   +  + +  NN
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVR-GPVNVELTILKLQHNN 237

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 64.3 bits (157), Expect = 6e-11
 Identities = 38/234 (16%), Positives = 86/234 (36%), Gaps = 37/234 (15%)

Query: 5   EIPANI-THCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSF 63
            I  +     + L+ L L  N+L  ++   L  +  L    ++ N  +     +L+    
Sbjct: 155 RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIA 206

Query: 64  LQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLV 123
           +++L  S NS++  +     +  +L + ++  N LT      L N   +    ++ N+L 
Sbjct: 207 VEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE 261

Query: 124 GEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGT 183
            +I ++    +  +  L + +N              ++      +  L  L+ + N+L  
Sbjct: 262 -KIMYHPFVKMQRLERLYISNN-----------RLVALNLYGQPIPTLKVLDLSHNHLLH 309

Query: 184 GKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRIS 237
                     +      LE + L  NS+  +    ++   + L  L +S N   
Sbjct: 310 -------VERNQPQFDRLENLYLDHNSIVTL---KLSTHHT-LKNLTLSHNDWD 352

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  136 bits (344), Expect = 2e-35
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 19/213 (8%)

Query: 567 IGIGGYGYVYKGIL----GTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKII 622
           +G G +G V               VAVK L        + F  E + L+++    +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
                    G +   LV E++P+G L ++L      Q  R +L+  + L  +  +   +E
Sbjct: 91  GVSYG---PGRQSLRLVMEYLPSGCLRDFL------QRHRARLDASRLLLYSSQICKGME 141

Query: 683 YLH-HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           YL    C    VH DL   N+L+++E    + DFGL++LL  +          +  I + 
Sbjct: 142 YLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
           APE  +    S   D +SFG+++ E+FT   + 
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  136 bits (344), Expect = 3e-35
 Identities = 70/219 (31%), Positives = 106/219 (48%), Gaps = 25/219 (11%)

Query: 567 IGIGGYGYVYKGIL---GTEETNVAVKVL----DLQQRGASKSFIAECEALRSIRHRNLV 619
           IG G  G V  G L   G  +  VA+K L      +QR   + F++E   +    H N++
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR---RDFLSEASIMGQFDHPNII 113

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
           ++        TRG     +V E+M NGSL+ +L      +    +  +MQ + +   V  
Sbjct: 114 RLEGVV----TRGRLA-MIVTEYMENGSLDTFL------RTHDGQFTIMQLVGMLRGVGA 162

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            + YL        VH DL   NVL+D+ +V  V DFGLSR+L D+     +T+  K  I 
Sbjct: 163 GMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219

Query: 740 YVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           + APE  A    S+  D +SFG++M E+   G+RP  +M
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  137 bits (346), Expect = 3e-35
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 25/219 (11%)

Query: 567 IGIGGYGYVYKGIL---GTEETNVAVKVL----DLQQRGASKSFIAECEALRSIRHRNLV 619
           +G G +G V  G L     +E +VA+K L      +QR   + F+ E   +    H N++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNII 109

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
           ++    +           +V E+M NGSL+++L      +    +  ++Q + +   +A+
Sbjct: 110 RLEGVVTKSKPV-----MIVTEYMENGSLDSFL------RKHDAQFTVIQLVGMLRGIAS 158

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            ++YL        VH DL   N+L+++ +V  V DFGL R+L D+     +T   K  I 
Sbjct: 159 GMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215

Query: 740 YVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           + +PE  A  + ++  D +S+GI++ E+ + G+RP  +M
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  134 bits (340), Expect = 3e-35
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 21/216 (9%)

Query: 567 IGIGGYGYVYKGIL--GTEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKIIT 623
           +G G +G V +G+     ++ +VA+KVL    ++  ++  + E + +  + +  +V++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
            C +      E   LV E    G L  +L        +R ++ +     +   V+  ++Y
Sbjct: 78  VCQA------EALMLVMEMAGGGPLHKFL------VGKREEIPVSNVAELLHQVSMGMKY 125

Query: 684 L-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           L   +     VH DL   NVLL N   A + DFGLS+ L  +    T+ S  K  + + A
Sbjct: 126 LEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 181

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           PE     + S+  D +S+G+ M E  + G++P   M
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  135 bits (342), Expect = 5e-35
 Identities = 65/220 (29%), Positives = 115/220 (52%), Gaps = 26/220 (11%)

Query: 567 IGIGGYGYVYKGIL----GTEETNVAVKVLDLQQRGAS----KSFIAECEALRSIRHRNL 618
           IG G +G VYKG+L    G +E  VA+K L   + G +      F+ E   +    H N+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTL---KAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
           +++    S           ++ E+M NG+L+ +L      + +  + +++Q + +   +A
Sbjct: 109 IRLEGVISKYKPM-----MIITEYMENGALDKFL------REKDGEFSVLQLVGMLRGIA 157

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSI 738
             ++YL +    + VH DL   N+L+++ +V  V DFGLSR+L D+     +TS  K  I
Sbjct: 158 AGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214

Query: 739 GYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
            + APE  +  + ++  D +SFGI+M E+ T G+RP  ++
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  133 bits (338), Expect = 6e-35
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 24/217 (11%)

Query: 567 IGIGGYGYVYKGIL---GTEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII 622
           IG G +G V++GI          VA+K   +       + F+ E   +R   H ++VK+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
              +           ++ E    G L ++L      Q ++  L+L   +  A  ++  L 
Sbjct: 83  GVITE------NPVWIIMELCTLGELRSFL------QVRKYSLDLASLILYAYQLSTALA 130

Query: 683 YL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           YL         VH D+   NVL+ +     +GDFGLSR + D+       S+ K  I ++
Sbjct: 131 YLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--TYYKASKGKLPIKWM 184

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           APE       ++  D + FG+ M E+   G +P   +
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  134 bits (339), Expect = 7e-35
 Identities = 60/243 (24%), Positives = 100/243 (41%), Gaps = 22/243 (9%)

Query: 567 IGIGGYGYVYKGIL----GTEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKI 621
           +G G +G V               VAVK L              E E LR++ H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
              C+     G     L+ EF+P+GSL+ +L         + K+NL Q+L  A+ +   +
Sbjct: 89  KGICTE---DGGNGIKLIMEFLPSGSLKEYL------PKNKNKINLKQQLKYAVQICKGM 139

Query: 682 EYLH-HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           +YL         VH DL   NVL+++E    +GDFGL++ +  +    T        + +
Sbjct: 140 DYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195

Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHK-YAKMGLPDQVAE 798
            APE     +     D +SFG+ + E+ T     +  M      +   + +M +   +  
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR-LVN 254

Query: 799 IID 801
            + 
Sbjct: 255 TLK 257

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  134 bits (339), Expect = 1e-34
 Identities = 50/217 (23%), Positives = 95/217 (43%), Gaps = 22/217 (10%)

Query: 567 IGIGGYGYVYKGIL----GTEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKI 621
           +G G +G VYKG+        +  VA+K L +     A+K  + E   + S+ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
           +  C +          L+ + MP G L +++      +  +  +     L+  + +A  +
Sbjct: 83  LGICLT------STVQLITQLMPFGCLLDYV------REHKDNIGSQYLLNWCVQIAKGM 130

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
            YL       +VH DL   NVL+       + DFGL++LL      +      K  I ++
Sbjct: 131 NYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKWM 186

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           A E       +   D +S+G+ + E+ T G +P D +
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  135 bits (343), Expect = 1e-34
 Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 23/216 (10%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
           IG G +G V+ G L  + T VAVK   +         F+ E   L+   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
           +       +   +V E +  G    +L      + +  +L +   L +  D A  +EYL 
Sbjct: 182 T-----QKQPIYIVMELVQGGDFLTFL------RTEGARLRVKTLLQMVGDAAAGMEYLE 230

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR---VKGSIGYVA 742
                  +H DL   N L+  + V  + DFG+SR   D     +   R   VK +    A
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----A 283

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           PE    G  S+  D +SFGIL+ E F+ G  P  ++
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  133 bits (338), Expect = 1e-34
 Identities = 57/327 (17%), Positives = 109/327 (33%), Gaps = 24/327 (7%)

Query: 160 SIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSI 219
           +I E               ++L     +         +   ++ + LS N LS +    +
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALAS------LRQSAWNVKELDLSGNPLSQISAADL 54

Query: 220 ANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSL 279
           A F+  L  L +S+N +       + +L  L  + +  N +       +     ++ L  
Sbjct: 55  APFTK-LELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHA 106

Query: 280 FGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPRE 339
             N IS  +  S G       + L  N I        G   ++Q LDL  N +      E
Sbjct: 107 ANNNIS-RVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163

Query: 340 VIG-LSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLN 398
           +     +   L+L  N +   +  +V     ++ LDLS NKL+  +     S  G+ +++
Sbjct: 164 LAASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220

Query: 399 FSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPS 458
             +N     I       + L+  DL  N F         + +  +   ++   ++     
Sbjct: 221 LRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVKKLTGQ 278

Query: 459 EGVFKNVRAVSIIGNNKLCGGSPELHL 485
                 V  +   G    C   P    
Sbjct: 279 NEEECTVPTLGHYGAY-CCEDLPAPFA 304

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  126 bits (319), Expect = 4e-32
 Identities = 49/378 (12%), Positives = 114/378 (30%), Gaps = 63/378 (16%)

Query: 53  SIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSM 112
           +I +   N +  +   ++++SL   + S       +    +S N L+  I          
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLA---- 55

Query: 113 DYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLI 172
                                   + +L L SN    E              L  L  L 
Sbjct: 56  --------------------PFTKLELLNLSSNVLY-ETLD-----------LESLSTLR 83

Query: 173 RLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMS 232
            L+   N +             L+    +E +  ++N++S V  +           +Y++
Sbjct: 84  TLDLNNNYVQ-----------ELLVGPSIETLHAANNNISRVSCSRGQG----KKNIYLA 128

Query: 233 ANRISGTIPTGVGNLKNLILIAMEVNLLTG-SIPTSVGYLLKLQVLSLFGNKISGEIPSS 291
            N+I+       G    +  + +++N +   +          L+ L+L  N I  ++   
Sbjct: 129 NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ 187

Query: 292 LGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDL 351
           +     L  +DL  N +   +     +   +  + L +N L   I + +    +    DL
Sbjct: 188 V-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDL 244

Query: 352 SRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSG 411
             N       L     K  +   +++  +      +   C      ++     +      
Sbjct: 245 RGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDL---- 299

Query: 412 FSSLKGLQDLDLSRNNFS 429
             +    + + L  ++  
Sbjct: 300 -PAPFADRLIALGHHHHH 316

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  132 bits (335), Expect = 2e-34
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 23/217 (10%)

Query: 567 IGIGGYGYVYKGIL--GTEETNVAVKVL--DLQQRGASKSFIAECEALRSIRHRNLVKII 622
           +G G +G V KG          VAVK+L  +          +AE   ++ + +  +V++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
             C +      E   LV E    G L  +L Q          +     + +   V+  ++
Sbjct: 85  GICEA------ESWMLVMEMAELGPLNKYLQQ-------NRHVKDKNIIELVHQVSMGMK 131

Query: 683 YL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           YL   +     VH DL   NVLL  +  A + DFGLS+ L  +     + +  K  + + 
Sbjct: 132 YLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 187

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           APE     + S+  D +SFG+LM E F+ G++P   M
Sbjct: 188 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  133 bits (336), Expect = 2e-34
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 22/217 (10%)

Query: 567 IGIGGYGYVYKGIL----GTEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKI 621
           +G G +G V+KG+      + +  V +KV+ D   R + ++      A+ S+ H ++V++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
           +  C            LV +++P GSL + +      +  R  L     L+  + +A  +
Sbjct: 81  LGLCPG------SSLQLVTQYLPLGSLLDHV------RQHRGALGPQLLLNWGVQIAKGM 128

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
            YL  H    +VH +L   NVLL +     V DFG++ LL  +   Q   S  K  I ++
Sbjct: 129 YYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD-KQLLYSEAKTPIKWM 184

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           A E    G+ +   D +S+G+ + E+ T G  P   +
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  132 bits (334), Expect = 3e-34
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 18/208 (8%)

Query: 567 IGIGGYGYVYKGIL----GTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKII 622
           +G G +G V               VAVK L        + F  E E L+S++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
             C S    G     L+ E++P GSL ++L      Q  + +++ ++ L     +   +E
Sbjct: 78  GVCYS---AGRRNLKLIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGME 128

Query: 683 YLH-HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           YL         +H DL   N+L++NE    +GDFGL+++L  +          +  I + 
Sbjct: 129 YLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFT 769
           APE     + S   D +SFG+++ E+FT
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  131 bits (333), Expect = 3e-34
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 25/215 (11%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITS 624
           +G G +G V  G     + +VA+K++   + G+     FI E + + ++ H  LV++   
Sbjct: 32  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
           C+           ++ E+M NG L N+L      +  R +    Q L +  DV   +EYL
Sbjct: 88  CTK-----QRPIFIITEYMANGCLLNYL------REMRHRFQTQQLLEMCKDVCEAMEYL 136

Query: 685 -HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
                    +H DL   N L++++ V  V DFGLSR + D+  + TS+   K  + +  P
Sbjct: 137 ESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPP 190

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           E     + S+  D ++FG+LM E+++ GK P +  
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  131 bits (333), Expect = 3e-34
 Identities = 54/217 (24%), Positives = 100/217 (46%), Gaps = 24/217 (11%)

Query: 567 IGIGGYGYVYKGIL---GTEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII 622
           +G G +G VY+G+      E+ NVAVK           + F++E   ++++ H ++VK+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
                      E   ++ E  P G L ++L      +  +  L ++  +  ++ +   + 
Sbjct: 80  GIIEE------EPTWIIMELYPYGELGHYL------ERNKNSLKVLTLVLYSLQICKAMA 127

Query: 683 YL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           YL   +C    VH D+   N+L+ +     +GDFGLSR + D   D    S  +  I ++
Sbjct: 128 YLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDE--DYYKASVTRLPIKWM 181

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           +PE       +T  D + F + M E+ + GK+P   +
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  136 bits (343), Expect = 4e-34
 Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 23/216 (10%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKS--FIAECEALRSIRHRNLVKII 622
             +G G +G V+ G      T VA+K L   + G      F+ E + ++ +RH  LV++ 
Sbjct: 190 VKLGQGCFGEVWMGTW-NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 245

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
              S       E   +V E+M  GSL ++L     +      L L Q + +A  +A+ + 
Sbjct: 246 AVVSE------EPIYIVTEYMSKGSLLDFL-----KGETGKYLRLPQLVDMAAQIASGMA 294

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           Y+      + VH DL+ +N+L+   +V  V DFGL+RL+ DN  + T+    K  I + A
Sbjct: 295 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTA 349

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           PE    G  +   D +SFGIL+ E+ T G+ P   M
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  131 bits (331), Expect = 4e-34
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 25/215 (11%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITS 624
           IG G +G V+ G     +  VA+K +   + GA   + FI E E +  + H  LV++   
Sbjct: 16  IGSGQFGLVHLGYW-LNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
           C            LV EFM +G L ++L      + QR        L + +DV   + YL
Sbjct: 72  C----LEQAPI-CLVTEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYL 120

Query: 685 -HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
                    +H DL   N L+    V  V DFG++R + D+    TS++  K  + + +P
Sbjct: 121 EEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASP 174

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           E  +    S+  D +SFG+LM E+F+ GK P ++ 
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  131 bits (332), Expect = 4e-34
 Identities = 52/219 (23%), Positives = 87/219 (39%), Gaps = 27/219 (12%)

Query: 565 NLIGIGGYGYVYKGIL---GTEETNVAVKVLDLQQRGAS----KSFIAECEALRSIRHRN 617
            +IG G +G VY G            A+K L    R       ++F+ E   +R + H N
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL---SRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           ++ +I               ++  +M +G L  ++      ++ +    +   +S  + V
Sbjct: 84  VLALIGIM----LPPEGLPHVLLPYMCHGDLLQFI------RSPQRNPTVKDLISFGLQV 133

Query: 678 ANVLEYL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSP-DQTSTSRVK 735
           A  +EYL         VH DL   N +LD      V DFGL+R + D            +
Sbjct: 134 ARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189

Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
             + + A E       +T  D +SFG+L+ E+ T G  P
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  130 bits (330), Expect = 5e-34
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITS 624
           +G G +G V  G     + +VAVK++   + G+     F  E + +  + H  LVK    
Sbjct: 16  LGSGQFGVVKLGKW-KGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
           C    ++      +V E++ NG L N+L      ++    L   Q L +  DV   + +L
Sbjct: 72  C----SKEYPI-YIVTEYISNGCLLNYL------RSHGKGLEPSQLLEMCYDVCEGMAFL 120

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
             H     +H DL   N L+D ++   V DFG++R + D+     S+   K  + + APE
Sbjct: 121 ESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--QYVSSVGTKFPVKWSAPE 175

Query: 745 YGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
                + S+  D ++FGILM E+F+ GK P D  
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  132 bits (333), Expect = 7e-34
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 18/208 (8%)

Query: 567 IGIGGYGYVYKGIL----GTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKII 622
           +G G +G V               VAVK L        + F  E E L+S++H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
             C S    G     L+ E++P GSL ++L      Q  + +++ ++ L     +   +E
Sbjct: 109 GVCYS---AGRRNLKLIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGME 159

Query: 683 YLH-HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           YL         +H DL   N+L++NE    +GDFGL+++L  +          +  I + 
Sbjct: 160 YLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 215

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFT 769
           APE     + S   D +SFG+++ E+FT
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  130 bits (329), Expect = 9e-34
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 21/214 (9%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITS 624
           +G G YG VY+G+       VAVK L   +      + F+ E   ++ I+H NLV+++  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
           C    TR   F  ++ EFM  G+L ++L +       R +++ +  L +A  +++ +EYL
Sbjct: 78  C----TREPPF-YIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYL 127

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
                 + +H DL   N L+    +  V DFGLSRL+  ++   T+ +  K  I + APE
Sbjct: 128 EKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 182

Query: 745 YGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
             A  + S   D ++FG+L+ E+ T G  P   +
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  130 bits (329), Expect = 1e-33
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 27/219 (12%)

Query: 565 NLIGIGGYGYVYKGIL---GTEETNVAVKVLDLQQRGASKS----FIAECEALRSIRHRN 617
            +IG G +G VY G L     ++ + AVK L    R         F+ E   ++   H N
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           ++ ++  C    + G+    +V  +M +G L N++      +N+     +   +   + V
Sbjct: 88  VLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFI------RNETHNPTVKDLIGFGLQV 137

Query: 678 ANVLEYLH-HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD-QTSTSRVK 735
           A  ++YL         VH DL   N +LD +    V DFGL+R ++D       + +  K
Sbjct: 138 AKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193

Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
             + ++A E     + +T  D +SFG+L+ E+ T G  P
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  130 bits (330), Expect = 1e-33
 Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 15/215 (6%)

Query: 567 IGIGGYGYVYKGIL---GTEETNVAVKVL--DLQQRGASKSFIAECEALRSIRHRNLVKI 621
           +G G +G V +G L         VAVK +  D   +   + F++E   ++   H N++++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
           +  C  + ++G     ++  FM  G L  +L      +     + L   L   +D+A  +
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 682 EYL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQ-TSTSRVKGSIG 739
           EYL + +     +H DL   N +L ++M   V DFGLS+ ++    D        K  + 
Sbjct: 161 EYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKKIYSG--DYYRQGRIAKMPVK 214

Query: 740 YVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
           ++A E  A    ++  D ++FG+ M E+ T G  P
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  132 bits (334), Expect = 1e-33
 Identities = 68/308 (22%), Positives = 121/308 (39%), Gaps = 40/308 (12%)

Query: 486 HSCRSRGSRKLWQHSTFKIVISAVLLPCLLSTCFIVFVFYQRRKRRRRSKALVNSSIEDK 545
           H     G R+    S    ++     P L   C I  +     K+          +    
Sbjct: 9   HHHHHHGRRR---ASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVH 65

Query: 546 YLKISYA-ELLKATEGF---------SSANLIGIGGYGYVYKGIL---GTEETNVAVKVL 592
               +   EL++A +               +IG G +G VY G L     ++ + AVK L
Sbjct: 66  IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 125

Query: 593 DLQQRGASKS----FIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSL 648
               R         F+ E   ++   H N++ ++  C    + G+    +V  +M +G L
Sbjct: 126 ---NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL--RSEGSPL--VVLPYMKHGDL 178

Query: 649 ENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL-HHHCHTSIVHCDLKPSNVLLDNE 707
            N++      +N+     +   +   + VA  +++L         VH DL   N +LD +
Sbjct: 179 RNFI------RNETHNPTVKDLIGFGLQVAKGMKFLASKKF----VHRDLAARNCMLDEK 228

Query: 708 MVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLE 766
               V DFGL+R ++D   D   + +  K  + ++A E     + +T  D +SFG+L+ E
Sbjct: 229 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 288

Query: 767 MFT-GKRP 773
           + T G  P
Sbjct: 289 LMTRGAPP 296

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  136 bits (344), Expect = 1e-33
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 21/216 (9%)

Query: 567 IGIGGYGYVYKGIL--GTEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKIIT 623
           +G G +G V +G+     ++ +VA+KVL    ++  ++  + E + +  + +  +V++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
            C +      E   LV E    G L  +L        +R ++ +     +   V+  ++Y
Sbjct: 404 VCQA------EALMLVMEMAGGGPLHKFL------VGKREEIPVSNVAELLHQVSMGMKY 451

Query: 684 L-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           L   +     VH +L   NVLL N   A + DFGLS+ L  +    T+ S  K  + + A
Sbjct: 452 LEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 507

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           PE     + S+  D +S+G+ M E  + G++P   M
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  135 bits (341), Expect = 2e-33
 Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 23/216 (10%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKS--FIAECEALRSIRHRNLVKII 622
             +G G +G V+ G      T VA+K L   + G      F+ E + ++ +RH  LV++ 
Sbjct: 273 VKLGQGCFGEVWMGTW-NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 328

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
              S       E   +V E+M  GSL ++L     +      L L Q + +A  +A+ + 
Sbjct: 329 AVVSE------EPIYIVTEYMSKGSLLDFL-----KGETGKYLRLPQLVDMAAQIASGMA 377

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           Y+      + VH DL+ +N+L+   +V  V DFGL+RL+ DN  + T+    K  I + A
Sbjct: 378 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTA 432

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           PE    G  +   D +SFGIL+ E+ T G+ P   M
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  133 bits (337), Expect = 2e-33
 Identities = 59/216 (27%), Positives = 110/216 (50%), Gaps = 23/216 (10%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKII 622
             +G G +G V+      + T VAVK +   + G+   ++F+AE   +++++H  LVK+ 
Sbjct: 194 KKLGAGQFGEVWMATY-NKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLH 249

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
              +       E   ++ EFM  GSL ++L     + ++  K  L + +  +  +A  + 
Sbjct: 250 AVVT------KEPIYIITEFMAKGSLLDFL-----KSDEGSKQPLPKLIDFSAQIAEGMA 298

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           ++      + +H DL+ +N+L+   +V  + DFGL+R++ DN  + T+    K  I + A
Sbjct: 299 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN--EYTAREGAKFPIKWTA 353

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           PE    G  +   D +SFGIL++E+ T G+ P   M
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  129 bits (326), Expect = 2e-33
 Identities = 62/214 (28%), Positives = 110/214 (51%), Gaps = 23/214 (10%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITS 624
           +G G +G V+ G      T VAVK L   ++G+    +F+AE   ++ ++H+ LV++   
Sbjct: 21  LGAGQFGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
            +       E   ++ E+M NGSL ++L     +     KL + + L +A  +A  + ++
Sbjct: 77  VT------QEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
                 + +H DL+ +N+L+ + +   + DFGL+RL+ DN  + T+    K  I + APE
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN--EYTAREGAKFPIKWTAPE 180

Query: 745 YGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
               G  +   D +SFGIL+ E+ T G+ P   M
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  129 bits (327), Expect = 4e-33
 Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 14/215 (6%)

Query: 567 IGIGGYGYVYKGIL---GTEETNVAVKVL--DLQQRGASKSFIAECEALRSIRHRNLVKI 621
           +G G +G V +  L         VAVK+L  D+      + F+ E   ++   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 622 ITSCSSIDTRGNEFKAL-VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
           +        +G     + +  FM +G L  +L            L L   +   +D+A  
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 681 LEYL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
           +EYL   +     +H DL   N +L  +M   V DFGLSR ++            K  + 
Sbjct: 150 MEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD-YYRQGCASKLPVK 204

Query: 740 YVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
           ++A E  A    + H D ++FG+ M E+ T G+ P
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  126 bits (318), Expect = 3e-32
 Identities = 53/231 (22%), Positives = 97/231 (41%), Gaps = 44/231 (19%)

Query: 567 IGIGGYGYVYKGIL-------GTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLV 619
           +G G +  ++KG+           ET V +KVLD   R  S+SF      +  + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
                C      G+E   LV EF+  GSL+ +L      +  +  +N++ +L +A  +A 
Sbjct: 76  LNYGVC----VCGDEN-ILVQEFVKFGSLDTYL------KKNKNCINILWKLEVAKQLAA 124

Query: 680 VLEYL-HHHCHTSIVHCDLKPSNVLLD--------NEMVAHVGDFGLSRLLHDNSPDQTS 730
            + +L  +      +H ++   N+LL         N     + D G+S  +         
Sbjct: 125 AMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP---KDIL 177

Query: 731 TSRVKGSIGYVAPE---YGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
             R+     +V PE         ++   D++SFG  + E+ + G +P   +
Sbjct: 178 QERIP----WVPPECIENP--KNLNLATDKWSFGTTLWEICSGGDKPLSAL 222

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  126 bits (319), Expect = 4e-32
 Identities = 57/236 (24%), Positives = 92/236 (38%), Gaps = 23/236 (9%)

Query: 567 IGIGGYGYVYKGIL----GTEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKI 621
           +G G +G V               VAVK L           +  E + LR++ H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
              C      G     LV E++P GSL ++L         R  + L Q L  A  +   +
Sbjct: 99  KGCCED---AGAASLQLVMEYVPLGSLRDYL--------PRHSIGLAQLLLFAQQICEGM 147

Query: 682 EYLH-HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
            YLH  H     +H DL   NVLLDN+ +  +GDFGL++ + +              + +
Sbjct: 148 AYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 203

Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHK-YAKMGLPD 794
            APE     +     D +SFG+ + E+ T          +    +     +M +  
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  132 bits (334), Expect = 4e-32
 Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 37/217 (17%)

Query: 566 LIGIGGYGYVYKG---ILGTEETNVAVKVL------DLQQRGASKSFIAECEALRSIRHR 616
            I  GG G++Y      +      V +K L      + Q        +AE + L  + H 
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRP--VVLKGLVHSGDAEAQAM-----AMAERQFLAEVVHP 139

Query: 617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAID 676
           ++V+I       D  G+    +V E++   SL+    QK         L + + ++  ++
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---------LPVAEAIAYLLE 190

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
           +   L YLH      +V+ DLKP N++L  E +  + D G    +        S   + G
Sbjct: 191 ILPALSYLHSI---GLVYNDLKPENIMLTEEQLK-LIDLGAVSRI-------NSFGYLYG 239

Query: 737 SIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + G+ APE       +   D Y+ G  +  +      
Sbjct: 240 TPGFQAPEI-VRTGPTVATDIYTVGRTLAALTLDLPT 275

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  127 bits (320), Expect = 4e-32
 Identities = 64/289 (22%), Positives = 114/289 (39%), Gaps = 22/289 (7%)

Query: 199 TFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEV 257
               ++ L +N ++ +      N   +L  L +  N+IS  I  G    L  L  + +  
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKIS-KISPGAFAPLVKLERLYLSK 109

Query: 258 NLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSI--PSA 315
           N L   +P  +     LQ L +  N+I+    S    L  +  V+L  N ++ S     A
Sbjct: 110 NQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 166

Query: 316 LGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLD 374
                +L  + ++D N++ TIP+ +    S   L L  N ++  +       L  + +L 
Sbjct: 167 FQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLG 222

Query: 375 LSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSG---- 430
           LS N +S     SLA+   L  L+ ++N     +  G +  K +Q + L  NN S     
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSN 281

Query: 431 --KIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSII--GNNK 475
               P +         ++L  N ++        F+ V   + +  GN K
Sbjct: 282 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  104 bits (261), Expect = 2e-24
 Identities = 68/380 (17%), Positives = 116/380 (30%), Gaps = 91/380 (23%)

Query: 12  HCSELRILDLVVNKLE---GNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLS 68
            C  LR++      LE    ++P +   L       L  N  T        NL  L  L 
Sbjct: 30  QCH-LRVVQCSDLGLEKVPKDLPPDTALLD------LQNNKITEIKDGDFKNLKNLHTLI 82

Query: 69  LSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPH 128
           L  N +S   P     L +L    +S N L   +P ++                      
Sbjct: 83  LINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--------------------- 120

Query: 129 YVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGND 188
                   ++ L +  N  T ++  S+            L  +I +    N L +    +
Sbjct: 121 ------KTLQELRVHENEIT-KVRKSV---------FNGLNQMIVVELGTNPLKSSGIEN 164

Query: 189 LRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLK 248
                +      L  + ++  +++ +         S L  L++  N+I+  +      LK
Sbjct: 165 ----GAFQGMKKLSYIRIADTNITTIPQGL---PPS-LTELHLDGNKIT-KVDAAS--LK 213

Query: 249 NLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSI 308
            L                       L  L L  N IS     SL N   L E+ L  N +
Sbjct: 214 GLN---------------------NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252

Query: 309 RGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-------GLSSFVLLDLSRNHLS-GPI 360
              +P  L +   +Q + L +NN+S  I              +S+  + L  N +    I
Sbjct: 253 V-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI 310

Query: 361 PLEV-GRLKGIQQLDLSENK 379
                  +     + L   K
Sbjct: 311 QPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  103 bits (259), Expect = 4e-24
 Identities = 62/282 (21%), Positives = 107/282 (37%), Gaps = 40/282 (14%)

Query: 134 LPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLD 193
           L N+  L+L +N  + +I P              L  L RL  ++N L            
Sbjct: 75  LKNLHTLILINNKIS-KISPGA---------FAPLVKLERLYLSKNQL-----------K 113

Query: 194 SLVNCTF--LEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRI-SGTIPTGV-GNLKN 249
            L       L+ + +  N ++ V  +     +  +I + +  N + S  I  G    +K 
Sbjct: 114 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQ-MIVVELGTNPLKSSGIENGAFQGMKK 172

Query: 250 LILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPS-SLGNLIFLTEVDLQGNSI 308
           L  I +    +T +IP  +     L  L L GNKI+ ++ + SL  L  L ++ L  NSI
Sbjct: 173 LSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSI 228

Query: 309 RGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSG------PIPL 362
                 +L N   L++L L++N L   +P  +       ++ L  N++S         P 
Sbjct: 229 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 287

Query: 363 EVGRLKGIQQLDLSENKLS-GEIPTSLASCVG-LEYLNFSDN 402
              +      + L  N +   EI  S   CV     +   + 
Sbjct: 288 YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  131 bits (332), Expect = 4e-32
 Identities = 71/342 (20%), Positives = 131/342 (38%), Gaps = 62/342 (18%)

Query: 13  CSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSEN 72
            +   +L++  + L   +P  L     +  L +  NN T S+P     L   + L +S N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPEL---RTLEVSGN 91

Query: 73  SLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGF 132
            L+ ++P     L +L++F     +L          +  +    +  N+L   +P     
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPALPS----GLCKLW---IFGNQL-TSLPV---- 138

Query: 133 TLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFL 192
             P ++ L +  N              S+P    +L  L   N           N L  L
Sbjct: 139 LPPGLQELSVSDNQLA-----------SLPALPSELCKLWAYN-----------NQLTSL 176

Query: 193 DSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLIL 252
             L   + L+ +S+S N L+  LP   +     L  L+   NR++ ++P     LK LI+
Sbjct: 177 PML--PSGLQELSVSDNQLA-SLPTLPSE----LYKLWAYNNRLT-SLPALPSGLKELIV 228

Query: 253 IAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSI 312
                N LT S+P       +L+ L + GN+++  +P     L+ L    +  N +   +
Sbjct: 229 ---SGNRLT-SLPVLPS---ELKELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RL 276

Query: 313 PSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRN 354
           P +L +      ++L  N LS    + +  ++S         
Sbjct: 277 PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPII 318

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  126 bits (319), Expect = 2e-30
 Identities = 80/449 (17%), Positives = 134/449 (29%), Gaps = 97/449 (21%)

Query: 64  LQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLV 123
              L++ E+ L+  +P  L     +    +  N LT                        
Sbjct: 42  NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT------------------------ 74

Query: 124 GEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGT 183
             +P       P +R L +  N  T           S+P     L  L   +    +L  
Sbjct: 75  -SLPA----LPPELRTLEVSGNQLT-----------SLPVLPPGLLELSIFSNPLTHLPA 118

Query: 184 GKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTG 243
                L  L             +  N L+  LP         L  L +S N+++ ++P  
Sbjct: 119 LPSG-LCKLW------------IFGNQLT-SLPVLPPG----LQELSVSDNQLA-SLPAL 159

Query: 244 VGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDL 303
              L  L       N LT S+P        LQ LS+  N+++  +P+    L  L   + 
Sbjct: 160 PSELCKLWA---YNNQLT-SLPMLPS---GLQELSVSDNQLA-SLPTLPSELYKLWAYNN 211

Query: 304 QGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLE 363
           +  S+             L++L +S N L+ ++P     L     L +S N L+  +P+ 
Sbjct: 212 RLTSLPALPSG-------LKELIVSGNRLT-SLPVLPSELKE---LMVSGNRLTS-LPML 259

Query: 364 VGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDL 423
              L     L +  N+L+  +P SL        +N   N            +        
Sbjct: 260 PSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSG 315

Query: 424 SRNNFSGKIPMFLNTFRFLQKL--NLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSP 481
               F           R L     +      EGE      +                 + 
Sbjct: 316 PIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQ---------EDNAD 366

Query: 482 ELHLHSCRSRGSRKLWQHSTFKIVISAVL 510
              L   R   +    + + FK  IS+ L
Sbjct: 367 AFSLFLDRLSETENFIKDAGFKAQISSWL 395

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  105 bits (263), Expect = 1e-23
 Identities = 71/346 (20%), Positives = 117/346 (33%), Gaps = 80/346 (23%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
            +P       EL I    +  L    P+    L KL    + GN  T S+P        L
Sbjct: 95  SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKLW---IFGNQLT-SLPVLPPG---L 143

Query: 65  QQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVG 124
           Q+LS+S+N L+ ++P+    L +L       N LT S+P+                    
Sbjct: 144 QELSVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPML------------------- 179

Query: 125 EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTG 184
                       ++ L +  N              S+P    +L  L   N         
Sbjct: 180 ---------PSGLQELSVSDNQLA-----------SLPTLPSELYKLWAYN--------- 210

Query: 185 KGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV 244
             N L  L +L   + L+ + +S N L+  LP       S L  L +S NR++ ++P   
Sbjct: 211 --NRLTSLPAL--PSGLKELIVSGNRLTS-LPVLP----SELKELMVSGNRLT-SLPMLP 260

Query: 245 GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQ 304
             L +L +     N LT  +P S+ +L     ++L GN +S     +L  +         
Sbjct: 261 SGLLSLSV---YRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGP 316

Query: 305 GNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLD 350
                 +  SA      L     + + L      E      + +  
Sbjct: 317 IIRFDMAGASAPRETRALH--LAAADWLVPAREGEPAPADRWHMFG 360

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 19/111 (17%), Positives = 39/111 (35%), Gaps = 10/111 (9%)

Query: 349 LDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQG-P 407
            + SR   +    +      G   L++ E+ L+  +P  L +   +  L   DN+    P
Sbjct: 21  AEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPAH--ITTLVIPDNNLTSLP 77

Query: 408 IHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPS 458
                +    L+ L++S N  +  +P+       L   +    +L      
Sbjct: 78  -----ALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG 122

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  132 bits (333), Expect = 4e-32
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 24/217 (11%)

Query: 567 IGIGGYGYVYKGIL---GTEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVKII 622
           IG G +G V++GI          VA+K   +       + F+ E   +R   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
              +           ++ E    G L ++L      Q ++  L+L   +  A  ++  L 
Sbjct: 458 GVITE------NPVWIIMELCTLGELRSFL------QVRKFSLDLASLILYAYQLSTALA 505

Query: 683 YLH-HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           YL         VH D+   NVL+ +     +GDFGLSR + D+       S+ K  I ++
Sbjct: 506 YLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--TYYKASKGKLPIKWM 559

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           APE       ++  D + FG+ M E+   G +P   +
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  125 bits (316), Expect = 8e-32
 Identities = 50/215 (23%), Positives = 94/215 (43%), Gaps = 22/215 (10%)

Query: 566 LIGIGGYGYVYKG---ILGTEETNVAVKVLDLQQRG---ASKSFIAECEALRSIRHRNLV 619
           ++G GG   V+         +   VAVKVL             F  E +   ++ H  +V
Sbjct: 19  ILGFGGMSEVHLARDLRDHRD---VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
            +  +  + +T       +V E++   +L + ++           +   + + +  D   
Sbjct: 76  AVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHT-------EGPMTPKRAIEVIADACQ 127

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            L + H +    I+H D+KP+N+++       V DFG++R + D+    T T+ V G+  
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184

Query: 740 YVAPEYGALGEVSTH-GDEYSFGILMLEMFTGKRP 773
           Y++PE  A G+      D YS G ++ E+ TG+ P
Sbjct: 185 YLSPEQ-ARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  124 bits (314), Expect = 8e-32
 Identities = 61/243 (25%), Positives = 99/243 (40%), Gaps = 20/243 (8%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIIT 623
            IG G +  VYKG+       VA   L  ++   S  + F  E E L+ ++H N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPK-LNLMQRLSIAIDVANVLE 682
           S  S          LV E M +G+L+ +L        +R K + +    S    +   L+
Sbjct: 93  SWESTVKGKKCI-VLVTELMTSGTLKTYL--------KRFKVMKIKVLRSWCRQILKGLQ 143

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEM-VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           +LH      I+H DLK  N+ +        +GD GL+ L        +    V G+  ++
Sbjct: 144 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-----ASFAKAVIGTPEFM 197

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIID 801
           APE     +     D Y+FG+ MLEM T + P  +         +      P    ++  
Sbjct: 198 APEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256

Query: 802 PAI 804
           P +
Sbjct: 257 PEV 259

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  129 bits (325), Expect = 9e-32
 Identities = 66/286 (23%), Positives = 116/286 (40%), Gaps = 17/286 (5%)

Query: 199 TFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEV 257
           T   ++ L  N +  +  +  A+F  HL  L ++ N +S  +  G   NL NL  + +  
Sbjct: 32  TETRLLDLGKNRIKTLNQDEFASFP-HLEELELNENIVS-AVEPGAFNNLFNLRTLGLRS 89

Query: 258 NLLTGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPS-A 315
           N L   IP  V   L  L  L +  NKI   +     +L  L  +++  N +   I   A
Sbjct: 90  NRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRA 147

Query: 316 LGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLD 374
                 L++L L   NL+ +IP E +  L   ++L L   +++        RL  ++ L+
Sbjct: 148 FSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206

Query: 375 LSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP- 433
           +S       +  +    + L  L+ +  +     +     L  L+ L+LS N  S  I  
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEG 265

Query: 434 -MFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSII--GNNKL 476
            M     R LQ++ L    L   V     F+ +  + ++    N+L
Sbjct: 266 SMLHELLR-LQEIQLVGGQLA-VVE-PYAFRGLNYLRVLNVSGNQL 308

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  127 bits (322), Expect = 2e-31
 Identities = 73/330 (22%), Positives = 129/330 (39%), Gaps = 30/330 (9%)

Query: 159 SSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNS 218
            ++PE +        L+  +N + T   ++            LE + L+ N +S V P +
Sbjct: 24  VAVPEGI--PTETRLLDLGKNRIKTLNQDEFASF------PHLEELELNENIVSAVEPGA 75

Query: 219 IANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVL 277
             N  + L  L + +NR+   IP GV   L NL  + +  N +   +      L  L+ L
Sbjct: 76  FNNLFN-LRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL 133

Query: 278 SLFGNKISGEIPS-SLGNLIFLTEVDLQGNSIRGSIPS-ALGNCLQLQKLDLSDNNLSGT 335
            +  N +   I   +   L  L ++ L+  ++  SIP+ AL +   L  L L   N++  
Sbjct: 134 EVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-A 190

Query: 336 IPREV-IGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPT-SLASCVG 393
           I       L    +L++S       +         +  L ++   L+  +P  ++   V 
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVY 249

Query: 394 LEYLNFSDNSFQGPIHSG-FSSLKGLQDLDLSRNNFSGKIP--MFLNTFRFLQKLNLSFN 450
           L +LN S N     I       L  LQ++ L     +  +    F     +L+ LN+S N
Sbjct: 250 LRFLNLSYNPIST-IEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGL-NYLRVLNVSGN 306

Query: 451 NLEGEVPSEGVF---KNVRAVSIIGNNKLC 477
            L   +  E VF    N+  + +  N   C
Sbjct: 307 QLT-TLE-ESVFHSVGNLETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  126 bits (318), Expect = 7e-31
 Identities = 71/341 (20%), Positives = 121/341 (35%), Gaps = 31/341 (9%)

Query: 94  SANYLTGSIPIQLF-NISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIP 152
                  ++P  +      +D   + +N++   +      + P++  L L  N  +  + 
Sbjct: 19  HRKRFV-AVPEGIPTETRLLD---LGKNRI-KTLNQDEFASFPHLEELELNENIVS-AVE 72

Query: 153 PSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLS 212
           P              L NL  L    N L          L +L        + +S N + 
Sbjct: 73  PGA---------FNNLFNLRTLGLRSNRLKLIPLGVFTGLSNL------TKLDISENKIV 117

Query: 213 GVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEVNLLTGSIPTSV-GY 270
            +L     +  + L  L +  N +   I       L +L  + +E   LT SIPT    +
Sbjct: 118 ILLDYMFQDLYN-LKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSH 174

Query: 271 LLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDN 330
           L  L VL L    I+     S   L  L  +++       ++       L L  L ++  
Sbjct: 175 LHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234

Query: 331 NLSGTIPREVI-GLSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLDLSENKLSGEIPTSL 388
           NL+  +P   +  L     L+LS N +S  I   +   L  +Q++ L   +L+   P + 
Sbjct: 235 NLT-AVPYLAVRHLVYLRFLNLSYNPIST-IEGSMLHELLRLQEIQLVGGQLAVVEPYAF 292

Query: 389 ASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFS 429
                L  LN S N       S F S+  L+ L L  N  +
Sbjct: 293 RGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  125 bits (315), Expect = 2e-30
 Identities = 72/376 (19%), Positives = 138/376 (36%), Gaps = 56/376 (14%)

Query: 12  HCS-ELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLS 70
            CS + R +     +    +P  +    +   L L  N          ++   L++L L+
Sbjct: 8   ECSAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELN 64

Query: 71  ENSLSGNIPSE-LGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHY 129
           EN +S  +       L  L    + +N L   IP+ +F                      
Sbjct: 65  ENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFT--------------------- 101

Query: 130 VGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDL 189
               L N+  L +  N     +   +            L NL  L    N+L        
Sbjct: 102 ---GLSNLTKLDISENKIV-ILLDYM---------FQDLYNLKSLEVGDNDLVYISHRAF 148

Query: 190 RFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLK 248
             L+S      LE ++L   +L+ +   ++++    LI L +    I+  I       L 
Sbjct: 149 SGLNS------LEQLTLEKCNLTSIPTEALSHLHG-LIVLRLRHLNIN-AIRDYSFKRLY 200

Query: 249 NLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPS-SLGNLIFLTEVDLQGNS 307
            L ++ +       ++  +  Y L L  LS+    ++  +P  ++ +L++L  ++L  N 
Sbjct: 201 RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNP 259

Query: 308 IRGSIPSALGNCLQLQKLDLSDNNLSGTIPREV-IGLSSFVLLDLSRNHLSGPIPLEV-G 365
           I     S L   L+LQ++ L    L+  +      GL+   +L++S N L+  +   V  
Sbjct: 260 ISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTT-LEESVFH 317

Query: 366 RLKGIQQLDLSENKLS 381
            +  ++ L L  N L+
Sbjct: 318 SVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  104 bits (262), Expect = 1e-23
 Identities = 56/280 (20%), Positives = 95/280 (33%), Gaps = 40/280 (14%)

Query: 203 VVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTG 262
            V         V P       +    L +  NRI  T+                      
Sbjct: 15  AVLCHRKRFVAV-P---EGIPTETRLLDLGKNRIK-TLN--------------------- 48

Query: 263 SIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPS-ALGNCLQ 321
                      L+ L L  N +S   P +  NL  L  + L+ N ++  IP         
Sbjct: 49  --QDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSN 105

Query: 322 LQKLDLSDNNLSGTIPREV-IGLSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLDLSENK 379
           L KLD+S+N +   +   +   L +   L++  N L   I       L  ++QL L +  
Sbjct: 106 LTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCN 163

Query: 380 LSGEIPT-SLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNT 438
           L+  IPT +L+   GL  L     +        F  L  L+ L++S   +   +      
Sbjct: 164 LT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222

Query: 439 FRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSII--GNNKL 476
              L  L+++  NL   VP     +++  +  +    N +
Sbjct: 223 GLNLTSLSITHCNLT-AVP-YLAVRHLVYLRFLNLSYNPI 260

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 60.1 bits (146), Expect = 2e-09
 Identities = 33/181 (18%), Positives = 66/181 (36%), Gaps = 18/181 (9%)

Query: 5   EIPANI-THCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSF 63
            IP    +H   L +L L    +          L++L  L ++   Y  ++  +      
Sbjct: 166 SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN 225

Query: 64  LQQLSLSENSLSGNIPSE-LGLLKQLNMFQVSANYLTGSIPIQLF-NISSMDYFAVTQNK 121
           L  LS++  +L+  +P   +  L  L    +S N ++ +I   +   +  +    +   +
Sbjct: 226 LTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQ 283

Query: 122 LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDL-GKLKNLIRLNFARNN 180
           L   +  Y    L  +RVL +  N             +++ E +   + NL  L    N 
Sbjct: 284 L-AVVEPYAFRGLNYLRVLNVSGN-----------QLTTLEESVFHSVGNLETLILDSNP 331

Query: 181 L 181
           L
Sbjct: 332 L 332

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  128 bits (323), Expect = 1e-31
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 25/213 (11%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS-KSFIAECEALRSIRHRNLVKIITSC 625
           IG G +G V  G        VAVK +   +  A+ ++F+AE   +  +RH NLV+++   
Sbjct: 201 IGKGEFGDVMLGDY--RGNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
                       +V E+M  GSL ++L         R  L     L  ++DV   +EYL 
Sbjct: 256 ----VEEKGGLYIVTEYMAKGSLVDYLRS-----RGRSVLGGDCLLKFSLDVCEAMEYLE 306

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEY 745
            +   + VH DL   NVL+  + VA V DFGL++         ++    K  + + APE 
Sbjct: 307 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEA 357

Query: 746 GALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
               + ST  D +SFGIL+ E+++ G+ P   +
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  124 bits (314), Expect = 1e-31
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 30/216 (13%)

Query: 566 LIGIGGYGYVYKG---ILGTEETNVAVKVLDLQQRG---ASKSFIAECEALRSIRHRNLV 619
            +G GG   VY     IL  +   VA+K + +  R      K F  E      + H+N+V
Sbjct: 18  KLGGGGMSTVYLAEDTILNIK---VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 620 KIITSCSSIDTRGNEFKA--LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
            +I      D    E     LV E++   +L  ++            L++   ++    +
Sbjct: 75  SMI------DV-DEEDDCYYLVMEYIEGPTLSEYIES-------HGPLSVDTAINFTNQI 120

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
            + +++ H      IVH D+KP N+L+D+     + DFG+++ L + S   T T+ V G+
Sbjct: 121 LDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS--LTQTNHVLGT 175

Query: 738 IGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           + Y +PE           D YS GI++ EM  G+ P
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  123 bits (310), Expect = 2e-31
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 25/215 (11%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS-KSFIAECEALRSIRHRNLVKIIT 623
             IG G +G V  G        VAVK +   +  A+ ++F+AE   +  +RH NLV+++ 
Sbjct: 27  QTIGKGEFGDVMLGDY--RGNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
                         +V E+M  GSL ++L         R  L     L  ++DV   +EY
Sbjct: 82  VI----VEEKGGLYIVTEYMAKGSLVDYLRS-----RGRSVLGGDCLLKFSLDVCEAMEY 132

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
           L  +   + VH DL   NVL+  + VA V DFGL++         ++    K  + + AP
Sbjct: 133 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAP 183

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM 777
           E     + ST  D +SFGIL+ E+++ G+ P   +
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  128 bits (322), Expect = 7e-31
 Identities = 72/402 (17%), Positives = 151/402 (37%), Gaps = 45/402 (11%)

Query: 30  IPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSE-LGLLKQL 88
           I S L        + +               L+  + ++   +++   +P+  L   +Q+
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77

Query: 89  NMFQVSANYLTGSIPIQLF-NISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWF 147
            +  ++   +   I    F    ++    +  N +   +P +V   +P + VL+L  N  
Sbjct: 78  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135

Query: 148 TGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLV--NCTFLEVVS 205
           +  +P  I               L  L+ + NNL          ++       T L+ + 
Sbjct: 136 S-SLPRGI---------FHNTPKLTTLSMSNNNL--------ERIEDDTFQATTSLQNLQ 177

Query: 206 LSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIP 265
           LSSN L+ V  + I +    L +  +S N +     + +     +  +    N +   + 
Sbjct: 178 LSSNRLTHVDLSLIPS----LFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVR 227

Query: 266 TSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKL 325
             V   ++L +L L  N ++    + L N   L EVDL  N +   +        +L++L
Sbjct: 228 GPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 283

Query: 326 DLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIP 385
            +S+N L   +      + +  +LDLS NHL   +     +   ++ L L  N +   + 
Sbjct: 284 YISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK 340

Query: 386 TSLASCVGLEYLNFSDNSFQG-PIHSGFSSLKGLQDLDLSRN 426
             L++   L+ L  S N +    + + F ++      D  ++
Sbjct: 341 --LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  122 bits (307), Expect = 5e-29
 Identities = 57/303 (18%), Positives = 110/303 (36%), Gaps = 18/303 (5%)

Query: 153 PSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLS 212
              +     PE      NL       +     +  D+ F    +     ++V+  ++++ 
Sbjct: 5   QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64

Query: 213 GVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEVNLLTGSIPTSV-GY 270
            +    + +F   +  L ++  +I   I T        +  + M  N +   +P  V   
Sbjct: 65  KLPAALLDSFRQ-VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQN 121

Query: 271 LLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDN 330
           +  L VL L  N +S        N   LT + +  N++             LQ L LS N
Sbjct: 122 VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 181

Query: 331 NLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLAS 390
            L+  +   +  + S    ++S N LS      +     +++LD S N ++  +   +  
Sbjct: 182 RLT-HVDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV-- 230

Query: 391 CVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFN 450
            V L  L    N+      +   +  GL ++DLS N     +       + L++L +S N
Sbjct: 231 NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN 288

Query: 451 NLE 453
            L 
Sbjct: 289 RLV 291

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 96.5 bits (240), Expect = 9e-21
 Identities = 40/207 (19%), Positives = 76/207 (36%), Gaps = 14/207 (6%)

Query: 270 YLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSD 329
            L   ++++   + +     + L +   +  ++L    I      A      +QKL +  
Sbjct: 49  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108

Query: 330 NNLSGTIPREVI-GLSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLDLSENKLSGEIPTS 387
           N +   +P  V   +    +L L RN LS  +P  +      +  L +S N L      +
Sbjct: 109 NAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDT 166

Query: 388 LASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNL 447
             +   L+ L  S N      H   S +  L   ++S N  S      L     +++L+ 
Sbjct: 167 FQATTSLQNLQLSSNRLT---HVDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDA 218

Query: 448 SFNNLEGEVPSEGVFKNVRAVSIIGNN 474
           S N++   V    V   +  + +  NN
Sbjct: 219 SHNSIN-VVR-GPVNVELTILKLQHNN 243

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  122 bits (309), Expect = 1e-30
 Identities = 63/289 (21%), Positives = 110/289 (38%), Gaps = 23/289 (7%)

Query: 199 TFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEV 257
               ++ L +N +S +  +       HL  L +  N+IS  I       L+ L  + +  
Sbjct: 54  PDTTLLDLQNNDISELRKDDFKGLQ-HLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISK 111

Query: 258 NLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIR-GSIPSAL 316
           N L   IP ++     L  L +  N+I          L  +  +++ GN +         
Sbjct: 112 NHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGA 168

Query: 317 GNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLDL 375
            + L+L  L +S+  L+  IP+++    +   L L  N +   I LE   R   + +L L
Sbjct: 169 FDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQA-IELEDLLRYSKLYRLGL 224

Query: 376 SENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP-- 433
             N++      SL+    L  L+  +N     + +G   LK LQ + L  NN + K+   
Sbjct: 225 GHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVN 282

Query: 434 -----MFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSII--GNNK 475
                 F     +   ++L  N +         F+ V     I  GN K
Sbjct: 283 DFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 97.0 bits (242), Expect = 6e-22
 Identities = 52/283 (18%), Positives = 97/283 (34%), Gaps = 43/283 (15%)

Query: 134 LPNIRVLLLGSNWFTGEIPPSISNASSIPED-LGKLKNLIRLNFARNNLGTGKGNDLRFL 192
           L ++  L+L +N  +            I E     L+ L +L  ++N+L           
Sbjct: 77  LQHLYALVLVNNKIS-----------KIHEKAFSPLRKLQKLYISKNHL----------- 114

Query: 193 DSLVNCTF--LEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRI-SGTIPTGVGNLKN 249
             +       L  + +  N +  V     +   + +  + M  N + +     G  +   
Sbjct: 115 VEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRN-MNCIEMGGNPLENSGFEPGAFDGLK 173

Query: 250 LILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPS-SLGNLIFLTEVDLQGNSI 308
           L  + +    LT  IP  +     L  L L  NKI   I    L     L  + L  N I
Sbjct: 174 LNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQI 229

Query: 309 RGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEV---- 364
           R     +L     L++L L +N LS  +P  +  L    ++ L  N+++  + +      
Sbjct: 230 RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK-VGVNDFCPV 287

Query: 365 ---GRLKGIQQLDLSENKLS-GEIPTSLASCV-GLEYLNFSDN 402
               +      + L  N +   E+  +   CV     + F + 
Sbjct: 288 GFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 91.2 bits (227), Expect = 5e-20
 Identities = 61/354 (17%), Positives = 109/354 (30%), Gaps = 66/354 (18%)

Query: 12  HCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSE 71
           HC  LR++      L+  +P E+        L L  N+ +         L  L  L L  
Sbjct: 32  HCH-LRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVN 87

Query: 72  NSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVG 131
           N +S         L++L    +S N+L   IP  L                         
Sbjct: 88  NKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP------------------------ 122

Query: 132 FTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRF 191
               ++  L +  N    ++P  +            L+N+  +    N L         F
Sbjct: 123 ---SSLVELRIHDNRIR-KVPKGV---------FSGLRNMNCIEMGGNPLENSGFEPGAF 169

Query: 192 LDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNL 250
                    L  + +S   L+G+  +        L  L++  N+I   I          L
Sbjct: 170 DGL-----KLNYLRISEAKLTGIPKDLPET----LNELHLDHNKIQ-AIELEDLLRYSKL 219

Query: 251 ILIAMEVNLLTGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIR 309
             + +  N +   I      +L  L+ L L  NK+S  +P+ L +L  L  V L  N+I 
Sbjct: 220 YRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277

Query: 310 GSIPS-------ALGNCLQLQKLDLSDNNLS-GTIPREVI-GLSSFVLLDLSRN 354
             +                   + L +N +    +       ++  + +     
Sbjct: 278 -KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 44.6 bits (106), Expect = 8e-05
 Identities = 22/110 (20%), Positives = 41/110 (37%), Gaps = 8/110 (7%)

Query: 5   EIPANI-THCSELRILDLVVNKLEGNIPSE-LGNLFKLVGLGLTGNNYTGSIPQSLSNLS 62
            I        S+L  L L  N++   I +  L  L  L  L L  N  +  +P  L +L 
Sbjct: 207 AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLK 264

Query: 63  FLQQLSLSENSLSGNIPSE--LGLLKQLNMFQVSANYLTGSIPIQLFNIS 110
            LQ + L  N+++  +       +   +     +   L  + P+  + + 
Sbjct: 265 LLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNN-PVPYWEVQ 312

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  120 bits (304), Expect = 4e-30
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 31/223 (13%)

Query: 567 IGIGGYGYVYKGIL-----GTEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVK 620
           +G G +G VY+G +           VAVK L ++        F+ E   +    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
            I        R      ++ E M  G L+++L +     +Q   L ++  L +A D+A  
Sbjct: 98  CIGVSLQSLPR-----FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 681 LEYL-HHHCHTSIVHCDLKPSNVLLDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
            +YL  +H     +H D+   N LL       VA +GDFG++R ++            KG
Sbjct: 153 CQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA--SYYR----KG 202

Query: 737 SIGYV-----APEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
               +      PE    G  ++  D +SFG+L+ E+F+ G  P
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  121 bits (306), Expect = 3e-29
 Identities = 82/464 (17%), Positives = 160/464 (34%), Gaps = 29/464 (6%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           +     ++I   S+LRIL +  N+++    S      +L  L L+ N           N 
Sbjct: 33  ISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVN- 91

Query: 62  SFLQQLSLSENSL-SGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
             L+ L LS N+  +  I  E G + QL    +S  +L  S  + + +++      V   
Sbjct: 92  --LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE 149

Query: 121 KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNN 180
               +        L +     L   + T +    I + S     +  + NL   N     
Sbjct: 150 TYGEKED---PEGLQDFNTESLHIVFPTNKEFHFILDVS-----VKTVANLELSNIKCVL 201

Query: 181 LGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANF--SSHLIYLYMSANRISG 238
                   L  L  L     L  ++L++   +      I      + + Y  +S  ++ G
Sbjct: 202 EDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQG 261

Query: 239 TIPTGVG-----NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLG 293
            +          +LK L +  +  ++              + + +   +           
Sbjct: 262 QLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPS 321

Query: 294 NLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREV---IGLSSFVLLD 350
            +     +D   N +  ++    G+  +L+ L L  N L   + +       + S   LD
Sbjct: 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLD 380

Query: 351 LSRNHLSGPIPLEV-GRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIH 409
           +S+N +S           K +  L++S N L+  I   L     ++ L+   N  +  I 
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIKS-IP 437

Query: 410 SGFSSLKGLQDLDLSRNNFSGKIPM-FLNTFRFLQKLNLSFNNL 452
                L+ LQ+L+++ N     +P    +    LQK+ L  N  
Sbjct: 438 KQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  104 bits (262), Expect = 1e-23
 Identities = 75/463 (16%), Positives = 156/463 (33%), Gaps = 41/463 (8%)

Query: 43  LGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSI 102
           L ++ N  +      + +LS L+ L +S N +     S     ++L    +S N L   I
Sbjct: 26  LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KI 84

Query: 103 PIQLFNISSMDYFAVTQNKLVGEIPHYVGFT-LPNIRVLLLGSNWFTGEIPPSISNASSI 161
                   ++ +  ++ N     +P    F  +  ++ L L +          I++ +  
Sbjct: 85  SCHPT--VNLKHLDLSFNAF-DALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNIS 141

Query: 162 ------------PEDLGKLKNLIRLNFARNNLGTGKGNDL--RFLDSLVNCTFLEVVSLS 207
                        ED   L++    +         + + +    + ++ N     +  + 
Sbjct: 142 KVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVL 201

Query: 208 SNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTS 267
            ++      + +A   ++     ++ N I  T  + +  L+ +    +    ++      
Sbjct: 202 EDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQG 261

Query: 268 VGY----------LLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALG 317
                        L  L +  +  +               +   +   +  R        
Sbjct: 262 QLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPS 321

Query: 318 NCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVG---RLKGIQQLD 374
                  LD S+N L+ T+      L+    L L  N L   +        ++K +QQLD
Sbjct: 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLD 380

Query: 375 LSENKLSGEIPTSL-ASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP 433
           +S+N +S +      +    L  LN S N     I         ++ LDL  N     IP
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIK-SIP 437

Query: 434 MFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSII--GNN 474
             +     LQ+LN++ N L+  VP +G+F  + ++  I    N
Sbjct: 438 KQVVKLEALQELNVASNQLK-SVP-DGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 86.5 bits (214), Expect = 1e-17
 Identities = 61/448 (13%), Positives = 137/448 (30%), Gaps = 74/448 (16%)

Query: 53  SIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSM 112
            +P+ LS       L++S+N +S    S++  L +L +  +S N +   + I +F     
Sbjct: 14  HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFK---- 66

Query: 113 DYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLI 172
                                   +  L L  N               I        NL 
Sbjct: 67  --------------------FNQELEYLDLSHNKLV-----------KISCH--PTVNLK 93

Query: 173 RLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMS 232
            L+ + N          +   ++     L+ + LS+  L       IA+ +   + L + 
Sbjct: 94  HLDLSFNAFDALP--ICKEFGNMSQ---LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLG 148

Query: 233 ANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPT-----SVGYLLKLQVLSLFGNKISGE 287
                   P     L++    ++ +   T          SV  +  L++ ++       +
Sbjct: 149 ETYGEKEDP---EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNK 205

Query: 288 ------IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCL---QLQKLDLSDNNLSGTIPR 338
                 I + L     L+ + L       +    +   +    +    +S+  L G +  
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDF 265

Query: 339 EVI-----GLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVG 393
                    L +  +  +  +    P          +   + + +          +    
Sbjct: 266 RDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP 325

Query: 394 LEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFR---FLQKLNLSFN 450
             +L+FS+N     +      L  L+ L L  N    ++            LQ+L++S N
Sbjct: 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQN 384

Query: 451 NLEGEVPSEGVFKNVRAVSI--IGNNKL 476
           ++  +   +G     +++    + +N L
Sbjct: 385 SVSYDEK-KGDCSWTKSLLSLNMSSNIL 411

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  119 bits (300), Expect = 3e-29
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 31/223 (13%)

Query: 567 IGIGGYGYVYKGIL-----GTEETNVAVKVL-DLQQRGASKSFIAECEALRSIRHRNLVK 620
           +G G +G VY+G +           VAVK L ++        F+ E   +    H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
            I        +      ++ E M  G L+++L +     +Q   L ++  L +A D+A  
Sbjct: 139 CIGVS----LQSLPR-FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 681 LEYL-HHHCHTSIVHCDLKPSNVLLDNE---MVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
            +YL  +H     +H D+   N LL       VA +GDFG++R ++            KG
Sbjct: 194 CQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA--GYY----RKG 243

Query: 737 SIGYV-----APEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
               +      PE    G  ++  D +SFG+L+ E+F+ G  P
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  117 bits (296), Expect = 4e-29
 Identities = 47/223 (21%), Positives = 84/223 (37%), Gaps = 44/223 (19%)

Query: 566 LIGIGGYGYVYKG---ILGTEETNVAVKVL--------DLQQRGASKSFIAECEALRSIR 614
           L+G GG G VY+    +       VA+K++          + R        E      ++
Sbjct: 41  LVGRGGMGDVYEAEDTVRERI---VALKLMSETLSSDPVFRTR-----MQREARTAGRLQ 92

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVY---EFMPNGSLENWLNQKEDEQNQRPKLNLMQRL 671
             ++V        I   G E    +Y     +    L   L +       +  L   + +
Sbjct: 93  EPHVV-------PIHDFG-EIDGQLYVDMRLINGVDLAAMLRR-------QGPLAPPRAV 137

Query: 672 SIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTST 731
           +I   + + L+  H        H D+KP N+L+  +  A++ DFG++    D     T  
Sbjct: 138 AIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK--LTQL 192

Query: 732 SRVKGSIGYVAPEYGALGEVSTH-GDEYSFGILMLEMFTGKRP 773
               G++ Y+APE       +T+  D Y+   ++ E  TG  P
Sbjct: 193 GNTVGTLYYMAPER-FSESHATYRADIYALTCVLYECLTGSPP 234

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  118 bits (297), Expect = 1e-28
 Identities = 52/308 (16%), Positives = 94/308 (30%), Gaps = 52/308 (16%)

Query: 566 LIGIGGYGYVYKG---ILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRH---- 615
           ++G        +      G       V V    +     A K    E   LR +R     
Sbjct: 85  VLGQEDPYAYLEATDQETGES---FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ 141

Query: 616 ------------RNLVKIITSCSSIDTRGNE---FKALVYEFMP--NGSLENWLNQKEDE 658
                        +LVK       I  R +E   +    +   P    +L+ +       
Sbjct: 142 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 201

Query: 659 QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS 718
            +    L    RL + + V  +L  LHH+    +VH  L+P +++LD      +  F   
Sbjct: 202 SSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL 258

Query: 719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRP 773
               D +   +   R        A      G+          D ++ G+ +  ++    P
Sbjct: 259 V--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

Query: 774 -TDDMFEEGLSLHKYAKMGLPDQVAEII------DPA---ILEEALEIQAGIVKELQPNL 823
            TDD    G      +   +P  V  ++            +  +A+E      ++L+  L
Sbjct: 317 NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME--TPEYEQLRTEL 374

Query: 824 RAKFHEIQ 831
            A     Q
Sbjct: 375 SAALPLYQ 382

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  116 bits (293), Expect = 1e-28
 Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 41/230 (17%)

Query: 567 IGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQRGASKS----FIAECEALRSIRHRN 617
           +G G +G V+           ++  VAVK L    + AS+S    F  E E L  ++H++
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL----KEASESARQDFQREAELLTMLQHQH 104

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL--------NQKEDEQNQRPKLNLMQ 669
           +V+    C+           +V+E+M +G L  +L             E      L L Q
Sbjct: 105 IVRFFGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159

Query: 670 RLSIAIDVANVLEYL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQ 728
            L++A  VA  + YL   H     VH DL   N L+   +V  +GDFG+SR ++      
Sbjct: 160 LLAVASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYST---- 211

Query: 729 TSTSRVKGS----IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
               RV G     I ++ PE     + +T  D +SFG+++ E+FT GK+P
Sbjct: 212 -DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  115 bits (291), Expect = 2e-28
 Identities = 51/233 (21%), Positives = 96/233 (41%), Gaps = 22/233 (9%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
            +G GG+ YV       +    A+K +   ++   +    E +  R   H N+++++  C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
                  +E   L+  F   G+L N + +    +++   L   Q L + + +   LE +H
Sbjct: 96  LRERGAKHEAW-LLLPFFKRGTLWNEIERL---KDKGNFLTEDQILWLLLGICRGLEAIH 151

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK------GSIG 739
                   H DLKP+N+LL +E    + D G       +         ++       +I 
Sbjct: 152 AK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208

Query: 740 YVAPE------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK 786
           Y APE      +  + E +   D +S G ++  M  G+ P D +F++G S+  
Sbjct: 209 YRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (293), Expect = 2e-28
 Identities = 27/257 (10%), Positives = 61/257 (23%), Gaps = 40/257 (15%)

Query: 566 LIGIGGYGYVYKGILGTEETN--VAVKVLD---LQQRGASKSFIAECEALRSIRHRNLV- 619
            + +G    V+       E     A+KV        R   +       A   +   +   
Sbjct: 69  PLRVGDRSVVFLVR--DVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126

Query: 620 --------------------KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ 659
                                        D        L+     +  LE   +  +   
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVY 185

Query: 660 NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR 719
             R    ++    +   +  +   L       +VH    P N+ +  +    +GD     
Sbjct: 186 VFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW 242

Query: 720 LLHDNSPDQTSTSRVKGSIGYVAPEY--GALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
                    T        + Y   E+   +    +   + +  G+ +  ++    P   +
Sbjct: 243 ------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296

Query: 778 FEEGLSLHKYAKMGLPD 794
                   K   + +P 
Sbjct: 297 TPGIKGSWKRPSLRVPG 313

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  114 bits (289), Expect = 2e-28
 Identities = 55/231 (23%), Positives = 102/231 (44%), Gaps = 41/231 (17%)

Query: 567 IGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQRGASKS----FIAECEALRSIRHRN 617
           +G   +G VYKG L     G +   VA+K L   +  A       F  E      ++H N
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL---KDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL---------NQKEDEQNQRPKLNLM 668
           +V ++       T+     ++++ +  +G L  +L            +D++  +  L   
Sbjct: 74  VVCLLGVV----TKDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 669 QRLSIAIDVANVLEYL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD 727
             + +   +A  +EYL  HH     VH DL   NVL+ +++   + D GL R ++     
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVYA---- 180

Query: 728 QTSTSRVKGS----IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
                ++ G+    I ++APE    G+ S   D +S+G+++ E+F+ G +P
Sbjct: 181 -ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  115 bits (291), Expect = 2e-28
 Identities = 51/225 (22%), Positives = 104/225 (46%), Gaps = 35/225 (15%)

Query: 567 IGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQRGASKS----FIAECEALRSIRHRN 617
           +G G +G VY+G+         ET VA+K +      AS      F+ E   ++     +
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFNCHH 89

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL---NQKEDEQNQRPKLNLMQRLSIA 674
           +V+++       ++G     ++ E M  G L+++L                +L + + +A
Sbjct: 90  VVRLLGVV----SQGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 675 IDVANVLEYLH-HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
            ++A+ + YL+ +      VH DL   N ++  +    +GDFG++R +++     T   R
Sbjct: 145 GEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-----TDYYR 195

Query: 734 VKGS----IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
             G     + +++PE    G  +T+ D +SFG+++ E+ T  ++P
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  115 bits (290), Expect = 2e-28
 Identities = 61/303 (20%), Positives = 108/303 (35%), Gaps = 31/303 (10%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITS 624
           ++G G    V++G         A+KV +           + E E L+ + H+N+VK+   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-- 73

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
            +  +      K L+ EF P GSL   L +          L   + L +  DV   + +L
Sbjct: 74  -AIEEETTTRHKVLIMEFCPCGSLYTVLEEPS----NAYGLPESEFLIVLRDVVGGMNHL 128

Query: 685 HHHCHTSIVHCDLKPSNVLL----DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
             +    IVH ++KP N++     D + V  + DFG +R L D+    +    + G+  Y
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS----LYGTEEY 181

Query: 741 VAPE-YGALGEVSTHGDEY-------SFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL 792
           + P+ Y        H  +Y       S G+      TG  P         +     K+ +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI-I 240

Query: 793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI 852
             + +  I      E   I       +  +L      +   +L   IL ++         
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA-NILEAD--QEKCWGF 297

Query: 853 QDA 855
              
Sbjct: 298 DQF 300

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  114 bits (287), Expect = 4e-28
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 42/231 (18%)

Query: 567 IGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQRGASKS----FIAECEALRSIRHRN 617
           +G G +G V+           ++  VAVK L    +  + +    F  E E L +++H +
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL----KDPTLAARKDFQREAELLTNLQHEH 78

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL---------NQKEDEQNQRPKLNLM 668
           +VK    C   D        +V+E+M +G L  +L               +  + +L L 
Sbjct: 79  IVKFYGVCGDGDPL-----IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133

Query: 669 QRLSIAIDVANVLEYL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD 727
           Q L IA  +A+ + YL   H     VH DL   N L+   ++  +GDFG+SR ++     
Sbjct: 134 QMLHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVYST--- 186

Query: 728 QTSTSRVKGS----IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
                RV G     I ++ PE     + +T  D +SFG+++ E+FT GK+P
Sbjct: 187 --DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  113 bits (284), Expect = 1e-27
 Identities = 55/283 (19%), Positives = 112/283 (39%), Gaps = 43/283 (15%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNL--VK 620
             IG GG   V++ +   ++   A+K ++L++       S+  E   L  ++  +   ++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
           +        T    +  +V E   N  L +WL +K+        ++  +R S   ++   
Sbjct: 93  LYDY---EITDQYIY--MVMECG-NIDLNSWLKKKK-------SIDPWERKSYWKNMLEA 139

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           +  +H H    IVH DLKP+N L+ + M+  + DFG++  +  ++      S   G++ Y
Sbjct: 140 VHTIHQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS-QVGTVNY 194

Query: 741 VAPE----YGALGEVSTHGDEY-------SFGILMLEMFTGKRPTDDMFEEGLSLHKYAK 789
           + PE      +  E      +        S G ++  M  GK P   +  +   LH    
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254

Query: 790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQ--PNLRAKFHEI 830
                +  +I +     +  ++   +   L+  P  R    E+
Sbjct: 255 PNHEIEFPDIPEK----DLQDV---LKCCLKRDPKQRISIPEL 290

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  112 bits (283), Expect = 1e-27
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 26/222 (11%)

Query: 566 LIGIGGYGYVYKGI-LGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
           ++G G YG VY G  L  +   +A+K +  +    S+    E    + ++H+N+V+ + S
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVR-IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE-- 682
            S      N F  +  E +P GSL   L      +++   L   ++  I      +LE  
Sbjct: 88  FSE-----NGFIKIFMEQVPGGSLSALL------RSKWGPLKDNEQT-IGFYTKQILEGL 135

Query: 683 -YLHHHCHTSIVHCDLKPSNVLLDNEM-VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
            YLH +    IVH D+K  NVL++    V  + DFG S+ L   +P   +     G++ Y
Sbjct: 136 KYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET---FTGTLQY 189

Query: 741 VAPE--YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEE 780
           +APE             D +S G  ++EM TGK P  ++ E 
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP 231

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  112 bits (283), Expect = 3e-27
 Identities = 60/281 (21%), Positives = 115/281 (40%), Gaps = 39/281 (13%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKII 622
             IG GG   V++ +   ++   A+K ++L++       S+  E   L  ++  +  KII
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKII 72

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
                  T    +  +V E   N  L +WL +K+        ++  +R S   ++   + 
Sbjct: 73  RLYDYEITDQYIY--MVMEC-GNIDLNSWLKKKK-------SIDPWERKSYWKNMLEAVH 122

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
            +H H    IVH DLKP+N L+ + M+  + DFG++  +  ++      S   G++ Y+ 
Sbjct: 123 TIHQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS-QVGTVNYMP 177

Query: 743 PE-----------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG 791
           PE             +  ++S   D +S G ++  M  GK P   +  +   LH      
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237

Query: 792 LPDQVAEIIDPAILEEALEIQAGIVKELQ--PNLRAKFHEI 830
              +  +I +        ++Q  +   L+  P  R    E+
Sbjct: 238 HEIEFPDIPEK-------DLQDVLKCCLKRDPKQRISIPEL 271

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  113 bits (285), Expect = 4e-27
 Identities = 62/314 (19%), Positives = 110/314 (35%), Gaps = 31/314 (9%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITS 624
           ++G G    V++G         A+KV +           + E E L+ + H+N+VK+   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-- 73

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
            +  +      K L+ EF P GSL   L +          L   + L +  DV   + +L
Sbjct: 74  -AIEEETTTRHKVLIMEFCPCGSLYTVLEEPS----NAYGLPESEFLIVLRDVVGGMNHL 128

Query: 685 HHHCHTSIVHCDLKPSNVLL----DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
             +    IVH ++KP N++     D + V  + DFG +R L D+    +    + G+  Y
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS----LYGTEEY 181

Query: 741 VAPE-YGALGEVSTHGDEY-------SFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL 792
           + P+ Y        H  +Y       S G+      TG  P         +     K+ +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI-I 240

Query: 793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI 852
             + +  I      E   I       +  +L      +   +L   IL ++         
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA-NILEAD--QEKCWGF 297

Query: 853 QDAIMELQEAQKMR 866
                E  +     
Sbjct: 298 DQFFAETSDILHRM 311

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  113 bits (284), Expect = 5e-27
 Identities = 60/281 (21%), Positives = 115/281 (40%), Gaps = 39/281 (13%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKII 622
             IG GG   V++ +   ++   A+K ++L++       S+  E   L  ++  +  KII
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKII 119

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
                  T    +  +V E   N  L +WL +K+        ++  +R S   ++   + 
Sbjct: 120 RLYDYEITDQYIY--MVMEC-GNIDLNSWLKKKK-------SIDPWERKSYWKNMLEAVH 169

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
            +H H    IVH DLKP+N L+ + M+  + DFG++  +  ++      S   G++ Y+ 
Sbjct: 170 TIHQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS-QVGAVNYMP 224

Query: 743 PE-----------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG 791
           PE             +  ++S   D +S G ++  M  GK P   +  +   LH      
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284

Query: 792 LPDQVAEIIDPAILEEALEIQAGIVKELQ--PNLRAKFHEI 830
              +  +I +        ++Q  +   L+  P  R    E+
Sbjct: 285 HEIEFPDIPEK-------DLQDVLKCCLKRDPKQRISIPEL 318

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  110 bits (278), Expect = 9e-27
 Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 47/235 (20%)

Query: 567 IGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQRGASKS----FIAECEALRSI-RHR 616
           +G G +G V +              VAVK+L   + GA+ S     ++E + L  I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 91

Query: 617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL---------NQKEDEQNQRPKLNL 667
           N+V ++ +C    T+      ++ EF   G+L  +L          +   E   +  L L
Sbjct: 92  NVVNLLGAC----TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147

Query: 668 MQRLSIAIDVANVLEYL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSP 726
              +  +  VA  +E+L    C    +H DL   N+LL  + V  + DFGL+R ++ +  
Sbjct: 148 EHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDP- 202

Query: 727 DQTSTSRVKGSIGYV-----APEYGAL--GEVSTHGDEYSFGILMLEMFT-GKRP 773
                  V+     +     APE   +     +   D +SFG+L+ E+F+ G  P
Sbjct: 203 -----DYVRKGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  113 bits (285), Expect = 1e-26
 Identities = 68/258 (26%), Positives = 104/258 (40%), Gaps = 17/258 (6%)

Query: 201 LEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEVNL 259
              V  +   LS V P       S+  YL +  N I   I      +L +L ++ +  N 
Sbjct: 56  FSKVVCTRRGLSEV-P---QGIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNS 110

Query: 260 LTGSIPTSV-GYLLKLQVLSLFGNKISGEIPS-SLGNLIFLTEVDLQGNSIRGSIPS-AL 316
           +   I       L  L  L LF N ++  IPS +   L  L E+ L+ N I  SIPS A 
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAF 167

Query: 317 GNCLQLQKLDLSDNNLSGTIPREV-IGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDL 375
                L +LDL +      I      GL +   L+L   ++   +P  +  L G+++L++
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEM 225

Query: 376 SENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSG-FSSLKGLQDLDLSRNNFSGKIPM 434
           S N      P S      L+ L   ++     I    F  L  L +L+L+ NN S     
Sbjct: 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAHNNLSSLPHD 284

Query: 435 FLNTFRFLQKLNLSFNNL 452
                R+L +L+L  N  
Sbjct: 285 LFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  106 bits (266), Expect = 2e-24
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 17/211 (8%)

Query: 274 LQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLS 333
            + L+L  N I      +  +L  L  + L  NSIR     A      L  L+L DN L+
Sbjct: 77  TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT 136

Query: 334 GTIPREV-IGLSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLDLSE-NKLSGEIPTSLAS 390
             IP      LS    L L  N +   IP     R+  + +LDL E  KL      +   
Sbjct: 137 -VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194

Query: 391 CVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFR---FLQKLNL 447
              L+YLN    + +  + +  + L GL++L++S N+F  +I     +F     L+KL +
Sbjct: 195 LFNLKYLNLGMCNIKD-MPN-LTPLVGLEELEMSGNHFP-EIRP--GSFHGLSSLKKLWV 249

Query: 448 SFNNLEGEVPSEGVFKNVRAVSI--IGNNKL 476
             + +   +     F  + ++    + +N L
Sbjct: 250 MNSQVS-LIE-RNAFDGLASLVELNLAHNNL 278

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 91.0 bits (226), Expect = 2e-19
 Identities = 51/247 (20%), Positives = 84/247 (34%), Gaps = 48/247 (19%)

Query: 135 PNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDS 194
            N R L L  N     I                L +L  L   RN++   +      L S
Sbjct: 75  SNTRYLNLMENNIQ-MIQAD---------TFRHLHHLEVLQLGRNSIRQIEVGAFNGLAS 124

Query: 195 LVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV---------- 244
           L        + L  N L+ +   +    S  L  L++  N I  +IP+            
Sbjct: 125 L------NTLELFDNWLTVIPSGAFEYLSK-LRELWLRNNPIE-SIPSYAFNRVPSLMRL 176

Query: 245 ----------------GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEI 288
                             L NL  + + +  +   +P     L+ L+ L + GN      
Sbjct: 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTP-LVGLEELEMSGNHFPEIR 234

Query: 289 PSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFV 347
           P S   L  L ++ +  + +     +A      L +L+L+ NNLS ++P ++   L   V
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLV 293

Query: 348 LLDLSRN 354
            L L  N
Sbjct: 294 ELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 86.7 bits (215), Expect = 6e-18
 Identities = 67/310 (21%), Positives = 103/310 (33%), Gaps = 79/310 (25%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
           E+P  I   S  R L+L+ N ++        +L  L  L L  N+       + + L+ L
Sbjct: 68  EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125

Query: 65  QQLSLSENSLSGNIPSE----LGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
             L L +N L+  IPS     L  L++L +     N +  SIP   FN            
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWL---RNNPIE-SIPSYAFN------------ 168

Query: 121 KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPED-LGKLKNLIRLNFARN 179
                        +P++  L LG           +     I E     L NL  LN    
Sbjct: 169 ------------RVPSLMRLDLGEL-------KKLE---YISEGAFEGLFNLKYLNLGMC 206

Query: 180 NLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGT 239
           N+        + + +L     LE + +S N    + P S    S  L  L++  +++S  
Sbjct: 207 NI--------KDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLS-SLKKLWVMNSQVS-L 256

Query: 240 IPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLT 299
           I                     G        L  L  L+L  N +S         L +L 
Sbjct: 257 IERNA---------------FDG--------LASLVELNLAHNNLSSLPHDLFTPLRYLV 293

Query: 300 EVDLQGNSIR 309
           E+ L  N   
Sbjct: 294 ELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 80.2 bits (198), Expect = 6e-16
 Identities = 53/285 (18%), Positives = 97/285 (34%), Gaps = 55/285 (19%)

Query: 53  SIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLF-NISS 111
            +PQ +   S  + L+L EN++          L  L + Q+  N +   I +  F  ++S
Sbjct: 68  EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLAS 124

Query: 112 MDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNL 171
           ++   +  N L   IP      L  +R L L +N     IP              ++ +L
Sbjct: 125 LNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYA---------FNRVPSL 173

Query: 172 IRLNFARNNLGTGKGNDLRFL--DSLVNCTFLEVVSLSSNSLSGVLPNSIANFS--SHLI 227
           +RL+             L ++   +      L+ ++L   ++       + N +    L 
Sbjct: 174 MRLDLGELK-------KLEYISEGAFEGLFNLKYLNLGMCNIK-----DMPNLTPLVGLE 221

Query: 228 YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
            L MS N     I  G                  G        L  L+ L +  +++S  
Sbjct: 222 ELEMSGNHFP-EIRPGS---------------FHG--------LSSLKKLWVMNSQVSLI 257

Query: 288 IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNL 332
             ++   L  L E++L  N++             L +L L  N  
Sbjct: 258 ERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  113 bits (285), Expect = 1e-26
 Identities = 72/410 (17%), Positives = 131/410 (31%), Gaps = 63/410 (15%)

Query: 45  LTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPI 104
                   +   S   L+ L  L    +S++ ++   +  L  L     ++N +T    +
Sbjct: 25  AAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITT---L 79

Query: 105 QLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPED 164
            L   +++ Y A   NKL   +       L  +  L   +N  T               D
Sbjct: 80  DLSQNTNLTYLACDSNKLT-NLDVT---PLTKLTYLNCDTNKLT-------------KLD 122

Query: 165 LGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSS 224
           + +   L  LN ARN L          +D + + T L  +    N     L  +     +
Sbjct: 123 VSQNPLLTYLNCARNTLTE--------ID-VSHNTQLTELDCHLNKKITKLDVT---PQT 170

Query: 225 HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKI 284
            L  L  S N+I+  +   V   K L  +  + N +T  +   +   ++L  L    NK+
Sbjct: 171 QLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL 224

Query: 285 SGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLS 344
           + EI   +  L  LT  D   N +   +   +    +L  L     +L        I L+
Sbjct: 225 T-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL------EIDLT 272

Query: 345 SFV-LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNS 403
               L+            L+V     +  LD     ++ E+   L+    L YL  ++  
Sbjct: 273 HNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTE 329

Query: 404 FQG-PIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNL 452
                +    S    L+ L     +        +     L     +    
Sbjct: 330 LTELDV----SHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQT 373

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  108 bits (272), Expect = 5e-25
 Identities = 74/446 (16%), Positives = 136/446 (30%), Gaps = 83/446 (18%)

Query: 9   NITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLS 68
           +    + L  LD   + +  ++   +  L  L  L  T NN T ++   LS  + L  L+
Sbjct: 37  SEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLA 91

Query: 69  LSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPH 128
              N L+ N+   +  L +L       N LT  + +                        
Sbjct: 92  CDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVS----------------------- 124

Query: 129 YVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGND 188
                 P +  L    N  T      I        D+     L  L+   N   T     
Sbjct: 125 ----QNPLLTYLNCARNTLT-----EI--------DVSHNTQLTELDCHLNKKIT----- 162

Query: 189 LRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLK 248
                 +   T L  +  S N ++ +    ++     L  L    N I+  +   +    
Sbjct: 163 ---KLDVTPQTQLTTLDCSFNKITEL---DVSQNKL-LNRLNCDTNNIT-KLD--LNQNI 212

Query: 249 NLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSI 308
            L  +    N LT  I   V  L +L       N ++ E+  S   L  LT +      +
Sbjct: 213 QLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDL 266

Query: 309 RGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLK 368
              I   L +  QL             +  +V   +   LLD     ++    L++ +  
Sbjct: 267 L-EID--LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT---ELDLSQNP 318

Query: 369 GIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNF 428
            +  L L+  +L+ E+   ++    L+ L+  +   Q    S    +  L +   +    
Sbjct: 319 KLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQT 373

Query: 429 SGKIPMFLNTFRFLQKLNLSFNNLEG 454
                  L        ++    +  G
Sbjct: 374 ITMPKETLTNNSLTIAVSPDLLDQFG 399

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  104 bits (262), Expect = 8e-24
 Identities = 76/399 (19%), Positives = 131/399 (32%), Gaps = 62/399 (15%)

Query: 9   NITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLS 68
            I   + L  L    N +   +   L     L  L    N  T ++   ++ L+ L  L+
Sbjct: 59  GIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLN 112

Query: 69  LSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPH 128
              N L+    S+  LL  LN    + N LT    I + + + +       NK + ++  
Sbjct: 113 CDTNKLTKLDVSQNPLLTYLNC---ARNTLT---EIDVSHNTQLTELDCHLNKKITKLD- 165

Query: 129 YVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGND 188
                   +  L    N  T               D+ + K L RLN   NN        
Sbjct: 166 --VTPQTQLTTLDCSFNKITE-------------LDVSQNKLLNRLNCDTNN-------- 202

Query: 189 LRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLK 248
           +  LD L     L  +  SSN L+ +    +   +  L Y   S N ++  +   V  L 
Sbjct: 203 ITKLD-LNQNIQLTFLDCSSNKLTEI---DVTPLTQ-LTYFDCSVNPLT-ELD--VSTLS 254

Query: 249 NLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSI 308
            L  +      L   I   + +  +L      G +   E+   + +   L  +D Q   I
Sbjct: 255 KLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGI 309

Query: 309 RGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLK 368
              +   L    +L  L L++  L+  +   V   +    L     H+       VG++ 
Sbjct: 310 T-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIP 361

Query: 369 GIQQLDLSENKLSGEIP-----TSLASCVGLEYLNFSDN 402
            +     +E +            SL   V  + L+   N
Sbjct: 362 ALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGN 400

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  103 bits (259), Expect = 2e-23
 Identities = 73/405 (18%), Positives = 123/405 (30%), Gaps = 83/405 (20%)

Query: 48  NNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLF 107
            ++    P    N +     +    +       +L  L  L+      + +T    I+  
Sbjct: 9   QSFNDWFP--DDNFASEVAAAFEMQATDTISEEQLATLTSLD---CHNSSITDMTGIE-- 61

Query: 108 NISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGK 167
                                     L  +  L+  SN  T     ++        DL +
Sbjct: 62  -------------------------KLTGLTKLICTSNNIT-----TL--------DLSQ 83

Query: 168 LKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLI 227
             NL  L    N L             +   T L  ++  +N L+ +  +        L 
Sbjct: 84  NTNLTYLACDSNKLTN---------LDVTPLTKLTYLNCDTNKLTKLDVSQNPL----LT 130

Query: 228 YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
           YL  + N ++  I   V +   L  +   +N     +   V    +L  L    NKI+  
Sbjct: 131 YLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE- 184

Query: 288 IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV 347
               +     L  ++   N+I   +   L   +QL  LD S N L+  I   V  L+   
Sbjct: 185 --LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLT 236

Query: 348 LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP 407
             D S N L+    L+V  L  +  L   +  L  EI   L     L Y           
Sbjct: 237 YFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKE 290

Query: 408 IHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNL 452
           +    +    L  LD      + ++ +  N    L  L L+   L
Sbjct: 291 LD--VTHNTQLYLLDCQAAGIT-ELDLSQNP--KLVYLYLNNTEL 330

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 85.1 bits (211), Expect = 2e-17
 Identities = 44/208 (21%), Positives = 78/208 (37%), Gaps = 22/208 (10%)

Query: 246 NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQG 305
           N  + +  A E+         S   L  L  L    + I+    + +  L  LT++    
Sbjct: 19  NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTS 73

Query: 306 NSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVG 365
           N+I  ++   L     L  L    N L+  +   V  L+    L+   N L+    L+V 
Sbjct: 74  NNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVS 124

Query: 366 RLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSR 425
           +   +  L+ + N L+ EI  S      L  L+   N     +    +    L  LD S 
Sbjct: 125 QNPLLTYLNCARNTLT-EIDVS--HNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSF 179

Query: 426 NNFSGKIPMFLNTFRFLQKLNLSFNNLE 453
           N  + ++   ++  + L +LN   NN+ 
Sbjct: 180 NKIT-ELD--VSQNKLLNRLNCDTNNIT 204

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 20/126 (15%), Positives = 36/126 (28%), Gaps = 13/126 (10%)

Query: 328 SDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTS 387
              + +   P +    +S V              +   +L  +  LD   + ++    T 
Sbjct: 7   QTQSFNDWFPDDN--FASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITD--MTG 59

Query: 388 LASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNL 447
           +    GL  L  + N+         S    L  L    N  +  +   +     L  LN 
Sbjct: 60  IEKLTGLTKLICTSNNITTLD---LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNC 113

Query: 448 SFNNLE 453
             N L 
Sbjct: 114 DTNKLT 119

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  110 bits (277), Expect = 1e-26
 Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 38/229 (16%)

Query: 565 NLIGIGGYGYVYKGIL--GTEETNVAVKVLDLQQRGASKS----FIAECEALRSI-RHRN 617
           ++IG G +G V K  +       + A+K +   +  ASK     F  E E L  +  H N
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYASKDDHRDFAGELEVLCKLGHHPN 87

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL---------NQKEDEQNQRPKLNLM 668
           ++ ++ +C            L  E+ P+G+L ++L                +    L+  
Sbjct: 88  IINLLGAC----EHRGYL-YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 669 QRLSIAIDVANVLEYL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD 727
           Q L  A DVA  ++YL         +H DL   N+L+    VA + DFGLSR        
Sbjct: 143 QLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR----GQEV 194

Query: 728 QTSTSRVKGSIGYVAPEYGAL--GEVSTHGDEYSFGILMLEMFT-GKRP 773
               +  +  + ++A E  +L     +T+ D +S+G+L+ E+ + G  P
Sbjct: 195 YVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  110 bits (277), Expect = 1e-26
 Identities = 60/240 (25%), Positives = 97/240 (40%), Gaps = 51/240 (21%)

Query: 567 IGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQRGASKS----FIAECEALRSIRHRN 617
           +G G +G V K            T VAVK+L   +  AS S     ++E   L+ + H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKML---KENASPSELRDLLSEFNVLKQVNHPH 87

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL-----------------NQKEDEQN 660
           ++K+  +C    ++      L+ E+   GSL  +L                 N    +  
Sbjct: 88  VIKLYGAC----SQDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 661 QRPKLNLMQRLSIAIDVANVLEYL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR 719
               L +   +S A  ++  ++YL         VH DL   N+L+       + DFGLSR
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSR 198

Query: 720 LLHDNSPDQTSTSRVKGSIGYV-----APEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
            +++        S VK S G +     A E       +T  D +SFG+L+ E+ T G  P
Sbjct: 199 DVYEED------SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  109 bits (274), Expect = 2e-26
 Identities = 51/227 (22%), Positives = 94/227 (41%), Gaps = 33/227 (14%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
            LIG GG+G V+K     +     +K +      A +    E +AL  + H N+V     
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNGC 72

Query: 625 --------CSSIDTRGNEFKALVY---EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
                    +S           ++   EF   G+LE W+ ++     +  KL+ +  L +
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-----RGEKLDKVLALEL 127

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
              +   ++Y+H      +++ DLKPSN+ L +     +GDFGL   L ++         
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR---- 180

Query: 734 VKGSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRPTDDM 777
            KG++ Y++PE         +G   D Y+ G+++ E+        + 
Sbjct: 181 SKGTLRYMSPE---QISSQDYGKEVDLYALGLILAELLHVCDTAFET 224

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  109 bits (275), Expect = 2e-26
 Identities = 54/232 (23%), Positives = 101/232 (43%), Gaps = 40/232 (17%)

Query: 567 IGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQRGASKS----FIAECEALRSI-RHR 616
           +G G +G V +              VAVK+L   +  A  +     ++E + L  +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKML---KPSAHLTEREALMSELKVLSYLGNHM 87

Query: 617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL-----------NQKEDEQNQRPKL 665
           N+V ++ +C    T G     ++ E+   G L N+L                 ++    L
Sbjct: 88  NIVNLLGAC----TIGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 666 NLMQRLSIAIDVANVLEYLH-HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
           +L   LS +  VA  + +L   +C    +H DL   N+LL +  +  + DFGL+R + ++
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 725 SPDQTSTSRVKGSIGYVAPEYGAL--GEVSTHGDEYSFGILMLEMFT-GKRP 773
           S +       +  + ++APE  ++     +   D +S+GI + E+F+ G  P
Sbjct: 199 S-NYVVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  110 bits (276), Expect = 2e-26
 Identities = 66/280 (23%), Positives = 121/280 (43%), Gaps = 42/280 (15%)

Query: 521 VFVFYQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEG-FSSANL-----IGIGGYGY 574
           V   Y+++ + +    ++ S   + Y  I   +L    +  F   NL     +G G +G 
Sbjct: 2   VDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGK 61

Query: 575 VYKGIL-----GTEETNVAVKVLDLQQRGASKS----FIAECEALRSI-RHRNLVKIITS 624
           V +              VAVK+L   +  A        ++E + +  + +H N+V ++ +
Sbjct: 62  VVEATAFGLGKEDAVLKVAVKML---KSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP-------KLNLMQRLSIAIDV 677
           C    T G     ++ E+   G L N+L +K       P         +    L  +  V
Sbjct: 119 C----THGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173

Query: 678 ANVLEYL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
           A  + +L   +C    +H D+   NVLL N  VA +GDFGL+R + ++S +       + 
Sbjct: 174 AQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNARL 228

Query: 737 SIGYVAPEYGAL--GEVSTHGDEYSFGILMLEMFT-GKRP 773
            + ++APE  ++     +   D +S+GIL+ E+F+ G  P
Sbjct: 229 PVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  110 bits (278), Expect = 2e-26
 Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 46/235 (19%)

Query: 567 IGIGGYGYVYKGIL-------GTEETNVAVKVLDLQQRGASKS----FIAECEALRSI-R 614
           +G G +G V                T VAVK+L   +  A++      I+E E ++ I +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---KSDATEKDLSDLISEMEMMKMIGK 133

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL---------NQKEDEQNQRPKL 665
           H+N++ ++ +C    T+      ++ E+   G+L  +L                N   +L
Sbjct: 134 HKNIINLLGAC----TQDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 666 NLMQRLSIAIDVANVLEYL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
           +    +S A  VA  +EYL    C    +H DL   NVL+  + V  + DFGL+R +H  
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244

Query: 725 SPDQTSTSRVKGSIGYV-----APEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
                     K + G +     APE       +   D +SFG+L+ E+FT G  P
Sbjct: 245 D------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  110 bits (276), Expect = 3e-26
 Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 55/289 (19%)

Query: 525 YQRRKRRRRSKAL----VNSSIEDKYLKISYAELLKATEG-FSSANL-----IGIGGYGY 574
           ++ +K+ R    L    V  S +++Y  + + E     +  F   NL     +G G +G 
Sbjct: 1   HKYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGK 60

Query: 575 VYKGIL-----GTEETNVAVKVLDLQQRGAS----KSFIAECEALRSI-RHRNLVKIITS 624
           V                VAVK+L   +  A     ++ ++E + +  +  H N+V ++ +
Sbjct: 61  VMNATAYGISKTGVSIQVAVKML---KEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWL----------------NQKEDEQNQRPKLNLM 668
           C    T       L++E+   G L N+L                 ++ +E+     L   
Sbjct: 118 C----TLSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 669 QRLSIAIDVANVLEYL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD 727
             L  A  VA  +E+L    C    VH DL   NVL+ +  V  + DFGL+R +  +S +
Sbjct: 173 DLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDIMSDS-N 227

Query: 728 QTSTSRVKGSIGYVAPEYGAL--GEVSTHGDEYSFGILMLEMFT-GKRP 773
                  +  + ++APE  +L  G  +   D +S+GIL+ E+F+ G  P
Sbjct: 228 YVVRGNARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  108 bits (273), Expect = 3e-26
 Identities = 52/224 (23%), Positives = 104/224 (46%), Gaps = 30/224 (13%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASK-SFIAECEALRSIRHRNLVKIITS 624
            +G GG+G V++     ++ N A+K + L  R  ++   + E +AL  + H  +V+   +
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 625 C----SSIDTRGNEFKALVY---EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
                ++   + +  K  +Y   +     +L++W+N     +    +      L I + +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG----RCTIEERERSVCLHIFLQI 127

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQT------ST 731
           A  +E+LH      ++H DLKPSN+    + V  VGDFGL   +  +  +QT      + 
Sbjct: 128 AEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184

Query: 732 SRVKGSIG---YVAPEYGALGEVSTHG---DEYSFGILMLEMFT 769
           +R  G +G   Y++PE       +++    D +S G+++ E+  
Sbjct: 185 ARHTGQVGTKLYMSPE---QIHGNSYSHKVDIFSLGLILFELLY 225

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  108 bits (273), Expect = 4e-26
 Identities = 59/270 (21%), Positives = 95/270 (35%), Gaps = 38/270 (14%)

Query: 525 YQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEE 584
           +Q + RR   +   + +++      S  E       F   + +G G YG V+K     + 
Sbjct: 24  HQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS-FQRLSRLGHGSYGEVFKVRSKEDG 82

Query: 585 TNVAVKVLDLQQRGAS--KSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKALVYE 641
              AVK      RG       +AE  +   + +H   V++     + +  G  +  L  E
Sbjct: 83  RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE---QAWEEGGILY--LQTE 137

Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
                SL+         +     L   Q      D    L +LH      +VH D+KP+N
Sbjct: 138 LC-GPSLQQHC------EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPAN 187

Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE-----YGALGEVSTHGD 756
           + L       +GDFGL   L      +      +G   Y+APE     YG      T  D
Sbjct: 188 IFLGPRGRCKLGDFGLLVELGTAGAGEV----QEGDPRYMAPELLQGSYG------TAAD 237

Query: 757 EYSFGILMLEMFTGKRPTDDMFEEGLSLHK 786
            +S G+ +LE+             G    +
Sbjct: 238 VFSLGLTILEVACNMEL----PHGGEGWQQ 263

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  109 bits (274), Expect = 4e-26
 Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 50/237 (21%)

Query: 567 IGIGGYGYVYKGIL-------GTEETNVAVKVLDLQQRGASKS----FIAECEALRSI-R 614
           +G G +G V              E   VAVK+L   +  A++      ++E E ++ I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGK 99

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL---------NQKEDEQNQRPKL 665
           H+N++ ++ +C    T+      ++ E+   G+L  +L            +  +    ++
Sbjct: 100 HKNIINLLGAC----TQDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 666 NLMQRLSIAIDVANVLEYL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
                +S    +A  +EYL    C    +H DL   NVL+    V  + DFGL+R +++ 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI 210

Query: 725 SPDQTSTSRVKGSIGYV-----APEYGAL--GEVSTHGDEYSFGILMLEMFT-GKRP 773
                     K + G +     APE  AL     +   D +SFG+LM E+FT G  P
Sbjct: 211 D------YYKKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  108 bits (272), Expect = 5e-26
 Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 44/238 (18%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS- 624
           ++G G +G V K     +    A+K +   +     + ++E   L S+ H+ +V+   + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNHQYVVRYYAAW 71

Query: 625 ----CSSIDTRGNEFKALVY---EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
                        + K+ ++   E+  NG+L + ++ +   Q +     L +++  A   
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA--- 128

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK-- 735
              L Y+H      I+H DLKP N+ +D      +GDFGL++ +H +       S+    
Sbjct: 129 ---LSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 736 ---------GSIGYVAPE-------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
                    G+  YVA E       Y    ++    D YS GI+  EM      +  M
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNE--KI----DMYSLGIIFFEMIYP--FSTGM 232

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  113 bits (283), Expect = 6e-26
 Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 32/223 (14%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIA-ECEALRSIRHRNLVK---II 622
           +G GG+GYV + I       VA+K    +    ++     E + ++ + H N+V    + 
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
                +         L  E+   G L  +LNQ E+       L      ++  D+++ L 
Sbjct: 82  DGLQKLAPNDLPL--LAMEYCEGGDLRKYLNQFENCC----GLKEGPIRTLLSDISSALR 135

Query: 683 YLHHHCHTSIVHCDLKPSNVLLD---NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
           YLH +    I+H DLKP N++L      ++  + D G ++ L              G++ 
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF----VGTLQ 188

Query: 740 YVAPE------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDD 776
           Y+APE      Y     V    D +SFG L  E  TG RP   
Sbjct: 189 YLAPELLEQKKYTV--TV----DYWSFGTLAFECITGFRPFLP 225

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  111 bits (279), Expect = 6e-26
 Identities = 77/437 (17%), Positives = 139/437 (31%), Gaps = 69/437 (15%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQ-SLSNLSF 63
           E+PA++ +      +DL +N +     +    L  L  L +        I   +   LS 
Sbjct: 27  ELPAHVNY------VDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80

Query: 64  LQQLSLSENSLSGNIPSE----LGLLKQLNMFQVSANYLTGS-IPIQLF-NISSMDYFAV 117
           L  L L  N     + +     L  L+ L +   +   L G+ +    F  ++S++   +
Sbjct: 81  LIILKLDYNQFL-QLETGAFNGLANLEVLTL---TQCNLDGAVLSGNFFKPLTSLEMLVL 136

Query: 118 TQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFA 177
             N +    P      +    VL L  N              SI E+   L N    +F 
Sbjct: 137 RDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-----------SICEED--LLNFQGKHFT 183

Query: 178 RNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRIS 237
              L       L+               ++   L      +    +S +  L +S N   
Sbjct: 184 LLRL---SSITLQ--------------DMNEYWLGWEKCGNPFKNTS-ITTLDLSGNGFK 225

Query: 238 GTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIF 297
            ++     +                 I + +         S            +   L  
Sbjct: 226 ESMAKRFFDAIAGT-----------KIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEA 274

Query: 298 --LTEVDLQGNSIRGSIPS-ALGNCLQLQKLDLSDNNLSGTIPREV-IGLSSFVLLDLSR 353
             +   DL  + I  ++      +   L++L L+ N ++  I      GL+  + L+LS+
Sbjct: 275 SGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQ 332

Query: 354 NHLSGPIPLEV-GRLKGIQQLDLSENKLSGEIPT-SLASCVGLEYLNFSDNSFQGPIHSG 411
           N L   I   +   L  ++ LDLS N +   +   S      L+ L    N  +      
Sbjct: 333 NFLGS-IDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGI 390

Query: 412 FSSLKGLQDLDLSRNNF 428
           F  L  LQ + L  N +
Sbjct: 391 FDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  107 bits (270), Expect = 8e-25
 Identities = 78/418 (18%), Positives = 135/418 (32%), Gaps = 73/418 (17%)

Query: 64  LQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLV 123
           +  + LS NS++    +    L+ L   +V        I    F                
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFR--------------- 76

Query: 124 GEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGT 183
                     L ++ +L L  N F  ++                L NL  L   + NL  
Sbjct: 77  ---------GLSSLIILKLDYNQFL-QLETGA---------FNGLANLEVLTLTQCNL-D 116

Query: 184 GKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTG 243
           G      F   L +   LE++ L  N++  + P S          L ++ N++  +I   
Sbjct: 117 GAVLSGNFFKPLTS---LEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEE 172

Query: 244 V-----------GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSL 292
                         L ++ L  M    L      +      +  L L GN     +    
Sbjct: 173 DLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF 232

Query: 293 GNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVL--LD 350
            + I  T+           I S + +            N          GL +  +   D
Sbjct: 233 FDAIAGTK-----------IQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCD 281

Query: 351 LSRNHLSGPIPLEV-GRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIH 409
           LS++ +   +   V      ++QL L++N+++     +      L  LN S N       
Sbjct: 282 LSKSKIFA-LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDS 340

Query: 410 SGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRF---LQKLNLSFNNLEGEVPSEGVFKN 464
             F +L  L+ LDLS N+    +     +F     L++L L  N L+  VP +G+F  
Sbjct: 341 RMFENLDKLEVLDLSYNHIRA-LGD--QSFLGLPNLKELALDTNQLK-SVP-DGIFDR 393

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 50.5 bits (121), Expect = 2e-06
 Identities = 46/231 (19%), Positives = 83/231 (35%), Gaps = 44/231 (19%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPS---ELGNLFKLVGLGLTGNNYTGS----- 53
           L  E   N    + +  LDL  N  + ++     +     K+  L L+ +   GS     
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259

Query: 54  IPQSLSNLSF-------LQQLSLSEN---SLSGNIPSELGLLKQLNMFQVSANYLTGSIP 103
             +   N +F       ++   LS++   +L  ++ S    L+QL +   + N +   I 
Sbjct: 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTL---AQNEIN-KID 315

Query: 104 IQLF-NISSMDYFAVTQNKLVGEIPHYVGFT-LPNIRVLLLGSNWFTGEIPPSISNASSI 161
              F  ++ +    ++QN L G I   + F  L  + VL L  N              ++
Sbjct: 316 DNAFWGLTHLLKLNLSQNFL-GSIDSRM-FENLDKLEVLDLSYNHIR-----------AL 362

Query: 162 PEDL-GKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSL 211
            +     L NL  L    N L +         D L +   L+ + L +N  
Sbjct: 363 GDQSFLGLPNLKELALDTNQLKSVPDG---IFDRLTS---LQKIWLHTNPW 407

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  109 bits (274), Expect = 6e-26
 Identities = 60/239 (25%), Positives = 97/239 (40%), Gaps = 49/239 (20%)

Query: 567 IGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQRGASKS----FIAECEALRSIRHRN 617
           IG G +G V++            T VAVK+L   +  AS      F  E   +    + N
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDNPN 111

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL-----------------NQKEDEQN 660
           +VK++  C      G     L++E+M  G L  +L                  +      
Sbjct: 112 IVKLLGVC----AVGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 661 QRPKLNLMQRLSIAIDVANVLEYLH-HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR 719
             P L+  ++L IA  VA  + YL         VH DL   N L+   MV  + DFGLSR
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSR 222

Query: 720 LLHDNSPDQTSTSRVKGS----IGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
            ++          +  G+    I ++ PE       +T  D +++G+++ E+F+ G +P
Sbjct: 223 NIYS-----ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  107 bits (270), Expect = 8e-26
 Identities = 58/268 (21%), Positives = 96/268 (35%), Gaps = 39/268 (14%)

Query: 204 VSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEVNLLTG 262
           +  +S  L+ V P       S    L + +N++  ++P GV   L  L            
Sbjct: 12  IRCNSKGLTSV-P---TGIPSSATRLELESNKLQ-SLPHGVFDKLTQL------------ 54

Query: 263 SIPTSVGYLLKLQVLSLFGNKIS--GEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCL 320
                         LSL  N +S  G    S      L  +DL  N +  ++ S      
Sbjct: 55  ------------TKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLE 101

Query: 321 QLQKLDLSDNNLSGTIPREV-IGLSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLDLSEN 378
           QL+ LD   +NL       V + L + + LD+S  H        +   L  ++ L ++ N
Sbjct: 102 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGN 160

Query: 379 KLSGEI-PTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLN 437
                  P        L +L+ S    +    + F+SL  LQ L++S NNF         
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220

Query: 438 TFRFLQKLNLSFNNLEGEVPSEGVFKNV 465
               LQ L+ S N++      +   ++ 
Sbjct: 221 CLNSLQVLDYSLNHIM-TSK-KQELQHF 246

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 91.6 bits (228), Expect = 3e-20
 Identities = 44/229 (19%), Positives = 84/229 (36%), Gaps = 23/229 (10%)

Query: 134 LPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLD 193
           L  +  L L SN         +S      +      +L  L+ + N + T   N      
Sbjct: 51  LTQLTKLSLSSN--------GLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN------ 96

Query: 194 SLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLIL 252
             +    LE +    ++L  +   S+     +LIYL +S          G+   L +L +
Sbjct: 97  -FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEV 154

Query: 253 IAMEVNLLTGSIPTSV-GYLLKLQVLSLFGNKISGEIPS-SLGNLIFLTEVDLQGNSIRG 310
           + M  N    +    +   L  L  L L   ++  ++   +  +L  L  +++  N+   
Sbjct: 155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS 213

Query: 311 SIPSALGNCLQLQKLDLSDNNLSGTIPREVIG--LSSFVLLDLSRNHLS 357
                      LQ LD S N++  T  ++ +    SS   L+L++N  +
Sbjct: 214 LDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 58/288 (20%), Positives = 91/288 (31%), Gaps = 54/288 (18%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNN--YTGSIPQSLSNLS 62
            +P  I   S    L+L  NKL+         L +L  L L+ N   + G   QS    +
Sbjct: 21  SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 63  FLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKL 122
            L+ L LS N +   + S    L+QL       +         L  +S    F       
Sbjct: 79  SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS--------NLKQMSEFSVFL------ 123

Query: 123 VGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLG 182
                     +L N+  L +            I            L +L  L  A N+  
Sbjct: 124 ----------SLRNLIYLDISHTHTR-VAFNGI---------FNGLSSLEVLKMAGNSF- 162

Query: 183 TGKGNDLRFL--DSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTI 240
                       D       L  + LS   L  + P +  + SS L  L MS N    ++
Sbjct: 163 ------QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS-LQVLNMSHNNFF-SL 214

Query: 241 PTGV-GNLKNLILIAMEVNLLTGSIPTSV--GYLLKLQVLSLFGNKIS 285
            T     L +L ++   +N +  +        +   L  L+L  N  +
Sbjct: 215 DTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  109 bits (273), Expect = 9e-26
 Identities = 40/275 (14%), Positives = 86/275 (31%), Gaps = 54/275 (19%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKS----------------------- 602
           ++G        +        +  V V    +R  S +                       
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 603 -----FIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKED 657
                FI   + ++  + + ++++      +    + F   +Y  M   +L+ +      
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL-SRF--FLYPRM-QSNLQTFGEVLLS 195

Query: 658 EQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL 717
             +    L    RL + + V  +L  LHH+    +VH  L+P +++LD      +  F  
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEH 252

Query: 718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG-----------DEYSFGILMLE 766
                    D         S G+  PE  A     ++            D ++ G+++  
Sbjct: 253 LV------RDGARVV-SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305

Query: 767 MFTGKRP-TDDMFEEGLSLHKYAKMGLPDQVAEII 800
           ++    P T D    G      +   +P  V  ++
Sbjct: 306 IWCADLPITKDAALGGSEWIFRSCKNIPQPVRALL 340

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  110 bits (276), Expect = 9e-26
 Identities = 68/258 (26%), Positives = 112/258 (43%), Gaps = 17/258 (6%)

Query: 201 LEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEVNL 259
              V     +L  V P      S++   L +  N+I   I      +L++L ++ +  N 
Sbjct: 45  FSKVICVRKNLREV-P---DGISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNH 99

Query: 260 LTGSIPTSV-GYLLKLQVLSLFGNKISGEIPS-SLGNLIFLTEVDLQGNSIRGSIPS-AL 316
           +  +I       L  L  L LF N+++  IP+ +   L  L E+ L+ N I  SIPS A 
Sbjct: 100 IR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAF 156

Query: 317 GNCLQLQKLDLSDNNLSGTIPREV-IGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDL 375
                L++LDL +      I      GLS+   L+L+  +L   IP  +  L  + +LDL
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDL 214

Query: 376 SENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSG-FSSLKGLQDLDLSRNNFSGKIPM 434
           S N LS   P S    + L+ L    +  Q  I    F +L+ L +++L+ NN +     
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAHNNLTLLPHD 273

Query: 435 FLNTFRFLQKLNLSFNNL 452
                  L++++L  N  
Sbjct: 274 LFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  104 bits (262), Expect = 6e-24
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 15/210 (7%)

Query: 274 LQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLS 333
            ++L+L  N+I     +S  +L  L  + L  N IR     A      L  L+L DN L+
Sbjct: 66  TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125

Query: 334 GTIPREV-IGLSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLDLSE-NKLSGEIPTSLAS 390
            TIP    + LS    L L  N +   IP     R+  +++LDL E  +LS     +   
Sbjct: 126 -TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183

Query: 391 CVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP--MFLNTFRFLQKLNLS 448
              L YLN +  + +  I +  + L  L +LDLS N+ S  I    F      LQKL + 
Sbjct: 184 LSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLS-AIRPGSFQG-LMHLQKLWMI 239

Query: 449 FNNLEGEVPSEGVFKNVRAVSII--GNNKL 476
            + ++  +     F N++++  I   +N L
Sbjct: 240 QSQIQ-VIE-RNAFDNLQSLVEINLAHNNL 267

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 99.8 bits (249), Expect = 3e-22
 Identities = 58/252 (23%), Positives = 104/252 (41%), Gaps = 20/252 (7%)

Query: 159 SSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNS 218
             +P+ +    N   LN   N +   K N  + L        LE++ LS N +  +   +
Sbjct: 56  REVPDGI--STNTRLLNLHENQIQIIKVNSFKHL------RHLEILQLSRNHIRTIEIGA 107

Query: 219 IANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEVNLLTGSIPTSV-GYLLKLQV 276
               ++ L  L +  NR++ TIP G    L  L  + +  N +  SIP+     +  L+ 
Sbjct: 108 FNGLAN-LNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRR 164

Query: 277 LSLFG-NKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGT 335
           L L    ++S     +   L  L  ++L   ++R  IP  L   ++L +LDLS N+LS  
Sbjct: 165 LDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS-A 221

Query: 336 IPREVI-GLSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLDLSENKLSGEIPTSLASCVG 393
           I      GL     L + ++ +   I       L+ + +++L+ N L+            
Sbjct: 222 IRPGSFQGLMHLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280

Query: 394 LEYLNFSDNSFQ 405
           LE ++   N + 
Sbjct: 281 LERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 90.6 bits (225), Expect = 3e-19
 Identities = 53/247 (21%), Positives = 91/247 (36%), Gaps = 48/247 (19%)

Query: 135 PNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDS 194
            N R+L L  N     I  +             L++L  L  +RN++ T     +    +
Sbjct: 64  TNTRLLNLHENQIQ-IIKVN---------SFKHLRHLEILQLSRNHIRT-----IEI-GA 107

Query: 195 LVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV---------- 244
                 L  + L  N L+ +   +    S  L  L++  N I  +IP+            
Sbjct: 108 FNGLANLNTLELFDNRLTTIPNGAFVYLSK-LKELWLRNNPIE-SIPSYAFNRIPSLRRL 165

Query: 245 ----------------GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEI 288
                             L NL  + + +  L   IP     L+KL  L L GN +S   
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTP-LIKLDELDLSGNHLSAIR 223

Query: 289 PSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFV 347
           P S   L+ L ++ +  + I+    +A  N   L +++L+ NNL+  +P ++   L    
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLE 282

Query: 348 LLDLSRN 354
            + L  N
Sbjct: 283 RIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 89.4 bits (222), Expect = 7e-19
 Identities = 70/310 (22%), Positives = 108/310 (34%), Gaps = 79/310 (25%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
           E+P  I+  +  R+L+L  N+++    +   +L  L  L L+ N+       + + L+ L
Sbjct: 57  EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114

Query: 65  QQLSLSENSLSGNIPSE----LGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
             L L +N L+  IP+     L  LK+L +     N +  SIP   FN            
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWL---RNNPIE-SIPSYAFN------------ 157

Query: 121 KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPED-LGKLKNLIRLNFARN 179
                        +P++R L LG           +S    I E     L NL  LN A  
Sbjct: 158 ------------RIPSLRRLDLGEL-------KRLS---YISEGAFEGLSNLRYLNLAMC 195

Query: 180 NLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGT 239
           NL        R + +L     L+ + LS N LS + P S      HL  L+M  ++I   
Sbjct: 196 NL--------REIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLM-HLQKLWMIQSQIQ-V 245

Query: 240 IPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLT 299
           I                              L  L  ++L  N ++         L  L 
Sbjct: 246 IERNA---------------FDN--------LQSLVEINLAHNNLTLLPHDLFTPLHHLE 282

Query: 300 EVDLQGNSIR 309
            + L  N   
Sbjct: 283 RIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 36/162 (22%), Positives = 59/162 (36%), Gaps = 14/162 (8%)

Query: 321 QLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKL 380
           Q  K+     NL   +P  +   ++  LL+L  N +          L+ ++ L LS N +
Sbjct: 44  QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100

Query: 381 SGEIPTSLASCVGLEYLNFSDNSFQGPIHSG-FSSLKGLQDLDLSRNNFSGKIPMFLNTF 439
                 +      L  L   DN     I +G F  L  L++L L  N     IP     F
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIE-SIPS--YAF 156

Query: 440 RF---LQKLNLSFNNLEGEVPSEGVFKNVRAVS--IIGNNKL 476
                L++L+L        +  EG F+ +  +    +    L
Sbjct: 157 NRIPSLRRLDLGELKRLSYIS-EGAFEGLSNLRYLNLAMCNL 197

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  107 bits (270), Expect = 1e-25
 Identities = 54/255 (21%), Positives = 91/255 (35%), Gaps = 30/255 (11%)

Query: 526 QRRKRRRRSKALVNSSIEDK-YLKISYAELLKATEGFSSANLIGIGGYGYVYKGI-LGTE 583
             + +R   +   N  +     LK    E  +     +    +G G +G V++     T 
Sbjct: 24  SAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTG 83

Query: 584 ETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
               AVK + L+          E  A   +    +V +  +      R   +  +  E +
Sbjct: 84  FQ-CAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAV-----REGPWVNIFMELL 132

Query: 644 PNGSLENWLNQ--KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
             GSL   + Q     E          + L         LEYLH      I+H D+K  N
Sbjct: 133 EGGSLGQLIKQMGCLPE---------DRALYYLGQALEGLEYLHTRR---ILHGDVKADN 180

Query: 702 VLLDNE-MVAHVGDFGLSRLLHDNSPDQTSTSR--VKGSIGYVAPEYGALGEVSTHGDEY 758
           VLL ++   A + DFG +  L  +   ++  +   + G+  ++APE           D +
Sbjct: 181 VLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 240

Query: 759 SFGILMLEMFTGKRP 773
           S   +ML M  G  P
Sbjct: 241 SSCCMMLHMLNGCHP 255

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  108 bits (271), Expect = 2e-25
 Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 50/237 (21%)

Query: 567 IGIGGYGYVYKGIL-------GTEETNVAVKVLDLQQRGASKS----FIAECEALRSI-R 614
           +G G +G V              E   VAVK+L   +  A++      ++E E ++ I +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGK 145

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWL---------NQKEDEQNQRPKL 665
           H+N++ ++ +C    T+      ++ E+   G+L  +L            +  +    ++
Sbjct: 146 HKNIINLLGAC----TQDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 666 NLMQRLSIAIDVANVLEYL-HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDN 724
                +S    +A  +EYL    C    +H DL   NVL+    V  + DFGL+R +++ 
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI 256

Query: 725 SPDQTSTSRVKGSIGYV-----APEYGAL--GEVSTHGDEYSFGILMLEMFT-GKRP 773
                     K + G +     APE  AL     +   D +SFG+LM E+FT G  P
Sbjct: 257 D------YYKKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  105 bits (263), Expect = 4e-25
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 25/218 (11%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIIT 623
            IG G YG   K    ++   +  K LD      +  +  ++E   LR ++H N+V+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
               ID        +V E+   G L + + +      +R  L+    L +   +   L+ 
Sbjct: 73  RI--IDRTNTTLY-IVMEYCEGGDLASVITKG---TKERQYLDEEFVLRVMTQLTLALKE 126

Query: 684 LH--HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
            H       +++H DLKP+NV LD +    +GDFGL+R+L ++      T    G+  Y+
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKT--FVGTPYYM 183

Query: 742 APE------YGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           +PE      Y      +   D +S G L+ E+     P
Sbjct: 184 SPEQMNRMSY------NEKSDIWSLGCLLYELCALMPP 215

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  105 bits (264), Expect = 5e-25
 Identities = 65/295 (22%), Positives = 100/295 (33%), Gaps = 27/295 (9%)

Query: 194 SLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILI 253
           S  NC     V L     S             L  +   A+    T      +LK L + 
Sbjct: 26  SAFNCLGAADVELYGGGRS---------LEYLLKRVDTEADLGQFTDIIKSLSLKRLTVR 76

Query: 254 AMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIF--LTEVDLQGNSI--R 309
           A  +          V  +  LQ L+L   +++G  P  L       L  ++L+  S   R
Sbjct: 77  AARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR 136

Query: 310 GSIPSALGNCLQ--LQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLE---- 363
            +  + L   L+  L+ L ++  +       +V    +   LDLS N   G   L     
Sbjct: 137 DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC 196

Query: 364 VGRLKGIQQLDLSENK---LSGEIPTSLASCVGLEYLNFSDNSFQG-PIHSGFSSLKGLQ 419
             +   +Q L L        SG      A+ V L+ L+ S NS +             L 
Sbjct: 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN 256

Query: 420 DLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNN 474
            L+LS         +       L  L+LS+N L+   PS      V  +S+ GN 
Sbjct: 257 SLNLSFTGLKQ---VPKGLPAKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGNP 307

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 95.3 bits (237), Expect = 1e-21
 Identities = 50/235 (21%), Positives = 88/235 (37%), Gaps = 22/235 (9%)

Query: 271 LLKLQVLSLFGNKISGEIPSS---LGNLIFLTEVDLQGNSIRGSIPSALGNC--LQLQKL 325
            L L+ L++   +I   I      +  +  L E+ L+   + G+ P  L       L  L
Sbjct: 67  SLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126

Query: 326 DLSDNNLSGTIPREVIGLSSFVL-----LDLSRNHLSGPIPLEVGRLKGIQQLDLSENKL 380
           +L + + +      +  L  ++      L +++ H       +V     +  LDLS+N  
Sbjct: 127 NLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185

Query: 381 SGEIPTSLASCVG----LEYLNFSDNSFQ---GPIHSGFSSLKGLQDLDLSRNNFSGKIP 433
            GE     A C      L+ L   +   +   G   +  ++   LQ LDLS N+      
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245

Query: 434 -MFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPELHLHS 487
               +    L  LNLSF  L+ +VP  G+   +  +  +  N+L        L  
Sbjct: 246 APSCDWPSQLNSLNLSFTGLK-QVPK-GLPAKLSVLD-LSYNRLDRNPSPDELPQ 297

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 93.8 bits (233), Expect = 6e-21
 Identities = 55/300 (18%), Positives = 92/300 (30%), Gaps = 22/300 (7%)

Query: 147 FTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSL 206
           F+   P   S  + +     +L    R           + +  +F D +     L+ +++
Sbjct: 17  FSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDII-KSLSLKRLTV 75

Query: 207 SSNSLSGVLPNSIANF--SSHLIYLYMSANRISGTIPTGVG-----NLKNLILIAMEVNL 259
            +  +   +          S L  L +    ++GT P  +      +L  L L  +    
Sbjct: 76  RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135

Query: 260 LTGSIPTSVGYLLK-LQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGN 318
               +     +L   L+VLS+            +     L+ +DL  N   G        
Sbjct: 136 RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195

Query: 319 CL----QLQKLDLSDNN---LSGTIPREVIGLSSFVLLDLSRNHLSG-PIPLEVGRLKGI 370
           C      LQ L L +      SG              LDLS N L              +
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255

Query: 371 QQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSG 430
             L+LS   L  ++P  L +   L  L+ S N            L  + +L L  N F  
Sbjct: 256 NSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 93.8 bits (233), Expect = 6e-21
 Identities = 55/271 (20%), Positives = 84/271 (30%), Gaps = 22/271 (8%)

Query: 201 LEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTG---VGNLKNLILIAMEV 257
           LE +    ++ + +   +    S  L  L + A RI   I  G   V  +  L  + +E 
Sbjct: 45  LEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLEN 104

Query: 258 NLLTGSIPTSVG--YLLKLQVLSLFGNKISGE--IPSSLGNLIF--LTEVDLQGNSIRGS 311
             +TG+ P  +       L +L+L     +      + L   +   L  + +        
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNF 164

Query: 312 IPSALGNCLQLQKLDLSDNNLSGTI-------PREVIGLSSFVLLDLSRNHLSGPIPLEV 364
               +     L  LDLSDN   G         P +   L    L +      SG      
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224

Query: 365 GRLKGIQQLDLSENKLSGEIPTSLASCVG-LEYLNFSDNSFQGPIHSGFSSLKGLQDLDL 423
                +Q LDLS N L              L  LN S    +       + L     LDL
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKL---SVLDL 281

Query: 424 SRNNFSGKIPMFLNTFRFLQKLNLSFNNLEG 454
           S N      P   +    +  L+L  N    
Sbjct: 282 SYNRLDR-NP-SPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 84.6 bits (209), Expect = 7e-18
 Identities = 62/319 (19%), Positives = 105/319 (32%), Gaps = 31/319 (9%)

Query: 49  NYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFN 108
           N++   P   S       L  ++  L G   S   LLK+++       +      + L  
Sbjct: 16  NFSDPKPDWSSAF---NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKR 72

Query: 109 ISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKL 168
           ++ +    +    L G +       +  ++ L L +   TG  PP +  A+         
Sbjct: 73  LT-VRAARIPSRILFGALRV---LGISGLQELTLENLEVTGTAPPPLLEAT--------G 120

Query: 169 KNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIY 228
            +L  LN  RN     +   L  L   +    L+V+S++           +  F + L  
Sbjct: 121 PDLNILNL-RNVSWATRDAWLAELQQWLK-PGLKVLSIAQAHSLNFSCEQVRVFPA-LST 177

Query: 229 LYMSANRISGTI-------PTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFG 281
           L +S N   G         P     L+ L L    +   +G         ++LQ L L  
Sbjct: 178 LDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSH 237

Query: 282 NKISGEIPSSL-GNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREV 340
           N +     +        L  ++L    ++  +P  L    +L  LDLS N L    P   
Sbjct: 238 NSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLD-RNPSP- 292

Query: 341 IGLSSFVLLDLSRNHLSGP 359
             L     L L  N     
Sbjct: 293 DELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 79.6 bits (196), Expect = 4e-16
 Identities = 53/278 (19%), Positives = 86/278 (30%), Gaps = 26/278 (9%)

Query: 19  LDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLS---NLSFLQQLSLSENSLS 75
           L  V  + +    +++     L  L +        I         +S LQ+L+L    ++
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 76  GNIPSELGLL--KQLNMFQVSANYLTGSIP----IQLFNISSMDYFAVTQNKLVGEIPHY 129
           G  P  L       LN+  +              +Q +    +   ++ Q          
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS-LNFSCE 167

Query: 130 VGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDL 189
                P +  L L  N   GE     +          K   L  L      + T  G   
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISALC------PLKFPTLQVLALRNAGMETPSGVCS 221

Query: 190 RFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVG-NLK 248
               + V    L+ + LS NSL         ++ S L  L +S   +   +P G+   L 
Sbjct: 222 ALAAARVQ---LQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLS 277

Query: 249 NLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISG 286
            L L     N L    P+    L ++  LSL GN    
Sbjct: 278 VLDL---SYNRLD-RNPSPDE-LPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 30/225 (13%), Positives = 60/225 (26%), Gaps = 34/225 (15%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGN-IPSELGNLFKLVGLGLT----GNNYTGSIP- 55
           + G  P  +   +   +  L +  +      + L  L + +  GL        ++ +   
Sbjct: 107 VTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSC 166

Query: 56  QSLSNLSFLQQLSLSENSLSGNI-------PSELGLLKQLNMFQVSANYLTGSIPIQLFN 108
           + +     L  L LS+N   G         P +   L+ L +        +G        
Sbjct: 167 EQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA 226

Query: 109 ISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKL 168
              +    ++ N L              +  L L       ++P  +             
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP------------ 273

Query: 169 KNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSG 213
             L  L+ + N         L    S      +  +SL  N    
Sbjct: 274 AKLSVLDLSYNR--------LDRNPSPDELPQVGNLSLKGNPFLD 310

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  104 bits (263), Expect = 5e-25
 Identities = 47/223 (21%), Positives = 88/223 (39%), Gaps = 39/223 (17%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKII 622
            +G GG+   ++      +   A K++    L +    +    E    RS+ H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANV 680
                 +     F  +V E     SL     +++   E   R     ++++ +       
Sbjct: 82  GF---FEDNDFVF--VVLELCRRRSLLELHKRRKALTEPEAR---YYLRQIVLGCQ---- 129

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH-DNSPDQTSTSRVKGSIG 739
             YLH +    ++H DLK  N+ L+ ++   +GDFGL+  +  D    +       G+  
Sbjct: 130 --YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPN 180

Query: 740 YVAPE------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDD 776
           Y+APE      +    EV    D +S G +M  +  GK P + 
Sbjct: 181 YIAPEVLSKKGHS--FEV----DVWSIGCIMYTLLVGKPPFET 217

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  107 bits (269), Expect = 6e-25
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 34/225 (15%)

Query: 561 FSSANLIGIGGYG-YVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALR-SIRHRNL 618
           F   +++G G  G  VY+G+    +  VAVK +  +    +     E + LR S  H N+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRD--VAVKRILPECFSFADR---EVQLLRESDEHPNV 80

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
           ++   +         +F+ +  E     +L+ ++ QK+        + L+Q         
Sbjct: 81  IRYFCTEKD-----RQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ------QTT 128

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDN-----EMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           + L +LH     +IVH DLKP N+L+       ++ A + DFGL + L       +  S 
Sbjct: 129 SGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185

Query: 734 VKGSIGYVAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRP 773
           V G+ G++APE   L E          D +S G +   + +    
Sbjct: 186 VPGTEGWIAPEM--LSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  105 bits (263), Expect = 1e-24
 Identities = 47/223 (21%), Positives = 88/223 (39%), Gaps = 39/223 (17%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKII 622
            +G GG+   ++      +   A K++    L +    +    E    RS+ H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANV 680
                 +     F  +V E     SL     +++   E   R     ++++ +       
Sbjct: 108 GF---FEDNDFVF--VVLELCRRRSLLELHKRRKALTEPEAR---YYLRQIVLGCQ---- 155

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH-DNSPDQTSTSRVKGSIG 739
             YLH +    ++H DLK  N+ L+ ++   +GDFGL+  +  D    +       G+  
Sbjct: 156 --YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPN 206

Query: 740 YVAPE------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDD 776
           Y+APE      +    EV    D +S G +M  +  GK P + 
Sbjct: 207 YIAPEVLSKKGHS--FEV----DVWSIGCIMYTLLVGKPPFET 243

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  107 bits (269), Expect = 2e-24
 Identities = 53/329 (16%), Positives = 108/329 (32%), Gaps = 58/329 (17%)

Query: 137 IRVLLLGSNWFTGEIPPSISNASSIPEDL----GKLKNLIRLNFARNNLGTGKGNDLRFL 192
           + ++L  +N F+       +  S    D      K +        RN            +
Sbjct: 1   MSIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEA----------V 50

Query: 193 DSLVNCTF--LEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNL 250
             L  C       + L+  +LS  LP+++      +  L ++ N +  ++P    +L+ L
Sbjct: 51  SLLKECLINQFSELQLNRLNLS-SLPDNLP---PQITVLEITQNALI-SLPELPASLEYL 105

Query: 251 ILIAMEVNLLTGSIPTSVGYLLKL-----------------QVLSLFGNKISGEIPSSLG 293
                  N L+ ++P     L  L                 + ++   N+++  +P    
Sbjct: 106 DACD---NRLS-TLPELPASLKHLDVDNNQLTMLPELPALLEYINADNNQLT-MLPELPT 160

Query: 294 NLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSS----FVLL 349
           +L  L    ++ N +   +P    +   L+ LD+S N L  ++P   +         +  
Sbjct: 161 SLEVL---SVRNNQLT-FLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFF 212

Query: 350 DLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIH 409
               N ++  IP  +  L     + L +N LS  I  SL+        +     F   + 
Sbjct: 213 RCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMS 269

Query: 410 SGFSSLKGLQDLDLSRNNFSGKIPMFLNT 438
            G  +       D     F       ++ 
Sbjct: 270 DGQQNTLHRPLADAVTAWFPENKQSDVSQ 298

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 96.6 bits (240), Expect = 8e-21
 Identities = 57/311 (18%), Positives = 102/311 (32%), Gaps = 57/311 (18%)

Query: 57  SLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIP-IQLFNISSMDYF 115
           SLS  SF   +S        +  S     ++  +   + N     +    +   S +   
Sbjct: 12  SLSQNSFYNTIS----GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQ-- 65

Query: 116 AVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLN 175
            + +  L   +P  +    P I VL +  N              S+PE    L+ L   +
Sbjct: 66  -LNRLNLS-SLPDNLP---PQITVLEITQNALI-----------SLPELPASLEYLDACD 109

Query: 176 FARNNLGTGKGNDLRFL-DSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSAN 234
                      N L  L +   +   L    + +N L+ +LP   A     L Y+    N
Sbjct: 110 -----------NRLSTLPELPASLKHL---DVDNNQLT-MLPELPAL----LEYINADNN 150

Query: 235 RISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGN 294
           +++  +P    +L+ L +     N LT  +P        L+ L +  N +   +P+    
Sbjct: 151 QLT-MLPELPTSLEVLSV---RNNQLT-FLPELPE---SLEALDVSTNLLE-SLPAVPVR 201

Query: 295 LIFLTEV----DLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLD 350
                E       + N I   IP  + +      + L DN LS  I   +   ++     
Sbjct: 202 NHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYH 260

Query: 351 LSRNHLSGPIP 361
             R + S    
Sbjct: 261 GPRIYFSMSDG 271

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 78.9 bits (194), Expect = 3e-15
 Identities = 60/346 (17%), Positives = 98/346 (28%), Gaps = 97/346 (28%)

Query: 16  LRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLS 75
              L L    L  ++P  L    ++  L +T N    S+P+  ++   L+ L   +N LS
Sbjct: 61  FSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPAS---LEYLDACDNRLS 113

Query: 76  GNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLP 135
             +P     LK L+   V  N LT                          +P        
Sbjct: 114 -TLPELPASLKHLD---VDNNQLT-------------------------MLPE----LPA 140

Query: 136 NIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSL 195
            +  +   +N  T            +PE    L+ L                        
Sbjct: 141 LLEYINADNNQLT-----------MLPELPTSLEVL------------------------ 165

Query: 196 VNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAM 255
                    S+ +N L+  LP    +    L  L +S N +  ++P       +     +
Sbjct: 166 ---------SVRNNQLT-FLPELPES----LEALDVSTNLLE-SLPAVPVRNHHSEETEI 210

Query: 256 EVNL----LTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGS 311
                   +T  IP ++  L     + L  N +S  I  SL         D  G  I  S
Sbjct: 211 FFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ--PDYHGPRIYFS 267

Query: 312 IPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLS 357
           +     N L     D            +V  +      +   N  S
Sbjct: 268 MSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS 313

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 59.6 bits (144), Expect = 3e-09
 Identities = 31/153 (20%), Positives = 50/153 (32%), Gaps = 20/153 (13%)

Query: 311 SIPSALGNCLQLQKLDLSDNNLSGT---IPREVIGLSSFVLLDLSRNHLSGPIPLEVGRL 367
           SI   + N   L   +   N +SGT               L   +RN     +      +
Sbjct: 2   SIMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLI 58

Query: 368 KGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQG-PIHSGFSSLKGLQDLDLSRN 426
               +L L+   LS  +P +L     +  L  + N+    P          L+ LD   N
Sbjct: 59  NQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALISLP-----ELPASLEYLDACDN 110

Query: 427 NFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE 459
             S  +P        L+ L++  N L   +P  
Sbjct: 111 RLS-TLP---ELPASLKHLDVDNNQLT-MLPEL 138

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 45.7 bits (108), Expect = 6e-05
 Identities = 22/106 (20%), Positives = 36/106 (33%), Gaps = 9/106 (8%)

Query: 4   GEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKL----VGLGLTGNNYTGSIPQSLS 59
             +P        L  LD+  N LE ++P+            +      N  T  IP+++ 
Sbjct: 173 TFLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL 227

Query: 60  NLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQ 105
           +L     + L +N LS  I   L        +     Y + S   Q
Sbjct: 228 SLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  102 bits (256), Expect = 3e-24
 Identities = 52/213 (24%), Positives = 80/213 (37%), Gaps = 16/213 (7%)

Query: 274 LQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLS 333
            Q + L GN+IS    +S      LT + L  N +     +A      L++LDLSDN   
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 334 GTIPREV-IGLSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLDLSENKLSGEIPT-SLAS 390
            ++      GL     L L R  L   +   +   L  +Q L L +N L   +P  +   
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRD 151

Query: 391 CVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRF---LQKLNL 447
              L +L    N         F  L  L  L L +N  +  +    + FR    L  L L
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHP--HAFRDLGRLMTLYL 208

Query: 448 SFNNLEGEVPSEGVF---KNVRAVSIIGNNKLC 477
             NNL   +P        + ++ + +  N  +C
Sbjct: 209 FANNLS-ALP-TEALAPLRALQYLRLNDNPWVC 239

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 49/223 (21%), Positives = 80/223 (35%), Gaps = 22/223 (9%)

Query: 135 PNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDS 194
              + + L  N  +  +P +              +NL  L    N L          L  
Sbjct: 32  AASQRIFLHGNRIS-HVPAA---------SFRACRNLTILWLHSNVLARIDAAAFTGLAL 81

Query: 195 LVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILI 253
           L      E + LS N+    +  +  +    L  L++    +   +  G+   L  L  +
Sbjct: 82  L------EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134

Query: 254 AMEVNLLTGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSI 312
            ++ N L  ++P      L  L  L L GN+IS     +   L  L  + L  N +    
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193

Query: 313 PSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRN 354
           P A  +  +L  L L  NNLS  +P E +  L +   L L+ N
Sbjct: 194 PHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 47/204 (23%), Positives = 80/204 (39%), Gaps = 26/204 (12%)

Query: 134 LPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFL- 192
             N+ +L L SN     I  +             L  L +L+ + N         LR + 
Sbjct: 55  CRNLTILWLHSNVLA-RIDAAA---------FTGLALLEQLDLSDNA-------QLRSVD 97

Query: 193 -DSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNL 250
             +      L  + L    L  + P      ++ L YLY+  N +   +P     +L NL
Sbjct: 98  PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA-LQYLYLQDNALQ-ALPDDTFRDLGNL 155

Query: 251 ILIAMEVNLLTGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIR 309
             + +  N ++ S+P      L  L  L L  N+++   P +  +L  L  + L  N++ 
Sbjct: 156 THLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214

Query: 310 GSIPS-ALGNCLQLQKLDLSDNNL 332
            ++P+ AL     LQ L L+DN  
Sbjct: 215 -ALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 50/262 (19%), Positives = 90/262 (34%), Gaps = 59/262 (22%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
            +P  I   +  + + L  N++     +       L  L L  N        + + L+ L
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 65  QQLSLSENSLSGNIPSE----LGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
           +QL LS+N+   ++       LG L  L++       L   +   LF             
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHL---DRCGLQ-ELGPGLFR------------ 126

Query: 121 KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPED-LGKLKNLIRLNFARN 179
                        L  ++ L L  N              ++P+D    L NL  L     
Sbjct: 127 ------------GLAALQYLYLQDN-----------ALQALPDDTFRDLGNLTHLFLH-- 161

Query: 180 NLGTGKGNDLRFL--DSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRIS 237
                 GN +  +   +      L+ + L  N ++ V P++  +    L+ LY+ AN +S
Sbjct: 162 ------GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR-LMTLYLFANNLS 214

Query: 238 GTIPTGV-GNLKNLILIAMEVN 258
             +PT     L+ L  + +  N
Sbjct: 215 -ALPTEALAPLRALQYLRLNDN 235

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  104 bits (260), Expect = 4e-24
 Identities = 51/267 (19%), Positives = 105/267 (39%), Gaps = 18/267 (6%)

Query: 199 TFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEV 257
             ++ + LS+N ++ +  + +     +L  L +++N I+ TI      +L +L  + +  
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCV-NLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSY 109

Query: 258 NLLTGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSL-GNLIFLTEVDLQGNSIRGSIPS- 314
           N L+ ++ +S    L  L  L+L GN       +SL  +L  L  + +        I   
Sbjct: 110 NYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168

Query: 315 ALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQL 373
                  L++L++  ++L  +   + +  + +   L L        + + V     ++ L
Sbjct: 169 DFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECL 227

Query: 374 DLSENKLSG----EIPT----SLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSR 425
           +L +  L      E+ T    SL        +  +D S    +    + + GL +L+ SR
Sbjct: 228 ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSR 286

Query: 426 NNFSGKIPMFLNTFRFLQKLNLSFNNL 452
           N          +    LQK+ L  N  
Sbjct: 287 NQLKSVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 90.9 bits (226), Expect = 9e-20
 Identities = 41/195 (21%), Positives = 71/195 (36%), Gaps = 12/195 (6%)

Query: 264 IPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPS-ALGNCLQL 322
           +  +      ++ L L  N+I+    S L   + L  + L  N I  +I   +  +   L
Sbjct: 50  LTEA------VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102

Query: 323 QKLDLSDNNLSGTIPREV-IGLSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLDLSENKL 380
           + LDLS N LS  +       LSS   L+L  N         +   L  +Q L +     
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161

Query: 381 SGEIPT-SLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTF 439
             +I     A    LE L    +  Q        S++ +  L L        + +F++  
Sbjct: 162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVT 221

Query: 440 RFLQKLNLSFNNLEG 454
             ++ L L   +L+ 
Sbjct: 222 SSVECLELRDTDLDT 236

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 87.9 bits (218), Expect = 8e-19
 Identities = 49/316 (15%), Positives = 104/316 (32%), Gaps = 59/316 (18%)

Query: 53  SIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSM 112
           SIP  L+    ++ L LS N ++    S+L     L    +++N +  +I    F+    
Sbjct: 45  SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFS---- 97

Query: 113 DYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDL-GKLKNL 171
                               +L ++  L L  N+ +           ++       L +L
Sbjct: 98  --------------------SLGSLEHLDLSYNYLS-----------NLSSSWFKPLSSL 126

Query: 172 IRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYM 231
             LN   N   T     L       + T L+++ + +      +        + L  L +
Sbjct: 127 TFLNLLGNPYKT-----LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEI 181

Query: 232 SANRISGTIPTGV-GNLKNLILIAMEVNLLTGSIPTSV-GYLLKLQVLSLFGNKISG--- 286
            A+ +  +       +++N+  + + +      +          ++ L L    +     
Sbjct: 182 DASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHF 239

Query: 287 -EIPS----SLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI 341
            E+ +    SL        V +   S+   +   L     L +L+ S N L  ++P  + 
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIF 297

Query: 342 -GLSSFVLLDLSRNHL 356
             L+S   + L  N  
Sbjct: 298 DRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 87.9 bits (218), Expect = 1e-18
 Identities = 62/333 (18%), Positives = 111/333 (33%), Gaps = 71/333 (21%)

Query: 6   IPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIP-QSLSNLSFL 64
           IP+ +T    ++ LDL  N++     S+L     L  L LT N    +I   S S+L  L
Sbjct: 46  IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102

Query: 65  QQLSLSENSLSGNIPSE----LGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
           + L LS N LS N+ S     L  L  LN+     N         LF+            
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNL---LGNPYKTLGETSLFS------------ 146

Query: 121 KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNN 180
                        L  +++L +G+     +I           +D   L  L  L    ++
Sbjct: 147 ------------HLTKLQILRVGNMDTFTKIQR---------KDFAGLTFLEELEIDASD 185

Query: 181 LGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTI 240
           L + +        SL +   +  + L       +L     + +S +  L +    +    
Sbjct: 186 LQSYEPK------SLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDT-- 236

Query: 241 PTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTE 300
                            + L+     S+      + + +    +  ++   L  +  L E
Sbjct: 237 --------------FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLE 281

Query: 301 VDLQGNSIRGSIP-SALGNCLQLQKLDLSDNNL 332
           ++   N ++ S+P         LQK+ L  N  
Sbjct: 282 LEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 25/151 (16%), Positives = 56/151 (37%), Gaps = 13/151 (8%)

Query: 5   EIPANI-THCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQ-SLSNLS 62
           +I        + L  L++  + L+   P  L ++  +  L L    +   + +  +   S
Sbjct: 164 KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTS 222

Query: 63  FLQQLSLSENSLSGNIPSEL--------GLLKQLNMFQVSANYLTGSIPIQLFNISSMDY 114
            ++ L L +  L     SEL                 +++   L   +   L  IS +  
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLE 281

Query: 115 FAVTQNKLVGEIPHYVGFTLPNIRVLLLGSN 145
              ++N+L   +P  +   L +++ + L +N
Sbjct: 282 LEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  106 bits (266), Expect = 5e-24
 Identities = 69/434 (15%), Positives = 145/434 (33%), Gaps = 39/434 (8%)

Query: 12  HCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQS--LSNLSFLQQLSL 69
              +L  LD+  N+L+ NI      +  L  L L+ N++   +P      NL+ L  L L
Sbjct: 98  FNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGL 153

Query: 70  SENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQ-----NKLVG 124
           S          +L  +  L++  +  + ++  I         +    V       N L  
Sbjct: 154 SAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFS 210

Query: 125 EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTG 184
              +     L ++++  +  N    +   +  +      +L +   L+ +          
Sbjct: 211 VQVNMSVNALGHLQLSNIKLNDENCQRLMTFLS------ELTRGPTLLNVTLQHIETTW- 263

Query: 185 KGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSH----LIYLYMSANRISGTI 240
                  L        +E +++ + +++  +      +S      L+  ++       + 
Sbjct: 264 --KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSK 321

Query: 241 PTGVGNLKNLILIAMEVNLLTGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSLGNLIFLT 299
                    + +  + ++     I             L+   N  +  +      L  L 
Sbjct: 322 EALYSVFAEMNIKMLSISDTP-FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQ 380

Query: 300 EVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNL----SGTIPREVIGLSSFVLLDLSRNH 355
            + LQ N ++ +          +  L+  D +L    S    R      S ++L+LS N 
Sbjct: 381 TLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNM 439

Query: 356 LSGPIPLEVGRL-KGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSS 414
           L+G +      L   ++ LDL  N++   IP  +     L+ LN + N  +      F  
Sbjct: 440 LTGSVF---RCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDR 495

Query: 415 LKGLQDLDLSRNNF 428
           L  LQ + L  N +
Sbjct: 496 LTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 96.9 bits (241), Expect = 6e-21
 Identities = 86/480 (17%), Positives = 163/480 (33%), Gaps = 53/480 (11%)

Query: 7   PANITHCSELRILDLVVNKLEGNIPSEL-GNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQ 65
             +I+  SELR+L L  N++  ++   +      L  L ++ N    +I      ++ L+
Sbjct: 69  MPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLR 124

Query: 66  QLSLSENSL-SGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVG 124
            L LS N      +  E G L +L    +SA        + + ++          +  + 
Sbjct: 125 HLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIK 184

Query: 125 EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTG 184
                         + L+        +  ++S  +     L    + I+LN         
Sbjct: 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQL----SNIKLNDENCQRLMT 240

Query: 185 KGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV 244
             ++L    +L+N T   +   +      +       +   + YL +    I+  I    
Sbjct: 241 FLSELTRGPTLLNVTLQHI-ETTWKCSVKLFQF---FWPRPVEYLNIYNLTITERIDREE 296

Query: 245 GN-----LKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLT 299
                  LK+L++  ++  +   S         ++ +  L  +           +    T
Sbjct: 297 FTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356

Query: 300 EVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLS--GTIPREVIGLSSFVLLDLSRNHL- 356
            ++   N    S+        +LQ L L  N L     +      +SS   LD+S N L 
Sbjct: 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLN 416

Query: 357 SGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLK 416
           S          + I  L+LS N L+G +   L                            
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP-------------------------- 450

Query: 417 GLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSII--GNN 474
            ++ LDL  N     IP  +   + LQ+LN++ N L+  VP +GVF  + ++  I   +N
Sbjct: 451 KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVP-DGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 77.6 bits (191), Expect = 8e-15
 Identities = 69/403 (17%), Positives = 130/403 (32%), Gaps = 58/403 (14%)

Query: 64  LQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLV 123
            + LSLS+NS+S     ++  L +L + ++S N +  S+   +F                
Sbjct: 54  TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFL--------------- 97

Query: 124 GEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGT 183
                       ++  L +  N              +I      + +L  L+ + N+   
Sbjct: 98  ---------FNQDLEYLDVSHNRLQ-----------NIS--CCPMASLRHLDLSFNDFDV 135

Query: 184 GKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPT- 242
                     +L     L  + LS+     +    +A+     I L + +  I G     
Sbjct: 136 LPVCKE--FGNLTK---LTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETES 190

Query: 243 -GVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIF---- 297
             + N   L L+    +L +  +  SV  L  LQ+ ++  N  + +   +  + +     
Sbjct: 191 LQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPT 250

Query: 298 LTEVDLQGNSIRGSIPSALGNCLQ---LQKLDLSDNNLSGTIPREVIG-----LSSFVLL 349
           L  V LQ           L        ++ L++ +  ++  I RE        L S ++ 
Sbjct: 251 LLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIE 310

Query: 350 DLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIH 409
            +                  +    LS +           S     +LNF+ N F   + 
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVF 370

Query: 410 SGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNL 452
            G S+LK LQ L L RN             + +  L     +L
Sbjct: 371 QGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSL 412

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 68.4 bits (167), Expect = 5e-12
 Identities = 56/332 (16%), Positives = 105/332 (31%), Gaps = 54/332 (16%)

Query: 11  THCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLS 70
               +L  + L     +  +            L +T  +   +   S+    F     + 
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279

Query: 71  ENSLSGN----------IPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
             ++                    LK L +  V       S        + M+   ++ +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339

Query: 121 KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNN 180
                I      +  +   L    N FT           S+ +    LK L  L   RN 
Sbjct: 340 DT-PFIHMVCPPSPSSFTFLNFTQNVFT----------DSVFQGCSTLKRLQTLILQRNG 388

Query: 181 LGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTI 240
           L               N + LE + +S NSL+    +    ++  ++ L +S+N ++G++
Sbjct: 389 LKNFFKVA----LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV 444

Query: 241 PTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTE 300
                                  +P       K++VL L  N+I   IP  + +L  L E
Sbjct: 445 --------------------FRCLPP------KVKVLDLHNNRIM-SIPKDVTHLQALQE 477

Query: 301 VDLQGNSIRGSIP-SALGNCLQLQKLDLSDNN 331
           +++  N ++ S+P         LQ + L DN 
Sbjct: 478 LNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  102 bits (257), Expect = 5e-24
 Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 17/218 (7%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASK---SFIAECEALRSIRH 615
             F     IG G +  VY+     +   VA+K + +     +K     I E + L+ + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 616 RNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI 675
            N++K   S        NE   +V E    G L   +      + Q+  +         +
Sbjct: 92  PNVIKYYASF----IEDNELN-IVLELADAGDLSRMIKHF---KKQKRLIPERTVWKYFV 143

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
            + + LE++H      ++H D+KP+NV +    V  +GD GL R    +      +  + 
Sbjct: 144 QLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHS--LV 197

Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  Y++PE       +   D +S G L+ EM   + P
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  102 bits (257), Expect = 8e-24
 Identities = 48/235 (20%), Positives = 89/235 (37%), Gaps = 26/235 (11%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITS 624
           ++  GG+ +VY+          A+K L   +   +++ I E   ++ +  H N+V+  ++
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 625 CSSIDTRGNEFKALVYEFM--PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
            S      +  +A          G L  +L + E     R  L+    L I       ++
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME----SRGPLSCDTVLKIFYQTCRAVQ 150

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK------- 735
           ++H      I+H DLK  N+LL N+    + DFG +  +        S  R         
Sbjct: 151 HMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 736 --GSIGYVAPE----YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSL 784
              +  Y  PE    Y     +    D ++ G ++  +   + P    FE+G  L
Sbjct: 210 RNTTPMYRTPEIIDLYSNF-PIGEKQDIWALGCILYLLCFRQHP----FEDGAKL 259

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  102 bits (257), Expect = 9e-24
 Identities = 41/210 (19%), Positives = 90/210 (42%), Gaps = 18/210 (8%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIIT 623
            IG G +G         +     +K +++ +  +   +    E   L +++H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
           S    +  G+ +  +V ++   G L   +N +     +       Q L   + +   L++
Sbjct: 91  S---FEENGSLY--IVMDYCEGGDLFKRINAQ-----KGVLFQEDQILDWFVQICLALKH 140

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
           +H      I+H D+K  N+ L  +    +GDFG++R+L +++ +        G+  Y++P
Sbjct: 141 VHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARA--CIGTPYYLSP 194

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFTGKRP 773
           E       +   D ++ G ++ E+ T K  
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHA 224

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  102 bits (256), Expect = 1e-23
 Identities = 52/275 (18%), Positives = 100/275 (36%), Gaps = 49/275 (17%)

Query: 525 YQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEE 584
            +       +   +N  +++K   I+   +++          +  G +  +       E+
Sbjct: 6   MKDILSNYSNLIYLNKYVKEKDKYINDYRIIR---------TLNQGKFNKIILC----EK 52

Query: 585 TN--VAVKVLDLQQRGASKSFIA-----------------ECEALRSIRHRNLVKIITSC 625
            N   A+K  +       + F                   E + +  I++   +      
Sbjct: 53  DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI- 111

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWL-NQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
             I      +  ++YE+M N S+  +       ++N    + +     I   V N   Y+
Sbjct: 112 --ITNYDEVY--IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI 167

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
           H+  +  I H D+KPSN+L+D      + DFG S  + D    +   SR  G+  ++ PE
Sbjct: 168 HNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSR--GTYEFMPPE 220

Query: 745 YGALGEVSTHG---DEYSFGILMLEMFTGKRPTDD 776
           +    E S +G   D +S GI +  MF    P   
Sbjct: 221 F-FSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  102 bits (255), Expect = 1e-23
 Identities = 45/291 (15%), Positives = 93/291 (31%), Gaps = 35/291 (12%)

Query: 565 NLIGIGGYGYVYKGILGTEETN-----VAVKVLDLQQRGASKSFIAECEALRSIRHRNLV 619
           +L+G G +  VY+   G            +KV                E L+       +
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
           K     S+   +      LV E    G+L N +N  ++   +   +     +S A+ +  
Sbjct: 131 KF---YSAHLFQNGSV--LVGELYSYGTLLNAINLYKNTPEKV--MPQGLVISFAMRMLY 183

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG-----------DFGLSRLLHDNSPDQ 728
           ++E +H      I+H D+KP N +L N  +               D G S  +       
Sbjct: 184 MIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 729 TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP----TDDMFEEGLSL 784
             T++   + G+   E  +    +   D +     +  M  G            +     
Sbjct: 241 IFTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299

Query: 785 HKYAKMGLPDQVAEII----DPAILEEALEIQAGIVKELQPNLRAKFHEIQ 831
            +   + + ++   ++    D   L     ++  + K  Q +   K   ++
Sbjct: 300 RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALR 350

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =   99 bits (250), Expect = 2e-23
 Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 46/227 (20%)

Query: 566 LIGIGGYGYVYKGILGTE-ETN--VAVKVLD---LQQRGASKSFIAECEALRSIRHRNLV 619
           L+G G +  VY         T   VA+K++D   + + G  +    E +    ++H +++
Sbjct: 18  LLGKGSFAGVY---RAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE---DEQNQRPKLNLMQRLSIAID 676
           ++       +     +  LV E   NG +  +L  +     E   R   + M ++     
Sbjct: 75  ELYNY---FEDSNYVY--LVLEMCHNGEMNRYLKNRVKPFSENEAR---HFMHQIITG-- 124

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS-RLLHDNSPDQTSTSRVK 735
               + YLH H    I+H DL  SN+LL   M   + DFGL+ +L   +    T      
Sbjct: 125 ----MLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---- 173

Query: 736 GSIGYVAPE------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDD 776
           G+  Y++PE      +G   E     D +S G +   +  G+ P D 
Sbjct: 174 GTPNYISPEIATRSAHGL--ES----DVWSLGCMFYTLLIGRPPFDT 214

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  102 bits (254), Expect = 2e-22
 Identities = 56/290 (19%), Positives = 115/290 (39%), Gaps = 29/290 (10%)

Query: 163 EDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANF 222
                    I+ N  + ++      D    + L +   ++ +  +++ +      S+   
Sbjct: 15  FPDDAFAETIKDNLKKKSV-----TDAVTQNELNS---IDQIIANNSDIK-----SVQGI 61

Query: 223 SS--HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLF 280
               ++  L+++ N+++      + NLKNL  + ++ N +   + +S+  L KL+ LSL 
Sbjct: 62  QYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLE 117

Query: 281 GNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREV 340
            N IS +I + L +L  L  + L  N I  +  + L    +L  L L DN +S  I   +
Sbjct: 118 HNGIS-DI-NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-PL 171

Query: 341 IGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFS 400
            GL+    L LS+NH+S    L    LK +  L+L   +   +     ++ V    +  +
Sbjct: 172 AGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT 229

Query: 401 DNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFN 450
           D S   P     S     +  ++  +       +    ++ +        
Sbjct: 230 DGSLVTPEI--ISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKAR 277

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 94.4 bits (234), Expect = 4e-20
 Identities = 45/228 (19%), Positives = 83/228 (36%), Gaps = 20/228 (8%)

Query: 247 LKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGN 306
           +   I ++  +  +            +    +L    ++  +      L  + ++    +
Sbjct: 1   MGETITVSTPIKQIFP-----DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS 53

Query: 307 SIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGR 366
            I+ S+   +     + KL L+ N L+   P  +  L +   L L  N +     L+   
Sbjct: 54  DIK-SV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSSLK--D 107

Query: 367 LKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRN 426
           LK ++ L L  N +S +I   L     LE L   +N       +  S L  L  L L  N
Sbjct: 108 LKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDN 163

Query: 427 NFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNN 474
             S  I   L     LQ L LS N++  ++ +    KN+  + +    
Sbjct: 164 QIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQE 208

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 88.6 bits (219), Expect = 3e-18
 Identities = 57/275 (20%), Positives = 99/275 (36%), Gaps = 58/275 (21%)

Query: 58  LSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAV 117
               +   + +L + S++  +      L  ++    + + +         ++  + Y   
Sbjct: 17  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--------SVQGIQY--- 63

Query: 118 TQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFA 177
                           LPN+  L L  N  T      I         L  LKNL  L   
Sbjct: 64  ----------------LPNVTKLFLNGNKLT-----DIKP-------LTNLKNLGWLFLD 95

Query: 178 RNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRIS 237
            N +      DL  L  L     L+ +SL  N +S +  N + +    L  LY+  N+I 
Sbjct: 96  ENKI-----KDLSSLKDLKK---LKSLSLEHNGISDI--NGLVHLPQ-LESLYLGNNKI- 143

Query: 238 GTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIF 297
            T  T +  L  L  +++E N ++  I   +  L KLQ L L  N IS ++  +L  L  
Sbjct: 144 -TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DL-RALAGLKN 198

Query: 298 LTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNL 332
           L  ++L          +   N +    +  +D +L
Sbjct: 199 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 82.1 bits (202), Expect = 3e-16
 Identities = 47/304 (15%), Positives = 102/304 (33%), Gaps = 64/304 (21%)

Query: 32  SELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMF 91
                  + +   L   + T ++    + L+ + Q+  + + +  ++   +  L  +   
Sbjct: 15  FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 70

Query: 92  QVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEI 151
            ++ N            ++ +                     L N+  L L  N      
Sbjct: 71  FLNGN-----------KLTDIKPLT----------------NLKNLGWLFLDENKIK--- 100

Query: 152 PPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSL 211
              +S+       L  LK L  L+   N +          ++ LV+   LE + L +N +
Sbjct: 101 --DLSS-------LKDLKKLKSLSLEHNGISD--------INGLVHLPQLESLYLGNNKI 143

Query: 212 SGVLPNSIANFS--SHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVG 269
           +      I   S  + L  L +  N+IS  I   +  L  L  + +  N ++  +  ++ 
Sbjct: 144 T-----DITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLR-ALA 194

Query: 270 YLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSD 329
            L  L VL LF  +   +  +   NL+    V     S+    P  + +    +K ++  
Sbjct: 195 GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKW 252

Query: 330 NNLS 333
           +   
Sbjct: 253 HLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 55.5 bits (133), Expect = 5e-08
 Identities = 48/245 (19%), Positives = 74/245 (30%), Gaps = 78/245 (31%)

Query: 9   NITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLS 68
            I +   +  L L  NKL  +I   L NL  L  L L  N     +  SL +L  L+ LS
Sbjct: 60  GIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLS 115

Query: 69  LSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPH 128
           L  N                                    IS ++               
Sbjct: 116 LEHN-----------------------------------GISDINGLV------------ 128

Query: 129 YVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGND 188
                LP +  L LG+N         I++       L +L  L  L+   N         
Sbjct: 129 ----HLPQLESLYLGNN--------KITD----ITVLSRLTKLDTLSLEDNQ-------- 164

Query: 189 LRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLK 248
           +  +  L   T L+ + LS N +S +   ++A   + L  L + +            NL 
Sbjct: 165 ISDIVPLAGLTKLQNLYLSKNHISDL--RALAGLKN-LDVLELFSQECLNKPINHQSNLV 221

Query: 249 NLILI 253
               +
Sbjct: 222 VPNTV 226

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 42.8 bits (100), Expect = 5e-04
 Identities = 21/97 (21%), Positives = 38/97 (39%), Gaps = 4/97 (4%)

Query: 9   NITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLS 68
            ++  ++L  L L  N++  +I   L  L KL  L L+ N+ +  + ++L+ L  L  L 
Sbjct: 148 VLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLE 203

Query: 69  LSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQ 105
           L          +    L   N  + +   L     I 
Sbjct: 204 LFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 97.0 bits (242), Expect = 4e-22
 Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 33/234 (14%)

Query: 559 EGFSSANLIGIGGYGYVYKGI-LGTEETNVAVKVLDLQQRGASKSFIA-ECEALRSIRHR 616
           + +    +IG G    V        +E  VA+K ++L++   S   +  E +A+    H 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEK-VAIKRINLEKCQTSMDELLKEIQAMSQCHHP 73

Query: 617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI- 675
           N+V   TS        +E   LV + +  GS+ + +  K        K  ++   +IA  
Sbjct: 74  NIVSYYTSF----VVKDEL-WLVMKLLSGGSVLDII--KHIVAKGEHKSGVLDESTIATI 126

Query: 676 --DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
             +V   LEYLH +     +H D+K  N+LL  +    + DFG+S  L        +  R
Sbjct: 127 LREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183

Query: 734 VKGSIG---YVAPEYGALGEVSTHGDEY-------SFGILMLEMFTGKRPTDDM 777
            K  +G   ++AP      EV      Y       SFGI  +E+ TG  P    
Sbjct: 184 -KTFVGTPCWMAP------EVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 97.3 bits (242), Expect = 5e-22
 Identities = 53/276 (19%), Positives = 105/276 (38%), Gaps = 69/276 (25%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIA-ECEALRSIRHRNLVKIITS 624
            +G GG+G V++     ++ N A+K + L  R  ++  +  E +AL  + H  +V+   +
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 625 -------------------------------------------------CSSIDTRGNEF 635
                                                             +    + +  
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 636 KALVY---EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSI 692
           K  +Y   +     +L++W+N++   +++   + L     I I +A  +E+LH      +
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL----HIFIQIAEAVEFLHSK---GL 185

Query: 693 VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK------GSIG---YVAP 743
           +H DLKPSN+    + V  VGDFGL   +  +  +QT  + +       G +G   Y++P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFE 779
           E       S   D +S G+++ E+        +   
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR 281

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 97.9 bits (244), Expect = 1e-21
 Identities = 51/243 (20%), Positives = 90/243 (37%), Gaps = 36/243 (14%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALR-SIRHRNLV 619
             S  ++G G  G V           VAVK + +         + E + L  S  H N++
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLIDF---CDIALMEIKLLTESDDHPNVI 72

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
           +   S ++     + F  +  E   N +L++ +  K               +S+   +A+
Sbjct: 73  RYYCSETT-----DRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG-------------DFGLSRLLHDN-S 725
            + +LH      I+H DLKP N+L+                      DFGL + L    S
Sbjct: 127 GVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 726 PDQTSTSRVKGSIGYVAPEY--GALGEVSTHG-----DEYSFGILMLEMFT-GKRPTDDM 777
             +T+ +   G+ G+ APE    +    +        D +S G +   + + GK P  D 
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243

Query: 778 FEE 780
           +  
Sbjct: 244 YSR 246

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 41/224 (18%)

Query: 565 NLIGIGGYGYVYKGILGTEETN---VAVKVLD---LQQRGASKSFIAECEALRSIRHRNL 618
             +G G +G VY   L  E+ +   +A+KVL    L++ G       E E    +RH N+
Sbjct: 15  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
           +++             +  L+ E+ P G++   L +      QR    + +       +A
Sbjct: 72  LRLYGY---FHDATRVY--LILEYAPLGTVYRELQKLSKFDEQRTATYITE-------LA 119

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSI 738
           N L Y H      ++H D+KP N+LL +     + DFG S     +           G++
Sbjct: 120 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-----GTL 171

Query: 739 GYVAPE------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDD 776
            Y+ PE      +    +V    D +S G+L  E   GK P + 
Sbjct: 172 DYLPPEMIEGRMHDE--KV----DLWSLGVLCYEFLVGKPPFEA 209

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 90.7 bits (226), Expect = 3e-20
 Identities = 56/222 (25%), Positives = 89/222 (40%), Gaps = 39/222 (17%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKII 622
            +G G +G VY       +  +A+KVL    L++ G       E E    +RH N++++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWL--NQKEDEQNQRPKLNLMQRLSIAIDVANV 680
                   R   +  L+ EF P G L   L  + + DEQ        M+ L+ A      
Sbjct: 81  NY---FHDRKRIY--LMLEFAPRGELYKELQKHGRFDEQRSA---TFMEELADA------ 126

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           L Y H      ++H D+KP N+L+  +    + DFG S         +  T    G++ Y
Sbjct: 127 LHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---RRRTM--CGTLDY 178

Query: 741 VAPE------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDD 776
           + PE      +    +V    D +  G+L  E   G  P D 
Sbjct: 179 LPPEMIEGKTHDE--KV----DLWCAGVLCYEFLVGMPPFDS 214

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 90.4 bits (225), Expect = 4e-20
 Identities = 44/233 (18%), Positives = 83/233 (35%), Gaps = 20/233 (8%)

Query: 204 VSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEVNLLTG 262
                 +   + P    N       L +S N +   + +    +   L ++ +    +  
Sbjct: 12  YQCMELNFYKI-P---DNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ- 65

Query: 263 SIPTSV-GYLLKLQVLSLFGNKISGEIPSSL-GNLIFLTEVDLQGNSIRGSIPS-ALGNC 319
           +I       L  L  L L GN I   +       L  L ++     ++  S+ +  +G+ 
Sbjct: 66  TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHL 123

Query: 320 LQLQKLDLSDNNLSGTIPREV-IGLSSFVLLDLSRNHLSGPIPLEV----GRLKGIQ-QL 373
             L++L+++ N +      E    L++   LDLS N +   I         ++  +   L
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSL 182

Query: 374 DLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRN 426
           DLS N ++  I       + L+ L    N  +      F  L  LQ + L  N
Sbjct: 183 DLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 24/211 (11%)

Query: 264 IPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCL-QL 322
           +P S       + L L  N +      S  +   L  +DL    I+ +I       L  L
Sbjct: 26  LPFS------TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78

Query: 323 QKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLDLSENKL 380
             L L+ N +  ++      GLSS   L     +L+  +     G LK +++L+++ N +
Sbjct: 79  STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLI 136

Query: 381 -SGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQ----DLDLSRNNFSGKIPMF 435
            S ++P   ++   LE+L+ S N  Q    +    L  +      LDLS N  +  I   
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP- 194

Query: 436 LNTFRF--LQKLNLSFNNLEGEVPSEGVFKN 464
              F+   L++L L  N L+  VP +G+F  
Sbjct: 195 -GAFKEIRLKELALDTNQLK-SVP-DGIFDR 222

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 49/217 (22%), Positives = 84/217 (38%), Gaps = 17/217 (7%)

Query: 199 TFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEV 257
              + + LS N L  +   S  +F   L  L +S   I  TI  G   +L +L  + +  
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFP-ELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTG 85

Query: 258 NLLTGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSL-GNLIFLTEVDLQGNSIRGSIPS- 314
           N +  S+       L  LQ L      ++  + +   G+L  L E+++  N I+ S    
Sbjct: 86  NPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLP 142

Query: 315 -ALGNCLQLQKLDLSDNNLSGTIPREVI-GLSS----FVLLDLSRNHLSGPIPLEVGRLK 368
               N   L+ LDLS N +  +I    +  L       + LDLS N ++  I     +  
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEI 200

Query: 369 GIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQ 405
            +++L L  N+L             L+ +    N + 
Sbjct: 201 RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 51/190 (26%), Positives = 75/190 (39%), Gaps = 25/190 (13%)

Query: 288 IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREV-IGLSSF 346
           +P S  NL      DL  N +R     +  +  +LQ LDLS   +  TI       LS  
Sbjct: 26  LPFSTKNL------DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78

Query: 347 VLLDLSRNHLSGPIPLEV-GRLKGIQQLDLSENKLSGEIPTSLAS-CVGLEYLNFSDNSF 404
             L L+ N +   + L     L  +Q+L   E  L+  +          L+ LN + N  
Sbjct: 79  STLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136

Query: 405 QG-PIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKL-------NLSFNNLEGEV 456
           Q   +   FS+L  L+ LDLS N     I       R L ++       +LS N +   +
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQ-SIY--CTDLRVLHQMPLLNLSLDLSLNPMN-FI 192

Query: 457 PSEGVFKNVR 466
              G FK +R
Sbjct: 193 Q-PGAFKEIR 201

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 63.1 bits (154), Expect = 6e-11
 Identities = 53/260 (20%), Positives = 87/260 (33%), Gaps = 52/260 (20%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSL-SNLSF 63
           +IP N+      + LDL  N L         +  +L  L L+      +I      +LS 
Sbjct: 21  KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 64  LQQLSLSEN---SLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
           L  L L+ N   SL+    S L  L++L         L  S+                  
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVA---VETNLA-SLENFPIGH----------- 122

Query: 121 KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNN 180
                        L  ++ L +  N               +PE    L NL  L+ + N 
Sbjct: 123 -------------LKTLKELNVAHNLIQ-SFK--------LPEYFSNLTNLEHLDLSSNK 160

Query: 181 LGTGKGNDLRFLDSLVNCTFLEVV-SLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGT 239
           + +    D   L  L     L +   LS N ++ + P +       L  L +  N++  +
Sbjct: 161 IQSIYCTD---LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI--RLKELALDTNQLK-S 214

Query: 240 IPTGV-GNLKNLILIAMEVN 258
           +P G+   L +L  I +  N
Sbjct: 215 VPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 60.0 bits (146), Expect = 7e-10
 Identities = 42/263 (15%), Positives = 87/263 (33%), Gaps = 58/263 (22%)

Query: 53  SIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSM 112
            IP +L      + L LS N L            +L +  +S   +  +I    +     
Sbjct: 21  KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQ---- 73

Query: 113 DYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLI 172
                               +L ++  L+L  N     +             L  L+ L 
Sbjct: 74  --------------------SLSHLSTLILTGNPIQ-SLALGA------FSGLSSLQKL- 105

Query: 173 RLNFARNNLGTGKGNDLRFLDSLV--NCTFLEVVSLSSNSLSGVLPNSIANFSS--HLIY 228
                          +L  L++    +   L+ ++++ N +          FS+  +L +
Sbjct: 106 VAV----------ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY--FSNLTNLEH 153

Query: 229 LYMSANRISGTIPTGV-GNLKNLILIAMEVNL----LTGSIPTSVGYLLKLQVLSLFGNK 283
           L +S+N+I  +I       L  + L+ + ++L    +   I       ++L+ L+L  N+
Sbjct: 154 LDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQ 211

Query: 284 ISGEIPSSLGNLIFLTEVDLQGN 306
           +          L  L ++ L  N
Sbjct: 212 LKSVPDGIFDRLTSLQKIWLHTN 234

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 89.7 bits (223), Expect = 8e-20
 Identities = 47/259 (18%), Positives = 92/259 (35%), Gaps = 49/259 (18%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSI-RHRN 617
           F     IG G +G V+K +   +    A+K       G+   ++ + E  A   + +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           +V+     S+     +    +  E+   GSL + +++              +   + + V
Sbjct: 73  VVRYF---SAWAEDDHML--IQNEYCNGGSLADAISEN---YRIMSYFKEAELKDLLLQV 124

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV-------------------GDFGLS 718
              L Y+H     S+VH D+KPSN+ +    + +                    GD G  
Sbjct: 125 GRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181

Query: 719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRPTD 775
             +       +S    +G   ++A E   L E  TH    D ++  + ++     +    
Sbjct: 182 TRI-------SSPQVEEGDSRFLANE--VLQENYTHLPKADIFALALTVVCAAGAEPL-- 230

Query: 776 DMFEEGLSLHKYAKMGLPD 794
                G   H+  +  LP 
Sbjct: 231 --PRNGDQWHEIRQGRLPR 247

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 90.7 bits (225), Expect = 1e-19
 Identities = 56/261 (21%), Positives = 95/261 (36%), Gaps = 19/261 (7%)

Query: 198 CT-FLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAM 255
           C     V     + ++ + P   ++   + I L     ++   I  G      +L  I +
Sbjct: 7   CHCSNRVFLCQESKVTEI-P---SDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEI 61

Query: 256 EVNLLTGSIPTSV-GYLLKLQVLSLF-GNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIP 313
             N +   I   V   L KL  + +   N +    P +  NL  L  + +    I+  +P
Sbjct: 62  SQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLP 120

Query: 314 S-ALGNCLQLQKLDLSDNNLSGTIPREVI-GLSS-FVLLDLSRNHLSGPIPLEVGRLKGI 370
                + LQ   LD+ DN    TI R    GLS   V+L L++N +   I         +
Sbjct: 121 DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQL 179

Query: 371 QQLDLSENKLSGEIPT-SLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFS 429
            +L+LS+N    E+P        G   L+ S          G  +LK L+          
Sbjct: 180 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK-- 237

Query: 430 GKIPMFLNTFRFLQKLNLSFN 450
            K+P        L + +L++ 
Sbjct: 238 -KLPTLEK-LVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 51/213 (23%), Positives = 82/213 (38%), Gaps = 21/213 (9%)

Query: 275 QVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPS-ALGNCLQLQKLDLSDNNLS 333
           +V     +K++ EIPS L       E+      +R  I   A      L+K+++S N++ 
Sbjct: 12  RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVL 67

Query: 334 GTIPREV-IGLSSFVLLDLSR-NHLSGPIPLEV-GRLKGIQQLDLSENKLSGEIP-TSLA 389
             I  +V   L     + + + N+L   I  E    L  +Q L +S   +   +P     
Sbjct: 68  EVIEADVFSNLPKLHEIRIEKANNLLY-INPEAFQNLPNLQYLLISNTGIK-HLPDVHKI 125

Query: 390 SCVGLEYLNFSDNSFQGPIHSG-FSSLKG-LQDLDLSRNNFSGKIPMFLNTFRFLQ--KL 445
             +    L+  DN     I    F  L      L L++N    +I    + F   Q  +L
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHN--SAFNGTQLDEL 182

Query: 446 NLSFNNLEGEVPSEGVFKNVRAVSI--IGNNKL 476
           NLS NN   E+P   VF       I  I   ++
Sbjct: 183 NLSDNNNLEELP-NDVFHGASGPVILDISRTRI 214

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 57/309 (18%), Positives = 107/309 (34%), Gaps = 62/309 (20%)

Query: 7   PANITHCSELRILDLVVNKLEGNIPSELGNLFK-LVGLGLTGNNYTGSIPQSLSNLSFLQ 65
              I HCS  R+     +K+   IPS   +L +  + L             + S    L+
Sbjct: 3   HHRICHCSN-RVFLCQESKVT-EIPS---DLPRNAIELRFVLTKLRVIQKGAFSGFGDLE 57

Query: 66  QLSLSENSLSGNIP----SELGLLKQLNMFQVSANYLTGSIPIQLF-NISSMDYFAVTQN 120
           ++ +S+N +   I     S L  L ++ + +  AN L   I  + F N+ ++ Y  ++  
Sbjct: 58  KIEISQNDVLEVIEADVFSNLPKLHEIRIEK--ANNLL-YINPEAFQNLPNLQYLLISNT 114

Query: 121 KLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDL--GKLKNLIRLNFAR 178
            +   +P           +L +  N           N  +I  +   G     + L   +
Sbjct: 115 GIK-HLPDVHKIHSLQKVLLDIQDN----------INIHTIERNSFVGLSFESVILWLNK 163

Query: 179 NNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISG 238
           N +     +              E+    +N+L  +  +      S  + L +S  RI  
Sbjct: 164 NGIQEIHNSAFNGTQL------DELNLSDNNNLEELPNDVFHGA-SGPVILDISRTRIH- 215

Query: 239 TIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFL 298
           ++P+    L+N                     L KL+  S +  K   ++P +L  L+ L
Sbjct: 216 SLPSYG--LEN---------------------LKKLRARSTYNLK---KLP-TLEKLVAL 248

Query: 299 TEVDLQGNS 307
            E  L   S
Sbjct: 249 MEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 43/247 (17%), Positives = 86/247 (34%), Gaps = 27/247 (10%)

Query: 135 PNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDS 194
            N   L          I                  +L ++  ++N++      D+    +
Sbjct: 30  RNAIELRFVLTKLR-VIQKG---------AFSGFGDLEKIEISQNDVLEVIEADV--FSN 77

Query: 195 LVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILI 253
           L     + +    +N+L  + P +  N  + L YL +S   I   +P     +    +L+
Sbjct: 78  LPKLHEIRI--EKANNLLYINPEAFQNLPN-LQYLLISNTGIK-HLPDVHKIHSLQKVLL 133

Query: 254 AMEVNLLTGSIPTSV--GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDL-QGNSIRG 310
            ++ N+   +I  +   G   +  +L L  N I  EI +S  N   L E++L   N++  
Sbjct: 134 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEE 192

Query: 311 SIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLSGPIPLEVGRLKG 369
                         LD+S   +  ++P   +  L           +L     LE  +L  
Sbjct: 193 LPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--YNLKKLPTLE--KLVA 247

Query: 370 IQQLDLS 376
           + +  L+
Sbjct: 248 LMEASLT 254

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 54/247 (21%), Positives = 94/247 (38%), Gaps = 31/247 (12%)

Query: 216 PNSIANFS-----SHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGY 270
           P  I         +  I   +    ++  +      L ++  I    + +  S+   + Y
Sbjct: 11  PTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQY 66

Query: 271 LLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDN 330
           L  +  L L GNK++ +I   L NL  L  + L  N ++  + S+L +  +L+ L L  N
Sbjct: 67  LPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHN 122

Query: 331 NLSGTIPREVIGLSSFV---LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTS 387
            +S     ++ GL        L L  N ++    L   RL  +  L L +N++S +I   
Sbjct: 123 GIS-----DINGLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIV-P 173

Query: 388 LASCVGLEYLNFSDNSFQGPIH--SGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKL 445
           LA    L+ L  S N     I      + LK L  L+L       K     +       +
Sbjct: 174 LAGLTKLQNLYLSKN----HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229

Query: 446 NLSFNNL 452
             +  +L
Sbjct: 230 KNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 56/267 (20%), Positives = 111/267 (41%), Gaps = 29/267 (10%)

Query: 163 EDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANF 222
                    I+ N  + ++      D    + L +   ++ +  +++ +      S+   
Sbjct: 18  FSDDAFAETIKDNLKKKSV-----TDAVTQNELNS---IDQIIANNSDIK-----SVQGI 64

Query: 223 SS--HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLF 280
               ++  L+++ N+++      + NLKNL  + ++ N +   + +S+  L KL+ LSL 
Sbjct: 65  QYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLE 120

Query: 281 GNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREV 340
            N IS +I + L +L  L  + L  N I  +  + L    +L  L L DN +S  I   +
Sbjct: 121 HNGIS-DI-NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-PL 174

Query: 341 IGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFS 400
            GL+    L LS+NH+S    L    LK +  L+L   +   +     ++ V    +  +
Sbjct: 175 AGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT 232

Query: 401 DNSFQGPIHSGFSSLKGLQDLDLSRNN 427
           D S   P     S     +  ++  + 
Sbjct: 233 DGSLVTP--EIISDDGDYEKPNVKWHL 257

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 81.3 bits (201), Expect = 5e-17
 Identities = 42/183 (22%), Positives = 69/183 (37%), Gaps = 14/183 (7%)

Query: 271 LLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDN 330
             +    +L    ++  +      L  + ++    + I+ S+   +     + KL L+ N
Sbjct: 23  FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGN 78

Query: 331 NLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLAS 390
            L+   P  +  L +   L L  N +     L+   LK ++ L L  N +S +I   L  
Sbjct: 79  KLTDIKP--LANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHNGIS-DI-NGLVH 132

Query: 391 CVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFN 450
              LE L   +N       +  S L  L  L L  N  S  I   L     LQ L LS N
Sbjct: 133 LPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKN 188

Query: 451 NLE 453
           ++ 
Sbjct: 189 HIS 191

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 57/277 (20%), Positives = 96/277 (34%), Gaps = 62/277 (22%)

Query: 58  LSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAV 117
               +   + +L + S++  +      L  ++    + + +         ++  + Y   
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--------SVQGIQY--- 66

Query: 118 TQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFA 177
                           LPN+  L L  N  T      I         L  LKNL  L   
Sbjct: 67  ----------------LPNVTKLFLNGNKLT-----DIKP-------LANLKNLGWLFLD 98

Query: 178 RNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFS--SHLIYLYMSANR 235
            N +      DL  L  L     L+ +SL  N +S      I        L  LY+  N+
Sbjct: 99  ENKV-----KDLSSLKDLKK---LKSLSLEHNGIS-----DINGLVHLPQLESLYLGNNK 145

Query: 236 ISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNL 295
           I  T  T +  L  L  +++E N ++  I   +  L KLQ L L  N IS ++  +L  L
Sbjct: 146 I--TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DL-RALAGL 199

Query: 296 IFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNL 332
             L  ++L          +   N +    +  +D +L
Sbjct: 200 KNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 51/231 (22%), Positives = 83/231 (35%), Gaps = 35/231 (15%)

Query: 134 LPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLD 193
           L +I  ++  ++        S+         +  L N+ +L    N L      D++ L 
Sbjct: 45  LNSIDQIIANNSDIK-----SVQG-------IQYLPNVTKLFLNGNKL-----TDIKPLA 87

Query: 194 SLVNCTFLEVVSLSSNSLSGVLPNSIANFSS--HLIYLYMSANRISGTIPTGVGNLKNLI 251
           +L N   L  + L  N +       +++      L  L +  N IS  I  G+ +L  L 
Sbjct: 88  NLKN---LGWLFLDENKVK-----DLSSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLE 137

Query: 252 LIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGS 311
            + +  N +T    T +  L KL  LSL  N+IS +I   L  L  L  + L  N I   
Sbjct: 138 SLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-D 192

Query: 312 IPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPL 362
           +  AL     L  L+L               L     +  +   L  P  +
Sbjct: 193 L-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII 242

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 51/306 (16%), Positives = 107/306 (34%), Gaps = 64/306 (20%)

Query: 32  SELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMF 91
                  + +   L   + T ++    + L+ + Q+  + + +  ++   +  L  +   
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73

Query: 92  QVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEI 151
            ++ N LT      +  +++                      L N+  L L  N      
Sbjct: 74  FLNGNKLT-----DIKPLAN----------------------LKNLGWLFLDEN------ 100

Query: 152 PPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSL 211
              + + SS    L  LK L  L+   N +          ++ LV+   LE + L +N +
Sbjct: 101 --KVKDLSS----LKDLKKLKSLSLEHNGISD--------INGLVHLPQLESLYLGNNKI 146

Query: 212 SGVLPNSIANFS--SHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVG 269
           +      I   S  + L  L +  N+IS  I   +  L  L  + +  N ++  +  ++ 
Sbjct: 147 T-----DITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DL-RALA 197

Query: 270 YLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSD 329
            L  L VL LF  +   +  +   NL+    V     S+    P  + +    +K ++  
Sbjct: 198 GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKW 255

Query: 330 NNLSGT 335
           +    T
Sbjct: 256 HLPEFT 261

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 37/175 (21%), Positives = 68/175 (38%), Gaps = 20/175 (11%)

Query: 282 NKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI 341
             I  +I  S        + +L+  S+  ++         + ++  +++++       V 
Sbjct: 12  TPIK-QI-FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-----SVQ 62

Query: 342 GLSSFV---LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLN 398
           G+        L L+ N L+   PL    LK +  L L ENK+  ++ +SL     L+ L+
Sbjct: 63  GIQYLPNVTKLFLNGNKLTDIKPLA--NLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLS 118

Query: 399 FSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLE 453
              N       +G   L  L+ L L  N  +  I   L+    L  L+L  N + 
Sbjct: 119 LEHNGISDI--NGLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQIS 169

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 51/245 (20%), Positives = 81/245 (33%), Gaps = 53/245 (21%)

Query: 9   NITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLS 68
            I +   +  L L  NKL  +I   L NL  L  L L  N     +  SL +L  L+ LS
Sbjct: 63  GIQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLS 118

Query: 69  LSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPH 128
           L  N +S +I   L  L QL    +  N +T        +I+ +                
Sbjct: 119 LEHNGIS-DING-LVHLPQLESLYLGNNKIT--------DITVLS--------------- 153

Query: 129 YVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGND 188
                L  +  L L  N  +      I         L  L  L  L  ++N++       
Sbjct: 154 ----RLTKLDTLSLEDNQIS-----DIVP-------LAGLTKLQNLYLSKNHISD----- 192

Query: 189 LRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLK 248
              L +L     L+V+ L S        N  +N            + ++  I +  G+ +
Sbjct: 193 ---LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 249

Query: 249 NLILI 253
              + 
Sbjct: 250 KPNVK 254

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 31/179 (17%), Positives = 70/179 (39%), Gaps = 11/179 (6%)

Query: 205 SLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSI 264
            L  +S + +    + +    L Y+ ++   ++    TG+    N+  + +     T   
Sbjct: 29  LLGQSSTANITEAQMNS----LTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYN 82

Query: 265 PTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQK 324
           P  +  L  L+ L + G  ++ +   +L  L  LT +D+  ++   SI + +    ++  
Sbjct: 83  P--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNS 140

Query: 325 LDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGE 383
           +DLS N     I   +  L     L++  + +     +E      + QL      + G+
Sbjct: 141 IDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 84.2 bits (209), Expect = 9e-19
 Identities = 27/185 (14%), Positives = 64/185 (34%), Gaps = 10/185 (5%)

Query: 246 NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQG 305
             K  +   +  +        +   +  L  ++L    ++ ++ + +     + ++ +  
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75

Query: 306 NSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVG 365
                   + +     L++L +   +++      + GL+S  LLD+S +     I  ++ 
Sbjct: 76  IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 366 RLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSR 425
            L  +  +DLS N    +I   L +   L+ LN   +        G      L  L    
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFS 190

Query: 426 NNFSG 430
               G
Sbjct: 191 QTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 80.4 bits (199), Expect = 2e-17
 Identities = 26/185 (14%), Positives = 66/185 (35%), Gaps = 10/185 (5%)

Query: 271 LLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDN 330
                   L  +  +     +   +  LT + L   ++   + + +     ++ L +++ 
Sbjct: 22  FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNI 76

Query: 331 NLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLAS 390
           + +   P  + GLS+   L +    ++      +  L  +  LD+S +     I T + +
Sbjct: 77  HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134

Query: 391 CVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFN 450
              +  ++ S N     I     +L  L+ L++  +         +  F  L +L     
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191

Query: 451 NLEGE 455
            + G+
Sbjct: 192 TIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 30/184 (16%), Positives = 69/184 (37%), Gaps = 15/184 (8%)

Query: 294 NLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV---LLD 350
                    L  +S      + + +   L  + L++ N++     ++ G+        L 
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNS---LTYITLANINVT-----DLTGIEYAHNIKDLT 72

Query: 351 LSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHS 410
           ++  H +   P+    L  +++L +    ++ +   +L+    L  L+ S ++    I +
Sbjct: 73  INNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 411 GFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSI 470
             ++L  +  +DLS N     I   L T   L+ LN+ F+ +      E  F  +  +  
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIED-FPKLNQLYA 188

Query: 471 IGNN 474
               
Sbjct: 189 FSQT 192

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 31/229 (13%), Positives = 75/229 (32%), Gaps = 52/229 (22%)

Query: 59  SNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVT 118
           S         L ++S +    +++  L  + +   +   +T        +++ ++Y    
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITL---ANINVT--------DLTGIEY---- 64

Query: 119 QNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFAR 178
                            NI+ L + +           +N +     +  L NL RL    
Sbjct: 65  ---------------AHNIKDLTINNI--------HATNYNP----ISGLSNLERLRIMG 97

Query: 179 NNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISG 238
            ++ +   + +  L  L +   L ++ +S ++    +   I      +  + +S N    
Sbjct: 98  KDVTS---DKIPNLSGLTS---LTLLDISHSAHDDSILTKINTLPK-VNSIDLSYNGAIT 150

Query: 239 TIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
            I   +  L  L  + ++ + +       +    KL  L  F   I G+
Sbjct: 151 DI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 55.7 bits (135), Expect = 5e-09
 Identities = 26/174 (14%), Positives = 57/174 (32%), Gaps = 40/174 (22%)

Query: 9   NITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLS 68
            I +   ++ L +       N  + +  L  L  L + G + T     +LS L+ L  L 
Sbjct: 61  GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118

Query: 69  LSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPH 128
           +S ++   +I +++  L ++N   +S N     I      + +                 
Sbjct: 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM----PLKT----------------- 157

Query: 129 YVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLG 182
                LP ++ L +  +         + +       +     L +L      +G
Sbjct: 158 -----LPELKSLNIQFD--------GVHDYRG----IEDFPKLNQLYAFSQTIG 194

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 17/99 (17%), Positives = 43/99 (43%), Gaps = 3/99 (3%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           +  +   N++  + L +LD+  +  + +I +++  L K+  + L+ N     I   L  L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTL 158

Query: 62  SFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTG 100
             L+ L++  + +  +    +    +LN     +  + G
Sbjct: 159 PELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQTIGG 195

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 88.0 bits (219), Expect = 4e-19
 Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 30/220 (13%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKV--LDLQQRGASKSFIAECEALRSIRHR 616
           E +     +G G YG VYK         VA+K   LD +  G   + I E   L+ + H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIREISLLKELHHP 79

Query: 617 NLVK---IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
           N+V    +I S   +         LV+EFM    L+  L+        +  L   Q    
Sbjct: 80  NIVSLIDVIHSERCL--------TLVFEFMEK-DLKKVLD------ENKTGLQDSQIKIY 124

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
              +   + + H H    I+H DLKP N+L++++    + DFGL+R      P ++ T  
Sbjct: 125 LYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHE 179

Query: 734 VKGSIGYVAPE--YGALGEVSTHGDEYSFGILMLEMFTGK 771
           V  ++ Y AP+   G+  + ST  D +S G +  EM TGK
Sbjct: 180 VV-TLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGK 217

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 89.6 bits (222), Expect = 4e-19
 Identities = 46/224 (20%), Positives = 79/224 (35%), Gaps = 33/224 (14%)

Query: 568 GIGGYGYVYKGILGTEETNVAVKVLDL--QQRGASKSFIAECEALRSIRHRNLVKIITSC 625
           G      V           V V+ ++L             E    +   H N+V    + 
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI---DVANVLE 682
                  NE   +V  FM  GS ++ +            ++ M  L+IA     V   L+
Sbjct: 96  ----IADNEL-WVVTSFMAYGSAKDLICTH--------FMDGMNELAIAYILQGVLKALD 142

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQ-TSTSRVKGSIG-- 739
           Y+HH      VH  +K S++L+  +   ++     +  +  +   Q       K S+   
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 740 -YVAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRPTDDM 777
            +++PE   + + +  G     D YS GI   E+  G  P  DM
Sbjct: 200 PWLSPE---VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 33/190 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKS---------FIAECEALRSI-RHR 616
           +G G    V + I        AVK++D+   G+  +          + E + LR +  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIA 674
           N++++     + +T    F  LV++ M  G L ++L +K    E+  R    +M+     
Sbjct: 85  NIIQLK---DTYETNTFFF--LVFDLMKKGELFDYLTEKVTLSEKETR---KIMR----- 131

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
             +  V+  LH     +IVH DLKP N+LLD++M   + DFG S  L      +     V
Sbjct: 132 -ALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE----V 183

Query: 735 KGSIGYVAPE 744
            G+  Y+APE
Sbjct: 184 CGTPSYLAPE 193

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 87.2 bits (217), Expect = 7e-19
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 31/223 (13%)

Query: 559 EGFSSANLIGIGGYGYVYKGI-LGTEETNVAVKV--LDLQQRGASKSFIAECEALRSIRH 615
           + +     IG G YG V+K     T E  VA+K   LD    G   S + E   L+ ++H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEI-VALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 616 RNLVK---IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLS 672
           +N+V+   ++ S   +         LV+EF     L+ + +      +    L+     S
Sbjct: 61  KNIVRLHDVLHSDKKL--------TLVFEFCDQ-DLKKYFD------SCNGDLDPEIVKS 105

Query: 673 IAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS 732
               +   L + H      ++H DLKP N+L++      + +FGL+R      P +  ++
Sbjct: 106 FLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSA 160

Query: 733 RVKGSIGYVAPE--YGALGEVSTHGDEYSFGILMLEMFTGKRP 773
            V  ++ Y  P+  +GA    ST  D +S G +  E+    RP
Sbjct: 161 EVV-TLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRP 201

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 87.3 bits (217), Expect = 8e-19
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 25/224 (11%)

Query: 555 LKATEGFSSANLIGIGGYGYVYKGI-LGTEETNVAVKVLDLQQR-GASKSFIAECEALRS 612
           + ++  F     +G G Y  VYKG+   T    VA+K + L    G   + I E   ++ 
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVY-VALKEVKLDSEEGTPSTAIREISLMKE 59

Query: 613 IRHRNLVK---IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQ 669
           ++H N+V+   +I + + +         LV+EFM N  L+ +++ +      R  L L  
Sbjct: 60  LKHENIVRLYDVIHTENKL--------TLVFEFMDN-DLKKYMDSRTVGNTPRG-LELNL 109

Query: 670 RLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQT 729
                  +   L + H +    I+H DLKP N+L++      +GDFGL+R      P  T
Sbjct: 110 VKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNT 164

Query: 730 STSRVKGSIGYVAPE--YGALGEVSTHGDEYSFGILMLEMFTGK 771
            +S V  ++ Y AP+   G+    ST  D +S G ++ EM TGK
Sbjct: 165 FSSEVV-TLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGK 206

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 88.2 bits (219), Expect = 1e-18
 Identities = 52/236 (22%), Positives = 94/236 (39%), Gaps = 35/236 (14%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVL---DLQQRGASKSFIAECEALRSIRHRN 617
           F    +IG G +  V    +       A+K++   D+ +RG    F  E + L +   R 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           + ++     +       +  LV E+   G L   L++  +          M R  +A ++
Sbjct: 123 ITQL---HFAFQDENYLY--LVMEYYVGGDLLTLLSKFGERIPAE-----MARFYLA-EI 171

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRLLHDNSPDQTSTSRVK 735
              ++ +H       VH D+KP N+LLD     H+   DFG    L  +   ++      
Sbjct: 172 VMAIDSVHRL---GYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLV--AV 224

Query: 736 GSIGYVAPE----YGALGEVSTHG---DEYSFGILMLEMFTGKRP-----TDDMFE 779
           G+  Y++PE     G      ++G   D ++ G+   EMF G+ P     T + + 
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 70/224 (31%), Positives = 106/224 (47%), Gaps = 41/224 (18%)

Query: 566 LIGIGGYGYVYKGI-LGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKI 621
            +G+G +G V  G    T    VAVK+L+   ++          E + L+  RH +++K+
Sbjct: 18  TLGVGTFGKVKIGEHQLTGH-KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWL--NQKEDEQNQRPKLNLMQRLSIAIDVAN 679
                 I T  + F  +V E++  G L +++  + + +E   R    L Q++  A+D   
Sbjct: 77  YQV---ISTPTDFF--MVMEYVSGGELFDYICKHGRVEEMEAR---RLFQQILSAVD--- 125

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
              Y H H    +VH DLKP NVLLD  M A + DFGLS ++ D    +TS     GS  
Sbjct: 126 ---YCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPN 175

Query: 740 YVAPE------Y-GALGEVSTHGDEYSFGILMLEMFTGKRPTDD 776
           Y APE      Y G   EV    D +S G+++  +  G  P DD
Sbjct: 176 YAAPEVISGRLYAGP--EV----DIWSCGVILYALLCGTLPFDD 213

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 87.8 bits (218), Expect = 1e-18
 Identities = 57/243 (23%), Positives = 106/243 (43%), Gaps = 46/243 (18%)

Query: 553 ELLKATEGFSSANLIGIGGYGYVYKGILGTEETNV--AVKVLD---LQQRGASKSFIAEC 607
           E+L+A         IG G +G V   I+   +T    A+K ++     +R   ++   E 
Sbjct: 18  EILRA---------IGKGSFGKVC--IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL 66

Query: 608 EALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNL 667
           + ++ + H  LV +     S     + F  +V + +  G L   L Q    + +  KL +
Sbjct: 67  QIMQGLEHPFLVNLW---YSFQDEEDMF--MVVDLLLGGDLRYHLQQNVHFKEETVKLFI 121

Query: 668 MQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD 727
            + L +A      L+YL +     I+H D+KP N+LLD     H+ DF ++ +L      
Sbjct: 122 CE-LVMA------LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--- 168

Query: 728 QTSTSRVKGSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP--------TDD 776
            T  + + G+  Y+APE  +  + + +    D +S G+   E+  G+RP        + +
Sbjct: 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE 227

Query: 777 MFE 779
           +  
Sbjct: 228 IVH 230

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 87.2 bits (216), Expect = 1e-18
 Identities = 70/351 (19%), Positives = 124/351 (35%), Gaps = 62/351 (17%)

Query: 527 RRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETN 586
             ++R+R +A +    + K  ++   +  K +E       +G G  G V+K         
Sbjct: 10  DEQQRKRLEAFLT--QKQKVGELKDDDFEKISE-------LGAGNGGVVFKVSHKPSGLV 60

Query: 587 VAVKVLDLQQRGASKSFIA-ECEALRSIRHRNLVK-----IITSCSSIDTRGNEFKALVY 640
           +A K++ L+ + A ++ I  E + L       +V            SI            
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI----------CM 110

Query: 641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS 700
           E M  GSL+  L +         ++       ++I V   L YL       I+H D+KPS
Sbjct: 111 EHMDGGSLDQVLKKAG-------RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPS 161

Query: 701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG---YVAPEYGALGEVSTHGDE 757
           N+L+++     + DFG+S  L D        S     +G   Y++PE       S   D 
Sbjct: 162 NILVNSRGEIKLCDFGVSGQLID--------SMANSFVGTRSYMSPERLQGTHYSVQSDI 213

Query: 758 YSFGILMLEMFTGKRP-------------TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAI 804
           +S G+ ++EM  G+ P                +  +        +          +D   
Sbjct: 214 WSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRP 273

Query: 805 LEEALEIQAGIVKELQPNLRA-KFHEIQVSILRVGILCSEELPRDRMKIQD 854
                E+   IV E  P L +  F       +     C  + P +R  ++ 
Sbjct: 274 PMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN---KCLIKNPAERADLKQ 321

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 86.0 bits (214), Expect = 2e-18
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 30/220 (13%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKV--LDLQQRGASKSFIAECEALRSIRHR 616
           E +     IG G YG VYK      ET  A+K   L+ +  G   + I E   L+ ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 617 NLVK---IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
           N+VK   +I +   +         LV+E +    L+  L+           L  +   S 
Sbjct: 61  NIVKLYDVIHTKKRL--------VLVFEHLDQ-DLKKLLD------VCEGGLESVTAKSF 105

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
            + + N + Y H      ++H DLKP N+L++ E    + DFGL+R      P +  T  
Sbjct: 106 LLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHE 160

Query: 734 VKGSIGYVAPE--YGALGEVSTHGDEYSFGILMLEMFTGK 771
           +  ++ Y AP+   G+  + ST  D +S G +  EM  G 
Sbjct: 161 IV-TLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGT 198

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 38/221 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIIT 623
           IG G +  V           VA+K++D   L      K F  E   ++ + H N+VK+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANVL 681
               I+T    +  L+ E+   G + ++L       E+  R K    Q +S A+      
Sbjct: 82  V---IETEKTLY--LIMEYASGGEVFDYLVAHGRMKEKEARSKF--RQIVS-AVQ----- 128

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
            Y H      IVH DLK  N+LLD +M   + DFG S                 G+  Y 
Sbjct: 129 -YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPPYA 180

Query: 742 APE------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDD 776
           APE      Y    EV    D +S G+++  + +G  P D 
Sbjct: 181 APELFQGKKYDGP-EV----DVWSLGVILYTLVSGSLPFDG 216

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 28/228 (12%)

Query: 566 LIGIGGYGYVYKGI-LGTEETNVAVKVLDLQQRGASKSFIA-ECEALRSIRHRNLVKIIT 623
            +G G YG V   +   TEE  VAVK++D+++       I  E    + + H N+VK   
Sbjct: 14  TLGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWL--NQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
                     ++  L  E+   G L + +  +    E + +       +L   +      
Sbjct: 73  H---RREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVV----- 119

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
            YLH      I H D+KP N+LLD      + DFGL+ +   N+ ++       G++ YV
Sbjct: 120 -YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYV 174

Query: 742 APEYGALGEVSTHG---DEYSFGILMLEMFTGKRPTDDMFEEGLSLHK 786
           APE   L     H    D +S GI++  M  G+ P D   +       
Sbjct: 175 APE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 85.3 bits (212), Expect = 4e-18
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 28/219 (12%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRN 617
           E +   + +G G Y  VYKG     +  VA+K + L+   GA  + I E   L+ ++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 618 LVK---IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
           +V    II +  S+         LV+E++    L+ +L+      +    +N+       
Sbjct: 62  IVTLHDIIHTEKSL--------TLVFEYLDK-DLKQYLD------DCGNIINMHNVKLFL 106

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
             +   L Y H      ++H DLKP N+L++      + DFGL+R    + P +T  + V
Sbjct: 107 FQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAK--SIPTKTYDNEV 161

Query: 735 KGSIGYVAPE--YGALGEVSTHGDEYSFGILMLEMFTGK 771
             ++ Y  P+   G+  + ST  D +  G +  EM TG+
Sbjct: 162 V-TLWYRPPDILLGST-DYSTQIDMWGVGCIFYEMATGR 198

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 85.0 bits (211), Expect = 5e-18
 Identities = 52/233 (22%), Positives = 93/233 (39%), Gaps = 36/233 (15%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETN---VAVKVLD---LQQRGASKSFIAECEALRSIR 614
           F    ++G G +  V    L  E       A+K+L+   + +         E + +  + 
Sbjct: 32  FKFGKILGEGSFSTVV---LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
           H   VK+  +        +E       +  NG L  ++      +          R   A
Sbjct: 89  HPFFVKLYFTFQD-----DEKLYFGLSYAKNGELLKYI------RKIGSFDETCTRFYTA 137

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
            ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S    + S V
Sbjct: 138 -EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 193

Query: 735 KGSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP-----TDDMFE 779
            G+  YV+PE   L    +     D ++ G ++ ++  G  P        +F+
Sbjct: 194 -GTAQYVSPE---LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 242

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 84.6 bits (210), Expect = 5e-18
 Identities = 55/224 (24%), Positives = 99/224 (44%), Gaps = 33/224 (14%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIA-ECEALRSIRHRNLVKI 621
           L+G G YG V + +        AVK+L    L++    ++ +  E + LR +RH+N++++
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLE--NWLNQK---EDEQNQRPKLNLMQRLSIAID 676
           +    + + +   +  +V E+   G  E  + + +K     +           +L   ++
Sbjct: 72  VDVLYN-EEKQKMY--MVMEYCVCGMQEMLDSVPEKRFPVCQ-----AHGYFCQLIDGLE 123

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQT-STSRVK 735
                 YLH      IVH D+KP N+LL       +   G++  LH  + D T  TS+  
Sbjct: 124 ------YLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-- 172

Query: 736 GSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRPTDD 776
           GS  +  PE  A G  +  G   D +S G+ +  + TG  P + 
Sbjct: 173 GSPAFQPPEI-ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 85.3 bits (211), Expect = 6e-18
 Identities = 51/265 (19%), Positives = 91/265 (34%), Gaps = 63/265 (23%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQ-----RGASKSFIAECEALRSIRHRNLVKI 621
           IG G YG V   I        A+K+++  +         +    E   ++ + H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRL---------- 671
                  +        LV E    G L + LN   D+   +  +++++            
Sbjct: 94  Y---EVYEDEQYIC--LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 672 -----------------------SIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM 708
                                  +I   + + L YLH+     I H D+KP N L     
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205

Query: 709 VAHV--GDFGLSRLLHDNSPDQTSTSRVK-GSIGYVAPE--------YGALGEVSTHGDE 757
              +   DFGLS+  +  +  +      K G+  +VAPE        YG   +     D 
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP--KC----DA 259

Query: 758 YSFGILMLEMFTGKRPTDDMFEEGL 782
           +S G+L+  +  G  P   + +   
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVNDADT 284

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 85.9 bits (213), Expect = 7e-18
 Identities = 53/244 (21%), Positives = 94/244 (38%), Gaps = 53/244 (21%)

Query: 514 LLSTCFIVFVFYQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYG 573
           L  +   VFVF+      +        ++ D+Y       + K          +G G  G
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYP---KALRDEY------IMSK---------TLGSGACG 149

Query: 574 YVYKGILGTEETNVAVKVLD--------LQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
            V           VA++++          ++   + +   E E L+ + H  ++KI    
Sbjct: 150 EVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK--- 206

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANVLEY 683
           +  D    E   +V E M  G L + +   +   E   +              +   ++Y
Sbjct: 207 NFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCK---------LYFYQMLLAVQY 254

Query: 684 LHHHCHTSIVHCDLKPSNVLL---DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           LH +    I+H DLKP NVLL   + + +  + DFG S++L + S  +T      G+  Y
Sbjct: 255 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC----GTPTY 307

Query: 741 VAPE 744
           +APE
Sbjct: 308 LAPE 311

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 82.7 bits (205), Expect = 9e-18
 Identities = 38/214 (17%), Positives = 80/214 (37%), Gaps = 20/214 (9%)

Query: 263 SIPTSVGYLLKLQVLSLFGNKISGEIPS-SLGNLIFLTEVDLQGNSIRGSIPS-ALGNCL 320
           S+P S       Q L L    +   IPS +  NL  ++ + +  +     + S +  N  
Sbjct: 28  SLPPS------TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS 80

Query: 321 QLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLSG-PIPLEVGRLKGIQQLDLSEN 378
           ++  +++ +      I  + +  L     L +    L   P   +V        L++++N
Sbjct: 81  KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDN 140

Query: 379 KLSGEIPTSLAS--CVGLEYLNFSDNSFQGPIHSG-FSSLKGLQDLDLSRNNFSGKIP-- 433
                IP +     C     L   +N F   +    F+  K L  + L++N +   I   
Sbjct: 141 PYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTK-LDAVYLNKNKYLTVIDKD 198

Query: 434 MFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRA 467
            F   +     L++S  ++   +PS    ++++ 
Sbjct: 199 AFGGVYSGPSLLDVSQTSVT-ALPS-KGLEHLKE 230

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 42/233 (18%), Positives = 77/233 (33%), Gaps = 27/233 (11%)

Query: 156 SNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSN-SLSGV 214
            +   IP       +   L     +L T   +    L        +  + +S + +L  +
Sbjct: 21  KDIQRIP---SLPPSTQTLKLIETHLRTIPSHAFSNL------PNISRIYVSIDVTLQQL 71

Query: 215 LPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEVNLLTGSIP--TSVGYL 271
             +S  N S  + ++ +   R    I       L  L  + +    L    P  T V   
Sbjct: 72  ESHSFYNLSK-VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYST 129

Query: 272 LKLQVLSLFGNKISGEIP----SSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDL 327
               +L +  N     IP      L N      + L  N    S+     N  +L  + L
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNE--TLTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186

Query: 328 SDNNLSGTIPREV-IGLSSF-VLLDLSRNHLSGPIPLEVGRLKGIQQLDLSEN 378
           + N     I ++   G+ S   LLD+S+  ++    L    L+ +++L     
Sbjct: 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA---LPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 34/188 (18%), Positives = 61/188 (32%), Gaps = 15/188 (7%)

Query: 298 LTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREV-IGLSSFVLLDLSRNHL 356
             +  +    I+  IPS   +    Q L L + +L  TIP      L +   + +S +  
Sbjct: 13  EEDFRVTCKDIQ-RIPSLPPS---TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVT 67

Query: 357 SGPIPLEV-GRLKGIQQLDLSENKLSGEIPTS-LASCVGLEYLNFSDNSFQG-PIHSGFS 413
              +       L  +  +++   +    I    L     L++L   +   +  P  +   
Sbjct: 68  LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVY 127

Query: 414 SLKGLQDLDLSRNNFSGKIP--MFLNTFRFLQKLNLSFNNLEGEVPSEGVFK--NVRAVS 469
           S      L+++ N +   IP   F         L L  N     V     F    + AV 
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQG-YAFNGTKLDAVY 185

Query: 470 IIGNNKLC 477
           +  N  L 
Sbjct: 186 LNKNKYLT 193

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 41/292 (14%), Positives = 81/292 (27%), Gaps = 72/292 (24%)

Query: 12  HCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQ-SLSNLSFLQQLSLS 70
            C +     +    ++  IPS   +      L L   +   +IP  + SNL  + ++ +S
Sbjct: 9   ECHQEEDFRVTCKDIQ-RIPSLPPST---QTLKLIETHLR-TIPSHAFSNLPNISRIYVS 63

Query: 71  ENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYV 130
            +                         L   +    F                       
Sbjct: 64  ID-----------------------VTLQ-QLESHSFY---------------------- 77

Query: 131 GFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLR 190
              L  +  + + +      I P           L +L  L  L      L      DL 
Sbjct: 78  --NLSKVTHIEIRNTRNLTYIDPDA---------LKELPLLKFLGIFNTGLKM--FPDLT 124

Query: 191 FLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNL 250
            + S      LE+    +  ++ +  N+     +  + L +  N  + ++     N   L
Sbjct: 125 KVYSTDIFFILEI--TDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKL 181

Query: 251 ILIAMEVNLLTGSIPTSV--GYLLKLQVLSLFGNKISGEIPS-SLGNLIFLT 299
             + +  N     I      G      +L +    ++  +PS  L +L  L 
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELI 232

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 36/232 (15%)

Query: 566 LIGIGGYGYVYKGI-LGTEETNVAVKVLDLQQRGASKSFIA-ECEALRSIRHRNLVKIIT 623
            +G G YG V   +   TEE  VAVK++D+++       I  E    + + H N+VK   
Sbjct: 14  TLGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWL--NQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
                     ++  L  E+   G L + +  +    E + +       +L   +      
Sbjct: 73  H---RREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQ---RFFHQLMAGVV----- 119

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
            YLH      I H D+KP N+LLD      + DFGL+ +   N+ ++       G++ YV
Sbjct: 120 -YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYV 174

Query: 742 APE------Y-GALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK 786
           APE      +      V    D +S GI++  M  G+ P D   +       
Sbjct: 175 APELLKRREFHAE--PV----DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 84.8 bits (210), Expect = 1e-17
 Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 32/189 (16%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIA--------ECEALRSIR-HRN 617
           IG G    V + +        AVK++++     S   +         E   LR +  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAI 675
           ++ +I    S ++    F  LV++ M  G L ++L +K    E+  R   ++M+      
Sbjct: 162 IITLI---DSYESSSFMF--LVFDLMRKGELFDYLTEKVALSEKETR---SIMR------ 207

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
            +   + +LH +   +IVH DLKP N+LLD+ M   + DFG S  L      +     + 
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE----LC 260

Query: 736 GSIGYVAPE 744
           G+ GY+APE
Sbjct: 261 GTPGYLAPE 269

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 85.2 bits (211), Expect = 1e-17
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 51/286 (17%)

Query: 532 RRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKV 591
             +K   +   + + L     E+LK         +IG G +G V    L   +   A+K+
Sbjct: 57  EWAKPFTSKVKQMR-LHREDFEILK---------VIGRGAFGEVAVVKLKNADKVFAMKI 106

Query: 592 L---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSL 648
           L   ++ +R  +  F  E + L +   + +  +     +     N +  LV ++   G L
Sbjct: 107 LNKWEMLKRAETACFREERDVLVNGDSKWITTL---HYAFQDDNNLY--LVMDYYVGGDL 161

Query: 649 ENWLNQKED---EQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
              L++ ED   E+        M R  +A ++   ++ +H       VH D+KP N+L+D
Sbjct: 162 LTLLSKFEDRLPEE--------MARFYLA-EMVIAIDSVHQL---HYVHRDIKPDNILMD 209

Query: 706 NEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE--YGALGEVSTHG---DEY 758
                H+   DFG    L ++   Q+S     G+  Y++PE      G    +G   D +
Sbjct: 210 MN--GHIRLADFGSCLKLMEDGTVQSSV--AVGTPDYISPEILQAMEGGKGRYGPECDWW 265

Query: 759 SFGILMLEMFTGKRP-----TDDMFEEGLSLHKYAKMGLPDQVAEI 799
           S G+ M EM  G+ P       + +     ++   +   P QV ++
Sbjct: 266 SLGVCMYEMLYGETPFYAESLVETYG--KIMNHKERFQFPTQVTDV 309

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 32/227 (14%)

Query: 558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFI-AECEALRSIRHR 616
            E F+    IG G +G V+KGI    +  VA+K++DL++       I  E   L      
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAID 676
            + K   S      +  +   ++ E++  GS  + L     ++ Q           IA  
Sbjct: 81  YVTKYYGSY----LKDTKL-WIIMEYLGGGSALDLLEPGPLDETQ-----------IATI 124

Query: 677 VANV---LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           +  +   L+YLH       +H D+K +NVLL       + DFG++  L D      +  +
Sbjct: 125 LREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD------TQIK 175

Query: 734 VKGSIG---YVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
               +G   ++APE        +  D +S GI  +E+  G+ P  ++
Sbjct: 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 43/225 (19%), Positives = 90/225 (40%), Gaps = 35/225 (15%)

Query: 522 FVFYQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILG 581
           F     +K   +   +   S+ D Y      ++L+          +G G +G V++ +  
Sbjct: 29  FYEDIWKKYVPQPVEVKQGSVYDYY------DILE---------ELGSGAFGVVHRCVEK 73

Query: 582 TEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
                   K ++        +   E   +  + H  L+ +     + + +      L+ E
Sbjct: 74  ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH---DAFEDKYEMV--LILE 128

Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
           F+  G L + +  ++ + ++   +N M+           L+++H H   SIVH D+KP N
Sbjct: 129 FLSGGELFDRIAAEDYKMSEAEVINYMR------QACEGLKHMHEH---SIVHLDIKPEN 179

Query: 702 VLLDNEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
           ++ + +  + V   DFGL+  L   +PD+        +  + APE
Sbjct: 180 IMCETKKASSVKIIDFGLATKL---NPDEIVKVTT-ATAEFAAPE 220

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 84.7 bits (210), Expect = 3e-17
 Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 38/219 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIIT 623
           +G G +G V            AVKV+    ++Q+   +S + E + L+ + H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANVL 681
                      +  LV E    G L + +  ++   E +            I   V + +
Sbjct: 94  FFED-----KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---------RIIRQVLSGI 139

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNE------MVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
            Y+H +    IVH DLKP N+LL+++       +    DFGLS         +    ++ 
Sbjct: 140 TYMHKN---KIVHRDLKPENLLLESKSKDANIRII---DFGLSTHFE---ASKKMKDKI- 189

Query: 736 GSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRP 773
           G+  Y+APE   L G      D +S G+++  + +G  P
Sbjct: 190 GTAYYIAPE--VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 63/233 (27%), Positives = 93/233 (39%), Gaps = 31/233 (13%)

Query: 558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHR 616
              F    L+G G YG VYKG         A+KV+D+      +    E   L+    HR
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81

Query: 617 NLVKIITSCSSIDTRGNEFKA-LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI 675
           N+     +    +  G + +  LV EF   GS+ + +   +         N ++   IA 
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--------NTLKEEWIAY 133

Query: 676 ---DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS 732
              ++   L +LH H    ++H D+K  NVLL       + DFG+S  L        +  
Sbjct: 134 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL------DRTVG 184

Query: 733 RVKGSIG---YVAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRPTDDM 777
           R    IG   ++APE  A  E          D +S GI  +EM  G  P  DM
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 82.7 bits (205), Expect = 4e-17
 Identities = 46/191 (24%), Positives = 79/191 (41%), Gaps = 35/191 (18%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD--------LQQRGASKSFIAECEALRSIRHRNL 618
           +G G  G V           VA+K++          ++   + +   E E L+ + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAID 676
           +KI    +  D    E   +V E M  G L + +   +   E   +              
Sbjct: 78  IKIK---NFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCK---LYFY------Q 122

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
           +   ++YLH +    I+H DLKP NVLL   + + +  + DFG S++L + S  +T    
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-- 177

Query: 734 VKGSIGYVAPE 744
             G+  Y+APE
Sbjct: 178 --GTPTYLAPE 186

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 83.1 bits (206), Expect = 4e-17
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 23/215 (10%)

Query: 567 IGIGGYGYVYKGI-LGTEETNVAVK--VLDLQQRGASKSFIAECEALRSIRHRNLVK--- 620
           IG G +G V+K     T +  VA+K  +++ ++ G   + + E + L+ ++H N+V    
Sbjct: 25  IGQGTFGEVFKARHRKTGQK-VALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
           I  + +S   R      LV++F  +  L   L+      N   K  L +   +   + N 
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS------NVLVKFTLSEIKRVMQMLLNG 136

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTS--TSRVKGSI 738
           L Y+H +    I+H D+K +NVL+  + V  + DFGL+R        Q +  T+RV  ++
Sbjct: 137 LYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TL 192

Query: 739 GYVAPEYGALGEV--STHGDEYSFGILMLEMFTGK 771
            Y  PE   LGE       D +  G +M EM+T  
Sbjct: 193 WYRPPEL-LLGERDYGPPIDLWGAGCIMAEMWTRS 226

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 49/233 (21%), Positives = 84/233 (36%), Gaps = 38/233 (16%)

Query: 197 NCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAME 256
                  V+    +L+ + P    +       L++S N +  T                 
Sbjct: 8   KVASHLEVNCDKRNLTAL-P---PDLPKDTTILHLSENLLY-TFSLAT------------ 50

Query: 257 VNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSAL 316
                      +    +L  L+L   +++ ++    G L  L  +DL  N ++ S+P   
Sbjct: 51  -----------LMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLG 96

Query: 317 GNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLD 374
                L  LD+S N L+ ++P   + GL     L L  N L   +P  +      +++L 
Sbjct: 97  QTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLS 154

Query: 375 LSENKLSGEIPTSL-ASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRN 426
           L+ N L+ E+P  L      L+ L   +NS    I  GF     L    L  N
Sbjct: 155 LANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 47/191 (24%), Positives = 75/191 (39%), Gaps = 18/191 (9%)

Query: 264 IPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQ 323
           +P          +L L  N +     ++L     LT+++L    +   +    G    L 
Sbjct: 29  LPKD------TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLG 80

Query: 324 KLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVG---RLKGIQQLDLSENKL 380
            LDLS N L  ++P     L +  +LD+S N L+    L +G    L  +Q+L L  N+L
Sbjct: 81  TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS---LPLGALRGLGELQELYLKGNEL 136

Query: 381 SGEIPTSL-ASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTF 439
              +P  L      LE L+ ++N+         + L+ L  L L  N+    IP      
Sbjct: 137 K-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGS 194

Query: 440 RFLQKLNLSFN 450
             L    L  N
Sbjct: 195 HLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 42/180 (23%), Positives = 69/180 (38%), Gaps = 17/180 (9%)

Query: 288 IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV 347
           +P     L       L  N +     + L    +L +L+L    L+  +  +   L    
Sbjct: 29  LPKDTTIL------HLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDG-TLPVLG 80

Query: 348 LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP 407
            LDLS N L   +PL    L  +  LD+S N+L+     +L     L+ L    N  +  
Sbjct: 81  TLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139

Query: 408 IHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRF---LQKLNLSFNNLEGEVPSEGVFKN 464
                +    L+ L L+ NN + ++P           L  L L  N+L   +P +G F +
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLT-ELPA--GLLNGLENLDTLLLQENSLYT-IP-KGFFGS 194

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 44/229 (19%), Positives = 78/229 (34%), Gaps = 32/229 (13%)

Query: 7   PANITHCS-ELRILDLVVNKLE---GNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLS 62
           P            ++     L     ++P +   L       L+ N        +L   +
Sbjct: 2   PICEVSKVASHLEVNCDKRNLTALPPDLPKDTTILH------LSENLLYTFSLATLMPYT 55

Query: 63  FLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKL 122
            L QL+L    L+  +  +   L  L    +S N L  S+P+    + ++    V+ N+L
Sbjct: 56  RLTQLNLDRAELT-KLQVDGT-LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL 112

Query: 123 VGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDL-GKLKNLIRLNFARNNL 181
              +P      L  ++ L L  N              ++P  L      L +L+ A NNL
Sbjct: 113 T-SLPLGALRGLGELQELYLKGNELK-----------TLPPGLLTPTPKLEKLSLANNNL 160

Query: 182 GTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLY 230
                     L+ L N   L+ + L  NSL  +      +      +L+
Sbjct: 161 TELPAG---LLNGLEN---LDTLLLQENSLYTIPKGFFGSHLLPFAFLH 203

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 30/120 (25%), Positives = 50/120 (41%), Gaps = 11/120 (9%)

Query: 6   IPANITHCSELRILDLVVNKLEGNIPSEL-GNLFKLVGLGLTGNNYTGSIPQSL-SNLSF 63
           +P        L +LD+  N+L  ++P      L +L  L L GN    ++P  L +    
Sbjct: 92  LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPK 149

Query: 64  LQQLSLSEN---SLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQN 120
           L++LSL+ N    L   + + L  L  L +     N L  +IP   F    + +  +  N
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLL---QENSLY-TIPKGFFGSHLLPFAFLHGN 205

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 82.3 bits (204), Expect = 5e-17
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 37/226 (16%)

Query: 559 EGFSSANLIGIGGYGYVYKGI-LGTEETNVAVKV--LDLQQRGASKSFIAECEALRSIRH 615
           + +     +G G YG VYK I   T ET VA+K   L+ ++ G   + I E   L+ ++H
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNET-VAIKRIRLEHEEEGVPGTAIREVSLLKELQH 92

Query: 616 RNLVK---IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLS 672
           RN+++   +I     +         L++E+  N  L+ ++++        P +++    S
Sbjct: 93  RNIIELKSVIHHNHRL--------HLIFEYAEN-DLKKYMDKN-------PDVSMRVIKS 136

Query: 673 IAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG-----DFGLSRLLHDNSPD 727
               + N + + H       +H DLKP N+LL     +        DFGL+R      P 
Sbjct: 137 FLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPI 191

Query: 728 QTSTSRVKGSIGYVAPE--YGALGEVSTHGDEYSFGILMLEMFTGK 771
           +  T  +  ++ Y  PE   G+    ST  D +S   +  EM    
Sbjct: 192 RQFTHEII-TLWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLMKT 235

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 84.5 bits (209), Expect = 5e-17
 Identities = 47/209 (22%), Positives = 87/209 (41%), Gaps = 20/209 (9%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS 626
           +G G +G V++        N A K +        ++   E + +  +RH  LV +  +  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH 686
                 +    ++YEFM  G L   +  + ++ ++   +  M+       V   L ++H 
Sbjct: 225 D-----DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR------QVCKGLCHMHE 273

Query: 687 HCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
           +   + VH DLKP N++   +    +   DFGL+  L    P Q+      G+  + APE
Sbjct: 274 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD---PKQSVKVTT-GTAEFAAPE 326

Query: 745 YGALGEVSTHGDEYSFGILMLEMFTGKRP 773
                 V  + D +S G+L   + +G  P
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 81.5 bits (202), Expect = 6e-17
 Identities = 45/187 (24%), Positives = 79/187 (42%), Gaps = 33/187 (17%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
           ++G G +  V+           A+K +         S   E   L+ I+H N+V +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE--- 72

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANVLEY 683
              ++  + +  LV + +  G L + + ++    E++      ++Q       V + ++Y
Sbjct: 73  DIYESTTHYY--LVMQLVSGGELFDRILERGVYTEKDAS---LVIQ------QVLSAVKY 121

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNE------MVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
           LH +    IVH DLKP N+L          M+    DFGLS++  +        S   G+
Sbjct: 122 LHEN---GIVHRDLKPENLLYLTPEENSKIMIT---DFGLSKMEQNG-----IMSTACGT 170

Query: 738 IGYVAPE 744
            GYVAPE
Sbjct: 171 PGYVAPE 177

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 83.7 bits (207), Expect = 6e-17
 Identities = 71/224 (31%), Positives = 106/224 (47%), Gaps = 41/224 (18%)

Query: 566 LIGIGGYGYVYKGI-LGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKI 621
            +G+G +G V  G    T    VAVK+L+   ++          E + L+  RH +++K+
Sbjct: 23  TLGVGTFGKVKVGKHELTGH-KVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWL--NQKEDEQNQRPKLNLMQRLSIAIDVAN 679
                 I T  + F  +V E++  G L +++  N + DE+  R    L Q++   +D   
Sbjct: 82  YQV---ISTPSDIF--MVMEYVSGGELFDYICKNGRLDEKESR---RLFQQILSGVD--- 130

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
              Y H H    +VH DLKP NVLLD  M A + DFGLS ++ D    +TS     GS  
Sbjct: 131 ---YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPN 180

Query: 740 YVAPE------Y-GALGEVSTHGDEYSFGILMLEMFTGKRPTDD 776
           Y APE      Y G   EV    D +S G+++  +  G  P DD
Sbjct: 181 YAAPEVISGRLYAGP--EV----DIWSSGVILYALLCGTLPFDD 218

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 82.8 bits (205), Expect = 7e-17
 Identities = 59/265 (22%), Positives = 105/265 (39%), Gaps = 48/265 (18%)

Query: 531 RRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETN--VA 588
             R K  +N  I D  +K    E++K         +IG G +G V   ++  + T    A
Sbjct: 51  LSRYKDTINK-IRDLRMKAEDYEVVK---------VIGRGAFGEVQ--LVRHKSTRKVYA 98

Query: 589 VKVL---DLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
           +K+L   ++ +R  S  F  E + +       +V++     +       +  +V E+MP 
Sbjct: 99  MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL---FYAFQDDRYLY--MVMEYMPG 153

Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L N +    D   +  +    +       V   L+ +H       +H D+KP N+LLD
Sbjct: 154 GDLVNLM-SNYDVPEKWARFYTAE-------VVLALDAIHSM---GFIHRDVKPDNMLLD 202

Query: 706 NEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE-YGALGEVSTHG---DEYS 759
                H+   DFG    ++     +  T+   G+  Y++PE   + G    +G   D +S
Sbjct: 203 KS--GHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWS 258

Query: 760 FGILMLEMFTGKRP-----TDDMFE 779
            G+ + EM  G  P         + 
Sbjct: 259 VGVFLYEMLVGDTPFYADSLVGTYS 283

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 80.7 bits (200), Expect = 7e-17
 Identities = 52/229 (22%), Positives = 89/229 (38%), Gaps = 43/229 (18%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS 626
           IG G +G V   +        A K +          F  E E ++S+ H N++++     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY---E 73

Query: 627 SIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANVLEYL 684
           + +   + +  LV E    G L   +  K    E +      +M+      DV + + Y 
Sbjct: 74  TFEDNTDIY--LVMELCTGGELFERVVHKRVFRESDAA---RIMK------DVLSAVAYC 122

Query: 685 HHHCHTSIVHCDLKPSNVLLDNE------MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSI 738
           H     ++ H DLKP N L   +       +    DFGL+       P +   ++V G+ 
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLI---DFGLAARFK---PGKMMRTKV-GTP 172

Query: 739 GYVAPE-----YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL 782
            YV+P+     YG   E     DE+S G++M  +  G  P     +  +
Sbjct: 173 YYVSPQVLEGLYGP--EC----DEWSAGVMMYVLLCGYPPFSAPTDSEV 215

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 81.9 bits (203), Expect = 7e-17
 Identities = 61/262 (23%), Positives = 103/262 (39%), Gaps = 62/262 (23%)

Query: 529 KRRRRSKALVNSSIE------DKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGT 582
                S  +   +        +KY  +                L+G G YG V K     
Sbjct: 4   HHHHHSSGVDLGTENLYFQSMEKYENL---------------GLVGEGSYGMVMKCR--N 46

Query: 583 EETN--VAVK--VLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL 638
           ++T   VA+K  +     +   K  + E + L+ +RH NLV ++  C     +   +  L
Sbjct: 47  KDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK---KKKRWY--L 101

Query: 639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH------HHCHT-S 691
           V+EF+              +      L+ ++     +D   V +YL         CH+ +
Sbjct: 102 VFEFV--------------DHTI---LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144

Query: 692 IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE--YGALG 749
           I+H D+KP N+L+    V  + DFG +R L   +P +     V  +  Y APE   G   
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYDDEVA-TRWYRAPELLVGD-V 200

Query: 750 EVSTHGDEYSFGILMLEMFTGK 771
           +     D ++ G L+ EMF G+
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGE 222

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 83.6 bits (207), Expect = 7e-17
 Identities = 52/231 (22%), Positives = 89/231 (38%), Gaps = 45/231 (19%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASK--SFIAECEALRSIRHRNLVKIITS 624
           +G G YG V            A+K++       S     + E   L+ + H N++K+   
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANVLE 682
                        LV E    G L + +  +   +E +            I   V + + 
Sbjct: 105 FED-----KRNYYLVMECYKGGELFDEIIHRMKFNEVDAA---------VIIKQVLSGVT 150

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNE------MVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
           YLH H   +IVH DLKP N+LL+++       +    DFGLS +       +    R+ G
Sbjct: 151 YLHKH---NIVHRDLKPENLLLESKEKDALIKIV---DFGLSAVFE---NQKKMKERL-G 200

Query: 737 SIGYVAPE-----YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL 782
           +  Y+APE     Y    +     D +S G+++  +  G  P     ++ +
Sbjct: 201 TAYYIAPEVLRKKYDE--KC----DVWSIGVILFILLAGYPPFGGQTDQEI 245

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 81.7 bits (202), Expect = 8e-17
 Identities = 47/231 (20%), Positives = 91/231 (39%), Gaps = 45/231 (19%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIA-----ECEALRSIRHRNL 618
           +G G +G+V+  +   +   V VK +    + +    +         E   L  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGS-LENWLNQKE--DEQNQRPKLNLMQRLSIAI 675
           +K++      + +G     LV E   +G  L  ++++    DE        + ++L  A+
Sbjct: 92  IKVLDI---FENQGFFQ--LVMEKHGSGLDLFAFIDRHPRLDEPLAS---YIFRQLVSAV 143

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
                  YL       I+H D+K  N+++  +    + DFG +  L       T      
Sbjct: 144 G------YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---- 190

Query: 736 GSIGYVAPE------Y-GALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFE 779
           G+I Y APE      Y G   E+    + +S G+ +  +   + P  ++ E
Sbjct: 191 GTIEYCAPEVLMGNPYRGP--EL----EMWSLGVTLYTLVFEENPFCELEE 235

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 80.7 bits (200), Expect = 9e-17
 Identities = 43/188 (22%), Positives = 82/188 (43%), Gaps = 34/188 (18%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITS 624
           +G G +  V + +  T     A K+++ ++  A   +    E    R ++H N+V++   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH-- 71

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANVLE 682
             SI      +  LV++ +  G L   +  +E   E +     + +Q       +   + 
Sbjct: 72  -DSIQEESFHY--LVFDLVTGGELFEDIVAREFYSEADAS---HCIQ------QILESIA 119

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNE------MVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
           Y H +    IVH +LKP N+LL ++       +A   DFGL+  ++D+           G
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLA---DFGLAIEVNDSEAWHG----FAG 169

Query: 737 SIGYVAPE 744
           + GY++PE
Sbjct: 170 TPGYLSPE 177

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 81.6 bits (202), Expect = 1e-16
 Identities = 43/189 (22%), Positives = 82/189 (43%), Gaps = 28/189 (14%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS-----KSFIAECEALRSIRHRNLVKI 621
           IG G +  V + I        AVK++D+ +  +S     +    E      ++H ++V++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQ---RPKLNLMQRLSIAIDVA 678
           +    +  + G  +  +V+EFM    L   + ++ D           + M+       + 
Sbjct: 92  L---ETYSSDGMLY--MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR------QIL 140

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
             L Y H +   +I+H D+KP  VLL   +N     +G FG++  L +      +  RV 
Sbjct: 141 EALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE--SGLVAGGRV- 194

Query: 736 GSIGYVAPE 744
           G+  ++APE
Sbjct: 195 GTPHFMAPE 203

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 38/183 (20%), Positives = 68/183 (37%), Gaps = 14/183 (7%)

Query: 271 LLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDN 330
           L     ++   + ++     +  +L  +T +   G  +  +I   +     L  L+L DN
Sbjct: 18  LANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDN 73

Query: 331 NLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLAS 390
            ++   P +   L+    L+LS N L     +    L+ I+ LDL+  +++   P  LA 
Sbjct: 74  QITDLAPLK--NLTKITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQITDVTP--LAG 127

Query: 391 CVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFN 450
              L+ L    N       S  + L  LQ L +     S  +   L     L  L    N
Sbjct: 128 LSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS-DLT-PLANLSKLTTLKADDN 183

Query: 451 NLE 453
            + 
Sbjct: 184 KIS 186

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 52/325 (16%), Positives = 104/325 (32%), Gaps = 72/325 (22%)

Query: 8   ANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQL 67
            +IT  + + ++                 L   + +    +N T ++    ++L  +  L
Sbjct: 1   GSITQPTAINVI------------FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTL 46

Query: 68  SLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIP 127
           S     ++  I   +  L  L   ++  N            I+ +               
Sbjct: 47  SAFGTGVT-TI-EGVQYLNNLIGLELKDN-----------QITDLAPLK----------- 82

Query: 128 HYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGN 187
                 L  I  L L  N        ++S        +  L+++  L+     +      
Sbjct: 83  -----NLTKITELELSGNPLK-----NVSA-------IAGLQSIKTLDLTSTQITD---- 121

Query: 188 DLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNL 247
               +  L   + L+V+ L  N ++ + P  +A  ++ L YL +   ++S    T + NL
Sbjct: 122 ----VTPLAGLSNLQVLYLDLNQITNISP--LAGLTN-LQYLSIGNAQVSDL--TPLANL 172

Query: 248 KNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNS 307
             L  +  + N ++  I   +  L  L  + L  N+IS    S L N   L  V L   +
Sbjct: 173 SKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQT 228

Query: 308 IRGSIPSALGNCLQLQKLDLSDNNL 332
           I         N +    +       
Sbjct: 229 ITNQPVFYNNNLVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 52/237 (21%), Positives = 96/237 (40%), Gaps = 37/237 (15%)

Query: 134 LPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLD 193
           L  I  L       T     +I         +  L NLI L    N +      DL  L 
Sbjct: 40  LDGITTLSAFGTGVT-----TIEG-------VQYLNNLIGLELKDNQI-----TDLAPLK 82

Query: 194 SLVNCTFLEVVSLSSNSLSGVLPNSIANFSS--HLIYLYMSANRISGTIPTGVGNLKNLI 251
           +L     +  + LS N L      +++  +    +  L +++ +I+   P  +  L NL 
Sbjct: 83  NLTK---ITELELSGNPLK-----NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQ 132

Query: 252 LIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGS 311
           ++ +++N +T +I   +  L  LQ LS+   ++S ++ + L NL  LT +    N I   
Sbjct: 133 VLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKIS-D 187

Query: 312 IPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLK 368
           I S L +   L ++ L +N +S   P  +   S+  ++ L+   ++         L 
Sbjct: 188 I-SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLV 241

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 28/151 (18%), Positives = 57/151 (37%), Gaps = 12/151 (7%)

Query: 303 LQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPL 362
            Q  +I    P          K+    +N++ T+ +    L     L      ++    +
Sbjct: 4   TQPTAINVIFP--DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGV 59

Query: 363 EVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLD 422
           +   L  +  L+L +N+++ ++   L +   +  L  S N  +    S  + L+ ++ LD
Sbjct: 60  Q--YLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLKNV--SAIAGLQSIKTLD 113

Query: 423 LSRNNFSGKIPMFLNTFRFLQKLNLSFNNLE 453
           L+    +   P  L     LQ L L  N + 
Sbjct: 114 LTSTQITDVTP--LAGLSNLQVLYLDLNQIT 142

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 83.3 bits (206), Expect = 1e-16
 Identities = 60/253 (23%), Positives = 105/253 (41%), Gaps = 31/253 (12%)

Query: 530 RRRRSKALVNSSIEDKYLKISYAELLKAT-EGFSSANLIGIGGYGYVYKGILGTEETNVA 588
                   ++S   +++L+  + E    T   F    ++G GG+G V    +       A
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA 213

Query: 589 VKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPN 645
            K L+   +++R      + E + L  +  R +V +     + +T+      LV   M  
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL---AYAYETKDALC--LVLTLMNG 268

Query: 646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD 705
           G L+  +         +      + +  A ++   LE LH      IV+ DLKP N+LLD
Sbjct: 269 GDLKFHI-----YHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLD 320

Query: 706 NEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DEYSF 760
           +    H+   D GL+         QT   RV G++GY+APE   + +   +    D ++ 
Sbjct: 321 DH--GHIRISDLGLAV---HVPEGQTIKGRV-GTVGYMAPE---VVKNERYTFSPDWWAL 371

Query: 761 GILMLEMFTGKRP 773
           G L+ EM  G+ P
Sbjct: 372 GCLLYEMIAGQSP 384

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 82.8 bits (205), Expect = 1e-16
 Identities = 54/263 (20%), Positives = 101/263 (38%), Gaps = 60/263 (22%)

Query: 526 QRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEET 585
                  R       +  ++Y       ++          ++G G +G V K      + 
Sbjct: 4   HHHHSSGRENLYFQGTFAERY------NIVC---------MLGKGSFGEVLKCKDRITQQ 48

Query: 586 NVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
             AVKV++        + + + E E L+ + H N++K+           +    +V E  
Sbjct: 49  EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSSFYIVGELY 103

Query: 644 PNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
             G L + + +++   E +            I   V + + Y+H H   +IVH DLKP N
Sbjct: 104 TGGELFDEIIKRKRFSEHDAA---------RIIKQVFSGITYMHKH---NIVHRDLKPEN 151

Query: 702 VLLDNE------MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE-----YGALGE 750
           +LL+++       +    DFGLS        +     R+ G+  Y+APE     Y    +
Sbjct: 152 ILLESKEKDCDIKII---DFGLSTCFQ---QNTKMKDRI-GTAYYIAPEVLRGTYDE--K 202

Query: 751 VSTHGDEYSFGILMLEMFTGKRP 773
                D +S G+++  + +G  P
Sbjct: 203 C----DVWSAGVILYILLSGTPP 221

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 25/223 (11%)

Query: 558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRN 617
                S   IG G  G V           VAVK++DL+++   +    E   +R  +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           +V++  S       G E   ++ EF+  G+L + ++Q    + Q           IA   
Sbjct: 104 VVEMYKSY----LVGEEL-WVLMEFLQGGALTDIVSQVRLNEEQ-----------IATVC 147

Query: 678 ANV---LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
             V   L YLH      ++H D+K  ++LL  +    + DFG    +  + P + S   +
Sbjct: 148 EAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS---L 201

Query: 735 KGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
            G+  ++APE  +    +T  D +S GI+++EM  G+ P    
Sbjct: 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 50/231 (21%), Positives = 91/231 (39%), Gaps = 34/231 (14%)

Query: 558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRN 617
            E +     +G G +G VYK          A KV++ +     + +I E E L +  H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI-- 675
           +VK++ +         +   ++ EF P G+++  + + +           +    I +  
Sbjct: 78  IVKLLGAY----YHDGKL-WIMIEFCPGGAVDAIMLELD---------RGLTEPQIQVVC 123

Query: 676 -DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
             +   L +LH      I+H DLK  NVL+  E    + DFG+S           +  + 
Sbjct: 124 RQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK------TLQKR 174

Query: 735 KGSIG---YVAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRPTDDM 777
              IG   ++APE      +         D +S GI ++EM   + P  ++
Sbjct: 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 25/223 (11%)

Query: 558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRN 617
            + ++    IG G  G VY  +       VA++ ++LQQ+   +  I E   +R  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI-- 675
           +V  + S       G+E   +V E++  GSL + + +   ++ Q           IA   
Sbjct: 79  IVNYLDSY----LVGDEL-WVVMEYLAGGSLTDVVTETCMDEGQ-----------IAAVC 122

Query: 676 -DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
            +    LE+LH +    ++H D+K  N+LL  +    + DFG    +      +++   +
Sbjct: 123 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---M 176

Query: 735 KGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
            G+  ++APE           D +S GI+ +EM  G+ P  + 
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 82.9 bits (205), Expect = 2e-16
 Identities = 59/260 (22%), Positives = 110/260 (42%), Gaps = 37/260 (14%)

Query: 538 VNSSIEDKYLKISYAELLKAT-EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLD--- 593
           ++S    ++L+  + E      + F    ++G GG+G V+   +       A K L+   
Sbjct: 163 LDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR 222

Query: 594 LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLN 653
           L++R   +  + E + L  +  R +V +     + +T+ +    LV   M  G +   + 
Sbjct: 223 LKKRKGYQGAMVEKKILAKVHSRFIVSLA---YAFETKTDLC--LVMTIMNGGDIRYHI- 276

Query: 654 QKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV- 712
              DE N   +         A  + + LE+LH     +I++ DLKP NVLLD++   +V 
Sbjct: 277 YNVDEDNPGFQEPRA-IFYTA-QIVSGLEHLHQR---NIIYRDLKPENVLLDDD--GNVR 329

Query: 713 -GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMF 768
             D GL+    +    QT T    G+ G++APE   L     +    D ++ G+ + EM 
Sbjct: 330 ISDLGLAV---ELKAGQTKTKGYAGTPGFMAPE---LLLGEEYDFSVDYFALGVTLYEMI 383

Query: 769 TGKRP---------TDDMFE 779
             + P           ++ +
Sbjct: 384 AARGPFRARGEKVENKELKQ 403

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 81.9 bits (203), Expect = 2e-16
 Identities = 68/359 (18%), Positives = 117/359 (32%), Gaps = 66/359 (18%)

Query: 134 LPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLD 193
           L   +V+ L     T            I   L     L  LN   N LG    + +    
Sbjct: 27  LQQCQVVRLDDCGLTEA------RCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGL 80

Query: 194 SLVNCTFLEVVSLSSNSLSGVLPNSIAN---FSSHLIYLYMSANRISGTIPTGVGNLKNL 250
              +C  ++ +SL +  L+G     +++       L  L++S N +      G+  L   
Sbjct: 81  QTPSCK-IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG---DAGLQLLCEG 136

Query: 251 ILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE----IPSSLGNLIFLTEVDLQGN 306
           +L   +                +L+ L L    +S      + S L       E+ +  N
Sbjct: 137 LL---DPQC-------------RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180

Query: 307 SIRGSIPSALGNCLQ-----LQKLDLSDNNLS----GTIPREVIGLSSFVLLDLSRNHL- 356
            I  +    L   L+     L+ L L    ++      +   V   +S   L L  N L 
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240

Query: 357 -SGPIPLEVGRLKG---IQQLDLSENKLSGE----IPTSLASCVGLEYLNFSDNSFQGPI 408
             G   L  G L     ++ L + E  ++ +    +   L +   L+ L+ + N      
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG--- 297

Query: 409 HSGFSSL--------KGLQDLDLSRNNFSGK----IPMFLNTFRFLQKLNLSFNNLEGE 455
             G   L          L+ L +   +F+          L   RFL +L +S N LE  
Sbjct: 298 DEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 76.9 bits (190), Expect = 9e-15
 Identities = 85/439 (19%), Positives = 147/439 (33%), Gaps = 81/439 (18%)

Query: 64  LQQLSLSENSLSGNIPSELG-LLKQLNMFQVSANYLT-------GSIPIQLFNISSMDYF 115
           +Q L +    LS    +EL  LL+Q  + ++    LT        S       ++ ++  
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN-- 62

Query: 116 AVTQNKLVGEIPHYVGFTL----PNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNL 171
            +  N+L     H V   L      I+ L L +   TG           +   L  L  L
Sbjct: 63  -LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA------GCGVLSSTLRTLPTL 115

Query: 172 IRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIAN---FSSHLIY 228
             L+ + N LG      L        C  LE + L   SLS      +A+          
Sbjct: 116 QELHLSDNLLGDAGLQLLCEGLLDPQCR-LEKLQLEYCSLSAASCEPLASVLRAKPDFKE 174

Query: 229 LYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE- 287
           L +S N I+     GV     ++   ++ +               L+ L L    ++ + 
Sbjct: 175 LTVSNNDIN---EAGV----RVLCQGLKDSPCQ------------LEALKLESCGVTSDN 215

Query: 288 ---IPSSLGNLIFLTEVDLQGNSIRGS-----IPSALGNCLQLQKLDLSDNNLS----GT 335
              +   + +   L E+ L  N +         P  L    +L+ L + +  ++    G 
Sbjct: 216 CRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGD 275

Query: 336 IPREVIGLSSFVLLDLSRNHL--SGPIPLEVGRLKG---IQQLDLSENKLSGE----IPT 386
           + R +    S   L L+ N L   G   L    L+    ++ L +     +        +
Sbjct: 276 LCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335

Query: 387 SLASCVGLEYLNFSDNSFQGPIHSGFSSL--------KGLQDLDLSRNNFSGK----IPM 434
            LA    L  L  S+N  +    +G   L          L+ L L+  + S      +  
Sbjct: 336 VLAQNRFLLELQISNNRLE---DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 392

Query: 435 FLNTFRFLQKLNLSFNNLE 453
            L     L++L+LS N L 
Sbjct: 393 TLLANHSLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 68.1 bits (167), Expect = 5e-12
 Identities = 48/273 (17%), Positives = 89/273 (32%), Gaps = 43/273 (15%)

Query: 223 SSHLIYLYMSANRISGT-IPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLK----LQVL 277
           S  +  L +    +S       +  L+   ++ ++   LT +    +   L+    L  L
Sbjct: 2   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61

Query: 278 SLFGNKISGEIPSSLGNLI-----FLTEVDLQGNSIR----GSIPSALGNCLQLQKLDLS 328
           +L  N++       +   +      + ++ LQ   +     G + S L     LQ+L LS
Sbjct: 62  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121

Query: 329 DNNLSGTIPREVIGLSSFVL--------LDLSRNHLS----GPIPLEVGRLKGIQQLDLS 376
           DN L       +  L   +L        L L    LS     P+   +      ++L +S
Sbjct: 122 DNLLG---DAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178

Query: 377 ENKLSGEIPTSLA-----SCVGLEYLNFSDNSFQ----GPIHSGFSSLKGLQDLDLSRNN 427
            N ++      L      S   LE L              +    +S   L++L L  N 
Sbjct: 179 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238

Query: 428 FSGK-----IPMFLNTFRFLQKLNLSFNNLEGE 455
                     P  L+    L+ L +    +  +
Sbjct: 239 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAK 271

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 63.4 bits (155), Expect = 2e-10
 Identities = 78/428 (18%), Positives = 140/428 (32%), Gaps = 77/428 (17%)

Query: 10  ITHCSELRILDLVVNKLEGNIPSELGNLFK-----LVGLGLTGNNYT----GSIPQSLSN 60
           +     L  L+L  N+L       +    +     +  L L     T    G +  +L  
Sbjct: 52  LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111

Query: 61  LSFLQQLSLSENSLSGNIPSEL--GLLKQ---LNMFQVSANYLTGSIPIQLF-------N 108
           L  LQ+L LS+N L       L  GLL     L   Q+    L+ +    L        +
Sbjct: 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD 171

Query: 109 ISSMDYFAVTQNKL----VGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPED 164
              +    V+ N +    V  +   +  +   +  L L S   T +      N   +   
Sbjct: 172 FKELT---VSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSD------NCRDLCGI 222

Query: 165 LGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANF-- 222
           +    +L  L    N LG     +L       +   L  + +    ++      +     
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSR-LRTLWIWECGITAKGCGDLCRVLR 281

Query: 223 -SSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFG 281
               L  L ++ N +      G    + L    +E                +L+ L +  
Sbjct: 282 AKESLKELSLAGNELG---DEGA---RLLCETLLEPG-------------CQLESLWVKS 322

Query: 282 NKISGE----IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQ-----LQKLDLSDNNL 332
              +        S L    FL E+ +  N +  +    L   L      L+ L L+D ++
Sbjct: 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382

Query: 333 S----GTIPREVIGLSSFVLLDLSRNHL--SGPIPLEVGRLK----GIQQLDLSENKLSG 382
           S     ++   ++   S   LDLS N L  +G + L V  ++     ++QL L +   S 
Sbjct: 383 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL-VESVRQPGCLLEQLVLYDIYWSE 441

Query: 383 EIPTSLAS 390
           E+   L +
Sbjct: 442 EMEDRLQA 449

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 38/181 (20%), Positives = 77/181 (42%), Gaps = 23/181 (12%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIA-ECEALRSIRHRNLVKIITSC 625
           +G G +G V++ +  + +     K + +  +G  +  +  E   L   RHRN++ +    
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTDQVLVKKEISILNIARHRNILHLH--- 67

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
            S ++       +++EF+    +   +N    E N+R  ++ +        V   L++LH
Sbjct: 68  ESFESMEELV--MIFEFISGLDIFERINTSAFELNEREIVSYVH------QVCEALQFLH 119

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
            H   +I H D++P N++      + +   +FG +R L    P          +  Y AP
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLF-TAPEYYAP 172

Query: 744 E 744
           E
Sbjct: 173 E 173

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 37/186 (19%), Positives = 77/186 (41%), Gaps = 20/186 (10%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVK 620
            S   ++G G +G V+K         +A K++  +     +    E   +  + H NL++
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
           +     + +++ +    LV E++  G L + +  +     +   +  M+       +   
Sbjct: 151 LY---DAFESKNDIV--LVMEYVDGGELFDRIIDESYNLTELDTILFMK------QICEG 199

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGSI 738
           + ++H      I+H DLKP N+L  N     +   DFGL+R        + +     G+ 
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF----GTP 252

Query: 739 GYVAPE 744
            ++APE
Sbjct: 253 EFLAPE 258

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 79.9 bits (198), Expect = 3e-16
 Identities = 57/231 (24%), Positives = 98/231 (42%), Gaps = 64/231 (27%)

Query: 567 IGIGGYGYVYKGI-LGTEETNVAVK-----VLDLQQRGASKSFIAECEALRSIRHRNLVK 620
           +G G +  VYK     T +  VA+K          + G +++ + E + L+ + H N++ 
Sbjct: 18  LGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76

Query: 621 ---IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
                   S+I        +LV++FM    LE                 +++  S+ +  
Sbjct: 77  LLDAFGHKSNI--------SLVFDFMET-DLEV----------------IIKDNSLVLTP 111

Query: 678 ANV----------LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD 727
           +++          LEYLH H    I+H DLKP+N+LLD   V  + DFGL++     SP+
Sbjct: 112 SHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPN 166

Query: 728 QTSTSRVKGSIGYV-----APE--YGALGEVSTHGDEYSFGILMLEMFTGK 771
           +  T +V      V     APE  +GA        D ++ G ++ E+    
Sbjct: 167 RAYTHQV------VTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRV 210

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 30/253 (11%), Positives = 66/253 (26%), Gaps = 59/253 (23%)

Query: 566 LIGIGGYGYVYKG---ILGTEETNVAVKVLDLQQRGASKS---FIAECEALRSIRHRNLV 619
             G       ++     L  +   VA+  +D Q           ++    L  I    + 
Sbjct: 38  FHGGVPPLQFWQALDTALDRQ---VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
           +++     + TR      +V E++  GSL+                + +  +     +A 
Sbjct: 95  RVL---DVVHTRAGGL--VVAEWIRGGSLQEVA---------DTSPSPVGAIRAMQSLAA 140

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
             +  H      +      PS V +  +    +                           
Sbjct: 141 AADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------------------- 174

Query: 740 YVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP-TDDMFEEGLSLHKYAKMGLPDQVAE 798
            +          +   D    G  +  +   + P  +     GL+  +    G P + A+
Sbjct: 175 TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPAD 227

Query: 799 IID--PAILEEAL 809
           I    P  +    
Sbjct: 228 IDRDIPFQISAVA 240

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 47/225 (20%), Positives = 91/225 (40%), Gaps = 41/225 (18%)

Query: 526 QRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEET 585
                  R       +  ++Y       ++          ++G G +G V K      + 
Sbjct: 4   HHHHSSGRENLYFQGTFAERY------NIVC---------MLGKGSFGEVLKCKDRITQQ 48

Query: 586 NVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF 642
             AVKV++    + +  + + + E E L+ + H N++K+       +   + +  +V E 
Sbjct: 49  EYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEIL---EDSSSFY--IVGEL 102

Query: 643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV 702
              G L + + +++       + +      I   V + + Y+H H   +IVH DLKP N+
Sbjct: 103 YTGGELFDEIIKRK-------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENI 152

Query: 703 LL---DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
           LL   + +    + DFGLS        +     R+ G+  Y+APE
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRI-GTAYYIAPE 193

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 81.3 bits (201), Expect = 4e-16
 Identities = 57/235 (24%), Positives = 90/235 (38%), Gaps = 56/235 (23%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-------------RGASKSFIAECEALR 611
             +G G YG V         +  A+KV+   Q                 +    E   L+
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 612 SIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQ 669
           S+ H N++K+            ++  LV EF   G L   +  +   DE +         
Sbjct: 102 SLDHPNIIKLFDVFED-----KKYFYLVTEFYEGGELFEQIINRHKFDECDAA------- 149

Query: 670 RLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE------MVAHVGDFGLSRLLHD 723
             +I   + + + YLH H   +IVH D+KP N+LL+N+       +    DFGLS     
Sbjct: 150 --NIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV---DFGLSSFFS- 200

Query: 724 NSPDQTSTSRVKGSIGYVAPE-----YGALGEVSTHGDEYSFGILMLEMFTGKRP 773
              D     R+ G+  Y+APE     Y    +     D +S G++M  +  G  P
Sbjct: 201 --KDYKLRDRL-GTAYYIAPEVLKKKYNE--KC----DVWSCGVIMYILLCGYPP 246

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 80.2 bits (198), Expect = 5e-16
 Identities = 48/218 (22%), Positives = 93/218 (42%), Gaps = 26/218 (11%)

Query: 567 IGIGGYGYVYKGILGTEETN--VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVK---I 621
           +G G YG+VYK      + +   A+K   ++  G S S   E   LR ++H N++    +
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALK--QIEGTGISMSACREIALLRELKHPNVISLQKV 86

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRL--SIAIDVAN 679
             S        +    L++++  +  L + +      +  +  + L + +  S+   + +
Sbjct: 87  FLS------HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH----VGDFGLSRLLHDNSPDQTSTSRVK 735
            + YLH +    ++H DLKP+N+L+  E        + D G +RL +           V 
Sbjct: 140 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 736 GSIGYVAPEYGALGEV--STHGDEYSFGILMLEMFTGK 771
            +  Y APE   LG    +   D ++ G +  E+ T +
Sbjct: 197 VTFWYRAPEL-LLGARHYTKAIDIWAIGCIFAELLTSE 233

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 79.7 bits (197), Expect = 5e-16
 Identities = 45/226 (19%), Positives = 88/226 (38%), Gaps = 43/226 (19%)

Query: 526 QRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEET 585
           Q+  R        ++   D Y      ++ +          +G G +  V + +  T   
Sbjct: 11  QQMGRGSEFMMNASTKFSDNY------DVKE---------ELGKGAFSVVRRCVHKTTGL 55

Query: 586 NVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
             A K+++ ++  A   +    E    R ++H N+V++     SI      +  LV++ +
Sbjct: 56  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH---DSIQEESFHY--LVFDLV 110

Query: 644 PNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
             G L   +  +E   E +     + +Q       +   + Y H +    IVH +LKP N
Sbjct: 111 TGGELFEDIVAREFYSEADAS---HCIQ------QILESIAYCHSN---GIVHRNLKPEN 158

Query: 702 VLL---DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
           +LL          + DFGL+  ++     +       G+ GY++PE
Sbjct: 159 LLLASKAKGAAVKLADFGLAIEVN---DSEAWHGFA-GTPGYLSPE 200

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 79.3 bits (196), Expect = 5e-16
 Identities = 51/225 (22%), Positives = 83/225 (36%), Gaps = 36/225 (16%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS-KSFIAECE-ALRSIRHRNLVK---- 620
           IG G YG V K +       +AVK +         K  + + +  +RS     +V+    
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 621 -IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
                   I            E M + S + +        +      ++ +  I +    
Sbjct: 90  LFREGDCWI----------CMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVK 136

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            L +L  +    I+H D+KPSN+LLD      + DFG+S  L  +S  +T         G
Sbjct: 137 ALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRD------AG 187

Query: 740 ---YVAPE----YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
              Y+APE      +        D +S GI + E+ TG+ P    
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 78.8 bits (195), Expect = 5e-16
 Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 41/218 (18%)

Query: 567 IGIGGYGYVYKGILGTEETN--VAVK--VLDLQQRGASKSFIAECEALRSIRHRNLVKII 622
           IG G YG V+K      +T   VA+K  +         K  + E   L+ ++H NLV ++
Sbjct: 11  IGEGSYGVVFKCR--NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
                   +      LV+E+               +      L+ + R    +    V  
Sbjct: 69  ---EVFRRKRRLH--LVFEYC--------------DHTV---LHELDRYQRGVPEHLVKS 106

Query: 683 YLH------HHCHT-SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
                    + CH  + +H D+KP N+L+    V  + DFG +RLL    P       V 
Sbjct: 107 ITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL--TGPSDYYDDEV- 163

Query: 736 GSIGYVAPEYGALGEV--STHGDEYSFGILMLEMFTGK 771
            +  Y +PE   +G+       D ++ G +  E+ +G 
Sbjct: 164 ATRWYRSPEL-LVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 81.5 bits (201), Expect = 6e-16
 Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 35/224 (15%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAE---CEALRSIR 614
           FS   +IG GG+G VY           A+K LD   ++ +      + E      + +  
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
              +V +     +  T        + + M  G L   L+Q         +    +     
Sbjct: 251 CPFIVCMS---YAFHTPDKLS--FILDLMNGGDLHYHLSQHGVFSEADMRFYAAE----- 300

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRLLHDNSPDQTSTS 732
             +   LE++H+     +V+ DLKP+N+LLD     HV   D GL+    D S  +    
Sbjct: 301 --IILGLEHMHNR---FVVYRDLKPANILLDEH--GHVRISDLGLAC---DFSKKKPHA- 349

Query: 733 RVKGSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP 773
            V G+ GY+APE   L +   +    D +S G ++ ++  G  P
Sbjct: 350 SV-GTHGYMAPE--VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 79.3 bits (196), Expect = 6e-16
 Identities = 48/190 (25%), Positives = 74/190 (38%), Gaps = 40/190 (21%)

Query: 566 LIGIGGYGYVYKGI-LGTEETNVAVKVLDLQQRGASKSFIA-ECEALRSIRHRNLVK--- 620
            IG G +G         T+E  VAVK ++          +  E    RS+RH N+V+   
Sbjct: 27  DIGSGNFGVARLMRDKLTKE-LVAVKYIERGAAIDEN--VQREIINHRSLRHPNIVRFKE 83

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQK----EDEQNQRPKLNLMQRLSIAID 676
           +I + + +        A++ E+   G L   +       EDE          Q+L   + 
Sbjct: 84  VILTPTHL--------AIIMEYASGGELYERICNAGRFSEDE-----ARFFFQQLLSGVS 130

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH--VGDFGLSRLLHDNSPDQTSTSRV 734
                 Y H      I H DLK  N LLD        + DFG S+    +S  +++    
Sbjct: 131 ------YCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--- 178

Query: 735 KGSIGYVAPE 744
            G+  Y+APE
Sbjct: 179 -GTPAYIAPE 187

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 80.4 bits (199), Expect = 6e-16
 Identities = 38/188 (20%), Positives = 78/188 (41%), Gaps = 33/188 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITS 624
           +G G +  V + +        A  +++ ++      +    E    R ++H N+V++   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH-- 76

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANVLE 682
             SI   G+ +  L+++ +  G L   +  +E   E +     + +Q       +   + 
Sbjct: 77  -DSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADAS---HCIQ------QILEAVL 124

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNE------MVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
           + H      +VH +LKP N+LL ++       +A   DFGL+  +      Q       G
Sbjct: 125 HCHQM---GVVHRNLKPENLLLASKLKGAAVKLA---DFGLAIEVEG--EQQAWFGFA-G 175

Query: 737 SIGYVAPE 744
           + GY++PE
Sbjct: 176 TPGYLSPE 183

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 79.2 bits (195), Expect = 7e-16
 Identities = 36/150 (24%), Positives = 67/150 (44%), Gaps = 5/150 (3%)

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
              +D+  +   +    F+   SL +   ++  E   +  L L   +  +  VA  +E+L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
                   +H DL   N+LL  + V  + DFGL+R ++ +  D       +  + ++APE
Sbjct: 210 ASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPE 265

Query: 745 YGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
                  +   D +SFG+L+ E+F+ G  P
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 78.4 bits (194), Expect = 1e-15
 Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 25/225 (11%)

Query: 556 KATEGFSSANLIGIGGYGYVYKGILGTEETN--VAVKV--LDLQQRGASKSFIAECEALR 611
           +A + +     IG G YG V+K     +     VA+K   +   + G   S I E   LR
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKAR-DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66

Query: 612 SIR---HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLM 668
            +    H N+V++   C+   T       LV+E +    L  +L     ++   P +   
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-----DKVPEPGVPTE 120

Query: 669 QRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQ 728
               +   +   L++LH H    +VH DLKP N+L+ +     + DFGL+R+    S   
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQM 174

Query: 729 TSTSRVKGSIGYVAPE--YGALGEVSTHGDEYSFGILMLEMFTGK 771
             TS V  ++ Y APE    +    +T  D +S G +  EMF  K
Sbjct: 175 ALTSVVV-TLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRK 216

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 55/222 (24%), Positives = 87/222 (39%), Gaps = 31/222 (13%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS-KSFIAECE-ALRSIRHRNLVK---- 620
           +G G YG V K         +AVK +         K  + + + ++R++     V     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 621 -IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
                   I            E M + SL+ +  Q  D+    P+  L +   IA+ +  
Sbjct: 75  LFREGDVWI----------CMELM-DTSLDKFYKQVIDKGQTIPEDILGK---IAVSIVK 120

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            LE+LH      ++H D+KPSNVL++      + DFG+S  L D+           G   
Sbjct: 121 ALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA----GCKP 174

Query: 740 YVAPE----YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
           Y+APE           S   D +S GI M+E+   + P D  
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 52/195 (26%), Positives = 89/195 (45%), Gaps = 16/195 (8%)

Query: 239 TIPTGV-GNLKNLILIAMEVNLLTGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSL-GNL 295
            IP+ +  + K L L   + N L+ S+P+     L KL++L L  NK+   +P+ +   L
Sbjct: 30  AIPSNIPADTKKLDL---QSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKEL 84

Query: 296 IFLTEVDLQGNSIRGSIPSALGNCL-QLQKLDLSDNNLSGTIPREV-IGLSSFVLLDLSR 353
             L  + +  N ++ ++P  + + L  L +L L  N L  ++P  V   L+    L L  
Sbjct: 85  KNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGY 142

Query: 354 NHLSGPIPLEV-GRLKGIQQLDLSENKLSGEIPTSL-ASCVGLEYLNFSDNSFQGPIHSG 411
           N L   +P  V  +L  +++L L  N+L   +P         L+ L   +N  +      
Sbjct: 143 NELQS-LPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGA 200

Query: 412 FSSLKGLQDLDLSRN 426
           F SL+ L+ L L  N
Sbjct: 201 FDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 75.0 bits (185), Expect = 6e-15
 Identities = 46/193 (23%), Positives = 72/193 (37%), Gaps = 18/193 (9%)

Query: 264 IPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCL-QL 322
           IP         + L L  NK+S     +   L  L  + L  N ++ ++P+ +   L  L
Sbjct: 35  IPAD------TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87

Query: 323 QKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLSGPIPLEVG---RLKGIQQLDLSEN 378
           + L ++DN L   +P  V   L +   L L RN L     L       L  +  L L  N
Sbjct: 88  ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS---LPPRVFDSLTKLTYLSLGYN 143

Query: 379 KLSGEIPTSL-ASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLN 437
           +L   +P  +      L+ L   +N  +      F  L  L+ L L  N          +
Sbjct: 144 ELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD 202

Query: 438 TFRFLQKLNLSFN 450
           +   L+ L L  N
Sbjct: 203 SLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 45/202 (22%), Positives = 79/202 (39%), Gaps = 31/202 (15%)

Query: 136 NIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFL--- 192
           + + L L SN  +  +P              +L  L  L    N L        + L   
Sbjct: 38  DTKKLDLQSNKLS-SLPSKA---------FHRLTKLRLLYLNDNKL--------QTLPAG 79

Query: 193 --DSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKN 249
               L N   LE + ++ N L   LP  + +   +L  L +  N++  ++P  V  +L  
Sbjct: 80  IFKELKN---LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTK 134

Query: 250 LILIAMEVNLLTGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSI 308
           L  +++  N L  S+P  V   L  L+ L L+ N++      +   L  L  + L  N +
Sbjct: 135 LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQL 193

Query: 309 RGSIPSALGNCLQLQKLDLSDN 330
           +     A  +  +L+ L L +N
Sbjct: 194 KRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 27/197 (13%)

Query: 6   IPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSL-SNLSFL 64
           IP+NI   ++ + LDL  NKL          L KL  L L  N    ++P  +   L  L
Sbjct: 31  IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87

Query: 65  QQLSLSEN---SLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLF-NISSMDYFAVTQN 120
           + L +++N   +L   +  +L  L +L +     N L  S+P ++F +++ + Y ++  N
Sbjct: 88  ETLWVTDNKLQALPIGVFDQLVNLAELRL---DRNQLK-SLPPRVFDSLTKLTYLSLGYN 143

Query: 121 KLVGEIPHYVGFT-LPNIRVLLLGSNWFTGEIPPSISNASSIPEDL-GKLKNLIRLNFAR 178
           +L   +P  V F  L +++ L L +N               +PE    KL  L  L    
Sbjct: 144 ELQ-SLPKGV-FDKLTSLKELRLYNNQLK-----------RVPEGAFDKLTELKTLKLDN 190

Query: 179 NNLGTGKGNDLRFLDSL 195
           N L          L+ L
Sbjct: 191 NQLKRVPEGAFDSLEKL 207

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 48.1 bits (115), Expect = 5e-06
 Identities = 50/211 (23%), Positives = 82/211 (38%), Gaps = 34/211 (16%)

Query: 29  NIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSEN---SLSGNIPSELGLL 85
           NIP++   L       L  N  +    ++   L+ L+ L L++N   +L   I  EL  L
Sbjct: 34  NIPADTKKLD------LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87

Query: 86  KQLNMFQVSANYLTGSIPIQLF-NISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGS 144
           + L +     N L  ++PI +F  + ++    + +N+L   +P  V  +L  +  L LG 
Sbjct: 88  ETLWVTD---NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGY 142

Query: 145 NWFTGEIPPSISNASSIPEDL-GKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEV 203
           N              S+P+ +  KL +L  L    N L   K       D L     L  
Sbjct: 143 NELQ-----------SLPKGVFDKLTSLKELRLYNNQL---KRVPEGAFDKLTELKTL-- 186

Query: 204 VSLSSNSLSGVLPNSIANFSSHLIYLYMSAN 234
             L +N L  V   +  +    L  L +  N
Sbjct: 187 -KLDNNQLKRVPEGAFDSLEK-LKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 44.6 bits (106), Expect = 7e-05
 Identities = 29/98 (29%), Positives = 44/98 (44%), Gaps = 10/98 (10%)

Query: 371 QQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSG-FSSLKGLQDLDLSRNNFS 429
           ++LDL  NKLS     +      L  L  +DN  Q  + +G F  LK L+ L ++ N   
Sbjct: 40  KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQ 98

Query: 430 GKIPMFLNTFRF---LQKLNLSFNNLEGEVPSEGVFKN 464
             +P  +  F     L +L L  N L+  +P   VF +
Sbjct: 99  -ALP--IGVFDQLVNLAELRLDRNQLK-SLPP-RVFDS 131

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 68/226 (30%), Positives = 104/226 (46%), Gaps = 46/226 (20%)

Query: 566 LIGIGGYGYVYKGI-LGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKI 621
            +G G +G V       T++  VA+K +    L++         E   L+ +RH +++K+
Sbjct: 16  TLGEGSFGKVKLATHYKTQQ-KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQK----EDEQNQRPKLNLMQRLSIAIDV 677
                 I T  +    +V E+   G L +++ +K    EDE          Q++  AI+ 
Sbjct: 75  YDV---ITTPTDIV--MVIEYA-GGELFDYIVEKKRMTEDE-----GRRFFQQIICAIE- 122

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
                Y H H    IVH DLKP N+LLD+ +   + DFGLS ++ D +  +TS     GS
Sbjct: 123 -----YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GS 170

Query: 738 IGYVAPE------Y-GALGEVSTHGDEYSFGILMLEMFTGKRPTDD 776
             Y APE      Y G   EV    D +S GI++  M  G+ P DD
Sbjct: 171 PNYAAPEVINGKLYAGP--EV----DVWSCGIVLYVMLVGRLPFDD 210

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.0 bits (192), Expect = 2e-15
 Identities = 43/193 (22%), Positives = 68/193 (35%), Gaps = 36/193 (18%)

Query: 264 IPTSVGYLLKLQVLSLFGNKISGEIPS--SLGNLIFLTEVDLQGNSIRGSIPS-ALGNCL 320
           +P+         +L L  N +S  + +  +   L  L  + L  N +   I S A     
Sbjct: 37  LPSYT------ALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88

Query: 321 QLQKLDLSDNNLSGTIPREV-IGLSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLDLSEN 378
            L+ LDLS N+L  T+   +   L +  +L L  NH+   +       +  +Q+L LS+N
Sbjct: 89  NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQN 146

Query: 379 KLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNT 438
           ++S                 F             + L  L  LDLS N         L  
Sbjct: 147 QIS----------------RFPVELI-----KDGNKLPKLMLLDLSSNKLKKLPLTDLQK 185

Query: 439 FRFLQKLNLSFNN 451
                K  L  +N
Sbjct: 186 LPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 36/160 (22%), Positives = 67/160 (41%), Gaps = 9/160 (5%)

Query: 199 TFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEV 257
           ++  ++ LS N+LS +         ++L  L +S N ++  I +     + NL  + +  
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97

Query: 258 NLLTGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIP--- 313
           N L  ++   +   L  L+VL L+ N I     ++  ++  L ++ L  N I    P   
Sbjct: 98  NHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155

Query: 314 -SALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLS 352
                   +L  LDLS N L      ++  L ++V   L 
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 42/187 (22%), Positives = 78/187 (41%), Gaps = 25/187 (13%)

Query: 29  NIPSELGNLFKLVGLGLTGNNYTGSIP--QSLSNLSFLQQLSLSENSLSGNIPSE-LGLL 85
           ++PS    L       L+ NN +  +    + + L+ L  L LS N L+  I SE    +
Sbjct: 36  SLPSYTALLD------LSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87

Query: 86  KQLNMFQVSANYLTGSIPIQLF-NISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGS 144
             L    +S+N+L  ++   LF ++ +++   +  N +V  +       +  ++ L L  
Sbjct: 88  PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ 145

Query: 145 NWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVV 204
           N  +   P  +       +D  KL  L+ L+ + N L      DL+ L + V       +
Sbjct: 146 NQIS-RFPVELI------KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV----KNGL 194

Query: 205 SLSSNSL 211
            L +N L
Sbjct: 195 YLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 47.9 bits (114), Expect = 9e-06
 Identities = 28/111 (25%), Positives = 47/111 (42%), Gaps = 11/111 (9%)

Query: 5   EIPANI-THCSELRILDLVVNKLEGNIPSE-LGNLFKLVGLGLTGNNYTGSIPQ-SLSNL 61
            I +        LR LDL  N L   +      +L  L  L L  N+    + + +  ++
Sbjct: 78  FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDM 135

Query: 62  SFLQQLSLSENSLSGNIPSE----LGLLKQLNMFQVSANYLTGSIPIQLFN 108
           + LQ+L LS+N +S   P E       L +L +  +S+N L   +P+    
Sbjct: 136 AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQ 184

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 45.6 bits (108), Expect = 5e-05
 Identities = 46/217 (21%), Positives = 76/217 (35%), Gaps = 58/217 (26%)

Query: 42  GLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGL--LKQLNMFQVSANYLT 99
              L       ++PQSL   S+   L LS N+LS  + +E     L  L+   +S N+L 
Sbjct: 27  KQQLP------NVPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN 77

Query: 100 GSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNAS 159
             I  + F                          +PN+R L L SN     +   +    
Sbjct: 78  -FISSEAFV------------------------PVPNLRYLDLSSNHLH-TLDEFLF--- 108

Query: 160 SIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLV--NCTFLEVVSLSSNSLSGVLPN 217
               DL  L+ L  L            N +  +D     +   L+ + LS N +S     
Sbjct: 109 ---SDLQALEVL-LLY----------NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVE 154

Query: 218 SIANFS--SHLIYLYMSANRISGTIPTGVGNLKNLIL 252
            I + +    L+ L +S+N++     T +  L   + 
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK 191

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 47/185 (25%), Positives = 78/185 (42%), Gaps = 25/185 (13%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSC 625
           +G G +G V+     +      +K ++  + +   +   AE E L+S+ H N++KI    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF--- 86

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
              +   N +  +V E    G L   L +    Q +   L+      +   + N L Y H
Sbjct: 87  EVFEDYHNMY--IVMETCEGGEL---LERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141

Query: 686 HHCHTSIVHCDLKPSNVLLDNE------MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
                 +VH DLKP N+L  +        +    DFGL+ L      D+ ST+   G+  
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKII---DFGLAELFK---SDEHSTNAA-GTAL 191

Query: 740 YVAPE 744
           Y+APE
Sbjct: 192 YMAPE 196

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 57/226 (25%), Positives = 94/226 (41%), Gaps = 31/226 (13%)

Query: 558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRN 617
            E F     +G G YG VYK I       VA+K + ++     +  I E   ++     +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           +VK   S      +  +   +V E+   GS+ + +  +            +    IA  +
Sbjct: 86  VVKYYGSYF----KNTDL-WIVMEYCGAGSVSDIIRLRN---------KTLTEDEIATIL 131

Query: 678 ANV---LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
            +    LEYLH       +H D+K  N+LL+ E  A + DFG++  L D      + ++ 
Sbjct: 132 QSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD------TMAKR 182

Query: 735 KGSIG---YVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM 777
              IG   ++APE       +   D +S GI  +EM  GK P  D+
Sbjct: 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 48/187 (25%), Positives = 77/187 (41%), Gaps = 34/187 (18%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
            +G G    VY+      +   A+KVL   +    K    E   L  + H N++K+    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLK--- 114

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANVLEY 683
              +T       LV E +  G L + + +K    E++     + ++       +   + Y
Sbjct: 115 EIFETPTEIS--LVLELVTGGELFDRIVEKGYYSERDAA---DAVK------QILEAVAY 163

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNE------MVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
           LH +    IVH DLKP N+L           +A   DFGLS+++      +T    V G+
Sbjct: 164 LHEN---GIVHRDLKPENLLYATPAPDAPLKIA---DFGLSKIVEHQVLMKT----VCGT 213

Query: 738 IGYVAPE 744
            GY APE
Sbjct: 214 PGYCAPE 220

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 54/240 (22%), Positives = 92/240 (38%), Gaps = 46/240 (19%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLD----LQQRGASKSFIA---------------- 605
            IG G YG V       + T  A+KVL     ++Q G  +                    
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 606 ------ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ 659
                 E   L+ + H N+VK++     +D    +   +V+E +  G +      K    
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVPTLK---- 132

Query: 660 NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR 719
                L+  Q      D+   +EYLH+     I+H D+KPSN+L+  +    + DFG+S 
Sbjct: 133 ----PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 720 LLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRPTDD 776
               +     S +   G+  ++APE  +       G   D ++ G+ +     G+ P  D
Sbjct: 186 EFKGSD-ALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 40/197 (20%), Positives = 80/197 (40%), Gaps = 26/197 (13%)

Query: 163 EDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANF 222
                L N ++ N  + ++      DL     L     ++  +  ++++      S+A  
Sbjct: 13  FPDPGLANAVKQNLGKQSV-----TDLVSQKELSG---VQNFNGDNSNIQ-----SLAGM 59

Query: 223 SS--HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLF 280
               +L  L++S N+IS  + + + +L  L  +++  N L      +      L  L L 
Sbjct: 60  QFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLD 114

Query: 281 GNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREV 340
            N++      SL +L  L  + ++ N ++ SI   LG   +L+ LDL  N ++ T    +
Sbjct: 115 NNELRD--TDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGG--L 168

Query: 341 IGLSSFVLLDLSRNHLS 357
             L     +DL+     
Sbjct: 169 TRLKKVNWIDLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 42/213 (19%), Positives = 71/213 (33%), Gaps = 19/213 (8%)

Query: 242 TGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEV 301
                L N +   +    +T     S   L  +Q  +   + I   + + +     L E+
Sbjct: 13  FPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68

Query: 302 DLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIP 361
            L  N I   + S L +  +L++L ++ N L        I  +    L L  N L     
Sbjct: 69  HLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRDTDS 123

Query: 362 LEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIH--SGFSSLKGLQ 419
           L    LK ++ L +  NKL   I   L     LE L+   N     I    G + LK + 
Sbjct: 124 LI--HLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGN----EITNTGGLTRLKKVN 175

Query: 420 DLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNL 452
            +DL+      +   +         +       
Sbjct: 176 WIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 37/197 (18%), Positives = 69/197 (35%), Gaps = 22/197 (11%)

Query: 281 GNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREV 340
              I+ ++      L    + +L   S+  +   +      +Q  +  ++N+       +
Sbjct: 6   PTPIN-QV-FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-----SL 56

Query: 341 IGLSSFV---LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYL 397
            G+  F     L LS N +S   PL+   L  +++L ++ N+L        A    L  L
Sbjct: 57  AGMQFFTNLKELHLSHNQISDLSPLK--DLTKLEELSVNRNRLKNLNGIPSAC---LSRL 111

Query: 398 NFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVP 457
              +N  +         LK L+ L +  N     I   L     L+ L+L  N +     
Sbjct: 112 FLDNNELRDT--DSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT-NTG 166

Query: 458 SEGVFKNVRAVSIIGNN 474
                K V  + + G  
Sbjct: 167 GLTRLKKVNWIDLTGQK 183

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 59.7 bits (145), Expect = 8e-10
 Identities = 47/281 (16%), Positives = 85/281 (30%), Gaps = 65/281 (23%)

Query: 58  LSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAV 117
              L+   + +L + S++         L  +  F    + +         +++ M +   
Sbjct: 15  DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ--------SLAGMQF--- 61

Query: 118 TQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFA 177
                             N++ L L  N             S +   L  L  L  L+  
Sbjct: 62  ----------------FTNLKELHLSHN-----------QISDL-SPLKDLTKLEELSVN 93

Query: 178 RNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSS--HLIYLYMSANR 235
           RN L      +L  + S      L  + L +N L         +     +L  L +  N+
Sbjct: 94  RNRL-----KNLNGIPSAC----LSRLFLDNNELR-----DTDSLIHLKNLEILSIRNNK 139

Query: 236 ISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNL 295
           +  +I   +G L  L ++ +  N +T +    +  L K+  + L G K   E       L
Sbjct: 140 LK-SIV-MLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPEL 195

Query: 296 IFLTEV-DLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGT 335
                V D  G  I    P  + N        +       T
Sbjct: 196 YITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWELPVYT 233

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 45.0 bits (107), Expect = 5e-05
 Identities = 18/103 (17%), Positives = 41/103 (39%), Gaps = 8/103 (7%)

Query: 351 LSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHS 410
                ++   P     L    + +L +  ++  +        G++  N  +++ Q    +
Sbjct: 4   QRPTPINQVFPDPG--LANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSL--A 57

Query: 411 GFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLE 453
           G      L++L LS N  S  +   L     L++L+++ N L+
Sbjct: 58  GMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK 98

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 45.0 bits (107), Expect = 5e-05
 Identities = 30/204 (14%), Positives = 66/204 (32%), Gaps = 54/204 (26%)

Query: 9   NITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLS 68
           +    S ++  +   + ++ ++ + +     L  L L+ N  +  +   L +L+ L++LS
Sbjct: 36  SQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELS 91

Query: 69  LSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPH 128
           ++ N L          L +L    +  N L         +  S+                
Sbjct: 92  VNRNRLKNLNGIPSACLSRLF---LDNNELR--------DTDSLI--------------- 125

Query: 129 YVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGND 188
                L N+ +L + +N         + +       LG L  L  L+   N +      +
Sbjct: 126 ----HLKNLEILSIRNN--------KLKSIVM----LGFLSKLEVLDLHGNEI-----TN 164

Query: 189 LRFLDSLVNCTFLEVVSLSSNSLS 212
              L  L     +  + L+     
Sbjct: 165 TGGLTRLKK---VNWIDLTGQKCV 185

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 76.1 bits (188), Expect = 4e-15
 Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 27/227 (11%)

Query: 556 KATEGFSSANLIGIGGYGYVYKGI-LGTEETNVAVKVLDL-QQRGASKSF-------IAE 606
            AT  +     IG+G YG VYK     +    VA+K + +    G            +A 
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHF-VALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 607 CEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLN 666
              L +  H N+V+++  C++  T       LV+E +    L  +L     ++   P L 
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-----DKAPPPGLP 118

Query: 667 LMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSP 726
                 +       L++LH +C   IVH DLKP N+L+ +     + DFGL+R+    S 
Sbjct: 119 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SY 172

Query: 727 DQTSTSRVKGSIGYVAPE--YGALGEVSTHGDEYSFGILMLEMFTGK 771
               T  V  ++ Y APE    +    +T  D +S G +  EMF  K
Sbjct: 173 QMALTPVVV-TLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRK 216

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 76.2 bits (188), Expect = 4e-15
 Identities = 50/232 (21%), Positives = 91/232 (39%), Gaps = 51/232 (21%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIA---ECEALRSIRHR--N 617
           L+G GG+G VY GI  ++   VA+K ++   +   G   +      E   L+ +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 618 LVKIITSCSSIDTRGNEFKALVYEF-MPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIA 674
           +++++      +   +    L+ E   P   L +++ ++    E+  R   +   ++  A
Sbjct: 110 VIRLLDW---FERPDSFV--LILERPEPVQDLFDFITERGALQEELAR---SFFWQVLEA 161

Query: 675 IDVANVLEYLHHHCHT-SIVHCDLKPSNVLLD-NEMVAHVGDFGLSRLLHDNSPDQTSTS 732
           +           HCH   ++H D+K  N+L+D N     + DFG   LL D +       
Sbjct: 162 V----------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFD- 209

Query: 733 RVKGSIGYVAPEYGALGEVSTHGDEY--------SFGILMLEMFTGKRPTDD 776
              G+  Y  PE+            Y        S GIL+ +M  G  P + 
Sbjct: 210 ---GTRVYSPPEW-------IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 49/219 (22%)

Query: 540 SSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGI-LGTEETNVAVKVLDLQQRG 598
              ED Y      +L +        +++G G +  V   I L T +   AVK+++ Q   
Sbjct: 8   GRFEDVY------QLQE--------DVLGEGAHARVQTCINLITSQE-YAVKIIEKQPGH 52

Query: 599 ASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE- 656
                  E E L   + HRN++++I      +     +  LV+E M  GS+ + ++++  
Sbjct: 53  IRSRVFREVEMLYQCQGHRNVLELI---EFFEEEDRFY--LVFEKMRGGSILSHIHKRRH 107

Query: 657 -DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE------MV 709
            +E        ++Q      DVA+ L++LH+     I H DLKP N+L ++        +
Sbjct: 108 FNELEAS---VVVQ------DVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKI 155

Query: 710 AHVGDFGLSRLLHDNSPDQTSTSRVK----GSIGYVAPE 744
               DF L   +  N      ++       GS  Y+APE
Sbjct: 156 C---DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 76.2 bits (188), Expect = 9e-15
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 43/220 (19%)

Query: 567 IGIGGYGYVYKGILGTEETN-VAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
           IG G +G V++  L   E++ VA+K +   +R  ++    E + +R ++H N+V +    
Sbjct: 48  IGNGSFGVVFQAKL--VESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFF 101

Query: 626 SSIDTRGNEFKA-LVYEFMPNGSLENWLNQKEDEQNQRP----KLNLMQRLSIAIDVANV 680
            S   + +E    LV E++P  ++          +   P    KL + Q L         
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL-------RS 153

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLD-NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
           L Y+H      I H D+KP N+LLD    V  + DFG +++L      + + S       
Sbjct: 154 LAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL---IAGEPNVS------- 200

Query: 740 YV------APE--YGALGEVSTHGDEYSFGILMLEMFTGK 771
           Y+      APE  +GA    +T+ D +S G +M E+  G+
Sbjct: 201 YICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQ 239

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 57/234 (24%), Positives = 92/234 (39%), Gaps = 53/234 (22%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIA---ECEALRSIR----H 615
           L+G GG+G V+ G   T+   VA+KV+    +         +    E   L  +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 616 RNLVKIITSCSSIDTRGNEFKALVYEF-MPNGSLENWLNQKE--DEQNQRPKLNLMQRLS 672
             +++++      +T+      LV E  +P   L +++ +K    E   R       ++ 
Sbjct: 98  PGVIRLLDW---FETQEGFM--LVLERPLPAQDLFDYITEKGPLGEGPSR---CFFGQVV 149

Query: 673 IAIDVANVLEYLHHHCHT-SIVHCDLKPSNVLLDNEM-VAHVGDFGLSRLLHDNSPDQTS 730
            AI           HCH+  +VH D+K  N+L+D     A + DFG   LLHD  P    
Sbjct: 150 AAIQ----------HCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD-EPYTDF 198

Query: 731 TSRVKGSIGYVAPEYGALGEVSTHGDEY--------SFGILMLEMFTGKRPTDD 776
                G+  Y  PE+           +Y        S GIL+ +M  G  P + 
Sbjct: 199 D----GTRVYSPPEW-------ISRHQYHALPATVWSLGILLYDMVCGDIPFER 241

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 44/215 (20%), Positives = 80/215 (37%), Gaps = 47/215 (21%)

Query: 539 NSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG 598
           +S     Y            +       +G G +    K +        AVK++  +   
Sbjct: 3   DSPFYQHY------------DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA 50

Query: 599 ASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE- 656
            ++    E  AL+    H N+VK+         + + F  LV E +  G L   + +K+ 
Sbjct: 51  NTQK---EITALKLCEGHPNIVKLH---EVFHDQLHTF--LVMELLNGGELFERIKKKKH 102

Query: 657 -DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE------MV 709
             E        +M+       + + + ++H      +VH DLKP N+L  +E       +
Sbjct: 103 FSETEAS---YIMR------KLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKI 150

Query: 710 AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
               DFG +RL   +  +Q   +    ++ Y APE
Sbjct: 151 I---DFGFARLKPPD--NQPLKTPC-FTLHYAAPE 179

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 75.2 bits (184), Expect = 4e-14
 Identities = 39/233 (16%), Positives = 69/233 (29%), Gaps = 17/233 (7%)

Query: 150 EIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSN 209
           E             D    + L R   +       +      L+S      LE  +    
Sbjct: 330 ECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQ----SELESCKELQELEPENKWCL 385

Query: 210 SLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVG 269
               +L  ++ +   +        + +    P           +    +           
Sbjct: 386 LTIILLMRAL-DPLLYEKETLQYFSTLKAVDP------MRAAYLDDLRSKFLLENSVLKM 438

Query: 270 YLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSD 329
               ++VL L    ++  +   L  L+ +T +DL  N +R ++P AL     L+ L  SD
Sbjct: 439 EYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASD 495

Query: 330 NNLSGTIPREVIGLSSFVLLDLSRNHLSG-PIPLEVGRLKGIQQLDLSENKLS 381
           N L   +   V  L     L L  N L        +     +  L+L  N L 
Sbjct: 496 NALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 66.3 bits (161), Expect = 2e-11
 Identities = 38/208 (18%), Positives = 74/208 (35%), Gaps = 14/208 (6%)

Query: 225 HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKI 284
            L    +S  + +  + + + + K L  +  E       + T +  +  L  L      +
Sbjct: 350 QLFRCELSVEKST-VLQSELESCKELQELEPENKW---CLLTIILLMRALDPLLYEKETL 405

Query: 285 SGEIPSSLGNLIFL--TEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIG 342
                S+L  +  +    +D   +               ++ L L+  +L  T+   +  
Sbjct: 406 QYF--STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQ 461

Query: 343 LSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDN 402
           L     LDLS N L   +P  +  L+ ++ L  S+N L   +   +A+   L+ L   +N
Sbjct: 462 LLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 518

Query: 403 SFQG-PIHSGFSSLKGLQDLDLSRNNFS 429
             Q         S   L  L+L  N+  
Sbjct: 519 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 62.9 bits (152), Expect = 3e-10
 Identities = 34/211 (16%), Positives = 71/211 (33%), Gaps = 11/211 (5%)

Query: 265 PTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQK 324
                   +L    L   K +  + S L +   L E++ +      +I   +     L  
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLM---RALDP 397

Query: 325 LDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEI 384
           L      L      + +       LD  R+       +       ++ L L+   L+  +
Sbjct: 398 LLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VL 456

Query: 385 PTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQK 444
              L   + + +L+ S N  +  +    ++L+ L+ L  S N     +   +     LQ+
Sbjct: 457 C-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQE 512

Query: 445 LNLSFNNLEG--EVPSEGVFKNVRAVSIIGN 473
           L L  N L+    +        +  +++ GN
Sbjct: 513 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 52.8 bits (126), Expect = 3e-07
 Identities = 29/141 (20%), Positives = 56/141 (39%), Gaps = 10/141 (7%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
           E        +++R+L L    L   +   L  L  +  L L+ N    ++P +L+ L  L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCL 488

Query: 65  QQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTG-SIPIQLFNISSMDYFAVTQNKLV 123
           + L  S+N+L  N+   +  L +L    +  N L   +    L +   +    +  N L 
Sbjct: 489 EVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

Query: 124 GEIPHY---VGFTLPNIRVLL 141
            +       +   LP++  +L
Sbjct: 547 -QEEGIQERLAEMLPSVSSIL 566

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 73.9 bits (182), Expect = 4e-14
 Identities = 45/185 (24%), Positives = 76/185 (41%), Gaps = 31/185 (16%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEAL-RSIRHRNLVKIITSC 625
           IG+G Y    + I        AVK++D  +R  ++    E E L R  +H N++ +    
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLK--- 82

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVANVLEY 683
              D     +  +V E M  G L + + +++   E+       ++        +   +EY
Sbjct: 83  DVYDDGKYVY--VVTELMKGGELLDKILRQKFFSEREAS---AVLF------TITKTVEY 131

Query: 684 LHHHCHTSIVHCDLKPSNVLL----DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
           LH      +VH DLKPSN+L      N     + DFG ++ L     +         +  
Sbjct: 132 LHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR---AENGLLMTPCYTAN 185

Query: 740 YVAPE 744
           +VAPE
Sbjct: 186 FVAPE 190

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 74.4 bits (183), Expect = 4e-14
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 40/219 (18%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS-C 625
           IG G +G VY+  L      VA+K +   +R  ++    E + +R + H N+V++     
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 117

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP----KLNLMQRLSIAIDVANVL 681
           SS + +   +  LV +++P  ++          +   P    KL + Q           L
Sbjct: 118 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SL 169

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEM-VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
            Y+H      I H D+KP N+LLD +  V  + DFG ++ L      + + S       Y
Sbjct: 170 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVS-------Y 216

Query: 741 V------APE--YGALGEVSTHGDEYSFGILMLEMFTGK 771
           +      APE  +GA  + ++  D +S G ++ E+  G+
Sbjct: 217 ICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQ 254

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 73.9 bits (182), Expect = 4e-14
 Identities = 45/190 (23%), Positives = 80/190 (42%), Gaps = 33/190 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIA------ECEALRSIRHRNLVK 620
           +G G +  V K    +     A K +  +Q  AS+  +       E   LR + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVA 678
           +       + R +    L+ E +  G L ++L QKE   E+      + ++       + 
Sbjct: 80  LH---DVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEAT---SFIK------QIL 125

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH----VGDFGLSRLLHDNSPDQTSTSRV 734
           + + YLH      I H DLKP N++L ++ +      + DFGL+  + D    +      
Sbjct: 126 DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--- 179

Query: 735 KGSIGYVAPE 744
            G+  +VAPE
Sbjct: 180 -GTPEFVAPE 188

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 73.5 bits (181), Expect = 4e-14
 Identities = 52/223 (23%), Positives = 81/223 (36%), Gaps = 52/223 (23%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-------HRNLV 619
           +G G Y  V++ I  T    V VK+L           + + +  R I+         N++
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKP---------VKKKKIKREIKILENLRGGPNII 94

Query: 620 KIITSCSSIDTRGNEFK-ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
            +      I         ALV+E + N   +       D   +      M  +  A    
Sbjct: 95  TLA----DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF----YMYEILKA---- 142

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNE-MVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
             L+Y H      I+H D+KP NV++D+E     + D+GL+   H   P Q    RV  S
Sbjct: 143 --LDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH---PGQEYNVRV-AS 193

Query: 738 IGYVAPE-------YGALGEVSTHGDEYSFGILMLEMFTGKRP 773
             +  PE       Y          D +S G ++  M   K P
Sbjct: 194 RYFKGPELLVDYQMY------DYSLDMWSLGCMLASMIFRKEP 230

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 73.1 bits (180), Expect = 5e-14
 Identities = 45/190 (23%), Positives = 81/190 (42%), Gaps = 33/190 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIA------ECEALRSIRHRNLVK 620
           +G G +  V K    +     A K +  +Q  AS+  ++      E   LR + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE--DEQNQRPKLNLMQRLSIAIDVA 678
           +       + R +    L+ E +  G L ++L QKE   E+      + ++       + 
Sbjct: 80  LH---DVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEAT---SFIK------QIL 125

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH----VGDFGLSRLLHDNSPDQTSTSRV 734
           + + YLH      I H DLKP N++L ++ +      + DFGL+  + D    +      
Sbjct: 126 DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--- 179

Query: 735 KGSIGYVAPE 744
            G+  +VAPE
Sbjct: 180 -GTPEFVAPE 188

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 73.5 bits (181), Expect = 6e-14
 Identities = 53/236 (22%), Positives = 93/236 (39%), Gaps = 46/236 (19%)

Query: 556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVK-VLDLQQRGASKSF----IAECEAL 610
           K  + F    + G G +G V  G   +   +VA+K V+          F    +   + L
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DPRFRNRELQIMQDL 73

Query: 611 RSIRHRNLVKI--ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP----K 664
             + H N+V++           R + +  +V E++P+ +L          Q   P    K
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIK 132

Query: 665 LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM-VAHVGDFGLSRLLHD 723
           + L Q +         +  LH     ++ H D+KP NVL++       + DFG ++ L  
Sbjct: 133 VFLFQLIR-------SIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-- 182

Query: 724 NSPDQTSTSRVKGSIGYV------APE--YGALGEVSTHGDEYSFGILMLEMFTGK 771
            SP + + +       Y+      APE  +G     +T  D +S G +  EM  G+
Sbjct: 183 -SPSEPNVA-------YICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGE 229

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 72.7 bits (179), Expect = 8e-14
 Identities = 39/188 (20%), Positives = 73/188 (38%), Gaps = 31/188 (16%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHR-NLVKIIT 623
           +G G +  V + I  +     A K L  ++RG       + E   L   +    ++ +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH- 95

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ-NQRPKLNLMQRLSIAIDVANVLE 682
                +        L+ E+   G + +    +  E  ++   + L++       +   + 
Sbjct: 96  --EVYENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLIK------QILEGVY 145

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNE------MVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
           YLH +   +IVH DLKP N+LL +        +    DFG+SR +      +       G
Sbjct: 146 YLHQN---NIVHLDLKPQNILLSSIYPLGDIKIV---DFGMSRKIGHACELREIM----G 195

Query: 737 SIGYVAPE 744
           +  Y+APE
Sbjct: 196 TPEYLAPE 203

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 71.8 bits (177), Expect = 9e-14
 Identities = 47/217 (21%), Positives = 89/217 (41%), Gaps = 48/217 (22%)

Query: 540 SSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGA 599
           S +ED Y      E+ +          +G G +  V K          A K +  ++  +
Sbjct: 1   SMVEDHY------EMGE---------ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSS 45

Query: 600 SKSFIA------ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLN 653
           S+  ++      E   LR IRH N++ +       + + +    L+ E +  G L ++L 
Sbjct: 46  SRRGVSREEIEREVNILREIRHPNIITLH---DIFENKTDVV--LILELVSGGELFDFLA 100

Query: 654 QKEDEQNQRPKLNLMQRLSIAI--DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH 711
           +KE         +L +  +      + + + YLH      I H DLKP N++L ++ V +
Sbjct: 101 EKE---------SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPN 148

Query: 712 ----VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
               + DFG++  +   +  +       G+  +VAPE
Sbjct: 149 PRIKLIDFGIAHKIEAGNEFKNIF----GTPEFVAPE 181

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 46/223 (20%), Positives = 83/223 (37%), Gaps = 35/223 (15%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS-KSFIAECEAL-RSIRHRNLVK---- 620
           +G G  G V+K         +AVK +         K  + + + + +S     +V+    
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 621 -IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
            I  +   I            E M     E    + +        +       + + +  
Sbjct: 93  FITNTDVFI----------AMELM-GTCAEKLKKRMQG------PIPERILGKMTVAIVK 135

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            L YL       ++H D+KPSN+LLD      + DFG+S  L  +   +  ++   G   
Sbjct: 136 ALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSA---GCAA 189

Query: 740 YVAPEYGALGEVSTHG-----DEYSFGILMLEMFTGKRPTDDM 777
           Y+APE     + +        D +S GI ++E+ TG+ P  + 
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 44/211 (20%), Positives = 83/211 (39%), Gaps = 39/211 (18%)

Query: 539 NSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG 598
             ++ D Y      +L K         ++G+G  G V +          A+K+L      
Sbjct: 23  KYAVTDDY------QLSK--------QVLGLGVNGKVLECFHRRTGQKCALKLLY----- 63

Query: 599 ASKSFIAECEAL-RSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKED 657
            S     E +   ++    ++V I+    ++         ++ E M  G L + + ++ D
Sbjct: 64  DSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL-LIIMECMEGGELFSRIQERGD 122

Query: 658 EQ-NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL-DNEMVAHV--G 713
           +   +R    +M+      D+   +++LH H   +I H D+KP N+L    E  A +   
Sbjct: 123 QAFTEREAAEIMR------DIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT 173

Query: 714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
           DFG ++       +   T     +  YVAPE
Sbjct: 174 DFGFAKETT---QNALQT--PCYTPYYVAPE 199

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 56/224 (25%), Positives = 90/224 (40%), Gaps = 40/224 (17%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLD--LQQRGASKSFIAECEALRSIRHRNL 618
           + +   IG G  G V        E NVA+K L    Q +  +K    E   ++ + H+N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86

Query: 619 VK---IITSCSSIDTRGNEFKA--LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
           +    + T   S++    EF+   +V E M   +L   +  + D +     L  M     
Sbjct: 87  IGLLNVFTPQKSLE----EFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC--- 138

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
                  +++LH      I+H DLKPSN+++ ++    + DFGL+R     S   T    
Sbjct: 139 ------GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMT---- 184

Query: 734 VKGSIGYV------APEYGALGEVSTHGDEYSFGILMLEMFTGK 771
                 YV      APE         + D +S G +M EM  G 
Sbjct: 185 -----PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 71.4 bits (176), Expect = 2e-13
 Identities = 67/253 (26%), Positives = 104/253 (41%), Gaps = 69/253 (27%)

Query: 553 ELLKATEGFSSANLIGIGGYGYVY---KGILGTEETNVAVKVLDLQQRGASKSFI----- 604
           ELLK         ++G G +G V+   K          A+KVL        K+ +     
Sbjct: 27  ELLK---------VLGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDR 70

Query: 605 ----AECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE---D 657
                E + L  + H  +VK+     +  T G  +  L+ +F+  G L   L  KE    
Sbjct: 71  VRTKMERDILVEVNHPFIVKLH---YAFQTEGKLY--LILDFLRGGDLFTRL-SKEVMFT 124

Query: 658 EQNQRPKLNLMQRLSIA-IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GD 714
           E+          +  +A + +A  L++LH      I++ DLKP N+LLD E   H+   D
Sbjct: 125 EE--------DVKFYLAELALA--LDHLHSL---GIIYRDLKPENILLDEE--GHIKLTD 169

Query: 715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGK 771
           FGLS+    +   +       G++ Y+APE   +     H    D +SFG+LM EM TG 
Sbjct: 170 FGLSKE---SIDHEKKAYSFCGTVEYMAPE---VVNRRGHTQSADWWSFGVLMFEMLTGT 223

Query: 772 RP-----TDDMFE 779
            P       +   
Sbjct: 224 LPFQGKDRKETMT 236

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 44/250 (17%), Positives = 79/250 (31%), Gaps = 54/250 (21%)

Query: 274 LQVLSLFGNKISGE----IPSSLGNLIFLTEVDLQGNSIR----------GSIPSALGNC 319
           ++ + L GN I  E    +  ++ +   L   +                   +  AL  C
Sbjct: 34  VKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKC 93

Query: 320 LQLQKLDLSDNNLSGTIPREVIGLSSFVL-------LDLSRNHLS-------------GP 359
            +L  + LSDN      P     L  F+        L L  N L                
Sbjct: 94  PKLHTVRLSDNAFG---PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELA 150

Query: 360 IPLEVGRLKGIQQLDLSENKLSGE----IPTSLASCVGLEYLNFSDNSF-----QGPIHS 410
           +  +      ++ +    N+L          +  S   L  +    N       +  +  
Sbjct: 151 VNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLE 210

Query: 411 GFSSLKGLQDLDLSRNNFSGK----IPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVR 466
           G +  + L+ LDL  N F+      + + L ++  L++L L+   L     + G    V 
Sbjct: 211 GLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS----ARGAAAVVD 266

Query: 467 AVSIIGNNKL 476
           A S + N  L
Sbjct: 267 AFSKLENIGL 276

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 68.6 bits (168), Expect = 3e-12
 Identities = 48/300 (16%), Positives = 91/300 (30%), Gaps = 58/300 (19%)

Query: 158 ASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPN 217
             S+   L +  ++  +  + N +GT     L   +++ +   LE+   S      V   
Sbjct: 21  EKSVFAVLLEDDSVKEIVLSGNTIGTEAARWL--SENIASKKDLEIAEFSDIFTGRVKDE 78

Query: 218 SIANFSS---------HLIYLYMSANRISGTIPTGVG----------NLKNLIL------ 252
                            L  + +S N      PT              L++L L      
Sbjct: 79  IPEALRLLLQALLKCPKLHTVRLSDNAFG---PTAQEPLIDFLSKHTPLEHLYLHNNGLG 135

Query: 253 ----IAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE----IPSSLGNLIFLTEVDLQ 304
                 +   L   ++         L+ +    N++          +  +   L  V + 
Sbjct: 136 PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMV 195

Query: 305 GNSIR-----GSIPSALGNCLQLQKLDLSDNNLSGT----IPREVIGLSSFVLLDLSRNH 355
            N IR       +   L  C +L+ LDL DN  +      +   +    +   L L+   
Sbjct: 196 QNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL 255

Query: 356 LSGP------IPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVG-----LEYLNFSDNSF 404
           LS                 G+Q L L  N++  +   +L + +      L +L  + N F
Sbjct: 256 LSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 24/197 (12%), Positives = 57/197 (28%), Gaps = 39/197 (19%)

Query: 298 LTEVDLQGNSIRG----SIPSALGNCLQLQKLDLSDNNLSGT----IPREVIGLSSFVLL 349
           +    L+ ++I      S+ + L     ++++ LS N +       +   +       + 
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 350 DLSRNHLSGPIPLEVGRLKGI----------QQLDLSENKLSGE----IPTSLASCVGLE 395
           + S              L+ +            + LS+N         +   L+    LE
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125

Query: 396 YLNFSDNSF-------------QGPIHSGFSSLKGLQDLDLSRNNFSGK----IPMFLNT 438
           +L   +N               +  ++    +   L+ +   RN               +
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185

Query: 439 FRFLQKLNLSFNNLEGE 455
            R L  + +  N +  E
Sbjct: 186 HRLLHTVKMVQNGIRPE 202

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 42.0 bits (99), Expect = 6e-04
 Identities = 52/353 (14%), Positives = 104/353 (29%), Gaps = 90/353 (25%)

Query: 8   ANITHCSELRILDLVVNKLEGNIPSELGNLFK-------LVGLGLTGNNYTG----SIPQ 56
           A+          D+   +++  IP  L  L +       L  + L+ N +       +  
Sbjct: 57  ASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLID 116

Query: 57  SLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFA 116
            LS  + L+ L L  N L                   +   +  +               
Sbjct: 117 FLSKHTPLEHLYLHNNGLG----------------PQAGAKIARA--------------- 145

Query: 117 VTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISN--ASSIPEDLGKLKNLIRL 174
                L     +      P +R ++ G N         + N       +     + L  +
Sbjct: 146 -----LQELAVNKKAKNAPPLRSIICGRN--------RLENGSMKEWAKTFQSHRLLHTV 192

Query: 175 NFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIAN---FSSHLIYLYM 231
              +N +   +G +   L+ L  C  L+V+ L  N+ + +  +++A       +L  L +
Sbjct: 193 KMVQNGIRP-EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 251

Query: 232 SANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSS 291
           +   +S     G   + +                 S    + LQ L L  N+I  +   +
Sbjct: 252 NDCLLS---ARGAAAVVDAF---------------SKLENIGLQTLRLQYNEIELDAVRT 293

Query: 292 LG-----NLIFLTEVDLQGNSIR------GSIPSALGNCLQLQKLDLSDNNLS 333
           L       +  L  ++L GN           I        + +  +L D    
Sbjct: 294 LKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEEL 346

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 71.2 bits (175), Expect = 3e-13
 Identities = 50/237 (21%), Positives = 90/237 (37%), Gaps = 49/237 (20%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFI----------AECEAL 610
           F     +G G +G V          + A+K+L        K  +           E   L
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKRIL 95

Query: 611 RSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQR 670
           +++    LVK+  S        N +  +V E++  G + + L +         +      
Sbjct: 96  QAVNFPFLVKLEFSFK---DNSNLY--MVMEYVAGGEMFSHLRRIGRFSEPHARF----- 145

Query: 671 LSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTS 730
              A  +    EYLH      +++ DLKP N+L+D +    V DFG ++ +      +T 
Sbjct: 146 --YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTW 196

Query: 731 TSRVKGSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP-----TDDMFE 779
           T  + G+   +APE   +     +    D ++ G+L+ EM  G  P        ++E
Sbjct: 197 T--LCGTPEALAPE---IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 31/225 (13%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKII 622
           L+G G +G V            A+K+L    +  +      + E   L++ RH  L  + 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
               S  T        V E+   G L   L        +R       R   A ++ + L+
Sbjct: 215 ---YSFQTHDRLC--FVMEYANGGELFFHL------SRERVFSEDRARFYGA-EIVSALD 262

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           YLH     ++V+ DLK  N++LD +    + DFGL +   +   D  +     G+  Y+A
Sbjct: 263 YLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLA 317

Query: 743 PEYGALGEVSTHG---DEYSFGILMLEMFTGKRP-----TDDMFE 779
           PE   + E + +G   D +  G++M EM  G+ P      + +FE
Sbjct: 318 PE---VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 70.4 bits (173), Expect = 4e-13
 Identities = 42/190 (22%), Positives = 79/190 (41%), Gaps = 33/190 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIA------ECEALRSIRHRNLVK 620
           +G G +  V K    +     A K +  ++  +S+  ++      E   L+ I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI--DVA 678
           +       + + +    L+ E +  G L ++L +KE         +L +  +      + 
Sbjct: 79  LH---EVYENKTDVI--LILELVAGGELFDFLAEKE---------SLTEEEATEFLKQIL 124

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH----VGDFGLSRLLHDNSPDQTSTSRV 734
           N + YLH      I H DLKP N++L +  V      + DFGL+  +          +  
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIF 178

Query: 735 KGSIGYVAPE 744
            G+  +VAPE
Sbjct: 179 -GTPEFVAPE 187

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 54/233 (23%), Positives = 92/233 (39%), Gaps = 42/233 (18%)

Query: 558 TEGFSSANLIGIGGYGYVYKGI-LGTEETNVAVKVLDLQQRGAS---KSFIAECEALRSI 613
            + FS    IG G +G VY    +   E  VA+K +    + ++   +  I E   L+ +
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111

Query: 614 RHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
           RH N ++          R +    LV E+    +         D      K   +Q + I
Sbjct: 112 RHPNTIQYRGCY----LREHTA-WLVMEYCLGSAS--------DLLEVHKKP--LQEVEI 156

Query: 674 AIDVANV---LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTS 730
           A         L YLH H   +++H D+K  N+LL    +  +GDFG + ++         
Sbjct: 157 AAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM--------- 204

Query: 731 TSRVKGSIG---YVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRPTDDM 777
            +     +G   ++APE     +   +    D +S GI  +E+   K P  +M
Sbjct: 205 -APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 68.7 bits (169), Expect = 1e-12
 Identities = 61/242 (25%), Positives = 98/242 (40%), Gaps = 59/242 (24%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETN---VAVKVLDLQQRGASKSFI----------AEC 607
           F     +G G +G V+   L     N    A+KVL        K  +           E 
Sbjct: 8   FQILRTLGTGSFGRVH---LIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDER 57

Query: 608 EALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNL 667
             L  + H  ++++  +          F  ++ +++  G L + L      +  +   N 
Sbjct: 58  LMLSIVTHPFIIRMWGTFQ---DAQQIF--MIMDYIEGGELFSLL------RKSQRFPNP 106

Query: 668 MQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRLLHDNS 725
           + +   A +V   LEYLH      I++ DLKP N+LLD     H+   DFG ++ +    
Sbjct: 107 VAKFYAA-EVCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFGFAKYV---- 156

Query: 726 PDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP-----TDDM 777
           PD T T  + G+  Y+APE   +     +    D +SFGIL+ EM  G  P     T   
Sbjct: 157 PDVTYT--LCGTPDYIAPE---VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211

Query: 778 FE 779
           +E
Sbjct: 212 YE 213

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 35/113 (30%), Positives = 53/113 (46%), Gaps = 22/113 (19%)

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGSI 738
           LE+LH      I++ D+K  N+LLD+    HV   DFGLS+    +  ++       G+I
Sbjct: 172 LEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYD--FCGTI 224

Query: 739 GYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP---------TDDMFE 779
            Y+AP+    G  S H    D +S G+LM E+ TG  P           ++  
Sbjct: 225 EYMAPDI-VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 38/188 (20%), Positives = 75/188 (39%), Gaps = 34/188 (18%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEA---LRSIRHRNLVKIIT 623
           +G+G  G V +      +   A+K+L            A  E     R+ +  ++V+I+ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ-NQRPKLNLMQRLSIAIDVANVLE 682
              ++         +V E +  G L + +  + D+   +R    +M+       +   ++
Sbjct: 123 VYENLYAGRKCL-LIVMECLDGGELFSRIQDRGDQAFTEREASEIMK------SIGEAIQ 175

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNE------MVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
           YLH     +I H D+KP N+L  ++       +    DFG ++    ++   T       
Sbjct: 176 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLT---DFGFAKETTSHNSLTT----PCY 225

Query: 737 SIGYVAPE 744
           +  YVAPE
Sbjct: 226 TPYYVAPE 233

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 68.3 bits (168), Expect = 2e-12
 Identities = 68/248 (27%), Positives = 105/248 (42%), Gaps = 57/248 (22%)

Query: 553 ELLKATEGFSSANLIGIGGYGYVY---KGILGTEETNVAVKVLD----LQQRGASKSFIA 605
           ELL+         ++G GGYG V+   K          A+KVL     ++    +    A
Sbjct: 20  ELLR---------VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 70

Query: 606 ECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE---DEQNQR 662
           E   L  ++H  +V +I    +  T G  +  L+ E++  G L   L ++E    E    
Sbjct: 71  ERNILEEVKHPFIVDLI---YAFQTGGKLY--LILEYLSGGELFMQL-EREGIFMED--- 121

Query: 663 PKLNLMQRLSIA-IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSR 719
                     +A I +A  L +LH      I++ DLKP N++L+++   HV   DFGL +
Sbjct: 122 -----TACFYLAEISMA--LGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCK 169

Query: 720 LLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP--- 773
               +  D T T    G+I Y+APE   +   S H    D +S G LM +M TG  P   
Sbjct: 170 E---SIHDGTVTHTFCGTIEYMAPE---ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223

Query: 774 --TDDMFE 779
                  +
Sbjct: 224 ENRKKTID 231

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 67.6 bits (166), Expect = 3e-12
 Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 42/230 (18%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVL---DLQQRGASKSFIAECEALRSIRHRNLVKII 622
           L+G G +G V            A+K+L    +  +      + E   L++ RH  L  + 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE---DEQNQRPKLNLMQRLSIAIDVAN 679
               +  T        V E+   G L   L  +E    E+          R   A ++ +
Sbjct: 72  ---YAFQTHDRLC--FVMEYANGGELFFHL-SRERVFTEE--------RARFYGA-EIVS 116

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGS 737
            LEYLH      +V+ D+K  N++LD +   H+   DFGL +   +   D  +     G+
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK---EGISDGATMKTFCGT 168

Query: 738 IGYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP-----TDDMFE 779
             Y+APE   + E + +G   D +  G++M EM  G+ P      + +FE
Sbjct: 169 PEYLAPE---VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 39/136 (28%), Positives = 67/136 (49%), Gaps = 12/136 (8%)

Query: 299 TEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLS 357
           TE+ L+ N+I+   P A     +L+++DLS+N +S  +  +   GL S   L L  N ++
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93

Query: 358 GPIPLEV-GRLKGIQQLDLSENKLSGEIPT----SLASCVGLEYLNFSDNSFQGPIHSGF 412
             +P  +   L  +Q L L+ NK++  +       L +   L  L+  DN  Q      F
Sbjct: 94  E-LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHN---LNLLSLYDNKLQTIAKGTF 148

Query: 413 SSLKGLQDLDLSRNNF 428
           S L+ +Q + L++N F
Sbjct: 149 SPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 29/131 (22%), Positives = 57/131 (43%), Gaps = 5/131 (3%)

Query: 202 EVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEVNLL 260
             + L  N++  + P + + +   L  + +S N+IS  +       L++L  + +  N +
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKK-LRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92

Query: 261 TGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNC 319
           T  +P S+   L  LQ+L L  NKI+     +  +L  L  + L  N ++          
Sbjct: 93  T-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151

Query: 320 LQLQKLDLSDN 330
             +Q + L+ N
Sbjct: 152 RAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 23/112 (20%), Positives = 49/112 (43%), Gaps = 12/112 (10%)

Query: 371 QQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSG-FSSLKGLQDLDLSRNNFS 429
            ++ L +N +    P + +    L  ++ S+N     +    F  L+ L  L L  N  +
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKIT 93

Query: 430 GKIPMFLNTFR---FLQKLNLSFNNLEGEVPSEGVFKNVRAVSI--IGNNKL 476
            ++P   + F     LQ L L+ N +   +     F+++  +++  + +NKL
Sbjct: 94  -ELPK--SLFEGLFSLQLLLLNANKIN-CLR-VDAFQDLHNLNLLSLYDNKL 140

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 47.3 bits (113), Expect = 6e-06
 Identities = 24/117 (20%), Positives = 43/117 (36%), Gaps = 8/117 (6%)

Query: 192 LDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNL 250
                    +    LS+N +S  L          L  L +  N+I+  +P  +   L +L
Sbjct: 52  FSPYKKLRRI---DLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSL 106

Query: 251 ILIAMEVNLLTGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGN 306
            L+ +  N +   +       L  L +LSL+ NK+      +   L  +  + L  N
Sbjct: 107 QLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 31/147 (21%), Positives = 59/147 (40%), Gaps = 15/147 (10%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQ-SLSNLSF 63
           EIP N+     +  + L  N ++   P       KL  + L+ N  +  +   +   L  
Sbjct: 25  EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81

Query: 64  LQQLSLSENSLSGNIPSE----LGLLKQLNMFQVSANYLTGSIPIQLF-NISSMDYFAVT 118
           L  L L  N ++  +P      L  L+ L +   +AN +   + +  F ++ +++  ++ 
Sbjct: 82  LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLL---NANKIN-CLRVDAFQDLHNLNLLSLY 136

Query: 119 QNKLVGEIPHYVGFTLPNIRVLLLGSN 145
            NKL   I       L  I+ + L  N
Sbjct: 137 DNKL-QTIAKGTFSPLRAIQTMHLAQN 162

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 66.6 bits (163), Expect = 9e-12
 Identities = 61/228 (26%), Positives = 93/228 (40%), Gaps = 43/228 (18%)

Query: 558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLD--LQQRGASKSFIAECEALRSIRH 615
            + + S   +G G YG V   I       VA+K L    Q    +K    E   L+ ++H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 616 RNLVK---IITSCSSIDTRGNEFKA--LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQR 670
            N++    + T  SS+      F    LV  FM    L+  +  K  E+  + +  + Q 
Sbjct: 83  ENVIGLLDVFTPASSLR----NFYDFYLVMPFMQT-DLQKIMGLKFSEE--KIQYLVYQM 135

Query: 671 LSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTS 730
           L         L+Y+H      +VH DLKP N+ ++ +    + DFGL+R       + T 
Sbjct: 136 L-------KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMT- 181

Query: 731 TSRVKGSIGYV------APE-YGALGEVSTHGDEYSFGILMLEMFTGK 771
                   GYV      APE   +    +   D +S G +M EM TGK
Sbjct: 182 --------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 66.7 bits (163), Expect = 9e-12
 Identities = 45/241 (18%), Positives = 85/241 (35%), Gaps = 52/241 (21%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVK-VLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
           +G G +G V +          A+K VL   +         E + ++ + H N++K++   
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-----NRELDIMKVLDHVNIIKLVDYF 69

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPK----LNL--------MQRLSI 673
            +      +      +    G   N +N         P     LN+        + ++  
Sbjct: 70  YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129

Query: 674 AIDVAN-VLEYLHH------------HCHTS-IVHCDLKPSNVLLD-NEMVAHVGDFGLS 718
           +   +   +                   H+  I H D+KP N+L++  +    + DFG +
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSA 189

Query: 719 RLLHDNSPDQTSTSRVKGSIGYV------APE--YGALGEVSTHGDEYSFGILMLEMFTG 770
           + L    P + S +       Y+      APE   GA  E +   D +S G +  E+  G
Sbjct: 190 KKL---IPSEPSVA-------YICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGELILG 238

Query: 771 K 771
           K
Sbjct: 239 K 239

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 66.5 bits (163), Expect = 9e-12
 Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 27/112 (24%)

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGSI 738
           L YLH     +IV+ DLKP N+LLD++   H+   DFGL +   +N    ++TS   G+ 
Sbjct: 152 LGYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCK---ENIEHNSTTSTFCGTP 203

Query: 739 GYVAPE------YGALGEVSTHGDEYSFGILMLEMFTGKRP-----TDDMFE 779
            Y+APE      Y     V    D +  G ++ EM  G  P     T +M++
Sbjct: 204 EYLAPEVLHKQPYDR--TV----DWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 66.1 bits (162), Expect = 1e-11
 Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 21/109 (19%)

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGSI 738
           L +L       I++ DLK  NV+LD+E   H+   DFG+ +   +N  D  +T    G+ 
Sbjct: 134 LFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK---ENIWDGVTTKTFCGTP 185

Query: 739 GYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP-----TDDMFE 779
            Y+APE   +     +G   D ++FG+L+ EM  G+ P      D++F+
Sbjct: 186 DYIAPE---IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 67.0 bits (163), Expect = 2e-11
 Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 21/109 (19%)

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGSI 738
           L +L       I++ DLK  NV+LD+E   H+   DFG+ +   +N  D  +T    G+ 
Sbjct: 455 LFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK---ENIWDGVTTKTFCGTP 506

Query: 739 GYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP-----TDDMFE 779
            Y+APE   +     +G   D ++FG+L+ EM  G+ P      D++F+
Sbjct: 507 DYIAPE---IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 51/258 (19%), Positives = 97/258 (37%), Gaps = 50/258 (19%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR--------HRN 617
            +G G +  V+        T+VA+K++   +     +   E + L+ +            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED-EIKLLQRVNDADNTKEDSMG 84

Query: 618 LVKIITSCSSIDTRGNEFK--ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI 675
              I+      + +G       +V+E +   +L   + +       R  + L+    I+ 
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKK----YEHRG-IPLIYVKQISK 138

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH------VGDFGLSRLLHDNSPDQT 729
            +   L+Y+H  C   I+H D+KP NVL++            + D G +    ++  +  
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196

Query: 730 STSRVKGSIGYVAPE------YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLS 783
             +R      Y +PE      +G         D +S   L+ E+ TG      +F E   
Sbjct: 197 Q-TRE-----YRSPEVLLGAPWG------CGADIWSTACLIFELITGDF----LF-EPDE 239

Query: 784 LHKYAKMGLPDQVAEIID 801
            H Y K    D +A+II+
Sbjct: 240 GHSYTKDD--DHIAQIIE 255

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 18/171 (10%)

Query: 264 IPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCL-QL 322
           IP         + L L    ++    ++   L  LT ++L  N ++ ++ + + + L +L
Sbjct: 33  IPADT------EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85

Query: 323 QKLDLSDNNLSGTIPREV-IGLSSFVLLDLSRNHLSGPIPLEVG---RLKGIQQLDLSEN 378
             L L++N L+ ++P  V   L+    L L  N L     L  G   RL  +++L L+ N
Sbjct: 86  GTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS---LPSGVFDRLTKLKELRLNTN 141

Query: 379 KLSGEIPTSL-ASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNF 428
           +L   IP         L+ L+ S N  Q   H  F  L  LQ + L  N F
Sbjct: 142 QLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 41.2 bits (97), Expect = 7e-04
 Identities = 27/94 (28%), Positives = 40/94 (42%), Gaps = 6/94 (6%)

Query: 371 QQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSG 430
           ++LDL    L+     +      L +LN   N  Q      F  L  L  L L+ N  + 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96

Query: 431 KIP--MFLNTFRFLQKLNLSFNNLEGEVPSEGVF 462
            +P  +F +  + L KL L  N L+  +P  GVF
Sbjct: 97  SLPLGVFDHLTQ-LDKLYLGGNQLK-SLP-SGVF 127

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 33/109 (30%), Positives = 54/109 (49%), Gaps = 21/109 (19%)

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGSI 738
           L++LH      IV+ DLK  N+LLD +   H+   DFG+ +   +N      T+   G+ 
Sbjct: 131 LQFLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCK---ENMLGDAKTNTFCGTP 182

Query: 739 GYVAPEYGALGEVSTHG---DEYSFGILMLEMFTGKRP-----TDDMFE 779
            Y+APE   +     +    D +SFG+L+ EM  G+ P      +++F 
Sbjct: 183 DYIAPE---ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 66.8 bits (162), Expect = 3e-11
 Identities = 77/478 (16%), Positives = 137/478 (28%), Gaps = 147/478 (30%)

Query: 47  GN-NYTGSIPQSLSNLSF-LQQLSLSENSLSGNIPSELGLLKQ-LNMFQVSANY---L-- 98
            N N   ++ + L  L + +     S +  S NI   +  ++  L     S  Y   L  
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249

Query: 99  -----TGSIPIQLFNISS-----------MDYFAVTQNKLVGEIPHYVGFTLPNIRVLLL 142
                        FN+S             D+ +      +    H +  T   ++ LL 
Sbjct: 250 LLNVQNAKA-WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL- 307

Query: 143 GSNWF---TGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNC- 198
              +      ++P  +   +  P  L  +   IR   A  +          +    VNC 
Sbjct: 308 -LKYLDCRPQDLPREVLTTN--PRRLSIIAESIRDGLATWD---------NWKH--VNCD 353

Query: 199 TFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVN 258
               ++  S N L    P            ++                   L +     +
Sbjct: 354 KLTTIIESSLNVLE---PAEYRK-------MF-----------------DRLSVFPPSAH 386

Query: 259 LLTGSIPTSVGYLLKLQVLSLF-GNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALG 317
                IPT         +LSL   + I  ++   +  L   + V+ Q      SIPS   
Sbjct: 387 -----IPT--------ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS--- 430

Query: 318 NCLQLQKLDLSDNNLSGTIPREVIG----LSSFVLLDLSRNHLSGPIPLEVGR-LKGIQQ 372
             + L+     +N  +  + R ++       +F   DL   +L       +G  LK I+ 
Sbjct: 431 --IYLELKVKLENEYA--LHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEH 486

Query: 373 LDLSE--NKLSGEIPTSLASCVGLEYLNFSDNSF-QGPI-HSGF------SSLKGLQDLD 422
            +       +               +L+F    F +  I H         S L  LQ L 
Sbjct: 487 PERMTLFRMV---------------FLDF---RFLEQKIRHDSTAWNASGSILNTLQQLK 528

Query: 423 LSRNNFSGKIPMF---LNTF-RFLQK-------------LNLSFNNLEGEVPSEGVFK 463
             +       P +   +N    FL K             L ++          E +F+
Sbjct: 529 FYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMA-----EDEAIFE 581

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.6 bits (133), Expect = 7e-08
 Identities = 89/635 (14%), Positives = 186/635 (29%), Gaps = 173/635 (27%)

Query: 84  LLKQLNMFQV------SANY--LTGSIPIQLFNISSMDY--FAVTQNKLVGEIPHYVGFT 133
           L KQ  M Q         NY  L   I  +     SM    +   +++L  +   +  + 
Sbjct: 72  LSKQEEMVQKFVEEVLRINYKFLMSPIKTE-QRQPSMMTRMYIEQRDRLYNDNQVFAKYN 130

Query: 134 LPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKN-LIRLNFARN-----NLGTGK-- 185
           +   R                        +   KL+  L+ L  A+N      LG+GK  
Sbjct: 131 VS--R-----------------------LQPYLKLRQALLELRPAKNVLIDGVLGSGKTW 165

Query: 186 --GNDLRFLDSLVNCTF-LEV--VSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTI 240
              +        V C    ++  ++L + +    +   +      +   + S +  S  I
Sbjct: 166 VALDVCL--SYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223

Query: 241 PTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKL------QVLSLFGN--KI-----SGE 287
              + +++  +   ++              LL L      +  + F    KI       +
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENC-------LLVLLNVQNAKAWNAFNLSCKILLTTRFKQ 276

Query: 288 IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV 347
           +   L      T + L  +S+  +        L L+ LD    +L    PREV+  +   
Sbjct: 277 VTDFLSAATT-THISLDHHSMTLTPDEVKS--LLLKYLDCRPQDL----PREVLTTNPRR 329

Query: 348 LL---DLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSF 404
           L    +  R+ L+             + ++   +KL+  I +SL        L  ++   
Sbjct: 330 LSIIAESIRDGLA--------TWDNWKHVNC--DKLTTIIESSL------NVLEPAE--- 370

Query: 405 QGPIHSGFSSLKGL-QDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFK 463
                      + +   L +   +    IP           L+L + ++        V K
Sbjct: 371 ----------YRKMFDRLSVFPPSA--HIPT--------ILLSLIWFDVIKSDVMVVVNK 410

Query: 464 NVRAVSIIGNNKLCGGSPELHLHS------CRSRGSRKLWQHSTFKIVISAVLLPCLLST 517
             +   +    K       + + S       +      L  H   + ++           
Sbjct: 411 LHKYSLVEKQPK----ESTISIPSIYLELKVKLENEYAL--H---RSIVDH--------- 452

Query: 518 CFIVFVFYQRRKRRRRSKALVNSSIEDKYL--KISY----AELLKATEGFSSANLIGIGG 571
                  Y   K       +      D+Y    I +     E  +    F    L     
Sbjct: 453 -------YNIPKTFDSDDLIPPY--LDQYFYSHIGHHLKNIEHPERMTLFRMVFL----D 499

Query: 572 YGYV-YKGILGTEETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSCSSID 629
           + ++  K    +   N +  +L+ LQQ    K +I + +         ++  +       
Sbjct: 500 FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENL 559

Query: 630 TRGNEFKALV-YEFM-PNGSLENWLNQKEDEQNQR 662
               ++  L+    M  + ++     +   +Q QR
Sbjct: 560 ICS-KYTDLLRIALMAEDEAI---FEEAH-KQVQR 589

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.6 bits (120), Expect = 2e-06
 Identities = 71/528 (13%), Positives = 131/528 (24%), Gaps = 192/528 (36%)

Query: 271 LLKLQV---LSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSA-----LGNC--- 319
           LL+L+    + + G   SG+  + +       +V      ++  +        L NC   
Sbjct: 144 LLELRPAKNVLIDGVLGSGK--TWVAL-----DV-CLSYKVQCKMDFKIFWLNLKNCNSP 195

Query: 320 -LQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEV----GRLKGIQQLD 374
              L+ L      L   I               SR+  S  I L +      L+ + +  
Sbjct: 196 ETVLEML----QKLLYQIDPN----------WTSRSDHSSNIKLRIHSIQAELRRLLKSK 241

Query: 375 LSENKL-------SGEIPTSLASCVGLEYLNFS--------DNS---FQGPIHSGFSSL- 415
             EN L       + +              N S              F     +   SL 
Sbjct: 242 PYENCLLVLLNVQNAKA---------WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLD 292

Query: 416 ---KGL---QDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVS 469
                L   +   L                  L+ L+    +L    P E +  N R +S
Sbjct: 293 HHSMTLTPDEVKSL-----------------LLKYLDCRPQDL----PREVLTTNPRRLS 331

Query: 470 IIGNNKLCGGSPELHLHSCRSRGSRKLWQH---STFKIVISA---VLLPCLLSTCFIVF- 522
           II           +             W+H        +I +   VL P      F    
Sbjct: 332 IIAE--------SIRDGLATW----DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLS 379

Query: 523 VFYQRRKRRRRSKALVNSSIEDKYLKI-----SYAELLKATEGFSSANLIGIGGYGYVYK 577
           VF              ++ I    L +       ++++         +L+          
Sbjct: 380 VF---PP---------SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI- 426

Query: 578 GILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVK--IITSCSSIDTRGNE- 634
                        +  +           + E   ++ HR++V    I      D      
Sbjct: 427 ------------SIPSIYLE-----LKVKLENEYAL-HRSIVDHYNIPKTFDSDDLIPPY 468

Query: 635 -----FKALVY-----------EFMPNGSLE-NWLNQK-----EDEQNQRPKLNLMQRL- 671
                +  + +                  L+  +L QK              LN +Q+L 
Sbjct: 469 LDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLK 528

Query: 672 --------------SIAIDVANVL----EYLHHHCHTSIVHCDLKPSN 701
                          +   + + L    E L    +T ++   L   +
Sbjct: 529 FYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAED 576

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 65.6 bits (160), Expect = 3e-11
 Identities = 59/236 (25%), Positives = 94/236 (39%), Gaps = 58/236 (24%)

Query: 558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR--- 614
            + + +   IG G  G V        + NVA+K L       S+ F  +  A R+ R   
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELV 113

Query: 615 ------HRNLVK---IITSCSSIDTRGNEFKA--LVYEFMPNGSLENWLNQ--KEDEQNQ 661
                 H+N++    + T   +++    EF+   LV E M     +  L Q  + +  ++
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLE----EFQDVYLVMELM-----DANLCQVIQMELDHE 164

Query: 662 RPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL 721
           R    L Q L         +++LH      I+H DLKPSN+++ ++    + DFGL+R  
Sbjct: 165 RMSYLLYQML-------CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214

Query: 722 HDNSPDQTSTSRVKGSIGYV------APEYGALGEVSTHGDEYSFGILMLEMFTGK 771
              S   T          YV      APE         + D +S G +M EM   K
Sbjct: 215 -GTSFMMT---------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 64.6 bits (158), Expect = 4e-11
 Identities = 37/112 (33%), Positives = 54/112 (48%), Gaps = 27/112 (24%)

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGSI 738
           L +LH      I++ DLK  NVLLD+E   H    DFG+ +   +   +  +T+   G+ 
Sbjct: 137 LMFLHDK---GIIYRDLKLDNVLLDHE--GHCKLADFGMCK---EGICNGVTTATFCGTP 188

Query: 739 GYVAPE------YGALGEVSTHGDEYSFGILMLEMFTGKRP-----TDDMFE 779
            Y+APE      YG    V    D ++ G+L+ EM  G  P      DD+FE
Sbjct: 189 DYIAPEILQEMLYGP--AV----DWWAMGVLLYEMLCGHAPFEAENEDDLFE 234

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 41/225 (18%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKII---- 622
           +G GG G V+  +    +  VA+K + L    + K  + E + +R + H N+VK+     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78

Query: 623 ---TSCSSIDTRGNEFKA--LVYEFMPNGSLENWLNQ---KEDEQNQRPKLNLMQRLSIA 674
              +  +       E  +  +V E+M     E  L     +     +  +L + Q L   
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLFMYQLL--- 130

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE-MVAHVGDFGLSRLLHDNSPDQTSTSR 733
                 L+Y+H     +++H DLKP+N+ ++ E +V  +GDFGL+R++  +   +   S 
Sbjct: 131 ----RGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS- 182

Query: 734 VKGSIGYV------APE-YGALGEVSTHGDEYSFGILMLEMFTGK 771
                  +      +P    +    +   D ++ G +  EM TGK
Sbjct: 183 -----EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 64.0 bits (156), Expect = 8e-11
 Identities = 59/260 (22%), Positives = 105/260 (40%), Gaps = 33/260 (12%)

Query: 523 VFYQRRKRRRRSKALVNSSI--EDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGIL 580
           +++Q     ++ + + N     ++    +   E     + +   +LIG G +G V K   
Sbjct: 18  LYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKW--MDRYEIDSLIGKGSFGQVVKAYD 75

Query: 581 GTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHR---NLVKIITSCSSIDTRGNEFKA 637
             E+  VA+K++  ++   +++ I E   L  +          I+        R +    
Sbjct: 76  RVEQEWVAIKIIKNKKAFLNQAQI-EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC-- 132

Query: 638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL 697
           LV+E + + +L + L            ++L      A  +   L +L      SI+HCDL
Sbjct: 133 LVFEML-SYNLYDLL-----RNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDL 185

Query: 698 KPSNVLLDNEMVAH--VGDFGLSRLLHDNSPDQTST---SRVKGSIGYVAPEYGALG-EV 751
           KP N+LL N   +   + DFG S  L      +      SR      Y +PE   LG   
Sbjct: 186 KPENILLCNPKRSAIKIVDFGSSCQLG----QRIYQYIQSRF-----YRSPEV-LLGMPY 235

Query: 752 STHGDEYSFGILMLEMFTGK 771
               D +S G +++EM TG+
Sbjct: 236 DLAIDMWSLGCILVEMHTGE 255

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 31/137 (22%), Positives = 57/137 (41%), Gaps = 13/137 (9%)

Query: 299 TEVDLQGNSIRGSIPSALGNCL-QLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHL 356
            E+ L  N       + +   L QL+K++ S+N ++  I      G S    + L+ N L
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93

Query: 357 SGPIPLEV-GRLKGIQQLDLSENKLSGEIP----TSLASCVGLEYLNFSDNSFQGPIHSG 411
              +  ++   L+ ++ L L  N+++  +       L+S   +  L+  DN         
Sbjct: 94  EN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSS---VRLLSLYDNQITTVAPGA 148

Query: 412 FSSLKGLQDLDLSRNNF 428
           F +L  L  L+L  N F
Sbjct: 149 FDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 28/132 (21%), Positives = 49/132 (37%), Gaps = 6/132 (4%)

Query: 202 EVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEVNLL 260
             + L++N  + +    I      L  +  S N+I+  I  G       +  I +  N L
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93

Query: 261 TGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIP-SALGN 318
             ++   +   L  L+ L L  N+I+     S   L  +  + L  N I  ++   A   
Sbjct: 94  E-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDT 151

Query: 319 CLQLQKLDLSDN 330
              L  L+L  N
Sbjct: 152 LHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 32/145 (22%), Positives = 55/145 (37%), Gaps = 11/145 (7%)

Query: 239 TIPTGV-GNLKNLILIAMEVNLLTGSIPTSV-GYLLKLQVLSLFGNKISGEIPSSLGNLI 296
            IP  +      L L     N  T    T +   L +L+ ++   NKI+     +     
Sbjct: 25  KIPEHIPQYTAELRL---NNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGAS 81

Query: 297 FLTEVDLQGNSIRGSIPS-ALGNCLQLQKLDLSDNNLSGTIPREV-IGLSSFVLLDLSRN 354
            + E+ L  N +  ++          L+ L L  N ++  +  +  IGLSS  LL L  N
Sbjct: 82  GVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN 139

Query: 355 HLSGPIPLEV-GRLKGIQQLDLSEN 378
            ++  +       L  +  L+L  N
Sbjct: 140 QIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 24/113 (21%), Positives = 46/113 (40%), Gaps = 13/113 (11%)

Query: 371 QQLDLSENKLSGEIPTSL-ASCVGLEYLNFSDNSFQGPIHSG-FSSLKGLQDLDLSRNNF 428
            +L L+ N+ +    T +      L  +NFS+N     I  G F    G+ ++ L+ N  
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRL 93

Query: 429 SGKIPMFLNTFR---FLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIG--NNKL 476
              +      F+    L+ L L  N +   V     F  + +V ++   +N++
Sbjct: 94  EN-VQ--HKMFKGLESLKTLMLRSNRIT-CVG-NDSFIGLSSVRLLSLYDNQI 141

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 30/147 (20%), Positives = 58/147 (39%), Gaps = 14/147 (9%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPS-ELGNLFKLVGLGLTGNNYTGSIPQSLSNLSF 63
           +IP +I        L L  N+      +     L +L  +  + N  T     +    S 
Sbjct: 25  KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82

Query: 64  LQQLSLSENSLSGNIPSE----LGLLKQLNMFQVSANYLTGSIPIQLF-NISSMDYFAVT 118
           + ++ L+ N L  N+  +    L  LK L +    +N +T  +    F  +SS+   ++ 
Sbjct: 83  VNEILLTSNRLE-NVQHKMFKGLESLKTLML---RSNRIT-CVGNDSFIGLSSVRLLSLY 137

Query: 119 QNKLVGEIPHYVGFTLPNIRVLLLGSN 145
            N++   +      TL ++  L L +N
Sbjct: 138 DNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 51/224 (22%), Positives = 76/224 (33%), Gaps = 41/224 (18%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVK--VLDLQQRGASKSFIAECEALRSIR---------H 615
           I  G YG V  G+  +E   VA+K     +                R +R         H
Sbjct: 30  ISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 616 RNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDE-QNQRPKLNLMQRLSIA 674
            N++ +       +        LV E M    L   ++ +      Q  +  +   L   
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL--- 144

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
                 L  LH      +VH DL P N+LL +     + DF L+R   +++ D   T   
Sbjct: 145 ----LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKT--- 191

Query: 735 KGSIGYV------APEY-GALGEVSTHGDEYSFGILMLEMFTGK 771
                YV      APE        +   D +S G +M EMF  K
Sbjct: 192 ----HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 62.5 bits (152), Expect = 3e-10
 Identities = 42/235 (17%), Positives = 77/235 (32%), Gaps = 28/235 (11%)

Query: 526 QRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEET 585
             +      +   +  I D+Y                  +LIG G YG+V +     E+ 
Sbjct: 35  SSKPTASMPRPHSDWQIPDRYEIR---------------HLIGTGSYGHVCEAYDKLEKR 79

Query: 586 NVAVK--VLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFM 643
            VA+K  +   +     K  + E   L  + H ++VK++      D    +   +V E  
Sbjct: 80  VVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA 139

Query: 644 PNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
            +   +              K  L   L         ++Y+H      I+H DLKP+N L
Sbjct: 140 DS-DFKKLFRTPVYLTELHIKTLLYNLL-------VGVKYVHSA---GILHRDLKPANCL 188

Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEY 758
           ++ +    V DFGL+R +       +               +     +      +
Sbjct: 189 VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH 243

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 52/310 (16%), Positives = 104/310 (33%), Gaps = 61/310 (19%)

Query: 158 ASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLS----G 213
           ++ + E       +  L+ + NNL +    +L    +    + +  ++LS NSL      
Sbjct: 11  SNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPAS-VTSLNLSGNSLGFKNSD 69

Query: 214 VLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLK 273
            L   +A   +++  L +S N +         +   L+     +                
Sbjct: 70  ELVQILAAIPANVTSLNLSGNFL------SYKSSDELVKTLAAIP-------------FT 110

Query: 274 LQVLSLFGNKISGEIPSSLGNLIF-----LTEVDLQGNSIRGSIPSALGNCLQ-----LQ 323
           + VL L  N  S +  S            +T ++L+GN +       L   L      + 
Sbjct: 111 ITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVN 170

Query: 324 KLDLSDNNLSGTIPREVIGLSSFVL--------LDLSRNHLSGPIPLEVGRL-----KGI 370
            L+L  NNL+    +    L+ F+         LDLS N L      E+  +       +
Sbjct: 171 SLNLRGNNLA---SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHV 227

Query: 371 QQLDLSENKLSGE----IPTSLASCVGLEYLNFSDNSFQGP-------IHSGFSSLKGLQ 419
             L+L  N L G     +     S   L+ +    +  +         + + F +++ + 
Sbjct: 228 VSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKII 287

Query: 420 DLDLSRNNFS 429
            +D +     
Sbjct: 288 LVDKNGKEIH 297

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 47/221 (21%), Positives = 69/221 (31%), Gaps = 41/221 (18%)

Query: 273 KLQVLSLFGNKISGEIPSSLG-----NLIFLTEVDLQGNSIRGSIPSALGNCLQ-----L 322
            +  L L  N +       L          +T ++L GNS+       L   L      +
Sbjct: 23  GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82

Query: 323 QKLDLSDNNLSGTIPREVIGLSSFVL--------LDLSRNHLSGPIPLEVGRL-----KG 369
             L+LS N LS    +    L   +         LDL  N  S     E  +        
Sbjct: 83  TSLNLSGNFLS---YKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139

Query: 370 IQQLDLSENKLSGEIPTSLASC-----VGLEYLNFSDNSFQGP----IHSGFSSL-KGLQ 419
           I  L+L  N L  +    L          +  LN   N+        +    +S+   + 
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVT 199

Query: 420 DLDLSRNNFSGK-----IPMFLNTFRFLQKLNLSFNNLEGE 455
            LDLS N    K       +F +    +  LNL  N L G 
Sbjct: 200 SLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 40/350 (11%), Positives = 100/350 (28%), Gaps = 78/350 (22%)

Query: 136 NIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLK-NLIRLNFARNNLGTGKGNDLRFLDS 194
           ++  L L  N    +      N+  + + L  +  N+  LN + N L     ++L    +
Sbjct: 52  SVTSLNLSGNSLGFK------NSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLA 105

Query: 195 LVNCTFLEVVSLSSNSLS--GV--LPNSIANFSSHLIYLYMSANRISGTIPTGVGNL--- 247
            +  T + V+ L  N  S         + +N  + +  L +  N +          L   
Sbjct: 106 AIPFT-ITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG---IKSSDELIQI 161

Query: 248 -----KNLILIAMEVNLLTGSIPTSVGYLLK-----LQVLSLFGNKISGEIPSSLG---- 293
                 N+  + +  N L       +   L      +  L L  N +  +  + L     
Sbjct: 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFS 221

Query: 294 -NLIFLTEVDLQGNSIRGS----IPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVL 348
                +  ++L  N + G     +     +   LQ + L  + +      +   L +   
Sbjct: 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAA-- 279

Query: 349 LDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCV-----GLEYLNFSDNS 403
                             ++ I  +D +  ++       +++ +       +  +  +  
Sbjct: 280 ---------------FPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQC 324

Query: 404 FQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLE 453
                     + K   +++                   L++   +   L 
Sbjct: 325 L-------IFAQKHQTNIEDLNIP------------DELRESIQTCKPLL 355

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 33/159 (20%), Positives = 50/159 (31%), Gaps = 34/159 (21%)

Query: 312 IPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQ 371
           +         +  LDLS NNL        + L        +    S            + 
Sbjct: 14  VEEFTSIPHGVTSLDLSLNNLY---SISTVELIQA----FANTPAS------------VT 54

Query: 372 QLDLSENKLSGEIPTSLAS-----CVGLEYLNFSDNSFQGP----IHSGFSSLK-GLQDL 421
            L+LS N L  +    L          +  LN S N         +    +++   +  L
Sbjct: 55  SLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVL 114

Query: 422 DLSRNNFSGK-----IPMFLNTFRFLQKLNLSFNNLEGE 455
           DL  N+FS K        F N    +  LNL  N+L  +
Sbjct: 115 DLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK 153

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 38/171 (22%), Positives = 67/171 (39%), Gaps = 30/171 (17%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQ--------------QRGASKSFIAECEALR 611
            IG GG+G +Y      +    A  V+ ++              QR A K  I +    +
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 612 SIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG-SLENWLNQKEDEQNQRPKLNLMQR 670
            + +  +          + +G  ++ +V E +  G  L+           Q         
Sbjct: 104 QLDYLGIPLFY-GSGLTEFKGRSYRFMVMERL--GIDLQKIS-------GQNGTFKKSTV 153

Query: 671 LSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD--NEMVAHVGDFGLSR 719
           L + I + +VLEY+H +     VH D+K +N+LL   N    ++ D+GLS 
Sbjct: 154 LQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 26/174 (14%), Positives = 65/174 (37%), Gaps = 35/174 (20%)

Query: 567 IGIGGYGYVYKGI--------LGTEETNVAVKV----------LDLQQRGASKSFIAECE 608
                 G +Y+           G ++   ++K+           +  QR A    + + +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 609 ALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG-SLENWLNQKEDEQNQRPKLNL 667
            L S     +   +          ++++ LV   +  G SL++ L+      + +  L+ 
Sbjct: 110 KLYSTPLLAIPTCMGF----GVHQDKYRFLVLPSL--GRSLQSALDV-----SPKHVLSE 158

Query: 668 MQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL--DNEMVAHVGDFGLSR 719
              L +A  + + LE+LH +     VH ++   N+ +  +++    +  +G + 
Sbjct: 159 RSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 55/243 (22%), Positives = 97/243 (39%), Gaps = 42/243 (17%)

Query: 196 VNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAM 255
           +          S+       P    +  +  I   +    ++    T    L ++  I  
Sbjct: 3   ITV--------STPIKQIF-P---DDAFAETIKANLKKKSVT-DAVTQNE-LNSIDQIIA 48

Query: 256 EVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLG---NLIFLTEVDLQGNSIRGSI 312
             + +  S+   + YL  ++ L+L GNK+       +     L  LT + L GN ++ S+
Sbjct: 49  NNSDIK-SVQ-GIQYLPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQ-SL 100

Query: 313 PSALGNCL-QLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLSGPIPLEVG---RL 367
           P+ + + L  L++L L +N L  ++P  V   L++   L+L+ N L     L  G   +L
Sbjct: 101 PNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQS---LPKGVFDKL 156

Query: 368 KGIQQLDLSENKLSGEIPT----SLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDL 423
             + +LDLS N+L   +P      L     L+ L    N  +      F  L  LQ + L
Sbjct: 157 TNLTELDLSYNQLQ-SLPEGVFDKLTQ---LKDLRLYQNQLKSVPDGVFDRLTSLQYIWL 212

Query: 424 SRN 426
             N
Sbjct: 213 HDN 215

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 61.5 bits (150), Expect = 3e-10
 Identities = 38/102 (37%), Positives = 51/102 (50%), Gaps = 24/102 (23%)

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRL-LHDNSPDQTSTSRVKGS 737
           L YLH      I++ DLK  NVLLD+E   H+   D+G+ +  L     D TST    G+
Sbjct: 123 LNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPG--DTTST--FCGT 173

Query: 738 IGYVAPE------YGALGEVSTHGDEYSFGILMLEMFTGKRP 773
             Y+APE      YG    V    D ++ G+LM EM  G+ P
Sbjct: 174 PNYIAPEILRGEDYGF--SV----DWWALGVLMFEMMAGRSP 209

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 61.5 bits (150), Expect = 3e-10
 Identities = 45/217 (20%), Positives = 93/217 (42%), Gaps = 27/217 (12%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
           +G G YG V           VA+K ++   +   +   + E + L+  +H N++ I    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQ---KEDEQNQRPKLNLMQRLSIAIDVANVLE 682
                       ++ E M     +  L++    +   +   +  + Q L         ++
Sbjct: 79  RPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTL-------RAVK 126

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSI-GYV 741
            LH    ++++H DLKPSN+L+++     V DFGL+R++ +++ D +  +  +  +  +V
Sbjct: 127 VLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183

Query: 742 ------APEY-GALGEVSTHGDEYSFGILMLEMFTGK 771
                 APE      + S   D +S G ++ E+F  +
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 38/102 (37%), Positives = 51/102 (50%), Gaps = 24/102 (23%)

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRL-LHDNSPDQTSTSRVKGS 737
           L YLH      I++ DLK  NVLLD+E   H+   D+G+ +  L     D TST    G+
Sbjct: 166 LNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPG--DTTST--FCGT 216

Query: 738 IGYVAPE------YGALGEVSTHGDEYSFGILMLEMFTGKRP 773
             Y+APE      YG    V    D ++ G+LM EM  G+ P
Sbjct: 217 PNYIAPEILRGEDYGF--SV----DWWALGVLMFEMMAGRSP 252

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 60.4 bits (147), Expect = 8e-10
 Identities = 57/219 (26%), Positives = 89/219 (40%), Gaps = 42/219 (19%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDL--QQRGASKSFIAECEALRSIRHRNLVK---I 621
           +G G YG V           VAVK L    Q    +K    E   L+ ++H N++    +
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96

Query: 622 ITSCSSIDTRGNEFKA--LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
            T   S++    EF    LV   M    L N +  ++   +   +  + Q L        
Sbjct: 97  FTPARSLE----EFNDVYLVTHLMGA-DLNNIVKCQKLT-DDHVQFLIYQIL-------R 143

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            L+Y+H      I+H DLKPSN+ ++ +    + DFGL+R     + + T         G
Sbjct: 144 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMT---------G 188

Query: 740 YV------APE-YGALGEVSTHGDEYSFGILMLEMFTGK 771
           YV      APE        +   D +S G +M E+ TG+
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 60/222 (27%), Positives = 87/222 (39%), Gaps = 48/222 (21%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD--LQQRGASKSFIAECEALRSIRHRNLVK---I 621
           +G G YG V   + G     VA+K L    Q    +K    E   L+ +RH N++    +
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92

Query: 622 ITSCSSIDTRGNEFKA--LVYEFMPNGSLENWLNQ---KEDEQNQRPKLNLMQRLSIAID 676
            T   ++D    +F    LV  FM        L +    E     R +  + Q L     
Sbjct: 93  FTPDETLD----DFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVYQML----- 138

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
               L Y+H      I+H DLKP N+ ++ +    + DFGL+R       + T       
Sbjct: 139 --KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMT------- 183

Query: 737 SIGYV------APEY-GALGEVSTHGDEYSFGILMLEMFTGK 771
             GYV      APE        +   D +S G +M EM TGK
Sbjct: 184 --GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 32/216 (14%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
           IG G YG V        +  VA+K +   + +   +  + E + L   RH N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQ---KEDEQNQRPKLNLMQRLSIAIDVANVLE 682
            +      +   +V + M     E  L +    +   N      L Q L         L+
Sbjct: 95  RAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQIL-------RGLK 142

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV- 741
           Y+H     +++H DLKPSN+LL+      + DFGL+R+   +       +       YV 
Sbjct: 143 YIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT------EYVA 193

Query: 742 -----APEY-GALGEVSTHGDEYSFGILMLEMFTGK 771
                APE        +   D +S G ++ EM + +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.0 bits (142), Expect = 2e-09
 Identities = 20/95 (21%), Positives = 35/95 (36%), Gaps = 2/95 (2%)

Query: 263 SIPTSVGYLLKLQVLSLFGNKISGEIPS-SLGNLIFLTEVDLQGNSIRGSIPSALGNCLQ 321
                +     L  L +   +    +    L  L  L  + +  + +R   P A     +
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 322 LQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHL 356
           L +L+LS N L  ++  + +   S   L LS N L
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.4 bits (138), Expect = 9e-09
 Identities = 19/96 (19%), Positives = 36/96 (37%), Gaps = 4/96 (4%)

Query: 287 EIPSSLGNLIFLTEVDLQGNSIRGSIPS-ALGNCLQLQKLDLSDNNLSGTIPREV-IGLS 344
           +    L     LTE+ ++       +    L    +L+ L +  + L   +  +      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 345 SFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKL 380
               L+LS N L   +  +  +   +Q+L LS N L
Sbjct: 81  RLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.8 bits (113), Expect = 1e-05
 Identities = 20/111 (18%), Positives = 35/111 (31%), Gaps = 3/111 (2%)

Query: 319 CLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLDLSE 377
                 L  + +         + G  +   L +        + L     L  ++ L + +
Sbjct: 7   PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 378 NKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNF 428
           + L    P +      L  LN S N+ +         L  LQ+L LS N  
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 17/96 (17%), Positives = 35/96 (36%), Gaps = 2/96 (2%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSE-LGNLFKLVGLGLTGNNYTGSIPQSLSNLSF 63
           +   ++     L  L +   +   ++    L  L +L  L +  +      P +      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 64  LQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLT 99
           L +L+LS N+L  ++  +      L    +S N L 
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 41.6 bits (97), Expect = 7e-04
 Identities = 22/127 (17%), Positives = 31/127 (24%), Gaps = 33/127 (25%)

Query: 157 NASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLP 216
            A      L   +NL  L                            +  L    L G L 
Sbjct: 19  GALDSLHHLPGAENLTELYIENQQ---------------------HLQHLELRDLRG-LG 56

Query: 217 NSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQ 275
                    L  L +  + +   +          L  + +  N L  S+       L LQ
Sbjct: 57  E--------LRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQ 106

Query: 276 VLSLFGN 282
            L L GN
Sbjct: 107 ELVLSGN 113

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 40/173 (23%), Positives = 72/173 (41%), Gaps = 31/173 (17%)

Query: 566 LIGIGGYGYVYKGILGTEE-----TNVAVKV-----------LDLQQRGASKSFIAECEA 609
            IG GG+G +Y   + + E         VKV           L   QR A    I +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 610 LRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNG-SLENWLNQKEDEQNQRPKLNLM 668
            R +++  + K        D  G  ++ ++ +    G  L+          N + + +  
Sbjct: 102 TRKLKYLGVPKYW-GSGLHDKNGKSYRFMIMDRF--GSDLQKIYEA-----NAK-RFSRK 152

Query: 669 QRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD--NEMVAHVGDFGLSR 719
             L +++ + ++LEY+H H     VH D+K SN+LL+  N    ++ D+GL+ 
Sbjct: 153 TVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.4 bits (140), Expect = 3e-09
 Identities = 31/208 (14%), Positives = 55/208 (26%), Gaps = 56/208 (26%)

Query: 555 LKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDL--------QQRGASKSFIAE 606
              TE       IG G +G V++ I   + T VA+K++ +          +   +  + E
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPE 73

Query: 607 CEALRSI---------RHRNLVKIITSC-------------------------SSIDTRG 632
               + +         R    + + +                              D   
Sbjct: 74  IIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFK 133

Query: 633 NEFKALVYEFMPNG-SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS 691
           ++   +V EF   G  LE    +                 SI   +   L          
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLSSLA---------TAKSILHQLTASLAVAEASLR-- 182

Query: 692 IVHCDLKPSNVLLDNEMVAHVGDFGLSR 719
             H DL   NVLL    +  +      +
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 58.0 bits (140), Expect = 9e-09
 Identities = 51/306 (16%), Positives = 101/306 (33%), Gaps = 18/306 (5%)

Query: 164 DLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFS 223
           +L    +    N   +  G      +  + S  + T+LE + L    ++      IA   
Sbjct: 72  ELKGKPHFADFNLVPDGWGGYVYPWIEAMSS--SYTWLEEIRLKRMVVTDDCLELIAKSF 129

Query: 224 SHLIYLYMSA-NRISGT----IPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLL-KLQVL 277
            +   L +S+    S      I     NLK L L   +V+ ++G   +        L  L
Sbjct: 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSL 189

Query: 278 SLFG--NKISGEIPSSLG-NLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLS------ 328
           ++    +++S      L      L  + L        + + L    QL++L         
Sbjct: 190 NISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEV 249

Query: 329 DNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGE-IPTS 387
             ++   +   + G      L    + +   +P        +  L+LS   +    +   
Sbjct: 250 RPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKL 309

Query: 388 LASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNL 447
           L  C  L+ L   D      +    S+ K L++L +  +      P    T + L  +++
Sbjct: 310 LCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSM 369

Query: 448 SFNNLE 453
               LE
Sbjct: 370 GCPKLE 375

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 56.4 bits (136), Expect = 3e-08
 Identities = 42/294 (14%), Positives = 93/294 (31%), Gaps = 23/294 (7%)

Query: 189 LRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSH---LIYLYMSANRIS----GTIP 241
           +R ++ L         +L  +   G +   I   SS    L  + +    ++      I 
Sbjct: 68  VRSVE-LKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIA 126

Query: 242 TGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLI----F 297
               N K L+L + E    T  +         L+ L L  + +       L +       
Sbjct: 127 KSFKNFKVLVLSSCE-GFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTS 185

Query: 298 LTEVDLQGNSIR---GSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLS-- 352
           L  +++   +      ++   +  C  L+ L L+       +   +        L     
Sbjct: 186 LVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGY 245

Query: 353 ----RNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP- 407
               R  +   + + +   K ++ L    + +   +P   + C  L  LN S  + Q   
Sbjct: 246 TAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYD 305

Query: 408 IHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGV 461
           +         LQ L +        + +  +T + L++L +  +      P+  +
Sbjct: 306 LVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVAL 359

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 40/276 (14%), Positives = 86/276 (31%), Gaps = 22/276 (7%)

Query: 194 SLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILI 253
           SLV  ++ E+       +   + N  A   + +I  +     +      G  +  +  L+
Sbjct: 31  SLVCKSWYEIERWCRRKVF--IGNCYAVSPATVIRRFPKVRSVE---LKGKPHFADFNLV 85

Query: 254 AMEVNLLTGS-IPTSVGYLLKLQVLSLFGNKISGEIPSSLG-NLIFLTEVDLQGNSI--R 309
                      I         L+ + L    ++ +    +  +      + L        
Sbjct: 86  PDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFST 145

Query: 310 GSIPSALGNCLQLQKLDLSDNNLSGTIPR--EVIGLSSFVLLDLSRNHLSGPIPLE---- 363
             + +    C  L++LDL ++++             +   L+ L+ + L+  +       
Sbjct: 146 DGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALER 205

Query: 364 -VGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFS------DNSFQGPIHSGFSSLK 416
            V R   ++ L L+      ++ T L     LE L                +    S  K
Sbjct: 206 LVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCK 265

Query: 417 GLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNL 452
            L+ L    +     +P   +    L  LNLS+  +
Sbjct: 266 ELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATV 301

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 41.8 bits (98), Expect = 8e-04
 Identities = 62/467 (13%), Positives = 138/467 (29%), Gaps = 77/467 (16%)

Query: 12  HCSELRILDLVVNKLEGNIPSELGNLFK-LVGLGLTGNNY--TGSIPQSLSNLSFLQQLS 68
             + L  + L    +  +    +   FK    L L+      T  +    +    L++L 
Sbjct: 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELD 162

Query: 69  LSENSLSG-------NIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK 121
           L E+ +         + P     L  LN+  ++              +S      +    
Sbjct: 163 LRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA------------SEVSFSALERLVTR- 209

Query: 122 LVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNL 181
                        PN++ L L            +   +++   L +   L  L       
Sbjct: 210 ------------CPNLKSLKLNRA-------VPLEKLATL---LQRAPQLEELGTGGYTA 247

Query: 182 GTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGT-I 240
                       +L  C  L  +S   +++   LP ++ +  S L  L +S   +    +
Sbjct: 248 EVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLP-AVYSVCSRLTTLNLSYATVQSYDL 306

Query: 241 PTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSS--------- 291
              +     L  + +   +    +         L+ L +F ++     P+          
Sbjct: 307 VKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVS 366

Query: 292 -LGNLIFLTEVDLQGNSIRGSIPSALG-NCLQLQKLDLSDNNLSGTIPREVIGLSSFVLL 349
                  L  V      +  +    +  N   + +  L               +      
Sbjct: 367 VSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLC-------------IIEPKAPD 413

Query: 350 DLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLAS-CVGLEYLNFS--DNSFQG 406
            L+   L       V   K +++L LS   L+ ++   + +    +E L+ +   +S  G
Sbjct: 414 YLTLEPLDIGFGAIVEHCKDLRRLSLSGL-LTDKVFEYIGTYAKKMEMLSVAFAGDSDLG 472

Query: 407 PIHSGFSSLKGLQDLDLSRNNFSGK-IPMFLNTFRFLQKLNLSFNNL 452
            +H   S    L+ L++    F  K +    +    ++ L +S  ++
Sbjct: 473 -MHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 25/109 (22%), Positives = 46/109 (42%), Gaps = 5/109 (4%)

Query: 367 LKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRN 426
               ++LDL   K+   I    A+    + ++FSDN  +     GF  L+ L+ L ++ N
Sbjct: 18  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNNN 74

Query: 427 NFSGKIPMFLNTFRFLQKLNLSFNNLE--GEVPSEGVFKNVRAVSIIGN 473
                          L +L L+ N+L   G++      K++  + I+ N
Sbjct: 75  RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 52.0 bits (125), Expect = 9e-08
 Identities = 27/127 (21%), Positives = 48/127 (37%), Gaps = 6/127 (4%)

Query: 301 VDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPI 360
           V L    I  +  +   N ++ ++LDL    +   I      L  F  +D S N +    
Sbjct: 2   VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD 58

Query: 361 PLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIH-SGFSSLKGLQ 419
                 L+ ++ L ++ N++         +   L  L  ++NS          +SLK L 
Sbjct: 59  GFP--LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116

Query: 420 DLDLSRN 426
            L + RN
Sbjct: 117 YLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 24/148 (16%), Positives = 37/148 (25%), Gaps = 35/148 (23%)

Query: 187 NDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSS---HLIYLYMSANRISGTIPTG 243
             +       N      + L    +       I N  +       +  S N I       
Sbjct: 7   ELIEQAAQYTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDNEIR------ 55

Query: 244 VGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDL 303
              L                       L +L+ L +  N+I          L  LTE+ L
Sbjct: 56  --KLDGF------------------PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95

Query: 304 QGNSIRG-SIPSALGNCLQLQKLDLSDN 330
             NS+        L +   L  L +  N
Sbjct: 96  TNNSLVELGDLDPLASLKSLTYLCILRN 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.5 bits (129), Expect = 2e-08
 Identities = 21/111 (18%), Positives = 46/111 (41%), Gaps = 5/111 (4%)

Query: 366 RLKGIQQLDLSENKLS-GEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLS 424
               +++L L  ++ + G++         LE+L+  +        +    L  L+ L+LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELS 72

Query: 425 RNNFSGKIPMFLNTFRFLQKLNLSFNNLE--GEVPSEGVFKNVRAVSIIGN 473
            N  SG + +       L  LNLS N ++    +      +N++++ +   
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.5 bits (129), Expect = 2e-08
 Identities = 26/133 (19%), Positives = 47/133 (35%), Gaps = 13/133 (9%)

Query: 298 LTEVDLQGNSI-RGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV---LLDLSR 353
           + E+ L  +    G +        +L+ L   +  L+      +  L        L+LS 
Sbjct: 19  VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKLELSD 73

Query: 354 NHLSGPIPLEVGRLKGIQQLDLSENKLSG-EIPTSLASCVGLEYLNFSDNSFQGPIH--- 409
           N +SG + +   +   +  L+LS NK+        L     L+ L+  +           
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRE 133

Query: 410 SGFSSLKGLQDLD 422
           + F  L  L  LD
Sbjct: 134 NVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.8 bits (109), Expect = 6e-06
 Identities = 25/112 (22%), Positives = 43/112 (38%), Gaps = 9/112 (8%)

Query: 246 NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQG 305
           ++K L+L     N   G +        +L+ LS     ++  I ++L  L  L +++L  
Sbjct: 18  DVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73

Query: 306 NSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSF---VLLDLSRN 354
           N + G +      C  L  L+LS N +       +  L        LDL   
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 34/149 (22%), Positives = 47/149 (31%), Gaps = 41/149 (27%)

Query: 187 NDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSS--HLIYLYMSANRISGTIPTGV 244
           N+ +          LE +S  +  L+     SIAN      L  L +S NR+SG +    
Sbjct: 30  NEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKLELSDNRVSGGLEVLA 84

Query: 245 GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISG-EIPSSLGNLIFLTEVDL 303
               NL                          L+L GNKI        L  L  L  +DL
Sbjct: 85  EKCPNL------------------------THLNLSGNKIKDLSTIEPLKKLENLKSLDL 120

Query: 304 QGNSI------RGSIPSALGNCLQLQKLD 326
               +      R ++        QL  LD
Sbjct: 121 FNCEVTNLNDYRENV---FKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 25/130 (19%), Positives = 44/130 (33%), Gaps = 32/130 (24%)

Query: 156 SNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVL 215
           SN   +     + + L  L+             L  + +L     L+ + LS N +SG L
Sbjct: 29  SNEGKLEGLTDEFEELEFLSTI--------NVGLTSIANLPKLNKLKKLELSDNRVSGGL 80

Query: 216 PNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQ 275
                   + L +L +S N+I     + +  LK L                       L+
Sbjct: 81  EVLAEKCPN-LTHLNLSGNKIKD--LSTIEPLKKLE---------------------NLK 116

Query: 276 VLSLFGNKIS 285
            L LF  +++
Sbjct: 117 SLDLFNCEVT 126

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 38/143 (26%), Positives = 57/143 (39%), Gaps = 15/143 (10%)

Query: 288 IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSF 346
           IP++   L       L  N I    P    + + L++L L  N L   +P  V   L+  
Sbjct: 38  IPTNAQIL------YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90

Query: 347 VLLDLSRNHLSGPIPLEVG---RLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNS 403
            +LDL  N L+    L      RL  +++L +  NKL+ E+P  +     L +L    N 
Sbjct: 91  TVLDLGTNQLTV---LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ 146

Query: 404 FQGPIHSGFSSLKGLQDLDLSRN 426
            +   H  F  L  L    L  N
Sbjct: 147 LKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 39/144 (27%), Positives = 60/144 (41%), Gaps = 17/144 (11%)

Query: 240 IPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKI----SGEIPSSLGNL 295
           IPT    L       +  N +T   P     L+ L+ L L  N++     G +  SL   
Sbjct: 38  IPTNAQILY------LHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-VFDSLTQ- 89

Query: 296 IFLTEVDLQGNSIRGSIPSALGNCL-QLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRN 354
             LT +DL  N +   +PSA+ + L  L++L +  N L+  +PR +  L+    L L +N
Sbjct: 90  --LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145

Query: 355 HLSGPIPLEVGRLKGIQQLDLSEN 378
            L         RL  +    L  N
Sbjct: 146 QLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.9 bits (104), Expect = 9e-05
 Identities = 34/115 (29%), Positives = 52/115 (45%), Gaps = 7/115 (6%)

Query: 193 DSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLI 251
           DSL+N   L    L SN L   LP  + +  + L  L +  N+++  +P+ V   L +L 
Sbjct: 61  DSLINLKEL---YLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLK 115

Query: 252 LIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGN 306
            + M  N LT  +P  +  L  L  L+L  N++      +   L  LT   L GN
Sbjct: 116 ELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 53.2 bits (128), Expect = 3e-08
 Identities = 26/111 (23%), Positives = 45/111 (40%), Gaps = 5/111 (4%)

Query: 366 RLKGIQQLDLSENKLS-GEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLS 424
               +++L L   K + G+I    A  V LE+L+  +        S    L  L+ L+LS
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELS 79

Query: 425 RNNFSGKIPMFLNTFRFLQKLNLSFNNLE--GEVPSEGVFKNVRAVSIIGN 473
            N   G + M       L  LNLS N L+    +      + ++++ +   
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 50.5 bits (121), Expect = 2e-07
 Identities = 30/135 (22%), Positives = 46/135 (34%), Gaps = 9/135 (6%)

Query: 298 LTEVDLQGNSIR-GSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHL 356
           + E+ L       G I       + L+ L L +  L          L     L+LS N +
Sbjct: 26  VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP--KLPKLKKLELSENRI 83

Query: 357 SGPIPLEVGRLKGIQQLDLSENKLS--GEIPTSLASCVGLEYLNFSDNSFQGPIH---SG 411
            G + +   +L  +  L+LS NKL     +   L     L+ L+  +           S 
Sbjct: 84  FGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYRESV 142

Query: 412 FSSLKGLQDLDLSRN 426
           F  L  L  LD    
Sbjct: 143 FKLLPQLTYLDGYDR 157

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 37/158 (23%), Positives = 49/158 (31%), Gaps = 37/158 (23%)

Query: 180 NLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSS--HLIYLYMSANRIS 237
            L   K ND +          LE +SL +  L      S++N      L  L +S NRI 
Sbjct: 30  VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKKLELSENRIF 84

Query: 238 GTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKIS--GEIPSSLGNL 295
           G +      L NL                          L+L GNK+     +   L  L
Sbjct: 85  GGLDMLAEKLPNL------------------------THLNLSGNKLKDISTL-EPLKKL 119

Query: 296 IFLTEVDLQGNSI---RGSIPSALGNCLQLQKLDLSDN 330
             L  +DL    +        S      QL  LD  D 
Sbjct: 120 ECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDR 157

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 27/112 (24%), Positives = 42/112 (37%), Gaps = 9/112 (8%)

Query: 246 NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQG 305
            ++ L+L   + N   G I       + L+ LSL    +   + S+L  L  L +++L  
Sbjct: 25  AVRELVLDNCKSND--GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSE 80

Query: 306 NSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSF---VLLDLSRN 354
           N I G +         L  L+LS N L       +  L        LDL   
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 24/130 (18%), Positives = 43/130 (33%), Gaps = 32/130 (24%)

Query: 156 SNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVL 215
           SN   I     +  NL  L+             L  + +L     L+ + LS N + G L
Sbjct: 36  SNDGKIEGLTAEFVNLEFLSLI--------NVGLISVSNLPKLPKLKKLELSENRIFGGL 87

Query: 216 PNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQ 275
                   + L +L +S N++         ++  L  +                 L  L+
Sbjct: 88  DMLAEKLPN-LTHLNLSGNKLK--------DISTLEPLKK---------------LECLK 123

Query: 276 VLSLFGNKIS 285
            L LF  +++
Sbjct: 124 SLDLFNCEVT 133

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 56.3 bits (136), Expect = 3e-08
 Identities = 61/264 (23%), Positives = 106/264 (40%), Gaps = 35/264 (13%)

Query: 519 FIVFVFYQRRKRRRRSKALVNSSIEDK--YLKISYAELLKATEGFSSANLIGIGGYGYVY 576
            I F+    +KR+  +    N   +D          + +     +    +IG G +G V 
Sbjct: 57  EIYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHV--AYRYEVLKVIGKGSFGQVV 114

Query: 577 KGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHR---NLVKIITSCSSIDTRGN 633
           K        +VA+K++  ++R   ++   E   L  +R +   N + +I    +   R +
Sbjct: 115 KAYDHKVHQHVALKMVRNEKRFHRQAAE-EIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173

Query: 634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIV 693
               + +E + + +L   +     ++N+    +L      A  +   L+ LH +    I+
Sbjct: 174 IC--MTFELL-SMNLYELI-----KKNKFQGFSLPLVRKFAHSILQCLDALHKN---RII 222

Query: 694 HCDLKPSNVLLDNEMVAH--VGDFGLSRLLHDNSPDQTST---SRVKGSIGYVAPEYGAL 748
           HCDLKP N+LL  +  +   V DFG S   H        T   SR      Y APE   L
Sbjct: 223 HCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR----VYTYIQSRF-----YRAPEV-IL 272

Query: 749 G-EVSTHGDEYSFGILMLEMFTGK 771
           G       D +S G ++ E+ TG 
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGY 296

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 44/201 (21%), Positives = 72/201 (35%), Gaps = 36/201 (17%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLD--LQQRGASKSFIAECEALRSIRHRNLVKIITS 624
           IG G YGYVY       E NVA+K ++   +     K  + E   L  ++   ++++   
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93

Query: 625 CSSIDTRGNEFKA--LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
               D    +F    +V E   +  L+           +  K  L   L           
Sbjct: 94  IIPDDLL--KFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLL-------LGEN 143

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSI---- 738
           ++H    + I+H DLKP+N LL+ +    V DFGL+R ++            +       
Sbjct: 144 FIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200

Query: 739 ---------GYV------APE 744
                     +V      APE
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPE 221

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 54.5 bits (131), Expect = 6e-08
 Identities = 41/250 (16%), Positives = 91/250 (36%), Gaps = 22/250 (8%)

Query: 190 RFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKN 249
           R+     + +  + + L+  +L   +   +   S  +I      + +   +       + 
Sbjct: 38  RWYRLASDESLWQTLDLTGKNLHPDVTGRL--LSQGVIAFRCPRSFMDQPLAEHFSPFRV 95

Query: 250 LILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSI- 308
             +      +   ++   +    KLQ LSL G ++S  I ++L     L  ++L G S  
Sbjct: 96  QHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF 155

Query: 309 -RGSIPSALGNCLQLQKLDLSD-NNLSGTIPREVIGLSSFVL--LDLSRNHLS---GPIP 361
              ++ + L +C +L +L+LS   + +    +  +   S  +  L+LS    +     + 
Sbjct: 156 SEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLS 215

Query: 362 LEVGRLKGIQQLDLSE-NKLSGEIPTSLASCVGLEYLNFS------DNSFQGPIHSGFSS 414
             V R   +  LDLS+   L  +          L++L+ S        +           
Sbjct: 216 TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLL-----ELGE 270

Query: 415 LKGLQDLDLS 424
           +  L+ L + 
Sbjct: 271 IPTLKTLQVF 280

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 54.2 bits (131), Expect = 7e-08
 Identities = 32/161 (19%), Positives = 64/161 (39%), Gaps = 30/161 (18%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEA---LRSIRHRNLVKIIT 623
           +G+G  G V +      +   A+K+L            A  E     R+ +  ++V+I+ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ-NQRPKLNLMQRLSIAIDVANVLE 682
              ++         +V E +  G L + +  + D+   +R    +M+       +   ++
Sbjct: 79  VYENLYAGRKCL-LIVMECLDGGELFSRIQDRGDQAFTEREASEIMK------SIGEAIQ 131

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNE------MVAHVGDFGL 717
           YLH     +I H D+KP N+L  ++       +    DFG 
Sbjct: 132 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLT---DFGF 166

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 32/183 (17%), Positives = 64/183 (34%), Gaps = 31/183 (16%)

Query: 272 LKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNN 331
            +   L      I  ++ ++L  L     + L  N+I   I S+L     L+ L L  N 
Sbjct: 25  AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNL 81

Query: 332 LSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASC 391
           +      ++  L +                        +++L +S N+++  + + +   
Sbjct: 82  IK-----KIENLDAV--------------------ADTLEELWISYNQIA-SL-SGIEKL 114

Query: 392 VGLEYLNFSDNSFQGPIH-SGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFN 450
           V L  L  S+N           ++L  L+DL L+ N           T  +  ++     
Sbjct: 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP 174

Query: 451 NLE 453
           NL+
Sbjct: 175 NLK 177

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 34/147 (23%), Positives = 60/147 (40%), Gaps = 23/147 (15%)

Query: 194 SLVNCTFLEVVSLSSNSLSGVLPNSIANFSS--HLIYLYMSANRISGTIPTGVGNLKNLI 251
           +L      + ++LS+N++       I++ S   +L  L +  N I   I         L 
Sbjct: 43  TLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 252 LIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKIS--GEIPSSLGNLIFLTEVDLQGNSIR 309
            + +  N +  S+ + +  L+ L+VL +  NKI+  GEI   L  L  L ++ L GN + 
Sbjct: 97  ELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLY 153

Query: 310 GSIPSA----------LGNCLQLQKLD 326
                           +     L+KLD
Sbjct: 154 NDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 37/171 (21%), Positives = 70/171 (40%), Gaps = 21/171 (12%)

Query: 217 NSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQV 276
            S+    +  + L+     I   +   +  LK    +A+  N +   I +S+  +  L++
Sbjct: 18  KSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRI 74

Query: 277 LSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTI 336
           LSL  N I  +I +       L E+ +  N I  S+ S +   + L+ L +S+N ++   
Sbjct: 75  LSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITN-- 129

Query: 337 PREVIGLSSF---VLLDLSRNHLSGPIPLE----------VGRLKGIQQLD 374
             E+  L++      L L+ N L                 V RL  +++LD
Sbjct: 130 WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 36/171 (21%), Positives = 65/171 (38%), Gaps = 29/171 (16%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
           ++ A ++     + L L  N +E  I S L  +  L  L L  N     I    +    L
Sbjct: 39  KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95

Query: 65  QQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVG 124
           ++L +S N ++ ++ S +  L  L +  +S N +T        N   +D  A        
Sbjct: 96  EELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT--------NWGEIDKLA-------- 137

Query: 125 EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLN 175
                    L  +  LLL  N    +   + + +    E + +L NL +L+
Sbjct: 138 --------ALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 51.6 bits (124), Expect = 6e-07
 Identities = 57/250 (22%), Positives = 90/250 (36%), Gaps = 83/250 (33%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR----------HR 616
           +G G YG V+K I       VAVK +         +F    +A R+ R          H 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSGHE 69

Query: 617 NLVKIITSCSSIDTRGNEFKA--LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLS-- 672
           N+V ++    +     +  +   LV+++M     E  L+           +     L   
Sbjct: 70  NIVNLLNVLRA-----DNDRDVYLVFDYM-----ETDLHA----------VIRANILEPV 109

Query: 673 ----IAIDVANVLEYLHHHCHTS--IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSP 726
               +   +  V++YLH     S  ++H D+KPSN+LL+ E    V DFGLSR   +   
Sbjct: 110 HKQYVVYQLIKVIKYLH-----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164

Query: 727 DQTSTSRVKGSI------------GYV------APE-------YGALGEVSTHGDEYSFG 761
              +                     YV      APE       Y      +   D +S G
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY------TKGIDMWSLG 218

Query: 762 ILMLEMFTGK 771
            ++ E+  GK
Sbjct: 219 CILGEILCGK 228

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 38/161 (23%), Positives = 70/161 (43%), Gaps = 27/161 (16%)

Query: 567 IGIGGYGYVYKGI-LGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRH-RNLVKIITS 624
           IG G +G +  G  L T E  VA+K+  ++ R        E    + +     + ++   
Sbjct: 17  IGCGNFGELRLGKNLYTNE-YVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYF 73

Query: 625 CSSIDTRGNEFKALVYEFMPNG-SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
                    ++ A+V E +  G SLE+  +            +L   L IAI + + +EY
Sbjct: 74  G-----PCGKYNAMVLELL--GPSLEDLFDL------CDRTFSLKTVLMIAIQLISRMEY 120

Query: 684 LHHHCHTSIVHCDLKPSNVLL-----DNEMVAHVGDFGLSR 719
           +H     ++++ D+KP N L+       + V H+ DF L++
Sbjct: 121 VHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.8 bits (115), Expect = 4e-06
 Identities = 26/164 (15%), Positives = 54/164 (32%), Gaps = 21/164 (12%)

Query: 310 GSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVG--RL 367
             +   L     L  L +   N      +    L S   L++    L   +  ++    L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKS---LEIISGGLPDSVVEDILGSDL 218

Query: 368 KGIQQLDL---SENKLSGEIPTSLA------SCVGLEYLNFSDNSFQGPIHSGFSS---L 415
             +++L L    E+                     L++L   D   Q  +   F     L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 416 KGLQDLDLSRNNFSGK----IPMFLNTFRFLQKLNLSFNNLEGE 455
             L+ +D+S    + +    +   ++  + L+ +N+ +N L  E
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.5 bits (109), Expect = 2e-05
 Identities = 15/129 (11%), Positives = 38/129 (29%), Gaps = 18/129 (13%)

Query: 223 SSHLIYLYMSANRISGTIPTGVG-----NLKNLILIAMEVNLLTGSIPTSVGYLL----- 272
             +L  L + +  +  ++   +      NL+ L+L     +            L      
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251

Query: 273 -KLQVLSLFGNKISGEIPSSLGNLIF---LTEVDLQGNSIRGS----IPSALGNCLQLQK 324
             L+ L +   +    +            L  +D+    +       +   +     L+ 
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311

Query: 325 LDLSDNNLS 333
           +++  N LS
Sbjct: 312 INMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.7 bits (107), Expect = 4e-05
 Identities = 20/138 (14%), Positives = 45/138 (32%), Gaps = 18/138 (13%)

Query: 271 LLKLQVLSLFGNKISGEIPSSLG--NLIFLTEVDL---QGNSIRGSIPSALGNCLQ---- 321
              L+ L +    +   +   +   +L  L ++ L     +       +           
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251

Query: 322 --LQKLDLSDNNLSGTIPR---EVIGLSSFVLLDLSRNHLSG----PIPLEVGRLKGIQQ 372
             L+ L + D      +     E   L     +D+S   L+      +   V ++K ++ 
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311

Query: 373 LDLSENKLSGEIPTSLAS 390
           +++  N LS E+   L  
Sbjct: 312 INMKYNYLSDEMKKELQK 329

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.7 bits (107), Expect = 5e-05
 Identities = 28/199 (14%), Positives = 60/199 (30%), Gaps = 36/199 (18%)

Query: 28  GNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGL--- 84
            ++   L  +  L  L + G N      +   NL   + L +    L  ++  ++     
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNL---KSLEIISGGLPDSVVEDILGSDL 218

Query: 85  --LKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLL 142
             L++L ++    +Y           + S D F                   PN++ L +
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF-------------------PNLKWLGI 259

Query: 143 GSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLE 202
                   +      +         L  L  ++ +   L       L  LD +     L+
Sbjct: 260 VDAEEQNVVVEMFLESDI-------LPQLETMDISAGVLTDEGARLL--LDHVDKIKHLK 310

Query: 203 VVSLSSNSLSGVLPNSIAN 221
            +++  N LS  +   +  
Sbjct: 311 FINMKYNYLSDEMKKELQK 329

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.8 bits (102), Expect = 2e-04
 Identities = 19/162 (11%), Positives = 53/162 (32%), Gaps = 21/162 (12%)

Query: 286 GEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIG--L 343
            ++   L  +  L  + ++G +   ++         L+ L++    L  ++  +++G  L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 344 SSFVLLDL---SRNHLSGPIP------LEVGRLKGIQQLDLSENKLSGEIPTSLASCV-- 392
            +   L L     ++                R   ++ L + + +    +          
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 393 -GLEYLNFSDNSFQG----PIHSGFSSLKGLQDLDLSRNNFS 429
             LE ++ S           +      +K L+ +++  N  S
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 41/133 (30%), Positives = 57/133 (42%), Gaps = 12/133 (9%)

Query: 299 TEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLS 357
           T VD  G  ++  IP  +   L   +L L+DN L       +   L   V L+L RN L+
Sbjct: 11  TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 358 GPIPLEVG---RLKGIQQLDLSENKLSGEIPTSL-ASCVGLEYLNFSDNSFQGPIHSGFS 413
           G   +E         IQ+L L ENK+  EI   +      L+ LN  DN     +   F 
Sbjct: 68  G---IEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFE 123

Query: 414 SLKGLQDLDLSRN 426
            L  L  L+L+ N
Sbjct: 124 HLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 26/106 (24%), Positives = 49/106 (46%), Gaps = 10/106 (9%)

Query: 206 LSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV----GNLKNLILIAMEVNLLT 261
           L+ N L  +  + +     HL+ L +  N+++  I         +++ L L     N + 
Sbjct: 36  LNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQL---GENKIK 91

Query: 262 GSIPTSV-GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGN 306
             I   +   L +L+ L+L+ N+IS  +P S  +L  LT ++L  N
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 48.1 bits (115), Expect = 5e-06
 Identities = 35/158 (22%), Positives = 67/158 (42%), Gaps = 23/158 (14%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRH-RNLVKIITSC 625
           IG G +G +Y G        VA+K+  ++ +        E +  + ++    +  I    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 626 SSIDTRGNEFKALVYEFMPNG-SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
                   ++  +V E +  G SLE+  N          K +L   L +A  + + +EY+
Sbjct: 75  -----AEGDYNVMVMELL--GPSLEDLFNF------CSRKFSLKTVLLLADQMISRIEYI 121

Query: 685 HHHCHTSIVHCDLKPSNVLL---DNEMVAHVGDFGLSR 719
           H     + +H D+KP N L+       + ++ DFGL++
Sbjct: 122 HSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 40/148 (27%), Positives = 58/148 (39%), Gaps = 24/148 (16%)

Query: 288 IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSF 346
           IP+    L      DL+ NS++            L +L L  N L  ++P  V   L+S 
Sbjct: 26  IPAQTTYL------DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78

Query: 347 VLLDLSRNHLSGPIPLEVG---RLKGIQQLDLSENKLSGEIPTSLASCV-----GLEYLN 398
             L+LS N L     L  G   +L  +++L L+ N+L      SL   V      L+ L 
Sbjct: 79  TYLNLSTNQLQS---LPNGVFDKLTQLKELALNTNQL-----QSLPDGVFDKLTQLKDLR 130

Query: 399 FSDNSFQGPIHSGFSSLKGLQDLDLSRN 426
              N  +      F  L  LQ + L  N
Sbjct: 131 LYQNQLKSVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 39/136 (28%), Positives = 53/136 (38%), Gaps = 19/136 (13%)

Query: 299 TEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSG 358
           T V+        S+P+  G   Q   LDL  N+L          L+S   L L  N L  
Sbjct: 10  TTVECYSQGRT-SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS 66

Query: 359 PIPLEVG---RLKGIQQLDLSENKLSGEIPTSLASCV-----GLEYLNFSDNSFQGPIHS 410
              L  G   +L  +  L+LS N+L      SL + V      L+ L  + N  Q     
Sbjct: 67  ---LPNGVFNKLTSLTYLNLSTNQL-----QSLPNGVFDKLTQLKELALNTNQLQSLPDG 118

Query: 411 GFSSLKGLQDLDLSRN 426
            F  L  L+DL L +N
Sbjct: 119 VFDKLTQLKDLRLYQN 134

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 34/176 (19%), Positives = 61/176 (34%), Gaps = 16/176 (9%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-----HRNLVKI 621
           +G G +  V+       +  VA+KV+   +     +   E   L+S+R       N   +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPNREMV 103

Query: 622 ITSCSSIDTRGNEFK--ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
           +         G       +V+E +      + L        Q   L  ++++   +    
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL----GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG- 158

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
            L+YLH  C   I+H D+KP N+LL             +     +     S S V 
Sbjct: 159 -LDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 36/136 (26%), Positives = 53/136 (38%), Gaps = 19/136 (13%)

Query: 299 TEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLS 357
           TE+      +  S+P+  G      +L+L  N L  ++P  V   L+    L LS+N + 
Sbjct: 10  TEIRCNSKGLT-SVPT--GIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ 65

Query: 358 GPIPLEVG---RLKGIQQLDLSENKLSGEIPT----SLASCVGLEYLNFSDNSFQGPIHS 410
               L  G   +L  +  L L ENKL   +P      L     L+ L    N  +     
Sbjct: 66  S---LPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQ---LKELALDTNQLKSVPDG 118

Query: 411 GFSSLKGLQDLDLSRN 426
            F  L  LQ + L  N
Sbjct: 119 IFDRLTSLQKIWLHTN 134

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 34/130 (26%), Positives = 50/130 (38%), Gaps = 29/130 (22%)

Query: 299 TEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLS 357
           TE+ L GN     +P  L N   L  +DLS+N +S T+  +    ++  + L LS N L 
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91

Query: 358 GPIPLEV-GRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLK 416
             IP      LK ++ L L  N +S  +P                          F+ L 
Sbjct: 92  C-IPPRTFDGLKSLRLLSLHGNDIS-VVP-----------------------EGAFNDLS 126

Query: 417 GLQDLDLSRN 426
            L  L +  N
Sbjct: 127 ALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 27/100 (27%), Positives = 42/100 (42%), Gaps = 10/100 (10%)

Query: 240 IPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLT 299
           IP  V  L       ++ N  T  +P  +     L ++ L  N+IS     S  N+  L 
Sbjct: 29  IPRDVTELY------LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81

Query: 300 EVDLQGNSIRGSIPSALGNCL-QLQKLDLSDNNLSGTIPR 338
            + L  N +R  IP    + L  L+ L L  N++S  +P 
Sbjct: 82  TLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPE 119

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 47.7 bits (114), Expect = 1e-05
 Identities = 33/168 (19%), Positives = 54/168 (32%), Gaps = 50/168 (29%)

Query: 639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK 698
           +YE +               +N     ++       I++   L YL      S+ H DLK
Sbjct: 122 LYEII--------------TRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLK 164

Query: 699 PSNVLL-DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK----GSIG-------------- 739
           P N+LL D      +               +T ++ +K    G                 
Sbjct: 165 PENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQ 224

Query: 740 YVAPE------YGALGEVSTHGDEYSFGILMLEMFTGKR--PTDDMFE 779
           Y APE      +          D +SFG ++ E++TG     T +  E
Sbjct: 225 YRAPEVILNLGW------DVSSDMWSFGCVLAELYTGSLLFRTHEHME 266

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 31/160 (19%), Positives = 61/160 (38%), Gaps = 25/160 (15%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRH-RNLVKIITSC 625
           IG G +G +++G        VA+K    +    +     E    + +     +  +    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 626 SSIDTRGNEFKALVYEFMPNG-SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
                +      LV + +  G SLE+ L+          K ++      A  +   ++ +
Sbjct: 76  -----QEGLHNVLVIDLL--GPSLEDLLDL------CGRKFSVKTVAMAAKQMLARVQSI 122

Query: 685 HHHCHTSIVHCDLKPSNVLL-----DNEMVAHVGDFGLSR 719
           H     S+V+ D+KP N L+      N  + +V DFG+ +
Sbjct: 123 HEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 46.1 bits (109), Expect = 4e-05
 Identities = 44/284 (15%), Positives = 85/284 (29%), Gaps = 53/284 (18%)

Query: 159 SSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSN-SLSGVLPN 217
           + +P        + +L+     L T           +  C  LEV+   +     G+   
Sbjct: 283 NEMPILFPFAAQIRKLDLLYALLETEDH-----CTLIQKCPNLEVLETRNVIGDRGLE-- 335

Query: 218 SIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVL 277
            +A +   L  L +        +    G +    LIA+                 +L+ +
Sbjct: 336 VLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL------------AQGCQELEYM 383

Query: 278 SLFGNKISGE----IPSSLGNLIFLTEVDLQGNS------IRGSIPSALGNCLQLQKLDL 327
           +++ + I+ E    I + L NL     V L          +   + S L  C +L++   
Sbjct: 384 AVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAF 443

Query: 328 SDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTS 387
                         GL+   L  + +                ++ + L     S E    
Sbjct: 444 YLRQ---------GGLTDLGLSYIGQY------------SPNVRWMLLGYVGESDEGLME 482

Query: 388 LA-SCVGLEYLNFSDNSFQGP-IHSGFSSLKGLQDLDLSRNNFS 429
            +  C  L+ L      F    I +  + L  L+ L +     S
Sbjct: 483 FSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 58/387 (14%), Positives = 118/387 (30%), Gaps = 54/387 (13%)

Query: 98  LTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISN 157
           L G     +FN+   ++       +       +   L  ++ +              +S+
Sbjct: 80  LKGKPRAAMFNLIPENWGGYVTPWVT-----EISNNLRQLKSVHFRRM--------IVSD 126

Query: 158 ASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPN 217
                    +  +L  L   + +  T  G  L  +  + +C  ++ + +  +S S     
Sbjct: 127 LDLDRLAKARADDLETLKLDKCSGFTTDG--LLSI--VTHCRKIKTLLMEESSFSEKDGK 182

Query: 218 SIANFSSH---LIYLYMSANRISG-------TIPTGVGNLKNLILIAMEVNLLTGSIPTS 267
            +   + H   L  L       +        TI     +L ++ +   E  L       +
Sbjct: 183 WLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFE-ILELVGFFKA 241

Query: 268 VGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDL 327
              L +    SL  +    E   +L     L  + L        +P       Q++KLDL
Sbjct: 242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDL 300

Query: 328 SDNNLSGTIPREVI-GLSSFVLLDLSRN-------HLSGPIP----LEVGRLKGIQQLDL 375
               L       +I    +  +L+            L+        L + R    Q ++ 
Sbjct: 301 LYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMED 360

Query: 376 SENKLSGEIPTSLA-SCVGLEYLNFS-----DNSFQGPIHSGFSSLKGLQDLDLSRNNFS 429
            E  +S     +LA  C  LEY+        + S +  I +   +L   + + L R    
Sbjct: 361 EEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLES-IGTYLKNLCDFRLVLLDREERI 419

Query: 430 GKIPM------FLNTFRFLQKLNLSFN 450
             +P+       L   + L++      
Sbjct: 420 TDLPLDNGVRSLLIGCKKLRRFAFYLR 446

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 45.4 bits (107), Expect = 7e-05
 Identities = 40/167 (23%), Positives = 72/167 (43%), Gaps = 23/167 (13%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLV-KIITSC 625
           IG G +G +Y G        VA+K+ +++ +      + E +  R ++    +  +    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 626 SSIDTRGNEFKALVYEFMPNG-SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
                   ++  LV + +  G SLE+  N          KL+L   L +A  + N +E++
Sbjct: 73  VE-----GDYNVLVMDLL--GPSLEDLFNF------CSRKLSLKTVLMLADQMINRVEFV 119

Query: 685 HHHCHTSIVHCDLKPSNVLL---DNEMVAHVGDFGLSRLLHDNSPDQ 728
           H     S +H D+KP N L+         ++ DFGL++   D S  Q
Sbjct: 120 HSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 44.7 bits (106), Expect = 9e-05
 Identities = 32/171 (18%), Positives = 53/171 (30%), Gaps = 34/171 (19%)

Query: 273 KLQVLSLFGNKISGEIPSSLGN-LIFLTEVDLQGNSIR----GSIPSAL-GNCLQLQKLD 326
            L  ++L   ++      +L    +   ++ LQ NS+       +   L  +  Q+  L 
Sbjct: 102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLR 161

Query: 327 LSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGE--- 383
           LS+N L+      V  L       L+ N               +  L L    L  E   
Sbjct: 162 LSNNPLT---AAGVAVLMEG----LAGN-------------TSVTHLSLLHTGLGDEGLE 201

Query: 384 -IPTSLASCVGLEYLNFSDNSFQGP----IHSGFSSLKGLQDLDLSRNNFS 429
            +   L     L+ LN + N         +         L+ L L  N  S
Sbjct: 202 LLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 44/262 (16%), Positives = 93/262 (35%), Gaps = 45/262 (17%)

Query: 543 EDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGI-LGTEETNVAVKVLDLQQRGASK 601
           ++ +L     + L   E +     +G G +G V + +     ++ VA+K++    +    
Sbjct: 5   KEGHLVCRIGDWL--QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 62

Query: 602 SFIAECEALRSIRHR---NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDE 658
           + + E   L+ I+ +   N    +      +  G+    + +E +   +   +L     +
Sbjct: 63  ARL-EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC--IAFELL-GKNTFEFL-----K 113

Query: 659 QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS 718
           +N      L     +A  + + L +LH +    + H DLKP N+L  N     + +   S
Sbjct: 114 ENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS 170

Query: 719 RLLHDNSPDQTSTSRVK----GSIGYV--------------APEYGALG-EVSTHGDEYS 759
                        + ++    GS  +                PE   L    +   D +S
Sbjct: 171 C-----EEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPE-VILELGWAQPCDVWS 224

Query: 760 FGILMLEMFTGKR--PTDDMFE 779
            G ++ E + G     T +  E
Sbjct: 225 IGCILFEYYRGFTLFQTHENRE 246

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.4 bits (103), Expect = 2e-04
 Identities = 43/240 (17%), Positives = 78/240 (32%), Gaps = 63/240 (26%)

Query: 566 LIGIGGYGYVYKGI-LGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHR---NLVKI 621
            +G G +G V + I       +VAVK++    R    +   E + L  +      +  + 
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-EIQVLEHLNTTDPNSTFRC 79

Query: 622 ITSCSSIDTRGNE---FKAL---VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI 675
           +      +  G+    F+ L    Y+F+              ++N      L     +A 
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLSTYDFI--------------KENGFLPFRLDHIRKMAY 125

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
            +   + +LH +    + H DLKP N+L          +  + R              +K
Sbjct: 126 QICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR-----DERTLINPDIK 177

Query: 736 ----GS--------IGYV------APE------YGALGEVSTHGDEYSFGILMLEMFTGK 771
               GS           V      APE      +      S   D +S G +++E + G 
Sbjct: 178 VVDFGSATYDDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYLGF 231

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	871
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.89
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.89
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.85
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.85
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.84
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.83
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.83
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.83
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.83
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.82
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.82
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.81
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.8
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.8
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.78
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.78
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.77
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.77
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.77
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.77
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.76
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.76
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.75
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.74
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.74
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.73
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.68
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.68
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.66
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.65
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.64
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.64
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.63
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.62
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.62
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.62
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.58
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.57
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.55
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.53
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.51
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.51
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.45
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.44
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.43
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.38
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.36
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.36
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.36
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.32
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.18
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.13
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.0
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.99
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.95
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.93
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.9
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.58
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.48
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.47
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.46
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.37
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.37
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.36
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.34
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.18
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	98.07
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.0
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.99
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.96
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.78
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.72
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.57
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.55
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.41
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.38
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.37
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.24
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.23
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.18
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.09
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.06
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.06
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.05
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.85
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.47
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.31
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.19
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.11
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.02
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.77
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	81.48
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	81.03

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=7.8e-60  Score=569.03  Aligned_cols=469  Identities=34%  Similarity=0.534  Sum_probs=372.8

Q ss_pred             ccccCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccc
Q 002883            3 QGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSEL   82 (871)
Q Consensus         3 ~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~   82 (871)
                      .+.+|. +.++++|++|+|++|++++.+|.+|+++++|++|+|++|++++.+|..  .+++|++|+|++|++++.+|..+
T Consensus       213 ~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~  289 (768)
T 3rgz_A          213 STGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFL  289 (768)
T ss_dssp             CSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCS
T ss_pred             CCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHH
Confidence            344554 666666666666666666666666666666666666666666555544  56666666666666666666666


Q ss_pred             ccc-ccccccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCC
Q 002883           83 GLL-KQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSI  161 (871)
Q Consensus        83 ~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~l  161 (871)
                      ..+ ++|++|++++|.+++.+|..+.++++|++|++++|.+.+.+|...+..+++|++|++++|.+++          .+
T Consensus       290 ~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~----------~~  359 (768)
T 3rgz_A          290 SGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG----------EL  359 (768)
T ss_dssp             CTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEE----------CC
T ss_pred             HhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCc----------cc
Confidence            554 7777777777777766777777777777777777777666666644567777777777777664          34


Q ss_pred             CccccCCC-cccEEecccccCCCCCCCCccccccccC--CCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCC
Q 002883          162 PEDLGKLK-NLIRLNFARNNLGTGKGNDLRFLDSLVN--CTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISG  238 (871)
Q Consensus       162 p~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~~l~~--l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~  238 (871)
                      |+.+..++ +|++|++++|++....      +..+..  +++|++|++++|.+++.+|..+..+ ++|++|++++|++++
T Consensus       360 p~~l~~l~~~L~~L~Ls~N~l~~~~------~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~  432 (768)
T 3rgz_A          360 PESLTNLSASLLTLDLSSNNFSGPI------LPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNC-SELVSLHLSFNYLSG  432 (768)
T ss_dssp             CTTHHHHTTTCSEEECCSSEEEEEC------CTTTTCSTTCCCCEEECCSSEEEEECCGGGGGC-TTCCEEECCSSEEES
T ss_pred             cHHHHhhhcCCcEEEccCCCcCCCc------ChhhhhcccCCccEEECCCCccccccCHHHhcC-CCCCEEECcCCcccC
Confidence            55566665 7888888888775321      222333  6778888888888888888888877 468888888888888


Q ss_pred             CCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccC
Q 002883          239 TIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGN  318 (871)
Q Consensus       239 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~  318 (871)
                      ..|..+..+++|+.|++++|.+++..|..+..+++|++|+|++|++++..|..+..+++|++|+|++|++++.+|..|+.
T Consensus       433 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  512 (768)
T 3rgz_A          433 TIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR  512 (768)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGG
T ss_pred             cccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhc
Confidence            88888888888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             CCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccc-----------------------------------
Q 002883          319 CLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLE-----------------------------------  363 (871)
Q Consensus       319 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~-----------------------------------  363 (871)
                      +++|+.|+|++|++++.+|..+..+++|+.|++++|++++.+|..                                   
T Consensus       513 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (768)
T 3rgz_A          513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGN  592 (768)
T ss_dssp             CTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEE
T ss_pred             CCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccc
Confidence            888888888888888888888888888888888888887666643                                   


Q ss_pred             -----------------------------------cCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccC
Q 002883          364 -----------------------------------VGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPI  408 (871)
Q Consensus       364 -----------------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  408 (871)
                                                         ++.+++|+.|+|++|++++.+|..+..+++|+.|+|++|++++.+
T Consensus       593 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~i  672 (768)
T 3rgz_A          593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI  672 (768)
T ss_dssp             EEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCC
T ss_pred             ccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCC
Confidence                                               344678999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCCcccccccceeccCCCCCccCCCccccccc
Q 002883          409 HSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPELHLHSC  488 (871)
Q Consensus       409 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~C~~~~~~~~~~c  488 (871)
                      |..|+.+++|+.|||++|++++.+|..+..+++|++||+++|+++|.+|..+.|..+....+.|||+.||.|.    ..|
T Consensus       673 p~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l----~~C  748 (768)
T 3rgz_A          673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL----PRC  748 (768)
T ss_dssp             CGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS----CCC
T ss_pred             ChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC----cCC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999764    367


Q ss_pred             ccCCCCc
Q 002883          489 RSRGSRK  495 (871)
Q Consensus       489 ~~~~~~~  495 (871)
                      ....+..
T Consensus       749 ~~~~~~~  755 (768)
T 3rgz_A          749 DPSNADG  755 (768)
T ss_dssp             CSCC---
T ss_pred             CCCccCC
Confidence            6554443

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=6.6e-56  Score=534.82  Aligned_cols=469  Identities=33%  Similarity=0.505  Sum_probs=317.3

Q ss_pred             cccccCc--cCcCCCCCCEEecCCCcccccCCccc-cCCCcCceeeCCCCcccccCCcc---c-----------------
Q 002883            2 LQGEIPA--NITHCSELRILDLVVNKLEGNIPSEL-GNLFKLVGLGLTGNNYTGSIPQS---L-----------------   58 (871)
Q Consensus         2 ~~~~~p~--~~~~l~~L~~L~l~~n~i~~~~~~~~-~~l~~L~~L~L~~n~l~~~~p~~---~-----------------   58 (871)
                      +.|++|.  .|+++++|++|||++|.+++..|..+ .++++|++|+|++|++++..|..   +                 
T Consensus       112 l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~  191 (768)
T 3rgz_A          112 LSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKIS  191 (768)
T ss_dssp             EEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEE
T ss_pred             CCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCccc
Confidence            4566776  77777777777777777776666654 56666666666666666554443   2                 


Q ss_pred             -----cCCcccceeeccCccccCCCCccccccccccccccccccccCCCCccccccCCCceeeeeccccccccccccccC
Q 002883           59 -----SNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFT  133 (871)
Q Consensus        59 -----~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~  133 (871)
                           ..+++|++|+|++|.+++.+|. |+.+++|++|++++|.+++.+|..+.++++|++|++++|.+.+.+|..   .
T Consensus       192 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~---~  267 (768)
T 3rgz_A          192 GDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---P  267 (768)
T ss_dssp             SCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC---C
T ss_pred             ccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc---c
Confidence                 4556666666666666655555 777777777777777777667777777777777777777776555543   5


Q ss_pred             CCCccEEEccCccCCCCCCccCcCC---------------CCCCccccCCCcccEEecccccCC-CCCCCCccccccccC
Q 002883          134 LPNIRVLLLGSNWFTGEIPPSISNA---------------SSIPEDLGKLKNLIRLNFARNNLG-TGKGNDLRFLDSLVN  197 (871)
Q Consensus       134 l~~L~~L~l~~n~i~~~~p~~~~~~---------------~~lp~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~l~~  197 (871)
                      +++|++|+|++|.+++.+|..+...               ..+|..|+.+++|++|++++|++. .++      ...+..
T Consensus       268 l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip------~~~l~~  341 (768)
T 3rgz_A          268 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP------MDTLLK  341 (768)
T ss_dssp             CTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECC------HHHHTT
T ss_pred             cCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCC------HHHHhc
Confidence            6677777777777776666665432               146677788888888888888775 322      123666


Q ss_pred             CCcccEEEccCCcCcccCChhhhhccccccEEEccC--------------------------CccCCCCCCCCCCccccc
Q 002883          198 CTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSA--------------------------NRISGTIPTGVGNLKNLI  251 (871)
Q Consensus       198 l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~--------------------------n~i~~~~~~~~~~l~~L~  251 (871)
                      +++|++|+|++|++++.+|..+..+..+|++|++++                          |++++..|..+.++++|+
T Consensus       342 l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~  421 (768)
T 3rgz_A          342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELV  421 (768)
T ss_dssp             CTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCC
T ss_pred             CCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCC
Confidence            777777777777777777777666543345554444                          444445555666666666


Q ss_pred             eeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCc
Q 002883          252 LIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNN  331 (871)
Q Consensus       252 ~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~  331 (871)
                      .|++++|.+++..|..|..+++|+.|+|++|++.+..|..+..+++|++|+|++|++++.+|..+.++++|++|+|++|+
T Consensus       422 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  501 (768)
T 3rgz_A          422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR  501 (768)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred             EEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCc
Confidence            66666666666666666666666666666666666666666666777777777777766666667777777777777777


Q ss_pred             CCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchh----------------------
Q 002883          332 LSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLA----------------------  389 (871)
Q Consensus       332 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----------------------  389 (871)
                      +++.+|..+..+++|++|++++|++++.+|..++.+++|+.|++++|++++.+|..+.                      
T Consensus       502 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (768)
T 3rgz_A          502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKND  581 (768)
T ss_dssp             CCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECC
T ss_pred             cCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccc
Confidence            7766777777777777777777777666677777777777777777776655554332                      


Q ss_pred             ------------------------------------------------cccCCceeeecCCcccccCccccCCCCCCCEE
Q 002883          390 ------------------------------------------------SCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDL  421 (871)
Q Consensus       390 ------------------------------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  421 (871)
                                                                      .+++|+.|+|++|++++.+|..++.++.|+.|
T Consensus       582 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L  661 (768)
T 3rgz_A          582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFIL  661 (768)
T ss_dssp             SCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEE
T ss_pred             cccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEE
Confidence                                                            23556777777777777777777777777777


Q ss_pred             eCCCCcCCCCCcccccccccccEEecCCCcCcccCCCC-cccccccceeccCCCCCccCCC
Q 002883          422 DLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE-GVFKNVRAVSIIGNNKLCGGSP  481 (871)
Q Consensus       422 ~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~C~~~~  481 (871)
                      +|++|++++.+|..+..+++|+.|||++|++++.+|.. ..+..++.+++.+|+. .|..|
T Consensus       662 ~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l-~g~iP  721 (768)
T 3rgz_A          662 NLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL-SGPIP  721 (768)
T ss_dssp             ECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEE-EEECC
T ss_pred             eCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcc-cccCC
Confidence            77777777777777777777777777777777777654 4556677777777654 34444

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.5e-54  Score=511.52  Aligned_cols=464  Identities=22%  Similarity=0.232  Sum_probs=340.6

Q ss_pred             cCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCcccccc
Q 002883            6 IPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLL   85 (871)
Q Consensus         6 ~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l   85 (871)
                      +|..+..  .++.|||++|+|++..|.+|+++++|++|+|++|++++..|++|+++++|++|+|++|++++..|..|+++
T Consensus        27 iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l  104 (606)
T 3t6q_A           27 IPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP  104 (606)
T ss_dssp             CCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSC
T ss_pred             CcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhccc
Confidence            4444432  45555555555555555555555555555555555555555555555555555555555554445555555


Q ss_pred             ccccccccccccccCCCCccccccCCCceeeeeccccccc-cccccccCCCCccEEEccCccCC----------------
Q 002883           86 KQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGE-IPHYVGFTLPNIRVLLLGSNWFT----------------  148 (871)
Q Consensus        86 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~~l~~L~~L~l~~n~i~----------------  148 (871)
                      ++|++|++++|++++..+..+.++++|++|++++|.+.+. +|...  .+++|++|++++|.++                
T Consensus       105 ~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l  182 (606)
T 3t6q_A          105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGF--PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL  182 (606)
T ss_dssp             TTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTC--CCTTCCEEECCSSCCCEECHHHHHTTTTCCSE
T ss_pred             ccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCccccc--CCcccCEEEcccCcccccChhhhhhhccccee
Confidence            5555555555555543344555555555555555555421 12222  2555555555555554                


Q ss_pred             ----------CCCCccCcCC--------------------------------------CCC-CccccCCC--cccEEecc
Q 002883          149 ----------GEIPPSISNA--------------------------------------SSI-PEDLGKLK--NLIRLNFA  177 (871)
Q Consensus       149 ----------~~~p~~~~~~--------------------------------------~~l-p~~~~~l~--~L~~L~l~  177 (871)
                                +..|..+...                                      ..+ +..+..+.  +|+.|+++
T Consensus       183 ~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~  262 (606)
T 3t6q_A          183 SLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ  262 (606)
T ss_dssp             EEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECT
T ss_pred             EEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEee
Confidence                      3333222110                                      000 00111111  56666666


Q ss_pred             cccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeeccc
Q 002883          178 RNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEV  257 (871)
Q Consensus       178 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~  257 (871)
                      +|.++.++.      ..+..+++|++|++++|.++ .+|..+..+ ++|++|++++|++++..|..+..+++|+.|++++
T Consensus       263 ~n~l~~~~~------~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  334 (606)
T 3t6q_A          263 KHYFFNISS------NTFHCFSGLQELDLTATHLS-ELPSGLVGL-STLKKLVLSANKFENLCQISASNFPSLTHLSIKG  334 (606)
T ss_dssp             TCCCSSCCT------TTTTTCTTCSEEECTTSCCS-CCCSSCCSC-TTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCS
T ss_pred             cCccCccCH------HHhccccCCCEEeccCCccC-CCChhhccc-ccCCEEECccCCcCcCchhhhhccCcCCEEECCC
Confidence            666665443      33667888999999999998 678877776 4699999999999887788899999999999999


Q ss_pred             ccccccCCc-cccCCCCCcEEEccCCCCCCCC--CcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCC
Q 002883          258 NLLTGSIPT-SVGYLLKLQVLSLFGNKISGEI--PSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSG  334 (871)
Q Consensus       258 N~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~  334 (871)
                      |.+.+..+. .+..+++|++|++++|++++..  +..+..+++|++|++++|++.+..|..|..+++|+.|++++|++++
T Consensus       335 n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  414 (606)
T 3t6q_A          335 NTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV  414 (606)
T ss_dssp             CSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEEC
T ss_pred             CCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCC
Confidence            988855544 5889999999999999998655  7789999999999999999998888999999999999999999987


Q ss_pred             CCcc-cccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCC---CccchhcccCCceeeecCCcccccCcc
Q 002883          335 TIPR-EVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGE---IPTSLASCVGLEYLNFSDNSFQGPIHS  410 (871)
Q Consensus       335 ~~~~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~L~~N~l~~~~~~  410 (871)
                      ..+. .+..+++|+.|++++|.+++..|..+..+++|++|++++|++++.   .+..+..+++|++|+|++|++++..|.
T Consensus       415 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~  494 (606)
T 3t6q_A          415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH  494 (606)
T ss_dssp             CTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTT
T ss_pred             cccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChh
Confidence            6654 488999999999999999988888999999999999999999862   346789999999999999999999999


Q ss_pred             ccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCC-cccccccceeccCCCCCccCCCc
Q 002883          411 GFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE-GVFKNVRAVSIIGNNKLCGGSPE  482 (871)
Q Consensus       411 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~C~~~~~  482 (871)
                      .|..+++|++|+|++|++++..|..+..+++| .|++++|++++.+|.. ..+++++.+++.+|||.|+|...
T Consensus       495 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~  566 (606)
T 3t6q_A          495 AFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI  566 (606)
T ss_dssp             TTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGH
T ss_pred             hhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcH
Confidence            99999999999999999999999999999999 9999999999877753 56788999999999999999753

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2e-53  Score=508.97  Aligned_cols=474  Identities=23%  Similarity=0.212  Sum_probs=340.5

Q ss_pred             cccCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCcccc
Q 002883            4 GEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELG   83 (871)
Q Consensus         4 ~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~   83 (871)
                      +..|..|.++++|++|+|++|.+++..|++|+++++|++|+|++|++++..+.+|+++++|++|+|++|++++..|..|+
T Consensus        39 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  118 (680)
T 1ziw_A           39 RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV  118 (680)
T ss_dssp             CCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTT
T ss_pred             CcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHcc
Confidence            33344577778888888888888777777788888888888888888755555688888888888888888755567788


Q ss_pred             ccccccccccccccccCCCCccccccCCCceeeeeccccccccccccc-cCCCCccEEEccCccCCCCCCccCcCCCC--
Q 002883           84 LLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVG-FTLPNIRVLLLGSNWFTGEIPPSISNASS--  160 (871)
Q Consensus        84 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~~l~~L~~L~l~~n~i~~~~p~~~~~~~~--  160 (871)
                      ++++|++|++++|.+++..|..+.++++|++|++++|.+.+..+..+. ..+++|+.|++++|.+++..|..+.....  
T Consensus       119 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~  198 (680)
T 1ziw_A          119 KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLF  198 (680)
T ss_dssp             TCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEEC
T ss_pred             ccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhh
Confidence            888888888888888777777777788888888888877644443321 24577888888888777666654432211  


Q ss_pred             ---------------------------------------CCccccCCCc--ccEEecccccCCCCCCCCccccccccCCC
Q 002883          161 ---------------------------------------IPEDLGKLKN--LIRLNFARNNLGTGKGNDLRFLDSLVNCT  199 (871)
Q Consensus       161 ---------------------------------------lp~~~~~l~~--L~~L~l~~n~l~~~~~~~~~~~~~l~~l~  199 (871)
                                                             .|..|..++.  |++|++++|+++.+++      ..+..++
T Consensus       199 ~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~------~~~~~l~  272 (680)
T 1ziw_A          199 GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN------DSFAWLP  272 (680)
T ss_dssp             EEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECT------TTTTTCT
T ss_pred             hhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCc------ccccCcc
Confidence                                                   1334444443  7777777777665432      3355666


Q ss_pred             cccEEEccCCcCcccCChhhhhc--------------------------------cccccEEEccCCccCCCCCCCCCCc
Q 002883          200 FLEVVSLSSNSLSGVLPNSIANF--------------------------------SSHLIYLYMSANRISGTIPTGVGNL  247 (871)
Q Consensus       200 ~L~~L~L~~n~l~~~~~~~~~~~--------------------------------~~~L~~L~L~~n~i~~~~~~~~~~l  247 (871)
                      +|++|+|++|++++..|..+..+                                .++|++|++++|++++..+..|.++
T Consensus       273 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  352 (680)
T 1ziw_A          273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL  352 (680)
T ss_dssp             TCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTC
T ss_pred             cccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccc
Confidence            77777777777665544433221                                1346666666666666656666665


Q ss_pred             cccceeeccc----------------------------ccccccCCccccCCCCCcEEEccCCCCCCCCC-cccCCCccc
Q 002883          248 KNLILIAMEV----------------------------NLLTGSIPTSVGYLLKLQVLSLFGNKISGEIP-SSLGNLIFL  298 (871)
Q Consensus       248 ~~L~~L~l~~----------------------------N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L  298 (871)
                      ++|++|++++                            |.+++..|.+|..+++|+.|+|++|++.+.+| ..|.++++|
T Consensus       353 ~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L  432 (680)
T 1ziw_A          353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENI  432 (680)
T ss_dssp             TTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTC
T ss_pred             cCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccc
Confidence            5555555544                            34444455566666666666666666654333 456666666


Q ss_pred             cEEEccCccccccCcccccCCCCCCEEecCCCcCC--CCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCC
Q 002883          299 TEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLS--GTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLS  376 (871)
Q Consensus       299 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~  376 (871)
                      ++|++++|++.+..+..|..+++|+.|++++|.++  +..|..|..+++|+.|++++|++++..+..|..+++|++|+|+
T Consensus       433 ~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls  512 (680)
T 1ziw_A          433 FEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQ  512 (680)
T ss_dssp             CEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             cEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCC
Confidence            66777766666666666777777777777777765  4567788889999999999999997777788999999999999


Q ss_pred             CCcCCCCCc--------cchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecC
Q 002883          377 ENKLSGEIP--------TSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLS  448 (871)
Q Consensus       377 ~N~l~~~~~--------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~  448 (871)
                      +|++++..+        ..|..+++|++|+|++|+++.+++..|.++++|+.|+|++|++++..+..|..+++|+.|+|+
T Consensus       513 ~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~  592 (680)
T 1ziw_A          513 HNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQ  592 (680)
T ss_dssp             SSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECC
Confidence            999885422        237888999999999999997777789999999999999999998878888999999999999


Q ss_pred             CCcCcccCCCC-c-ccccccceeccCCCCCccCCC-cc
Q 002883          449 FNNLEGEVPSE-G-VFKNVRAVSIIGNNKLCGGSP-EL  483 (871)
Q Consensus       449 ~N~l~~~~~~~-~-~~~~l~~l~l~~N~~~C~~~~-~~  483 (871)
                      +|++++..+.. . .+++++.+++.+|||.|+|.. .|
T Consensus       593 ~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~  630 (680)
T 1ziw_A          593 KNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAW  630 (680)
T ss_dssp             TSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSS
T ss_pred             CCcCCccChhHhcccccccCEEEccCCCcccCCccHHH
Confidence            99999876653 2 578899999999999999985 44

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=4.6e-53  Score=515.32  Aligned_cols=459  Identities=20%  Similarity=0.172  Sum_probs=305.5

Q ss_pred             CCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccC-CccccCCcccceeeccCccccCCCCccccccccccccc
Q 002883           14 SELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSI-PQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQ   92 (871)
Q Consensus        14 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~   92 (871)
                      ++|+.|||++|.|++..|.+|+++++|++|+|++|...+.+ |++|+++++|++|+|++|.+++..|+.|+++++|++|+
T Consensus        24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  103 (844)
T 3j0a_A           24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR  103 (844)
T ss_dssp             TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred             CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence            57788888888887777778888888888888888544344 67788888888888888888766777888888888888


Q ss_pred             cccccccCCCCcc--ccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCC------------
Q 002883           93 VSANYLTGSIPIQ--LFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNA------------  158 (871)
Q Consensus        93 l~~n~l~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~------------  158 (871)
                      |++|.+++.+|..  +.++++|++|+|++|.+.+..+...+..+++|++|+|++|.+++..|..+..+            
T Consensus       104 Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~  183 (844)
T 3j0a_A          104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA  183 (844)
T ss_dssp             CTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECC
T ss_pred             CcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCC
Confidence            8888887655554  77788888888888877755454444577888888888887775444333211            


Q ss_pred             ----CCCCccccCCCc------ccEEecccccCCCCCCCCccc------------------------------cccccC-
Q 002883          159 ----SSIPEDLGKLKN------LIRLNFARNNLGTGKGNDLRF------------------------------LDSLVN-  197 (871)
Q Consensus       159 ----~~lp~~~~~l~~------L~~L~l~~n~l~~~~~~~~~~------------------------------~~~l~~-  197 (871)
                          ...|..++.+.+      |+.|++++|.+.......+..                              ...+.. 
T Consensus       184 n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l  263 (844)
T 3j0a_A          184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGL  263 (844)
T ss_dssp             SBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTT
T ss_pred             CccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhcc
Confidence                011222222222      555555555544321111000                              000111 


Q ss_pred             -CCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcE
Q 002883          198 -CTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQV  276 (871)
Q Consensus       198 -l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  276 (871)
                       .++|++|+|++|.+++..|..+..+ ++|+.|+|++|+|++..|..|.++++|+.|+|++|.+++..+..|..+++|+.
T Consensus       264 ~~~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  342 (844)
T 3j0a_A          264 ARSSVRHLDLSHGFVFSLNSRVFETL-KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY  342 (844)
T ss_dssp             TTSCCCEEECTTCCCCEECSCCSSSC-CCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCE
T ss_pred             ccCCccEEECCCCcccccChhhhhcC-CCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCE
Confidence             1455556666665554444444444 34666666666665555555555666666666666655555555555666666


Q ss_pred             EEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcc------------------
Q 002883          277 LSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPR------------------  338 (871)
Q Consensus       277 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~------------------  338 (871)
                      |+|++|++....+..|..+++|++|+|++|.+++. +    .+++|+.|++++|+++ .+|.                  
T Consensus       343 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l~~N~l~-~l~~~~~~l~~L~ls~N~l~~l  416 (844)
T 3j0a_A          343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLENL  416 (844)
T ss_dssp             EECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEEESCCCC-CCCCCCTTCCEEECCSCCCCSS
T ss_pred             EECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhccCCCCcc-cccccccccceeecccCccccC
Confidence            66666665555555555556666666666555521 1    1333333333333333 1111                  


Q ss_pred             ----cccCCCCCcEEeccCCCCCCCCcc-ccCCCCCCCEEeCCCCcCC-----CCCccchhcccCCceeeecCCcccccC
Q 002883          339 ----EVIGLSSFVLLDLSRNHLSGPIPL-EVGRLKGIQQLDLSENKLS-----GEIPTSLASCVGLEYLNFSDNSFQGPI  408 (871)
Q Consensus       339 ----~~~~l~~L~~L~ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~  408 (871)
                          .+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++     +..+..|..+++|++|+|++|+|++.+
T Consensus       417 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  496 (844)
T 3j0a_A          417 DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLP  496 (844)
T ss_dssp             TTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCC
T ss_pred             chhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccC
Confidence                234678888888888888754432 4566888999999999887     344567889999999999999999999


Q ss_pred             ccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCCcccccccceeccCCCCCccCCCcc
Q 002883          409 HSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       409 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      +..|.++++|+.|+|++|+|++..+..+.  ++|+.|+|++|++++..|..  +.++..+++.+|||.|+|...+
T Consensus       497 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~~~~  567 (844)
T 3j0a_A          497 PGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECELST  567 (844)
T ss_dssp             TTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSSCCS
T ss_pred             hhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccccccHH
Confidence            99999999999999999999987777776  89999999999999988754  7789999999999999997644

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=9.9e-53  Score=496.06  Aligned_cols=467  Identities=19%  Similarity=0.177  Sum_probs=384.6

Q ss_pred             ccCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccc
Q 002883            5 EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGL   84 (871)
Q Consensus         5 ~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~   84 (871)
                      ++|..+.  +.|+.|+|++|++++..+.+|+++++|++|+|++|++++..|++|+++++|++|+|++|++++..|..|++
T Consensus        25 ~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~  102 (606)
T 3vq2_A           25 KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG  102 (606)
T ss_dssp             SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTT
T ss_pred             cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCC
Confidence            4666665  67889999999998777888889999999999999988777888888999999999999888777888889


Q ss_pred             cccccccccccccccCCCCccccccCCCceeeeecccccc-ccccccccCCCCccEEEccCccCCCCCCccCcCCC----
Q 002883           85 LKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVG-EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNAS----  159 (871)
Q Consensus        85 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~----  159 (871)
                      +++|++|++++|++++..+..++++++|++|++++|.+.+ .+|..+. .+++|+.|++++|.+++..|..+..+.    
T Consensus       103 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~  181 (606)
T 3vq2_A          103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS-NLTNLVHVDLSYNYIQTITVNDLQFLRENPQ  181 (606)
T ss_dssp             CTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGG-TCTTCCEEECCSSCCCEECTTTTHHHHHCTT
T ss_pred             cccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHh-hcCCCCEEEccCCcceecChhhhhhhhcccc
Confidence            9999999999999886666788889999999999988875 4676655 788999999999988865554432221    


Q ss_pred             -------------CCCccccCCCcccEEecccccCCC-------------------------------------------
Q 002883          160 -------------SIPEDLGKLKNLIRLNFARNNLGT-------------------------------------------  183 (871)
Q Consensus       160 -------------~lp~~~~~l~~L~~L~l~~n~l~~-------------------------------------------  183 (871)
                                   .+|.......+|++|++++|.+..                                           
T Consensus       182 ~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l  261 (606)
T 3vq2_A          182 VNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV  261 (606)
T ss_dssp             CCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGS
T ss_pred             ccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhc
Confidence                         233333333467777777776530                                           


Q ss_pred             --------CCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeec
Q 002883          184 --------GKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAM  255 (871)
Q Consensus       184 --------~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l  255 (871)
                              ...........+..+++|+.|++++|.++ .+| .+..+ ++|++|++++|++. .+| .+ .+++|+.|++
T Consensus       262 ~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~-~l~-~l~~~-~~L~~L~l~~n~l~-~lp-~~-~l~~L~~L~l  335 (606)
T 3vq2_A          262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLE-DVPKH-FKWQSLSIIRCQLK-QFP-TL-DLPFLKSLTL  335 (606)
T ss_dssp             EEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCC-CCC-CCCTT-CCCSEEEEESCCCS-SCC-CC-CCSSCCEEEE
T ss_pred             cHhheeccccccccccccccccCCCCCEEEecCccch-hhh-hcccc-ccCCEEEcccccCc-ccc-cC-CCCccceeec
Confidence                    00000001122566788888888888887 455 55555 46999999999994 666 45 8999999999


Q ss_pred             ccccccccCCccccCCCCCcEEEccCCCCCCC--CCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCC
Q 002883          256 EVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE--IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLS  333 (871)
Q Consensus       256 ~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  333 (871)
                      ++|...+..  .+..+++|++|++++|++++.  .+..+..+++|++|+|++|.+++ +|..|..+++|+.|++++|++.
T Consensus       336 ~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~  412 (606)
T 3vq2_A          336 TMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLK  412 (606)
T ss_dssp             ESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEE
T ss_pred             cCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccC
Confidence            999655333  677899999999999999865  37889999999999999999984 6688999999999999999999


Q ss_pred             CCCc-ccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCC-CCccchhcccCCceeeecCCcccccCccc
Q 002883          334 GTIP-REVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSG-EIPTSLASCVGLEYLNFSDNSFQGPIHSG  411 (871)
Q Consensus       334 ~~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  411 (871)
                      +..+ ..+..+++|++|++++|.+++..|..+..+++|++|++++|.+++ ..|..|..+++|++|+|++|++++..+..
T Consensus       413 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~  492 (606)
T 3vq2_A          413 RVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV  492 (606)
T ss_dssp             STTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred             CccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhh
Confidence            7777 689999999999999999998889999999999999999999997 47889999999999999999999999999


Q ss_pred             cCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCCcccc-cccceeccCCCCCccCCCcc
Q 002883          412 FSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFK-NVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       412 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~~-~l~~l~l~~N~~~C~~~~~~  483 (871)
                      |..+++|++|++++|++++..|..+..+++|++|++++|+++..++....++ +++.+++.+|||.|+|+..|
T Consensus       493 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~  565 (606)
T 3vq2_A          493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQK  565 (606)
T ss_dssp             TTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTTHH
T ss_pred             hcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCccHH
Confidence            9999999999999999999889999999999999999999997666555565 59999999999999998754

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=2.1e-51  Score=484.78  Aligned_cols=453  Identities=21%  Similarity=0.201  Sum_probs=306.1

Q ss_pred             CCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCcccccccccccccccc
Q 002883           16 LRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSA   95 (871)
Q Consensus        16 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~   95 (871)
                      -+.++.++..++ .+|..+..  ++++|+|++|+|++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus        14 ~~~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~   90 (606)
T 3t6q_A           14 NKTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTA   90 (606)
T ss_dssp             TTEEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             CceEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCC
Confidence            457999999998 78887765  799999999999988899999999999999999999988899999999999999999


Q ss_pred             ccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCC-------------CC-
Q 002883           96 NYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNAS-------------SI-  161 (871)
Q Consensus        96 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~-------------~l-  161 (871)
                      |++++..|..|.++++|++|++++|.+. .++...+..+++|++|++++|.+++..++.+....             .+ 
T Consensus        91 n~l~~~~~~~~~~l~~L~~L~L~~n~i~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  169 (606)
T 3t6q_A           91 NPLIFMAETALSGPKALKHLFFIQTGIS-SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS  169 (606)
T ss_dssp             CCCSEECTTTTSSCTTCCEEECTTSCCS-CGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEEC
T ss_pred             CcccccChhhhcccccccEeeccccCcc-cCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccC
Confidence            9999888999999999999999999998 45444456999999999999999853222211111             11 


Q ss_pred             CccccCCCccc--EEecccccCCCCCCCCcccc-------------------------------------------cccc
Q 002883          162 PEDLGKLKNLI--RLNFARNNLGTGKGNDLRFL-------------------------------------------DSLV  196 (871)
Q Consensus       162 p~~~~~l~~L~--~L~l~~n~l~~~~~~~~~~~-------------------------------------------~~l~  196 (871)
                      |+.++.+++|+  .|++++|+++.+++..+...                                           ..+.
T Consensus       170 ~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~  249 (606)
T 3t6q_A          170 KEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE  249 (606)
T ss_dssp             HHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGG
T ss_pred             hhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhc
Confidence            23344555555  55555555554433222110                                           0000


Q ss_pred             CC--CcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCC
Q 002883          197 NC--TFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKL  274 (871)
Q Consensus       197 ~l--~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  274 (871)
                      .+  .+|++|++++|.+++..+..+..+ ++|++|++++|+++ .+|..+.++++|++|++++|.+++..|..+..+++|
T Consensus       250 ~l~~~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  327 (606)
T 3t6q_A          250 GLCEMSVESINLQKHYFFNISSNTFHCF-SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL  327 (606)
T ss_dssp             GGGGSEEEEEECTTCCCSSCCTTTTTTC-TTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTC
T ss_pred             hhhcCceeEEEeecCccCccCHHHhccc-cCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcC
Confidence            00  045566666666654444444444 35666666666666 455666666666666666666665556666666666


Q ss_pred             cEEEccCCCCCCCCC-cccCCCccccEEEccCccccccC--cccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEec
Q 002883          275 QVLSLFGNKISGEIP-SSLGNLIFLTEVDLQGNSIRGSI--PSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDL  351 (871)
Q Consensus       275 ~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  351 (871)
                      ++|++++|.+.+..+ ..+..+++|++|++++|++++..  +..+..+++|++|++++|++++..|..+..+++|++|++
T Consensus       328 ~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  407 (606)
T 3t6q_A          328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL  407 (606)
T ss_dssp             SEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEEC
T ss_pred             CEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEEC
Confidence            666666666654333 33666666666666666666444  556666666777777777666666666666667777777


Q ss_pred             cCCCCCCCCcc-ccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCccccc---CccccCCCCCCCEEeCCCCc
Q 002883          352 SRNHLSGPIPL-EVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP---IHSGFSSLKGLQDLDLSRNN  427 (871)
Q Consensus       352 s~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~l~~N~  427 (871)
                      ++|.+++..+. .+..+++|+.|++++|.+++..|..+..+++|++|++++|++++.   .+..+..+++|++|++++|+
T Consensus       408 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~  487 (606)
T 3t6q_A          408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD  487 (606)
T ss_dssp             TTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSC
T ss_pred             CCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCc
Confidence            77766654443 366666777777777776666666666667777777777766642   22456666677777777777


Q ss_pred             CCCCCcccccccccccEEecCCCcCcccCCCC-cccccccceeccCCCC
Q 002883          428 FSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE-GVFKNVRAVSIIGNNK  475 (871)
Q Consensus       428 l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~  475 (871)
                      +++..|..+..+++|++|+|++|++++..|.. ..++.+ .+++.+|..
T Consensus       488 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l  535 (606)
T 3t6q_A          488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI  535 (606)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCC
T ss_pred             cCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcc
Confidence            76666666666777777777777776655432 334445 566666654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.9e-52  Score=438.83  Aligned_cols=266  Identities=25%  Similarity=0.383  Sum_probs=213.1

Q ss_pred             cCCCCCceeeccccceEEEEEEC-----CCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILG-----TEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ++|.+.+.||+|+||+||+|++.     .+++.||||+++.......+.|.+|++++++++|||||+++++|.+.     
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-----   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-----   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----
Confidence            46888999999999999999974     35788999999876666678899999999999999999999999765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhccccc------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDE------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE  707 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  707 (871)
                      +..|+|||||++|+|.++++..+..      ......+++.++..++.|||.||+|||++   +||||||||+|||++.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence            5689999999999999999765321      11233699999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHH
Q 002883          708 MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHK  786 (871)
Q Consensus       708 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~  786 (871)
                      +.+||+|||+|+...... .........||+.|||||++.++.|+.++|||||||++|||+| |+.||........ ...
T Consensus       165 ~~~Ki~DFGla~~~~~~~-~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~-~~~  242 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-IEC  242 (299)
T ss_dssp             GCEEECCCSCHHHHTGGG-CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHH
T ss_pred             CcEEECCcccceecCCCC-ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHH
Confidence            999999999998764322 1222333568999999999999999999999999999999999 9999986433221 111


Q ss_pred             HhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          787 YAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       787 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      ......++. .                              ..++.++.+++.+||+.||++|||++|+.+.|+++.+.
T Consensus       243 i~~~~~~~~-p------------------------------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          243 ITQGRVLQR-P------------------------------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHTCCCCC-C------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHcCCCCCC-C------------------------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            111111100 0                              12334677999999999999999999999999988764

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-51  Score=439.11  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=209.9

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      ..|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|+++++.++|||||+++++|.+.     +.+|+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEE
Confidence            5699999999999999999999999999999999766655667789999999999999999999999876     67999


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      |||||+||+|.+++...        .+++.++..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|
T Consensus       149 vmEy~~gg~L~~~l~~~--------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla  217 (346)
T 4fih_A          149 VMEFLEGGALTDIVTHT--------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFC  217 (346)
T ss_dssp             EECCCTTEEHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEeCCCCCcHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCc
Confidence            99999999999999753        489999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE  798 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  798 (871)
                      +.+....   ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.......  ....+....+.... 
T Consensus       218 ~~~~~~~---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~~~~~~~~-  291 (346)
T 4fih_A          218 AQVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRDNLPPRLK-  291 (346)
T ss_dssp             EECCSSS---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSSCCCCS-
T ss_pred             eecCCCC---CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHcCCCCCCC-
Confidence            9875432   22344689999999999999999999999999999999999999997543221  11111111111100 


Q ss_pred             hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                                 ....+..++.+++.+||+.||++|||++|+++
T Consensus       292 ---------------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 ---------------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ---------------------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                                       00123346779999999999999999999986

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.8e-52  Score=434.72  Aligned_cols=261  Identities=25%  Similarity=0.414  Sum_probs=202.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||+||+|++..   .||||+++...  ....+.|.+|++++++++|||||++++++.+      +.
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence            4578889999999999999999753   59999986433  3345789999999999999999999998743      34


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+|||||++|+|.+++.....      .+++.++..|+.|||.||+|||++   +||||||||+|||+++++.+||+||
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~~------~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DF  176 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQET------KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDF  176 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSCC------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCC
T ss_pred             EEEEEEcCCCCCHHHHHhhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeec
Confidence            7999999999999999976432      599999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA---LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |+|+...... .........||+.|||||++.   .++|+.++|||||||++|||+||+.||.+................
T Consensus       177 Gla~~~~~~~-~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~  255 (307)
T 3omv_A          177 GLATVKSRWS-GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA  255 (307)
T ss_dssp             SSCBC-------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC
T ss_pred             cCceecccCC-cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence            9998765432 122234467999999999875   346899999999999999999999999754322221111111111


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      ++...+                           ....++.++.+++.+||+.||++|||+.||++.|+.++.
T Consensus       256 ~p~~~~---------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          256 SPDLSK---------------------------LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             CCCSTT---------------------------SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             CCCccc---------------------------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            111111                           111334567899999999999999999999999988764

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.3e-49  Score=475.86  Aligned_cols=460  Identities=20%  Similarity=0.223  Sum_probs=301.3

Q ss_pred             ccCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccc
Q 002883            5 EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGL   84 (871)
Q Consensus         5 ~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~   84 (871)
                      ++|..+.  ++++.|+|++|+|++..+.+|+++++|++|+|++|++++..|+.|+++++|++|+|++|.+++..+..|++
T Consensus        18 ~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~   95 (680)
T 1ziw_A           18 QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF   95 (680)
T ss_dssp             SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhcc
Confidence            5787776  68999999999999888889999999999999999999989999999999999999999999555557999


Q ss_pred             cccccccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCcc
Q 002883           85 LKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPED  164 (871)
Q Consensus        85 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~  164 (871)
                      +++|++|+|++|++++..|..|.++++|++|++++|.+.+..|..+ ..+++|++|++++|.+++..|..+.        
T Consensus        96 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~--------  166 (680)
T 1ziw_A           96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQ-VQLENLQELLLSNNKIQALKSEELD--------  166 (680)
T ss_dssp             CTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSS-SCCTTCCEEECCSSCCCCBCHHHHG--------
T ss_pred             CCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhh-cccccCCEEEccCCcccccCHHHhh--------
Confidence            9999999999999997777889999999999999999986655554 4899999999999999843322111        


Q ss_pred             ccCCCcccEEecccccCCCCCCCCcccccccc---------------------CCCcccEEEccCCcCcccCChhhhhcc
Q 002883          165 LGKLKNLIRLNFARNNLGTGKGNDLRFLDSLV---------------------NCTFLEVVSLSSNSLSGVLPNSIANFS  223 (871)
Q Consensus       165 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~---------------------~l~~L~~L~L~~n~l~~~~~~~~~~~~  223 (871)
                      +..+++|++|++++|+++.+.+..+..+..+.                     ..++|+.|++++|.+++..|..+..+.
T Consensus       167 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~  246 (680)
T 1ziw_A          167 IFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK  246 (680)
T ss_dssp             GGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGG
T ss_pred             ccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccC
Confidence            22456777777777777766554332222111                     113445555555555444444444332


Q ss_pred             -ccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCc---------------------------------ccc
Q 002883          224 -SHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPT---------------------------------SVG  269 (871)
Q Consensus       224 -~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~---------------------------------~~~  269 (871)
                       ++|+.|++++|++++..|..|..+++|++|++++|.+++..|.                                 .|.
T Consensus       247 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~  326 (680)
T 1ziw_A          247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQ  326 (680)
T ss_dssp             GSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTT
T ss_pred             cCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcc
Confidence             1255555555555444444455555555555555544433333                                 344


Q ss_pred             CCCCCcEEEccCCCCCCCCCcccCCCccccEEEccC----------------------------ccccccCcccccCCCC
Q 002883          270 YLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQG----------------------------NSIRGSIPSALGNCLQ  321 (871)
Q Consensus       270 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~----------------------------N~i~~~~~~~~~~l~~  321 (871)
                      .+++|++|++++|++++..+..|.++++|++|++++                            |++++..|.+|..+++
T Consensus       327 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~  406 (680)
T 1ziw_A          327 WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGH  406 (680)
T ss_dssp             TCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             cCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCC
Confidence            455555556666666655555555555555444443                            3444444556666666


Q ss_pred             CCEEecCCCcCCCCCc-ccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCC--CCCccchhcccCCceee
Q 002883          322 LQKLDLSDNNLSGTIP-REVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLS--GEIPTSLASCVGLEYLN  398 (871)
Q Consensus       322 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~  398 (871)
                      |+.|++++|.+++.+| ..+.++++|++|++++|++.+..+..|..+++|+.|++++|.++  +..|..|..+++|+.|+
T Consensus       407 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~  486 (680)
T 1ziw_A          407 LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD  486 (680)
T ss_dssp             CCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEE
T ss_pred             CCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEE
Confidence            6666666666654333 45666666666666666665444455555555555555555554  34556666666777777


Q ss_pred             ecCCcccccCccccCCCCCCCEEeCCCCcCCCCCc--------ccccccccccEEecCCCcCcccCCC-Cccccccccee
Q 002883          399 FSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP--------MFLNTFRFLQKLNLSFNNLEGEVPS-EGVFKNVRAVS  469 (871)
Q Consensus       399 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~--------~~~~~~~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~  469 (871)
                      |++|+|+++.+..|.++++|++|++++|++++..+        ..+..+++|+.|+|++|+++..++. ...++.++.++
T Consensus       487 Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~  566 (680)
T 1ziw_A          487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIID  566 (680)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeE
Confidence            77777766666666666677777777776664311        2356666666666666666644332 23455666666


Q ss_pred             ccCCCC
Q 002883          470 IIGNNK  475 (871)
Q Consensus       470 l~~N~~  475 (871)
                      +.+|..
T Consensus       567 Ls~N~l  572 (680)
T 1ziw_A          567 LGLNNL  572 (680)
T ss_dssp             CCSSCC
T ss_pred             CCCCCC
Confidence            666643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.2e-52  Score=442.32  Aligned_cols=252  Identities=19%  Similarity=0.277  Sum_probs=203.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...  ....+.+.+|++++++++|||||++++++.+.     +.
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-----~~   97 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-----GS   97 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-----CE
Confidence            368999999999999999999999999999999996543  23456789999999999999999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+|||||+||+|.+++...+..     .+++.+++.++.||+.||+|||++   +||||||||+|||++.++.+||+||
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DF  169 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGV-----LFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDF  169 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECST
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccc
Confidence            89999999999999999765422     579999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |+|+.....   .......+||+.|||||++.+..|+.++||||+||++|||+||+.||....... .+........++.
T Consensus       170 Gla~~~~~~---~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~~~  245 (350)
T 4b9d_A          170 GIARVLNST---VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIISGSFPPV  245 (350)
T ss_dssp             TEESCCCHH---HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCCCC
T ss_pred             ccceeecCC---cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCCCCC
Confidence            999875421   122344679999999999999999999999999999999999999998543222 1122222211110


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       .                              ..++.++.+++.+||+.||++|||++|+++
T Consensus       246 -~------------------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 -S------------------------------LHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -C------------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -C------------------------------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0                              012345779999999999999999999986

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-51  Score=439.19  Aligned_cols=266  Identities=26%  Similarity=0.378  Sum_probs=206.8

Q ss_pred             cCCCCCceeeccccceEEEEEEC-----CCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILG-----TEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ++|.+.+.||+|+||+||+|++.     .+++.||||+++.......+.|.+|++++++++|||||+++++|.+.     
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-----  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG-----  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----
Confidence            45777899999999999999975     35788999999876666678899999999999999999999999765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccc--------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQ--------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD  705 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  705 (871)
                      ...|+|||||++|+|.++++......        ....++++.+++.|+.|||.||+|||+.   +||||||||+|||++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence            56899999999999999998654211        1233699999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhH
Q 002883          706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSL  784 (871)
Q Consensus       706 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~  784 (871)
                      .++.+||+|||+|+...... .........||+.|||||++.+..|+.++|||||||++|||+| |+.||........  
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~-~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~--  269 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTD-YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA--  269 (329)
T ss_dssp             TTTEEEECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH--
T ss_pred             CCCcEEEcccccceeccCCC-cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH--
Confidence            99999999999998765432 1222334579999999999999999999999999999999999 9999986433221  


Q ss_pred             HHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          785 HKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      ........+....                              ..+++++.+++.+||+.||++|||++||++.|+.+.+
T Consensus       270 ~~~i~~g~~~~~p------------------------------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          270 IDCITQGRELERP------------------------------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHHHTCCCCCC------------------------------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCc------------------------------ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            1111111100000                              0233467799999999999999999999999998865


Q ss_pred             H
Q 002883          865 M  865 (871)
Q Consensus       865 ~  865 (871)
                      .
T Consensus       320 ~  320 (329)
T 4aoj_A          320 A  320 (329)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.7e-51  Score=426.11  Aligned_cols=251  Identities=25%  Similarity=0.385  Sum_probs=201.4

Q ss_pred             CC-CCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          560 GF-SSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       560 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      +| ++.+.||+|+||+||+|++..+++.||+|++....  ....+.+.+|++++++++|||||+++++|.+. ..+...+
T Consensus        26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~  104 (290)
T 3fpq_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI  104 (290)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEE
T ss_pred             ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEE
Confidence            44 56778999999999999999999999999996432  33456789999999999999999999998653 2233668


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCceeeCC-CCceEEe
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS--IVHCDLKPSNVLLDN-EMVAHVG  713 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~-~~~~kl~  713 (871)
                      |+|||||+||+|.+++....       .+++..+..++.||+.||+|||++   +  ||||||||+|||++. ++.+||+
T Consensus       105 ~lvmEy~~gg~L~~~l~~~~-------~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~  174 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRFK-------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred             EEEEeCCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEE
Confidence            99999999999999998654       689999999999999999999998   6  999999999999974 7999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||+|+....     ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+................|
T Consensus       175 DFGla~~~~~-----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~  248 (290)
T 3fpq_A          175 DLGLATLKRA-----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP  248 (290)
T ss_dssp             CTTGGGGCCT-----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred             eCcCCEeCCC-----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC
Confidence            9999986432     22334679999999998764 69999999999999999999999997533222222221111111


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ......                              ..+++.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~------------------------------~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          249 ASFDKV------------------------------AIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGGGC------------------------------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCcc------------------------------CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111111                              1234678999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.5e-51  Score=435.24  Aligned_cols=260  Identities=22%  Similarity=0.206  Sum_probs=208.8

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .+.|++.++||+|+||+||+|++..+++.||||+++....     ..+|+.+++.++|||||++++++.+.     ..+|
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~-----~~~~  126 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREG-----PWVN  126 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEE
Confidence            3468888999999999999999999999999999975432     24699999999999999999998765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEEeecc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM-VAHVGDFG  716 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg  716 (871)
                      +|||||+||+|.++++..+       .+++.++..++.||+.||+|||++   +||||||||+|||++.++ .+||+|||
T Consensus       127 ivmEy~~gg~L~~~l~~~~-------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFG  196 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQMG-------CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFG  196 (336)
T ss_dssp             EEECCCTTCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCT
T ss_pred             EEEeccCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCC
Confidence            9999999999999998654       599999999999999999999999   999999999999999988 69999999


Q ss_pred             cceecCCCCCCcc--ccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          717 LSRLLHDNSPDQT--STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       717 ~a~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      +|+.+........  .....+||+.|||||++.+..|+.++||||+||++|||+||+.||........ .........+ 
T Consensus       197 la~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~~~-  274 (336)
T 4g3f_A          197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEPPP-  274 (336)
T ss_dssp             TCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSCCG-
T ss_pred             CCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCCCC-
Confidence            9998764322211  22345799999999999999999999999999999999999999975432221 1111111100 


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQ  867 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~~  867 (871)
                       ..+                           ....++..+.+++.+||+.||++||||.|+++.|..+.....
T Consensus       275 -~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          275 -IRE---------------------------IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             -GGG---------------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             -chh---------------------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence             000                           001234467789999999999999999999999988765543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.5e-51  Score=431.24  Aligned_cols=249  Identities=20%  Similarity=0.300  Sum_probs=208.2

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||+||+|++..+++.||||+++..   .....+.+.+|++++++++|||||+++++|.+.     ..
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----EK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CE
Confidence            5799999999999999999999999999999999643   233457889999999999999999999998775     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+|||||+||+|.++++..+       .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~-------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DF  176 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIG-------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDF  176 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEecCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEc
Confidence            999999999999999998754       599999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |+|+.+.... ........+||+.|||||++.+..|+.++||||+||++|||+||+.||....... ...........  
T Consensus       177 Gla~~~~~~~-~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~~--  252 (311)
T 4aw0_A          177 GTAKVLSPES-KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-IFAKIIKLEYD--  252 (311)
T ss_dssp             TTCEECCTTT-TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC--
T ss_pred             CCceecCCCC-CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCC--
Confidence            9999875432 2223445689999999999999999999999999999999999999997543221 11111111110  


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAI  856 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl  856 (871)
                      +.+                              .+..++.+++.+||+.||++|||++|++
T Consensus       253 ~p~------------------------------~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          253 FPE------------------------------KFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CCT------------------------------TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             CCc------------------------------ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            000                              1223567899999999999999999874

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=3.6e-50  Score=474.21  Aligned_cols=441  Identities=22%  Similarity=0.178  Sum_probs=374.4

Q ss_pred             cccccCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCcc
Q 002883            2 LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSE   81 (871)
Q Consensus         2 ~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~   81 (871)
                      +++..|..|.++++|++|+|++|+|++..|++|+++++|++|+|++|++++..|++|+++++|++|+|++|++++..+..
T Consensus        44 l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~  123 (606)
T 3vq2_A           44 LKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFP  123 (606)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSC
T ss_pred             cCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccc
Confidence            44555668999999999999999999888899999999999999999999878999999999999999999998666688


Q ss_pred             ccccccccccccccccccC-CCCccccccCCCceeeeeccccccccccccccCCCCcc----EEEccCccCCCCCCccCc
Q 002883           82 LGLLKQLNMFQVSANYLTG-SIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIR----VLLLGSNWFTGEIPPSIS  156 (871)
Q Consensus        82 ~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~----~L~l~~n~i~~~~p~~~~  156 (871)
                      |+++++|++|++++|.+++ .+|..+.++++|++|++++|++.+..|..+. .+.+|+    +|++++|.+++..+..+.
T Consensus       124 ~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~~l~~L~l~~n~l~~~~~~~~~  202 (606)
T 3vq2_A          124 IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ-FLRENPQVNLSLDMSLNPIDFIQDQAFQ  202 (606)
T ss_dssp             CTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTH-HHHHCTTCCCEEECTTCCCCEECTTTTT
T ss_pred             cCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhh-hhhccccccceeeccCCCcceeCccccc
Confidence            9999999999999999985 5688899999999999999988754443222 333322    444444444422211110


Q ss_pred             ----------------------------------------------------------------------CCC-CCCccc
Q 002883          157 ----------------------------------------------------------------------NAS-SIPEDL  165 (871)
Q Consensus       157 ----------------------------------------------------------------------~~~-~lp~~~  165 (871)
                                                                                            ..+ .+|. +
T Consensus       203 ~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~  281 (606)
T 3vq2_A          203 GIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-F  281 (606)
T ss_dssp             TCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-C
T ss_pred             CceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-c
Confidence                                                                                  011 1222 7


Q ss_pred             cCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCC
Q 002883          166 GKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVG  245 (871)
Q Consensus       166 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~  245 (871)
                      ..+++|+.|++++|.+..++        .+..+++|++|++++|.+. .+| .+ .+ ++|++|++++|+.....  .+.
T Consensus       282 ~~l~~L~~L~l~~~~~~~l~--------~l~~~~~L~~L~l~~n~l~-~lp-~~-~l-~~L~~L~l~~n~~~~~~--~~~  347 (606)
T 3vq2_A          282 HCLANVSAMSLAGVSIKYLE--------DVPKHFKWQSLSIIRCQLK-QFP-TL-DL-PFLKSLTLTMNKGSISF--KKV  347 (606)
T ss_dssp             GGGTTCSEEEEESCCCCCCC--------CCCTTCCCSEEEEESCCCS-SCC-CC-CC-SSCCEEEEESCSSCEEC--CCC
T ss_pred             ccCCCCCEEEecCccchhhh--------hccccccCCEEEcccccCc-ccc-cC-CC-CccceeeccCCcCccch--hhc
Confidence            78899999999999998744        5678899999999999995 778 44 55 67999999999665333  678


Q ss_pred             Cccccceeeccccccccc--CCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCc-ccccCCCCC
Q 002883          246 NLKNLILIAMEVNLLTGS--IPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIP-SALGNCLQL  322 (871)
Q Consensus       246 ~l~~L~~L~l~~N~l~~~--~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L  322 (871)
                      .+++|+.|++++|.+++.  .+..+..+++|++|+|++|.++ ..|..+..+++|++|++++|++.+..+ ..|..+++|
T Consensus       348 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L  426 (606)
T 3vq2_A          348 ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL  426 (606)
T ss_dssp             CCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTC
T ss_pred             cCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccC
Confidence            999999999999999966  3888999999999999999998 567899999999999999999998877 689999999


Q ss_pred             CEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCC-CCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecC
Q 002883          323 QKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSG-PIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSD  401 (871)
Q Consensus       323 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  401 (871)
                      +.|++++|.+++..|..+.++++|++|++++|.+++ ..|..++.+++|+.|+|++|++++..|..|..+++|++|+|++
T Consensus       427 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~  506 (606)
T 3vq2_A          427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH  506 (606)
T ss_dssp             CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCC
Confidence            999999999998899999999999999999999986 4788999999999999999999988899999999999999999


Q ss_pred             CcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccc-cccEEecCCCcCcccCCCCc
Q 002883          402 NSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFR-FLQKLNLSFNNLEGEVPSEG  460 (871)
Q Consensus       402 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-~L~~L~l~~N~l~~~~~~~~  460 (871)
                      |++++..|..|..+++|++|++++|+++ .+|..+..++ +|++|++++|++.|.++..+
T Consensus       507 N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~  565 (606)
T 3vq2_A          507 NNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQK  565 (606)
T ss_dssp             SCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTHH
T ss_pred             CcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccHH
Confidence            9999999999999999999999999999 6777788887 59999999999999888643

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=7e-50  Score=487.29  Aligned_cols=439  Identities=21%  Similarity=0.203  Sum_probs=337.2

Q ss_pred             cccccCccCcCCCCCCEEecCCCcccccC-CccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCc
Q 002883            2 LQGEIPANITHCSELRILDLVVNKLEGNI-PSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPS   80 (871)
Q Consensus         2 ~~~~~p~~~~~l~~L~~L~l~~n~i~~~~-~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~   80 (871)
                      +.+..|..|.++++|++|||++|.+.+.+ |++|+++++|++|+|++|++++..|+.|+++++|++|+|++|.+++..|.
T Consensus        36 i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~  115 (844)
T 3j0a_A           36 IRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK  115 (844)
T ss_dssp             CCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCST
T ss_pred             CCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCccccc
Confidence            34455667777777777777777443333 67777777777777777777766677777777777777777777765554


Q ss_pred             c--ccccccccccccccccccCCCC-ccccccCCCceeeeeccccccccccccccCC--CC-------------------
Q 002883           81 E--LGLLKQLNMFQVSANYLTGSIP-IQLFNISSMDYFAVTQNKLVGEIPHYVGFTL--PN-------------------  136 (871)
Q Consensus        81 ~--~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l--~~-------------------  136 (871)
                      .  |+.+++|++|+|++|.+++..+ ..|.++++|++|++++|.+.+..+..+. .+  ++                   
T Consensus       116 ~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~-~l~~~~L~~L~L~~n~l~~~~~~~~  194 (844)
T 3j0a_A          116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELE-PLQGKTLSFFSLAANSLYSRVSVDW  194 (844)
T ss_dssp             TCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGH-HHHHCSSCCCEECCSBSCCCCCCCC
T ss_pred             CccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcc-cccCCccceEECCCCccccccccch
Confidence            4  7777777777777777765443 4567777777777777776644443332 22  33                   


Q ss_pred             -----------ccEEEccCccCCCCCCccCcCCCC--------------------------CCccccC--CCcccEEecc
Q 002883          137 -----------IRVLLLGSNWFTGEIPPSISNASS--------------------------IPEDLGK--LKNLIRLNFA  177 (871)
Q Consensus       137 -----------L~~L~l~~n~i~~~~p~~~~~~~~--------------------------lp~~~~~--l~~L~~L~l~  177 (871)
                                 |+.|++++|.+++.+|..+.....                          .+..|.+  .++|+.|+++
T Consensus       195 ~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls  274 (844)
T 3j0a_A          195 GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLS  274 (844)
T ss_dssp             CSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECT
T ss_pred             hhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECC
Confidence                       556666666555555444332100                          0111222  2789999999


Q ss_pred             cccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeeccc
Q 002883          178 RNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEV  257 (871)
Q Consensus       178 ~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~  257 (871)
                      +|.+..+.+      ..+..+++|++|+|++|++++..|..+..+ ++|++|+|++|++++..|..|.++++|+.|++++
T Consensus       275 ~n~l~~~~~------~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  347 (844)
T 3j0a_A          275 HGFVFSLNS------RVFETLKDLKVLNLAYNKINKIADEAFYGL-DNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK  347 (844)
T ss_dssp             TCCCCEECS------CCSSSCCCCCEEEEESCCCCEECTTTTTTC-SSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCS
T ss_pred             CCcccccCh------hhhhcCCCCCEEECCCCcCCCCChHHhcCC-CCCCEEECCCCCCCccCHHHhcCCCCCCEEECCC
Confidence            999987543      457788999999999999998878888777 5799999999999988899999999999999999


Q ss_pred             ccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcc----------------------c
Q 002883          258 NLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPS----------------------A  315 (871)
Q Consensus       258 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~----------------------~  315 (871)
                      |.++...+..|..+++|++|+|++|.+++ ++    .+++|+.|++++|+++. +|.                      .
T Consensus       348 N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~----~~~~L~~L~l~~N~l~~-l~~~~~~l~~L~ls~N~l~~l~~~~~  421 (844)
T 3j0a_A          348 NHIAIIQDQTFKFLEKLQTLDLRDNALTT-IH----FIPSIPDIFLSGNKLVT-LPKINLTANLIHLSENRLENLDILYF  421 (844)
T ss_dssp             CCCCCCCSSCSCSCCCCCEEEEETCCSCC-CS----SCCSCSEEEEESCCCCC-CCCCCTTCCEEECCSCCCCSSTTHHH
T ss_pred             CCCCccChhhhcCCCCCCEEECCCCCCCc-cc----CCCCcchhccCCCCccc-ccccccccceeecccCccccCchhhh
Confidence            99998888889999999999999999984 22    25666666666666652 222                      2


Q ss_pred             ccCCCCCCEEecCCCcCCCCCcc-cccCCCCCcEEeccCCCCC-----CCCccccCCCCCCCEEeCCCCcCCCCCccchh
Q 002883          316 LGNCLQLQKLDLSDNNLSGTIPR-EVIGLSSFVLLDLSRNHLS-----GPIPLEVGRLKGIQQLDLSENKLSGEIPTSLA  389 (871)
Q Consensus       316 ~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~ls~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  389 (871)
                      +.++++|+.|+|++|++++..+. .+..+++|+.|++++|.++     +..+..|..+++|+.|+|++|.+++..|..|.
T Consensus       422 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  501 (844)
T 3j0a_A          422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS  501 (844)
T ss_dssp             HTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSS
T ss_pred             hhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHcc
Confidence            45789999999999999865443 4567899999999999997     34456788999999999999999998999999


Q ss_pred             cccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCC
Q 002883          390 SCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE  459 (871)
Q Consensus       390 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~  459 (871)
                      .+++|+.|+|++|+|++.++..+.  ++|+.|+|++|+|++..|..+   .+|+.|++++|++.|.|+..
T Consensus       502 ~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~~  566 (844)
T 3j0a_A          502 HLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELS  566 (844)
T ss_dssp             SCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSCC
T ss_pred             chhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccccH
Confidence            999999999999999988887776  899999999999999888776   47899999999999998754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.6e-50  Score=440.87  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=210.2

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      +.|++.+.||+|+||.||+|++..+|+.||||+++.......+.+.+|+++|+.++|||||+++++|.+.     +.+|+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEEE
Confidence            5699999999999999999999999999999999766665667789999999999999999999999876     67999


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      |||||+||+|.++++..        .+++.++..++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|
T Consensus       226 VmEy~~gG~L~~~i~~~--------~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla  294 (423)
T 4fie_A          226 VMEFLEGGALTDIVTHT--------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFC  294 (423)
T ss_dssp             EEECCTTEEHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTC
T ss_pred             EEeCCCCCcHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccc
Confidence            99999999999999653        489999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE  798 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  798 (871)
                      +.+....   ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.....  ....+....+.....
T Consensus       295 ~~~~~~~---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~~~~~~~~~  369 (423)
T 4fie_A          295 AQVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRDNLPPRLKN  369 (423)
T ss_dssp             EECCSSC---CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCCCSC
T ss_pred             eECCCCC---ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHcCCCCCCcc
Confidence            8875432   22344689999999999999999999999999999999999999997543221  111111111111100


Q ss_pred             hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                                  ...+..++.+++.+||+.||++||||+|+++
T Consensus       370 ----------------------------~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          370 ----------------------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             ----------------------------TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                                        0122345779999999999999999999986

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-49  Score=464.45  Aligned_cols=450  Identities=20%  Similarity=0.198  Sum_probs=378.4

Q ss_pred             ccCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccc
Q 002883            5 EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGL   84 (871)
Q Consensus         5 ~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~   84 (871)
                      ++|..+.  +.++.|||++|+|++..+.+|.++++|++|+|++|++++..|+.|+++++|++|+|++|++++..|..|++
T Consensus        21 ~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   98 (570)
T 2z63_A           21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG   98 (570)
T ss_dssp             SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred             ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcC
Confidence            4676665  47999999999999888889999999999999999999888889999999999999999999777789999


Q ss_pred             cccccccccccccccCCCCccccccCCCceeeeecccccc-ccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCc
Q 002883           85 LKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVG-EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPE  163 (871)
Q Consensus        85 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~  163 (871)
                      +++|++|++++|.+++..+..+.++++|++|++++|.+.+ .+|..+. .+++|+.|++++|.+++.          .|.
T Consensus        99 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~-~l~~L~~L~l~~n~l~~~----------~~~  167 (570)
T 2z63_A           99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS-NLTNLEHLDLSSNKIQSI----------YCT  167 (570)
T ss_dssp             CTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGG-GCTTCCEEECTTSCCCEE----------CGG
T ss_pred             ccccccccccccccccCCCccccccccccEEecCCCccceecChhhhc-ccCCCCEEeCcCCcccee----------cHH
Confidence            9999999999999996556679999999999999999975 4677665 899999999999999832          234


Q ss_pred             cccCCCcc----cEEecccccCCCCCCCCccccccccCCCcccEEEccCC------------------------------
Q 002883          164 DLGKLKNL----IRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSN------------------------------  209 (871)
Q Consensus       164 ~~~~l~~L----~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n------------------------------  209 (871)
                      .++.+++|    +.|++++|.++.+++..+      .. .+|+.|++++|                              
T Consensus       168 ~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~------~~-~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~  240 (570)
T 2z63_A          168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAF------KE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE  240 (570)
T ss_dssp             GGHHHHTCTTCCCEEECTTCCCCEECTTTT------TT-CEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCC
T ss_pred             HccchhccchhhhhcccCCCCceecCHHHh------cc-CcceeEecccccccccchhhhhcCccccceeeeccccccCc
Confidence            56777777    788899888877654322      22 25666666665                              


Q ss_pred             ----------------------------cCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeeccccccc
Q 002883          210 ----------------------------SLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLT  261 (871)
Q Consensus       210 ----------------------------~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~  261 (871)
                                                  .+.+..|..+..+ ++|+.|++++|.++ .+|..+..+ +|+.|++++|.++
T Consensus       241 ~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l-~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~  317 (570)
T 2z63_A          241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL-TNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG  317 (570)
T ss_dssp             SSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGG-TTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS
T ss_pred             hhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCc-CcccEEEecCccch-hhhhhhccC-CccEEeeccCccc
Confidence                                        3344455555555 46889999999888 577778888 8999999999888


Q ss_pred             ccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccC--cccccCCCCCCEEecCCCcCCCCCccc
Q 002883          262 GSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSI--PSALGNCLQLQKLDLSDNNLSGTIPRE  339 (871)
Q Consensus       262 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~  339 (871)
                       .+|.  ..+++|+.|++++|.+.+..+.  ..+++|++|++++|++++..  +..+..+++|++|++++|.+++. +..
T Consensus       318 -~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~  391 (570)
T 2z63_A          318 -QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSN  391 (570)
T ss_dssp             -SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEE-EEE
T ss_pred             -ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccc-ccc
Confidence             4444  4678899999999988755544  78899999999999998554  67888999999999999999854 444


Q ss_pred             ccCCCCCcEEeccCCCCCCCCc-cccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCccc-ccCccccCCCCC
Q 002883          340 VIGLSSFVLLDLSRNHLSGPIP-LEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQ-GPIHSGFSSLKG  417 (871)
Q Consensus       340 ~~~l~~L~~L~ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~  417 (871)
                      +..+++|+.|++++|.+.+..+ ..+..+++|++|++++|.+++..|..|..+++|++|+|++|+++ +..|..|..+++
T Consensus       392 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~  471 (570)
T 2z63_A          392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN  471 (570)
T ss_dssp             EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred             ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccC
Confidence            9999999999999999986655 57889999999999999999888999999999999999999997 568889999999


Q ss_pred             CCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCC-cccccccceeccCCCCCccCCCcc
Q 002883          418 LQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE-GVFKNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       418 L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      |++|++++|++++..|..+..+++|++|++++|++++.++.. ..+++++.+++.+|++.|+|+..+
T Consensus       472 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~  538 (570)
T 2z63_A          472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  538 (570)
T ss_dssp             CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             CCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence            999999999999888999999999999999999999887653 567889999999999999998643

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.6e-50  Score=418.01  Aligned_cols=247  Identities=23%  Similarity=0.332  Sum_probs=191.1

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...   ....+.+.+|++++++++|||||++++++.+.     +
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----D   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----C
Confidence            368999999999999999999999999999999996432   23356789999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||+ +|+|.+++...+       .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~~-------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~D  155 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQRD-------KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIAD  155 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHSC-------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECC
T ss_pred             EEEEEEeCC-CCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEee
Confidence            789999999 789999997654       699999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV-STHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||+|+...+..    .....+||+.|||||++.+..+ ++++||||+||++|+|+||+.||....... ..........+
T Consensus       156 FGla~~~~~~~----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-~~~~i~~~~~~  230 (275)
T 3hyh_A          156 FGLSNIMTDGN----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-LFKNISNGVYT  230 (275)
T ss_dssp             SSCC-------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC
T ss_pred             cCCCeecCCCC----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCC
Confidence            99998765322    2234679999999999988876 589999999999999999999997532221 11111111100


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                        ..+                              .++.++.+++.+||+.||++|||++|+++
T Consensus       231 --~p~------------------------------~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          231 --LPK------------------------------FLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             --CCT------------------------------TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --CCC------------------------------CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              000                              12345678999999999999999999987

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.8e-51  Score=431.50  Aligned_cols=264  Identities=21%  Similarity=0.323  Sum_probs=208.7

Q ss_pred             cCCCCCceeeccccceEEEEEEC-----CCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILG-----TEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      .++++.+.||+|+||+||+|++.     .+++.||||+++... ....+.|.+|+.++++++|||||+++|+|.+.    
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~----  101 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD----  101 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC----
Confidence            34667889999999999999974     356889999996443 33457899999999999999999999999765    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccc---------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcee
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQ---------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL  703 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  703 (871)
                       ...++|||||++|+|.+++.......         .....+++.++..++.|||.||+|||++   +||||||||+|||
T Consensus       102 -~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL  177 (308)
T 4gt4_A          102 -QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL  177 (308)
T ss_dssp             -SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             -CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence             56899999999999999997543210         1123689999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhh
Q 002883          704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGL  782 (871)
Q Consensus       704 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~  782 (871)
                      +++++.+||+|||+|+...... .........||+.|||||++.++.|+.++|||||||++|||+| |+.||.+....+.
T Consensus       178 l~~~~~~Ki~DFGlar~~~~~~-~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~  256 (308)
T 4gt4_A          178 VYDKLNVKISDLGLFREVYAAD-YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV  256 (308)
T ss_dssp             ECGGGCEEECCSCCBCGGGGGG-CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred             ECCCCCEEECCcccceeccCCC-ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999998764332 1222344579999999999999999999999999999999999 8999986533221


Q ss_pred             hHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          783 SLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       783 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                        ............                              ...++..+.+++.+||+.||++|||++||++.|++.
T Consensus       257 --~~~i~~~~~~~~------------------------------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          257 --VEMIRNRQVLPC------------------------------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             --HHHHHTTCCCCC------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --HHHHHcCCCCCC------------------------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence              111111110000                              012344677999999999999999999999999864


Q ss_pred             H
Q 002883          863 Q  863 (871)
Q Consensus       863 ~  863 (871)
                      .
T Consensus       305 ~  305 (308)
T 4gt4_A          305 G  305 (308)
T ss_dssp             C
T ss_pred             c
Confidence            3

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.3e-49  Score=463.82  Aligned_cols=460  Identities=20%  Similarity=0.220  Sum_probs=361.1

Q ss_pred             ccCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccc
Q 002883            5 EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGL   84 (871)
Q Consensus         5 ~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~   84 (871)
                      ++|..+.  ++|+.|+|++|+|++..|.+|+++++|++|+|++|++++..|++|+++++|++|+|++|++++..|..|++
T Consensus        19 ~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~   96 (549)
T 2z81_A           19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGP   96 (549)
T ss_dssp             SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTT
T ss_pred             cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhcc
Confidence            5777765  78999999999999888999999999999999999999888899999999999999999999777777999


Q ss_pred             cccccccccccccccC-CCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCC---
Q 002883           85 LKQLNMFQVSANYLTG-SIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASS---  160 (871)
Q Consensus        85 l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~---  160 (871)
                      +++|++|++++|++++ ..|..+.++++|++|++++|.+.+.+|...+..+++|+.|++++|.+++.+|..+.....   
T Consensus        97 l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~  176 (549)
T 2z81_A           97 LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH  176 (549)
T ss_dssp             CTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEE
T ss_pred             CCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCce
Confidence            9999999999999986 357789999999999999999666888766678999999999999999766655543221   


Q ss_pred             ----------CCcc-ccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhh---ccccc
Q 002883          161 ----------IPED-LGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIAN---FSSHL  226 (871)
Q Consensus       161 ----------lp~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~---~~~~L  226 (871)
                                +|+. +..+++|++|++++|+++..+...   ......+++|+.|++++|.+++..+..+..   ...+|
T Consensus       177 L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~---~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L  253 (549)
T 2z81_A          177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSP---LPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILEL  253 (549)
T ss_dssp             EEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCC---CSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTC
T ss_pred             EecccCcccccchhhHhhcccccEEEccCCccccccccc---cchhhhhhcccceeccccccchhHHHHHHHHhhhhccc
Confidence                      1222 234556666666666655432111   111233455666666666665433333322   12357


Q ss_pred             cEEEccCCccCCCC------CCCCCCccccceeeccccccccc-----CCccccCCCCCcEEEccCCCCCCCCCccc-CC
Q 002883          227 IYLYMSANRISGTI------PTGVGNLKNLILIAMEVNLLTGS-----IPTSVGYLLKLQVLSLFGNKISGEIPSSL-GN  294 (871)
Q Consensus       227 ~~L~L~~n~i~~~~------~~~~~~l~~L~~L~l~~N~l~~~-----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~  294 (871)
                      +.|++++|.+.+..      ...+..+.+|+.|++.++.+...     .+..+....+|+.|++++|+++ .+|..+ ..
T Consensus       254 ~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~  332 (549)
T 2z81_A          254 SEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQH  332 (549)
T ss_dssp             CEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhc
Confidence            77777777665421      22356677778888877776532     1122344578999999999998 566655 67


Q ss_pred             CccccEEEccCccccccCc---ccccCCCCCCEEecCCCcCCCCCc--ccccCCCCCcEEeccCCCCCCCCccccCCCCC
Q 002883          295 LIFLTEVDLQGNSIRGSIP---SALGNCLQLQKLDLSDNNLSGTIP--REVIGLSSFVLLDLSRNHLSGPIPLEVGRLKG  369 (871)
Q Consensus       295 l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~  369 (871)
                      +++|++|+|++|++++..|   ..+..+++|+.|++++|++++..+  ..+..+++|++|++++|+++ .+|..+..+++
T Consensus       333 l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~  411 (549)
T 2z81_A          333 LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEK  411 (549)
T ss_dssp             CTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTT
T ss_pred             CccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhccccc
Confidence            9999999999999997664   347889999999999999985432  56889999999999999999 78888999999


Q ss_pred             CCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCC
Q 002883          370 IQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSF  449 (871)
Q Consensus       370 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~  449 (871)
                      |++|++++|+++ .+|..+.  ++|++|+|++|+|++..    ..+++|++|+|++|+|+ .+|. ...+++|++|+|++
T Consensus       412 L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~  482 (549)
T 2z81_A          412 MRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISR  482 (549)
T ss_dssp             CCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCS
T ss_pred             ccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCC
Confidence            999999999998 4555443  68999999999999753    57899999999999999 5665 46799999999999


Q ss_pred             CcCcccCCC-CcccccccceeccCCCCCccCC
Q 002883          450 NNLEGEVPS-EGVFKNVRAVSIIGNNKLCGGS  480 (871)
Q Consensus       450 N~l~~~~~~-~~~~~~l~~l~l~~N~~~C~~~  480 (871)
                      |++++.+|. ...+++++.+++.+|+|.|+|+
T Consensus       483 N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          483 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             SCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             CccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            999998776 3677899999999999999987

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=5e-49  Score=463.80  Aligned_cols=412  Identities=19%  Similarity=0.249  Sum_probs=203.8

Q ss_pred             CCCCEEecCCCcccccCCccccCCCcCceeeCCCCccc------c------cCCccccCCcccceeeccCccccCC----
Q 002883           14 SELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYT------G------SIPQSLSNLSFLQQLSLSENSLSGN----   77 (871)
Q Consensus        14 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~------~------~~p~~~~~l~~L~~L~Ls~n~l~~~----   77 (871)
                      ..++.|+|++|+++|.+|.+|++|++|++|+|++|.+.      +      .+|...  +..|+ +++++|.+.+.    
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~  157 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED  157 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence            46889999999999999999999999999999999762      1      222222  33344 44444444433    


Q ss_pred             ----------------------------------------CCccccccccccccccccccccCC----------------
Q 002883           78 ----------------------------------------IPSELGLLKQLNMFQVSANYLTGS----------------  101 (871)
Q Consensus        78 ----------------------------------------~~~~~~~l~~L~~L~l~~n~l~~~----------------  101 (871)
                                                              +|..|+++++|++|+|++|.+++.                
T Consensus       158 ~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~  237 (636)
T 4eco_A          158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ  237 (636)
T ss_dssp             SCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHH
T ss_pred             HHHHHHHHhhcCccccccccccccchhhhhhccccCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcc
Confidence                                                    454555555555555555555432                


Q ss_pred             -CCcccc--ccCCCceeeeeccccccccccccccCCCCccEEEccCcc-CCC-CCCccCcCCCCCCccccCC------Cc
Q 002883          102 -IPIQLF--NISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNW-FTG-EIPPSISNASSIPEDLGKL------KN  170 (871)
Q Consensus       102 -~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~-i~~-~~p~~~~~~~~lp~~~~~l------~~  170 (871)
                       +|..++  ++++|++|++++|.+.+.+|..++ .+++|++|+|++|+ +++ .          +|..++.+      ++
T Consensus       238 ~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~~l~~~~----------lp~~~~~L~~~~~l~~  306 (636)
T 4eco_A          238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACNRGISGEQ----------LKDDWQALADAPVGEK  306 (636)
T ss_dssp             HTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT-TCSSCCEEECTTCTTSCHHH----------HHHHHHHHHHSGGGGT
T ss_pred             cCchhhhhcccCCCCEEEecCCcCCccChHHHh-cCCCCCEEECcCCCCCcccc----------chHHHHhhhccccCCC
Confidence             444444  555555555555554444444433 45555555555554 432 2          22222222      45


Q ss_pred             ccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccc-
Q 002883          171 LIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKN-  249 (871)
Q Consensus       171 L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~-  249 (871)
                      |++|++++|+++.++.     ...+..+++|++|+|++|++++.+| .+..+ ++|++|++++|+++ .+|..+.++++ 
T Consensus       307 L~~L~L~~n~l~~ip~-----~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l-~~L~~L~L~~N~l~-~lp~~l~~l~~~  378 (636)
T 4eco_A          307 IQIIYIGYNNLKTFPV-----ETSLQKMKKLGMLECLYNQLEGKLP-AFGSE-IKLASLNLAYNQIT-EIPANFCGFTEQ  378 (636)
T ss_dssp             CCEEECCSSCCSSCCC-----HHHHTTCTTCCEEECCSCCCEEECC-CCEEE-EEESEEECCSSEEE-ECCTTSEEECTT
T ss_pred             CCEEECCCCcCCccCc-----hhhhccCCCCCEEeCcCCcCccchh-hhCCC-CCCCEEECCCCccc-cccHhhhhhccc
Confidence            5555555554443220     0034444455555555555544444 33333 23555555555554 44444555554 


Q ss_pred             cceeecccccccccCCccccCCC--CCcEEEccCCCCCCCCCcccC-------CCccccEEEccCccccccCcccccCCC
Q 002883          250 LILIAMEVNLLTGSIPTSVGYLL--KLQVLSLFGNKISGEIPSSLG-------NLIFLTEVDLQGNSIRGSIPSALGNCL  320 (871)
Q Consensus       250 L~~L~l~~N~l~~~~~~~~~~l~--~L~~L~L~~n~l~~~~~~~~~-------~l~~L~~L~L~~N~i~~~~~~~~~~l~  320 (871)
                      |+.|++++|.++ .+|..+..+.  +|+.|+|++|++++..|..+.       .+++|++|+|++|+++...+..+..++
T Consensus       379 L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~  457 (636)
T 4eco_A          379 VENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS  457 (636)
T ss_dssp             CCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTC
T ss_pred             CcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCC
Confidence            555555555554 3444444332  455555555555444444444       444455555555555432222333445


Q ss_pred             CCCEEecCCCcCCCCCcc-cccCCC-------CCcEEeccCCCCCCCCccccC--CCCCCCEEeCCCCcCCCCCccchhc
Q 002883          321 QLQKLDLSDNNLSGTIPR-EVIGLS-------SFVLLDLSRNHLSGPIPLEVG--RLKGIQQLDLSENKLSGEIPTSLAS  390 (871)
Q Consensus       321 ~L~~L~L~~N~l~~~~~~-~~~~l~-------~L~~L~ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~  390 (871)
                      +|+.|+|++|+++ .+|. .+....       +|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..
T Consensus       458 ~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~  534 (636)
T 4eco_A          458 PLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN  534 (636)
T ss_dssp             CCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGG
T ss_pred             CCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhc
Confidence            5555555555554 2222 222111       4555555555554 3444443  44555555555555543 4444444


Q ss_pred             ccCCceeee------cCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcc
Q 002883          391 CVGLEYLNF------SDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEG  454 (871)
Q Consensus       391 l~~L~~L~L------~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~  454 (871)
                      +++|++|+|      ++|++.+..|..+..+++|++|+|++|+++ .+|..+.  ++|+.|+|++|++.+
T Consensus       535 l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          535 SSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT--PNISVLDIKDNPNIS  601 (636)
T ss_dssp             CSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCCC--TTCCEEECCSCTTCE
T ss_pred             CCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHhHh--CcCCEEECcCCCCcc
Confidence            555555555      234444444444444555555555555552 3443332  445555555554443

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.2e-50  Score=429.55  Aligned_cols=281  Identities=22%  Similarity=0.323  Sum_probs=221.4

Q ss_pred             cccCHHHHHHhhcCCCCCceeeccccceEEEEEECCC-----CcEEEEEEeecccc-chHHHHHHHHHHHHcCCC-Cccc
Q 002883          547 LKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTE-----ETNVAVKVLDLQQR-GASKSFIAECEALRSIRH-RNLV  619 (871)
Q Consensus       547 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv  619 (871)
                      ..++.++++...++|++.+.||+|+||+||+|++...     ++.||||+++.... ...+.+.+|++++++++| ||||
T Consensus        52 lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV  131 (353)
T 4ase_A           52 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV  131 (353)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence            3456666777778999999999999999999998543     36799999965432 345678999999999965 8999


Q ss_pred             eeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccc---------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 002883          620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ---------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHT  690 (871)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~  690 (871)
                      +++++|.+.    +...|+|||||++|+|.++++......         .....+++.++..++.|||+||+|||++   
T Consensus       132 ~l~g~~~~~----~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---  204 (353)
T 4ase_A          132 NLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---  204 (353)
T ss_dssp             CEEEEECCT----TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             EEEEEEEec----CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---
Confidence            999998653    245799999999999999997654311         1133589999999999999999999999   


Q ss_pred             CeEecCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-
Q 002883          691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-  769 (871)
Q Consensus       691 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-  769 (871)
                      +||||||||+|||++.++.+||+|||+|+.+.... .........||+.|||||++.+..|+.++|||||||++|||+| 
T Consensus       205 ~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~-~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~  283 (353)
T 4ase_A          205 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL  283 (353)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             CeecCccCccceeeCCCCCEEECcchhhhhcccCC-CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhC
Confidence            99999999999999999999999999998765433 2233445679999999999999999999999999999999998 


Q ss_pred             CCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCC
Q 002883          770 GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDR  849 (871)
Q Consensus       770 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  849 (871)
                      |+.||.+...... +......+......+                              .++.++.+++.+||+.||++|
T Consensus       284 G~~Pf~~~~~~~~-~~~~i~~g~~~~~p~------------------------------~~~~~~~~li~~c~~~dP~~R  332 (353)
T 4ase_A          284 GASPYPGVKIDEE-FCRRLKEGTRMRAPD------------------------------YTTPEMYQTMLDCWHGEPSQR  332 (353)
T ss_dssp             SCCSSTTCCCSHH-HHHHHHHTCCCCCCT------------------------------TCCHHHHHHHHHHTCSSGGGS
T ss_pred             CCCCCCCCCHHHH-HHHHHHcCCCCCCCc------------------------------cCCHHHHHHHHHHcCcChhHC
Confidence            9999986432221 111111111111000                              123457789999999999999


Q ss_pred             CCHHHHHHHHHHHHHHH
Q 002883          850 MKIQDAIMELQEAQKMR  866 (871)
Q Consensus       850 Pta~evl~~L~~i~~~~  866 (871)
                      ||+.|+++.|+++.+..
T Consensus       333 Pt~~eil~~L~~llq~~  349 (353)
T 4ase_A          333 PTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             CCHHHHHHHHHHHHHHT
T ss_pred             cCHHHHHHHHHHHHHHh
Confidence            99999999999986543

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=456.20  Aligned_cols=459  Identities=22%  Similarity=0.219  Sum_probs=384.1

Q ss_pred             cccccCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCcc
Q 002883            2 LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSE   81 (871)
Q Consensus         2 ~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~   81 (871)
                      +.+..|..|.++++|++|||++|+|++..|++|+++++|++|+|++|++++..|++|+++++|++|+|++|++++..+..
T Consensus        40 l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~  119 (570)
T 2z63_A           40 LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP  119 (570)
T ss_dssp             CCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCS
T ss_pred             cCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCcc
Confidence            34455668999999999999999999888899999999999999999999888899999999999999999999555557


Q ss_pred             ccccccccccccccccccC-CCCccccccCCCceeeeeccccccccccccccCCCCc----cEEEccCccCCCCCCccCc
Q 002883           82 LGLLKQLNMFQVSANYLTG-SIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNI----RVLLLGSNWFTGEIPPSIS  156 (871)
Q Consensus        82 ~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L----~~L~l~~n~i~~~~p~~~~  156 (871)
                      |+.+++|++|++++|.+++ .+|..+.++++|++|++++|++.+..|.. +..+.+|    +.|++++|.+++..|..  
T Consensus       120 ~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~~~~~L~l~~n~l~~~~~~~--  196 (570)
T 2z63_A          120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD-LRVLHQMPLLNLSLDLSLNPMNFIQPGA--  196 (570)
T ss_dssp             CTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGG-GHHHHTCTTCCCEEECTTCCCCEECTTT--
T ss_pred             ccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHH-ccchhccchhhhhcccCCCCceecCHHH--
Confidence            9999999999999999986 46999999999999999999998444443 3477788    89999999998544432  


Q ss_pred             CCCCCCccccCCCcccEEecccccCC-------------------------------CCCCCCc----------------
Q 002883          157 NASSIPEDLGKLKNLIRLNFARNNLG-------------------------------TGKGNDL----------------  189 (871)
Q Consensus       157 ~~~~lp~~~~~l~~L~~L~l~~n~l~-------------------------------~~~~~~~----------------  189 (871)
                              +..+ +|+.|++++|...                               .++...+                
T Consensus       197 --------~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~  267 (570)
T 2z63_A          197 --------FKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL  267 (570)
T ss_dssp             --------TTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEET
T ss_pred             --------hccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcc
Confidence                    2222 5666666665211                               1111100                


Q ss_pred             -----cccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccC
Q 002883          190 -----RFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSI  264 (871)
Q Consensus       190 -----~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~  264 (871)
                           ..+..+..+++|++|++++|.++ .+|..+..+  +|++|++++|.++ .+|.  ..+++|+.|++++|.+.+..
T Consensus       268 ~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~--~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~  341 (570)
T 2z63_A          268 DYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF--GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAF  341 (570)
T ss_dssp             TEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC--CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBC
T ss_pred             hhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC--CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccc
Confidence                 01244667899999999999998 678888776  6999999999998 4554  57899999999999998665


Q ss_pred             CccccCCCCCcEEEccCCCCCCCC--CcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCc-cccc
Q 002883          265 PTSVGYLLKLQVLSLFGNKISGEI--PSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIP-REVI  341 (871)
Q Consensus       265 ~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~  341 (871)
                      +.  ..+++|++|++++|++++..  +..+..+++|++|++++|.+.+..+. +..+++|+.|++++|.+++..+ ..+.
T Consensus       342 ~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~  418 (570)
T 2z63_A          342 SE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFL  418 (570)
T ss_dssp             CC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTT
T ss_pred             cc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhh
Confidence            54  78899999999999998544  67889999999999999999965554 9999999999999999987665 5788


Q ss_pred             CCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCC-CCCccchhcccCCceeeecCCcccccCccccCCCCCCCE
Q 002883          342 GLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLS-GEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQD  420 (871)
Q Consensus       342 ~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  420 (871)
                      .+++|++|++++|.+.+..|..+..+++|+.|++++|.++ +.+|..+..+++|++|+|++|++++..|..|..+++|++
T Consensus       419 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  498 (570)
T 2z63_A          419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV  498 (570)
T ss_dssp             TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             cCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCE
Confidence            9999999999999999888999999999999999999997 578999999999999999999999998999999999999


Q ss_pred             EeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCCccc-ccc--cceeccCCCCCccCCCc
Q 002883          421 LDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVF-KNV--RAVSIIGNNKLCGGSPE  482 (871)
Q Consensus       421 L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~-~~l--~~l~l~~N~~~C~~~~~  482 (871)
                      |++++|++++..|..+..+++|+.|++++|+++|.+|....+ ..+  ....+.+.+ .|..+..
T Consensus       499 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~~~~  562 (570)
T 2z63_A          499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSA-KCSGSGK  562 (570)
T ss_dssp             EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGGGEESCC-BBTTTCC
T ss_pred             EeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhccccCCCch-hhCCCCC
Confidence            999999999988889999999999999999999999876433 111  122344555 7776543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.5e-49  Score=413.83  Aligned_cols=258  Identities=23%  Similarity=0.383  Sum_probs=194.7

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCc-------
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDT-------  630 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------  630 (871)
                      ++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|++++++++|||||+++++|.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            468999999999999999999999999999999965433 345678999999999999999999999876432       


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCce
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA  710 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  710 (871)
                      ....+.|+|||||++|+|.+++......    ...++..++.++.||+.||+|||++   +|+||||||+|||++.++.+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~----~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTI----EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSG----GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCC----ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcE
Confidence            1234679999999999999999865421    1356777899999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCCCc---------cccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhh
Q 002883          711 HVGDFGLSRLLHDNSPDQ---------TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG  781 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~  781 (871)
                      ||+|||+|+.........         ......+||+.|||||++.+..|+.++||||+||++|||++   ||....+..
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~  234 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV  234 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH
Confidence            999999998876432211         11233579999999999999999999999999999999996   786533222


Q ss_pred             hhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          782 LSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...........|+                               .+....+...+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~p~-------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          235 RTLTDVRNLKFPP-------------------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHTTCCCH-------------------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhcCCCCC-------------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            2222211111111                               11123334568999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.8e-50  Score=419.18  Aligned_cols=248  Identities=24%  Similarity=0.291  Sum_probs=195.2

Q ss_pred             cCCCCCceeeccccceEEEEEEC---CCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILG---TEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ++|++.+.||+|+||+||+|++.   .+++.||||+++...  ......+.+|++++++++|||||++++++.+.     
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE-----   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-----
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----
Confidence            57999999999999999999873   467899999996432  22234678899999999999999999998775     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      +..|+|||||+||+|.+++.+.+       .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~~-------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~  168 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKEV-------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLT  168 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEec
Confidence            67899999999999999998754       699999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||+|+......   ......+||+.|||||++.+..|+.++||||+||++|||+||+.||........ .........+
T Consensus       169 DFGla~~~~~~~---~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-~~~i~~~~~~  244 (304)
T 3ubd_A          169 DFGLSKESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-MTMILKAKLG  244 (304)
T ss_dssp             SSEEEEC--------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCC
T ss_pred             ccccceeccCCC---ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH-HHHHHcCCCC
Confidence            999998654322   223346799999999999999999999999999999999999999985432221 1111111110


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCH-----HHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI-----QDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta-----~evl~  857 (871)
                        ..+                              .++.++.+++.+||+.||++||||     +|+++
T Consensus       245 --~p~------------------------------~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          245 --MPQ------------------------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             --CCT------------------------------TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             --CCC------------------------------cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence              000                              123456789999999999999995     56654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.4e-49  Score=416.87  Aligned_cols=282  Identities=21%  Similarity=0.257  Sum_probs=203.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      ++|.+.+.||+|+||+||+|++  +|+.||||+++.... .......|+..+.+++|||||++++++.+.. ......|+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEE
Confidence            4678889999999999999998  588999999965432 1222344555667789999999999987642 22246799


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCceeeCCCCceEEe
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC-----HTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      |||||++|+|.++++..        .+++..+.+++.|++.||+|||+++     .++||||||||+|||++.++.+||+
T Consensus        79 V~Ey~~~gsL~~~l~~~--------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~  150 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRY--------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             EEECCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             EecCCCCCcHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence            99999999999999754        4899999999999999999999752     3589999999999999999999999


Q ss_pred             ecccceecCCCCCCc-cccccccccccccCcccccCC------CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHH
Q 002883          714 DFGLSRLLHDNSPDQ-TSTSRVKGSIGYVAPEYGALG------EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK  786 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~  786 (871)
                      |||+|+......... .......||+.|||||++.+.      .++.++|||||||++|||+||+.||.........+..
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~  230 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence            999998775433211 123345799999999987654      4678999999999999999999887542211100000


Q ss_pred             HhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHH--hHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          787 YAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRA--KFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       787 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      ...          .++... .....  ......+|....  ...++...+.+++.+||+.||++|||+.||++.|+++.+
T Consensus       231 ~~~----------~~~~~~-~~~~~--~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          231 LVP----------SDPSVE-EMRKV--VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TSC----------SSCCHH-HHHHH--HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccc----------ccchHH-HHHHH--HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            000          000000 00000  000111121111  112456678899999999999999999999999999876


Q ss_pred             H
Q 002883          865 M  865 (871)
Q Consensus       865 ~  865 (871)
                      .
T Consensus       298 ~  298 (303)
T 3hmm_A          298 Q  298 (303)
T ss_dssp             C
T ss_pred             H
Confidence            4

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.7e-48  Score=447.12  Aligned_cols=437  Identities=19%  Similarity=0.215  Sum_probs=310.4

Q ss_pred             ccCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccc
Q 002883            5 EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGL   84 (871)
Q Consensus         5 ~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~   84 (871)
                      ++|..+.  ++|++|+|++|+|++..|++|+++++|++|+|++|++++..|+.|+++++|++|+|++|+++ .+|..  .
T Consensus        14 ~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~   88 (520)
T 2z7x_B           14 HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--P   88 (520)
T ss_dssp             SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--C
T ss_pred             ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--c
Confidence            5888777  89999999999999888899999999999999999999888999999999999999999999 67776  8


Q ss_pred             cccccccccccccccC-CCCccccccCCCceeeeeccccccccccccccCCCCc--cEEEccCccC--CCCCCccCcCCC
Q 002883           85 LKQLNMFQVSANYLTG-SIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNI--RVLLLGSNWF--TGEIPPSISNAS  159 (871)
Q Consensus        85 l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L--~~L~l~~n~i--~~~~p~~~~~~~  159 (871)
                      +++|++|+|++|++++ .+|..++++++|++|++++|.+.+    ..+..+++|  +.|++++|.+  ++..|..+..+.
T Consensus        89 l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~  164 (520)
T 2z7x_B           89 TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK----SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN  164 (520)
T ss_dssp             CCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG----GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCC
T ss_pred             cCCccEEeccCCccccccchhhhccCCcceEEEecCcccch----hhccccccceeeEEEeecccccccccccccccccc
Confidence            9999999999999996 478899999999999999999874    223467788  9999999999  777777666533


Q ss_pred             ---------------CCC-ccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhc-
Q 002883          160 ---------------SIP-EDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANF-  222 (871)
Q Consensus       160 ---------------~lp-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~-  222 (871)
                                     .++ ..+..+++|+.|++++|.-...-......++.+..+++|+.|++++|.+++..+..+... 
T Consensus       165 ~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~  244 (520)
T 2z7x_B          165 TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV  244 (520)
T ss_dssp             EEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHH
T ss_pred             cceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHh
Confidence                           122 235567777777777765100000000022345666777777777777664332222211 


Q ss_pred             -cccccEEEccCCccCCCCCCCC-----CCccccceeecccccccccCC-ccccCC---CCCcEEEccCCCCCCCCCccc
Q 002883          223 -SSHLIYLYMSANRISGTIPTGV-----GNLKNLILIAMEVNLLTGSIP-TSVGYL---LKLQVLSLFGNKISGEIPSSL  292 (871)
Q Consensus       223 -~~~L~~L~L~~n~i~~~~~~~~-----~~l~~L~~L~l~~N~l~~~~~-~~~~~l---~~L~~L~L~~n~l~~~~~~~~  292 (871)
                       .++|++|++++|++++.+|..+     ..+++|+.+++++|.+  .+| ..+..+   .+|+.|++++|.+....  .+
T Consensus       245 ~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~  320 (520)
T 2z7x_B          245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CP  320 (520)
T ss_dssp             HTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CC
T ss_pred             hhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--ch
Confidence             1257777777777776677766     7777777777777777  233 444443   56777777777765321  12


Q ss_pred             CCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCC--CCcccccCCCCCcEEeccCCCCCCCCcc-ccCCCCC
Q 002883          293 GNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSG--TIPREVIGLSSFVLLDLSRNHLSGPIPL-EVGRLKG  369 (871)
Q Consensus       293 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~l~~  369 (871)
                      ..+++|++|++++|++++..|..+..+++|++|++++|++++  .+|..+..+++|++|++++|.+++.+|. .+..+++
T Consensus       321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  400 (520)
T 2z7x_B          321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS  400 (520)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred             hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence            566777777777777776667777777777777777777764  3445667777777777777777753443 3666777


Q ss_pred             CCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCC
Q 002883          370 IQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSF  449 (871)
Q Consensus       370 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~  449 (871)
                      |++|++++|++++..|..+.  ++|++|+|++|+|+ .+|..+..+++|++|++++|++++..+..+..+++|++|++++
T Consensus       401 L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~  477 (520)
T 2z7x_B          401 LLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT  477 (520)
T ss_dssp             CCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcC
Confidence            77777777777655555443  56777777777777 4444455777777777777777743333366777777777777


Q ss_pred             CcCcccCC
Q 002883          450 NNLEGEVP  457 (871)
Q Consensus       450 N~l~~~~~  457 (871)
                      |+++|.++
T Consensus       478 N~~~c~c~  485 (520)
T 2z7x_B          478 NPWDCSCP  485 (520)
T ss_dssp             SCBCCCHH
T ss_pred             CCCcccCC
Confidence            77777665

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.7e-47  Score=456.87  Aligned_cols=446  Identities=17%  Similarity=0.187  Sum_probs=365.2

Q ss_pred             CCCCEEecCCCcccccCCccccCCCcCceeeC-CCCcccccCCcc-----------------------------------
Q 002883           14 SELRILDLVVNKLEGNIPSELGNLFKLVGLGL-TGNNYTGSIPQS-----------------------------------   57 (871)
Q Consensus        14 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L-~~n~l~~~~p~~-----------------------------------   57 (871)
                      ..++.|+|++|+++|.+|.+|++|++|++|+| ++|.+.+..|-.                                   
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            46899999999999999999999999999999 999877653321                                   


Q ss_pred             ----------------ccCCcccceeeccC--ccccCCCCccccccccccccccccccccC-----------------CC
Q 002883           58 ----------------LSNLSFLQQLSLSE--NSLSGNIPSELGLLKQLNMFQVSANYLTG-----------------SI  102 (871)
Q Consensus        58 ----------------~~~l~~L~~L~Ls~--n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-----------------~~  102 (871)
                                      ......++.+.+..  |.+++ +|..|++|++|++|+|++|.+++                 .+
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i  481 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE  481 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence                            01223455555554  88886 89999999999999999999997                 38


Q ss_pred             Ccccc--ccCCCceeeeeccccccccccccccCCCCccEEEccCcc-CCC-CCCccCcCCCCCCccccCCCcccEEeccc
Q 002883          103 PIQLF--NISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNW-FTG-EIPPSISNASSIPEDLGKLKNLIRLNFAR  178 (871)
Q Consensus       103 ~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~-i~~-~~p~~~~~~~~lp~~~~~l~~L~~L~l~~  178 (871)
                      |..++  ++++|++|+|++|.+.+.+|..+. .+++|+.|+|++|+ +++ .+|..+.++   +..+..+++|+.|+|++
T Consensus       482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~-~L~~L~~L~Ls~N~~lsg~~iP~~i~~L---~~~~~~l~~L~~L~Ls~  557 (876)
T 4ecn_A          482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLY-DLPELQSLNIACNRGISAAQLKADWTRL---ADDEDTGPKIQIFYMGY  557 (876)
T ss_dssp             TSCCCGGGCTTCCEEEEESCTTCCSCCGGGG-GCSSCCEEECTTCTTSCHHHHHHHHHHH---HHCTTTTTTCCEEECCS
T ss_pred             ChhhhhccCCCCCEEECcCCCCCccChHHHh-CCCCCCEEECcCCCCcccccchHHHHhh---hhcccccCCccEEEeeC
Confidence            99987  999999999999999999997765 89999999999998 875 555444321   11344556999999999


Q ss_pred             ccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccc-cceeeccc
Q 002883          179 NNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKN-LILIAMEV  257 (871)
Q Consensus       179 n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~-L~~L~l~~  257 (871)
                      |+++.++.     ...+.++++|++|+|++|+++ .+| .+..+ ++|+.|+|++|+++ .+|..+.++++ |+.|+|++
T Consensus       558 N~L~~ip~-----~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L-~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~  628 (876)
T 4ecn_A          558 NNLEEFPA-----SASLQKMVKLGLLDCVHNKVR-HLE-AFGTN-VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSH  628 (876)
T ss_dssp             SCCCBCCC-----HHHHTTCTTCCEEECTTSCCC-BCC-CCCTT-SEESEEECCSSCCS-CCCTTSCEECTTCCEEECCS
T ss_pred             CcCCccCC-----hhhhhcCCCCCEEECCCCCcc-cch-hhcCC-CcceEEECcCCccc-cchHHHhhccccCCEEECcC
Confidence            99986431     126888999999999999999 778 67666 57999999999999 88889999999 99999999


Q ss_pred             ccccccCCccccCCCC--CcEEEccCCCCCCCCCccc---C--CCccccEEEccCccccccCcccccCCCCCCEEecCCC
Q 002883          258 NLLTGSIPTSVGYLLK--LQVLSLFGNKISGEIPSSL---G--NLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDN  330 (871)
Q Consensus       258 N~l~~~~~~~~~~l~~--L~~L~L~~n~l~~~~~~~~---~--~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  330 (871)
                      |.++ .+|..+..++.  |+.|+|++|++.+.+|...   .  .+++|+.|+|++|+++...+..+..+++|+.|+|++|
T Consensus       629 N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N  707 (876)
T 4ecn_A          629 NKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN  707 (876)
T ss_dssp             SCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSC
T ss_pred             CCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCC
Confidence            9999 77888877754  9999999999987665432   2  3458999999999999544445568999999999999


Q ss_pred             cCCCCCcccccCC--------CCCcEEeccCCCCCCCCccccC--CCCCCCEEeCCCCcCCCCCccchhcccCCceeeec
Q 002883          331 NLSGTIPREVIGL--------SSFVLLDLSRNHLSGPIPLEVG--RLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFS  400 (871)
Q Consensus       331 ~l~~~~~~~~~~l--------~~L~~L~ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  400 (871)
                      +|+ .+|..+...        ++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|+
T Consensus       708 ~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls  784 (876)
T 4ecn_A          708 LMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIR  784 (876)
T ss_dssp             CCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECC
T ss_pred             cCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECC
Confidence            999 556544432        28999999999999 7888887  99999999999999996 78899999999999997


Q ss_pred             C------CcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCCc-ccccccceeccCC
Q 002883          401 D------NSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEG-VFKNVRAVSIIGN  473 (871)
Q Consensus       401 ~------N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~-~~~~l~~l~l~~N  473 (871)
                      +      |++.+..|..|..+++|+.|+|++|++ +.+|..+.  ++|+.|+|++|++....+... .......+.+.+|
T Consensus       785 ~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n  861 (876)
T 4ecn_A          785 HQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD  861 (876)
T ss_dssp             CCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECC
T ss_pred             CCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCC
Confidence            6      888889999999999999999999999 57887765  699999999999987654321 1223455666677


Q ss_pred             CCCc--cCC
Q 002883          474 NKLC--GGS  480 (871)
Q Consensus       474 ~~~C--~~~  480 (871)
                      ++.|  +|+
T Consensus       862 ~~~~I~gC~  870 (876)
T 4ecn_A          862 KTQDIRGCD  870 (876)
T ss_dssp             TTSEEESCG
T ss_pred             CccccCCCC
Confidence            6554  665

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.9e-48  Score=446.98  Aligned_cols=438  Identities=18%  Similarity=0.199  Sum_probs=355.7

Q ss_pred             CEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccccccc
Q 002883           17 RILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSAN   96 (871)
Q Consensus        17 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n   96 (871)
                      +.||+++|+++ .+|..+.  ++|++|+|++|++++..|+.|.++++|++|+|++|++++..|+.|+++++|++|+|++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            68999999999 6888776  89999999999999888889999999999999999999777999999999999999999


Q ss_pred             cccCCCCccccccCCCceeeeecccccc-ccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcc--cE
Q 002883           97 YLTGSIPIQLFNISSMDYFAVTQNKLVG-EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNL--IR  173 (871)
Q Consensus        97 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L--~~  173 (871)
                      +++ .+|..  .+++|++|++++|.+.+ .+|..+. .+++|++|++++|.+++             ..+..+++|  ++
T Consensus        80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~-~l~~L~~L~L~~n~l~~-------------~~~~~l~~L~L~~  142 (520)
T 2z7x_B           80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFG-NMSQLKFLGLSTTHLEK-------------SSVLPIAHLNISK  142 (520)
T ss_dssp             CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGG-GCTTCCEEEEEESSCCG-------------GGGGGGTTSCEEE
T ss_pred             cee-ecCcc--ccCCccEEeccCCccccccchhhhc-cCCcceEEEecCcccch-------------hhccccccceeeE
Confidence            999 67766  89999999999999985 4566655 89999999999999872             346677777  99


Q ss_pred             EecccccC--CCCCCCCccccc--------------------cccCCCcccEEEccCCc-------CcccCChhhhhccc
Q 002883          174 LNFARNNL--GTGKGNDLRFLD--------------------SLVNCTFLEVVSLSSNS-------LSGVLPNSIANFSS  224 (871)
Q Consensus       174 L~l~~n~l--~~~~~~~~~~~~--------------------~l~~l~~L~~L~L~~n~-------l~~~~~~~~~~~~~  224 (871)
                      |++++|++  ....+..+..+.                    .+..+++|+.|++++|.       +.+.+| .+..+ +
T Consensus       143 L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l-~  220 (520)
T 2z7x_B          143 VLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTN-P  220 (520)
T ss_dssp             EEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGC-T
T ss_pred             EEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccc-c
Confidence            99999998  433332222211                    23456677777777775       443333 44444 4


Q ss_pred             cccEEEccCCccCCCCCCCCC---CccccceeecccccccccCCccc-----cCCCCCcEEEccCCCCCCCCC-cccCCC
Q 002883          225 HLIYLYMSANRISGTIPTGVG---NLKNLILIAMEVNLLTGSIPTSV-----GYLLKLQVLSLFGNKISGEIP-SSLGNL  295 (871)
Q Consensus       225 ~L~~L~L~~n~i~~~~~~~~~---~l~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~L~~n~l~~~~~-~~~~~l  295 (871)
                      +|+.|++++|.+++..+..+.   .+++|+.|++++|.+++.+|..+     ..+++|+.+++++|.+  .+| ..+..+
T Consensus       221 ~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~  298 (520)
T 2z7x_B          221 KLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEI  298 (520)
T ss_dssp             TCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHH
T ss_pred             chhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcc
Confidence            577777777776643222111   13578888888888887788877     8888888888888888  344 445444


Q ss_pred             ---ccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCC--CCccccCCCCCC
Q 002883          296 ---IFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSG--PIPLEVGRLKGI  370 (871)
Q Consensus       296 ---~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~--~~~~~~~~l~~L  370 (871)
                         .+|+.|++++|.+....  .+..+++|++|++++|++++..|..+..+++|++|++++|++++  .+|..++.+++|
T Consensus       299 ~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L  376 (520)
T 2z7x_B          299 FSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSL  376 (520)
T ss_dssp             HHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTC
T ss_pred             cccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCC
Confidence               57899999999887432  23688999999999999998899999999999999999999996  455779999999


Q ss_pred             CEEeCCCCcCCCCCcc-chhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCC
Q 002883          371 QQLDLSENKLSGEIPT-SLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSF  449 (871)
Q Consensus       371 ~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~  449 (871)
                      ++|++++|.+++.+|. .+..+++|++|++++|++++..+..+.  ++|+.|++++|+++ .+|..+..+++|++|++++
T Consensus       377 ~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~  453 (520)
T 2z7x_B          377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVAS  453 (520)
T ss_dssp             CEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCS
T ss_pred             CEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCC
Confidence            9999999999974555 488899999999999999877776664  79999999999999 7787777999999999999


Q ss_pred             CcCcccCCC-CcccccccceeccCCCCCccCCCcc
Q 002883          450 NNLEGEVPS-EGVFKNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       450 N~l~~~~~~-~~~~~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      |+++..++. ...+++++.+++.+|++.|+|+..|
T Consensus       454 N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~  488 (520)
T 2z7x_B          454 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  488 (520)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHHHH
T ss_pred             CcCCccCHHHhccCCcccEEECcCCCCcccCCchH
Confidence            999976554 4567889999999999999997544

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.2e-47  Score=452.14  Aligned_cols=402  Identities=20%  Similarity=0.272  Sum_probs=345.9

Q ss_pred             CcccccCccCcCCCCCCEEecCCCccc------c---------------------------cCCcccc------------
Q 002883            1 MLQGEIPANITHCSELRILDLVVNKLE------G---------------------------NIPSELG------------   35 (871)
Q Consensus         1 ~~~~~~p~~~~~l~~L~~L~l~~n~i~------~---------------------------~~~~~~~------------   35 (871)
                      .+.|++|++|++|++|+.|||++|.+.      +                           .+|..++            
T Consensus        92 ~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~  171 (636)
T 4eco_A           92 GASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQ  171 (636)
T ss_dssp             CCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTT
T ss_pred             ccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCcc
Confidence            368999999999999999999999762      1                           1111121            


Q ss_pred             -------CCCcCceeeCC--CCcccccCCccccCCcccceeeccCccccCC-----------------CCcccc--cccc
Q 002883           36 -------NLFKLVGLGLT--GNNYTGSIPQSLSNLSFLQQLSLSENSLSGN-----------------IPSELG--LLKQ   87 (871)
Q Consensus        36 -------~l~~L~~L~L~--~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~-----------------~~~~~~--~l~~   87 (871)
                             ....++.+.+.  .|++++ +|.+|+++++|++|+|++|++++.                 +|..++  ++++
T Consensus       172 ~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~  250 (636)
T 4eco_A          172 QKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKD  250 (636)
T ss_dssp             SCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTT
T ss_pred             ccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCC
Confidence                   11122222232  689997 899999999999999999999975                 999999  9999


Q ss_pred             ccccccccccccCCCCccccccCCCceeeeeccc-ccc-ccccccccCC------CCccEEEccCccCCCCCCccCcCCC
Q 002883           88 LNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNK-LVG-EIPHYVGFTL------PNIRVLLLGSNWFTGEIPPSISNAS  159 (871)
Q Consensus        88 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~-~~~~~~~~~l------~~L~~L~l~~n~i~~~~p~~~~~~~  159 (871)
                      |++|+|++|.+.+.+|..++++++|++|++++|+ +.+ .+|..++ .+      ++|+.|++++|.++           
T Consensus       251 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~-~L~~~~~l~~L~~L~L~~n~l~-----------  318 (636)
T 4eco_A          251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ-ALADAPVGEKIQIIYIGYNNLK-----------  318 (636)
T ss_dssp             CCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHH-HHHHSGGGGTCCEEECCSSCCS-----------
T ss_pred             CCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHH-hhhccccCCCCCEEECCCCcCC-----------
Confidence            9999999999999999999999999999999998 887 7888776 44      99999999999997           


Q ss_pred             CCCc--cccCCCcccEEecccccCC-CCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCcc
Q 002883          160 SIPE--DLGKLKNLIRLNFARNNLG-TGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRI  236 (871)
Q Consensus       160 ~lp~--~~~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i  236 (871)
                      .+|.  .++.+++|++|++++|+++ .++        .+..+++|++|+|++|+++ .+|..+..+..+|++|++++|++
T Consensus       319 ~ip~~~~l~~l~~L~~L~L~~N~l~g~ip--------~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l  389 (636)
T 4eco_A          319 TFPVETSLQKMKKLGMLECLYNQLEGKLP--------AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKL  389 (636)
T ss_dssp             SCCCHHHHTTCTTCCEEECCSCCCEEECC--------CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCC
T ss_pred             ccCchhhhccCCCCCEEeCcCCcCccchh--------hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcC
Confidence            6777  7899999999999999997 533        5678899999999999999 88988888854499999999999


Q ss_pred             CCCCCCCCCCcc--ccceeecccccccccCCcccc-------CCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCcc
Q 002883          237 SGTIPTGVGNLK--NLILIAMEVNLLTGSIPTSVG-------YLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNS  307 (871)
Q Consensus       237 ~~~~~~~~~~l~--~L~~L~l~~N~l~~~~~~~~~-------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  307 (871)
                      + .+|..+..++  +|+.|++++|.+++..|..|.       .+++|++|+|++|+++...+..+..+++|++|+|++|+
T Consensus       390 ~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~  468 (636)
T 4eco_A          390 K-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNM  468 (636)
T ss_dssp             S-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSC
T ss_pred             c-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCC
Confidence            9 7888887765  999999999999999999888       88899999999999995545556779999999999999


Q ss_pred             ccccCcccccCCC-------CCCEEecCCCcCCCCCccccc--CCCCCcEEeccCCCCCCCCccccCCCCCCCEEeC---
Q 002883          308 IRGSIPSALGNCL-------QLQKLDLSDNNLSGTIPREVI--GLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDL---  375 (871)
Q Consensus       308 i~~~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L---  375 (871)
                      ++...+..+....       +|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|   
T Consensus       469 l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N  546 (636)
T 4eco_A          469 LTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ  546 (636)
T ss_dssp             CSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSC
T ss_pred             CCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCC
Confidence            9944444444333       9999999999999 7888887  99999999999999996 8999999999999999   


Q ss_pred             ---CCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCC
Q 002883          376 ---SENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSG  430 (871)
Q Consensus       376 ---~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  430 (871)
                         ++|++.+.+|..+..+++|++|+|++|+|+ .+|..+.  ++|+.|+|++|++..
T Consensus       547 ~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT--PNISVLDIKDNPNIS  601 (636)
T ss_dssp             BCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCCC--TTCCEEECCSCTTCE
T ss_pred             cccccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHhHh--CcCCEEECcCCCCcc
Confidence               568888899999999999999999999996 5566655  799999999998874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=418.65  Aligned_cols=285  Identities=19%  Similarity=0.219  Sum_probs=210.8

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  635 (871)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++...  ....+.+.+|+++|+.++|||||++++++..... .....
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999999999999999996432  2334678899999999999999999998865422 23467


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      +|+|||||+ |+|.+++...+       .+++.++..++.||+.||+|||++   +||||||||+|||++.++.+||+||
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~-------~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DF  202 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ-------PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDF  202 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeec
Confidence            899999995 68999997654       699999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCC-CccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          716 GLSRLLHDNSP-DQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       716 g~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |+|+.+..... ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+....+.........+.+
T Consensus       203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p  282 (398)
T 4b99_A          203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP  282 (398)
T ss_dssp             TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99987643221 12233456899999999987765 56999999999999999999999998654332222212222222


Q ss_pred             ch-hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQ-VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .. ..........   ...........+......++....++.+|+.+||..||++||||+|+++
T Consensus       283 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          283 SPAVIQAVGAERV---RAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CGGGTC-----CH---HHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ChHHhhhhhhhhh---hhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            21 1111111100   0001111111111222223344567889999999999999999999986

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.3e-46  Score=438.48  Aligned_cols=435  Identities=20%  Similarity=0.179  Sum_probs=351.9

Q ss_pred             cccccCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccC-CCCc
Q 002883            2 LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSG-NIPS   80 (871)
Q Consensus         2 ~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~-~~~~   80 (871)
                      +.+..|..|.++++|++|+|++|+|++..|++|+++++|++|+|++|++++..|..|+++++|++|+|++|++++ ..|.
T Consensus        38 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~  117 (549)
T 2z81_A           38 ITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS  117 (549)
T ss_dssp             CCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSC
T ss_pred             cCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhh
Confidence            455667889999999999999999998888999999999999999999998777789999999999999999985 3577


Q ss_pred             cccccccccccccccccccCCCC-ccccccCCCceeeeeccccccccccccc-----------------------cCCCC
Q 002883           81 ELGLLKQLNMFQVSANYLTGSIP-IQLFNISSMDYFAVTQNKLVGEIPHYVG-----------------------FTLPN  136 (871)
Q Consensus        81 ~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~-----------------------~~l~~  136 (871)
                      .|+++++|++|++++|.+.+.+| ..+.++++|++|++++|.+.+.+|..+.                       ..+++
T Consensus       118 ~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~  197 (549)
T 2z81_A          118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS  197 (549)
T ss_dssp             SCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTT
T ss_pred             hhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhccc
Confidence            89999999999999998544554 6789999999999999998876666543                       13566


Q ss_pred             ccEEEccCccCCCCCCccCcCCCCCCcc-ccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccC
Q 002883          137 IRVLLLGSNWFTGEIPPSISNASSIPED-LGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVL  215 (871)
Q Consensus       137 L~~L~l~~n~i~~~~p~~~~~~~~lp~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~  215 (871)
                      |+.|++++|.+++...        .|.. ...+++|+.|++++|.++.....  .....+..+++|+.|++++|.+.+..
T Consensus       198 L~~L~L~~n~l~~~~~--------~~~~~~~~~~~L~~L~l~~n~l~~~~~~--~l~~~~~~~~~L~~l~l~~~~~~~~~  267 (549)
T 2z81_A          198 VRYLELRDTNLARFQF--------SPLPVDEVSSPMKKLAFRGSVLTDESFN--ELLKLLRYILELSEVEFDDCTLNGLG  267 (549)
T ss_dssp             BSEEEEESCBCTTCCC--------CCCSSCCCCCCCCEEEEESCEEEHHHHH--HHHGGGGGCTTCCEEEEESCEEECCS
T ss_pred             ccEEEccCCccccccc--------cccchhhhhhcccceeccccccchhHHH--HHHHHhhhhccccccccccccccccc
Confidence            7777777777763210        0111 34578999999999988642211  12234567789999999999987531


Q ss_pred             C------hhhhhccccccEEEccCCccCCCC-----CCCCCCccccceeecccccccccCCccc-cCCCCCcEEEccCCC
Q 002883          216 P------NSIANFSSHLIYLYMSANRISGTI-----PTGVGNLKNLILIAMEVNLLTGSIPTSV-GYLLKLQVLSLFGNK  283 (871)
Q Consensus       216 ~------~~~~~~~~~L~~L~L~~n~i~~~~-----~~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~L~~n~  283 (871)
                      .      ..+..+ .+|+.|+++++.+....     +..+..+++|+.|++++|.++ .+|..+ ..+++|++|+|++|+
T Consensus       268 ~~~~~~~~~~~~l-~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~  345 (549)
T 2z81_A          268 DFNPSESDVVSEL-GKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENL  345 (549)
T ss_dssp             CCCCCTTTCCCCC-TTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSC
T ss_pred             cccccchhhhhhh-cccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCc
Confidence            1      112233 57999999999886321     111233578999999999998 566665 679999999999999


Q ss_pred             CCCCCC---cccCCCccccEEEccCccccccCc--ccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCC
Q 002883          284 ISGEIP---SSLGNLIFLTEVDLQGNSIRGSIP--SALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSG  358 (871)
Q Consensus       284 l~~~~~---~~~~~l~~L~~L~L~~N~i~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  358 (871)
                      +++..|   ..++.+++|++|+|++|++++..+  ..+..+++|++|++++|+++ .+|..+..+++|++|++++|.++ 
T Consensus       346 l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-  423 (549)
T 2z81_A          346 MVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-  423 (549)
T ss_dssp             CCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-
T ss_pred             cccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-
Confidence            987653   447889999999999999986543  56899999999999999999 78888999999999999999998 


Q ss_pred             CCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccc
Q 002883          359 PIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNT  438 (871)
Q Consensus       359 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  438 (871)
                      .+|..+  .++|+.|+|++|++++..    ..+++|++|+|++|+|+.+ |. ...+++|++|+|++|++++.+|..+..
T Consensus       424 ~l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~~i-p~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~  495 (549)
T 2z81_A          424 VVKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLKTL-PD-ASLFPVLLVMKISRNQLKSVPDGIFDR  495 (549)
T ss_dssp             CCCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCSSC-CC-GGGCTTCCEEECCSSCCCCCCTTGGGG
T ss_pred             cccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccCcC-CC-cccCccCCEEecCCCccCCcCHHHHhc
Confidence            445443  368999999999999643    5789999999999999954 44 467899999999999999999999999


Q ss_pred             cccccEEecCCCcCcccCCC
Q 002883          439 FRFLQKLNLSFNNLEGEVPS  458 (871)
Q Consensus       439 ~~~L~~L~l~~N~l~~~~~~  458 (871)
                      +++|+.|++++|++.|.+|.
T Consensus       496 l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          496 LTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             CTTCCEEECCSSCBCCCHHH
T ss_pred             CcccCEEEecCCCccCCCcc
Confidence            99999999999999998874

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=2.1e-46  Score=447.59  Aligned_cols=418  Identities=19%  Similarity=0.211  Sum_probs=351.0

Q ss_pred             CcCceeeCCCCcccccCCccccCCcccceeec-cCccccCCCCccc----------------------------------
Q 002883           38 FKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSL-SENSLSGNIPSEL----------------------------------   82 (871)
Q Consensus        38 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-s~n~l~~~~~~~~----------------------------------   82 (871)
                      .+++.|+|++|.+.|.+|.+|++|++|++|+| ++|.+++..|-..                                  
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            67999999999999999999999999999999 9998876533210                                  


Q ss_pred             -----------------ccccccccccccc--ccccCCCCccccccCCCceeeeecccccc-----------------cc
Q 002883           83 -----------------GLLKQLNMFQVSA--NYLTGSIPIQLFNISSMDYFAVTQNKLVG-----------------EI  126 (871)
Q Consensus        83 -----------------~~l~~L~~L~l~~--n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-----------------~~  126 (871)
                                       .....++.+.+..  |.+++ +|..++++++|++|+|++|.+.+                 .+
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i  481 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE  481 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence                             1223445555554  89996 99999999999999999999997                 38


Q ss_pred             cccc-ccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEeccccc-CCC--CCCCCcccc-ccccCCCcc
Q 002883          127 PHYV-GFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNN-LGT--GKGNDLRFL-DSLVNCTFL  201 (871)
Q Consensus       127 ~~~~-~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~-l~~--~~~~~~~~~-~~l~~l~~L  201 (871)
                      |..+ +..+++|+.|+|++|.+.+          .+|..|+++++|+.|+|++|+ ++.  +|.. +..+ ..+..+++|
T Consensus       482 P~~l~f~~L~~L~~L~Ls~N~l~~----------~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~-i~~L~~~~~~l~~L  550 (876)
T 4ecn_A          482 NEELSWSNLKDLTDVELYNCPNMT----------QLPDFLYDLPELQSLNIACNRGISAAQLKAD-WTRLADDEDTGPKI  550 (876)
T ss_dssp             TSCCCGGGCTTCCEEEEESCTTCC----------SCCGGGGGCSSCCEEECTTCTTSCHHHHHHH-HHHHHHCTTTTTTC
T ss_pred             ChhhhhccCCCCCEEECcCCCCCc----------cChHHHhCCCCCCEEECcCCCCcccccchHH-HHhhhhcccccCCc
Confidence            8877 4589999999999999885          566678899999999999998 753  2211 1111 134556699


Q ss_pred             cEEEccCCcCcccCCh--hhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCC-CcEEE
Q 002883          202 EVVSLSSNSLSGVLPN--SIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLK-LQVLS  278 (871)
Q Consensus       202 ~~L~L~~n~l~~~~~~--~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~-L~~L~  278 (871)
                      ++|+|++|+++ .+|.  .+..+ ++|+.|+|++|+++ .+| .|+.+++|+.|+|++|.++ .+|..+..+++ |+.|+
T Consensus       551 ~~L~Ls~N~L~-~ip~~~~l~~L-~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~  625 (876)
T 4ecn_A          551 QIFYMGYNNLE-EFPASASLQKM-VKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLG  625 (876)
T ss_dssp             CEEECCSSCCC-BCCCHHHHTTC-TTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEE
T ss_pred             cEEEeeCCcCC-ccCChhhhhcC-CCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEE
Confidence            99999999999 7888  88887 47999999999999 777 8999999999999999999 88889999999 99999


Q ss_pred             ccCCCCCCCCCcccCCCcc--ccEEEccCccccccCcccc---c--CCCCCCEEecCCCcCCCCCccc-ccCCCCCcEEe
Q 002883          279 LFGNKISGEIPSSLGNLIF--LTEVDLQGNSIRGSIPSAL---G--NCLQLQKLDLSDNNLSGTIPRE-VIGLSSFVLLD  350 (871)
Q Consensus       279 L~~n~l~~~~~~~~~~l~~--L~~L~L~~N~i~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~  350 (871)
                      |++|+++ .+|..+..+..  |+.|+|++|++.+.+|...   .  .+++|+.|+|++|+++ .+|.. +..+++|+.|+
T Consensus       626 Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~  703 (876)
T 4ecn_A          626 FSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTII  703 (876)
T ss_dssp             CCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEE
T ss_pred             CcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEE
Confidence            9999999 78888887764  9999999999997666432   2  3458999999999999 55554 45899999999


Q ss_pred             ccCCCCCCCCccccCC--------CCCCCEEeCCCCcCCCCCccchh--cccCCceeeecCCcccccCccccCCCCCCCE
Q 002883          351 LSRNHLSGPIPLEVGR--------LKGIQQLDLSENKLSGEIPTSLA--SCVGLEYLNFSDNSFQGPIHSGFSSLKGLQD  420 (871)
Q Consensus       351 ls~N~l~~~~~~~~~~--------l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  420 (871)
                      |++|+++ .+|..+..        +++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|+|++ +|..+..+++|+.
T Consensus       704 Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~  780 (876)
T 4ecn_A          704 LSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKA  780 (876)
T ss_dssp             CCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCE
T ss_pred             CCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCE
Confidence            9999999 56654443        239999999999999 7888887  99999999999999997 6888899999999


Q ss_pred             EeCCC------CcCCCCCcccccccccccEEecCCCcCcccCCCCcccccccceeccCCCCCccC
Q 002883          421 LDLSR------NNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGG  479 (871)
Q Consensus       421 L~l~~------N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~C~~  479 (871)
                      |+|++      |++.+.+|..+..+++|+.|+|++|++ +.+|.. .+++++.+++.+|++..-.
T Consensus       781 L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l~~~L~~LdLs~N~l~~i~  843 (876)
T 4ecn_A          781 FGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-LTPQLYILDIADNPNISID  843 (876)
T ss_dssp             EECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCSSSCEEECCSCTTCEEE
T ss_pred             EECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHh-hcCCCCEEECCCCCCCccC
Confidence            99977      888899999999999999999999999 555654 3478999999999976543

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=4.3e-45  Score=433.86  Aligned_cols=467  Identities=21%  Similarity=0.191  Sum_probs=359.1

Q ss_pred             ccCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccc
Q 002883            5 EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGL   84 (871)
Q Consensus         5 ~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~   84 (871)
                      ++|..|.  +++++|||++|+|++..|.+|+++++|++|+|++|+|+++.|++|.++++|++|+|++|+|++..+..|++
T Consensus        45 ~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~  122 (635)
T 4g8a_A           45 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG  122 (635)
T ss_dssp             SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTT
T ss_pred             ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcC
Confidence            5777765  47999999999999888899999999999999999999888889999999999999999999666678999


Q ss_pred             cccccccccccccccCCCCccccccCCCceeeeeccccccc-cccccccCCCCccEEEccCccCCCCCCccCcCCCC---
Q 002883           85 LKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGE-IPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASS---  160 (871)
Q Consensus        85 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~---  160 (871)
                      |++|++|+|++|++++..+..|.++++|++|++++|.+.+. +|..+ ..+++|+.|+|++|+|++..|.++..+..   
T Consensus       123 L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~  201 (635)
T 4g8a_A          123 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF-SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL  201 (635)
T ss_dssp             CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGG-GGCTTCCEEECCSSCCCEECGGGGHHHHTCTT
T ss_pred             CCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhh-ccchhhhhhcccCccccccccccccchhhhhh
Confidence            99999999999999976677899999999999999999753 45444 48999999999999998655554422111   


Q ss_pred             --------------CCccccCCCcccEEecccccCC-------------------------------CCCCCCcc-----
Q 002883          161 --------------IPEDLGKLKNLIRLNFARNNLG-------------------------------TGKGNDLR-----  190 (871)
Q Consensus       161 --------------lp~~~~~l~~L~~L~l~~n~l~-------------------------------~~~~~~~~-----  190 (871)
                                    ++........++.+++++|...                               ......+.     
T Consensus       202 ~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l  281 (635)
T 4g8a_A          202 LNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL  281 (635)
T ss_dssp             CCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGS
T ss_pred             hhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccch
Confidence                          1111112222333333333211                               00000000     


Q ss_pred             ----------------ccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceee
Q 002883          191 ----------------FLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIA  254 (871)
Q Consensus       191 ----------------~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~  254 (871)
                                      ....+..+.+++.+++.+|.+... + .+... ..|+.|++.+|.+....+   ..++.|+.++
T Consensus       282 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~-~-~~~~~-~~L~~L~l~~~~~~~~~~---~~l~~L~~l~  355 (635)
T 4g8a_A          282 TIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV-K-DFSYN-FGWQHLELVNCKFGQFPT---LKLKSLKRLT  355 (635)
T ss_dssp             EEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC-G-GGGSC-CCCSEEEEESCEESSCCC---CBCTTCCEEE
T ss_pred             hhhhhhhhhhcccccchhhhhhhhcccccccccccccccc-c-ccccc-hhhhhhhcccccccCcCc---ccchhhhhcc
Confidence                            001122234455555555555422 1 12222 357788888887764443   3456677788


Q ss_pred             cccccccccCCccccCCCCCcEEEccCCCCCC--CCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcC
Q 002883          255 MEVNLLTGSIPTSVGYLLKLQVLSLFGNKISG--EIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNL  332 (871)
Q Consensus       255 l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  332 (871)
                      +..|.+...  ..+..+++|+.|++++|.+..  ..+..+..+.+|+.|++..|.+. ..+..+..+++|+.+++++|..
T Consensus       356 l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~  432 (635)
T 4g8a_A          356 FTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL  432 (635)
T ss_dssp             EESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEE
T ss_pred             cccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccc
Confidence            888877632  334568899999999998863  23555667888999999999887 4566788899999999999887


Q ss_pred             CCCCc-ccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCC-CCCccchhcccCCceeeecCCcccccCcc
Q 002883          333 SGTIP-REVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLS-GEIPTSLASCVGLEYLNFSDNSFQGPIHS  410 (871)
Q Consensus       333 ~~~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  410 (871)
                      ....+ ..+..+++++.++++.|.+.+..+..+..++.|+.|++++|.+. +..|..|..+++|++|+|++|+|+++.|.
T Consensus       433 ~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~  512 (635)
T 4g8a_A          433 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT  512 (635)
T ss_dssp             ESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChH
Confidence            65443 56788999999999999999888889999999999999999754 45788899999999999999999999999


Q ss_pred             ccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCC-ccc-ccccceeccCCCCCccCCCcc
Q 002883          411 GFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE-GVF-KNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       411 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~-~~~-~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      .|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++..|.. ..+ .+++.+++.+|||.|+|...|
T Consensus       513 ~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~  587 (635)
T 4g8a_A          513 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQS  587 (635)
T ss_dssp             TTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHH
T ss_pred             HHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHH
Confidence            9999999999999999999988999999999999999999999988764 233 578999999999999997543

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=9.4e-46  Score=431.42  Aligned_cols=436  Identities=19%  Similarity=0.200  Sum_probs=288.2

Q ss_pred             ccCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccc
Q 002883            5 EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGL   84 (871)
Q Consensus         5 ~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~   84 (871)
                      ++|..+.  ++|+.|+|++|+|++..|++|+++++|++|+|++|++++..|+.|.++++|++|+|++|+++ .+|..  .
T Consensus        45 ~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~  119 (562)
T 3a79_B           45 HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--P  119 (562)
T ss_dssp             SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--C
T ss_pred             cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--c
Confidence            3676665  67888888888888777788888888888888888888777888888888888888888887 66665  7


Q ss_pred             cccccccccccccccC-CCCccccccCCCceeeeeccccccccccccccCCCCc--cEEEccCccC--CCCCCccCcCCC
Q 002883           85 LKQLNMFQVSANYLTG-SIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNI--RVLLLGSNWF--TGEIPPSISNAS  159 (871)
Q Consensus        85 l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L--~~L~l~~n~i--~~~~p~~~~~~~  159 (871)
                      +++|++|+|++|++++ .+|..|.++++|++|++++|++.+.    .+..+++|  +.|++++|.+  ++..|..+.++.
T Consensus       120 l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~  195 (562)
T 3a79_B          120 MASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL----DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN  195 (562)
T ss_dssp             CTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT----TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECC
T ss_pred             cccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC----chhhhhhceeeEEEeecccccccccCcccccccC
Confidence            8888888888888875 3357788888888888888887632    12244555  8888888888  666665554432


Q ss_pred             ---------------CCCc-cccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhh--
Q 002883          160 ---------------SIPE-DLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIAN--  221 (871)
Q Consensus       160 ---------------~lp~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~--  221 (871)
                                     .+++ .+..+++|+.|++++|+....  .....++.+..+++|+.|+++++.+++.....+..  
T Consensus       196 ~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~--~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~  273 (562)
T 3a79_B          196 TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ--RLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF  273 (562)
T ss_dssp             EEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH--HHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH
T ss_pred             cceEEEEecCccchhhhhhhcccccceEEEecccccccccc--hHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhh
Confidence                           1121 244555566666655531100  00001223445555555655555554221111110  


Q ss_pred             ccccccEEEccCCccCCCCCCCC-----CCccccceeecccccccccCC-ccccCC---CCCcEEEccCCCCCCCCCccc
Q 002883          222 FSSHLIYLYMSANRISGTIPTGV-----GNLKNLILIAMEVNLLTGSIP-TSVGYL---LKLQVLSLFGNKISGEIPSSL  292 (871)
Q Consensus       222 ~~~~L~~L~L~~n~i~~~~~~~~-----~~l~~L~~L~l~~N~l~~~~~-~~~~~l---~~L~~L~L~~n~l~~~~~~~~  292 (871)
                      ..++|++|++++|++++.+|..+     ..+++|+.++++.|.+  ..| ..+..+   .+|++|++++|.+....  ..
T Consensus       274 ~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~  349 (562)
T 3a79_B          274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CP  349 (562)
T ss_dssp             TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CC
T ss_pred             hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--Cc
Confidence            01257777777777776677666     6666777777776666  233 222222   56777888877775221  12


Q ss_pred             CCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCC--cccccCCCCCcEEeccCCCCCCCCc-cccCCCCC
Q 002883          293 GNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTI--PREVIGLSSFVLLDLSRNHLSGPIP-LEVGRLKG  369 (871)
Q Consensus       293 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~ls~N~l~~~~~-~~~~~l~~  369 (871)
                      ..+++|++|++++|++++..|..+.++++|++|++++|++++..  |..+..+++|++|++++|.+++.+| ..+..+++
T Consensus       350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~  429 (562)
T 3a79_B          350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES  429 (562)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred             cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence            56777778888888877767777777778888888888777432  3557777778888888887776344 34677777


Q ss_pred             CCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCC
Q 002883          370 IQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSF  449 (871)
Q Consensus       370 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~  449 (871)
                      |+.|++++|++++..|..+.  ++|++|+|++|+|+. +|..+..+++|++|+|++|++++..+..+..+++|+.|++++
T Consensus       430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~  506 (562)
T 3a79_B          430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHD  506 (562)
T ss_dssp             CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCC-CCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCS
T ss_pred             CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcc-cChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecC
Confidence            88888888877755554443  577777888887774 444444777778888888877743333377777777777877


Q ss_pred             CcCcccCCC
Q 002883          450 NNLEGEVPS  458 (871)
Q Consensus       450 N~l~~~~~~  458 (871)
                      |+++|.++.
T Consensus       507 N~~~c~c~~  515 (562)
T 3a79_B          507 NPWDCTCPG  515 (562)
T ss_dssp             CCBCCCHHH
T ss_pred             CCcCCCcch
Confidence            777776664

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.3e-46  Score=403.78  Aligned_cols=204  Identities=23%  Similarity=0.347  Sum_probs=172.0

Q ss_pred             hhcCCCCCceeeccccceEEEEEEC---CCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILG---TEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  632 (871)
                      -.++|++.+.||+|+||+||+|+++   .+++.||+|++....  ...++.+|+++++.+ +||||++++++|.+.    
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~----   92 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN----   92 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET----
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC----
Confidence            3578999999999999999999874   457889999986443  346788999999998 699999999998765    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-CceE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE-MVAH  711 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~k  711 (871)
                       ++.|+||||+++|+|.+++.          .+++.+++.++.||+.||+|||++   ||+||||||+|||++.+ +.+|
T Consensus        93 -~~~~lvmE~~~g~~L~~~~~----------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~k  158 (361)
T 4f9c_A           93 -DHVVIAMPYLEHESFLDILN----------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYA  158 (361)
T ss_dssp             -TEEEEEEECCCCCCHHHHHT----------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEE
T ss_pred             -CEEEEEEeCCCcccHHHHHc----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEE
Confidence             77999999999999999984          388999999999999999999999   99999999999999876 7999


Q ss_pred             EeecccceecCCCCCC-------------------------ccccccccccccccCcccccCC-CCCCccchhhHHHHHH
Q 002883          712 VGDFGLSRLLHDNSPD-------------------------QTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILML  765 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~  765 (871)
                      |+|||+|+...+....                         .......+||+.|+|||++.+. .|+.++||||+||++|
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~  238 (361)
T 4f9c_A          159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL  238 (361)
T ss_dssp             ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred             ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence            9999999876542211                         0112335799999999988765 4899999999999999


Q ss_pred             HHHhCCCCCchhhhh
Q 002883          766 EMFTGKRPTDDMFEE  780 (871)
Q Consensus       766 elltG~~pf~~~~~~  780 (871)
                      ||++|+.||....++
T Consensus       239 ell~G~~Pf~~~~~~  253 (361)
T 4f9c_A          239 SLLSGRYPFYKASDD  253 (361)
T ss_dssp             HHHHTCSSSSCCSSH
T ss_pred             HHHHCCCCCCCCCCH
Confidence            999999999754443

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=7.2e-45  Score=423.91  Aligned_cols=442  Identities=17%  Similarity=0.151  Sum_probs=334.0

Q ss_pred             CCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccc
Q 002883           13 CSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQ   92 (871)
Q Consensus        13 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~   92 (871)
                      +...+.+|+++|+++ .+|..+.  ++|++|+|++|++++..|++|.++++|++|+|++|++++..|+.|+++++|++|+
T Consensus        30 ~~~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  106 (562)
T 3a79_B           30 NELESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLD  106 (562)
T ss_dssp             ---CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred             cCCCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEE
Confidence            344589999999999 5787664  8999999999999988888999999999999999999988899999999999999


Q ss_pred             cccccccCCCCccccccCCCceeeeecccccc-ccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcc
Q 002883           93 VSANYLTGSIPIQLFNISSMDYFAVTQNKLVG-EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNL  171 (871)
Q Consensus        93 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L  171 (871)
                      |++|+++ .+|..  .+++|++|++++|++.+ .+|..+ ..+++|+.|++++|.+++             ..+..+++|
T Consensus       107 Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~-~~l~~L~~L~L~~n~l~~-------------~~~~~l~~L  169 (562)
T 3a79_B          107 VSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEF-GNLTKLTFLGLSAAKFRQ-------------LDLLPVAHL  169 (562)
T ss_dssp             CTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGG-GGCTTCCEEEEECSBCCT-------------TTTGGGTTS
T ss_pred             CCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhh-cccCcccEEecCCCcccc-------------Cchhhhhhc
Confidence            9999999 67776  89999999999999984 233444 489999999999999972             224455555


Q ss_pred             --cEEecccccC--CCCCCCCccccc--------------------cccCCCcccEEEccCCcCc----ccCChhhhhcc
Q 002883          172 --IRLNFARNNL--GTGKGNDLRFLD--------------------SLVNCTFLEVVSLSSNSLS----GVLPNSIANFS  223 (871)
Q Consensus       172 --~~L~l~~n~l--~~~~~~~~~~~~--------------------~l~~l~~L~~L~L~~n~l~----~~~~~~~~~~~  223 (871)
                        ++|++++|++  ....+..+..+.                    .+..+++|+.|++++|...    ......+..+ 
T Consensus       170 ~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l-  248 (562)
T 3a79_B          170 HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRG-  248 (562)
T ss_dssp             CEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSC-
T ss_pred             eeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhcc-
Confidence              9999999998  554433222211                    1223344444444444210    0011122222 


Q ss_pred             ccccEEEccCCccCCCC----CCCCCCccccceeecccccccccCCccc-----cCCCCCcEEEccCCCCCCCCC-cccC
Q 002883          224 SHLIYLYMSANRISGTI----PTGVGNLKNLILIAMEVNLLTGSIPTSV-----GYLLKLQVLSLFGNKISGEIP-SSLG  293 (871)
Q Consensus       224 ~~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~L~~n~l~~~~~-~~~~  293 (871)
                      ++|+.|+++++.+++..    +.. ...++|++|++++|.+++.+|..+     ..+++|+.++++.|.+  .+| ..+.
T Consensus       249 ~~L~~L~L~~~~l~~~~~~~~~~~-~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~  325 (562)
T 3a79_B          249 PTLLNVTLQHIETTWKCSVKLFQF-FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALY  325 (562)
T ss_dssp             SSCEEEEEEEEEECHHHHHHHHHH-HTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHH
T ss_pred             CcceEEEecCCcCcHHHHHHHHHh-hhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhh
Confidence            23444444444433210    111 112478888888888887777766     6666666666666666  233 2222


Q ss_pred             CC---ccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCC--CccccCCCC
Q 002883          294 NL---IFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGP--IPLEVGRLK  368 (871)
Q Consensus       294 ~l---~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~--~~~~~~~l~  368 (871)
                      .+   .+|++|++++|.+....  ....+++|++|++++|++++..|..+..+++|+.|++++|++++.  .|..++.++
T Consensus       326 ~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~  403 (562)
T 3a79_B          326 SVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMS  403 (562)
T ss_dssp             HHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCT
T ss_pred             hhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCC
Confidence            22   56999999999886332  236889999999999999988999999999999999999999953  346789999


Q ss_pred             CCCEEeCCCCcCCCCCc-cchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEec
Q 002883          369 GIQQLDLSENKLSGEIP-TSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNL  447 (871)
Q Consensus       369 ~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l  447 (871)
                      +|+.|++++|++++.+| ..+..+++|++|+|++|++++..+..+.  ++|+.|+|++|+++ .+|..+..+++|++|+|
T Consensus       404 ~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L  480 (562)
T 3a79_B          404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNV  480 (562)
T ss_dssp             TCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEEC
T ss_pred             CCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEEC
Confidence            99999999999997455 4588999999999999999876666554  79999999999999 67776679999999999


Q ss_pred             CCCcCcccCCC-CcccccccceeccCCCCCccCCCcc
Q 002883          448 SFNNLEGEVPS-EGVFKNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       448 ~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      ++|+++..++. ...++.++.+++.+|||.|+|+..|
T Consensus       481 ~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~  517 (562)
T 3a79_B          481 ASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIR  517 (562)
T ss_dssp             CSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHHH
T ss_pred             CCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchHH
Confidence            99999976655 4667889999999999999997544

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.9e-45  Score=412.56  Aligned_cols=249  Identities=19%  Similarity=0.251  Sum_probs=199.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHH---HHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSF---IAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++...   .......   ..++.+++.++|||||+++++|.+.   
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~---  264 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP---  264 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS---
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC---
Confidence            467999999999999999999999999999999996432   1122233   3446677788999999999999876   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                        ..+|+|||||+||+|.+++...+       .+++..++.++.||+.||+|||++   |||||||||+|||++.+|.+|
T Consensus       265 --~~lylVmEy~~GGdL~~~l~~~~-------~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vK  332 (689)
T 3v5w_A          265 --DKLSFILDLMNGGDLHYHLSQHG-------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVR  332 (689)
T ss_dssp             --SEEEEEECCCCSCBHHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEE
T ss_pred             --CEEEEEEecCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEE
Confidence              77999999999999999998754       699999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhh-hHHHHhh
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL-SLHKYAK  789 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~-~~~~~~~  789 (871)
                      |+|||+|+......     ....+||+.|||||++.+ ..|+.++|+||+||++|||++|+.||........ .......
T Consensus       333 L~DFGlA~~~~~~~-----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~  407 (689)
T 3v5w_A          333 ISDLGLACDFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL  407 (689)
T ss_dssp             ECCCTTCEECSSCC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH
T ss_pred             ecccceeeecCCCC-----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Confidence            99999998775432     233579999999999864 5799999999999999999999999975432211 1111111


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC-----HHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK-----IQDAIM  857 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----a~evl~  857 (871)
                      .. +.....                              .+..++.+++.+||+.||++|++     |+||++
T Consensus       408 ~~-~~~~p~------------------------------~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          408 TM-AVELPD------------------------------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HC-CCCCCT------------------------------TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CC-CCCCCc------------------------------cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            10 000000                              12345679999999999999998     677754

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.8e-45  Score=417.78  Aligned_cols=251  Identities=22%  Similarity=0.314  Sum_probs=209.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++........+.+.+|+++|+.++|||||+++++|.+.     ..+|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS-----SEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEE
Confidence            36899999999999999999999999999999999766655667889999999999999999999998765     7799


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC--CceEEeec
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE--MVAHVGDF  715 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~Df  715 (871)
                      +|||||+||+|.+++.....      .+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+||
T Consensus       231 iv~E~~~gg~L~~~i~~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DF  301 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHN------KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDF  301 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTS------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             EEEeecCCCcHHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeec
Confidence            99999999999999965432      589999999999999999999999   99999999999999854  89999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC--CC
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG--LP  793 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~--~~  793 (871)
                      |+|+.+...    ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+...... +.......  ++
T Consensus       302 G~a~~~~~~----~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-~~~i~~~~~~~~  376 (573)
T 3uto_A          302 GLTAHLDPK----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKSCDWNMD  376 (573)
T ss_dssp             SSCEECCTT----SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTTCCCCC
T ss_pred             cceeEccCC----CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHhCCCCCC
Confidence            999987543    223345799999999999999999999999999999999999999986433221 11111111  11


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...                              +..+..++.+|+.+||+.||++|||+.|+++
T Consensus       377 ~~~------------------------------~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          377 DSA------------------------------FSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             SGG------------------------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccc------------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111                              1122345678999999999999999999987

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=3.4e-43  Score=417.49  Aligned_cols=466  Identities=21%  Similarity=0.202  Sum_probs=371.9

Q ss_pred             ccccCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccc
Q 002883            3 QGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSEL   82 (871)
Q Consensus         3 ~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~   82 (871)
                      ++..|.+|.++++|++|||++|+|++..|++|++|++|++|+|++|+|++..++.|.++++|++|+|++|++++..+..|
T Consensus        65 ~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~  144 (635)
T 4g8a_A           65 RHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI  144 (635)
T ss_dssp             CEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCC
T ss_pred             CCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhh
Confidence            33344679999999999999999998888999999999999999999997777889999999999999999996666789


Q ss_pred             cccccccccccccccccC-CCCccccccCCCceeeeeccccccccccccccCCCCc----cEEEccCccCCCCCCccCcC
Q 002883           83 GLLKQLNMFQVSANYLTG-SIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNI----RVLLLGSNWFTGEIPPSISN  157 (871)
Q Consensus        83 ~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L----~~L~l~~n~i~~~~p~~~~~  157 (871)
                      +++++|++|+|++|+++. ..|..+..+++|++|++++|++.+..|..+. .+.++    ..++++.|.++...|..+..
T Consensus       145 ~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~-~L~~l~~~~~~~~ls~n~l~~i~~~~~~~  223 (635)
T 4g8a_A          145 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR-VLHQMPLLNLSLDLSLNPMNFIQPGAFKE  223 (635)
T ss_dssp             TTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGH-HHHTCTTCCCEEECTTCCCCEECTTTTTT
T ss_pred             hcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccccc-chhhhhhhhhhhhcccCcccccCcccccc
Confidence            999999999999999985 4578889999999999999999854444332 33332    35666666665322211110


Q ss_pred             C-----------------------------------------------------------------------CCCCcccc
Q 002883          158 A-----------------------------------------------------------------------SSIPEDLG  166 (871)
Q Consensus       158 ~-----------------------------------------------------------------------~~lp~~~~  166 (871)
                      .                                                                       ..++..+.
T Consensus       224 ~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~  303 (635)
T 4g8a_A          224 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFN  303 (635)
T ss_dssp             CEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTG
T ss_pred             hhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhh
Confidence            0                                                                       00112233


Q ss_pred             CCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCC
Q 002883          167 KLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGN  246 (871)
Q Consensus       167 ~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~  246 (871)
                      .+.+++.+++.+|.+..        ...+.....|+.|++++|.+....+..    ...|+.+++++|.+..  +.....
T Consensus       304 ~~~~l~~l~~~~~~~~~--------~~~~~~~~~L~~L~l~~~~~~~~~~~~----l~~L~~l~l~~n~~~~--~~~~~~  369 (635)
T 4g8a_A          304 CLTNVSSFSLVSVTIER--------VKDFSYNFGWQHLELVNCKFGQFPTLK----LKSLKRLTFTSNKGGN--AFSEVD  369 (635)
T ss_dssp             GGTTCSEEEEESCEEEE--------CGGGGSCCCCSEEEEESCEESSCCCCB----CTTCCEEEEESCCSCC--BCCCCB
T ss_pred             hhccccccccccccccc--------ccccccchhhhhhhcccccccCcCccc----chhhhhcccccccCCC--Cccccc
Confidence            44555666666665543        234556778999999999998543332    2469999999999874  334568


Q ss_pred             ccccceeecccccccc--cCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCc-ccccCCCCCC
Q 002883          247 LKNLILIAMEVNLLTG--SIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIP-SALGNCLQLQ  323 (871)
Q Consensus       247 l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~  323 (871)
                      +++|+.|++++|.+..  ..+..+..+.+|+.|+++.|.+. ..+..+..+++|+.+++++|.+....+ ..|..+++++
T Consensus       370 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~  448 (635)
T 4g8a_A          370 LPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI  448 (635)
T ss_dssp             CTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCC
T ss_pred             ccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccc
Confidence            9999999999999863  45666778899999999999998 567778999999999999988775544 5688999999


Q ss_pred             EEecCCCcCCCCCcccccCCCCCcEEeccCCCC-CCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCC
Q 002883          324 KLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHL-SGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDN  402 (871)
Q Consensus       324 ~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  402 (871)
                      .+++++|.+.+..+..+..+++|+.|++++|.+ ....|..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus       449 ~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N  528 (635)
T 4g8a_A          449 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN  528 (635)
T ss_dssp             EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCC
Confidence            999999999988899999999999999999985 4457888999999999999999999989999999999999999999


Q ss_pred             cccccCccccCCCCCCCEEeCCCCcCCCCCccccccc-ccccEEecCCCcCcccCCCCccccccc---ceeccCCCCCcc
Q 002883          403 SFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTF-RFLQKLNLSFNNLEGEVPSEGVFKNVR---AVSIIGNNKLCG  478 (871)
Q Consensus       403 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-~~L~~L~l~~N~l~~~~~~~~~~~~l~---~l~l~~N~~~C~  478 (871)
                      +|+++.+..|.++++|++|||++|+|++..|..+..+ ++|+.|+|++|+|.|.|...+....++   ..........|.
T Consensus       529 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~~wl~~~~~~~~~~~~~~C~  608 (635)
T 4g8a_A          529 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECA  608 (635)
T ss_dssp             CCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHHHHHHHTTTTBSCGGGCBBC
T ss_pred             cCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHHHHHHhCCCccCCCCCceeC
Confidence            9999999999999999999999999999999999988 689999999999999886432221121   111122335677


Q ss_pred             CCCccc
Q 002883          479 GSPELH  484 (871)
Q Consensus       479 ~~~~~~  484 (871)
                      .|+...
T Consensus       609 ~P~~~~  614 (635)
T 4g8a_A          609 TPSDKQ  614 (635)
T ss_dssp             SSTTTT
T ss_pred             CchHHC
Confidence            776653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.5e-42  Score=369.56  Aligned_cols=251  Identities=22%  Similarity=0.314  Sum_probs=208.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||++........+.+.+|+.+++.++||||+++++++...     ...|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEE
Confidence            46899999999999999999999989999999999776666677889999999999999999999998765     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++|+|.+++...        .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        94 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  162 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF  162 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEECCCCCCHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCC
Confidence            999999999999999754        489999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +.......   .......||+.|+|||++.+..++.++||||+||++|+|++|+.||........... ......+..  
T Consensus       163 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~--  236 (297)
T 3fxz_A          163 CAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNGTPEL--  236 (297)
T ss_dssp             CEECCSTT---CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HHHHCSCCC--
T ss_pred             ceecCCcc---cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhCCCCCC--
Confidence            98765432   223345799999999999999999999999999999999999999975432221111 111111000  


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                        ..                         ...+...+.+++.+||+.||++|||++|+++
T Consensus       237 --~~-------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          237 --QN-------------------------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             --SC-------------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CC-------------------------ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence              00                         0022345678999999999999999999986

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=6.7e-42  Score=388.78  Aligned_cols=372  Identities=18%  Similarity=0.179  Sum_probs=237.1

Q ss_pred             CCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccC-CccccCCcccceeeccCccccCCCCccccccccccccc
Q 002883           14 SELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSI-PQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQ   92 (871)
Q Consensus        14 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~   92 (871)
                      ++|++|||++|.|++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            45677777777776666667777777777777777665333 45567777777777777777655666677777777777


Q ss_pred             cccccccCCCCcc--ccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCC--
Q 002883           93 VSANYLTGSIPIQ--LFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKL--  168 (871)
Q Consensus        93 l~~n~l~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l--  168 (871)
                      |++|.+++..+..  +.++++|++|++++|.+.+..|...+..+++|++|++++|.+++..|..          +..+  
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~----------l~~l~~  179 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEED----------LLNFQG  179 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTT----------SGGGTT
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhh----------hhcccc
Confidence            7777776544433  6666777777777777665555554456677777777777666433322          2222  


Q ss_pred             CcccEEecccccCCCCCCCCcc--ccccccCCCcccEEEccCCcCcccCChhhhhcc--ccccEEEccCCccCCCCCCCC
Q 002883          169 KNLIRLNFARNNLGTGKGNDLR--FLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFS--SHLIYLYMSANRISGTIPTGV  244 (871)
Q Consensus       169 ~~L~~L~l~~n~l~~~~~~~~~--~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~--~~L~~L~L~~n~i~~~~~~~~  244 (871)
                      .+|+.|++++|.+..++...+.  ....+..+++|++|++++|++++..|..+....  .+|+.|++++|.+.+..    
T Consensus       180 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~----  255 (455)
T 3v47_A          180 KHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS----  255 (455)
T ss_dssp             CEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC----
T ss_pred             ccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc----
Confidence            4666666666666654432211  011233445666666666666655555554431  24555555555443211    


Q ss_pred             CCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCC--CccccEEEccCccccccCcccccCCCCC
Q 002883          245 GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGN--LIFLTEVDLQGNSIRGSIPSALGNCLQL  322 (871)
Q Consensus       245 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~--l~~L~~L~L~~N~i~~~~~~~~~~l~~L  322 (871)
                                +                        ..+.+....+..+..  .++|++|++++|++++..|..|..+++|
T Consensus       256 ----------~------------------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L  301 (455)
T 3v47_A          256 ----------F------------------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDL  301 (455)
T ss_dssp             ----------T------------------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred             ----------c------------------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCC
Confidence                      0                        111111111222222  2456666666666666666666667777


Q ss_pred             CEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCC
Q 002883          323 QKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDN  402 (871)
Q Consensus       323 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  402 (871)
                      ++|+|++|++++..|..|.++++|++|+|++|.+++..|..+..+++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus       302 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  381 (455)
T 3v47_A          302 EQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTN  381 (455)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCC
Confidence            77777777776666666777777777777777776666677777888888888888887777778888888888888888


Q ss_pred             cccccCccccCCCCCCCEEeCCCCcCCCCCc
Q 002883          403 SFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP  433 (871)
Q Consensus       403 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  433 (871)
                      +|++.++..|..+++|++|++++|++++..|
T Consensus       382 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          382 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             ccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            8887777778888899999999999987766

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=1e-41  Score=387.31  Aligned_cols=389  Identities=18%  Similarity=0.172  Sum_probs=292.9

Q ss_pred             CceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccccccccccCCC-CccccccCCCceeeee
Q 002883           40 LVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSI-PIQLFNISSMDYFAVT  118 (871)
Q Consensus        40 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~  118 (871)
                      -+.++.+++.++ .+|. +.  ++|++|+|++|.+++..|..|+++++|++|++++|.+.+.+ +..|.++++|++|+|+
T Consensus        12 ~~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls   87 (455)
T 3v47_A           12 GYNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD   87 (455)
T ss_dssp             TTEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred             ccccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence            356788888888 6666 33  78899999999988777888888999999999988887444 5567888888888888


Q ss_pred             ccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCccccccccCC
Q 002883          119 QNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNC  198 (871)
Q Consensus       119 ~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l  198 (871)
                      +|.+.+..|..+. .+++|++|+|++|.+++.+|..        ..|..+++|++|++++|+++.+.+.     ..+..+
T Consensus        88 ~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~--------~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~~l  153 (455)
T 3v47_A           88 YNQFLQLETGAFN-GLANLEVLTLTQCNLDGAVLSG--------NFFKPLTSLEMLVLRDNNIKKIQPA-----SFFLNM  153 (455)
T ss_dssp             TCTTCEECTTTTT-TCTTCCEEECTTSCCBTHHHHS--------STTTTCTTCCEEECCSSBCCSCCCC-----GGGGGC
T ss_pred             CCccCccChhhcc-CcccCCEEeCCCCCCCccccCc--------ccccCcccCCEEECCCCccCccCcc-----cccCCC
Confidence            8888744454443 7788888888888776322111        1266777777777777777664321     125566


Q ss_pred             CcccEEEccCCcCcccCChhhhhcc-ccccEEEccCCccCCCCCCCC--------CCccccceeecccccccccCCcccc
Q 002883          199 TFLEVVSLSSNSLSGVLPNSIANFS-SHLIYLYMSANRISGTIPTGV--------GNLKNLILIAMEVNLLTGSIPTSVG  269 (871)
Q Consensus       199 ~~L~~L~L~~n~l~~~~~~~~~~~~-~~L~~L~L~~n~i~~~~~~~~--------~~l~~L~~L~l~~N~l~~~~~~~~~  269 (871)
                      ++|++|++++|.+++..|..+..+. .+|+.|++++|.+.+..+..+        ..+++|+.|++++|.+++..|..+.
T Consensus       154 ~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~  233 (455)
T 3v47_A          154 RRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFF  233 (455)
T ss_dssp             TTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHH
T ss_pred             CcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhh
Confidence            7777777777777766666665542 357777777777775444332        2456666666666666655555554


Q ss_pred             CC---CCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccC--CCCCCEEecCCCcCCCCCcccccCCC
Q 002883          270 YL---LKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGN--CLQLQKLDLSDNNLSGTIPREVIGLS  344 (871)
Q Consensus       270 ~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~  344 (871)
                      .+   ++|+.|++++|.+.+..              +..+.+....+..+..  .++|+.|++++|++++..|..+..++
T Consensus       234 ~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~  299 (455)
T 3v47_A          234 DAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFT  299 (455)
T ss_dssp             HHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCT
T ss_pred             ccccccceeeEeeccccccccc--------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCC
Confidence            33   56666666666654221              1122222222333333  36899999999999988999999999


Q ss_pred             CCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCC
Q 002883          345 SFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLS  424 (871)
Q Consensus       345 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  424 (871)
                      +|++|++++|.+++..|..|+.+++|++|+|++|.+++..|..|..+++|++|+|++|++++..+..|..+++|++|+|+
T Consensus       300 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  379 (455)
T 3v47_A          300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALD  379 (455)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECC
Confidence            99999999999998888899999999999999999998889999999999999999999999989999999999999999


Q ss_pred             CCcCCCCCcccccccccccEEecCCCcCcccCCCCc
Q 002883          425 RNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEG  460 (871)
Q Consensus       425 ~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~  460 (871)
                      +|++++..+..+..+++|++|++++|+++|.+|...
T Consensus       380 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  415 (455)
T 3v47_A          380 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  415 (455)
T ss_dssp             SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             CCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence            999998777888999999999999999999998643

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.7e-41  Score=381.84  Aligned_cols=394  Identities=22%  Similarity=0.288  Sum_probs=266.9

Q ss_pred             CccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCccc-------------ceeeccCcc
Q 002883            7 PANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL-------------QQLSLSENS   73 (871)
Q Consensus         7 p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-------------~~L~Ls~n~   73 (871)
                      |..+. .+.|++|++++|.+ +.+|++|++|++|++|++++|++++.+|.+++++.+|             ++|++++|.
T Consensus         5 p~~~~-~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~   82 (454)
T 1jl5_A            5 PRNVS-NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLG   82 (454)
T ss_dssp             -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSC
T ss_pred             ccccc-cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCc
Confidence            34444 58899999999999 5999999999999999999999999999999999876             999999999


Q ss_pred             ccCCCCccccccccccccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCc
Q 002883           74 LSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPP  153 (871)
Q Consensus        74 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~  153 (871)
                      ++ .+|..   .++|++|++++|.+++ +|..   +++|++|++++|.+. .+|..    .++|++|++++|.++     
T Consensus        83 l~-~lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~~----~~~L~~L~L~~n~l~-----  144 (454)
T 1jl5_A           83 LS-SLPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSNNQLE-----  144 (454)
T ss_dssp             CS-CCCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCSC----CTTCCEEECCSSCCS-----
T ss_pred             cc-cCCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccC-cccCC----CCCCCEEECcCCCCC-----
Confidence            98 56652   4789999999999995 6653   478999999999887 45432    268999999999887     


Q ss_pred             cCcCCCCCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccC
Q 002883          154 SISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSA  233 (871)
Q Consensus       154 ~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~  233 (871)
                            .+| .|+++++|++|++++|+++.++..          ..+|++|++++|++++ +| .+..+ ++|++|++++
T Consensus       145 ------~lp-~~~~l~~L~~L~l~~N~l~~lp~~----------~~~L~~L~L~~n~l~~-l~-~~~~l-~~L~~L~l~~  204 (454)
T 1jl5_A          145 ------KLP-ELQNSSFLKIIDVDNNSLKKLPDL----------PPSLEFIAAGNNQLEE-LP-ELQNL-PFLTAIYADN  204 (454)
T ss_dssp             ------SCC-CCTTCTTCCEEECCSSCCSCCCCC----------CTTCCEEECCSSCCSS-CC-CCTTC-TTCCEEECCS
T ss_pred             ------CCc-ccCCCCCCCEEECCCCcCcccCCC----------cccccEEECcCCcCCc-Cc-cccCC-CCCCEEECCC
Confidence                  456 488899999999999999875531          2489999999999985 56 46666 5699999999


Q ss_pred             CccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCc
Q 002883          234 NRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIP  313 (871)
Q Consensus       234 n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~  313 (871)
                      |++++ +|...   ++|+.|++++|.++ .+| .++.+++|++|++++|++++ +|..   +++|++|++++|++++ +|
T Consensus       205 N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~  273 (454)
T 1jl5_A          205 NSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LP  273 (454)
T ss_dssp             SCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CC
T ss_pred             CcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cC
Confidence            99985 44433   58999999999998 566 48899999999999999984 4543   4789999999999985 45


Q ss_pred             ccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCC-CCCCEEeCCCCcCCCCCccchhccc
Q 002883          314 SALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRL-KGIQQLDLSENKLSGEIPTSLASCV  392 (871)
Q Consensus       314 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~  392 (871)
                      ..   +++|+.|++++|++++. |..   .++|+.|++++|.+++ ++    .+ ++|++|++++|++++ +|..   ++
T Consensus       274 ~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~  337 (454)
T 1jl5_A          274 EL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PP  337 (454)
T ss_dssp             CC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CT
T ss_pred             cc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CC
Confidence            43   37899999999999852 211   2689999999999984 22    23 589999999999985 5554   57


Q ss_pred             CCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCC--CCccccccc-------------ccccEEecCCCcCcc--c
Q 002883          393 GLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSG--KIPMFLNTF-------------RFLQKLNLSFNNLEG--E  455 (871)
Q Consensus       393 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~~-------------~~L~~L~l~~N~l~~--~  455 (871)
                      +|++|++++|+++++ |.   .+++|++|++++|++++  .+|..+..+             ++|+.|++++|++++  .
T Consensus       338 ~L~~L~L~~N~l~~l-p~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~  413 (454)
T 1jl5_A          338 RLERLIASFNHLAEV-PE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPD  413 (454)
T ss_dssp             TCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC---------------------------
T ss_pred             cCCEEECCCCccccc-cc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCcccc
Confidence            899999999999854 43   47889999999999998  678888777             788999999999887  3


Q ss_pred             CCCCcccccccceeccCCCCC
Q 002883          456 VPSEGVFKNVRAVSIIGNNKL  476 (871)
Q Consensus       456 ~~~~~~~~~l~~l~l~~N~~~  476 (871)
                      +|     ..+..+.+.+|...
T Consensus       414 iP-----~sl~~L~~~~~~~~  429 (454)
T 1jl5_A          414 IP-----ESVEDLRMNSERVV  429 (454)
T ss_dssp             ---------------------
T ss_pred             ch-----hhHhheeCcCcccC
Confidence            33     23555666555443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.3e-42  Score=370.03  Aligned_cols=265  Identities=22%  Similarity=0.333  Sum_probs=213.8

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||+||+|++..+++.||+|++........+.+.+|++++++++||||+++++++.+.     ...+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----CeeE
Confidence            46799999999999999999999999999999998766666678899999999999999999999998765     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++|+|.+++.....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        84 lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  154 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDS------QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGL  154 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCT------TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred             EEEEecCCCcHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeeccc
Confidence            99999999999999987432      589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCcc-----------ccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHH
Q 002883          718 SRLLHDNSPDQT-----------STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK  786 (871)
Q Consensus       718 a~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~  786 (871)
                      +...........           ......||+.|+|||++.+..++.++||||||+++|+|++|..||........... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-  233 (310)
T 3s95_A          155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-  233 (310)
T ss_dssp             CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-
T ss_pred             ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-
Confidence            987654322110           11135699999999999999999999999999999999999999875322111000 


Q ss_pred             HhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          787 YAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       787 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                             .......+               ...+       ..++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       234 -------~~~~~~~~---------------~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          234 -------LNVRGFLD---------------RYCP-------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             -------BCHHHHHH---------------HTCC-------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------hhhhcccc---------------ccCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence                   00000000               0000       122345778999999999999999999999999887653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=373.03  Aligned_cols=264  Identities=26%  Similarity=0.404  Sum_probs=210.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCc---EEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEET---NVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .++|++.+.||+|+||+||+|++..+++   .||||+++.. .....+.+.+|+++++.++||||+++++++.+.     
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  122 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG-----  122 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG-----
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----
Confidence            3579999999999999999999975544   5999999654 333456789999999999999999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||+++|+|.+++.....      .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~  193 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDG------QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVS  193 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTT------CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             CccEEEeeCCCCCcHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEEC
Confidence            668999999999999999976432      589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |||++.................+|+.|+|||++.+..++.++|||||||++|+|++ |+.||..........  ......
T Consensus       194 Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~--~~~~~~  271 (325)
T 3kul_A          194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS--SVEEGY  271 (325)
T ss_dssp             CCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH--HHHTTC
T ss_pred             CCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHH--HHHcCC
Confidence            99999987654333333334456788999999988899999999999999999999 999997643322111  111100


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQ  867 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~~  867 (871)
                      .....                              ..++..+.+++.+||+.||++|||+.|+++.|+++.+...
T Consensus       272 ~~~~~------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          272 RLPAP------------------------------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             CCCCC------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             CCCCC------------------------------CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            00000                              0223457789999999999999999999999999876543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.1e-42  Score=374.44  Aligned_cols=287  Identities=34%  Similarity=0.596  Sum_probs=225.7

Q ss_pred             ccccCHHHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeee
Q 002883          546 YLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITS  624 (871)
Q Consensus       546 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~  624 (871)
                      ...++..++....++|++.+.||+|+||.||+|++. +++.||||++..... .....+.+|+++++.++||||++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            345788899999999999999999999999999865 689999999964432 223468899999999999999999999


Q ss_pred             ecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 002883          625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL  704 (871)
Q Consensus       625 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  704 (871)
                      +...     ...++||||+++|+|.+++......   ...+++..++.++.|++.||+|||+.+.++|+||||||+||++
T Consensus        96 ~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~  167 (326)
T 3uim_A           96 CMTP-----TERLLVYPYMANGSVASCLRERPES---QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL  167 (326)
T ss_dssp             ECCS-----SCCEEEEECCTTCBHHHHHHCCSTT---CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred             EecC-----CceEEEEEeccCCCHHHHHHhcccc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence            8765     5679999999999999999875432   3358999999999999999999999866799999999999999


Q ss_pred             CCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhh---h
Q 002883          705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEE---G  781 (871)
Q Consensus       705 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~---~  781 (871)
                      +.++.+||+|||.+.......  ........||+.|+|||++.+..++.++||||+||++|+|++|+.||......   .
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  245 (326)
T 3uim_A          168 DEEFEAVVGDFGLAKLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD  245 (326)
T ss_dssp             CTTCCEEECCCSSCEECCSSS--SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC
T ss_pred             CCCCCEEeccCccccccCccc--ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccc
Confidence            999999999999998765432  22233456999999999988888999999999999999999999999743221   1


Q ss_pred             hhHHHHhhhCCCc-hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          782 LSLHKYAKMGLPD-QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       782 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                      .....+....... ......+.....                  .........+.+++.+||+.||++|||+.|+++.|+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          246 VMLLDWVKGLLKEKKLEALVDVDLQG------------------NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             SBHHHHHTTTTSSCCSTTSSCTTCTT------------------SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hhHHHHHHHHhhchhhhhhcChhhcc------------------ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            1222222221111 122222221111                  111245667899999999999999999999999997


Q ss_pred             H
Q 002883          861 E  861 (871)
Q Consensus       861 ~  861 (871)
                      +
T Consensus       308 ~  308 (326)
T 3uim_A          308 G  308 (326)
T ss_dssp             T
T ss_pred             C
Confidence            4

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.5e-42  Score=371.67  Aligned_cols=281  Identities=30%  Similarity=0.486  Sum_probs=220.5

Q ss_pred             HHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          555 LKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       555 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ....++|++.+.||+|+||.||+|++. +++.||||++........+.+.+|+++++.++||||+++++++.+.     .
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~  108 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER-----N  108 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT-----T
T ss_pred             HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----C
Confidence            345689999999999999999999975 6899999999766666678899999999999999999999998654     5


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+++|+|.+++......   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D  182 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLP---TMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITD  182 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCC---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECC
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCC---ccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEee
Confidence            689999999999999999764321   23589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhh-hhHHHHhhh-CC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG-LSLHKYAKM-GL  792 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~-~~~~~~~~~-~~  792 (871)
                      ||.+........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+... ..
T Consensus       183 fg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  261 (321)
T 2qkw_B          183 FGISKKGTELDQ-THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN  261 (321)
T ss_dssp             CTTCEECSSSSC-CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred             cccccccccccc-cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence            999987543221 122233568999999999888899999999999999999999999997533221 111111100 00


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      ........++...                  ..........+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus       262 ~~~~~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          262 NGQLEQIVDPNLA------------------DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             TTCCCSSSSSSCT------------------TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             cccHHHhcChhhc------------------cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            0011111111110                  0111245667889999999999999999999999999987654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.5e-42  Score=370.13  Aligned_cols=249  Identities=20%  Similarity=0.284  Sum_probs=204.8

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||||++....  ....+.+.+|+++++.++||||+++++++...     .
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~   87 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-----K   87 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----C
Confidence            3468999999999999999999998899999999996542  23456788999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||+++|+|.+++....       .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~D  157 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHG-------RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIAD  157 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred             EEEEEEECCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEee
Confidence            7899999999999999997654       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVS-THGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||++......    .......||+.|+|||++.+..+. +++||||+||++|+|++|+.||......... .........
T Consensus       158 FG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~  232 (328)
T 3fe3_A          158 FGFSNEFTVG----GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR-ERVLRGKYR  232 (328)
T ss_dssp             TTCCGGGSSS----CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHCCCC
T ss_pred             ccCceecCCC----CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH-HHHHhCCCC
Confidence            9999866432    223445799999999998887775 8999999999999999999999754322111 111111000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                        ...                              .....+.+++.+||+.||++|||++|+++
T Consensus       233 --~p~------------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          233 --IPF------------------------------YMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             --CCT------------------------------TSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             --CCC------------------------------CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              000                              11234678999999999999999999976

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.5e-42  Score=364.97  Aligned_cols=280  Identities=23%  Similarity=0.328  Sum_probs=211.8

Q ss_pred             hcCCCCCceeeccccceEEEEE----ECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGI----LGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .++|++.+.||+|+||+||+|+    +..+++.||||++........+.+.+|++++++++||||+++++++...+.   
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH---
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC---
Confidence            4689999999999999999999    456789999999976666666789999999999999999999998865322   


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+++|+|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~  156 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKE------RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIG  156 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGG------GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred             CceEEEEEeCCCCCHHHHHHhccc------ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEc
Confidence            457999999999999999987543      489999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||++.................++..|+|||.+.+..++.++||||||+++|+|++|..||.....+...   .......
T Consensus       157 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~  233 (295)
T 3ugc_A          157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR---MIGNDKQ  233 (295)
T ss_dssp             CCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHH---HHCTTCC
T ss_pred             cCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHh---hhcCccc
Confidence            9999987754432223333445778899999999899999999999999999999999999754332111   1000000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      ..       ........   .........   ....++.++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       234 ~~-------~~~~~~~~---~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          234 GQ-------MIVFHLIE---LLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             TH-------HHHHHHHH---HHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cc-------hhHHHHHH---HHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            00       00000000   000000000   0113345788999999999999999999999999998764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2e-41  Score=369.30  Aligned_cols=252  Identities=22%  Similarity=0.307  Sum_probs=206.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG------ASKSFIAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++.....      ..+.+.+|+.+++.++||||+++++++.+.   
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---   87 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR---   87 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS---
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC---
Confidence            46799999999999999999999999999999999654321      346789999999999999999999998765   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC---
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM---  708 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---  708 (871)
                        ...|+||||+++|+|.+++....       .+++..+..++.||+.||.|||+.   +|+||||||+||+++.++   
T Consensus        88 --~~~~lv~e~~~gg~L~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~  155 (361)
T 2yab_A           88 --TDVVLILELVSGGELFDFLAQKE-------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPI  155 (361)
T ss_dssp             --SEEEEEEECCCSCBHHHHHTTCS-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSS
T ss_pred             --CEEEEEEEcCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCc
Confidence              67899999999999999997643       589999999999999999999999   999999999999998776   


Q ss_pred             -ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHH
Q 002883          709 -VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKY  787 (871)
Q Consensus       709 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~  787 (871)
                       .+||+|||++.......    ......||+.|+|||++.+..++.++||||+||++|+|++|..||........ ....
T Consensus       156 ~~vkl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-~~~i  230 (361)
T 2yab_A          156 PHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANI  230 (361)
T ss_dssp             CCEEECCCSSCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHH
T ss_pred             cCEEEEecCCceEcCCCC----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence             79999999998775432    22335699999999999988999999999999999999999999975432211 1111


Q ss_pred             hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .......      ++                      ..+..+...+.+++.+||..||++|||+.|+++
T Consensus       231 ~~~~~~~------~~----------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          231 TAVSYDF------DE----------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HTTCCCC------CH----------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhcCCCC------Cc----------------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1111000      00                      111133456789999999999999999999985

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-41  Score=365.74  Aligned_cols=253  Identities=22%  Similarity=0.314  Sum_probs=208.1

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.... .....+.+|+++++.++||||+++++++.+.     ...+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM-----EELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----CEEE
Confidence            468999999999999999999999999999999997543 2446788999999999999999999998765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC--CCceEEeec
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN--EMVAHVGDF  715 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Df  715 (871)
                      +||||+++|+|.+++.....      .+++.+++.++.|++.||.|||+.   +|+||||||+||+++.  ++.+||+||
T Consensus        78 lv~e~~~g~~L~~~l~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Df  148 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSAF------ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEF  148 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             EEEEeCCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEEC
Confidence            99999999999999976432      589999999999999999999999   9999999999999987  789999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |.+......    .......||+.|+|||++.+..++.++||||+||++|+|++|+.||........ ........... 
T Consensus       149 g~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~-  222 (321)
T 1tki_A          149 GQARQLKPG----DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-IENIMNAEYTF-  222 (321)
T ss_dssp             TTCEECCTT----CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCCCC-
T ss_pred             CCCeECCCC----CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-HHHHHcCCCCC-
Confidence            999877543    223345689999999999888899999999999999999999999975432211 11111111100 


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                                 ....+..++.++.+++.+||..||++|||+.|+++.
T Consensus       223 ---------------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          223 ---------------------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ---------------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---------------------------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                                       001112344567899999999999999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.8e-42  Score=369.70  Aligned_cols=284  Identities=23%  Similarity=0.293  Sum_probs=211.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||+||+|++.  ++.||||++..... ......+|+.++++++||||+++++++.... ......+
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~   98 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW   98 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence            468999999999999999999985  78999999965433 3345667899999999999999999987642 2235679


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC-------CCCeEecCCCCCceeeCCCCce
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC-------HTSIVHCDLKPSNVLLDNEMVA  710 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------~~~ivH~Dlkp~Nill~~~~~~  710 (871)
                      +||||+++|+|.++++..        .+++..++.++.|++.||+|||+..       ..+|+||||||+||+++.++.+
T Consensus        99 lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN--------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred             EEEecCCCCCHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence            999999999999999753        4899999999999999999999851       2389999999999999999999


Q ss_pred             EEeecccceecCCCCCCccccccccccccccCcccccCC-----CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHH
Q 002883          711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-----EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLH  785 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~  785 (871)
                      ||+|||+|+........ .......||+.|+|||++.+.     .++.++|||||||++|||+||+.||...........
T Consensus       171 kL~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~  249 (322)
T 3soc_A          171 CIADFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF  249 (322)
T ss_dssp             EECCCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred             EEccCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence            99999999877654322 223335699999999987763     456788999999999999999999975432211110


Q ss_pred             HHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHh--HHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          786 KYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAK--FHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                      .......+.         . .......  ......+.....  ......++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       250 ~~~~~~~~~---------~-~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          250 EEEIGQHPS---------L-EDMQEVV--VHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             HHHHCSSCC---------H-HHHHHHH--TTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhhhccCCc---------h-hhhhhhh--hcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            000000000         0 0000000  001111111111  1134567899999999999999999999999999997


Q ss_pred             HHH
Q 002883          864 KMR  866 (871)
Q Consensus       864 ~~~  866 (871)
                      +..
T Consensus       318 ~~~  320 (322)
T 3soc_A          318 RLT  320 (322)
T ss_dssp             HHC
T ss_pred             HHh
Confidence            653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7.6e-41  Score=360.46  Aligned_cols=262  Identities=23%  Similarity=0.316  Sum_probs=212.4

Q ss_pred             ccCHHHHHHhhcC----------CCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCc
Q 002883          548 KISYAELLKATEG----------FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRN  617 (871)
Q Consensus       548 ~~~~~~~~~~~~~----------y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  617 (871)
                      .++++++..+.+.          |+..+.||+|+||+||+|++..+++.||||++........+.+.+|+.+++.++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4566666665543          677789999999999999999899999999997766666778999999999999999


Q ss_pred             cceeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 002883          618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL  697 (871)
Q Consensus       618 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  697 (871)
                      |+++++++...     ...++||||+++++|.+++...        .+++..+..++.|++.||.|||+.   +|+||||
T Consensus       104 iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~--------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dl  167 (321)
T 2c30_A          104 VVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQV--------RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDI  167 (321)
T ss_dssp             BCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTTC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             cceEEEEEEEC-----CEEEEEEecCCCCCHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCC
Confidence            99999998765     5689999999999999998653        489999999999999999999999   9999999


Q ss_pred             CCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          698 KPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       698 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      ||+||+++.++.+||+|||++........   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       168 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~  244 (321)
T 2c30_A          168 KSDSILLTLDGRVKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD  244 (321)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             CHHHEEECCCCcEEEeeeeeeeecccCcc---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999987654321   223457999999999999999999999999999999999999999753


Q ss_pred             hhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          778 FEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ..... .... ....++...                            ........+.+++.+||+.||++|||+.|+++
T Consensus       245 ~~~~~-~~~~-~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          245 SPVQA-MKRL-RDSPPPKLK----------------------------NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             CHHHH-HHHH-HHSSCCCCT----------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHHHH-HHHH-hcCCCCCcC----------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            22211 1111 111110000                            00122345778999999999999999999987


Q ss_pred             H
Q 002883          858 E  858 (871)
Q Consensus       858 ~  858 (871)
                      .
T Consensus       295 h  295 (321)
T 2c30_A          295 H  295 (321)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.7e-41  Score=363.07  Aligned_cols=267  Identities=24%  Similarity=0.335  Sum_probs=203.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHc--CCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRS--IRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||+||+|++  +++.||||++....   ...+.+|.+++..  ++||||+++++++... ......
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence            46899999999999999999998  58899999986432   3556667777766  7999999999987653 223466


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEecCCCCCceeeCCC
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH--------HHCHTSIVHCDLKPSNVLLDNE  707 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~Nill~~~  707 (871)
                      .++||||+++|+|.++++..        .+++..++.++.|++.||+|||        +.   +|+||||||+||+++.+
T Consensus        81 ~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~  149 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQLT--------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKN  149 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTTC--------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTT
T ss_pred             eEEehhhccCCCHHHHHhhc--------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCC
Confidence            89999999999999999643        4899999999999999999999        77   99999999999999999


Q ss_pred             CceEEeecccceecCCCCCCcc-ccccccccccccCcccccCC------CCCCccchhhHHHHHHHHHhC----------
Q 002883          708 MVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALG------EVSTHGDEYSFGILMLEMFTG----------  770 (871)
Q Consensus       708 ~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltG----------  770 (871)
                      +.+||+|||+|........... ......||+.|+|||++.+.      .+++++|||||||++|||++|          
T Consensus       150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~  229 (301)
T 3q4u_A          150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY  229 (301)
T ss_dssp             SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence            9999999999987654322111 12234799999999988766      455799999999999999999          


Q ss_pred             CCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC
Q 002883          771 KRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM  850 (871)
Q Consensus       771 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  850 (871)
                      +.||.............................                     .........+.+++.+||+.||++||
T Consensus       230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~l~~li~~cl~~dP~~Rp  288 (301)
T 3q4u_A          230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNR---------------------WFSDPTLTSLAKLMKECWYQNPSARL  288 (301)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG---------------------GGGSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred             cccccccCCCCcchhhhhHHHhccCCCCCCChh---------------------hccCccHHHHHHHHHHHhhcChhhCC
Confidence            778765432221111111100000000000000                     01113456788999999999999999


Q ss_pred             CHHHHHHHHHHH
Q 002883          851 KIQDAIMELQEA  862 (871)
Q Consensus       851 ta~evl~~L~~i  862 (871)
                      |+.|+++.|+++
T Consensus       289 s~~~i~~~L~~i  300 (301)
T 3q4u_A          289 TALRIKKTLTKI  300 (301)
T ss_dssp             CHHHHHHHHHHH
T ss_pred             CHHHHHHHHhcc
Confidence            999999999986

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.3e-41  Score=362.26  Aligned_cols=262  Identities=26%  Similarity=0.367  Sum_probs=201.8

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ...++|++.+.||+|+||+||+|++  .++.||||++....  ....+.+.+|++++++++||||+++++++...     
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----  106 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-----  106 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-----
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----
Confidence            4457899999999999999999988  57889999986443  23346788999999999999999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCceeeCCCCceE
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS--IVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~k  711 (871)
                      ...++||||+++|+|.+++......    ..+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.+|
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~k  179 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAR----EQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVK  179 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHH----HHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEE
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCC----CCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEE
Confidence            5689999999999999999765321    1489999999999999999999999   8  99999999999999999999


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      |+|||+++.....   ........||+.|+|||++.+..++.++|||||||++|+|++|+.||............ ....
T Consensus       180 L~Dfg~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~-~~~~  255 (309)
T 3p86_A          180 VCDFGLSRLKAST---FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV-GFKC  255 (309)
T ss_dssp             ECCCC--------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH-HHSC
T ss_pred             ECCCCCCcccccc---ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcC
Confidence            9999999865432   12223456999999999999999999999999999999999999999864332211111 0000


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      .......                              .+..++.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       256 ~~~~~~~------------------------------~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          256 KRLEIPR------------------------------NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CCCCCCT------------------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CCCCCCc------------------------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            0000000                              1234567899999999999999999999999988653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.2e-41  Score=364.37  Aligned_cols=250  Identities=20%  Similarity=0.283  Sum_probs=205.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++..   .......+.+|+++++.++||||+++++++.+.     .
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----D   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----S
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----C
Confidence            46799999999999999999999999999999999643   233456788999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||+++|+|.+++....       .+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~D  148 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRER-------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITD  148 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEee
Confidence            7899999999999999997643       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||+|+.....   ........||+.|+|||++.+..++.++||||+||++|||++|+.||........ .......... 
T Consensus       149 FG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~~-  223 (337)
T 1o6l_A          149 FGLCKEGISD---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEEIR-  223 (337)
T ss_dssp             CTTCBCSCCT---TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCC-
T ss_pred             ccchhhcccC---CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH-HHHHHcCCCC-
Confidence            9999864322   1223345799999999999999999999999999999999999999975322211 1111110000 


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIME  858 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~~  858 (871)
                       .                       +       .....++.+++.+||+.||++||     +++|+++.
T Consensus       224 -~-----------------------p-------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          224 -F-----------------------P-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -C-----------------------C-------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -C-----------------------C-------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence             0                       0       01234567899999999999999     89998763

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.8e-41  Score=360.78  Aligned_cols=261  Identities=23%  Similarity=0.375  Sum_probs=206.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.     .
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED-----D   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-----S
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-----C
Confidence            368999999999999999999999899999999985432   23346788999999999999999999998665     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||+++++|.+++....       .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~D  154 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHG-------PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFD  154 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC-------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             eEEEEEeCCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEe
Confidence            7899999999999999997654       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||.+.......  ........||+.|+|||.+.+..++.++||||+|+++|+|++|+.||............ .....+.
T Consensus       155 fg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~  231 (294)
T 4eqm_A          155 FGIAKALSETS--LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH-IQDSVPN  231 (294)
T ss_dssp             CSSSTTC---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH-HSSCCCC
T ss_pred             CCCcccccccc--ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hhccCCC
Confidence            99998664322  12233456999999999999999999999999999999999999999864332221111 1111111


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-CHHHHHHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-KIQDAIMELQEAQ  863 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-ta~evl~~L~~i~  863 (871)
                      ...                           .....++..+.+++.+|++.||++|| +++++.+.|+++.
T Consensus       232 ~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          232 VTT---------------------------DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             HHH---------------------------HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             cch---------------------------hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            100                           00112345677999999999999999 8999999998764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.5e-41  Score=373.23  Aligned_cols=263  Identities=25%  Similarity=0.441  Sum_probs=198.6

Q ss_pred             hcCCCCCceeeccccceEEEEEEC---CCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILG---TEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..+|++.+.||+|+||.||+|++.   .++..||||+++... ....+.+.+|++++++++||||+++++++...     
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  118 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS-----  118 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----
Confidence            357999999999999999999986   467789999996543 33456789999999999999999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+++|+|.+++.....      .+++.+++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~  189 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVS  189 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTT------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred             CceEEEEeCCCCCcHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEEC
Confidence            568999999999999999976532      589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |||+++................+++.|+|||++.+..++.++|||||||++|||++ |+.||........  ........
T Consensus       190 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~--~~~i~~~~  267 (373)
T 2qol_A          190 DFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--IKAVDEGY  267 (373)
T ss_dssp             CC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH--HHHHHTTE
T ss_pred             cCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcCC
Confidence            99999876543222222222345778999999988999999999999999999998 9999975432211  11111000


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      ...                         .     ...++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       268 ~~~-------------------------~-----~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          268 RLP-------------------------P-----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             ECC-------------------------C-----CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             CCC-------------------------C-----CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            000                         0     0022346779999999999999999999999999987643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.7e-41  Score=369.96  Aligned_cols=269  Identities=23%  Similarity=0.368  Sum_probs=212.8

Q ss_pred             hcCCCCCceeeccccceEEEEEEC-------CCCcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeeccc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILG-------TEETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCSSI  628 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  628 (871)
                      .++|++.+.||+|+||.||+|++.       .++..||||+++... ....+.+.+|+++++.+ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467999999999999999999974       345679999996543 23456789999999999 899999999998765


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhccccc---------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDE---------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP  699 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  699 (871)
                           ...|+||||+++|+|.+++......         ......+++.+++.++.||+.||+|||+.   +|+||||||
T Consensus       160 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp  231 (370)
T 2psq_A          160 -----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  231 (370)
T ss_dssp             -----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred             -----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence                 5689999999999999999875421         00122589999999999999999999999   999999999


Q ss_pred             CceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhh
Q 002883          700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMF  778 (871)
Q Consensus       700 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~  778 (871)
                      +||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hhEEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9999999999999999999876543221 22233457889999999989999999999999999999999 999997543


Q ss_pred             hhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          779 EEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ....  .............                              ..+...+.+++.+||+.||++|||+.|+++.
T Consensus       311 ~~~~--~~~~~~~~~~~~~------------------------------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          311 VEEL--FKLLKEGHRMDKP------------------------------ANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GGGH--HHHHHTTCCCCCC------------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHH--HHHHhcCCCCCCC------------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2211  1111111000000                              0223457789999999999999999999999


Q ss_pred             HHHHHHHHH
Q 002883          859 LQEAQKMRQ  867 (871)
Q Consensus       859 L~~i~~~~~  867 (871)
                      |+.+.....
T Consensus       359 L~~il~~~~  367 (370)
T 2psq_A          359 LDRILTLTT  367 (370)
T ss_dssp             HHHHHHHHC
T ss_pred             HHHHHHHhc
Confidence            999987653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.9e-42  Score=376.77  Aligned_cols=263  Identities=26%  Similarity=0.395  Sum_probs=211.0

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++...     ..
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  186 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QP  186 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----SS
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----CC
Confidence            3467899999999999999999999899999999986442 22345688999999999999999999998665     56


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++.....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~Df  257 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEGA------RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDF  257 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCG
T ss_pred             cEEEEEcCCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcC
Confidence            8999999999999999976542      489999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      |+++...... .........++..|+|||.+.++.++.++|||||||++|||++ |+.||........  ..........
T Consensus       258 G~s~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~--~~~~~~~~~~  334 (377)
T 3cbl_A          258 GMSREEADGV-YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT--REFVEKGGRL  334 (377)
T ss_dssp             GGCEECTTSE-EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH--HHHHHTTCCC
T ss_pred             CCceecCCCc-eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcCCCC
Confidence            9998654321 1111112235778999999988899999999999999999998 9999986433211  1111111000


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      ...                              ..++..+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus       335 ~~~------------------------------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~  376 (377)
T 3cbl_A          335 PCP------------------------------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH  376 (377)
T ss_dssp             CCC------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCC------------------------------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence            000                              012345778999999999999999999999999997643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.7e-41  Score=366.07  Aligned_cols=255  Identities=20%  Similarity=0.277  Sum_probs=205.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-----RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...     ....+.+.+|+++++.++||||+++++++.+.     
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----   98 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD-----   98 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----
Confidence            57999999999999999999999999999999985432     12357789999999999999999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc---e
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV---A  710 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~  710 (871)
                      ...|+||||+++++|.+++......   ...+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.   +
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~v  172 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRADA---GFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPV  172 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCE
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcE
Confidence            6789999999999999888654321   22589999999999999999999999   9999999999999986654   9


Q ss_pred             EEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh
Q 002883          711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM  790 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~  790 (871)
                      ||+|||++.......   .......||+.|+|||++.+..++.++||||+||++|+|++|+.||......  ........
T Consensus       173 kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~i~~~  247 (351)
T 3c0i_A          173 KLGGFGVAIQLGESG---LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--LFEGIIKG  247 (351)
T ss_dssp             EECCCTTCEECCTTS---CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH--HHHHHHHT
T ss_pred             EEecCcceeEecCCC---eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH--HHHHHHcC
Confidence            999999998775432   1223456999999999999889999999999999999999999999863221  11111111


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .....                            ...+..+..++.+++.+||+.||++|||+.|+++
T Consensus       248 ~~~~~----------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          248 KYKMN----------------------------PRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CCCCC----------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCC----------------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11000                            0111133456789999999999999999999986

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2e-41  Score=365.14  Aligned_cols=255  Identities=24%  Similarity=0.330  Sum_probs=204.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.     ...
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----CeE
Confidence            4689999999999999999999999999999999964432 2346688999999999999999999998765     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||+++|+|.+++....       .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg  150 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDI-------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  150 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTT-------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEee
Confidence            99999999999999997643       589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV-STHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      ++....... .........||+.|+|||++.+..+ +.++||||+||++|+|++|+.||............+........
T Consensus       151 ~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  229 (323)
T 3tki_A          151 LATVFRYNN-RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN  229 (323)
T ss_dssp             TCEECEETT-EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTST
T ss_pred             ccceeccCC-cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCC
Confidence            998764322 1122334579999999999877766 78899999999999999999999754333222222222111100


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .                              ...+...+.+++.+||+.||++|||+.|+++.
T Consensus       230 ~------------------------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          230 P------------------------------WKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             T------------------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             c------------------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0                              01223456789999999999999999999763

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.4e-41  Score=361.92  Aligned_cols=251  Identities=21%  Similarity=0.296  Sum_probs=205.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR------GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.....      ...+.+.+|+++++.++||||+++++++.+.    
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   86 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK----   86 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC----
Confidence            568999999999999999999999999999999964432      1357789999999999999999999998765    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC----
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM----  708 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----  708 (871)
                       ...++||||+++++|.+++....       .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++    
T Consensus        87 -~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~  155 (326)
T 2y0a_A           87 -TDVILILELVAGGELFDFLAEKE-------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP  155 (326)
T ss_dssp             -SEEEEEEECCCSCBHHHHHTTSS-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSC
T ss_pred             -CEEEEEEEcCCCCCHHHHHHhcC-------CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCC
Confidence             67899999999999999997643       589999999999999999999999   999999999999998887    


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA  788 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~  788 (871)
                      .+||+|||++.......    ......||+.|+|||++.+..++.++||||+||++|+|++|+.||........ .....
T Consensus       156 ~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~  230 (326)
T 2y0a_A          156 RIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANVS  230 (326)
T ss_dssp             CEEECCCTTCEECCTTS----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHH
T ss_pred             CEEEEECCCCeECCCCC----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHH
Confidence            89999999998775332    12335699999999999888999999999999999999999999975332211 11111


Q ss_pred             hhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          789 KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ......                            ....+......+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~----------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          231 AVNYEF----------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HTCCCC----------------------------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hcCCCc----------------------------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            110000                            00111123456779999999999999999999987

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.3e-41  Score=377.01  Aligned_cols=259  Identities=22%  Similarity=0.265  Sum_probs=207.2

Q ss_pred             HHHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecc
Q 002883          551 YAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSS  627 (871)
Q Consensus       551 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  627 (871)
                      +.++....++|++.++||+|+||+||+|++..+++.||+|+++...   ......+.+|+.++..++||||++++++|.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            3445556789999999999999999999999899999999996432   1223347889999999999999999999876


Q ss_pred             cCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC
Q 002883          628 IDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE  707 (871)
Q Consensus       628 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  707 (871)
                      .     ...|+||||+++|+|.+++.....      .+++..++.++.||+.||+|||+.   +|+||||||+|||++.+
T Consensus       146 ~-----~~~~lV~Ey~~gg~L~~~l~~~~~------~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~  211 (437)
T 4aw2_A          146 D-----NNLYLVMDYYVGGDLLTLLSKFED------RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMN  211 (437)
T ss_dssp             S-----SEEEEEECCCTTCBHHHHHHTTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred             C-----CEEEEEEecCCCCcHHHHHHHccC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCC
Confidence            5     678999999999999999976432      599999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccceecCCCCCCccccccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhh
Q 002883          708 MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA-----LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL  782 (871)
Q Consensus       708 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~  782 (871)
                      +.+||+|||+|+......  .......+||+.|+|||++.     .+.++.++||||+||++|||++|+.||........
T Consensus       212 g~vkL~DFGla~~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~  289 (437)
T 4aw2_A          212 GHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  289 (437)
T ss_dssp             SCEEECCCTTCEECCTTS--CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             CCEEEcchhhhhhcccCC--CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH
Confidence            999999999998765432  22233457999999999876     56789999999999999999999999975432211


Q ss_pred             hHHHHhh----hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCC--CCCHHHHH
Q 002883          783 SLHKYAK----MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRD--RMKIQDAI  856 (871)
Q Consensus       783 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPta~evl  856 (871)
                       ......    ..+|...                               ..+..++.+++.+||..+|++  ||+++|++
T Consensus       290 -~~~i~~~~~~~~~p~~~-------------------------------~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil  337 (437)
T 4aw2_A          290 -YGKIMNHKERFQFPTQV-------------------------------TDVSENAKDLIRRLICSREHRLGQNGIEDFK  337 (437)
T ss_dssp             -HHHHHTHHHHCCCCSSC-------------------------------CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHH
T ss_pred             -HHhhhhccccccCCccc-------------------------------ccCCHHHHHHHHHHhcccccccCCCCHHHHh
Confidence             111110    0111100                               012345678999999888888  99999987


Q ss_pred             H
Q 002883          857 M  857 (871)
Q Consensus       857 ~  857 (871)
                      +
T Consensus       338 ~  338 (437)
T 4aw2_A          338 K  338 (437)
T ss_dssp             T
T ss_pred             C
Confidence            6

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=2.5e-40  Score=372.38  Aligned_cols=380  Identities=23%  Similarity=0.289  Sum_probs=278.0

Q ss_pred             cccCccCcCCCCCCEEecCCCcccccCCccccCCCcC-------------ceeeCCCCcccccCCccccCCcccceeecc
Q 002883            4 GEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKL-------------VGLGLTGNNYTGSIPQSLSNLSFLQQLSLS   70 (871)
Q Consensus         4 ~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L-------------~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls   70 (871)
                      |+||++|++|++|++|++++|++++.+|.+++++.+|             ++|++++|.++ .+|..   .++|++|+++
T Consensus        24 ~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~lp~~---~~~L~~L~l~   99 (454)
T 1jl5_A           24 TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL---PPHLESLVAS   99 (454)
T ss_dssp             ----------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CCCSC---CTTCSEEECC
T ss_pred             hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cCCCC---cCCCCEEEcc
Confidence            8999999999999999999999999999999999976             99999999999 45552   3799999999


Q ss_pred             CccccCCCCccccccccccccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCC
Q 002883           71 ENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGE  150 (871)
Q Consensus        71 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~  150 (871)
                      +|.+++ +|..   +++|++|++++|++++ ++..   .++|++|++++|++. .+|.  +..+++|++|++++|+++  
T Consensus       100 ~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~-~lp~--~~~l~~L~~L~l~~N~l~--  166 (454)
T 1jl5_A          100 CNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLE-KLPE--LQNSSFLKIIDVDNNSLK--  166 (454)
T ss_dssp             SSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCS-SCCC--CTTCTTCCEEECCSSCCS--
T ss_pred             CCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCC-CCcc--cCCCCCCCEEECCCCcCc--
Confidence            999995 7764   4889999999999984 4432   279999999999998 4884  558999999999999998  


Q ss_pred             CCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEE
Q 002883          151 IPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLY  230 (871)
Q Consensus       151 ~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~  230 (871)
                               .+|..+   .+|++|++++|+++.++        .+..+++|++|++++|++++ +|...    .+|++|+
T Consensus       167 ---------~lp~~~---~~L~~L~L~~n~l~~l~--------~~~~l~~L~~L~l~~N~l~~-l~~~~----~~L~~L~  221 (454)
T 1jl5_A          167 ---------KLPDLP---PSLEFIAAGNNQLEELP--------ELQNLPFLTAIYADNNSLKK-LPDLP----LSLESIV  221 (454)
T ss_dssp             ---------CCCCCC---TTCCEEECCSSCCSSCC--------CCTTCTTCCEEECCSSCCSS-CCCCC----TTCCEEE
T ss_pred             ---------ccCCCc---ccccEEECcCCcCCcCc--------cccCCCCCCEEECCCCcCCc-CCCCc----CcccEEE
Confidence                     334332   48999999999998743        47889999999999999985 45432    4799999


Q ss_pred             ccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccc
Q 002883          231 MSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRG  310 (871)
Q Consensus       231 L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~  310 (871)
                      +++|+++ .+| .++.+++|+.|++++|++++ +|..   +++|+.|++++|++++ +|..   +++|++|++++|++++
T Consensus       222 l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~  291 (454)
T 1jl5_A          222 AGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG  291 (454)
T ss_dssp             CCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE
T ss_pred             CcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc
Confidence            9999999 566 49999999999999999995 4543   4799999999999995 5543   3789999999999985


Q ss_pred             cCcccccCCCCCCEEecCCCcCCCCCcccccCC-CCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchh
Q 002883          311 SIPSALGNCLQLQKLDLSDNNLSGTIPREVIGL-SSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLA  389 (871)
Q Consensus       311 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  389 (871)
                      . |..   .++|+.|++++|++++ ++    .+ ++|++|++++|++++ +|..   +++|+.|++++|+++ .+|.   
T Consensus       292 l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---  354 (454)
T 1jl5_A          292 L-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---  354 (454)
T ss_dssp             E-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---
T ss_pred             c-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---
Confidence            3 321   2689999999999984 22    33 589999999999995 5543   589999999999999 5666   


Q ss_pred             cccCCceeeecCCcccc--cCccccCCC-------------CCCCEEeCCCCcCCC--CCcccccccccccEEecCCCcC
Q 002883          390 SCVGLEYLNFSDNSFQG--PIHSGFSSL-------------KGLQDLDLSRNNFSG--KIPMFLNTFRFLQKLNLSFNNL  452 (871)
Q Consensus       390 ~l~~L~~L~L~~N~l~~--~~~~~~~~l-------------~~L~~L~l~~N~l~~--~~~~~~~~~~~L~~L~l~~N~l  452 (871)
                      .+++|++|++++|++++  ..|..+..+             ++|+.|++++|++++  .+|.      +++.|.+.+|.+
T Consensus       355 ~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~------sl~~L~~~~~~~  428 (454)
T 1jl5_A          355 LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPE------SVEDLRMNSERV  428 (454)
T ss_dssp             CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC------------------------------------------------
T ss_pred             hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchh------hHhheeCcCccc
Confidence            47899999999999998  677778777             889999999999996  4553      467788999998


Q ss_pred             cccCCC
Q 002883          453 EGEVPS  458 (871)
Q Consensus       453 ~~~~~~  458 (871)
                      .+..+.
T Consensus       429 ~~~~~~  434 (454)
T 1jl5_A          429 VDPYEF  434 (454)
T ss_dssp             ------
T ss_pred             CCcccc
Confidence            876553

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.2e-41  Score=365.67  Aligned_cols=265  Identities=20%  Similarity=0.359  Sum_probs=200.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||+++...   ......+.+|++++++++||||+++++++.... ..+.
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence            468999999999999999999999899999999996543   223457889999999999999999999986652 2234


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||+++++|.+++....       .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D  159 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG-------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMD  159 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC-------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECC
T ss_pred             ccEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEee
Confidence            5699999999999999997643       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||.+.................||+.|+|||++.+..++.++|||||||++|+|++|+.||..................+.
T Consensus       160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (311)
T 3ork_A          160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP  239 (311)
T ss_dssp             CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH
T ss_pred             ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc
Confidence            99998765543333333445789999999999989999999999999999999999999976433322111111111110


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHH-HHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDA-IMELQEA  862 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~ev-l~~L~~i  862 (871)
                      .                             .....+..++.+++.+||+.||++||++.++ .+.+..+
T Consensus       240 ~-----------------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          240 S-----------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             H-----------------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             c-----------------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            0                             0011234567799999999999999975554 4555444

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.4e-41  Score=353.39  Aligned_cols=258  Identities=26%  Similarity=0.439  Sum_probs=209.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||+||+|++. +++.||+|++..... ..+.+.+|++++++++||||+++++++.+.     ...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   81 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APIC   81 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CceE
Confidence            467999999999999999999997 577899999975443 346789999999999999999999998765     5689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        82 lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  152 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRG------LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGM  152 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTG
T ss_pred             EEEEeCCCCcHHHHHHhcCc------ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccc
Confidence            99999999999999976432      589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +.......  ........+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||........  ............
T Consensus       153 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~--~~~~~~~~~~~~  228 (269)
T 4hcu_A          153 TRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--VEDISTGFRLYK  228 (269)
T ss_dssp             GGGBCCHH--HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHHTTCCCCC
T ss_pred             cccccccc--cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH--HHHHhcCccCCC
Confidence            98654321  112223456788999999988899999999999999999999 9999975432211  111111110000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      ..                              .....+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       229 ~~------------------------------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          229 PR------------------------------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             CT------------------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CC------------------------------cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            00                              1123567899999999999999999999999998763

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3e-41  Score=370.77  Aligned_cols=281  Identities=21%  Similarity=0.333  Sum_probs=219.6

Q ss_pred             cccCHHHHHHhhcCCCCCceeeccccceEEEEE-----ECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccc
Q 002883          547 LKISYAELLKATEGFSSANLIGIGGYGYVYKGI-----LGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLV  619 (871)
Q Consensus       547 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv  619 (871)
                      ..+....+....++|++.+.||+|+||.||+|+     ...+++.||||+++... ....+.+.+|+++++++ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            345556666778899999999999999999999     45567899999996543 23346789999999999 799999


Q ss_pred             eeeeeecccCcCCCceeeEEEeccCCCCHHHHhhccccccc---------------------------------------
Q 002883          620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQN---------------------------------------  660 (871)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~---------------------------------------  660 (871)
                      ++++++.+.    +...++||||+++|+|.+++........                                       
T Consensus        90 ~~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (359)
T 3vhe_A           90 NLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS  165 (359)
T ss_dssp             CEEEEECST----TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------
T ss_pred             eeeeeeecC----CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccc
Confidence            999998654    2447999999999999999987542100                                       


Q ss_pred             --------------------ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          661 --------------------QRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       661 --------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                                          ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  242 (359)
T 3vhe_A          166 GFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD  242 (359)
T ss_dssp             ------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred             ccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceee
Confidence                                011289999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhhhh
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEI  799 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  799 (871)
                      ..... .........||+.|+|||++.+..++.++|||||||++|||+| |+.||............... ........ 
T Consensus       243 ~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~-  319 (359)
T 3vhe_A          243 IYKDP-DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GTRMRAPD-  319 (359)
T ss_dssp             TTSCT-TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH-TCCCCCCT-
T ss_pred             ecccc-cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc-CCCCCCCC-
Confidence            65432 2223344568999999999888999999999999999999998 99999754322211111111 11100000 


Q ss_pred             cChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          800 IDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                                                   .+..++.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       320 -----------------------------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          320 -----------------------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             -----------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----------------------------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence                                         12235678999999999999999999999999987654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.1e-41  Score=352.74  Aligned_cols=258  Identities=27%  Similarity=0.411  Sum_probs=208.8

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||.||+|++. ++..||+|++..... ..+.+.+|++++++++||||+++++++...     ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   79 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE-----YPIY   79 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CceE
Confidence            467999999999999999999887 677899999975443 346789999999999999999999998654     5689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        80 lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~  150 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGK------GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGM  150 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTC
T ss_pred             EEEEccCCCcHHHHHHHcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCcc
Confidence            99999999999999977542      489999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +.......  ........+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||........... .... .....
T Consensus       151 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~-~~~~~  226 (268)
T 3sxs_A          151 TRYVLDDQ--YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK-VSQG-HRLYR  226 (268)
T ss_dssp             EEECCTTC--EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHTT-CCCCC
T ss_pred             ceecchhh--hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH-HHcC-CCCCC
Confidence            98765432  122233456778999999988889999999999999999999 9999975433221111 1110 00000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      ..                              .....+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       227 ~~------------------------------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          227 PH------------------------------LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CT------------------------------TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CC------------------------------cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            00                              1123567899999999999999999999999987554

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3e-41  Score=362.10  Aligned_cols=280  Identities=24%  Similarity=0.322  Sum_probs=209.2

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHHHHcC---CCCccceeeeeeccc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-----RGASKSFIAECEALRSI---RHRNLVKIITSCSSI  628 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~  628 (871)
                      ..++|++.+.||+|+||+||+|++..+++.||||++....     ......+.+|+++++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3578999999999999999999998899999999986432     12235667788887776   499999999999876


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM  708 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  708 (871)
                      ........++||||++ ++|.+++......     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~  157 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP-----GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGG  157 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTS
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCC
Confidence            5554557899999996 6999999875432     489999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA  788 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~  788 (871)
                      .+||+|||.|.......    ......||+.|+|||++.+..++.++||||+||++|+|++|+.||..............
T Consensus       158 ~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  233 (308)
T 3g33_A          158 TVKLADFGLARIYSYQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD  233 (308)
T ss_dssp             CEEECSCSCTTTSTTCC----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred             CEEEeeCccccccCCCc----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999998664322    22345789999999999889999999999999999999999999976544332222221


Q ss_pred             hhCCCch--hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          789 KMGLPDQ--VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       789 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ....+..  ......  ...      ................++..++.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~--~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          234 LIGLPPEDDWPRDVS--LPR------GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHCCCCTTTSCSSCS--SCG------GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhCCCChhhccchhh--ccc------cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1111111  000000  000      000000011111222234567889999999999999999999986

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.4e-41  Score=374.97  Aligned_cols=254  Identities=17%  Similarity=0.249  Sum_probs=204.7

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+++++.++||||+++++++.+.     .
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~   83 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE-----G   83 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS-----S
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC-----C
Confidence            3467999999999999999999999999999999996543  23346788999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC---CCCceE
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD---NEMVAH  711 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~k  711 (871)
                      ..|+||||+++|+|.+++....       .+++..+..++.||+.||.|||+.   +|+||||||+||+++   .++.+|
T Consensus        84 ~~~lv~E~~~gg~L~~~i~~~~-------~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vk  153 (444)
T 3soa_A           84 HHYLIFDLVTGGELFEDIVARE-------YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVK  153 (444)
T ss_dssp             EEEEEECCCBCCBHHHHHHHCS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEE
T ss_pred             EEEEEEEeCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEE
Confidence            7899999999999999997653       589999999999999999999999   999999999999998   567899


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      |+|||+|.......   .......||+.|+|||++.+..++.++||||+||++|+|++|+.||........ ........
T Consensus       154 L~DFG~a~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~~~  229 (444)
T 3soa_A          154 LADFGLAIEVEGEQ---QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL-YQQIKAGA  229 (444)
T ss_dssp             ECCCSSCBCCCTTC---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHTC
T ss_pred             EccCceeEEecCCC---ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhCC
Confidence            99999998765432   222345799999999999988999999999999999999999999975432211 11111111


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ....     .                       +.+..+..++.+++.+||+.||++|||+.|+++
T Consensus       230 ~~~~-----~-----------------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          230 YDFP-----S-----------------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CCCC-----T-----------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCC-----c-----------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1000     0                       001122345779999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=371.73  Aligned_cols=268  Identities=22%  Similarity=0.363  Sum_probs=210.6

Q ss_pred             hcCCCCCceeeccccceEEEEEE-----CCCCcEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGIL-----GTEETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      .++|++.+.||+|+||+||+|++     ..+++.||||+++.. .......+.+|+.++++++||||+++++++...   
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---  146 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS---  146 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence            45789999999999999999995     346778999999643 233446788999999999999999999998765   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC---
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM---  708 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---  708 (871)
                        ...++||||+++|+|.+++............+++.+++.++.||+.||+|||+.   +|+||||||+||+++.++   
T Consensus       147 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          147 --LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             --SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             --CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCc
Confidence              557999999999999999987654433344699999999999999999999999   999999999999999555   


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHH
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKY  787 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~  787 (871)
                      .+||+|||+|+...... .........||+.|+|||++.+..++.++|||||||++|||++ |..||........  ...
T Consensus       222 ~~kL~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~--~~~  298 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAG-YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--LEF  298 (367)
T ss_dssp             CEEECCCHHHHHHHHHS-SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HHH
T ss_pred             eEEECCCcccccccccc-ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH
Confidence            59999999998653321 1122233467899999999988999999999999999999998 9999975432211  111


Q ss_pred             hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      ..........                              ..++..+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus       299 i~~~~~~~~~------------------------------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          299 VTSGGRMDPP------------------------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HHTTCCCCCC------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHcCCCCCCC------------------------------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            1111000000                              012345778999999999999999999999999886643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.8e-41  Score=367.27  Aligned_cols=251  Identities=22%  Similarity=0.281  Sum_probs=200.1

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcC
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  631 (871)
                      ...++|++.+.||+|+||+||+|++..+++.||||+++..   .......+.+|.++++.+ +||||+++++++.+.   
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~---   96 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP---   96 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS---
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC---
Confidence            3457899999999999999999999999999999999643   233456778899999988 799999999998765   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                        ...|+||||+++|+|.+++....       .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        97 --~~~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ik  164 (353)
T 3txo_A           97 --DRLFFVMEFVNGGDLMFHIQKSR-------RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCK  164 (353)
T ss_dssp             --SEEEEEEECCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred             --CEEEEEEeCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEE
Confidence              67899999999999999997754       599999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      |+|||+|+.....   .......+||+.|+|||++.+..++.++||||+||++|||++|+.||........ ........
T Consensus       165 L~DFG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-~~~i~~~~  240 (353)
T 3txo_A          165 LADFGMCKEGICN---GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL-FEAILNDE  240 (353)
T ss_dssp             ECCCTTCBCSCC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCC
T ss_pred             EccccceeecccC---CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH-HHHHHcCC
Confidence            9999999854322   2223446799999999999888899999999999999999999999975433221 11111111


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCH------HHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI------QDAIM  857 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta------~evl~  857 (871)
                      ..  ...                              .....+.+++.+||+.||++||++      +|+++
T Consensus       241 ~~--~p~------------------------------~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 VV--YPT------------------------------WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CC--CCT------------------------------TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CC--CCC------------------------------CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            00  000                              122346789999999999999998      67665

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.1e-41  Score=366.81  Aligned_cols=253  Identities=19%  Similarity=0.310  Sum_probs=205.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+++++.++||||+++++++.+.     ..
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~  102 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SF  102 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CE
Confidence            467999999999999999999999999999999996543  23346788999999999999999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC---ceEE
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM---VAHV  712 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl  712 (871)
                      .|+||||+++|+|.+++....       .+++..+..++.||+.||.|||+.   +|+||||||+||+++.++   .+||
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~-------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl  172 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVARE-------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL  172 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTCS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred             EEEEEecCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence            899999999999999997643       589999999999999999999999   999999999999997654   5999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      +|||++.......    ......||+.|+|||++.+..++.++||||+||++|+|++|+.||........ .........
T Consensus       173 ~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~~~i~~~~~  247 (362)
T 2bdw_A          173 ADFGLAIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-YAQIKAGAY  247 (362)
T ss_dssp             CCCTTCBCCTTCC----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCC
T ss_pred             eecCcceEecCCc----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCC
Confidence            9999998765332    22335699999999999988999999999999999999999999975432211 111111111


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ...     .                       +.+..+..++.+++.+||+.||++|||+.|+++.
T Consensus       248 ~~~-----~-----------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          248 DYP-----S-----------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CCC-----T-----------------------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCC-----c-----------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000     0                       0011233457799999999999999999998864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-40  Score=370.04  Aligned_cols=287  Identities=23%  Similarity=0.296  Sum_probs=200.8

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  633 (871)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.+++.+. ||||+++++++...+   .
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~   83 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN---D   83 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---S
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---C
Confidence            457899999999999999999999999999999998432  2334567789999999996 999999999986532   2


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||++ ++|.+++...        .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~  151 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRAN--------ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA  151 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHHT--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             CEEEEEecccC-cCHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence            56899999996 6999998753        489999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCC------------------CccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCC
Q 002883          714 DFGLSRLLHDNSP------------------DQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPT  774 (871)
Q Consensus       714 Dfg~a~~~~~~~~------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf  774 (871)
                      |||+|+.......                  .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||
T Consensus       152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  231 (388)
T 3oz6_A          152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF  231 (388)
T ss_dssp             CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence            9999987643111                  1112234579999999998776 67899999999999999999999999


Q ss_pred             chhhhhhhhHHHHhhhCCCch-hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHH-------------HHHHHHHhhhcc
Q 002883          775 DDMFEEGLSLHKYAKMGLPDQ-VAEIIDPAILEEALEIQAGIVKELQPNLRAKFH-------------EIQVSILRVGIL  840 (871)
Q Consensus       775 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~l~~li~~  840 (871)
                      ................+.|.. ....+..........................+.             .+..++.+++.+
T Consensus       232 ~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  311 (388)
T 3oz6_A          232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK  311 (388)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence            865433322222222233322 111111111111111100000000000001111             234578899999


Q ss_pred             cccCCCCCCCCHHHHHHH
Q 002883          841 CSEELPRDRMKIQDAIME  858 (871)
Q Consensus       841 cl~~dP~~RPta~evl~~  858 (871)
                      ||+.||++|||++|+++.
T Consensus       312 ~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          312 LLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HCCSSGGGSCCHHHHTTS
T ss_pred             hhccCcccCCCHHHHhCC
Confidence            999999999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1e-40  Score=367.08  Aligned_cols=254  Identities=18%  Similarity=0.281  Sum_probs=207.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+++++.++||||+++++++.+.     ...+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-----CEEE
Confidence            46799999999999999999999999999999999766555566889999999999999999999998765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC--CCCceEEeec
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD--NEMVAHVGDF  715 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Df  715 (871)
                      +||||+++|+|.+++.....      .+++..++.++.||+.||+|||+.   +|+||||||+||+++  .++.+||+||
T Consensus       125 lv~E~~~gg~L~~~l~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DF  195 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAEDY------KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDF  195 (387)
T ss_dssp             EEEECCCCCBHHHHTTCTTC------CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred             EEEEcCCCCcHHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEec
Confidence            99999999999999976432      489999999999999999999999   999999999999997  4578999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |+|.......    ......||+.|+|||++.+..++.++||||+||++|+|++|+.||....... .............
T Consensus       196 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~  270 (387)
T 1kob_A          196 GLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWEFD  270 (387)
T ss_dssp             TTCEECCTTS----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCCCC
T ss_pred             ccceecCCCc----ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCC
Confidence            9998765432    2233469999999999999999999999999999999999999997543221 1111111110000


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                               +   ..+..+..++.+++.+||+.||++|||+.|+++.
T Consensus       271 -------------------------~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          271 -------------------------E---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             -------------------------S---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -------------------------c---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                                     0   0001233467799999999999999999999873

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.4e-40  Score=352.35  Aligned_cols=285  Identities=32%  Similarity=0.474  Sum_probs=221.2

Q ss_pred             cccccCHHHHHHhhcCCCCC------ceeeccccceEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHHHHHcCC
Q 002883          545 KYLKISYAELLKATEGFSSA------NLIGIGGYGYVYKGILGTEETNVAVKVLDLQ----QRGASKSFIAECEALRSIR  614 (871)
Q Consensus       545 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~  614 (871)
                      ....+++.++...+++|...      +.||+|+||.||+|.+  +++.||||++...    .....+.+.+|++++++++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            34567889999988887766      9999999999999997  5789999998542    2334578899999999999


Q ss_pred             CCccceeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 002883          615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVH  694 (871)
Q Consensus       615 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  694 (871)
                      ||||+++++++.+.     ...++||||+++++|.+++.....    ...+++..++.++.|++.||.|||+.   +|+|
T Consensus        89 h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H  156 (307)
T 2nru_A           89 HENLVELLGFSSDG-----DDLCLVYVYMPNGSLLDRLSCLDG----TPPLSWHMRCKIAQGAANGINFLHEN---HHIH  156 (307)
T ss_dssp             CTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTGGG----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             CCCeEEEEEEEecC-----CceEEEEEecCCCcHHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHhcC---Ceec
Confidence            99999999998765     568999999999999999975432    23589999999999999999999999   9999


Q ss_pred             cCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCC
Q 002883          695 CDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPT  774 (871)
Q Consensus       695 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf  774 (871)
                      |||||+||+++.++.+||+|||.+........ ........||+.|+|||.+.+ .++.++||||||+++|+|++|+.||
T Consensus       157 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~  234 (307)
T 2nru_A          157 RDIKSANILLDEAFTAKISDFGLARASEKFAQ-TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAV  234 (307)
T ss_dssp             SCCCGGGEEECTTCCEEECCCTTCEECCSCSS-CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSB
T ss_pred             CCCCHHHEEEcCCCcEEEeecccccccccccc-cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCc
Confidence            99999999999999999999999987654321 222334568999999998654 5899999999999999999999999


Q ss_pred             chhhhhhhhHHHH-hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHH
Q 002883          775 DDMFEEGLSLHKY-AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQ  853 (871)
Q Consensus       775 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~  853 (871)
                      ............. ........+.+++++..                   ..........+.+++.+||+.||++|||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~  295 (307)
T 2nru_A          235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-------------------NDADSTSVEAMYSVASQCLHEKKNKRPDIK  295 (307)
T ss_dssp             CTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC-------------------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             ccCcchHHHHHHHHHhhhhhhhhhhhccccc-------------------cccchHHHHHHHHHHHHHcCCCcccCcCHH
Confidence            8643221111000 00011111112222111                   111224556788999999999999999999


Q ss_pred             HHHHHHHHHHH
Q 002883          854 DAIMELQEAQK  864 (871)
Q Consensus       854 evl~~L~~i~~  864 (871)
                      |+++.|+++.+
T Consensus       296 ~l~~~L~~l~~  306 (307)
T 2nru_A          296 KVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHHHC-
T ss_pred             HHHHHHHHHhc
Confidence            99999998854

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2e-40  Score=355.57  Aligned_cols=246  Identities=23%  Similarity=0.295  Sum_probs=203.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.     .
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----Q   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----S
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-----C
Confidence            467999999999999999999999999999999996432   23456788999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||+++|+|.+++....       .+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~D  149 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKSQ-------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITD  149 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS-------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEEEeCCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEee
Confidence            7899999999999999997643       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||+++.....      .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........... 
T Consensus       150 fg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~-  221 (318)
T 1fot_A          150 FGFAKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAELR-  221 (318)
T ss_dssp             CSSCEECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCCCC-
T ss_pred             cCcceecCCc------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC-
Confidence            9999875432      223569999999999999999999999999999999999999997532221 11111111000 


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~  857 (871)
                                              .++       ....++.+++.+|++.||++||     +++|+++
T Consensus       222 ------------------------~p~-------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          222 ------------------------FPP-------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ------------------------CCT-------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------------------------CCC-------CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                                    000       1223567899999999999999     8888875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.7e-41  Score=363.43  Aligned_cols=248  Identities=25%  Similarity=0.346  Sum_probs=201.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ......+.+|+.+++.++||||+++++++...     .
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----T   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence            468999999999999999999999899999999996432   22346788999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+ +|+|.+++....       .+++.+++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~D  151 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKK-------RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIAD  151 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHC-------SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECC
T ss_pred             EEEEEEECC-CCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEE
Confidence            689999999 789999987644       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV-STHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||++.......    ......||+.|+|||++.+..+ ++++||||+||++|+|++|+.||.........  .    ...
T Consensus       152 FG~s~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--~----~i~  221 (336)
T 3h4j_B          152 FGLSNIMTDGN----FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF--K----KVN  221 (336)
T ss_dssp             SSCTBTTTTSB----TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB--C----CCC
T ss_pred             eccceeccCCc----ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH--H----HHH
Confidence            99998765332    2233569999999999887776 78999999999999999999999753221100  0    000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .....  .+                         ......+.+++.+||+.||++|||++|+++.
T Consensus       222 ~~~~~--~p-------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          222 SCVYV--MP-------------------------DFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             SSCCC--CC-------------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             cCCCC--Cc-------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            00000  00                         0122356789999999999999999999763

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.6e-40  Score=356.32  Aligned_cols=275  Identities=24%  Similarity=0.312  Sum_probs=203.8

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||+||+|++. +++.||+|++....  ......+.+|++++++++||||+++++++.+.     ..
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~   93 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-----RC   93 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-----SC
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-----CE
Confidence            468999999999999999999996 68999999986432  23346788999999999999999999998765     66


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||++ ++|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        94 ~~lv~e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  163 (311)
T 3niz_A           94 LTLVFEFME-KDLKKVLDENKT------GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADF  163 (311)
T ss_dssp             EEEEEECCS-EEHHHHHHTCTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEcCCC-CCHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccC
Confidence            899999997 588888876432      489999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC--
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL--  792 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~--  792 (871)
                      |.+.......   .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..................  
T Consensus       164 g~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  240 (311)
T 3niz_A          164 GLARAFGIPV---RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN  240 (311)
T ss_dssp             TTCEETTSCC---C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCC
T ss_pred             cCceecCCCc---ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCC
Confidence            9998765322   22233468999999998765 56899999999999999999999999865443322222221111  


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcC-chhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQ-PNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      +.......+....      ......... .........+..++.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          241 PREWPQVQELPLW------KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TTTSGGGTTSHHH------HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hHHhhhhhccchh------hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1111111110000      000000000 0111111233456789999999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=362.58  Aligned_cols=250  Identities=22%  Similarity=0.310  Sum_probs=202.1

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.     .
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-----E   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----C
Confidence            467999999999999999999999999999999996432   33456788999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||+.+|+|.+++....       .+++..++.++.||+.||.|||+.   ||+||||||+||+++.++.+||+|
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~D  158 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNV-------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITD  158 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             EEEEEEecCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEec
Confidence            7899999999999999998643       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhh-hHHHHhhh
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA---LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL-SLHKYAKM  790 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~-~~~~~~~~  790 (871)
                      ||+|......    .......||+.|+|||++.   +..++.++||||+||++|||++|+.||........ ........
T Consensus       159 FG~a~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~  234 (384)
T 4fr4_A          159 FNIAAMLPRE----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET  234 (384)
T ss_dssp             CTTCEECCTT----CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH
T ss_pred             cceeeeccCC----CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh
Confidence            9999876533    2233457999999999876   34689999999999999999999999974322111 11111000


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC-HHHHHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK-IQDAIM  857 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-a~evl~  857 (871)
                      ....                        .+       ..+...+.+++.+||+.||++||+ ++++.+
T Consensus       235 ~~~~------------------------~p-------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          235 TVVT------------------------YP-------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCCC------------------------CC-------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             cccC------------------------CC-------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            0000                        00       012345779999999999999998 666653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=359.85  Aligned_cols=284  Identities=20%  Similarity=0.254  Sum_probs=213.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++....   ....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceE
Confidence            367999999999999999999999899999999996433 234567889999999999999999999886542   2467


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee----CCCCceEE
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL----DNEMVAHV  712 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl  712 (871)
                      ++||||+++++|.+++......    ..+++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL  157 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNA----YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKL  157 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred             EEEEeCCCCCCHHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEE
Confidence            9999999999999999875421    2389999999999999999999999   99999999999999    78888999


Q ss_pred             eecccceecCCCCCCccccccccccccccCccccc--------CCCCCCccchhhHHHHHHHHHhCCCCCchhhhh---h
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA--------LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEE---G  781 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~---~  781 (871)
                      +|||.+.......    ......||+.|+|||++.        +..++.++|||||||++|||++|+.||......   .
T Consensus       158 ~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  233 (319)
T 4euu_A          158 TDFGAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (319)
T ss_dssp             CCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH
T ss_pred             ccCCCceecCCCC----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH
Confidence            9999998775432    222356999999999865        578899999999999999999999999743221   1


Q ss_pred             hhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          782 LSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                      ...........+.....+.......      ....... +............+.+++.+||+.||++|||++|+++...+
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~------~~~~~~~-~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          234 EVMYKIITGKPSGAISGVQKAENGP------IDWSGDM-PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             HHHHHHHHHCCTTCCEEEECSTTCC------EEEESSC-CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHhcCCCcccchhhhcccCCc------cccCccC-CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            1112222211111111000000000      0000000 00011123556678899999999999999999999999876


Q ss_pred             H
Q 002883          862 A  862 (871)
Q Consensus       862 i  862 (871)
                      .
T Consensus       307 ~  307 (319)
T 4euu_A          307 I  307 (319)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-40  Score=360.26  Aligned_cols=280  Identities=22%  Similarity=0.271  Sum_probs=215.5

Q ss_pred             hcCCCCCceeeccccceEEEEE----ECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGI----LGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .++|++.+.||+|+||.||+|+    ...+++.||||++........+.+.+|++++++++||||+++++++...   +.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---GR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---CC
Confidence            3679999999999999999999    4567899999999776666667899999999999999999999987643   23


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+++++|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~  169 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRA------RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIA  169 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred             ceEEEEEeecCCCCHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEc
Confidence            668999999999999999986542      489999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||.+.................+|..|+|||++.+..++.++|||||||++|+|++|+.||.....+.........  ..
T Consensus       170 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~--~~  247 (327)
T 3lxl_A          170 DFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER--DV  247 (327)
T ss_dssp             CGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------C
T ss_pred             ccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc--cc
Confidence            9999998765433223334456888999999988888999999999999999999999999754332111100000  00


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      ....         ....   ..........   ...+...+.+++.+||+.||++|||+.|+++.|+.++...
T Consensus       248 ~~~~---------~~~~---~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          248 PALS---------RLLE---LLEEGQRLPA---PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             CHHH---------HHHH---HHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             ccHH---------HHHH---HhhcccCCCC---CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            0000         0000   0000000000   1133456789999999999999999999999999886544

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4e-40  Score=371.77  Aligned_cols=280  Identities=20%  Similarity=0.201  Sum_probs=205.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  634 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||++...  .....+.+.+|+.+++.++||||+++++++..... ....
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46899999999999999999999999999999999643  33345678899999999999999999999866532 2346


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||+++ ++.+.+..         .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~D  207 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  207 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             eEEEEEeCCCC-CHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEE
Confidence            68999999965 57766643         488999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||+|+.....    .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+.........+.+.
T Consensus       208 FG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~  283 (464)
T 3ttj_A          208 FGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  283 (464)
T ss_dssp             CCCC-----C----CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             EEeeeecCCC----cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9999876532    123345799999999999999999999999999999999999999986443322221111222221


Q ss_pred             -hhhhhcChhHHHHHHHHHhhh------------hhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          795 -QVAEIIDPAILEEALEIQAGI------------VKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       795 -~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                       .....+.+...    ......            .....+...........++.+++.+||+.||++|||++|+++.
T Consensus       284 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          284 PEFMKKLQPTVR----NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHTTSCHHHH----HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHcchhhh----hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             11111111111    000000            0000111111222346678999999999999999999999863

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.9e-41  Score=362.69  Aligned_cols=251  Identities=24%  Similarity=0.320  Sum_probs=203.0

Q ss_pred             HHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCc
Q 002883          555 LKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDT  630 (871)
Q Consensus       555 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  630 (871)
                      ....++|++.+.||+|+||.||+|++..+++.||||+++...   ......+..|.++++.+ +||||+++++++.+.  
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--   90 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--   90 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--
Confidence            345678999999999999999999999999999999996532   23456678899999876 999999999998765  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCce
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA  710 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  710 (871)
                         ...|+||||+++|+|.+++....       .+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+
T Consensus        91 ---~~~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~v  157 (345)
T 1xjd_A           91 ---ENLFFVMEYLNGGDLMYHIQSCH-------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHI  157 (345)
T ss_dssp             ---SEEEEEEECCTTCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred             ---CEEEEEEeCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCE
Confidence               67899999999999999997643       589999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh
Q 002883          711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM  790 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~  790 (871)
                      ||+|||+|+......   .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .......
T Consensus       158 kL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~~~  233 (345)
T 1xjd_A          158 KIADFGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-FHSIRMD  233 (345)
T ss_dssp             EECCCTTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHC
T ss_pred             EEeEChhhhhcccCC---CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHHhC
Confidence            999999998643221   223446799999999999999999999999999999999999999975432211 1111111


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHH-HHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQ-DAI  856 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~-evl  856 (871)
                      . + ....                              ....++.+++.+||+.||++||++. |++
T Consensus       234 ~-~-~~p~------------------------------~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          234 N-P-FYPR------------------------------WLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             C-C-CCCT------------------------------TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             C-C-CCCc------------------------------ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            0 0 0000                              1224567899999999999999997 654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-40  Score=377.26  Aligned_cols=286  Identities=20%  Similarity=0.232  Sum_probs=197.7

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++.+.||+|+||+||+|++..+++.||||++...  .....+.+.+|+++++.++||||+++++++...........
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            6899999999999999999999999999999998543  23345678899999999999999999999876654555778


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||+ +++|.+++....       .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFG  201 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTPV-------YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG  201 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSSC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEecc-ccchhhhcccCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccc
Confidence            9999998 679999997643       599999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCc------------------------cccccccccccccCcccc-cCCCCCCccchhhHHHHHHHHHh--
Q 002883          717 LSRLLHDNSPDQ------------------------TSTSRVKGSIGYVAPEYG-ALGEVSTHGDEYSFGILMLEMFT--  769 (871)
Q Consensus       717 ~a~~~~~~~~~~------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ellt--  769 (871)
                      +|+.........                        ......+||+.|+|||++ ....++.++||||+||++|||++  
T Consensus       202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            998765322110                        123345789999999975 56679999999999999999999  


Q ss_pred             ---------CCCCCchhhhh-------------------hhhHHHHh-hhCCCc-hhhhhcChhHHHHHHHHHhhhhhhc
Q 002883          770 ---------GKRPTDDMFEE-------------------GLSLHKYA-KMGLPD-QVAEIIDPAILEEALEIQAGIVKEL  819 (871)
Q Consensus       770 ---------G~~pf~~~~~~-------------------~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  819 (871)
                               |+++|.+....                   ...+..+. ..+.+. .....+....   .........+..
T Consensus       282 ~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~---~~~~~~~~~~~~  358 (458)
T 3rp9_A          282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED---AKRYIRIFPKRE  358 (458)
T ss_dssp             TTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHH---HHHHHTTSCCCC
T ss_pred             cccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHH---HHHHHHhcCCCC
Confidence                     56666432210                   00000000 011111 1111111110   111111111111


Q ss_pred             CchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          820 QPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       820 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .......+.....++.+|+.+||..||++|||++|+++.
T Consensus       359 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          359 GTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             CCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            222333344456778899999999999999999999873

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.9e-41  Score=356.88  Aligned_cols=277  Identities=21%  Similarity=0.267  Sum_probs=202.5

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++.+.||+|+||+||+|++..+++.||+|++....  ......+.+|++++++++||||+++++++.+.     ...
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEE
Confidence            57999999999999999999999999999999996443  23346788999999999999999999998765     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++ ++.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        77 ~lv~e~~~~-~l~~~~~~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg  146 (292)
T 3o0g_A           77 TLVFEFCDQ-DLKKYFDSCNG------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             EEEEECCSE-EHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEecCCC-CHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence            999999965 66666654322      599999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hCCCc
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE-VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MGLPD  794 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~~  794 (871)
                      .+.......   .......||+.|+|||++.+.. ++.++||||+||++|+|++|..||............... ...+.
T Consensus       147 ~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~  223 (292)
T 3o0g_A          147 LARAFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  223 (292)
T ss_dssp             TCEECCSCC---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cceecCCcc---ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence            998765322   2223356899999999887665 799999999999999999988886433222222222221 11111


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      . ..+...........   ....................+.+++.+||+.||++|||++|+++
T Consensus       224 ~-~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          224 E-EQWPSMTKLPDYKP---YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             T-TTCTTGGGSTTCCC---CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             h-hhhhhhcccccccc---cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0 00000000000000   00000000001111233456789999999999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.6e-40  Score=348.08  Aligned_cols=251  Identities=20%  Similarity=0.260  Sum_probs=206.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||+||+|++..++..||+|++........+.+.+|++++++++||||+++++++.+.     ...+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN-----TDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CeEE
Confidence            45799999999999999999999999999999999766666678899999999999999999999998765     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee---CCCCceEEee
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAHVGD  714 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~D  714 (871)
                      +||||+++++|.+++....       .+++..++.++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|
T Consensus        83 lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~D  152 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHKR-------VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLID  152 (277)
T ss_dssp             EEEECCCSCBHHHHHHHHC-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEEeccCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEe
Confidence            9999999999999987644       589999999999999999999999   99999999999999   7889999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||.+.......    ......||+.|+|||.+.+ .+++++||||+|+++|+|++|+.||........ ...........
T Consensus       153 fg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~  226 (277)
T 3f3z_A          153 FGLAARFKPGK----MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-MLKIREGTFTF  226 (277)
T ss_dssp             CTTCEECCTTS----CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCC
T ss_pred             cccceeccCcc----chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCCC
Confidence            99998765432    2233468999999998765 499999999999999999999999976433221 11111111100


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .                            ......+...+.+++.+|++.||++|||+.|+++
T Consensus       227 ~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          227 P----------------------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             C----------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             C----------------------------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0                            0111123456789999999999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.3e-40  Score=357.60  Aligned_cols=263  Identities=17%  Similarity=0.238  Sum_probs=209.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||++.....  .+.+.+|+++++.+ +||||+++++++...     ...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~   80 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCG-----KYN   80 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEET-----TEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecC-----Ccc
Confidence            3679999999999999999999988999999999865432  34678999999999 999999999998765     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc-----eE
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV-----AH  711 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~k  711 (871)
                      ++||||+ +++|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.     +|
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~k  150 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDR------TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIH  150 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEE
T ss_pred             EEEEEeC-CCCHHHHHHHcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEE
Confidence            9999999 9999999986432      599999999999999999999999   9999999999999998887     99


Q ss_pred             EeecccceecCCCCCCcc----ccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhh--HH
Q 002883          712 VGDFGLSRLLHDNSPDQT----STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLS--LH  785 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~--~~  785 (871)
                      |+|||+|+..........    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....+...  ..
T Consensus       151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~  230 (330)
T 2izr_A          151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ  230 (330)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH
T ss_pred             EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHH
Confidence            999999997654332211    123467999999999999999999999999999999999999999853221110  00


Q ss_pred             HHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          786 KYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      ......                         ...+  ........+ ++.+++..|++.||.+||+++++.+.|+++.+.
T Consensus       231 ~i~~~~-------------------------~~~~--~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          231 KIGDTK-------------------------RATP--IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             HHHHHH-------------------------HHSC--HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHhhh-------------------------ccCC--HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence            000000                         0000  000001123 788999999999999999999999999987654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=353.52  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=196.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--------------------------chHHHHHHHHHHHH
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--------------------------GASKSFIAECEALR  611 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  611 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4689999999999999999999998999999999854321                          11346889999999


Q ss_pred             cCCCCccceeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 002883          612 SIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS  691 (871)
Q Consensus       612 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  691 (871)
                      +++||||+++++++.+.   .....|+||||+++++|.+++...        .+++..++.++.|++.||+|||+.   +
T Consensus        92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~  157 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPTLK--------PLSEDQARFYFQDLIKGIEYLHYQ---K  157 (298)
T ss_dssp             TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSCSS--------CCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            99999999999998653   236789999999999998765432        589999999999999999999999   9


Q ss_pred             eEecCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCC---CCCccchhhHHHHHHHHH
Q 002883          692 IVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE---VSTHGDEYSFGILMLEMF  768 (871)
Q Consensus       692 ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~ell  768 (871)
                      |+||||||+||+++.++.+||+|||++.......   .......||+.|+|||.+.+..   ++.++|||||||++|+|+
T Consensus       158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~  234 (298)
T 2zv2_A          158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV  234 (298)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCTTCEECSSSS---CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred             eeccCCCHHHEEECCCCCEEEecCCCcccccccc---ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence            9999999999999999999999999998765432   1223456999999999987655   378899999999999999


Q ss_pred             hCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCC
Q 002883          769 TGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRD  848 (871)
Q Consensus       769 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  848 (871)
                      +|+.||........ ............                              ....+...+.+++.+||+.||++
T Consensus       235 ~g~~pf~~~~~~~~-~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~dp~~  283 (298)
T 2zv2_A          235 FGQCPFMDERIMCL-HSKIKSQALEFP------------------------------DQPDIAEDLKDLITRMLDKNPES  283 (298)
T ss_dssp             HSSCSSCCSSHHHH-HHHHHHCCCCCC------------------------------SSSCCCHHHHHHHHHHTCSCTTT
T ss_pred             HCCCCCCCccHHHH-HHHHhcccCCCC------------------------------CccccCHHHHHHHHHHhhcChhh
Confidence            99999975322111 001111000000                              00012345779999999999999


Q ss_pred             CCCHHHHHH
Q 002883          849 RMKIQDAIM  857 (871)
Q Consensus       849 RPta~evl~  857 (871)
                      |||+.|+++
T Consensus       284 R~s~~e~l~  292 (298)
T 2zv2_A          284 RIVVPEIKL  292 (298)
T ss_dssp             SCCHHHHTT
T ss_pred             CCCHHHHhc
Confidence            999999975

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.2e-40  Score=353.63  Aligned_cols=253  Identities=28%  Similarity=0.434  Sum_probs=203.1

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccch-------HHHHHHHHHHHHcCCCCccceeeeeecccCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGA-------SKSFIAECEALRSIRHRNLVKIITSCSSIDT  630 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  630 (871)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.......       .+.+.+|++++++++||||+++++++.+.  
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   95 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--   95 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence            468999999999999999999999899999999985433211       16788999999999999999999998654  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCceeeCCCC
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS--IVHCDLKPSNVLLDNEM  708 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~  708 (871)
                           .++||||+++|+|.+++.....      .+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++
T Consensus        96 -----~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~  161 (287)
T 4f0f_A           96 -----PRMVMEFVPCGDLYHRLLDKAH------PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLD  161 (287)
T ss_dssp             -----TEEEEECCTTCBHHHHHHCTTS------CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCC
T ss_pred             -----CeEEEEecCCCCHHHHHhcccC------CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccC
Confidence                 2699999999999998866432      589999999999999999999999   8  99999999999998877


Q ss_pred             c-----eEEeecccceecCCCCCCccccccccccccccCcccc--cCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhh
Q 002883          709 V-----AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYG--ALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG  781 (871)
Q Consensus       709 ~-----~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~  781 (871)
                      .     +||+|||.+.....      ......||+.|+|||++  ....++.++||||+||++|+|++|+.||.......
T Consensus       162 ~~~~~~~kl~Dfg~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  235 (287)
T 4f0f_A          162 ENAPVCAKVADFGLSQQSVH------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK  235 (287)
T ss_dssp             TTCSCCEEECCCTTCBCCSS------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred             CCCceeEEeCCCCccccccc------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence            6     99999999975432      23345689999999987  45567899999999999999999999997543322


Q ss_pred             hhHHHHh-hhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          782 LSLHKYA-KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       782 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                      ....... ....+.....                              .++..+.+++.+||+.||++|||++|+++.|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~------------------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  285 (287)
T 4f0f_A          236 IKFINMIREEGLRPTIPE------------------------------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELS  285 (287)
T ss_dssp             HHHHHHHHHSCCCCCCCT------------------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHhccCCCCCCCc------------------------------ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            2111111 1111111100                              22345779999999999999999999999998


Q ss_pred             HH
Q 002883          861 EA  862 (871)
Q Consensus       861 ~i  862 (871)
                      ++
T Consensus       286 ~l  287 (287)
T 4f0f_A          286 EL  287 (287)
T ss_dssp             TC
T ss_pred             hC
Confidence            63

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.3e-40  Score=352.02  Aligned_cols=262  Identities=23%  Similarity=0.358  Sum_probs=199.2

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCC---CcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTE---ETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ..++|++.+.||+|+||.||+|++..+   +..||+|++.... ....+.+.+|+.++++++||||+++++++.+     
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----   87 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-----   87 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-----
Confidence            356899999999999999999998643   4579999986432 3345678899999999999999999998743     


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                       ...|+||||+++++|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        88 -~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl  157 (281)
T 1mp8_A           88 -NPVWIIMELCTLGELRSFLQVRKY------SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKL  157 (281)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTTT------TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEE
T ss_pred             -CccEEEEecCCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEE
Confidence             347899999999999999976432      489999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      +|||++........  .......+++.|+|||.+.+..++.++|||||||++|||++ |..||........ ........
T Consensus       158 ~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~-~~~i~~~~  234 (281)
T 1mp8_A          158 GDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-IGRIENGE  234 (281)
T ss_dssp             CC---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHTTC
T ss_pred             CccccccccCcccc--cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH-HHHHHcCC
Confidence            99999987654321  12223456789999999888899999999999999999997 9999975433221 11111100


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQ  867 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~~  867 (871)
                       ....                       +       ..++..+.+++.+||+.||++|||+.|+++.|+++.+..+
T Consensus       235 -~~~~-----------------------~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  279 (281)
T 1mp8_A          235 -RLPM-----------------------P-------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  279 (281)
T ss_dssp             -CCCC-----------------------C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             -CCCC-----------------------C-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence             0000                       0       0223457789999999999999999999999999977654

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=4.8e-39  Score=365.51  Aligned_cols=345  Identities=26%  Similarity=0.362  Sum_probs=199.0

Q ss_pred             CCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccc
Q 002883           13 CSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQ   92 (871)
Q Consensus        13 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~   92 (871)
                      +++|+.|++++|.++ .+|. +..+++|++|+|++|.+++. |. |.++++|++|+|++|+++ .++. ++.+++|++|+
T Consensus        45 l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L~  118 (466)
T 1o6v_A           45 LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLT  118 (466)
T ss_dssp             HHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEE
T ss_pred             hccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccc-cChh-hcCCCCCCEEE
Confidence            456666666666665 3443 56666666666666666633 33 666666666666666666 3333 66666666666


Q ss_pred             cccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCccc
Q 002883           93 VSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLI  172 (871)
Q Consensus        93 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~  172 (871)
                      +++|.+++. +. +.++++|++|++++|.+. .++.  +..+++|+.|+++ |.+.           .++ .+..+++|+
T Consensus       119 L~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~-~~~~--~~~l~~L~~L~l~-~~~~-----------~~~-~~~~l~~L~  180 (466)
T 1o6v_A          119 LFNNQITDI-DP-LKNLTNLNRLELSSNTIS-DISA--LSGLTSLQQLSFG-NQVT-----------DLK-PLANLTTLE  180 (466)
T ss_dssp             CCSSCCCCC-GG-GTTCTTCSEEEEEEEEEC-CCGG--GTTCTTCSEEEEE-ESCC-----------CCG-GGTTCTTCC
T ss_pred             CCCCCCCCC-hH-HcCCCCCCEEECCCCccC-CChh--hccCCcccEeecC-Cccc-----------Cch-hhccCCCCC
Confidence            666666632 22 555556666666555554 2332  2245555555553 2222           111 144444444


Q ss_pred             EEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccce
Q 002883          173 RLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLIL  252 (871)
Q Consensus       173 ~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~  252 (871)
                      +|++++|.++.+        ..+..+++                         |++|++++|++++..+  ++.+++|+.
T Consensus       181 ~L~l~~n~l~~~--------~~l~~l~~-------------------------L~~L~l~~n~l~~~~~--~~~l~~L~~  225 (466)
T 1o6v_A          181 RLDISSNKVSDI--------SVLAKLTN-------------------------LESLIATNNQISDITP--LGILTNLDE  225 (466)
T ss_dssp             EEECCSSCCCCC--------GGGGGCTT-------------------------CSEEECCSSCCCCCGG--GGGCTTCCE
T ss_pred             EEECcCCcCCCC--------hhhccCCC-------------------------CCEEEecCCccccccc--ccccCCCCE
Confidence            444444444331        12333444                         5555555555553333  445555555


Q ss_pred             eecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcC
Q 002883          253 IAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNL  332 (871)
Q Consensus       253 L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  332 (871)
                      |++++|.+++.  ..+..+++|+.|++++|++++..+  +..+++|++|++++|++++..+  +..+++|+.|++++|++
T Consensus       226 L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l  299 (466)
T 1o6v_A          226 LSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL  299 (466)
T ss_dssp             EECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCC
T ss_pred             EECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcc
Confidence            55555555532  345566666666666666664333  6666666666666666664333  66666677777777766


Q ss_pred             CCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCcccc
Q 002883          333 SGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGF  412 (871)
Q Consensus       333 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  412 (871)
                      ++..+  +..+++|+.|++++|++++..|  +..+++|+.|++++|++++.  ..+..+++|+.|++++|++++..|  +
T Consensus       300 ~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~  371 (466)
T 1o6v_A          300 EDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--L  371 (466)
T ss_dssp             SCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--G
T ss_pred             cCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--h
Confidence            64332  5666677777777777665444  56667777777777777643  356667777777777777766555  6


Q ss_pred             CCCCCCCEEeCCCCcCCC
Q 002883          413 SSLKGLQDLDLSRNNFSG  430 (871)
Q Consensus       413 ~~l~~L~~L~l~~N~l~~  430 (871)
                      ..+++|+.|++++|++++
T Consensus       372 ~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          372 ANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             TTCTTCCEEECCCEEEEC
T ss_pred             hcCCCCCEEeccCCcccC
Confidence            667777777777777764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.3e-40  Score=357.40  Aligned_cols=259  Identities=22%  Similarity=0.360  Sum_probs=203.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCc------
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDT------  630 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------  630 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457999999999999999999999899999999996443 3345788999999999999999999999865422      


Q ss_pred             ----------------------------------------------CCCceeeEEEeccCCCCHHHHhhcccccccccCC
Q 002883          631 ----------------------------------------------RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPK  664 (871)
Q Consensus       631 ----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~  664 (871)
                                                                    ....+.++||||+++++|.+++......    ..
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~----~~  160 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL----ED  160 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG----GG
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc----cc
Confidence                                                          1123589999999999999999875432    24


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCCCCCCc---------ccccccc
Q 002883          665 LNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQ---------TSTSRVK  735 (871)
Q Consensus       665 l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~~  735 (871)
                      .++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..........         .......
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            57778999999999999999999   99999999999999999999999999999876542111         1223356


Q ss_pred             ccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhh
Q 002883          736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGI  815 (871)
Q Consensus       736 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (871)
                      ||+.|+|||++.+..++.++||||+||++|||++|..|+......   .........+                      
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~---~~~~~~~~~~----------------------  292 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI---ITDVRNLKFP----------------------  292 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH---HHHHHTTCCC----------------------
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH---HHHhhccCCC----------------------
Confidence            999999999999899999999999999999999998876432111   1111111111                      


Q ss_pred             hhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          816 VKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       816 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                               .........+.+++.+||+.||++|||+.|+++
T Consensus       293 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          293 ---------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             ---------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             ---------cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence                     111233445678999999999999999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=361.07  Aligned_cols=251  Identities=22%  Similarity=0.291  Sum_probs=190.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||+++...  ..+.+.+|++++++++||||+++++++...     ...+
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  124 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETP-----TEIS  124 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECS-----SEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecC-----CeEE
Confidence            467999999999999999999999899999999997543  346688999999999999999999998765     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEEee
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN---EMVAHVGD  714 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~D  714 (871)
                      +||||+++|+|.+++....       .+++.+++.++.|++.||.|||+.   +|+||||||+||+++.   ++.+||+|
T Consensus       125 lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~D  194 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEKG-------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIAD  194 (349)
T ss_dssp             EEECCCCSCBHHHHHTTCS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEcc
Confidence            9999999999999997643       589999999999999999999999   9999999999999975   88999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||++.......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||....................
T Consensus       195 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~  270 (349)
T 2w4o_A          195 FGLSKIVEHQV----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF  270 (349)
T ss_dssp             CC--------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC
T ss_pred             CccccccCccc----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc
Confidence            99998764321    22335689999999999988999999999999999999999999975433322222222111100


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .     .                       +....+..++.+++.+||+.||++|||+.|+++
T Consensus       271 ~-----~-----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          271 I-----S-----------------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             C-----T-----------------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C-----C-----------------------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0     0                       001123346779999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.2e-40  Score=352.55  Aligned_cols=264  Identities=16%  Similarity=0.184  Sum_probs=211.1

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||++....  ..+.+.+|+++++.+ +|++++++++++...     ...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~   81 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHN   81 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCC-----cee
Confidence            467999999999999999999998899999999986433  234678899999999 899999999987654     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc-----eE
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV-----AH  711 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~k  711 (871)
                      ++||||+ +++|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.     +|
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~k  151 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGR------KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIY  151 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEE
Confidence            9999999 9999999986532      489999999999999999999999   9999999999999987776     99


Q ss_pred             EeecccceecCCCCCCc----cccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhh--hHH
Q 002883          712 VGDFGLSRLLHDNSPDQ----TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL--SLH  785 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~--~~~  785 (871)
                      |+|||.+..........    .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ...
T Consensus       152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  231 (298)
T 1csn_A          152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE  231 (298)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred             EEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHH
Confidence            99999999876543221    123345699999999999999999999999999999999999999975321110  000


Q ss_pred             HHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          786 KYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      ......                           ..+........++..+.+++.+||+.||++|||++++++.|+++.+.
T Consensus       232 ~~~~~~---------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          232 RIGEKK---------------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             HHHHHH---------------------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHhhc---------------------------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            000000                           00000011113456788999999999999999999999999998764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.9e-40  Score=357.24  Aligned_cols=269  Identities=24%  Similarity=0.359  Sum_probs=212.2

Q ss_pred             hhcCCCCCceeeccccceEEEEEE-----CCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDT  630 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  630 (871)
                      ..++|++.+.||+|+||.||+|++     ..+++.||+|+++... ....+.+.+|+++++.++||||+++++++.+.  
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--   98 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD--   98 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC--
Confidence            356799999999999999999998     3455889999996543 33456788999999999999999999998665  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccc-----------------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQ-----------------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIV  693 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  693 (871)
                         ...++||||+++++|.+++.......                 .....+++.+++.++.|++.||+|||+.   +|+
T Consensus        99 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iv  172 (314)
T 2ivs_A           99 ---GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLV  172 (314)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ---CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCc
Confidence               56899999999999999998754210                 0112489999999999999999999999   999


Q ss_pred             ecCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCC
Q 002883          694 HCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKR  772 (871)
Q Consensus       694 H~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~  772 (871)
                      ||||||+||+++.++.+||+|||.+........ ........+++.|+|||.+.+..++.++||||+||++|+|++ |+.
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccccchheEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999987654321 122233457889999999888889999999999999999999 999


Q ss_pred             CCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCH
Q 002883          773 PTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI  852 (871)
Q Consensus       773 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta  852 (871)
                      ||........  .............                              ..+...+.+++.+||+.||++|||+
T Consensus       252 p~~~~~~~~~--~~~~~~~~~~~~~------------------------------~~~~~~~~~li~~~l~~dp~~Rps~  299 (314)
T 2ivs_A          252 PYPGIPPERL--FNLLKTGHRMERP------------------------------DNCSEEMYRLMLQCWKQEPDKRPVF  299 (314)
T ss_dssp             SSTTCCGGGH--HHHHHTTCCCCCC------------------------------TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCHHHH--HHHhhcCCcCCCC------------------------------ccCCHHHHHHHHHHccCChhhCcCH
Confidence            9975432211  1111111000000                              0223457799999999999999999


Q ss_pred             HHHHHHHHHHHHHH
Q 002883          853 QDAIMELQEAQKMR  866 (871)
Q Consensus       853 ~evl~~L~~i~~~~  866 (871)
                      .|+++.|+++.+.+
T Consensus       300 ~~l~~~l~~~~~~~  313 (314)
T 2ivs_A          300 ADISKDLEKMMVKR  313 (314)
T ss_dssp             HHHHHHHHHHHHTC
T ss_pred             HHHHHHHHHHHhhc
Confidence            99999999987643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.5e-40  Score=358.49  Aligned_cols=246  Identities=21%  Similarity=0.236  Sum_probs=203.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+++++.++||||+++++++.+.     .
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~  114 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----S  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----C
Confidence            467999999999999999999999999999999996432   23456788999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||+++|+|.+++....       .+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~D  184 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIG-------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTD  184 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcc
Confidence            7899999999999999998654       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||+++.....      .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........... 
T Consensus       185 Fg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~~~~~~-  256 (350)
T 1rdq_E          185 FGFAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGKVR-  256 (350)
T ss_dssp             CTTCEECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCC-
T ss_pred             cccceeccCC------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-HHHHHHcCCCC-
Confidence            9999876432      223569999999999999999999999999999999999999997532221 11111111000 


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC-----HHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK-----IQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----a~evl~  857 (871)
                       .                       +       ..+...+.+++.+||+.||++||+     ++|+++
T Consensus       257 -~-----------------------p-------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          257 -F-----------------------P-------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -C-----------------------C-------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -C-----------------------C-------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence             0                       0       012345679999999999999998     788765

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.7e-40  Score=362.35  Aligned_cols=202  Identities=25%  Similarity=0.332  Sum_probs=176.8

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  632 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|..++.++ +||||+++++++.+.    
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~----  125 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE----  125 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS----
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC----
Confidence            3468999999999999999999999999999999996542   22234578899999887 899999999998765    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                       ...|+||||+++|+|.+++....       .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||
T Consensus       126 -~~~~lV~E~~~gg~L~~~l~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL  194 (396)
T 4dc2_A          126 -SRLFFVIEYVNGGDLMFHMQRQR-------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKL  194 (396)
T ss_dssp             -SEEEEEEECCTTCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             -CEEEEEEEcCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEE
Confidence             67899999999999999998654       599999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCch
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDD  776 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  776 (871)
                      +|||+|+.....   .......+||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       195 ~DFGla~~~~~~---~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          195 TDYGMCKEGLRP---GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             CCCTTCBCCCCT---TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             eecceeeecccC---CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            999999853322   1223446799999999999999999999999999999999999999964

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.7e-40  Score=371.07  Aligned_cols=285  Identities=21%  Similarity=0.267  Sum_probs=208.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||++...  .....+.+.+|+++++.++||||+++++++..........
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46899999999999999999999999999999999643  2334568899999999999999999999987664444467


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||++ ++|.+++....       .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~-------~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DF  173 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI-------FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDF  173 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEecCC-cCHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccC
Confidence            899999995 69999997643       589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCc-------------------cccccccccccccCcccc-cCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 002883          716 GLSRLLHDNSPDQ-------------------TSTSRVKGSIGYVAPEYG-ALGEVSTHGDEYSFGILMLEMFTGKRPTD  775 (871)
Q Consensus       716 g~a~~~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltG~~pf~  775 (871)
                      |+|+.........                   ......+||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus       174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            9998875432110                   123456799999999975 56679999999999999999998665554


Q ss_pred             hhhhhh---------------------------hhHHHHh-hhCCCch--hhhhcChhHHHHHHHHHhhhhhhcCchhHH
Q 002883          776 DMFEEG---------------------------LSLHKYA-KMGLPDQ--VAEIIDPAILEEALEIQAGIVKELQPNLRA  825 (871)
Q Consensus       776 ~~~~~~---------------------------~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  825 (871)
                      ......                           ..+.... ..+.|..  ...+..+..    .................
T Consensus       254 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  329 (432)
T 3n9x_A          254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV----IKYIKLFPHRKPINLKQ  329 (432)
T ss_dssp             SSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHH----HHHHHTSCCCCCCCHHH
T ss_pred             cccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHH----HHHHHhCCCCCCCCHHH
Confidence            321110                           0000000 1111111  111111111    11111111222222333


Q ss_pred             hHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          826 KFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       826 ~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .++.+...+.+++.+||+.||++|||++|+++
T Consensus       330 ~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          330 KYPSISDDGINLLESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            34456778899999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=9.1e-41  Score=362.75  Aligned_cols=276  Identities=23%  Similarity=0.327  Sum_probs=216.0

Q ss_pred             HHhhcCCCCCceeeccccceEEEEEECCCCc-----EEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeecc
Q 002883          555 LKATEGFSSANLIGIGGYGYVYKGILGTEET-----NVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCSS  627 (871)
Q Consensus       555 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  627 (871)
                      ....++|++.+.||+|+||.||+|.+..+++     .||+|++.... ....+.+.+|+++++.+ +||||+++++++..
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3445789999999999999999999976554     79999996543 23456788999999999 89999999999876


Q ss_pred             cCcCCCceeeEEEeccCCCCHHHHhhccccccc-------ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 002883          628 IDTRGNEFKALVYEFMPNGSLENWLNQKEDEQN-------QRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPS  700 (871)
Q Consensus       628 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  700 (871)
                      .     ...++||||+++|+|.+++........       ....+++..++.++.|++.||+|||+.   +|+||||||+
T Consensus       122 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  193 (333)
T 2i1m_A          122 G-----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAAR  193 (333)
T ss_dssp             S-----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             C-----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccc
Confidence            5     568999999999999999976532100       022579999999999999999999999   9999999999


Q ss_pred             ceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhh
Q 002883          701 NVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFE  779 (871)
Q Consensus       701 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~  779 (871)
                      ||+++.++.+||+|||++....... .........+|+.|+|||.+.+..++.++|||||||++|+|+| |..||.....
T Consensus       194 NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  272 (333)
T 2i1m_A          194 NVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV  272 (333)
T ss_dssp             GCEEEGGGEEEBCCCGGGCCGGGCT-TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred             eEEECCCCeEEECcccccccccccc-ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence            9999999999999999998765432 1222333457889999999888899999999999999999999 9999975432


Q ss_pred             hhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          780 EGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       780 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                      .... ..............                              ..+..+.+++.+||+.||++|||+.|+++.|
T Consensus       273 ~~~~-~~~~~~~~~~~~~~------------------------------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L  321 (333)
T 2i1m_A          273 NSKF-YKLVKDGYQMAQPA------------------------------FAPKNIYSIMQACWALEPTHRPTFQQICSFL  321 (333)
T ss_dssp             SHHH-HHHHHHTCCCCCCT------------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hHHH-HHHHhcCCCCCCCC------------------------------CCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence            2111 11111111000000                              1124567899999999999999999999999


Q ss_pred             HHHHHHHHhhc
Q 002883          860 QEAQKMRQAIK  870 (871)
Q Consensus       860 ~~i~~~~~~~~  870 (871)
                      +++.+..++.+
T Consensus       322 ~~~~~~~~~~r  332 (333)
T 2i1m_A          322 QEQAQEDRRER  332 (333)
T ss_dssp             HHHHHHHHHHC
T ss_pred             HHHHHhhhccC
Confidence            99987776653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.4e-40  Score=350.54  Aligned_cols=259  Identities=24%  Similarity=0.407  Sum_probs=206.6

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|+++.... ..+.+.+|++++++++||||+++++++.+.     ...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~   94 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPI   94 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecC-----CCe
Confidence            3568999999999999999999987 677899999975443 346789999999999999999999998665     568


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++++|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  165 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMRH------RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFG  165 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGGG------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred             EEEEeccCCCcHHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccc
Confidence            999999999999999976432      589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      .+.......  ........+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||..........  .........
T Consensus       166 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~--~~~~~~~~~  241 (283)
T 3gen_A          166 LSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE--HIAQGLRLY  241 (283)
T ss_dssp             GGGGBCCHH--HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH--HHHTTCCCC
T ss_pred             ccccccccc--cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH--HHhcccCCC
Confidence            998664321  111223346788999999888899999999999999999998 999997543322111  111110000


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      ...                              .....+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus       242 ~~~------------------------------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          242 RPH------------------------------LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CCT------------------------------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCC------------------------------cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            000                              1123567899999999999999999999999988653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.2e-40  Score=353.77  Aligned_cols=262  Identities=26%  Similarity=0.425  Sum_probs=196.9

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ..++|++.+.||+|+||+||+|++..   .||+|+++...  ....+.+.+|++++++++||||+++++++..      .
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~   92 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------P   92 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------C
Confidence            45789999999999999999998753   59999996443  3345678999999999999999999997532      4


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+++++|.+++.....      .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~D  163 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASET------KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGD  163 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECC
T ss_pred             ccEEEEEecCCCcHHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEcc
Confidence            47899999999999999975432      589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA---LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      ||.+....... .........||+.|+|||.+.   +..++.++||||+|+++|+|++|+.||.................
T Consensus       164 fg~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  242 (289)
T 3og7_A          164 FGLATEKSRWS-GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS  242 (289)
T ss_dssp             CC-------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS
T ss_pred             ceecccccccc-ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc
Confidence            99998654322 122233456899999999875   66788999999999999999999999976433322222222211


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      .+......                           ...++..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       243 ~~~~~~~~---------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          243 LSPDLSKV---------------------------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CCCCTTSS---------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCcchhhc---------------------------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            11111111                           01233567899999999999999999999999998753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.3e-40  Score=360.04  Aligned_cols=260  Identities=23%  Similarity=0.384  Sum_probs=201.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcE----EEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETN----VAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      .++|++.+.||+|+||+||+|++..+++.    ||+|.+... .....+.+.+|+.++++++||||+++++++.+.    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   89 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS----
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC----
Confidence            35799999999999999999998777665    577777432 233457889999999999999999999998753    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                        ..++|+||+++|+|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        90 --~~~~v~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl  158 (327)
T 3poz_A           90 --TVQLITQLMPFGCLLDYVREHKD------NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKI  158 (327)
T ss_dssp             --SEEEEEECCTTCBHHHHHHHSTT------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEE
T ss_pred             --CeEEEEEecCCCcHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEE
Confidence              36899999999999999977542      589999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      +|||+|+........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........  .......
T Consensus       159 ~Dfg~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~~  235 (327)
T 3poz_A          159 TDFGLAKLLGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSILEKG  235 (327)
T ss_dssp             CCTTHHHHHTTTCC--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHHTT
T ss_pred             ccCcceeEccCCccc-ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH--HHHHHcC
Confidence            999999877544322 22233457889999999999999999999999999999999 9999975432221  1111111


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      ......                              ..+...+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       236 ~~~~~~------------------------------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          236 ERLPQP------------------------------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCCCCC------------------------------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCCCC------------------------------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            000000                              01233567899999999999999999999999988654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.6e-40  Score=366.99  Aligned_cols=287  Identities=16%  Similarity=0.177  Sum_probs=206.9

Q ss_pred             hhcCCCCCceeecc--ccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          557 ATEGFSSANLIGIG--GYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       557 ~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ..++|++.+.||+|  +||+||+|++..+++.||||+++...  ....+.+.+|+++++.++||||+++++++.+.    
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----   98 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD----   98 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET----
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC----
Confidence            45789999999999  99999999999999999999996543  33456788899999999999999999998765    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                       ...|+||||+++|+|.+++......     .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        99 -~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl  169 (389)
T 3gni_B           99 -NELWVVTSFMAYGSAKDLICTHFMD-----GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYL  169 (389)
T ss_dssp             -TEEEEEEECCTTCBHHHHHHHTCTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEE
T ss_pred             -CEEEEEEEccCCCCHHHHHhhhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence             6789999999999999999775322     589999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCC----CccccccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHH
Q 002883          713 GDFGLSRLLHDNSP----DQTSTSRVKGSIGYVAPEYGAL--GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK  786 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~  786 (871)
                      +|||.+........    .........||+.|+|||++.+  ..++.++||||+||++|+|++|+.||............
T Consensus       170 ~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  249 (389)
T 3gni_B          170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK  249 (389)
T ss_dssp             CCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred             cccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999875532211    1111223468999999999877  57899999999999999999999999764332221111


Q ss_pred             HhhhCCCchh-------hhhc--------ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC
Q 002883          787 YAKMGLPDQV-------AEII--------DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK  851 (871)
Q Consensus       787 ~~~~~~~~~~-------~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt  851 (871)
                       .....+...       ....        .......... .............+....+...+.+++.+||+.||++|||
T Consensus       250 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt  327 (389)
T 3gni_B          250 -LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTT-STPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS  327 (389)
T ss_dssp             ----------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCC
T ss_pred             -hcCCCCcccccccccccccccccccccccccccccccc-CccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC
Confidence             111000000       0000        0000000000 0000000000011122345567899999999999999999


Q ss_pred             HHHHHHH
Q 002883          852 IQDAIME  858 (871)
Q Consensus       852 a~evl~~  858 (871)
                      +.|+++.
T Consensus       328 a~ell~h  334 (389)
T 3gni_B          328 ASTLLNH  334 (389)
T ss_dssp             HHHHTTS
T ss_pred             HHHHhcC
Confidence            9999853

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1e-40  Score=366.57  Aligned_cols=275  Identities=18%  Similarity=0.258  Sum_probs=207.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCC-----CcEEEEEEeeccccch-----------HHHHHHHHHHHHcCCCCcccee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTE-----ETNVAVKVLDLQQRGA-----------SKSFIAECEALRSIRHRNLVKI  621 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~  621 (871)
                      .++|++.+.||+|+||+||+|.+..+     ++.||||++.......           ......|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            45899999999999999999999754     5789999986543211           1233455666777889999999


Q ss_pred             eeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 002883          622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN  701 (871)
Q Consensus       622 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  701 (871)
                      ++++... ..+..+.|+||||+ +++|.+++.....      .+++..++.++.||+.||+|||+.   +|+||||||+|
T Consensus       114 ~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N  182 (364)
T 3op5_A          114 WGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEANAK------RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN  182 (364)
T ss_dssp             EEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred             Eeeeeec-cCCcceEEEEEeCC-CCCHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence            9998764 33346689999999 9999999976432      599999999999999999999999   99999999999


Q ss_pred             eeeC--CCCceEEeecccceecCCCCCCc----cccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCc
Q 002883          702 VLLD--NEMVAHVGDFGLSRLLHDNSPDQ----TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTD  775 (871)
Q Consensus       702 ill~--~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~  775 (871)
                      |+++  .++.+||+|||+|+.+.......    .......||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~  262 (364)
T 3op5_A          183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE  262 (364)
T ss_dssp             EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9998  88999999999998765432111    11133459999999999999999999999999999999999999998


Q ss_pred             hhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHH
Q 002883          776 DMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDA  855 (871)
Q Consensus       776 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~ev  855 (871)
                      ....+.... ............++.++.+.                     ...++.++.+++..|++.||++||++.++
T Consensus       263 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~li~~cl~~~p~~RP~~~~l  320 (364)
T 3op5_A          263 DNLKDPKYV-RDSKIRYRENIASLMDKCFP---------------------AANAPGEIAKYMETVKLLDYTEKPLYENL  320 (364)
T ss_dssp             GGTTCHHHH-HHHHHHHHHCHHHHHHHHSC---------------------TTCCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             ccccCHHHH-HHHHHHhhhhHHHHHHHhcc---------------------cccCHHHHHHHHHHHhcCCCCCCCCHHHH
Confidence            643221111 11111001111111111000                     01234578899999999999999999999


Q ss_pred             HHHHHHHHHH
Q 002883          856 IMELQEAQKM  865 (871)
Q Consensus       856 l~~L~~i~~~  865 (871)
                      ++.|+++.+.
T Consensus       321 ~~~l~~~~~~  330 (364)
T 3op5_A          321 RDILLQGLKA  330 (364)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999988664

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.4e-40  Score=357.78  Aligned_cols=271  Identities=23%  Similarity=0.357  Sum_probs=196.0

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCc---EEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEET---NVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      ..++|++.+.||+|+||+||+|++..++.   .||||+++..  .....+.+.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            45689999999999999999999876664   8999999654  334457889999999999999999999998765332


Q ss_pred             C-CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCce
Q 002883          632 G-NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA  710 (871)
Q Consensus       632 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  710 (871)
                      + ....++||||+++|+|.+++....... ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGE-NPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccc-cccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence            1 123489999999999999997654221 122589999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhh
Q 002883          711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAK  789 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~  789 (871)
                      ||+|||.|......... .......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||........ ......
T Consensus       177 kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~~~~~~  254 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYY-RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-YNYLIG  254 (323)
T ss_dssp             EECCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHT
T ss_pred             EEeeccccccccccccc-cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-HHHHhc
Confidence            99999999876543211 22223456889999999988999999999999999999999 9999975432221 111111


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      ......                        +       ..+...+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       255 ~~~~~~------------------------~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          255 GNRLKQ------------------------P-------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             TCCCCC------------------------C-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCC------------------------C-------CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            100000                        0       0123457799999999999999999999999998864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=362.85  Aligned_cols=248  Identities=19%  Similarity=0.261  Sum_probs=198.3

Q ss_pred             CCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEEec
Q 002883          563 SANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEF  642 (871)
Q Consensus       563 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  642 (871)
                      ..+.||+|+||.||+|++..+++.||+|+++.......+.+.+|++++++++||||+++++++.+.     ...++||||
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~E~  167 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-----NDIVLVMEY  167 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEEC
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEeC
Confidence            367899999999999999989999999999876655667899999999999999999999998765     668999999


Q ss_pred             cCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee--CCCCceEEeeccccee
Q 002883          643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL--DNEMVAHVGDFGLSRL  720 (871)
Q Consensus       643 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill--~~~~~~kl~Dfg~a~~  720 (871)
                      +++++|.+++.....      .+++..++.++.||+.||+|||+.   +|+||||||+||++  +.++.+||+|||++..
T Consensus       168 ~~~~~L~~~l~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~  238 (373)
T 2x4f_A          168 VDGGELFDRIIDESY------NLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARR  238 (373)
T ss_dssp             CTTCEEHHHHHHTGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred             CCCCcHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence            999999999875432      489999999999999999999999   99999999999999  6778999999999987


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhc
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII  800 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  800 (871)
                      .....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .............     
T Consensus       239 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~-----  308 (373)
T 2x4f_A          239 YKPRE----KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNILACRWDLE-----  308 (373)
T ss_dssp             CCTTC----BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCSC-----
T ss_pred             cCCcc----ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCCCC-----
Confidence            75432    1223469999999999988889999999999999999999999997543221 1111111111000     


Q ss_pred             ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                             ...+..+..++.+++.+||+.||++|||+.|+++
T Consensus       309 -----------------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          309 -----------------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             -----------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----------------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                                   0011123456789999999999999999999997

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.5e-40  Score=352.94  Aligned_cols=277  Identities=23%  Similarity=0.320  Sum_probs=210.5

Q ss_pred             hcCCCCCceeeccccceEEEEE----ECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGI----LGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      .++|++.+.||+|+||.||+|+    +..+++.||+|++.... ....+.+.+|+++++.++||||+++++++....   
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---
Confidence            3568999999999999999999    45688999999996433 334578899999999999999999999987542   


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                      ....++||||+++++|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl  167 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKN------KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKI  167 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEE
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccc------cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEE
Confidence            2557999999999999999966432      589999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      +|||.+.................||..|+|||.+.+..++.++||||+|+++|+|++|..|+.........   ... ..
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~-~~  243 (302)
T 4e5w_A          168 GDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK---MIG-PT  243 (302)
T ss_dssp             CCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH---HHC-SC
T ss_pred             CcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhh---ccC-Cc
Confidence            99999988765433223344456888999999988888999999999999999999999997643222110   000 00


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                      ....       .......   ..........   ...++..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       244 ~~~~-------~~~~~~~---~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          244 HGQM-------TVTRLVN---TLKEGKRLPC---PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             CGGG-------HHHHHHH---HHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccc-------CHHHHHH---HHhccCCCCC---CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0000       0000000   0000000000   0123456889999999999999999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.4e-40  Score=355.05  Aligned_cols=281  Identities=25%  Similarity=0.354  Sum_probs=192.9

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ..++|++.+.||+|+||+||+|++..+++.||+|+++... ....+.+.+|++++++++||||+++++++...     ..
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~   77 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE-----NK   77 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT-----TE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC-----Ce
Confidence            3468999999999999999999999899999999996543 23346788999999999999999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||++ |+|.+++...... .....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        78 ~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  152 (317)
T 2pmi_A           78 LTLVFEFMD-NDLKKYMDSRTVG-NTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDF  152 (317)
T ss_dssp             EEEEEECCC-CBHHHHHHHHHSS-SCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEEecC-CCHHHHHHhcccc-ccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcC
Confidence            899999997 6999998765321 1122589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      |.+.......   .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..................+.
T Consensus       153 g~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  229 (317)
T 2pmi_A          153 GLARAFGIPV---NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN  229 (317)
T ss_dssp             SSCEETTSCC---CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             ccceecCCCc---ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9998765322   12233468999999998765 4689999999999999999999999976543322211111111111


Q ss_pred             -hh-hhhcC-hhHHHHHHHHHhhhhhhcCchhHHhH-----HHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 -QV-AEIID-PAILEEALEIQAGIVKELQPNLRAKF-----HEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 -~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       .. ..... +....       ..............     .....++.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          230 ESLWPSVTKLPKYNP-------NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             TTTCGGGGGCTTCCT-------TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhHhhhhhhhhhccc-------ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence             00 00000 00000       00000000000000     023456889999999999999999999986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.3e-40  Score=358.53  Aligned_cols=250  Identities=21%  Similarity=0.284  Sum_probs=203.0

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  632 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|..++..+ +||+|+++++++.+.    
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~----   93 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM----   93 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS----
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC----
Confidence            4578999999999999999999999889999999996432   23456788999999988 899999999998765    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                       ...|+||||++||+|.+++....       .+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+||
T Consensus        94 -~~~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL  162 (353)
T 2i0e_A           94 -DRLYFVMEYVNGGDLMYHIQQVG-------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKI  162 (353)
T ss_dssp             -SEEEEEEECCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             -CEEEEEEeCCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEE
Confidence             67899999999999999997644       589999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      +|||+|+.....   ........||+.|+|||++.+..++.++||||+||++|||++|+.||........ .........
T Consensus       163 ~DFG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-~~~i~~~~~  238 (353)
T 2i0e_A          163 ADFGMCKENIWD---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-FQSIMEHNV  238 (353)
T ss_dssp             CCCTTCBCCCCT---TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCC
T ss_pred             EeCCcccccccC---CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH-HHHHHhCCC
Confidence            999999864322   1223345799999999999999999999999999999999999999975432211 111111100


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC-----HHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK-----IQDAIM  857 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----a~evl~  857 (871)
                      .  .                       +       .....++.+++.+||+.||++||+     ++|+++
T Consensus       239 ~--~-----------------------p-------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 A--Y-----------------------P-------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             C--C-----------------------C-------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             C--C-----------------------C-------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            0  0                       0       012345678999999999999996     466654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=7.7e-40  Score=355.33  Aligned_cols=201  Identities=26%  Similarity=0.336  Sum_probs=177.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  633 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|..+++++ +||||+++++++.+.     
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-----   82 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----   82 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-----
Confidence            467999999999999999999999999999999996542   23345678999999988 899999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||+++|+|.+++....       .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~  152 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQRQR-------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLT  152 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEE
Confidence            67899999999999999997643       589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCch
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDD  776 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  776 (871)
                      |||+|+......   .......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       153 DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          153 DYGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             CGGGCBCSCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             eccccccccCCC---CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            999998643221   223345799999999999999999999999999999999999999964

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7.4e-40  Score=353.33  Aligned_cols=252  Identities=22%  Similarity=0.312  Sum_probs=205.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR------GASKSFIAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.....      ...+.+.+|++++++++||||+++++++.+.   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---   87 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR---   87 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC---
Confidence            3569999999999999999999998999999999964432      1357789999999999999999999998765   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC---
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM---  708 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---  708 (871)
                        ...++||||+++++|.+++....       .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++   
T Consensus        88 --~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~  155 (321)
T 2a2a_A           88 --TDVVLILELVSGGELFDFLAQKE-------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPI  155 (321)
T ss_dssp             --SEEEEEECCCCSCBHHHHHHTCS-------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSS
T ss_pred             --CEEEEEEEcCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCc
Confidence              67899999999999999997643       589999999999999999999999   999999999999999887   


Q ss_pred             -ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHH
Q 002883          709 -VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKY  787 (871)
Q Consensus       709 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~  787 (871)
                       .+||+|||.+.......    ......||+.|+|||++.+..++.++||||+||++|+|++|+.||........ ....
T Consensus       156 ~~~kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i  230 (321)
T 2a2a_A          156 PHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANI  230 (321)
T ss_dssp             CCEEECCCTTCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHH
T ss_pred             CCEEEccCccceecCccc----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-HHHH
Confidence             79999999998765432    12334689999999999989999999999999999999999999975432211 1111


Q ss_pred             hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ......      .++                      .........+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~------~~~----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          231 TSVSYD------FDE----------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HTTCCC------CCH----------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             Hhcccc------cCh----------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111000      000                      011123456789999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.7e-40  Score=362.02  Aligned_cols=215  Identities=24%  Similarity=0.324  Sum_probs=183.8

Q ss_pred             cccccccCHHHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-----CCc
Q 002883          543 EDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-----HRN  617 (871)
Q Consensus       543 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~n  617 (871)
                      ++....+++.+.....++|++.+.||+|+||+||+|++..+++.||||+++... ...+.+..|+++++.+.     |||
T Consensus        19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~   97 (360)
T 3llt_A           19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNN   97 (360)
T ss_dssp             -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred             CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCC
Confidence            344445555555556689999999999999999999999899999999996432 34466788999999986     999


Q ss_pred             cceeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 002883          618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDL  697 (871)
Q Consensus       618 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  697 (871)
                      |+++++++...     ...++||||+ +++|.+++......     .+++..++.++.||+.||+|||+.   +|+||||
T Consensus        98 iv~~~~~~~~~-----~~~~lv~e~~-~~~L~~~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDl  163 (360)
T 3llt_A           98 IVKYHGKFMYY-----DHMCLIFEPL-GPSLYEIITRNNYN-----GFHIEDIKLYCIEILKALNYLRKM---SLTHTDL  163 (360)
T ss_dssp             BCCEEEEEEET-----TEEEEEECCC-CCBHHHHHHHTTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             eecccceeeEC-----CeeEEEEcCC-CCCHHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCC
Confidence            99999998765     6789999999 99999999875432     589999999999999999999999   9999999


Q ss_pred             CCCceeeCC-------------------------CCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCC
Q 002883          698 KPSNVLLDN-------------------------EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVS  752 (871)
Q Consensus       698 kp~Nill~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  752 (871)
                      ||+||+++.                         ++.+||+|||+|......      .....||+.|+|||++.+..++
T Consensus       164 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~  237 (360)
T 3llt_A          164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLGWD  237 (360)
T ss_dssp             SGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCCCC
T ss_pred             CcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCCCC
Confidence            999999975                         789999999999875432      2235689999999999999999


Q ss_pred             CccchhhHHHHHHHHHhCCCCCchhh
Q 002883          753 THGDEYSFGILMLEMFTGKRPTDDMF  778 (871)
Q Consensus       753 ~~~DiwSlG~il~elltG~~pf~~~~  778 (871)
                      .++||||+||++|+|++|+.||....
T Consensus       238 ~~~DiwslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          238 VSSDMWSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CccchHHHHHHHHHHHHCCCCCCCCc
Confidence            99999999999999999999997543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-40  Score=361.60  Aligned_cols=279  Identities=20%  Similarity=0.239  Sum_probs=205.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  634 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||++...  .....+.+.+|+++++.++||||+++++++..... ....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            36799999999999999999999999999999998533  23345678899999999999999999999866422 1224


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||+ +++|.+++...        .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--------~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D  171 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD  171 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEecC-CCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEe
Confidence            569999999 88999999753        489999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||+|+.....      .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||................+.+
T Consensus       172 fg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~  245 (367)
T 1cm8_A          172 FGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP  245 (367)
T ss_dssp             CTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eecccccccc------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999875432      223568999999998776 678999999999999999999999998643332221111122222


Q ss_pred             -chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 -DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       ......+.......+.   ..............+......+.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          246 PAEFVQRLQSDEAKNYM---KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             CHHHHHTCSCHHHHHHH---HHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHhhhHHHHHHH---HhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence             2222222211111111   111111111222223344567889999999999999999999987

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.8e-40  Score=351.05  Aligned_cols=262  Identities=24%  Similarity=0.398  Sum_probs=213.8

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.     ...
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~   84 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPF   84 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCE
Confidence            4568999999999999999999999889999999996543 3457889999999999999999999998665     568


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++++|.+++......     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg  156 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG  156 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTT-----TSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             EEEEEcCCCCcHHHHHHhcccC-----CccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCc
Confidence            9999999999999999765422     589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      .+.......  ........+++.|+|||.+.+..++.++||||+|+++|+|++ |..||........  ...........
T Consensus       157 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~--~~~~~~~~~~~  232 (288)
T 3kfa_A          157 LSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YELLEKDYRME  232 (288)
T ss_dssp             GGGTSCSSS--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHHHTTCCCC
T ss_pred             cceeccCCc--cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHhccCCCC
Confidence            998765332  223334457889999999988899999999999999999999 9999975322211  11111110000


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      ..                              ..++..+.+++.+|++.||++|||+.|+++.|+.+....
T Consensus       233 ~~------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          233 RP------------------------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             CC------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CC------------------------------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            00                              022345779999999999999999999999999886543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.4e-40  Score=361.52  Aligned_cols=284  Identities=20%  Similarity=0.241  Sum_probs=212.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++...........
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999999999999999996433 3334678899999999999999999999877654555678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||++ |+|.+++...        .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       106 ~iv~e~~~-~~L~~~l~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ--------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEcccC-cCHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence            99999996 5999998653        489999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc-
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA-LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD-  794 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-  794 (871)
                      .+.................||+.|+|||++. ...++.++||||+||++|+|++|+.||..................+. 
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  253 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9987654322222234457999999999754 45589999999999999999999999976543322222111111111 


Q ss_pred             -hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 -QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       ....+.+..... .   ...............+.....++.+++.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          254 EDLNCIINLKARN-Y---LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHTCCCHHHHH-H---HHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhhhhhHHH-H---HHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             111111111100 0   0000000111111222234567889999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.9e-40  Score=353.78  Aligned_cols=269  Identities=21%  Similarity=0.251  Sum_probs=210.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+++++.++||||+++++++... .......|
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCceeE
Confidence            46899999999999999999999889999999999766666677899999999999999999999998643 22236789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++|+|.+++......   ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDK---GNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             EEEEeCCCCcHHHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence            999999999999999764221   23689999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCc------cccccccccccccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh
Q 002883          718 SRLLHDNSPDQ------TSTSRVKGSIGYVAPEYGALGE---VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA  788 (871)
Q Consensus       718 a~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~  788 (871)
                      +..........      .......||+.|+|||++.+..   +++++|||||||++|+|++|+.||..............
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  260 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV  260 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence            87653211010      0112345799999999876544   68999999999999999999999976433322221111


Q ss_pred             hhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          789 KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                      ........                              ...+...+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       261 ~~~~~~~~------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          261 QNQLSIPQ------------------------------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HCC--CCC------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hccCCCCc------------------------------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            11000000                              0122345779999999999999999999999998774

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3e-40  Score=361.47  Aligned_cols=253  Identities=21%  Similarity=0.233  Sum_probs=193.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||++..... ..+.+.+|+.+++.++||||+++++++.+.     ...|
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~   92 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTP-----THLA   92 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-----CEEE
Confidence            4689999999999999999999999999999999965433 346788999999999999999999998765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc--eEEeec
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV--AHVGDF  715 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Df  715 (871)
                      +||||+++|+|.+++....       .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.  +||+||
T Consensus        93 lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Df  162 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAG-------RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDF  162 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred             EEEEeCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeec
Confidence            9999999999999997643       589999999999999999999999   9999999999999987765  999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCc-cchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hCCC
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTH-GDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MGLP  793 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~  793 (871)
                      |+|+.....    .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||............... ....
T Consensus       163 g~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~  238 (361)
T 3uc3_A          163 GYSKSSVLH----SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK  238 (361)
T ss_dssp             CCC-------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC
T ss_pred             Ccccccccc----CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC
Confidence            999753322    12233569999999999888777655 89999999999999999999864332111110000 0000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ..                       .+.     ...+...+.+++.+||+.||++|||+.|+++.
T Consensus       239 ~~-----------------------~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          239 YS-----------------------IPD-----DIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CC-----------------------CCT-----TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CC-----------------------CCC-----cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            00                       000     00123456789999999999999999999874

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.1e-40  Score=346.77  Aligned_cols=253  Identities=19%  Similarity=0.306  Sum_probs=205.1

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|++++++++||||+++++++...     ..
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-----CE
Confidence            468999999999999999999999999999999996543  23346788999999999999999999998765     66


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc---eEE
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV---AHV  712 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl  712 (871)
                      .++||||+++++|.+++....       .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.   +||
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl  149 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVARE-------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL  149 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEE
Confidence            899999999999999887653       589999999999999999999999   9999999999999986655   999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      +|||.+.......    ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||........ .........
T Consensus       150 ~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~  224 (284)
T 3kk8_A          150 ADFGLAIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-YAQIKAGAY  224 (284)
T ss_dssp             CCCTTCEECCSSC----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCC
T ss_pred             eeceeeEEcccCc----cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH-HHHHHhccc
Confidence            9999998765432    22335689999999999999999999999999999999999999975432211 111111111


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ....                            +....+..++.+++.+||+.||++|||+.|+++.
T Consensus       225 ~~~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          225 DYPS----------------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             CCCT----------------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             cCCc----------------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0000                            0001223457789999999999999999999874

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-40  Score=355.56  Aligned_cols=264  Identities=28%  Similarity=0.456  Sum_probs=202.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECCC----CcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTE----ETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ..+|++.+.||+|+||+||+|++..+    +..||||+++... ......+.+|++++++++||||+++++++...    
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----  118 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY----  118 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS----
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC----
Confidence            35788899999999999999998644    3469999996543 23345788999999999999999999998654    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                       ...++||||+++|+|.+++.....      .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||
T Consensus       119 -~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl  188 (333)
T 1mqb_A          119 -KPMMIITEYMENGALDKFLREKDG------EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKV  188 (333)
T ss_dssp             -SSEEEEEECCTTEEHHHHHHHTTT------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred             -CCcEEEEeCCCCCcHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEE
Confidence             568999999999999999976432      589999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      +|||.+.................+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........  .......
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~~~~~~~  266 (333)
T 1mqb_A          189 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--MKAINDG  266 (333)
T ss_dssp             CCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHHTT
T ss_pred             CCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH--HHHHHCC
Confidence            999999876543222222233446789999999988899999999999999999999 9999975432211  1111110


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQ  867 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~~  867 (871)
                      .....                              ...+...+.+++.+||+.||++|||+.|+++.|+++.+...
T Consensus       267 ~~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          267 FRLPT------------------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             CCCCC------------------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             CcCCC------------------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            00000                              00123457789999999999999999999999999876544

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8.5e-41  Score=369.59  Aligned_cols=256  Identities=21%  Similarity=0.285  Sum_probs=206.1

Q ss_pred             HHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeeccc
Q 002883          552 AELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSI  628 (871)
Q Consensus       552 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  628 (871)
                      .++....++|++.+.||+|+||+||+|++..+++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344456688999999999999999999999999999999996422   12234578899999999999999999998765


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM  708 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  708 (871)
                           ...|+||||++||+|.+++...        .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++
T Consensus       142 -----~~~~lV~E~~~gg~L~~~l~~~--------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g  205 (410)
T 3v8s_A          142 -----RYLYMVMEYMPGGDLVNLMSNY--------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG  205 (410)
T ss_dssp             -----SEEEEEECCCTTEEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred             -----CEEEEEEeCCCCCcHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCC
Confidence                 6789999999999999999653        489999999999999999999999   999999999999999999


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCchhhhhhhhH
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE----VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSL  784 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~  784 (871)
                      .+||+|||+|+......  .......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||........ .
T Consensus       206 ~ikL~DFG~a~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~  282 (410)
T 3v8s_A          206 HLKLADFGTCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-Y  282 (410)
T ss_dssp             CEEECCCTTCEECCTTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-H
T ss_pred             CEEEeccceeEeeccCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-H
Confidence            99999999998765431  12233467999999999877654    78999999999999999999999975332211 1


Q ss_pred             HHHhh----hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCC--CCCHHHHHHH
Q 002883          785 HKYAK----MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRD--RMKIQDAIME  858 (871)
Q Consensus       785 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPta~evl~~  858 (871)
                      .....    ..+|.                                ...+..++.+++.+||..+|++  ||+++|+++.
T Consensus       283 ~~i~~~~~~~~~p~--------------------------------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          283 SKIMNHKNSLTFPD--------------------------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHHHTHHHHCCCCT--------------------------------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             HHHHhccccccCCC--------------------------------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            11110    00010                                0012345678999999999998  9999999863

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4e-40  Score=346.54  Aligned_cols=254  Identities=24%  Similarity=0.377  Sum_probs=193.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR----GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .++|++.+.||+|+||.||+|++.  ++.||||+++....    ...+.+.+|+++++.++||||+++++++...     
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-----   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----
Confidence            468999999999999999999984  78999999854322    2346788999999999999999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-------
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-------  706 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-------  706 (871)
                      ...++||||+++++|.+++...        .+++..++.++.|++.||+|||+....+|+||||||+||+++.       
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~  150 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLSGK--------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDL  150 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTSS--------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCC
T ss_pred             CceEEEEEcCCCCCHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccc
Confidence            5689999999999999998642        5899999999999999999999992112999999999999985       


Q ss_pred             -CCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHH
Q 002883          707 -EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLH  785 (871)
Q Consensus       707 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~  785 (871)
                       ++.+||+|||.+.......     .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||...........
T Consensus       151 ~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  225 (271)
T 3dtc_A          151 SNKILKITDFGLAREWHRTT-----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG  225 (271)
T ss_dssp             SSCCEEECCCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH
T ss_pred             cCcceEEccCCccccccccc-----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Confidence             7789999999998654322     2234689999999998888999999999999999999999999986433222111


Q ss_pred             HHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          786 KYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      .. .........                              ..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       226 ~~-~~~~~~~~~------------------------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          226 VA-MNKLALPIP------------------------------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HH-TSCCCCCCC------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             hh-cCCCCCCCC------------------------------cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            11 111100000                              01234577899999999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.3e-40  Score=351.98  Aligned_cols=251  Identities=24%  Similarity=0.380  Sum_probs=202.8

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCC-------cEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEE-------TNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT  630 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  630 (871)
                      .++|++.+.||+|+||+||+|++..++       ..||+|++........+.+.+|++++++++||||+++++++.+.  
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG--   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT--
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC--
Confidence            467999999999999999999987665       47999999776666778899999999999999999999998765  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc-
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV-  709 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-  709 (871)
                         ...++||||+++|+|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++. 
T Consensus        85 ---~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~  152 (289)
T 4fvq_A           85 ---DENILVQEFVKFGSLDTYLKKNKN------CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDR  152 (289)
T ss_dssp             ---TCCEEEEECCTTCBHHHHHHHTGG------GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBG
T ss_pred             ---CCCEEEEECCCCCCHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcc
Confidence               557999999999999999987542      389999999999999999999999   9999999999999988876 


Q ss_pred             -------eEEeecccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhh
Q 002883          710 -------AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG  781 (871)
Q Consensus       710 -------~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~  781 (871)
                             +||+|||.+.....       .....||+.|+|||++.+ ..++.++|||||||++|+|++|..|+.......
T Consensus       153 ~~~~~~~~kl~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~  225 (289)
T 4fvq_A          153 KTGNPPFIKLSDPGISITVLP-------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ  225 (289)
T ss_dssp             GGTBCCEEEECCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             cccccceeeeccCcccccccC-------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH
Confidence                   99999999865421       223458899999998876 678999999999999999999655443322111


Q ss_pred             hhHHHHhh-hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          782 LSLHKYAK-MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       782 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                      ........ ...+.                                  ....++.+++.+||+.||++|||+.|+++.|+
T Consensus       226 ~~~~~~~~~~~~~~----------------------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  271 (289)
T 4fvq_A          226 RKLQFYEDRHQLPA----------------------------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLN  271 (289)
T ss_dssp             HHHHHHHTTCCCCC----------------------------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHhhccCCCCC----------------------------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            11111100 00000                                  01224668999999999999999999999998


Q ss_pred             HHH
Q 002883          861 EAQ  863 (871)
Q Consensus       861 ~i~  863 (871)
                      ++.
T Consensus       272 ~l~  274 (289)
T 4fvq_A          272 SLF  274 (289)
T ss_dssp             TCC
T ss_pred             Hhc
Confidence            764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.1e-40  Score=369.23  Aligned_cols=248  Identities=26%  Similarity=0.366  Sum_probs=203.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|.+.+.||+|+||.||+|++..+++.||||++....   ......+.+|+++++.++||||+++++++...     .
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~   89 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----S   89 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence            367999999999999999999999899999999996432   22346789999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||+++|+|.+++....       .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~D  159 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKNG-------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIAD  159 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSSS-------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEe
Confidence            6899999999999999997643       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV-STHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||++.......    ......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+...... ..........
T Consensus       160 FG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~~  234 (476)
T 2y94_A          160 FGLSNMMSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL-FKKICDGIFY  234 (476)
T ss_dssp             CSSCEECCTTC----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH-HHHHHTTCCC
T ss_pred             ccchhhccccc----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH-HHHHhcCCcC
Confidence            99998765432    2233569999999999888766 6899999999999999999999975322111 1111111000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                        ...                              ....++.+++.+||+.||++|||++|+++
T Consensus       235 --~p~------------------------------~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          235 --TPQ------------------------------YLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             --CCT------------------------------TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --CCc------------------------------cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence              000                              11235678999999999999999999987

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.9e-40  Score=348.99  Aligned_cols=269  Identities=24%  Similarity=0.336  Sum_probs=200.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++.+.||+|+||+||+|++ .+++.||+|++.....  ...+.+.+|+++++.++||||+++++++.+.     ...
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeE
Confidence            5799999999999999999999 5789999999954432  2346788999999999999999999998765     668


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++ +|.+++.....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~lv~e~~~~-~l~~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  145 (288)
T 1ob3_A           76 VLVFEHLDQ-DLKKLLDVCEG------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFG  145 (288)
T ss_dssp             EEEEECCSE-EHHHHHHTSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred             EEEEEecCC-CHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECc
Confidence            999999965 99999876432      589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      .+.......   .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..................+..
T Consensus       146 ~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  222 (288)
T 1ob3_A          146 LARAFGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS  222 (288)
T ss_dssp             HHHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccCccc---cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCCh
Confidence            998764321   12233468999999998765 45899999999999999999999999865433222221111111110


Q ss_pred             --hhhh-----cChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 --VAEI-----IDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 --~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                        ....     .++..           ....+............++.+++.+||+.||++|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          223 KNWPNVTELPKYDPNF-----------TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTSTTGGGSTTCCTTC-----------CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhchhhhccccccccc-----------ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              0000     00000           000000001111123456789999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.2e-40  Score=348.32  Aligned_cols=263  Identities=23%  Similarity=0.393  Sum_probs=207.0

Q ss_pred             hhcCCCCCceeeccccceEEEEEECC---CCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGT---EETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ..++|++.+.||+|+||+||+|++..   ++..||+|++.... ....+.+.+|+++++.++||||+++++++.+     
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----   84 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-----   84 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence            35689999999999999999999743   34569999996542 3345778999999999999999999998754     


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                       ...|+||||+++++|.+++.....      .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||
T Consensus        85 -~~~~~v~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl  154 (281)
T 3cc6_A           85 -EPTWIIMELYPYGELGHYLERNKN------SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKL  154 (281)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHTT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEE
T ss_pred             -CCCEEEEecCCCCCHHHHHHhccc------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEe
Confidence             235899999999999999976532      489999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      +|||.+.......  ........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......... .......
T Consensus       155 ~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~-~~~~~~~  231 (281)
T 3cc6_A          155 GDFGLSRYIEDED--YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-GVLEKGD  231 (281)
T ss_dssp             CCCCGGGCC-----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH-HHHHHTC
T ss_pred             CccCCCccccccc--ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH-HHHhcCC
Confidence            9999998765432  112233457889999999888899999999999999999998 99999753322211 1111100


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHHHh
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQA  868 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~~~  868 (871)
                      .. ...                              ..+...+.+++.+||+.||++|||+.|+++.|+++.+..+.
T Consensus       232 ~~-~~~------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  277 (281)
T 3cc6_A          232 RL-PKP------------------------------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD  277 (281)
T ss_dssp             CC-CCC------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             CC-CCC------------------------------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence            00 000                              01234577899999999999999999999999999887654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4e-40  Score=355.98  Aligned_cols=260  Identities=23%  Similarity=0.360  Sum_probs=204.1

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcE----EEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETN----VAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      .++|++.+.||+|+||+||+|++..+++.    ||+|++.... ......+.+|+.++++++||||+++++++..     
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----   86 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-----   86 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-----
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----
Confidence            35799999999999999999999877765    7777764322 2233567789999999999999999998753     


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                       ...++||||+++|+|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        87 -~~~~~v~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl  156 (325)
T 3kex_A           87 -SSLQLVTQYLPLGSLLDHVRQHRG------ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQV  156 (325)
T ss_dssp             -SSEEEEEECCTTCBSHHHHHSSGG------GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEE
T ss_pred             -CccEEEEEeCCCCCHHHHHHHccc------cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEE
Confidence             447899999999999999976532      488999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      +|||+++....... ........++..|+|||++.++.++.++|||||||++|+|++ |+.||........  .......
T Consensus       157 ~Dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~  233 (325)
T 3kex_A          157 ADFGVADLLPPDDK-QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--PDLLEKG  233 (325)
T ss_dssp             CSCSGGGGSCCCTT-CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH--HHHHHTT
T ss_pred             CCCCcccccCcccc-cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH--HHHHHcC
Confidence            99999988754432 222334567889999999998899999999999999999999 9999985432211  1111111


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      .......                              .+...+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       234 ~~~~~~~------------------------------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          234 ERLAQPQ------------------------------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             CBCCCCT------------------------------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CCCCCCC------------------------------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            0000000                              1122467899999999999999999999999988543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.5e-40  Score=356.91  Aligned_cols=246  Identities=21%  Similarity=0.272  Sum_probs=180.0

Q ss_pred             CceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCceeeEEEec
Q 002883          564 ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFKALVYEF  642 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~  642 (871)
                      .+.||+|+||+||+|++..+++.||||++...   ....+.+|+.+++.+. ||||+++++++.+.     ...|+||||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~-----~~~~lv~e~   87 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQ-----LHTFLVMEL   87 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEECC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC-----CEEEEEEEc
Confidence            47899999999999999999999999999643   3467788999999996 99999999998765     678999999


Q ss_pred             cCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC---ceEEeecccce
Q 002883          643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM---VAHVGDFGLSR  719 (871)
Q Consensus       643 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~a~  719 (871)
                      +++|+|.+++....       .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++   .+||+|||++.
T Consensus        88 ~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           88 LNGGELFERIKKKK-------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             CCSCBHHHHHHHCS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             cCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999999997653       589999999999999999999999   999999999999997665   89999999998


Q ss_pred             ecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhh-----hhHHHHhhhCCCc
Q 002883          720 LLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG-----LSLHKYAKMGLPD  794 (871)
Q Consensus       720 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~-----~~~~~~~~~~~~~  794 (871)
                      ......   .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.......     ..........   
T Consensus       158 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~---  231 (325)
T 3kn6_A          158 LKPPDN---QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG---  231 (325)
T ss_dssp             ECCC-------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT---
T ss_pred             ecCCCC---CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC---
Confidence            765432   22234568999999999999999999999999999999999999998543210     0000000000   


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                              ..+........+..++.+++.+||+.||++|||++|+++
T Consensus       232 ------------------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          232 ------------------------DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             ------------------------CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ------------------------CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence                                    000011112234567889999999999999999998873

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.5e-40  Score=353.38  Aligned_cols=269  Identities=22%  Similarity=0.368  Sum_probs=212.5

Q ss_pred             hhcCCCCCceeeccccceEEEEEE-----CCCCcEEEEEEeecccc-chHHHHHHHHHHHHcC-CCCccceeeeeecccC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQR-GASKSFIAECEALRSI-RHRNLVKIITSCSSID  629 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  629 (871)
                      ..++|++.+.||+|+||.||+|++     ..+++.||+|+++.... ...+.+.+|+++++++ +||||+++++++... 
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-   99 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-   99 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-
Confidence            356899999999999999999985     44678999999965433 3457789999999999 999999999998765 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhccccc-----------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDE-----------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK  698 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  698 (871)
                          ...++||||+++|+|.+++......           ......+++..++.++.|++.||+|||+.   +|+|||||
T Consensus       100 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk  172 (313)
T 1t46_A          100 ----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA  172 (313)
T ss_dssp             ----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             ----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence                5679999999999999999865421           01122489999999999999999999999   99999999


Q ss_pred             CCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchh
Q 002883          699 PSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM  777 (871)
Q Consensus       699 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~  777 (871)
                      |+||+++.++.+||+|||.+........ ........+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||...
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cceEEEcCCCCEEEcccccccccccccc-ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            9999999999999999999987654321 122333457889999999888899999999999999999999 99999754


Q ss_pred             hhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          778 FEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ....... ............                              ...+..+.+++.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~-~~~~~~~~~~~~------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~  300 (313)
T 1t46_A          252 PVDSKFY-KMIKEGFRMLSP------------------------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (313)
T ss_dssp             CSSHHHH-HHHHHTCCCCCC------------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchhHHH-HHhccCCCCCCc------------------------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            3221111 111111000000                              012345778999999999999999999999


Q ss_pred             HHHHHHHH
Q 002883          858 ELQEAQKM  865 (871)
Q Consensus       858 ~L~~i~~~  865 (871)
                      .|+++.+.
T Consensus       301 ~L~~~~~~  308 (313)
T 1t46_A          301 LIEKQISE  308 (313)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99988654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-39  Score=349.67  Aligned_cols=262  Identities=20%  Similarity=0.229  Sum_probs=201.0

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++.....   ...+.+.+|+.++++++||||+++++++...     
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----  106 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-----  106 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-----
Confidence            45789999999999999999999998999999999964432   2346788999999999999999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||+++++|.+++....       .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~  176 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQG-------PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLV  176 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHHC-------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             CeEEEEEEecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEe
Confidence            67899999999999999998643       589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||.+.......  ........|++.|+|||.+.+..++.++||||||+++|+|++|+.||......  ..........+
T Consensus       177 Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~  252 (309)
T 2h34_A          177 DFGIASATTDEK--LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIP  252 (309)
T ss_dssp             SCCC------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCC
T ss_pred             cCccCccccccc--cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCC
Confidence            999998764322  12223456899999999998889999999999999999999999999864332  11111111111


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-CHHHHHHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-KIQDAIMELQEAQKM  865 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-ta~evl~~L~~i~~~  865 (871)
                      .. .                           .....++.++.+++.+||+.||++|| |++++++.|+.+.+.
T Consensus       253 ~~-~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          253 RP-S---------------------------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             CG-G---------------------------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             Cc-c---------------------------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            10 0                           00012234577899999999999999 899999999876443

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.5e-38  Score=361.46  Aligned_cols=348  Identities=29%  Similarity=0.384  Sum_probs=256.4

Q ss_pred             CCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccccccccccCCCCccccccCCCceee
Q 002883           37 LFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFA  116 (871)
Q Consensus        37 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  116 (871)
                      +.+|+.|++++|.++ .+|. +..+++|++|+|++|.++ .+|. ++.+++|++|++++|.+++..+  +.         
T Consensus        45 l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~---------  109 (466)
T 1o6v_A           45 LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIADITP--LA---------  109 (466)
T ss_dssp             HHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCCGG--GT---------
T ss_pred             hccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccC-Cchh-hhccccCCEEECCCCccccChh--hc---------
Confidence            445555555555555 3332 455555555555555555 2232 5555555555555555542221  44         


Q ss_pred             eeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCcccccccc
Q 002883          117 VTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLV  196 (871)
Q Consensus       117 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~  196 (871)
                                      .+++|++|++++|.++           .+|. +..+++|++|++++|++..+        ..+.
T Consensus       110 ----------------~l~~L~~L~L~~n~l~-----------~~~~-~~~l~~L~~L~l~~n~l~~~--------~~~~  153 (466)
T 1o6v_A          110 ----------------NLTNLTGLTLFNNQIT-----------DIDP-LKNLTNLNRLELSSNTISDI--------SALS  153 (466)
T ss_dssp             ----------------TCTTCCEEECCSSCCC-----------CCGG-GTTCTTCSEEEEEEEEECCC--------GGGT
T ss_pred             ----------------CCCCCCEEECCCCCCC-----------CChH-HcCCCCCCEEECCCCccCCC--------hhhc
Confidence                            4555555555555554           2222 55566666666666665542        2355


Q ss_pred             CCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcE
Q 002883          197 NCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQV  276 (871)
Q Consensus       197 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  276 (871)
                      .+++|++|+++ |.+.+.  ..+..+ ++|+.|++++|.+++.  ..+..+++|+.|++++|.+++..+  ++.+++|+.
T Consensus       154 ~l~~L~~L~l~-~~~~~~--~~~~~l-~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~  225 (466)
T 1o6v_A          154 GLTSLQQLSFG-NQVTDL--KPLANL-TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDE  225 (466)
T ss_dssp             TCTTCSEEEEE-ESCCCC--GGGTTC-TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCE
T ss_pred             cCCcccEeecC-CcccCc--hhhccC-CCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCE
Confidence            56666666665 334322  224444 4577888888877643  348889999999999999996654  788999999


Q ss_pred             EEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCC
Q 002883          277 LSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHL  356 (871)
Q Consensus       277 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l  356 (871)
                      |++++|++++.  ..+..+++|+.|++++|++++..+  +..+++|+.|++++|.+++..+  +..+++|+.|++++|++
T Consensus       226 L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l  299 (466)
T 1o6v_A          226 LSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL  299 (466)
T ss_dssp             EECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCC
T ss_pred             EECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcc
Confidence            99999999853  468899999999999999996655  8999999999999999995544  88999999999999999


Q ss_pred             CCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccc
Q 002883          357 SGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFL  436 (871)
Q Consensus       357 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  436 (871)
                      ++..+  +..+++|+.|++++|++++..|  +..+++|++|++++|++++.  ..+..+++|+.|++++|++++..|  +
T Consensus       300 ~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~  371 (466)
T 1o6v_A          300 EDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--L  371 (466)
T ss_dssp             SCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--G
T ss_pred             cCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--h
Confidence            96544  8899999999999999997655  88999999999999999975  478999999999999999998777  8


Q ss_pred             cccccccEEecCCCcCcccCC
Q 002883          437 NTFRFLQKLNLSFNNLEGEVP  457 (871)
Q Consensus       437 ~~~~~L~~L~l~~N~l~~~~~  457 (871)
                      ..+++|+.|++++|++++.+.
T Consensus       372 ~~l~~L~~L~l~~n~~~~~p~  392 (466)
T 1o6v_A          372 ANLTRITQLGLNDQAWTNAPV  392 (466)
T ss_dssp             TTCTTCCEEECCCEEEECCCB
T ss_pred             hcCCCCCEEeccCCcccCCch
Confidence            999999999999999998543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-40  Score=361.91  Aligned_cols=268  Identities=25%  Similarity=0.376  Sum_probs=212.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECC-------CCcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeeccc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGT-------EETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCSSI  628 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  628 (871)
                      .++|.+.+.||+|+||+||+|++..       .+..||||+++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            4689999999999999999999743       33579999996543 23346788999999999 999999999998765


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhcccccc---------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDEQ---------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP  699 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  699 (871)
                           ...++||||+++|+|.+++.......         .....+++..++.++.|++.||+|||+.   +|+||||||
T Consensus       148 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp  219 (382)
T 3tt0_A          148 -----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  219 (382)
T ss_dssp             -----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             -----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence                 56899999999999999998754210         1123589999999999999999999999   999999999


Q ss_pred             CceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhh
Q 002883          700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMF  778 (871)
Q Consensus       700 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~  778 (871)
                      +||+++.++.+||+|||+|+....... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCT-TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceEEEcCCCcEEEcccCcccccccccc-cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999987654321 122333457889999999999999999999999999999999 999997543


Q ss_pred             hhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          779 EEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ...  ..............                              ..+..++.+++.+||+.||++|||+.|+++.
T Consensus       299 ~~~--~~~~~~~~~~~~~~------------------------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          299 VEE--LFKLLKEGHRMDKP------------------------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHH--HHHHHHTTCCCCCC------------------------------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHH--HHHHHHcCCCCCCC------------------------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            221  11111111000000                              0123457789999999999999999999999


Q ss_pred             HHHHHHHH
Q 002883          859 LQEAQKMR  866 (871)
Q Consensus       859 L~~i~~~~  866 (871)
                      |+++.+..
T Consensus       347 L~~~~~~~  354 (382)
T 3tt0_A          347 LDRIVALT  354 (382)
T ss_dssp             HHHHHHHS
T ss_pred             HHHHHHHH
Confidence            99987654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=7.5e-40  Score=345.96  Aligned_cols=249  Identities=22%  Similarity=0.336  Sum_probs=201.8

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      +.++|++.+.||+|+||+||+|++..+++.||+|++....   ......+.+|+++++.++||||+++++++.+.     
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   81 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----   81 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-----
Confidence            3568999999999999999999999999999999985432   22346788999999999999999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+++++|.+++....       .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~  151 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA  151 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEEC
T ss_pred             CEEEEEEecCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEE
Confidence            66899999999999999997654       589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||.+......     ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||........ ..........
T Consensus       152 Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~  225 (279)
T 3fdn_A          152 DFGWSVHAPSS-----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YKRISRVEFT  225 (279)
T ss_dssp             SCCEESCC-------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCCC
T ss_pred             eccccccCCcc-----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-HHHHHhCCCC
Confidence            99998654322     22335689999999999988999999999999999999999999975322211 1111110000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                        ...                              .....+.+++.+||+.||++|||++|+++.
T Consensus       226 --~~~------------------------------~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          226 --FPD------------------------------FVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             --CCT------------------------------TSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             --CCC------------------------------cCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              000                              122356789999999999999999999975

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9.5e-40  Score=368.40  Aligned_cols=255  Identities=26%  Similarity=0.369  Sum_probs=206.7

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ..++|++.+.||+|+||.||+|.+.  ++.||||+++...  ..+.+.+|++++++++||||+++++++...    ....
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~  262 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGL  262 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSCE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCce
Confidence            3467899999999999999999985  7799999997543  457899999999999999999999997654    1357


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||+++|+|.+++......     .+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  334 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGRS-----VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFG  334 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCcHHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCC
Confidence            9999999999999999875422     478999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      +++.....      .....++..|+|||.+.+..++.++|||||||++|||++ |+.||........  ...........
T Consensus       335 ~a~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~~i~~~~~~~  406 (450)
T 1k9a_A          335 LTKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVEKGYKMD  406 (450)
T ss_dssp             TCEECC------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--HHHHHTTCCCC
T ss_pred             Cccccccc------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcCCCCC
Confidence            99864321      112357889999999999999999999999999999998 9999986432211  11111110000


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      ..                              ..++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       407 ~p------------------------------~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          407 AP------------------------------DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             CC------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CC------------------------------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            00                              12334677999999999999999999999999998754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=348.59  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=198.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||+||+|++.  ++.||+|++...  ...+.+.+|++++++++||||+++++++.+       ..+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~   75 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN-------PVC   75 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcE
Confidence            457899999999999999999985  788999998643  345788999999999999999999998763       268


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc-eEEeecc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV-AHVGDFG  716 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-~kl~Dfg  716 (871)
                      +||||+++|+|.+++.....    .+.+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||
T Consensus        76 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg  151 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEP----LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG  151 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSS----EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred             EEEEcCCCCCHHHHHhccCC----CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence            99999999999999976542    124789999999999999999999932229999999999999988886 7999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      .+......      .....||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus       152 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  225 (307)
T 2eva_A          152 TACDIQTH------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL  225 (307)
T ss_dssp             C------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCC
T ss_pred             cccccccc------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCc
Confidence            99765422      223458999999999998899999999999999999999999997532221111111111100000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      .                              ..++..+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus       226 ~------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          226 I------------------------------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             B------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             c------------------------------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            0                              01234567899999999999999999999999988654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.4e-39  Score=344.14  Aligned_cols=252  Identities=25%  Similarity=0.366  Sum_probs=202.9

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ..|++.+.||+|+||+||+|.+..++..||+|++....  ....+.+.+|+.+++.++||||+++++++... ..+....
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceE
Confidence            45888899999999999999999999999999996443  33456789999999999999999999988654 3334678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCceeeC-CCCceEEe
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS--IVHCDLKPSNVLLD-NEMVAHVG  713 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~  713 (871)
                      ++||||+++++|.+++....       .+++..++.++.|++.||.|||+.   +  |+||||||+||+++ .++.+||+
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~  174 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFK-------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             EEEEEecCCCCHHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEe
Confidence            99999999999999997643       589999999999999999999998   7  99999999999997 78999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||.+......     ......||+.|+|||++. +.++.++||||+||++|+|++|+.||..................+
T Consensus       175 Dfg~~~~~~~~-----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  248 (290)
T 1t4h_A          175 DLGLATLKRAS-----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP  248 (290)
T ss_dssp             CTTGGGGCCTT-----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred             eCCCccccccc-----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc
Confidence            99999754322     223356899999999876 569999999999999999999999997543322222222111111


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .....                              ....++.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~------------------------------~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          249 ASFDK------------------------------VAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGGG------------------------------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCC------------------------------CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11111                              11235678999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.2e-39  Score=350.04  Aligned_cols=265  Identities=21%  Similarity=0.295  Sum_probs=201.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+++++.++||||+++++++...     .
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~  105 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----N  105 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----C
Confidence            45799999999999999999999889999999999643   233456788999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+++++|.+++......   ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~D  179 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQ---KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGD  179 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             cEEEEEecCCCCCHHHHHHHhccc---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEe
Confidence            789999999999999999754321   23589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh-CCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM-GLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~~~  793 (871)
                      ||.+.......   .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||................ ..+
T Consensus       180 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  256 (310)
T 2wqm_A          180 LGLGRFFSSKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP  256 (310)
T ss_dssp             C---------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC
T ss_pred             ccceeeecCCC---ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC
Confidence            99998764321   12233468999999999988899999999999999999999999997532221111111111 111


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      ....                              ..+...+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       257 ~~~~------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          257 PLPS------------------------------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             CCCT------------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCcc------------------------------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            0000                              012345778999999999999999999999999997764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-40  Score=358.17  Aligned_cols=271  Identities=24%  Similarity=0.339  Sum_probs=209.3

Q ss_pred             HhhcCCCCCceeeccccceEEEEEE-----CCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeeccc
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCSSI  628 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  628 (871)
                      ...++|++.+.||+|+||.||+|++     ..+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            3457899999999999999999997     3356789999996432 23456789999999999 899999999998765


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhcccccc----------------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDEQ----------------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSI  692 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  692 (871)
                           ...++||||+++|+|.+++.......                .....+++..++.++.||+.||+|||+.   +|
T Consensus       122 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  193 (344)
T 1rjb_A          122 -----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SC  193 (344)
T ss_dssp             -----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             -----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                 56899999999999999997654210                0112479999999999999999999999   99


Q ss_pred             EecCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CC
Q 002883          693 VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GK  771 (871)
Q Consensus       693 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~  771 (871)
                      +||||||+||+++.++.+||+|||.+....... .........+|+.|+|||.+.+..++.++|||||||++|+|+| |.
T Consensus       194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  272 (344)
T 1rjb_A          194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV  272 (344)
T ss_dssp             EETTCSGGGEEEETTTEEEECCCGGGSCGGGCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             ccCCCChhhEEEcCCCcEEeCCCccCcccccCc-cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence            999999999999999999999999998765432 2222334567889999999888899999999999999999998 99


Q ss_pred             CCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC
Q 002883          772 RPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK  851 (871)
Q Consensus       772 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt  851 (871)
                      .||........ ...............                              .....+.+++.+||+.||++|||
T Consensus       273 ~p~~~~~~~~~-~~~~~~~~~~~~~~~------------------------------~~~~~l~~li~~~l~~dp~~Rps  321 (344)
T 1rjb_A          273 NPYPGIPVDAN-FYKLIQNGFKMDQPF------------------------------YATEEIYIIMQSCWAFDSRKRPS  321 (344)
T ss_dssp             CSSTTCCCSHH-HHHHHHTTCCCCCCT------------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCcccCCcHHH-HHHHHhcCCCCCCCC------------------------------CCCHHHHHHHHHHcCCCchhCcC
Confidence            99976432211 111111111100000                              12345778999999999999999


Q ss_pred             HHHHHHHHHHHHHHH
Q 002883          852 IQDAIMELQEAQKMR  866 (871)
Q Consensus       852 a~evl~~L~~i~~~~  866 (871)
                      +.|+++.|+.+.+..
T Consensus       322 ~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          322 FPNLTSFLGCQLADA  336 (344)
T ss_dssp             HHHHHHHHHHHC---
T ss_pred             HHHHHHHHHHHHHHH
Confidence            999999999886543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-40  Score=359.29  Aligned_cols=268  Identities=25%  Similarity=0.372  Sum_probs=210.1

Q ss_pred             hhcCCCCCceeeccccceEEEEEEC-----CCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILG-----TEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDT  630 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  630 (871)
                      ..++|++.+.||+|+||.||+|++.     .+++.||||+++... ....+.+.+|++++++++||||+++++++.+.  
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--  122 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG--  122 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC--
Confidence            4578999999999999999999996     345889999997543 33456789999999999999999999998764  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccc-----------------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQ-----------------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIV  693 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  693 (871)
                         ...|+||||+++|+|.+++.......                 .....+++.+++.++.||+.||.|||+.   +|+
T Consensus       123 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv  196 (343)
T 1luf_A          123 ---KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  196 (343)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ---CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence               56899999999999999998743210                 0113689999999999999999999999   999


Q ss_pred             ecCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCC
Q 002883          694 HCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKR  772 (871)
Q Consensus       694 H~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~  772 (871)
                      ||||||+||+++.++.+||+|||.+....... .........+|+.|+|||++.+..++.++|||||||++|+|++ |+.
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCc-cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            99999999999999999999999998664322 1122233467899999999888899999999999999999999 999


Q ss_pred             CCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCH
Q 002883          773 PTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI  852 (871)
Q Consensus       773 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta  852 (871)
                      ||......... ........+ ...                              ..++..+.+++.+||+.||++|||+
T Consensus       276 p~~~~~~~~~~-~~~~~~~~~-~~~------------------------------~~~~~~l~~li~~~l~~~p~~Rps~  323 (343)
T 1luf_A          276 PYYGMAHEEVI-YYVRDGNIL-ACP------------------------------ENCPLELYNLMRLCWSKLPADRPSF  323 (343)
T ss_dssp             TTTTSCHHHHH-HHHHTTCCC-CCC------------------------------TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cCCCCChHHHH-HHHhCCCcC-CCC------------------------------CCCCHHHHHHHHHHcccCcccCCCH
Confidence            99754332211 111111000 000                              0123457789999999999999999


Q ss_pred             HHHHHHHHHHHHH
Q 002883          853 QDAIMELQEAQKM  865 (871)
Q Consensus       853 ~evl~~L~~i~~~  865 (871)
                      .|+++.|+++.+.
T Consensus       324 ~~~~~~L~~~~~~  336 (343)
T 1luf_A          324 CSIHRILQRMCER  336 (343)
T ss_dssp             HHHHHHHHHTTC-
T ss_pred             HHHHHHHHHHHhh
Confidence            9999999987543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1e-39  Score=348.32  Aligned_cols=267  Identities=18%  Similarity=0.265  Sum_probs=206.7

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||||++.....  .+.+.+|+++++.++|++++..+.++...    ....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~   80 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYN   80 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCC----CCce
Confidence            35789999999999999999999988999999998754332  24578899999999998888887776442    2567


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee---CCCCceEEe
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAHVG  713 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~  713 (871)
                      ++||||+ +++|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||++   +.++.+||+
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~  150 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSR------KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEEC
T ss_pred             EEEEEcc-CCCHHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEe
Confidence            9999999 9999999975432      589999999999999999999999   99999999999999   788999999


Q ss_pred             ecccceecCCCCCCc----cccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhh--hHHHH
Q 002883          714 DFGLSRLLHDNSPDQ----TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL--SLHKY  787 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~--~~~~~  787 (871)
                      |||.+..........    .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........  .....
T Consensus       151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 4hgt_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence            999999876543211    122345789999999999999999999999999999999999999975322110  00000


Q ss_pred             hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      ...            ..               ..........++.++.+++.+||+.||++|||++|+++.|+++.+..
T Consensus       231 ~~~------------~~---------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          231 SEK------------KM---------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHH------------HH---------------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hcc------------cc---------------cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence            000            00               00000001123457889999999999999999999999999987654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=352.57  Aligned_cols=281  Identities=23%  Similarity=0.340  Sum_probs=214.5

Q ss_pred             hcCCCCCceeeccccceEEEEEE----CCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGIL----GTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .++|++.+.||+|+||.||+|++    ..+++.||||++........+.+.+|++++++++||||+++++++...+   .
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC---C
Confidence            45799999999999999999994    5578999999997666666678999999999999999999999876542   2


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+++++|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~  187 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHKE------RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIG  187 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHSTT------SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred             CceEEEEECCCCCCHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEe
Confidence            467999999999999999976532      489999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||.+.................++..|+|||.+.+..++.++||||||+++|+|+||..||........   ........
T Consensus       188 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~---~~~~~~~~  264 (326)
T 2w1i_A          188 DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM---RMIGNDKQ  264 (326)
T ss_dssp             CCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH---HHHCTTCC
T ss_pred             cCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH---Hhhccccc
Confidence            999998875443222222334577889999998888899999999999999999999999875322211   00000000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      ..       ...........   ......   ....++.++.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       265 ~~-------~~~~~~~~~~~---~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          265 GQ-------MIVFHLIELLK---NNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             TH-------HHHHHHHHHHH---TTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hh-------hhHHHHHHHhh---cCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            00       00000000000   000000   01123456889999999999999999999999999997754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.2e-40  Score=350.14  Aligned_cols=263  Identities=24%  Similarity=0.341  Sum_probs=207.9

Q ss_pred             hhcCCCCCc-eeeccccceEEEEEE--CCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          557 ATEGFSSAN-LIGIGGYGYVYKGIL--GTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       557 ~~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      ..++|++.+ .||+|+||+||+|.+  ..+++.||||+++...  ....+.+.+|+++++.++||||+++++++..    
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   89 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA----   89 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES----
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC----
Confidence            346788888 999999999999954  5567899999996443  2235678999999999999999999999832    


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                        ...++||||+++++|.+++....       .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        90 --~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~k  157 (291)
T 1xbb_A           90 --ESWMLVMEMAELGPLNKYLQQNR-------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAK  157 (291)
T ss_dssp             --SSEEEEEECCTTEEHHHHHHHCT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred             --CCcEEEEEeCCCCCHHHHHHhCc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEE
Confidence              45789999999999999997643       589999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhh
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKM  790 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~  790 (871)
                      |+|||.+.................+++.|+|||.+.+..++.++||||||+++|+|++ |+.||........  ......
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~  235 (291)
T 1xbb_A          158 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAMLEK  235 (291)
T ss_dssp             ECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHHHT
T ss_pred             EccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHHc
Confidence            9999999877544322222233446789999999888889999999999999999999 9999986433211  111111


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQ  867 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~~  867 (871)
                      .......                              ..++..+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus       236 ~~~~~~~------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          236 GERMGCP------------------------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             TCCCCCC------------------------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCC------------------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            1000000                              0223457799999999999999999999999999876553

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-39  Score=368.15  Aligned_cols=350  Identities=19%  Similarity=0.166  Sum_probs=284.2

Q ss_pred             eeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCccccc
Q 002883          114 YFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLD  193 (871)
Q Consensus       114 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~  193 (871)
                      .++.+++.+. .+|..+.   ++++.|+|++|.|++.          .|+.|.++++|++|+|++|.++.+.+      .
T Consensus        15 ~v~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~----------~~~~~~~l~~L~~L~L~~n~i~~~~~------~   74 (477)
T 2id5_A           15 AVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTL----------NQDEFASFPHLEELELNENIVSAVEP------G   74 (477)
T ss_dssp             EEECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEE----------CTTTTTTCTTCCEEECTTSCCCEECT------T
T ss_pred             EEEeCCCCcC-cCCCCCC---CCCcEEECCCCccceE----------CHhHccCCCCCCEEECCCCccCEeCh------h
Confidence            3444444443 4554432   4667777777777621          23446677777777777777766432      4


Q ss_pred             cccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCC
Q 002883          194 SLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLK  273 (871)
Q Consensus       194 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  273 (871)
                      .+.++++|++|+|++|+++...+..+..+ ++|++|+|++|+++...+..|.++++|+.|++++|.+++..+..|..+++
T Consensus        75 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  153 (477)
T 2id5_A           75 AFNNLFNLRTLGLRSNRLKLIPLGVFTGL-SNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS  153 (477)
T ss_dssp             TTTTCTTCCEEECCSSCCCSCCTTSSTTC-TTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTT
T ss_pred             hhhCCccCCEEECCCCcCCccCcccccCC-CCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCC
Confidence            56677788888888888874433344454 56888888888888888888899999999999999998888888999999


Q ss_pred             CcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccC
Q 002883          274 LQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSR  353 (871)
Q Consensus       274 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  353 (871)
                      |++|+|++|++++..+..|..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.++.......+|+.|++++
T Consensus       154 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~  233 (477)
T 2id5_A          154 LEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH  233 (477)
T ss_dssp             CCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEES
T ss_pred             CCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcC
Confidence            99999999999876667788999999999999999988888899999999999999888777777777777999999999


Q ss_pred             CCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCc
Q 002883          354 NHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP  433 (871)
Q Consensus       354 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  433 (871)
                      |.++...+..+..+++|+.|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..+
T Consensus       234 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  313 (477)
T 2id5_A          234 CNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEE  313 (477)
T ss_dssp             SCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCG
T ss_pred             CcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCH
Confidence            99996555788999999999999999998888889999999999999999999999999999999999999999998888


Q ss_pred             ccccccccccEEecCCCcCcccCCCCcccccccceeccCCCCCccCCCccc
Q 002883          434 MFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPELH  484 (871)
Q Consensus       434 ~~~~~~~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~C~~~~~~~  484 (871)
                      ..|..+++|++|+|++|+|.|.++..+.+.....+.+.++...|..|..+.
T Consensus       314 ~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~~~  364 (477)
T 2id5_A          314 SVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEFVQ  364 (477)
T ss_dssp             GGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESGGGT
T ss_pred             hHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCchHHc
Confidence            889999999999999999999887655555555677788889999887653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.8e-40  Score=355.20  Aligned_cols=261  Identities=23%  Similarity=0.374  Sum_probs=201.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEE----EEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNV----AVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      .++|++.+.||+|+||+||+|++..+++.|    |+|.+... .....+.+.+|+.++++++||||+++++++...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence            467999999999999999999998777655    66666432 334567889999999999999999999998653    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                        ..++|+||+.+|+|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        90 --~~~~v~~~~~~g~L~~~l~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL  158 (327)
T 3lzb_A           90 --TVQLITQLMPFGCLLDYVREHKD------NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKI  158 (327)
T ss_dssp             --SEEEEECCCSSCBHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEE
T ss_pred             --CceEEEEecCCCcHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEE
Confidence              36899999999999999977542      589999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      +|||+++........ .......+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||........  .......
T Consensus       159 ~DfG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~~~~~~  235 (327)
T 3lzb_A          159 TDFGLAKLLGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSILEKG  235 (327)
T ss_dssp             CCTTC-----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHHTT
T ss_pred             ccCcceeEccCcccc-ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HHHHHcC
Confidence            999999876543221 22223456889999999999999999999999999999999 9999976433221  1111111


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      ......                              ..+...+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       236 ~~~~~~------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          236 ERLPQP------------------------------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             CCCCCC------------------------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             CCCCCC------------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence            100000                              012235678999999999999999999999999987544

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.3e-40  Score=376.33  Aligned_cols=257  Identities=25%  Similarity=0.401  Sum_probs=209.8

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ..+|++.+.||+|+||.||+|++..++..||||+++.... ..+.+.+|++++++++||||+++++++...     ...|
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~  292 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFY  292 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecC-----CcEE
Confidence            4568899999999999999999988899999999975433 457899999999999999999999998765     5689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++|+|.+++.....     ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       293 lv~E~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  364 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGL  364 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred             EEEEccCCCCHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeeccc
Confidence            99999999999999986542     2589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      ++......  ........++..|+|||++.+..++.++|||||||++|||++ |+.||.......  .............
T Consensus       365 a~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~~  440 (495)
T 1opk_A          365 SRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDYRMER  440 (495)
T ss_dssp             EECCTTCC--EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTCCCCC
T ss_pred             ceeccCCc--eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCCCC
Confidence            98764321  122223446789999999988899999999999999999999 999997543221  1111111100000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                                                    ...++..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus       441 ------------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          441 ------------------------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             ------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ------------------------------CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence                                          012234677899999999999999999999999865

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-39  Score=356.16  Aligned_cols=267  Identities=19%  Similarity=0.259  Sum_probs=203.4

Q ss_pred             HHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHHHHHcCCCCccceeeeeecccC
Q 002883          555 LKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ-----QRGASKSFIAECEALRSIRHRNLVKIITSCSSID  629 (871)
Q Consensus       555 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  629 (871)
                      ....++|++.+.||+|+||+||+|++..+++.||+|++...     .....+.+.+|++++++++||||+++++++.+. 
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-  100 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE-  100 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC-
Confidence            34567899999999999999999999999999999998643     234457889999999999999999999998765 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccc---------------------------------cccCCCCHHHHHHHHHH
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQ---------------------------------NQRPKLNLMQRLSIAID  676 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------------------------~~~~~l~~~~~~~i~~~  676 (871)
                          ...++||||+++|+|.+++.......                                 .....+++..++.++.|
T Consensus       101 ----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  176 (345)
T 3hko_A          101 ----QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ  176 (345)
T ss_dssp             ----SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred             ----CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence                67899999999999999996321110                                 00112467788999999


Q ss_pred             HHHHHHHHhhcCCCCeEecCCCCCceeeCCCC--ceEEeecccceecCCCCC-CccccccccccccccCcccccC--CCC
Q 002883          677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM--VAHVGDFGLSRLLHDNSP-DQTSTSRVKGSIGYVAPEYGAL--GEV  751 (871)
Q Consensus       677 i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~  751 (871)
                      ++.||+|||+.   +|+||||||+||+++.++  .+||+|||.+........ .........||+.|+|||++.+  ..+
T Consensus       177 i~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  253 (345)
T 3hko_A          177 IFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY  253 (345)
T ss_dssp             HHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred             HHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence            99999999999   999999999999998776  899999999987643221 1112334569999999998764  678


Q ss_pred             CCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHH
Q 002883          752 STHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQ  831 (871)
Q Consensus       752 ~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  831 (871)
                      +.++|||||||++|+|++|+.||......... ...........                            .+......
T Consensus       254 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~----------------------------~~~~~~~~  304 (345)
T 3hko_A          254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI-SQVLNKKLCFE----------------------------NPNYNVLS  304 (345)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHCCCCTT----------------------------SGGGGGSC
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCChHHHH-HHHHhcccccC----------------------------CcccccCC
Confidence            99999999999999999999999754333211 11111111000                            00111233


Q ss_pred             HHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          832 VSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       832 ~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ..+.+++.+||+.||++|||+.|+++.
T Consensus       305 ~~~~~li~~~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          305 PLARDLLSNLLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            467799999999999999999999873

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.1e-40  Score=358.18  Aligned_cols=268  Identities=20%  Similarity=0.252  Sum_probs=202.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECC---CCcEEEEEEeeccccc-----------hHHHHHHHHHHHHcCCCCccceeee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGT---EETNVAVKVLDLQQRG-----------ASKSFIAECEALRSIRHRNLVKIIT  623 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~  623 (871)
                      .++|++.+.||+|+||.||+|++..   ++..||+|++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3579999999999999999999986   7889999998654321           1134667888999999999999999


Q ss_pred             eecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcee
Q 002883          624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL  703 (871)
Q Consensus       624 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  703 (871)
                      ++... ..+....|+||||+ +++|.+++....       .+++.+++.++.||+.||+|||+.   +|+||||||+||+
T Consensus       116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  183 (345)
T 2v62_A          116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQNG-------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLL  183 (345)
T ss_dssp             EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGGG-------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             ccccc-cCCCcEEEEEEecc-CCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEE
Confidence            98763 23347789999999 999999998654       589999999999999999999999   9999999999999


Q ss_pred             eCCCC--ceEEeecccceecCCCCCC----ccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          704 LDNEM--VAHVGDFGLSRLLHDNSPD----QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       704 l~~~~--~~kl~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      ++.++  .+||+|||+|+.+......    ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  263 (345)
T 2v62_A          184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN  263 (345)
T ss_dssp             EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred             EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            98877  9999999999876532211    11223457999999999999889999999999999999999999999753


Q ss_pred             hhhhhhHHHHh---hhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHH
Q 002883          778 FEEGLSLHKYA---KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQD  854 (871)
Q Consensus       778 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~e  854 (871)
                      ...........   ....+........                         ...++.++.+++.+||+.||++|||++|
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~  318 (345)
T 2v62_A          264 LKDPVAVQTAKTNLLDELPQSVLKWAP-------------------------SGSSCCEIAQFLVCAHSLAYDEKPNYQA  318 (345)
T ss_dssp             TTCHHHHHHHHHHHHHTTTHHHHHHSC-------------------------TTSCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             ccccHHHHHHHHhhcccccHHHHhhcc-------------------------ccccHHHHHHHHHHHhhcCcccCCCHHH
Confidence            22211111111   1111111110000                         0023456889999999999999999999


Q ss_pred             HHHHHHHH
Q 002883          855 AIMELQEA  862 (871)
Q Consensus       855 vl~~L~~i  862 (871)
                      +++.|+++
T Consensus       319 l~~~L~~~  326 (345)
T 2v62_A          319 LKKILNPH  326 (345)
T ss_dssp             HHHHHCTT
T ss_pred             HHHHHhcc
Confidence            99999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.2e-40  Score=352.09  Aligned_cols=271  Identities=21%  Similarity=0.275  Sum_probs=200.6

Q ss_pred             hcCCCCC-ceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSA-NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++. +.||+|+||+||+|++..+++.||||++........+.+.+|++++.++ +||||+++++++.+.     ..
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-----~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-----DR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CE
Confidence            3578885 7899999999999999989999999999766555677899999999985 799999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc---eEE
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV---AHV  712 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl  712 (871)
                      .|+||||+++++|.+++....       .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.   +||
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl  155 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKRR-------HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKI  155 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEE
T ss_pred             EEEEEEcCCCCcHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEE
Confidence            899999999999999997653       589999999999999999999999   9999999999999988776   999


Q ss_pred             eecccceecCCCCCC----ccccccccccccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhh
Q 002883          713 GDFGLSRLLHDNSPD----QTSTSRVKGSIGYVAPEYGAL-----GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLS  783 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~  783 (871)
                      +|||++.........    ........||+.|+|||++.+     ..++.++||||+||++|+|++|+.||......+..
T Consensus       156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  235 (316)
T 2ac3_A          156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG  235 (316)
T ss_dssp             CCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred             EEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence            999999765432111    111223459999999998764     56889999999999999999999999754322110


Q ss_pred             HHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          784 LHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      +..   .       + ..+........   ................+...+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~---~-------~-~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          236 WDR---G-------E-ACPACQNMLFE---SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             C---------------CCHHHHHHHHH---HHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccc---c-------c-cchhHHHHHHH---HHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            000   0       0 00000000000   00000000111112234567889999999999999999999987

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.1e-40  Score=356.40  Aligned_cols=280  Identities=23%  Similarity=0.315  Sum_probs=198.2

Q ss_pred             HHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccC
Q 002883          552 AELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSID  629 (871)
Q Consensus       552 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  629 (871)
                      .......++|++.+.||+|+||+||+|++..+++.||||+++....  ...+.+.+|++++++++||||+++++++.+. 
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-  105 (329)
T 3gbz_A           27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-  105 (329)
T ss_dssp             -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-
T ss_pred             CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-
Confidence            3344566899999999999999999999999999999999964432  2245678999999999999999999998765 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee-----
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL-----  704 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill-----  704 (871)
                          ...++||||++ |+|.+++....       .+++..++.++.||+.||+|||+.   +|+||||||+||++     
T Consensus       106 ----~~~~lv~e~~~-~~L~~~~~~~~-------~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~  170 (329)
T 3gbz_A          106 ----HRLHLIFEYAE-NDLKKYMDKNP-------DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDA  170 (329)
T ss_dssp             ----TEEEEEEECCS-EEHHHHHHHCT-------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC---
T ss_pred             ----CEEEEEEecCC-CCHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCC
Confidence                67899999997 59999997654       589999999999999999999999   99999999999999     


Q ss_pred             CCCCceEEeecccceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhh
Q 002883          705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLS  783 (871)
Q Consensus       705 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~  783 (871)
                      +.++.+||+|||.+.......   .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.........
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  247 (329)
T 3gbz_A          171 SETPVLKIGDFGLARAFGIPI---RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL  247 (329)
T ss_dssp             --CCEEEECCTTHHHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CccceEEECcCCCccccCCcc---cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH
Confidence            455569999999998764321   222334689999999988764 5899999999999999999999999765443322


Q ss_pred             HHHHhhhCCCchh--hhhc-ChhHHHHHHHHHhhhhhhcCchhHHhH-HHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          784 LHKYAKMGLPDQV--AEII-DPAILEEALEIQAGIVKELQPNLRAKF-HEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       784 ~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .........+...  .... .+.+...       ............. .....++.+++.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          248 FKIFEVLGLPDDTTWPGVTALPDWKQS-------FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHHHCCCCTTTSTTGGGSTTCCTT-------CCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhCCCchhhhhhhhhhhhhhhh-------hhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            2222222222110  0000 0000000       0000000000111 113456789999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.2e-40  Score=353.48  Aligned_cols=281  Identities=21%  Similarity=0.321  Sum_probs=218.9

Q ss_pred             cccCHHHHHHhhcCCCCCceeeccccceEEEEEE-----CCCCcEEEEEEeecccc-chHHHHHHHHHHHHcC-CCCccc
Q 002883          547 LKISYAELLKATEGFSSANLIGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQR-GASKSFIAECEALRSI-RHRNLV  619 (871)
Q Consensus       547 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv  619 (871)
                      ..+....+....++|++.+.||+|+||+||+|++     ..+++.||||+++.... ...+.+.+|+++++++ +||||+
T Consensus        15 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv   94 (316)
T 2xir_A           15 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   94 (316)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCee
Confidence            3455566666778999999999999999999985     34678999999965432 3346788999999999 799999


Q ss_pred             eeeeeecccCcCCCceeeEEEeccCCCCHHHHhhccccccc---------ccCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 002883          620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQN---------QRPKLNLMQRLSIAIDVANVLEYLHHHCHT  690 (871)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~  690 (871)
                      ++++++...    +...++||||+++++|.+++........         ....+++..++.++.|++.||.|||+.   
T Consensus        95 ~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---  167 (316)
T 2xir_A           95 NLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---  167 (316)
T ss_dssp             CEEEEECCT----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             eEEEEEecC----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---
Confidence            999998653    2457999999999999999987543110         011378999999999999999999999   


Q ss_pred             CeEecCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-
Q 002883          691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-  769 (871)
Q Consensus       691 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-  769 (871)
                      +|+||||||+||+++.++.+||+|||.+....... .........||+.|+|||++.+..++.++|||||||++|+|++ 
T Consensus       168 ~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~  246 (316)
T 2xir_A          168 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL  246 (316)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CcccccCccceEEECCCCCEEECCCccccccccCc-cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhC
Confidence            99999999999999999999999999998765432 2222334567899999999988999999999999999999998 


Q ss_pred             CCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCC
Q 002883          770 GKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDR  849 (871)
Q Consensus       770 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  849 (871)
                      |+.||................ .......                              .....+.+++.+||+.||++|
T Consensus       247 g~~p~~~~~~~~~~~~~~~~~-~~~~~~~------------------------------~~~~~l~~li~~~l~~dp~~R  295 (316)
T 2xir_A          247 GASPYPGVKIDEEFCRRLKEG-TRMRAPD------------------------------YTTPEMYQTMLDCWHGEPSQR  295 (316)
T ss_dssp             SCCSSTTCCCSHHHHHHHHHT-CCCCCCT------------------------------TCCHHHHHHHHHHTCSSGGGS
T ss_pred             CCCCCcccchhHHHHHHhccC-ccCCCCC------------------------------CCCHHHHHHHHHHcCCChhhC
Confidence            999997543222111111111 0000000                              122356789999999999999


Q ss_pred             CCHHHHHHHHHHHHHHH
Q 002883          850 MKIQDAIMELQEAQKMR  866 (871)
Q Consensus       850 Pta~evl~~L~~i~~~~  866 (871)
                      ||+.|+++.|+++.+..
T Consensus       296 ps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          296 PTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CCHHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHhhh
Confidence            99999999999987654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.1e-39  Score=342.07  Aligned_cols=257  Identities=20%  Similarity=0.302  Sum_probs=205.4

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR------GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++....      ...+.+.+|++++++++||||+++++++...    
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----   80 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK----   80 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC----
Confidence            569999999999999999999998999999999864321      1357889999999999999999999998765    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC----
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM----  708 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----  708 (871)
                       ...++||||+++++|.+++....       .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++    
T Consensus        81 -~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~  149 (283)
T 3bhy_A           81 -TDVVLILELVSGGELFDFLAEKE-------SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNP  149 (283)
T ss_dssp             -SEEEEEEECCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSC
T ss_pred             -CeEEEEEeecCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCC
Confidence             66899999999999999997643       589999999999999999999999   999999999999998877    


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA  788 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~  788 (871)
                      .+||+|||.+.......    ......|++.|+|||++.+..++.++||||||+++|+|++|+.||........ .....
T Consensus       150 ~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~  224 (283)
T 3bhy_A          150 RIKLIDFGIAHKIEAGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-LTNIS  224 (283)
T ss_dssp             CEEECCCTTCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHH
T ss_pred             ceEEEecccceeccCCC----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-HHHhH
Confidence            89999999998765432    22334689999999999888999999999999999999999999975432211 11111


Q ss_pred             hhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH--HHHHHH
Q 002883          789 KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM--ELQEAQ  863 (871)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~--~L~~i~  863 (871)
                      ......      .                      ..........+.+++.+||+.||++|||+.|+++  .++.+.
T Consensus       225 ~~~~~~------~----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          225 AVNYDF------D----------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             TTCCCC------C----------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             hcccCC------c----------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            110000      0                      0111123456789999999999999999999998  455553

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1e-39  Score=343.39  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=204.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||.||+|++.  ++.||||++....  ....+.+.+|+.++++++||||+++++++.+..   ...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCC
Confidence            467999999999999999999995  8889999996543  334567899999999999999999999986542   256


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCceeeCCCCceEEe
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS--IVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      .++||||+++|+|.+++......     .+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.++++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~  155 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNF-----VVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARIS  155 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSC-----CCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEE
T ss_pred             eEeeecccCCCcHHHHHhhcccC-----CCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEE
Confidence            79999999999999999875422     589999999999999999999998   8  9999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCC---ccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVST---HGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM  790 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~  790 (871)
                      |||++.....        ....||+.|+|||.+.+..++.   ++|||||||++|||++|+.||........... ....
T Consensus       156 ~~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~  226 (271)
T 3kmu_A          156 MADVKFSFQS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK-VALE  226 (271)
T ss_dssp             GGGSCCTTSC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH-HHHS
T ss_pred             eccceeeecc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH-HHhc
Confidence            9988754321        2245899999999987665544   79999999999999999999986433322111 1111


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      ........                              .+...+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       227 ~~~~~~~~------------------------------~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          227 GLRPTIPP------------------------------GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CCCCCCCT------------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCCCCCC------------------------------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            11111100                              123457789999999999999999999999998753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1e-39  Score=352.60  Aligned_cols=249  Identities=24%  Similarity=0.295  Sum_probs=192.7

Q ss_pred             hcCCCCCceeeccccceEEEEEEC---CCCcEEEEEEeeccc----cchHHHHHHHHHHHHcCCCCccceeeeeecccCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILG---TEETNVAVKVLDLQQ----RGASKSFIAECEALRSIRHRNLVKIITSCSSIDT  630 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  630 (871)
                      .++|++.+.||+|+||.||+|++.   .+++.||+|+++...    ......+.+|+++++.++||||+++++++...  
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--   93 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG--   93 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS--
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC--
Confidence            468999999999999999999984   578999999996432    22345678899999999999999999998765  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCce
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA  710 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  710 (871)
                         ...|+||||+++++|.+++....       .+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+
T Consensus        94 ---~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~  160 (327)
T 3a62_A           94 ---GKLYLILEYLSGGELFMQLEREG-------IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHV  160 (327)
T ss_dssp             ---SCEEEEEECCTTEEHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCE
T ss_pred             ---CEEEEEEeCCCCCcHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcE
Confidence               66899999999999999997643       589999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh
Q 002883          711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM  790 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~  790 (871)
                      ||+|||+++......   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .......
T Consensus       161 kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~  236 (327)
T 3a62_A          161 KLTDFGLCKESIHDG---TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-IDKILKC  236 (327)
T ss_dssp             EECCCSCC-------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHT
T ss_pred             EEEeCCcccccccCC---ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhC
Confidence            999999997643221   223345699999999999888999999999999999999999999975432211 1111111


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIM  857 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~  857 (871)
                      ...                         .++       .....+.+++.+||+.||++||     ++.|+++
T Consensus       237 ~~~-------------------------~p~-------~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          237 KLN-------------------------LPP-------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CCC-------------------------CCT-------TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CCC-------------------------CCC-------CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            000                         000       1234567899999999999999     6777765

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.1e-40  Score=343.38  Aligned_cols=258  Identities=26%  Similarity=0.430  Sum_probs=208.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||.||+|++. +++.||+|++..... ..+.+.+|++++++++||||+++++++.+.     ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   79 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APIC   79 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCeE
Confidence            467999999999999999999997 678899999975543 346789999999999999999999998765     5689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++.....      .+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||.
T Consensus        80 lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~  150 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRG------LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGM  150 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred             EEEeCCCCCcHHHHHhhCcc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccc
Confidence            99999999999999976532      589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +.......  ........++..|+|||+..+..++.++||||+|+++|+|++ |+.||........  ............
T Consensus       151 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~i~~~~~~~~  226 (267)
T 3t9t_A          151 TRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--VEDISTGFRLYK  226 (267)
T ss_dssp             GGGBCCHH--HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHHTTCCCCC
T ss_pred             cccccccc--ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH--HHHHhcCCcCCC
Confidence            98654321  111223456788999999888899999999999999999999 8999975322211  111111100000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      ..                              .....+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       227 ~~------------------------------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          227 PR------------------------------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             CT------------------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             Cc------------------------------cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            00                              1123567899999999999999999999999998763

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.3e-39  Score=350.22  Aligned_cols=273  Identities=22%  Similarity=0.362  Sum_probs=201.6

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECC---CCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCc
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGT---EETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDT  630 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  630 (871)
                      ...++|.+.+.||+|+||.||+|++..   +++.||+|+++...  ....+.+.+|+.++++++||||+++++++.+...
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            345689999999999999999998754   45689999996443  3344678899999999999999999999877654


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCce
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA  710 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  710 (871)
                      .+....++||||+++++|.+++...... .....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLE-TGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBT-TSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhh-cCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence            4445679999999999999999543211 1123689999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhh
Q 002883          711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAK  789 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~  789 (871)
                      ||+|||.+........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||........  .....
T Consensus       187 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~~  263 (313)
T 3brb_A          187 CVADFGLSKKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--YDYLL  263 (313)
T ss_dssp             EECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHHH
T ss_pred             EEeecCcceecccccc-cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHHH
Confidence            9999999987654321 112233457889999999988999999999999999999999 8999975432211  11111


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      ........                              ..+...+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       264 ~~~~~~~~------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          264 HGHRLKQP------------------------------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             TTCCCCCB------------------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCCC------------------------------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            11000000                              02234577999999999999999999999999998764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-39  Score=344.38  Aligned_cols=253  Identities=21%  Similarity=0.290  Sum_probs=198.1

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.     ...+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   96 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY-----HNMY   96 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC-----CeEE
Confidence            57999999999999999999999899999999996543 33457889999999999999999999998765     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee---CCCCceEEee
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAHVGD  714 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~D  714 (871)
                      +||||+++|+|.+++......   ...+++..++.++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~D  170 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQAR---GKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIID  170 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeCCCCcHHHHHHhhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEe
Confidence            999999999999998654321   23689999999999999999999999   99999999999999   4567899999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||.+.......    ......||+.|+|||++. +.++.++||||+||++|+|++|+.||............  ....+.
T Consensus       171 fg~a~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~--~~~~~~  243 (285)
T 3is5_A          171 FGLAELFKSDE----HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPN  243 (285)
T ss_dssp             CCCCCC--------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCCCC
T ss_pred             eecceecCCcc----cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh--ccCCcc
Confidence            99998664322    223456899999999865 57899999999999999999999999764332211111  100000


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ..                            .........+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~----------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          244 YA----------------------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CC----------------------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cc----------------------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00                            000012345678999999999999999999985

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.4e-39  Score=350.66  Aligned_cols=278  Identities=22%  Similarity=0.307  Sum_probs=211.1

Q ss_pred             cCC-CCCceeeccccceEEEEEE----CCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          559 EGF-SSANLIGIGGYGYVYKGIL----GTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       559 ~~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ++| ++.+.||+|+||+||+|.+    ..+++.||||+++... ....+.+.+|++++++++||||+++++++.+..   
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---  106 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG---  106 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC---
Confidence            345 8999999999999988764    4478899999997543 234567899999999999999999999987542   


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                      ....++||||+++|+|.+++...        .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl  175 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPRH--------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKI  175 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGGS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             CceEEEEEecccCCcHHHHHhhC--------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEE
Confidence            25689999999999999999754        389999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      +|||.+.................+|..|+|||++.+..++.++||||+||++|+|++|+.||............     .
T Consensus       176 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-----~  250 (318)
T 3lxp_A          176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG-----I  250 (318)
T ss_dssp             CCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC-----S
T ss_pred             CCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhc-----c
Confidence            99999998765432222334456888999999998888999999999999999999999999754332111110     0


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQ  867 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~~  867 (871)
                      .......      .....   .........   ....++..+.+++.+||+.||++|||+.|+++.|+++.+..+
T Consensus       251 ~~~~~~~------~~~~~---~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          251 AQGQMTV------LRLTE---LLERGERLP---RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             CCHHHHH------HHHHH---HHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             cccchhH------HHHHH---HHhcccCCC---CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            0000000      00000   000000000   011234568899999999999999999999999999877654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=356.74  Aligned_cols=276  Identities=22%  Similarity=0.283  Sum_probs=200.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG-ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ++|++.+.||+|+||+||+|++..+++.||+|++...... ....+.+|+++++.++||||+++++++...     ...+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-----SCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEEE
Confidence            5799999999999999999999989999999998643321 112445799999999999999999998765     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||++ |+|.+++.....      .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        77 lv~e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  146 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLDDCGN------IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGL  146 (324)
T ss_dssp             EEEECCS-EEHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSE
T ss_pred             EEecccc-cCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcc
Confidence            9999996 599999876542      589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc--
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD--  794 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~--  794 (871)
                      +.......   .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..................+.  
T Consensus       147 a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  223 (324)
T 3mtl_A          147 ARAKSIPT---KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE  223 (324)
T ss_dssp             EECC---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             cccccCCc---cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChH
Confidence            98654321   22233468999999998765 5689999999999999999999999986544332222222112111  


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ..........   ...  .................+...+.+++.+||+.||++|||++|+++
T Consensus       224 ~~~~~~~~~~---~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          224 TWPGILSNEE---FKT--YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             TSTTGGGCHH---HHH--TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hchhhhcchh---hcc--cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            1111111100   000  000000011111222234567789999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.5e-40  Score=361.82  Aligned_cols=262  Identities=19%  Similarity=0.232  Sum_probs=205.7

Q ss_pred             HHHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecc
Q 002883          551 YAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSS  627 (871)
Q Consensus       551 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  627 (871)
                      ..+.....++|++.+.||+|+||.||+|++..+++.||||+++...   ....+.+.+|.+++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444456688999999999999999999999999999999996432   2233457889999999999999999999876


Q ss_pred             cCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC
Q 002883          628 IDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE  707 (871)
Q Consensus       628 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  707 (871)
                      .     ...|+||||+++|+|.+++...+.      .+++..++.++.||+.||+|||+.   +|+||||||+||+++.+
T Consensus       133 ~-----~~~~lVmE~~~gg~L~~~l~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~  198 (412)
T 2vd5_A          133 E-----NYLYLVMEYYVGGDLLTLLSKFGE------RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRC  198 (412)
T ss_dssp             S-----SEEEEEECCCCSCBHHHHHHHHSS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred             C-----CEEEEEEcCCCCCcHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCC
Confidence            5     678999999999999999976432      589999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccceecCCCCCCccccccccccccccCccccc-------CCCCCCccchhhHHHHHHHHHhCCCCCchhhhh
Q 002883          708 MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA-------LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEE  780 (871)
Q Consensus       708 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  780 (871)
                      +.+||+|||+|+......  .......+||+.|+|||++.       ...++.++|||||||++|||++|+.||......
T Consensus       199 g~vkL~DFGla~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~  276 (412)
T 2vd5_A          199 GHIRLADFGSCLKLRADG--TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA  276 (412)
T ss_dssp             SCEEECCCTTCEECCTTS--CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             CCEEEeechhheeccCCC--ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH
Confidence            999999999998765432  11223457999999999876       457899999999999999999999999754322


Q ss_pred             hhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCC---CCHHHHHH
Q 002883          781 GLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDR---MKIQDAIM  857 (871)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pta~evl~  857 (871)
                      .. ........     .....                   |.   ....+..++.+++.+||. +|++|   |+++|+++
T Consensus       277 ~~-~~~i~~~~-----~~~~~-------------------p~---~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          277 ET-YGKIVHYK-----EHLSL-------------------PL---VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HH-HHHHHTHH-----HHCCC-------------------C-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HH-HHHHHhcc-----cCcCC-------------------Cc---cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            11 11111000     00000                   00   001234567899999999 99998   58988865

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.5e-39  Score=360.60  Aligned_cols=255  Identities=19%  Similarity=0.272  Sum_probs=194.5

Q ss_pred             hcCCCCC-ceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHc-CCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSA-NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRS-IRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|.+. +.||+|+||+||+|++..+++.||||+++..     ..+.+|++++.+ .+||||+++++++... ..+...
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~  133 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC  133 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence            3567776 7899999999999999999999999998632     456788888744 5899999999988652 223367


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEE
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN---EMVAHV  712 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl  712 (871)
                      .|+||||+++|+|.+++......     .+++..++.++.||+.||.|||+.   +|+||||||+||+++.   ++.+||
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl  205 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQ-----AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKL  205 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC--------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEE
Confidence            89999999999999999875422     589999999999999999999999   9999999999999987   789999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhh---hHHHHhh
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL---SLHKYAK  789 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~---~~~~~~~  789 (871)
                      +|||+++......    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........   .......
T Consensus       206 ~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~  281 (400)
T 1nxk_A          206 TDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM  281 (400)
T ss_dssp             CCCTTCEECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH
T ss_pred             EecccccccCCCC----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc
Confidence            9999998764321    22345689999999999999999999999999999999999999975432211   0011111


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ......                            ...+..+..++.+++.+||+.||++|||+.|+++.
T Consensus       282 ~~~~~~----------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          282 GQYEFP----------------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TCCCCC----------------------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CcccCC----------------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            000000                            00011234567899999999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.1e-40  Score=372.12  Aligned_cols=259  Identities=25%  Similarity=0.442  Sum_probs=208.3

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ...++|++.+.||+|+||.||+|++. .+..||||+++.... ..+.+.+|++++++++||||+++++++..      ..
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~  256 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP  256 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEeC------Cc
Confidence            34567899999999999999999996 577899999975443 46789999999999999999999998752      44


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++......     .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DF  328 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDEGS-----KQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADF  328 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHHHH-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECST
T ss_pred             cEEEEeecCCCcHHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeC
Confidence            79999999999999999865432     588999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      |+++......  ........++..|+|||++..+.++.++|||||||++|||+| |+.||.........  .........
T Consensus       329 G~a~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~--~~i~~~~~~  404 (454)
T 1qcf_A          329 GLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI--RALERGYRM  404 (454)
T ss_dssp             TGGGGBCCHH--HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--HHHHHTCCC
T ss_pred             CCceEcCCCc--eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH--HHHHcCCCC
Confidence            9998764321  111222346788999999988899999999999999999999 99999764332211  111111000


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      ..                              ...++.++.+++.+||+.||++|||++++++.|+++..
T Consensus       405 ~~------------------------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          405 PR------------------------------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             CC------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             CC------------------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            00                              01233467799999999999999999999999987643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=349.96  Aligned_cols=245  Identities=22%  Similarity=0.242  Sum_probs=193.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.++||+|+||+||+|++..+++.||||++.....  ........|+..+..+ +||||+++++++.+.     ..
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-----~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-----GI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-----CE
Confidence            579999999999999999999998999999999854322  2233455566555555 899999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+ +++|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DF  201 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWGA------SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDF  201 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCC
T ss_pred             EEEEEecc-CCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccc
Confidence            89999999 7799999876542      599999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |++.......    ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....    .........+..
T Consensus       202 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~~~~~~~~~  272 (311)
T 3p1a_A          202 GLLVELGTAG----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----WQQLRQGYLPPE  272 (311)
T ss_dssp             TTCEECC----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHHHTTTCCCHH
T ss_pred             eeeeecccCC----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHhccCCCcc
Confidence            9998765332    2233468999999998765 799999999999999999999776653211    111111111111


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .                              ...+..++.+++.+||+.||++|||++|+++
T Consensus       273 ~------------------------------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          273 F------------------------------TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             H------------------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             c------------------------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            0                              0123456789999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.6e-39  Score=346.79  Aligned_cols=266  Identities=18%  Similarity=0.267  Sum_probs=209.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....  .+.+.+|+.+++.++|++++..+.++...    ....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCC----CCceE
Confidence            4689999999999999999999988999999999865433  24688999999999998887777666432    25679


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee---CCCCceEEee
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAHVGD  714 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~D  714 (871)
                      +||||+ +++|.+++.....      .+++..++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|
T Consensus        82 lv~e~~-~~~L~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  151 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCSR------KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred             EEEEec-CCCHHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEee
Confidence            999999 9999999975432      589999999999999999999999   99999999999999   4888999999


Q ss_pred             cccceecCCCCCCc----cccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhh--hhHHHHh
Q 002883          715 FGLSRLLHDNSPDQ----TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG--LSLHKYA  788 (871)
Q Consensus       715 fg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~--~~~~~~~  788 (871)
                      ||.+..........    .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.......  .......
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 3uzp_A          152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             CTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             CCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence            99998876543211    11234579999999999999999999999999999999999999998532111  0000000


Q ss_pred             hhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          789 KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      ..            ..               ..........++.++.+++.+||+.||++|||++|+++.|+++.+..
T Consensus       232 ~~------------~~---------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          232 EK------------KM---------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HH------------HH---------------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cc------------cc---------------CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            00            00               00000001123456889999999999999999999999999987653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.2e-40  Score=359.86  Aligned_cols=279  Identities=21%  Similarity=0.231  Sum_probs=193.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  634 (871)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+++++.++||||+++++++..... ....
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            36899999999999999999999999999999998543  23345678899999999999999999999865421 2235


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+|||++ +++|.+++...        .+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~D  175 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ--------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD  175 (367)
T ss_dssp             CCEEEEECC-CEECC-----C--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEeccc-CCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEee
Confidence            579999999 78999988652        489999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||+++.....      .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||................+.+
T Consensus       176 FG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  249 (367)
T 2fst_X          176 FGLARHTADE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  249 (367)
T ss_dssp             ---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             cccccccccc------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999865422      233568999999998776 678999999999999999999999998644332221111112222


Q ss_pred             c-hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 D-QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      . .....+.......+   ...............+......+.+++.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          250 GAELLKKISSESARNY---IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CHHHHTTCCCHHHHHH---HHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHhhhHHHHHH---HhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            1 11111111111111   1111111111222233344567889999999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.9e-40  Score=359.75  Aligned_cols=250  Identities=27%  Similarity=0.331  Sum_probs=193.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHH-HHcCCCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEA-LRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++....   .....+.+|..+ ++.++||||+++++++.+.     
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~-----  111 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----  111 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS-----
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC-----
Confidence            4679999999999999999999999999999999965432   233456667766 4678999999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||++||+|.+++....       .+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~  181 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRER-------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLT  181 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEEC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEe
Confidence            67899999999999999997644       589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||+++......   .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......... 
T Consensus       182 DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-~~~i~~~~~-  256 (373)
T 2r5t_A          182 DFGLCKENIEHN---STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-YDNILNKPL-  256 (373)
T ss_dssp             CCCBCGGGBCCC---CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH-HHHHHHSCC-
T ss_pred             eCccccccccCC---CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHhccc-
Confidence            999998643321   223346799999999999999999999999999999999999999975332211 111111100 


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                       .                       .++       .+...+.+++.+||+.||++||++.+.++.
T Consensus       257 -~-----------------------~~~-------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~  290 (373)
T 2r5t_A          257 -Q-----------------------LKP-------NITNSARHLLEGLLQKDRTKRLGAKDDFME  290 (373)
T ss_dssp             -C-----------------------CCS-------SSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred             -C-----------------------CCC-------CCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence             0                       000       122356789999999999999998644433

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.2e-40  Score=352.54  Aligned_cols=277  Identities=21%  Similarity=0.238  Sum_probs=202.5

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++.+.||+|+||+||+|++..+++.||+|++.....  ...+.+.+|++++++++||||+++++++...     ...
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----CeE
Confidence            689999999999999999999998999999999854432  2346778999999999999999999998765     668


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++++|.+++....       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  147 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQR-------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFG  147 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTSS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeCCCchHHHHHhhhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCC
Confidence            99999999999999887543       589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hCCCc
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MGLPD  794 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~~  794 (871)
                      .+.......   .......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||............... ....+
T Consensus       148 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  224 (311)
T 4agu_A          148 FARLLTGPS---DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP  224 (311)
T ss_dssp             TCEECC---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             CchhccCcc---cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccc
Confidence            998765322   12233568999999998765 67899999999999999999999999765433222111111 11111


Q ss_pred             hhhh-hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAE-IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .... +.........    ..............+..+...+.+++.+||+.||++|||++|+++
T Consensus       225 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          225 RHQQVFSTNQYFSGV----KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHHHHHTCGGGTTC----CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccC----cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            1000 0000000000    000000000111222345567889999999999999999999985

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.8e-39  Score=342.49  Aligned_cols=254  Identities=24%  Similarity=0.328  Sum_probs=205.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.     ...
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----CEE
Confidence            467999999999999999999999899999999996443 23457889999999999999999999998765     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||+++++|.+++....       .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  150 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPDI-------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  150 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTTT-------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecCCCcHHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCC
Confidence            99999999999999986543       589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV-STHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      .+....... .........|++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||............+........
T Consensus       151 ~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  229 (276)
T 2yex_A          151 LATVFRYNN-RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN  229 (276)
T ss_dssp             TCEECEETT-EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTST
T ss_pred             CccccCCCc-chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccC
Confidence            998764322 1112234568999999999877665 78899999999999999999999764333222222221110000


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                                    ....+...+.+++.+||+.||++|||++|+++
T Consensus       230 ------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 ------------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ------------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------------------------------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                                          00122345678999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=366.83  Aligned_cols=285  Identities=21%  Similarity=0.261  Sum_probs=214.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++....   ....
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCee
Confidence            467999999999999999999999899999999996433 234567889999999999999999999886542   2467


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee----CCCCceEE
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL----DNEMVAHV  712 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl  712 (871)
                      ++||||+++|+|.+++......    ..+++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL  157 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNA----YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKL  157 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred             EEEEecCCCCCHHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEE
Confidence            9999999999999999875421    2389999999999999999999999   99999999999999    78888999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccC--------CCCCCccchhhHHHHHHHHHhCCCCCchhhhhh---
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL--------GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG---  781 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~---  781 (871)
                      +|||.|+......    ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||.......   
T Consensus       158 ~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~  233 (396)
T 4eut_A          158 TDFGAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (396)
T ss_dssp             CCGGGCEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH
T ss_pred             ecCCCceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH
Confidence            9999998765422    2233569999999998654        567889999999999999999999997532211   


Q ss_pred             hhHHHHhhhCCCch-hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          782 LSLHKYAKMGLPDQ-VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       782 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                      ........ ..|.. ...+...... ..     . +....+............+.+++.+||+.||++|||+.|+++.++
T Consensus       234 ~~~~~~~~-~~p~~~~~~~~~~~~~-~~-----~-~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~  305 (396)
T 4eut_A          234 EVMYKIIT-GKPSGAISGVQKAENG-PI-----D-WSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (396)
T ss_dssp             HHHHHHHH-SCCTTCCEEEECSTTC-CE-----E-EESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHhc-CCCcccchhheeccCC-Cc-----c-cCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence            11112222 12211 1100000000 00     0 000000011112355667889999999999999999999999998


Q ss_pred             HHHH
Q 002883          861 EAQK  864 (871)
Q Consensus       861 ~i~~  864 (871)
                      ++.+
T Consensus       306 ~il~  309 (396)
T 4eut_A          306 DILH  309 (396)
T ss_dssp             HHHT
T ss_pred             HHhh
Confidence            8765

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.4e-40  Score=356.14  Aligned_cols=287  Identities=26%  Similarity=0.340  Sum_probs=204.1

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHH--HcCCCCccceeeeeecccCcCCCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEAL--RSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l--~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ..++|++.+.||+|+||.||+|++  +++.||||++.....   ..+..|.++.  ..++||||+++++.+......+..
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            357899999999999999999987  588999999975432   3444455554  457999999999877655455556


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeEecCCCCCceeeCCCC
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC------HTSIVHCDLKPSNVLLDNEM  708 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~Nill~~~~  708 (871)
                      ..++||||+++|+|.+++...        ..++..++.++.|++.||+|||+..      ..+|+||||||+||+++.++
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~  157 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLH--------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG  157 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred             eEEEEEecCCCCcHHHHHhhc--------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence            789999999999999999754        3688999999999999999999862      23899999999999999999


Q ss_pred             ceEEeecccceecCCCCCC-----ccccccccccccccCcccccC-------CCCCCccchhhHHHHHHHHHhCCCCCch
Q 002883          709 VAHVGDFGLSRLLHDNSPD-----QTSTSRVKGSIGYVAPEYGAL-------GEVSTHGDEYSFGILMLEMFTGKRPTDD  776 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltG~~pf~~  776 (871)
                      .+||+|||+|..+......     ........||+.|+|||++.+       ..++.++|||||||++|||++|..||..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            9999999999876543211     112223569999999998776       3567889999999999999999877654


Q ss_pred             hhhhhh-hHHHHhhhCCCchhhhhcChhHHHHHHHHHh-hhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHH
Q 002883          777 MFEEGL-SLHKYAKMGLPDQVAEIIDPAILEEALEIQA-GIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQD  854 (871)
Q Consensus       777 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~e  854 (871)
                      ...... ...........+.        . ........ .......+........+..++.+++.+||+.||++|||++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  308 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGNHPT--------F-EDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQX  308 (336)
T ss_dssp             TSCCCCCCCTTHHHHCSSCC--------H-HHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             ccchhHHHHhhhcccCCCch--------H-HHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHH
Confidence            221110 0000000000000        0 00000000 00000000111111235567899999999999999999999


Q ss_pred             HHHHHHHHHHH
Q 002883          855 AIMELQEAQKM  865 (871)
Q Consensus       855 vl~~L~~i~~~  865 (871)
                      +++.|+++...
T Consensus       309 ~l~~L~~ll~~  319 (336)
T 3g2f_A          309 AEERMAELMMI  319 (336)
T ss_dssp             HHHHHHHHHHC
T ss_pred             HHHHHHHHHHH
Confidence            99999998654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.6e-39  Score=352.85  Aligned_cols=269  Identities=23%  Similarity=0.370  Sum_probs=210.2

Q ss_pred             hhcCCCCCceeeccccceEEEEEEC-------CCCcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeeeeecc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILG-------TEETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIITSCSS  627 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  627 (871)
                      ..++|++.+.||+|+||.||+|++.       .+++.||+|+++... ....+.+.+|+++++++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3578999999999999999999985       356789999996543 23456788999999999 89999999999876


Q ss_pred             cCcCCCceeeEEEeccCCCCHHHHhhcccccc---------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 002883          628 IDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ---------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK  698 (871)
Q Consensus       628 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  698 (871)
                      .     ...|+||||+++|+|.+++.......         .....+++..++.++.|++.||+|||+.   +|+|||||
T Consensus       113 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlk  184 (334)
T 2pvf_A          113 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLA  184 (334)
T ss_dssp             S-----SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred             C-----CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCc
Confidence            5     56899999999999999998654210         0112489999999999999999999999   99999999


Q ss_pred             CCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchh
Q 002883          699 PSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM  777 (871)
Q Consensus       699 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~  777 (871)
                      |+||+++.++.+||+|||.+........ ........+++.|+|||++.+..++.++|||||||++|+|++ |+.||...
T Consensus       185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          185 ARNVLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cceEEEcCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            9999999999999999999987654321 122233457889999999888889999999999999999999 99999754


Q ss_pred             hhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          778 FEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .....  ............                       +       ..+...+.+++.+||+.||++|||+.|+++
T Consensus       264 ~~~~~--~~~~~~~~~~~~-----------------------~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~  311 (334)
T 2pvf_A          264 PVEEL--FKLLKEGHRMDK-----------------------P-------ANCTNELYMMMRDCWHAVPSQRPTFKQLVE  311 (334)
T ss_dssp             CHHHH--HHHHHHTCCCCC-----------------------C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHH--HHHHhcCCCCCC-----------------------C-------ccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            32211  111111000000                       0       012345778999999999999999999999


Q ss_pred             HHHHHHHHH
Q 002883          858 ELQEAQKMR  866 (871)
Q Consensus       858 ~L~~i~~~~  866 (871)
                      .|+++....
T Consensus       312 ~L~~l~~~~  320 (334)
T 2pvf_A          312 DLDRILTLT  320 (334)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHhcc
Confidence            999997654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-39  Score=350.32  Aligned_cols=273  Identities=23%  Similarity=0.335  Sum_probs=203.0

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC--CCCccceeeeeecccCcCCCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI--RHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ..++|++.+.||+|+||.||+|++.  ++.||||++....   .....+|.+++...  +||||+++++++.... ....
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~  108 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWT  108 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGC
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCC
Confidence            4468999999999999999999985  8899999986433   34555666666665  8999999999986642 2235


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCceeeCCCCc
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC-----HTSIVHCDLKPSNVLLDNEMV  709 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~  709 (871)
                      ..|+||||+++|+|.++++..        .+++..++.++.|++.||+|||+..     ..+|+||||||+||+++.++.
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKST--------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             ceEEEEeccCCCcHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence            689999999999999999653        4899999999999999999999752     338999999999999999999


Q ss_pred             eEEeecccceecCCCCCCc-cccccccccccccCcccccCCCCCCc------cchhhHHHHHHHHHhC----------CC
Q 002883          710 AHVGDFGLSRLLHDNSPDQ-TSTSRVKGSIGYVAPEYGALGEVSTH------GDEYSFGILMLEMFTG----------KR  772 (871)
Q Consensus       710 ~kl~Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwSlG~il~elltG----------~~  772 (871)
                      +||+|||+|.......... .......||+.|+|||++.+..++.+      +|||||||++|||+||          +.
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            9999999998765432211 11223569999999999887766665      9999999999999999          55


Q ss_pred             CCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhH--HhHHHHHHHHHhhhcccccCCCCCCC
Q 002883          773 PTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLR--AKFHEIQVSILRVGILCSEELPRDRM  850 (871)
Q Consensus       773 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RP  850 (871)
                      ||.................                       ......+...  .....+..++.+++.+||+.||++||
T Consensus       261 p~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  317 (337)
T 3mdy_A          261 PYHDLVPSDPSYEDMREIV-----------------------CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL  317 (337)
T ss_dssp             TTTTTSCSSCCHHHHHHHH-----------------------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSC
T ss_pred             cHhhhcCCCCchhhhHHHH-----------------------hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCC
Confidence            5543221111111110000                       0000011100  11125567789999999999999999


Q ss_pred             CHHHHHHHHHHHHHHH
Q 002883          851 KIQDAIMELQEAQKMR  866 (871)
Q Consensus       851 ta~evl~~L~~i~~~~  866 (871)
                      |+.|+++.|+++.+..
T Consensus       318 s~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          318 TALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CHHHHHHHHHHHHHTT
T ss_pred             CHHHHHHHHHHHHhhc
Confidence            9999999999987654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-39  Score=345.19  Aligned_cols=262  Identities=24%  Similarity=0.371  Sum_probs=208.8

Q ss_pred             cCCCCCc-eeeccccceEEEEEEC--CCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          559 EGFSSAN-LIGIGGYGYVYKGILG--TEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       559 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ++|.+.+ .||+|+||.||+|.+.  .+++.||+|+++... ....+.+.+|+++++.++||||+++++++..      .
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC------C
Confidence            4566766 9999999999999863  467889999997543 3345778999999999999999999999832      3


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+++++|.+++.....      .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~D  153 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISD  153 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTT------TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECC
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECc
Confidence            47999999999999999975432      589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||.+.................+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........  .........
T Consensus       154 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~i~~~~~  231 (287)
T 1u59_A          154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAFIEQGKR  231 (287)
T ss_dssp             CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HHHHHTTCC
T ss_pred             ccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--HHHHhcCCc
Confidence            9999887544322222333456889999999888889999999999999999998 9999975432211  111111100


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQ  867 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~~  867 (871)
                      ....                              ..++..+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus       232 ~~~~------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          232 MECP------------------------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             CCCC------------------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCC------------------------------CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            0000                              0223467799999999999999999999999999976654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.9e-39  Score=342.95  Aligned_cols=259  Identities=27%  Similarity=0.453  Sum_probs=208.8

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++..... ..+.+.+|+++++.++||||+++++++..      ...
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~   82 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPI   82 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC------CCc
Confidence            3467999999999999999999986 677899999965433 45788999999999999999999998753      347


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++++|.+++......     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  154 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGI-----KLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFG  154 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHH-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEecCCCCCHHHHHhcCCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCc
Confidence            8999999999999999765322     589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      .+.......  ........++..|+|||...++.++.++||||||+++|+|++ |+.||........  ...........
T Consensus       155 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~~~~~~~~  230 (279)
T 1qpc_A          155 LARLIEDNE--YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--IQNLERGYRMV  230 (279)
T ss_dssp             TCEECSSSC--EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHHHTTCCCC
T ss_pred             ccccccCcc--cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH--HHHHhcccCCC
Confidence            998765432  122223456789999999888889999999999999999999 9999975432211  11111100000


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      ..                              ..+...+.+++.+|++.||++|||++|+++.|+++.+.
T Consensus       231 ~~------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          231 RP------------------------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             CC------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             Cc------------------------------ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            00                              02234677999999999999999999999999998654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.5e-40  Score=370.63  Aligned_cols=250  Identities=20%  Similarity=0.278  Sum_probs=195.2

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++..   .......+.+|+++++.++||||+++++++...     
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----  220 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----  220 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----
Confidence            346799999999999999999999999999999999643   223345678899999999999999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceeeCCCCceEE
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH-HCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                      ...|+||||+++|+|.+++....       .+++..+..++.||+.||+|||+ .   +|+||||||+||+++.++.+||
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl  290 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSRER-------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKI  290 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEE
T ss_pred             CEEEEEEeeCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEE
Confidence            66899999999999999997644       58999999999999999999998 7   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      +|||+|+.....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ .........
T Consensus       291 ~DFG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~  366 (446)
T 4ejn_A          291 TDFGLCKEGIKD---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FELILMEEI  366 (446)
T ss_dssp             CCCCCCCTTCC--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCC
T ss_pred             ccCCCceeccCC---CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-HHHHHhCCC
Confidence            999999754322   1223346799999999999999999999999999999999999999975432211 111111100


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIM  857 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~  857 (871)
                      .  .                       +       .....++.+++.+||+.||++||     |++|+++
T Consensus       367 ~--~-----------------------p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 R--F-----------------------P-------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             C--C-----------------------C-------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C--C-----------------------C-------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            0  0                       0       01224567899999999999999     9999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4e-40  Score=356.69  Aligned_cols=244  Identities=18%  Similarity=0.312  Sum_probs=202.2

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--------chHHHHHHHHHHHHcCCCCccceeeeeeccc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--------GASKSFIAECEALRSIRHRNLVKIITSCSSI  628 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  628 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++....        .....+.+|++++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            35689999999999999999999999999999999965421        1234567899999999999999999998765


Q ss_pred             CcCCCceeeEEEeccCCC-CHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC
Q 002883          629 DTRGNEFKALVYEFMPNG-SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE  707 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  707 (871)
                           ...++||||+.+| +|.+++....       .+++..++.++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus       102 -----~~~~lv~e~~~~g~~l~~~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  166 (335)
T 3dls_A          102 -----GFFQLVMEKHGSGLDLFAFIDRHP-------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAED  166 (335)
T ss_dssp             -----SEEEEEEECCTTSCBHHHHHHTCC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred             -----CEEEEEEEeCCCCccHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCC
Confidence                 6789999999776 9999997654       589999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccceecCCCCCCccccccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHH
Q 002883          708 MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV-STHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK  786 (871)
Q Consensus       708 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~  786 (871)
                      +.+||+|||.+.......    ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......     
T Consensus       167 ~~~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----  237 (335)
T 3dls_A          167 FTIKLIDFGSAAYLERGK----LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-----  237 (335)
T ss_dssp             SCEEECCCTTCEECCTTC----CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----
T ss_pred             CcEEEeecccceECCCCC----ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----
Confidence            999999999998765432    2233569999999999888777 789999999999999999999997532110     


Q ss_pred             HhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          787 YAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       787 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                        ......  ..                              .+..++.+++.+||+.||++|||+.|+++.
T Consensus       238 --~~~~~~--~~------------------------------~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 --EAAIHP--PY------------------------------LVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             --TTCCCC--SS------------------------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             --hhccCC--Cc------------------------------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              000000  00                              022356789999999999999999999874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=8e-39  Score=352.10  Aligned_cols=283  Identities=19%  Similarity=0.201  Sum_probs=201.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  634 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||++...  .....+.+.+|+.+++.++||||+++++++..... ....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46899999999999999999999989999999999643  23345678899999999999999999999876532 2234


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||++ ++|.+++..         .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D  170 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM---------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  170 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ceEEEEEcCC-CCHHHHHhh---------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEE
Confidence            7899999996 578888853         488999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-hCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-MGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-~~~~  793 (871)
                      ||+|......    .......||+.|+|||++.+..++.++||||+||++|+|++|+.||........ +..... ...+
T Consensus       171 fg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~  245 (371)
T 2xrw_A          171 FGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTP  245 (371)
T ss_dssp             CCC--------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCC
T ss_pred             eecccccccc----cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCC
Confidence            9999865432    122335689999999999988999999999999999999999999986433221 111111 1111


Q ss_pred             -chhhhhcChhHHHHHHHH--------HhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 -DQVAEIIDPAILEEALEI--------QAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 -~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                       +.....+.+.+.......        .........+............+.+++.+||+.||++|||++|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence             111111111111100000        00000000111112223446778999999999999999999999874

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.7e-39  Score=347.81  Aligned_cols=251  Identities=24%  Similarity=0.308  Sum_probs=202.1

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|.+.+.||+|+||+||+|++..+++.||+|+++.......+.+.+|+++++.++||||+++++++.+.     ...|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST-----THYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC-----CEEE
Confidence            35799999999999999999999989999999999765544556788999999999999999999998765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee---CCCCceEEee
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAHVGD  714 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~D  714 (871)
                      +||||+++++|.+++....       .+++..++.++.|++.||.|||+.   +|+||||||+||++   +.++.+||+|
T Consensus        83 lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~D  152 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERG-------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITD  152 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred             EEEEcCCCccHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEcc
Confidence            9999999999999997643       589999999999999999999999   99999999999999   7888999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||.+......     ......||+.|+|||++.+..++.++||||+||++|+|++|+.||........ ...........
T Consensus       153 fg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~  226 (304)
T 2jam_A          153 FGLSKMEQNG-----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL-FEKIKEGYYEF  226 (304)
T ss_dssp             CSTTCCCCCB-----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHCCCCC
T ss_pred             CCcceecCCC-----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHcCCCCC
Confidence            9999754321     22335689999999999999999999999999999999999999975432211 11111110000


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .     .                       +....+...+.+++.+||+.||++|||++|+++
T Consensus       227 ~-----~-----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          227 E-----S-----------------------PFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             C-----T-----------------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             C-----c-----------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0     0                       000122346779999999999999999999987

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9e-40  Score=354.35  Aligned_cols=251  Identities=22%  Similarity=0.315  Sum_probs=199.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||+++....    ...+|++++.++ +||||+++++++.+.     ...
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~   91 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDG-----KYV   91 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECS-----SEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcC-----CEE
Confidence            4579999999999999999999999999999999975443    234688888887 799999999998765     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC----CceEE
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE----MVAHV  712 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl  712 (871)
                      |+||||+++|+|.+++....       .+++..+..++.||+.||+|||+.   ||+||||||+||++..+    +.+||
T Consensus        92 ~lv~E~~~gg~L~~~i~~~~-------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQK-------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTCT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             EEEEeCCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEE
Confidence            99999999999999997643       589999999999999999999999   99999999999998433    35999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhh-hhHHHHh-hh
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG-LSLHKYA-KM  790 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~-~~~~~~~-~~  790 (871)
                      +|||++.......   .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.....+. ....... ..
T Consensus       162 ~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~  238 (342)
T 2qr7_A          162 CDFGFAKQLRAEN---GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG  238 (342)
T ss_dssp             CCCTTCEECBCTT---CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC
T ss_pred             EECCCcccCcCCC---CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC
Confidence            9999998765432   12234568999999999888788999999999999999999999997532211 1111111 11


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .....     .                       .....+..++.+++.+||+.||++|||+.|+++.
T Consensus       239 ~~~~~-----~-----------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          239 KFSLS-----G-----------------------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             CCCCC-----S-----------------------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CcccC-----c-----------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11000     0                       0001233467799999999999999999999863

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.1e-39  Score=343.67  Aligned_cols=256  Identities=22%  Similarity=0.371  Sum_probs=207.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-------
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-------  630 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------  630 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....    ..+.+|+++++.++||||+++++++...+.       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            457999999999999999999999899999999997543    346789999999999999999998754211       


Q ss_pred             ----CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC
Q 002883          631 ----RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN  706 (871)
Q Consensus       631 ----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  706 (871)
                          ......++||||+++++|.+++.....     ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-----EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD  157 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence                123568999999999999999976542     2689999999999999999999999   9999999999999999


Q ss_pred             CCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHH
Q 002883          707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK  786 (871)
Q Consensus       707 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~  786 (871)
                      ++.+||+|||.+.......    ......|++.|+|||.+.+..++.++||||||+++|+|++|..||......   ...
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~  230 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF---FTD  230 (284)
T ss_dssp             TTEEEECCCTTCEESSCCS----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH---HHH
T ss_pred             CCCEEECcchhheeccccc----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH---HHH
Confidence            9999999999998775432    122346899999999998889999999999999999999999997642211   000


Q ss_pred             HhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          787 YAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       787 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      ......+    .                              .+...+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus       231 ~~~~~~~----~------------------------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          231 LRDGIIS----D------------------------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             HHTTCCC----T------------------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             hhccccc----c------------------------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            1000000    0                              11234668999999999999999999999999886544

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.2e-39  Score=353.36  Aligned_cols=277  Identities=21%  Similarity=0.236  Sum_probs=203.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..   ..+.+.+|++++++++ ||||+++++++.+..   ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC---CCce
Confidence            36799999999999999999999989999999999643   3477899999999996 999999999986532   2567


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEEeec
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM-VAHVGDF  715 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Df  715 (871)
                      ++||||+++++|.+++..          +++..++.++.|++.||+|||+.   +|+||||||+||+++.++ .+||+||
T Consensus       109 ~lv~e~~~~~~l~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Df  175 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQT----------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDW  175 (330)
T ss_dssp             EEEEECCCCCCHHHHGGG----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEEeccCchhHHHHHHh----------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeC
Confidence            999999999999999853          78899999999999999999999   999999999999999776 8999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      |+|........    .....|+..|+|||++.+ ..++.++||||+||++|+|++|+.||...................+
T Consensus       176 g~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~  251 (330)
T 3nsz_A          176 GLAEFYHPGQE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  251 (330)
T ss_dssp             TTCEECCTTCC----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred             CCceEcCCCCc----cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCc
Confidence            99987654322    233468999999998776 6789999999999999999999999964433222222222111111


Q ss_pred             hhhhhcCh---hHHHHHHHHHhhhh-hhcCc-hhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDP---AILEEALEIQAGIV-KELQP-NLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~---~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...+.++.   .............. ..... ........+..++.+++.+||+.||++||||+|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            11110000   00000000000000 00000 000001124567889999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.6e-39  Score=351.73  Aligned_cols=268  Identities=23%  Similarity=0.361  Sum_probs=205.9

Q ss_pred             hcCCCCCceeeccccceEEEEE-----ECCCCcEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGI-----LGTEETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      .++|++.+.||+|+||.||+|+     ...+++.||||++... .......+.+|+.++++++||||+++++++...   
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---  105 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS---  105 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC---
Confidence            4689999999999999999999     4456789999999643 233456788999999999999999999998765   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CC
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN---EM  708 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~  708 (871)
                        ...|+||||+++++|.+++............+++..++.++.|++.||.|||+.   +|+||||||+||+++.   +.
T Consensus       106 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          106 --LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             --SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             --CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence              557999999999999999987654333334689999999999999999999999   9999999999999984   44


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHH
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKY  787 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~  787 (871)
                      .+||+|||.+........ ........+++.|+|||++.+..++.++|||||||++|+|++ |+.||.......  ....
T Consensus       181 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~  257 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEF  257 (327)
T ss_dssp             CEEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHH
T ss_pred             eEEECccccccccccccc-cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HHHH
Confidence            699999999986543321 112233467899999999888899999999999999999998 999997543221  1111


Q ss_pred             hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      ..........                              ..+...+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus       258 ~~~~~~~~~~------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          258 VTSGGRMDPP------------------------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HHTTCCCCCC------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HhcCCCCCCC------------------------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            1111000000                              012345678999999999999999999999999886544

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.8e-39  Score=352.02  Aligned_cols=255  Identities=23%  Similarity=0.353  Sum_probs=204.4

Q ss_pred             HHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--------chHHHHHHHHHHHHcC-CCCccceeeeee
Q 002883          555 LKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--------GASKSFIAECEALRSI-RHRNLVKIITSC  625 (871)
Q Consensus       555 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~~~  625 (871)
                      ....++|++.+.||+|+||+||+|++..+|+.||||+++....        ...+.+.+|+++++++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            3445789999999999999999999988999999999865431        1245678999999999 899999999998


Q ss_pred             cccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC
Q 002883          626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD  705 (871)
Q Consensus       626 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  705 (871)
                      ...     ...|+||||+++++|.+++....       .+++..+..++.||+.||.|||+.   ||+||||||+||+++
T Consensus       170 ~~~-----~~~~lv~e~~~g~~L~~~l~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~  234 (365)
T 2y7j_A          170 ESS-----SFMFLVFDLMRKGELFDYLTEKV-------ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLD  234 (365)
T ss_dssp             EBS-----SEEEEEECCCTTCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             eeC-----CEEEEEEEeCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            665     67899999999999999997643       589999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccceecCCCCCCccccccccccccccCccccc------CCCCCCccchhhHHHHHHHHHhCCCCCchhhh
Q 002883          706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA------LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFE  779 (871)
Q Consensus       706 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  779 (871)
                      .++.+||+|||++.......    ......||+.|+|||++.      ...++.++|||||||++|+|++|+.||.....
T Consensus       235 ~~~~ikl~DfG~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~  310 (365)
T 2y7j_A          235 DNMQIRLSDFGFSCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ  310 (365)
T ss_dssp             TTCCEEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CCCCEEEEecCcccccCCCc----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH
Confidence            99999999999998775432    223457999999999865      33688999999999999999999999975322


Q ss_pred             hhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          780 EGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       780 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .. .............                            .+........+.+++.+||+.||++|||+.|+++
T Consensus       311 ~~-~~~~i~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          311 IL-MLRMIMEGQYQFS----------------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HH-HHHHHHHTCCCCC----------------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HH-HHHHHHhCCCCCC----------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11 1111111110000                            0111123446789999999999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=354.07  Aligned_cols=252  Identities=21%  Similarity=0.367  Sum_probs=193.8

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCC--CccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRH--RNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~  633 (871)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....  ....+.+.+|+++++.++|  |||+++++++...     
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-----   81 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----   81 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-----
Confidence            457999999999999999999985 68899999996443  2334678899999999976  9999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||| +.+++|.+++....       .+++.++..++.|++.||.|||+.   +|+||||||+||+++ ++.+||+
T Consensus        82 ~~~~lv~e-~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~  149 (343)
T 3dbq_A           82 QYIYMVME-CGNIDLNSWLKKKK-------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLI  149 (343)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHSC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEEC
T ss_pred             CEEEEEEe-CCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEe
Confidence            67899999 45889999998653       589999999999999999999999   999999999999997 6789999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhh
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-----------GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL  782 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~  782 (871)
                      |||++....... .........||+.|+|||++.+           ..++.++|||||||++|+|++|+.||........
T Consensus       150 DFG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  228 (343)
T 3dbq_A          150 DFGIANQMQPDT-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS  228 (343)
T ss_dssp             CCSSSCCC-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred             ecccccccCccc-ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH
Confidence            999998765432 1122334579999999998754           6789999999999999999999999975332222


Q ss_pred             hHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          783 SLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       783 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ................                              .....+.+++.+||+.||++|||+.|+++.
T Consensus       229 ~~~~~~~~~~~~~~~~------------------------------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          229 KLHAIIDPNHEIEFPD------------------------------IPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHHHHCTTSCCCCCC------------------------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhcCCcccCCcc------------------------------cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            2211111111100000                              012346789999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.4e-39  Score=343.74  Aligned_cols=250  Identities=19%  Similarity=0.278  Sum_probs=205.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.     .
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----D   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-----C
Confidence            467999999999999999999999899999999986442   23456788999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+++++|.+++....       .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d  158 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRRK-------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGD  158 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             EEEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEe
Confidence            7899999999999999987643       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||.+.......   .......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||........ .......... 
T Consensus       159 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~-  233 (294)
T 2rku_A          159 FGLATKVEYDG---ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKNEYS-  233 (294)
T ss_dssp             CTTCEECCSTT---CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTTCCC-
T ss_pred             ccCceecccCc---cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhhccCC-
Confidence            99998765322   122335689999999999888899999999999999999999999975432211 1111110000 


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                       ...                              .....+.+++.+||+.||++|||++|+++.
T Consensus       234 -~~~------------------------------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          234 -IPK------------------------------HINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             -CCT------------------------------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -Ccc------------------------------ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence             000                              112356789999999999999999999874

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.8e-39  Score=341.47  Aligned_cols=248  Identities=21%  Similarity=0.315  Sum_probs=204.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.     .
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-----K   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-----C
Confidence            467999999999999999999999899999999995432   22346788999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+++++|.+++....       .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~D  157 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHG-------RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIAD  157 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEec
Confidence            7899999999999999997653       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||.+......     ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||........ .......... 
T Consensus       158 fg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~-  230 (284)
T 2vgo_A          158 FGWSVHAPSL-----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-HRRIVNVDLK-  230 (284)
T ss_dssp             CTTCEECSSS-----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTTCCC-
T ss_pred             ccccccCccc-----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-HHHHhccccC-
Confidence            9999765432     12235689999999999988999999999999999999999999975332211 1111110000 


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                                              .+       ......+.+++.+|++.||++|||++|+++.
T Consensus       231 ------------------------~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          231 ------------------------FP-------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ------------------------CC-------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ------------------------CC-------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                                    00       0123456789999999999999999999873

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.3e-39  Score=352.02  Aligned_cols=261  Identities=17%  Similarity=0.236  Sum_probs=204.6

Q ss_pred             HHHHHhhcCCCCC-ceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcC-CCCccceeeeeecc
Q 002883          552 AELLKATEGFSSA-NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSI-RHRNLVKIITSCSS  627 (871)
Q Consensus       552 ~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  627 (871)
                      .......++|.+. +.||+|+||.||+|++..+++.||+|++....  ......+.+|+.+++.+ .||||+++++++..
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3344556678887 89999999999999999999999999996433  33457889999999999 56999999999876


Q ss_pred             cCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-
Q 002883          628 IDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-  706 (871)
Q Consensus       628 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-  706 (871)
                      .     ...++||||+++|+|.+++.....     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++. 
T Consensus       101 ~-----~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~  167 (327)
T 3lm5_A          101 T-----SEIILILEYAAGGEIFSLCLPELA-----EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSI  167 (327)
T ss_dssp             S-----SEEEEEEECCTTEEGGGGGSSCC------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCB
T ss_pred             C-----CeEEEEEEecCCCcHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecC
Confidence            5     668999999999999999865432     2689999999999999999999999   9999999999999987 


Q ss_pred             --CCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhH
Q 002883          707 --EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSL  784 (871)
Q Consensus       707 --~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~  784 (871)
                        ++.+||+|||.+.......    ......||+.|+|||++.+..++.++||||+||++|+|++|+.||..........
T Consensus       168 ~~~~~~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  243 (327)
T 3lm5_A          168 YPLGDIKIVDFGMSRKIGHAC----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL  243 (327)
T ss_dssp             TTBCCEEECCGGGCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCcEEEeeCccccccCCcc----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence              7899999999998765332    2233569999999999999999999999999999999999999997543322111


Q ss_pred             HHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          785 HKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                       ..........                            ......+...+.+++.+||+.||++|||++|+++.
T Consensus       244 -~i~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          244 -NISQVNVDYS----------------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -HHHHTCCCCC----------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -HHHhcccccC----------------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence             1111110000                            00011233457789999999999999999999863

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.2e-39  Score=352.46  Aligned_cols=247  Identities=23%  Similarity=0.313  Sum_probs=199.4

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||+||+|++..+++.||||++.....   ...+.+.+|++++++++||||+++++++...     ..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence            458899999999999999999988999999999964432   2345788999999999999999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||+. |++.+++.....      .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus       129 ~~lv~e~~~-g~l~~~l~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  198 (348)
T 1u5q_A          129 AWLVMEYCL-GSASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF  198 (348)
T ss_dssp             EEEEEECCS-EEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCC
T ss_pred             EEEEEecCC-CCHHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeec
Confidence            899999996 688888865432      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA---LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |++......       ....||+.|+|||++.   .+.++.++|||||||++|||++|+.||......... ........
T Consensus       199 G~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~  270 (348)
T 1u5q_A          199 GSASIMAPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNES  270 (348)
T ss_dssp             TTCBSSSSB-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHSCC
T ss_pred             cCceecCCC-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCC
Confidence            999865422       2346899999999873   578899999999999999999999999754322211 11111111


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      +....                              ......+.+++.+||+.||++|||++|+++.
T Consensus       271 ~~~~~------------------------------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          271 PALQS------------------------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CCCCC------------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCC------------------------------CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            11000                              0122356789999999999999999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=343.92  Aligned_cols=251  Identities=22%  Similarity=0.358  Sum_probs=183.5

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++.+.     
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   83 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-----   83 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-----
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-----
Confidence            3467999999999999999999998899999999996432   22346789999999999999999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+++++|.+++.....      .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~  154 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKNRVK------PFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIA  154 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHTCSS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEEC
T ss_pred             CeEEEEEecCCCCcHHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEE
Confidence            678999999999999999976432      589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||.+.......   .......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||........ ........  
T Consensus       155 dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~--  228 (278)
T 3cok_A          155 DFGLATQLKMPH---EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKVVLAD--  228 (278)
T ss_dssp             CCTTCEECC-------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSSC--
T ss_pred             eecceeeccCCC---CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHHhhcc--
Confidence            999998765322   112235689999999999888899999999999999999999999975321110 00000000  


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                           ...+                         .....++.+++.+||+.||++|||++|+++
T Consensus       229 -----~~~~-------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          229 -----YEMP-------------------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -----CCCC-------------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -----cCCc-------------------------cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                 0000                         012335678999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.9e-39  Score=362.42  Aligned_cols=254  Identities=20%  Similarity=0.294  Sum_probs=194.2

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--------chHHHHHHHHHHHHcCCCCccceeeeeeccc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--------GASKSFIAECEALRSIRHRNLVKIITSCSSI  628 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  628 (871)
                      ..++|.+.+.||+|+||+||+|.+..+++.||||++.....        .....+.+|++++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            35789999999999999999999999999999999964321        112357899999999999999999998743 


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM  708 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  708 (871)
                           ...|+||||+++|+|.+++....       .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus       212 -----~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~  276 (419)
T 3i6u_A          212 -----EDYYIVLELMEGGELFDKVVGNK-------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE  276 (419)
T ss_dssp             -----SEEEEEEECCTTCBGGGGTSSSC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS
T ss_pred             -----CceEEEEEcCCCCcHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC
Confidence                 34689999999999999887643       589999999999999999999999   999999999999997544


Q ss_pred             ---ceEEeecccceecCCCCCCccccccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhh
Q 002883          709 ---VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA---LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL  782 (871)
Q Consensus       709 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~  782 (871)
                         .+||+|||+|+.....    .......||+.|+|||++.   ...++.++||||+||++|+|++|+.||........
T Consensus       277 ~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~  352 (419)
T 3i6u_A          277 EDCLIKITDFGHSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS  352 (419)
T ss_dssp             SSCCEEECCSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC
T ss_pred             CcceEEEeecccceecCCC----ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH
Confidence               5999999999876532    2223457999999999875   36788999999999999999999999975322211


Q ss_pred             hHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          783 SLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       783 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ........... .                           .......+...+.+++.+||+.||++|||++|+++.
T Consensus       353 ~~~~i~~~~~~-~---------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          353 LKDQITSGKYN-F---------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHHHHHTTCCC-C---------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHhcCCCC-C---------------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            11111111000 0                           001112334567899999999999999999999873

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-39  Score=342.92  Aligned_cols=263  Identities=23%  Similarity=0.325  Sum_probs=204.2

Q ss_pred             CCCCCceeeccccceEEEEEECCCCc---EEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEET---NVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .|...+.||+|+||+||+|++..++.   .||+|++.... ....+.+.+|+++++.++||||+++++++.+.    ...
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP----EGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----SSC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----CCC
Confidence            46677999999999999999754443   79999986433 23457788999999999999999999998654    233


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||+.+|+|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Df  168 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQR------NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADF  168 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTC------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCT
T ss_pred             cEEEEecccCCCHHHHHhcccc------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcC
Confidence            5899999999999999976432      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCC-CccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          716 GLSRLLHDNSP-DQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      |.+........ .........+++.|+|||...+..++.++||||+|+++|+|++|..|+........ ...........
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~  247 (298)
T 3pls_A          169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQGRRL  247 (298)
T ss_dssp             TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHHHTTCCC
T ss_pred             CCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHhhcCCCC
Confidence            99986543211 11122334678999999999999999999999999999999996665543222211 11111111100


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      ....                              .+...+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       248 ~~~~------------------------------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          248 PQPE------------------------------YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             CCCT------------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCc------------------------------cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence            0000                              12245778999999999999999999999999987654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.6e-39  Score=349.93  Aligned_cols=250  Identities=19%  Similarity=0.278  Sum_probs=205.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.     .
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----D  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----C
Confidence            467999999999999999999999999999999986442   23456788999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||+++++|.+++....       .+++.+++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~D  184 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRRK-------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGD  184 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHC-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEecCCCCCHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEee
Confidence            7899999999999999987643       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||.+.......   .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .......... 
T Consensus       185 fg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~-  259 (335)
T 2owb_A          185 FGLATKVEYDG---ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKNEYS-  259 (335)
T ss_dssp             CTTCEECCSTT---CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCCC-
T ss_pred             ccCceecccCc---ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHhcCCCC-
Confidence            99998765322   122335689999999999888899999999999999999999999975432211 1111110000 


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                       ...                              .+...+.+++.+||+.||++|||+.|+++.
T Consensus       260 -~~~------------------------------~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          260 -IPK------------------------------HINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             -CCT------------------------------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -CCc------------------------------cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             000                              112356789999999999999999999873

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4e-39  Score=368.36  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=199.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++.+.||+|+||+||+|++..+++.||+|++....  ......+.+|+.+++.++||||+++++++.+.     ...
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~  111 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-----RNY  111 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEE
Confidence            46999999999999999999999999999999996442  23357789999999999999999999998765     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEEe
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN---EMVAHVG  713 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~  713 (871)
                      |+||||+++|+|.+++....       .+++..+..++.||+.||.|||+.   +|+||||||+||+++.   ++.+||+
T Consensus       112 ~lv~e~~~~g~L~~~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~  181 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHRM-------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV  181 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEE
Confidence            99999999999999887653       589999999999999999999999   9999999999999976   4559999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||+|.......    ......||+.|+|||++. +.++.++||||+||++|+|++|+.||........ ..........
T Consensus       182 DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~  255 (494)
T 3lij_A          182 DFGLSAVFENQK----KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-LRKVEKGKYT  255 (494)
T ss_dssp             CCTTCEECBTTB----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCC
T ss_pred             ECCCCeECCCCc----cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCC
Confidence            999998765432    233456999999999875 5799999999999999999999999986433221 1111111111


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ..     .                       +.+..+...+.+++.+||+.||++|||+.|+++.
T Consensus       256 ~~-----~-----------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          256 FD-----S-----------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CC-----S-----------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CC-----c-----------------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            00     0                       0111233457799999999999999999999863

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.5e-39  Score=367.12  Aligned_cols=257  Identities=28%  Similarity=0.452  Sum_probs=201.9

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ..++|++.+.||+|+||.||+|.+. .+..||||+++.... ..+.+.+|++++++++||||+++++++.+      ...
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~  253 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  253 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cce
Confidence            4567899999999999999999997 456799999975443 35788999999999999999999998754      346


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||+++|+|.+++......     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  325 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETGK-----YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  325 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             EEEehhhcCCCHHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCc
Confidence            8999999999999999764322     589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      +++......  ........++..|+|||.+.++.++.++|||||||++|||++ |+.||........  ...........
T Consensus       326 ~a~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~~i~~~~~~~  401 (452)
T 1fmk_A          326 LARLIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQVERGYRMP  401 (452)
T ss_dssp             TTC----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHHHTTCCCC
T ss_pred             cceecCCCc--eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcCCCCC
Confidence            998765322  112223456789999999888899999999999999999999 9999976433211  11111110000


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                      .                       +       ..++..+.+++.+||+.||++|||++++++.|+++.
T Consensus       402 ~-----------------------~-------~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          402 C-----------------------P-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             C-----------------------C-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             C-----------------------C-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            0                       0       023346778999999999999999999999998764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=348.67  Aligned_cols=282  Identities=21%  Similarity=0.289  Sum_probs=201.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-------
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-------  630 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------  630 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++.....       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            3689999999999999999999998999999999976666666788999999999999999999998754311       


Q ss_pred             --CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC-CC
Q 002883          631 --RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD-NE  707 (871)
Q Consensus       631 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~  707 (871)
                        ......|+||||++ |+|.+++...        .+++..++.++.|++.||+|||+.   +|+||||||+||+++ .+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED  157 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--------CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence              23367899999997 6999999653        489999999999999999999999   999999999999997 56


Q ss_pred             CceEEeecccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHH
Q 002883          708 MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK  786 (871)
Q Consensus       708 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~  786 (871)
                      +.+||+|||.+.................++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ...
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~  236 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQL  236 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence            79999999999876543222223334567999999997654 6789999999999999999999999986543221 111


Q ss_pred             Hhhh-CCCc--hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          787 YAKM-GLPD--QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       787 ~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .... ....  ...+.... . ...   ..................+..++.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~-~-~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          237 ILESIPVVHEEDRQELLSV-I-PVY---IRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHSCCCCHHHHHHHHTT-S-CHH---HHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHhcCCCchhhhhhhhhc-C-ccc---ccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            1111 1000  00000000 0 000   0000000011111122234667889999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.8e-40  Score=364.76  Aligned_cols=261  Identities=16%  Similarity=0.164  Sum_probs=194.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHH---HHHcCCCCccceeee-------e
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECE---ALRSIRHRNLVKIIT-------S  624 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~~~~-------~  624 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||++...   .....+.+.+|++   ++++++||||+++++       +
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46799999999999999999999888999999999632   3345578899995   455558999999984       3


Q ss_pred             ecccCc--------C-CC---ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 002883          625 CSSIDT--------R-GN---EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSI  692 (871)
Q Consensus       625 ~~~~~~--------~-~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  692 (871)
                      +.+...        . +.   ...|+||||+ +|+|.+++............+++..++.++.||+.||+|||+.   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            332210        0 00   1378999999 6899999987542211111344588889999999999999999   99


Q ss_pred             EecCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCC-----------CCCCccchhhHH
Q 002883          693 VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-----------EVSTHGDEYSFG  761 (871)
Q Consensus       693 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwSlG  761 (871)
                      +||||||+|||++.++.+||+|||+|+....      ......| +.|+|||++.+.           .++.++||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            9999999999999999999999999986432      2234467 999999998877           899999999999


Q ss_pred             HHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhccc
Q 002883          762 ILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILC  841 (871)
Q Consensus       762 ~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  841 (871)
                      |++|||++|+.||.........          .......                           ..++.++.+++.+|
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~----------~~~~~~~---------------------------~~~~~~~~~li~~~  343 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGS----------EWIFRSC---------------------------KNIPQPVRALLEGF  343 (377)
T ss_dssp             HHHHHHHHSSCCC------CCS----------GGGGSSC---------------------------CCCCHHHHHHHHHH
T ss_pred             HHHHHHHHCCCCCcccccccch----------hhhhhhc---------------------------cCCCHHHHHHHHHH
Confidence            9999999999999753222110          0000000                           01234577899999


Q ss_pred             ccCCCCCCCCHHHHHH--HHHHHHHHH
Q 002883          842 SEELPRDRMKIQDAIM--ELQEAQKMR  866 (871)
Q Consensus       842 l~~dP~~RPta~evl~--~L~~i~~~~  866 (871)
                      |+.||++|||+.|+++  .++++....
T Consensus       344 L~~dp~~Rpt~~e~l~hp~f~~~~~~~  370 (377)
T 3byv_A          344 LRYPKEDRLLPLQAMETPEYEQLRTEL  370 (377)
T ss_dssp             TCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred             cCCCchhCCCHHHHhhChHHHHHHHHH
Confidence            9999999999999997  556555443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=339.64  Aligned_cols=254  Identities=26%  Similarity=0.378  Sum_probs=199.6

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      ++|.....||+|+||.||+|++..+++.||||++........+.+.+|+.+++.++||||+++++++...     ...++
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l   96 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKI   96 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEE
Confidence            3455667999999999999999989999999999766655667899999999999999999999998765     67899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CCceEEeeccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-EMVAHVGDFGL  717 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~  717 (871)
                      ||||+++++|.+++.....    ...+++..+..++.|++.||.|||+.   +|+||||||+||+++. ++.+||+|||.
T Consensus        97 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~  169 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSKWG----PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGT  169 (295)
T ss_dssp             EEECCSEEEHHHHHHHTTC----CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred             EEEeCCCCCHHHHHHhhcc----CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccc
Confidence            9999999999999976532    12467889999999999999999999   9999999999999987 89999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE--VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      +.......   .......|++.|+|||++.+..  ++.++||||||+++|+|++|+.||.....................
T Consensus       170 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (295)
T 2clq_A          170 SKRLAGIN---PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE  246 (295)
T ss_dssp             CEESCC--------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCC
T ss_pred             ccccCCCC---CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccc
Confidence            98765322   1223356899999999876543  789999999999999999999999753222111111111111000


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ..                              ..+..++.+++.+||+.||++|||+.|+++
T Consensus       247 ~~------------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          247 IP------------------------------ESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CC------------------------------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cc------------------------------ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00                              012345678999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-39  Score=358.28  Aligned_cols=281  Identities=18%  Similarity=0.225  Sum_probs=201.3

Q ss_pred             HHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCc----
Q 002883          555 LKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT----  630 (871)
Q Consensus       555 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----  630 (871)
                      ....++|++.+.||+|+||+||+|++..+++.||||++.....    ...+|+++++.++||||+++++++.....    
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            3456789999999999999999999999999999999864432    22469999999999999999999865432    


Q ss_pred             -----------------------------CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHH
Q 002883          631 -----------------------------RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL  681 (871)
Q Consensus       631 -----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L  681 (871)
                                                   ....+.++||||++ |+|.+.+......   ...+++..++.++.||+.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS---GRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc---CCCCCHHHHHHHHHHHHHHH
Confidence                                         33456899999997 5888877653211   22699999999999999999


Q ss_pred             HHHhhcCCCCeEecCCCCCceeeC-CCCceEEeecccceecCCCCCCccccccccccccccCcccccCC-CCCCccchhh
Q 002883          682 EYLHHHCHTSIVHCDLKPSNVLLD-NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYS  759 (871)
Q Consensus       682 ~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS  759 (871)
                      +|||+.   ||+||||||+||+++ .++.+||+|||.|+......    ......||+.|+|||.+.+. .++.++||||
T Consensus       155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  227 (383)
T 3eb0_A          155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE----PSVAYICSRFYRAPELMLGATEYTPSIDLWS  227 (383)
T ss_dssp             HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS----CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred             HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC----CCcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence            999999   999999999999997 68899999999998765432    22234689999999987764 4899999999


Q ss_pred             HHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch--hhhhcChhHHHHHHHHHhhhhhhcCchhHHhH-HHHHHHHHh
Q 002883          760 FGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ--VAEIIDPAILEEALEIQAGIVKELQPNLRAKF-HEIQVSILR  836 (871)
Q Consensus       760 lG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~  836 (871)
                      +||++|||++|+.||......+.........+.+..  .... .+.....      .............+ ...+..+.+
T Consensus       228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~-~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~  300 (383)
T 3eb0_A          228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRM-NPHYTEV------RFPTLKAKDWRKILPEGTPSLAID  300 (383)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH-CTTC--C------CCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh-Ccccccc------cCCccCcccHHhhCCCCCCHHHHH
Confidence            999999999999999865433322222222222211  0000 0000000      00000000000000 123456789


Q ss_pred             hhcccccCCCCCCCCHHHHHH
Q 002883          837 VGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       837 li~~cl~~dP~~RPta~evl~  857 (871)
                      ++.+||+.||++|||+.|+++
T Consensus       301 li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          301 LLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCChhhCCCHHHHhc
Confidence            999999999999999999985

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.9e-39  Score=367.94  Aligned_cols=252  Identities=22%  Similarity=0.324  Sum_probs=202.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||++....  ......+.+|++++++++||||+++++++.+.     ..
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~   95 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SS   95 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-----CE
Confidence            467999999999999999999999999999999985432  23457889999999999999999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC---CCCceEE
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD---NEMVAHV  712 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl  712 (871)
                      .|+||||+++|+|.+++....       .+++..+..++.||+.||.|||+.   +|+||||||+||+++   .++.+||
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl  165 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKRK-------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI  165 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence            899999999999999987653       589999999999999999999999   999999999999995   4567999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      +|||+|.......    ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||........ .........
T Consensus       166 ~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~  239 (486)
T 3mwu_A          166 IDFGLSTCFQQNT----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-LKRVETGKY  239 (486)
T ss_dssp             CSCSCTTTBCCC--------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCC
T ss_pred             EECCcCeECCCCC----ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCC
Confidence            9999998665332    2234569999999999765 699999999999999999999999975432221 111111111


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      +...                            +.+..+...+.+++.+||+.||++|||+.|+++.
T Consensus       240 ~~~~----------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          240 AFDL----------------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CSCS----------------------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCCC----------------------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1000                            0111234457799999999999999999999873

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5e-39  Score=343.24  Aligned_cols=264  Identities=22%  Similarity=0.341  Sum_probs=203.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCC---CcEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTE---ETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..+|++.+.||+|+||+||+|++..+   ...||+|.+... .....+.+.+|+.++++++||||+++++++...    .
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----C
Confidence            35688999999999999999997533   346899998643 333457789999999999999999999986543    2


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+++|+|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~~------~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~  170 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVA  170 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEEC
T ss_pred             CceEEEEeCCCCCCHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEEC
Confidence            457899999999999999976432      589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCc-cccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          714 DFGLSRLLHDNSPDQ-TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      |||.+.......... .......+|+.|+|||.+.+..++.++||||+|+++|+|++ |.+||........ ....... 
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-~~~~~~~-  248 (298)
T 3f66_A          171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-TVYLLQG-  248 (298)
T ss_dssp             SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-HHHHHTT-
T ss_pred             cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-HHHHhcC-
Confidence            999998765432111 12233457889999999988899999999999999999999 5556654322211 1111111 


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      .......                              .++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       249 ~~~~~~~------------------------------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          249 RRLLQPE------------------------------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             CCCCCCT------------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             CCCCCCc------------------------------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            0000000                              11235778999999999999999999999999987643

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.2e-39  Score=350.43  Aligned_cols=272  Identities=22%  Similarity=0.321  Sum_probs=208.2

Q ss_pred             HHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHc--CCCCccceeeeeecccCcCC
Q 002883          555 LKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRS--IRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       555 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~  632 (871)
                      ....++|++.+.||+|+||.||+|++  +++.||||++...   ..+.+.+|+++++.  ++||||+++++++.... ..
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~  111 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GT  111 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SS
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Cc
Confidence            34457899999999999999999998  4889999999643   34667889998887  68999999999987652 22


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEecCCCCCceee
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH--------HHCHTSIVHCDLKPSNVLL  704 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~Nill  704 (871)
                      ....++||||+++|+|.+++...        .+++..++.++.|++.||.|||        +.   +|+||||||+||++
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll  180 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY--------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV  180 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred             cceeEEEEeecCCCcHHHHHhcc--------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence            23689999999999999999753        4899999999999999999999        77   99999999999999


Q ss_pred             CCCCceEEeecccceecCCCCCCcc-ccccccccccccCcccccCC------CCCCccchhhHHHHHHHHHhC-------
Q 002883          705 DNEMVAHVGDFGLSRLLHDNSPDQT-STSRVKGSIGYVAPEYGALG------EVSTHGDEYSFGILMLEMFTG-------  770 (871)
Q Consensus       705 ~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltG-------  770 (871)
                      +.++.+||+|||++........... ......||+.|+|||++.+.      .++.++|||||||++|||++|       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            9999999999999987654321111 22345699999999987765      234789999999999999999       


Q ss_pred             ---CCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHH--hHHHHHHHHHhhhcccccCC
Q 002883          771 ---KRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRA--KFHEIQVSILRVGILCSEEL  845 (871)
Q Consensus       771 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~d  845 (871)
                         ..||...................                       ....+....  ...++...+.+++.+||+.|
T Consensus       261 ~~~~~p~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  317 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDPSVEEMRKVVCE-----------------------QKLRPNIPNRWQSCEALRVMAKIMRECWYAN  317 (342)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTT-----------------------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSS
T ss_pred             cccccCccccCcCcccHHHHHHHHHH-----------------------HHhCCCCcccccchhHHHHHHHHHHHHhccC
Confidence               67776532221111111100000                       000010000  11245567889999999999


Q ss_pred             CCCCCCHHHHHHHHHHHHHHH
Q 002883          846 PRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       846 P~~RPta~evl~~L~~i~~~~  866 (871)
                      |++|||+.|+++.|+++.+..
T Consensus       318 p~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          318 GAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             GGGSCCHHHHHHHHHHHHHTT
T ss_pred             hhhCCCHHHHHHHHHHHHHHh
Confidence            999999999999999987653

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.3e-39  Score=366.72  Aligned_cols=252  Identities=24%  Similarity=0.330  Sum_probs=202.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-------------chHHHHHHHHHHHHcCCCCccceeeee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-------------GASKSFIAECEALRSIRHRNLVKIITS  624 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~  624 (871)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.....             ...+.+.+|++++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4689999999999999999999999999999999964321             234678899999999999999999999


Q ss_pred             ecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 002883          625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL  704 (871)
Q Consensus       625 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  704 (871)
                      +.+.     ...|+||||+++|+|.+++....       .+++..+..++.||+.||+|||+.   +|+||||||+||++
T Consensus       115 ~~~~-----~~~~lv~e~~~gg~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~  179 (504)
T 3q5i_A          115 FEDK-----KYFYLVTEFYEGGELFEQIINRH-------KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILL  179 (504)
T ss_dssp             EECS-----SEEEEEEECCTTCBHHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             EEcC-----CEEEEEEecCCCCcHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEE
Confidence            8765     67899999999999999997643       589999999999999999999999   99999999999999


Q ss_pred             CCCC---ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhh
Q 002883          705 DNEM---VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG  781 (871)
Q Consensus       705 ~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~  781 (871)
                      +.++   .+||+|||+|.......    ......||+.|+|||++. +.++.++||||+||++|+|++|+.||.......
T Consensus       180 ~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  254 (504)
T 3q5i_A          180 ENKNSLLNIKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD  254 (504)
T ss_dssp             SSTTCCSSEEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ecCCCCccEEEEECCCCEEcCCCC----ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            8775   69999999998775432    223456999999999876 569999999999999999999999998643321


Q ss_pred             hhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          782 LSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      . ............                            .+.+..++.++.+++.+||+.||++|||++|+++.
T Consensus       255 ~-~~~i~~~~~~~~----------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          255 I-IKKVEKGKYYFD----------------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             H-HHHHHHCCCCCC----------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             H-HHHHHcCCCCCC----------------------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            1 111111111000                            01112334567899999999999999999999863

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.5e-39  Score=367.29  Aligned_cols=253  Identities=21%  Similarity=0.320  Sum_probs=205.5

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....   ......+.+|+++++.++||||+++++++.+.     
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----  256 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----  256 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC-----
Confidence            3467999999999999999999999999999999996432   23346788999999999999999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||++||+|.+++.....     ..+++..++.++.||+.||.|||++   +|+||||||+||+++.++.+||+
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~~-----~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~  328 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMGQ-----AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRIS  328 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEE
Confidence            678999999999999999976542     2589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhh--hhHHHHhhhC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG--LSLHKYAKMG  791 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~--~~~~~~~~~~  791 (871)
                      |||+|.......    ......||+.|+|||++.+..++.++||||+||++|||++|+.||.......  ......... 
T Consensus       329 DFGla~~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-  403 (576)
T 2acx_A          329 DLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-  403 (576)
T ss_dssp             CCTTCEECCTTC----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-
T ss_pred             ecccceecccCc----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-
Confidence            999998765432    2233579999999999998899999999999999999999999997532210  011111110 


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIM  857 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~  857 (871)
                      .+....                              ..+..++.+++.+||+.||++||     +++|+++
T Consensus       404 ~~~~~p------------------------------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          404 VPEEYS------------------------------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCCCCC------------------------------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ccccCC------------------------------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            000000                              01234577999999999999999     7888875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.1e-39  Score=357.04  Aligned_cols=251  Identities=22%  Similarity=0.375  Sum_probs=193.8

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCC--CCccceeeeeecccCcCCCc
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIR--HRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~  634 (871)
                      .+|++.+.||+|+||.||+|.+.. ++.||||++....  ....+.+.+|+++++.++  ||||+++++++...     .
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-----~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----Q  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----S
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----C
Confidence            469999999999999999999874 8999999996443  334577899999999996  59999999998765     5


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||| +.+++|.+++....       .+++.+++.++.||+.||.|||+.   +|+||||||+||+++ ++.+||+|
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~D  197 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKKKK-------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID  197 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHHCS-------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECC
T ss_pred             EEEEEEe-cCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEe
Confidence            6899999 56889999998654       588999999999999999999999   999999999999995 58999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhh
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-----------GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLS  783 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~  783 (871)
                      ||++........ ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........
T Consensus       198 FG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~  276 (390)
T 2zmd_A          198 FGIANQMQPDTT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK  276 (390)
T ss_dssp             CSSSCCC----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred             cCccccccCCCc-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH
Confidence            999987654321 112234579999999998754           46899999999999999999999999753222111


Q ss_pred             HHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          784 LHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ................                              ....+.+++.+||+.||++|||+.|+++.
T Consensus       277 ~~~~~~~~~~~~~~~~------------------------------~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          277 LHAIIDPNHEIEFPDI------------------------------PEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHHHCTTSCCCCCCC------------------------------SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhCccccCCCCcc------------------------------chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            1111111110000000                              12356789999999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-39  Score=356.31  Aligned_cols=261  Identities=23%  Similarity=0.388  Sum_probs=194.8

Q ss_pred             CCCCCceeeccccceEEEEEECCC---CcEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTE---ETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .|++.+.||+|+||+||+|++..+   +..||+|.++.. .....+.+.+|+.++++++||||+++++++...    ...
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~~~  165 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGS  165 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----SSC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----CCC
Confidence            467789999999999999997433   346899998543 334557889999999999999999999987543    245


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||+++|+|.+++.....      .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DF  236 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF  236 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTC------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEECCCCCCHHHHHhhccc------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeec
Confidence            7899999999999999976432      488999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCc-cccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCC
Q 002883          716 GLSRLLHDNSPDQ-TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       716 g~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |+++......... .......+|+.|+|||.+.+..++.++|||||||++|||+| |.+||.........  ........
T Consensus       237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~--~~~~~~~~  314 (373)
T 3c1x_A          237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--VYLLQGRR  314 (373)
T ss_dssp             ---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH--HHHHTTCC
T ss_pred             cccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH--HHHHcCCC
Confidence            9998764332111 12233457889999999988999999999999999999999 67777653222111  11111000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      ..     .                   +      ..++..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       315 ~~-----~-------------------p------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          315 LL-----Q-------------------P------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             CC-----C-------------------C------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CC-----C-------------------C------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            00     0                   0      01234577899999999999999999999999998654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.8e-39  Score=351.64  Aligned_cols=284  Identities=20%  Similarity=0.245  Sum_probs=210.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|+++++.++||||+++++++...........
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999999899999999996433 2334677899999999999999999998876544445678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||++ ++|.+++...        .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--------MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFG  157 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEeccC-ccHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecc
Confidence            99999996 6999998753        489999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCcc-------ccccccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh
Q 002883          717 LSRLLHDNSPDQT-------STSRVKGSIGYVAPEYGA-LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA  788 (871)
Q Consensus       717 ~a~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~  788 (871)
                      .+...........       ......||+.|+|||++. +..++.++|||||||++|+|++|+.||..............
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  237 (353)
T 2b9h_A          158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG  237 (353)
T ss_dssp             TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence            9987754321111       122346899999999765 46789999999999999999999999986543322222221


Q ss_pred             hhCCCch--hh-hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          789 KMGLPDQ--VA-EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       789 ~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ....+..  .. ........    +...................+..++.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAR----EYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHH----HHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCchhccccccccchhh----HHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1122211  11 11111111    111111111111122222345667889999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.2e-39  Score=342.15  Aligned_cols=254  Identities=26%  Similarity=0.368  Sum_probs=199.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||.||+|++.  ++.||||+++...  ..+.+.+|++++++++||||+++++++.+.    ....+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCceE
Confidence            468999999999999999999984  8899999996443  457789999999999999999999986543    24579


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++++|.+++......     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~  163 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRS-----VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL  163 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHH-----HCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             EEEecCCCCCHHHHHHhcccc-----cCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccc
Confidence            999999999999999765422     478999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +......      .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||........  ............
T Consensus       164 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~~~~~~~~~~~  235 (278)
T 1byg_A          164 TKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVEKGYKMDA  235 (278)
T ss_dssp             ------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HHHHTTTCCCCC
T ss_pred             ccccccc------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHhcCCCCCC
Confidence            9865432      122357889999999988899999999999999999998 9999975432211  111111000000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      .                              ..++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       236 ~------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          236 P------------------------------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             C------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c------------------------------ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            0                              02234577899999999999999999999999998764

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=2.5e-38  Score=356.36  Aligned_cols=361  Identities=22%  Similarity=0.235  Sum_probs=228.5

Q ss_pred             ccCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccc
Q 002883            5 EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGL   84 (871)
Q Consensus         5 ~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~   84 (871)
                      .-|..++++++|++|+|++|+|++ +| .++.+++|++|+|++|++++ +|  ++.+++|++|+|++|++++ +|  ++.
T Consensus        33 ~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~  104 (457)
T 3bz5_A           33 TDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTP  104 (457)
T ss_dssp             TSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTT
T ss_pred             ccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCC
Confidence            334456667777777777777774 34 57777777777777777774 33  6777777777777777774 33  677


Q ss_pred             cccccccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCcc
Q 002883           85 LKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPED  164 (871)
Q Consensus        85 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~  164 (871)
                      +++|++|++++|++++ +|  +..+++|++|++++|++.+ ++   ...+++|+.|++++|...+.          +  .
T Consensus       105 l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~---l~~l~~L~~L~l~~n~~~~~----------~--~  165 (457)
T 3bz5_A          105 LTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID---VSHNTQLTELDCHLNKKITK----------L--D  165 (457)
T ss_dssp             CTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC---CTTCTTCCEEECTTCSCCCC----------C--C
T ss_pred             CCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec---cccCCcCCEEECCCCCcccc----------c--c
Confidence            7777777777777774 33  6666777777777776653 32   23566666666666643321          1  2


Q ss_pred             ccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCC
Q 002883          165 LGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV  244 (871)
Q Consensus       165 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~  244 (871)
                      +..+++|++|++++|+++.++         +..+++|++|++++|++++.   .+..+ ++|++|++++|++++ +|  +
T Consensus       166 ~~~l~~L~~L~ls~n~l~~l~---------l~~l~~L~~L~l~~N~l~~~---~l~~l-~~L~~L~Ls~N~l~~-ip--~  229 (457)
T 3bz5_A          166 VTPQTQLTTLDCSFNKITELD---------VSQNKLLNRLNCDTNNITKL---DLNQN-IQLTFLDCSSNKLTE-ID--V  229 (457)
T ss_dssp             CTTCTTCCEEECCSSCCCCCC---------CTTCTTCCEEECCSSCCSCC---CCTTC-TTCSEEECCSSCCSC-CC--C
T ss_pred             cccCCcCCEEECCCCccceec---------cccCCCCCEEECcCCcCCee---ccccC-CCCCEEECcCCcccc-cC--c
Confidence            455666666666666665532         34555666666666666633   13333 346666666666664 33  5


Q ss_pred             CCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCE
Q 002883          245 GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQK  324 (871)
Q Consensus       245 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  324 (871)
                      ..+++|+.|++++|.+++..   ++.+++|+.|++++|              +|+.|++++|.+.+.+|  ++.+++|+.
T Consensus       230 ~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~  290 (457)
T 3bz5_A          230 TPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKE  290 (457)
T ss_dssp             TTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCC
T ss_pred             cccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCE
Confidence            56666666666666666432   334455666655554              24455666666655554  456677777


Q ss_pred             EecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcc
Q 002883          325 LDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSF  404 (871)
Q Consensus       325 L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  404 (871)
                      |++++|.+.+.+|.   ..++|+.|++++|             ++|+.|++++|++++. +  +..+++|+.|++++|+|
T Consensus       291 L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l  351 (457)
T 3bz5_A          291 LDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHI  351 (457)
T ss_dssp             CCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCC
T ss_pred             EECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCC
Confidence            77777776555543   3344444444443             6788888888888863 3  77788888888888888


Q ss_pred             cccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCC
Q 002883          405 QGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE  459 (871)
Q Consensus       405 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~  459 (871)
                      ++        ++.|..|++++|++++.     ..+..|..+++++|.++|.+|..
T Consensus       352 ~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          352 QD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             CB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred             CC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence            75        24566677888888754     34556778888888888887754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.2e-39  Score=354.84  Aligned_cols=288  Identities=21%  Similarity=0.205  Sum_probs=207.2

Q ss_pred             HHHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-----------chHHHHHHHHHHHHcCCCCccc
Q 002883          551 YAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-----------GASKSFIAECEALRSIRHRNLV  619 (871)
Q Consensus       551 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv  619 (871)
                      ..++....++|++.+.||+|+||.||+|++. +++.||||++.....           ...+.+.+|++++++++||||+
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            4566777899999999999999999999987 489999999843221           1236789999999999999999


Q ss_pred             eeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 002883          620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP  699 (871)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  699 (871)
                      ++++++...+.......|+||||++ |+|.+++.....      .+++..++.++.|++.||.|||+.   +|+||||||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp  162 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI------VISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHP  162 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCG
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCCh
Confidence            9999987765555678899999996 688888875432      589999999999999999999999   999999999


Q ss_pred             CceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhh
Q 002883          700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMF  778 (871)
Q Consensus       700 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~  778 (871)
                      +||+++.++.+||+|||.+......    .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....
T Consensus       163 ~NIl~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          163 GNILLADNNDITICDFNLAREDTAD----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             GGEEECTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             HHEEEcCCCCEEEEecCcccccccc----cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999754432    22233568999999998776 678999999999999999999999998644


Q ss_pred             hhhhhHHHHhhhCCCch--hhhhcChhHHHHHHHHHhhhhhhcC-chhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHH
Q 002883          779 EEGLSLHKYAKMGLPDQ--VAEIIDPAILEEALEIQAGIVKELQ-PNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDA  855 (871)
Q Consensus       779 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~ev  855 (871)
                      ..............+..  ...+..+...    ..........+ .............+.+++.+||+.||++|||+.|+
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  314 (362)
T 3pg1_A          239 FYNQLNKIVEVVGTPKIEDVVMFSSPSAR----DYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA  314 (362)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHTSCHHHH----HHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHHcCCCChHHhhhccchhhh----HHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence            33222211111111111  1111111110    00000000111 11112222345668899999999999999999999


Q ss_pred             HH
Q 002883          856 IM  857 (871)
Q Consensus       856 l~  857 (871)
                      ++
T Consensus       315 l~  316 (362)
T 3pg1_A          315 LR  316 (362)
T ss_dssp             HT
T ss_pred             Hc
Confidence            86

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.4e-39  Score=359.62  Aligned_cols=202  Identities=23%  Similarity=0.311  Sum_probs=174.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC------CCCccceeeeeecccCcC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI------RHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~  631 (871)
                      ..+|++.+.||+|+||+||+|++..+++.||||+++... ...+.+.+|+++++.+      .|+||+++++++...   
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~---  171 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR---  171 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET---
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC---
Confidence            357999999999999999999999899999999996543 2345677888888776      577999999998765   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc--
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV--  709 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--  709 (871)
                        ...++||||+. ++|.+++......     .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.  
T Consensus       172 --~~~~lv~e~~~-~~L~~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~  240 (429)
T 3kvw_A          172 --NHICMTFELLS-MNLYELIKKNKFQ-----GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSG  240 (429)
T ss_dssp             --TEEEEEECCCC-CBHHHHHHHTTTC-----CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCC
T ss_pred             --CeEEEEEeccC-CCHHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcc
Confidence              67899999995 6999999875432     589999999999999999999999   9999999999999999887  


Q ss_pred             eEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhh
Q 002883          710 AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEE  780 (871)
Q Consensus       710 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  780 (871)
                      +||+|||+|......      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       241 vkL~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  305 (429)
T 3kvw_A          241 IKVIDFGSSCYEHQR------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG  305 (429)
T ss_dssp             EEECCCTTCEETTCC------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             eEEeecccceecCCc------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            999999999865432      22346899999999999989999999999999999999999999865443

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=2e-38  Score=357.14  Aligned_cols=338  Identities=20%  Similarity=0.199  Sum_probs=286.3

Q ss_pred             cCccCcCCCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCcccccc
Q 002883            6 IPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLL   85 (871)
Q Consensus         6 ~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l   85 (871)
                      +| .|..+++|++|+|++|+|++ +|  ++.+++|++|+|++|++++. |  |+++++|++|+|++|++++ +|  ++.+
T Consensus        57 ~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l  126 (457)
T 3bz5_A           57 MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQN  126 (457)
T ss_dssp             CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTC
T ss_pred             Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCC
Confidence            45 68999999999999999996 44  99999999999999999964 4  8999999999999999995 55  9999


Q ss_pred             ccccccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccc
Q 002883           86 KQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDL  165 (871)
Q Consensus        86 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~  165 (871)
                      ++|++|++++|++++ ++  +..+++|++|++++|...+.++   +..+++|+.|++++|.++           .+|  +
T Consensus       127 ~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~-----------~l~--l  187 (457)
T 3bz5_A          127 PLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKIT-----------ELD--V  187 (457)
T ss_dssp             TTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCCC---CTTCTTCCEEECCSSCCC-----------CCC--C
T ss_pred             CcCCEEECCCCccce-ec--cccCCcCCEEECCCCCcccccc---cccCCcCCEEECCCCccc-----------eec--c
Confidence            999999999999995 43  8899999999999997665663   448999999999999998           444  7


Q ss_pred             cCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCC
Q 002883          166 GKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVG  245 (871)
Q Consensus       166 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~  245 (871)
                      +.+++|+.|++++|+++.+         .+..+++|++|++++|++++ +|  +..+ ++|++|++++|++++..   +.
T Consensus       188 ~~l~~L~~L~l~~N~l~~~---------~l~~l~~L~~L~Ls~N~l~~-ip--~~~l-~~L~~L~l~~N~l~~~~---~~  251 (457)
T 3bz5_A          188 SQNKLLNRLNCDTNNITKL---------DLNQNIQLTFLDCSSNKLTE-ID--VTPL-TQLTYFDCSVNPLTELD---VS  251 (457)
T ss_dssp             TTCTTCCEEECCSSCCSCC---------CCTTCTTCSEEECCSSCCSC-CC--CTTC-TTCSEEECCSSCCSCCC---CT
T ss_pred             ccCCCCCEEECcCCcCCee---------ccccCCCCCEEECcCCcccc-cC--cccc-CCCCEEEeeCCcCCCcC---HH
Confidence            7899999999999999874         26788999999999999996 56  5555 57999999999999654   56


Q ss_pred             CccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEE
Q 002883          246 NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKL  325 (871)
Q Consensus       246 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  325 (871)
                      .+++|+.|++++|              +|+.|++++|.+.+.+|  ++.+++|+.|+|++|...+.+|.   ..++|+.|
T Consensus       252 ~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L  312 (457)
T 3bz5_A          252 TLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITEL  312 (457)
T ss_dssp             TCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCC
T ss_pred             HCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEe
Confidence            7788999998876              46678899998876666  67889999999999998777664   44667777


Q ss_pred             ecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCccc
Q 002883          326 DLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQ  405 (871)
Q Consensus       326 ~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  405 (871)
                      ++++|             ++|++|++++|++++.   .++.+++|+.|++++|++++        ++.|..|++++|.+.
T Consensus       313 ~l~~~-------------~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~  368 (457)
T 3bz5_A          313 DLSQN-------------PKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFE  368 (457)
T ss_dssp             CCTTC-------------TTCCEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEE
T ss_pred             chhhc-------------ccCCEEECCCCccccc---ccccCCcCcEEECCCCCCCC--------ccccccccccCCcEE
Confidence            66665             6899999999999964   38999999999999999985        356788899999998


Q ss_pred             ccCccccCCCCCCCEEeCCCCcCCCCCcccc
Q 002883          406 GPIHSGFSSLKGLQDLDLSRNNFSGKIPMFL  436 (871)
Q Consensus       406 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  436 (871)
                      +.     ..+..|+.+++++|+++|.+|..+
T Consensus       369 g~-----~~~~~l~~l~l~~N~l~g~ip~~~  394 (457)
T 3bz5_A          369 AE-----GQTITMPKETLTNNSLTIAVSPDL  394 (457)
T ss_dssp             EE-----EEEEECCCBCCBTTBEEEECCTTC
T ss_pred             ec-----ceeeecCccccccCcEEEEcChhH
Confidence            75     245678889999999999888654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.7e-39  Score=340.70  Aligned_cols=259  Identities=22%  Similarity=0.312  Sum_probs=205.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|++++++++||||+++++++....   ...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG---GTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC---Cce
Confidence            468999999999999999999999899999999996543  334567889999999999999999999875432   256


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----eEecCCCCCceeeCCCCce
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS-----IVHCDLKPSNVLLDNEMVA  710 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlkp~Nill~~~~~~  710 (871)
                      .++||||+++++|.+++......   ...+++..++.++.|++.||+|||+.   +     |+||||||+||+++.++.+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~  155 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKE---RQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNV  155 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCE
T ss_pred             EEEEEeCCCCCCHHHHHHhhccc---CCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCE
Confidence            89999999999999999765321   22589999999999999999999999   7     9999999999999999999


Q ss_pred             EEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh
Q 002883          711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM  790 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~  790 (871)
                      ||+|||.+......   ........|++.|+|||.+.+..++.++||||||+++|+|++|+.||........ .......
T Consensus       156 kl~dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~i~~~  231 (279)
T 2w5a_A          156 KLGDFGLARILNHD---TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREG  231 (279)
T ss_dssp             EECCCCHHHHC------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHT
T ss_pred             EEecCchheeeccc---cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH-HHHHhhc
Confidence            99999999876432   1222335689999999999888999999999999999999999999985432211 1111111


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ  860 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~  860 (871)
                      ..+ ..                       +       ..+..++.+++.+||+.||++|||+.|+++.+.
T Consensus       232 ~~~-~~-----------------------~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          232 KFR-RI-----------------------P-------YRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             CCC-CC-----------------------C-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ccc-cC-----------------------C-------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            000 00                       0       012345779999999999999999999998653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.8e-40  Score=353.26  Aligned_cols=269  Identities=22%  Similarity=0.379  Sum_probs=210.3

Q ss_pred             HHHHhhcCCCCCceeeccccceEEEEEEC-----CCCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeec
Q 002883          553 ELLKATEGFSSANLIGIGGYGYVYKGILG-----TEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCS  626 (871)
Q Consensus       553 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~  626 (871)
                      ++....++|++.+.||+|+||.||+|++.     .+++.||+|++..... .....+.+|+++++.++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            34455678999999999999999999876     3578899999964432 33457889999999999999999999986


Q ss_pred             ccCcCCCceeeEEEeccCCCCHHHHhhcccccc---cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCcee
Q 002883          627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ---NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL  703 (871)
Q Consensus       627 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  703 (871)
                      +.     ...++||||+++|+|.+++.......   .....+++..++.++.|++.||.|||+.   +|+||||||+||+
T Consensus        99 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIl  170 (322)
T 1p4o_A           99 QG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM  170 (322)
T ss_dssp             SS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEE
T ss_pred             cC-----CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEE
Confidence            64     56799999999999999997643210   0112578999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhh
Q 002883          704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGL  782 (871)
Q Consensus       704 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~  782 (871)
                      ++.++.+||+|||.+....... .........+|+.|+|||++.+..++.++||||+||++|+|++ |+.||........
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  249 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV  249 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGG-CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred             EcCCCeEEECcCcccccccccc-ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH
Confidence            9999999999999998654322 1112233457889999999888899999999999999999999 8999975432211


Q ss_pred             hHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          783 SLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       783 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                       .........+..                               ...++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       250 -~~~~~~~~~~~~-------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          250 -LRFVMEGGLLDK-------------------------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             -HHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             -HHHHHcCCcCCC-------------------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence             111111110000                               002234577899999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4e-39  Score=348.66  Aligned_cols=265  Identities=23%  Similarity=0.376  Sum_probs=206.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEE--EEEEeecc-ccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNV--AVKVLDLQ-QRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  633 (871)
                      .++|++.+.||+|+||.||+|++..++..+  |+|.++.. .....+.+.+|+++++++ +||||+++++++.+.     
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----   98 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----   98 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-----
Confidence            368999999999999999999998788755  99988643 233446788999999999 999999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhccccc---------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDE---------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL  704 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  704 (871)
                      ...|+||||+++++|.+++......         ......+++..++.++.|++.||+|||+.   +|+||||||+||++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~  175 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV  175 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEE
Confidence            6789999999999999999765310         01123689999999999999999999999   99999999999999


Q ss_pred             CCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhh
Q 002883          705 DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLS  783 (871)
Q Consensus       705 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~  783 (871)
                      +.++.+||+|||++......    .......+++.|+|||++.+..++.++|||||||++|+|++ |+.||........ 
T Consensus       176 ~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-  250 (327)
T 1fvr_A          176 GENYVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-  250 (327)
T ss_dssp             CGGGCEEECCTTCEESSCEE----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-
T ss_pred             cCCCeEEEcccCcCcccccc----ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-
Confidence            99999999999999743221    11222356889999999888889999999999999999998 9999975432211 


Q ss_pred             HHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          784 LHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                       .............                              ..+...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       251 -~~~~~~~~~~~~~------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  299 (327)
T 1fvr_A          251 -YEKLPQGYRLEKP------------------------------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  299 (327)
T ss_dssp             -HHHGGGTCCCCCC------------------------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHhhcCCCCCCC------------------------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             1111110000000                              012345779999999999999999999999999987


Q ss_pred             HHH
Q 002883          864 KMR  866 (871)
Q Consensus       864 ~~~  866 (871)
                      +.+
T Consensus       300 ~~~  302 (327)
T 1fvr_A          300 EER  302 (327)
T ss_dssp             HSS
T ss_pred             Hhh
Confidence            654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.9e-38  Score=339.63  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=206.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...     ...
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   95 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKL   95 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeE
Confidence            467999999999999999999999899999999996543 33457889999999999999999999998765     668


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++++|.+++...        .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        96 ~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg  164 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEPG--------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG  164 (303)
T ss_dssp             EEEEECCTTEEHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecc
Confidence            9999999999999999653        489999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      .+.......   .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.........  .......+...
T Consensus       165 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~  239 (303)
T 3a7i_A          165 VAGQLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL--FLIPKNNPPTL  239 (303)
T ss_dssp             TCEECBTTB---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHHSCCCCC
T ss_pred             cceecCccc---cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH--HHhhcCCCCCC
Confidence            998765432   1223456899999999999899999999999999999999999999754322111  11111111100


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                      ..                              .+...+.+++.+||+.||++|||+.|+++..
T Consensus       240 ~~------------------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          240 EG------------------------------NYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             CS------------------------------SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             cc------------------------------ccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            00                              1234577899999999999999999998754

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.6e-39  Score=344.23  Aligned_cols=254  Identities=23%  Similarity=0.312  Sum_probs=200.0

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|+++++.++||||+++++++...     ...
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   91 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKL   91 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeE
Confidence            346899999999999999999999989999999999766666678899999999999999999999998765     568


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++++|.+++.....      .+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  162 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELDR------GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG  162 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred             EEEEEeCCCCcHHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECC
Confidence            999999999999999876432      589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccc-----cCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYG-----ALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      .+......   ........||+.|+|||++     .+..++.++||||||+++|+|++|+.||........ ........
T Consensus       163 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~  238 (302)
T 2j7t_A          163 VSAKNLKT---LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSD  238 (302)
T ss_dssp             HHHHHHHH---HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSC
T ss_pred             CCcccccc---ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHHhccC
Confidence            87543211   1112234689999999986     467789999999999999999999999975432211 11111111


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .+..    ..+                         ..+...+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~----~~~-------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          239 PPTL----LTP-------------------------SKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CCCC----SSG-------------------------GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             Cccc----CCc-------------------------cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1100    000                         012345778999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.9e-39  Score=337.60  Aligned_cols=249  Identities=26%  Similarity=0.381  Sum_probs=195.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||++....   ....+.+.+|+++++.++||||+++++++...     .
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-----T   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----C
Confidence            468999999999999999999999899999999996432   23356788999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+++++|.+++....       .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d  154 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHG-------RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIAD  154 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC-------SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECC
T ss_pred             eEEEEEeccCCCcHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEee
Confidence            7899999999999999997653       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV-STHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||.+.......    ......|++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||........  .........
T Consensus       155 fg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~  228 (276)
T 2h6d_A          155 FGLSNMMSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL--FKKIRGGVF  228 (276)
T ss_dssp             CCGGGCCCC-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCC
T ss_pred             cccccccCCCc----ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--HHHhhcCcc
Confidence            99998764322    1223468999999999887765 6899999999999999999999975322211  111111000


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .                        .+       ......+.+++.+||+.||++|||+.|+++.
T Consensus       229 ~------------------------~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 Y------------------------IP-------EYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             C------------------------CC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             c------------------------Cc-------hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0                        00       0112356789999999999999999999874

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=341.17  Aligned_cols=252  Identities=24%  Similarity=0.300  Sum_probs=199.9

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....  ..+.+.+|+.+++.++||||+++++++...     ...
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   99 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDL   99 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEE
Confidence            4568999999999999999999999899999999997543  346788999999999999999999998765     668


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||+++++|.+++.....      .+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  170 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRNK------TLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFG  170 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEeecCCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecc
Confidence            999999999999999974322      589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      .+.......   .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .... ..+...
T Consensus       171 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~-~~~~~~  245 (314)
T 3com_A          171 VAGQLTDTM---AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPT-NPPPTF  245 (314)
T ss_dssp             TCEECBTTB---SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHH-SCCCCC
T ss_pred             cchhhhhhc---cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHhc-CCCccc
Confidence            998765432   12233568999999999988899999999999999999999999997543221111 1100 000000


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                         ..                         ...+...+.+++.+||+.||++|||+.|+++
T Consensus       246 ---~~-------------------------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          246 ---RK-------------------------PELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ---SS-------------------------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---CC-------------------------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence               00                         0012345778999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.2e-39  Score=351.29  Aligned_cols=277  Identities=22%  Similarity=0.318  Sum_probs=203.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....  ...+.+.+|++++++++||||+++++++.+.     ..
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~   98 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-----KR   98 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-----CE
Confidence            4689999999999999999999998999999999854432  2345678999999999999999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||+++++|.++.....       .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  168 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFPN-------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDF  168 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHSTT-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEecCCcchHHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeC
Confidence            899999999999998876543       589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh-CCC
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM-GLP  793 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~~~  793 (871)
                      |.+.......   .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||................ ...
T Consensus       169 g~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (331)
T 4aaa_A          169 GFARTLAAPG---EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLI  245 (331)
T ss_dssp             TTC---------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             CCceeecCCc---cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Confidence            9998664322   122335689999999987765 78999999999999999999999997654332222111111 111


Q ss_pred             chhhhhcChhHHHHHHHHHhhh-hh--hcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGI-VK--ELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      +...........      ..+. ..  ..........+.+...+.+++.+||+.||++|||+.|+++.
T Consensus       246 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          246 PRHQELFNKNPV------FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHHHHHHHCGG------GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hhhhhHhhhccc------cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            110000000000      0000 00  00001112223456678999999999999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3e-39  Score=369.05  Aligned_cols=251  Identities=23%  Similarity=0.341  Sum_probs=204.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||++....   ....+.+.+|++++++++||||+++++++.+.     .
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~   99 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK-----G   99 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----C
Confidence            357999999999999999999999999999999995432   33467889999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee---CCCCceE
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAH  711 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~k  711 (871)
                      ..|+||||+.+|+|.+++....       .+++..++.++.||+.||.|||++   +|+||||||+||++   +.++.+|
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k  169 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISRK-------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIR  169 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCS-------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEE
T ss_pred             EEEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEE
Confidence            7899999999999999997643       589999999999999999999999   99999999999999   5678999


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      |+|||+|.......    ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||........ ........
T Consensus       170 l~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~  243 (484)
T 3nyv_A          170 IIDFGLSTHFEASK----KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI-LKKVEKGK  243 (484)
T ss_dssp             ECCTTHHHHBCCCC----SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCC
T ss_pred             EEeeeeeEEccccc----ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHcCC
Confidence            99999998765432    2334569999999998765 799999999999999999999999986432211 11111111


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .....                            +.+..++..+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~~----------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          244 YTFEL----------------------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CCCCS----------------------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCC----------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            11000                            011123446779999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.8e-39  Score=348.31  Aligned_cols=266  Identities=19%  Similarity=0.255  Sum_probs=194.8

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-CCccceeeeeecccC---cCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSCSSID---TRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~---~~~~  633 (871)
                      ..+|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+.+++++. ||||+++++++....   ....
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457999999999999999999999899999999997666666678899999999995 999999999984322   2334


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCceeeCCCCceE
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS--IVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~k  711 (871)
                      ...++||||++ |+|.+++.....    ...+++..++.++.||+.||+|||+.   +  |+||||||+||+++.++.+|
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMES----RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHT----TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence            67899999995 799999876322    12599999999999999999999998   8  99999999999999999999


Q ss_pred             EeecccceecCCCCCCc---------cccccccccccccCcccc---cCCCCCCccchhhHHHHHHHHHhCCCCCchhhh
Q 002883          712 VGDFGLSRLLHDNSPDQ---------TSTSRVKGSIGYVAPEYG---ALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFE  779 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  779 (871)
                      |+|||.+..........         .......||+.|+|||++   .+..++.++|||||||++|+|++|+.||.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            99999998765432211         011134589999999987   566789999999999999999999999975322


Q ss_pred             hhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHH
Q 002883          780 EGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL  859 (871)
Q Consensus       780 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L  859 (871)
                      ...     ...........                              .....+.+++.+||+.||++|||+.|+++.|
T Consensus       259 ~~~-----~~~~~~~~~~~------------------------------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          259 LRI-----VNGKYSIPPHD------------------------------TQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             ------------CCCCTTC------------------------------CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             HHh-----hcCcccCCccc------------------------------ccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            110     00000000000                              0112356899999999999999999999999


Q ss_pred             HHHHHHH
Q 002883          860 QEAQKMR  866 (871)
Q Consensus       860 ~~i~~~~  866 (871)
                      +++.+..
T Consensus       304 ~~~~~~~  310 (337)
T 3ll6_A          304 QEIAAAR  310 (337)
T ss_dssp             HHHHHHT
T ss_pred             HHHHhcc
Confidence            9987643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=353.72  Aligned_cols=269  Identities=14%  Similarity=0.179  Sum_probs=204.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECC--------CCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccee--------
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGT--------EETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKI--------  621 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~--------  621 (871)
                      .++|++.+.||+|+||.||+|++..        .++.||+|++...     +.+.+|++++++++||||+++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999986        4789999998643     457789999999999999984        


Q ss_pred             -------eeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 002883          622 -------ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVH  694 (871)
Q Consensus       622 -------~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  694 (871)
                             ++++..    .....|+||||+ +++|.+++.....     ..+++..++.++.||+.||+|||+.   +|+|
T Consensus       116 ~~~i~~~~~~~~~----~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH  182 (352)
T 2jii_A          116 LLAIPTCMGFGVH----QDKYRFLVLPSL-GRSLQSALDVSPK-----HVLSERSVLQVACRLLDALEFLHEN---EYVH  182 (352)
T ss_dssp             TCSCCCCCEEEEE----TTTEEEEEEECC-CEEHHHHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHHT---TCBC
T ss_pred             ccCccchhhcccc----CCcEEEEEecCC-CcCHHHHHHhCCc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccC
Confidence                   344332    236789999999 9999999987532     2699999999999999999999999   9999


Q ss_pred             cCCCCCceeeCCCC--ceEEeecccceecCCCCCC----ccccccccccccccCcccccCCCCCCccchhhHHHHHHHHH
Q 002883          695 CDLKPSNVLLDNEM--VAHVGDFGLSRLLHDNSPD----QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMF  768 (871)
Q Consensus       695 ~Dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  768 (871)
                      |||||+||+++.++  .+||+|||+++........    ........||+.|+|||++.+..++.++|||||||++|||+
T Consensus       183 ~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~  262 (352)
T 2jii_A          183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL  262 (352)
T ss_dssp             SCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence            99999999999998  9999999999876543211    11123347999999999999889999999999999999999


Q ss_pred             hCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCC
Q 002883          769 TGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRD  848 (871)
Q Consensus       769 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  848 (871)
                      +|+.||................ .......+.+..                     .....+..++.+++.+||+.||++
T Consensus       263 ~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---------------------~~~~~~~~~l~~li~~~l~~dp~~  320 (352)
T 2jii_A          263 YGFLPWTNCLPNTEDIMKQKQK-FVDKPGPFVGPC---------------------GHWIRPSETLQKYLKVVMALTYEE  320 (352)
T ss_dssp             HSCCTTGGGTTCHHHHHHHHHH-HHHSCCCEECTT---------------------SCEECCCHHHHHHHHHHHTCCTTC
T ss_pred             hCCCCcccCCcCHHHHHHHHHh-ccCChhhhhhhc---------------------cccCCCcHHHHHHHHHHHhCChhh
Confidence            9999998653221111111100 000000000000                     000012346789999999999999


Q ss_pred             CCCHHHHHHHHHHHHHHH
Q 002883          849 RMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       849 RPta~evl~~L~~i~~~~  866 (871)
                      |||++|+++.|+++.+..
T Consensus       321 Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          321 KPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             CCCHHHHHHHHHHHHHHT
T ss_pred             CCCHHHHHHHHHHHHHhc
Confidence            999999999999987654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.5e-39  Score=344.38  Aligned_cols=263  Identities=29%  Similarity=0.389  Sum_probs=198.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECC-CC--cEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGT-EE--TNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      .++|++.+.||+|+||+||+|++.. ++  ..||+|+++..   .....+.+.+|++++++++||||+++++++...   
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence            4679999999999999999998642 33  36999998643   233457889999999999999999999998653   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                         ..++||||+++++|.+++.....      .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+|
T Consensus        94 ---~~~~v~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~k  161 (291)
T 1u46_A           94 ---PMKMVTELAPLGSLLDRLRKHQG------HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVK  161 (291)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHHHGG------GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEE
T ss_pred             ---CceeeEecccCCCHHHHHHhccC------CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEE
Confidence               26899999999999999976532      489999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhh
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKM  790 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~  790 (871)
                      |+|||.+.................+|..|+|||++.+..++.++||||||+++|+|++ |+.||........ .......
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~  240 (291)
T 1u46_A          162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-LHKIDKE  240 (291)
T ss_dssp             ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTS
T ss_pred             EccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH-HHHHHcc
Confidence            9999999887654322223334567889999999888889999999999999999999 9999975432211 1111111


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      ......                              ...++..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus       241 ~~~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          241 GERLPR------------------------------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             CCCCCC------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CCCCCC------------------------------CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence            000000                              0122346779999999999999999999999999886544

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.4e-39  Score=352.67  Aligned_cols=280  Identities=23%  Similarity=0.302  Sum_probs=205.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...     ...
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----TEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CEE
Confidence            357999999999999999999999999999999997543 33456789999999999999999999998765     668


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||+++++|.+++....       .+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|||
T Consensus       107 ~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg  177 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKAG-------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG  177 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             EEEEECCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECC
Confidence            99999999999999997654       5899999999999999999999831  89999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh-C-CCc
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM-G-LPD  794 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~-~-~~~  794 (871)
                      .+......     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||................ . ...
T Consensus       178 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3eqc_A          178 VSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE  252 (360)
T ss_dssp             CCHHHHHH-----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred             CCcccccc-----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence            99755321     1223568999999999999999999999999999999999999997643332211110000 0 000


Q ss_pred             hhh------hhc-----ChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          795 QVA------EII-----DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       795 ~~~------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ...      ...     +........+..........+...  ...+..++.+++.+||+.||++|||++|+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ---------------------CCCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCC--cccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            000      000     000000000000000000000000  01234568899999999999999999999874

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-39  Score=350.30  Aligned_cols=279  Identities=22%  Similarity=0.285  Sum_probs=200.1

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc-----hHHHHHHHHHHHHcCCCCccceeeeeecccCc
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG-----ASKSFIAECEALRSIRHRNLVKIITSCSSIDT  630 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  630 (871)
                      ...++|++.+.||+|+||.||+|++..+++.||||++......     ..+.+.+|+++++.++||||+++++++.+.  
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   84 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--   84 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC--
Confidence            3457899999999999999999999989999999999643221     124678999999999999999999998665  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCce
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA  710 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  710 (871)
                         ...++||||+++ +|.+++.....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        85 ---~~~~lv~e~~~~-~l~~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~  151 (346)
T 1ua2_A           85 ---SNISLVFDFMET-DLEVIIKDNSL------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVL  151 (346)
T ss_dssp             ---TCCEEEEECCSE-EHHHHHTTCCS------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             ---CceEEEEEcCCC-CHHHHHHhcCc------CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCE
Confidence               568999999975 89998876432      588899999999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh
Q 002883          711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK  789 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~  789 (871)
                      ||+|||.+.......   .......||+.|+|||++.+. .++.++||||+||++|+|++|.+||...............
T Consensus       152 kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~  228 (346)
T 1ua2_A          152 KLADFGLAKSFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET  228 (346)
T ss_dssp             EECCCGGGSTTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEEecccceeccCCc---ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence            999999998764322   122335689999999987654 5899999999999999999999999765433222221211


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCc-hhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQP-NLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ...+.. ..+.+..-.....     .....+. .....+..+..++.+++.+||+.||++|||++|+++.
T Consensus       229 ~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          229 LGTPTE-EQWPDMCSLPDYV-----TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HCCCCT-TTSSSTTSSTTCC-----CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cCCCCh-hhhhhhccCcccc-----cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            111111 0000000000000     0000000 0111112344678899999999999999999999863

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8.3e-39  Score=351.98  Aligned_cols=279  Identities=20%  Similarity=0.228  Sum_probs=206.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcC-CCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTR-GNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~  634 (871)
                      .++|.+.+.||+|+||.||+|++..+++.||||++....  ....+.+.+|+.+++.++||||+++++++...... ...
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            368999999999999999999999999999999996432  23356788999999999999999999998765332 122


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||++ ++|.+++..         .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~D  187 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD  187 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECS
T ss_pred             eEEEEEcccc-ccHHHHhhc---------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEe
Confidence            3499999996 688888743         489999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||.+......      .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..................+
T Consensus       188 fg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  261 (371)
T 4exu_A          188 FGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  261 (371)
T ss_dssp             TTCC--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cCcccccccC------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999865432      223568999999998776 688999999999999999999999998654333222222222222


Q ss_pred             c-hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 D-QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      . ...............   ..............+..+...+.+++.+||+.||++|||+.|+++.
T Consensus       262 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          262 GTEFVQKLNDKAAKSYI---QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CHHHHTTCSCHHHHHHH---HHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cHHHHHHhhhhhhhhhh---hccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            2 222222221111111   1111111112222223446778999999999999999999999863

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.3e-39  Score=349.46  Aligned_cols=285  Identities=21%  Similarity=0.270  Sum_probs=206.1

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCc---CC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDT---RG  632 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  632 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||++....  ......+.+|+++++.++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            468999999999999999999999899999999985433  2234677899999999999999999999876432   11


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                      ....|+||||+++ ++.+.+.....      .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl  165 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLV------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL  165 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             CceEEEEEeccCC-CHHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEE
Confidence            3568999999964 78877765432      589999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCC-ccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh-
Q 002883          713 GDFGLSRLLHDNSPD-QTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK-  789 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~-  789 (871)
                      +|||.|......... ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||............... 
T Consensus       166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  245 (351)
T 3mi9_A          166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC  245 (351)
T ss_dssp             CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            999999876533211 122334568999999998765 46799999999999999999999999865433222111111 


Q ss_pred             hCCCchhh-hhcChhHHHHHHHHHhhhhhhcCchhHHhHH--HHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          790 MGLPDQVA-EIIDPAILEEALEIQAGIVKELQPNLRAKFH--EIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       790 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...+.... ..........     ........+.......  .....+.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEK-----LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTS-----SCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCChhhccccccchhhcc-----cccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            11111111 1000000000     0000000011111111  12346789999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=350.98  Aligned_cols=258  Identities=15%  Similarity=0.110  Sum_probs=202.9

Q ss_pred             hhcCCCCCceeeccccceEEEEE-----ECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC---CCccceeeeeeccc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGI-----LGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR---HRNLVKIITSCSSI  628 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~  628 (871)
                      ..++|++.+.||+|+||+||+|+     +..+++.||||+++...   ...+.+|+++++.++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            34679999999999999999994     56678999999996543   456788888888886   99999999998765


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC--
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN--  706 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--  706 (871)
                           +..|+||||+++|+|.+++......  ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.  
T Consensus       140 -----~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~  209 (365)
T 3e7e_A          140 -----NGSVLVGELYSYGTLLNAINLYKNT--PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGF  209 (365)
T ss_dssp             -----SCEEEEECCCCSCBHHHHHHHHHTS--TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGG
T ss_pred             -----CCcEEEEeccCCCcHHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccc
Confidence                 5679999999999999999764321  122599999999999999999999999   9999999999999988  


Q ss_pred             ---------CCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          707 ---------EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       707 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                               ++.+||+|||+|+.+.... .........||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  288 (365)
T 3e7e_A          210 LEQDDEDDLSAGLALIDLGQSIDMKLFP-KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN  288 (365)
T ss_dssp             TCC------CTTEEECCCTTCEEGGGSC-TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred             cCccccccccCCEEEeeCchhhhhhccC-CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence                     8999999999998664322 223334467999999999999999999999999999999999999999753


Q ss_pred             hhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-CHHHHH
Q 002883          778 FEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-KIQDAI  856 (871)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-ta~evl  856 (871)
                      .......            ........                         ..+.+.+++..|++.+|.+|+ +++++.
T Consensus       289 ~~~~~~~------------~~~~~~~~-------------------------~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          289 EGGECKP------------EGLFRRLP-------------------------HLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             ETTEEEE------------CSCCTTCS-------------------------SHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             CCCceee------------chhccccC-------------------------cHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence            2221100            00000000                         012345788889999999994 688888


Q ss_pred             HHHHHHHHH
Q 002883          857 MELQEAQKM  865 (871)
Q Consensus       857 ~~L~~i~~~  865 (871)
                      +.|+++...
T Consensus       332 ~~l~~~l~~  340 (365)
T 3e7e_A          332 QKLKKVFQQ  340 (365)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            888876544

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.6e-38  Score=361.29  Aligned_cols=255  Identities=21%  Similarity=0.296  Sum_probs=204.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||+||+|++..+++.||+|++....   ......+.+|+++++.++||||+++++++.+.     .
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~  258 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-----T  258 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-----C
Confidence            367999999999999999999999899999999996432   23346788999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||++||+|.+++......   ...+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~D  332 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDED---NPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISD  332 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTT---SCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcc---cccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEee
Confidence            689999999999999999764321   23589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhh--hhHHHHhhhCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG--LSLHKYAKMGL  792 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~--~~~~~~~~~~~  792 (871)
                      ||+++......   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......  ...........
T Consensus       333 FGla~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~  409 (543)
T 3c4z_A          333 LGLAVELKAGQ---TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA  409 (543)
T ss_dssp             CTTCEECCTTC---CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC
T ss_pred             cceeeeccCCC---cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc
Confidence            99998765432   12233579999999999999999999999999999999999999997532110  01111110000


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCH-----HHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI-----QDAIM  857 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta-----~evl~  857 (871)
                      .                        ..+       ..+...+.+++.+||+.||++||++     +|+++
T Consensus       410 ~------------------------~~p-------~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          410 V------------------------TYP-------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             C------------------------CCC-------TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             c------------------------CCC-------cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            0                        000       0223456789999999999999975     56653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.8e-38  Score=339.02  Aligned_cols=253  Identities=24%  Similarity=0.349  Sum_probs=203.7

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHHHHHcCC-CCccceeeeeec
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---------RGASKSFIAECEALRSIR-HRNLVKIITSCS  626 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~  626 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++...         ....+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999999999999999996543         122456789999999995 999999999986


Q ss_pred             ccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC
Q 002883          627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN  706 (871)
Q Consensus       627 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  706 (871)
                      ..     ...++||||+++++|.+++....       .+++..++.++.|++.||.|||+.   +++||||||+||+++.
T Consensus        95 ~~-----~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~  159 (298)
T 1phk_A           95 TN-----TFFFLVFDLMKKGELFDYLTEKV-------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDD  159 (298)
T ss_dssp             CS-----SEEEEEEECCTTCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred             cC-----CeEEEEEeccCCCcHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcC
Confidence            54     67899999999999999997643       589999999999999999999999   9999999999999999


Q ss_pred             CCceEEeecccceecCCCCCCccccccccccccccCccccc------CCCCCCccchhhHHHHHHHHHhCCCCCchhhhh
Q 002883          707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA------LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEE  780 (871)
Q Consensus       707 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  780 (871)
                      ++.+||+|||.+.......    ......|++.|+|||++.      ...++.++||||||+++|+|++|+.||......
T Consensus       160 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  235 (298)
T 1phk_A          160 DMNIKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM  235 (298)
T ss_dssp             TCCEEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             CCcEEEecccchhhcCCCc----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH
Confidence            9999999999998765432    223356899999999864      457899999999999999999999999753322


Q ss_pred             hhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          781 GLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .. ............     .                       +....+...+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~-~~~~~~~~~~~~-----~-----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          236 LM-LRMIMSGNYQFG-----S-----------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HH-HHHHHHTCCCCC-----T-----------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HH-HHHHhcCCcccC-----c-----------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            11 111111110000     0                       001123446789999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.8e-39  Score=372.62  Aligned_cols=258  Identities=24%  Similarity=0.373  Sum_probs=200.5

Q ss_pred             CCCCc-eeeccccceEEEEEEC--CCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          561 FSSAN-LIGIGGYGYVYKGILG--TEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       561 y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      |.+.+ .||+|+||.||+|.+.  .++..||||+++... ....+.+.+|++++++++||||+++++++..      +..
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~  410 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EAL  410 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCe
Confidence            34444 7999999999999875  356779999996543 3356789999999999999999999999854      347


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++||||+++|+|.+++.....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFG  481 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKRE------EIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFG  481 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTT------TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred             EEEEEeCCCCcHHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeecc
Confidence            999999999999999975432      589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      +|+................+++.|+|||++.+..++.++|||||||++|||++ |+.||.......  ............
T Consensus       482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~~~  559 (613)
T 2ozo_A          482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKRME  559 (613)
T ss_dssp             TTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHHTTCCCC
T ss_pred             CcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCCCC
Confidence            99876543222222223346789999999988999999999999999999998 999998643221  111111110000


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                      ..                              ..++.++.+++..||+.||++|||+.++++.|+.+...
T Consensus       560 ~p------------------------------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          560 CP------------------------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             CC------------------------------TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CC------------------------------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            00                              02335677999999999999999999999999988654

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.3e-39  Score=373.56  Aligned_cols=252  Identities=25%  Similarity=0.366  Sum_probs=198.6

Q ss_pred             ceeeccccceEEEEEE--CCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGIL--GTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||.||+|.+  ...++.||||+++...  ....+.+.+|++++++++||||+++++++..      ...++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence            4799999999999965  4567889999996543  2345789999999999999999999999853      3468999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++|+|.+++....       .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+|+.
T Consensus       449 E~~~~g~L~~~l~~~~-------~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~  518 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNR-------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA  518 (635)
T ss_dssp             ECCTTEEHHHHHHHCT-------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred             EccCCCCHHHHHhhCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence            9999999999997643       589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhhhh
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEI  799 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  799 (871)
                      ...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||........  .............  
T Consensus       519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--~~~i~~~~~~~~p--  594 (635)
T 4fl3_A          519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAMLEKGERMGCP--  594 (635)
T ss_dssp             TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHHHTTCCCCCC--
T ss_pred             cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcCCCCCCC--
Confidence            7654322233333457889999999999999999999999999999998 9999986433221  1111111100000  


Q ss_pred             cChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          800 IDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                                                  ..++.++.+++..||+.||++|||+.++++.|+++..
T Consensus       595 ----------------------------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          595 ----------------------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             ----------------------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----------------------------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                                        0223467799999999999999999999999998754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.2e-38  Score=344.26  Aligned_cols=252  Identities=21%  Similarity=0.286  Sum_probs=197.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--------chHHHHHHHHHHHHcCCCCccceeeeeecccC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--------GASKSFIAECEALRSIRHRNLVKIITSCSSID  629 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  629 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....        .....+.+|++++++++||||+++++++... 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   87 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-   87 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence            4579999999999999999999998999999999854321        1234578999999999999999999997542 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV  709 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  709 (871)
                           ..|+||||+++++|.+++....       .+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.
T Consensus        88 -----~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~  152 (322)
T 2ycf_A           88 -----DYYIVLELMEGGELFDKVVGNK-------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEE  152 (322)
T ss_dssp             -----SEEEEEECCTTEETHHHHSTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSS
T ss_pred             -----ceEEEEecCCCCcHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCC
Confidence                 3799999999999999997643       589999999999999999999999   9999999999999987654


Q ss_pred             ---eEEeecccceecCCCCCCccccccccccccccCcccc---cCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhh
Q 002883          710 ---AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYG---ALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLS  783 (871)
Q Consensus       710 ---~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~  783 (871)
                         +||+|||.+......    .......||+.|+|||++   ....++.++|||||||++|+|++|+.||.........
T Consensus       153 ~~~~kl~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  228 (322)
T 2ycf_A          153 DCLIKITDFGHSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL  228 (322)
T ss_dssp             SCCEEECCCTTCEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH
T ss_pred             CCeEEEccCccceecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH
Confidence               999999999876432    222345689999999985   3567899999999999999999999999753322111


Q ss_pred             HHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          784 LHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .......... .                           .......+...+.+++.+||+.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          229 KDQITSGKYN-F---------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHHHTCCC-C---------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHhCccc-c---------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1111111000 0                           00011123456789999999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.2e-38  Score=337.28  Aligned_cols=255  Identities=21%  Similarity=0.311  Sum_probs=199.8

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ----RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....    ....+.+.+|+++++.++||||+++++++...+   .
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE---K   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---C
Confidence            478999999999999999999999899999999996432    234577899999999999999999999985432   2


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...|+||||++++ +.+++......     .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~  151 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDSVPEK-----RFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKIS  151 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHHSTTC-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             CeEEEEehhccCC-HHHHHHhCccc-----ccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEee
Confidence            5689999999776 77777654322     689999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE--VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      |||.+........ ........||+.|+|||+..+..  ++.++||||+|+++|+|++|+.||........ ........
T Consensus       152 dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~i~~~~  229 (305)
T 2wtk_C          152 ALGVAEALHPFAA-DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-FENIGKGS  229 (305)
T ss_dssp             CCTTCEECCTTCS-SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCC
T ss_pred             ccccccccCcccc-ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-HHHHhcCC
Confidence            9999987654321 22233456899999999877543  37899999999999999999999975322111 11110100


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .+                         .+       ..+...+.+++.+||+.||++|||+.|+++.
T Consensus       230 ~~-------------------------~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 YA-------------------------IP-------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             CC-------------------------CC-------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             CC-------------------------CC-------CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00                         00       0123456789999999999999999999874

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.9e-38  Score=357.70  Aligned_cols=267  Identities=21%  Similarity=0.289  Sum_probs=206.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....  ...+.+|+++++.+.|++.+..+.++...    ....+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~----~~~~~   79 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVE----GDYNV   79 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEE----TTEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEee----CCEEE
Confidence            4689999999999999999999988999999999865433  24578899999999875544444443321    26679


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee---CCCCceEEee
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL---DNEMVAHVGD  714 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~D  714 (871)
                      +||||+ +++|.+++.....      .+++..++.++.||+.||+|||+.   +|+||||||+|||+   +.++.+||+|
T Consensus        80 lvme~~-g~sL~~ll~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~D  149 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCSR------KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIID  149 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECC
T ss_pred             EEEECC-CCCHHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEe
Confidence            999999 9999999975432      599999999999999999999999   99999999999999   5889999999


Q ss_pred             cccceecCCCCCCc----cccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh
Q 002883          715 FGLSRLLHDNSPDQ----TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM  790 (871)
Q Consensus       715 fg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~  790 (871)
                      ||+++.+.......    .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+   
T Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~-~~---  225 (483)
T 3sv0_A          150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-KY---  225 (483)
T ss_dssp             CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH-HH---
T ss_pred             CCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH-HH---
Confidence            99999876543221    11224679999999999999999999999999999999999999997532211000 00   


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                            ..+.....               ..........++.++.+++..||+.||++||++.++++.|+++...
T Consensus       226 ------~~i~~~~~---------------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          226 ------EKISEKKV---------------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             ------HHHHHHHH---------------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ------HHHhhccc---------------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence                  00000000               0000111123356788999999999999999999999999988653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=343.46  Aligned_cols=260  Identities=23%  Similarity=0.289  Sum_probs=200.0

Q ss_pred             HHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcC-C
Q 002883          555 LKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTR-G  632 (871)
Q Consensus       555 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~-~  632 (871)
                      ....++|++.+.||+|+||.||+|++..+++.||||++..... ..+.+.+|+.+++++ +||||+++++++...... .
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            3456789999999999999999999988999999999965433 446788999999998 899999999998764322 1


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                      ....|+||||+++++|.+++......     .+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTKGN-----TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence            36789999999999999999875422     689999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHH
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA-----LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKY  787 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~  787 (871)
                      +|||++.......   .......||+.|+|||++.     +..++.++|||||||++|+|++|+.||......... ...
T Consensus       171 ~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~  246 (326)
T 2x7f_A          171 VDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-FLI  246 (326)
T ss_dssp             CCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHH
T ss_pred             eeCcCceecCcCc---cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH-HHh
Confidence            9999998764321   1223356899999999876     567899999999999999999999999754322111 111


Q ss_pred             hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .....+...    .                          ..+...+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~----~--------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          247 PRNPAPRLK----S--------------------------KKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHSCCCCCS----C--------------------------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hcCccccCC----c--------------------------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            111100000    0                          012345778999999999999999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.5e-38  Score=372.50  Aligned_cols=251  Identities=22%  Similarity=0.292  Sum_probs=204.2

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcC
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  631 (871)
                      ...++|++.+.||+|+||.||+|++..+++.||||+++..   .....+.+..|..++..+ +||+|+++++++.+.   
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~---  414 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM---  414 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS---
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC---
Confidence            3457899999999999999999999999999999999643   223456778899999988 799999999998765   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                        ...|+||||+++|+|.+++....       .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+|
T Consensus       415 --~~~~lV~E~~~gg~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ik  482 (674)
T 3pfq_A          415 --DRLYFVMEYVNGGDLMYHIQQVG-------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK  482 (674)
T ss_dssp             --SEEEEEEECCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEE
T ss_pred             --CEEEEEEeCcCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEE
Confidence              67899999999999999998754       599999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      |+|||+|+......   .......||+.|+|||++.+..|+.++|||||||++|||++|+.||........ ........
T Consensus       483 L~DFGla~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~~  558 (674)
T 3pfq_A          483 IADFGMCKENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-FQSIMEHN  558 (674)
T ss_dssp             ECCCTTCEECCCTT---CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHSSC
T ss_pred             EeecceeeccccCC---cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH-HHHHHhCC
Confidence            99999998643321   223446799999999999999999999999999999999999999986432211 11111110


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCH-----HHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKI-----QDAIM  857 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta-----~evl~  857 (871)
                      ..  ...                              ....++.+++.+||+.||++||++     +|+++
T Consensus       559 ~~--~p~------------------------------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 VA--YPK------------------------------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             CC--CCT------------------------------TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             CC--CCc------------------------------cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            00  000                              123456789999999999999997     66553

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.2e-38  Score=356.13  Aligned_cols=276  Identities=21%  Similarity=0.299  Sum_probs=198.4

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~  637 (871)
                      .+|++.+.||+|+||.||+|++..+++.||||++.....    ...+|+++++.++||||++++++|..... ....+.+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            468999999999999999999998999999999864332    23469999999999999999999865432 2335578


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-CceEEeecc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE-MVAHVGDFG  716 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg  716 (871)
                      +||||+++ ++.+.+......   ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.+ +.+||+|||
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRA---KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eehhcccc-cHHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence            99999965 777766542211   23689999999999999999999999   99999999999999965 578999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      +|+.......    .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.........+.+..
T Consensus       203 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~  278 (420)
T 1j1b_A          203 SAKQLVRGEP----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR  278 (420)
T ss_dssp             TCEECCTTCC----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             hhhhcccCCC----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9987654321    2235689999999987654 7899999999999999999999999864333222111111111110


Q ss_pred             --hhhhcChhHHHHHHHHHhhhhhhcCc-hhHHhH-HHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 --VAEIIDPAILEEALEIQAGIVKELQP-NLRAKF-HEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 --~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                        +.+. .+.....       ....... .....+ .....++.+++.+||+.||++|||+.|+++
T Consensus       279 ~~~~~~-~~~~~~~-------~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          279 EQIREM-NPNYTEF-------KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHH-CSCCCCC-------CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhh-Chhhhhh-------ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence              1000 0000000       0000000 000000 122456889999999999999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.9e-38  Score=337.41  Aligned_cols=255  Identities=22%  Similarity=0.254  Sum_probs=187.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++....  ...+.+.++...++.++||||+++++++.+.     ..
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~~   80 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----GD   80 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----CC
Confidence            4689999999999999999999998999999999964422  2223344555557888999999999998765     56


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||++ |+|.+++......   ...+++..++.++.|++.||+|||+.  .+|+||||||+||+++.++.+||+||
T Consensus        81 ~~lv~e~~~-~~l~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Df  154 (290)
T 3fme_A           81 VWICMELMD-TSLDKFYKQVIDK---GQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDF  154 (290)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC
T ss_pred             EEEEEehhc-cchHHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeec
Confidence            899999996 5888887653211   23699999999999999999999985  28999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccc----cCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYG----ALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      |.+.......    ......||+.|+|||++    .+..++.++||||+||++|+|++|+.||.................
T Consensus       155 g~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  230 (290)
T 3fme_A          155 GISGYLVDDV----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP  230 (290)
T ss_dssp             -------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC
T ss_pred             CCcccccccc----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC
Confidence            9998765432    22234689999999985    566789999999999999999999999975322222222222211


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .+....                              .....++.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~------------------------------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 SPQLPA------------------------------DKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CCCCCT------------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCccc------------------------------ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            111100                              012345778999999999999999999988

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.7e-38  Score=349.58  Aligned_cols=204  Identities=25%  Similarity=0.308  Sum_probs=172.1

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-CC-----ccceeeeeecccCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-HR-----NLVKIITSCSSIDT  630 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~  630 (871)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++... .....+.+|+.+++.++ |+     +++++++++...  
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~--  128 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR--  128 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET--
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC--
Confidence            4578999999999999999999999899999999996432 23466778888888874 54     489999988765  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC--CCC
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD--NEM  708 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~  708 (871)
                         ...|+||||++ ++|.+++......     .+++..++.++.|++.||.|||++ ..+|+||||||+||+++  .++
T Consensus       129 ---~~~~lv~e~~~-~~L~~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~  198 (382)
T 2vx3_A          129 ---NHLCLVFEMLS-YNLYDLLRNTNFR-----GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRS  198 (382)
T ss_dssp             ---TEEEEEEECCC-CBHHHHHHHTTTS-----CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSC
T ss_pred             ---CceEEEEecCC-CCHHHHHhhcCcC-----CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCC
Confidence               67899999995 5999999875422     589999999999999999999952 12999999999999994  577


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhh
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFE  779 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  779 (871)
                      .+||+|||+|+.....      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       199 ~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          199 AIKIVDFGSSCQLGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             CEEECCCTTCEETTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cEEEEeccCceecccc------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            8999999999876432      2235689999999999999999999999999999999999999986443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=355.14  Aligned_cols=327  Identities=20%  Similarity=0.185  Sum_probs=296.5

Q ss_pred             ccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCC
Q 002883          137 IRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLP  216 (871)
Q Consensus       137 L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~  216 (871)
                      -+.++.+++.++           .+|..+.  ++++.|+|++|+++.+++      ..+..+++|++|+|++|.+++..|
T Consensus        13 ~~~v~c~~~~l~-----------~ip~~~~--~~l~~L~L~~n~l~~~~~------~~~~~l~~L~~L~L~~n~i~~~~~   73 (477)
T 2id5_A           13 DRAVLCHRKRFV-----------AVPEGIP--TETRLLDLGKNRIKTLNQ------DEFASFPHLEELELNENIVSAVEP   73 (477)
T ss_dssp             TTEEECCSCCCS-----------SCCSCCC--TTCSEEECCSSCCCEECT------TTTTTCTTCCEEECTTSCCCEECT
T ss_pred             CCEEEeCCCCcC-----------cCCCCCC--CCCcEEECCCCccceECH------hHccCCCCCCEEECCCCccCEeCh
Confidence            357888888887           5565553  589999999999988653      467789999999999999998888


Q ss_pred             hhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCc
Q 002883          217 NSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLI  296 (871)
Q Consensus       217 ~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  296 (871)
                      ..+..+ ++|++|+|++|+++...+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|.+++
T Consensus        74 ~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  152 (477)
T 2id5_A           74 GAFNNL-FNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLN  152 (477)
T ss_dssp             TTTTTC-TTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCT
T ss_pred             hhhhCC-ccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCC
Confidence            888887 4799999999999987778899999999999999999999899999999999999999999988888999999


Q ss_pred             cccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCC
Q 002883          297 FLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLS  376 (871)
Q Consensus       297 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~  376 (871)
                      +|++|+|++|++++..+..|.++++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|.......+|+.|+|+
T Consensus       153 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~  232 (477)
T 2id5_A          153 SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSIT  232 (477)
T ss_dssp             TCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEE
T ss_pred             CCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECc
Confidence            99999999999998888889999999999999999998888899999999999999999887888777777899999999


Q ss_pred             CCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccC
Q 002883          377 ENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEV  456 (871)
Q Consensus       377 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~  456 (871)
                      +|.+++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|.+++..
T Consensus       233 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  312 (477)
T 2id5_A          233 HCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLE  312 (477)
T ss_dssp             SSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCC
T ss_pred             CCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeC
Confidence            99999665578999999999999999999999999999999999999999999999999999999999999999999876


Q ss_pred             CCC-cccccccceeccCCCCCccCCCcc
Q 002883          457 PSE-GVFKNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       457 ~~~-~~~~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      +.. ..+++++.+++.+|+|.|+|...|
T Consensus       313 ~~~~~~l~~L~~L~l~~N~l~c~c~~~~  340 (477)
T 2id5_A          313 ESVFHSVGNLETLILDSNPLACDCRLLW  340 (477)
T ss_dssp             GGGBSCGGGCCEEECCSSCEECSGGGHH
T ss_pred             HhHcCCCcccCEEEccCCCccCccchHh
Confidence            643 456789999999999999998665

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.6e-38  Score=344.02  Aligned_cols=280  Identities=24%  Similarity=0.317  Sum_probs=205.4

Q ss_pred             hhcCCCCCceeeccccceEEEEEEC-CCCcEEEEEEeecccc--chHHHHHHHHHHHHcC---CCCccceeeeeecccCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILG-TEETNVAVKVLDLQQR--GASKSFIAECEALRSI---RHRNLVKIITSCSSIDT  630 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~  630 (871)
                      ..++|++.+.||+|+||.||+|++. .+++.||+|+++....  .....+.+|+.+++.+   +||||+++++++.....
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999995 6789999999864332  1223566777777766   89999999999874433


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCce
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA  710 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  710 (871)
                      ......++||||++ |+|.+++......     .+++..++.++.|++.||.|||+.   ||+||||||+||+++.++.+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~  159 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEP-----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQI  159 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCE
Confidence            34577899999997 6999999765422     589999999999999999999999   99999999999999999999


Q ss_pred             EEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh
Q 002883          711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM  790 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~  790 (871)
                      ||+|||.+......    .......||+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus       160 kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  235 (326)
T 1blx_A          160 KLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI  235 (326)
T ss_dssp             EECSCCSCCCCCGG----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEecCcccccccCC----CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHc
Confidence            99999999865421    22334568999999999988899999999999999999999999998644332211111111


Q ss_pred             CCCch--hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          791 GLPDQ--VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       791 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ..+..  .........  .      ................+...+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~--~------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          236 GLPGEEDWPRDVALPR--Q------AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCCGGGSCTTCSSCG--G------GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCcccCccccccch--h------hhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11110  000000000  0      00000000011111233456789999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.9e-39  Score=369.31  Aligned_cols=257  Identities=28%  Similarity=0.447  Sum_probs=205.9

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ..++|++.+.||+|+||.||+|++. .+..||||+++.... ..+.+.+|++++++++||||+++++++.+      ...
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~  336 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  336 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             chhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccc
Confidence            4567899999999999999999997 456799999975443 35789999999999999999999998754      347


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||+++|+|.+++......     .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  408 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGK-----YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  408 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred             eEeeehhcCCcHHHHHhhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccc
Confidence            8999999999999999764322     589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      +++......  ........++..|+|||++.++.++.++|||||||++|||++ |+.||........  ...........
T Consensus       409 ~a~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~--~~~i~~~~~~~  484 (535)
T 2h8h_A          409 LARLIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQVERGYRMP  484 (535)
T ss_dssp             STTTCCCHH--HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH--HHHHHTTCCCC
T ss_pred             cceecCCCc--eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcCCCCC
Confidence            998654211  111222346788999999888899999999999999999999 9999976433211  11111110000


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                      .                              ...+...+.+++.+||+.||++|||++++++.|+++.
T Consensus       485 ~------------------------------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          485 C------------------------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             C------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             C------------------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            0                              0023345778999999999999999999999998763

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=353.72  Aligned_cols=209  Identities=22%  Similarity=0.294  Sum_probs=157.1

Q ss_pred             CCCC-CceeeccccceEEEEEEC--CCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          560 GFSS-ANLIGIGGYGYVYKGILG--TEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       560 ~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .|++ .++||+|+||+||+|++.  .+++.||||++....  ....+.+|+++++.++||||+++++++....   ....
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~~   95 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHA---DRKV   95 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCeE
Confidence            4665 568999999999999965  468899999996443  2357889999999999999999999985432   2678


Q ss_pred             eEEEeccCCCCHHHHhhcccccc--cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee----CCCCce
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQ--NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL----DNEMVA  710 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~  710 (871)
                      |+||||++ ++|.+++.......  .....+++..++.++.||+.||+|||+.   +|+||||||+||++    +.++.+
T Consensus        96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcE
Confidence            99999995 58888886543211  1122489999999999999999999999   99999999999999    677899


Q ss_pred             EEeecccceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       711 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      ||+|||+|+................||+.|+|||++.+. .++.++||||+||++|+|++|+.||...
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            999999998775432222333446799999999988764 5899999999999999999999999643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.4e-38  Score=333.01  Aligned_cols=248  Identities=17%  Similarity=0.249  Sum_probs=198.1

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||+||+|++..+++.||+|++....  ......+.+|+..+..+ +||||+++++++.+.     .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----~   84 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----D   84 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----T
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----C
Confidence            467999999999999999999999899999999996532  33456788999999999 999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC-------
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE-------  707 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-------  707 (871)
                      ..++||||+++++|.+++......   ...+++..++.++.||+.||+|||+.   +|+||||||+||+++.+       
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~  158 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRI---MSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAAS  158 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------
T ss_pred             eEEEEEEecCCCcHHHHHHhhccc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccc
Confidence            789999999999999999765321   12589999999999999999999999   99999999999999844       


Q ss_pred             ------------CceEEeecccceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCC
Q 002883          708 ------------MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPT  774 (871)
Q Consensus       708 ------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf  774 (871)
                                  ..+||+|||.+.......       ...||+.|+|||.+.+. .+++++|||||||++|+|++|.+|+
T Consensus       159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~  231 (289)
T 1x8b_A          159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQ-------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP  231 (289)
T ss_dssp             -----------CCCEEECCCTTCEETTCSC-------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cccccccccCCceEEEEcccccccccCCcc-------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence                        479999999998765321       23489999999988765 5668999999999999999999877


Q ss_pred             chhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHH
Q 002883          775 DDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQD  854 (871)
Q Consensus       775 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~e  854 (871)
                      .....    .........+. ...                              .+...+.+++.+||+.||++|||+.|
T Consensus       232 ~~~~~----~~~~~~~~~~~-~~~------------------------------~~~~~~~~li~~~l~~dp~~Rps~~~  276 (289)
T 1x8b_A          232 RNGDQ----WHEIRQGRLPR-IPQ------------------------------VLSQEFTELLKVMIHPDPERRPSAMA  276 (289)
T ss_dssp             SSSHH----HHHHHTTCCCC-CSS------------------------------CCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cchhH----HHHHHcCCCCC-CCc------------------------------ccCHHHHHHHHHHhCCCcccCCCHHH
Confidence            53211    11111111110 000                              12345678999999999999999999


Q ss_pred             HHHH
Q 002883          855 AIME  858 (871)
Q Consensus       855 vl~~  858 (871)
                      +++.
T Consensus       277 ll~h  280 (289)
T 1x8b_A          277 LVKH  280 (289)
T ss_dssp             HHTC
T ss_pred             HhhC
Confidence            9863

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5e-39  Score=344.18  Aligned_cols=271  Identities=21%  Similarity=0.315  Sum_probs=186.3

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ...++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++...     .
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   86 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----D   86 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS-----S
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----C
Confidence            44678999999999999999999998889999999986433 23346788999999999999999999998765     5


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccc-cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQ-NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ..++||||+++++|.+++....... .....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  163 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIA  163 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEE
Confidence            6899999999999999997532111 1123589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCC--ccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh
Q 002883          714 DFGLSRLLHDNSPD--QTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM  790 (871)
Q Consensus       714 Dfg~a~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~  790 (871)
                      |||.+.........  ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............. ..
T Consensus       164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~  242 (303)
T 2vwi_A          164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QN  242 (303)
T ss_dssp             CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-TS
T ss_pred             eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh-cc
Confidence            99999876532211  112233568999999998765 568999999999999999999999997643322111111 11


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ..+.......++.                      ....+...+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 DPPSLETGVQDKE----------------------MLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SCCCTTC-----C----------------------CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCccccccccch----------------------hhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1110000000000                      00122345778999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.9e-38  Score=345.72  Aligned_cols=277  Identities=20%  Similarity=0.231  Sum_probs=203.4

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcC-CCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTR-GNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~~  635 (871)
                      ++|.+.+.||+|+||.||+|++..+++.||||++....  ....+.+.+|+.+++.++||||+++++++...... ....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            67999999999999999999999899999999996432  23346788999999999999999999998764221 1234


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||++ ++|.+++..         .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       104 ~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df  170 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL---------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF  170 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECST
T ss_pred             EEEEecccc-CCHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeec
Confidence            599999996 688877743         489999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC-
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP-  793 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~-  793 (871)
                      |.+......      .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||................+.+ 
T Consensus       171 g~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  244 (353)
T 3coi_A          171 GLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  244 (353)
T ss_dssp             TCTTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred             ccccCCCCC------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999765322      223468999999998776 678999999999999999999999998644332211111111211 


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ......+.........   ........+............+.+++.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYI---QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHTTCSCHHHHHHH---HTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHhhHHHHHHH---HhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1121111111111111   111111111112222344567889999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.4e-39  Score=353.23  Aligned_cols=260  Identities=9%  Similarity=0.028  Sum_probs=182.1

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHHcC--CCCccceeeeee-------
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEALRSI--RHRNLVKIITSC-------  625 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~~~~-------  625 (871)
                      ..+|++.+.||+|+||.||+|++..+++.||||++.....   ...+.+.+|+.+++.+  +||||++++..+       
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            3458999999999999999999998999999999976432   3345677785544444  699988855333       


Q ss_pred             cccCcC------------CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHH------HHHHHHHHHHHHHHhhc
Q 002883          626 SSIDTR------------GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQR------LSIAIDVANVLEYLHHH  687 (871)
Q Consensus       626 ~~~~~~------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~  687 (871)
                      .....+            .....|+||||++ |+|.+++.....      .+++..+      ..++.||+.||+|||++
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~------~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF------VYVFRGDEGILALHILTAQLIRLAANLQSK  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH------SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc------ccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence            221110            0145799999998 899999987532      2445555      67889999999999999


Q ss_pred             CCCCeEecCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccC--CCCCCccchhhHHHHHH
Q 002883          688 CHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL--GEVSTHGDEYSFGILML  765 (871)
Q Consensus       688 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~  765 (871)
                         +|+||||||+|||++.++.+||+|||+|+....      ......+|+.|+|||++.+  ..++.++|||||||++|
T Consensus       214 ---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~  284 (371)
T 3q60_A          214 ---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY  284 (371)
T ss_dssp             ---TEEETTCSGGGEEECTTSCEEECCGGGEEETTC------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHH
T ss_pred             ---CCccCcCCHHHEEECCCCCEEEEecceeeecCC------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHH
Confidence               999999999999999999999999999987542      1213457799999999877  67899999999999999


Q ss_pred             HHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCC
Q 002883          766 EMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEEL  845 (871)
Q Consensus       766 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  845 (871)
                      ||++|+.||................. .........                       +....+...+.+++.+||+.|
T Consensus       285 elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~L~~d  340 (371)
T 3q60_A          285 RVWCLFLPFGLVTPGIKGSWKRPSLR-VPGTDSLAF-----------------------GSCTPLPDFVKTLIGRFLNFD  340 (371)
T ss_dssp             HHHHSSCSTTBCCTTCTTCCCBCCTT-SCCCCSCCC-----------------------TTSSCCCHHHHHHHHHHTCSS
T ss_pred             HHHhCCCCCCCcCcccccchhhhhhh-hccccccch-----------------------hhccCCCHHHHHHHHHHcCCC
Confidence            99999999986432211100000000 000000000                       000123446779999999999


Q ss_pred             CCCCCCHHHHHH
Q 002883          846 PRDRMKIQDAIM  857 (871)
Q Consensus       846 P~~RPta~evl~  857 (871)
                      |++|||+.|+++
T Consensus       341 P~~Rpt~~e~l~  352 (371)
T 3q60_A          341 RRRRLLPLEAME  352 (371)
T ss_dssp             TTTCCCHHHHTT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.1e-38  Score=347.45  Aligned_cols=277  Identities=22%  Similarity=0.311  Sum_probs=197.1

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~  636 (871)
                      ..+|++.+.||+|+||+||+|++..+++ ||+|++.....    ...+|+++++.++||||+++++++..... ....+.
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            3579999999999999999999986555 88888753322    22369999999999999999999876543 334567


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC-CCCceEEeec
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD-NEMVAHVGDF  715 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Df  715 (871)
                      ++||||++++ +.+.+.....   ....+++..++.++.||+.||+|||+.   +|+||||||+||+++ .++.+||+||
T Consensus       114 ~lv~e~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DF  186 (394)
T 4e7w_A          114 NLVLEYVPET-VYRASRHYAK---LKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDF  186 (394)
T ss_dssp             EEEEECCSEE-HHHHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEeeccCcc-HHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeC
Confidence            8999999764 4444332111   122689999999999999999999999   999999999999998 7999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      |+|+.......    .....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+.........+.+.
T Consensus       187 G~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~  262 (394)
T 4e7w_A          187 GSAKILIAGEP----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS  262 (394)
T ss_dssp             TTCEECCTTCC----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             CCcccccCCCC----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99987654322    2235689999999987654 589999999999999999999999986543332222222222221


Q ss_pred             h-hhhhcChhHHHHHHHHHhhhhhhcCc-hhHHhH-HHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 Q-VAEIIDPAILEEALEIQAGIVKELQP-NLRAKF-HEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      . ......+....       .......+ .....+ .....++.+++.+||+.||++|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          263 REQIKTMNPNYME-------HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHHHHCGGGSS-------SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhChhhhh-------hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            1 00000000000       00000000 000000 123457889999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.2e-38  Score=343.09  Aligned_cols=288  Identities=20%  Similarity=0.247  Sum_probs=195.3

Q ss_pred             HHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-
Q 002883          552 AELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-  630 (871)
Q Consensus       552 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-  630 (871)
                      .......++|++.+.||+|+||+||+|++..+++.||||++..... ......+|++.++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            3455667899999999999999999999998999999999854332 23456678888888999999999999866433 


Q ss_pred             -CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeEecCCCCCceeeCC-
Q 002883          631 -RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH--HHCHTSIVHCDLKPSNVLLDN-  706 (871)
Q Consensus       631 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlkp~Nill~~-  706 (871)
                       ....+.++||||+++ ++.+.+.....   ....+++..+..++.|++.|+.|||  +.   +|+||||||+||+++. 
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~  167 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYR---RQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA  167 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence             233457899999975 55554443211   1226899999999999999999999  87   9999999999999996 


Q ss_pred             CCceEEeecccceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHH
Q 002883          707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLH  785 (871)
Q Consensus       707 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~  785 (871)
                      ++.+||+|||++.......    ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  243 (360)
T 3e3p_A          168 DGTLKLCDFGSAKKLSPSE----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE  243 (360)
T ss_dssp             TTEEEECCCTTCBCCCTTS----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCcEEEeeCCCceecCCCC----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence            8999999999998765432    12234689999999987654 489999999999999999999999986543322222


Q ss_pred             HHhhhCCCch-hhhhcChhHHHHHHHHHhhhhhhcCchhHHhH----HHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          786 KYAKMGLPDQ-VAEIIDPAILEEALEIQAGIVKELQPNLRAKF----HEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       786 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .......+.. .....++......      ............+    .....++.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          244 IVRVLGCPSREVLRKLNPSHTDVD------LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHCCCCHHHHHHHCTTCCCGG------GGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHcCCCCHHHHHhcccchhhcc------ccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            1111111111 1111110000000      0000000000000    123567889999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.2e-38  Score=333.26  Aligned_cols=252  Identities=22%  Similarity=0.318  Sum_probs=202.2

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|++++++++||||+++++++...     .
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   94 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----S   94 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-----C
Confidence            3468999999999999999999999899999999996433  23457889999999999999999999998765     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC---CceE
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE---MVAH  711 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~k  711 (871)
                      ..++||||+++++|.+++....       .+++..++.++.|++.||.|||+.   +|+||||||+||+++.+   +.+|
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~k  164 (287)
T 2wei_A           95 SFYIVGELYTGGELFDEIIKRK-------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK  164 (287)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             eEEEEEEccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEE
Confidence            6899999999999999987643       589999999999999999999999   99999999999999754   4799


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      |+|||.+.......    ......|++.|+|||.+.+ .++.++||||+|+++|+|++|+.||........ ........
T Consensus       165 L~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~  238 (287)
T 2wei_A          165 IIDFGLSTCFQQNT----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-LKRVETGK  238 (287)
T ss_dssp             ECSTTGGGTBCCCS----SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCC
T ss_pred             EeccCcceeecCCC----ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHcCC
Confidence            99999998765332    1223458999999998765 589999999999999999999999975432211 11111111


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .+...                            +....+..++.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          239 YAFDL----------------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCCCS----------------------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCc----------------------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            11000                            001123346779999999999999999999997

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-38  Score=345.50  Aligned_cols=254  Identities=23%  Similarity=0.280  Sum_probs=198.9

Q ss_pred             hcCCCCCceeeccccceEEEEEEC---CCCcEEEEEEeeccc----cchHHHHHHHHHHHHcC-CCCccceeeeeecccC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILG---TEETNVAVKVLDLQQ----RGASKSFIAECEALRSI-RHRNLVKIITSCSSID  629 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  629 (871)
                      .++|++.+.||+|+||+||+|++.   .+++.||||+++...    ....+.+.+|+++++.+ +||||+++++++... 
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-  131 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  131 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence            468999999999999999999984   478999999985432    22345677899999999 799999999998765 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV  709 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  709 (871)
                          ...++||||+++|+|.+++....       .+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.
T Consensus       132 ----~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~  197 (355)
T 1vzo_A          132 ----TKLHLILDYINGGELFTHLSQRE-------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGH  197 (355)
T ss_dssp             ----TEEEEEECCCCSCBHHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred             ----ceEEEEeecCCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCc
Confidence                66899999999999999997643       589999999999999999999999   9999999999999999999


Q ss_pred             eEEeecccceecCCCCCCccccccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhh--hHH
Q 002883          710 AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL--GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL--SLH  785 (871)
Q Consensus       710 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~--~~~  785 (871)
                      +||+|||+++......  ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||........  ...
T Consensus       198 ~kl~DfG~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  275 (355)
T 1vzo_A          198 VVLTDFGLSKEFVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS  275 (355)
T ss_dssp             EEESCSSEEEECCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred             EEEeeCCCCeecccCC--CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH
Confidence            9999999998754321  122334579999999999875  3578999999999999999999999974322111  000


Q ss_pred             HHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHHHH
Q 002883          786 KYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIMEL  859 (871)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~~L  859 (871)
                      .......+.                        .+       ..+...+.+++.+||+.||++||     |++|+++..
T Consensus       276 ~~~~~~~~~------------------------~~-------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          276 RRILKSEPP------------------------YP-------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHHHHCCCC------------------------CC-------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             HHHhccCCC------------------------CC-------cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            000000000                        00       01234567899999999999999     999998754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.3e-37  Score=338.85  Aligned_cols=279  Identities=18%  Similarity=0.219  Sum_probs=204.7

Q ss_pred             hcCCCCCceeeccccceEEEEEE-CCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCC------ccceeeeeecccCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGIL-GTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHR------NLVKIITSCSSIDT  630 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~  630 (871)
                      .++|++.+.||+|+||+||+|.+ ..+++.||||+++... ...+.+.+|+++++.++|+      +++++++++...  
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~--   89 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH--   89 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET--
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC--
Confidence            36899999999999999999998 5578999999996433 3456788999999888655      499999988765  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC----
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN----  706 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----  706 (871)
                         ...++||||+ +++|.+++......     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.    
T Consensus        90 ---~~~~lv~e~~-~~~l~~~l~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~  157 (339)
T 1z57_A           90 ---GHICIVFELL-GLSTYDFIKENGFL-----PFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYT  157 (339)
T ss_dssp             ---TEEEEEEECC-CCBHHHHHHHTTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEE
T ss_pred             ---CcEEEEEcCC-CCCHHHHHHhcCCC-----CCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccc
Confidence               6789999999 89999999765422     589999999999999999999999   9999999999999987    


Q ss_pred             ---------------CCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCC
Q 002883          707 ---------------EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGK  771 (871)
Q Consensus       707 ---------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~  771 (871)
                                     ++.+||+|||.+......      .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  231 (339)
T 1z57_A          158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF  231 (339)
T ss_dssp             EEEC----CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             cccCCccccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCC
Confidence                           668999999999875432      22346899999999999889999999999999999999999


Q ss_pred             CCCchhhhhhhh-HHHHhhhCCCchhhhhcC-hh--------HH--HHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhc
Q 002883          772 RPTDDMFEEGLS-LHKYAKMGLPDQVAEIID-PA--------IL--EEALEIQAGIVKELQPNLRAKFHEIQVSILRVGI  839 (871)
Q Consensus       772 ~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~--------~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  839 (871)
                      .||......... .........+........ ..        +.  ............... ...........++.+++.
T Consensus       232 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~  310 (339)
T 1z57_A          232 TVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK-EFMLSQDVEHERLFDLIQ  310 (339)
T ss_dssp             CSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGG-GGCSCCSHHHHHHHHHHH
T ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchh-hhcccchhhHHHHHHHHH
Confidence            999754332211 111111122222111000 00        00  000000000000000 000111234567899999


Q ss_pred             ccccCCCCCCCCHHHHHHH
Q 002883          840 LCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       840 ~cl~~dP~~RPta~evl~~  858 (871)
                      +||+.||++|||+.|+++.
T Consensus       311 ~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          311 KMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             HHTCSSTTTSCCHHHHTTS
T ss_pred             HHhCcCcccccCHHHHhcC
Confidence            9999999999999999853

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.2e-37  Score=347.10  Aligned_cols=204  Identities=22%  Similarity=0.307  Sum_probs=172.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC--------CCccceeeeeecccC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR--------HRNLVKIITSCSSID  629 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~  629 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+++++.++        |+||+++++++... 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~-  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS-  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE-
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec-
Confidence            368999999999999999999999899999999996432 34567889999999885        78899999988643 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM-  708 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-  708 (871)
                      .......|+||||+ ++++.+++.....     ..+++..++.++.||+.||+|||+++  +|+||||||+|||++.++ 
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~  185 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNY-----QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccch
Confidence            22336789999999 6677776655432     25899999999999999999999852  899999999999998775 


Q ss_pred             ------------------------------------------------ceEEeecccceecCCCCCCccccccccccccc
Q 002883          709 ------------------------------------------------VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY  740 (871)
Q Consensus       709 ------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y  740 (871)
                                                                      .+||+|||.|......      .....||+.|
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y  259 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQY  259 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGG
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcc
Confidence                                                            7999999999876432      2234689999


Q ss_pred             cCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       741 ~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      +|||++.+..++.++|||||||++|||++|+.||...
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  296 (397)
T 1wak_A          260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH  296 (397)
T ss_dssp             CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence            9999999889999999999999999999999999753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.7e-38  Score=343.00  Aligned_cols=265  Identities=18%  Similarity=0.256  Sum_probs=203.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccch-----------------HHHHHHHHHHHHcCCCCccce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGA-----------------SKSFIAECEALRSIRHRNLVK  620 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~  620 (871)
                      .++|++.+.||+|+||.||+|++  +++.||||++.......                 .+.+.+|++++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46899999999999999999999  89999999996432211                 178899999999999999999


Q ss_pred             eeeeecccCcCCCceeeEEEeccCCCCHHHH------hhcccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeE
Q 002883          621 IITSCSSIDTRGNEFKALVYEFMPNGSLENW------LNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH-HCHTSIV  693 (871)
Q Consensus       621 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iv  693 (871)
                      +++++.+.     ...++||||+++++|.++      +....     ...+++..++.++.|++.||.|||+ .   +|+
T Consensus       108 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~  174 (348)
T 2pml_X          108 CEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNY-----TCFIPIQVIKCIIKSVLNSFSYIHNEK---NIC  174 (348)
T ss_dssp             CSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSS-----CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred             EEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhcc-----ccCCCHHHHHHHHHHHHHHHHHHhccC---CEe
Confidence            99998765     678999999999999998      44321     2369999999999999999999999 8   999


Q ss_pred             ecCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCC-CCCC-ccchhhHHHHHHHHHhCC
Q 002883          694 HCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVST-HGDEYSFGILMLEMFTGK  771 (871)
Q Consensus       694 H~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwSlG~il~elltG~  771 (871)
                      ||||||+||+++.++.+||+|||.+......     ......|++.|+|||.+.+. .++. ++||||+||++|+|++|+
T Consensus       175 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~  249 (348)
T 2pml_X          175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV  249 (348)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSS
T ss_pred             ecCCChHhEEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999876432     23345689999999998877 6666 999999999999999999


Q ss_pred             CCCchhhhhhhhHHHHhhhC--CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCC
Q 002883          772 RPTDDMFEEGLSLHKYAKMG--LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDR  849 (871)
Q Consensus       772 ~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  849 (871)
                      .||.................  .+.....+..+..               ..........+...+.+++.+||+.||++|
T Consensus       250 ~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  314 (348)
T 2pml_X          250 VPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLT---------------NKKSTCSNNFLSNEDIDFLKLFLRKNPAER  314 (348)
T ss_dssp             CSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTC---------------C--------CCCHHHHHHHHHHCCSSGGGS
T ss_pred             CCCCCCCcHHHHHHHHhccCcCCccchhhhhcccc---------------ccccccchhhcCHHHHHHHHHHccCChhhC
Confidence            99986433222222221111  1111000000000               000001112344567899999999999999


Q ss_pred             CCHHHHHH
Q 002883          850 MKIQDAIM  857 (871)
Q Consensus       850 Pta~evl~  857 (871)
                      ||+.|+++
T Consensus       315 ps~~e~l~  322 (348)
T 2pml_X          315 ITSEDALK  322 (348)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhc
Confidence            99999987

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2e-37  Score=331.63  Aligned_cols=258  Identities=21%  Similarity=0.326  Sum_probs=195.7

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-------
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-------  630 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------  630 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|++++++++||||+++++++.+...       
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            457999999999999999999999899999999996432 345778899999999999999999998865321       


Q ss_pred             -CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 002883          631 -RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV  709 (871)
Q Consensus       631 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  709 (871)
                       ......|+||||+++|+|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENL------NQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCG------GGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcccc------ccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence             224678999999999999999976432      478899999999999999999999   9999999999999999999


Q ss_pred             eEEeecccceecCCCCC-----------CccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          710 AHVGDFGLSRLLHDNSP-----------DQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       710 ~kl~Dfg~a~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      +||+|||.+........           .........||+.|+|||++.+. .++.++||||+||++|+|++   ||...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~  231 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG  231 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence            99999999987643210           01122345689999999987754 78999999999999999998   56533


Q ss_pred             hhhhhhHHHHhhh--CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHH
Q 002883          778 FEEGLSLHKYAKM--GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDA  855 (871)
Q Consensus       778 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~ev  855 (871)
                      .............  ..+...    .                          ......+.+++.+||+.||++|||+.|+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~----~--------------------------~~~~~~~~~li~~~l~~dp~~Rps~~~l  281 (303)
T 1zy4_A          232 MERVNILKKLRSVSIEFPPDF----D--------------------------DNKMKVEKKIIRLLIDHDPNKRPGARTL  281 (303)
T ss_dssp             HHHHHHHHHHHSTTCCCCTTC----C--------------------------TTTSHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             hhHHHHHHhccccccccCccc----c--------------------------ccchHHHHHHHHHHHhcCcccCcCHHHH
Confidence            2222111111111  011110    0                          0223456789999999999999999999


Q ss_pred             HHH
Q 002883          856 IME  858 (871)
Q Consensus       856 l~~  858 (871)
                      ++.
T Consensus       282 l~h  284 (303)
T 1zy4_A          282 LNS  284 (303)
T ss_dssp             HHS
T ss_pred             hCC
Confidence            873

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-37  Score=365.80  Aligned_cols=261  Identities=23%  Similarity=0.358  Sum_probs=205.2

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCC---CcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTE---ETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ..++|++.+.||+|+||.||+|++..+   +..||+|+++... ....+.+.+|+.++++++||||+++++++.+     
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----  462 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-----  462 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence            346789999999999999999998543   4679999986433 3344678999999999999999999998743     


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                       +..|+||||+++|+|.+++.....      .+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||
T Consensus       463 -~~~~lv~E~~~~g~L~~~l~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL  532 (656)
T 2j0j_A          463 -NPVWIIMELCTLGELRSFLQVRKF------SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKL  532 (656)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTTT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEE
T ss_pred             -CceEEEEEcCCCCcHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEE
Confidence             347899999999999999976432      489999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      +|||++.......  ........+|+.|+|||++.+..++.++|||||||++|||++ |..||........ ........
T Consensus       533 ~DFG~a~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-~~~i~~~~  609 (656)
T 2j0j_A          533 GDFGLSRYMEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-IGRIENGE  609 (656)
T ss_dssp             CCCCCCCSCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHHTC
T ss_pred             EecCCCeecCCCc--ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHcCC
Confidence            9999998765432  112223456789999999988899999999999999999997 9999975432221 11111110


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                       ....                       +       ..++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       610 -~~~~-----------------------~-------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          610 -RLPM-----------------------P-------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             -CCCC-----------------------C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -CCCC-----------------------C-------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence             0000                       0       022345778999999999999999999999999987654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=7.6e-38  Score=339.35  Aligned_cols=258  Identities=20%  Similarity=0.291  Sum_probs=176.2

Q ss_pred             hcCCCCCc-eeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSAN-LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|.+.+ .||+|+||+||+|++..+++.||||++....    ....+....++.++||||+++++++... ..+....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENM-HHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhc-cCCCceE
Confidence            46788855 6999999999999999999999999986432    2222233345667999999999998653 2234668


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEEe
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN---EMVAHVG  713 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~  713 (871)
                      ++||||+++|+|.+++......     .+++.+++.++.|++.||.|||+.   +|+||||||+||+++.   ++.+||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~-----~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQ-----AFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEeccCCCCHHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence            9999999999999999875432     589999999999999999999999   9999999999999976   4559999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||.+......     ......||+.|+|||++.+..++.++||||+||++|+|++|+.||................  .
T Consensus       174 Dfg~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~  246 (336)
T 3fhr_A          174 DFGFAKETTQN-----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI--R  246 (336)
T ss_dssp             CCTTCEEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             ccccceecccc-----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh--h
Confidence            99999875432     1223468999999999988889999999999999999999999997543321110000000  0


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .......                       .+....+..++.+++.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~-----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          247 LGQYGFP-----------------------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             ----CCC-----------------------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ccccccC-----------------------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0000000                       00011234567799999999999999999999973

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.9e-38  Score=340.87  Aligned_cols=263  Identities=23%  Similarity=0.322  Sum_probs=197.4

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ..++|++.+.||+|+||.||+|++..   .||+|+++...  ....+.+.+|+.++++++||||+++++++.+.     .
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~  102 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-----P  102 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-----S
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----C
Confidence            45789999999999999999999863   49999986432  22335677899999999999999999998765     5


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..++||||+++++|.+++.....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++ ++.+||+|
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~D  172 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKI------VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITD  172 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCC------CCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECC
T ss_pred             ceEEEeecccCCcHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEee
Confidence            68999999999999999976432      589999999999999999999999   999999999999998 67999999


Q ss_pred             cccceecCCCCC--CccccccccccccccCcccccC---------CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhh
Q 002883          715 FGLSRLLHDNSP--DQTSTSRVKGSIGYVAPEYGAL---------GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLS  783 (871)
Q Consensus       715 fg~a~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~  783 (871)
                      ||++........  .........|++.|+|||++.+         ..++.++|||||||++|+|++|+.||.........
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  252 (319)
T 2y4i_B          173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII  252 (319)
T ss_dssp             CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred             cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999876542211  1122233458999999998753         45789999999999999999999999854333211


Q ss_pred             HHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          784 LHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                      . .......+.....                              .+..++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       253 ~-~~~~~~~~~~~~~------------------------------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~  301 (319)
T 2y4i_B          253 W-QMGTGMKPNLSQI------------------------------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP  301 (319)
T ss_dssp             H-HHHTTCCCCCCCS------------------------------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred             H-HhccCCCCCCCcC------------------------------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            1 1111100100000                              11234678999999999999999999999999887


Q ss_pred             HHHHh
Q 002883          864 KMRQA  868 (871)
Q Consensus       864 ~~~~~  868 (871)
                      +..++
T Consensus       302 ~~~~~  306 (319)
T 2y4i_B          302 KRNRR  306 (319)
T ss_dssp             -----
T ss_pred             Hhhcc
Confidence            65543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.9e-37  Score=333.33  Aligned_cols=253  Identities=21%  Similarity=0.363  Sum_probs=193.3

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCC--CCccceeeeeecccCcCC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIR--HRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~  632 (871)
                      ..++|++.+.||+|+||.||+|++. +++.||||++....  ....+.+.+|++++++++  ||||+++++++...    
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~----  100 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD----  100 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS----
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC----
Confidence            3567999999999999999999986 58899999996443  334577899999999996  59999999998765    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                       ...++||| +.+++|.+++....       .+++..++.++.|++.||.|||+.   +|+||||||+||++++ +.+||
T Consensus       101 -~~~~lv~e-~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL  167 (313)
T 3cek_A          101 -QYIYMVME-CGNIDLNSWLKKKK-------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKL  167 (313)
T ss_dssp             -SEEEEEEC-CCSEEHHHHHHHCS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEE
T ss_pred             -CEEEEEEe-cCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEE
Confidence             66899999 55889999998643       589999999999999999999999   9999999999999964 89999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCCCCchhhhhh
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-----------GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG  781 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~  781 (871)
                      +|||.+........ ........||+.|+|||.+.+           ..++.++|||||||++|+|++|+.||.......
T Consensus       168 ~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (313)
T 3cek_A          168 IDFGIANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI  246 (313)
T ss_dssp             CCCSSSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred             eeccccccccCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH
Confidence            99999987654321 112234568999999998764           478899999999999999999999997543222


Q ss_pred             hhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          782 LSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .................                              ....++.+++.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~------------------------------~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          247 SKLHAIIDPNHEIEFPD------------------------------IPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHHHHHHCTTSCCCCCC------------------------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHhcccccCCcc------------------------------cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            11111111110000000                              012356789999999999999999999874

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.8e-37  Score=336.08  Aligned_cols=277  Identities=17%  Similarity=0.233  Sum_probs=201.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCC-cEEEEEEeeccccchHHHHHHHHHHHHcCCCCc------cceeeeeecccCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEE-TNVAVKVLDLQQRGASKSFIAECEALRSIRHRN------LVKIITSCSSIDT  630 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~  630 (871)
                      .++|++.+.||+|+||+||+|++..++ +.||+|+++... ...+.+.+|+++++.++|++      ++.+++++...  
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~--   94 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH--   94 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET--
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC--
Confidence            468999999999999999999997766 789999996432 34567888999999987655      88888887665  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee------
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL------  704 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill------  704 (871)
                         ...++||||+ ++++.+++.....     ..+++.+++.++.||+.||+|||+.   +|+||||||+||++      
T Consensus        95 ---~~~~lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~  162 (355)
T 2eu9_A           95 ---GHMCIAFELL-GKNTFEFLKENNF-----QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFE  162 (355)
T ss_dssp             ---TEEEEEEECC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEE
T ss_pred             ---CeEEEEEecc-CCChHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccc
Confidence               6789999999 6778777765432     2589999999999999999999999   99999999999999      


Q ss_pred             -------------CCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCC
Q 002883          705 -------------DNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGK  771 (871)
Q Consensus       705 -------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~  771 (871)
                                   +.++.+||+|||.+......      .....||+.|+|||++.+..++.++||||+||++|||++|+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  236 (355)
T 2eu9_A          163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF  236 (355)
T ss_dssp             EEECCC-CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccccccccccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCC
Confidence                         56789999999999875432      22346899999999999999999999999999999999999


Q ss_pred             CCCchhhhhhhhH-HHHhhhCCCchhhhhcC------------hhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhh
Q 002883          772 RPTDDMFEEGLSL-HKYAKMGLPDQVAEIID------------PAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVG  838 (871)
Q Consensus       772 ~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  838 (871)
                      .||.......... ........|........            +...... ......+..... ..........++.+++
T Consensus       237 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~l~~li  314 (355)
T 2eu9_A          237 TLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDG-RYVKENCKPLKS-YMLQDSLEHVQLFDLM  314 (355)
T ss_dssp             CSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHH-HHHHHHCCCGGG-GCSCCSHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchh-ccccccCCcccc-cccccchhHHHHHHHH
Confidence            9998643332111 11111122222111000            0000000 000000000000 0011123355788999


Q ss_pred             cccccCCCCCCCCHHHHHH
Q 002883          839 ILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       839 ~~cl~~dP~~RPta~evl~  857 (871)
                      .+||+.||++|||+.|+++
T Consensus       315 ~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          315 RRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHTCSSTTTSCCHHHHTT
T ss_pred             HHHhcCChhhCcCHHHHhc
Confidence            9999999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.9e-37  Score=342.37  Aligned_cols=281  Identities=17%  Similarity=0.227  Sum_probs=202.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-----------CCccceeeeeec
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-----------HRNLVKIITSCS  626 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~  626 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+++++++.           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            368999999999999999999999899999999996432 24567888999998875           899999999987


Q ss_pred             ccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC-
Q 002883          627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD-  705 (871)
Q Consensus       627 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-  705 (871)
                      .. .......++||||+ +++|.+++......     .+++..++.++.||+.||+|||+++  +|+||||||+||+++ 
T Consensus        97 ~~-~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~  167 (373)
T 1q8y_A           97 HK-GPNGVHVVMVFEVL-GENLLALIKKYEHR-----GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEI  167 (373)
T ss_dssp             EE-ETTEEEEEEEECCC-CEEHHHHHHHTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEE
T ss_pred             cc-CCCCceEEEEEecC-CCCHHHHHHHhhcc-----CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEec
Confidence            64 22335789999999 99999999875422     5899999999999999999999942  899999999999994 


Q ss_pred             -----CCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhh
Q 002883          706 -----NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEE  780 (871)
Q Consensus       706 -----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  780 (871)
                           ..+.+||+|||++......      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       168 ~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  241 (373)
T 1q8y_A          168 VDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH  241 (373)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             cCCCcCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence                 4458999999999876432      22346899999999999999999999999999999999999999854321


Q ss_pred             -----hhhHHHHhh--hCCCchhhhhcChhHHHHHHHHHhhhhhhcC-----------chhHHhHHHHHHHHHhhhcccc
Q 002883          781 -----GLSLHKYAK--MGLPDQVAEIIDPAILEEALEIQAGIVKELQ-----------PNLRAKFHEIQVSILRVGILCS  842 (871)
Q Consensus       781 -----~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~li~~cl  842 (871)
                           .........  ...|.....-..  ....+.. ..+......           ............++.+++.+||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  318 (373)
T 1q8y_A          242 SYTKDDDHIAQIIELLGELPSYLLRNGK--YTRTFFN-SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML  318 (373)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCT--THHHHBC-C--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred             ccCChHHHHHHHHHhcCCCCHHHHhccc--hhhhhcC-CcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence                 111111111  111111100000  0000000 000000000           0000011355678899999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 002883          843 EELPRDRMKIQDAIM  857 (871)
Q Consensus       843 ~~dP~~RPta~evl~  857 (871)
                      +.||++|||++|+++
T Consensus       319 ~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          319 QLDPRKRADAGGLVN  333 (373)
T ss_dssp             CSSTTTCBCHHHHHT
T ss_pred             ccCccccCCHHHHhh
Confidence            999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.1e-38  Score=338.52  Aligned_cols=242  Identities=21%  Similarity=0.312  Sum_probs=198.1

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHHHHcCC--CCccceeeeeeccc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG------ASKSFIAECEALRSIR--HRNLVKIITSCSSI  628 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~  628 (871)
                      ..++|++.+.||+|+||.||+|++..+++.||||++......      ....+.+|+.++++++  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            456899999999999999999999989999999999654321      2245677999999995  59999999998765


Q ss_pred             CcCCCceeeEEEeccCC-CCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC-C
Q 002883          629 DTRGNEFKALVYEFMPN-GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD-N  706 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~  706 (871)
                           ...++|||++.+ ++|.+++....       .+++..++.++.|++.||+|||+.   +|+||||||+||+++ .
T Consensus       121 -----~~~~lv~e~~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          121 -----DSFVLILERPEPVQDLFDFITERG-------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN  185 (320)
T ss_dssp             -----SEEEEEEECCSSEEEHHHHHHHHC-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred             -----CcEEEEEEcCCCCccHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCC
Confidence                 668999999976 89999997643       589999999999999999999999   999999999999998 7


Q ss_pred             CCceEEeecccceecCCCCCCccccccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCchhhhhhhhHH
Q 002883          707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV-STHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLH  785 (871)
Q Consensus       707 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~  785 (871)
                      ++.+||+|||.+......     ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......     
T Consensus       186 ~~~~kL~Dfg~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----  255 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----  255 (320)
T ss_dssp             TTEEEECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----
T ss_pred             CCCEEEeeCccccccccc-----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-----
Confidence            899999999999876532     1223468999999998877666 68899999999999999999999753211     


Q ss_pred             HHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          786 KYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                        ......      ...                          .+..++.+++.+||+.||++|||++|+++
T Consensus       256 --~~~~~~------~~~--------------------------~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          256 --IRGQVF------FRQ--------------------------RVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             --HHCCCC------CSS--------------------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --hccccc------ccc--------------------------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              000000      000                          12235678999999999999999999987

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.1e-37  Score=335.30  Aligned_cols=260  Identities=23%  Similarity=0.277  Sum_probs=178.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHH-HHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECE-ALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++.... .....+.+|+. +++.++||||+++++++...     +.
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----GD   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----SE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----Cc
Confidence            4689999999999999999999998999999999965432 23345556666 66778999999999998765     66


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||+++ +|.+++......  ....+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+||
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Df  170 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSV--LDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDF  170 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHT--TCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             eEEEEeecCC-ChHHHHHHHHhh--hcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccC
Confidence            8999999975 888887642211  122689999999999999999999985  28999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccc----cCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYG----ALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      |.+.......    ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||.................
T Consensus       171 g~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  246 (327)
T 3aln_A          171 GISGQLVDSI----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD  246 (327)
T ss_dssp             SSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC
T ss_pred             CCceeccccc----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC
Confidence            9998764321    12234689999999987    466789999999999999999999999975322111111000000


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                       +......                          ....+...+.+++.+||+.||++|||+.|+++.
T Consensus       247 -~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          247 -PPQLSNS--------------------------EEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             -CCCCCCC--------------------------SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             -CCCCCCc--------------------------ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence             0000000                          000123457799999999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=334.58  Aligned_cols=243  Identities=23%  Similarity=0.342  Sum_probs=191.7

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHHHHcC----CCCccceeeeee
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG------ASKSFIAECEALRSI----RHRNLVKIITSC  625 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~~~~~~  625 (871)
                      ...++|++.+.||+|+||.||+|++..+++.||||+++.....      ....+.+|+.+++++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            3457899999999999999999999889999999999644321      223456789999888    899999999998


Q ss_pred             cccCcCCCceeeEEEec-cCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceee
Q 002883          626 SSIDTRGNEFKALVYEF-MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLL  704 (871)
Q Consensus       626 ~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  704 (871)
                      ...     ...++|||+ +.+++|.+++....       .+++..++.++.|++.||+|||+.   +|+||||||+||++
T Consensus       108 ~~~-----~~~~~v~e~~~~~~~L~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  172 (312)
T 2iwi_A          108 ETQ-----EGFMLVLERPLPAQDLFDYITEKG-------PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILI  172 (312)
T ss_dssp             ----------CEEEEECCSSEEEHHHHHHHHC-------SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEE
T ss_pred             ecC-----CeEEEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEE
Confidence            665     567999999 78999999997643       589999999999999999999999   99999999999999


Q ss_pred             C-CCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCchhhhhhh
Q 002883          705 D-NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVS-THGDEYSFGILMLEMFTGKRPTDDMFEEGL  782 (871)
Q Consensus       705 ~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~  782 (871)
                      + .++.+||+|||.+.......     .....|+..|+|||++.+..+. .++||||+||++|+|++|+.||......  
T Consensus       173 ~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--  245 (312)
T 2iwi_A          173 DLRRGCAKLIDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--  245 (312)
T ss_dssp             ETTTTEEEECCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--
T ss_pred             eCCCCeEEEEEcchhhhcccCc-----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH--
Confidence            8 88999999999998765422     2334689999999988776664 5899999999999999999999753211  


Q ss_pred             hHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          783 SLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       783 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                           ......  .                       +       ..+...+.+++.+||+.||++|||++|+++
T Consensus       246 -----~~~~~~--~-----------------------~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          246 -----LEAELH--F-----------------------P-------AHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -----HHTCCC--C-----------------------C-------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----hhhccC--C-----------------------c-------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 000000  0                       0       012235678999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.2e-37  Score=343.70  Aligned_cols=257  Identities=20%  Similarity=0.262  Sum_probs=184.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      +.|.+.+.||+|+||+||.+.. .+++.||||++....   .+.+.+|+++++++ +||||+++++++.+.     ...|
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~~~~   85 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTD-----RFLY   85 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECS-----SEEE
T ss_pred             heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecC-----CeEE
Confidence            3456678899999999987654 378999999986432   35678899999876 899999999987654     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC----------
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE----------  707 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----------  707 (871)
                      +||||++ |+|.+++.............++..++.++.||+.||+|||+.   +|+||||||+||+++.+          
T Consensus        86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccC
Confidence            9999995 699999987543211111123445678999999999999999   99999999999999754          


Q ss_pred             ---CceEEeecccceecCCCCCC-ccccccccccccccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCCCCc
Q 002883          708 ---MVAHVGDFGLSRLLHDNSPD-QTSTSRVKGSIGYVAPEYGAL-------GEVSTHGDEYSFGILMLEMFT-GKRPTD  775 (871)
Q Consensus       708 ---~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-G~~pf~  775 (871)
                         +.+||+|||+|......... ........||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence               48999999999987643211 112234579999999998765       678999999999999999999 999997


Q ss_pred             hhhhhhhhHHHHhhhCCC-chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHH
Q 002883          776 DMFEEGLSLHKYAKMGLP-DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQD  854 (871)
Q Consensus       776 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~e  854 (871)
                      ........   ....... +......                          ...+..++.+++.+||+.||++|||+.|
T Consensus       242 ~~~~~~~~---i~~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e  292 (434)
T 2rio_A          242 DKYSRESN---IIRGIFSLDEMKCLH--------------------------DRSLIAEATDLISQMIDHDPLKRPTAMK  292 (434)
T ss_dssp             STTTHHHH---HHHTCCCCCCCTTCC--------------------------CHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CchhhHHH---HhcCCCCcccccccc--------------------------cccchHHHHHHHHHHhhCChhhCCCHHH
Confidence            54322211   1111100 0000000                          0134456789999999999999999999


Q ss_pred             HHH
Q 002883          855 AIM  857 (871)
Q Consensus       855 vl~  857 (871)
                      +++
T Consensus       293 il~  295 (434)
T 2rio_A          293 VLR  295 (434)
T ss_dssp             HHT
T ss_pred             HHh
Confidence            986

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=5.1e-36  Score=332.71  Aligned_cols=338  Identities=21%  Similarity=0.240  Sum_probs=245.5

Q ss_pred             cCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCC
Q 002883          109 ISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGND  188 (871)
Q Consensus       109 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~  188 (871)
                      +.+++.|++++|.+. .+|...+..+++|++|+|++|.+++          ..+..|..+++|++|++++|+++.+++  
T Consensus        44 l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~----------~~~~~~~~l~~L~~L~L~~n~l~~~~~--  110 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE----------IDTYAFAYAHTIQKLYMGFNAIRYLPP--  110 (390)
T ss_dssp             GCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCE----------ECTTTTTTCTTCCEEECCSSCCCCCCT--
T ss_pred             cCCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccc----------cChhhccCCCCcCEEECCCCCCCcCCH--
Confidence            456666666666665 5666655567777777777777762          112346677777777777777776543  


Q ss_pred             ccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccc
Q 002883          189 LRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSV  268 (871)
Q Consensus       189 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  268 (871)
                          ..+..+++|++|+|++|.++ .+|..++.-.++|++|++++|++++..+..|..+++|+.|++++|.+++.   .+
T Consensus       111 ----~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~  182 (390)
T 3o6n_A          111 ----HVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DL  182 (390)
T ss_dssp             ----TTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CG
T ss_pred             ----HHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---cc
Confidence                34566777888888888887 44554433235688888888888877777788888888888888888754   35


Q ss_pred             cCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcE
Q 002883          269 GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVL  348 (871)
Q Consensus       269 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  348 (871)
                      ..+++|+.|++++|.+++     +...++|++|++++|.+... |..+  .++|+.|++++|.+++.  ..+..+++|++
T Consensus       183 ~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~  252 (390)
T 3o6n_A          183 SLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVE  252 (390)
T ss_dssp             GGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred             ccccccceeecccccccc-----cCCCCcceEEECCCCeeeec-cccc--cccccEEECCCCCCccc--HHHcCCCCccE
Confidence            667888888888888773     23345788888888888744 4322  47888888888888743  56778888888


Q ss_pred             EeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcC
Q 002883          349 LDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNF  428 (871)
Q Consensus       349 L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  428 (871)
                      |++++|.+++..|..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|++++ .|..+..+++|+.|++++|++
T Consensus       253 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i  330 (390)
T 3o6n_A          253 VDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSI  330 (390)
T ss_dssp             EECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCC
T ss_pred             EECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCcc
Confidence            888888888777888888888888888888888 456666778888888888888884 455577788888888888888


Q ss_pred             CCCCcccccccccccEEecCCCcCcccCCCCcccccccceeccCCCCCccCCCcc
Q 002883          429 SGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       429 ~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      ++. +  +..+++|+.|++++|+++|.+.. ..+..+....+.+++..|.++...
T Consensus       331 ~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~~~~  381 (390)
T 3o6n_A          331 VTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDYQL  381 (390)
T ss_dssp             CCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTTCEE
T ss_pred             cee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceecccccc
Confidence            854 3  66778888999999998886532 234555556667788888865443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7.2e-37  Score=329.81  Aligned_cols=253  Identities=21%  Similarity=0.270  Sum_probs=180.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG--ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||.||+|++..+++.||||++......  ..+.+.++..+++.++||||+++++++...     ..
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-----TD   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----Cc
Confidence            46799999999999999999999989999999999654322  223344555577888999999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH-HCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      .++||||+ ++.+..+.....      ..+++..++.++.|++.||.|||+ .   +|+||||||+||+++.++.+||+|
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~d  168 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRMQ------GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCD  168 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEEecc-CCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEE
Confidence            89999999 556666554322      258999999999999999999998 6   899999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhh
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA-----LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK  789 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~  789 (871)
                      ||.+.......    ......||+.|+|||++.     ...++.++|||||||++|+|++|+.||...............
T Consensus       169 fg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  244 (318)
T 2dyl_A          169 FGISGRLVDDK----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ  244 (318)
T ss_dssp             CTTC------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH
T ss_pred             CCCchhccCCc----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc
Confidence            99997664322    122346899999999874     567889999999999999999999999753222222221111


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .. +.....                            ...+..++.+++.+||+.||++|||+.|+++.
T Consensus       245 ~~-~~~~~~----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          245 EE-PPLLPG----------------------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             SC-CCCCCS----------------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cC-CCCCCc----------------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11 100000                            00123457789999999999999999999873

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.2e-37  Score=341.43  Aligned_cols=251  Identities=21%  Similarity=0.288  Sum_probs=183.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ..+|.+.+.||+|+||+||.... .+++.||||++.....   ..+.+|+++++.+ +||||+++++++.+.     ...
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-----~~~   93 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDR-----QFQ   93 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEET-----TEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecC-----CEE
Confidence            35688999999999999664333 3789999999864432   2356799999999 899999999988665     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-----CCceE
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-----EMVAH  711 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~k  711 (871)
                      |+||||++ |+|.+++.....      ...+..++.++.||+.||+|||+.   +|+||||||+||+++.     ...+|
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~k  163 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKDF------AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAM  163 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSSC------CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEE
T ss_pred             EEEEECCC-CCHHHHHHhcCC------CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEE
Confidence            99999995 699999976542      244556778999999999999999   9999999999999953     23578


Q ss_pred             EeecccceecCCCCCCccccccccccccccCccccc---CCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHH
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA---LGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKY  787 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~  787 (871)
                      |+|||+|+................||+.|+|||++.   ...++.++||||+||++|||++ |..||..........  .
T Consensus       164 L~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--~  241 (432)
T 3p23_A          164 ISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--L  241 (432)
T ss_dssp             ECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--H
T ss_pred             EecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--H
Confidence            999999987754432223334467999999999987   4567889999999999999999 999997532221111  0


Q ss_pred             hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       ......   ....+.                        ......+.+++.+||+.||++|||+.|+++
T Consensus       242 -~~~~~~---~~~~~~------------------------~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          242 -LGACSL---DCLHPE------------------------KHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             -TTCCCC---TTSCTT------------------------CHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -hccCCc---cccCcc------------------------ccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence             000000   000000                        012334678999999999999999999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.7e-37  Score=352.64  Aligned_cols=287  Identities=21%  Similarity=0.283  Sum_probs=204.3

Q ss_pred             hhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCCc
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGNE  634 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  634 (871)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++..... ....
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            347899999999999999999999989999999998653 33345678999999999999999999999765322 2246


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc---eE
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV---AH  711 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~k  711 (871)
                      ..|+||||+++|+|.+++.....    ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.   +|
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~----~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vK  164 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFEN----CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHK  164 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSC----TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEE
T ss_pred             eEEEEEEeCCCCCHHHHHHhccc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEE
Confidence            77999999999999999986542    12488899999999999999999999   9999999999999987664   99


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      |+|||.+.......    ......||+.|+|||.+.+..++.++||||+||++|+|++|+.||........    +....
T Consensus       165 L~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~----~~~~i  236 (676)
T 3qa8_A          165 IIDLGYAKELDQGE----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ----WHGKV  236 (676)
T ss_dssp             ECSCCCCCBTTSCC----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH----SSTTC
T ss_pred             Eccccccccccccc----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh----hhhhh
Confidence            99999998765432    22335689999999999999999999999999999999999999975322110    00000


Q ss_pred             CCchhhh-hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHH-----HHHHHHHHHH
Q 002883          792 LPDQVAE-IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQD-----AIMELQEAQK  864 (871)
Q Consensus       792 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~e-----vl~~L~~i~~  864 (871)
                      ....... ..........      ......+............+.+++.+||+.||++|||+.|     +.+.++++.+
T Consensus       237 ~~~~~~~~~~~~~l~g~~------~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          237 REKSNEHIVVYDDLTGAV------KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             C------CCSCCCCSSSC------CCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hcccchhhhhhhhhcccc------ccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            0000000 0000000000      0000000001111234567889999999999999999988     4555555543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.2e-35  Score=329.57  Aligned_cols=310  Identities=17%  Similarity=0.131  Sum_probs=199.5

Q ss_pred             CCCCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccc
Q 002883           13 CSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQ   92 (871)
Q Consensus        13 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~   92 (871)
                      +++++.|++++|.++...+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|+.+++|++|+
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  123 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  123 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence            34555555555555533333345555555555555555544444555555555555555555544444455555555555


Q ss_pred             cccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCccc
Q 002883           93 VSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLI  172 (871)
Q Consensus        93 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~  172 (871)
                      +++|+++                         .+|..++..+++|++|++++|.+++          ..|+.+..+++|+
T Consensus       124 L~~n~l~-------------------------~l~~~~~~~l~~L~~L~L~~n~l~~----------~~~~~~~~l~~L~  168 (390)
T 3o6n_A          124 LERNDLS-------------------------SLPRGIFHNTPKLTTLSMSNNNLER----------IEDDTFQATTSLQ  168 (390)
T ss_dssp             CCSSCCC-------------------------CCCTTTTTTCTTCCEEECCSSCCCB----------CCTTTTSSCTTCC
T ss_pred             CCCCccC-------------------------cCCHHHhcCCCCCcEEECCCCccCc----------cChhhccCCCCCC
Confidence            5555554                         4444444455556666666665542          1123355566666


Q ss_pred             EEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccce
Q 002883          173 RLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLIL  252 (871)
Q Consensus       173 ~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~  252 (871)
                      +|++++|+++.++         +..+++|+.|++++|.+++. +     ...+|++|++++|.++.. |..  ..++|+.
T Consensus       169 ~L~l~~n~l~~~~---------~~~l~~L~~L~l~~n~l~~~-~-----~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~  230 (390)
T 3o6n_A          169 NLQLSSNRLTHVD---------LSLIPSLFHANVSYNLLSTL-A-----IPIAVEELDASHNSINVV-RGP--VNVELTI  230 (390)
T ss_dssp             EEECCSSCCSBCC---------GGGCTTCSEEECCSSCCSEE-E-----CCSSCSEEECCSSCCCEE-ECC--CCSSCCE
T ss_pred             EEECCCCcCCccc---------cccccccceeeccccccccc-C-----CCCcceEEECCCCeeeec-ccc--ccccccE
Confidence            6666666665432         34456677777777766632 1     123577777777777644 322  2467888


Q ss_pred             eecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcC
Q 002883          253 IAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNL  332 (871)
Q Consensus       253 L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  332 (871)
                      |++++|.+++.  ..+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++ +|..+..+++|+.|+|++|++
T Consensus       231 L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l  307 (390)
T 3o6n_A          231 LKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL  307 (390)
T ss_dssp             EECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCC
T ss_pred             EECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcc
Confidence            88888888743  567888888888888888887778888888888888888888884 566677788888899988888


Q ss_pred             CCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCC
Q 002883          333 SGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSG  382 (871)
Q Consensus       333 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  382 (871)
                      + .+|..+..+++|+.|++++|.++.. +  +..+++|+.|++++|+++.
T Consensus       308 ~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~  353 (390)
T 3o6n_A          308 L-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC  353 (390)
T ss_dssp             C-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred             e-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence            8 5677778888899999999988743 3  6778889999999998874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.8e-36  Score=318.55  Aligned_cols=235  Identities=11%  Similarity=0.056  Sum_probs=184.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||.||+|++..+++.||||++.....   ...+.+.+|+.++++++||||+++++++...     +.
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~  105 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-----AG  105 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-----Cc
Confidence            679999999999999999999998899999999965432   2346789999999999999999999998765     66


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||++|++|.++++..         ....++..++.|++.||+|||+.   ||+||||||+||+++.++.+||+++
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~---------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~  173 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTS---------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP  173 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC
T ss_pred             EEEEEEecCCCCHHHHHhcC---------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec
Confidence            89999999999999999542         35567889999999999999999   9999999999999999999999744


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |                       |++       +++.++|||||||++|||+||+.||...............      
T Consensus       174 ~-----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~------  217 (286)
T 3uqc_A          174 A-----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD------  217 (286)
T ss_dssp             C-----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC------
T ss_pred             c-----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH------
Confidence            3                       333       3689999999999999999999999854322100000000      


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQ  867 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~~  867 (871)
                      ......                    ........++.++.+++.+||+.||++| |+.|+++.|+++.....
T Consensus       218 ~~~~~~--------------------~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          218 TAGQPI--------------------EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             TTSCBC--------------------CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             hccCCC--------------------ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            000000                    0000111334567899999999999999 99999999999876543

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=2.5e-35  Score=345.15  Aligned_cols=342  Identities=21%  Similarity=0.246  Sum_probs=243.6

Q ss_pred             cCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCC
Q 002883          109 ISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGND  188 (871)
Q Consensus       109 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~  188 (871)
                      +.+++.+++++|.+. .+|..++..+++|+.|+|++|.|++.          .|..|+.+++|+.|+|++|.++.+++  
T Consensus        50 l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~----------~~~~~~~l~~L~~L~L~~n~l~~~~~--  116 (597)
T 3oja_B           50 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEI----------DTYAFAYAHTIQKLYMGFNAIRYLPP--  116 (597)
T ss_dssp             GCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEE----------CTTTTTTCTTCCEEECCSSCCCCCCT--
T ss_pred             CCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCC----------ChHHhcCCCCCCEEECCCCcCCCCCH--
Confidence            455666666666664 56665555677777777777776621          22346667777777777777766543  


Q ss_pred             ccccccccCCCcccEEEccCCcCcccCChhh-hhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCcc
Q 002883          189 LRFLDSLVNCTFLEVVSLSSNSLSGVLPNSI-ANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTS  267 (871)
Q Consensus       189 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~-~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  267 (871)
                          ..+..+++|++|+|++|.+++ +|..+ ..+ ++|++|+|++|.+++..|..|+++++|+.|++++|.+++.   .
T Consensus       117 ----~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~  187 (597)
T 3oja_B          117 ----HVFQNVPLLTVLVLERNDLSS-LPRGIFHNT-PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---D  187 (597)
T ss_dssp             ----TTTTTCTTCCEEECCSSCCCC-CCTTTTTTC-TTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---C
T ss_pred             ----HHHcCCCCCCEEEeeCCCCCC-CCHHHhccC-CCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---C
Confidence                345667777777888777773 44443 444 5688888888888877777788888888888888888754   2


Q ss_pred             ccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCc
Q 002883          268 VGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV  347 (871)
Q Consensus       268 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  347 (871)
                      ++.+++|+.|++++|.+++     +...++|+.|++++|.+... +..+  .++|+.|+|++|.+++  +..+..+++|+
T Consensus       188 ~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~  257 (597)
T 3oja_B          188 LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTD--TAWLLNYPGLV  257 (597)
T ss_dssp             GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEE-ECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCS
T ss_pred             hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccc-cccc--CCCCCEEECCCCCCCC--ChhhccCCCCC
Confidence            5567788888888887763     23445788888888888743 3322  2678888888888874  36677888888


Q ss_pred             EEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCc
Q 002883          348 LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNN  427 (871)
Q Consensus       348 ~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  427 (871)
                      .|+|++|.+++..|..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+
T Consensus       258 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~l~~L~~L~L~~N~  335 (597)
T 3oja_B          258 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNS  335 (597)
T ss_dssp             EEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSC
T ss_pred             EEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCc-cCcccccCCCCCEEECCCCC
Confidence            88888888887778888888888888888888884 56667778888888888888884 55667778888888888888


Q ss_pred             CCCCCcccccccccccEEecCCCcCcccCCCCcccccccceeccCCCCCccCCCccccccc
Q 002883          428 FSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPELHLHSC  488 (871)
Q Consensus       428 l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~C~~~~~~~~~~c  488 (871)
                      +++. |  +..+++|+.|++++|+|+|.+.. ..+..+....+.+++..|+.+.......|
T Consensus       336 l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~~~~~~~~c  392 (597)
T 3oja_B          336 IVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDYQLEHGLC  392 (597)
T ss_dssp             CCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTTCEEETTEE
T ss_pred             CCCc-C--hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcchhccCCcc
Confidence            8754 2  66778888899999998886532 23445555556778888887665444444

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=2.1e-34  Score=314.45  Aligned_cols=263  Identities=22%  Similarity=0.302  Sum_probs=179.1

Q ss_pred             ccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCC
Q 002883          165 LGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV  244 (871)
Q Consensus       165 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~  244 (871)
                      +..+++|++|++++|.++.+        +.+..+++|++|++++|.+++. +. +..+ ++|++|++++|.... .+..+
T Consensus        84 ~~~l~~L~~L~L~~n~i~~~--------~~~~~l~~L~~L~l~~n~i~~~-~~-~~~l-~~L~~L~l~~n~~~~-~~~~~  151 (347)
T 4fmz_A           84 LSNLVKLTNLYIGTNKITDI--------SALQNLTNLRELYLNEDNISDI-SP-LANL-TKMYSLNLGANHNLS-DLSPL  151 (347)
T ss_dssp             GTTCTTCCEEECCSSCCCCC--------GGGTTCTTCSEEECTTSCCCCC-GG-GTTC-TTCCEEECTTCTTCC-CCGGG
T ss_pred             hhcCCcCCEEEccCCcccCc--------hHHcCCCcCCEEECcCCcccCc-hh-hccC-CceeEEECCCCCCcc-cccch
Confidence            44555555555555555432        2345555566666666665532 22 3333 346666666664432 23336


Q ss_pred             CCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCE
Q 002883          245 GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQK  324 (871)
Q Consensus       245 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  324 (871)
                      ..+++|+.|++++|.+++..+  +..+++|++|++++|++.+. +. +..+++|+.|++++|.+++..+  +..+++|+.
T Consensus       152 ~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~  225 (347)
T 4fmz_A          152 SNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI-SP-LASLTSLHYFTAYVNQITDITP--VANMTRLNS  225 (347)
T ss_dssp             TTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCE
T ss_pred             hhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccc-cc-ccCCCccceeecccCCCCCCch--hhcCCcCCE
Confidence            667777777777777664332  66777788888887777743 32 7777788888888887775443  777788888


Q ss_pred             EecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcc
Q 002883          325 LDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSF  404 (871)
Q Consensus       325 L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  404 (871)
                      |++++|++++..+  +..+++|++|++++|.+++.  ..+..+++|+.|++++|++++.  ..+..+++|++|++++|++
T Consensus       226 L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l  299 (347)
T 4fmz_A          226 LKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQL  299 (347)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred             EEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcC
Confidence            8888888874333  77788888888888888743  4577788888888888888743  4577888888888888888


Q ss_pred             cccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCc
Q 002883          405 QGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLE  453 (871)
Q Consensus       405 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~  453 (871)
                      ++..+..|..+++|++|++++|++++..|  +..+++|++|++++|+++
T Consensus       300 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          300 GNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             CGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             CCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            87778888888888888888888886655  777888888888888875

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.4e-34  Score=316.03  Aligned_cols=306  Identities=25%  Similarity=0.333  Sum_probs=198.8

Q ss_pred             cCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccccccccccCCCCccccccCCCce
Q 002883           35 GNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDY  114 (871)
Q Consensus        35 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  114 (871)
                      ..+++|++|++++|.++ .+|. +..+++|++|+|++|+++ .++. +..+++|++|++++|.+++ ++ .+.++++|++
T Consensus        41 ~~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~-~~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~  114 (347)
T 4fmz_A           41 EELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRE  114 (347)
T ss_dssp             HHHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSE
T ss_pred             hhcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCccc-cchh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCE
Confidence            34455555555555554 2322 445555555555555554 2332 5555555555555555542 22 3555555555


Q ss_pred             eeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCcccccc
Q 002883          115 FAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDS  194 (871)
Q Consensus       115 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~  194 (871)
                      |++++|.+. .++.  +..+++|+.|++++|...           ..+..+..+++|++|++++|.+..++        .
T Consensus       115 L~l~~n~i~-~~~~--~~~l~~L~~L~l~~n~~~-----------~~~~~~~~l~~L~~L~l~~~~~~~~~--------~  172 (347)
T 4fmz_A          115 LYLNEDNIS-DISP--LANLTKMYSLNLGANHNL-----------SDLSPLSNMTGLNYLTVTESKVKDVT--------P  172 (347)
T ss_dssp             EECTTSCCC-CCGG--GTTCTTCCEEECTTCTTC-----------CCCGGGTTCTTCCEEECCSSCCCCCG--------G
T ss_pred             EECcCCccc-Cchh--hccCCceeEEECCCCCCc-----------ccccchhhCCCCcEEEecCCCcCCch--------h
Confidence            555555554 3333  235666666666666443           12233666677777777777665532        2


Q ss_pred             ccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCC
Q 002883          195 LVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKL  274 (871)
Q Consensus       195 l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  274 (871)
                      +..+++|++|++++|.+++. +. +..+ ++|+.|++++|.+++..+  +..+++|+.|++++|.+++..+  +..+++|
T Consensus       173 ~~~l~~L~~L~l~~n~l~~~-~~-~~~l-~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L  245 (347)
T 4fmz_A          173 IANLTDLYSLSLNYNQIEDI-SP-LASL-TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQL  245 (347)
T ss_dssp             GGGCTTCSEEECTTSCCCCC-GG-GGGC-TTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTC
T ss_pred             hccCCCCCEEEccCCccccc-cc-ccCC-CccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCC
Confidence            55667777777777777633 22 4444 457778888877775443  7777888888888888875433  7788888


Q ss_pred             cEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCC
Q 002883          275 QVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRN  354 (871)
Q Consensus       275 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N  354 (871)
                      ++|++++|+++..  ..+..+++|++|++++|++++.  ..+..+++|+.|++++|++++..+..+..+++|++|++++|
T Consensus       246 ~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n  321 (347)
T 4fmz_A          246 TWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN  321 (347)
T ss_dssp             CEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSS
T ss_pred             CEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCC
Confidence            8888888888743  4578888888888888888854  45788888888888888888777888888888899999998


Q ss_pred             CCCCCCccccCCCCCCCEEeCCCCcCC
Q 002883          355 HLSGPIPLEVGRLKGIQQLDLSENKLS  381 (871)
Q Consensus       355 ~l~~~~~~~~~~l~~L~~L~L~~N~l~  381 (871)
                      ++++..|  +..+++|+.|++++|+|+
T Consensus       322 ~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          322 HITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             SCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             ccccccC--hhhhhccceeehhhhccc
Confidence            8886555  788888999999998876

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-36  Score=336.22  Aligned_cols=252  Identities=17%  Similarity=0.156  Sum_probs=184.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHHcCCC-Cccceeeee----------
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEALRSIRH-RNLVKIITS----------  624 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~~~~~----------  624 (871)
                      ..|...+.||+|+||+||+|++..+++.||||++.....   ...+.+.+|+.+++.+.| ++...+..+          
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            457788999999999999999999999999999863322   235778999999999977 322111111          


Q ss_pred             -----------ecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 002883          625 -----------CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIV  693 (871)
Q Consensus       625 -----------~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  693 (871)
                                 +...........+++|+++ +++|.++++...........+++..++.++.|++.||+|||++   +|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence                       1111001123457778766 7899999863321111122578889999999999999999999   999


Q ss_pred             ecCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccc----------cCCCCCCccchhhHHHH
Q 002883          694 HCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYG----------ALGEVSTHGDEYSFGIL  763 (871)
Q Consensus       694 H~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwSlG~i  763 (871)
                      ||||||+|||++.++.+||+|||+++.....      .....| +.|+|||++          .+..++.++|||||||+
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            9999999999999999999999999875422      333467 999999988          55568899999999999


Q ss_pred             HHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhccccc
Q 002883          764 MLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSE  843 (871)
Q Consensus       764 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  843 (871)
                      +|||++|+.||..........             .+...                        ...++..+.+++.+||+
T Consensus       307 l~elltg~~Pf~~~~~~~~~~-------------~~~~~------------------------~~~~~~~~~~li~~~l~  349 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSE-------------WIFRS------------------------CKNIPQPVRALLEGFLR  349 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSG-------------GGGSS------------------------CCCCCHHHHHHHHHHTC
T ss_pred             HHHHHHCCCCCCCcchhhhHH-------------HHHhh------------------------cccCCHHHHHHHHHHcc
Confidence            999999999997543221100             00000                        00122457799999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 002883          844 ELPRDRMKIQDAIME  858 (871)
Q Consensus       844 ~dP~~RPta~evl~~  858 (871)
                      .||++|||+.|+++.
T Consensus       350 ~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          350 YPKEDRLLPLQAMET  364 (413)
T ss_dssp             SSGGGSCCHHHHTTS
T ss_pred             CChhhCcCHHHHHhC
Confidence            999999999998754

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.9e-36  Score=354.65  Aligned_cols=246  Identities=23%  Similarity=0.347  Sum_probs=197.3

Q ss_pred             cCCCCCceeeccccceEEEEEECC-CCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGT-EETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++.+.||+|+||+||+|++.. +++.||||++.... ......+.+|++++++++||||+++++++...+..+....
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            689999999999999999999975 68999999985432 3345678899999999999999999999987644444457


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||+++++|.+++..         .+++.+++.++.||+.||.|||++   +|+||||||+||+++.+ .+||+|||
T Consensus       160 ~lv~E~~~g~~L~~~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG  226 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ---------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG  226 (681)
T ss_dssp             EEEEECCCCEECC----C---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence            999999999999987754         489999999999999999999999   99999999999999875 89999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +++.....       ....||+.|+|||++.++ ++.++|||||||++|+|++|..||.......          .+.. 
T Consensus       227 ~a~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~~~-  287 (681)
T 2pzi_A          227 AVSRINSF-------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LPED-  287 (681)
T ss_dssp             TCEETTCC-------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CCTT-
T ss_pred             cchhcccC-------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc----------cccc-
Confidence            99876432       235699999999987665 4899999999999999999999887421110          0000 


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC-HHHHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK-IQDAIMELQEAQK  864 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-a~evl~~L~~i~~  864 (871)
                          .                        ........+.+++.+||+.||++||+ ++++.+.+..+.+
T Consensus       288 ----~------------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          288 ----D------------------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             ----C------------------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             ----c------------------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence                0                        00122345778999999999999995 7777777776643

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=2.6e-35  Score=315.69  Aligned_cols=256  Identities=30%  Similarity=0.486  Sum_probs=221.4

Q ss_pred             cccEEEccCCccCC--CCCCCCCCccccceeeccc-ccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEE
Q 002883          225 HLIYLYMSANRISG--TIPTGVGNLKNLILIAMEV-NLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEV  301 (871)
Q Consensus       225 ~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  301 (871)
                      +++.|+|++|.+++  .+|..|.++++|++|++++ |.+++.+|..|+.+++|++|+|++|++++..|..|..+++|++|
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  130 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence            47777777777776  6777777788888888884 77777788888888888888888888887788888888888888


Q ss_pred             EccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCC-CCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcC
Q 002883          302 DLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLS-SFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKL  380 (871)
Q Consensus       302 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  380 (871)
                      +|++|++++..|..|..+++|++|++++|++++.+|..+..++ +|++|++++|++++..|..+..++ |+.|++++|.+
T Consensus       131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l  209 (313)
T 1ogq_A          131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred             eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence            8888888888888888888888888888888878888888887 888899998888888888888887 99999999999


Q ss_pred             CCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCCc
Q 002883          381 SGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEG  460 (871)
Q Consensus       381 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~  460 (871)
                      ++..|..|..+++|+.|+|++|++++..+. +..+++|++|+|++|++++.+|..+..+++|+.|+|++|++++.+|...
T Consensus       210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~  288 (313)
T 1ogq_A          210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence            888888899999999999999999866665 8889999999999999999999999999999999999999999999888


Q ss_pred             ccccccceeccCCCCCccCCCc
Q 002883          461 VFKNVRAVSIIGNNKLCGGSPE  482 (871)
Q Consensus       461 ~~~~l~~l~l~~N~~~C~~~~~  482 (871)
                      .++.++.+++.+|++.|+.|..
T Consensus       289 ~l~~L~~l~l~~N~~lc~~p~~  310 (313)
T 1ogq_A          289 NLQRFDVSAYANNKCLCGSPLP  310 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTTSS
T ss_pred             cccccChHHhcCCCCccCCCCC
Confidence            8999999999999999997653

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=7.5e-35  Score=341.11  Aligned_cols=310  Identities=16%  Similarity=0.126  Sum_probs=220.1

Q ss_pred             CCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccccccccccCCCCccccccCCCceee
Q 002883           37 LFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFA  116 (871)
Q Consensus        37 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  116 (871)
                      +.+++.|++++|.++...+..|..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|.++++|++|+
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            44555566666655544444455556666666666665544445555666666666666666554455555666666666


Q ss_pred             eeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCcccccccc
Q 002883          117 VTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLV  196 (871)
Q Consensus       117 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~  196 (871)
                      |++|.+. .+|..++..+++|+.|+|++|.+++          ..|..|+.+++|++|++++|.++.++         +.
T Consensus       130 L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~----------~~~~~~~~l~~L~~L~L~~N~l~~~~---------~~  189 (597)
T 3oja_B          130 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER----------IEDDTFQATTSLQNLQLSSNRLTHVD---------LS  189 (597)
T ss_dssp             CCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCB----------CCTTTTTTCTTCCEEECTTSCCSBCC---------GG
T ss_pred             eeCCCCC-CCCHHHhccCCCCCEEEeeCCcCCC----------CChhhhhcCCcCcEEECcCCCCCCcC---------hh
Confidence            6666655 5555555566677777777776652          22334666777777777777776532         34


Q ss_pred             CCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcE
Q 002883          197 NCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQV  276 (871)
Q Consensus       197 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  276 (871)
                      .+++|+.|++++|.+++..      ...+|+.|++++|.++...+..   .++|+.|+|++|.+++  +..+..+++|+.
T Consensus       190 ~l~~L~~L~l~~n~l~~l~------~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~  258 (597)
T 3oja_B          190 LIPSLFHANVSYNLLSTLA------IPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVE  258 (597)
T ss_dssp             GCTTCSEEECCSSCCSEEE------CCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSE
T ss_pred             hhhhhhhhhcccCcccccc------CCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCE
Confidence            5567777788887776421      1235888888888887443322   2678888888888885  477888999999


Q ss_pred             EEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCC
Q 002883          277 LSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHL  356 (871)
Q Consensus       277 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l  356 (871)
                      |+|++|.+++..|..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+
T Consensus       259 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l  336 (597)
T 3oja_B          259 VDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI  336 (597)
T ss_dssp             EECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCC
T ss_pred             EECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCC
Confidence            9999999998888899999999999999999985 5777788999999999999998 6788888899999999999999


Q ss_pred             CCCCccccCCCCCCCEEeCCCCcCCC
Q 002883          357 SGPIPLEVGRLKGIQQLDLSENKLSG  382 (871)
Q Consensus       357 ~~~~~~~~~~l~~L~~L~L~~N~l~~  382 (871)
                      ++. +  +..+++|+.|++++|++.+
T Consensus       337 ~~~-~--~~~~~~L~~L~l~~N~~~~  359 (597)
T 3oja_B          337 VTL-K--LSTHHTLKNLTLSHNDWDC  359 (597)
T ss_dssp             CCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred             CCc-C--hhhcCCCCEEEeeCCCCCC
Confidence            843 3  7788999999999999874

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.5e-35  Score=313.29  Aligned_cols=237  Identities=19%  Similarity=0.297  Sum_probs=182.3

Q ss_pred             hcCCCCC-ceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHH-HcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSA-NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEAL-RSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|.+. +.||+|+||.||+|.+..+++.||+|+++.     ...+.+|++++ +..+||||+++++++... ..+...
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~   89 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC   89 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCce
Confidence            3567777 789999999999999998999999999863     24567888888 556999999999998652 223367


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEE
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN---EMVAHV  712 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl  712 (871)
                      .++||||+++|+|.+++......     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl  161 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQ-----AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKL  161 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEE
T ss_pred             EEEEEeecCCCcHHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEE
Confidence            89999999999999999875432     589999999999999999999999   9999999999999998   789999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      +|||++....                         +..++.++||||+||++|+|++|+.||...........  .....
T Consensus       162 ~Dfg~a~~~~-------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~--~~~~~  214 (299)
T 3m2w_A          162 TDFGFAKETT-------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRI  214 (299)
T ss_dssp             CCCTTCEECT-------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC--SCCSS
T ss_pred             eccccccccc-------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH--HHHHH
Confidence            9999987532                         23467899999999999999999999975432210000  00000


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ...  ..                     +...+....+..++.+++.+||+.||++|||+.|+++.
T Consensus       215 ~~~--~~---------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          215 RMG--QY---------------------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CTT--CC---------------------SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhc--cc---------------------cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            000  00                     00001112345567899999999999999999999873

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.5e-35  Score=320.01  Aligned_cols=246  Identities=19%  Similarity=0.140  Sum_probs=183.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--------cchHHHHHHHHHHHHcCC---------C-----
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--------RGASKSFIAECEALRSIR---------H-----  615 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h-----  615 (871)
                      .++|++.+.||+|+||+||+|++  +++.||||+++...        ....+.+.+|+++++.++         |     
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46799999999999999999998  67999999996542        223477889999998886         5     


Q ss_pred             ------------CccceeeeeecccC--------cCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHH
Q 002883          616 ------------RNLVKIITSCSSID--------TRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI  675 (871)
Q Consensus       616 ------------~niv~~~~~~~~~~--------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~  675 (871)
                                  |||+++++++.+..        .......|+||||+++|++.+.+...        .+++..++.++.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~--------~~~~~~~~~i~~  168 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--------LSSLATAKSILH  168 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT--------CCCHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc--------CCCHHHHHHHHH
Confidence                        45555555444310        01246789999999999776666431        489999999999


Q ss_pred             HHHHHHHHHh-hcCCCCeEecCCCCCceeeCCCC--------------------ceEEeecccceecCCCCCCccccccc
Q 002883          676 DVANVLEYLH-HHCHTSIVHCDLKPSNVLLDNEM--------------------VAHVGDFGLSRLLHDNSPDQTSTSRV  734 (871)
Q Consensus       676 ~i~~~L~~LH-~~~~~~ivH~Dlkp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~  734 (871)
                      ||+.||+||| +.   +|+||||||+|||++.++                    .+||+|||+|+.....        ..
T Consensus       169 qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~  237 (336)
T 2vuw_A          169 QLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IV  237 (336)
T ss_dssp             HHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EE
T ss_pred             HHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cE
Confidence            9999999999 88   999999999999999887                    8999999999876431        24


Q ss_pred             cccccccCcccccCCCCCCccchhhHHHH-HHHHHhCCCCCchhhhhhhhHHHHhhh-CCCchhhhhcChhHHHHHHHHH
Q 002883          735 KGSIGYVAPEYGALGEVSTHGDEYSFGIL-MLEMFTGKRPTDDMFEEGLSLHKYAKM-GLPDQVAEIIDPAILEEALEIQ  812 (871)
Q Consensus       735 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~i-l~elltG~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  812 (871)
                      .||+.|+|||++.+.. +.++||||+|++ .+++++|..||................ ..+                   
T Consensus       238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------  297 (336)
T 2vuw_A          238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK-------------------  297 (336)
T ss_dssp             ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS-------------------
T ss_pred             EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC-------------------
Confidence            7999999999987665 899999998877 788999999986421111011111100 000                   


Q ss_pred             hhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHH
Q 002883          813 AGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAI  856 (871)
Q Consensus       813 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl  856 (871)
                             ..........+..++.+++.+||+.|     ||+|++
T Consensus       298 -------~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          298 -------TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             -------SCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             -------cccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence                   00011223356678899999999976     999988

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=1.9e-33  Score=304.51  Aligned_cols=288  Identities=18%  Similarity=0.221  Sum_probs=162.2

Q ss_pred             cCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccccccccccCCCCccccccCCCceeeee
Q 002883           39 KLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVT  118 (871)
Q Consensus        39 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  118 (871)
                      +|+.++++++.++ .+|..+.  ++|++|+|++|.+++..|..|.++++|++|++++|++++..|..|.++++|++|+++
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            4566666666665 4555443  456666666666654445556666666666666666664445556666666666666


Q ss_pred             ccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCc-cccCCCcccEEecccccCCCCCCCCccccccccC
Q 002883          119 QNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPE-DLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVN  197 (871)
Q Consensus       119 ~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~  197 (871)
                      +|.+. .+|..++   ++|++|++++|.++           .+|. .|.++++|++|++++|.++..+.    .+..+..
T Consensus       111 ~n~l~-~l~~~~~---~~L~~L~l~~n~i~-----------~~~~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~~~  171 (332)
T 2ft3_A          111 KNHLV-EIPPNLP---SSLVELRIHDNRIR-----------KVPKGVFSGLRNMNCIEMGGNPLENSGF----EPGAFDG  171 (332)
T ss_dssp             SSCCC-SCCSSCC---TTCCEEECCSSCCC-----------CCCSGGGSSCSSCCEEECCSCCCBGGGS----CTTSSCS
T ss_pred             CCcCC-ccCcccc---ccCCEEECCCCccC-----------ccCHhHhCCCccCCEEECCCCccccCCC----CcccccC
Confidence            66555 5555443   56777777777665           3333 36666777777777776643111    1223334


Q ss_pred             CCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEE
Q 002883          198 CTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVL  277 (871)
Q Consensus       198 l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  277 (871)
                      + +|++|++++|+++ .+|..+.   ++|++|++++|++++..+..|..+++|+.|++++|.+++..+..|..+++|++|
T Consensus       172 l-~L~~L~l~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  246 (332)
T 2ft3_A          172 L-KLNYLRISEAKLT-GIPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLREL  246 (332)
T ss_dssp             C-CCSCCBCCSSBCS-SCCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEE
T ss_pred             C-ccCEEECcCCCCC-ccCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEE
Confidence            4 6666666666666 3444433   356667777776666555666666666666666666665555566666666666


Q ss_pred             EccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCC------CCCCEEecCCCcCC--CCCcccccCCCCCcEE
Q 002883          278 SLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNC------LQLQKLDLSDNNLS--GTIPREVIGLSSFVLL  349 (871)
Q Consensus       278 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l------~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L  349 (871)
                      +|++|+++ .+|..+..+++|++|+|++|+|++..+..|+.+      .+|+.|++++|.+.  +..|..|..+++|+.|
T Consensus       247 ~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l  325 (332)
T 2ft3_A          247 HLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAI  325 (332)
T ss_dssp             ECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTE
T ss_pred             ECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhh
Confidence            66666666 455556666666666666666665544444432      33444444444443  2333333334444444


Q ss_pred             eccCC
Q 002883          350 DLSRN  354 (871)
Q Consensus       350 ~ls~N  354 (871)
                      ++++|
T Consensus       326 ~l~~n  330 (332)
T 2ft3_A          326 QFGNY  330 (332)
T ss_dssp             EC---
T ss_pred             hcccc
Confidence            44333

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=7.9e-33  Score=299.69  Aligned_cols=268  Identities=18%  Similarity=0.256  Sum_probs=161.8

Q ss_pred             CcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCcc
Q 002883          169 KNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLK  248 (871)
Q Consensus       169 ~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~  248 (871)
                      ++|+.|++++|+++.+++      ..+..+++|++|+|++|.+++..|..+..+ ++|++|++++|+++ .+|..+.  +
T Consensus        54 ~~l~~L~l~~n~i~~~~~------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~n~l~-~l~~~~~--~  123 (332)
T 2ft3_A           54 PDTTLLDLQNNDISELRK------DDFKGLQHLYALVLVNNKISKIHEKAFSPL-RKLQKLYISKNHLV-EIPPNLP--S  123 (332)
T ss_dssp             TTCCEEECCSSCCCEECT------TTTTTCTTCCEEECCSSCCCEECGGGSTTC-TTCCEEECCSSCCC-SCCSSCC--T
T ss_pred             CCCeEEECCCCcCCccCH------hHhhCCCCCcEEECCCCccCccCHhHhhCc-CCCCEEECCCCcCC-ccCcccc--c
Confidence            355555666555554322      234455566666666666655445555554 34666666666665 3333333  5


Q ss_pred             ccceeecccccccccCCccccCCCCCcEEEccCCCCCC--CCCcccCCCccccEEEccCccccccCcccccCCCCCCEEe
Q 002883          249 NLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISG--EIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLD  326 (871)
Q Consensus       249 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  326 (871)
                      +|++|++++|.+++..+..|..+++|++|++++|.++.  ..+..+..+ +|++|++++|++++ +|..+.  ++|+.|+
T Consensus       124 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~  199 (332)
T 2ft3_A          124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELH  199 (332)
T ss_dssp             TCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCB
T ss_pred             cCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEE
Confidence            66666666666665555556666666666666666642  445555555 66666666666663 343333  5666667


Q ss_pred             cCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccc
Q 002883          327 LSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQG  406 (871)
Q Consensus       327 L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  406 (871)
                      +++|++++..+..+..+++|+.|++++|.+++..+..+..+++|+.|+|++|+++ .+|..+..+++|++|++++|+|++
T Consensus       200 l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~  278 (332)
T 2ft3_A          200 LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK  278 (332)
T ss_dssp             CCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCB
T ss_pred             CCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCc
Confidence            7777766555566666667777777777766555556666677777777777776 566666667777777777777766


Q ss_pred             cCccccCCC------CCCCEEeCCCCcCC--CCCcccccccccccEEecCCCc
Q 002883          407 PIHSGFSSL------KGLQDLDLSRNNFS--GKIPMFLNTFRFLQKLNLSFNN  451 (871)
Q Consensus       407 ~~~~~~~~l------~~L~~L~l~~N~l~--~~~~~~~~~~~~L~~L~l~~N~  451 (871)
                      ..+..|...      ..|+.|++++|.++  +..|..+..+++|+.+++++|+
T Consensus       279 ~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          279 VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             CCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             cChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            665555442      45667777777665  4566666677777777776664

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.9e-32  Score=296.53  Aligned_cols=248  Identities=21%  Similarity=0.250  Sum_probs=121.1

Q ss_pred             cCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCc
Q 002883          196 VNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQ  275 (871)
Q Consensus       196 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  275 (871)
                      ..+++|++|+|++|.+++..|..+..+ ++|++|++++|+++ .+|..+.  ++|++|++++|.+++..+..|..+++|+
T Consensus        73 ~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~  148 (330)
T 1xku_A           73 KNLKNLHTLILINNKISKISPGAFAPL-VKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMI  148 (330)
T ss_dssp             TTCTTCCEEECCSSCCCCBCTTTTTTC-TTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCC
T ss_pred             ccCCCCCEEECCCCcCCeeCHHHhcCC-CCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCcccc
Confidence            334444444444444443334444433 23444444444444 2222222  3444444554444444444444555555


Q ss_pred             EEEccCCCCCC--CCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccC
Q 002883          276 VLSLFGNKISG--EIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSR  353 (871)
Q Consensus       276 ~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  353 (871)
                      +|++++|.++.  ..+..+..+++|++|++++|+++. +|..+.  ++|++|++++|++++..+..+..+++|+.|++++
T Consensus       149 ~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~  225 (330)
T 1xku_A          149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF  225 (330)
T ss_dssp             EEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCS
T ss_pred             EEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCC
Confidence            55555555432  334444555555555555555542 332222  4555555555555544455555555555555555


Q ss_pred             CCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCC------CCCCEEeCCCCc
Q 002883          354 NHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSL------KGLQDLDLSRNN  427 (871)
Q Consensus       354 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~l~~N~  427 (871)
                      |.+++..+..+..+++|+.|+|++|+++ .+|..+..+++|++|++++|+|+++.+..|...      ..|+.|++++|.
T Consensus       226 n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~  304 (330)
T 1xku_A          226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP  304 (330)
T ss_dssp             SCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSS
T ss_pred             CcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCc
Confidence            5555444445555555555555555555 445555555555555555555555544444322      455566666666


Q ss_pred             CCC--CCcccccccccccEEecCCCc
Q 002883          428 FSG--KIPMFLNTFRFLQKLNLSFNN  451 (871)
Q Consensus       428 l~~--~~~~~~~~~~~L~~L~l~~N~  451 (871)
                      +..  ..|..+..+++++.++|++|+
T Consensus       305 ~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          305 VQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             SCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             ccccccCccccccccceeEEEecccC
Confidence            542  445556666666666666653

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=6.9e-34  Score=304.59  Aligned_cols=253  Identities=28%  Similarity=0.460  Sum_probs=231.2

Q ss_pred             CcccEEEccCCcCcc--cCChhhhhccccccEEEccC-CccCCCCCCCCCCccccceeecccccccccCCccccCCCCCc
Q 002883          199 TFLEVVSLSSNSLSG--VLPNSIANFSSHLIYLYMSA-NRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQ  275 (871)
Q Consensus       199 ~~L~~L~L~~n~l~~--~~~~~~~~~~~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  275 (871)
                      .++++|+|++|.+++  .+|..+..+ ++|++|++++ |.+.+.+|..|+++++|++|++++|.+++..|..|..+++|+
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l-~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~  128 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANL-PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGC-TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             ceEEEEECCCCCccCCcccChhHhCC-CCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence            468889999999987  788888887 4699999995 999888999999999999999999999988999999999999


Q ss_pred             EEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCC-CCCEEecCCCcCCCCCcccccCCCCCcEEeccCC
Q 002883          276 VLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCL-QLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRN  354 (871)
Q Consensus       276 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N  354 (871)
                      +|+|++|++++..|..+..+++|++|+|++|++++.+|..+..++ +|+.|++++|++++..|..+..++ |+.|++++|
T Consensus       129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N  207 (313)
T 1ogq_A          129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN  207 (313)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred             EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCC
Confidence            999999999988999999999999999999999988999999998 999999999999988999999887 999999999


Q ss_pred             CCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcc
Q 002883          355 HLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPM  434 (871)
Q Consensus       355 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  434 (871)
                      .+++..|..+..+++|+.|+|++|.+++..|. +..+++|++|+|++|+|++..|..|..+++|++|+|++|++++.+|.
T Consensus       208 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~  286 (313)
T 1ogq_A          208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ  286 (313)
T ss_dssp             EEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred             cccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCC
Confidence            99988899999999999999999999966555 88899999999999999999999999999999999999999988887


Q ss_pred             cccccccccEEecCCCcCccc
Q 002883          435 FLNTFRFLQKLNLSFNNLEGE  455 (871)
Q Consensus       435 ~~~~~~~L~~L~l~~N~l~~~  455 (871)
                      . ..+++|+.|++++|+.-|.
T Consensus       287 ~-~~l~~L~~l~l~~N~~lc~  306 (313)
T 1ogq_A          287 G-GNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             S-TTGGGSCGGGTCSSSEEES
T ss_pred             C-ccccccChHHhcCCCCccC
Confidence            6 8899999999999995443

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.4e-32  Score=297.58  Aligned_cols=289  Identities=17%  Similarity=0.225  Sum_probs=150.0

Q ss_pred             cCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccccccccccCCCCccccccCCCceeeee
Q 002883           39 KLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVT  118 (871)
Q Consensus        39 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  118 (871)
                      +|+.++++++.++ .+|..+.  ++|++|+|++|.+++..+..|+.+++|++|+|++|.+++..|..|.++++|++|+++
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS  108 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence            4445555555544 3444332  344555555555543333345555555555555555554444445555555555555


Q ss_pred             ccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCC-ccccCCCcccEEecccccCCCCCCCCccccccccC
Q 002883          119 QNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIP-EDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVN  197 (871)
Q Consensus       119 ~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~  197 (871)
                      +|.+. .+|..++   ++|+.|++++|.++           .++ ..+.++++|++|++++|.++..+.    ....+..
T Consensus       109 ~n~l~-~l~~~~~---~~L~~L~l~~n~l~-----------~~~~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~~~  169 (330)
T 1xku_A          109 KNQLK-ELPEKMP---KTLQELRVHENEIT-----------KVRKSVFNGLNQMIVVELGTNPLKSSGI----ENGAFQG  169 (330)
T ss_dssp             SSCCS-BCCSSCC---TTCCEEECCSSCCC-----------BBCHHHHTTCTTCCEEECCSSCCCGGGB----CTTGGGG
T ss_pred             CCcCC-ccChhhc---ccccEEECCCCccc-----------ccCHhHhcCCccccEEECCCCcCCccCc----ChhhccC
Confidence            55544 4444432   45666666666655           222 235566666666666666543111    1234455


Q ss_pred             CCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEE
Q 002883          198 CTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVL  277 (871)
Q Consensus       198 l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  277 (871)
                      +++|++|++++|.++ .+|..+.   ++|++|++++|++++..+..|..+++|+.|++++|.+++..+..+..+++|++|
T Consensus       170 l~~L~~L~l~~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  245 (330)
T 1xku_A          170 MKKLSYIRIADTNIT-TIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL  245 (330)
T ss_dssp             CTTCCEEECCSSCCC-SCCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEE
T ss_pred             CCCcCEEECCCCccc-cCCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEE
Confidence            566666666666665 3444332   346666666666665555666666666666666666665555556666666666


Q ss_pred             EccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCC------CCCCEEecCCCcCCC--CCcccccCCCCCcEE
Q 002883          278 SLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNC------LQLQKLDLSDNNLSG--TIPREVIGLSSFVLL  349 (871)
Q Consensus       278 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l------~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L  349 (871)
                      +|++|+++ .+|..+..+++|++|+|++|+|++..+..|+..      +.|+.|++++|.+..  ..|..|..+.+++.+
T Consensus       246 ~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l  324 (330)
T 1xku_A          246 HLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV  324 (330)
T ss_dssp             ECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGE
T ss_pred             ECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEE
Confidence            66666666 455556666666666666666665544444322      344444444444431  233334444444444


Q ss_pred             eccCC
Q 002883          350 DLSRN  354 (871)
Q Consensus       350 ~ls~N  354 (871)
                      +|++|
T Consensus       325 ~L~~N  329 (330)
T 1xku_A          325 QLGNY  329 (330)
T ss_dssp             EC---
T ss_pred             Eeccc
Confidence            44443

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=5.8e-37  Score=348.81  Aligned_cols=356  Identities=17%  Similarity=0.139  Sum_probs=190.6

Q ss_pred             CCCCEEecCCCcccccCCcc-ccCCCcCceeeCCCCcccc----cCCccccCCcccceeeccCccccCCCCcccc-ccc-
Q 002883           14 SELRILDLVVNKLEGNIPSE-LGNLFKLVGLGLTGNNYTG----SIPQSLSNLSFLQQLSLSENSLSGNIPSELG-LLK-   86 (871)
Q Consensus        14 ~~L~~L~l~~n~i~~~~~~~-~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~-   86 (871)
                      +.|++|||++|+++...... +..+++|++|+|++|++++    .++..+..+++|++|+|++|.++...+..+. .++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            46788999999887544443 7788889999999998874    3466777888899999998888744444433 355 


Q ss_pred             ---cccccccccccccC----CCCccccccCCCceeeeeccccccccccccc----cCCCCccEEEccCccCCCCCCccC
Q 002883           87 ---QLNMFQVSANYLTG----SIPIQLFNISSMDYFAVTQNKLVGEIPHYVG----FTLPNIRVLLLGSNWFTGEIPPSI  155 (871)
Q Consensus        87 ---~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~----~~l~~L~~L~l~~n~i~~~~p~~~  155 (871)
                         +|++|+|++|.+++    .++..+..+++|++|++++|.+....+..+.    ...++|++|+|++|.+++..+.  
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--  160 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE--  160 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH--
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH--
Confidence               68888888888773    3466666677777777777766533222221    1233455555555544421100  


Q ss_pred             cCCCCCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhc----cccccEEEc
Q 002883          156 SNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANF----SSHLIYLYM  231 (871)
Q Consensus       156 ~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~----~~~L~~L~L  231 (871)
                          .+                              ...+..+++|++|++++|.+++..+..+...    .++|++|++
T Consensus       161 ----~l------------------------------~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L  206 (461)
T 1z7x_W          161 ----PL------------------------------ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKL  206 (461)
T ss_dssp             ----HH------------------------------HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEEC
T ss_pred             ----HH------------------------------HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEc
Confidence                11                              2233344556666666665553333333221    124666666


Q ss_pred             cCCccCCC----CCCCCCCccccceeecccccccccC-----CccccCCCCCcEEEccCCCCCCC----CCcccCCCccc
Q 002883          232 SANRISGT----IPTGVGNLKNLILIAMEVNLLTGSI-----PTSVGYLLKLQVLSLFGNKISGE----IPSSLGNLIFL  298 (871)
Q Consensus       232 ~~n~i~~~----~~~~~~~l~~L~~L~l~~N~l~~~~-----~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L  298 (871)
                      ++|.+++.    ++..+..+++|+.|++++|.++...     +..+..+++|++|+|++|+++..    ++..+..+++|
T Consensus       207 ~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L  286 (461)
T 1z7x_W          207 ESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL  286 (461)
T ss_dssp             TTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTC
T ss_pred             cCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCc
Confidence            66666532    2334444555555555555554322     11122345566666666655532    33444445555


Q ss_pred             cEEEccCccccccCcccccC-----CCCCCEEecCCCcCCCC----CcccccCCCCCcEEeccCCCCCCCCccccCC---
Q 002883          299 TEVDLQGNSIRGSIPSALGN-----CLQLQKLDLSDNNLSGT----IPREVIGLSSFVLLDLSRNHLSGPIPLEVGR---  366 (871)
Q Consensus       299 ~~L~L~~N~i~~~~~~~~~~-----l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~---  366 (871)
                      ++|+|++|.+++..+..+..     .++|+.|++++|.+++.    ++..+..+++|++|++++|.+++..+..+..   
T Consensus       287 ~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~  366 (461)
T 1z7x_W          287 KELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLG  366 (461)
T ss_dssp             CEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHT
T ss_pred             ceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHc
Confidence            55555555554332222221     14555555555555532    2333344455555555555554332222221   


Q ss_pred             --CCCCCEEeCCCCcCCC----CCccchhcccCCceeeecCCccc
Q 002883          367 --LKGIQQLDLSENKLSG----EIPTSLASCVGLEYLNFSDNSFQ  405 (871)
Q Consensus       367 --l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~  405 (871)
                        .++|++|++++|.+++    .+|..+..+++|++|+|++|+++
T Consensus       367 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~  411 (461)
T 1z7x_W          367 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG  411 (461)
T ss_dssp             STTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred             CCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence              3455555555555543    34444444555555555555544

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=1.2e-35  Score=337.94  Aligned_cols=364  Identities=19%  Similarity=0.147  Sum_probs=178.3

Q ss_pred             cCceeeCCCCcccccCCcc-ccCCcccceeeccCccccC----CCCccccccccccccccccccccCCCCccccccCCCc
Q 002883           39 KLVGLGLTGNNYTGSIPQS-LSNLSFLQQLSLSENSLSG----NIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMD  113 (871)
Q Consensus        39 ~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  113 (871)
                      +|++|+|++|+++...... +..+++|++|+|++|.++.    .++..+..+++|++|+|++|.+.              
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~--------------   69 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG--------------   69 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH--------------
T ss_pred             cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCC--------------
Confidence            4555555555555332222 4455555555555555442    12333344444444444444443              


Q ss_pred             eeeeeccccccccccccccCCC----CccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCc
Q 002883          114 YFAVTQNKLVGEIPHYVGFTLP----NIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDL  189 (871)
Q Consensus       114 ~L~l~~n~l~~~~~~~~~~~l~----~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~  189 (871)
                                ...+..++..++    +|++|+|++|.+++..      ...+|+.+..+++|++|++++|.++...... 
T Consensus        70 ----------~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~------~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~-  132 (461)
T 1z7x_W           70 ----------DVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG------CGVLSSTLRTLPTLQELHLSDNLLGDAGLQL-  132 (461)
T ss_dssp             ----------HHHHHHHHHTTCSTTCCCCEEECTTSCCBGGG------HHHHHHHTTSCTTCCEEECCSSBCHHHHHHH-
T ss_pred             ----------hHHHHHHHHHHhhCCCceeEEEccCCCCCHHH------HHHHHHHHccCCceeEEECCCCcCchHHHHH-
Confidence                      222222222233    5666666666654110      0023444555556666666665553211000 


Q ss_pred             ccccc-ccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccc
Q 002883          190 RFLDS-LVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSV  268 (871)
Q Consensus       190 ~~~~~-l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  268 (871)
                       .... ....++|++|+|++|++++.....+                     +..+..+++|++|++++|.++...+..+
T Consensus       133 -l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l---------------------~~~l~~~~~L~~L~L~~n~i~~~~~~~l  190 (461)
T 1z7x_W          133 -LCEGLLDPQCRLEKLQLEYCSLSAASCEPL---------------------ASVLRAKPDFKELTVSNNDINEAGVRVL  190 (461)
T ss_dssp             -HHHHHTSTTCCCCEEECTTSCCBGGGHHHH---------------------HHHHHHCTTCCEEECCSSBCHHHHHHHH
T ss_pred             -HHHHHhcCCCcceEEECCCCCCCHHHHHHH---------------------HHHHhhCCCCCEEECcCCCcchHHHHHH
Confidence             0000 1123345555555555553221111                     2223333444444444444443222222


Q ss_pred             c-----CCCCCcEEEccCCCCCCC----CCcccCCCccccEEEccCccccccC-----cccccCCCCCCEEecCCCcCCC
Q 002883          269 G-----YLLKLQVLSLFGNKISGE----IPSSLGNLIFLTEVDLQGNSIRGSI-----PSALGNCLQLQKLDLSDNNLSG  334 (871)
Q Consensus       269 ~-----~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~-----~~~~~~l~~L~~L~L~~N~l~~  334 (871)
                      .     ..++|++|+|++|.++..    ++..+..+++|++|+|++|+++...     +..+..+++|+.|++++|.+++
T Consensus       191 ~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~  270 (461)
T 1z7x_W          191 CQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITA  270 (461)
T ss_dssp             HHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred             HHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCH
Confidence            2     134555666666655532    2444455556666666666555322     2222345566666666666653


Q ss_pred             C----CcccccCCCCCcEEeccCCCCCCCCccccCC-----CCCCCEEeCCCCcCCCC----CccchhcccCCceeeecC
Q 002883          335 T----IPREVIGLSSFVLLDLSRNHLSGPIPLEVGR-----LKGIQQLDLSENKLSGE----IPTSLASCVGLEYLNFSD  401 (871)
Q Consensus       335 ~----~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~  401 (871)
                      .    ++..+..+++|++|++++|.+++..+..+..     .++|++|++++|.+++.    ++..+..+++|++|+|++
T Consensus       271 ~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~  350 (461)
T 1z7x_W          271 KGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISN  350 (461)
T ss_dssp             HHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCS
T ss_pred             HHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccC
Confidence            2    3444555666666666666665333322222     24666666666666643    344455556677777777


Q ss_pred             CcccccCccccCC-----CCCCCEEeCCCCcCCC----CCcccccccccccEEecCCCcCccc
Q 002883          402 NSFQGPIHSGFSS-----LKGLQDLDLSRNNFSG----KIPMFLNTFRFLQKLNLSFNNLEGE  455 (871)
Q Consensus       402 N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~----~~~~~~~~~~~L~~L~l~~N~l~~~  455 (871)
                      |++++..+..+..     .++|++|++++|++++    .+|..+..+++|++|++++|++++.
T Consensus       351 n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          351 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             SBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             CccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence            7666544333321     4567777777777664    5566666667777777777776643

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=1.3e-31  Score=286.72  Aligned_cols=277  Identities=23%  Similarity=0.240  Sum_probs=230.7

Q ss_pred             cEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeeccccccccc--CCccccCCCCCcEEEc
Q 002883          202 EVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGS--IPTSVGYLLKLQVLSL  279 (871)
Q Consensus       202 ~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~l~~L~~L~L  279 (871)
                      +.++++++.++ .+|..+.   ++|++|+|++|+++...+..|.++++|+.|++++|.++..  .+..+..+++|++|+|
T Consensus        10 ~~l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L   85 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL   85 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred             CEEEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence            46777777776 5565443   4688888888888866556678889999999999988733  2566778899999999


Q ss_pred             cCCCCCCCCCcccCCCccccEEEccCccccccCc-ccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCC
Q 002883          280 FGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIP-SALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSG  358 (871)
Q Consensus       280 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  358 (871)
                      ++|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+..+.++++|++|++++|.+++
T Consensus        86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  164 (306)
T 2z66_A           86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE  164 (306)
T ss_dssp             CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred             CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence            999998 567778899999999999999986655 578899999999999999988888889999999999999999985


Q ss_pred             -CCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCccccc
Q 002883          359 -PIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLN  437 (871)
Q Consensus       359 -~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  437 (871)
                       ..|..+..+++|++|++++|.+++..|..|..+++|++|+|++|++++..+..|..+++|++|++++|++++..|..+.
T Consensus       165 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  244 (306)
T 2z66_A          165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ  244 (306)
T ss_dssp             GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCC
T ss_pred             ccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHH
Confidence             5788899999999999999999988889999999999999999999988888899999999999999999998999999


Q ss_pred             ccc-cccEEecCCCcCcccCCCCcc---cccccceeccCCCCCccCCCcc
Q 002883          438 TFR-FLQKLNLSFNNLEGEVPSEGV---FKNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       438 ~~~-~L~~L~l~~N~l~~~~~~~~~---~~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      .++ +|++|+|++|+++|.++....   +...+.+....+...|..|...
T Consensus       245 ~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~  294 (306)
T 2z66_A          245 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK  294 (306)
T ss_dssp             CCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGG
T ss_pred             hhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhh
Confidence            885 899999999999988764322   2334455566777888877654

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=1.3e-30  Score=293.69  Aligned_cols=254  Identities=23%  Similarity=0.287  Sum_probs=227.3

Q ss_pred             cccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEc
Q 002883          200 FLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSL  279 (871)
Q Consensus       200 ~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L  279 (871)
                      ....++.+++.++ .+|..+.   ++++.|+|++|+|+...+..|.++++|+.|+|++|.|++..+..|.++++|++|+|
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L  119 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL  119 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred             CCCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence            3567778888887 5676654   46899999999999888899999999999999999999888889999999999999


Q ss_pred             cCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCC-CcCCCCCcccccCCCCCcEEeccCCCCCC
Q 002883          280 FGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSD-NNLSGTIPREVIGLSSFVLLDLSRNHLSG  358 (871)
Q Consensus       280 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  358 (871)
                      ++|+|+...+..|..+++|++|+|++|+|+...+..|..+++|+.|+|++ |.+....+..|.++++|++|++++|.++ 
T Consensus       120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-  198 (440)
T 3zyj_A          120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-  198 (440)
T ss_dssp             CSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-
T ss_pred             CCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-
Confidence            99999977777899999999999999999988788999999999999999 5566555567899999999999999998 


Q ss_pred             CCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccc
Q 002883          359 PIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNT  438 (871)
Q Consensus       359 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  438 (871)
                      .+| .+..+++|+.|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..
T Consensus       199 ~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  277 (440)
T 3zyj_A          199 EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP  277 (440)
T ss_dssp             SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSS
T ss_pred             ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcc
Confidence            555 5889999999999999999888999999999999999999999999999999999999999999999888888999


Q ss_pred             cccccEEecCCCcCcccCCCC
Q 002883          439 FRFLQKLNLSFNNLEGEVPSE  459 (871)
Q Consensus       439 ~~~L~~L~l~~N~l~~~~~~~  459 (871)
                      +++|+.|+|++|+|.|.+...
T Consensus       278 l~~L~~L~L~~Np~~CdC~l~  298 (440)
T 3zyj_A          278 LHHLERIHLHHNPWNCNCDIL  298 (440)
T ss_dssp             CTTCCEEECCSSCEECSSTTH
T ss_pred             ccCCCEEEcCCCCccCCCCch
Confidence            999999999999999988654

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=1.8e-30  Score=293.62  Aligned_cols=253  Identities=23%  Similarity=0.288  Sum_probs=224.2

Q ss_pred             ccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEcc
Q 002883          201 LEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLF  280 (871)
Q Consensus       201 L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~  280 (871)
                      ...++.+++.++ .+|..+.   ++|++|+|++|+|++..+..|.++++|+.|+|++|.|++..+..|.++++|++|+|+
T Consensus        56 ~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~  131 (452)
T 3zyi_A           56 FSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF  131 (452)
T ss_dssp             SCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence            456777777777 5666544   468999999999998888899999999999999999998888899999999999999


Q ss_pred             CCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCC-CcCCCCCcccccCCCCCcEEeccCCCCCCC
Q 002883          281 GNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSD-NNLSGTIPREVIGLSSFVLLDLSRNHLSGP  359 (871)
Q Consensus       281 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  359 (871)
                      +|+|+...+..|..+++|++|+|++|+|+...+..|.++++|+.|++++ |.+....+..|.++++|++|+|++|.+++ 
T Consensus       132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-  210 (452)
T 3zyi_A          132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-  210 (452)
T ss_dssp             SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-
T ss_pred             CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-
Confidence            9999977777899999999999999999977777899999999999998 56665555678899999999999999984 


Q ss_pred             CccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCccccccc
Q 002883          360 IPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTF  439 (871)
Q Consensus       360 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~  439 (871)
                      +| .+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+|++..+..+..+
T Consensus       211 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  289 (452)
T 3zyi_A          211 MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL  289 (452)
T ss_dssp             CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred             cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence            44 58899999999999999998889999999999999999999999999999999999999999999998888889999


Q ss_pred             ccccEEecCCCcCcccCCCC
Q 002883          440 RFLQKLNLSFNNLEGEVPSE  459 (871)
Q Consensus       440 ~~L~~L~l~~N~l~~~~~~~  459 (871)
                      ++|+.|+|++|++.|.+...
T Consensus       290 ~~L~~L~L~~Np~~CdC~~~  309 (452)
T 3zyi_A          290 RYLVELHLHHNPWNCDCDIL  309 (452)
T ss_dssp             TTCCEEECCSSCEECSTTTH
T ss_pred             cCCCEEEccCCCcCCCCCch
Confidence            99999999999999988754

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=2.8e-30  Score=273.22  Aligned_cols=254  Identities=22%  Similarity=0.238  Sum_probs=158.5

Q ss_pred             cEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccC
Q 002883          202 EVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFG  281 (871)
Q Consensus       202 ~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~  281 (871)
                      ++++++++.++ .+|..+.   ++|++|++++|+|++..+..|..+++|++|++++|.+++..+..              
T Consensus        14 ~~~~c~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~--------------   75 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA--------------   75 (285)
T ss_dssp             CEEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT--------------
T ss_pred             eEEEcCcCCcc-cCCcCCC---CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhh--------------
Confidence            45666666665 3444332   34666666666665444444555555555555555555444444              


Q ss_pred             CCCCCCCCcccCCCccccEEEccCcc-ccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCC
Q 002883          282 NKISGEIPSSLGNLIFLTEVDLQGNS-IRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPI  360 (871)
Q Consensus       282 n~l~~~~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~  360 (871)
                                |..+++|++|+|++|+ ++...+..|..+++|++|++++|++++..+..+..+++|++|++++|.+++..
T Consensus        76 ----------~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  145 (285)
T 1ozn_A           76 ----------FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP  145 (285)
T ss_dssp             ----------TTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             ----------cCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccC
Confidence                      4444455555555554 44333445555555555555555555444555555556666666666665444


Q ss_pred             ccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccc
Q 002883          361 PLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFR  440 (871)
Q Consensus       361 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~  440 (871)
                      +..++.+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|++++..+..+..++
T Consensus       146 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  225 (285)
T 1ozn_A          146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR  225 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred             HhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCc
Confidence            45566666777777777777655555677777777777777777777777777778888888888888876666777888


Q ss_pred             cccEEecCCCcCcccCCCCcccccccceeccCCCCCccCCCcc
Q 002883          441 FLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       441 ~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      +|+.|++++|++.|.++..+.+..++.+....+...|..|..+
T Consensus       226 ~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~~l  268 (285)
T 1ozn_A          226 ALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL  268 (285)
T ss_dssp             TCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGG
T ss_pred             ccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCchHh
Confidence            8888888888888777655555556666666777777776654

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=4.3e-31  Score=288.68  Aligned_cols=281  Identities=16%  Similarity=0.181  Sum_probs=204.3

Q ss_pred             CCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCC
Q 002883          167 KLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGN  246 (871)
Q Consensus       167 ~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~  246 (871)
                      .++.....++++|.++.+|..       +.  ++|++|++++|.+++..+..+..+ ++|++|++++|+|++..+..|.+
T Consensus        29 ~C~~~~~c~~~~~~l~~iP~~-------~~--~~L~~L~l~~n~i~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~   98 (353)
T 2z80_A           29 SCDRNGICKGSSGSLNSIPSG-------LT--EAVKSLDLSNNRITYISNSDLQRC-VNLQALVLTSNGINTIEEDSFSS   98 (353)
T ss_dssp             EECTTSEEECCSTTCSSCCTT-------CC--TTCCEEECTTSCCCEECTTTTTTC-TTCCEEECTTSCCCEECTTTTTT
T ss_pred             CCCCCeEeeCCCCCccccccc-------cc--ccCcEEECCCCcCcccCHHHhccC-CCCCEEECCCCccCccCHhhcCC
Confidence            344555678888888876642       11  468888888888886555566665 46888888888888777777888


Q ss_pred             ccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCC-cccCCCccccEEEccCc-cccccCcccccCCCCCCE
Q 002883          247 LKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIP-SSLGNLIFLTEVDLQGN-SIRGSIPSALGNCLQLQK  324 (871)
Q Consensus       247 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~  324 (871)
                      +++|++|++++|.+++..+..|..+++|++|+|++|+++...+ ..+..+++|++|++++| .++...+..|.++++|++
T Consensus        99 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~  178 (353)
T 2z80_A           99 LGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEE  178 (353)
T ss_dssp             CTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEE
T ss_pred             CCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCE
Confidence            8888888888888886555557888888888888888874433 46778888888888887 466666677888888888


Q ss_pred             EecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchh---cccCCceeeecC
Q 002883          325 LDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLA---SCVGLEYLNFSD  401 (871)
Q Consensus       325 L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~L~~  401 (871)
                      |++++|++++..|..+..+++|++|++++|.++...+..+..+++|+.|++++|.+++..+..+.   ....++.++|++
T Consensus       179 L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~  258 (353)
T 2z80_A          179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN  258 (353)
T ss_dssp             EEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEES
T ss_pred             EECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhcccccc
Confidence            88888888877778888888888888888888633333345578888888888888765544443   345677777777


Q ss_pred             Ccccc----cCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCC
Q 002883          402 NSFQG----PIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVP  457 (871)
Q Consensus       402 N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~  457 (871)
                      |.+++    .+|..+..+++|+.|++++|+++...+..+..+++|++|++++|+++|.+|
T Consensus       259 ~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          259 VKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             CBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            77764    245667778888888888888884444445778888888888888887766

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=9e-30  Score=286.86  Aligned_cols=254  Identities=20%  Similarity=0.205  Sum_probs=230.5

Q ss_pred             cccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEcc
Q 002883          225 HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQ  304 (871)
Q Consensus       225 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  304 (871)
                      +...++.+++.++ .+|..+.  ++++.|+|++|.|+...+..|..+++|++|+|++|+|+...+..|.++++|++|+|+
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~  120 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF  120 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred             CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence            4678999999998 6676665  789999999999999888999999999999999999998888899999999999999


Q ss_pred             CccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCC-CCCCCCccccCCCCCCCEEeCCCCcCCCC
Q 002883          305 GNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRN-HLSGPIPLEVGRLKGIQQLDLSENKLSGE  383 (871)
Q Consensus       305 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  383 (871)
                      +|+|+...+..|..+++|++|+|++|+|++..+..|..+++|++|++++| .+....+..|..+++|++|+|++|.++ .
T Consensus       121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~  199 (440)
T 3zyj_A          121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-E  199 (440)
T ss_dssp             SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-S
T ss_pred             CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-c
Confidence            99999877788999999999999999999887889999999999999995 555444557999999999999999999 5


Q ss_pred             CccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCC-ccc
Q 002883          384 IPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE-GVF  462 (871)
Q Consensus       384 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~-~~~  462 (871)
                      +| .+..+++|++|+|++|+|++..+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++.++.. ..+
T Consensus       200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  278 (440)
T 3zyj_A          200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL  278 (440)
T ss_dssp             CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred             cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence            55 4889999999999999999999999999999999999999999999999999999999999999999877654 557


Q ss_pred             ccccceeccCCCCCccCCCcc
Q 002883          463 KNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       463 ~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      ++++.+++.+|||.|+|...|
T Consensus       279 ~~L~~L~L~~Np~~CdC~l~~  299 (440)
T 3zyj_A          279 HHLERIHLHHNPWNCNCDILW  299 (440)
T ss_dssp             TTCCEEECCSSCEECSSTTHH
T ss_pred             cCCCEEEcCCCCccCCCCchH
Confidence            889999999999999997654

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=1.4e-29  Score=286.28  Aligned_cols=254  Identities=21%  Similarity=0.195  Sum_probs=229.9

Q ss_pred             cccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEcc
Q 002883          225 HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQ  304 (871)
Q Consensus       225 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  304 (871)
                      +...++.+++.++ .+|..+.  ++|+.|+|++|.|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~  131 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF  131 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence            4678999999998 5666554  689999999999999999999999999999999999998888999999999999999


Q ss_pred             CccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCC-CCCCCCccccCCCCCCCEEeCCCCcCCCC
Q 002883          305 GNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRN-HLSGPIPLEVGRLKGIQQLDLSENKLSGE  383 (871)
Q Consensus       305 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  383 (871)
                      +|+|+...+..|.++++|++|+|++|+|++..+..|..+++|+.|++++| .+....+..|..+++|++|+|++|++++ 
T Consensus       132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-  210 (452)
T 3zyi_A          132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-  210 (452)
T ss_dssp             SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-
T ss_pred             CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-
Confidence            99999888888999999999999999999777789999999999999994 5554445579999999999999999994 


Q ss_pred             CccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCC-ccc
Q 002883          384 IPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE-GVF  462 (871)
Q Consensus       384 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~-~~~  462 (871)
                      +| .+..+++|++|+|++|+|++..+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++.++.. ..+
T Consensus       211 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  289 (452)
T 3zyi_A          211 MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL  289 (452)
T ss_dssp             CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred             cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence            44 4888999999999999999999999999999999999999999999999999999999999999999877654 457


Q ss_pred             ccccceeccCCCCCccCCCcc
Q 002883          463 KNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       463 ~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      ++++.+++.+|||.|+|...|
T Consensus       290 ~~L~~L~L~~Np~~CdC~~~~  310 (452)
T 3zyi_A          290 RYLVELHLHHNPWNCDCDILW  310 (452)
T ss_dssp             TTCCEEECCSSCEECSTTTHH
T ss_pred             cCCCEEEccCCCcCCCCCchH
Confidence            889999999999999997643

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.6e-30  Score=284.26  Aligned_cols=277  Identities=19%  Similarity=0.177  Sum_probs=143.0

Q ss_pred             cccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEc
Q 002883          200 FLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSL  279 (871)
Q Consensus       200 ~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L  279 (871)
                      .....++++|.++ .+|..+.   ++|++|++++|+|++..+..|.++++|+.|++++|.+++..+..|..+++|++|+|
T Consensus        32 ~~~~c~~~~~~l~-~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (353)
T 2z80_A           32 RNGICKGSSGSLN-SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL  107 (353)
T ss_dssp             TTSEEECCSTTCS-SCCTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCeEeeCCCCCcc-ccccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence            3344555555555 3444433   24555555555555444445555555555555555555555555555555555555


Q ss_pred             cCCCCCCCCCcccCCCccccEEEccCccccccCc-ccccCCCCCCEEecCCC-cCCCCCcccccCCCCCcEEeccCCCCC
Q 002883          280 FGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIP-SALGNCLQLQKLDLSDN-NLSGTIPREVIGLSSFVLLDLSRNHLS  357 (871)
Q Consensus       280 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~ls~N~l~  357 (871)
                      ++|++++..+..|.++++|++|+|++|+++...+ ..|..+++|++|++++| .+++..+..+.++++|++|++++|.++
T Consensus       108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~  187 (353)
T 2z80_A          108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ  187 (353)
T ss_dssp             CSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred             CCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcC
Confidence            5555553333335555555555555555553322 24555555555555555 344444455555555555555555555


Q ss_pred             CCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccC---CCCCCCEEeCCCCcCCC----
Q 002883          358 GPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFS---SLKGLQDLDLSRNNFSG----  430 (871)
Q Consensus       358 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~l~~N~l~~----  430 (871)
                      +..|..+..+++|++|++++|.++...+..+..+++|++|++++|++++..+..+.   ....++.+++++|.+++    
T Consensus       188 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~  267 (353)
T 2z80_A          188 SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF  267 (353)
T ss_dssp             EECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHH
T ss_pred             ccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchh
Confidence            44455555555555555555555422222233455555555555555544333222   23445555555555543    


Q ss_pred             CCcccccccccccEEecCCCcCcccCCCC-cccccccceeccCCCCCccCC
Q 002883          431 KIPMFLNTFRFLQKLNLSFNNLEGEVPSE-GVFKNVRAVSIIGNNKLCGGS  480 (871)
Q Consensus       431 ~~~~~~~~~~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~C~~~  480 (871)
                      .+|..+..+++|++|++++|+++..++.. ..+++++.+++.+|++.|+|+
T Consensus       268 ~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          268 QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             HHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             hhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            23444555555555555555555433322 344555555555555555553

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=7.1e-30  Score=273.23  Aligned_cols=234  Identities=20%  Similarity=0.235  Sum_probs=158.9

Q ss_pred             cccEEEccCCccCCC--CCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCC-cccCCCccccEE
Q 002883          225 HLIYLYMSANRISGT--IPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIP-SSLGNLIFLTEV  301 (871)
Q Consensus       225 ~L~~L~L~~n~i~~~--~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L  301 (871)
                      +|++|+|++|+++..  .+..+..+++|++|++++|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|
T Consensus        53 ~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  131 (306)
T 2z66_A           53 QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL  131 (306)
T ss_dssp             TCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEE
T ss_pred             cCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEE
Confidence            344444444444421  1333444555555555555555 344456666666666666666664433 456666777777


Q ss_pred             EccCccccccCcccccCCCCCCEEecCCCcCCC-CCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcC
Q 002883          302 DLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSG-TIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKL  380 (871)
Q Consensus       302 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  380 (871)
                      ++++|.+.+..+..|..+++|++|++++|.+++ ..|..+..+++|++|++++|.+++..|..+..+++|+.|+|++|++
T Consensus       132 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l  211 (306)
T 2z66_A          132 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF  211 (306)
T ss_dssp             ECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             ECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCcc
Confidence            777777766666667777777777777777764 4566777777777777777777766677777788888888888888


Q ss_pred             CCCCccchhcccCCceeeecCCcccccCccccCCCC-CCCEEeCCCCcCCCCCc--ccccccccccEEecCCCcCcccCC
Q 002883          381 SGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLK-GLQDLDLSRNNFSGKIP--MFLNTFRFLQKLNLSFNNLEGEVP  457 (871)
Q Consensus       381 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~--~~~~~~~~L~~L~l~~N~l~~~~~  457 (871)
                      ++..+..+..+++|++|+|++|++++..+..+..++ +|++|+|++|++++..+  .....+...+.+.+..|.+.|..|
T Consensus       212 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p  291 (306)
T 2z66_A          212 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP  291 (306)
T ss_dssp             SBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEES
T ss_pred             CccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCc
Confidence            766666788888888888888888888888888874 89999999998886432  223344556667778888888777


Q ss_pred             CC
Q 002883          458 SE  459 (871)
Q Consensus       458 ~~  459 (871)
                      ..
T Consensus       292 ~~  293 (306)
T 2z66_A          292 SD  293 (306)
T ss_dssp             GG
T ss_pred             hh
Confidence            54

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=7.8e-31  Score=298.03  Aligned_cols=244  Identities=18%  Similarity=0.139  Sum_probs=170.8

Q ss_pred             cccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEcc
Q 002883          225 HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQ  304 (871)
Q Consensus       225 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  304 (871)
                      +|++|+|++|.|++..|..|..+++|+.|+|++|.+++..|  |..+++|++|+|++|.|++..     ..++|++|+|+
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L~  107 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAA  107 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEECC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEECc
Confidence            57777777777776666777777777777777777775444  777777777777777777432     22677777777


Q ss_pred             CccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccC-CCCCCCEEeCCCCcCCCC
Q 002883          305 GNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVG-RLKGIQQLDLSENKLSGE  383 (871)
Q Consensus       305 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~  383 (871)
                      +|.|++..+.   .+++|+.|+|++|.+++..|..+..+++|+.|+|++|.+++..|..+. .+++|+.|+|++|.|++.
T Consensus       108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~  184 (487)
T 3oja_A          108 NNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV  184 (487)
T ss_dssp             SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred             CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence            7777755543   346777778888877776677777777788888888877766666665 677788888888887744


Q ss_pred             CccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCC--Ccc
Q 002883          384 IPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPS--EGV  461 (871)
Q Consensus       384 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~--~~~  461 (871)
                       |. +..+++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++ +|..+..+++|+.|++++|++.|..+.  ...
T Consensus       185 -~~-~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~  260 (487)
T 3oja_A          185 -KG-QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK  260 (487)
T ss_dssp             -EC-CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred             -cc-cccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence             22 33477788888888888765444 7777888888888888874 566677778888888888888743221  233


Q ss_pred             cccccceecc-------CCCCCccCCCc
Q 002883          462 FKNVRAVSII-------GNNKLCGGSPE  482 (871)
Q Consensus       462 ~~~l~~l~l~-------~N~~~C~~~~~  482 (871)
                      ++.+..+.+.       .|++.|.|+..
T Consensus       261 l~~L~~l~~~~~~~~~~~~~~~c~~~~~  288 (487)
T 3oja_A          261 NQRVQTVAKQTVKKLTGQNEEECTVPTL  288 (487)
T ss_dssp             CHHHHHHHHHHHHHHTSSSSCCCSSTTC
T ss_pred             CCCCcEEeccccccccCCCcccccCCcc
Confidence            4445555554       77788887643

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=2.3e-29  Score=266.25  Aligned_cols=254  Identities=20%  Similarity=0.185  Sum_probs=178.5

Q ss_pred             ccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCcccc
Q 002883          171 LIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNL  250 (871)
Q Consensus       171 L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L  250 (871)
                      -+.++++++.++.++..         -.++|++|+|++|.+++..+..+..+ ++|++|++++|++++..|..|.++++|
T Consensus        13 ~~~~~c~~~~l~~ip~~---------~~~~l~~L~l~~n~i~~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L   82 (285)
T 1ozn_A           13 KVTTSCPQQGLQAVPVG---------IPAASQRIFLHGNRISHVPAASFRAC-RNLTILWLHSNVLARIDAAAFTGLALL   82 (285)
T ss_dssp             SCEEECCSSCCSSCCTT---------CCTTCSEEECTTSCCCEECTTTTTTC-TTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred             CeEEEcCcCCcccCCcC---------CCCCceEEEeeCCcCCccCHHHcccC-CCCCEEECCCCccceeCHhhcCCccCC
Confidence            47899999999987642         13689999999999997666677776 579999999999998889999999999


Q ss_pred             ceeeccccc-ccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCC
Q 002883          251 ILIAMEVNL-LTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSD  329 (871)
Q Consensus       251 ~~L~l~~N~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  329 (871)
                      ++|++++|. ++...+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++
T Consensus        83 ~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  162 (285)
T 1ozn_A           83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG  162 (285)
T ss_dssp             CEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCC
Confidence            999999997 8877788888888888888888888876677777788888888888877766666677777777777777


Q ss_pred             CcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCc
Q 002883          330 NNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIH  409 (871)
Q Consensus       330 N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  409 (871)
                      |++++..+..+..+++|+.|++++|.+++..|..+..++                        +|+.|++++|++++..+
T Consensus       163 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~------------------------~L~~L~l~~n~l~~~~~  218 (285)
T 1ozn_A          163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG------------------------RLMTLYLFANNLSALPT  218 (285)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT------------------------TCCEEECCSSCCSCCCH
T ss_pred             CcccccCHHHhcCccccCEEECCCCcccccCHhHccCcc------------------------cccEeeCCCCcCCcCCH
Confidence            777644444455555555555555555544444444444                        45555555555544444


Q ss_pred             cccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCC
Q 002883          410 SGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE  459 (871)
Q Consensus       410 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~  459 (871)
                      ..|..+++|+.|++++|++....+. .+.+..++.+..+.|.+.|..|..
T Consensus       219 ~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~  267 (285)
T 1ozn_A          219 EALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQR  267 (285)
T ss_dssp             HHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGG
T ss_pred             HHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchH
Confidence            4455555555555555555533221 122233555566677777766653

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=2.8e-32  Score=320.49  Aligned_cols=423  Identities=14%  Similarity=0.078  Sum_probs=259.0

Q ss_pred             CcCCCCCCEEecCCCccc---ccCCcccc------------CCCcCceeeCCCCcccccCCccccCC--cccceeeccCc
Q 002883           10 ITHCSELRILDLVVNKLE---GNIPSELG------------NLFKLVGLGLTGNNYTGSIPQSLSNL--SFLQQLSLSEN   72 (871)
Q Consensus        10 ~~~l~~L~~L~l~~n~i~---~~~~~~~~------------~l~~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~Ls~n   72 (871)
                      +.++++|+.|+|+++...   +.+|..++            .+++|++|+|++|.+++..+..+..+  .+|++|+|++|
T Consensus        69 ~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~  148 (592)
T 3ogk_B           69 SRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKC  148 (592)
T ss_dssp             HHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESC
T ss_pred             HHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCC
Confidence            567888999999885431   23333333            67889999999998887666777664  44999999888


Q ss_pred             c-ccC-CCCccccccccccccccccccccCC----CCccccccCCCceeeeeccccc----cccccccccCCCCccEEEc
Q 002883           73 S-LSG-NIPSELGLLKQLNMFQVSANYLTGS----IPIQLFNISSMDYFAVTQNKLV----GEIPHYVGFTLPNIRVLLL  142 (871)
Q Consensus        73 ~-l~~-~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~----~~~~~~~~~~l~~L~~L~l  142 (871)
                      . ++. .++..+..+++|++|+|++|.+++.    ++..+.++++|++|++++|.+.    +.++..+ ..+++|+.|++
T Consensus       149 ~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~-~~~~~L~~L~L  227 (592)
T 3ogk_B          149 SGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIA-RNCRSLVSVKV  227 (592)
T ss_dssp             EEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHH-HHCTTCCEEEC
T ss_pred             CCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHH-hhCCCCcEEec
Confidence            6 221 1223334788899999999888755    3334556788888888888875    2233322 36788888888


Q ss_pred             cCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhc
Q 002883          143 GSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANF  222 (871)
Q Consensus       143 ~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~  222 (871)
                      ++|.+.           .+|..+..+++|++|+++.+......   ......+..+++|+.|+++++... .+|..+..+
T Consensus       228 ~~~~~~-----------~l~~~~~~~~~L~~L~l~~~~~~~~~---~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~  292 (592)
T 3ogk_B          228 GDFEIL-----------ELVGFFKAAANLEEFCGGSLNEDIGM---PEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFA  292 (592)
T ss_dssp             SSCBGG-----------GGHHHHHHCTTCCEEEECBCCCCTTC---TTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGG
T ss_pred             cCccHH-----------HHHHHHhhhhHHHhhcccccccccch---HHHHHHhhccccccccCccccchh-HHHHHHhhc
Confidence            888776           46667888888888888864322111   113345667778888888876443 455555444


Q ss_pred             cccccEEEccCCccCCCCC-CCCCCccccceeecccccccc-cCCccccCCCCCcEEEccC-----------CCCCCCC-
Q 002883          223 SSHLIYLYMSANRISGTIP-TGVGNLKNLILIAMEVNLLTG-SIPTSVGYLLKLQVLSLFG-----------NKISGEI-  288 (871)
Q Consensus       223 ~~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~L~~-----------n~l~~~~-  288 (871)
                       ++|++|+|++|.+++... ..+..+++|+.|+++ |.+.. ..+..+..+++|++|+|++           |.++... 
T Consensus       293 -~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~  370 (592)
T 3ogk_B          293 -AQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGL  370 (592)
T ss_dssp             -GGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHH
T ss_pred             -CCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHH
Confidence             468888888887664333 235677788888887 44432 2233335567788888773           4554321 


Q ss_pred             CcccCCCccccEEEccCccccccCcccccC-CCCCCEEecC----CCcCCCC-----CcccccCCCCCcEEeccCCC--C
Q 002883          289 PSSLGNLIFLTEVDLQGNSIRGSIPSALGN-CLQLQKLDLS----DNNLSGT-----IPREVIGLSSFVLLDLSRNH--L  356 (871)
Q Consensus       289 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~~~~~~~l~~L~~L~ls~N~--l  356 (871)
                      +..+..+++|++|+++.|++++..+..+.. +++|+.|+++    .|.+++.     ++..+.++++|+.|++++|.  +
T Consensus       371 ~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l  450 (592)
T 3ogk_B          371 IALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGL  450 (592)
T ss_dssp             HHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGC
T ss_pred             HHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCc
Confidence            122344677777777777776555555544 6777777774    5666642     22234556677777776433  4


Q ss_pred             CCCCccccCC-CCCCCEEeCCCCcCCCC-CccchhcccCCceeeecCCccccc-CccccCCCCCCCEEeCCCCcCCCCCc
Q 002883          357 SGPIPLEVGR-LKGIQQLDLSENKLSGE-IPTSLASCVGLEYLNFSDNSFQGP-IHSGFSSLKGLQDLDLSRNNFSGKIP  433 (871)
Q Consensus       357 ~~~~~~~~~~-l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~  433 (871)
                      ++..+..+.. +++|++|++++|++++. ++..+..+++|++|+|++|++++. .+..+..+++|++|+|++|+++....
T Consensus       451 ~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~  530 (592)
T 3ogk_B          451 TDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQ  530 (592)
T ss_dssp             CHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCT
T ss_pred             cHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHH
Confidence            4333333332 56677777777766532 233445566677777777766533 22233456666666666666664322


Q ss_pred             cc-ccccccccEEecCCC
Q 002883          434 MF-LNTFRFLQKLNLSFN  450 (871)
Q Consensus       434 ~~-~~~~~~L~~L~l~~N  450 (871)
                      .. ...+|.+....+..+
T Consensus       531 ~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          531 DLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             TGGGGCCTTEEEEEECCC
T ss_pred             HHHHHhCCCcEEEEecCc
Confidence            22 233455544444433

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=1.5e-28  Score=264.73  Aligned_cols=225  Identities=18%  Similarity=0.250  Sum_probs=162.3

Q ss_pred             cccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEcc
Q 002883          225 HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQ  304 (871)
Q Consensus       225 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  304 (871)
                      +++.|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..+..+++|++|+|+
T Consensus        82 ~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~  158 (328)
T 4fcg_A           82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR  158 (328)
T ss_dssp             TCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred             ceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence            3555555555555 44444555555555555555555 45555555555555555555555 445555555555555555


Q ss_pred             CccccccCccccc---------CCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeC
Q 002883          305 GNSIRGSIPSALG---------NCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDL  375 (871)
Q Consensus       305 ~N~i~~~~~~~~~---------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L  375 (871)
                      +|++.+.+|..+.         ++++|++|+|++|+++ .+|..+..+++|++|++++|.++ .+|..++.+++|++|+|
T Consensus       159 ~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~L  236 (328)
T 4fcg_A          159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDL  236 (328)
T ss_dssp             EETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEEC
T ss_pred             CCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEEC
Confidence            5555555554443         4888888888888887 77777888888888888888888 45667888888888888


Q ss_pred             CCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcc
Q 002883          376 SENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEG  454 (871)
Q Consensus       376 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~  454 (871)
                      ++|.+.+.+|..|..+++|++|+|++|++.+..|..+..+++|++|+|++|++.+.+|..+..+++|+.+++..|.+..
T Consensus       237 s~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~  315 (328)
T 4fcg_A          237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ  315 (328)
T ss_dssp             TTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred             cCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHH
Confidence            8888888888888888888888888888888888888888888888888888888888888888888888888777654

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=3.3e-28  Score=261.95  Aligned_cols=225  Identities=21%  Similarity=0.253  Sum_probs=167.7

Q ss_pred             CcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEE
Q 002883          199 TFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLS  278 (871)
Q Consensus       199 ~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  278 (871)
                      ++++.|+|++|.++ .+|..+..+ ++|++|+|++|.++ .+|..++++++|++|+|++|.++ .+|..+..+++|++|+
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~~l-~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~  156 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAFRL-SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS  156 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGGGG-TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred             cceeEEEccCCCch-hcChhhhhC-CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence            45666666666666 556666664 35667777776666 56666666777777777777766 5566677777777777


Q ss_pred             ccCCCCCCCCCcccCC---------CccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEE
Q 002883          279 LFGNKISGEIPSSLGN---------LIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLL  349 (871)
Q Consensus       279 L~~n~l~~~~~~~~~~---------l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  349 (871)
                      |++|++.+.+|..+..         +++|++|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..+..+++|++|
T Consensus       157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L  234 (328)
T 4fcg_A          157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEEL  234 (328)
T ss_dssp             EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEE
T ss_pred             CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEE
Confidence            7776666566665543         788888888888887 66777888888888888888887 455567788888888


Q ss_pred             eccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCC
Q 002883          350 DLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFS  429 (871)
Q Consensus       350 ~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  429 (871)
                      ++++|.+.+.+|..++.+++|+.|+|++|.+.+.+|..+..+++|++|+|++|++.+.+|..+..+++|+.+++..|.+.
T Consensus       235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            88888887778888888888888888888887788888888888888888888888888888888888888888777655

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=1.1e-27  Score=277.33  Aligned_cols=129  Identities=24%  Similarity=0.324  Sum_probs=74.9

Q ss_pred             CCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEe
Q 002883          271 LLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLD  350 (871)
Q Consensus       271 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  350 (871)
                      +++|+.|+|++|+|++ +|..   +++|+.|++++|.++ .+|..   +++|+.|+|++|+|++ +|   ..+++|+.|+
T Consensus       180 ~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~  247 (622)
T 3g06_A          180 PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELM  247 (622)
T ss_dssp             CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEE
T ss_pred             CCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEE
Confidence            3455555555555552 2221   245555555555555 23321   3556666666666663 33   3445666666


Q ss_pred             ccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCC
Q 002883          351 LSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLK  416 (871)
Q Consensus       351 ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  416 (871)
                      +++|.|+ .+|.   .+++|+.|+|++|+|+ .+|..|..+++|+.|+|++|++++..+..+..++
T Consensus       248 Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          248 VSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             CCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             CCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            6666666 3443   4566777777777777 5566677777777777777777766666555443

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=2.5e-27  Score=274.20  Aligned_cols=221  Identities=26%  Similarity=0.300  Sum_probs=125.2

Q ss_pred             CcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEE
Q 002883          199 TFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLS  278 (871)
Q Consensus       199 ~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  278 (871)
                      ++|++|+|++|+++ .+|.    ..++|++|+|++|+|++ +|.   .+++|+.|++++|+++. +|..   +++|++|+
T Consensus        81 ~~L~~L~Ls~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~  147 (622)
T 3g06_A           81 PELRTLEVSGNQLT-SLPV----LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELS  147 (622)
T ss_dssp             TTCCEEEECSCCCS-CCCC----CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEE
T ss_pred             CCCCEEEcCCCcCC-cCCC----CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEE
Confidence            44555555555554 2333    11345555555555553 222   34555555555555553 2322   35566666


Q ss_pred             ccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCC
Q 002883          279 LFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSG  358 (871)
Q Consensus       279 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  358 (871)
                      |++|++++ +|.   .+.+|+.|++++|+|++ +|   ..+++|+.|++++|+|++ +|.   .+++|+.|++++|.++ 
T Consensus       148 Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~-  214 (622)
T 3g06_A          148 VSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPT---LPSELYKLWAYNNRLT-  214 (622)
T ss_dssp             CCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-
T ss_pred             CcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCC---ccchhhEEECcCCccc-
Confidence            66666653 332   23456666666666663 33   334566666666666663 332   2356666666666666 


Q ss_pred             CCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccc
Q 002883          359 PIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNT  438 (871)
Q Consensus       359 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  438 (871)
                      .+|.   .+++|+.|+|++|.|++ +|   ..+++|+.|+|++|+|+++++    .+++|+.|+|++|+|+ .+|..+..
T Consensus       215 ~l~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~----~~~~L~~L~Ls~N~L~-~lp~~l~~  282 (622)
T 3g06_A          215 SLPA---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM----LPSGLLSLSVYRNQLT-RLPESLIH  282 (622)
T ss_dssp             SCCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCC-SCCGGGGG
T ss_pred             ccCC---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc----ccccCcEEeCCCCCCC-cCCHHHhh
Confidence            3332   23567777777777763 44   344667777777777764333    4566777777777777 55666777


Q ss_pred             cccccEEecCCCcCcccCC
Q 002883          439 FRFLQKLNLSFNNLEGEVP  457 (871)
Q Consensus       439 ~~~L~~L~l~~N~l~~~~~  457 (871)
                      +++|+.|+|++|++++..|
T Consensus       283 l~~L~~L~L~~N~l~~~~~  301 (622)
T 3g06_A          283 LSSETTVNLEGNPLSERTL  301 (622)
T ss_dssp             SCTTCEEECCSCCCCHHHH
T ss_pred             ccccCEEEecCCCCCCcCH
Confidence            7777777777777776544

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=6.5e-30  Score=273.84  Aligned_cols=202  Identities=22%  Similarity=0.227  Sum_probs=99.9

Q ss_pred             ccccceeecccccccccCCccc--cCCCCCcEEEccCCCCCCCCCcccCCC-----ccccEEEccCccccccCcccccCC
Q 002883          247 LKNLILIAMEVNLLTGSIPTSV--GYLLKLQVLSLFGNKISGEIPSSLGNL-----IFLTEVDLQGNSIRGSIPSALGNC  319 (871)
Q Consensus       247 l~~L~~L~l~~N~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~i~~~~~~~~~~l  319 (871)
                      +++|++|++++|.+++..|..+  ..+++|++|+|++|++++. |..++.+     ++|++|+|++|+|++..+..|+++
T Consensus        94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l  172 (312)
T 1wwl_A           94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF  172 (312)
T ss_dssp             TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred             cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence            4444444444444444444433  4444455555555554433 4444443     445555555555544444445555


Q ss_pred             CCCCEEecCCCcCCCC--Ccccc--cCCCCCcEEeccCCCCCCC--Cc-cccCCCCCCCEEeCCCCcCCCCCc-cchhcc
Q 002883          320 LQLQKLDLSDNNLSGT--IPREV--IGLSSFVLLDLSRNHLSGP--IP-LEVGRLKGIQQLDLSENKLSGEIP-TSLASC  391 (871)
Q Consensus       320 ~~L~~L~L~~N~l~~~--~~~~~--~~l~~L~~L~ls~N~l~~~--~~-~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l  391 (871)
                      ++|++|+|++|++.+.  .+..+  ..+++|++|++++|.+++.  .+ ..+..+++|++|+|++|++++..| ..+..+
T Consensus       173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l  252 (312)
T 1wwl_A          173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP  252 (312)
T ss_dssp             SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCC
T ss_pred             CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhc
Confidence            5555555555554322  12222  4445555555555555411  11 122344555555555555554432 334445


Q ss_pred             cCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcc
Q 002883          392 VGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEG  454 (871)
Q Consensus       392 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~  454 (871)
                      ++|++|+|++|+|+ .+|..+.  ++|++|||++|+|++. |. +..+++|++|++++|++++
T Consensus       253 ~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          253 SQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             TTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             CCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            55666666666655 3333333  5666666666666644 44 6666666666666666654

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.95  E-value=5.8e-31  Score=309.30  Aligned_cols=398  Identities=14%  Similarity=0.061  Sum_probs=298.2

Q ss_pred             CCCCCCEEecCCCcccccCCccccCC--CcCceeeCCCCc-ccc-cCCccccCCcccceeeccCccccCC----CCcccc
Q 002883           12 HCSELRILDLVVNKLEGNIPSELGNL--FKLVGLGLTGNN-YTG-SIPQSLSNLSFLQQLSLSENSLSGN----IPSELG   83 (871)
Q Consensus        12 ~l~~L~~L~l~~n~i~~~~~~~~~~l--~~L~~L~L~~n~-l~~-~~p~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~   83 (871)
                      ++++|++|+|++|.+++..+..++.+  .+|++|+|++|. ++. .++..+.++++|++|+|++|.+++.    ++..+.
T Consensus       110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~  189 (592)
T 3ogk_B          110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ  189 (592)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred             hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence            78999999999999988778888775  459999999987 221 1233345889999999999998866    334567


Q ss_pred             cccccccccccccccc----CCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCC
Q 002883           84 LLKQLNMFQVSANYLT----GSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNAS  159 (871)
Q Consensus        84 ~l~~L~~L~l~~n~l~----~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~  159 (871)
                      .+++|++|++++|.++    +.++..+.++++|+.|++++|.+. .+|..+ ..+++|+.|+++.+...  ++     ..
T Consensus       190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~-~l~~~~-~~~~~L~~L~l~~~~~~--~~-----~~  260 (592)
T 3ogk_B          190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL-ELVGFF-KAAANLEEFCGGSLNED--IG-----MP  260 (592)
T ss_dssp             HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGG-GGHHHH-HHCTTCCEEEECBCCCC--TT-----CT
T ss_pred             cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHH-HHHHHH-hhhhHHHhhcccccccc--cc-----hH
Confidence            8899999999999997    234445668899999999999987 466554 48999999999874332  11     11


Q ss_pred             CCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCC
Q 002883          160 SIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGT  239 (871)
Q Consensus       160 ~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~  239 (871)
                      ..+..+..+++|+.|+++++....       .+..+..+++|++|+|++|.+++.....+....++|++|+++ +.+.+.
T Consensus       261 ~~~~~l~~~~~L~~L~l~~~~~~~-------l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~  332 (592)
T 3ogk_B          261 EKYMNLVFPRKLCRLGLSYMGPNE-------MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDR  332 (592)
T ss_dssp             TSSSCCCCCTTCCEEEETTCCTTT-------GGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHH
T ss_pred             HHHHHhhccccccccCccccchhH-------HHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHH
Confidence            345567888999999999875443       345567789999999999998754433333334689999999 545433


Q ss_pred             -CCCCCCCccccceeecc-----------cccccccCCcc-ccCCCCCcEEEccCCCCCCCCCcccCC-CccccEEEcc-
Q 002883          240 -IPTGVGNLKNLILIAME-----------VNLLTGSIPTS-VGYLLKLQVLSLFGNKISGEIPSSLGN-LIFLTEVDLQ-  304 (871)
Q Consensus       240 -~~~~~~~l~~L~~L~l~-----------~N~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~-  304 (871)
                       .+..+..+++|++|+++           .|.++...... +..+++|++|+++.|++++..+..+.. +++|+.|+|+ 
T Consensus       333 ~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~  412 (592)
T 3ogk_B          333 GLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVL  412 (592)
T ss_dssp             HHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEE
T ss_pred             HHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEee
Confidence             33334678999999999           46776433333 456899999999999998766666665 8899999996 


Q ss_pred             ---Ccccccc-----CcccccCCCCCCEEecCCCc--CCCCCccccc-CCCCCcEEeccCCCCCCC-CccccCCCCCCCE
Q 002883          305 ---GNSIRGS-----IPSALGNCLQLQKLDLSDNN--LSGTIPREVI-GLSSFVLLDLSRNHLSGP-IPLEVGRLKGIQQ  372 (871)
Q Consensus       305 ---~N~i~~~-----~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~-~l~~L~~L~ls~N~l~~~-~~~~~~~l~~L~~  372 (871)
                         .|.+++.     ++..+.++++|+.|++++|.  +++..+..+. .+++|++|++++|.+++. ++..+..+++|++
T Consensus       413 ~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~  492 (592)
T 3ogk_B          413 LDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQK  492 (592)
T ss_dssp             CSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCE
T ss_pred             cCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCe
Confidence               6778753     33446779999999998644  6654444443 488999999999999853 3455678999999


Q ss_pred             EeCCCCcCCCC-CccchhcccCCceeeecCCcccccCcccc-CCCCCCCEEeCCCC
Q 002883          373 LDLSENKLSGE-IPTSLASCVGLEYLNFSDNSFQGPIHSGF-SSLKGLQDLDLSRN  426 (871)
Q Consensus       373 L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~l~~N  426 (871)
                      |++++|.+++. ++..+..+++|++|+|++|+++......+ ..++.+....+..+
T Consensus       493 L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          493 LEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             EEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             eeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence            99999998744 34445678999999999999986544433 35677777666555

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=4.2e-29  Score=267.55  Aligned_cols=249  Identities=21%  Similarity=0.212  Sum_probs=204.9

Q ss_pred             ccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCc-ccCChhhh-------hccccccEEEccCCcc
Q 002883          165 LGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLS-GVLPNSIA-------NFSSHLIYLYMSANRI  236 (871)
Q Consensus       165 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~-~~~~~~~~-------~~~~~L~~L~L~~n~i  236 (871)
                      ++..++|+.|++++|.+ .++       ..+..  .|++|+|++|.++ ..+|..+.       .+ ++|++|+|++|++
T Consensus        39 ~~~~~~L~~l~l~~n~l-~~p-------~~~~~--~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l-~~L~~L~L~~n~l  107 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE-ADL-------GQFTD--IIKSLSLKRLTVRAARIPSRILFGALRVLGI-SGLQELTLENLEV  107 (312)
T ss_dssp             EEEEEECTTHHHHCCTT-CCC-------HHHHH--HHHHCCCCEEEEEEEECBHHHHHHHHHHHTT-SCCCEEEEEEEBC
T ss_pred             EccCCCceeEeeccccc-ccH-------HHHHH--HHhhcccccccccCCCcCHHHHHHHHHhcCc-CCccEEEccCCcc
Confidence            55667788888888877 433       22222  2788888888884 34566554       44 5799999999999


Q ss_pred             CCCCCCCC--CCccccceeecccccccccCCccccCC-----CCCcEEEccCCCCCCCCCcccCCCccccEEEccCcccc
Q 002883          237 SGTIPTGV--GNLKNLILIAMEVNLLTGSIPTSVGYL-----LKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIR  309 (871)
Q Consensus       237 ~~~~~~~~--~~l~~L~~L~l~~N~l~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~  309 (871)
                      ++..|..+  ..+++|++|++++|.+++. |..+..+     ++|++|+|++|+|++..+..|+.+++|++|+|++|++.
T Consensus       108 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  186 (312)
T 1wwl_A          108 TGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPEL  186 (312)
T ss_dssp             BSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTC
T ss_pred             cchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcC
Confidence            98888876  8999999999999999976 8888877     89999999999999888899999999999999999987


Q ss_pred             cc--Ccccc--cCCCCCCEEecCCCcCCCC---CcccccCCCCCcEEeccCCCCCCCCc-cccCCCCCCCEEeCCCCcCC
Q 002883          310 GS--IPSAL--GNCLQLQKLDLSDNNLSGT---IPREVIGLSSFVLLDLSRNHLSGPIP-LEVGRLKGIQQLDLSENKLS  381 (871)
Q Consensus       310 ~~--~~~~~--~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  381 (871)
                      +.  .+..+  ..+++|++|+|++|+|++.   ....+..+++|++|++++|++++..| ..+..+++|++|+|++|+|+
T Consensus       187 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~  266 (312)
T 1wwl_A          187 GERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK  266 (312)
T ss_dssp             HHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred             cchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence            54  23344  8899999999999999832   22445688999999999999997664 45677899999999999999


Q ss_pred             CCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCC
Q 002883          382 GEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSG  430 (871)
Q Consensus       382 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  430 (871)
                       .+|..+.  ++|++|+|++|+|++. |. +..+++|++|++++|++++
T Consensus       267 -~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          267 -QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             -SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             -hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence             7777776  8999999999999977 54 8999999999999999985

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=6e-29  Score=266.99  Aligned_cols=237  Identities=22%  Similarity=0.238  Sum_probs=124.2

Q ss_pred             CCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcE
Q 002883          197 NCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQV  276 (871)
Q Consensus       197 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  276 (871)
                      .+++|++|+|++|++++..|..+..+ ++|++|+|++|++++..+  +..+++|++|++++|.+++..     ..++|++
T Consensus        32 ~~~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~  103 (317)
T 3o53_A           32 SAWNVKELDLSGNPLSQISAADLAPF-TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIET  103 (317)
T ss_dssp             TGGGCSEEECTTSCCCCCCHHHHTTC-TTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCE
T ss_pred             cCCCCCEEECcCCccCcCCHHHhhCC-CcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCE
Confidence            34455666666666654444444444 346666666665554333  555555666666665555321     2255555


Q ss_pred             EEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCccccc-CCCCCcEEeccCCC
Q 002883          277 LSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNH  355 (871)
Q Consensus       277 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~ls~N~  355 (871)
                      |++++|++++..+.   .+++|++|++++|++++..+..+..+++|++|++++|.+++..+..+. .+++|++|++++|.
T Consensus       104 L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~  180 (317)
T 3o53_A          104 LHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF  180 (317)
T ss_dssp             EECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred             EECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCc
Confidence            55555555533322   234555555555555555455555555555555555555544444442 45555555555555


Q ss_pred             CCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCC-CCCcc
Q 002883          356 LSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFS-GKIPM  434 (871)
Q Consensus       356 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~  434 (871)
                      +++. + ....+++|++|+|++|++++ +|..+..+++|++|+|++|+|++ +|..+..+++|+.|++++|+++ +.+|.
T Consensus       181 l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~  256 (317)
T 3o53_A          181 IYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD  256 (317)
T ss_dssp             CCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHH
T ss_pred             Cccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHH
Confidence            5522 2 22235555555555555552 33335555555555555555553 3444555555555555555555 44455


Q ss_pred             cccccccccEEecC
Q 002883          435 FLNTFRFLQKLNLS  448 (871)
Q Consensus       435 ~~~~~~~L~~L~l~  448 (871)
                      .+..+++|+.|+++
T Consensus       257 ~~~~~~~L~~l~l~  270 (317)
T 3o53_A          257 FFSKNQRVQTVAKQ  270 (317)
T ss_dssp             HHHTCHHHHHHHHH
T ss_pred             HHhccccceEEECC
Confidence            55555555555555

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=6.5e-29  Score=266.69  Aligned_cols=259  Identities=18%  Similarity=0.125  Sum_probs=215.7

Q ss_pred             cccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEc
Q 002883          200 FLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSL  279 (871)
Q Consensus       200 ~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L  279 (871)
                      +++.++++.+.+. ..+..+....++|++|+|++|+|++..|..|.++++|+.|+|++|.+++..+  +..+++|++|+|
T Consensus        11 ~l~i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L   87 (317)
T 3o53_A           11 RYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL   87 (317)
T ss_dssp             EEEEESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred             ceeEeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence            4667788888887 3445555555689999999999998888899999999999999999996554  899999999999


Q ss_pred             cCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCC
Q 002883          280 FGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGP  359 (871)
Q Consensus       280 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  359 (871)
                      ++|++++..     ..++|++|++++|++++..+..   +++|+.|++++|++++..+..+..+++|++|++++|.+++.
T Consensus        88 s~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  159 (317)
T 3o53_A           88 NNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV  159 (317)
T ss_dssp             CSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEE
T ss_pred             cCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcc
Confidence            999998432     3489999999999999765544   57899999999999987788899999999999999999977


Q ss_pred             CccccC-CCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccc
Q 002883          360 IPLEVG-RLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNT  438 (871)
Q Consensus       360 ~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  438 (871)
                      .+..+. .+++|++|+|++|.+++. +. ...+++|++|+|++|+|++.++ .|..+++|+.|+|++|+++ .+|..+..
T Consensus       160 ~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~-~l~~~~~~  235 (317)
T 3o53_A          160 NFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLV-LIEKALRF  235 (317)
T ss_dssp             EGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCC-EECTTCCC
T ss_pred             cHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCccc-chhhHhhc
Confidence            677664 789999999999999954 33 3358999999999999997655 4889999999999999999 57888999


Q ss_pred             cccccEEecCCCcCcccCCC--CcccccccceeccCC
Q 002883          439 FRFLQKLNLSFNNLEGEVPS--EGVFKNVRAVSIIGN  473 (871)
Q Consensus       439 ~~~L~~L~l~~N~l~~~~~~--~~~~~~l~~l~l~~N  473 (871)
                      +++|+.|++++|+++|..+.  ...++.++.+++.++
T Consensus       236 l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~  272 (317)
T 3o53_A          236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV  272 (317)
T ss_dssp             CTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHH
T ss_pred             CCCCCEEEccCCCccCcCHHHHHhccccceEEECCCc
Confidence            99999999999999954322  234566777777633

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=3.4e-28  Score=276.34  Aligned_cols=247  Identities=23%  Similarity=0.235  Sum_probs=206.7

Q ss_pred             CCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEE
Q 002883          198 CTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVL  277 (871)
Q Consensus       198 l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  277 (871)
                      +++|++|+|++|.+++..|..+..+ ++|++|+|++|.|++..|  +..+++|+.|+|++|.|++..     ..++|++|
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L  104 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPF-TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETL  104 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTC-TTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEE
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCC-CCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEE
Confidence            4478888888888886666677666 468888888888886555  888899999999999988543     23889999


Q ss_pred             EccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCccccc-CCCCCcEEeccCCCC
Q 002883          278 SLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHL  356 (871)
Q Consensus       278 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~ls~N~l  356 (871)
                      +|++|.|++..+.   .+++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++..|..+. .+++|+.|+|++|.+
T Consensus       105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l  181 (487)
T 3oja_A          105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI  181 (487)
T ss_dssp             ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred             ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence            9999999865554   457899999999999988888999999999999999999988888876 789999999999999


Q ss_pred             CCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCC-CCCccc
Q 002883          357 SGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFS-GKIPMF  435 (871)
Q Consensus       357 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~  435 (871)
                      ++. + .+..+++|+.|+|++|.+++. |..+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|.++ +.+|..
T Consensus       182 ~~~-~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~  257 (487)
T 3oja_A          182 YDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF  257 (487)
T ss_dssp             CEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHH
T ss_pred             ccc-c-ccccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHH
Confidence            854 3 344699999999999999964 5559999999999999999996 5667899999999999999998 677888


Q ss_pred             ccccccccEEecC-------CCcCcccCCCC
Q 002883          436 LNTFRFLQKLNLS-------FNNLEGEVPSE  459 (871)
Q Consensus       436 ~~~~~~L~~L~l~-------~N~l~~~~~~~  459 (871)
                      +..++.|+.++++       .|+..|.++..
T Consensus       258 ~~~l~~L~~l~~~~~~~~~~~~~~~c~~~~~  288 (487)
T 3oja_A          258 FSKNQRVQTVAKQTVKKLTGQNEEECTVPTL  288 (487)
T ss_dssp             HTTCHHHHHHHHHHHHHHTSSSSCCCSSTTC
T ss_pred             HHhCCCCcEEeccccccccCCCcccccCCcc
Confidence            9999999999997       77777666543

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=7.9e-27  Score=245.43  Aligned_cols=210  Identities=23%  Similarity=0.212  Sum_probs=148.7

Q ss_pred             ccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecC
Q 002883          249 NLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLS  328 (871)
Q Consensus       249 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  328 (871)
                      +|++|++++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            34444455554444444455555556666666665554444556666666666666666665555666666666666666


Q ss_pred             CCcCCCCCcccccCCCCCcEEeccCCCCCCC-CccccCCCCCCCEEeCCCCcCCCCCccchhcccCCc----eeeecCCc
Q 002883          329 DNNLSGTIPREVIGLSSFVLLDLSRNHLSGP-IPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLE----YLNFSDNS  403 (871)
Q Consensus       329 ~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~  403 (871)
                      +|.+++..+..+..+++|++|++++|.+++. +|..+..+++|++|++++|++++..+..|..+.+|+    +|++++|+
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            6666655555666677777777777777643 477778888888888888888877777777777777    88999999


Q ss_pred             ccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCC
Q 002883          404 FQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE  459 (871)
Q Consensus       404 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~  459 (871)
                      +++..+..+.. .+|+.|++++|++++..+..+..+++|+.|++++|+++|.++..
T Consensus       189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred             ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence            98777666654 48999999999999877777889999999999999999988754

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=6.1e-29  Score=286.06  Aligned_cols=186  Identities=16%  Similarity=0.044  Sum_probs=131.0

Q ss_pred             eeccccceEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCce
Q 002883          567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQ----------RGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       567 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .+.|++|.+..++..-.|+.||||++....          ....+.+.+|+++|+++ .|+||+++++++.+.     ..
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~-----~~  316 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA-----QS  316 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS-----SE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC-----CE
Confidence            456666766666665578889999996432          12335789999999999 799999999998776     77


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .||||||++|++|.+++...+       +++..   +|+.||+.||+|+|++   |||||||||+|||++.+|.+||+||
T Consensus       317 ~yLVMEyv~G~~L~d~i~~~~-------~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DF  383 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAAGE-------EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDF  383 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHTTC-------CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEecCCCCcHHHHHHhCC-------CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeec
Confidence            999999999999999998754       45554   4889999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCC
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPT  774 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf  774 (871)
                      |+|+......   ......+||+.|||||++.+ .+..++|+||+|++.+++.+|..|+
T Consensus       384 GlAr~~~~~~---~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          384 GSIVTTPQDC---SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             TTEESCC------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             ccCeeCCCCC---ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            9998765432   22334679999999998764 5678899999999988887665544

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.94  E-value=2.4e-30  Score=304.20  Aligned_cols=428  Identities=14%  Similarity=0.069  Sum_probs=252.7

Q ss_pred             CcCCCCCCEEecCCCcccc---cCC------------ccccCCCcCceeeCCCCcccccCCcccc-CCcccceeeccCc-
Q 002883           10 ITHCSELRILDLVVNKLEG---NIP------------SELGNLFKLVGLGLTGNNYTGSIPQSLS-NLSFLQQLSLSEN-   72 (871)
Q Consensus        10 ~~~l~~L~~L~l~~n~i~~---~~~------------~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~n-   72 (871)
                      +..++.|+.|+|+++....   ..|            ..+..+++|++|+|++|.+++..+..+. .+++|++|+|++| 
T Consensus        62 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~  141 (594)
T 2p1m_B           62 IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE  141 (594)
T ss_dssp             HHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCE
T ss_pred             HhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcC
Confidence            4667889999999876321   112            1234677899999999988877777775 6889999999988 


Q ss_pred             cccCC-CCccccccccccccccccccccCCCCcccc----ccCCCceeeeeccc--cccccccccccCCCCccEEEccCc
Q 002883           73 SLSGN-IPSELGLLKQLNMFQVSANYLTGSIPIQLF----NISSMDYFAVTQNK--LVGEIPHYVGFTLPNIRVLLLGSN  145 (871)
Q Consensus        73 ~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~----~l~~L~~L~l~~n~--l~~~~~~~~~~~l~~L~~L~l~~n  145 (871)
                      .++.. ++..+..+++|++|+|++|.+++..+..+.    .+++|+.|++++|.  +.......+...+++|+.|++++|
T Consensus       142 ~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~  221 (594)
T 2p1m_B          142 GFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA  221 (594)
T ss_dssp             EEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred             CCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCC
Confidence            55422 444455788999999998888765544443    56688888888886  221111122224688888888887


Q ss_pred             -cCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEE-EccCCcCcccCChhhhhcc
Q 002883          146 -WFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVV-SLSSNSLSGVLPNSIANFS  223 (871)
Q Consensus       146 -~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L-~L~~n~l~~~~~~~~~~~~  223 (871)
                       .++           .+|..+..+++|++|+++.+...-.....-.....+.++++|+.| .+.+.... .++..+..+ 
T Consensus       222 ~~~~-----------~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~-~l~~~~~~~-  288 (594)
T 2p1m_B          222 VPLE-----------KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPA-YLPAVYSVC-  288 (594)
T ss_dssp             SCHH-----------HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGG-GGGGGHHHH-
T ss_pred             CcHH-----------HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchh-hHHHHHHhh-
Confidence             222           355667778888888866553210000000022346677778877 34433322 333333333 


Q ss_pred             ccccEEEccCCccCCCCCC-CCCCccccceeecccccccccCCcc-ccCCCCCcEEEccC---------CCCCCCCCccc
Q 002883          224 SHLIYLYMSANRISGTIPT-GVGNLKNLILIAMEVNLLTGSIPTS-VGYLLKLQVLSLFG---------NKISGEIPSSL  292 (871)
Q Consensus       224 ~~L~~L~L~~n~i~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~-~~~l~~L~~L~L~~---------n~l~~~~~~~~  292 (871)
                      ++|++|+|++|.+++.... .+..+++|+.|++++| ++...... ...+++|++|+|++         +.++......+
T Consensus       289 ~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l  367 (594)
T 2p1m_B          289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV  367 (594)
T ss_dssp             TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHH
T ss_pred             CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHH
Confidence            4688888888886643222 2456778888888877 44222222 23467788887743         34432222222


Q ss_pred             C-CCccccEEEccCccccccCccccc-CCCCCCEEecC--C----CcCCCCC-----cccccCCCCCcEEeccCCCCCCC
Q 002883          293 G-NLIFLTEVDLQGNSIRGSIPSALG-NCLQLQKLDLS--D----NNLSGTI-----PREVIGLSSFVLLDLSRNHLSGP  359 (871)
Q Consensus       293 ~-~l~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~~-----~~~~~~l~~L~~L~ls~N~l~~~  359 (871)
                      . .+++|+.|+++.|.+++.....+. .+++|+.|+++  +    |.+++..     +..+..+++|+.|++++ .+++.
T Consensus       368 ~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~  446 (594)
T 2p1m_B          368 SMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDK  446 (594)
T ss_dssp             HHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHH
T ss_pred             HHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHH
Confidence            2 366777777777777654444444 46777777777  3    4454211     11245566777777765 55544


Q ss_pred             CccccCC-CCCCCEEeCCCCcCCCCCccch-hcccCCceeeecCCcccccCcc-ccCCCCCCCEEeCCCCcCCCCCcccc
Q 002883          360 IPLEVGR-LKGIQQLDLSENKLSGEIPTSL-ASCVGLEYLNFSDNSFQGPIHS-GFSSLKGLQDLDLSRNNFSGKIPMFL  436 (871)
Q Consensus       360 ~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~  436 (871)
                      .+..++. +++|+.|+|++|.+++..+..+ ..+++|++|+|++|++++.... ....+++|+.|++++|+++......+
T Consensus       447 ~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l  526 (594)
T 2p1m_B          447 VFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLL  526 (594)
T ss_dssp             HHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHH
T ss_pred             HHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHH
Confidence            4444444 6667777777777664444333 4567777777777776533332 23346677777777776643222223


Q ss_pred             -cccccccEEecCCCcC
Q 002883          437 -NTFRFLQKLNLSFNNL  452 (871)
Q Consensus       437 -~~~~~L~~L~l~~N~l  452 (871)
                       ..+++|+...+..+.-
T Consensus       527 ~~~lp~l~i~~~~~~~~  543 (594)
T 2p1m_B          527 GQKMPKLNVEVIDERGA  543 (594)
T ss_dssp             HHHCTTEEEEEECSSSC
T ss_pred             HHhCCCCEEEEecCCCc
Confidence             3456665555555543

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=1.3e-25  Score=234.96  Aligned_cols=206  Identities=21%  Similarity=0.211  Sum_probs=141.9

Q ss_pred             cceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCC
Q 002883          250 LILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSD  329 (871)
Q Consensus       250 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  329 (871)
                      .+.+++++|.++ .+|..+.  ++|+.|+|++|+++...+..|..+++|++|+|++|+++...+..|.++++|++|++++
T Consensus        18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~   94 (270)
T 2o6q_A           18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD   94 (270)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred             CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence            334444444444 2333332  4566666666666655555666666666666666666655555566666677777777


Q ss_pred             CcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCc
Q 002883          330 NNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIH  409 (871)
Q Consensus       330 N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  409 (871)
                      |++++..+..|..+++|++|++++|.+++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|+++++.+
T Consensus        95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  174 (270)
T 2o6q_A           95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE  174 (270)
T ss_dssp             SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence            77665555566667777777777777776666667777777777777777776555667777888888888888887777


Q ss_pred             cccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCC
Q 002883          410 SGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPS  458 (871)
Q Consensus       410 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~  458 (871)
                      ..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++.|.+..
T Consensus       175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  223 (270)
T 2o6q_A          175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG  223 (270)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred             hHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence            7788888888888888888876666788888888888888888877753

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.94  E-value=6e-26  Score=239.60  Aligned_cols=206  Identities=23%  Similarity=0.209  Sum_probs=131.5

Q ss_pred             CCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCC
Q 002883          244 VGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQ  323 (871)
Q Consensus       244 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  323 (871)
                      +.++++++++++++|.++ .+|..+.  ++++.|+|++|+|++..+..|..+++|++|+|++|+|++..+  ...+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCC
Confidence            456667777777777777 3444442  567777777777766566667777777777777777764322  25666677


Q ss_pred             EEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCc
Q 002883          324 KLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNS  403 (871)
Q Consensus       324 ~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  403 (871)
                      +|++++|+|+ .+|..+.++++|++|++++|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            7777777766 555666666666666666666665555566666666666666666665555556666666666666666


Q ss_pred             ccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccC
Q 002883          404 FQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEV  456 (871)
Q Consensus       404 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~  456 (871)
                      |+++.+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|.|.+
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c  211 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence            66555555666666666666666666 44555555556666666666665544

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=5.2e-26  Score=239.17  Aligned_cols=226  Identities=19%  Similarity=0.197  Sum_probs=187.2

Q ss_pred             EEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCC
Q 002883          203 VVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGN  282 (871)
Q Consensus       203 ~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n  282 (871)
                      .++.++..++ .+|..+.   ++|++|++++|+|++..+..|.++++|++|++++|.+++..+..|..+++|++|+|++|
T Consensus        11 ~~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n   86 (276)
T 2z62_A           11 TYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN   86 (276)
T ss_dssp             EEECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             eEEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence            4556666665 4565443   46888888888888777778888888899999888888777778888899999999999


Q ss_pred             CCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCC-CcccccCCCCCcEEeccCCCCCCCCc
Q 002883          283 KISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGT-IPREVIGLSSFVLLDLSRNHLSGPIP  361 (871)
Q Consensus       283 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~ls~N~l~~~~~  361 (871)
                      ++++..+..|.++++|++|++++|++++..+..+..+++|++|++++|.+++. +|..+..+++|++|++++|++++..+
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~  166 (276)
T 2z62_A           87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC  166 (276)
T ss_dssp             CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred             ccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence            98877778888899999999999999877777788899999999999999854 58888999999999999999987777


Q ss_pred             cccCCCCCCC----EEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCc
Q 002883          362 LEVGRLKGIQ----QLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP  433 (871)
Q Consensus       362 ~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  433 (871)
                      ..+..+.+|+    .|++++|.+++..+..+. ..+|++|+|++|++++..+..|..+++|+.|++++|++++..+
T Consensus       167 ~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             GGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             HHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence            7787777777    899999999965555554 4589999999999998888888999999999999999986543

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=1.7e-25  Score=236.15  Aligned_cols=207  Identities=22%  Similarity=0.164  Sum_probs=166.7

Q ss_pred             ccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCc
Q 002883          268 VGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV  347 (871)
Q Consensus       268 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  347 (871)
                      ++.+++++++++++|.++ .+|..+.  ++++.|+|++|+|++..+..|.++++|+.|+|++|.|++. +. ...+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QV-DGTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-EC-CSCCTTCC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cC-CCCCCcCC
Confidence            566788888888888888 4555443  5788888888888877778888888888888888888744 32 26788888


Q ss_pred             EEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCc
Q 002883          348 LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNN  427 (871)
Q Consensus       348 ~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  427 (871)
                      +|++++|+++ .+|..+..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            8888888888 677778888888888888888887767788888888888888888888777778888888888888888


Q ss_pred             CCCCCcccccccccccEEecCCCcCcccCCCCcccccccceeccCCCCCccCC
Q 002883          428 FSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGS  480 (871)
Q Consensus       428 l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~C~~~  480 (871)
                      |++..+..+..+++|+.|+|++|+++..++.......++.+.+.+|||.|+|.
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~  212 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCc
Confidence            88766667788888888888888888666555556678888888888888884

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=4.5e-25  Score=230.99  Aligned_cols=206  Identities=21%  Similarity=0.230  Sum_probs=187.3

Q ss_pred             CCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEec
Q 002883          272 LKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDL  351 (871)
Q Consensus       272 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  351 (871)
                      .+.+.+++++++++ .+|..+.  ++|++|+|++|+++...+..|.++++|++|++++|++++..+..|..+++|++|++
T Consensus        16 ~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l   92 (270)
T 2o6q_A           16 NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV   92 (270)
T ss_dssp             TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred             CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence            46889999999999 5666554  68999999999999887789999999999999999999776677889999999999


Q ss_pred             cCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCC
Q 002883          352 SRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGK  431 (871)
Q Consensus       352 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  431 (871)
                      ++|.+++..+..|..+++|++|++++|.+++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++.
T Consensus        93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  172 (270)
T 2o6q_A           93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV  172 (270)
T ss_dssp             CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence            99999977777889999999999999999988888899999999999999999988888899999999999999999988


Q ss_pred             CcccccccccccEEecCCCcCcccCCC-CcccccccceeccCCCCCccCC
Q 002883          432 IPMFLNTFRFLQKLNLSFNNLEGEVPS-EGVFKNVRAVSIIGNNKLCGGS  480 (871)
Q Consensus       432 ~~~~~~~~~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~C~~~  480 (871)
                      .+..+..+++|++|++++|++++.++. ...++.++.+++.+|||.|+|.
T Consensus       173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  222 (270)
T 2o6q_A          173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN  222 (270)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred             ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence            888899999999999999999987664 3457889999999999999996

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=1.6e-29  Score=297.27  Aligned_cols=404  Identities=14%  Similarity=0.082  Sum_probs=286.0

Q ss_pred             cCCCCCCEEecCCCcccccCCcccc-CCCcCceeeCCCC-ccccc-CCccccCCcccceeeccCccccCCCCcccc----
Q 002883           11 THCSELRILDLVVNKLEGNIPSELG-NLFKLVGLGLTGN-NYTGS-IPQSLSNLSFLQQLSLSENSLSGNIPSELG----   83 (871)
Q Consensus        11 ~~l~~L~~L~l~~n~i~~~~~~~~~-~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~----   83 (871)
                      ..+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.    
T Consensus       102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~  181 (594)
T 2p1m_B          102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD  181 (594)
T ss_dssp             HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred             HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence            4688999999999999887788886 6999999999999 66533 445566899999999999998866655554    


Q ss_pred             cccccccccccccc--ccCC-CCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCC
Q 002883           84 LLKQLNMFQVSANY--LTGS-IPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASS  160 (871)
Q Consensus        84 ~l~~L~~L~l~~n~--l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~  160 (871)
                      .+++|++|++++|.  +... ++.-+..+++|+.|++++|...+.+|..+. .+++|+.|+++.+... .-+   ..+..
T Consensus       182 ~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~-~~~~L~~L~l~~~~~~-~~~---~~~~~  256 (594)
T 2p1m_B          182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQ-RAPQLEELGTGGYTAE-VRP---DVYSG  256 (594)
T ss_dssp             TCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHH-HCTTCSEEECSBCCCC-CCH---HHHHH
T ss_pred             cCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHh-cCCcceEcccccccCc-cch---hhHHH
Confidence            66799999999997  2211 111234569999999999943334665554 8899999997766421 000   01113


Q ss_pred             CCccccCCCcccEE-ecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCC
Q 002883          161 IPEDLGKLKNLIRL-NFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGT  239 (871)
Q Consensus       161 lp~~~~~l~~L~~L-~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~  239 (871)
                      ++..+.++++|+.| .+.+.....       ....+..+++|++|+|++|.+++.....+....++|++|++++| +++.
T Consensus       257 l~~~l~~~~~L~~Ls~~~~~~~~~-------l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~  328 (594)
T 2p1m_B          257 LSVALSGCKELRCLSGFWDAVPAY-------LPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDA  328 (594)
T ss_dssp             HHHHHHTCTTCCEEECCBTCCGGG-------GGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHH
T ss_pred             HHHHHhcCCCcccccCCcccchhh-------HHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHH
Confidence            55568889999998 444332211       22233467899999999999874433333333467999999998 5432


Q ss_pred             CCCC-CCCccccceeecc---------cccccccCCcccc-CCCCCcEEEccCCCCCCCCCcccC-CCccccEEEcc--C
Q 002883          240 IPTG-VGNLKNLILIAME---------VNLLTGSIPTSVG-YLLKLQVLSLFGNKISGEIPSSLG-NLIFLTEVDLQ--G  305 (871)
Q Consensus       240 ~~~~-~~~l~~L~~L~l~---------~N~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~--~  305 (871)
                      .... ...+++|+.|++.         .+.+++.....+. .+++|+.|+++.|+++......+. .+++|+.|+|+  +
T Consensus       329 ~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~  408 (594)
T 2p1m_B          329 GLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIE  408 (594)
T ss_dssp             HHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESS
T ss_pred             HHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeeccc
Confidence            2222 2357899999883         3556544333443 489999999999999865555554 58899999999  4


Q ss_pred             ----ccccccC-----cccccCCCCCCEEecCCCcCCCCCcccccC-CCCCcEEeccCCCCCCCCcccc-CCCCCCCEEe
Q 002883          306 ----NSIRGSI-----PSALGNCLQLQKLDLSDNNLSGTIPREVIG-LSSFVLLDLSRNHLSGPIPLEV-GRLKGIQQLD  374 (871)
Q Consensus       306 ----N~i~~~~-----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~ls~N~l~~~~~~~~-~~l~~L~~L~  374 (871)
                          |.++...     +..+..+++|+.|+|++ .+++..+..+.. +++|+.|++++|.+++..+..+ ..+++|+.|+
T Consensus       409 ~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~  487 (594)
T 2p1m_B          409 PKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLE  487 (594)
T ss_dssp             TTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEE
T ss_pred             CCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEE
Confidence                5665221     22366789999999987 676555555555 8999999999999976555555 6689999999


Q ss_pred             CCCCcCCCCCcc-chhcccCCceeeecCCcccccCcccc-CCCCCCCEEeCCCCcC
Q 002883          375 LSENKLSGEIPT-SLASCVGLEYLNFSDNSFQGPIHSGF-SSLKGLQDLDLSRNNF  428 (871)
Q Consensus       375 L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~l~~N~l  428 (871)
                      |++|.+++.... ....+++|++|++++|+++......+ ..+++|+...+..+.-
T Consensus       488 L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~  543 (594)
T 2p1m_B          488 IRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA  543 (594)
T ss_dssp             EESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred             CcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence            999999744443 34568999999999999964444444 5678887777766643

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=3.2e-25  Score=232.30  Aligned_cols=221  Identities=22%  Similarity=0.246  Sum_probs=165.2

Q ss_pred             ccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccC
Q 002883          226 LIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQG  305 (871)
Q Consensus       226 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  305 (871)
                      +..+++.++.+.+.  ..+..+++|+.|++++|.++.  ...+..+++|++|+|++|++++ . ..+..+++|++|+|++
T Consensus        21 l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~   94 (272)
T 3rfs_A           21 TIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTG   94 (272)
T ss_dssp             HHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTT
T ss_pred             HHHHHhcCcccccc--cccccccceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCC
Confidence            44555555555432  234556666777777766662  2346677777777777777764 2 3677777788888888


Q ss_pred             ccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCc
Q 002883          306 NSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIP  385 (871)
Q Consensus       306 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  385 (871)
                      |.+++..+..|..+++|++|++++|++++..+..|..+++|++|++++|.+++..+..++.+++|+.|++++|++++..+
T Consensus        95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  174 (272)
T 3rfs_A           95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE  174 (272)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence            88876666677778888888888888876666667778888888888888876666667888888888888888887777


Q ss_pred             cchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCC
Q 002883          386 TSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSE  459 (871)
Q Consensus       386 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~  459 (871)
                      ..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+.+.       +++|+.|++++|.++|.+|..
T Consensus       175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~  241 (272)
T 3rfs_A          175 GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS  241 (272)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred             HHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence            7778888888888888888887777788888888888888888754       457888889999998887754

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=3.8e-25  Score=231.76  Aligned_cols=206  Identities=21%  Similarity=0.231  Sum_probs=145.5

Q ss_pred             cccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEcc
Q 002883          225 HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQ  304 (871)
Q Consensus       225 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  304 (871)
                      +|+.|++++|.++.  ...+..+++|++|++++|.+++  ...+..+++|++|+|++|++++..+..|..+++|++|+|+
T Consensus        42 ~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  117 (272)
T 3rfs_A           42 SIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHD--ISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLV  117 (272)
T ss_dssp             TCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCC--CGGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             ceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCC--chhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECC
Confidence            46666666666652  2346666666666666666664  2356677777777777777776666667777777777777


Q ss_pred             CccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCC
Q 002883          305 GNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEI  384 (871)
Q Consensus       305 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  384 (871)
                      +|++++..+..|..+++|++|++++|++++..+..+..+++|+.|++++|++++..+..++.+++|+.|++++|++++..
T Consensus       118 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  197 (272)
T 3rfs_A          118 ENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVP  197 (272)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccC
Confidence            77777666666777777777777777777666666677777777777777777666666777777888888888877766


Q ss_pred             ccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCccccccccc
Q 002883          385 PTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRF  441 (871)
Q Consensus       385 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~  441 (871)
                      +..|..+++|+.|+|++|++.+       .+++|+.|+++.|+++|.+|..+..++.
T Consensus       198 ~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          198 DGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             TTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             HHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCcccccCC
Confidence            6667777888888888887763       2456777888888888888877766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=2e-25  Score=255.39  Aligned_cols=189  Identities=14%  Similarity=0.149  Sum_probs=142.0

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--------chHHHHHHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--------GASKSFIAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      .+...+.||+|+||+||+|..  .++.+++|+......        ...+++.+|++++++++||||+++..++...   
T Consensus       337 ~~~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~---  411 (540)
T 3en9_A          337 RKIPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL---  411 (540)
T ss_dssp             -----------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET---
T ss_pred             cCCCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC---
Confidence            345567999999999999965  578899998633211        1134579999999999999999554444332   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                        ...|+||||+++++|.+++..               +..++.|+++||+|||++   +|+||||||+|||++.  .+|
T Consensus       412 --~~~~lVmE~~~ggsL~~~l~~---------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~k  469 (540)
T 3en9_A          412 --DNKRIMMSYINGKLAKDVIED---------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLY  469 (540)
T ss_dssp             --TTTEEEEECCCSEEHHHHSTT---------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEE
T ss_pred             --CccEEEEECCCCCCHHHHHHH---------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEE
Confidence              346999999999999999864               457899999999999999   9999999999999998  999


Q ss_pred             EeecccceecCCCCCCcc----ccccccccccccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCc
Q 002883          712 VGDFGLSRLLHDNSPDQT----STSRVKGSIGYVAPEYGAL--GEVSTHGDEYSFGILMLEMFTGKRPTD  775 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~  775 (871)
                      |+|||+|+..........    ......||+.|+|||++..  ..|+..+|+||..+-..+-+.++.+|.
T Consensus       470 L~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          470 IIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             ECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             EEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            999999998754211100    1234679999999998776  567888999999998888888877764

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.91  E-value=5.3e-24  Score=227.71  Aligned_cols=224  Identities=20%  Similarity=0.199  Sum_probs=147.3

Q ss_pred             CcccEEEccCCcCcccCChh---hhhccccccEEEccCCccCCCCCCCC--CCccccceeecccccccccCC----cccc
Q 002883          199 TFLEVVSLSSNSLSGVLPNS---IANFSSHLIYLYMSANRISGTIPTGV--GNLKNLILIAMEVNLLTGSIP----TSVG  269 (871)
Q Consensus       199 ~~L~~L~L~~n~l~~~~~~~---~~~~~~~L~~L~L~~n~i~~~~~~~~--~~l~~L~~L~l~~N~l~~~~~----~~~~  269 (871)
                      ..++.+.+.++.++...-..   .... ++|++|++++|++++..|..+  ..+++|++|++++|.+++..+    ..+.
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~  142 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAY-SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW  142 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHH-SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhccc-CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh
Confidence            34677777777765221111   1122 358999999999988888887  888889999999998886544    3345


Q ss_pred             CCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCcccccc--C--cccccCCCCCCEEecCCCcCCCCCcc----ccc
Q 002883          270 YLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGS--I--PSALGNCLQLQKLDLSDNNLSGTIPR----EVI  341 (871)
Q Consensus       270 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~--~--~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~  341 (871)
                      .+++|++|+|++|++.+..+..|+.+++|++|+|++|++.+.  .  +..+..+++|++|+|++|+++ .++.    .+.
T Consensus       143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~  221 (310)
T 4glp_A          143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAA  221 (310)
T ss_dssp             BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHH
T ss_pred             hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHh
Confidence            678888888888888877777888888888888888886532  1  223456777888888888776 3333    245


Q ss_pred             CCCCCcEEeccCCCCCCCCccccCCC---CCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCC
Q 002883          342 GLSSFVLLDLSRNHLSGPIPLEVGRL---KGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGL  418 (871)
Q Consensus       342 ~l~~L~~L~ls~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  418 (871)
                      .+++|++|+|++|++++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|++|+|++|+|++. |. +..+++|
T Consensus       222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L  296 (310)
T 4glp_A          222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEV  296 (310)
T ss_dssp             HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCC
T ss_pred             cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCc
Confidence            66777777777777776556555554   46666666666666 4454443  4566666666665543 11 4445555


Q ss_pred             CEEeCCCCcCC
Q 002883          419 QDLDLSRNNFS  429 (871)
Q Consensus       419 ~~L~l~~N~l~  429 (871)
                      +.|+|++|+++
T Consensus       297 ~~L~L~~N~l~  307 (310)
T 4glp_A          297 DNLTLDGNPFL  307 (310)
T ss_dssp             SCEECSSTTTS
T ss_pred             cEEECcCCCCC
Confidence            55555555554

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=2.8e-25  Score=243.15  Aligned_cols=251  Identities=19%  Similarity=0.162  Sum_probs=152.5

Q ss_pred             EEccCCcCcccCChhhhhccccccEEEccCCccCCCCC----CCCCCcc-ccceeecccccccccCCccccCC-----CC
Q 002883          204 VSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIP----TGVGNLK-NLILIAMEVNLLTGSIPTSVGYL-----LK  273 (871)
Q Consensus       204 L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~----~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l-----~~  273 (871)
                      ++|++|.+++.+|..+ ...++|++|+|++|.|++..+    ..|.+++ +|++|+|++|.+++..+..+..+     ++
T Consensus         3 ~~ls~n~~~~~~~~~~-~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFT-SIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EECCCCTTCCHHHHHH-TSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             cccccccchHHHHHHH-hCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            4555566654443332 233346666666666665444    4555566 66666666666665555555554     66


Q ss_pred             CcEEEccCCCCCCCCCcccC----CC-ccccEEEccCccccccCccccc----C-CCCCCEEecCCCcCCCCCcc----c
Q 002883          274 LQVLSLFGNKISGEIPSSLG----NL-IFLTEVDLQGNSIRGSIPSALG----N-CLQLQKLDLSDNNLSGTIPR----E  339 (871)
Q Consensus       274 L~~L~L~~n~l~~~~~~~~~----~l-~~L~~L~L~~N~i~~~~~~~~~----~-l~~L~~L~L~~N~l~~~~~~----~  339 (871)
                      |++|+|++|++++..+..+.    .+ ++|++|+|++|+|++..+..+.    . .++|++|+|++|++++..+.    .
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~  161 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI  161 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence            77777777777654444333    33 6677777777777655544433    2 24777777777777643332    3


Q ss_pred             ccCCC-CCcEEeccCCCCCCCCccccC----CC-CCCCEEeCCCCcCCCC----Cccchhc-ccCCceeeecCCcccccC
Q 002883          340 VIGLS-SFVLLDLSRNHLSGPIPLEVG----RL-KGIQQLDLSENKLSGE----IPTSLAS-CVGLEYLNFSDNSFQGPI  408 (871)
Q Consensus       340 ~~~l~-~L~~L~ls~N~l~~~~~~~~~----~l-~~L~~L~L~~N~l~~~----~~~~~~~-l~~L~~L~L~~N~l~~~~  408 (871)
                      +..++ +|++|+|++|.+++..+..++    .+ ++|++|+|++|.|++.    ++..+.. .++|++|+|++|+|++..
T Consensus       162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~  241 (362)
T 3goz_A          162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS  241 (362)
T ss_dssp             HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred             HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence            34444 777777777777655554333    33 4777777777777743    3344444 347777777777777544


Q ss_pred             c----cccCCCCCCCEEeCCCCcCCCCCc-------ccccccccccEEecCCCcCccc
Q 002883          409 H----SGFSSLKGLQDLDLSRNNFSGKIP-------MFLNTFRFLQKLNLSFNNLEGE  455 (871)
Q Consensus       409 ~----~~~~~l~~L~~L~l~~N~l~~~~~-------~~~~~~~~L~~L~l~~N~l~~~  455 (871)
                      +    ..+..+++|+.|+|++|.+.+..+       ..+..+++|+.||+++|++...
T Consensus       242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS  299 (362)
T ss_dssp             HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred             HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence            4    334666778888888887554333       3566677788888888887765

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=5.6e-24  Score=218.38  Aligned_cols=199  Identities=16%  Similarity=0.179  Sum_probs=97.1

Q ss_pred             cccEEEccCCccCCCCCCCCCCccccceeeccccc-ccccCCccccCCCCCcEEEccC-CCCCCCCCcccCCCccccEEE
Q 002883          225 HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNL-LTGSIPTSVGYLLKLQVLSLFG-NKISGEIPSSLGNLIFLTEVD  302 (871)
Q Consensus       225 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~  302 (871)
                      +|++|++++|+|+++.+..|.++++|++|++++|. ++...+..|..+++|++|+|++ |+++...+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            46666666666665444455555555555555554 5544444555555555555555 555544444455555555555


Q ss_pred             ccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCC-CCCCCCccccCCCCCCC-EEeCCCCcC
Q 002883          303 LQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRN-HLSGPIPLEVGRLKGIQ-QLDLSENKL  380 (871)
Q Consensus       303 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l  380 (871)
                      +++|++++ +|. |..+++|+                     .|++|++++| .+++..+..|..+++|+ .|++++|++
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~---------------------~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l  168 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTD---------------------IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF  168 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCC---------------------SEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCC
T ss_pred             CCCCCCcc-ccc-cccccccc---------------------cccEEECCCCcchhhcCcccccchhcceeEEEcCCCCC
Confidence            55555543 332 44444444                     0004444444 44433333344444454 555555544


Q ss_pred             CCCCccchhcccCCceeeecCCc-ccccCccccCCC-CCCCEEeCCCCcCCCCCcccccccccccEEecCCC
Q 002883          381 SGEIPTSLASCVGLEYLNFSDNS-FQGPIHSGFSSL-KGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFN  450 (871)
Q Consensus       381 ~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N  450 (871)
                      +...+..|.. ++|++|+|++|+ ++++.+..|.++ ++|+.|++++|++++..+.   .+++|+.|+++++
T Consensus       169 ~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          169 TSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             CEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             cccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            4222222322 455555555553 554445555555 5555555555555532222   3445555555543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=1.5e-25  Score=245.33  Aligned_cols=262  Identities=18%  Similarity=0.180  Sum_probs=178.7

Q ss_pred             EEecCCCcccccCCccccCCCcCceeeCCCCcccccCC----ccccCCc-ccceeeccCccccCCCCcccccc-----cc
Q 002883           18 ILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIP----QSLSNLS-FLQQLSLSENSLSGNIPSELGLL-----KQ   87 (871)
Q Consensus        18 ~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l-----~~   87 (871)
                      .++|++|++++.+|+.+....+|++|+|++|++++..+    +.|..++ +|++|+|++|.+++..+..|..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            46889999998888888777889999999999986666    7788888 89999999999987778888776     88


Q ss_pred             ccccccccccccCCCCcccccc-----CCCceeeeecccccccccccccc---C-CCCccEEEccCccCCCCCCccCcCC
Q 002883           88 LNMFQVSANYLTGSIPIQLFNI-----SSMDYFAVTQNKLVGEIPHYVGF---T-LPNIRVLLLGSNWFTGEIPPSISNA  158 (871)
Q Consensus        88 L~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~l~~n~l~~~~~~~~~~---~-l~~L~~L~l~~n~i~~~~p~~~~~~  158 (871)
                      |++|+|++|++++..+..+...     ++|++|++++|.+.+..+..+..   . ..+|++|+|++|.+++..+.     
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~-----  156 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSD-----  156 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHH-----
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHH-----
Confidence            9999999999986666655443     78888888888887544433321   2 25888888888887743221     


Q ss_pred             CCCCccccCCC-cccEEecccccCCCCCCCCccccccccCC-CcccEEEccCCcCccc----CChhhhhccccccEEEcc
Q 002883          159 SSIPEDLGKLK-NLIRLNFARNNLGTGKGNDLRFLDSLVNC-TFLEVVSLSSNSLSGV----LPNSIANFSSHLIYLYMS  232 (871)
Q Consensus       159 ~~lp~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~~l~~l-~~L~~L~L~~n~l~~~----~~~~~~~~~~~L~~L~L~  232 (871)
                       .+++.+..++ +|++|+|++|+++......  ....+..+ ++|++|+|++|.+++.    ++..+....++|++|+|+
T Consensus       157 -~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~--l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls  233 (362)
T 3goz_A          157 -ELIQILAAIPANVNSLNLRGNNLASKNCAE--LAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLC  233 (362)
T ss_dssp             -HHHHHHHTSCTTCCEEECTTSCGGGSCHHH--HHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECC
T ss_pred             -HHHHHHhcCCccccEeeecCCCCchhhHHH--HHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECc
Confidence             2344455555 7888888888776543211  11234445 4788888888888743    344444444468888888


Q ss_pred             CCccCCCCC----CCCCCccccceeecccccccccC-------CccccCCCCCcEEEccCCCCCCC
Q 002883          233 ANRISGTIP----TGVGNLKNLILIAMEVNLLTGSI-------PTSVGYLLKLQVLSLFGNKISGE  287 (871)
Q Consensus       233 ~n~i~~~~~----~~~~~l~~L~~L~l~~N~l~~~~-------~~~~~~l~~L~~L~L~~n~l~~~  287 (871)
                      +|+|++..+    ..+..+++|+.|++++|.+....       +..+..+++|+.||+++|++...
T Consensus       234 ~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          234 LNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS  299 (362)
T ss_dssp             SSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred             CCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence            887775433    23455666777777777644322       22445556666666666666543

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=5.6e-24  Score=218.40  Aligned_cols=197  Identities=17%  Similarity=0.219  Sum_probs=159.8

Q ss_pred             CcccEEEccCCcCcccCChhhhhccccccEEEccCCc-cCCCCCCCCCCccccceeeccc-ccccccCCccccCCCCCcE
Q 002883          199 TFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANR-ISGTIPTGVGNLKNLILIAMEV-NLLTGSIPTSVGYLLKLQV  276 (871)
Q Consensus       199 ~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~  276 (871)
                      ++|++|++++|++++..+..+..+ ++|++|++++|+ ++.+.+..|.++++|++|++++ |.+++..+..|..+++|++
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l-~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~  109 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNL-PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF  109 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTC-TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred             CcccEEEEeCCcceEECHHHccCC-CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence            489999999999996666567666 579999999997 9877778999999999999999 9999888889999999999


Q ss_pred             EEccCCCCCCCCCcccCCCcccc---EEEccCc-cccccCcccccCCCCCC-EEecCCCcCCCCCcccccCCCCCcEEec
Q 002883          277 LSLFGNKISGEIPSSLGNLIFLT---EVDLQGN-SIRGSIPSALGNCLQLQ-KLDLSDNNLSGTIPREVIGLSSFVLLDL  351 (871)
Q Consensus       277 L~L~~n~l~~~~~~~~~~l~~L~---~L~L~~N-~i~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~l  351 (871)
                      |++++|++++ +|. |..+++|+   +|++++| ++++..+..|.++++|+ .|++++|+++...+..+.. ++|+.|++
T Consensus       110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L  186 (239)
T 2xwt_C          110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYL  186 (239)
T ss_dssp             EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEEC
T ss_pred             EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEc
Confidence            9999999995 666 88888888   9999999 99977777899999999 9999999998443334444 77888888


Q ss_pred             cCCC-CCCCCccccCCC-CCCCEEeCCCCcCCCCCccchhcccCCceeeecCC
Q 002883          352 SRNH-LSGPIPLEVGRL-KGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDN  402 (871)
Q Consensus       352 s~N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  402 (871)
                      ++|+ ++...+..|..+ ++|+.|++++|++++ +|..  .+++|+.|+++++
T Consensus       187 ~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             TTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred             CCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence            8884 775555667777 777777777777773 3332  4556666666654

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.90  E-value=1.1e-23  Score=224.68  Aligned_cols=189  Identities=24%  Similarity=0.341  Sum_probs=104.5

Q ss_pred             cccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEcc
Q 002883          225 HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQ  304 (871)
Q Consensus       225 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  304 (871)
                      +|++|++++|.++. ++ .+..+++|+.|++++|.+++..+  +..+++|++|+|++|++++ + ..+..+++|++|+|+
T Consensus        42 ~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~-~~~~~l~~L~~L~l~  115 (308)
T 1h6u_A           42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIKTLDLT  115 (308)
T ss_dssp             TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEECT
T ss_pred             CcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-c-hhhcCCCCCCEEECC
Confidence            46677777776663 22 45666666666666666664332  5666666666666666653 2 245556666666666


Q ss_pred             CccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCC
Q 002883          305 GNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEI  384 (871)
Q Consensus       305 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  384 (871)
                      +|++++. + .+..+++|+.|++++|++++..+  +..+++|+.|++++|.+++. +. +..+++|+.|++++|++++..
T Consensus       116 ~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~  189 (308)
T 1h6u_A          116 STQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKISDIS  189 (308)
T ss_dssp             TSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCG
T ss_pred             CCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCccCcCh
Confidence            6666532 2 25556666666666666653322  55555566666666555532 22 555555555555555555322


Q ss_pred             ccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCC
Q 002883          385 PTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFS  429 (871)
Q Consensus       385 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  429 (871)
                      +  +..+++|++|+|++|++++..+  +..+++|+.|++++|+++
T Consensus       190 ~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          190 P--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             G--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred             h--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence            2  4555555555555555554332  455555555555555554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=7.1e-23  Score=211.72  Aligned_cols=158  Identities=22%  Similarity=0.210  Sum_probs=75.8

Q ss_pred             ccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCC
Q 002883          298 LTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSE  377 (871)
Q Consensus       298 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~  377 (871)
                      |+.|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++
T Consensus        37 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  116 (251)
T 3m19_A           37 TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGG  116 (251)
T ss_dssp             CCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCC
Confidence            33344444444333333344444444444444444433333344444444444444444433333444444455555555


Q ss_pred             CcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCccc
Q 002883          378 NKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGE  455 (871)
Q Consensus       378 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~  455 (871)
                      |+|++..+..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|+|+|.
T Consensus       117 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          117 NQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            555443344444555555555555555544444555555555555555555555455555555555555555555554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=5.9e-23  Score=212.30  Aligned_cols=181  Identities=22%  Similarity=0.244  Sum_probs=165.9

Q ss_pred             cccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEec
Q 002883          248 KNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDL  327 (871)
Q Consensus       248 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  327 (871)
                      .+.+.++++++.++ .+|..+.  ++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            46788999999999 5666554  68999999999999888889999999999999999999888888999999999999


Q ss_pred             CCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCccccc
Q 002883          328 SDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP  407 (871)
Q Consensus       328 ~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  407 (871)
                      ++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++.
T Consensus        91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  170 (251)
T 3m19_A           91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV  170 (251)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence            99999988888899999999999999999977777789999999999999999977777899999999999999999998


Q ss_pred             CccccCCCCCCCEEeCCCCcCCCC
Q 002883          408 IHSGFSSLKGLQDLDLSRNNFSGK  431 (871)
Q Consensus       408 ~~~~~~~l~~L~~L~l~~N~l~~~  431 (871)
                      .+..|..+++|+.|+|++|++++.
T Consensus       171 ~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          171 PHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CHHHHhCCCCCCEEEeeCCceeCC
Confidence            888999999999999999999865

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=5.5e-24  Score=227.57  Aligned_cols=224  Identities=21%  Similarity=0.159  Sum_probs=146.0

Q ss_pred             cccEEEccCCccCCCCCC---CCCCccccceeecccccccccCCccc--cCCCCCcEEEccCCCCCCCCC----cccCCC
Q 002883          225 HLIYLYMSANRISGTIPT---GVGNLKNLILIAMEVNLLTGSIPTSV--GYLLKLQVLSLFGNKISGEIP----SSLGNL  295 (871)
Q Consensus       225 ~L~~L~L~~n~i~~~~~~---~~~~l~~L~~L~l~~N~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~l  295 (871)
                      .++.|.+.++.++.....   .+..+++|++|++++|.+++..|..+  ..+++|++|+|++|++++..+    ..+..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            367777777776521111   12234567777777777777777776  777777777777777775433    234467


Q ss_pred             ccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCC--C--cccccCCCCCcEEeccCCCCCCCCcc----ccCCC
Q 002883          296 IFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGT--I--PREVIGLSSFVLLDLSRNHLSGPIPL----EVGRL  367 (871)
Q Consensus       296 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~--~--~~~~~~l~~L~~L~ls~N~l~~~~~~----~~~~l  367 (871)
                      ++|++|+|++|++.+..+..|..+++|++|+|++|++.+.  .  +..+..+++|++|+|++|+++ .++.    .++.+
T Consensus       145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l  223 (310)
T 4glp_A          145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG  223 (310)
T ss_dssp             SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred             cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence            7777777777777766667777777777777777776531  1  122356677777777777776 2332    24566


Q ss_pred             CCCCEEeCCCCcCCCCCccchhcc---cCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccE
Q 002883          368 KGIQQLDLSENKLSGEIPTSLASC---VGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQK  444 (871)
Q Consensus       368 ~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~  444 (871)
                      ++|++|+|++|++++..|..+..+   ++|++|+|++|+|+. +|..+.  ++|++|+|++|+|++. |. +..+++|+.
T Consensus       224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~-lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~  298 (310)
T 4glp_A          224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ-VPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN  298 (310)
T ss_dssp             CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS-CCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred             CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc-hhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence            777777777777776656666555   577777777777773 344443  5777777777777743 33 566677777


Q ss_pred             EecCCCcCcc
Q 002883          445 LNLSFNNLEG  454 (871)
Q Consensus       445 L~l~~N~l~~  454 (871)
                      |+|++|+|+.
T Consensus       299 L~L~~N~l~~  308 (310)
T 4glp_A          299 LTLDGNPFLV  308 (310)
T ss_dssp             EECSSTTTSC
T ss_pred             EECcCCCCCC
Confidence            7777777763

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=2.4e-25  Score=246.29  Aligned_cols=232  Identities=18%  Similarity=0.215  Sum_probs=158.9

Q ss_pred             ccEEEccCCccCCCC----CCCCCCccccceeeccccc---ccccCCccc-------cCCCCCcEEEccCCCCCC----C
Q 002883          226 LIYLYMSANRISGTI----PTGVGNLKNLILIAMEVNL---LTGSIPTSV-------GYLLKLQVLSLFGNKISG----E  287 (871)
Q Consensus       226 L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~l~~N~---l~~~~~~~~-------~~l~~L~~L~L~~n~l~~----~  287 (871)
                      |++|+|++|+|+...    +..+..+++|+.|+|++|.   +++.+|..+       ..+++|++|+|++|+++.    .
T Consensus        34 L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~  113 (386)
T 2ca6_A           34 VKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEP  113 (386)
T ss_dssp             CCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHH
T ss_pred             ccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHH
Confidence            555555555544332    2224455566666665542   233333333       567778888888887775    2


Q ss_pred             CCcccCCCccccEEEccCccccccCccccc----CC---------CCCCEEecCCCcCC-CCCc---ccccCCCCCcEEe
Q 002883          288 IPSSLGNLIFLTEVDLQGNSIRGSIPSALG----NC---------LQLQKLDLSDNNLS-GTIP---REVIGLSSFVLLD  350 (871)
Q Consensus       288 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~----~l---------~~L~~L~L~~N~l~-~~~~---~~~~~l~~L~~L~  350 (871)
                      ++..+..+++|++|+|++|.++...+..+.    .+         ++|++|+|++|+++ +..+   ..+..+++|++|+
T Consensus       114 l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~  193 (386)
T 2ca6_A          114 LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVK  193 (386)
T ss_dssp             HHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEE
T ss_pred             HHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEE
Confidence            555677777888888888877644333333    33         78888888888886 2333   3566778888888


Q ss_pred             ccCCCCCC-----CCccccCCCCCCCEEeCCCCcCC----CCCccchhcccCCceeeecCCccccc----Ccccc--CCC
Q 002883          351 LSRNHLSG-----PIPLEVGRLKGIQQLDLSENKLS----GEIPTSLASCVGLEYLNFSDNSFQGP----IHSGF--SSL  415 (871)
Q Consensus       351 ls~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~--~~l  415 (871)
                      +++|+++.     ..+..+..+++|+.|+|++|.++    ..+|..+..+++|++|+|++|+|++.    ++..+  +.+
T Consensus       194 L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~  273 (386)
T 2ca6_A          194 MVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN  273 (386)
T ss_dssp             CCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSS
T ss_pred             CcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccC
Confidence            88888862     23337778888888888888885    46677788888888899988888765    34555  348


Q ss_pred             CCCCEEeCCCCcCCC----CCcccc-cccccccEEecCCCcCcccCC
Q 002883          416 KGLQDLDLSRNNFSG----KIPMFL-NTFRFLQKLNLSFNNLEGEVP  457 (871)
Q Consensus       416 ~~L~~L~l~~N~l~~----~~~~~~-~~~~~L~~L~l~~N~l~~~~~  457 (871)
                      ++|++|+|++|++++    .+|..+ ..+++|++|++++|++++..+
T Consensus       274 ~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          274 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             CCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             CCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            889999999999886    366666 667889999999999886553

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=1.8e-25  Score=247.22  Aligned_cols=270  Identities=16%  Similarity=0.204  Sum_probs=172.3

Q ss_pred             CCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcC---cccCChhhhhccccccEEEccCCcc
Q 002883          160 SIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSL---SGVLPNSIANFSSHLIYLYMSANRI  236 (871)
Q Consensus       160 ~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l---~~~~~~~~~~~~~~L~~L~L~~n~i  236 (871)
                      .++..+..+++|++|+|++|+++.....  .....+..+++|++|+|++|.+   ++.+|..+..+              
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~--~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l--------------   86 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAAR--WLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL--------------   86 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHH--HHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHH--------------
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHH--HHHHHHHhCCCccEEeCcccccCccccchhHHHHHH--------------
Confidence            4566666677777777777766542110  0112355566666666666433   33334333211              


Q ss_pred             CCCCCCCCCCccccceeecccccccc----cCCccccCCCCCcEEEccCCCCCCCCCcccC----CC---------cccc
Q 002883          237 SGTIPTGVGNLKNLILIAMEVNLLTG----SIPTSVGYLLKLQVLSLFGNKISGEIPSSLG----NL---------IFLT  299 (871)
Q Consensus       237 ~~~~~~~~~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~----~l---------~~L~  299 (871)
                          ...+..+++|++|+|++|.++.    .++..+..+++|++|+|++|.++...+..+.    .+         ++|+
T Consensus        87 ----~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~  162 (386)
T 2ca6_A           87 ----LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR  162 (386)
T ss_dssp             ----HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred             ----HHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCc
Confidence                0123455666666666666664    2455566677777777777777533333332    23         6778


Q ss_pred             EEEccCcccc-ccCc---ccccCCCCCCEEecCCCcCCC-----CCcccccCCCCCcEEeccCCCCC----CCCccccCC
Q 002883          300 EVDLQGNSIR-GSIP---SALGNCLQLQKLDLSDNNLSG-----TIPREVIGLSSFVLLDLSRNHLS----GPIPLEVGR  366 (871)
Q Consensus       300 ~L~L~~N~i~-~~~~---~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~ls~N~l~----~~~~~~~~~  366 (871)
                      +|+|++|+++ ...+   ..+..+++|+.|+|++|+|+.     ..+..+..+++|+.|+|++|.++    ..+|..+..
T Consensus       163 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~  242 (386)
T 2ca6_A          163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS  242 (386)
T ss_dssp             EEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred             EEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHcc
Confidence            8888888776 2333   356677788888888888762     23346777888888888888885    456777888


Q ss_pred             CCCCCEEeCCCCcCCCC----Cccchhc--ccCCceeeecCCcccc----cCcccc-CCCCCCCEEeCCCCcCCCCCc--
Q 002883          367 LKGIQQLDLSENKLSGE----IPTSLAS--CVGLEYLNFSDNSFQG----PIHSGF-SSLKGLQDLDLSRNNFSGKIP--  433 (871)
Q Consensus       367 l~~L~~L~L~~N~l~~~----~~~~~~~--l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~l~~N~l~~~~~--  433 (871)
                      +++|++|+|++|.+++.    ++..+..  +++|++|+|++|+|++    ..+..+ .++++|++|++++|++++..+  
T Consensus       243 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~  322 (386)
T 2ca6_A          243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVV  322 (386)
T ss_dssp             CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHH
T ss_pred             CCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHH
Confidence            88888888888888754    4555533  8889999999999987    355555 668999999999999997664  


Q ss_pred             c-cccccccccEEecCC
Q 002883          434 M-FLNTFRFLQKLNLSF  449 (871)
Q Consensus       434 ~-~~~~~~~L~~L~l~~  449 (871)
                      . ....+++++.+++..
T Consensus       323 ~~l~~~l~~~~~~~l~~  339 (386)
T 2ca6_A          323 DEIREVFSTRGRGELDE  339 (386)
T ss_dssp             HHHHHHHHHHTCCEECC
T ss_pred             HHHHHHhhhcCcchhhh
Confidence            2 233355555555533

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.89  E-value=6.2e-23  Score=223.30  Aligned_cols=239  Identities=21%  Similarity=0.209  Sum_probs=139.6

Q ss_pred             cEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccC-CccccCCCCCcE-EEc
Q 002883          202 EVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSI-PTSVGYLLKLQV-LSL  279 (871)
Q Consensus       202 ~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~-L~L  279 (871)
                      ++++.++++++ .+|..+.   .++++|+|++|+|+.+.+..|.++++|++|+|++|.+.+.+ +.+|.+++++++ +.+
T Consensus        12 ~~v~C~~~~Lt-~iP~~l~---~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             TEEEEESTTCC-SCCTTCC---TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             CEEEecCCCCC-ccCcCcC---CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            45667777776 5565542   45777777777777555566777777777777777765433 345667766554 555


Q ss_pred             cCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCC-CcCCCCCcccccCCC-CCcEEeccCCCCC
Q 002883          280 FGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSD-NNLSGTIPREVIGLS-SFVLLDLSRNHLS  357 (871)
Q Consensus       280 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~ls~N~l~  357 (871)
                      ++|+|+...|+.|..+++|++|++++|+|+...+..+....++..|++.+ |++....+..|.++. .++.|+|++|+|+
T Consensus        88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~  167 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  167 (350)
T ss_dssp             EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence            56777766666777777777777777777755555566666666676644 455544444555543 4566666666666


Q ss_pred             CCCccccCCCCCCCEEeCCC-CcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccc
Q 002883          358 GPIPLEVGRLKGIQQLDLSE-NKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFL  436 (871)
Q Consensus       358 ~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  436 (871)
                       .++.......+|+.|++++ |.++...++.|..+++|++|+|++|+|+.+++..|.++++|+.+++  ++++ .+| .+
T Consensus       168 -~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l  242 (350)
T 4ay9_X          168 -EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TL  242 (350)
T ss_dssp             -EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CT
T ss_pred             -CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-Cc
Confidence             3333333445566666653 4555333345566666666666666666554444433333322221  2233 334 24


Q ss_pred             cccccccEEecCC
Q 002883          437 NTFRFLQKLNLSF  449 (871)
Q Consensus       437 ~~~~~L~~L~l~~  449 (871)
                      ..+++|+.+++++
T Consensus       243 ~~l~~L~~l~l~~  255 (350)
T 4ay9_X          243 EKLVALMEASLTY  255 (350)
T ss_dssp             TTCCSCCEEECSC
T ss_pred             hhCcChhhCcCCC
Confidence            4555555555543

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=1.7e-22  Score=215.46  Aligned_cols=210  Identities=25%  Similarity=0.367  Sum_probs=134.0

Q ss_pred             EEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCcc
Q 002883          228 YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNS  307 (871)
Q Consensus       228 ~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  307 (871)
                      .+.+..+.+++..  .+.++++|+.|++++|.++. ++ .+..+++|++|+|++|++++..+  +..+++|++|+|++|+
T Consensus        23 ~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~   96 (308)
T 1h6u_A           23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP   96 (308)
T ss_dssp             HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred             HHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCc
Confidence            3345555554322  24556677777777777763 33 46667777777777777764333  6677777777777777


Q ss_pred             ccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccc
Q 002883          308 IRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTS  387 (871)
Q Consensus       308 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  387 (871)
                      +++. + .+..+++|+.|++++|++++ ++ .+..+++|++|++++|.+++..+  ++.+++|+.|++++|.+++ ++. 
T Consensus        97 l~~~-~-~~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-  168 (308)
T 1h6u_A           97 LKNV-S-AIAGLQSIKTLDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-  168 (308)
T ss_dssp             CSCC-G-GGTTCTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-
T ss_pred             CCCc-h-hhcCCCCCCEEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-
Confidence            7642 2 46667777777777777764 33 26667777777777777764332  6667777777777777764 333 


Q ss_pred             hhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCccc
Q 002883          388 LASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGE  455 (871)
Q Consensus       388 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~  455 (871)
                      +..+++|+.|++++|++++..+  +..+++|++|++++|++++..+  +..+++|+.|++++|++++.
T Consensus       169 l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~  232 (308)
T 1h6u_A          169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ  232 (308)
T ss_dssp             GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred             hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence            6667777777777777765443  6667777777777777764332  66677777777777777653

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.89  E-value=4.6e-23  Score=224.34  Aligned_cols=250  Identities=19%  Similarity=0.156  Sum_probs=200.5

Q ss_pred             ccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCC-CcccCCCccccE-EEc
Q 002883          226 LIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEI-PSSLGNLIFLTE-VDL  303 (871)
Q Consensus       226 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~-L~L  303 (871)
                      -+.++.++++++ .+|..+  .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+ +..|.++++|++ +.+
T Consensus        11 ~~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X           11 NRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             TTEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             CCEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            357899999999 667666  368999999999999777788999999999999999986544 457899998776 667


Q ss_pred             cCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccC-CCCCCCCccccCCCC-CCCEEeCCCCcCC
Q 002883          304 QGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSR-NHLSGPIPLEVGRLK-GIQQLDLSENKLS  381 (871)
Q Consensus       304 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~-N~l~~~~~~~~~~l~-~L~~L~L~~N~l~  381 (871)
                      ++|+|+.+.|..|..+++|++|++++|+|+...+..+....++..|++++ |.+....+..|..+. .++.|+|++|+|+
T Consensus        88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~  167 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  167 (350)
T ss_dssp             EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence            78999988899999999999999999999977777778888899999966 677755566677765 6899999999999


Q ss_pred             CCCccchhcccCCceeeec-CCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCCc
Q 002883          382 GEIPTSLASCVGLEYLNFS-DNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEG  460 (871)
Q Consensus       382 ~~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~  460 (871)
                      .+ +.......+|++|+++ +|.++.+.+..|.++++|++|||++|+|+...+..+..+++|+.+++  +.++ ..|...
T Consensus       168 ~i-~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP~l~  243 (350)
T 4ay9_X          168 EI-HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPTLE  243 (350)
T ss_dssp             EE-CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCCCTT
T ss_pred             CC-ChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCCCch
Confidence            54 4444456789999997 47888777788999999999999999999666655655554444333  3344 455566


Q ss_pred             ccccccceeccCCCCCccCCCcc
Q 002883          461 VFKNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       461 ~~~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      .+++++.+++ .|++.|.+-..|
T Consensus       244 ~l~~L~~l~l-~~~~~c~~~~~~  265 (350)
T 4ay9_X          244 KLVALMEASL-TYPSHCCAFANW  265 (350)
T ss_dssp             TCCSCCEEEC-SCHHHHHHHHHS
T ss_pred             hCcChhhCcC-CCCccccchhhh
Confidence            7888888887 588889775544

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.89  E-value=5.1e-24  Score=231.03  Aligned_cols=252  Identities=18%  Similarity=0.214  Sum_probs=196.1

Q ss_pred             cccEEEccCCcCcccCChhhhhc-cccccEEEccCCccCCCCCCCCCCccccceeeccccccccc-CCccccCCCCCcEE
Q 002883          200 FLEVVSLSSNSLSGVLPNSIANF-SSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGS-IPTSVGYLLKLQVL  277 (871)
Q Consensus       200 ~L~~L~L~~n~l~~~~~~~~~~~-~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L  277 (871)
                      .++.+++++|.+.   +..+..+ ..+++.|++++|.+++..+. +..+++|++|++++|.+++. .+..+..+++|++|
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L  123 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL  123 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred             hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence            4788899988876   3444444 14699999999999866554 56789999999999998855 67778889999999


Q ss_pred             EccCCCCCCCCCcccCCCccccEEEccCc-ccccc-CcccccCCCCCCEEecCCC-cCCCC-CcccccCCC-CCcEEecc
Q 002883          278 SLFGNKISGEIPSSLGNLIFLTEVDLQGN-SIRGS-IPSALGNCLQLQKLDLSDN-NLSGT-IPREVIGLS-SFVLLDLS  352 (871)
Q Consensus       278 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~ls  352 (871)
                      +|++|++++..+..++.+++|++|+|++| .+++. ++..+.++++|++|++++| .+++. ++..+..++ +|++|+++
T Consensus       124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~  203 (336)
T 2ast_B          124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS  203 (336)
T ss_dssp             ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred             eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence            99999988777888888999999999999 67642 5666788899999999999 88753 566778888 99999999


Q ss_pred             CC--CCC-CCCccccCCCCCCCEEeCCCCc-CCCCCccchhcccCCceeeecCCc-ccccCccccCCCCCCCEEeCCCCc
Q 002883          353 RN--HLS-GPIPLEVGRLKGIQQLDLSENK-LSGEIPTSLASCVGLEYLNFSDNS-FQGPIHSGFSSLKGLQDLDLSRNN  427 (871)
Q Consensus       353 ~N--~l~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l~~N~  427 (871)
                      +|  .++ +.++..+..+++|+.|++++|. +++..+..+..+++|++|++++|. +.......+..+++|+.|++++| 
T Consensus       204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-  282 (336)
T 2ast_B          204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-  282 (336)
T ss_dssp             SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred             CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence            99  454 3456677788999999999998 776777788888999999999985 33332335778899999999988 


Q ss_pred             CCCCCccccccc-ccccEEecCCCcCcccCCCC
Q 002883          428 FSGKIPMFLNTF-RFLQKLNLSFNNLEGEVPSE  459 (871)
Q Consensus       428 l~~~~~~~~~~~-~~L~~L~l~~N~l~~~~~~~  459 (871)
                      ++   ...+..+ .+++.|++++|.+++..|..
T Consensus       283 i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~  312 (336)
T 2ast_B          283 VP---DGTLQLLKEALPHLQINCSHFTTIARPT  312 (336)
T ss_dssp             SC---TTCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred             cC---HHHHHHHHhhCcceEEecccCccccCCc
Confidence            44   2233444 34777778999998877654

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.88  E-value=1e-23  Score=228.74  Aligned_cols=236  Identities=19%  Similarity=0.242  Sum_probs=120.3

Q ss_pred             ccCC--CcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCccc-CChhhhhccccccEEEccCCccCCCCC
Q 002883          165 LGKL--KNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGV-LPNSIANFSSHLIYLYMSANRISGTIP  241 (871)
Q Consensus       165 ~~~l--~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~~~~~L~~L~L~~n~i~~~~~  241 (871)
                      +..+  ++++.|++++|.+....       ..+..+++|++|+|++|.+++. ++..+..+ ++|++|+|++|++++..+
T Consensus        64 ~~~~~~~~l~~L~l~~n~l~~~~-------~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~-~~L~~L~L~~~~l~~~~~  135 (336)
T 2ast_B           64 TGRLLSQGVIAFRCPRSFMDQPL-------AEHFSPFRVQHMDLSNSVIEVSTLHGILSQC-SKLQNLSLEGLRLSDPIV  135 (336)
T ss_dssp             HHHHHHTTCSEEECTTCEECSCC-------CSCCCCBCCCEEECTTCEECHHHHHHHHTTB-CCCSEEECTTCBCCHHHH
T ss_pred             HHhhhhccceEEEcCCccccccc-------hhhccCCCCCEEEccCCCcCHHHHHHHHhhC-CCCCEEeCcCcccCHHHH
Confidence            4444  55666666666555432       1233456666666666666533 44444444 356666666666655555


Q ss_pred             CCCCCccccceeecccc-ccccc-CCccccCCCCCcEEEccCC-CCCCC-CCcccCCCc-cccEEEccCcc--cc-ccCc
Q 002883          242 TGVGNLKNLILIAMEVN-LLTGS-IPTSVGYLLKLQVLSLFGN-KISGE-IPSSLGNLI-FLTEVDLQGNS--IR-GSIP  313 (871)
Q Consensus       242 ~~~~~l~~L~~L~l~~N-~l~~~-~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~-~L~~L~L~~N~--i~-~~~~  313 (871)
                      ..++.+++|++|++++| .+++. .+..+..+++|++|+|++| .+++. .+..+..++ +|++|+|++|.  ++ +.++
T Consensus       136 ~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~  215 (336)
T 2ast_B          136 NTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLS  215 (336)
T ss_dssp             HHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHH
T ss_pred             HHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHH
Confidence            55555666666666665 44431 3344555666666666666 55532 344455555 66666666663  32 2334


Q ss_pred             ccccCCCCCCEEecCCCc-CCCCCcccccCCCCCcEEeccCCC-CCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcc
Q 002883          314 SALGNCLQLQKLDLSDNN-LSGTIPREVIGLSSFVLLDLSRNH-LSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASC  391 (871)
Q Consensus       314 ~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  391 (871)
                      ..+..+++|+.|++++|. +++..+..+..+++|++|++++|. +.......++.+++|+.|++++| ++   ...+..+
T Consensus       216 ~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l  291 (336)
T 2ast_B          216 TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLL  291 (336)
T ss_dssp             HHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHH
T ss_pred             HHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHH
Confidence            444555566666666665 444444455555555555555553 22111123445555555555555 32   1122222


Q ss_pred             -cCCceeeecCCcccccCcccc
Q 002883          392 -VGLEYLNFSDNSFQGPIHSGF  412 (871)
Q Consensus       392 -~~L~~L~L~~N~l~~~~~~~~  412 (871)
                       .+|..|++++|++++..|..+
T Consensus       292 ~~~l~~L~l~~n~l~~~~~~~~  313 (336)
T 2ast_B          292 KEALPHLQINCSHFTTIARPTI  313 (336)
T ss_dssp             HHHSTTSEESCCCSCCTTCSSC
T ss_pred             HhhCcceEEecccCccccCCcc
Confidence             124444455555554444443

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=1.3e-22  Score=212.48  Aligned_cols=150  Identities=20%  Similarity=0.125  Sum_probs=119.3

Q ss_pred             HHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc------------------chHHHHHHHHHHHHcCCC
Q 002883          554 LLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR------------------GASKSFIAECEALRSIRH  615 (871)
Q Consensus       554 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h  615 (871)
                      +......|.+.+.||+|+||.||+|++ .+++.||+|+++....                  .....+.+|++++++++|
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~  163 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG  163 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence            334455677889999999999999999 6899999999954321                  124568899999999984


Q ss_pred             CccceeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 002883          616 RNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC  695 (871)
Q Consensus       616 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  695 (871)
                         +++.+++..      +..|+||||++|++|.+ +..             .....++.|++.||.|||+.   ||+||
T Consensus       164 ---~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~~-------------~~~~~i~~qi~~~l~~lH~~---giiHr  217 (282)
T 1zar_A          164 ---LAVPKVYAW------EGNAVLMELIDAKELYR-VRV-------------ENPDEVLDMILEEVAKFYHR---GIVHG  217 (282)
T ss_dssp             ---SSSCCEEEE------ETTEEEEECCCCEEGGG-CCC-------------SCHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             ---CCcCeEEec------cceEEEEEecCCCcHHH-cch-------------hhHHHHHHHHHHHHHHHHHC---CCEeC
Confidence               555554422      44699999999999998 421             12346999999999999999   99999


Q ss_pred             CCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCccccc
Q 002883          696 DLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA  747 (871)
Q Consensus       696 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  747 (871)
                      ||||+|||++ ++.+||+|||+|..                +..|+|||++.
T Consensus       218 Dlkp~NILl~-~~~vkl~DFG~a~~----------------~~~~~a~e~l~  252 (282)
T 1zar_A          218 DLSQYNVLVS-EEGIWIIDFPQSVE----------------VGEEGWREILE  252 (282)
T ss_dssp             CCSTTSEEEE-TTEEEECCCTTCEE----------------TTSTTHHHHHH
T ss_pred             CCCHHHEEEE-CCcEEEEECCCCeE----------------CCCCCHHHHHH
Confidence            9999999999 99999999999974                33467888754

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.85  E-value=2e-21  Score=196.03  Aligned_cols=182  Identities=19%  Similarity=0.201  Sum_probs=122.4

Q ss_pred             cEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCc-ccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCC
Q 002883          299 TEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIP-REVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSE  377 (871)
Q Consensus       299 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~  377 (871)
                      +.+++++|.++ .+|..+.  ..++.|+|++|+|++..+ ..|..+++|+.|+|++|.|++..+..|..+++|++|+|++
T Consensus        14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            35555555555 2343332  334566666666664433 3456666666666666666655555677777777777777


Q ss_pred             CcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCC
Q 002883          378 NKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVP  457 (871)
Q Consensus       378 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~  457 (871)
                      |++++..+..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|+|++..|..+..+++|+.|+|++|+|.|.++
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            77776666677778888888888888887777888888888888888888887778888888888888888888888776


Q ss_pred             CCcccccccceeccCCCCCccCCCcc
Q 002883          458 SEGVFKNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       458 ~~~~~~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      ..+....++...+...+..|..|...
T Consensus       171 l~~l~~~~~~~~~~~~~~~C~~P~~l  196 (220)
T 2v70_A          171 LAWLGEWLRKKRIVTGNPRCQKPYFL  196 (220)
T ss_dssp             GHHHHHHHHHSCCBCCCCEEEESGGG
T ss_pred             hHHHHHHHHhcCccccCCccCCChHH
Confidence            44332223222232333467777654

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.85  E-value=2.4e-21  Score=195.49  Aligned_cols=182  Identities=20%  Similarity=0.251  Sum_probs=113.4

Q ss_pred             cEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCC
Q 002883          299 TEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSEN  378 (871)
Q Consensus       299 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N  378 (871)
                      +.+++++|.++ .+|..+.  ++|+.|++++|+|++..+..|..+++|+.|+|++|.|++..|..|..+++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            34455555554 3333332  45556666666665544555556666666666666666555666666666666777777


Q ss_pred             cCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCC
Q 002883          379 KLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPS  458 (871)
Q Consensus       379 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~  458 (871)
                      +|+...+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|+|.|.+..
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l  170 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL  170 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCcc
Confidence            66655555566777777777777777777777777777888888888888777677777788888888888888876653


Q ss_pred             CcccccccceeccCCCCCccCCCcc
Q 002883          459 EGVFKNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       459 ~~~~~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      .+....+....+......|..|...
T Consensus       171 ~~l~~~l~~~~~~~~~~~C~~P~~l  195 (220)
T 2v9t_B          171 KWLADYLHTNPIETSGARCTSPRRL  195 (220)
T ss_dssp             HHHHHHHHHCCCBCSCCBEEESGGG
T ss_pred             HHHHHHHHhCCCCccCCCcCCchHH
Confidence            3222222222233344556666544

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=6.5e-21  Score=190.90  Aligned_cols=151  Identities=21%  Similarity=0.198  Sum_probs=74.0

Q ss_pred             cEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccC
Q 002883          202 EVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFG  281 (871)
Q Consensus       202 ~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~  281 (871)
                      +.++++++.++ .+|..+.   ++|++|++++|++++..+..|..+++|++|++++|.+++..+..|..+++|++|+|++
T Consensus        10 ~~v~c~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~   85 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGIP---AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST   85 (208)
T ss_dssp             TEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEecCCCcc-CCCCCCC---CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence            34555555554 3343322   2456666666666544444455555555555555555544444445555555555555


Q ss_pred             CCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCC
Q 002883          282 NKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHL  356 (871)
Q Consensus       282 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l  356 (871)
                      |++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|++++|++++..+..+..+++|+.|++++|.+
T Consensus        86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  160 (208)
T 2o6s_A           86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW  160 (208)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCB
T ss_pred             CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCe
Confidence            555543334444555555555555555544444444444555555555544433333344444444444444433

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=1.3e-20  Score=188.62  Aligned_cols=178  Identities=23%  Similarity=0.247  Sum_probs=90.9

Q ss_pred             cEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCc
Q 002883          227 IYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGN  306 (871)
Q Consensus       227 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  306 (871)
                      +.++++++.++ .+|..+  .++|++|++++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus        10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n   86 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN   86 (208)
T ss_dssp             TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence            45666666665 333322  235555666666555444444555555555555555555444444555555555555555


Q ss_pred             cccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCcc
Q 002883          307 SIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPT  386 (871)
Q Consensus       307 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  386 (871)
                      ++++..+..|..+++|++|++++|+|++..+..|..+++|++|++++|.+++..+..+..+++|+.|++++|.+.+    
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~----  162 (208)
T 2o6s_A           87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC----  162 (208)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred             cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence            5554444445555555555555555554444444555555555555555554333344455555555555554432    


Q ss_pred             chhcccCCceeeecCCcccccCccccCC
Q 002883          387 SLASCVGLEYLNFSDNSFQGPIHSGFSS  414 (871)
Q Consensus       387 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~  414 (871)
                         .+++|+.|+++.|++++.+|..++.
T Consensus       163 ---~~~~l~~L~~~~n~~~g~ip~~~~~  187 (208)
T 2o6s_A          163 ---TCPGIRYLSEWINKHSGVVRNSAGS  187 (208)
T ss_dssp             ---CTTTTHHHHHHHHHCTTTBBCTTSS
T ss_pred             ---CCCCHHHHHHHHHhCCceeeccCcc
Confidence               1234444444444444444444443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=1.2e-20  Score=215.40  Aligned_cols=188  Identities=22%  Similarity=0.341  Sum_probs=100.9

Q ss_pred             cccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEcc
Q 002883          225 HLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQ  304 (871)
Q Consensus       225 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  304 (871)
                      +|+.|+|++|+|++ +|..+.  ++|+.|+|++|.|+ .+|   ..+++|++|+|++|+|++ +|. +.+  +|+.|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            34445555554443 333221  44555555555554 233   234555555555555553 343 333  56666666


Q ss_pred             CccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCC
Q 002883          305 GNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEI  384 (871)
Q Consensus       305 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  384 (871)
                      +|+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|++|+|++|.|++ +|. |.  ++|+.|+|++|+|+ .+
T Consensus       129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l  195 (571)
T 3cvr_A          129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL  195 (571)
T ss_dssp             SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred             CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence            666654 333   35566666666666653 333   34566666666666663 444 44  56666666666666 44


Q ss_pred             ccchhcccCC-------ceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccc
Q 002883          385 PTSLASCVGL-------EYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFR  440 (871)
Q Consensus       385 ~~~~~~l~~L-------~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~  440 (871)
                      |. |..  +|       +.|+|++|+|+. +|..+..+++|+.|+|++|++++.+|..+..+.
T Consensus       196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~  254 (571)
T 3cvr_A          196 PA-VPV--RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQT  254 (571)
T ss_dssp             CC-CC----------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred             hh-HHH--hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence            44 433  44       666677666663 444444566777777777777666666655543

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.84  E-value=9e-21  Score=207.04  Aligned_cols=180  Identities=23%  Similarity=0.207  Sum_probs=110.5

Q ss_pred             cEEEccCCCCCCCCCcccCCCccccEEEccCccccccCccccc-CCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccC
Q 002883          275 QVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALG-NCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSR  353 (871)
Q Consensus       275 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  353 (871)
                      +.+++++|+++ .+|..+.  ..++.|+|++|+|++..+..|. ++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            34555555555 3343332  2355566666666555555554 566666666666666655555566666666666666


Q ss_pred             CCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCcccc---CCCCCCCEEeCCCCcCCC
Q 002883          354 NHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGF---SSLKGLQDLDLSRNNFSG  430 (871)
Q Consensus       354 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~l~~N~l~~  430 (871)
                      |+|+...+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+++.+..|   ..+++|+.|+|++|+|++
T Consensus        98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            66654445556666666666666666665556666666777777777777766555555   457778888888888876


Q ss_pred             CCcccccccccc--cEEecCCCcCcccCC
Q 002883          431 KIPMFLNTFRFL--QKLNLSFNNLEGEVP  457 (871)
Q Consensus       431 ~~~~~~~~~~~L--~~L~l~~N~l~~~~~  457 (871)
                      ..+..+..++.+  +.|+|++|+|.|.+.
T Consensus       178 l~~~~~~~l~~~~l~~l~l~~N~~~C~C~  206 (361)
T 2xot_A          178 LPLTDLQKLPAWVKNGLYLHNNPLECDCK  206 (361)
T ss_dssp             CCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred             cCHHHhhhccHhhcceEEecCCCccCCcC
Confidence            666667666663  667777777776553

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.83  E-value=1e-20  Score=199.76  Aligned_cols=171  Identities=25%  Similarity=0.299  Sum_probs=90.1

Q ss_pred             CCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEE
Q 002883          270 YLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLL  349 (871)
Q Consensus       270 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  349 (871)
                      .+++|+.|++++|.++. ++ .+..+++|++|+|++|++++..+  +..+++|+.|++++|++++ ++ .+..+++|++|
T Consensus        44 ~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L  117 (291)
T 1h6t_A           44 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL  117 (291)
T ss_dssp             HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred             hcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence            34444444444444442 22 24444444444444444443222  4445555555555555542 22 24555555555


Q ss_pred             eccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCC
Q 002883          350 DLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFS  429 (871)
Q Consensus       350 ~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  429 (871)
                      ++++|++++.  ..+..+++|+.|++++|++++.  ..+..+++|++|+|++|++++..+  +..+++|+.|++++|+++
T Consensus       118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~  191 (291)
T 1h6t_A          118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS  191 (291)
T ss_dssp             ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence            5555555532  2455555666666666666532  445566666666666666665443  566666666666666666


Q ss_pred             CCCcccccccccccEEecCCCcCcc
Q 002883          430 GKIPMFLNTFRFLQKLNLSFNNLEG  454 (871)
Q Consensus       430 ~~~~~~~~~~~~L~~L~l~~N~l~~  454 (871)
                      + ++ .+..+++|+.|++++|+++.
T Consensus       192 ~-l~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          192 D-LR-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             B-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred             C-Ch-hhccCCCCCEEECcCCcccC
Confidence            3 33 25666666666666666654

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.83  E-value=1.2e-20  Score=205.90  Aligned_cols=181  Identities=24%  Similarity=0.194  Sum_probs=156.5

Q ss_pred             ccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCccccc-CCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCC
Q 002883          298 LTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLS  376 (871)
Q Consensus       298 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~  376 (871)
                      -+.+++++|.++ .+|..+.  +.++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..+..|..+++|++|+|+
T Consensus        20 ~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           20 SNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             TTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence            368999999999 5676554  5689999999999987777787 99999999999999997777889999999999999


Q ss_pred             CCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccc---cccccccEEecCCCcCc
Q 002883          377 ENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFL---NTFRFLQKLNLSFNNLE  453 (871)
Q Consensus       377 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~---~~~~~L~~L~l~~N~l~  453 (871)
                      +|+|++..+..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|+|++..+..+   ..+++|+.|+|++|+|+
T Consensus        97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~  176 (361)
T 2xot_A           97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK  176 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred             CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence            999998878889999999999999999999999999999999999999999997666666   67999999999999999


Q ss_pred             ccCCCC-ccccc--ccceeccCCCCCccCCC
Q 002883          454 GEVPSE-GVFKN--VRAVSIIGNNKLCGGSP  481 (871)
Q Consensus       454 ~~~~~~-~~~~~--l~~l~l~~N~~~C~~~~  481 (871)
                      ..++.. ..++.  ++.+++.+|||.|+|..
T Consensus       177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l  207 (361)
T 2xot_A          177 KLPLTDLQKLPAWVKNGLYLHNNPLECDCKL  207 (361)
T ss_dssp             CCCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred             ccCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence            755422 22333  36799999999999864

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.83  E-value=1.4e-20  Score=217.53  Aligned_cols=190  Identities=25%  Similarity=0.347  Sum_probs=106.9

Q ss_pred             ccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccC
Q 002883          226 LIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQG  305 (871)
Q Consensus       226 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  305 (871)
                      +..+.++.+.+.+..+  +..|++|+.|++++|.|... + .+..+++|+.|+|++|+|++..+  +..+++|+.|+|++
T Consensus        23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~   96 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE   96 (605)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred             HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence            3334444444443222  34455555555555555522 2 35555666666666666653332  55566666666666


Q ss_pred             ccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCc
Q 002883          306 NSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIP  385 (871)
Q Consensus       306 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  385 (871)
                      |+|++ ++ .+..+++|+.|+|++|+|++ + ..+..+++|+.|+|++|.+++.  ..++.+++|+.|+|++|.|++..|
T Consensus        97 N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~  170 (605)
T 1m9s_A           97 NKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP  170 (605)
T ss_dssp             SCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred             CCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence            66653 22 45566666666666666653 2 2355566666666666666533  455666666666666666664433


Q ss_pred             cchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCC
Q 002883          386 TSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGK  431 (871)
Q Consensus       386 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  431 (871)
                        +..+++|+.|+|++|+|+++  ..+..+++|+.|+|++|++++.
T Consensus       171 --l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          171 --LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK  212 (605)
T ss_dssp             --GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred             --hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence              66666666666666666643  2466666666666666666643

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.83  E-value=6.4e-20  Score=209.50  Aligned_cols=188  Identities=21%  Similarity=0.281  Sum_probs=159.1

Q ss_pred             CCCCcc-----ccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCccccc
Q 002883          243 GVGNLK-----NLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALG  317 (871)
Q Consensus       243 ~~~~l~-----~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~  317 (871)
                      .+.+++     +|+.|+|++|.+++ +|..+  .++|++|+|++|+|+ .+|   ..+++|+.|+|++|+|++ +|. +.
T Consensus        49 ~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~  119 (571)
T 3cvr_A           49 AVSLLKECLINQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LP  119 (571)
T ss_dssp             HHHHHHHHHHTTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CC
T ss_pred             hhhhccccccCCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hh
Confidence            355555     89999999999996 66655  378999999999999 566   557999999999999996 666 66


Q ss_pred             CCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCcee
Q 002883          318 NCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYL  397 (871)
Q Consensus       318 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  397 (871)
                      .  +|+.|+|++|+|++ +|.   .+++|+.|+|++|.|++ +|.   .+++|+.|+|++|+|++ +|. |.  ++|+.|
T Consensus       120 ~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L  185 (571)
T 3cvr_A          120 A--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEAL  185 (571)
T ss_dssp             T--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEE
T ss_pred             c--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEE
Confidence            5  99999999999996 665   68999999999999995 565   57899999999999995 666 65  899999


Q ss_pred             eecCCcccccCccccCCCCCC-------CEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCC
Q 002883          398 NFSDNSFQGPIHSGFSSLKGL-------QDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPS  458 (871)
Q Consensus       398 ~L~~N~l~~~~~~~~~~l~~L-------~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~  458 (871)
                      +|++|+|+.+ |. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|++++..|.
T Consensus       186 ~Ls~N~L~~l-p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~  248 (571)
T 3cvr_A          186 DVSTNLLESL-PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE  248 (571)
T ss_dssp             ECCSSCCSSC-CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred             ECcCCCCCch-hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence            9999999954 44 554  77       99999999999 5788788899999999999999987664

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.82  E-value=3.7e-20  Score=195.38  Aligned_cols=171  Identities=26%  Similarity=0.362  Sum_probs=88.3

Q ss_pred             CccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEE
Q 002883          246 NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKL  325 (871)
Q Consensus       246 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  325 (871)
                      .+++|+.|++++|.++..  ..+..+++|++|+|++|++++..+  +..+++|++|+|++|++++ ++ .+..+++|+.|
T Consensus        44 ~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L  117 (291)
T 1h6t_A           44 ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL  117 (291)
T ss_dssp             HHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred             hcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence            344444444444444422  124444555555555555543222  4555555555555555542 22 25555555555


Q ss_pred             ecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCccc
Q 002883          326 DLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQ  405 (871)
Q Consensus       326 ~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  405 (871)
                      ++++|++++.  ..+..+++|+.|++++|.+++.  ..++.+++|+.|++++|++++..+  +..+++|++|+|++|+|+
T Consensus       118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~  191 (291)
T 1h6t_A          118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS  191 (291)
T ss_dssp             ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence            5555555532  2355555555555555555532  345556666666666666653322  555666666666666665


Q ss_pred             ccCccccCCCCCCCEEeCCCCcCCC
Q 002883          406 GPIHSGFSSLKGLQDLDLSRNNFSG  430 (871)
Q Consensus       406 ~~~~~~~~~l~~L~~L~l~~N~l~~  430 (871)
                      +. + .+..+++|+.|++++|+++.
T Consensus       192 ~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          192 DL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             BC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             CC-h-hhccCCCCCEEECcCCcccC
Confidence            43 2 25666666666666666654

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.82  E-value=7.3e-20  Score=184.53  Aligned_cols=153  Identities=28%  Similarity=0.376  Sum_probs=95.4

Q ss_pred             cEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCC
Q 002883          275 QVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRN  354 (871)
Q Consensus       275 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N  354 (871)
                      +.++++++.++ .+|..+.  ++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            34555555555 3343332  45556666666665555555666666666666666666555566666666666666666


Q ss_pred             CCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCC
Q 002883          355 HLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSG  430 (871)
Q Consensus       355 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  430 (871)
                      .|+...+..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|++..
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            6664444445666666666677776666666667677777777777777776666667777777777777777764

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.81  E-value=1.2e-19  Score=182.99  Aligned_cols=156  Identities=20%  Similarity=0.256  Sum_probs=106.6

Q ss_pred             cEEEccCCCCCCCCCcccCCCccccEEEccCccccccCc-ccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccC
Q 002883          275 QVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIP-SALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSR  353 (871)
Q Consensus       275 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  353 (871)
                      +.+++++|.++ .+|..+.  ..+++|+|++|+|++..+ ..|..+++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus        14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            35666666665 3444332  234566666666665433 3466667777777777777666666677777777777777


Q ss_pred             CCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCc
Q 002883          354 NHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP  433 (871)
Q Consensus       354 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  433 (871)
                      |.+++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|.+++..+
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            77776666667777777777777777776667777777777777787777777777777788888888888888775443

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.81  E-value=6.6e-20  Score=211.94  Aligned_cols=196  Identities=23%  Similarity=0.272  Sum_probs=171.4

Q ss_pred             CccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEE
Q 002883          246 NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKL  325 (871)
Q Consensus       246 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  325 (871)
                      .+.++..+.+..+.+....  .+..+++|+.|++++|.|.. ++ .+..+++|+.|+|++|+|++..+  +..+++|+.|
T Consensus        19 ~l~~l~~l~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L   92 (605)
T 1m9s_A           19 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWL   92 (605)
T ss_dssp             HHHHHHHHHTTCSCTTSEE--CHHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEE
T ss_pred             HHHHHHHHhccCCCccccc--chhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEE
Confidence            3566777888888888543  35789999999999999984 44 58999999999999999996655  8999999999


Q ss_pred             ecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCccc
Q 002883          326 DLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQ  405 (871)
Q Consensus       326 ~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  405 (871)
                      +|++|.|++ ++ .+..+++|+.|+|++|.+++ + ..+..+++|+.|+|++|.+++.  ..+..+++|+.|+|++|+|+
T Consensus        93 ~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~  166 (605)
T 1m9s_A           93 FLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS  166 (605)
T ss_dssp             ECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCC
T ss_pred             ECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCC
Confidence            999999984 44 78999999999999999995 3 4689999999999999999954  67999999999999999999


Q ss_pred             ccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCC
Q 002883          406 GPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVP  457 (871)
Q Consensus       406 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~  457 (871)
                      +..+  +..+++|+.|+|++|+|++. | .+..+++|+.|+|++|++++.+.
T Consensus       167 ~~~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~~p~  214 (605)
T 1m9s_A          167 DIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNKPI  214 (605)
T ss_dssp             CCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEECCCC
T ss_pred             Cchh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcCCcc
Confidence            8766  99999999999999999954 4 68999999999999999987643

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.80  E-value=3.4e-19  Score=180.95  Aligned_cols=155  Identities=23%  Similarity=0.212  Sum_probs=89.3

Q ss_pred             cEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCC
Q 002883          299 TEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSEN  378 (871)
Q Consensus       299 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N  378 (871)
                      +.++.++++++ .+|..+.  ++|+.|+|++|+|++..|..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|
T Consensus        22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N   98 (229)
T 3e6j_A           22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN   98 (229)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence            34445555544 3333222  45555555555555444555555555555555555555333444555566666666666


Q ss_pred             cCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCC
Q 002883          379 KLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVP  457 (871)
Q Consensus       379 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~  457 (871)
                      +|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..+..+++|+.|++++|++.|.++
T Consensus        99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A           99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            665444455556666666666666666 345555666666666666666665555566666777777777777776654

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.80  E-value=1.4e-18  Score=176.45  Aligned_cols=156  Identities=21%  Similarity=0.271  Sum_probs=114.6

Q ss_pred             CcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccC
Q 002883          274 LQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSR  353 (871)
Q Consensus       274 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  353 (871)
                      -+.++.+++.++ .+|..+.  ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+...+..|..+++|+.|+|++
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            455666666666 4444332  5677777777777766666677777777777777777655555667777777777777


Q ss_pred             CCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCc
Q 002883          354 NHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP  433 (871)
Q Consensus       354 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  433 (871)
                      |+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.+..+
T Consensus        98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A           98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            7777655666777888888888888887 677778888888888888888887777778888889999999998886543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.78  E-value=6.2e-21  Score=219.34  Aligned_cols=204  Identities=22%  Similarity=0.211  Sum_probs=111.9

Q ss_pred             cCCCcCceeeCCCCcccccCCccccCCcccceeeccCcc-------------ccCCCCccccccccccccc-cccccccC
Q 002883           35 GNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENS-------------LSGNIPSELGLLKQLNMFQ-VSANYLTG  100 (871)
Q Consensus        35 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~-------------l~~~~~~~~~~l~~L~~L~-l~~n~l~~  100 (871)
                      ..+++|+.|+|++|+++ .+|++++++++|+.|++++|.             +.+..|..++.+++|+.|+ ++.|.+. 
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-  423 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-  423 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence            45566666666666666 566666666666666665554             2334444555555555555 4444332 


Q ss_pred             CCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEeccccc
Q 002883          101 SIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNN  180 (871)
Q Consensus       101 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~  180 (871)
                                +|..+.+++|.+. .+|.      ..|+.|+|++|.|+           .+|.                 
T Consensus       424 ----------~L~~l~l~~n~i~-~l~~------~~L~~L~Ls~n~l~-----------~lp~-----------------  458 (567)
T 1dce_A          424 ----------DLRSKFLLENSVL-KMEY------ADVRVLHLAHKDLT-----------VLCH-----------------  458 (567)
T ss_dssp             ----------HHHHHHHHHHHHH-HHHH------TTCSEEECTTSCCS-----------SCCC-----------------
T ss_pred             ----------hhhhhhhhccccc-ccCc------cCceEEEecCCCCC-----------CCcC-----------------
Confidence                      2333444444443 1211      12445555555444           2332                 


Q ss_pred             CCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccc
Q 002883          181 LGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLL  260 (871)
Q Consensus       181 l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l  260 (871)
                                    +..+++|++|+|++|.|+ .+|..+..+ ++|+.|+|++|+|++ +| .++++++|+.|+|++|.|
T Consensus       459 --------------~~~l~~L~~L~Ls~N~l~-~lp~~~~~l-~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l  520 (567)
T 1dce_A          459 --------------LEQLLLVTHLDLSHNRLR-ALPPALAAL-RCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRL  520 (567)
T ss_dssp             --------------GGGGTTCCEEECCSSCCC-CCCGGGGGC-TTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCC
T ss_pred             --------------ccccccCcEeecCccccc-ccchhhhcC-CCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCC
Confidence                          344455555555555555 455555555 346666666666664 34 566666666666666666


Q ss_pred             cccC-CccccCCCCCcEEEccCCCCCCCCCcc---cCCCccccEEEc
Q 002883          261 TGSI-PTSVGYLLKLQVLSLFGNKISGEIPSS---LGNLIFLTEVDL  303 (871)
Q Consensus       261 ~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~---~~~l~~L~~L~L  303 (871)
                      ++.. |..|+.+++|+.|+|++|++++..+..   +..+++|+.|++
T Consensus       521 ~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          521 QQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             CSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             CCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence            6554 666777777777777777776433321   223566666653

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.78  E-value=4.3e-19  Score=174.81  Aligned_cols=157  Identities=24%  Similarity=0.326  Sum_probs=76.2

Q ss_pred             CEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCcc-ccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecC
Q 002883          323 QKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPL-EVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSD  401 (871)
Q Consensus       323 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  401 (871)
                      +.+++++|+++ .+|..+..  +|++|++++|.+++..+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            34444444443 33333221  444455555544433322 244555555555555555544455555555555555555


Q ss_pred             CcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCCcccccccceeccCCCCCccCCC
Q 002883          402 NSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSP  481 (871)
Q Consensus       402 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~C~~~~  481 (871)
                      |+|++..+..|..+++|++|+|++|+|++..|..+..+++|++|+|++|+|+|.++..+....++...+.++...|+.|+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~  167 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS  167 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence            55555555555555555555555555555555555555555555555555555544322222233333344444555444


Q ss_pred             c
Q 002883          482 E  482 (871)
Q Consensus       482 ~  482 (871)
                      .
T Consensus       168 ~  168 (192)
T 1w8a_A          168 K  168 (192)
T ss_dssp             T
T ss_pred             H
Confidence            3

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.78  E-value=2.9e-19  Score=185.48  Aligned_cols=167  Identities=22%  Similarity=0.260  Sum_probs=76.2

Q ss_pred             cccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEec
Q 002883          248 KNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDL  327 (871)
Q Consensus       248 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  327 (871)
                      .++..+++++|.+++..  .+..+++|+.|++++|+|+ .++ .+..+++|++|+|++|+|++..+  +..+++|+.|+|
T Consensus        19 ~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L   92 (263)
T 1xeu_A           19 ANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV   92 (263)
T ss_dssp             HHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred             HHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence            33444444444444221  3444455555555555554 222 34445555555555555553322  455555555555


Q ss_pred             CCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCccccc
Q 002883          328 SDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP  407 (871)
Q Consensus       328 ~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  407 (871)
                      ++|++++ +|.. .. ++|+.|++++|++++ ++ .+..+++|+.|+|++|++++. + .+..+++|++|+|++|+|++.
T Consensus        93 ~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~  165 (263)
T 1xeu_A           93 NRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT  165 (263)
T ss_dssp             CSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred             CCCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence            5555542 2211 11 445555555555442 22 344455555555555555422 2 344444455555555544433


Q ss_pred             CccccCCCCCCCEEeCCCCcCC
Q 002883          408 IHSGFSSLKGLQDLDLSRNNFS  429 (871)
Q Consensus       408 ~~~~~~~l~~L~~L~l~~N~l~  429 (871)
                        ..+..+++|+.|++++|+++
T Consensus       166 --~~l~~l~~L~~L~l~~N~~~  185 (263)
T 1xeu_A          166 --GGLTRLKKVNWIDLTGQKCV  185 (263)
T ss_dssp             --TTSTTCCCCCEEEEEEEEEE
T ss_pred             --HHhccCCCCCEEeCCCCccc
Confidence              33444444444444444444

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.77  E-value=2.3e-19  Score=186.16  Aligned_cols=167  Identities=18%  Similarity=0.298  Sum_probs=113.6

Q ss_pred             ccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccC
Q 002883          226 LIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQG  305 (871)
Q Consensus       226 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  305 (871)
                      +..+++++|.+++..  .+..+++|+.|++++|.++. ++ .+..+++|++|+|++|+|++..+  +..+++|++|+|++
T Consensus        21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~   94 (263)
T 1xeu_A           21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR   94 (263)
T ss_dssp             HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred             HHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence            555566666665332  45666666666666666663 33 56667777777777777774333  77777777777777


Q ss_pred             ccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCc
Q 002883          306 NSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIP  385 (871)
Q Consensus       306 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  385 (871)
                      |++++. +. +.. ++|+.|+|++|++++ ++ .+..+++|+.|++++|++++. + .++.+++|+.|+|++|++++.  
T Consensus        95 N~l~~l-~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--  165 (263)
T 1xeu_A           95 NRLKNL-NG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--  165 (263)
T ss_dssp             SCCSCC-TT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--
T ss_pred             CccCCc-Cc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--
Confidence            777643 32 222 777777777777774 33 477777888888888887743 3 577788888888888888754  


Q ss_pred             cchhcccCCceeeecCCccccc
Q 002883          386 TSLASCVGLEYLNFSDNSFQGP  407 (871)
Q Consensus       386 ~~~~~l~~L~~L~L~~N~l~~~  407 (871)
                      ..+..+++|+.|++++|++...
T Consensus       166 ~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          166 GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             TTSTTCCCCCEEEEEEEEEECC
T ss_pred             HHhccCCCCCEEeCCCCcccCC
Confidence            5677788888888888888754

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.77  E-value=2.1e-19  Score=185.87  Aligned_cols=138  Identities=19%  Similarity=0.155  Sum_probs=107.7

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcE--EEEEEeeccccc------------------------hHHHHHHHHHHHHcC
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETN--VAVKVLDLQQRG------------------------ASKSFIAECEALRSI  613 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  613 (871)
                      -|++.+.||+|+||.||+|.+..+|+.  ||||+++.....                        ....+.+|+++++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999999667888  999997533111                        113678999999999


Q ss_pred             CCCcc--ceeeeeecccCcCCCceeeEEEeccCC-C----CHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHh-
Q 002883          614 RHRNL--VKIITSCSSIDTRGNEFKALVYEFMPN-G----SLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH-  685 (871)
Q Consensus       614 ~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-  685 (871)
                      .|+++  +.++++         ...++||||+.+ |    +|.++...          .++..+..++.|++.|+.||| 
T Consensus       128 ~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~----------~~~~~~~~i~~qi~~~l~~lH~  188 (258)
T 1zth_A          128 KEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE----------LKELDVEGIFNDVVENVKRLYQ  188 (258)
T ss_dssp             HHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG----------GGGSCHHHHHHHHHHHHHHHHH
T ss_pred             HhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc----------cChHHHHHHHHHHHHHHHHHHH
Confidence            88754  334432         235899999942 3    67766532          224457789999999999999 


Q ss_pred             hcCCCCeEecCCCCCceeeCCCCceEEeecccceec
Q 002883          686 HHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL  721 (871)
Q Consensus       686 ~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  721 (871)
                      +.   ||+||||||+|||++.  .++|+|||+|...
T Consensus       189 ~~---givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          189 EA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            88   9999999999999988  9999999999764

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.77  E-value=1.2e-18  Score=172.56  Aligned_cols=153  Identities=16%  Similarity=0.220  Sum_probs=95.5

Q ss_pred             CCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCE
Q 002883          245 GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQK  324 (871)
Q Consensus       245 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  324 (871)
                      +.+++|+.|++++|.++ .++ .+..+++|++|++++|.++  .+..+..+++|++|++++|++++..+..|+.+++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            55566666666666666 333 4666666777777766554  2235666667777777777766555666666777777


Q ss_pred             EecCCCcCCCCCcccccCCCCCcEEeccCCC-CCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCc
Q 002883          325 LDLSDNNLSGTIPREVIGLSSFVLLDLSRNH-LSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNS  403 (871)
Q Consensus       325 L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  403 (871)
                      |++++|++++..+..+..+++|++|++++|. ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|++|++++|+
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence            7777777765556666666667777777666 54 334 46666677777777776663 33 56666666666666666


Q ss_pred             cc
Q 002883          404 FQ  405 (871)
Q Consensus       404 l~  405 (871)
                      |.
T Consensus       193 i~  194 (197)
T 4ezg_A          193 IG  194 (197)
T ss_dssp             --
T ss_pred             cC
Confidence            64

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.77  E-value=3e-21  Score=221.93  Aligned_cols=217  Identities=20%  Similarity=0.154  Sum_probs=122.3

Q ss_pred             cCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCc
Q 002883          196 VNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQ  275 (871)
Q Consensus       196 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  275 (871)
                      ..+++|+.|+|++|+++ .+|..+..+. +|+.|++++|......|          . .+..+.+.+..|..++.+++|+
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~-~L~~L~l~~n~~l~~l~----------~-ll~~~~~~~~~~~~l~~l~~L~  412 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCK-ELQELEPENKWCLLTII----------L-LMRALDPLLYEKETLQYFSTLK  412 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHH-HHHHHCTTCHHHHHHHH----------H-HHHHHCTGGGHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHH-HHHHhccccchhhhhHH----------H-HHHhcccccCCHHHHHHHHhcc
Confidence            44566666777777665 5666666663 46666665543110000          0 0011112234445555555555


Q ss_pred             EEE-ccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCC
Q 002883          276 VLS-LFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRN  354 (871)
Q Consensus       276 ~L~-L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N  354 (871)
                      .|+ ++.|.+           ..|+.+.+++|.|+...+      ..|+.|+|++|+|++ +|. +..+++|+.|+|++|
T Consensus       413 ~L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N  473 (567)
T 1dce_A          413 AVDPMRAAYL-----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHN  473 (567)
T ss_dssp             HHCGGGHHHH-----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSS
T ss_pred             cCcchhhccc-----------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCcc
Confidence            555 444432           234445555555553222      136666666666663 444 666666666666666


Q ss_pred             CCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccC-ccccCCCCCCCEEeCCCCcCCCCCc
Q 002883          355 HLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPI-HSGFSSLKGLQDLDLSRNNFSGKIP  433 (871)
Q Consensus       355 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~  433 (871)
                      .|+ .+|..++.+++|+.|+|++|+|++ +| .+..+++|+.|+|++|+|++.. |..|..+++|+.|+|++|++++.+|
T Consensus       474 ~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          474 RLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             CCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             ccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            666 556666666666666666666663 45 5666666666666666666655 6666666777777777777665443


Q ss_pred             c---cccccccccEEec
Q 002883          434 M---FLNTFRFLQKLNL  447 (871)
Q Consensus       434 ~---~~~~~~~L~~L~l  447 (871)
                      .   .+..+++|+.|++
T Consensus       551 ~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          551 IQERLAEMLPSVSSILT  567 (567)
T ss_dssp             CTTHHHHHCTTCSEEEC
T ss_pred             HHHHHHHHCcccCccCC
Confidence            2   2333666666653

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.77  E-value=9.7e-19  Score=173.24  Aligned_cols=152  Identities=16%  Similarity=0.268  Sum_probs=81.8

Q ss_pred             cCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcE
Q 002883          269 GYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVL  348 (871)
Q Consensus       269 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  348 (871)
                      +.+++|+.|++++|.++ .+| .+..+++|++|++++|.++ . +..+..+++|++|++++|++++..+..+..+++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            55666777777777776 344 4666666666666666554 2 234556666666666666665444555555555555


Q ss_pred             EeccCCCCCCCCccccCCCCCCCEEeCCCCc-CCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCc
Q 002883          349 LDLSRNHLSGPIPLEVGRLKGIQQLDLSENK-LSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNN  427 (871)
Q Consensus       349 L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  427 (871)
                      |++++|.+++..+..++.+++|++|++++|+ ++ .+| .+..+++|++|++++|++++..  .+..+++|++|++++|+
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC-
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcc
Confidence            5555555554445555555555555555554 43 222 3444444444444444444321  34444444444444444


Q ss_pred             C
Q 002883          428 F  428 (871)
Q Consensus       428 l  428 (871)
                      +
T Consensus       193 i  193 (197)
T 4ezg_A          193 I  193 (197)
T ss_dssp             -
T ss_pred             c
Confidence            3

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.76  E-value=2.8e-19  Score=212.28  Aligned_cols=196  Identities=21%  Similarity=0.204  Sum_probs=116.9

Q ss_pred             CcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEE
Q 002883          199 TFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLS  278 (871)
Q Consensus       199 ~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  278 (871)
                      +.++.|+|.+|.+.. .+..      .|+.++|+.|.|.              .+++..|.+. ..++.|..+++|+.|+
T Consensus       173 ~~~~~l~L~~n~~~~-~~~~------~l~~l~Ls~~~i~--------------~~~~~~n~~~-~~~~~~~~l~~L~~L~  230 (727)
T 4b8c_D          173 PLTPKIELFANGKDE-ANQA------LLQHKKLSQYSID--------------EDDDIENRMV-MPKDSKYDDQLWHALD  230 (727)
T ss_dssp             -----------------------------------------------------------------------CCCCCCEEE
T ss_pred             CccceEEeeCCCCCc-chhh------HhhcCccCccccc--------------Ccccccccee-cChhhhccCCCCcEEE
Confidence            446666666666653 2221      2555666666655              2344556666 6677888888899999


Q ss_pred             ccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCC
Q 002883          279 LFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSG  358 (871)
Q Consensus       279 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  358 (871)
                      |++|.+. .+|..+..+++|++|+|++|.|+ .+|..|+++++|+.|+|++|+|+ .+|..|..+++|++|+|++|.|+ 
T Consensus       231 Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-  306 (727)
T 4b8c_D          231 LSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-  306 (727)
T ss_dssp             CTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-
T ss_pred             CCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-
Confidence            9999988 66767778889999999999998 77888899999999999999998 77888999999999999999998 


Q ss_pred             CCccccCCCCCCCEEeCCCCcCCCCCccchhcccC-CceeeecCCcccccCccccCCCCCCCEEeCCCC
Q 002883          359 PIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVG-LEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRN  426 (871)
Q Consensus       359 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  426 (871)
                      .+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|.      .|+.|++++|
T Consensus       307 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n  369 (727)
T 4b8c_D          307 TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTD  369 (727)
T ss_dssp             CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C---------
T ss_pred             ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecc
Confidence            67878999999999999999999888888766532 34578999999877665      4556677776

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.76  E-value=1.1e-18  Score=188.11  Aligned_cols=132  Identities=11%  Similarity=0.048  Sum_probs=70.1

Q ss_pred             cccCccCcC--CCCCCEEecCCCcccccCCccccC-CCcCceeeCCCCccc--ccCCccccCCcccceeeccCccccCCC
Q 002883            4 GEIPANITH--CSELRILDLVVNKLEGNIPSELGN-LFKLVGLGLTGNNYT--GSIPQSLSNLSFLQQLSLSENSLSGNI   78 (871)
Q Consensus         4 ~~~p~~~~~--l~~L~~L~l~~n~i~~~~~~~~~~-l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~Ls~n~l~~~~   78 (871)
                      |+++..+..  +.+++.|.++++ +....-..+.. +++|++|+|++|+|.  ...+.   .++.+..+.+..|.|.   
T Consensus        13 g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I~---   85 (329)
T 3sb4_A           13 GTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFVP---   85 (329)
T ss_dssp             TCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEEC---
T ss_pred             CcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccc---cccccccccccccccC---
Confidence            444444443  556777777654 22122223333 566777777777766  22222   2222455555555332   


Q ss_pred             Cccccc--------cccccccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccC
Q 002883           79 PSELGL--------LKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGS  144 (871)
Q Consensus        79 ~~~~~~--------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~  144 (871)
                      +..|.+        +++|+.|+|.+ .++...+..|.++++|+.+++++|.+. .++...|....++..+.+..
T Consensus        86 ~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~-~i~~~aF~~~~~l~~l~~~~  157 (329)
T 3sb4_A           86 AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAP-NLLPEALADSVTAIFIPLGS  157 (329)
T ss_dssp             TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCC-EECTTSSCTTTCEEEECTTC
T ss_pred             HHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCcc-ccchhhhcCCCceEEecCcc
Confidence            345556        67777777766 565444455666666666666666665 55555555544444444433

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.75  E-value=5.8e-18  Score=166.69  Aligned_cols=178  Identities=26%  Similarity=0.344  Sum_probs=118.7

Q ss_pred             cEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcc-cccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCC
Q 002883          299 TEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPR-EVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSE  377 (871)
Q Consensus       299 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~  377 (871)
                      +.+++++|+++ .+|..+.  .+|++|++++|+|++..+. .|..+++|++|+|++|.|++..|..|..+++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            45566666665 3444333  2666666666666644443 366677777777777777766677777777777777777


Q ss_pred             CcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCC
Q 002883          378 NKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVP  457 (871)
Q Consensus       378 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~  457 (871)
                      |+|++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|++++..+.. +-...++...+.++...|..|
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~-~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcch-HHHHHHHHcCCCCCCCCCCCC
Confidence            7777767777777888888888888888877888888888888888888888655421 111224444566777776666


Q ss_pred             CCcccccccceeccCCCCCccCCCc
Q 002883          458 SEGVFKNVRAVSIIGNNKLCGGSPE  482 (871)
Q Consensus       458 ~~~~~~~l~~l~l~~N~~~C~~~~~  482 (871)
                      ..  +......++..+...|....+
T Consensus       167 ~~--l~~~~l~~l~~~~~~C~~~~~  189 (192)
T 1w8a_A          167 SK--VRDVQIKDLPHSEFKCSSENS  189 (192)
T ss_dssp             TT--TTTSBGGGSCTTTCCCCCC--
T ss_pred             hH--HcCCChhhCcHhhcCcCCCCC
Confidence            43  455555667778788876543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.74  E-value=6.8e-18  Score=166.07  Aligned_cols=159  Identities=23%  Similarity=0.236  Sum_probs=119.3

Q ss_pred             CEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCC
Q 002883          323 QKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDN  402 (871)
Q Consensus       323 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  402 (871)
                      +.+++++|+++ .+|..+.  ++|++|++++|.|+ .+|..|..+++|+.|+|++|.|++..+..|..+++|++|+|++|
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            46777777776 4555443  57778888888887 66677888888888888888888777778888888888888888


Q ss_pred             cccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCCcccccccceeccCCCCCccCCCc
Q 002883          403 SFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPE  482 (871)
Q Consensus       403 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~C~~~~~  482 (871)
                      +|+++.+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|.|.+...+....+.......+...|..|+.
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~~~~~~~~~~~~~~C~~P~~  168 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSDWVKSEYKEPGIARCAGPGE  168 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHHHHHSSCCCSCCBEEESGG
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHHHHHHHhccCCCCCcCcCCchH
Confidence            88888888888999999999999999877677788899999999999999987764332222222222334456877766


Q ss_pred             ccc
Q 002883          483 LHL  485 (871)
Q Consensus       483 ~~~  485 (871)
                      ..+
T Consensus       169 l~g  171 (193)
T 2wfh_A          169 MAD  171 (193)
T ss_dssp             GTT
T ss_pred             HCC
Confidence            543

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.74  E-value=1.1e-18  Score=188.06  Aligned_cols=196  Identities=11%  Similarity=0.054  Sum_probs=112.9

Q ss_pred             ccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccc----cccCcccccCCCCC
Q 002883          247 LKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSI----RGSIPSALGNCLQL  322 (871)
Q Consensus       247 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i----~~~~~~~~~~l~~L  322 (871)
                      +++|+.|+|.+ .++.+...+|.++++|+.|++++|.+..+.+..|.++.++..+.+..+..    ......+|.++.+|
T Consensus       100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L  178 (329)
T 3sb4_A          100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL  178 (329)
T ss_dssp             CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred             cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence            66666666666 55555556666666666666666666555556666665555555544322    11223334444444


Q ss_pred             C--------------------------EEecCCCcCCCCCcccc-cCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeC
Q 002883          323 Q--------------------------KLDLSDNNLSGTIPREV-IGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDL  375 (871)
Q Consensus       323 ~--------------------------~L~L~~N~l~~~~~~~~-~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L  375 (871)
                      +                          .+.+.++-.. .....+ ..+++|+.|+|++|.++...+..|..+.+|+.|+|
T Consensus       179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l  257 (329)
T 3sb4_A          179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKL  257 (329)
T ss_dssp             EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred             ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence            4                          3333222111 111111 12566777777766666555556666777777777


Q ss_pred             CCCcCCCCCccchhcccCCc-eeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEe
Q 002883          376 SENKLSGEIPTSLASCVGLE-YLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLN  446 (871)
Q Consensus       376 ~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~  446 (871)
                      .+| ++.+.+.+|.+|.+|+ .+++.+ .++.+.+.+|.++++|+.+++++|+++...+..|..+++|+.++
T Consensus       258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          258 PHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             CTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             Ccc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence            666 5555566667777776 777766 56656666677777777777766767666666666666666665

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.73  E-value=1.2e-18  Score=206.71  Aligned_cols=192  Identities=22%  Similarity=0.231  Sum_probs=87.9

Q ss_pred             CCCCEEecCCCcccccCCccccCCCcCcee-----eCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccc
Q 002883           14 SELRILDLVVNKLEGNIPSELGNLFKLVGL-----GLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQL   88 (871)
Q Consensus        14 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L-----~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L   88 (871)
                      +.++.|+|++|.+.. .+..+....+|..+     +++.|++. ..|+.|..+.+|+.|+|++|.+. .+|..+..+++|
T Consensus       173 ~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L  249 (727)
T 4b8c_D          173 PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL  249 (727)
T ss_dssp             ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred             CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence            446677777777763 34443222222222     22223333 34455555555555555555555 445444455555


Q ss_pred             cccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCC
Q 002883           89 NMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKL  168 (871)
Q Consensus        89 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l  168 (871)
                      ++|+|++|.|+ .+|..|.                         .+++|+.|+|++|.|+           .+|..|+.+
T Consensus       250 ~~L~Ls~N~l~-~lp~~~~-------------------------~l~~L~~L~Ls~N~l~-----------~lp~~~~~l  292 (727)
T 4b8c_D          250 TRLYLNGNSLT-ELPAEIK-------------------------NLSNLRVLDLSHNRLT-----------SLPAELGSC  292 (727)
T ss_dssp             SCCBCTTSCCS-CCCGGGG-------------------------GGTTCCEEECTTSCCS-----------SCCSSGGGG
T ss_pred             CEEEeeCCcCc-ccChhhh-------------------------CCCCCCEEeCcCCcCC-----------ccChhhcCC
Confidence            55555555555 4444443                         5556666666666655           455666677


Q ss_pred             CcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCcc
Q 002883          169 KNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLK  248 (871)
Q Consensus       169 ~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~  248 (871)
                      ++|++|+|++|.|+.++       ..|..+++|++|+|++|.+++.+|..+......+..|+|++|.+++.+|.      
T Consensus       293 ~~L~~L~L~~N~l~~lp-------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------  359 (727)
T 4b8c_D          293 FQLKYFYFFDNMVTTLP-------WEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------  359 (727)
T ss_dssp             TTCSEEECCSSCCCCCC-------SSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------
T ss_pred             CCCCEEECCCCCCCccC-------hhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------
Confidence            77777777777776543       34667788888888888888777777766543345577888888876664      


Q ss_pred             ccceeecccc
Q 002883          249 NLILIAMEVN  258 (871)
Q Consensus       249 ~L~~L~l~~N  258 (871)
                      .|..|+++.|
T Consensus       360 ~l~~l~l~~n  369 (727)
T 4b8c_D          360 ERRFIEINTD  369 (727)
T ss_dssp             C---------
T ss_pred             ccceeEeecc
Confidence            3445556555

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.68  E-value=1.3e-16  Score=157.00  Aligned_cols=133  Identities=20%  Similarity=0.273  Sum_probs=120.7

Q ss_pred             cEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCC
Q 002883          347 VLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRN  426 (871)
Q Consensus       347 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  426 (871)
                      +.+++++|.++ .+|..+.  ++|+.|+|++|.|+ .+|..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            57999999999 6776553  68999999999999 78899999999999999999999999999999999999999999


Q ss_pred             cCCCCCcccccccccccEEecCCCcCcccCCC-CcccccccceeccCCCCCccCCCcc
Q 002883          427 NFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPS-EGVFKNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       427 ~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~-~~~~~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      +|++..|..|..+++|+.|+|++|+++..++. ...+++++.+++.+|+|.|+|...|
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~  146 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQW  146 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHH
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHH
Confidence            99998888999999999999999999987764 3567889999999999999997654

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.68  E-value=6.8e-16  Score=169.57  Aligned_cols=241  Identities=10%  Similarity=0.059  Sum_probs=152.7

Q ss_pred             cccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEc
Q 002883          200 FLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSL  279 (871)
Q Consensus       200 ~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L  279 (871)
                      +|+.+.+..| ++.....+|..  .+|+.+.+.+ .++.+...+|.++++|+.++++.|.++.+...+|. ..+|+.+.|
T Consensus       136 ~L~~i~l~~~-i~~I~~~aF~~--~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~l  210 (401)
T 4fdw_A          136 QIAKVVLNEG-LKSIGDMAFFN--STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLL  210 (401)
T ss_dssp             CCSEEECCTT-CCEECTTTTTT--CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEEC
T ss_pred             CccEEEeCCC-ccEECHHhcCC--CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEe
Confidence            4666666655 54343444444  2477777764 55556666777777777777777777765556665 467777777


Q ss_pred             cCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCC--
Q 002883          280 FGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLS--  357 (871)
Q Consensus       280 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~--  357 (871)
                      ..+ ++.+....|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .+.++.+...+|.++++|+.+++.+|.+.  
T Consensus       211 p~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~  286 (401)
T 4fdw_A          211 PVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDD  286 (401)
T ss_dssp             CTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCC
T ss_pred             CCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCC
Confidence            643 55556666777777777777664 44455566666 66777777 34455455666777777777777666553  


Q ss_pred             ---CCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcc
Q 002883          358 ---GPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPM  434 (871)
Q Consensus       358 ---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  434 (871)
                         ...+..|..+++|+.++|.+ .++.+...+|.+|.+|+.+.|..| ++.+...+|.++ +|+.+++++|.+....+.
T Consensus       287 ~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~  363 (401)
T 4fdw_A          287 PEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEK  363 (401)
T ss_dssp             TTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCS
T ss_pred             cccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccc
Confidence               24455666777777777763 355555666777777777777444 555666677777 777777777766655555


Q ss_pred             cccccc-cccEEecCCCcC
Q 002883          435 FLNTFR-FLQKLNLSFNNL  452 (871)
Q Consensus       435 ~~~~~~-~L~~L~l~~N~l  452 (871)
                      .|..++ +++.|++..|.+
T Consensus       364 ~F~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          364 VWYGFPDDITVIRVPAESV  382 (401)
T ss_dssp             SCCCSCTTCCEEEECGGGH
T ss_pred             cccCCCCCccEEEeCHHHH
Confidence            566553 556666655543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.67  E-value=1.7e-16  Score=152.61  Aligned_cols=134  Identities=19%  Similarity=0.206  Sum_probs=86.2

Q ss_pred             CCCCEEecCCCcCC-CCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceee
Q 002883          320 LQLQKLDLSDNNLS-GTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLN  398 (871)
Q Consensus       320 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  398 (871)
                      ++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++.  ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            45566666666655 44555555566666666666666533  4566666666666666666655666666677777777


Q ss_pred             ecCCcccccCc-cccCCCCCCCEEeCCCCcCCCCCc---ccccccccccEEecCCCcCccc
Q 002883          399 FSDNSFQGPIH-SGFSSLKGLQDLDLSRNNFSGKIP---MFLNTFRFLQKLNLSFNNLEGE  455 (871)
Q Consensus       399 L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~~~~L~~L~l~~N~l~~~  455 (871)
                      |++|+|++... ..+..+++|++|++++|++++..+   ..+..+++|++|++++|.+...
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~  162 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA  162 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence            77777765432 566777777777777777775444   3677777777777777776644

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.66  E-value=2.7e-16  Score=151.21  Aligned_cols=132  Identities=23%  Similarity=0.235  Sum_probs=74.9

Q ss_pred             CCCcEEEccCCCCC-CCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEe
Q 002883          272 LKLQVLSLFGNKIS-GEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLD  350 (871)
Q Consensus       272 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  350 (871)
                      ++|+.|+|++|+++ +.+|..+..+++|+.|+|++|.|++.  ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            45666666666665 34555556666666666666666543  4555666666666666666644555555556666666


Q ss_pred             ccCCCCCCCC-ccccCCCCCCCEEeCCCCcCCCCCc---cchhcccCCceeeecCCccc
Q 002883          351 LSRNHLSGPI-PLEVGRLKGIQQLDLSENKLSGEIP---TSLASCVGLEYLNFSDNSFQ  405 (871)
Q Consensus       351 ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~  405 (871)
                      +++|.+++.. +..+..+++|+.|++++|++++..+   ..+..+++|++|++++|.+.
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            6666665321 1455556666666666666653333   24555555555555555554

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.65  E-value=5.8e-16  Score=150.32  Aligned_cols=133  Identities=22%  Similarity=0.279  Sum_probs=95.0

Q ss_pred             CCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecC
Q 002883          322 LQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSD  401 (871)
Q Consensus       322 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  401 (871)
                      .+.+++++|+++ .+|..+.  ++|+.|++++|.+++..+..+..+++|++|++++|.+++..+..|..+++|++|+|++
T Consensus         9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            355666666666 3443332  5667777777777655555567777777777777777765556677777788888888


Q ss_pred             CcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCC
Q 002883          402 NSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVP  457 (871)
Q Consensus       402 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~  457 (871)
                      |+|++..+..|..+++|++|++++|++++..+..+..+++|++|++++|+++|.+|
T Consensus        86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            88877777777778888888888888886666667778888888888888887665

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.64  E-value=3.5e-15  Score=164.81  Aligned_cols=334  Identities=11%  Similarity=0.044  Sum_probs=178.4

Q ss_pred             ccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccccccccccCCCCcc
Q 002883           26 LEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQ  105 (871)
Q Consensus        26 i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  105 (871)
                      ++.....+|.++.+|+.+.|..+ ++.+...+|.++++|+.++|.++ ++.....+|.++++|+.+.+..+ +.......
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a  135 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA  135 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence            44455667777777777777643 66555666777777777777655 44355566777777777766554 33233444


Q ss_pred             ccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCc-cccCCCcccEEecccccCCCC
Q 002883          106 LFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPE-DLGKLKNLIRLNFARNNLGTG  184 (871)
Q Consensus       106 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~-~~~~l~~L~~L~l~~n~l~~~  184 (871)
                      |.+...++........   .+....|....+|+.+.+.++..            .+++ .|.++.+|+.+.+..| ++.+
T Consensus       136 F~~~~~~~~~~~~~~~---~i~~~aF~~c~~L~~i~l~~~~~------------~I~~~~F~~c~~L~~i~l~~~-~~~I  199 (394)
T 4fs7_A          136 FKGCDFKEITIPEGVT---VIGDEAFATCESLEYVSLPDSME------------TLHNGLFSGCGKLKSIKLPRN-LKII  199 (394)
T ss_dssp             TTTCCCSEEECCTTCC---EECTTTTTTCTTCCEEECCTTCC------------EECTTTTTTCTTCCBCCCCTT-CCEE
T ss_pred             eecccccccccCcccc---ccchhhhcccCCCcEEecCCccc------------eeccccccCCCCceEEEcCCC-ceEe
Confidence            5544433322221111   34444555556666666544321            1222 2555555555555443 3332


Q ss_pred             CCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccC
Q 002883          185 KGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSI  264 (871)
Q Consensus       185 ~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~  264 (871)
                      ..      ..+.++..|+.+.+..+...                           +...+....+|+.+.+..+ ++.+.
T Consensus       200 ~~------~~F~~~~~L~~i~~~~~~~~---------------------------i~~~~~~~~~l~~i~ip~~-~~~i~  245 (394)
T 4fs7_A          200 RD------YCFAECILLENMEFPNSLYY---------------------------LGDFALSKTGVKNIIIPDS-FTELG  245 (394)
T ss_dssp             CT------TTTTTCTTCCBCCCCTTCCE---------------------------ECTTTTTTCCCCEEEECTT-CCEEC
T ss_pred             Cc------hhhccccccceeecCCCceE---------------------------eehhhcccCCCceEEECCC-ceecc
Confidence            22      22334444544444443322                           1122222334444444322 22233


Q ss_pred             CccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCC
Q 002883          265 PTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLS  344 (871)
Q Consensus       265 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  344 (871)
                      ..+|..+..|+.+.+..+... .....|..+..++.+....+.+.   ...|..+.+|+.+.+..+ ++.+...+|.+++
T Consensus       246 ~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~  320 (394)
T 4fs7_A          246 KSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCT  320 (394)
T ss_dssp             SSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCT
T ss_pred             cccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCC
Confidence            445555555666666555443 44555556666666655554332   235556666666666544 4434455666666


Q ss_pred             CCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEE
Q 002883          345 SFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDL  421 (871)
Q Consensus       345 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  421 (871)
                      +|+.+++.++ ++.....+|.++.+|+.+++..| ++.+...+|.+|.+|+.+++..+ ++ ....+|.+.++|+.+
T Consensus       321 ~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          321 SLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             TCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             CCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            6666666543 44344556677777777777665 55455667777777777777654 33 224556666666653

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.64  E-value=3.9e-16  Score=146.83  Aligned_cols=127  Identities=20%  Similarity=0.274  Sum_probs=75.5

Q ss_pred             CCCCEEecCCCcCC-CCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceee
Q 002883          320 LQLQKLDLSDNNLS-GTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLN  398 (871)
Q Consensus       320 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  398 (871)
                      ++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++.  ..++.+++|++|++++|.+++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            44555555555554 44455555555555555555555533  4555666666666666666654565555666666666


Q ss_pred             ecCCccccc-CccccCCCCCCCEEeCCCCcCCCCCc---ccccccccccEEecC
Q 002883          399 FSDNSFQGP-IHSGFSSLKGLQDLDLSRNNFSGKIP---MFLNTFRFLQKLNLS  448 (871)
Q Consensus       399 L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~~~~L~~L~l~  448 (871)
                      +++|++++. .+..+..+++|++|++++|++++..+   ..+..+++|+.|+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            666666653 23556666666666666666665444   356666667766665

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.63  E-value=6.6e-15  Score=161.66  Aligned_cols=244  Identities=13%  Similarity=0.082  Sum_probs=202.8

Q ss_pred             CcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEE
Q 002883          199 TFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLS  278 (871)
Q Consensus       199 ~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  278 (871)
                      ..++.+.+.++ ++......|..  .+|+.+.+.+| ++.+...+|.+ .+|+.+.+.. .++.+...+|.++++|+.++
T Consensus       113 ~~l~~i~ip~~-i~~I~~~aF~~--~~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~  186 (401)
T 4fdw_A          113 KGYNEIILPNS-VKSIPKDAFRN--SQIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD  186 (401)
T ss_dssp             SSCSEEECCTT-CCEECTTTTTT--CCCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred             CCccEEEECCc-cCEehHhhccc--CCccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence            55677777653 55344455554  36999999887 77788888988 4799999996 77778889999999999999


Q ss_pred             ccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCC
Q 002883          279 LFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSG  358 (871)
Q Consensus       279 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  358 (871)
                      |++|+++.+....|. ..+|+.+.|..+ ++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+. |.++.
T Consensus       187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~  261 (401)
T 4fdw_A          187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTN  261 (401)
T ss_dssp             CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCE
T ss_pred             cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccE
Confidence            999999966666776 689999999855 77688889999999999999986 56566777877 899999994 55665


Q ss_pred             CCccccCCCCCCCEEeCCCCcCC-----CCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCc
Q 002883          359 PIPLEVGRLKGIQQLDLSENKLS-----GEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP  433 (871)
Q Consensus       359 ~~~~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  433 (871)
                      ....+|..+++|+.+++.+|.+.     ...+..|.+|++|+.++|. |.++.+...+|.++.+|+.++|.+| ++...+
T Consensus       262 I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~  339 (401)
T 4fdw_A          262 IASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINF  339 (401)
T ss_dssp             ECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECT
T ss_pred             EChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcH
Confidence            67889999999999999998875     4677899999999999999 5588888999999999999999655 777778


Q ss_pred             ccccccccccEEecCCCcCcccC
Q 002883          434 MFLNTFRFLQKLNLSFNNLEGEV  456 (871)
Q Consensus       434 ~~~~~~~~L~~L~l~~N~l~~~~  456 (871)
                      ..|..+ +|+.+++++|.+....
T Consensus       340 ~aF~~~-~L~~l~l~~n~~~~l~  361 (401)
T 4fdw_A          340 SAFNNT-GIKEVKVEGTTPPQVF  361 (401)
T ss_dssp             TSSSSS-CCCEEEECCSSCCBCC
T ss_pred             HhCCCC-CCCEEEEcCCCCcccc
Confidence            899999 9999999999876543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.63  E-value=4.4e-16  Score=146.44  Aligned_cols=127  Identities=20%  Similarity=0.209  Sum_probs=67.3

Q ss_pred             CCCcEEEccCCCCC-CCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEe
Q 002883          272 LKLQVLSLFGNKIS-GEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLD  350 (871)
Q Consensus       272 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  350 (871)
                      ++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++.  ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            45666666666665 44555555566666666666666533  4455555566666666655544555554555555555


Q ss_pred             ccCCCCCCC-CccccCCCCCCCEEeCCCCcCCCCCc---cchhcccCCceeeec
Q 002883          351 LSRNHLSGP-IPLEVGRLKGIQQLDLSENKLSGEIP---TSLASCVGLEYLNFS  400 (871)
Q Consensus       351 ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~  400 (871)
                      +++|.+++. .+..++.+++|++|++++|++++..+   ..+..+++|+.|+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            555555531 12445555555555555555553332   244444555554443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.62  E-value=7.6e-15  Score=162.10  Aligned_cols=335  Identities=11%  Similarity=0.030  Sum_probs=204.5

Q ss_pred             ccccCCccccCCcccceeeccCccccCCCCccccccccccccccccccccCCCCccccccCCCceeeeeccccccccccc
Q 002883           50 YTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHY  129 (871)
Q Consensus        50 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  129 (871)
                      ++.+...+|.++.+|+.+.|..+ ++.+...+|.++++|+.+++.++ ++......|.++.+|+.+.+..+ +. .+...
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~-~i~~~  134 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LK-SIGVE  134 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CC-EECTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-ee-eecce
Confidence            44444456667777777777643 55444556666677776666544 33233445555555555544332 11 22222


Q ss_pred             cccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCC
Q 002883          130 VGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSN  209 (871)
Q Consensus       130 ~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n  209 (871)
                      .|                                  .+...+.......  +..+.      -..+.++++|+.+.+.++
T Consensus       135 aF----------------------------------~~~~~~~~~~~~~--~~~i~------~~aF~~c~~L~~i~l~~~  172 (394)
T 4fs7_A          135 AF----------------------------------KGCDFKEITIPEG--VTVIG------DEAFATCESLEYVSLPDS  172 (394)
T ss_dssp             TT----------------------------------TTCCCSEEECCTT--CCEEC------TTTTTTCTTCCEEECCTT
T ss_pred             ee----------------------------------ecccccccccCcc--ccccc------hhhhcccCCCcEEecCCc
Confidence            22                                  2222111111111  11111      134556677777777655


Q ss_pred             cCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCC
Q 002883          210 SLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIP  289 (871)
Q Consensus       210 ~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  289 (871)
                      ..+ .....+... .+|+.+.+..| ++.+....|.++..|+.+.+..+...  +.+.+....+|+.+.+..+- +....
T Consensus       173 ~~~-I~~~~F~~c-~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~  246 (394)
T 4fs7_A          173 MET-LHNGLFSGC-GKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-TELGK  246 (394)
T ss_dssp             CCE-ECTTTTTTC-TTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-CEECS
T ss_pred             cce-eccccccCC-CCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCCc-eeccc
Confidence            332 323333333 45777777665 44466677888888888887776544  23334445678888876543 33556


Q ss_pred             cccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCC
Q 002883          290 SSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKG  369 (871)
Q Consensus       290 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~  369 (871)
                      ..|..+..|+.+.+..+... +....|..+..++.+....+.+.   ...|.+..+|+.+.+.++ ++.....+|..+.+
T Consensus       247 ~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~  321 (394)
T 4fs7_A          247 SVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTS  321 (394)
T ss_dssp             STTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTT
T ss_pred             ccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCC
Confidence            67788888888888777655 66777888888888877766543   346777788888888765 55455667888888


Q ss_pred             CCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEE
Q 002883          370 IQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKL  445 (871)
Q Consensus       370 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L  445 (871)
                      |+.+++.++ ++.+...+|.+|.+|+.+.+..| ++.+...+|.++.+|+.+++..+ ++ .+...|.++++|+.+
T Consensus       322 L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          322 LVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             CCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             CCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            888888654 65566777888888888888766 66677778888888888887644 43 345567777777654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.62  E-value=5e-16  Score=165.92  Aligned_cols=137  Identities=15%  Similarity=0.191  Sum_probs=99.3

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc--------------chHHH--------HHHHHHHHHcCCCCc
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR--------------GASKS--------FIAECEALRSIRHRN  617 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~n  617 (871)
                      =|++.+.||+|+||.||+|.+. +|+.||||+++....              .....        ..+|...+.++.+..
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            3999999999999999999986 799999999753210              00111        234566666664333


Q ss_pred             cc--eeeeeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 002883          618 LV--KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHC  695 (871)
Q Consensus       618 iv--~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  695 (871)
                      +.  ..++.         ...++||||++|++|.++...             .....++.|++.++.|||+.   |||||
T Consensus       175 v~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~-------------~~~~~l~~qll~~l~~lH~~---gIVHr  229 (397)
T 4gyi_A          175 FPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSV-------------PDPASLYADLIALILRLAKH---GLIHG  229 (397)
T ss_dssp             CSCCCEEEE---------ETTEEEEECCSCEEGGGCCCC-------------SCHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             CCCCeeeec---------cCceEEEEecCCccHhhhccc-------------HHHHHHHHHHHHHHHHHHHC---CCcCC
Confidence            22  22221         223799999999887654321             13456889999999999998   99999


Q ss_pred             CCCCCceeeCCCC----------ceEEeecccceecC
Q 002883          696 DLKPSNVLLDNEM----------VAHVGDFGLSRLLH  722 (871)
Q Consensus       696 Dlkp~Nill~~~~----------~~kl~Dfg~a~~~~  722 (871)
                      ||||.|||++.++          .+.|+||+-+....
T Consensus       230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            9999999998776          38999999887543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.62  E-value=2.9e-15  Score=145.36  Aligned_cols=133  Identities=23%  Similarity=0.262  Sum_probs=96.1

Q ss_pred             ccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCC
Q 002883          298 LTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSE  377 (871)
Q Consensus       298 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~  377 (871)
                      .+.+++++|+++ .+|..+.  ++|+.|++++|++++..+..|..+++|++|++++|.+++..+..+..+++|+.|+|++
T Consensus         9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            355666666666 3333332  5677777777777655555666777777777777777755555677788888888888


Q ss_pred             CcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCc
Q 002883          378 NKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP  433 (871)
Q Consensus       378 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  433 (871)
                      |.+++..+..|..+++|++|+|++|+|++..+..|..+++|++|++++|++++..|
T Consensus        86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            88886666667788888888888888887777777888889999999998886544

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.58  E-value=3.1e-15  Score=144.94  Aligned_cols=132  Identities=20%  Similarity=0.221  Sum_probs=84.5

Q ss_pred             ccCCCCCcEEEccCCCCCCCCCcccCCCc-cccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCC
Q 002883          268 VGYLLKLQVLSLFGNKISGEIPSSLGNLI-FLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSF  346 (871)
Q Consensus       268 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  346 (871)
                      +..+.+|+.|++++|+++. ++. +..+. +|+.|+|++|+|++.  ..|..+++|++|++++|+|++..+..+..+++|
T Consensus        15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   90 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   90 (176)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence            4455666666666666663 333 33333 677777777776643  456667777777777777765444445667777


Q ss_pred             cEEeccCCCCCCCCcc--ccCCCCCCCEEeCCCCcCCCCCccc----hhcccCCceeeecCCccc
Q 002883          347 VLLDLSRNHLSGPIPL--EVGRLKGIQQLDLSENKLSGEIPTS----LASCVGLEYLNFSDNSFQ  405 (871)
Q Consensus       347 ~~L~ls~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~  405 (871)
                      ++|++++|.++ .+|.  .+..+++|+.|++++|+++ ..|..    +..+++|+.|++++|.+.
T Consensus        91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            77777777775 3444  5667777777777777776 44443    666777777777777665

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.57  E-value=3.4e-15  Score=144.66  Aligned_cols=135  Identities=19%  Similarity=0.176  Sum_probs=91.5

Q ss_pred             ccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCc
Q 002883          316 LGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLE  395 (871)
Q Consensus       316 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  395 (871)
                      +.++.+|+.|++++|+++ .++......++|++|++++|.+++.  ..++.+++|++|+|++|+|++..+..|..+++|+
T Consensus        15 ~~~~~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   91 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   91 (176)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             cCCcCCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence            455666667777777666 3343222223677777777777643  4677777777777777777755445557777888


Q ss_pred             eeeecCCcccccCc-cccCCCCCCCEEeCCCCcCCCCCcc----cccccccccEEecCCCcCcc
Q 002883          396 YLNFSDNSFQGPIH-SGFSSLKGLQDLDLSRNNFSGKIPM----FLNTFRFLQKLNLSFNNLEG  454 (871)
Q Consensus       396 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~~~~L~~L~l~~N~l~~  454 (871)
                      +|+|++|+|+...+ ..+..+++|+.|++++|+++ ..|.    .+..+++|+.||+++|....
T Consensus        92 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A           92 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             EEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            88888888764332 26777888888888888887 4455    37788888888888887654

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.55  E-value=3.1e-17  Score=162.52  Aligned_cols=133  Identities=23%  Similarity=0.285  Sum_probs=81.5

Q ss_pred             cccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCC
Q 002883          315 ALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGL  394 (871)
Q Consensus       315 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  394 (871)
                      .|..+++|++|++++|++++ +| .+..+++|+.|++++|.++ .+|..+..+++|+.|++++|++++ +| .+..+++|
T Consensus        43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L  117 (198)
T 1ds9_A           43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL  117 (198)
T ss_dssp             HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred             HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence            55556666666666666653 44 5555666666666666665 445555556666666666666663 33 46666677


Q ss_pred             ceeeecCCcccccCc-cccCCCCCCCEEeCCCCcCCCCCcc----------cccccccccEEecCCCcCcc
Q 002883          395 EYLNFSDNSFQGPIH-SGFSSLKGLQDLDLSRNNFSGKIPM----------FLNTFRFLQKLNLSFNNLEG  454 (871)
Q Consensus       395 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~----------~~~~~~~L~~L~l~~N~l~~  454 (871)
                      ++|++++|+|++..+ ..+..+++|++|++++|++++..|.          .+..+++|+.||  +|+++.
T Consensus       118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred             CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence            777777777664333 4566677777777777776654443          266677777765  666553

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.53  E-value=2.4e-14  Score=137.52  Aligned_cols=110  Identities=19%  Similarity=0.212  Sum_probs=82.1

Q ss_pred             CcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCC
Q 002883          346 FVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSR  425 (871)
Q Consensus       346 L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  425 (871)
                      .+.+++++|.++ .+|..+.  ++|+.|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            355666666666 4554442  6677777777777766677777778888888888888877777778888888888888


Q ss_pred             CcCCCCCcccccccccccEEecCCCcCcccCCC
Q 002883          426 NNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPS  458 (871)
Q Consensus       426 N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~  458 (871)
                      |+|++..+..|..+++|+.|+|++|+|+|.++.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~  120 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD  120 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence            888876666788888888888888888887753

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.51  E-value=9.4e-17  Score=159.00  Aligned_cols=64  Identities=27%  Similarity=0.245  Sum_probs=25.1

Q ss_pred             cccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCC
Q 002883          267 SVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLS  333 (871)
Q Consensus       267 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  333 (871)
                      .+..+++|++|+|++|++++ +| .+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++
T Consensus        43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~  106 (198)
T 1ds9_A           43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA  106 (198)
T ss_dssp             HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECC
T ss_pred             HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCC
Confidence            33344444444444444432 22 3333444444444444443 23333333334444444444443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.51  E-value=5.6e-14  Score=135.36  Aligned_cols=108  Identities=22%  Similarity=0.294  Sum_probs=74.1

Q ss_pred             cEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCC
Q 002883          347 VLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRN  426 (871)
Q Consensus       347 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  426 (871)
                      +.+++++|.++ .+|..+.  ++|+.|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            45566666665 4454443  56677777777776666666777777777777777777666666677777777777777


Q ss_pred             cCCCCCcccccccccccEEecCCCcCcccCC
Q 002883          427 NFSGKIPMFLNTFRFLQKLNLSFNNLEGEVP  457 (871)
Q Consensus       427 ~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~  457 (871)
                      +|++..+..+..+++|+.|+|++|+|.+.++
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~  122 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR  122 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence            7776555567777777777777777777654

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.45  E-value=3e-13  Score=129.80  Aligned_cols=108  Identities=23%  Similarity=0.306  Sum_probs=85.6

Q ss_pred             CCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecC
Q 002883          322 LQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSD  401 (871)
Q Consensus       322 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  401 (871)
                      .+.+++++|+++ .+|..+.  ++|++|+|++|.|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            467777777777 4555443  6778888888888876677788888888888888888876677778888888888888


Q ss_pred             CcccccCccccCCCCCCCEEeCCCCcCCCCC
Q 002883          402 NSFQGPIHSGFSSLKGLQDLDLSRNNFSGKI  432 (871)
Q Consensus       402 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  432 (871)
                      |+|+++.+..|..+++|++|+|++|+++...
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  118 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC  118 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence            8888877778888899999999999888543

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.44  E-value=3.1e-12  Score=141.06  Aligned_cols=133  Identities=15%  Similarity=0.302  Sum_probs=65.6

Q ss_pred             CcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCC
Q 002883          289 PSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLK  368 (871)
Q Consensus       289 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~  368 (871)
                      ...|.++.+|+.+.+.++... +...+|.++++|+.+.+. +.++.+....|.++.+|+.+++..+ ++.....+|.++.
T Consensus       258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~  334 (394)
T 4gt6_A          258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE  334 (394)
T ss_dssp             TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred             cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence            344555555555555444332 444455555555555554 2333344445555555666555543 3334445566666


Q ss_pred             CCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcC
Q 002883          369 GIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNF  428 (871)
Q Consensus       369 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  428 (871)
                      +|+.+.+..+ ++.+...+|.+|.+|+.+++.+|....   ..|....+|+.+.+..|.+
T Consensus       335 ~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          335 QLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             TCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             CCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence            6666666543 444555666666666666666665431   3455556666666655543

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.43  E-value=3.9e-13  Score=129.43  Aligned_cols=106  Identities=22%  Similarity=0.285  Sum_probs=82.6

Q ss_pred             CEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCC
Q 002883          323 QKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDN  402 (871)
Q Consensus       323 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  402 (871)
                      +.+++++|+++ .+|..+.  ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            56777777776 5555443  67777888888887666777888888888888888888665666788888888888888


Q ss_pred             cccccCccccCCCCCCCEEeCCCCcCCCC
Q 002883          403 SFQGPIHSGFSSLKGLQDLDLSRNNFSGK  431 (871)
Q Consensus       403 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  431 (871)
                      +|+++.+..|..+++|++|+|++|++...
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence            88877777788888999999999988843

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.38  E-value=2.5e-11  Score=133.87  Aligned_cols=336  Identities=11%  Similarity=0.127  Sum_probs=188.0

Q ss_pred             ccccCCccccCCC-cCceeeCCCCcccccCCccccCCcccceeeccCcc---ccCCCCccccccccccccccccccccCC
Q 002883           26 LEGNIPSELGNLF-KLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENS---LSGNIPSELGLLKQLNMFQVSANYLTGS  101 (871)
Q Consensus        26 i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~---l~~~~~~~~~~l~~L~~L~l~~n~l~~~  101 (871)
                      ++.....+|.+.+ .|+...|..+ ++.+...+|.++.+|+.+.+++|.   ++.....+|..+.+|+.+.+..+ ++..
T Consensus        51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I  128 (394)
T 4gt6_A           51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEI  128 (394)
T ss_dssp             EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEE
T ss_pred             eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-ccee
Confidence            3434456666653 4666666544 554555667777777777776653   44344556667777776666554 3324


Q ss_pred             CCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCcc-ccCCCcccEEeccccc
Q 002883          102 IPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPED-LGKLKNLIRLNFARNN  180 (871)
Q Consensus       102 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~-~~~l~~L~~L~l~~n~  180 (871)
                      ....|.++.+|+.+.+..+.-  .++...+....+|+.+.+..+ ++           .+.+. |. ..+|+.+.+..+-
T Consensus       129 ~~~aF~~c~~L~~i~lp~~~~--~I~~~~F~~c~~L~~i~~~~~-~~-----------~I~~~aF~-~~~l~~i~ip~~~  193 (394)
T 4gt6_A          129 DSEAFHHCEELDTVTIPEGVT--SVADGMFSYCYSLHTVTLPDS-VT-----------AIEERAFT-GTALTQIHIPAKV  193 (394)
T ss_dssp             CTTTTTTCTTCCEEECCTTCC--EECTTTTTTCTTCCEEECCTT-CC-----------EECTTTTT-TCCCSEEEECTTC
T ss_pred             hhhhhhhhcccccccccceee--eecccceecccccccccccce-ee-----------Eecccccc-ccceeEEEECCcc
Confidence            445566677777777654322  566666666777777776554 22           22222 32 2456666665442


Q ss_pred             CCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccc
Q 002883          181 LGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLL  260 (871)
Q Consensus       181 l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l  260 (871)
                      . .+.      ...+..+.+++......+... .....+.........-.           ..+.....+..+.+. +.+
T Consensus       194 ~-~i~------~~af~~c~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~ip-~~v  253 (394)
T 4gt6_A          194 T-RIG------TNAFSECFALSTITSDSESYP-AIDNVLYEKSANGDYAL-----------IRYPSQREDPAFKIP-NGV  253 (394)
T ss_dssp             C-EEC------TTTTTTCTTCCEEEECCSSSC-BSSSCEEEECTTSCEEE-----------EECCTTCCCSEEECC-TTE
T ss_pred             c-ccc------cchhhhccccceecccccccc-cccceeecccccccccc-----------cccccccccceEEcC-Ccc
Confidence            2 211      234556677777776665554 22222211110000000           011112233333333 233


Q ss_pred             cccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccc
Q 002883          261 TGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREV  340 (871)
Q Consensus       261 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  340 (871)
                      +.+...+|.++.+|+.+.+.++... +....|.++.+|+.+.+. +.++.+...+|.++.+|+.+.+..+ ++.+...+|
T Consensus       254 ~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF  330 (394)
T 4gt6_A          254 ARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAF  330 (394)
T ss_dssp             EEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTT
T ss_pred             eEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHh
Confidence            3355566777777777777665544 566677777777777775 4455466667777888888888654 554566677


Q ss_pred             cCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCccc
Q 002883          341 IGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQ  405 (871)
Q Consensus       341 ~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  405 (871)
                      .++.+|+.+.+..+ ++.....+|.++.+|+.+++.+|...   -..+..+.+|+.+.+..|.+.
T Consensus       331 ~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~~~~  391 (394)
T 4gt6_A          331 AGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPGSID  391 (394)
T ss_dssp             TTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH---HHTCBCCCCC-----------
T ss_pred             hCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee---hhhhhccCCCCEEEeCCCCEE
Confidence            78888888888654 55455677888888888888877654   245666778888877766553

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.36  E-value=9.3e-15  Score=158.93  Aligned_cols=66  Identities=17%  Similarity=0.036  Sum_probs=27.4

Q ss_pred             hhcccCCceeeecCCcccccC----ccccCCCCCCCEEeCCCCcCCCCCcccccccc-----cccEEe--cCCCcCc
Q 002883          388 LASCVGLEYLNFSDNSFQGPI----HSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFR-----FLQKLN--LSFNNLE  453 (871)
Q Consensus       388 ~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-----~L~~L~--l~~N~l~  453 (871)
                      +...++|++|+|++|.|++..    ...+...++|++|||++|.|+......+..+.     .|+.+.  +.+|.++
T Consensus       207 L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~  283 (372)
T 3un9_A          207 LDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS  283 (372)
T ss_dssp             GGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred             HhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence            333444555555555544321    22233345566666666665533333332221     155555  5566554

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.36  E-value=9.7e-15  Score=158.78  Aligned_cols=89  Identities=22%  Similarity=0.268  Sum_probs=59.9

Q ss_pred             CCCCCEEeCCCCcCCCC----CccchhcccCCceeeecCCcccccC----ccccCCCCCCCEEeCCCCcCCCC----Ccc
Q 002883          367 LKGIQQLDLSENKLSGE----IPTSLASCVGLEYLNFSDNSFQGPI----HSGFSSLKGLQDLDLSRNNFSGK----IPM  434 (871)
Q Consensus       367 l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~----~~~  434 (871)
                      .++|++|+|++|.|++.    ++..+..+++|++|+|++|.|++..    ...+...++|++|+|++|.|+..    ++.
T Consensus       154 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~  233 (372)
T 3un9_A          154 QCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALAR  233 (372)
T ss_dssp             TCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHH
Confidence            45566666666666532    2333455677777777777776432    44566777899999999988753    334


Q ss_pred             cccccccccEEecCCCcCccc
Q 002883          435 FLNTFRFLQKLNLSFNNLEGE  455 (871)
Q Consensus       435 ~~~~~~~L~~L~l~~N~l~~~  455 (871)
                      .+...++|++|+|++|+|+..
T Consensus       234 ~L~~~~~L~~L~Ls~N~i~~~  254 (372)
T 3un9_A          234 AAREHPSLELLHLYFNELSSE  254 (372)
T ss_dssp             HHHHCSSCCEEECTTSSCCHH
T ss_pred             HHHhCCCCCEEeccCCCCCHH
Confidence            455668899999999988754

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.36  E-value=9.7e-13  Score=142.66  Aligned_cols=103  Identities=21%  Similarity=0.248  Sum_probs=53.7

Q ss_pred             EEecCCC-cCCCCCcccccCCCCCcEEeccC-CCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecC
Q 002883          324 KLDLSDN-NLSGTIPREVIGLSSFVLLDLSR-NHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSD  401 (871)
Q Consensus       324 ~L~L~~N-~l~~~~~~~~~~l~~L~~L~ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  401 (871)
                      .++++++ +|+ .+|. +..+++|+.|+|++ |.|++..+..|..+++|+.|+|++|+|++..|..|..+++|++|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            3455555 555 3444 55555555555553 555544444555555555555555555555555555555555555555


Q ss_pred             CcccccCccccCCCCCCCEEeCCCCcCC
Q 002883          402 NSFQGPIHSGFSSLKGLQDLDLSRNNFS  429 (871)
Q Consensus       402 N~l~~~~~~~~~~l~~L~~L~l~~N~l~  429 (871)
                      |+|+++++..|..++ |+.|+|++|.+.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            555544444444443 555555555554

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.32  E-value=2.8e-12  Score=139.06  Aligned_cols=131  Identities=18%  Similarity=0.140  Sum_probs=80.8

Q ss_pred             EEeccCC-CCCCCCccccCCCCCCCEEeCCC-CcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCC
Q 002883          348 LLDLSRN-HLSGPIPLEVGRLKGIQQLDLSE-NKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSR  425 (871)
Q Consensus       348 ~L~ls~N-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  425 (871)
                      .++++++ .|+ .+|. +..+++|+.|+|++ |.|++..+..|..+++|+.|+|++|+|+++.+..|.++++|+.|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            3566666 666 4555 66677777777774 777766566677777777777777777766666677777777777777


Q ss_pred             CcCCCCCcccccccccccEEecCCCcCcccCCCCcc--cccccceeccCCCCCccCCC
Q 002883          426 NNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGV--FKNVRAVSIIGNNKLCGGSP  481 (871)
Q Consensus       426 N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~--~~~l~~l~l~~N~~~C~~~~  481 (871)
                      |+|++..+..+..++ |+.|+|.+|+|.|.+...+.  +.......+..+...|..+.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            777765555555554 77777777777766542211  11112223344556666554

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.27  E-value=1.3e-11  Score=127.98  Aligned_cols=147  Identities=16%  Similarity=0.092  Sum_probs=112.6

Q ss_pred             HHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCC
Q 002883          555 LKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       555 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  633 (871)
                      .....+|++....+.|+.+.||++...  ++.+++|+...........+.+|+++++.+. +..+.++++++...     
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----   82 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-----   82 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-----
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC-----
Confidence            344567888888999999999999864  6789999986532223346888999999884 67788888876543     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC-------------------------  688 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------  688 (871)
                      +..|+||||++|.++.+....            ......++.+++++++.||+..                         
T Consensus        83 ~~~~lv~e~i~G~~l~~~~~~------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (263)
T 3tm0_A           83 GWSNLLMSEADGVLCSEEYED------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL  150 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHCCT------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred             CceEEEEEecCCeehhhccCC------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence            567999999999999876321            1123467889999999999821                         


Q ss_pred             -------------------------------CCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          689 -------------------------------HTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       689 -------------------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                                                     ...++|||++|.||+++.+..+.|+||+.+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                           13699999999999998766677999998753

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.18  E-value=1.1e-09  Score=120.15  Aligned_cols=316  Identities=12%  Similarity=0.100  Sum_probs=162.2

Q ss_pred             cccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccccccccccCCCCccccccCCC
Q 002883           33 ELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSM  112 (871)
Q Consensus        33 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  112 (871)
                      ++..-.+|+.+.+.. .++.+...+|.++.+|+.++|..+ ++.+...+|.+. +|+.+.+..+ ++ .+....+...+|
T Consensus        41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~-~I~~~aF~~~~L  115 (379)
T 4h09_A           41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VK-KFGDYVFQGTDL  115 (379)
T ss_dssp             TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CC-EECTTTTTTCCC
T ss_pred             ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-ee-EeccceeccCCc
Confidence            344555666666653 345444556666666666666544 443445556555 4555555433 33 233322233466


Q ss_pred             ceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCC-ccccCCCcccEEecccccCCCCCCCCccc
Q 002883          113 DYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIP-EDLGKLKNLIRLNFARNNLGTGKGNDLRF  191 (871)
Q Consensus       113 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  191 (871)
                      +.+.+..+..  .+....+. -.+|+.+.+..+ ++           .+. ..+....+++...+..+..........  
T Consensus       116 ~~i~lp~~~~--~i~~~~F~-~~~l~~~~~~~~-v~-----------~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~--  178 (379)
T 4h09_A          116 DDFEFPGATT--EIGNYIFY-NSSVKRIVIPKS-VT-----------TIKDGIGYKAENLEKIEVSSNNKNYVAENYV--  178 (379)
T ss_dssp             SEEECCTTCC--EECTTTTT-TCCCCEEEECTT-CC-----------EECSCTTTTCTTCCEEEECTTCSSEEEETTE--
T ss_pred             ccccCCCccc--cccccccc-cceeeeeeccce-ee-----------ccccchhcccccccccccccccceeecccce--
Confidence            6666655422  34444442 234444444332 11           111 224555566666555443221110000  


Q ss_pred             cccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCC
Q 002883          192 LDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYL  271 (871)
Q Consensus       192 ~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  271 (871)
                                   ....+.   .....+... ..+..+.+..+.-. .....+...++|+.+.+..+ ++.+...+|..+
T Consensus       179 -------------~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~  239 (379)
T 4h09_A          179 -------------LYNKNK---TILESYPAA-KTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGM  239 (379)
T ss_dssp             -------------EEETTS---SEEEECCTT-CCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTC
T ss_pred             -------------eccccc---ceecccccc-ccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCC
Confidence                         000000   000011111 12333333332222 34455556666666666544 333455566666


Q ss_pred             CCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEec
Q 002883          272 LKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDL  351 (871)
Q Consensus       272 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  351 (871)
                      .+|+.+.+..+ ++.+....|.++.+|+.+.+..+ ++.+...+|.++++|+.+.+.++.++.+....|.++.+|+.+.|
T Consensus       240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l  317 (379)
T 4h09_A          240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTL  317 (379)
T ss_dssp             SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred             ccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEc
Confidence            67777776654 44455566666777777776544 44355566777777777777777666555666777777777777


Q ss_pred             cCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccC
Q 002883          352 SRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVG  393 (871)
Q Consensus       352 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  393 (871)
                      ..+ ++.....+|.++.+|+.+.+..+ ++.+...+|.++..
T Consensus       318 p~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~~  357 (379)
T 4h09_A          318 PTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSSI  357 (379)
T ss_dssp             CTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSSC
T ss_pred             Ccc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCCC
Confidence            654 44345566777777777777654 55455666766643

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.13  E-value=1.9e-09  Score=118.07  Aligned_cols=317  Identities=12%  Similarity=0.103  Sum_probs=221.6

Q ss_pred             cccCCcccceeeccCccccCCCCccccccccccccccccccccCCCCccccccCCCceeeeeccccccccccccccCCCC
Q 002883           57 SLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPN  136 (871)
Q Consensus        57 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~  136 (871)
                      .+....+|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++......|.+. +|+.+.+..+ +. .++...|. ..+
T Consensus        41 ~~~~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~-~I~~~aF~-~~~  114 (379)
T 4h09_A           41 WYKDRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VK-KFGDYVFQ-GTD  114 (379)
T ss_dssp             TGGGGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CC-EECTTTTT-TCC
T ss_pred             ccccccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-ee-Eeccceec-cCC
Confidence            4566788999999864 66567788999999999999765 664555667665 6888877654 33 67777774 458


Q ss_pred             ccEEEccCccCCCCCCccCcCCCCCCcc-ccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccC
Q 002883          137 IRVLLLGSNWFTGEIPPSISNASSIPED-LGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVL  215 (871)
Q Consensus       137 L~~L~l~~n~i~~~~p~~~~~~~~lp~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~  215 (871)
                      |+.+.+..+- +           .+.+. |.. .+|+.+.+-.+ ++.+..      ..+..+.+++.+.+..+......
T Consensus       115 L~~i~lp~~~-~-----------~i~~~~F~~-~~l~~~~~~~~-v~~i~~------~~f~~~~~l~~~~~~~~~~~~~~  174 (379)
T 4h09_A          115 LDDFEFPGAT-T-----------EIGNYIFYN-SSVKRIVIPKS-VTTIKD------GIGYKAENLEKIEVSSNNKNYVA  174 (379)
T ss_dssp             CSEEECCTTC-C-----------EECTTTTTT-CCCCEEEECTT-CCEECS------CTTTTCTTCCEEEECTTCSSEEE
T ss_pred             cccccCCCcc-c-----------ccccccccc-ceeeeeeccce-eecccc------chhcccccccccccccccceeec
Confidence            9999887652 2           22222 332 35666555433 333322      34567788888887776554211


Q ss_pred             ChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCC
Q 002883          216 PNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNL  295 (871)
Q Consensus       216 ~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  295 (871)
                       ......         ..+.   .....+....++..+.+..+.-. .....+....+|+.+.+..+ +.......|.++
T Consensus       175 -~~~~~~---------~~~~---~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~  239 (379)
T 4h09_A          175 -ENYVLY---------NKNK---TILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGM  239 (379)
T ss_dssp             -ETTEEE---------ETTS---SEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTC
T ss_pred             -ccceec---------cccc---ceeccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCC
Confidence             111100         1111   12233445556666666554433 55677888889999999766 444667788999


Q ss_pred             ccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeC
Q 002883          296 IFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDL  375 (871)
Q Consensus       296 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L  375 (871)
                      ..|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++......|.++++|+.+.+.++.++.....+|.++.+|+.+.|
T Consensus       240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l  317 (379)
T 4h09_A          240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTL  317 (379)
T ss_dssp             SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred             ccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEc
Confidence            99999999876 66577788999999999999765 55466778999999999999999888667788999999999999


Q ss_pred             CCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCC
Q 002883          376 SENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGL  418 (871)
Q Consensus       376 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  418 (871)
                      ..+ ++.+...+|.+|.+|+.+.+..+ ++.+...+|.+...+
T Consensus       318 p~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~~~  358 (379)
T 4h09_A          318 PTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSSIT  358 (379)
T ss_dssp             CTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSSCC
T ss_pred             Ccc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCCCC
Confidence            765 66567788999999999999765 777778888876543

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.00  E-value=5.6e-10  Score=115.46  Aligned_cols=138  Identities=15%  Similarity=0.075  Sum_probs=96.7

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCc--cceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRN--LVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~  636 (871)
                      .+|.+....+.|..+.||++... +|+.+++|+....   ....+.+|+++++.+.+.+  +.+++++....     +..
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~~~   90 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRD   90 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCE
T ss_pred             CCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----CCC
Confidence            34555443346667999999764 6778999997543   2245778999998885434  55677765432     457


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC----------------------------  688 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------  688 (871)
                      ++||||++|.++.  ...          .+   ...++.++++.+..||+..                            
T Consensus        91 ~~v~e~i~G~~l~--~~~----------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--SSH----------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQ  155 (264)
T ss_dssp             EEEEECCSSEETT--TSC----------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCT
T ss_pred             EEEEEecCCcccC--cCc----------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccc
Confidence            9999999998874  211          11   1256677778888888642                            


Q ss_pred             ---------------------------CCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          689 ---------------------------HTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       689 ---------------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                                                 ...++|||++|.||++++++.+.|+|||.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          156 DDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                       12399999999999998876677999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.99  E-value=2.5e-10  Score=120.91  Aligned_cols=193  Identities=15%  Similarity=0.162  Sum_probs=124.2

Q ss_pred             CceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcC-CCCc--cceeeeeecccCcCCCceeeEEE
Q 002883          564 ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSI-RHRN--LVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      .+.++.|....||++.     ..+++|+....  .....+.+|+++++.+ .+..  +.+++.....  .......|+||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceEEE
Confidence            4678999999999864     45889986432  2346788999999887 3333  3444443221  11113458999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC--------------------------------  688 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------  688 (871)
                      |+++|.++.+....         .++..+...++.+++..++.||+..                                
T Consensus        96 ~~i~G~~l~~~~~~---------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (304)
T 3sg8_A           96 TKIKGVPLTPLLLN---------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK  166 (304)
T ss_dssp             ECCCCEECCHHHHH---------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred             cccCCeECCccccc---------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence            99999888754321         3677788888888888888888621                                


Q ss_pred             -----------------------CCCeEecCCCCCceeeCC--CCceEEeecccceecCCCCCCcccc-----------c
Q 002883          689 -----------------------HTSIVHCDLKPSNVLLDN--EMVAHVGDFGLSRLLHDNSPDQTST-----------S  732 (871)
Q Consensus       689 -----------------------~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~-----------~  732 (871)
                                             ...++|+|++|.||+++.  ...+.++||+.+..-+...+.....           .
T Consensus       167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~  246 (304)
T 3sg8_A          167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVS  246 (304)
T ss_dssp             HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHH
T ss_pred             cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHH
Confidence                                   136899999999999988  5668899999987643210000000           0


Q ss_pred             cccccccccC-cccccCCCCCCccchhhHHHHHHHHHhCCCCCch
Q 002883          733 RVKGSIGYVA-PEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDD  776 (871)
Q Consensus       733 ~~~gt~~y~a-PE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  776 (871)
                      ......++.. |+....  .....+.|++|.++|.+.+|..+|..
T Consensus       247 ~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~~  289 (304)
T 3sg8_A          247 KILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWYE  289 (304)
T ss_dssp             HHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred             HHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence            0000011111 221110  11225899999999999999988753

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.95  E-value=1.8e-10  Score=123.81  Aligned_cols=83  Identities=13%  Similarity=0.164  Sum_probs=41.5

Q ss_pred             CCCCCEEeCCCCcCCCCCccchh---cccCCceeeecCCcccccC----ccccCCCCCCCEEeCCCCcCCCCCcccccc-
Q 002883          367 LKGIQQLDLSENKLSGEIPTSLA---SCVGLEYLNFSDNSFQGPI----HSGFSSLKGLQDLDLSRNNFSGKIPMFLNT-  438 (871)
Q Consensus       367 l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-  438 (871)
                      +++|+.|+|++|.+.+..+..+.   .+++|++|+|+.|.|++..    +..+..+++|+.|+|++|.++...-..+.. 
T Consensus       251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a  330 (362)
T 2ra8_A          251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS  330 (362)
T ss_dssp             CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred             CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence            45555555555555432222222   2456666666666665432    222234566777777777665322222222 


Q ss_pred             cccccEEecCCCc
Q 002883          439 FRFLQKLNLSFNN  451 (871)
Q Consensus       439 ~~~L~~L~l~~N~  451 (871)
                      +  ...+++++|+
T Consensus       331 l--g~~~~~~~~~  341 (362)
T 2ra8_A          331 L--PMKIDVSDSQ  341 (362)
T ss_dssp             C--CSEEECCSBC
T ss_pred             c--CCEEEecCCc
Confidence            1  2456776666

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.93  E-value=2.3e-10  Score=123.08  Aligned_cols=65  Identities=20%  Similarity=0.352  Sum_probs=38.5

Q ss_pred             cccCCceeeecCCcccccCcccc---CCCCCCCEEeCCCCcCCCC----CcccccccccccEEecCCCcCcc
Q 002883          390 SCVGLEYLNFSDNSFQGPIHSGF---SSLKGLQDLDLSRNNFSGK----IPMFLNTFRFLQKLNLSFNNLEG  454 (871)
Q Consensus       390 ~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~l~~N~l~~~----~~~~~~~~~~L~~L~l~~N~l~~  454 (871)
                      .+++|++|+|++|.+.+..+..+   ..+++|++|+|+.|.|++.    ++..+..+++|+.|+|++|.++.
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d  321 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD  321 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence            35677777777777654322222   2456777777777776642    23333456677777777776654

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.90  E-value=3.5e-09  Score=115.02  Aligned_cols=145  Identities=18%  Similarity=0.195  Sum_probs=105.8

Q ss_pred             CCceeeccccceEEEEEECCCCcEEEEEEee--cccc-chHHHHHHHHHHHHcCC--CCccceeeeeecccCcCCCceee
Q 002883          563 SANLIGIGGYGYVYKGILGTEETNVAVKVLD--LQQR-GASKSFIAECEALRSIR--HRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       563 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ..+.++.|.++.||++...  +..+++|+..  .... .....+.+|+++++.+.  +..+++++.++.+...  .+..|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~--~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV--IGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--TSSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--cCCeE
Confidence            4577899999999999875  4678888875  3221 12356788999999986  4557888887654321  13468


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC-----------------------------  688 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------  688 (871)
                      +||||++|..+.+...         ..++..+...++.+++++|+.||+..                             
T Consensus       118 ~vme~v~G~~l~~~~~---------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQSL---------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL  188 (359)
T ss_dssp             EEEECCCCBCCCCTTC---------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred             EEEEecCCeecCCCcc---------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence            9999999877643111         13678888899999999999999731                             


Q ss_pred             --------------------------CCCeEecCCCCCceeeCCCCc--eEEeeccccee
Q 002883          689 --------------------------HTSIVHCDLKPSNVLLDNEMV--AHVGDFGLSRL  720 (871)
Q Consensus       689 --------------------------~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a~~  720 (871)
                                                ...++|||++|.||+++.++.  +.++||+.+..
T Consensus       189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                      247999999999999987653  68999999875

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.48  E-value=6.4e-07  Score=92.84  Aligned_cols=137  Identities=16%  Similarity=0.113  Sum_probs=99.2

Q ss_pred             ceeeccccc-eEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCceeeEEEec
Q 002883          565 NLIGIGGYG-YVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFKALVYEF  642 (871)
Q Consensus       565 ~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~  642 (871)
                      +.+..|..+ .||+......+..+++|+-...   ....+.+|++.++.+. +--+.++++++.+.     +..|+|||+
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~  101 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTA  101 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEEC
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEe
Confidence            345556655 6999888777888999987533   3456788999998873 33466777776544     457999999


Q ss_pred             cCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 002883          643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC----------------------------------  688 (871)
Q Consensus       643 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------  688 (871)
                      ++|.++.+......           .....++.+++..++.||...                                  
T Consensus       102 l~G~~~~~~~~~~~-----------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (272)
T 4gkh_A          102 IPGKTAFQVLEEYP-----------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE  170 (272)
T ss_dssp             CCSEEHHHHHHHCG-----------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred             eCCccccccccCCH-----------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence            99988887654321           123456667777777777532                                  


Q ss_pred             ---------------------CCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          689 ---------------------HTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       689 ---------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                                           ...++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                 12389999999999999887778999998864

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.47  E-value=2.2e-08  Score=96.99  Aligned_cols=12  Identities=17%  Similarity=-0.020  Sum_probs=5.3

Q ss_pred             CCCCcEEEccCC
Q 002883          271 LLKLQVLSLFGN  282 (871)
Q Consensus       271 l~~L~~L~L~~n  282 (871)
                      .++|++|+|++|
T Consensus        35 ~~~L~~L~L~~n   46 (185)
T 1io0_A           35 DPDLEEVNLNNI   46 (185)
T ss_dssp             CTTCCEEECTTC
T ss_pred             CCCCCEEEecCC
Confidence            344444444444

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.46  E-value=1.5e-08  Score=98.29  Aligned_cols=13  Identities=23%  Similarity=0.309  Sum_probs=5.6

Q ss_pred             ccccEEecCCCcC
Q 002883          440 RFLQKLNLSFNNL  452 (871)
Q Consensus       440 ~~L~~L~l~~N~l  452 (871)
                      ++|++|+|++|.+
T Consensus       151 ~~L~~L~L~~n~i  163 (185)
T 1io0_A          151 TTLLKFGYHFTQQ  163 (185)
T ss_dssp             SSCCEEECCCSSH
T ss_pred             CCcCEEeccCCCC
Confidence            3444444444443

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.37  E-value=7.1e-08  Score=98.04  Aligned_cols=66  Identities=29%  Similarity=0.376  Sum_probs=35.7

Q ss_pred             cCCCCCCEEecCCCcCCCC--CcccccCCCCCcEEeccCCCCCCCCccccCCCC--CCCEEeCCCCcCCCCC
Q 002883          317 GNCLQLQKLDLSDNNLSGT--IPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLK--GIQQLDLSENKLSGEI  384 (871)
Q Consensus       317 ~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~  384 (871)
                      .++++|+.|+|++|+|++.  ++..+..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.+.+..
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~  236 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTF  236 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGC
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcccc
Confidence            3456667777777776642  234444566666666666666532  1222222  5666666666655433

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.37  E-value=2.8e-08  Score=101.07  Aligned_cols=105  Identities=21%  Similarity=0.227  Sum_probs=63.8

Q ss_pred             ccCCCcCce--eeCCCCcccccCCc----cccCCcccceeeccCccccC--CCCccccccccccccccccccccCCCCcc
Q 002883           34 LGNLFKLVG--LGLTGNNYTGSIPQ----SLSNLSFLQQLSLSENSLSG--NIPSELGLLKQLNMFQVSANYLTGSIPIQ  105 (871)
Q Consensus        34 ~~~l~~L~~--L~L~~n~l~~~~p~----~~~~l~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  105 (871)
                      |...+.|..  ++++.|+.. .++.    ...++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..
T Consensus       137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~  213 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RE  213 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GG
T ss_pred             cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hh
Confidence            444445554  566666433 2222    22456777777777777774  3345566777777777777777743  22


Q ss_pred             ccccC--CCceeeeecccccccccc------ccccCCCCccEEE
Q 002883          106 LFNIS--SMDYFAVTQNKLVGEIPH------YVGFTLPNIRVLL  141 (871)
Q Consensus       106 ~~~l~--~L~~L~l~~n~l~~~~~~------~~~~~l~~L~~L~  141 (871)
                      +..+.  +|++|+|++|.+.+.+|.      .+...+|+|+.||
T Consensus       214 l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          214 LDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             GGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             hhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            33333  777788888777765552      2344788888876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.34  E-value=2.1e-06  Score=90.53  Aligned_cols=137  Identities=15%  Similarity=0.145  Sum_probs=92.8

Q ss_pred             CceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCC---ccceeeeeecccCcCCCceeeEEE
Q 002883          564 ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHR---NLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      .+.++.|....||+.     +..+++|+..  .......+.+|+++++.+.+.   .+.+++.+...    ..+..++||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~v~   92 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFVGY   92 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEEEE
Confidence            466888888899998     4568889853  223356788999999998642   35566655431    124468999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhc---------------------------------
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHH---------------------------------  687 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------  687 (871)
                      |+++|.++.+..-.         .++..+...++.++++.++.||+.                                 
T Consensus        93 e~i~G~~l~~~~~~---------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~  163 (306)
T 3tdw_A           93 RKVQGQILGEDGMA---------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPL  163 (306)
T ss_dssp             ECCCSEECHHHHHT---------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGG
T ss_pred             eccCCeECchhhhh---------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccc
Confidence            99999888763211         234444455555555555555532                                 


Q ss_pred             ------------------------CCCCeEecCCCCCceeeCC---CCc-eEEeeccccee
Q 002883          688 ------------------------CHTSIVHCDLKPSNVLLDN---EMV-AHVGDFGLSRL  720 (871)
Q Consensus       688 ------------------------~~~~ivH~Dlkp~Nill~~---~~~-~kl~Dfg~a~~  720 (871)
                                              ....++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       164 l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          164 LDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             SCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             cchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                    2236799999999999987   355 48999998864

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=98.07  E-value=6.9e-07  Score=83.99  Aligned_cols=92  Identities=13%  Similarity=0.217  Sum_probs=55.2

Q ss_pred             CCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCcc-ccCCCCcccccc----cccccccccccc-ccCCCC
Q 002883           30 IPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENS-LSGNIPSELGLL----KQLNMFQVSANY-LTGSIP  103 (871)
Q Consensus        30 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~l----~~L~~L~l~~n~-l~~~~~  103 (871)
                      +|.....-.+|+.|+|+++.|+...-..+..+++|++|+|++|. |+...-..+..+    ++|++|+|++|. +++..-
T Consensus        53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl  132 (176)
T 3e4g_A           53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI  132 (176)
T ss_dssp             SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred             CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence            34433333456677777766665555566667777777777764 543222334443    357777777764 665555


Q ss_pred             ccccccCCCceeeeeccc
Q 002883          104 IQLFNISSMDYFAVTQNK  121 (871)
Q Consensus       104 ~~~~~l~~L~~L~l~~n~  121 (871)
                      ..+..+++|+.|+++++.
T Consensus       133 ~~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A          133 IALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             HHGGGCTTCCEEEEESCT
T ss_pred             HHHhcCCCCCEEECCCCC
Confidence            556667777777777765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.00  E-value=1.9e-05  Score=86.67  Aligned_cols=76  Identities=17%  Similarity=0.097  Sum_probs=48.8

Q ss_pred             CceeeccccceEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHHHHHcCCC--C-ccceeeeeecccCcCCC
Q 002883          564 ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-------GASKSFIAECEALRSIRH--R-NLVKIITSCSSIDTRGN  633 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~~  633 (871)
                      .+.+|.|..+.||+++...+++.|+||.......       ....++..|+++++.+..  + .+.+++.+.  .     
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~-----  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T-----  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T-----
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C-----
Confidence            5679999999999998765678899998643211       123456789998887732  3 344555432  1     


Q ss_pred             ceeeEEEeccCCC
Q 002883          634 EFKALVYEFMPNG  646 (871)
Q Consensus       634 ~~~~lv~e~~~~g  646 (871)
                      ...++|||++++.
T Consensus       108 ~~~~lvmE~l~g~  120 (397)
T 2olc_A          108 EMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CccEEEEEeCCCc
Confidence            2247999999763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.99  E-value=1.4e-05  Score=86.41  Aligned_cols=84  Identities=6%  Similarity=-0.050  Sum_probs=54.6

Q ss_pred             Ccee-eccccceEEEEEEC--C----CCcEEEEEEeeccc---cchHHHHHHHHHHHHcCC-C--CccceeeeeecccCc
Q 002883          564 ANLI-GIGGYGYVYKGILG--T----EETNVAVKVLDLQQ---RGASKSFIAECEALRSIR-H--RNLVKIITSCSSIDT  630 (871)
Q Consensus       564 ~~~l-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~  630 (871)
                      .+.| +.|....+|+....  .    +++.+++|+.....   ......+.+|+.+++.+. +  -.+.+++.++.+...
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78889999998753  1    15678999875432   101245678888888873 2  356777776543211


Q ss_pred             CCCceeeEEEeccCCCCHH
Q 002883          631 RGNEFKALVYEFMPNGSLE  649 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~  649 (871)
                        .+..|+||||++|.++.
T Consensus       105 --~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 --LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             --TSSCEEEEECCCCBCCC
T ss_pred             --cCCceEEEEecCCCChh
Confidence              13457999999987654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.96  E-value=1.7e-06  Score=81.28  Aligned_cols=84  Identities=10%  Similarity=0.034  Sum_probs=50.3

Q ss_pred             CCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCc-CCCCCccchhcc----cCCceeeecCCc-ccccCccccCCCCC
Q 002883          344 SSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENK-LSGEIPTSLASC----VGLEYLNFSDNS-FQGPIHSGFSSLKG  417 (871)
Q Consensus       344 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~l~~  417 (871)
                      .+|+.||++++.|++..-..+..+++|++|+|++|. |++..-..++.+    ++|++|+|++|. |++..-..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            356666666666665555556666677777777764 554333334432    357777777763 66544455566677


Q ss_pred             CCEEeCCCCc
Q 002883          418 LQDLDLSRNN  427 (871)
Q Consensus       418 L~~L~l~~N~  427 (871)
                      |++|+|+++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            7777776664

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.78  E-value=8.5e-05  Score=77.36  Aligned_cols=79  Identities=16%  Similarity=0.125  Sum_probs=56.8

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCC---CccceeeeeecccCcCCCcee
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRH---RNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ....++.+|.|..+.||+++.. +|+.|++|+...........+..|++.|+.+.-   -.+++++++         +..
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---------~~~   85 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---------DDR   85 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---------ETT
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---------cCc
Confidence            3445678999999999999986 788999998754444334567889999988742   234555554         123


Q ss_pred             eEEEeccCCCCH
Q 002883          637 ALVYEFMPNGSL  648 (871)
Q Consensus       637 ~lv~e~~~~gsL  648 (871)
                      ++||||++++..
T Consensus        86 ~lv~e~l~~~~~   97 (288)
T 3f7w_A           86 TLAMEWVDERPP   97 (288)
T ss_dssp             EEEEECCCCCCC
T ss_pred             eEEEEeecccCC
Confidence            789999987653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.72  E-value=0.00012  Score=78.38  Aligned_cols=150  Identities=15%  Similarity=0.105  Sum_probs=79.7

Q ss_pred             ceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC--CCccceeeeeecccC-cCCCceeeEEEe
Q 002883          565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR--HRNLVKIITSCSSID-TRGNEFKALVYE  641 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~-~~~~~~~~lv~e  641 (871)
                      +.++.|..+.||++...  +..+++|+....    ...+..|+++++.+.  .-.+++++....... ....+..++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            44666778999999874  335899998642    233445666665552  113344443210000 001245789999


Q ss_pred             ccCCCCHH-----------H---Hhhcccccc--cc-----cCCCCHHH-------------------------------
Q 002883          642 FMPNGSLE-----------N---WLNQKEDEQ--NQ-----RPKLNLMQ-------------------------------  669 (871)
Q Consensus       642 ~~~~gsL~-----------~---~l~~~~~~~--~~-----~~~l~~~~-------------------------------  669 (871)
                      |++|.++.           .   .++......  ..     .....|..                               
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542           0   111111000  00     00012211                               


Q ss_pred             HHHHHHHHHHHHHHHhh----------cCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          670 RLSIAIDVANVLEYLHH----------HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       670 ~~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ...+..++..++.+|++          .....++|||+++.||+++.++.+.++||+.+..
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            11112234446666663          1235899999999999998888999999998753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.57  E-value=0.00035  Score=73.00  Aligned_cols=142  Identities=17%  Similarity=0.111  Sum_probs=89.1

Q ss_pred             CceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC---CCccceeeeeecccCcCCCceeeEEE
Q 002883          564 ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR---HRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      .+.|+.|....+|+...  ++..+++|+....   ....+..|++.++.+.   ...+++++.+....     +..++||
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-----g~~~lvm  110 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-----GHSFLLL  110 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-----SEEEEEE
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-----CceEEEE
Confidence            46789999999999986  4678889987643   3467888999988873   35677888775432     4579999


Q ss_pred             eccCCCCHH--------H---Hhhcccc--ccc-----------c--cCCCCHHHHH---HHH----------------H
Q 002883          641 EFMPNGSLE--------N---WLNQKED--EQN-----------Q--RPKLNLMQRL---SIA----------------I  675 (871)
Q Consensus       641 e~~~~gsL~--------~---~l~~~~~--~~~-----------~--~~~l~~~~~~---~i~----------------~  675 (871)
                      ||+++..+.        +   .++....  ...           +  ...-+|....   ++.                .
T Consensus       111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~  190 (312)
T 3jr1_A          111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID  190 (312)
T ss_dssp             ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred             EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence            999987642        1   1222111  000           0  0012344322   111                1


Q ss_pred             HHHHH-HHHHhh-cCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          676 DVANV-LEYLHH-HCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       676 ~i~~~-L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      +++.. ...|.. ...+.+||+|+.+.|++++.++ +.++||.
T Consensus       191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            11111 223322 2246899999999999999887 8899974

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.55  E-value=7.7e-05  Score=66.87  Aligned_cols=62  Identities=16%  Similarity=0.270  Sum_probs=45.5

Q ss_pred             ceeeecCCccc-ccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCC
Q 002883          395 EYLNFSDNSFQ-GPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPS  458 (871)
Q Consensus       395 ~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~  458 (871)
                      ..++.+++.++ ..+|..+.  ++|++|+|++|+|+...+..|..+++|+.|+|++|+|.|.+..
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l   73 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRL   73 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGG
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCcc
Confidence            36777777776 12333332  3688888888888877777888888899999999988887653

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.41  E-value=4e-05  Score=73.39  Aligned_cols=10  Identities=10%  Similarity=0.189  Sum_probs=4.5

Q ss_pred             CCCcEEEccC
Q 002883          272 LKLQVLSLFG  281 (871)
Q Consensus       272 ~~L~~L~L~~  281 (871)
                      +.|+.|+|++
T Consensus        41 ~~L~~L~L~~   50 (197)
T 1pgv_A           41 TDLKEVNINN   50 (197)
T ss_dssp             SSCCEEECTT
T ss_pred             CCccEEECCC
Confidence            3444444444

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.38  E-value=0.00056  Score=75.40  Aligned_cols=76  Identities=13%  Similarity=0.037  Sum_probs=47.7

Q ss_pred             CCeEecCCCCCceeeCCCCceEEeecccceecCCCCCCcccccccc--ccccccCcccccCC---CCCCccchhhHHHHH
Q 002883          690 TSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK--GSIGYVAPEYGALG---EVSTHGDEYSFGILM  764 (871)
Q Consensus       690 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~~DiwSlG~il  764 (871)
                      ..++|||++|.|||++.++ ++++||+.+..-...    .......  -...|++|+.....   ......++.+....+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~----~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG----FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH----HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH----HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            4899999999999998776 999999998753211    0000011  12346666654311   112234556788888


Q ss_pred             HHHHhC
Q 002883          765 LEMFTG  770 (871)
Q Consensus       765 ~elltG  770 (871)
                      |+.+++
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            888764

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.37  E-value=7.4e-05  Score=71.55  Aligned_cols=87  Identities=14%  Similarity=0.231  Sum_probs=41.1

Q ss_pred             CCCCCCCEEeCCCCcCCCC----CccchhcccCCceeeecCCccccc----CccccCCCCCCCEEeCCCCc---CCC---
Q 002883          365 GRLKGIQQLDLSENKLSGE----IPTSLASCVGLEYLNFSDNSFQGP----IHSGFSSLKGLQDLDLSRNN---FSG---  430 (871)
Q Consensus       365 ~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~---l~~---  430 (871)
                      ..-+.|+.|+|++|.|.+.    +...+..-+.|++|+|++|.|...    +..++..-+.|++|+|++|.   +..   
T Consensus        67 ~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~  146 (197)
T 1pgv_A           67 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVE  146 (197)
T ss_dssp             TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHH
T ss_pred             hhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHH
Confidence            3344455555555554422    222233344555555555555532    22234444557777776542   221   


Q ss_pred             -CCcccccccccccEEecCCCc
Q 002883          431 -KIPMFLNTFRFLQKLNLSFNN  451 (871)
Q Consensus       431 -~~~~~~~~~~~L~~L~l~~N~  451 (871)
                       .+.+.+..-+.|+.|+++.|.
T Consensus       147 ~~ia~aL~~N~tL~~L~l~~~~  168 (197)
T 1pgv_A          147 MDMMMAIEENESLLRVGISFAS  168 (197)
T ss_dssp             HHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHHHHHhCCCcCeEeccCCC
Confidence             122344445566666665443

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.24  E-value=0.00098  Score=69.71  Aligned_cols=74  Identities=8%  Similarity=0.066  Sum_probs=45.2

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCceeeEE
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFKALV  639 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv  639 (871)
                      +.-.+.|+.|....+|++      ..+++|+....... .....+|+.+++.+. +.-..+++++..+       .-++|
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~-------~~~~v   85 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPA-------TGVMV   85 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT-------TCCEE
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECC-------CCEEE
Confidence            333688999999999998      45899988543211 112346777777763 2222455554321       23689


Q ss_pred             Eecc-CCCCH
Q 002883          640 YEFM-PNGSL  648 (871)
Q Consensus       640 ~e~~-~~gsL  648 (871)
                      +||+ +|.++
T Consensus        86 ~e~i~~g~~l   95 (301)
T 3dxq_A           86 TRYIAGAQTM   95 (301)
T ss_dssp             EECCTTCEEC
T ss_pred             EeecCCCccC
Confidence            9999 66544

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.23  E-value=0.00039  Score=62.22  Aligned_cols=63  Identities=19%  Similarity=0.186  Sum_probs=49.7

Q ss_pred             CEEeCCCCcCC-CCCcccccccccccEEecCCCcCcccCCCC-cccccccceeccCCCCCccCCCcc
Q 002883          419 QDLDLSRNNFS-GKIPMFLNTFRFLQKLNLSFNNLEGEVPSE-GVFKNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       419 ~~L~l~~N~l~-~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~-~~~~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      ..++.+++.|+ ..+|..+.  ++|+.|+|++|.|+...+.. ..++.++.+++.+|||.|+|...|
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~   75 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVP   75 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHH
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHH
Confidence            47899999997 34565443  36999999999999876654 446788999999999999997543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.18  E-value=0.0013  Score=69.41  Aligned_cols=169  Identities=12%  Similarity=0.095  Sum_probs=88.1

Q ss_pred             ccCHHHHHHhhcCCCC-----CceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCc--cce
Q 002883          548 KISYAELLKATEGFSS-----ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRN--LVK  620 (871)
Q Consensus       548 ~~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~  620 (871)
                      .++.+++.....+|.+     .+.|+.|....+|++... ++ .+++|+.....  ....+..|+.+++.+....  +.+
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~   81 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL   81 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCc
Confidence            3555666666666655     244667888899999874 33 68899886421  1234566777777763212  333


Q ss_pred             eeeeecccC-cCCCceeeEEEeccCCCCHHH-----------H---hhccccccc-cc-CCC---CHHHHHH--------
Q 002883          621 IITSCSSID-TRGNEFKALVYEFMPNGSLEN-----------W---LNQKEDEQN-QR-PKL---NLMQRLS--------  672 (871)
Q Consensus       621 ~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~~~~~~-~~-~~l---~~~~~~~--------  672 (871)
                      ++....... ..-.+..+++|+|++|..+..           .   ++....... .. ...   .|.....        
T Consensus        82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~  161 (322)
T 2ppq_A           82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  161 (322)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence            332210000 000134689999998865311           0   111100000 00 000   1111000        


Q ss_pred             ----HHHHHHHHHHHHhhc----CCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          673 ----IAIDVANVLEYLHHH----CHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       673 ----i~~~i~~~L~~LH~~----~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                          +...+...++++++.    ...+++|+|+.+.||+++++..+.++||+.+..
T Consensus       162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                011234455555532    134799999999999998876668999998763

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.09  E-value=0.0013  Score=72.58  Aligned_cols=75  Identities=15%  Similarity=0.081  Sum_probs=47.8

Q ss_pred             CceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCcc-ceeeeeecccCcCCCceeeEEEec
Q 002883          564 ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNL-VKIITSCSSIDTRGNEFKALVYEF  642 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~  642 (871)
                      .+.|+.|-...+|++.....+..+++|+........ -...+|..+++.+...++ .++++.+..         ..||||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~---------G~v~e~  182 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN---------GRIEEF  182 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT---------EEEEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC---------eEEEEe
Confidence            456888888999999986445789999874332211 122578888888854333 566666421         259999


Q ss_pred             cCCCCH
Q 002883          643 MPNGSL  648 (871)
Q Consensus       643 ~~~gsL  648 (871)
                      ++|.++
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            987544

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.06  E-value=0.0014  Score=70.38  Aligned_cols=147  Identities=13%  Similarity=0.124  Sum_probs=83.9

Q ss_pred             CceeeccccceEEEEEECC-------CCcEEEEEEeeccccchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCce
Q 002883          564 ANLIGIGGYGYVYKGILGT-------EETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .+.+..|-...+|++....       +++.|++|+..... .....+.+|.++++.+. +.-..++++++..        
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--------  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE--------  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--------
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--------
Confidence            3567778889999998742       35789999874322 23455668999998873 3334666665432        


Q ss_pred             eeEEEeccCCCCHHH-----------H---hhccccc-ccccCCC--CHHHHHHHHHHHHH-------------------
Q 002883          636 KALVYEFMPNGSLEN-----------W---LNQKEDE-QNQRPKL--NLMQRLSIAIDVAN-------------------  679 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~-----------~---l~~~~~~-~~~~~~l--~~~~~~~i~~~i~~-------------------  679 (871)
                       .+||||++|.++..           .   +.+-... .......  -+.++.++..++..                   
T Consensus       126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  204 (379)
T 3feg_A          126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD  204 (379)
T ss_dssp             -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred             -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence             28999998855431           1   1000000 0001111  23455555544322                   


Q ss_pred             HHHHHhh----c-CCCCeEecCCCCCceeeCCC----CceEEeeccccee
Q 002883          680 VLEYLHH----H-CHTSIVHCDLKPSNVLLDNE----MVAHVGDFGLSRL  720 (871)
Q Consensus       680 ~L~~LH~----~-~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~a~~  720 (871)
                      .+..|.+    . ....++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2333322    1 23479999999999999876    7899999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.06  E-value=0.0011  Score=72.84  Aligned_cols=74  Identities=18%  Similarity=0.167  Sum_probs=49.3

Q ss_pred             CceeeccccceEEEEEECC-------CCcEEEEEEeeccccchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCce
Q 002883          564 ANLIGIGGYGYVYKGILGT-------EETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .+.|+.|....||++....       +++.|++|+....  .....+.+|..+++.+. +.-.+++++.+..        
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~--------  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG--------  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--------
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC--------
Confidence            3567888889999998753       2578999998432  11245567999888874 3334566665421        


Q ss_pred             eeEEEeccCCCCH
Q 002883          636 KALVYEFMPNGSL  648 (871)
Q Consensus       636 ~~lv~e~~~~gsL  648 (871)
                       .+|+||++|.++
T Consensus       148 -g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 -GRLEEYIPSRPL  159 (429)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -CEEEEEeCCccc
Confidence             389999986443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.05  E-value=0.0035  Score=66.32  Aligned_cols=168  Identities=12%  Similarity=0.111  Sum_probs=89.2

Q ss_pred             cccCHHHHHHhhcCCCC-----CceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCC--ccc
Q 002883          547 LKISYAELLKATEGFSS-----ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHR--NLV  619 (871)
Q Consensus       547 ~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv  619 (871)
                      ...+.+.+......|.+     .+.++ |....||++... +|+.+++|+...... ....+..|..+++.+...  .++
T Consensus         9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A            9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeec
Confidence            34455555544444432     34566 888899988764 466799999864321 345667788888777321  244


Q ss_pred             eeeeeecccC-cCCCceeeEEEeccCCCCHH-----HH---------hhccccc--ccccCCCCHHHH----HH------
Q 002883          620 KIITSCSSID-TRGNEFKALVYEFMPNGSLE-----NW---------LNQKEDE--QNQRPKLNLMQR----LS------  672 (871)
Q Consensus       620 ~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~-----~~---------l~~~~~~--~~~~~~l~~~~~----~~------  672 (871)
                      +++.. .... ....+..++|||+++|.++.     .+         ++.....  ....+..++...    ..      
T Consensus        86 ~~~~~-~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  164 (328)
T 1zyl_A           86 APVAF-NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT  164 (328)
T ss_dssp             CCCCB-TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred             ceeec-CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence            44433 1100 00124568899999875431     11         1110000  001111222111    00      


Q ss_pred             ---------HHHHHHHHHHHHhhc----CCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          673 ---------IAIDVANVLEYLHHH----CHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       673 ---------i~~~i~~~L~~LH~~----~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                               +...+...++.+.+.    ....++|||+++.||+++ + .+.++||+.+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                     111111223333221    234789999999999998 4 899999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.85  E-value=0.007  Score=64.17  Aligned_cols=145  Identities=12%  Similarity=0.040  Sum_probs=73.5

Q ss_pred             ceeeccccce-EEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-C-CccceeeeeecccCcCCCceeeEEEe
Q 002883          565 NLIGIGGYGY-VYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-H-RNLVKIITSCSSIDTRGNEFKALVYE  641 (871)
Q Consensus       565 ~~lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~niv~~~~~~~~~~~~~~~~~~lv~e  641 (871)
                      +.++.|.... +|+.... ++..+++|.......   ..+..|+.+++.+. + -.+.+++.+....     +  ++|||
T Consensus        24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~-----g--~ll~e   92 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR-----G--LLLIE   92 (333)
T ss_dssp             CC--------CCEEEECT-TCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT-----T--EEEEC
T ss_pred             eECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC-----C--EEEEe
Confidence            3455554444 6777642 356777887643321   23345677666663 2 2355666542211     2  68999


Q ss_pred             ccCCCCHHHHhhccccc-------------------ccccCCCCHHHHH-------H-H------------HHHHHHHHH
Q 002883          642 FMPNGSLENWLNQKEDE-------------------QNQRPKLNLMQRL-------S-I------------AIDVANVLE  682 (871)
Q Consensus       642 ~~~~gsL~~~l~~~~~~-------------------~~~~~~l~~~~~~-------~-i------------~~~i~~~L~  682 (871)
                      ++++.++.+++......                   ....+.++.....       . +            ...+...+.
T Consensus        93 ~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~  172 (333)
T 3csv_A           93 DLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFA  172 (333)
T ss_dssp             CCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHH
T ss_pred             eCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence            99877776655432110                   0000112221100       0 0            011112222


Q ss_pred             HHhh---cCCCCeEecCCCCCceeeCCC----CceEEeeccccee
Q 002883          683 YLHH---HCHTSIVHCDLKPSNVLLDNE----MVAHVGDFGLSRL  720 (871)
Q Consensus       683 ~LH~---~~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~a~~  720 (871)
                      .+.+   .....++|||+.+.||+++.+    +.+.++||+.+..
T Consensus       173 ~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          173 QILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             HHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            2211   123489999999999999874    6789999998875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.47  E-value=0.0045  Score=66.73  Aligned_cols=74  Identities=14%  Similarity=0.147  Sum_probs=43.6

Q ss_pred             ceeeccccceEEEEEECC--------CCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCc-cceeeeeecccCcCCCce
Q 002883          565 NLIGIGGYGYVYKGILGT--------EETNVAVKVLDLQQRGASKSFIAECEALRSIRHRN-LVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~  635 (871)
                      +.++.|....+|++....        .++.+++|+....... ......|.++++.+.... +.++++...         
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~---------  108 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN---------  108 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET---------
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC---------
Confidence            457788888999998753        1268999987543221 112356888888774222 446665431         


Q ss_pred             eeEEEeccCCCCH
Q 002883          636 KALVYEFMPNGSL  648 (871)
Q Consensus       636 ~~lv~e~~~~gsL  648 (871)
                      -++||||++|.++
T Consensus       109 ~~~v~e~i~G~~l  121 (369)
T 3c5i_A          109 GGRIEEWLYGDPL  121 (369)
T ss_dssp             TEEEEECCCSEEC
T ss_pred             CcEEEEEecCCcC
Confidence            2689999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.31  E-value=0.0068  Score=64.36  Aligned_cols=32  Identities=28%  Similarity=0.366  Sum_probs=28.4

Q ss_pred             CCeEecCCCCCceeeCCCCceEEeecccceec
Q 002883          690 TSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL  721 (871)
Q Consensus       690 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  721 (871)
                      ..++|+|+.+.||+++.++.+.++||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            47999999999999998888999999887653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.11  E-value=0.019  Score=55.03  Aligned_cols=99  Identities=15%  Similarity=0.119  Sum_probs=64.7

Q ss_pred             CCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccceecCCCC
Q 002883          646 GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNS  725 (871)
Q Consensus       646 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  725 (871)
                      -+|.+.++..+.      +++++++|.++.|.+.+|.-.-.... . ..+=+.|..|++..+|.|...+ +.+.      
T Consensus        33 vSL~eIL~~~~~------PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------   97 (229)
T 2yle_A           33 LSLEEILRLYNQ------PINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD------   97 (229)
T ss_dssp             EEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C---------
T ss_pred             ccHHHHHHHcCC------CcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc------
Confidence            479999987653      69999999999999999887622111 1 1222346888899998887753 1110      


Q ss_pred             CCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh
Q 002883          726 PDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT  769 (871)
Q Consensus       726 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt  769 (871)
                               .....+.|||... ...+.+.=|||+|+++|..+-
T Consensus        98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence                     1223566888753 345678899999999999986

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.02  E-value=0.073  Score=57.86  Aligned_cols=75  Identities=13%  Similarity=0.114  Sum_probs=48.3

Q ss_pred             CceeeccccceEEEEEECCC-------CcEEEEEEeeccccchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCce
Q 002883          564 ANLIGIGGYGYVYKGILGTE-------ETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .+.+..|-...+|++.....       ++.|++|+...... ..-...+|..+++.+. +.-..++++.+.         
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~---------  144 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP---------  144 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET---------
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC---------
Confidence            35677788899999987521       57899999754322 1123357888888773 333455565321         


Q ss_pred             eeEEEeccCCCCH
Q 002883          636 KALVYEFMPNGSL  648 (871)
Q Consensus       636 ~~lv~e~~~~gsL  648 (871)
                      -+.||||++|.++
T Consensus       145 ~~~I~efI~G~~l  157 (424)
T 3mes_A          145 EGRIEEFIDGEPL  157 (424)
T ss_dssp             TEEEEECCCSEEC
T ss_pred             CCEEEEEeCCccC
Confidence            2689999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.77  E-value=0.058  Score=58.57  Aligned_cols=30  Identities=27%  Similarity=0.349  Sum_probs=25.5

Q ss_pred             CeEecCCCCCceee------CCCCceEEeeccccee
Q 002883          691 SIVHCDLKPSNVLL------DNEMVAHVGDFGLSRL  720 (871)
Q Consensus       691 ~ivH~Dlkp~Nill------~~~~~~kl~Dfg~a~~  720 (871)
                      .++|+|+.+.||++      +.+..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46799999999999      4566799999998864

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=81.48  E-value=0.36  Score=32.88  Aligned_cols=18  Identities=17%  Similarity=0.209  Sum_probs=8.8

Q ss_pred             hhHHHHHHHHHHHHHhhh
Q 002883          515 LSTCFIVFVFYQRRKRRR  532 (871)
Q Consensus       515 ~~~~~~~~~~~~rr~~~~  532 (871)
                      ++++.+.++++.||++++
T Consensus        24 ~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           24 LLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             HHHHHHHHHHHHHTTTCC
T ss_pred             HHHHHHHHHHHhhhhHhh
Confidence            334444555555555443

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=81.03  E-value=0.36  Score=32.71  Aligned_cols=17  Identities=18%  Similarity=0.342  Sum_probs=7.8

Q ss_pred             hHHHHHHHHHHHHHhhh
Q 002883          516 STCFIVFVFYQRRKRRR  532 (871)
Q Consensus       516 ~~~~~~~~~~~rr~~~~  532 (871)
                      .++.+++.+|.|||++.
T Consensus        25 vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           25 VVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHCSC
T ss_pred             HHHHHHHHhheehhhhh
Confidence            33344445555555443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	871
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-57
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-50
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-49
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-49
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-49
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-49
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-47
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-47
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-47
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-45
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-45
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-45
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-44
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-44
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-44
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-44
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-44
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-44
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-43
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-43
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-43
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-43
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-42
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-42
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-42
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-41
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-41
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-41
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-40
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-40
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-39
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-37
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-36
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-36
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-35
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-35
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-35
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-35
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-34
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-34
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-34
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-34
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-33
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-33
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-33
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-31
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-31
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-26
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-13
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-04
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-24
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-22
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-20
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-10
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	9e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-20
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-13
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-06
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-05
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-05
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-17
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.003
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.004
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	6e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	5e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	8e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	4e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	5e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.001
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 8e-57
 Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 26/271 (9%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGAS--KSFIAECEALRSIRHRNLVKII 622
             IG G +G VYKG    +   VAVK+L++        ++F  E   LR  RH N++  +
Sbjct: 14  QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
              +          A+V ++    SL + L           K  +++ + IA   A  ++
Sbjct: 71  GYST------APQLAIVTQWCEGSSLYHHL------HIIETKFEMIKLIDIARQTAQGMD 118

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           YLH      I+H DLK +N+ L  ++   +GDFGL+ +    S       ++ GSI ++A
Sbjct: 119 YLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMA 174

Query: 743 PEY---GALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEI 799
           PE          S   D Y+FGI++ E+ TG+ P  ++      +      G        
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMVGRGYLSPDLSK 233

Query: 800 IDPAILEEALEIQAGIVKELQPNLRAKFHEI 830
           +     +    + A  +K+ + + R  F +I
Sbjct: 234 VRSNCPKAMKRLMAECLKK-KRDERPLFPQI 263

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  175 bits (445), Expect = 9e-50
 Identities = 74/337 (21%), Positives = 138/337 (40%), Gaps = 62/337 (18%)

Query: 550 SYAELLKATEGFSSA---------NLIGIGGYGYVYKGIL---GTEETNVAVKVLDLQQ- 596
           ++ +  +A   F+            +IG G +G V  G L   G  E  VA+K L     
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 597 RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE 656
               + F++E   +    H N++ +    +      +    ++ EFM NGSL+++     
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSF----- 117

Query: 657 DEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG 716
             +    +  ++Q + +   +A  ++YL        VH DL   N+L+++ +V  V DFG
Sbjct: 118 -LRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFG 173

Query: 717 LSRLLHDNSPDQTSTSRV--KGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP 773
           LSR L D++ D T TS +  K  I + APE     + ++  D +S+GI+M E+ + G+RP
Sbjct: 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 233

Query: 774 TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVS 833
             DM  +                 ++I+    +  L         L              
Sbjct: 234 YWDMTNQ-----------------DVINAIEQDYRLPPPMDCPSALH------------- 263

Query: 834 ILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQAIK 870
             ++ + C ++    R K    +  L +  +   ++K
Sbjct: 264 --QLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 298

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 3e-49
 Identities = 63/267 (23%), Positives = 109/267 (40%), Gaps = 23/267 (8%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITS 624
           IG G +  VYKG+       VA   L  ++  +   + F  E E L+ ++H N+V+   S
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
             S   +G +   LV E M +G+L+ +L +          + +    S    +   L++L
Sbjct: 77  WES-TVKGKKCIVLVTELMTSGTLKTYLKR-------FKVMKIKVLRSWCRQILKGLQFL 128

Query: 685 HHHCHTSIVHCDLKPSNVLLDNE-MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
           H      I+H DLK  N+ +        +GD GL+ L        +    V G+  ++AP
Sbjct: 129 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-----SFAKAVIGTPEFMAP 182

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPA 803
           E     +     D Y+FG+ MLEM T + P  +         +      P    ++  P 
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241

Query: 804 ILEEALEIQAGIVKELQPNLRAKFHEI 830
           + E    I+  I +    + R    ++
Sbjct: 242 VKE---IIEGCIRQN--KDERYSIKDL 263

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 3e-49
 Identities = 64/289 (22%), Positives = 123/289 (42%), Gaps = 28/289 (9%)

Query: 553 ELLKATEGFSSANL-IGIGGYGYVYKGIL--GTEETNVAVKVLDLQ-QRGASKSFIAECE 608
           +L    +    A++ +G G +G V +G+     ++ +VA+KVL    ++  ++  + E +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 609 ALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLM 668
            +  + +  +V++I  C +          LV E    G L  +L        +R ++ + 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEA------LMLVMEMAGGGPLHKFL------VGKREEIPVS 109

Query: 669 QRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQ 728
               +   V+  ++YL      + VH DL   NVLL N   A + DFGLS+ L  +    
Sbjct: 110 NVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166

Query: 729 TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKY 787
           T+ S  K  + + APE     + S+  D +S+G+ M E  + G++P   M  +G  +  +
Sbjct: 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAF 224

Query: 788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILR 836
            + G   +      P    E   + +      +   R  F  +    +R
Sbjct: 225 IEQGKRME----CPPECPPELYALMSDCWIY-KWEDRPDFLTV-EQRMR 267

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 4e-49
 Identities = 53/235 (22%), Positives = 95/235 (40%), Gaps = 20/235 (8%)

Query: 557 ATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRH 615
             + F   + +G G  G V+K         +A K++ L+ +       I E + L     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 616 RNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI 675
             +V    +  S     +   ++  E M  GSL+  L +         ++       ++I
Sbjct: 64  PYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKAG-------RIPEQILGKVSI 111

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
            V   L YL       I+H D+KPSN+L+++     + DFG+S  L D     +  +   
Sbjct: 112 AVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFV 164

Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM 790
           G+  Y++PE       S   D +S G+ ++EM  G+ P      + L L    ++
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 5e-49
 Identities = 68/271 (25%), Positives = 117/271 (43%), Gaps = 25/271 (9%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
             +G G +G V+ G      T VAVK L  Q   +  +F+AE   ++ ++H+ LV++   
Sbjct: 19  ERLGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
            +       E   ++ E+M NGSL ++L           KL + + L +A  +A  + ++
Sbjct: 77  VT------QEPIYIITEYMENGSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAFI 125

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
                   +H DL+ +N+L+ + +   + DFGL+RL+ DN          K  I + APE
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG--AKFPIKWTAPE 180

Query: 745 YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAI 804
               G  +   D +SFGIL+ E+ T  R           +    +         +     
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-----VRPDNC 235

Query: 805 LEEALEIQAGIVKELQPNLRAKFHEIQVSIL 835
            EE  ++     KE +P  R  F  +  S+L
Sbjct: 236 PEELYQLMRLCWKE-RPEDRPTFDYL-RSVL 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 2e-47
 Identities = 64/276 (23%), Positives = 109/276 (39%), Gaps = 20/276 (7%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHR 616
           E +     IG G YG   K    ++   +  K LD         +  ++E   LR ++H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAID 676
           N+V+          R N    +V E+   G L + + +      +R  L+    L +   
Sbjct: 64  NIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKG---TKERQYLDEEFVLRVMTQ 117

Query: 677 VANVLEYLHHH--CHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
           +   L+  H       +++H DLKP+NV LD +    +GDFGL+R+L+    D +     
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH---DTSFAKAF 174

Query: 735 KGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD 794
            G+  Y++PE       +   D +S G L+ E+     P     ++ L   K  +     
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREGKFRR 233

Query: 795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEI 830
                I     +E  EI   ++  L+   R    EI
Sbjct: 234 -----IPYRYSDELNEIITRML-NLKDYHRPSVEEI 263

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 4e-47
 Identities = 64/319 (20%), Positives = 121/319 (37%), Gaps = 40/319 (12%)

Query: 567 IGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCS 626
           IG G +G V++G    EE  VAVK+   ++   S    AE      +RH N++  I + +
Sbjct: 11  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADN 67

Query: 627 SIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH 686
             +    +   LV ++  +GSL ++LN        R  + +   + +A+  A+ L +LH 
Sbjct: 68  KDNGTWTQL-WLVSDYHEHGSLFDYLN--------RYTVTVEGMIKLALSTASGLAHLHM 118

Query: 687 HCHTS-----IVHCDLKPSNVLLDNEMVAHVGDFGLSRLL-HDNSPDQTSTSRVKGSIGY 740
               +     I H DLK  N+L+       + D GL+            + +   G+  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 741 VAPEY------GALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD 794
           +APE           E     D Y+ G++  E+           +       Y  +   D
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ---LPYYDLVPSD 235

Query: 795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVS--ILRVGILCSEELPRDRMKI 852
              E +   + E+          +L+PN+  ++   +    + ++   C       R+  
Sbjct: 236 PSVEEMRKVVCEQ----------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285

Query: 853 QDAIMELQEAQKMRQAIKL 871
                 L +  +  + IK+
Sbjct: 286 LRIKKTLSQLSQQ-EGIKM 303

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 5e-47
 Identities = 69/269 (25%), Positives = 117/269 (43%), Gaps = 28/269 (10%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
             +G G +G V+ G      T VA+K L        ++F+ E + ++ +RH  LV++   
Sbjct: 23  VKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
            S       E   +V E+M  GSL ++L  +  +  + P     Q + +A  +A+ + Y+
Sbjct: 81  VS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP-----QLVDMAAQIASGMAYV 129

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
                   VH DL+ +N+L+   +V  V DFGL+RL+ DN  + T+    K  I + APE
Sbjct: 130 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPE 184

Query: 745 YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAI 804
               G  +   D +SFGIL+ E+ T  R           L +  +            P  
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-----CPPEC 239

Query: 805 LEEALEIQAGIVKELQ--PNLRAKFHEIQ 831
            E   ++   + +  +  P  R  F  +Q
Sbjct: 240 PESLHDL---MCQCWRKEPEERPTFEYLQ 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (414), Expect = 2e-45
 Identities = 70/326 (21%), Positives = 119/326 (36%), Gaps = 48/326 (14%)

Query: 558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDL---QQRGASKSFIAECEALRSIR 614
            + FS    IG G +G VY          VA+K +     Q     +  I E   L+ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
           H N ++                 LV E+    + +     K+        L  ++  ++ 
Sbjct: 74  HPNTIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVHKK-------PLQEVEIAAVT 121

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
                 L YLH H   +++H D+K  N+LL    +  +GDFG + ++          +  
Sbjct: 122 HGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANSF 171

Query: 735 KGSIGYVAPEY---GALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG 791
            G+  ++APE       G+     D +S GI  +E+   K P  +M      L+  A+  
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNE 230

Query: 792 LPDQVAEIIDPAILEEALEIQAGIVKELQ--PNLRAKFHEIQVSILRVGILCSEELPRDR 849
            P     +      E        +   LQ  P  R         +L+   +  E  P   
Sbjct: 231 SP----ALQSGHWSEYFRNF---VDSCLQKIPQDRPTSEV----LLKHRFVLRERPPTVI 279

Query: 850 M----KIQDAIMELQEAQ--KMRQAI 869
           M    + +DA+ EL   Q  KM++ +
Sbjct: 280 MDLIQRTKDAVRELDNLQYRKMKKIL 305

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-45
 Identities = 69/280 (24%), Positives = 111/280 (39%), Gaps = 35/280 (12%)

Query: 565 NLIGIGGYGYVYKGILGTEETN--VAVKVL--DLQQRGASKSFIAECEALRSIRHRNLVK 620
             +G G +G V KG    ++    VAVK+L  +          +AE   ++ + +  +V+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
           +I  C        E   LV E    G L  +L Q          +     + +   V+  
Sbjct: 73  MIGICE------AESWMLVMEMAELGPLNKYLQQ-------NRHVKDKNIIELVHQVSMG 119

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           ++YL        VH DL   NVLL  +  A + DFGLS+ L  +     + +  K  + +
Sbjct: 120 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176

Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGL--SLHKYAKMGLPDQV- 796
            APE     + S+  D +SFG+LM E F+ G++P   M    +   L K  +MG P    
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 236

Query: 797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILR 836
            E+ D  ++                  R  F  +    LR
Sbjct: 237 REMYD--LMNLCWTY--------DVENRPGFAAV-ELRLR 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 3e-45
 Identities = 69/317 (21%), Positives = 129/317 (40%), Gaps = 50/317 (15%)

Query: 559 EGFSSANLIGIGGYGYVYKGIL----GTEETNVAVKVLDLQQR-GASKSFIAECEALRSI 613
              +   +IG G +G VYKG+L    G +E  VA+K L           F+ E   +   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 614 RHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSI 673
            H N++++    S           ++ E+M NG+L+ +       + +  + +++Q + +
Sbjct: 67  SHHNIIRLEGVISKYKPM-----MIITEYMENGALDKF------LREKDGEFSVLQLVGM 115

Query: 674 AIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSR 733
              +A  ++YL +      VH DL   N+L+++ +V  V DFGLSR+L D+     +TS 
Sbjct: 116 LRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172

Query: 734 VKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP 793
            K  I + APE  +  + ++  D +SFGI+M E+ T                        
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------------N 219

Query: 794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQ 853
            +V + I+       L         +                ++ + C ++    R K  
Sbjct: 220 HEVMKAINDGFR---LPTPMDCPSAI---------------YQLMMQCWQQERARRPKFA 261

Query: 854 DAIMELQEAQKMRQAIK 870
           D +  L +  +   ++K
Sbjct: 262 DIVSILDKLIRAPDSLK 278

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (407), Expect = 1e-44
 Identities = 57/273 (20%), Positives = 103/273 (37%), Gaps = 31/273 (11%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
             +G G +G VYK          A KV+D +     + ++ E + L S  H N+VK++ +
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
                        ++ EF   G+++  + + E        L   Q   +     + L YL
Sbjct: 78  FYY-----ENNLWILIEFCAGGAVDAVMLELER------PLTESQIQVVCKQTLDALNYL 126

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
           H +    I+H DLK  N+L   +    + DFG+S                 G+  ++APE
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR---TIQRRDSFIGTPYWMAPE 180

Query: 745 Y-----GALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEI 799
                           D +S GI ++EM   + P  ++    + L K AK   P     +
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPP----TL 235

Query: 800 IDPAILEEALE--IQAGIVKELQPNLRAKFHEI 830
             P+      +  ++  + K    + R    ++
Sbjct: 236 AQPSRWSSNFKDFLKKCLEKN--VDARWTTSQL 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-44
 Identities = 62/276 (22%), Positives = 104/276 (37%), Gaps = 27/276 (9%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRN 617
           E +     +G G YG V   +    E  VAVK++D+++     ++   E    + + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           +VK          R    + L  E+   G L + +            +           +
Sbjct: 65  VVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDI-------GMPEPDAQRFFHQL 112

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGS 737
              + YLH      I H D+KP N+LLD      + DFGL+ +   N+ ++       G+
Sbjct: 113 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GT 168

Query: 738 IGYVAPEYGALGEVSTHG-DEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV 796
           + YVAPE     E      D +S GI++  M  G+ P D   +       + +       
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228

Query: 797 AEIIDPAILEEALEIQAGIVKELQ--PNLRAKFHEI 830
            + ID       L +   + K L   P+ R    +I
Sbjct: 229 WKKIDS----APLAL---LHKILVENPSARITIPDI 257

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 2e-44
 Identities = 67/266 (25%), Positives = 110/266 (41%), Gaps = 28/266 (10%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
             IG G +G V  G        VAVK +       +++F+AE   +  +RH NLV+++  
Sbjct: 13  QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGV 68

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
              ++ +G  +  +V E+M  GSL ++L  +      R  L     L  ++DV   +EYL
Sbjct: 69  I--VEEKGGLY--IVTEYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYL 119

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
             +     VH DL   NVL+  + VA V DFGL++          +    K  + + APE
Sbjct: 120 EGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS------TQDTGKLPVKWTAPE 170

Query: 745 YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAI 804
                + ST  D +SFGIL+ E+++  R           + +  K    D          
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD-----APDGC 225

Query: 805 LEEALEIQAGIVKELQPNLRAKFHEI 830
                E+           +R  F ++
Sbjct: 226 PPAVYEVMKNCWHL-DAAMRPSFLQL 250

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 4e-44
 Identities = 61/277 (22%), Positives = 106/277 (38%), Gaps = 35/277 (12%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRH 615
           E F     +G G +G VY       +  +A+KVL    L++ G       E E    +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 616 RNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAI 675
            N++++                L+ E+ P G++   L +         K +  +  +   
Sbjct: 66  PNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQK-------LSKFDEQRTATYIT 113

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++AN L Y H      ++H D+KP N+LL +     + DFG S          +  + + 
Sbjct: 114 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA-----PSSRRTTLC 165

Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP-TDDMFEEGLSLHKYAKMGLPD 794
           G++ Y+ PE           D +S G+L  E   GK P   + ++E        +   PD
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 225

Query: 795 QV-AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEI 830
            V     D  ++   L+          P+ R    E+
Sbjct: 226 FVTEGARD--LISRLLKH--------NPSQRPMLREV 252

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 4e-44
 Identities = 65/273 (23%), Positives = 115/273 (42%), Gaps = 24/273 (8%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
             +G G +G V  G    +   VA+K++          FI E + + ++ H  LV++   
Sbjct: 10  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGV 67

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
           C+           ++ E+M NG L N+L +       R +    Q L +  DV   +EYL
Sbjct: 68  CTK-----QRPIFIITEYMANGCLLNYLREM------RHRFQTQQLLEMCKDVCEAMEYL 116

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
                   +H DL   N L++++ V  V DFGLSR + D+  + TS+   K  + +  PE
Sbjct: 117 ESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPE 171

Query: 745 YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAI 804
                + S+  D ++FG+LM E+++  +   + F    +    A+ GL      +    +
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKV 230

Query: 805 LEEALEIQAGIVKELQPNLRAKFHEIQVSILRV 837
                          + + R  F  +  +IL V
Sbjct: 231 YTIMYSCWH-----EKADERPTFKILLSNILDV 258

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  158 bits (401), Expect = 6e-44
 Identities = 70/266 (26%), Positives = 122/266 (45%), Gaps = 22/266 (8%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
           + +G G YG VY+G+       VAVK L  +     + F+ E   ++ I+H NLV+++  
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
           C+           ++ EFM  G+L ++L +       R +++ +  L +A  +++ +EYL
Sbjct: 82  CTR-----EPPFYIITEFMTYGNLLDYLREC-----NRQEVSAVVLLYMATQISSAMEYL 131

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
                   +H DL   N L+    +  V DFGLSRL+  ++   T+ +  K  I + APE
Sbjct: 132 EKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 186

Query: 745 YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAI 804
             A  + S   D ++FG+L+ E+ T           G+ L +  ++   D   E      
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMS----PYPGIDLSQVYELLEKDYRME-RPEGC 241

Query: 805 LEEALEIQAGIVKELQPNLRAKFHEI 830
            E+  E+     +   P+ R  F EI
Sbjct: 242 PEKVYELMRACWQW-NPSDRPSFAEI 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 1e-43
 Identities = 60/268 (22%), Positives = 111/268 (41%), Gaps = 28/268 (10%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
             IG G  G VY  +       VA++ ++LQQ+   +  I E   +R  ++ N+V  + S
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
                    +   +V E++  GSL + + +   ++         Q  ++  +    LE+L
Sbjct: 86  YLV-----GDELWVVMEYLAGGSLTDVVTETCMDEG--------QIAAVCRECLQALEFL 132

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
           H +    ++H D+K  N+LL  +    + DFG    +    P+Q+  S + G+  ++APE
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT---PEQSKRSTMVGTPYWMAPE 186

Query: 745 YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAI 804
                      D +S GI+ +EM  G+ P  +       L+  A  G P    E+ +P  
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP----ELQNPEK 241

Query: 805 LEEALE--IQAGIVKELQPNLRAKFHEI 830
           L       +   +  +     R    E+
Sbjct: 242 LSAIFRDFLNRCLDMD--VEKRGSAKEL 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-43
 Identities = 77/303 (25%), Positives = 105/303 (34%), Gaps = 51/303 (16%)

Query: 567 IGIGGYGYVYKGIL---GTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVK 620
           +G G +G V +G       +  +VAVK L    L Q  A   FI E  A+ S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
           +     +   +      +V E  P GSL + L +       +    L      A+ VA  
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKH------QGHFLLGTLSRYAVQVAEG 123

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           + YL        +H DL   N+LL    +  +GDFGL R L  N          K    +
Sbjct: 124 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEII 800
            APE       S   D + FG+ + EMFT  +           LHK  K G      E  
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240

Query: 801 DPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQ 860
              I                                V + C    P DR         L 
Sbjct: 241 PQDIYN------------------------------VMVQCWAHKPEDRPTFVALRDFLL 270

Query: 861 EAQ 863
           EAQ
Sbjct: 271 EAQ 273

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 4e-43
 Identities = 66/297 (22%), Positives = 115/297 (38%), Gaps = 49/297 (16%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITS 624
             IG G +G V+ G    ++  VA+K +        + FI E E +  + H  LV++   
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
           C            LV+EFM +G L ++       + QR        L + +DV   + YL
Sbjct: 69  CLE-----QAPICLVFEFMEHGCLSDY------LRTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPE 744
              C   ++H DL   N L+    V  V DFG++R + D+    TS++  K  + + +PE
Sbjct: 118 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPE 172

Query: 745 YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAI 804
             +    S+  D +SFG+LM E+F+  +   +       +   +          +  P +
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG------FRLYKPRL 226

Query: 805 LEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE 861
               +                          ++   C +E P DR      + +L E
Sbjct: 227 ASTHV-------------------------YQIMNHCWKERPEDRPAFSRLLRQLAE 258

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 9e-43
 Identities = 60/302 (19%), Positives = 112/302 (37%), Gaps = 49/302 (16%)

Query: 565 NLIGIGGYGYVYKGIL---GTEETNVAVKVLD-LQQRGASKSFIAECEALRSIRHRNLVK 620
            +IG G +G VY G L     ++ + AVK L+ +   G    F+ E   ++   H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
           ++  C  + + G+    +V  +M +G L N+       +N+     +   +   + VA  
Sbjct: 93  LLGIC--LRSEGSPL--VVLPYMKHGDLRNF------IRNETHNPTVKDLIGFGLQVA-- 140

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQ-TSTSRVKGSIG 739
            + +        VH DL   N +LD +    V DFGL+R ++D   D   + +  K  + 
Sbjct: 141 -KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199

Query: 740 YVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEI 799
           ++A E     + +T  D +SFG+L+ E+ T   P        ++              +I
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTF------------DI 243

Query: 800 IDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMEL 859
               +    L         L                 V + C       R    + +  +
Sbjct: 244 TVYLLQGRRLLQPEYCPDPLY---------------EVMLKCWHPKAEMRPSFSELVSRI 288

Query: 860 QE 861
             
Sbjct: 289 SA 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 1e-42
 Identities = 59/284 (20%), Positives = 110/284 (38%), Gaps = 32/284 (11%)

Query: 565 NLIGIGGYGYVYKGILGTEETN-----VAVKVLDLQQR-GASKSFIAECEALRSI-RHRN 617
             +G G +G V +        +     VAVK+L         ++ ++E + L  +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDE-----------QNQRPKLN 666
           +V ++ +C+           ++ E+   G L N+L +K D            ++    L+
Sbjct: 89  IVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 667 LMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSP 726
           L   LS +  VA  + +L        +H DL   N+LL +  +  + DFGL+R + ++S 
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS- 199

Query: 727 DQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK 786
           +       +  + ++APE       +   D +S+GI + E+F+               +K
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 787 YAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEI 830
             K G       +       E  +I         P  R  F +I
Sbjct: 260 MIKEGFRM----LSPEHAPAEMYDIMKTCWDA-DPLKRPTFKQI 298

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-42
 Identities = 66/293 (22%), Positives = 114/293 (38%), Gaps = 38/293 (12%)

Query: 566 LIGIGGYGYVYKGIL-GTEETN----VAVKVLDLQ-QRGASKSFIAECEALRSI-RHRNL 618
           ++G G +G V      G  +T     VAVK+L  +      ++ ++E + +  +  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE----------------DEQNQR 662
           V ++ +C+      +    L++E+   G L N+L  K                 +E+   
Sbjct: 104 VNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158

Query: 663 PKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLH 722
             L     L  A  VA  +E+L      S VH DL   NVL+ +  V  + DFGL+R + 
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 723 DNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGL 782
            +S +       +  + ++APE    G  +   D +S+GIL+ E+F+             
Sbjct: 216 SDS-NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 783 SLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSIL 835
           + +K  + G              EE   I            R  F  +  S L
Sbjct: 275 NFYKLIQNGFKMD----QPFYATEEIYIIMQSCWAF-DSRKRPSFPNL-TSFL 321

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (387), Expect = 6e-42
 Identities = 71/338 (21%), Positives = 113/338 (33%), Gaps = 63/338 (18%)

Query: 547 LKISYAELLKATEGFSSANLIGIGGYGYVYKGIL-----GTEETNVAVKVLDLQ-QRGAS 600
           L      L            IG G +G V++            T VAVK+L  +      
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 601 KSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDE-- 658
             F  E   +    + N+VK++  C+       +   L++E+M  G L  +L        
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTV 115

Query: 659 ---------------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVL 703
                              P L+  ++L IA  VA  + YL        VH DL   N L
Sbjct: 116 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCL 172

Query: 704 LDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGIL 763
           +   MV  + DFGLSR ++     +   +     I ++ PE       +T  D +++G++
Sbjct: 173 VGENMVVKIADFGLSRNIYSADYYKADGN-DAIPIRWMPPESIFYNRYTTESDVWAYGVV 231

Query: 764 MLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNL 823
           + E+F+                 Y  M   + +  + D  I    L        EL    
Sbjct: 232 LWEIFSYGLQP------------YYGMAHEEVIYYVRDGNI----LACPENCPLELY--- 272

Query: 824 RAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE 861
                        +  LC  +LP DR         LQ 
Sbjct: 273 ------------NLMRLCWSKLPADRPSFCSIHRILQR 298

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 2e-41
 Identities = 55/281 (19%), Positives = 102/281 (36%), Gaps = 31/281 (11%)

Query: 556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRS 612
           K  E F    ++G G +  V            A+K+L+   + +         E + +  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 613 IRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLS 672
           + H   VK+  +        +E       +  NG L  ++ +           +      
Sbjct: 65  LDHPFFVKLYFTFQD-----DEKLYFGLSYAKNGELLKYIRK-------IGSFDETCTRF 112

Query: 673 IAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTS 732
              ++ + LEYLH      I+H DLKP N+LL+ +M   + DFG +++L   S  Q   +
Sbjct: 113 YTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARAN 168

Query: 733 RVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL 792
              G+  YV+PE           D ++ G ++ ++  G  P     E  +   K  K+  
Sbjct: 169 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-FQKIIKLEY 227

Query: 793 PDQVAEIIDPAILEEALEIQAGIVKELQ--PNLRAKFHEIQ 831
                         +A ++   + K L      R    E++
Sbjct: 228 D------FPEKFFPKARDL---VEKLLVLDATKRLGCEEME 259

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  150 bits (380), Expect = 3e-41
 Identities = 56/278 (20%), Positives = 115/278 (41%), Gaps = 23/278 (8%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKII 622
           ++G GG   V+         +VAVKVL     +       F  E +   ++ H  +V + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
            +  +    G     +V E++   +L + ++ +         +   + + +  D    L 
Sbjct: 74  DTGEAETPAGPLP-YIVMEYVDGVTLRDIVHTEG-------PMTPKRAIEVIADACQALN 125

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           + H +    I+H D+KP+N+++       V DFG++R + D+    T T+ V G+  Y++
Sbjct: 126 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDP 802
           PE      V    D YS G ++ E+ TG+ P        ++     +  +P         
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---SARHE 239

Query: 803 AILEEALEIQAGIVKELQPNLRAKF---HEIQVSILRV 837
            +  +   +   ++K L  N   ++    E++  ++RV
Sbjct: 240 GLSADLDAV---VLKALAKNPENRYQTAAEMRADLVRV 274

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  152 bits (386), Expect = 3e-41
 Identities = 62/314 (19%), Positives = 116/314 (36%), Gaps = 45/314 (14%)

Query: 522 FVFYQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILG 581
           +VF   ++   +   + +  + D Y      ++ +          +G G +G V++    
Sbjct: 4   YVFDIWKQYYPQPVEIKHDHVLDHY------DIHE---------ELGTGAFGVVHRVTER 48

Query: 582 TEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
               N A K +        ++   E + +  +RH  LV +  +        +    ++YE
Sbjct: 49  ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMVMIYE 103

Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
           FM  G L   +       ++  K++  + +     V   L ++H +     VH DLKP N
Sbjct: 104 FMSGGELFEKV------ADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPEN 154

Query: 702 VLLDNEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYS 759
           ++   +    +   DFGL+  L      +       G+  + APE      V  + D +S
Sbjct: 155 IMFTTKRSNELKLIDFGLTAHLDPKQSVKV----TTGTAEFAAPEVAEGKPVGYYTDMWS 210

Query: 760 FGILMLEMFTGKRP-TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKE 818
            G+L   + +G  P   +  +E L   K     + D         I E+  +    I K 
Sbjct: 211 VGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS----AFSGISEDGKDF---IRKL 263

Query: 819 LQ--PNLRAKFHEI 830
           L   PN R   H+ 
Sbjct: 264 LLADPNTRMTIHQA 277

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 3e-41
 Identities = 59/283 (20%), Positives = 113/283 (39%), Gaps = 28/283 (9%)

Query: 553 ELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVL-----DLQQRGASKSFIAEC 607
            +LK TE F    ++G G +G VYKG+   E   V + V      +     A+K  + E 
Sbjct: 4   RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62

Query: 608 EALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNL 667
             + S+ + ++ +++  C +   +      L+ + MP G L +++ + +D    +     
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQ----- 111

Query: 668 MQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD 727
              L+  + +A  + YL       +VH DL   NVL+       + DFGL++LL      
Sbjct: 112 -YLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-K 166

Query: 728 QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKY 787
           +      K  I ++A E       +   D +S+G+ + E+ T          +G+   + 
Sbjct: 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----PYDGIPASEI 222

Query: 788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEI 830
           + +    +      P    +   I          + R KF E+
Sbjct: 223 SSILEKGERLP-QPPICTIDVYMIMVKCWMI-DADSRPKFREL 263

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  149 bits (377), Expect = 5e-40
 Identities = 58/313 (18%), Positives = 115/313 (36%), Gaps = 43/313 (13%)

Query: 522 FVFYQRRKRRRRSKALVNSSIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILG 581
           F     +K   +   +   S+ D Y      ++L+          +G G +G V++ +  
Sbjct: 7   FYEDIWKKYVPQPVEVKQGSVYDYY------DILE---------ELGSGAFGVVHRCVEK 51

Query: 582 TEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
                   K ++        +   E   +  + H  L+ +  +             L+ E
Sbjct: 52  ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMVLILE 106

Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
           F+  G L + +        +  K++  + ++        L+++H H   SIVH D+KP N
Sbjct: 107 FLSGGELFDRI------AAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPEN 157

Query: 702 VLLDNEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYS 759
           ++ + +  + V   DFGL+  L+ +            +  + APE      V  + D ++
Sbjct: 158 IMCETKKASSVKIIDFGLATKLNPDEI----VKVTTATAEFAAPEIVDREPVGFYTDMWA 213

Query: 760 FGILMLEMFTGKRP-TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALE-IQAGIVK 817
            G+L   + +G  P   +   E L   K       +     + P    EA + I+  + K
Sbjct: 214 IGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP----EAKDFIKNLLQK 269

Query: 818 ELQPNLRAKFHEI 830
           E  P  R   H+ 
Sbjct: 270 E--PRKRLTVHDA 280

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 7e-40
 Identities = 57/281 (20%), Positives = 118/281 (41%), Gaps = 25/281 (8%)

Query: 565 NLIGIGGYGYVYKGIL-----GTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNL 618
             +G G +G VY+G+         ET VA+K ++          F+ E   ++     ++
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRP---KLNLMQRLSIAI 675
           V+++   S       +   ++ E M  G L+++L          P     +L + + +A 
Sbjct: 86  VRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 676 DVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVK 735
           ++A+ + YL+ +     VH DL   N ++  +    +GDFG++R +++    +    +  
Sbjct: 141 EIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG-KGL 196

Query: 736 GSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ 795
             + +++PE    G  +T+ D +SFG+++ E+ T              L    + GL D 
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD- 255

Query: 796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILR 836
                     +   E+     +   P +R  F EI +S ++
Sbjct: 256 ----KPDNCPDMLFELMRMCWQY-NPKMRPSFLEI-ISSIK 290

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-39
 Identities = 57/269 (21%), Positives = 100/269 (37%), Gaps = 27/269 (10%)

Query: 566 LIGIGGYGYVYKGIL---GTEETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKI 621
            IG G +G V++GI          VA+K           + F+ E   +R   H ++VK+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
           I   +           ++ E    G L ++       Q ++  L+L   +  A  ++  L
Sbjct: 74  IGVIT------ENPVWIIMELCTLGELRSF------LQVRKYSLDLASLILYAYQLSTAL 121

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
            YL        VH D+   NVL+ +     +GDFGLSR + D+       S+ K  I ++
Sbjct: 122 AYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--TYYKASKGKLPIKWM 176

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIID 801
           APE       ++  D + FG+ M E+           +    + +             + 
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-----MP 231

Query: 802 PAILEEALEIQAGIVKELQPNLRAKFHEI 830
           P        +         P+ R +F E+
Sbjct: 232 PNCPPTLYSLMTKCWAY-DPSRRPRFTEL 259

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-38
 Identities = 60/283 (21%), Positives = 113/283 (39%), Gaps = 31/283 (10%)

Query: 561 FSSANLIGIGGYGYVYKGIL--GTEETNVAVKVLD-LQQRGASKSFIAECEALRSI-RHR 616
               ++IG G +G V K  +       + A+K +     +   + F  E E L  +  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQK---------EDEQNQRPKLNL 667
           N++ ++ +C         +  L  E+ P+G+L ++L +              +    L+ 
Sbjct: 72  NIINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 668 MQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPD 727
            Q L  A DVA  ++YL        +H DL   N+L+    VA + DFGLSR        
Sbjct: 127 QQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY--- 180

Query: 728 QTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKY 787
               +  +  + ++A E       +T+ D +S+G+L+ E+ +           G++  + 
Sbjct: 181 -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCAEL 235

Query: 788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEI 830
            +  LP            +E  ++     +E +P  R  F +I
Sbjct: 236 YEK-LPQGYRLEKPLNCDDEVYDLMRQCWRE-KPYERPSFAQI 276

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 2e-37
 Identities = 60/306 (19%), Positives = 112/306 (36%), Gaps = 16/306 (5%)

Query: 553 ELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLD-LQQRGASKSFIAECEALR 611
           ++      +++ + IG G YG V        +  VA+K +   + +   +  + E + L 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 612 SIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRL 671
             RH N++ I     +      +   LV   M    L   L  +         L+     
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQ--------HLSNDHIC 112

Query: 672 SIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTST 731
                +   L+Y+H      ++H DLKPSN+LL+      + DFGL+R+   +       
Sbjct: 113 YFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 169

Query: 732 SRVKGSIGYVAPEYGALGEVSTH-GDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM 790
           +    +  Y APE     +  T   D +S G ++ EM + +             H    +
Sbjct: 170 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 229

Query: 791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM 850
           G P Q  E ++  I  +A      +  + +      F       L +        P  R+
Sbjct: 230 GSPSQ--EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287

Query: 851 KIQDAI 856
           +++ A+
Sbjct: 288 EVEQAL 293

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 4e-36
 Identities = 59/281 (20%), Positives = 108/281 (38%), Gaps = 27/281 (9%)

Query: 565 NLIGIGGYGYVYKGILGTEETN-----VAVKVLDLQQ-RGASKSFIAECEALRSIRHRNL 618
             +G G +G V +      +       VAVK+L         ++ ++E + L  I H   
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKE---------DEQNQRPKLNLMQ 669
           V  +    +          ++ EF   G+L  +L  K           E   +  L L  
Sbjct: 79  VVNLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 670 RLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQT 729
            +  +  VA  +E+L        +H DL   N+LL  + V  + DFGL+R ++ + PD  
Sbjct: 136 LICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD-PDYV 191

Query: 730 STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAK 789
                +  + ++APE       +   D +SFG+L+ E+F+         +      +  K
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

Query: 790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEI 830
            G   +  +   P + +  L+         +P+ R  F E+
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCW-----HGEPSQRPTFSEL 287

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 9e-36
 Identities = 70/311 (22%), Positives = 118/311 (37%), Gaps = 27/311 (8%)

Query: 565 NLIGIGGYGYVYKGI-LGTEETNVAVKVLDLQ--QRGASKSFIAECEALR---SIRHRNL 618
             IG G YG V+K   L      VA+K + +Q  + G   S I E   LR   +  H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 619 VKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVA 678
           V++   C+   T       LV+E +               +   P +       +   + 
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD------KVPEPGVPTETIKDMMFQLL 126

Query: 679 NVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSI 738
             L++LH H    +VH DLKP N+L+ +     + DFGL+R+        +    V  ++
Sbjct: 127 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS----VVVTL 179

Query: 739 GYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE 798
            Y APE       +T  D +S G +  EMF  K       +          +GLP +   
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME 858
             D A+  +A   ++    +          E+   +L     C    P  R+    A+  
Sbjct: 240 PRDVALPRQAFHSKS---AQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSALSH 293

Query: 859 --LQEAQKMRQ 867
              Q+ ++ ++
Sbjct: 294 PYFQDLERCKE 304

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  135 bits (341), Expect = 1e-35
 Identities = 54/269 (20%), Positives = 91/269 (33%), Gaps = 25/269 (9%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIIT 623
           +++G G +  V        +  VA+K +  +   G   S   E   L  I+H N+V +  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
              S          L+ + +  G L + + +K                 +   V + ++Y
Sbjct: 75  IYES-----GGHLYLIMQLVSGGELFDRIVEK-------GFYTERDASRLIFQVLDAVKY 122

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
           LH                  LD +    + DFGLS++    S   T      G+ GYVAP
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST----ACGTPGYVAP 178

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPA 803
           E  A    S   D +S G++   +  G  P  D  +  L   +  K              
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-FEQILKAEYEFD--SPYWDD 235

Query: 804 ILEEALEIQAGIVKELQ--PNLRAKFHEI 830
           I + A +    I   ++  P  R    + 
Sbjct: 236 ISDSAKDF---IRHLMEKDPEKRFTCEQA 261

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  137 bits (345), Expect = 1e-35
 Identities = 49/251 (19%), Positives = 92/251 (36%), Gaps = 27/251 (10%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDL------QQRGASKSFIAECEALRSIR 614
           FS   +IG GG+G VY           A+K LD       Q    + +       + +  
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
              +V +  +  +      +  + + + M  G L   L+Q                   A
Sbjct: 66  CPFIVCMSYAFHT-----PDKLSFILDLMNGGDLHYHLSQHGVFSEA-------DMRFYA 113

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRV 734
            ++   LE++H+     +V+ DLKP+N+LLD      + D GL+         +      
Sbjct: 114 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF-----SKKKPHAS 165

Query: 735 KGSIGYVAPEYGALGE-VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP 793
            G+ GY+APE    G    +  D +S G ++ ++  G  P      +         + + 
Sbjct: 166 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 225

Query: 794 DQVAEIIDPAI 804
            ++ +   P +
Sbjct: 226 VELPDSFSPEL 236

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 1e-35
 Identities = 54/270 (20%), Positives = 105/270 (38%), Gaps = 31/270 (11%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
            +G G +G V++ +  + +     K + ++          E   L   RHRN++ +  S 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESF 70

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
            S      E   +++EF+    +   +N          +LN  + +S    V   L++LH
Sbjct: 71  ES-----MEELVMIFEFISGLDIFERINTS------AFELNEREIVSYVHQVCEALQFLH 119

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHV--GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAP 743
            H    I H D++P N++      + +   +FG +R L      +     +  +  Y AP
Sbjct: 120 SHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL----LFTAPEYYAP 172

Query: 744 EYGALGEVSTHGDEYSFGILMLEMFTGKRP-TDDMFEEGLSLHKYAKMGLPDQVAEIIDP 802
           E      VST  D +S G L+  + +G  P   +  ++ +     A+    ++  + I  
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232

Query: 803 AILEEALEIQAGIVKELQ--PNLRAKFHEI 830
               EA++    + + L      R    E 
Sbjct: 233 ----EAMDF---VDRLLVKERKSRMTASEA 255

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  135 bits (341), Expect = 1e-35
 Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 25/238 (10%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKI 621
             +G G +G V+           A+KVL    + +    +    E   L  + H  ++++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
             +         +   ++ +++  G L +          +  +         A +V   L
Sbjct: 70  WGTFQD-----AQQIFMIMDYIEGGELFSL-------LRKSQRFPNPVAKFYAAEVCLAL 117

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           EYLH      I++ DLKP N+LLD      + DFG ++ + D       T  + G+  Y+
Sbjct: 118 EYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYI 168

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFTGKRP-TDDMFEEGLSLHKYAKMGLPDQVAE 798
           APE  +    +   D +SFGIL+ EM  G  P  D    +       A++  P    E
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 226

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 3e-35
 Identities = 66/299 (22%), Positives = 120/299 (40%), Gaps = 20/299 (6%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKII 622
             IG G +G V+K         VA+K + ++  + G   + + E + L+ ++H N+V +I
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 623 TSCSSIDTRGNEFKA---LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
             C +  +  N  K    LV++F  +       N          K  +            
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM---------- 125

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQ-TSTSRVKGSI 738
           +L  L++     I+H D+K +NVL+  + V  + DFGL+R        Q    +    ++
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 739 GYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRP-TDDMFEEGLSLHKYAKMGLPDQV 796
            Y  PE      +     D +  G +M EM+T       +  +  L+L       +  +V
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245

Query: 797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDA 855
              +D   L E LE+  G  ++++  L+A   +     L   +L  +  P  R+   DA
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD--PAQRIDSDDA 302

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  132 bits (334), Expect = 4e-35
 Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 35/231 (15%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDL---------QQRGASKSFIAECEA 609
           E +    ++G G    V + I        AVK++D+         + +   ++ + E + 
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 610 LRSIR-HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLM 668
           LR +  H N++++  +  +     N F  LV++ M  G L ++L +       +  L+  
Sbjct: 63  LRKVSGHPNIIQLKDTYET-----NTFFFLVFDLMKKGELFDYLTE-------KVTLSEK 110

Query: 669 QRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQ 728
           +   I   +  V+  LH      IVH DLKP N+LLD++M   + DFG S  L       
Sbjct: 111 ETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--- 164

Query: 729 TSTSRVKGSIGYVAPEYGALGEVSTHG------DEYSFGILMLEMFTGKRP 773
                V G+  Y+APE         H       D +S G++M  +  G  P
Sbjct: 165 -KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 9e-35
 Identities = 66/287 (22%), Positives = 113/287 (39%), Gaps = 39/287 (13%)

Query: 565 NLIGIGGYGYVYKGIL-------GTEETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RH 615
             +G G +G V                T VAVK+L            I+E E ++ I +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 616 RNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQK---------EDEQNQRPKLN 666
           +N++ ++ +C+      +    ++ E+   G+L  +L  +             N   +L+
Sbjct: 79  KNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 667 LMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSP 726
               +S A  VA  +EYL        +H DL   NVL+  + V  + DFGL+R +H    
Sbjct: 134 SKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHID- 189

Query: 727 DQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLH 785
               T+  +  + ++APE       +   D +SFG+L+ E+FT G  P   +  E   L 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--ELF 247

Query: 786 KYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQ--PNLRAKFHEI 830
           K  K G               E   +   +       P+ R  F ++
Sbjct: 248 KLLKEGHRMD----KPSNCTNELYMM---MRDCWHAVPSQRPTFKQL 287

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 2e-34
 Identities = 51/271 (18%), Positives = 102/271 (37%), Gaps = 26/271 (9%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEAL-RSIRHRNLVKIITS 624
           ++G+G  G V +      +   A+K+L    +        E E   R+ +  ++V+I+  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73

Query: 625 CSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYL 684
             ++         +V E +  G L + +  + D+          +   I   +   ++YL
Sbjct: 74  YENLYAGRKCL-LIVMECLDGGELFSRIQDRGDQ-----AFTEREASEIMKSIGEAIQYL 127

Query: 685 HHHCHTSIVHCDLKPSNVLLDNEM---VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
           H     +I H D+KP N+L  ++    +  + DFG ++    ++   T       +  YV
Sbjct: 128 HSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT----PCYTPYYV 180

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD-QVAEII 800
           APE     +     D +S G++M  +  G  P        +S     ++ +   +     
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240

Query: 801 DPAILEEALE-IQAGIVKELQPNLRAKFHEI 830
              + EE    I+  +  E  P  R    E 
Sbjct: 241 WSEVSEEVKMLIRNLLKTE--PTQRMTITEF 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-34
 Identities = 53/237 (22%), Positives = 92/237 (38%), Gaps = 23/237 (9%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEAL-RSIRHRNLVK 620
            ++G G +G V+           A+K L    +      +  + E   L  +  H  L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 621 IITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANV 680
           +  +  +      E    V E++  G L   +           K +L +    A ++   
Sbjct: 68  MFCTFQT-----KENLFFVMEYLNGGDLMYHIQS-------CHKFDLSRATFYAAEIILG 115

Query: 681 LEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           L++LH      IV+ DLK  N+LLD +    + DFG+ +   +N      T+   G+  Y
Sbjct: 116 LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNTFCGTPDY 169

Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP-TDDMFEEGLSLHKYAKMGLPDQV 796
           +APE     + +   D +SFG+L+ EM  G+ P      EE     +      P  +
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL 226

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 4e-34
 Identities = 59/299 (19%), Positives = 110/299 (36%), Gaps = 22/299 (7%)

Query: 561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVK 620
           ++   +IG G +G VY+  L      VA+K +   +R        E + +R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVR 77

Query: 621 IITSC-SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
           +     SS + +   +  LV +++P        +    +Q     L ++        +  
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ----TLPVIYVKLYMYQLFR 133

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNE-MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSI 738
            L Y+H      I H D+KP N+LLD +  V  + DFG ++ L    P+ +         
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS----R 186

Query: 739 GYVAPEYGALGEVSTHG-DEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA 797
            Y APE        T   D +S G ++ E+  G+            L +  K+       
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTRE 245

Query: 798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAI 856
           +I +        +             R +     +++    +L     P  R+   +A 
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS-RLLEYT--PTARLTPLEAC 301

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (326), Expect = 7e-34
 Identities = 45/274 (16%), Positives = 95/274 (34%), Gaps = 25/274 (9%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
            IG G +G +Y G        VA+K+  ++ +        E +  + ++    +  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
            +      ++  +V E +     + +            K +L   L +A  + + +EY+H
Sbjct: 72  GA----EGDYNVMVMELLGPSLEDLFNFCS-------RKFSLKTVLLLADQMISRIEYIH 120

Query: 686 HHCHTSIVHCDLKPSNVL---LDNEMVAHVGDFGLSRLLHDNSPDQT----STSRVKGSI 738
                + +H D+KP N L        + ++ DFGL++   D    Q         + G+ 
Sbjct: 121 SK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 739 GYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMF-EEGLSLHKYAKMGLPDQVA 797
            Y +       E S   D  S G +++    G  P   +        ++           
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237

Query: 798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQ 831
           E++      E           L+ + +  +  ++
Sbjct: 238 EVLCKGYPSEFATYLNFCRS-LRFDDKPDYSYLR 270

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 3e-33
 Identities = 65/300 (21%), Positives = 111/300 (37%), Gaps = 22/300 (7%)

Query: 559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVL--DLQQRGASKSFIAECEALRSIRHR 616
           E F     IG G YG VYK         VA+K +  D +  G   + I E   L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAID 676
           N+VK++    +          LV+EF+      +   +K  + +    + L    S    
Sbjct: 62  NIVKLLDVIHT-----ENKLYLVFEFL------HQDLKKFMDASALTGIPLPLIKSYLFQ 110

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
           +   L + H H    ++H DLKP N+L++ E    + DFGL+R      P +T T  V  
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVT 165

Query: 737 SIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV 796
                          ST  D +S G +  EM T +       E       +  +G PD+V
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225

Query: 797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAI 856
                 ++ +          ++    +     + +  + +         P  R+  + A+
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQ----MLHYDPNKRISAKAAL 281

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 4e-33
 Identities = 58/298 (19%), Positives = 110/298 (36%), Gaps = 29/298 (9%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR-----GASKSFIAECEALRSIRHRNLV 619
           + +G G +  VYK         VA+K + L  R     G +++ + E + L+ + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 620 KIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVAN 679
            ++ +            +LV++FM               ++    L      +  +    
Sbjct: 64  GLLDAFGH-----KSNISLVFDFMETDLEVII-------KDNSLVLTPSHIKAYMLMTLQ 111

Query: 680 VLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIG 739
            LEYLH H    I+H DLKP+N+LLD   V  + DFGL++          + +    +  
Sbjct: 112 GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS---PNRAYTHQVVTRW 165

Query: 740 YVAPE-YGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE 798
           Y APE            D ++ G ++ E+           +       +  +G P +  +
Sbjct: 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE-EQ 224

Query: 799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAI 856
             D   L + +  ++     L     A   ++   I    +      P  R+    A+
Sbjct: 225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG--LFLFN--PCARITATQAL 278

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 5e-33
 Identities = 59/293 (20%), Positives = 108/293 (36%), Gaps = 22/293 (7%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKII 622
             IG G YG V+K         VA+K + L     G   S + E   L+ ++H+N+V++ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
               S     ++   LV+EF      + + +   D   +  K  L Q          +L+
Sbjct: 68  DVLHS-----DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ----------LLK 112

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
            L      +++H DLKP N+L++      + +FGL+R      P +  ++ V        
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPP 170

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDP 802
                    ST  D +S G +  E+    RP     +    L +  ++       +    
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230

Query: 803 AILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDA 855
             L +              N+  K +     +L+  +L     P  R+  ++A
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ-NLLKCN--PVQRISAEEA 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  126 bits (318), Expect = 8e-33
 Identities = 42/277 (15%), Positives = 86/277 (31%), Gaps = 29/277 (10%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
            IG G +G +++G        VA+K     +R  +     E    + +     +  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 626 SSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLH 685
                       LV + +     +              K ++      A  +   ++ +H
Sbjct: 70  GQEG----LHNVLVIDLLGPSLEDLL-------DLCGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 686 HHCHTSIVHCDLKPSNVLLDNEMVAHVG-----DFGLSRLLHDNSPDQT----STSRVKG 736
                 +V+ D+KP N L+      +       DFG+ +   D    Q         + G
Sbjct: 119 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 737 SIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV 796
           +  Y++       E S   D  + G + +    G  P   +        KY ++G   Q 
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-KQKYERIGEKKQS 234

Query: 797 AEI--IDPAILEEALEIQAGIVKELQPNLRAKFHEIQ 831
             +  +     EE  +      + L  +    +  +Q
Sbjct: 235 TPLRELCAGFPEEFYKY-MHYARNLAFDATPDYDYLQ 270

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-32
 Identities = 49/304 (16%), Positives = 99/304 (32%), Gaps = 56/304 (18%)

Query: 541 SIEDKYLKISYAELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDL------ 594
           +++D Y      +  +          +G G +  V K    +     A K +        
Sbjct: 7   NVDDYY------DTGE---------ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSS 51

Query: 595 QQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQ 654
           ++  + +    E   L+ I+H N++ +     +          L+ E +  G L ++   
Sbjct: 52  RRGVSREDIEREVSILKEIQHPNVITLHEVYEN-----KTDVILILELVAGGELFDF--- 103

Query: 655 KEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVA---- 710
                 ++  L   +          +L  +++     I H DLKP N++L +  V     
Sbjct: 104 ----LAEKESLTEEEATEFL---KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRI 156

Query: 711 HVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG 770
            + DFGL+  +            + G+  +VAPE      +    D +S G++   + +G
Sbjct: 157 KIIDFGLAHKIDFG----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

Query: 771 KRP-TDDMFEEGLSLHKYAKMGLPDQVAEIIDPA---ILEEALEIQAGIVKELQPNLRAK 826
             P   D  +E L+          D+            +   L           P  R  
Sbjct: 213 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK--------DPKKRMT 264

Query: 827 FHEI 830
             + 
Sbjct: 265 IQDS 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-31
 Identities = 50/246 (20%), Positives = 89/246 (36%), Gaps = 30/246 (12%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVL------DLQQRGASKSFIAECEALRSIR--HRN 617
           L+G GG+G VY GI  ++   VA+K +      D  +         E   L+ +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 618 LVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDV 677
           +++++           +   L+ E             +      R  L      S    V
Sbjct: 71  VIRLLDWFER-----PDSFVLILERPEPVQDLFDFITE------RGALQEELARSFFWQV 119

Query: 678 ANVLEYLHHHCHTSIVHCDLKPSNVLLD-NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
              + + H+     ++H D+K  N+L+D N     + DFG   LL D     T  +   G
Sbjct: 120 LEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----TVYTDFDG 171

Query: 737 SIGYVAPEYGALGEVSTHG-DEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ 795
           +  Y  PE+             +S GIL+ +M  G  P +   EE +    + +  +  +
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-EEIIRGQVFFRQRVSSE 230

Query: 796 VAEIID 801
              +I 
Sbjct: 231 CQHLIR 236

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  122 bits (306), Expect = 2e-31
 Identities = 65/296 (21%), Positives = 113/296 (38%), Gaps = 28/296 (9%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKII 622
             IG G YG VYK      ET  A+K + L++   G   + I E   L+ ++H N+VK+ 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
               +      +   LV+E +     +     +   ++   K  L+Q          +L 
Sbjct: 67  DVIHT-----KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ----------LLN 111

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
            + +     ++H DLKP N+L++ E    + DFGL+R      P +  T  +        
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAP 169

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDP 802
                  + ST  D +S G +  EM  G      + E    +  +  +G P+       P
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN---SKNWP 226

Query: 803 AILEEALEIQAGIVKELQP--NLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAI 856
            + E         V E  P  +      E  + +L   +L  +  P  R+  + A+
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS-KMLKLD--PNQRITAKQAL 279

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 3e-31
 Identities = 58/293 (19%), Positives = 97/293 (33%), Gaps = 22/293 (7%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVL--DLQQRGASKSFIAECEALRSIRHRNLVKIIT 623
            +G G YG V   + G     VA+K L    Q    +K    E   L+ +RH N++ ++ 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 624 SCSSIDTRGNEFK-ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
             +  +T  +     LV  FM              +  +  KL   +   +   +   L 
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTD---------LGKLMKHEKLGEDRIQFLVYQMLKGLR 135

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           Y+H        H DLKP N+ ++ +    + DFGL+R       D   T  V        
Sbjct: 136 YIHAAGII---HRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAP 187

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDP 802
                    +   D +S G +M EM TGK                   G P    E +  
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA--EFVQR 245

Query: 803 AILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDA 855
              +EA     G+ +  + +  +         + +           R+   +A
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-30
 Identities = 47/236 (19%), Positives = 89/236 (37%), Gaps = 22/236 (9%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLD---LQQRGASKSFIAECEALRSIRHRNLVKI 621
            L+G G +G V            A+K+L    +  +      + E   L++ RH  L  +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 622 ITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
             +  +     ++    V E+   G L   L+++     +R               A ++
Sbjct: 71  KYAFQT-----HDRLCFVMEYANGGELFFHLSRERVFTEER----------ARFYGAEIV 115

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYV 741
             L +     +V+ D+K  N++LD +    + DFGL +       D  +     G+  Y+
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS---DGATMKTFCGTPEYL 172

Query: 742 APEYGALGEVSTHGDEYSFGILMLEMFTGKRP-TDDMFEEGLSLHKYAKMGLPDQV 796
           APE     +     D +  G++M EM  G+ P  +   E    L    ++  P  +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL 228

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  119 bits (300), Expect = 6e-30
 Identities = 57/276 (20%), Positives = 101/276 (36%), Gaps = 26/276 (9%)

Query: 526 QRRKRRRRSKALVNSSIEDKYLKISYAELLKAT-EGFSSANLIGIGGYGYVYKGILGTEE 584
           ++   +   K  +  + ED   K        A  + F     +G G +G V         
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66

Query: 585 TNVAVKVLDLQQRGASK---SFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVYE 641
            + A+K+LD Q+    K     + E   L+++    LVK+  S              V E
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM-----VME 121

Query: 642 FMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSN 701
           ++  G + + L +         + +       A  +    EYLH      +++ DLKP N
Sbjct: 122 YVAGGEMFSHLRR-------IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPEN 171

Query: 702 VLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFG 761
           +L+D +    V DFG ++ +         T  + G+   +APE       +   D ++ G
Sbjct: 172 LLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALG 225

Query: 762 ILMLEMFTGKRP-TDDMFEEGLSLHKYAKMGLPDQV 796
           +L+ EM  G  P   D   +        K+  P   
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  116 bits (291), Expect = 6e-29
 Identities = 58/305 (19%), Positives = 107/305 (35%), Gaps = 43/305 (14%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIIT 623
             +G G Y  V++ I  T    V VK+L   ++   K    E + L ++R   N++ +  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLAD 97

Query: 624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEY 683
                    +   ALV+E + N   +               L          ++   L+Y
Sbjct: 98  IVKDPV---SRTPALVFEHVNNTDFKQLYQ----------TLTDYDIRFYMYEILKALDY 144

Query: 684 LHHHCHTSIVHCDLKPSNVLLDNE-MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
            H      I+H D+KP NV++D+E     + D+GL+   H         +    S  +  
Sbjct: 145 CHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKG 197

Query: 743 PEYGALGEVSTHG-DEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIID 801
           PE     ++  +  D +S G ++  M   K P     +    L + AK+   + + + ID
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257

Query: 802 PAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEEL-----------PRDRM 850
              +E        + +  +       H           L S E             + R+
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHS------ENQHLVSPEALDFLDKLLRYDHQSRL 311

Query: 851 KIQDA 855
             ++A
Sbjct: 312 TAREA 316

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 1e-28
 Identities = 54/293 (18%), Positives = 93/293 (31%), Gaps = 20/293 (6%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVL--DLQQRGASKSFIAECEALRSIRHRNLVKII 622
           + +G G YG V           VAVK L    Q    +K    E   L+ ++H N++ ++
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
              +   +        +   +    L N          +  KL       +   +   L+
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNI--------VKCQKLTDDHVQFLIYQILRGLK 135

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           Y+H        H DLKPSN+ ++ +    + DFGL+        D   T  V        
Sbjct: 136 YIHSADII---HRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRAP 187

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAEIIDP 802
                    +   D +S G +M E+ TG+                  +G P   AE++  
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG--AELLKK 245

Query: 803 AILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDA 855
              E A      + +  + N    F       + +           R+    A
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 6e-27
 Identities = 48/231 (20%), Positives = 86/231 (37%), Gaps = 20/231 (8%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVL--DLQQRGASKSFIAECEALRSIRHRNLVKIIT 623
            IG G  G V        + NVA+K L    Q +  +K    E   ++ + H+N++ ++ 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 624 SCSSIDTRGNEFK-ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLE 682
             +   T        LV E M     +    + + E+             +   +   ++
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER----------MSYLLYQMLCGIK 133

Query: 683 YLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVA 742
           +LH       +H DLKPSN+++ ++    + DFGL+R    +       +    +  Y A
Sbjct: 134 HLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTPYVVTRYYRA 186

Query: 743 PEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP 793
           PE         + D +S G +M EM   K                 ++G P
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 4e-26
 Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 27/219 (12%)

Query: 565 NLIGIGGYGYVYKGILGTEETN---VAVKVLD----LQQRGASKSFIAECEALRSIRHR- 616
            ++G G YG V+     +        A+KVL     +Q+   ++    E + L  IR   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 617 NLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAID 676
            LV +  +  +          L+ +++  G L   L+Q+E       ++ + +       
Sbjct: 90  FLVTLHYAFQT-----ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE------- 137

Query: 677 VANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKG 736
              ++  L H     I++ D+K  N+LLD+     + DFGLS+    +  +        G
Sbjct: 138 ---IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD--ETERAYDFCG 192

Query: 737 SIGYVAPEYGALGE--VSTHGDEYSFGILMLEMFTGKRP 773
           +I Y+AP+    G+       D +S G+LM E+ TG  P
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  104 bits (259), Expect = 2e-24
 Identities = 89/415 (21%), Positives = 158/415 (38%), Gaps = 51/415 (12%)

Query: 36  NLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSA 95
            L + +   L   N T ++ Q+  +L  +  L      +  +I   +  L  L     S 
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75

Query: 96  NYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSI 155
           N LT   P++  N++ +    +  N++    P      L  + +    +     +   ++
Sbjct: 76  NQLTDITPLK--NLTKLVDILMNNNQIADITPLANLTNLTGLTLF--NNQITDIDPLKNL 131

Query: 156 SNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVL 215
           +N + +      + ++  L+   +      GN +  L  L N T LE + +SSN    V 
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK---VS 188

Query: 216 PNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQ 275
             S+    ++L  L  + N+IS   P G+                             L 
Sbjct: 189 DISVLAKLTNLESLIATNNQISDITPLGILT--------------------------NLD 222

Query: 276 VLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGT 335
            LSL GN++      +L +L  LT++DL  N I    P  L    +L +L L  N +S  
Sbjct: 223 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI 278

Query: 336 IPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLE 395
            P  + GL++   L+L+ N         +  LK +  L L  N +S   P  ++S   L+
Sbjct: 279 SP--LAGLTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQ 332

Query: 396 YLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFN 450
            L F++N       S  ++L  +  L    N  S   P  L     + +L L+  
Sbjct: 333 RLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  102 bits (255), Expect = 6e-24
 Identities = 83/390 (21%), Positives = 141/390 (36%), Gaps = 29/390 (7%)

Query: 14  SELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENS 73
           +E     L    +   +     +L ++  L         SI   +  L+ L Q++ S N 
Sbjct: 22  AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQ 77

Query: 74  LSGNIPSELGLLKQLNMFQVSANYLTG-SIPIQLFNISSMDYFAVTQNKLVGEIPHYVGF 132
           L+   P  L  L +L    ++ N +   +    L N++ +  F      +          
Sbjct: 78  LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135

Query: 133 TLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFL 192
            L      +   +  +G       +  +   DL  L NL               N +  +
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLT-----TLERLDISSNKVSDI 190

Query: 193 DSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLIL 252
             L   T LE +  ++N +S + P       ++L  L ++ N++       + +L NL  
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPL---GILTNLDELSLNGNQLKD--IGTLASLTNLTD 245

Query: 253 IAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSI 312
           + +  N ++   P  +  L KL  L L  N+IS   P  L  L  LT ++L  N +    
Sbjct: 246 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS 301

Query: 313 PSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQ 372
           P    N   L  L L  NN+S   P  V  L+    L  + N +S    L    L  I  
Sbjct: 302 PI--SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSL--ANLTNINW 355

Query: 373 LDLSENKLSGEIPTSLASCVGLEYLNFSDN 402
           L    N++S   P  LA+   +  L  +D 
Sbjct: 356 LSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 89.3 bits (220), Expect = 2e-19
 Identities = 69/358 (19%), Positives = 124/358 (34%), Gaps = 47/358 (13%)

Query: 9   NITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGL------------TGNNYTGSIPQ 56
            + + + L  ++   N+L    P  L NL KLV + +               N TG    
Sbjct: 61  GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF 118

Query: 57  SLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFA 116
           +          +L+  +      + +  +  L+          G+    L  ++++    
Sbjct: 119 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLE 178

Query: 117 VTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNF 176
                        V   L N+  L+  +N  +   P  I              NL  L+ 
Sbjct: 179 RLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT------------NLDELSL 226

Query: 177 ARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRI 236
                    GN L+ + +L + T L  + L++N +S + P S     + L  L + AN+I
Sbjct: 227 --------NGNQLKDIGTLASLTNLTDLDLANNQISNLAPLS---GLTKLTELKLGANQI 275

Query: 237 SGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLI 296
           S   P  +  L  L  + +  N       + +  L  L  L+L+ N IS   P  + +L 
Sbjct: 276 SNISP--LAGLTALTNLELNEN--QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLT 329

Query: 297 FLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRN 354
            L  +    N +     S+L N   +  L    N +S   P  +  L+    L L+  
Sbjct: 330 KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 80.4 bits (197), Expect = 1e-16
 Identities = 67/330 (20%), Positives = 112/330 (33%), Gaps = 32/330 (9%)

Query: 134 LPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLD 193
           L N+  +   +N  T   P            L  L  L+ +    N +            
Sbjct: 65  LNNLTQINFSNNQLTDITP------------LKNLTKLVDILMNNNQIADITPLANLTNL 112

Query: 194 SLVNCTFLEVVSLSSNSLSGVLP------NSIANFSSHLIYLYMSANRISGTIPTGVGNL 247
           + +     ++  +        L       N+I++ S+      +        +       
Sbjct: 113 TGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLA 172

Query: 248 KNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNS 307
               L  ++++    S  + +  L  L+ L    N+IS   P  +     L E+ L GN 
Sbjct: 173 NLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQ 230

Query: 308 IRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRL 367
           ++      L +   L  LDL++N +S   P    GL+    L L  N +S   PL    L
Sbjct: 231 LKD--IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNISPLA--GL 284

Query: 368 KGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNN 427
             +  L+L+EN+L    P S  +   L YL    N+         SSL  LQ L  + N 
Sbjct: 285 TALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNK 340

Query: 428 FSGKIPMFLNTFRFLQKLNLSFNNLEGEVP 457
            S      L     +  L+   N +    P
Sbjct: 341 VSD--VSSLANLTNINWLSAGHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 69.6 bits (169), Expect = 5e-13
 Identities = 73/409 (17%), Positives = 132/409 (32%), Gaps = 72/409 (17%)

Query: 117 VTQNKLVGEIPHYVGFTLPNIR---VLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIR 173
           +TQ+  + +I     FT   +      +LG    T  +  +             L  +  
Sbjct: 6   ITQDTPINQI-----FTDTALAEKMKTVLGKTNVTDTVSQT------------DLDQVTT 48

Query: 174 LNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLP------------NSIAN 221
           L   R  + +        +D +     L  ++ S+N L+ + P            N+   
Sbjct: 49  LQADRLGIKS--------IDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQI 100

Query: 222 FSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFG 281
                +    +   ++              L  +    L+ +  + +  L  L  L    
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160

Query: 282 NKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI 341
                     L NL  L  +D+  N +             L+ L  ++N +S   P  ++
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDITPLGIL 218

Query: 342 GLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSD 401
             ++   L L+ N L     L    L  +  LDL+ N++S   P  L+    L  L    
Sbjct: 219 --TNLDELSLNGNQLKDIGTL--ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272

Query: 402 NSFQGPI--------------------HSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRF 441
           N                           S  S+LK L  L L  NN S   P  +++   
Sbjct: 273 NQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTK 330

Query: 442 LQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPELHLHSCRS 490
           LQ+L  + N +   V S     N+  +S  G+N++   +P  +L     
Sbjct: 331 LQRLFFANNKVSD-VSSLANLTNINWLS-AGHNQISDLTPLANLTRITQ 377

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.5 bits (122), Expect = 3e-07
 Identities = 18/71 (25%), Positives = 32/71 (45%), Gaps = 6/71 (8%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           +    P  ++  ++L+ L    NK+     S L NL  +  L    N  +   P  L+NL
Sbjct: 319 ISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANL 372

Query: 62  SFLQQLSLSEN 72
           + + QL L++ 
Sbjct: 373 TRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.8 bits (120), Expect = 4e-07
 Identities = 28/124 (22%), Positives = 47/124 (37%), Gaps = 26/124 (20%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIP--------------------SELGNLFKLV 41
           +    P  ++  ++L  L L  N++    P                    S + NL  L 
Sbjct: 253 ISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLT 310

Query: 42  GLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGS 101
            L L  NN +   P  +S+L+ LQ+L  + N +S    S L  L  +N      N ++  
Sbjct: 311 YLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDL 366

Query: 102 IPIQ 105
            P+ 
Sbjct: 367 TPLA 370

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.0 bits (118), Expect = 6e-07
 Identities = 34/159 (21%), Positives = 57/159 (35%), Gaps = 29/159 (18%)

Query: 7   PANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIP----------- 55
              +   + L  LDL  N++    P  L  L KL  L L  N  +   P           
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291

Query: 56  ---------QSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQL 106
                      +SNL  L  L+L  N++S   P  +  L +L     + N ++      L
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSL 347

Query: 107 FNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSN 145
            N++++++ +   N++    P      L  I  L L   
Sbjct: 348 ANLTNINWLSAGHNQISDLTPL---ANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 1e-04
 Identities = 42/280 (15%), Positives = 92/280 (32%), Gaps = 31/280 (11%)

Query: 246 NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQG 305
            L   +   +    +T ++  +   L ++  L      I       +  L  LT+++   
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75

Query: 306 NSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVG 365
           N +    P  L N  +L  + +++N ++   P   +   + + L  ++     P+     
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 366 ---------RLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP----IHSGF 412
                     +  I  L    +         +     L  L   +            S  
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 413 SSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIG 472
           + L  L+ L  + N  S   P+ + T   L +L+L+ N L+  + +     N+  +  + 
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD-IGTLASLTNLTDLD-LA 249

Query: 473 NNKLCGGSP--------ELHLHSCRSRGSRKLWQHSTFKI 504
           NN++   +P        EL L + +      L   +    
Sbjct: 250 NNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTN 289

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (255), Expect = 4e-24
 Identities = 44/310 (14%), Positives = 108/310 (34%), Gaps = 24/310 (7%)

Query: 566 LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSC 625
            +G G +  V+        T+VA+K++    +  +++   E + L+ +   +  K  +  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 626 SSIDTR----GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVL 681
           ++   +     N         +    +         ++ +   + L+    I+  +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 682 EYLHHHCHTSIVHCDLKPSNVLLD-NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGY 740
           +Y+H  C   I+H D+KP NVL++  +   ++    ++ L +    D+   +    +  Y
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-YTNSIQTREY 195

Query: 741 VAPEYGALGEVSTHGDEYSFGILMLEMFTGKRP--TDDMFEEGLSLHKYAKM--GLPDQV 796
            +PE           D +S   L+ E+ TG      D+           A++   L +  
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255

Query: 797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEEL----------- 845
           + ++             G+++ +         ++     +     ++E+           
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315

Query: 846 PRDRMKIQDA 855
           PR R      
Sbjct: 316 PRKRADAGGL 325

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.9 bits (234), Expect = 5e-22
 Identities = 55/254 (21%), Positives = 83/254 (32%), Gaps = 4/254 (1%)

Query: 201 LEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLL 260
            + + L  N +S V   S     +  I    S            G      L   +   L
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 261 TGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCL 320
               P +   L +L  L L    +    P     L  L  + LQ N+++        +  
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 321 QLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKL 380
            L  L L  N +S    R   GL S   L L +N ++   P     L  +  L L  N L
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213

Query: 381 SGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFR 440
           S     +LA    L+YL  +DN +     +       LQ    S +     +P       
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLP---QRLA 269

Query: 441 FLQKLNLSFNNLEG 454
                 L+ N+L+G
Sbjct: 270 GRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.5 bits (220), Expect = 4e-20
 Identities = 56/277 (20%), Positives = 98/277 (35%), Gaps = 9/277 (3%)

Query: 203 VVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTG 262
             S     L  V P       +    +++  NRIS          +NL ++ +  N+L  
Sbjct: 15  TTSCPQQGLQAV-P---VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70

Query: 263 SIPTSVGYLLKLQVLSLFGNKISGEI-PSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQ 321
               +   L  L+ L L  N     + P++   L  L  + L    ++   P        
Sbjct: 71  IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130

Query: 322 LQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLS 381
           LQ L L DN L          L +   L L  N +S         L  + +L L +N+++
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190

Query: 382 GEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRF 441
              P +      L  L    N+         + L+ LQ L L+ N +          + +
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAW 249

Query: 442 LQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCG 478
           LQK   S + +   +P     ++++ ++    N L G
Sbjct: 250 LQKFRGSSSEVPCSLPQRLAGRDLKRLA---ANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.7 bits (205), Expect = 3e-18
 Identities = 50/306 (16%), Positives = 98/306 (32%), Gaps = 47/306 (15%)

Query: 53  SIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSM 112
           ++P  +      Q++ L  N +S    +     + L +  + +N L          ++ +
Sbjct: 25  AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 113 DYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLI 172
           +   ++ N  +  +       L  +  L L         P                    
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP-------------------- 122

Query: 173 RLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMS 232
                                       L+ + L  N+L  +  ++  +   +L +L++ 
Sbjct: 123 --------------------GLFRGLAALQYLYLQDNALQALPDDTFRDL-GNLTHLFLH 161

Query: 233 ANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSL 292
            NRIS         L +L  + +  N +    P +   L +L  L LF N +S     +L
Sbjct: 162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221

Query: 293 GNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLS 352
             L  L  + L  N       +       LQK   S + +  ++P+ + G     L  L+
Sbjct: 222 APLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRD---LKRLA 277

Query: 353 RNHLSG 358
            N L G
Sbjct: 278 ANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.0 bits (146), Expect = 1e-10
 Identities = 40/283 (14%), Positives = 73/283 (25%), Gaps = 49/283 (17%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSI---------- 54
            +P  I   +  + + L  N++     +       L  L L  N                
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 55  ---------------PQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLT 99
                          P +   L  L  L L    L    P     L  L    +  N L 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 100 GSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNAS 159
                   ++ ++ +  +  N++   +P      L ++  LLL  N      P +     
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHA----- 196

Query: 160 SIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSI 219
                         L                  ++L     L+ + L+ N          
Sbjct: 197 -----------FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--A 243

Query: 220 ANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTG 262
               + L     S++ +  ++P     L    L  +  N L G
Sbjct: 244 RPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.8 bits (117), Expect = 6e-07
 Identities = 28/147 (19%), Positives = 43/147 (29%), Gaps = 28/147 (19%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           LQ            L  L L  N++          L  L  L L  N      P +  +L
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200

Query: 62  SF------------------------LQQLSLSENSLSGNIPSELGLLKQLNMFQVSANY 97
                                     LQ L L++N    +  +   L   L  F+ S++ 
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSE 259

Query: 98  LTGSIPIQLFNISSMDYFAVTQNKLVG 124
           +  S+P +L          +  N L G
Sbjct: 260 VPCSLPQRLAGRDLKR---LAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.7 bits (96), Expect = 2e-04
 Identities = 27/142 (19%), Positives = 46/142 (32%), Gaps = 4/142 (2%)

Query: 349 LDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPI 408
               +  L   +P+ +      Q++ L  N++S     S  +C  L  L    N      
Sbjct: 16  TSCPQQGLQA-VPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72

Query: 409 HSGFSSLKGLQDLDLSRNNFSGKI-PMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRA 467
            + F+ L  L+ LDLS N     + P   +    L  L+L    L+   P          
Sbjct: 73  AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132

Query: 468 VSIIGNNKLCGGSPELHLHSCR 489
              + +N L     +       
Sbjct: 133 YLYLQDNALQALPDDTFRDLGN 154

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 94.7 bits (234), Expect = 8e-22
 Identities = 54/254 (21%), Positives = 100/254 (39%), Gaps = 9/254 (3%)

Query: 201 LEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLL 260
           L VV  S   L  V      +       L +  N+I+        NLKNL  + +  N +
Sbjct: 12  LRVVQCSDLGLEKVP----KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 261 TGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCL 320
           +   P +   L+KL+ L L  N++          L  L   + +   +R S+ + L   +
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127

Query: 321 QLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKL 380
            ++ L  +    SG       G+     + ++  +++    +  G    + +L L  NK+
Sbjct: 128 VVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKI 183

Query: 381 SGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFR 440
           +     SL     L  L  S NS     +   ++   L++L L+ N    K+P  L   +
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 242

Query: 441 FLQKLNLSFNNLEG 454
           ++Q + L  NN+  
Sbjct: 243 YIQVVYLHNNNISA 256

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 83.5 bits (205), Expect = 6e-18
 Identities = 62/297 (20%), Positives = 97/297 (32%), Gaps = 30/297 (10%)

Query: 135 PNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDS 194
           P+  +L L +N  T        N          LKNL  L    N +            +
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKN----------LKNLHTLILINNKISK------ISPGA 74

Query: 195 LVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIA 254
                 LE + LS N L   LP  +      L        ++  ++  G+  +  + L  
Sbjct: 75  FAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 133

Query: 255 MEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPS 314
                 +G    +   + KL  + +    I+  IP  L     LTE+ L GN I     +
Sbjct: 134 NP-LKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAA 189

Query: 315 ALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLD 374
           +L     L KL LS N++S      +        L L+ N L   +P  +   K IQ + 
Sbjct: 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248

Query: 375 LSENKLSG------EIPTSLASCVGLEYLNFSDNSFQ-GPIHSG-FSSLKGLQDLDL 423
           L  N +S         P           ++   N  Q   I    F  +     + L
Sbjct: 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 82.4 bits (202), Expect = 1e-17
 Identities = 47/206 (22%), Positives = 74/206 (35%), Gaps = 8/206 (3%)

Query: 274 LQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLS 333
             +L L  NKI+        NL  L  + L  N I    P A    ++L++L LS N L 
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92

Query: 334 GTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDL--SENKLSGEIPTSLASC 391
             +P ++    +   L +  N ++         L  +  ++L  +  K SG    +    
Sbjct: 93  -ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149

Query: 392 VGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNN 451
             L Y+  +D +          S   L +L L  N  +      L     L KL LSFN+
Sbjct: 150 KKLSYIRIADTNITTIPQGLPPS---LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206

Query: 452 LEGEVPSEGVFKNVRAVSIIGNNKLC 477
           +                  + NNKL 
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLV 232

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 77.0 bits (188), Expect = 9e-16
 Identities = 56/307 (18%), Positives = 112/307 (36%), Gaps = 33/307 (10%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
           ++P ++    +  +LDL  NK+      +  NL  L  L L  N  +   P + + L  L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 65  QQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVG 124
           ++L LS+N L          L++L + +     +  S+   L  +  ++           
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 125 EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTG 184
           E   + G  +  +  + +     T  IP  +              +L  L+   N +   
Sbjct: 142 ENGAFQG--MKKLSYIRIADTNIT-TIPQGL------------PPSLTELHLDGNKITKV 186

Query: 185 KGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV 244
               L+ L++L            S +    + N     + HL  L+++ N++   +P G+
Sbjct: 187 DAASLKGLNNLAKLGL-------SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 238

Query: 245 GNLKNLILIAMEVNLLTG------SIPTSVGYLLKLQVLSLFGNKIS-GEI-PSSLGNLI 296
            + K + ++ +  N ++         P           +SLF N +   EI PS+   + 
Sbjct: 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 298

Query: 297 FLTEVDL 303
               V L
Sbjct: 299 VRAAVQL 305

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 89.0 bits (219), Expect = 7e-20
 Identities = 74/308 (24%), Positives = 119/308 (38%), Gaps = 15/308 (4%)

Query: 189 LRFLDSLVNCTFLEVVSLSSN----SLSGVLPNSIANFSSHLIYLYMSANRISG--TIPT 242
           L+    L N T L     +++    +  GVL ++    +  +  L +S   +     IP+
Sbjct: 12  LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDT-DTQTYRVNNLDLSGLNLPKPYPIPS 70

Query: 243 GVGNLKNLILIAMEVNL-LTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEV 301
            + NL  L  + +     L G IP ++  L +L  L +    +SG IP  L  +  L  +
Sbjct: 71  SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130

Query: 302 DLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREV-IGLSSFVLLDLSRNHLSGPI 360
           D   N++ G++P ++ +   L  +    N +SG IP         F  + +SRN L+G I
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190

Query: 361 PLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQD 420
           P     L                     +     +     ++        G S      D
Sbjct: 191 PPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLD 250

Query: 421 LDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGS 480
           L    N   G +P  L   +FL  LN+SFNNL GE+P  G  +     +   N  LCG  
Sbjct: 251 L--RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS- 307

Query: 481 PELHLHSC 488
               L +C
Sbjct: 308 ---PLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 81.7 bits (200), Expect = 2e-17
 Identities = 64/288 (22%), Positives = 104/288 (36%), Gaps = 25/288 (8%)

Query: 35  GNLFKLVGLGLTGNNYTG--SIPQSLSNLSFLQQLSLSEN-SLSGNIPSELGLLKQLNMF 91
              +++  L L+G N      IP SL+NL +L  L +    +L G IP  +  L QL+  
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 92  QVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEI 151
            ++   ++G+IP  L  I ++     + N L G +P  +  +LPN+  +    N  +G I
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI-SSLPNLVGITFDGNRISGAI 165

Query: 152 PPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSL 211
           P S  + S +   +   +N +                    + L                
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDAS----------- 214

Query: 212 SGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYL 271
                  +   S         A          VG  KNL  + +  N + G++P  +  L
Sbjct: 215 -------VLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267

Query: 272 LKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNC 319
             L  L++  N + GEIP   GNL          N      P  L  C
Sbjct: 268 KFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP--LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 77.9 bits (190), Expect = 4e-16
 Identities = 70/266 (26%), Positives = 109/266 (40%), Gaps = 11/266 (4%)

Query: 9   NITHCSELRILDLVVNKLEGN--IPSELGNLFKLVGLGLTGN-NYTGSIPQSLSNLSFLQ 65
             T    +  LDL    L     IPS L NL  L  L + G  N  G IP +++ L+ L 
Sbjct: 45  TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104

Query: 66  QLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGE 125
            L ++  ++SG IP  L  +K L     S N L+G++P  + ++ ++       N++ G 
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164

Query: 126 IPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNAS------SIPEDLGKLKNLIRLNFARN 179
           IP   G        + +  N  TG+IPP+ +N +      S     G    L   +    
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQ 224

Query: 180 NLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGT 239
            +   K +    L  +     L  + L +N + G LP  +      L  L +S N + G 
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF-LHSLNVSFNNLCGE 283

Query: 240 IPTGVGNLKNLILIAMEVNLLTGSIP 265
           IP G GNL+   + A   N      P
Sbjct: 284 IPQG-GNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.6 bits (171), Expect = 1e-13
 Identities = 56/273 (20%), Positives = 101/273 (36%), Gaps = 18/273 (6%)

Query: 133 TLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFL 192
               +  L L         P        IP  L  L  L         +G          
Sbjct: 48  QTYRVNNLDLSGLNLPKPYP--------IPSSLANLPYLNF-----LYIGGINNLVGPIP 94

Query: 193 DSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLIL 252
            ++   T L  + ++  +          +    L+ L  S N +SGT+P  + +L NL+ 
Sbjct: 95  PAIAKLTQLHYLYITHTN-VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153

Query: 253 IAMEVNLLTGSIPTSVGYLLKLQV-LSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGS 311
           I  + N ++G+IP S G   KL   +++  N+++G+IP +               ++   
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT--FANLNLAFVDLSRNMLEG 211

Query: 312 IPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQ 371
             S L    +  +      N       +V    +   LDL  N + G +P  + +LK + 
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271

Query: 372 QLDLSENKLSGEIPTSLASCVGLEYLNFSDNSF 404
            L++S N L GEIP    +    +   +++N  
Sbjct: 272 SLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 66.3 bits (160), Expect = 3e-12
 Identities = 58/282 (20%), Positives = 100/282 (35%), Gaps = 23/282 (8%)

Query: 59  SNLSFLQQLSLSENSLSGN--IPSELGLLKQLNMFQVSANY-LTGSIPIQLFNISSMDYF 115
           +    +  L LS  +L     IPS L  L  LN   +     L G IP  +  ++ + Y 
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 116 AVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLN 175
            +T   + G IP ++      + +    +               ++P  +  L NL+ + 
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG-----------TLPPSISSLPNLVGIT 155

Query: 176 FARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANR 235
           F  N +     +       L     +       N L+G +P + AN +   + L  +   
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTIS-----RNRLTGKIPPTFANLNLAFVDLSRNMLE 210

Query: 236 ISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNL 295
              ++  G       I +A             VG    L  L L  N+I G +P  L  L
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSL---AFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267

Query: 296 IFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIP 337
            FL  +++  N++ G IP   GN  +      ++N      P
Sbjct: 268 KFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 48.6 bits (114), Expect = 2e-06
 Identities = 15/55 (27%), Positives = 22/55 (40%), Gaps = 1/55 (1%)

Query: 1   MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIP 55
            + G +P  +T    L  L++  N L G IP + GNL +        N      P
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 45.1 bits (105), Expect = 2e-05
 Identities = 49/232 (21%), Positives = 80/232 (34%), Gaps = 39/232 (16%)

Query: 2   LQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNL 61
           L G IP  I   ++L  L +    + G IP  L  +  LV L  + N  +G++P S+S+L
Sbjct: 89  LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148

Query: 62  SFLQQLSLSENSLSGNIPSELGLLKQL--------NMFQVSANYLTGSIPIQLFNISSMD 113
             L  ++   N +SG IP   G   +L        N           ++ +   ++S   
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM 208

Query: 114 YFAVTQNKLV--------------GEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNAS 159
                                               N+  L L +N   G +P       
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQG----- 263

Query: 160 SIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSL 211
                L +LK L  LN + NNL  G+      +    N    +V + ++N  
Sbjct: 264 -----LTQLKFLHSLNVSFNNL-CGE------IPQGGNLQRFDVSAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 43.6 bits (101), Expect = 7e-05
 Identities = 20/72 (27%), Positives = 30/72 (41%), Gaps = 3/72 (4%)

Query: 86  KQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSN 145
           K LN   +  N + G++P  L  +  +    V+ N L GEIP   G  L    V    +N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANN 301

Query: 146 -WFTGEIPPSIS 156
               G   P+ +
Sbjct: 302 KCLCGSPLPACT 313

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 77.9 bits (191), Expect = 5e-17
 Identities = 28/174 (16%), Positives = 47/174 (27%), Gaps = 31/174 (17%)

Query: 565 NLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASK----------SFIAECEALRSIR 614
            L+G G    V+            VK   +      K           F           
Sbjct: 6   KLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 615 HRNLVKIITSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIA 674
            R L K+    +       E  A++ E +    L                  +     + 
Sbjct: 65  FRALQKLQ-GLAVPKVYAWEGNAVLMELIDAKELYRV--------------RVENPDEVL 109

Query: 675 IDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRLL-HDNSPD 727
             +   +   +H     IVH DL   NVL+  E +  + DF  S  +  +   +
Sbjct: 110 DMILEEVAKFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWRE 159

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.2 bits (139), Expect = 1e-09
 Identities = 27/131 (20%), Positives = 49/131 (37%), Gaps = 4/131 (3%)

Query: 371 QQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSG 430
           Q LDL+   L  ++   L S  G+       +    P+   FS  + +Q +DLS +    
Sbjct: 3   QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60

Query: 431 K-IPMFLNTFRFLQKLNLSFNNLEGEVPSE-GVFKNVRAVSIIGNNKLCGGSPELHLHSC 488
             +   L+    LQ L+L    L   + +      N+  +++ G +     + +  L SC
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 489 RSRGSRKLWQH 499
                  L   
Sbjct: 121 SRLDELNLSWC 131

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.3 bits (108), Expect = 7e-06
 Identities = 42/306 (13%), Positives = 87/306 (28%), Gaps = 40/306 (13%)

Query: 65  QQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVG 124
           Q L L+  +L  ++   L L + +  F+   +++   +  + F+   + +  ++ + +  
Sbjct: 3   QTLDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60

Query: 125 EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFAR--NNLG 182
              H +      ++ L L     +  I  ++           K  NL+RLN +       
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTL----------AKNSNLVRLNLSGCSGFSE 110

Query: 183 TGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPT 242
                 L     L           +   +   + +     +   +  Y    + S     
Sbjct: 111 FALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTL 170

Query: 243 GVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVD 302
                  + L   +  +L          L  LQ LSL                       
Sbjct: 171 VRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC-------------------- 210

Query: 303 LQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPL 362
                I       LG    L+ L +      GT+      L     L ++ +H +     
Sbjct: 211 ---YDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARP 264

Query: 363 EVGRLK 368
            +G  K
Sbjct: 265 TIGNKK 270

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.9 bits (133), Expect = 5e-09
 Identities = 39/190 (20%), Positives = 69/190 (36%), Gaps = 6/190 (3%)

Query: 263 SIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQL 322
           ++P  +       +L L  N +     ++L     LT+++L    +           L +
Sbjct: 24  ALPPDLPKDT--TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD---GTLPV 78

Query: 323 QKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSG 382
                  +N   ++P     L +  +LD+S N L+      +  L  +Q+L L  N+L  
Sbjct: 79  LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138

Query: 383 EIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFL 442
             P  L     LE L+ ++N+         + L+ L  L L  N+    IP        L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197

Query: 443 QKLNLSFNNL 452
               L  N  
Sbjct: 198 PFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.2 bits (126), Expect = 4e-08
 Identities = 38/209 (18%), Positives = 67/209 (32%), Gaps = 8/209 (3%)

Query: 197 NCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAME 256
                  V+    +L+ + P+           L++S N +       +     L  + ++
Sbjct: 8   KVASHLEVNCDKRNLTALPPD----LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 257 VNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSAL 316
                      V   L +       +     +P     L  LT +D+  N +      AL
Sbjct: 64  RAE---LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 317 GNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLS 376
               +LQ+L L  N L    P  +        L L+ N+L+      +  L+ +  L L 
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180

Query: 377 ENKLSGEIPTSLASCVGLEYLNFSDNSFQ 405
           EN L   IP        L +     N + 
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.2 bits (108), Expect = 7e-06
 Identities = 44/211 (20%), Positives = 78/211 (36%), Gaps = 8/211 (3%)

Query: 218 SIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVL 277
            ++  +SHL  +      ++  +P  +   K+  ++ +  NLL      ++    +L  L
Sbjct: 5   EVSKVASHL-EVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 278 SLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIP 337
           +L   +++         L  L  +DL  N ++            L  LD+S N L+    
Sbjct: 61  NLDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPL 117

Query: 338 REVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYL 397
             + GL     L L  N L    P  +     +++L L+ N L+      L     L+ L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177

Query: 398 NFSDNSFQGPIHSGFSSLKGLQDLDLSRNNF 428
              +NS    I  GF     L    L  N +
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.8 bits (99), Expect = 1e-04
 Identities = 34/196 (17%), Positives = 51/196 (26%), Gaps = 28/196 (14%)

Query: 125 EIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTG 184
            +P  +     +  +L L  N        ++               L +LN  R  L   
Sbjct: 24  ALPPDLP---KDTTILHLSENLLYTFSLATLMP----------YTRLTQLNLDRAELTKL 70

Query: 185 KG-NDLRFLDSLVNCTFLEVVSLSSNSLSGV-------------LPNSIANFSSHLIYLY 230
           +    L  L +L                                LP         L  LY
Sbjct: 71  QVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130

Query: 231 MSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPS 290
           +  N +    P  +     L  +++  N LT      +  L  L  L L  N +   IP 
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189

Query: 291 SLGNLIFLTEVDLQGN 306
                  L    L GN
Sbjct: 190 GFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.4 bits (98), Expect = 1e-04
 Identities = 33/211 (15%), Positives = 59/211 (27%), Gaps = 19/211 (9%)

Query: 33  ELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQL---- 88
           E+  +   + +     N T ++P  L        L LSEN L     + L    +L    
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 89  -----NMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLG 143
                         L     + L +        + Q      +       L ++ +  L 
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 144 SNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEV 203
                 E+    +   ++P  L      +      NN  T           L     L+ 
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL-----PAGLLNGLENLDT 176

Query: 204 VSLSSNSLSGVLPNSIANFSSHLIYLYMSAN 234
           + L  NSL   +P         L + ++  N
Sbjct: 177 LLLQENSLY-TIPKGFFGSHL-LPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.2 bits (95), Expect = 3e-04
 Identities = 34/198 (17%), Positives = 54/198 (27%), Gaps = 35/198 (17%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNN-YTGSIPQSLSNLSF 63
            +P ++    +  IL L  N L     + L    +L  L L         +  +L  L  
Sbjct: 24  ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81

Query: 64  LQQLSLSE--------------------NSLSGNIPSELGLLKQLNMFQVSANYLTGSIP 103
           L                           N L+      L  L +L    +  N L    P
Sbjct: 82  LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141

Query: 104 IQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPE 163
             L     ++  ++  N L       +   L N+  LLL  N           +  +IP+
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNG-LENLDTLLLQEN-----------SLYTIPK 189

Query: 164 DLGKLKNLIRLNFARNNL 181
                  L       N  
Sbjct: 190 GFFGSHLLPFAFLHGNPW 207

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.3 bits (136), Expect = 5e-09
 Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 9/80 (11%)

Query: 273 KLQVLSLFGNKISGE----IPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQ-----LQ 323
            L+VL L    +S      + ++L     L E+DL  N +  +    L   ++     L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 324 KLDLSDNNLSGTIPREVIGL 343
           +L L D   S  +   +  L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.8 bits (127), Expect = 6e-08
 Identities = 19/92 (20%), Positives = 29/92 (31%), Gaps = 5/92 (5%)

Query: 272 LKLQVLSLFGNKISGE-IPSSLGNLIFLTEVDLQGNSIRG----SIPSALGNCLQLQKLD 326
           L +Q L +   ++S       L  L     V L    +       I SAL     L +L+
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 327 LSDNNLSGTIPREVIGLSSFVLLDLSRNHLSG 358
           L  N L       V+         + +  L  
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.4 bits (126), Expect = 8e-08
 Identities = 18/92 (19%), Positives = 28/92 (30%), Gaps = 10/92 (10%)

Query: 370 IQQLDLSENKLSGEIPTSLASCV-GLEYLNFSDNSFQG----PIHSGFSSLKGLQDLDLS 424
           IQ LD+   +LS      L   +   + +   D          I S       L +L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 425 RNNFSGKIPMFL-----NTFRFLQKLNLSFNN 451
            N         +          +QKL+L    
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 5e-07
 Identities = 16/93 (17%), Positives = 34/93 (36%), Gaps = 6/93 (6%)

Query: 246 NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE----IPSSLGNLIFLTEV 301
           ++++L +      L        +  L + QV+ L    ++      I S+L     L E+
Sbjct: 3   DIQSLDI--QCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 302 DLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSG 334
           +L+ N +       +   LQ     +   +L  
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 8e-07
 Identities = 15/92 (16%), Positives = 26/92 (28%), Gaps = 5/92 (5%)

Query: 349 LDLSRNHLSGPIPLEV-GRLKGIQQLDLSENKLSGE----IPTSLASCVGLEYLNFSDNS 403
           LD+    LS     E+   L+  Q + L +  L+      I ++L     L  LN   N 
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 404 FQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMF 435
                              + + +        
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 8e-06
 Identities = 19/82 (23%), Positives = 34/82 (41%), Gaps = 9/82 (10%)

Query: 318 NCLQLQKLDLSDNNLSGT----IPREVIGLSSFVLLDLSRNHLSGPIPLEVGR-----LK 368
               L+ L L+D ++S +    +   ++   S   LDLS N L     L++         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 369 GIQQLDLSENKLSGEIPTSLAS 390
            ++QL L +   S E+   L +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQA 448

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 18/92 (19%), Positives = 30/92 (32%), Gaps = 9/92 (9%)

Query: 7   PANITHCSELRILDLVVNKLEGN----IPSELGNLFKLVGLGLTGNNYTGSIPQSLS--- 59
                  S LR+L L    +  +    + + L     L  L L+ N    +    L    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 60  --NLSFLQQLSLSENSLSGNIPSELGLLKQLN 89
                 L+QL L +   S  +   L  L++  
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 1e-05
 Identities = 15/86 (17%), Positives = 30/86 (34%), Gaps = 12/86 (13%)

Query: 370 IQQLDLSENKLSGE----IPTSLASCVGLEYLNFSDNSFQGPIHSGFSS-----LKGLQD 420
           ++ L L++  +S      +  +L +   L  L+ S+N                    L+ 
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 421 LDLSRNNFSGKIPMFLNTFRFLQKLN 446
           L L    +S ++   L     L+K  
Sbjct: 431 LVLYDIYWSEEMEDRLQA---LEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 16/89 (17%), Positives = 32/89 (35%), Gaps = 11/89 (12%)

Query: 394 LEYLNFSDNSFQG----PIHSGFSSLKGLQDLDLSRNNFSGKIPMFL-----NTFRFLQK 444
           L  L  +D          + +   +   L++LDLS N       + L          L++
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 445 LNLSFNNLEGEVPS--EGVFKNVRAVSII 471
           L L       E+    + + K+  ++ +I
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 1e-04
 Identities = 18/87 (20%), Positives = 31/87 (35%), Gaps = 9/87 (10%)

Query: 135 PNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDS 194
             +RVL L     +          SS+   L    +L  L+ + N LG      L  ++S
Sbjct: 369 SVLRVLWLADCDVSDSS------CSSLAATLLANHSLRELDLSNNCLGDAGILQL--VES 420

Query: 195 L-VNCTFLEVVSLSSNSLSGVLPNSIA 220
           +      LE + L     S  + + + 
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQ 447

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 16/101 (15%), Positives = 31/101 (30%), Gaps = 15/101 (14%)

Query: 136 NIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSL 195
           +I+ L +     +              E L  L+    +      L   +  D+    +L
Sbjct: 3   DIQSLDIQCEELSDA---------RWAELLPLLQQCQVVRLDDCGLTEARCKDI--SSAL 51

Query: 196 VNCTFLEVVSLSSNSLSGV----LPNSIANFSSHLIYLYMS 232
                L  ++L SN L  V    +   +   S  +  L + 
Sbjct: 52  RVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 16/84 (19%), Positives = 28/84 (33%), Gaps = 6/84 (7%)

Query: 169 KNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSG----VLPNSIANFSS 224
             L  L  A  ++     + L    +L+    L  + LS+N L       L  S+     
Sbjct: 369 SVLRVLWLADCDVSDSSCSSL--AATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 225 HLIYLYMSANRISGTIPTGVGNLK 248
            L  L +     S  +   +  L+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 15/74 (20%), Positives = 27/74 (36%), Gaps = 5/74 (6%)

Query: 15 ELRILDLVVNKLEGNIPSEL-GNLFKLVGLGLTGNNYTG----SIPQSLSNLSFLQQLSL 69
          +++ LD+   +L     +EL   L +   + L     T      I  +L     L +L+L
Sbjct: 3  DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 70 SENSLSGNIPSELG 83
            N L       + 
Sbjct: 63 RSNELGDVGVHCVL 76

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.002
 Identities = 18/115 (15%), Positives = 33/115 (28%), Gaps = 22/115 (19%)

Query: 184 GKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANF---SSHLIYLYMSANRISGTI 240
             G            + L V+ L+   +S    +S+A     +  L  L +S N +    
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413

Query: 241 PTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNL 295
              +         ++                  L+ L L+    S E+   L  L
Sbjct: 414 ILQLVE-------SVRQP------------GCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.004
 Identities = 23/110 (20%), Positives = 36/110 (32%), Gaps = 17/110 (15%)

Query: 101 SIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASS 160
           S+ IQ  +I           +L       +   L   +V+ L     T      IS+A  
Sbjct: 1   SLDIQSLDIQC--------EELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA-- 50

Query: 161 IPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSL-VNCTFLEVVSLSSN 209
               L     L  LN   N LG    + +  L  L      ++ +SL + 
Sbjct: 51  ----LRVNPALAELNLRSNELGDVGVHCV--LQGLQTPSCKIQKLSLQNC 94

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.3 bits (117), Expect = 8e-08
 Identities = 35/108 (32%), Positives = 49/108 (45%), Gaps = 6/108 (5%)

Query: 349 LDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPI 408
           L L+   L+    L   +L  +  LDLS N+L    P +LA+   LE L  SDN+ +   
Sbjct: 3   LHLAHKDLTVLCHL--EQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV- 58

Query: 409 HSGFSSLKGLQDLDLSRNNF-SGKIPMFLNTFRFLQKLNLSFNNLEGE 455
             G ++L  LQ+L L  N          L +   L  LNL  N+L  E
Sbjct: 59  -DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.9 bits (116), Expect = 1e-07
 Identities = 28/125 (22%), Positives = 48/125 (38%), Gaps = 6/125 (4%)

Query: 323 QKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSG 382
           + L L+  +L  T+   +  L     LDLS N L    P  +  L+ ++ L  S+N    
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--L 55

Query: 383 EIPTSLASCVGLEYLNFSDNSFQG-PIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRF 441
           E    +A+   L+ L   +N  Q         S   L  L+L  N+   +  +       
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 442 LQKLN 446
           L  ++
Sbjct: 116 LPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.0 bits (111), Expect = 5e-07
 Identities = 27/107 (25%), Positives = 42/107 (39%), Gaps = 8/107 (7%)

Query: 302 DLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIP 361
            L    +  ++   L   L +  LDLS N L    P     L++   L++ +   +    
Sbjct: 4   HLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALEN 57

Query: 362 LE-VGRLKGIQQLDLSENKL-SGEIPTSLASCVGLEYLNFSDNSFQG 406
           ++ V  L  +Q+L L  N+L        L SC  L  LN   NS   
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.6 bits (97), Expect = 5e-05
 Identities = 25/108 (23%), Positives = 47/108 (43%), Gaps = 6/108 (5%)

Query: 228 YLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGE 287
            L+++   +  T+   +  L  +  + +  N L    P ++  L  L+VL    N +  E
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNAL--E 56

Query: 288 IPSSLGNLIFLTEVDLQGNSIRG-SIPSALGNCLQLQKLDLSDNNLSG 334
               + NL  L E+ L  N ++  +    L +C +L  L+L  N+L  
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.5 bits (89), Expect = 5e-04
 Identities = 19/113 (16%), Positives = 36/113 (31%), Gaps = 4/113 (3%)

Query: 186 GNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVG 245
             DL  L  L     +  + LS N L  + P   A     ++    +A      +     
Sbjct: 7   HKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN---VDGVAN 63

Query: 246 NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFL 298
             +   L+     L   +    +    +L +L+L GN +  +       L  +
Sbjct: 64  LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.6 bits (84), Expect = 0.003
 Identities = 21/108 (19%), Positives = 36/108 (33%), Gaps = 5/108 (4%)

Query: 43  LGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSI 102
           L L   + T  +   L  L  +  L LS N L    P+   L     +  + A+      
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA---LAALRCLEVLQASDNALEN 57

Query: 103 PIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGE 150
              + N+  +    +  N+L          + P + +L L  N    E
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.5 bits (124), Expect = 1e-07
 Identities = 48/328 (14%), Positives = 96/328 (29%), Gaps = 22/328 (6%)

Query: 43  LGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSI 102
           L L     + S+P+   +L   + L  S NSL+  +P     LK L +   +   L+   
Sbjct: 43  LELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLP 97

Query: 103 PIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIP 162
           P+  +   S +                +     +++ L             +        
Sbjct: 98  PLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPE 157

Query: 163 EDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANF 222
                    I  +             L  + +  N         +   L+ +  ++    
Sbjct: 158 LQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK 217

Query: 223 SSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGN 282
           +   +   + A  +     T +  L   +        +   +      L  L   S    
Sbjct: 218 TLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR 277

Query: 283 KISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIG 342
            +    PS       L E+++  N +   +P+       L++L  S N+L+  +P     
Sbjct: 278 SLCDLPPS-------LEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQN 325

Query: 343 LSSFVLLDLSRNHLSG--PIPLEVGRLK 368
           L     L +  N L     IP  V  L+
Sbjct: 326 LKQ---LHVEYNPLREFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.1 bits (123), Expect = 1e-07
 Identities = 45/339 (13%), Positives = 93/339 (27%), Gaps = 25/339 (7%)

Query: 10  ITHCSE--LRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQL 67
           +  C +     L+L    L  ++P    +L  LV    + N+ T  +P+   +       
Sbjct: 32  LRDCLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQS------- 79

Query: 68  SLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIP 127
            L    +  N    L  L  L  +   +N     +P    +           +       
Sbjct: 80  -LKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDL 138

Query: 128 HYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGN 187
                 +      L            +   A +          L   +    N    +  
Sbjct: 139 PPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELP 198

Query: 188 DLRFLDSLVNCTFLEVVSLS-SNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGN 246
           +L+ L  L        +  +  +    +   ++ +     +     +             
Sbjct: 199 ELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSG 258

Query: 247 LKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGN 306
           L  L      +N  +  I +       L+ L++  NK+  E+P+    L  L       N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFN 314

Query: 307 SIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSS 345
            +   +P    N   L++L +  N L    P     +  
Sbjct: 315 HL-AEVPELPQN---LKQLHVEYNPLR-EFPDIPESVED 348

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.8 bits (117), Expect = 8e-07
 Identities = 21/90 (23%), Positives = 36/90 (40%), Gaps = 9/90 (10%)

Query: 1   MLQGEIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSN 60
               EI +       L  L++  NKL   +P+    L +L+    + N+    +P+   N
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQN 325

Query: 61  LSFLQQLSLSENSLSGNIPSELGLLKQLNM 90
              L+QL +  N L    P     ++ L M
Sbjct: 326 ---LKQLHVEYNPLRE-FPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.1 bits (115), Expect = 1e-06
 Identities = 21/101 (20%), Positives = 34/101 (33%), Gaps = 14/101 (13%)

Query: 351 LSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHS 410
              N  S  I         +++L++S NKL  E+P        LE L  S N        
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA----E 318

Query: 411 GFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNN 451
                + L+ L +  N    + P    +       +L  N+
Sbjct: 319 VPELPQNLKQLHVEYNPLR-EFPDIPESVE-----DLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.3 bits (100), Expect = 8e-05
 Identities = 19/80 (23%), Positives = 33/80 (41%), Gaps = 8/80 (10%)

Query: 375 LSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPM 434
              N  S EI +       LE LN S+N     +    +    L+ L  S N+ + ++P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNK----LIELPALPPRLERLIASFNHLA-EVPE 321

Query: 435 FLNTFRFLQKLNLSFNNLEG 454
                  L++L++ +N L  
Sbjct: 322 LPQN---LKQLHVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.7 bits (96), Expect = 2e-04
 Identities = 21/80 (26%), Positives = 32/80 (40%), Gaps = 10/80 (12%)

Query: 197 NCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAME 256
               LE +++S+N L   LP         L  L  S N ++  +P    NLK L +   E
Sbjct: 282 LPPSLEELNVSNNKLIE-LPALP----PRLERLIASFNHLA-EVPELPQNLKQLHV---E 332

Query: 257 VNLLTGSIPTSVGYLLKLQV 276
            N L    P     +  L++
Sbjct: 333 YNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.4 bits (90), Expect = 0.002
 Identities = 19/77 (24%), Positives = 35/77 (45%), Gaps = 7/77 (9%)

Query: 398 NFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVP 457
            +  N+    I S       L++L++S N    ++P        L++L  SFN+L  EVP
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320

Query: 458 SEGVFKNVRAVSIIGNN 474
                +N++ + +  N 
Sbjct: 321 EL--PQNLKQLHVEYNP 335

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.7 bits (88), Expect = 0.003
 Identities = 21/92 (22%), Positives = 39/92 (42%), Gaps = 10/92 (10%)

Query: 48  NNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLF 107
           N  +  I         L++L++S N L   +P+    L++L     S N+L   +P    
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIA---SFNHLA-EVPELPQ 324

Query: 108 NISSMDYFAVTQNKLVGEIPHYVGFTLPNIRV 139
           N+  +    V  N L  E P     ++ ++R+
Sbjct: 325 NLKQLH---VEYNPLR-EFPDIPE-SVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.3 bits (87), Expect = 0.004
 Identities = 19/67 (28%), Positives = 31/67 (46%), Gaps = 7/67 (10%)

Query: 316 LGNCL--QLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQL 373
           L +CL  Q  +L+L++  LS ++P     L S   L  S N L+  +P     LK +   
Sbjct: 32  LRDCLDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVD 86

Query: 374 DLSENKL 380
           + +   L
Sbjct: 87  NNNLKAL 93

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.9 bits (115), Expect = 8e-07
 Identities = 38/217 (17%), Positives = 65/217 (29%), Gaps = 22/217 (10%)

Query: 246 NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQG 305
            L N I IA   + +T ++  +   L  +  LS FG  ++      +  L  L  ++L+ 
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 306 NSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVG 365
           N I    P      +   +L  +       I       +  +      +         + 
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 366 RLKGIQQLDLSENKL--------------SGEIPTSLASCVGLEYLNFSDNSFQGPIHSG 411
            L        + + L                   T LA+   L  L   DN         
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS--P 190

Query: 412 FSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLS 448
            +SL  L ++ L  N  S   P  L     L  + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 4e-05
 Identities = 38/239 (15%), Positives = 75/239 (31%), Gaps = 31/239 (12%)

Query: 154 SISNASSIPE--DLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSL 211
           SI+  ++I        L N I++   ++N+      D      L   T L   S     +
Sbjct: 2   SITQPTAINVIFPDPALANAIKIAAGKSNV-----TDTVTQADLDGITTL---SAFGTGV 53

Query: 212 SGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPT----- 266
           + +    +   ++ LI L +  N+I+   P         + ++        +I       
Sbjct: 54  TTI--EGVQYLNN-LIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIK 110

Query: 267 ---------SVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALG 317
                    +    L              +I +            L   + + S  + L 
Sbjct: 111 TLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLA 170

Query: 318 NCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLS 376
           N  +L  L   DN +S   P  +  L + + + L  N +S   PL       +  + L+
Sbjct: 171 NLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPL--ANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 6e-05
 Identities = 21/57 (36%), Positives = 26/57 (45%), Gaps = 4/57 (7%)

Query: 273 KLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSD 329
           KL  L    NKIS   P  L +L  L EV L+ N I    P  L N   L  + L++
Sbjct: 174 KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 1e-04
 Identities = 33/219 (15%), Positives = 71/219 (32%), Gaps = 12/219 (5%)

Query: 14  SELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENS 73
           +    +    + +   +     +L  +  L   G   T +I   +  L+ L  L L +N 
Sbjct: 19  ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQ 74

Query: 74  LSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFT 133
           ++   P +            +      +I       +         +         +   
Sbjct: 75  ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134

Query: 134 LPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLD 193
             ++  +   S          +S  ++   DL  L NL +L   + +      N +  + 
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD-----DNKISDIS 189

Query: 194 SLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMS 232
            L +   L  V L +N +S V P  +AN S+ L  + ++
Sbjct: 190 PLASLPNLIEVHLKNNQISDVSP--LANTSN-LFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 4e-04
 Identities = 31/232 (13%), Positives = 68/232 (29%), Gaps = 37/232 (15%)

Query: 134 LPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLD 193
           L N   +  G +  T  +                L  +  L+     + T        ++
Sbjct: 18  LANAIKIAAGKSNVTDTVT------------QADLDGITTLSAFGTGVTT--------IE 57

Query: 194 SLVNCTFLEVVSLSSNSLSGVLPNS-----------IANFSSHLIYLYMSANRISGTIPT 242
            +     L  + L  N ++ + P                  +      + + +      T
Sbjct: 58  GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTST 117

Query: 243 GVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKI--SGEIPSSLGNLIFLTE 300
            + ++  L  ++    L       +    L       + +         + L NL  LT 
Sbjct: 118 QITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTT 177

Query: 301 VDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLS 352
           +    N I    P  L +   L ++ L +N +S   P  +   S+  ++ L+
Sbjct: 178 LKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 48.7 bits (114), Expect = 2e-06
 Identities = 38/318 (11%), Positives = 88/318 (27%), Gaps = 27/318 (8%)

Query: 38  FKLVGLGLTGNNYTG----SIPQSLSNLSFLQQLSLSENSLSGN----IPSELGLLKQLN 89
           F + G  L  +  T     S+   L     ++++ LS N++       +   +   K L 
Sbjct: 3   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62

Query: 90  MFQVSANY---LTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNW 146
           + + S  +   +   IP  L  +          + +      +       +   L     
Sbjct: 63  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122

Query: 147 FTGEIPPSISNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSL 206
                  +          + +    + +N    N        LR +    N      +  
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKN-----APPLRSIICGRNRLENGSMKE 177

Query: 207 SSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPT 266
            + +              + I      + +   +          +      +L + ++  
Sbjct: 178 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237

Query: 267 SVGYLLKLQVLSLFGNKISGEIPSSLGNLIF------LTEVDLQGNSIRGSIPSALGNCL 320
           ++     L+ L L    +S    +++ +         L  + LQ N I       L   +
Sbjct: 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 297

Query: 321 -----QLQKLDLSDNNLS 333
                 L  L+L+ N  S
Sbjct: 298 DEKMPDLLFLELNGNRFS 315

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.5 bits (90), Expect = 0.001
 Identities = 12/89 (13%), Positives = 26/89 (29%), Gaps = 5/89 (5%)

Query: 368 KGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP----IHSGFSSLKGLQDLDL 423
           K ++   ++       +   L     ++ +  S N+        +    +S K L+  + 
Sbjct: 8   KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 424 SRNNFSGKIPMFLNTFRFLQKLNLSFNNL 452
           S               R L +  L    L
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKL 95

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.003
 Identities = 15/84 (17%), Positives = 29/84 (34%), Gaps = 5/84 (5%)

Query: 348 LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGE----IPTSLASCVGLEYLNFSDNS 403
           L  ++       +   +     ++++ LS N +  E    +  ++AS   LE   FSD  
Sbjct: 12  LDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF 70

Query: 404 FQGPIHSGFSSLKGLQDLDLSRNN 427
                     +L+ L    L    
Sbjct: 71  TGRVKDEIPEALRLLLQALLKCPK 94

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (108), Expect = 3e-06
 Identities = 27/140 (19%), Positives = 47/140 (33%), Gaps = 7/140 (5%)

Query: 290 SSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLL 349
           +   N +   E+DL+G  I   I +      Q   +D SDN +          L     L
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 68

Query: 350 DLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSG----EIPTSLASCVGLEYLNFSDNSFQ 405
            ++ N +          L  + +L L+ N L      +   SL S   L  L     + +
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 406 GPIHSGFSSLKGLQDLDLSR 425
                    +  ++ LD  +
Sbjct: 129 HYRLYVIYKVPQVRVLDFQK 148

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.2 bits (98), Expect = 6e-05
 Identities = 25/135 (18%), Positives = 43/135 (31%), Gaps = 7/135 (5%)

Query: 271 LLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDN 330
            ++ + L L G KI   I +    L     +D   N IR           +L+ L +++N
Sbjct: 17  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNNN 73

Query: 331 NLSGTIPREVIGLSSFVLLDLSRNHLSG-PIPLEVGRLKGIQQLDLSENK---LSGEIPT 386
            +          L     L L+ N L        +  LK +  L +  N           
Sbjct: 74  RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133

Query: 387 SLASCVGLEYLNFSD 401
            +     +  L+F  
Sbjct: 134 VIYKVPQVRVLDFQK 148

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (88), Expect = 0.001
 Identities = 24/145 (16%), Positives = 47/145 (32%), Gaps = 10/145 (6%)

Query: 32  SELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMF 91
           ++  N  +   L L G      I    + L     +  S+N +         LL++L   
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68

Query: 92  QVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEI 151
            V+ N +          +  +    +T N LV         +L ++  L +  N  T + 
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 152 PPSISNASSIPEDLGKLKNLIRLNF 176
                        + K+  +  L+F
Sbjct: 129 HYR-------LYVIYKVPQVRVLDF 146

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 42.8 bits (99), Expect = 5e-05
 Identities = 34/178 (19%), Positives = 60/178 (33%), Gaps = 11/178 (6%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIP------SELGNLFKLVGLGLTGNNYTGSIPQSL 58
           +          +   +    +L G IP      + L  L     L L+ NN    I  SL
Sbjct: 9   DAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS-SL 66

Query: 59  SNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVT 118
           S +  L+ LSL  N +      +        ++       + S   +L N+  +      
Sbjct: 67  SGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMS--- 123

Query: 119 QNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNF 176
            NK+           L  +  LLL  N    +   + + +    E + +L NL +L+ 
Sbjct: 124 NNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLDG 181

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 6e-05
 Identities = 31/207 (14%), Positives = 58/207 (28%), Gaps = 28/207 (13%)

Query: 239 TIPTGVG------NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSL 292
           T+PT +            I   ++   +T ++  +   L  +  +    + I       +
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64

Query: 293 GNLIFLTEVDLQGNSIRG---------------SIPSALGNCLQLQKLDLSDNNLSGTIP 337
             L  +T++ L GN +                                 L   +L     
Sbjct: 65  QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124

Query: 338 REVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYL 397
            ++ GL     L+      +    + V            E+    +I   LA    L+ L
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNL 183

Query: 398 NFSDNSFQGPIHSGFSSLKGLQDLDLS 424
             S N          + LK L  L+L 
Sbjct: 184 YLSKNHISDL--RALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 8e-05
 Identities = 29/208 (13%), Positives = 61/208 (29%), Gaps = 30/208 (14%)

Query: 263 SIPTSVGY------LLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSAL 316
           ++PT +          +    +L    ++  +  +   L  + ++    + I+      +
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64

Query: 317 GNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLS 376
                + KL L+ N L+   P     L +   L L  N +     L+  +      L+ +
Sbjct: 65  QYLPNVTKLFLNGNKLTDIKPLA--NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122

Query: 377 ENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIH----------------SGFSSLKGLQD 420
                  +             N   +                          + L  LQ+
Sbjct: 123 GISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQN 182

Query: 421 LDLSRNNFSGKIPMFLNTFRFLQKLNLS 448
           L LS+N+ S  +       + L  L L 
Sbjct: 183 LYLSKNHISD-LRALAG-LKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 3e-04
 Identities = 32/212 (15%), Positives = 67/212 (31%), Gaps = 45/212 (21%)

Query: 30  IPSELGNLF------KLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELG 83
           +P+ +  +F      + +   L   + T ++ Q+   L+ + Q+  + + +       + 
Sbjct: 10  VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQ 65

Query: 84  LLKQLNMFQVSANYLTGSIPI--------------------------QLFNISSMDYFAV 117
            L  +    ++ N LT   P+                          +L ++S       
Sbjct: 66  YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125

Query: 118 TQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTG-EIPPSISNASSIPEDLGKLKNLIRLNF 176
             N LV        +   N    +   +  T  +      N  S    L  L  L  L  
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYL 185

Query: 177 ARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSS 208
           ++N++          L +L     L+V+ L S
Sbjct: 186 SKNHISD--------LRALAGLKNLDVLELFS 209

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (91), Expect = 4e-04
 Identities = 18/147 (12%), Positives = 42/147 (28%), Gaps = 3/147 (2%)

Query: 12  HCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIP-QSLSNLSFLQQLSLS 70
                  L    +    +    L     L  L +    +   +  + L  L  L+ L++ 
Sbjct: 6   CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 71  ENSLSGNIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYV 130
           ++ L    P       +L+   +S N L  S+  +     S+    ++ N L        
Sbjct: 65  KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRW 123

Query: 131 GFTLPNIRVLLLGSNWFTGEIPPSISN 157
                   +  +            +++
Sbjct: 124 LQRWEEEGLGGVPEQKLQCHGQGPLAH 150

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (91), Expect = 4e-04
 Identities = 17/109 (15%), Positives = 34/109 (31%), Gaps = 3/109 (2%)

Query: 298 LTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVI-GLSSFVLLDLSRNHL 356
            + +    +         L     L +L + +      +    + GL     L + ++ L
Sbjct: 10  SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 357 SGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQ 405
               P        + +L+LS N L   +       + L+ L  S N   
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 4e-04
 Identities = 30/224 (13%), Positives = 60/224 (26%), Gaps = 33/224 (14%)

Query: 263 SIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSI--PSALGNCL 320
            IP+ +        L     K+      +      L ++++  N +   I          
Sbjct: 22  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 321 QLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQ--------- 371
             +      NNL    P     L +   L +S   +     +                  
Sbjct: 80  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139

Query: 372 -----------------QLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSS 414
                             L L++N +      +       E     +N+ +   +  F  
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199

Query: 415 LKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPS 458
             G   LD+SR          L   + L+  +    NL+ ++P+
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPT 240

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 5e-04
 Identities = 30/179 (16%), Positives = 50/179 (27%), Gaps = 7/179 (3%)

Query: 36  NLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSA 95
            L + +   L   N T ++ Q+  +L  +  L      +  +I   +  L  L     S 
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71

Query: 96  NYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSI 155
           N LT   P++             Q     +I      T      L          +    
Sbjct: 72  NQLTDITPLKNLTKLVDILMNNNQIA---DITPLANLTNLTGLTLFNNQITDIDPLKNLT 128

Query: 156 SNASSIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGV 214
           +                              N +  L  L N T LE + +SSN +S +
Sbjct: 129 NLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDI 187

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.3 bits (88), Expect = 0.001
 Identities = 21/144 (14%), Positives = 45/144 (31%), Gaps = 11/144 (7%)

Query: 5   EIPANITHCSELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFL 64
           ++   ++   +     L +  L      +L      V L    ++   ++     N+  L
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPEL 67

Query: 65  QQLSLSENSLSG--NIPSELGLLKQLNMFQVSANYLTGSIPIQLFNISSMDYFAVTQNKL 122
             L+LS N L    ++ S +     L +  +S N L     +       ++   +  N L
Sbjct: 68  LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127

Query: 123 VGEIPHYVGF------TLPNIRVL 140
                    +        P +  L
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRL 151

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.9 bits (86), Expect = 0.002
 Identities = 39/226 (17%), Positives = 69/226 (30%), Gaps = 57/226 (25%)

Query: 204 VSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGV-GNLKNLILIAMEVNLLTG 262
           V  +   L  + P    +   H   L ++ N +      G+ G L +L+ + ++ N LTG
Sbjct: 13  VDCTGRGLKEI-P---RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG 68

Query: 263 SIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQL 322
             P +      +Q L L  NKI          L  L  ++L  N I   +P +  +   L
Sbjct: 69  IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL 128

Query: 323 QKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSG 382
             L+L+ N  +              L   +                  ++  L+      
Sbjct: 129 TSLNLASNPFNCNCH----------LAWFAEWL---------------RKKSLNGGAARC 163

Query: 383 EIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNF 428
             P                           S ++ +Q  DL  + F
Sbjct: 164 GAP---------------------------SKVRDVQIKDLPHSEF 182

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	871
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.93
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.92
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.88
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.87
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.81
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.8
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.79
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.79
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.79
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.79
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.77
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.77
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.77
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.76
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.74
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.58
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.57
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.57
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.56
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.55
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.54
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.53
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.52
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.43
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.41
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.39
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.39
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.63
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.56
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.55
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.93
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.82
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.8
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.79
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.28
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.15
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.15
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.75
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.66

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-50  Score=420.45  Aligned_cols=249  Identities=22%  Similarity=0.320  Sum_probs=209.2

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|++++++++||||+++++++.+.     +..|+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CEEEE
Confidence            5799999999999999999999999999999999766665677899999999999999999999998776     67899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      |||||+||+|.+++...        .+++.+++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+|
T Consensus        95 vmEy~~gg~L~~~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a  163 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC  163 (293)
T ss_dssp             EEECCTTCBHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEecCCCcHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhh
Confidence            99999999999988653        489999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc-hhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD-QVA  797 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-~~~  797 (871)
                      +......   .......||+.|+|||++.+..++.++||||+||++|+|+||+.||.+....... ........+. ...
T Consensus       164 ~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~  239 (293)
T d1yhwa1         164 AQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGTPELQNP  239 (293)
T ss_dssp             EECCSTT---CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHHCSCCCSSG
T ss_pred             eeecccc---ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH-HHHHhCCCCCCCCc
Confidence            9875432   2234457999999999999999999999999999999999999999754322211 1111111110 000


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                                    ..+...+.+++.+||+.||++|||++|+++
T Consensus       240 ------------------------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         240 ------------------------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             ------------------------------GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ------------------------------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                                          122345778999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-51  Score=419.99  Aligned_cols=254  Identities=24%  Similarity=0.326  Sum_probs=205.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.+.     ...
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----cee
Confidence            357999999999999999999999999999999996543 23346788999999999999999999998776     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||+++|+|.+++....       .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~-------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG  148 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDI-------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  148 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTT-------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEeccCCCcHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccch
Confidence            99999999999999997543       599999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV-STHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      +|+....... .......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.....................
T Consensus       149 ~a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~  227 (271)
T d1nvra_         149 LATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN  227 (271)
T ss_dssp             TCEECEETTE-ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTST
T ss_pred             hheeeccCCc-cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Confidence            9997654321 122344679999999999888776 57899999999999999999999754433222222221111110


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .                              ...+..++.+++.+||+.||++|||++|+++
T Consensus       228 ~------------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         228 P------------------------------WKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             T------------------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c------------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0                              0122345678999999999999999999975

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-50  Score=418.01  Aligned_cols=261  Identities=26%  Similarity=0.421  Sum_probs=203.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||+||+|++.   ..||||+++..  .....+.+.+|++++++++||||+++++++.+      ..
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence            468999999999999999999875   35999998643  23445789999999999999999999998643      34


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||+++|+|.+++.....      .+++..+..++.||++||+|||++   +||||||||+|||++.++.+||+||
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~------~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DF  148 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIET------KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDF  148 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCC
T ss_pred             EEEEEecCCCCCHHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccc
Confidence            7899999999999999976532      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL---GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |+|+...... .........||+.|||||++.+   +.|+.++|||||||++|||+||+.||.+................
T Consensus       149 Gla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~  227 (276)
T d1uwha_         149 GLATVKSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL  227 (276)
T ss_dssp             CCSCC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC
T ss_pred             cceeeccccC-CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence            9998765432 1222344679999999998753   46899999999999999999999999864332222211111111


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      ++...+                           ....+++++.+++.+||+.||++|||++|+++.|+.+.+
T Consensus       228 ~p~~~~---------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         228 SPDLSK---------------------------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             CCCGGG---------------------------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcchh---------------------------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            111111                           111234567899999999999999999999999998865

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-50  Score=413.73  Aligned_cols=246  Identities=22%  Similarity=0.340  Sum_probs=206.1

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||+||+|++..+++.||+|++...   .....+.+.+|++++++++||||+++++++.+.     ..
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-----CE
Confidence            5799999999999999999999999999999998643   233457789999999999999999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+|||||++|+|.+++....       .+++..+..++.||+.||+|||++   +||||||||+|||++.++.+||+||
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~~-------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DF  150 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADF  150 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEeecCCCcHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeeccc
Confidence            899999999999999998654       599999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |+|......     ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..........  .
T Consensus       151 G~a~~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~--~  222 (263)
T d2j4za1         151 GWSVHAPSS-----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRVEF--T  222 (263)
T ss_dssp             CSCSCCCCC-----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCC--C
T ss_pred             ceeeecCCC-----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCC--C
Confidence            999865432     2234579999999999999999999999999999999999999997543221 1111111110  0


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ..+                              .+++++.+++.+||+.||++|||++|+++
T Consensus       223 ~p~------------------------------~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 FPD------------------------------FVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCT------------------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCc------------------------------cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            000                              12345678999999999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=408.21  Aligned_cols=249  Identities=25%  Similarity=0.372  Sum_probs=200.9

Q ss_pred             CCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEE
Q 002883          562 SSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV  639 (871)
Q Consensus       562 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  639 (871)
                      +..+.||+|+||+||+|++..+++.||+|++....  ....+.+.+|++++++++|||||++++++.+. ..+...+|+|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEE
Confidence            56678999999999999999999999999986442  33456789999999999999999999998654 3334678999


Q ss_pred             EeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCceeeC-CCCceEEeecc
Q 002883          640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTS--IVHCDLKPSNVLLD-NEMVAHVGDFG  716 (871)
Q Consensus       640 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg  716 (871)
                      |||+++|+|.+++....       .+++..++.++.||+.||+|||++   +  |+||||||+|||++ .++.+||+|||
T Consensus        91 mE~~~~g~L~~~l~~~~-------~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFG  160 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK-------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG  160 (270)
T ss_dssp             EECCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EeCCCCCcHHHHHhccc-------cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence            99999999999997654       589999999999999999999998   6  99999999999996 57899999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      +|+....     .......||+.|+|||++.+ .++.++||||+||++|||++|+.||..................+...
T Consensus       161 la~~~~~-----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~  234 (270)
T d1t4ha_         161 LATLKRA-----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF  234 (270)
T ss_dssp             GGGGCCT-----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred             cceeccC-----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCccc
Confidence            9986432     22334679999999998765 69999999999999999999999997543222222222111111111


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ..                              ...+++.+++.+||+.||++||||+|+++
T Consensus       235 ~~------------------------------~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         235 DK------------------------------VAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GG------------------------------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Cc------------------------------cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            11                              12234678999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=414.71  Aligned_cols=252  Identities=23%  Similarity=0.299  Sum_probs=207.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      +.|++.+.||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++|||||++++++.+.     +..|+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeEEE
Confidence            5689999999999999999999999999999999776666667899999999999999999999998775     67899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      |||||++|+|.+++.....      .+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus        87 vmEy~~~g~L~~~~~~~~~------~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a  157 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELER------PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS  157 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEecCCCCcHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhh
Confidence            9999999999999875432      599999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccc-----cCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYG-----ALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      +.....   ........||+.|+|||++     .+..|+.++||||+||++|||+||+.||.+...... +........+
T Consensus       158 ~~~~~~---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i~~~~~~  233 (288)
T d2jfla1         158 AKNTRT---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPP  233 (288)
T ss_dssp             EECHHH---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHHSCCC
T ss_pred             hccCCC---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHHHcCCCC
Confidence            765321   1223346799999999986     355689999999999999999999999976433221 1111111111


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       ...                            ....++.++.+++.+||+.||++|||++|+++
T Consensus       234 -~~~----------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         234 -TLA----------------------------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -CCS----------------------------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCC----------------------------ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000                            00122346779999999999999999999987

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-50  Score=413.75  Aligned_cols=258  Identities=22%  Similarity=0.315  Sum_probs=195.8

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++...  ....+.+.+|++++++++||||+++++++.+..   ....
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCEE
Confidence            57999999999999999999999999999999996543  334567889999999999999999999886532   2567


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCceeeCCCCceEEee
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC--HTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      |+|||||++|+|.+++......   ...+++..++.++.||+.||+|||++.  ..+|+||||||+|||++.++.+||+|
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKE---RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             EEEEecCCCCcHHHHHHhcccc---CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            9999999999999999764321   236999999999999999999999972  11499999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||+|+......   .......||+.|+|||++.+..|++++|||||||++|||+||+.||........ .........+ 
T Consensus       158 FG~a~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-~~~i~~~~~~-  232 (269)
T d2java1         158 FGLARILNHDT---SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREGKFR-  232 (269)
T ss_dssp             HHHHHHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHTCCC-
T ss_pred             ccceeecccCC---CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-HHHHHcCCCC-
Confidence            99998865432   223346799999999999999999999999999999999999999975432211 1111111111 


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...                              ..+++++.+++.+||+.||++|||++|+++
T Consensus       233 ~~~------------------------------~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 RIP------------------------------YRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CCC------------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC------------------------------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            000                              012345779999999999999999999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-49  Score=416.15  Aligned_cols=265  Identities=25%  Similarity=0.406  Sum_probs=200.6

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCc---EEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEET---NVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ++|++.+.||+|+||+||+|++..+++   .||||++... .....+.+.+|++++++++|||||++++++.+.     +
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----T  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----C
Confidence            568888999999999999999976554   5899988543 333456799999999999999999999998765     5


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+|||||++|+|.+++.....      .+++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~------~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~D  171 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDG------QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSD  171 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTT------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             EEEEEEEecCCCcceeeeccccC------CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECC
Confidence            68999999999999999876542      589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCcc--ccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhC
Q 002883          715 FGLSRLLHDNSPDQT--STSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       715 fg~a~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      ||+|+..........  ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||.+......  .......
T Consensus       172 FGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~--~~~i~~~  249 (299)
T d1jpaa_         172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV--INAIEQD  249 (299)
T ss_dssp             C-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHHTT
T ss_pred             cccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH--HHHHHcC
Confidence            999987764332221  1223457899999999999999999999999999999998 8999986433221  1111111


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHHHhh
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQAI  869 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~~~~  869 (871)
                      .....                              ..+++.++.+++.+||+.||++|||+.||++.|+++.+.-..+
T Consensus       250 ~~~~~------------------------------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~sl  297 (299)
T d1jpaa_         250 YRLPP------------------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSL  297 (299)
T ss_dssp             CCCCC------------------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred             CCCCC------------------------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhhC
Confidence            10000                              0123346778999999999999999999999999987654444

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.1e-50  Score=418.22  Aligned_cols=261  Identities=24%  Similarity=0.376  Sum_probs=212.4

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ...++|++.+.||+|+||+||+|++..+++.||||+++.... ..+++.+|++++++++|||||+++++|.+.     +.
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~   87 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PP   87 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeC-----Ce
Confidence            345678899999999999999999998999999999965433 457899999999999999999999998765     56


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++......     .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~~~-----~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DF  159 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADF  159 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             eEEEeecccCcchHHHhhhcccc-----chHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccc
Confidence            89999999999999999765422     689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |+|+.....  .........|++.|+|||++.++.|+.++|||||||++|||++|..||........ ............
T Consensus       160 G~a~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~i~~~~~~~  236 (287)
T d1opja_         160 GLSRLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRME  236 (287)
T ss_dssp             CCTTTCCSS--SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHTTCCCC
T ss_pred             cceeecCCC--CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHHHhcCCCCC
Confidence            999876543  22233345689999999999999999999999999999999997777654322211 111111111111


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQ  863 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~  863 (871)
                      ..                              ..++.++.+++.+||+.||++|||++|+++.|+.+.
T Consensus       237 ~~------------------------------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         237 RP------------------------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             CC------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CC------------------------------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            00                              022346779999999999999999999999998763

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-49  Score=406.33  Aligned_cols=256  Identities=26%  Similarity=0.437  Sum_probs=198.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      ++|++.+.||+|+||+||+|++. +++.||||+++.... ..+.+.+|++++++++||||++++++|.+.     ...|+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~l   77 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICL   77 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEE
Confidence            57889999999999999999997 577899999975433 457899999999999999999999998765     56899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLS  718 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  718 (871)
                      ||||+++|+|.+++.....      .+++..+..++.|||.||+|||+.   +|+||||||+||+++.++.+||+|||+|
T Consensus        78 v~E~~~~g~L~~~l~~~~~------~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla  148 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRG------LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT  148 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred             EEEecCCCcHHHHhhcccc------CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchh
Confidence            9999999999999876532      589999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhC-CCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          719 RLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG-KRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       719 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      +......  ........||+.|+|||++.+..++.++|||||||++|||+|| ++||...... ..... ..........
T Consensus       149 ~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-~~~~~-i~~~~~~~~p  224 (263)
T d1sm2a_         149 RFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVED-ISTGFRLYKP  224 (263)
T ss_dssp             ------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-HHHHH-HHHTCCCCCC
T ss_pred             eeccCCC--ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-HHHHH-HHhcCCCCCc
Confidence            8765432  1222335689999999999999999999999999999999995 5555432221 11111 1111110000


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      +                              .++.++.+++.+||+.||++|||++|+++.|+++.+
T Consensus       225 ~------------------------------~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         225 R------------------------------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             T------------------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             c------------------------------ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            0                              123457799999999999999999999999999865

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=412.49  Aligned_cols=250  Identities=20%  Similarity=0.295  Sum_probs=203.9

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||+||+|++..+++.||||+++..   .....+.+.+|++++++++||||+++++++.+.     ..
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----EK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-----SE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-----CE
Confidence            5799999999999999999999989999999999643   233456789999999999999999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+++|+|.+++...+       .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~~-------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DF  152 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKIG-------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDF  152 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEccCCCCHHHhhhccC-------CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEeccc
Confidence            899999999999999988754       699999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |+|+.+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..........  .
T Consensus       153 G~a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~--~  228 (288)
T d1uu3a_         153 GTAKVLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEY--D  228 (288)
T ss_dssp             TTCEECC-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTTCC--C
T ss_pred             ccceecccCCc-ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-HHHHHHcCCC--C
Confidence            99998754321 222334579999999999999999999999999999999999999997542221 1111111110  0


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ..+                              .+.+++.+++.+||+.||++|||++|+++
T Consensus       229 ~p~------------------------------~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         229 FPE------------------------------KFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             CCT------------------------------TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             CCc------------------------------cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            000                              12345679999999999999999999754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-49  Score=419.08  Aligned_cols=200  Identities=26%  Similarity=0.362  Sum_probs=178.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+.++++++|||||+++++|.+.     ...
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----SEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence            468999999999999999999999999999999996543 33456789999999999999999999999876     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH-HCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      |+||||+++|+|.+++.+.+       .+++..++.++.|++.||.|||+ +   +|+||||||+|||++.++.+||+||
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~-------~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DF  149 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAG-------RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDF  149 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeC
Confidence            99999999999999997654       58999999999999999999996 5   8999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchh
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDM  777 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  777 (871)
                      |+|+...+.     .....+||+.|+|||++.+..|++++||||+||++|||++|+.||...
T Consensus       150 Gla~~~~~~-----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         150 GVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             CCCHHHHHH-----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             CCccccCCC-----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            999876432     223457999999999999999999999999999999999999999754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=406.18  Aligned_cols=258  Identities=26%  Similarity=0.437  Sum_probs=207.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||+||+|++. +++.||||+++.... ..+.+.+|++++++++|||||++++++.+      +..|
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~   83 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY   83 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeE
Confidence            467899999999999999999986 678899999975433 45789999999999999999999998753      3468


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++|+|.+++......     .+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~~-----~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGl  155 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSGI-----KLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGL  155 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHHH-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeCCCCcHHHHHhhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccc
Confidence            999999999999988765432     589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      |+......  ........||+.|+|||++.++.++.++|||||||++|||+||..|+............... .......
T Consensus       156 a~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~-~~~~~~p  232 (272)
T d1qpca_         156 ARLIEDNE--YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRP  232 (272)
T ss_dssp             CEECSSSC--EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCC
T ss_pred             eEEccCCc--cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCCCCCc
Confidence            99875432  22233456899999999999899999999999999999999966555432222111111111 1100000


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                                                    ..+++++.+++.+||+.||++|||++|+++.|+++-.
T Consensus       233 ------------------------------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         233 ------------------------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             ------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------------------------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence                                          0223457799999999999999999999999987643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.7e-49  Score=413.31  Aligned_cols=252  Identities=25%  Similarity=0.317  Sum_probs=191.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.     +..
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG-----GHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECS-----SEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence            356999999999999999999999999999999996443 22345678999999999999999999998765     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC---CCCceEEe
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD---NEMVAHVG  713 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~  713 (871)
                      |+|||||+||+|.+++....       .+++.++..++.||+.||+|||++   +|+||||||+||++.   .++.+||+
T Consensus        83 ~lvmE~~~gg~L~~~l~~~~-------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~  152 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEKG-------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMIS  152 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEEeccCCCcHHHhhhccc-------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEe
Confidence            99999999999999997643       599999999999999999999999   999999999999994   57899999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||+|+......    .....+||+.|+|||++.+..|++++||||+||++|||++|+.||.+...... .........+
T Consensus       153 DFG~a~~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~~~~~~  227 (307)
T d1a06a_         153 DFGLSKMEDPGS----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-FEQILKAEYE  227 (307)
T ss_dssp             CC----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHTTCCC
T ss_pred             ccceeEEccCCC----eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHhccCCC
Confidence            999998765332    22345799999999999999999999999999999999999999976433221 1111111110


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...                            +....+++++.+++.+||+.||++|||++|+++
T Consensus       228 ~~~----------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         228 FDS----------------------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CCT----------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCC----------------------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            000                            001123346779999999999999999999987

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=405.97  Aligned_cols=259  Identities=24%  Similarity=0.387  Sum_probs=208.1

Q ss_pred             cCCCCCce-eeccccceEEEEEECC--CCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          559 EGFSSANL-IGIGGYGYVYKGILGT--EETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       559 ~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ++|.+.+. ||+|+||+||+|.+..  ++..||||+++... ....+.+.+|++++++++|||||++++++.+      +
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence            45666674 9999999999998753  45579999996443 3345789999999999999999999999854      2


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||+++|+|.+++.....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~------~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~D  152 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISD  152 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTT------TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECC
T ss_pred             eEEEEEEeCCCCcHHHHhhcccc------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeecc
Confidence            37899999999999999865432      589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCC
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      ||+|+................||+.|+|||++.++.++.++|||||||++|||+| |+.||.+.....  .......+..
T Consensus       153 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~~i~~~~~  230 (285)
T d1u59a_         153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKR  230 (285)
T ss_dssp             CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHTTCC
T ss_pred             chhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC
Confidence            9999987654433333444568999999999998999999999999999999998 999998643221  1111111111


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      ....                              ..++.++.+++.+||+.||++|||+.+|.+.|+.+..
T Consensus       231 ~~~p------------------------------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         231 MECP------------------------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             CCCC------------------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCC------------------------------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            1000                              0223467799999999999999999999999998754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.2e-48  Score=416.11  Aligned_cols=253  Identities=22%  Similarity=0.307  Sum_probs=209.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||+||+|++..+|+.||||++........+.+.+|++++++++|||||++++++.+.     +..|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-----TEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEE
Confidence            35899999999999999999999999999999999766655667889999999999999999999998775     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC--CCCceEEeec
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD--NEMVAHVGDF  715 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Df  715 (871)
                      +|||||+||+|.+++.....      .+++..+..++.||+.||+|||++   +||||||||+|||++  .++.+||+||
T Consensus       100 ivmE~~~gg~L~~~l~~~~~------~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DF  170 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHN------KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDF  170 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTS------CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCC
T ss_pred             EEEEcCCCCCHHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeec
Confidence            99999999999999965432      599999999999999999999999   999999999999995  4678999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |+|+.+...    .......||+.|||||++.+..++.++||||+||++|+|++|+.||....... .+...........
T Consensus       171 G~a~~~~~~----~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~~  245 (350)
T d1koaa2         171 GLTAHLDPK----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWNMD  245 (350)
T ss_dssp             TTCEECCTT----SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCSC
T ss_pred             chheecccc----cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCC
Confidence            999887543    22334679999999999999999999999999999999999999997543221 1222211111000


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                           .                       .....+.+++.+++.+||+.||++|||++|+++
T Consensus       246 -----~-----------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         246 -----D-----------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             -----C-----------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -----c-----------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0                       001123345779999999999999999999987

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-48  Score=403.74  Aligned_cols=263  Identities=26%  Similarity=0.414  Sum_probs=200.4

Q ss_pred             cCCCCCceeeccccceEEEEEECCCC----cEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEE----TNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      ..|+..++||+|+||+||+|.+..++    ..||||+++... ......+.+|++++++++|||||++++++.+.     
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-----   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-----   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-----
Confidence            46888999999999999999986544    479999996443 23345789999999999999999999998765     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      ...++||||+.++++.+++.....      .+++.++..++.||+.|++|||+.   +|+||||||+|||++.++.+||+
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~------~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~  152 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDG------EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVS  152 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTT------CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred             CceEEEEEecccCcchhhhhcccc------cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEc
Confidence            568999999999999998876542      599999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLP  793 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~  793 (871)
                      |||+|+................||+.|+|||++.++.++.++|||||||++|||++|..|+........... .......
T Consensus       153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~-~i~~~~~  231 (283)
T d1mqba_         153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK-AINDGFR  231 (283)
T ss_dssp             CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HHHTTCC
T ss_pred             ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHH-HHhccCC
Confidence            999998876543333333445689999999999999999999999999999999997666543222211111 1111111


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      ....                              ..++.++.+++.+||+.||++|||+.||++.|+++.+.-
T Consensus       232 ~~~~------------------------------~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         232 LPTP------------------------------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             CCCC------------------------------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             CCCc------------------------------hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence            0000                              022345779999999999999999999999999887643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-48  Score=396.22  Aligned_cols=254  Identities=25%  Similarity=0.424  Sum_probs=210.0

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||+||+|+++ +++.||||+++.... ..+.+.+|+.++++++||||++++++|.+.     ...+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~   75 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIF   75 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceE
Confidence            368999999999999999999996 788999999976543 457899999999999999999999998765     5689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++|++.+++.....      .+++..+.+++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        76 iv~Ey~~~g~l~~~~~~~~~------~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~  146 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREMRH------RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGL  146 (258)
T ss_dssp             EEEECCTTEEHHHHHHSGGG------CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSS
T ss_pred             EEEEccCCCcHHHhhhcccc------CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchh
Confidence            99999999999999866543      589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      |+......  ........||+.|+|||.+.+..++.++|||||||++|||+| |+.||.........  ...........
T Consensus       147 a~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~--~~i~~~~~~~~  222 (258)
T d1k2pa_         147 SRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--EHIAQGLRLYR  222 (258)
T ss_dssp             CCBCSSSS--CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH--HHHHTTCCCCC
T ss_pred             heeccCCC--ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH--HHHHhCCCCCC
Confidence            98765432  222334568999999999999999999999999999999998 89999865433221  11111111110


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQE  861 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~  861 (871)
                      .+                              ..++++.+++.+||+.||++|||++|+++.|.+
T Consensus       223 p~------------------------------~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         223 PH------------------------------LASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CT------------------------------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             cc------------------------------cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            00                              123467799999999999999999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.1e-48  Score=414.84  Aligned_cols=251  Identities=18%  Similarity=0.279  Sum_probs=209.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++||||+++++++.+.     ...|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEE
Confidence            35799999999999999999999999999999999766655567888999999999999999999998765     6789


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC--CCCceEEeec
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD--NEMVAHVGDF  715 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Df  715 (871)
                      +|||||+||+|.+++.....      .+++.+++.++.||+.||+|||+.   ||+||||||+|||++  .++.+||+||
T Consensus       103 ivmE~~~gg~L~~~~~~~~~------~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DF  173 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDY------KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDF  173 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTC------CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred             EEEEcCCCChHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeec
Confidence            99999999999998866432      599999999999999999999999   999999999999997  6789999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC--C
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL--P  793 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~--~  793 (871)
                      |+|..+....    ......||+.|+|||++.+..++.++||||+||++|+|+||+.||.+...... +........  +
T Consensus       174 Gla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~~~~~~  248 (352)
T d1koba_         174 GLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQNVKRCDWEFD  248 (352)
T ss_dssp             TTCEECCTTS----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHHCCCCCC
T ss_pred             ccceecCCCC----ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCC
Confidence            9999876432    23345799999999999999999999999999999999999999975433221 111111111  1


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ....                              ..++.++.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~------------------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         249 EDAF------------------------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             SSTT------------------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccc------------------------------cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1110                              123345679999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.1e-48  Score=404.45  Aligned_cols=265  Identities=21%  Similarity=0.356  Sum_probs=206.9

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...   ....+.+.+|+++++.++||||+++++++... ......
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~-~~~~~~   85 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE-TPAGPL   85 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-CSSSEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec-cCCCce
Confidence            67999999999999999999999999999999996432   23346789999999999999999999998765 233356


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||++|++|.+++...+       .+++.+++.++.||+.||+|||++   +|+||||||+||+++.++..+++||
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~  155 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF  155 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCC
T ss_pred             EEEEEECCCCCEehhhhcccC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehh
Confidence            899999999999999987654       589999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |.+.................||+.|+|||++.+..+++++||||+||++|||+||+.||..................+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~  235 (277)
T d1o6ya_         156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS  235 (277)
T ss_dssp             TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG
T ss_pred             hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc
Confidence            99987655443334445567999999999999999999999999999999999999999854332221111111111100


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-CHHHHHHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-KIQDAIMELQEAQ  863 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-ta~evl~~L~~i~  863 (871)
                                                   .....+++++.+++.+||+.||++|| ||+|+++.|.++.
T Consensus       236 -----------------------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         236 -----------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             -----------------------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -----------------------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                                         00112345677999999999999999 8999999988765

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-48  Score=400.84  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=200.8

Q ss_pred             ceeeccccceEEEEEEC--CCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEEE
Q 002883          565 NLIGIGGYGYVYKGILG--TEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALVY  640 (871)
Q Consensus       565 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  640 (871)
                      +.||+|+||+||+|.+.  .+++.||||+++..  .....+.+.+|++++++++|||||+++++|..      +..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence            57999999999999864  34578999999543  23345689999999999999999999999853      2368999


Q ss_pred             eccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          641 EFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       641 e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      ||+++|+|.+++....       .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+|+.
T Consensus        87 E~~~~g~L~~~l~~~~-------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~  156 (277)
T d1xbba_          87 EMAELGPLNKYLQQNR-------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA  156 (277)
T ss_dssp             ECCTTEEHHHHHHHCT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EcCCCCcHHHHHhhcc-------CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhh
Confidence            9999999999997654       599999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchhhhh
Q 002883          721 LHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQVAEI  799 (871)
Q Consensus       721 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  799 (871)
                      ...............||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.....  .......+.+....  
T Consensus       157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~~~i~~~~~~~~p--  232 (277)
T d1xbba_         157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGERMGCP--  232 (277)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCCCCCC--
T ss_pred             ccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--HHHHHHcCCCCCCC--
Confidence            7654333333444678999999999999999999999999999999998 899998643321  11111111110000  


Q ss_pred             cChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          800 IDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                                                  ..++.++.+++.+||+.||++|||++||.+.|+....
T Consensus       233 ----------------------------~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         233 ----------------------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             ----------------------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----------------------------cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence                                        0223467789999999999999999999999887643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=402.71  Aligned_cols=251  Identities=21%  Similarity=0.301  Sum_probs=206.6

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ------RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRG  632 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  632 (871)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++...      ....+.+.+|++++++++|||||++++++.+.    
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~----   85 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK----   85 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC----
Confidence            57999999999999999999999999999999985432      12357899999999999999999999998776    


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC----
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM----  708 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----  708 (871)
                       ...|+|||||++|+|.+++....       .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++    
T Consensus        86 -~~~~iv~E~~~gg~L~~~i~~~~-------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~  154 (293)
T d1jksa_          86 -TDVILILELVAGGELFDFLAEKE-------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP  154 (293)
T ss_dssp             -SEEEEEEECCCSCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSC
T ss_pred             -CEEEEEEEcCCCccccchhcccc-------ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCccc
Confidence             67899999999999999997654       599999999999999999999999   999999999999998776    


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHh
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYA  788 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~  788 (871)
                      .+|++|||+|.......    ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+...... .....
T Consensus       155 ~vkl~DfG~a~~~~~~~----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~  229 (293)
T d1jksa_         155 RIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANVS  229 (293)
T ss_dssp             CEEECCCTTCEECTTSC----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHH
T ss_pred             ceEecchhhhhhcCCCc----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-HHHHH
Confidence            49999999998875432    22345689999999999999999999999999999999999999985432221 11111


Q ss_pred             hhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          789 KMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .......                            ......++..+.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~----------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         230 AVNYEFE----------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             TTCCCCC----------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hcCCCCC----------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111000                            0111133456779999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-48  Score=408.01  Aligned_cols=246  Identities=23%  Similarity=0.303  Sum_probs=201.4

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR---GASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      +.|+..+.||+|+||+||+|++..+++.||||+++....   ...+.+.+|++++++++|||||++++++.+.     ..
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CE
Confidence            359999999999999999999999999999999965432   2345788999999999999999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+|||||++|++..++....       .+++.+++.++.||+.||.|||++   +||||||||+|||++.++.+||+||
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~~-------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DF  159 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHKK-------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF  159 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCC
T ss_pred             EEEEEEecCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeec
Confidence            899999999999987765543       599999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA---LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |+|.....       .....||+.|+|||++.   .+.|+.++|||||||++|||++|+.||.+...... .........
T Consensus       160 G~a~~~~~-------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-~~~i~~~~~  231 (309)
T d1u5ra_         160 GSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNES  231 (309)
T ss_dssp             TTCBSSSS-------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCC
T ss_pred             ccccccCC-------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCC
Confidence            99986542       22356999999999875   35689999999999999999999999975432221 111111111


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      +.....                              .+++.+.+++.+||+.||++||||+|+++
T Consensus       232 ~~~~~~------------------------------~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         232 PALQSG------------------------------HWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCCSCT------------------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCC------------------------------CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            111000                              12345779999999999999999999976

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=407.70  Aligned_cols=263  Identities=24%  Similarity=0.366  Sum_probs=205.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCC-----cEEEEEEeecc-ccchHHHHHHHHHHHHcC-CCCccceeeeeecccCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEE-----TNVAVKVLDLQ-QRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDT  630 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  630 (871)
                      .++|++.+.||+|+||+||+|++...+     ..||+|++... .......+.+|+.++.++ +|||||++++++.+.  
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS--  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--
Confidence            467999999999999999999986544     36999998533 333456789999999998 899999999998765  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccc----------------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQ----------------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVH  694 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  694 (871)
                         +..|+|||||++|+|.++++......                .....+++..++.++.||+.||+|||++   +|||
T Consensus       114 ---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH  187 (325)
T d1rjba_         114 ---GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH  187 (325)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             ---CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence               66899999999999999997654211                0123589999999999999999999999   9999


Q ss_pred             cCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCC
Q 002883          695 CDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRP  773 (871)
Q Consensus       695 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~p  773 (871)
                      |||||+||+++.++.+||+|||+|+...... .........||+.|||||++.++.+++++|||||||++|||+| |+.|
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P  266 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  266 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCC-ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence            9999999999999999999999998765433 2222334568999999999999999999999999999999998 8999


Q ss_pred             CchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHH
Q 002883          774 TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQ  853 (871)
Q Consensus       774 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~  853 (871)
                      |.+..... .+..............                              .+++++.+++.+||+.||++|||++
T Consensus       267 f~~~~~~~-~~~~~~~~~~~~~~p~------------------------------~~~~~l~~li~~cl~~dP~~RPt~~  315 (325)
T d1rjba_         267 YPGIPVDA-NFYKLIQNGFKMDQPF------------------------------YATEEIYIIMQSCWAFDSRKRPSFP  315 (325)
T ss_dssp             STTCCCSH-HHHHHHHTTCCCCCCT------------------------------TCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCHHH-HHHHHHhcCCCCCCCC------------------------------cCCHHHHHHHHHHcCCChhHCcCHH
Confidence            97543222 1222222111111000                              1234677999999999999999999


Q ss_pred             HHHHHHH
Q 002883          854 DAIMELQ  860 (871)
Q Consensus       854 evl~~L~  860 (871)
                      ||++.|.
T Consensus       316 ei~~~L~  322 (325)
T d1rjba_         316 NLTSFLG  322 (325)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHh
Confidence            9999985

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-47  Score=403.36  Aligned_cols=249  Identities=20%  Similarity=0.284  Sum_probs=207.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++++.||+|+||.||+|++..+++.||||+++..   .....+.+.+|+.++++++||||+++++++.+.     .
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----D   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----S
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-----c
Confidence            46799999999999999999999999999999999643   233457788999999999999999999999876     7


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+|||||+||+|.+++...+       .+++..++.++.||+.||+|||++   +|+||||||+|||++.+|.+||+|
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~~-------~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~D  148 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRER-------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITD  148 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             ccccceeccCCCchhhhhhccc-------CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEee
Confidence            7999999999999999998755       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||+|+......   ......+||+.|+|||++.+..|+.++||||+||++|||++|++||........ .........+ 
T Consensus       149 FG~a~~~~~~~---~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~i~~~~~~-  223 (337)
T d1o6la_         149 FGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEEIR-  223 (337)
T ss_dssp             CTTCBCSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCC-
T ss_pred             cccccccccCC---cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-HHHHhcCCCC-
Confidence            99998754322   223446799999999999999999999999999999999999999986433221 1111111100 


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC-----HHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK-----IQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----a~evl~  857 (871)
                       ...                              .+..++.+++.+||+.||++||+     ++|+++
T Consensus       224 -~p~------------------------------~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         224 -FPR------------------------------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -CCT------------------------------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -CCc------------------------------cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence             000                              12345678999999999999995     788876

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.7e-46  Score=397.49  Aligned_cols=246  Identities=23%  Similarity=0.293  Sum_probs=205.1

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++..   .....+.+.+|+.++++++||||+++++++.+.     .
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~   77 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----Q   77 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----S
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-----C
Confidence            35799999999999999999999999999999999643   223457889999999999999999999998765     7


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||++||++..++....       .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~D  147 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKSQ-------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITD  147 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS-------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred             eeeeEeeecCCccccccccccc-------cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEec
Confidence            7899999999999999998754       588999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||+|+.....      .....||+.|+|||++.+..|+.++||||+||++|||+||+.||........ .........+ 
T Consensus       148 FG~a~~~~~~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~~~-  219 (316)
T d1fota_         148 FGFAKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-YEKILNAELR-  219 (316)
T ss_dssp             CSSCEECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHCCCC-
T ss_pred             CccceEeccc------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-HHHHHcCCCC-
Confidence            9999886532      2235799999999999999999999999999999999999999975432211 1111111100 


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~  857 (871)
                       .                       ++       ...+++.+++.+||+.||++||     |++|+++
T Consensus       220 -~-----------------------p~-------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         220 -F-----------------------PP-------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             -C-----------------------CT-------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -C-----------------------CC-------CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence             0                       00       1224567899999999999996     8999976

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=398.96  Aligned_cols=252  Identities=22%  Similarity=0.316  Sum_probs=206.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||+++.... ....+.+|+++++.++||||+++++++.+.     ...|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM-----EELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEE
Confidence            3689999999999999999999999999999999976543 345688999999999999999999998765     6799


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC--CceEEeec
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE--MVAHVGDF  715 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~Df  715 (871)
                      +|||||+||+|.+++.....      .+++.+++.++.||+.||+|||+.   +|+||||||+|||++.+  ..+||+||
T Consensus        78 lvmE~~~gg~L~~~i~~~~~------~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DF  148 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAF------ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEF  148 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             EEEecCCCCcHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEccc
Confidence            99999999999999976532      489999999999999999999999   99999999999999854  58999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |.++.....    .......+|+.|+|||...+..++.++||||+||++|+|++|+.||........ +.......... 
T Consensus       149 G~~~~~~~~----~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-~~~i~~~~~~~-  222 (321)
T d1tkia_         149 GQARQLKPG----DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-IENIMNAEYTF-  222 (321)
T ss_dssp             TTCEECCTT----CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCCCC-
T ss_pred             chhhccccC----CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCC-
Confidence            999876432    223345689999999999999999999999999999999999999986433221 11111111000 


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                                                 ....+..+..++.+++.+||..||++|||++|+++
T Consensus       223 ---------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         223 ---------------------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---------------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---------------------------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                                       00111233456789999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-47  Score=394.23  Aligned_cols=261  Identities=23%  Similarity=0.358  Sum_probs=199.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCC---CcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTE---ETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .++|++.+.||+|+||+||+|++..+   +..||||+++... ....+.+.+|++++++++||||+++++++.+      
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            45799999999999999999998643   3568999885433 3345678999999999999999999999853      


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                      +..|+||||+++|++.+++.....      .+++..++.++.||++||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~------~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~  150 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKY------SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG  150 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTT------TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred             CeEEEEEEeccCCcHHhhhhccCC------CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEc
Confidence            457999999999999998866432      589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |||+|+......  ........||+.|+|||++.++.++.++|||||||++|||+| |.+||........  ........
T Consensus       151 DfG~a~~~~~~~--~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--~~~i~~~~  226 (273)
T d1mp8a_         151 DFGLSRYMEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGRIENGE  226 (273)
T ss_dssp             C---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHHTTC
T ss_pred             cchhheeccCCc--ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH--HHHHHcCC
Confidence            999998765432  222334568999999999999999999999999999999998 8999976433221  11111111


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMRQ  867 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~~  867 (871)
                      .....                              ..++.++.+++.+||+.||++|||++|+++.|+++.+..+
T Consensus       227 ~~~~~------------------------------~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k  271 (273)
T d1mp8a_         227 RLPMP------------------------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  271 (273)
T ss_dssp             CCCCC------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCC------------------------------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence            10000                              1223467799999999999999999999999999876654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.6e-46  Score=389.75  Aligned_cols=252  Identities=24%  Similarity=0.349  Sum_probs=205.1

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc---------chHHHHHHHHHHHHcCC-CCccceeeeeecc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR---------GASKSFIAECEALRSIR-HRNLVKIITSCSS  627 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  627 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||+++....         ...+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            3689999999999999999999998999999999964421         12346889999999996 9999999999876


Q ss_pred             cCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCC
Q 002883          628 IDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNE  707 (871)
Q Consensus       628 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  707 (871)
                      .     +..|+||||+++|+|.++++...       .+++.+++.++.||+.||+|||++   +|+||||||+||+++.+
T Consensus        82 ~-----~~~~ivmE~~~~g~L~~~l~~~~-------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~  146 (277)
T d1phka_          82 N-----TFFFLVFDLMKKGELFDYLTEKV-------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD  146 (277)
T ss_dssp             S-----SEEEEEEECCTTCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred             C-----cceEEEEEcCCCchHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCC
Confidence            5     77999999999999999997644       599999999999999999999999   99999999999999999


Q ss_pred             CceEEeecccceecCCCCCCccccccccccccccCccccc------CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhh
Q 002883          708 MVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGA------LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEG  781 (871)
Q Consensus       708 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~  781 (871)
                      +.+||+|||.|+......    ......||+.|+|||++.      ...++.++||||+||++|||++|+.||.+.....
T Consensus       147 ~~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~  222 (277)
T d1phka_         147 MNIKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML  222 (277)
T ss_dssp             CCEEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             CCeEEccchheeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence            999999999999876432    223457999999999764      3457899999999999999999999998653322


Q ss_pred             hhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          782 LSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      . ............                            .+....+++++.+++.+||+.||++|||++|+++
T Consensus       223 ~-~~~i~~~~~~~~----------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         223 M-LRMIMSGNYQFG----------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             H-HHHHHHTCCCCC----------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             H-HHHHHhCCCCCC----------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1 111111111000                            0011123456789999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=392.59  Aligned_cols=256  Identities=28%  Similarity=0.433  Sum_probs=200.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||+||+|++. +++.||||+++.... ..+.+.+|+.++++++|||||++++++.+      +..|
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~   87 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY   87 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeE
Confidence            467999999999999999999997 446799999965443 45789999999999999999999999753      3368


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++|+|.+++......     .+++.+++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~-----~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGl  159 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGK-----YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL  159 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             EEEEecCCCchhhhhhhcccc-----cchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccch
Confidence            999999999999998765422     599999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVA  797 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  797 (871)
                      |+...+..  ........||+.|+|||++..+.++.++|||||||++|||+||..||............... .......
T Consensus       160 a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~-~~~~~~~  236 (285)
T d1fmka3         160 ARLIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCP  236 (285)
T ss_dssp             TC----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCC
T ss_pred             hhhccCCC--ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCCCCCC
Confidence            98765432  22233456899999999999999999999999999999999976666543222222222111 1111110


Q ss_pred             hhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          798 EIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                                                    ..+++++.+++.+||+.||++|||++||++.|++.
T Consensus       237 ------------------------------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         237 ------------------------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             ------------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             ------------------------------cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence                                          12234677999999999999999999999988764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-46  Score=395.45  Aligned_cols=276  Identities=21%  Similarity=0.321  Sum_probs=204.0

Q ss_pred             HHHHHHhhcCCCCCceeeccccceEEEEEECC-----CCcEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccceeee
Q 002883          551 YAELLKATEGFSSANLIGIGGYGYVYKGILGT-----EETNVAVKVLDLQQ-RGASKSFIAECEALRSI-RHRNLVKIIT  623 (871)
Q Consensus       551 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~  623 (871)
                      .+.++...++|++.+.||+|+||.||+|++..     +++.||||+++... ....+.+.+|..++.++ +|+||+.+++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            34444455789999999999999999999753     34689999996433 33456677888888776 7899999999


Q ss_pred             eecccCcCCCceeeEEEeccCCCCHHHHhhcccccc---------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 002883          624 SCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQ---------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVH  694 (871)
Q Consensus       624 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  694 (871)
                      ++.+.    +...++|||||++|+|.+++.......         .....+++.++..++.||++||+|||++   +|||
T Consensus        85 ~~~~~----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivH  157 (299)
T d1ywna1          85 ACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH  157 (299)
T ss_dssp             EECST----TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             eeccC----CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcC
Confidence            87553    245799999999999999997654321         1123589999999999999999999999   9999


Q ss_pred             cCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhC-CCC
Q 002883          695 CDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTG-KRP  773 (871)
Q Consensus       695 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG-~~p  773 (871)
                      |||||+|||++.++.+||+|||+|+...... .........||+.|+|||++.++.++.++|||||||++|||+|| ..|
T Consensus       158 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p  236 (299)
T d1ywna1         158 RDLAARNILLSEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  236 (299)
T ss_dssp             SCCCGGGEEECGGGCEEECC------CCSCT-TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CcCCccceeECCCCcEEEccCcchhhccccc-cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCC
Confidence            9999999999999999999999998765432 22233445799999999999999999999999999999999996 457


Q ss_pred             CchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHH
Q 002883          774 TDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQ  853 (871)
Q Consensus       774 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~  853 (871)
                      |....... ...............+                              .+++++.+++.+||+.||++|||++
T Consensus       237 ~~~~~~~~-~~~~~~~~~~~~~~~~------------------------------~~~~~l~~li~~cl~~dP~~Rpt~~  285 (299)
T d1ywna1         237 YPGVKIDE-EFCRRLKEGTRMRAPD------------------------------YTTPEMYQTMLDCWHGEPSQRPTFS  285 (299)
T ss_dssp             STTCCCSH-HHHHHHHHTCCCCCCT------------------------------TCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCHHH-HHHHHHhcCCCCCCCc------------------------------cCCHHHHHHHHHHcCCChhHCcCHH
Confidence            76432222 1111111111111100                              1234577899999999999999999


Q ss_pred             HHHHHHHHHHHH
Q 002883          854 DAIMELQEAQKM  865 (871)
Q Consensus       854 evl~~L~~i~~~  865 (871)
                      |+++.|+++.+.
T Consensus       286 eil~~L~~ilq~  297 (299)
T d1ywna1         286 ELVEHLGNLLQA  297 (299)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhC
Confidence            999999998654

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-47  Score=392.45  Aligned_cols=259  Identities=29%  Similarity=0.398  Sum_probs=199.6

Q ss_pred             hcCCCCCceeeccccceEEEEEECCC---CcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTE---ETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      .++|++.+.||+|+||+||+|++...   ...||||+++..   .....+.+.+|++++++++||||+++++++.+.   
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---   83 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---   83 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---
Confidence            35799999999999999999987432   346899998543   233456899999999999999999999998542   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                         ..++||||+++|++.+++.....      .+++..++.++.||+.||.|||++   +|+||||||+||+++.++.+|
T Consensus        84 ---~~~lv~e~~~~~~l~~~~~~~~~------~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vk  151 (273)
T d1u46a_          84 ---PMKMVTELAPLGSLLDRLRKHQG------HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVK  151 (273)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHHHGG------GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEE
T ss_pred             ---chheeeeeecCcchhhhhhcccC------CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhcccccccee
Confidence               35899999999999998876543      499999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhh
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKM  790 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~  790 (871)
                      |+|||+++................|+..|+|||.+.+..++.++|||||||++|||+| |+.||........ .......
T Consensus       152 l~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~-~~~i~~~  230 (273)
T d1u46a_         152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-LHKIDKE  230 (273)
T ss_dssp             ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTS
T ss_pred             eccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH-HHHHHhC
Confidence            9999999987665434344445668899999999999999999999999999999998 8999986433322 1111111


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      .......                              ..++.++.+++.+||+.||++|||+.||.+.|+++
T Consensus       231 ~~~~~~~------------------------------~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         231 GERLPRP------------------------------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCCCCCC------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCc------------------------------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1111100                              02234577999999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=398.99  Aligned_cols=260  Identities=23%  Similarity=0.379  Sum_probs=204.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCc----EEEEEEeecc-ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCC
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEET----NVAVKVLDLQ-QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  633 (871)
                      .+|++++.||+|+||+||+|++..+++    +||+|.++.. .....+.+.+|++++++++|||||+++++|.+.     
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence            469999999999999999999977765    5888887533 334567899999999999999999999998653     


Q ss_pred             ceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEe
Q 002883          634 EFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVG  713 (871)
Q Consensus       634 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  713 (871)
                       ..++++||+.+|+|.+++.....      .+++..++.++.|||.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~~------~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~  153 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHKD------NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT  153 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred             -CeeEEEEeccCCccccccccccc------CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEee
Confidence             35789999999999998876543      589999999999999999999999   99999999999999999999999


Q ss_pred             ecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCC
Q 002883          714 DFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       714 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      |||+|+....... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||.......  .......+.
T Consensus       154 DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~~  230 (317)
T d1xkka_         154 DFGLAKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGE  230 (317)
T ss_dssp             CCSHHHHTTTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHTC
T ss_pred             ccccceecccccc-cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCC
Confidence            9999998764432 222333568999999999999999999999999999999999 888987543222  111111111


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKMR  866 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~~  866 (871)
                      .....                              ..++.++.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus       231 ~~~~p------------------------------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~  274 (317)
T d1xkka_         231 RLPQP------------------------------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  274 (317)
T ss_dssp             CCCCC------------------------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred             CCCCC------------------------------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence            10000                              022345778999999999999999999999999886543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=384.84  Aligned_cols=253  Identities=26%  Similarity=0.374  Sum_probs=198.9

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .++|++.+.||+|+||.||+|++.  ++.||||+++...  ..+.+.+|++++++++||||+++++++.+.    .+..|
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~   77 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY   77 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcEE
Confidence            457888999999999999999994  7789999996443  457899999999999999999999988543    14479


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+++|+|.+++......     .+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+|++|||+
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~-----~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~  149 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRS-----VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL  149 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHH-----HCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             EEEeccCCCCHHHHHHhcCCC-----CCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeeccccc
Confidence            999999999999999765432     589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      ++.....      .....++..|+|||++.++.+++++|||||||++|||+| |++||.......  .............
T Consensus       150 s~~~~~~------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i~~~~~~~~  221 (262)
T d1byga_         150 TKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYKMDA  221 (262)
T ss_dssp             ------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTTTCCCCC
T ss_pred             ceecCCC------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCCCCC
Confidence            9865432      223457899999999988999999999999999999998 788877543222  1111111111111


Q ss_pred             hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          797 AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      ..                              .++.++.+++.+||+.||++|||+.|+++.|+.++.
T Consensus       222 ~~------------------------------~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         222 PD------------------------------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             CT------------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Cc------------------------------cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            00                              122456789999999999999999999999998864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.7e-46  Score=399.56  Aligned_cols=245  Identities=21%  Similarity=0.236  Sum_probs=204.7

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ---QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++|++++.||+|+||.||+|++..+|+.||||+++..   .....+.+.+|+++++.++||||+++++++.+.     ..
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-----cc
Confidence            5799999999999999999999999999999998643   223456789999999999999999999998765     67


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .++||||+.+|+|.+++...+       .+++..++.++.||+.||.|||++   +||||||||+|||++.++.+||+||
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~-------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DF  185 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIG-------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF  185 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             cccccccccccchhhhHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeec
Confidence            899999999999999997754       599999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      |+|+.+...      .....||+.|||||++.+..++.++||||+||++|||+||+.||....... ........... .
T Consensus       186 G~a~~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~~-~  257 (350)
T d1rdqe_         186 GFAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGKVR-F  257 (350)
T ss_dssp             TTCEECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCC-C
T ss_pred             eeeeecccc------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-HHHHHhcCCCC-C
Confidence            999986532      223579999999999999999999999999999999999999997542221 11111111100 0


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~  857 (871)
                       .                              ..+..++.+++.+||+.||.+|+     |++|+++
T Consensus       258 -p------------------------------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         258 -P------------------------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -C------------------------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -C------------------------------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence             0                              01234567899999999999994     8999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.1e-46  Score=400.45  Aligned_cols=250  Identities=19%  Similarity=0.253  Sum_probs=198.8

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHH---HHHHHHHcCCCCccceeeeeecccCcC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFI---AECEALRSIRHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~  631 (871)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....   ......+.   +|+++++.++|||||++++++.+.   
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~---   79 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP---   79 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS---
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC---
Confidence            367999999999999999999999999999999985332   11222333   446777788999999999998775   


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                        +..|+||||++||+|.+++....       .+++..++.++.||+.||+|||++   +||||||||+|||++.++.+|
T Consensus        80 --~~~~ivmE~~~gg~L~~~l~~~~-------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iK  147 (364)
T d1omwa3          80 --DKLSFILDLMNGGDLHYHLSQHG-------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVR  147 (364)
T ss_dssp             --SEEEEEECCCCSCBHHHHHHHHC-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEE
T ss_pred             --CEEEEEEEecCCCcHHHHHHhcc-------cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEE
Confidence              67899999999999999997754       589999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhh
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKM  790 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~  790 (871)
                      |+|||+|+......     .....||+.|+|||++.. ..|++++||||+||++|||+||+.||................
T Consensus       148 l~DFGla~~~~~~~-----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~  222 (364)
T d1omwa3         148 ISDLGLACDFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL  222 (364)
T ss_dssp             ECCCTTCEECSSSC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS
T ss_pred             EeeeceeeecCCCc-----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence            99999999765432     233579999999998864 568999999999999999999999997543221111111111


Q ss_pred             CCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC-----HHHHHH
Q 002883          791 GLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK-----IQDAIM  857 (871)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----a~evl~  857 (871)
                      ..+.....                              .+.+++.+++.+||+.||++|||     |+|+++
T Consensus       223 ~~~~~~~~------------------------------~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         223 TMAVELPD------------------------------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SCCCCCCS------------------------------SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             cCCCCCCC------------------------------CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            11111100                              12345679999999999999999     688875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-46  Score=398.41  Aligned_cols=257  Identities=20%  Similarity=0.286  Sum_probs=201.8

Q ss_pred             hcCCCCCc-eeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHc-CCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSAN-LIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRS-IRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|.+.+ .||+|+||+||+|++..+++.||||+++.     ...+.+|++++.+ .+||||++++++|.+. .....+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence            35788875 69999999999999998999999999863     2567789998765 4899999999998653 223367


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC---CCceEE
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN---EMVAHV  712 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl  712 (871)
                      +|+|||||+||+|.+++...+..     .+++.+++.++.||+.||+|||+.   +|+||||||+||+++.   ++.+||
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~-----~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl  155 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQ-----AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKL  155 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCC-----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCC-----CcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccc
Confidence            89999999999999999765422     599999999999999999999999   9999999999999975   567999


Q ss_pred             eecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC
Q 002883          713 GDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL  792 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~  792 (871)
                      +|||+|+......    ......||+.|+|||++.+..|+.++||||+||++|+|+||+.||.+........ . .....
T Consensus       156 ~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~-~-~~~~i  229 (335)
T d2ozaa1         156 TDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-G-MKTRI  229 (335)
T ss_dssp             CCCTTCEECCCCC----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CC
T ss_pred             cccceeeeccCCC----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH-H-HHHHH
Confidence            9999998775432    2234579999999999999999999999999999999999999997542211100 0 00000


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ......+.                       .+....+++++.+++.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~-----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         230 RMGQYEFP-----------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CSCSSSCC-----------------------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcCCCCCC-----------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            00000000                       0112244567889999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-46  Score=396.77  Aligned_cols=267  Identities=24%  Similarity=0.365  Sum_probs=209.2

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECC-----CCcEEEEEEeecccc-chHHHHHHHHHHHHcCCCCccceeeeeecccC
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGT-----EETNVAVKVLDLQQR-GASKSFIAECEALRSIRHRNLVKIITSCSSID  629 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  629 (871)
                      ...++|++.+.||+|+||+||+|++..     +++.||||+++.... ...+++.+|++++++++||||+++++++... 
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-   88 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-   88 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC-
Confidence            345689999999999999999999753     457899999965433 2356799999999999999999999998765 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhccccc-----------------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDE-----------------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSI  692 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  692 (871)
                          ...++||||+++|+|.+++......                 ......+++..++.++.|++.||+|||+.   +|
T Consensus        89 ----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i  161 (301)
T d1lufa_          89 ----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF  161 (301)
T ss_dssp             ----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             ----CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence                5689999999999999999754321                 01123589999999999999999999999   99


Q ss_pred             EecCCCCCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCC-
Q 002883          693 VHCDLKPSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGK-  771 (871)
Q Consensus       693 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~-  771 (871)
                      |||||||+|||++.++.+||+|||+|+...+.. .........|++.|+|||.+.+..+++++|||||||++|||++|. 
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~  240 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  240 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCc-cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence            999999999999999999999999998664332 222233456889999999999999999999999999999999985 


Q ss_pred             CCCchhhhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCC
Q 002883          772 RPTDDMFEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMK  851 (871)
Q Consensus       772 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt  851 (871)
                      +||......+. .........++ ..                              ..++.++.+++.+||+.||++|||
T Consensus       241 ~p~~~~~~~e~-~~~v~~~~~~~-~p------------------------------~~~~~~~~~li~~cl~~~P~~RPt  288 (301)
T d1lufa_         241 QPYYGMAHEEV-IYYVRDGNILA-CP------------------------------ENCPLELYNLMRLCWSKLPADRPS  288 (301)
T ss_dssp             CTTTTSCHHHH-HHHHHTTCCCC-CC------------------------------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCHHHH-HHHHHcCCCCC-CC------------------------------ccchHHHHHHHHHHcCCChhHCcC
Confidence            56765433321 11111111110 00                              022345779999999999999999


Q ss_pred             HHHHHHHHHHHH
Q 002883          852 IQDAIMELQEAQ  863 (871)
Q Consensus       852 a~evl~~L~~i~  863 (871)
                      |.||++.|++|.
T Consensus       289 ~~ev~~~L~~i~  300 (301)
T d1lufa_         289 FCSIHRILQRMC  300 (301)
T ss_dssp             HHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhc
Confidence            999999999874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-46  Score=395.18  Aligned_cols=248  Identities=24%  Similarity=0.328  Sum_probs=202.8

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHHHH-cCCCCccceeeeeecccCcCCCc
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ---RGASKSFIAECEALR-SIRHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...   ....+.+.+|..++. .++||||+++++++.+.     .
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----E   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----S
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-----C
Confidence            57999999999999999999999999999999996432   233456677777665 68999999999998776     6


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ..|+||||+++|+|.+++....       .+++.+++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~-------~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~D  146 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCH-------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIAD  146 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS-------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             ceeEEEeecCCCcHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccc
Confidence            7899999999999999998654       589999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD  794 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~  794 (871)
                      ||.|+......   .......||+.|+|||++.+..+++++||||+||++|||+||+.||.+......  ........+.
T Consensus       147 FG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~~i~~~~~~  221 (320)
T d1xjda_         147 FGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FHSIRMDNPF  221 (320)
T ss_dssp             CTTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCCC
T ss_pred             cchhhhccccc---ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHHcCCCC
Confidence            99998654322   223345799999999999999999999999999999999999999985433221  1111111110


Q ss_pred             hhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHH-HHHH
Q 002883          795 QVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQ-DAIM  857 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~-evl~  857 (871)
                       ...                              .++.++.+++.+||+.||++|||+. |+++
T Consensus       222 -~p~------------------------------~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 -YPR------------------------------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             -CCT------------------------------TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -CCc------------------------------cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence             000                              1234567999999999999999995 6754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=387.89  Aligned_cols=280  Identities=21%  Similarity=0.282  Sum_probs=203.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHH--HHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIA--ECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|...+.||+|+||+||+|++  +|+.||||+++....   ..+.+  |+..+.+++||||+++++++.+.. ......
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEE
Confidence            4678889999999999999997  588999999964432   33444  444556779999999999987652 233568


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCceeeCCCCceE
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC-----HTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                      |+||||+++|+|.+++++.        .+++..++.++.|+|.||+|+|+..     ..+||||||||+|||++.++.+|
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~--------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K  148 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY--------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             EEEEecccCCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence            9999999999999999764        4899999999999999999999731     24999999999999999999999


Q ss_pred             EeecccceecCCCCCCc-cccccccccccccCcccccCCC------CCCccchhhHHHHHHHHHhCCCCCchhhhhhhhH
Q 002883          712 VGDFGLSRLLHDNSPDQ-TSTSRVKGSIGYVAPEYGALGE------VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSL  784 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~  784 (871)
                      |+|||+++......... .......||+.|+|||++.+..      ++.++|||||||++|||+||..||..........
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            99999998876543221 2334567999999999876542      5778999999999999999998886432211110


Q ss_pred             HHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchh--HHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          785 HKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNL--RAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      ......          ++.. ......  ......+|..  .....+....+.+++.+||+.||++|||+.||++.|+++
T Consensus       229 ~~~~~~----------~~~~-~~~~~~--~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         229 YDLVPS----------DPSV-EEMRKV--VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             TTTSCS----------SCCH-HHHHHH--HTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcccc----------cchH-HHHHHH--HhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            000000          0000 000000  0011112211  111224556788999999999999999999999999988


Q ss_pred             HHH
Q 002883          863 QKM  865 (871)
Q Consensus       863 ~~~  865 (871)
                      .+.
T Consensus       296 ~~~  298 (303)
T d1vjya_         296 SQQ  298 (303)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-46  Score=391.16  Aligned_cols=279  Identities=24%  Similarity=0.323  Sum_probs=205.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++++.||+|+||+||+|++..+++.||||+++...  ....+.+.+|++++++++||||+++++++.+.     ...
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----cce
Confidence            58999999999999999999999999999999995433  22357889999999999999999999999776     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      |+||||+.+ ++.+++.....     ..+++..++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||
T Consensus        77 ~iv~e~~~~-~~~~~~~~~~~-----~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG  147 (298)
T d1gz8a_          77 YLVFEFLHQ-DLKKFMDASAL-----TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG  147 (298)
T ss_dssp             EEEEECCSE-EHHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             eEEEeecCC-chhhhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCC
Confidence            999999965 55555543322     2599999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE-VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      .|+......   .......||+.|+|||...... ++.++||||+||++|+|++|+.||..................+..
T Consensus       148 ~a~~~~~~~---~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~  224 (298)
T d1gz8a_         148 LARAFGVPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE  224 (298)
T ss_dssp             HHHHHCCCS---BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cceeccCCc---ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence            998765432   2233457999999999866655 478999999999999999999999865433322222222222211


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ...   +..... .......................+++.+++.+||+.||++||||+|+++.
T Consensus       225 ~~~---~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         225 VVW---PGVTSM-PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TTS---TTGGGS-TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhc---cccccc-cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            000   000000 00000000111111222223445678899999999999999999999873

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-45  Score=385.61  Aligned_cols=267  Identities=25%  Similarity=0.380  Sum_probs=207.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCC-------cEEEEEEeecccc-chHHHHHHHHHHHHcC-CCCccceeeeeeccc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEE-------TNVAVKVLDLQQR-GASKSFIAECEALRSI-RHRNLVKIITSCSSI  628 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  628 (871)
                      .++|++.+.||+|+||.||+|+....+       ..||||+++.... .....+.+|+..+.++ +|||||+++++|.+.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            468999999999999999999975443       4799999965443 3346788899988888 899999999999765


Q ss_pred             CcCCCceeeEEEeccCCCCHHHHhhccccc---------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 002883          629 DTRGNEFKALVYEFMPNGSLENWLNQKEDE---------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKP  699 (871)
Q Consensus       629 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  699 (871)
                           ...++||||+++|+|.+++......         ......+++.+++.++.||+.||+|||+.   +||||||||
T Consensus        92 -----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp  163 (299)
T d1fgka_          92 -----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  163 (299)
T ss_dssp             -----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             -----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence                 5689999999999999999765421         11233589999999999999999999999   999999999


Q ss_pred             CceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchhh
Q 002883          700 SNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDMF  778 (871)
Q Consensus       700 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~  778 (871)
                      +|||++.++.+||+|||.++........ .......||+.|+|||.+.++.|++++||||||||+|||++ |++||....
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceeecCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence            9999999999999999999877654322 23344568999999999999999999999999999999998 788887543


Q ss_pred             hhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          779 EEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      ...  .......+.......                              .++.++.+++.+||+.||++||||.||++.
T Consensus       243 ~~~--~~~~i~~~~~~~~p~------------------------------~~~~~l~~li~~cl~~dP~~Rps~~eil~~  290 (299)
T d1fgka_         243 VEE--LFKLLKEGHRMDKPS------------------------------NCTNELYMMMRDCWHAVPSQRPTFKQLVED  290 (299)
T ss_dssp             HHH--HHHHHHTTCCCCCCS------------------------------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHH--HHHHHHcCCCCCCCc------------------------------cchHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            322  111111111111000                              123457799999999999999999999999


Q ss_pred             HHHHHHH
Q 002883          859 LQEAQKM  865 (871)
Q Consensus       859 L~~i~~~  865 (871)
                      |+++.+.
T Consensus       291 L~~i~a~  297 (299)
T d1fgka_         291 LDRIVAL  297 (299)
T ss_dssp             HHHHHHH
T ss_pred             HHHHhhc
Confidence            9999765

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-46  Score=391.82  Aligned_cols=269  Identities=21%  Similarity=0.252  Sum_probs=197.6

Q ss_pred             CCceeeccccceEEEEEECCCCcEEEEEEeeccccc-----hHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          563 SANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRG-----ASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       563 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .+++||+|+||+||+|++..+++.||||+++.....     ..+.+.+|+.++++++|||||++++++...     +..|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-----~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-----Ccee
Confidence            357899999999999999999999999998543321     134688999999999999999999998776     6689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +||||+.++++..+.....       .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||.
T Consensus        77 ivmE~~~~~~~~~~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~  146 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNSL-------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL  146 (299)
T ss_dssp             EEEECCSEEHHHHHTTCCS-------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             ehhhhhcchHHhhhhhccc-------CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCcc
Confidence            9999998887776665432       589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch-
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ-  795 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~-  795 (871)
                      |+......   ......+||+.|+|||++.+ ..|+.++||||+||++|||+||+.||....+.+.........+.+.. 
T Consensus       147 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~  223 (299)
T d1ua2a_         147 AKSFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE  223 (299)
T ss_dssp             GSTTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccCCCc---ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            98765432   12233579999999998764 46799999999999999999999999764433221111111111111 


Q ss_pred             -hhhhcChhHHHHHHHHHhhhhhhcC-chhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 -VAEIIDPAILEEALEIQAGIVKELQ-PNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 -~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       ..........        ...+..+ ......+....+++.+++.+||+.||++||||+|+++
T Consensus       224 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         224 QWPDMCSLPDY--------VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TSSSTTSSTTC--------CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hccchhccchh--------hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence             0000000000        0000000 0111112233456889999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-45  Score=383.60  Aligned_cols=258  Identities=22%  Similarity=0.359  Sum_probs=203.1

Q ss_pred             CceeeccccceEEEEEECCCC---cEEEEEEeec-cccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeEE
Q 002883          564 ANLIGIGGYGYVYKGILGTEE---TNVAVKVLDL-QQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKALV  639 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  639 (871)
                      .++||+|+||+||+|++..++   ..||||+++. ......+++.+|++++++++||||+++++++.+.    ....++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCceEEE
Confidence            478999999999999985433   3689999863 3444557899999999999999999999997653    2457999


Q ss_pred             EeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecccce
Q 002883          640 YEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSR  719 (871)
Q Consensus       640 ~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  719 (871)
                      ||||++|+|.+++.....      ..++..+..++.|++.||.|+|+.   +|+||||||+|||+++++.+||+|||+++
T Consensus       108 ~E~~~~g~l~~~~~~~~~------~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~  178 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR  178 (311)
T ss_dssp             EECCTTCBHHHHHHCTTC------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGC
T ss_pred             EEEeecCchhhhhccccc------cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchh
Confidence            999999999999876543      478889999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCCCc-cccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchhhh
Q 002883          720 LLHDNSPDQ-TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQVAE  798 (871)
Q Consensus       720 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  798 (871)
                      ......... .......||+.|+|||.+..+.++.++||||||+++|||+||..||........... ....+...... 
T Consensus       179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~-~i~~g~~~~~p-  256 (311)
T d1r0pa_         179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-YLLQGRRLLQP-  256 (311)
T ss_dssp             CTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH-HHHTTCCCCCC-
T ss_pred             hccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH-HHHcCCCCCCc-
Confidence            875443222 223345689999999999999999999999999999999998888765332221111 11111110000 


Q ss_pred             hcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHHH
Q 002883          799 IIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQKM  865 (871)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~~  865 (871)
                                                   ..++.++.+++.+||+.||++|||+.||++.|+++.+.
T Consensus       257 -----------------------------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         257 -----------------------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             -----------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----------------------------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                                         01234577999999999999999999999999999764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=392.00  Aligned_cols=281  Identities=24%  Similarity=0.306  Sum_probs=204.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCC-CcEEEEEEeeccc--cchHHHHHHHHHHHHcC---CCCccceeeeeecccCcC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTE-ETNVAVKVLDLQQ--RGASKSFIAECEALRSI---RHRNLVKIITSCSSIDTR  631 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~  631 (871)
                      .++|++++.||+|+||+||+|++..+ ++.||||+++...  ......+.+|+.+++.+   +||||++++++|......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999999655 6789999985432  22234566788777665   799999999998765555


Q ss_pred             CCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceE
Q 002883          632 GNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAH  711 (871)
Q Consensus       632 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  711 (871)
                      .....+++|||++++.+........      ..+++..++.++.|++.||+|||++   +||||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~------~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~k  156 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE------PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK  156 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             cCceEEEEEEeccCCchhhhhhccC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCee
Confidence            5678899999998877665544332      2589999999999999999999999   999999999999999999999


Q ss_pred             EeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC
Q 002883          712 VGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG  791 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~  791 (871)
                      |+|||.+.....    ........||+.|+|||++.+..|+.++||||+||++|||++|+.||.................
T Consensus       157 l~dfg~~~~~~~----~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  232 (305)
T d1blxa_         157 LADFGLARIYSF----QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG  232 (305)
T ss_dssp             ECSCCSCCCCCG----GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ecchhhhhhhcc----cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhC
Confidence            999999876432    2234456799999999999999999999999999999999999999986543322111111111


Q ss_pred             CCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          792 LPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .+... .+........     ...................+.+.+++.+||+.||++||||+|+++
T Consensus       233 ~~~~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         233 LPGEE-DWPRDVALPR-----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCCGG-GSCTTCSSCG-----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCchh-cccccccchh-----hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11110 0000000000     000000000011111223456778999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-45  Score=388.29  Aligned_cols=264  Identities=23%  Similarity=0.364  Sum_probs=205.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcE--EEEEEeecc-ccchHHHHHHHHHHHHcC-CCCccceeeeeecccCcCCCc
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETN--VAVKVLDLQ-QRGASKSFIAECEALRSI-RHRNLVKIITSCSSIDTRGNE  634 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  634 (871)
                      ++|++.+.||+|+||+||+|++..++..  ||||.++.. .....+.+.+|+++++++ +||||++++++|.+.     +
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----C
Confidence            5789999999999999999999877764  677777432 333456789999999998 799999999999875     6


Q ss_pred             eeeEEEeccCCCCHHHHhhccccc---------ccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDE---------QNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD  705 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  705 (871)
                      ..|+||||+++|+|.++++.....         ......+++.++..++.|||.||.|+|+.   +|+||||||+|||++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence            789999999999999999764211         11234699999999999999999999999   999999999999999


Q ss_pred             CCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCC-CCchhhhhhhhH
Q 002883          706 NEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKR-PTDDMFEEGLSL  784 (871)
Q Consensus       706 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~-pf~~~~~~~~~~  784 (871)
                      .++.+||+|||+|+......    ......||..|+|||.+.++.++.++|||||||++|||++|.. ||.......  .
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--~  235 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--L  235 (309)
T ss_dssp             GGGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H
T ss_pred             CCCceEEccccccccccccc----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--H
Confidence            99999999999998654321    1223458999999999999999999999999999999999764 665432221  1


Q ss_pred             HHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          785 HKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      .............                              ..+++++.+++.+||+.||++|||++||++.|+++.+
T Consensus       236 ~~~i~~~~~~~~~------------------------------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         236 YEKLPQGYRLEKP------------------------------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HHHGGGTCCCCCC------------------------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCC------------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1111111110000                              0123467799999999999999999999999999876


Q ss_pred             HH
Q 002883          865 MR  866 (871)
Q Consensus       865 ~~  866 (871)
                      ..
T Consensus       286 ~~  287 (309)
T d1fvra_         286 ER  287 (309)
T ss_dssp             SS
T ss_pred             cC
Confidence            43

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-45  Score=385.71  Aligned_cols=269  Identities=23%  Similarity=0.365  Sum_probs=211.9

Q ss_pred             hhcCCCCCceeeccccceEEEEEEC-----CCCcEEEEEEeecccc-chHHHHHHHHHHHHcC-CCCccceeeeeecccC
Q 002883          557 ATEGFSSANLIGIGGYGYVYKGILG-----TEETNVAVKVLDLQQR-GASKSFIAECEALRSI-RHRNLVKIITSCSSID  629 (871)
Q Consensus       557 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  629 (871)
                      ..++|++.+.||+|+||.||+|++.     .+++.||||+++.... .....+.+|+.+++.+ +|||||++++++.+. 
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-   99 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-   99 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-
Confidence            3468999999999999999999863     3567899999965433 3455788999999999 699999999998765 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccc-----------cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQ-----------NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLK  698 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  698 (871)
                          ...++|||||++|+|.++++......           .....+++..+..++.||+.|++|||++   ++||||||
T Consensus       100 ----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLK  172 (311)
T d1t46a_         100 ----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA  172 (311)
T ss_dssp             ----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             ----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccc
Confidence                56899999999999999997654211           1223589999999999999999999999   99999999


Q ss_pred             CCceeeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCchh
Q 002883          699 PSNVLLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFT-GKRPTDDM  777 (871)
Q Consensus       699 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~  777 (871)
                      |+||+++.++.+|++|||.++...... .........||+.|+|||.+.++.++.++|||||||++|||+| |.+||...
T Consensus       173 p~NIl~~~~~~~ki~DfG~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~  251 (311)
T d1t46a_         173 ARNILLTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (311)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cccccccccCcccccccchheeccCCC-cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876543 2233445678999999999999999999999999999999999 55555432


Q ss_pred             hhhhhhHHHHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          778 FEEGLSLHKYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      . ....+........+....+                              ..+.++.+++.+||+.||++|||++|+++
T Consensus       252 ~-~~~~~~~~i~~~~~~~~~~------------------------------~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         252 P-VDSKFYKMIKEGFRMLSPE------------------------------HAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             C-SSHHHHHHHHHTCCCCCCT------------------------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C-HHHHHHHHHhcCCCCCCcc------------------------------cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            2 2222222222221111111                              12345779999999999999999999999


Q ss_pred             HHHHHHHH
Q 002883          858 ELQEAQKM  865 (871)
Q Consensus       858 ~L~~i~~~  865 (871)
                      .|+++.+.
T Consensus       301 ~L~~~i~~  308 (311)
T d1t46a_         301 LIEKQISE  308 (311)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHhhcc
Confidence            99987543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=389.02  Aligned_cols=284  Identities=20%  Similarity=0.236  Sum_probs=208.8

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      .+|++++.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.........+.|
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            57999999999999999999999999999999996433 33456788999999999999999999998766444445555


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeeccc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFGL  717 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  717 (871)
                      +++ |+.+|+|.+++...        .+++..++.++.|++.||+|||++   |||||||||+|||++.++.+||+|||+
T Consensus        88 l~~-~~~~g~L~~~l~~~--------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~  155 (345)
T d1pmea_          88 LVT-HLMGADLYKLLKTQ--------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL  155 (345)
T ss_dssp             EEE-ECCCEEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEE-eecCCchhhhhhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCc
Confidence            655 55699999999653        489999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCchh
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGA-LGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQV  796 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  796 (871)
                      |.................||+.|+|||++. +..++.++||||+||++|+|++|+.||......+...........+...
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  235 (345)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence            987655433333345567999999999874 4567899999999999999999999997654333222222222222211


Q ss_pred             --hhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          797 --AEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       797 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                        ............    ..............+.....++.+++.+||+.||++||||+|+++.
T Consensus       236 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         236 DLNCIINLKARNYL----LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHTCCCHHHHHHH----HTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhccc----ccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              111111111000    0011111111222222344568899999999999999999999863

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=383.61  Aligned_cols=240  Identities=20%  Similarity=0.307  Sum_probs=195.8

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHHHHHcCC--CCccceeeeeecccCc
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR------GASKSFIAECEALRSIR--HRNLVKIITSCSSIDT  630 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~  630 (871)
                      ++|++.+.||+|+||+||+|++..+++.||||+++....      ....++.+|+.++++++  ||||+++++++.+.  
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~--   81 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP--   81 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS--
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC--
Confidence            579999999999999999999999999999999864321      11234678999999986  89999999998775  


Q ss_pred             CCCceeeEEEeccCC-CCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-CC
Q 002883          631 RGNEFKALVYEFMPN-GSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-EM  708 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~  708 (871)
                         +..|+||||+.+ +++.+++....       .+++.+++.++.||+.||+|||+.   +|+||||||+||+++. ++
T Consensus        82 ---~~~~lv~e~~~~~~~l~~~~~~~~-------~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~  148 (273)
T d1xwsa_          82 ---DSFVLILERPEPVQDLFDFITERG-------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG  148 (273)
T ss_dssp             ---SEEEEEEECCSSEEEHHHHHHHHC-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTT
T ss_pred             ---CeEEEEEEeccCcchHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCC
Confidence               678999999976 68888887644       599999999999999999999999   9999999999999985 47


Q ss_pred             ceEEeecccceecCCCCCCccccccccccccccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHH
Q 002883          709 VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEV-STHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKY  787 (871)
Q Consensus       709 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~  787 (871)
                      .+||+|||+|+.....     ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.....       .
T Consensus       149 ~vkl~DFG~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------i  216 (273)
T d1xwsa_         149 ELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------I  216 (273)
T ss_dssp             EEEECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------H
T ss_pred             eEEECccccceecccc-----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------H
Confidence            9999999999875432     2234579999999999877766 5779999999999999999999975321       0


Q ss_pred             hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          788 AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ......      +.+                          .++.++.+++.+||+.||++|||++|+++
T Consensus       217 ~~~~~~------~~~--------------------------~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         217 IRGQVF------FRQ--------------------------RVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHCCCC------CSS--------------------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhcccC------CCC--------------------------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            110000      000                          12245678999999999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.8e-44  Score=379.12  Aligned_cols=276  Identities=22%  Similarity=0.278  Sum_probs=201.2

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++.+.||+|+||+||+|++. +++.||||+++...  ....+.+.+|+.++++++||||+++++++...     ...
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence            58999999999999999999996 78999999995432  33357899999999999999999999998776     668


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      +++||++.++.+..+.....       .+++..++.++.||+.||+|||+.   +||||||||+|||++.++.+|++|||
T Consensus        76 ~i~~e~~~~~~~~~~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG  145 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCEG-------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFG  145 (286)
T ss_dssp             EEEEECCSEEHHHHHHTSTT-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred             eEEEEeehhhhHHHHHhhcC-------CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccc
Confidence            99999998777766665433       599999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      .|.......   .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+.....+.....+..
T Consensus       146 ~a~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~  222 (286)
T d1ob3a_         146 LARAFGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS  222 (286)
T ss_dssp             HHHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cceecccCc---cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCCh
Confidence            998765432   22333468999999998765 45689999999999999999999999865433322221211111110


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       ..+.+..-....   ......................+.+++.+||+.||++||||+|+++
T Consensus       223 -~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         223 -KNWPNVTELPKY---DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             -TTSTTGGGSTTC---CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -hhccchhhhhhc---ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000000000000   0000000000011111223456789999999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-44  Score=384.24  Aligned_cols=280  Identities=20%  Similarity=0.239  Sum_probs=205.5

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCCc
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGNE  634 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  634 (871)
                      .++|++++.||+|+||+||+|++..+++.||||+++..  .....+.+.+|++++++++|||||+++++|...+. ....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            36899999999999999999999999999999999643  23345678899999999999999999999876533 2345


Q ss_pred             eeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEee
Q 002883          635 FKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGD  714 (871)
Q Consensus       635 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  714 (871)
                      ++|+||||+ +.+|..+++..        .+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+|++|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~D  164 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD  164 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEecc-cccHHHHHHhc--------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccc
Confidence            679999999 67888877543        499999999999999999999999   999999999999999999999999


Q ss_pred             cccceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhC-C
Q 002883          715 FGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMG-L  792 (871)
Q Consensus       715 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~-~  792 (871)
                      ||.|+.....      .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||................. .
T Consensus       165 fg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~  238 (346)
T d1cm8a_         165 FGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP  238 (346)
T ss_dssp             CTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ccceeccCCc------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCC
Confidence            9999876432      233569999999998765 4568999999999999999999999976543322222111122 2


Q ss_pred             CchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          793 PDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      +....+............   ....................+.+++.+||+.||++||||+|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         239 PAEFVQRLQSDEAKNYMK---GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             CHHHHHTCSCHHHHHHHH---HSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cHHHHhhhcchhhhhhhc---cCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            222222222222111111   111111112222223344567899999999999999999999873

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-44  Score=379.63  Aligned_cols=266  Identities=22%  Similarity=0.374  Sum_probs=209.1

Q ss_pred             HhhcCCCCCceeeccccceEEEEEECC-----CCcEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCccceeeeeecccC
Q 002883          556 KATEGFSSANLIGIGGYGYVYKGILGT-----EETNVAVKVLDLQQ-RGASKSFIAECEALRSIRHRNLVKIITSCSSID  629 (871)
Q Consensus       556 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  629 (871)
                      ...++|++.+.||+|+||+||+|.+..     +++.||||+++... ......+.+|++++++++||||+++++++... 
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-   95 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-   95 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS-
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC-
Confidence            345788999999999999999999852     35789999996433 33345689999999999999999999998665 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccc---cccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQ---NQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN  706 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  706 (871)
                          ...++||||+++|+|.+++.......   .....+++..+..++.|+|+||.|||++   +|+||||||+|||+++
T Consensus        96 ----~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~  168 (308)
T d1p4oa_          96 ----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE  168 (308)
T ss_dssp             ----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred             ----CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecC
Confidence                56899999999999999987653221   1122478999999999999999999999   9999999999999999


Q ss_pred             CCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCC-CCCchhhhhhhhHH
Q 002883          707 EMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGK-RPTDDMFEEGLSLH  785 (871)
Q Consensus       707 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~-~pf~~~~~~~~~~~  785 (871)
                      ++++||+|||+|+...... .........||+.|+|||.+.++.++.++|||||||++|||+||. .||........ ..
T Consensus       169 ~~~~Kl~DFGla~~~~~~~-~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~-~~  246 (308)
T d1p4oa_         169 DFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-LR  246 (308)
T ss_dssp             TCCEEECCTTCCCGGGGGG-CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-HH
T ss_pred             CceEEEeecccceeccCCc-ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH-HH
Confidence            9999999999998765432 222334456899999999999999999999999999999999985 66764332211 11


Q ss_pred             HHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHH
Q 002883          786 KYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEA  862 (871)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i  862 (871)
                      .......++..                               ..++..+.+++.+||+.||++|||++||++.|++.
T Consensus       247 ~i~~~~~~~~p-------------------------------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         247 FVMEGGLLDKP-------------------------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HHHTTCCCCCC-------------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHhCCCCCCc-------------------------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            11111111000                               01234678999999999999999999999998765

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-43  Score=373.77  Aligned_cols=285  Identities=21%  Similarity=0.253  Sum_probs=203.4

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCccceeeeeecccCc---CC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQ--QRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT---RG  632 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  632 (871)
                      .++|++++.||+|+||+||+|++..+++.||||++...  .....+++.+|++++++++||||+++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47899999999999999999999999999999998533  23345778899999999999999999999865422   12


Q ss_pred             CceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEE
Q 002883          633 NEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHV  712 (871)
Q Consensus       633 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  712 (871)
                      ....|+||||++++.+..+.....       .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~-------~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl  158 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV-------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL  158 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred             CceEEEEEeccCCCccchhhhccc-------ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEe
Confidence            356899999998776665544322       589999999999999999999999   9999999999999999999999


Q ss_pred             eecccceecCCCCCC-ccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHH-Hhh
Q 002883          713 GDFGLSRLLHDNSPD-QTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHK-YAK  789 (871)
Q Consensus       713 ~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~-~~~  789 (871)
                      +|||+|......... ........||+.|+|||++.+. .+++++||||+||++|||++|+.||............ ...
T Consensus       159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~  238 (318)
T d3blha1         159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC  238 (318)
T ss_dssp             CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999876543211 1222335699999999987654 6899999999999999999999999764433221111 111


Q ss_pred             hCCCchhh-hhcChhHHHHHHHHHhhhhhhcCchhHHhHH--HHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          790 MGLPDQVA-EIIDPAILEEALEIQAGIVKELQPNLRAKFH--EIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       790 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...++... ...........     .......+.....+.  .....+.+++.+||++||++||||+|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKL-----ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCCCTTTSTTCCCC------------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCChhhccccchhhhhhhh-----cccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            11221111 11111110000     001111122222222  22446778999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.9e-43  Score=368.61  Aligned_cols=263  Identities=18%  Similarity=0.270  Sum_probs=202.0

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCceeeE
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFKAL  638 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  638 (871)
                      ++|++.+.||+|+||+||+|++..+++.||||++.....  .+.+.+|+++++.++|++++..++.+...    ....++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEE
Confidence            579999999999999999999998999999999865433  24578899999999887766666555332    266899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeC---CCCceEEeec
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLD---NEMVAHVGDF  715 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Df  715 (871)
                      ||||+ ++++.+.+.....      .+++..+..++.|++.||+|||++   +|+||||||+||+++   .+..+|++||
T Consensus        81 vme~~-~~~l~~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DF  150 (299)
T d1ckia_          81 VMELL-GPSLEDLFNFCSR------KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF  150 (299)
T ss_dssp             EEECC-CCBHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             EEEEc-CCchhhhhhhccC------CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeecc
Confidence            99999 6677776655432      599999999999999999999999   999999999999985   3557999999


Q ss_pred             ccceecCCCCCCc----cccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHH--HHhh
Q 002883          716 GLSRLLHDNSPDQ----TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLH--KYAK  789 (871)
Q Consensus       716 g~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~--~~~~  789 (871)
                      |+|+.........    .......||+.|+|||.+.+..+++++|||||||++|||+||+.||...........  ....
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~  230 (299)
T d1ckia_         151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  230 (299)
T ss_dssp             SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred             CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence            9999876543221    123345799999999999999999999999999999999999999975322211110  0000


Q ss_pred             hCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          790 MGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      .                           ............++.++.+++..|++.+|++||+++++.+.|+.+..
T Consensus       231 ~---------------------------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         231 K---------------------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             H---------------------------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             c---------------------------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            0                           00000011112345678899999999999999999999999988754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-42  Score=373.87  Aligned_cols=283  Identities=19%  Similarity=0.178  Sum_probs=200.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCCce
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGNEF  635 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  635 (871)
                      ++|++.++||+|+||+||+|++..+|+.||||++....  ....+++.+|+.++++++||||++++++|..... +...+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            68999999999999999999999999999999996443  3344678899999999999999999999865533 24578


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .|+||||+.++ +.+.+..         .+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+|++||
T Consensus        97 ~~iv~Ey~~~~-l~~~~~~---------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df  163 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQM---------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_dssp             EEEEEECCSEE-HHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEeccchH-HHHhhhc---------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeech
Confidence            89999999665 4444432         489999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC-Cc
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL-PD  794 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~-~~  794 (871)
                      |.++.....    .......+|+.|+|||++.+..+++++||||+||++|+|++|+.||.................. ..
T Consensus       164 ~~~~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~  239 (355)
T d2b1pa1         164 GLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  239 (355)
T ss_dssp             CC-------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             hhhhccccc----cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence            998865532    2333456899999999999999999999999999999999999999754332221111111111 11


Q ss_pred             hhhhhcChhHHHHHHHH--------HhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHH
Q 002883          795 QVAEIIDPAILEEALEI--------QAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIME  858 (871)
Q Consensus       795 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~  858 (871)
                      .................        .........+............+.+|+.+||+.||++||||+|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            11111111111100000        00000111122223344567788999999999999999999999853

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-43  Score=379.17  Aligned_cols=275  Identities=20%  Similarity=0.258  Sum_probs=196.7

Q ss_pred             CCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCccceeeeeecccCc-CCCceeeE
Q 002883          560 GFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRNLVKIITSCSSIDT-RGNEFKAL  638 (871)
Q Consensus       560 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~l  638 (871)
                      +|+..++||+|+||+||+|++..+++.||||++.....    ...+|++++++++||||++++++|..... .+..+.|+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            58889999999999999999999999999999965432    23479999999999999999999865432 34467899


Q ss_pred             EEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEEeeccc
Q 002883          639 VYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM-VAHVGDFGL  717 (871)
Q Consensus       639 v~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~  717 (871)
                      ||||++++. .+.+.....   ....+++.+++.++.||+.||+|||++   ||+||||||+|||++.++ .+||+|||+
T Consensus        97 v~Ey~~~~~-~~~l~~~~~---~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          97 VLDYVPETV-YRVARHYSR---AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEECCSEEH-HHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEeccCCcc-HHHHHhhhh---ccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence            999997654 433332111   122699999999999999999999999   999999999999999775 899999999


Q ss_pred             ceecCCCCCCccccccccccccccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCc-h
Q 002883          718 SRLLHDNSPDQTSTSRVKGSIGYVAPEYGAL-GEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPD-Q  795 (871)
Q Consensus       718 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~-~  795 (871)
                      |.......    ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.........+.+. .
T Consensus       170 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~  245 (350)
T d1q5ka_         170 AKQLVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  245 (350)
T ss_dssp             CEECCTTS----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             hhhccCCc----ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence            98775432    2223569999999997654 5789999999999999999999999975433322111111111111 0


Q ss_pred             -hhhhcChhHHHHHHHHHhhhhhhcC--chhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 -VAEIIDPAILEEALEIQAGIVKELQ--PNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 -~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                       ...... ...       ........  +...........++.+++.+||+.||++||||.|+++
T Consensus       246 ~~~~~~~-~~~-------~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         246 QIREMNP-NYT-------EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHHCC-----------CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhcc-chh-------hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000000 000       00000000  0000011123456789999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3e-43  Score=377.46  Aligned_cols=274  Identities=20%  Similarity=0.229  Sum_probs=199.5

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCceee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEFKA  637 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  637 (871)
                      ++|++++.||+|+||+||+|++..+++.||||+++..   ..+++.+|+++++++. ||||+++++++....   ....+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~---~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecC---CCcee
Confidence            5799999999999999999999999999999999643   3467889999999995 999999999986432   25689


Q ss_pred             EEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCC-ceEEeecc
Q 002883          638 LVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEM-VAHVGDFG  716 (871)
Q Consensus       638 lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg  716 (871)
                      +||||+++++|..+.+          .+++..++.++.||+.||+|||++   |||||||||+|||++.++ .+||+|||
T Consensus       109 ~v~e~~~~~~L~~~~~----------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG  175 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ----------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWG  175 (328)
T ss_dssp             EEEECCCSCBGGGTTT----------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGG
T ss_pred             EEEeecCCCcHHHHhc----------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccc
Confidence            9999999999876642          489999999999999999999999   999999999999998655 69999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      +|.......    ......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||...................+.
T Consensus       176 ~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~  251 (328)
T d3bqca1         176 LAEFYHPGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED  251 (328)
T ss_dssp             GCEECCTTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred             cceeccCCC----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCch
Confidence            998775432    22345689999999987654 5799999999999999999999999754322211111111000000


Q ss_pred             hhhhc---ChhHHHHHHHHHhh----hhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEII---DPAILEEALEIQAG----IVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      .....   .......+......    ......  .......+..++.+++.+||..||++||||+|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFV--HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGC--CTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhcccccCcccchhcccccccchhhcc--cccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000   00000000000000    000000  00111223456789999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-43  Score=370.97  Aligned_cols=278  Identities=20%  Similarity=0.213  Sum_probs=206.3

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCcee
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  636 (871)
                      ++|++++.||+|+||+||+|++..+++.||||+++...  .....++.+|+.+++.++||||+++++++.+.     ...
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cce
Confidence            58999999999999999999999999999999996443  33457889999999999999999999998776     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeecc
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDFG  716 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  716 (871)
                      ++|+|++.++++..++...+       .+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        77 ~iv~~~~~~~~l~~~~~~~~-------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG  146 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCNG-------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             eEEeeecccccccccccccc-------ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecc
Confidence            99999999999988887654       589999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCCCch
Q 002883          717 LSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGE-VSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGLPDQ  795 (871)
Q Consensus       717 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  795 (871)
                      .|+......   .......+++.|+|||.+.... ++.++||||+||++|||++|+.||....+.............+..
T Consensus       147 ~a~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  223 (292)
T d1unla_         147 LARAFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  223 (292)
T ss_dssp             TCEECCSCC---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hhhcccCCC---ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCC
Confidence            998875432   1222345788999999876654 689999999999999999999997544333222222221111100


Q ss_pred             hhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          796 VAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...+..........   .....................+.+++.+||+.||++||||+|+++
T Consensus       224 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         224 EEQWPSMTKLPDYK---PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTTCTTGGGSTTCC---CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhhccccc---ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000000000000   000000000111111223446778999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-43  Score=378.52  Aligned_cols=280  Identities=19%  Similarity=0.199  Sum_probs=205.3

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCccceeeeeecccCcCCCce
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ--RGASKSFIAECEALRSIRHRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  635 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...  ....+.+.+|++++++++|||++++++++..........
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999999999999999996443  234467889999999999999999999987654433344


Q ss_pred             eeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCceEEeec
Q 002883          636 KALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMVAHVGDF  715 (871)
Q Consensus       636 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  715 (871)
                      .+++|+|+.+|+|.+++...        .+++.+++.++.||+.||+|||++   ||+||||||+||+++.++.+|++||
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--------~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEeecCCchhhhcccc--------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccccccc
Confidence            56667778899999999643        499999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHHhhhCC-C
Q 002883          716 GLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG-EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKYAKMGL-P  793 (871)
Q Consensus       716 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~~~~~~-~  793 (871)
                      |.|....      .......|++.|+|||...+. .++.++||||+||++|+|++|+.||.................. +
T Consensus       166 g~a~~~~------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~  239 (348)
T d2gfsa1         166 GLARHTD------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  239 (348)
T ss_dssp             ----CCT------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             chhcccC------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9997643      223345689999999986655 4689999999999999999999999754333222111111111 1


Q ss_pred             chhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHH
Q 002883          794 DQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIM  857 (871)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~  857 (871)
                      ...............   ...............+......+.+++.+||+.||++||||+|+++
T Consensus       240 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         240 AELLKKISSESARNY---IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHHTTCCCHHHHHH---HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hHHhhhccchhhhhh---hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            112111111111111   1111111111222222344567889999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.8e-42  Score=362.33  Aligned_cols=263  Identities=16%  Similarity=0.191  Sum_probs=207.2

Q ss_pred             hcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCC-CccceeeeeecccCcCCCcee
Q 002883          558 TEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRH-RNLVKIITSCSSIDTRGNEFK  636 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~  636 (871)
                      .++|++.+.||+|+||+||+|++..+++.||||+++....  .+.+.+|+++++.+.| +|++.+++++.+.     ...
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~   76 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHN   76 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecC-----Ccc
Confidence            3689999999999999999999999999999999854332  3457789999999965 8999999887654     678


Q ss_pred             eEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCC-----CCceE
Q 002883          637 ALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDN-----EMVAH  711 (871)
Q Consensus       637 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~k  711 (871)
                      ++||||+ +++|.+++.....      .+++..+..++.|++.||+|||+.   ||+||||||+||+++.     ++.+|
T Consensus        77 ~~vme~~-~~~l~~~~~~~~~------~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vk  146 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCGR------KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIY  146 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred             EEEEEec-CCCHHHHHHhhcc------chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceE
Confidence            9999999 7899999876542      589999999999999999999999   9999999999999964     57899


Q ss_pred             EeecccceecCCCCCCc----cccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhhhhhh--HH
Q 002883          712 VGDFGLSRLLHDNSPDQ----TSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLS--LH  785 (871)
Q Consensus       712 l~Dfg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~--~~  785 (871)
                      |+|||+|+...+.....    .......||+.|||||++.+..+++++|||||||++|||+||+.||.........  ..
T Consensus       147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~  226 (293)
T d1csna_         147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE  226 (293)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred             EcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH
Confidence            99999999876432221    1233457999999999999999999999999999999999999999743221110  00


Q ss_pred             HHhhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCCCHHHHHHHHHHHHH
Q 002883          786 KYAKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRMKIQDAIMELQEAQK  864 (871)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPta~evl~~L~~i~~  864 (871)
                      ......                           ..+........+++++.+++..|+..+|++||+++.+.+.++++.+
T Consensus       227 ~i~~~~---------------------------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         227 RIGEKK---------------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             HHHHHH---------------------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHhcc---------------------------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence            000000                           0000011112344568889999999999999999999999888754

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-42  Score=367.58  Aligned_cols=252  Identities=23%  Similarity=0.280  Sum_probs=199.4

Q ss_pred             hcCCCCCceeeccccceEEEEEE---CCCCcEEEEEEeecc----ccchHHHHHHHHHHHHcCCC-CccceeeeeecccC
Q 002883          558 TEGFSSANLIGIGGYGYVYKGIL---GTEETNVAVKVLDLQ----QRGASKSFIAECEALRSIRH-RNLVKIITSCSSID  629 (871)
Q Consensus       558 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~  629 (871)
                      .++|++.+.||+|+||+||+|++   +.+|+.||||+++..    .....+.+.+|++++++++| |||+++++++.+. 
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence            36799999999999999999987   346899999998532    22234678899999999966 8999999998776 


Q ss_pred             cCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceeeCCCCc
Q 002883          630 TRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNVLLDNEMV  709 (871)
Q Consensus       630 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  709 (871)
                          ...++||||+.+|+|.+++....       .+++..+..++.||+.|++|+|+.   +||||||||+||+++.++.
T Consensus       102 ----~~~~~v~e~~~~~~L~~~i~~~~-------~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~  167 (322)
T d1vzoa_         102 ----TKLHLILDYINGGELFTHLSQRE-------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGH  167 (322)
T ss_dssp             ----TEEEEEECCCCSCBHHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred             ----CceeeeeecccccHHHHHHHhcc-------cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCC
Confidence                67899999999999999998765       578899999999999999999999   9999999999999999999


Q ss_pred             eEEeecccceecCCCCCCccccccccccccccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCchhhhhhhhHHHH
Q 002883          710 AHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALG--EVSTHGDEYSFGILMLEMFTGKRPTDDMFEEGLSLHKY  787 (871)
Q Consensus       710 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~~~~~~  787 (871)
                      +||+|||+|+.+....  ........|++.|+|||.+.+.  .++.++||||+||++|+|++|+.||.............
T Consensus       168 vkL~DFG~a~~~~~~~--~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~  245 (322)
T d1vzoa_         168 VVLTDFGLSKEFVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS  245 (322)
T ss_dssp             EEESCSSEEEECCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred             EEEeeccchhhhcccc--cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999998765332  2223446799999999987654  46889999999999999999999997543221111100


Q ss_pred             --hhhCCCchhhhhcChhHHHHHHHHHhhhhhhcCchhHHhHHHHHHHHHhhhcccccCCCCCCC-----CHHHHHH
Q 002883          788 --AKMGLPDQVAEIIDPAILEEALEIQAGIVKELQPNLRAKFHEIQVSILRVGILCSEELPRDRM-----KIQDAIM  857 (871)
Q Consensus       788 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----ta~evl~  857 (871)
                        .....+ ..                              ......++.+++.+||++||++||     ||+|+++
T Consensus       246 ~~~~~~~~-~~------------------------------~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         246 RRILKSEP-PY------------------------------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHHCCC-CC------------------------------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HhcccCCC-CC------------------------------cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence              000000 00                              012345678999999999999999     4888876

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.8e-37  Score=335.40  Aligned_cols=278  Identities=17%  Similarity=0.178  Sum_probs=190.5

Q ss_pred             cCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-----------CCccceeeeeecc
Q 002883          559 EGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-----------HRNLVKIITSCSS  627 (871)
Q Consensus       559 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~  627 (871)
                      +||+++++||+|+||+||+|++..+|+.||||+++.... ..+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            469999999999999999999999999999999975432 3467788999888774           5789999988755


Q ss_pred             cCcCCCceeeEEEeccCCCCH-HHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceeeC
Q 002883          628 IDTRGNEFKALVYEFMPNGSL-ENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHH-HCHTSIVHCDLKPSNVLLD  705 (871)
Q Consensus       628 ~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~  705 (871)
                      ...   ...+++|+++..+.. ........     ...+++..++.++.||+.|++|||+ .   ||+||||||+|||++
T Consensus        92 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~  160 (362)
T d1q8ya_          92 KGP---NGVHVVMVFEVLGENLLALIKKYE-----HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLME  160 (362)
T ss_dssp             EET---TEEEEEEEECCCCEEHHHHHHHTT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEE
T ss_pred             ccc---cceeeeeeeccccccccccccccc-----ccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeee
Confidence            322   345566666544433 33332222     2368999999999999999999998 6   999999999999997


Q ss_pred             CCC------ceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCchhhh
Q 002883          706 NEM------VAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILMLEMFTGKRPTDDMFE  779 (871)
Q Consensus       706 ~~~------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  779 (871)
                      .++      .++++|||.|.....      ......||+.|+|||+.....++.++||||+||++++|++|+.||.....
T Consensus       161 ~~~~~~~~~~~kl~dfg~s~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~  234 (362)
T d1q8ya_         161 IVDSPENLIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  234 (362)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             ccCcccccceeeEeeccccccccc------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence            655      499999999986532      22345699999999999999999999999999999999999999975322


Q ss_pred             h-----hhhHHHHhh--hCCCchhhhhcChhHHHHHHHHHhhhh---hhcC--------chhHHhHHHHHHHHHhhhccc
Q 002883          780 E-----GLSLHKYAK--MGLPDQVAEIIDPAILEEALEIQAGIV---KELQ--------PNLRAKFHEIQVSILRVGILC  841 (871)
Q Consensus       780 ~-----~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--------~~~~~~~~~~~~~l~~li~~c  841 (871)
                      .     .........  ...+..........  ..... .....   ....        +...........++.+++.+|
T Consensus       235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~m  311 (362)
T d1q8ya_         235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYT--RTFFN-SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM  311 (362)
T ss_dssp             ----CHHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBC-C--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred             ccccchhHHHHHHHHHhCCCCHHHhhccccc--ccccc-cchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHH
Confidence            1     011111111  11111110000000  00000 00000   0000        000111235667889999999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 002883          842 SEELPRDRMKIQDAIM  857 (871)
Q Consensus       842 l~~dP~~RPta~evl~  857 (871)
                      |++||++||||+|+++
T Consensus       312 L~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         312 LQLDPRKRADAGGLVN  327 (362)
T ss_dssp             GCSSTTTCBCHHHHHT
T ss_pred             CCCChhHCcCHHHHhc
Confidence            9999999999999986

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=2.6e-31  Score=282.65  Aligned_cols=255  Identities=29%  Similarity=0.473  Sum_probs=221.1

Q ss_pred             cccEEEccCCccCC--CCCCCCCCccccceeeccc-ccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEE
Q 002883          225 HLIYLYMSANRISG--TIPTGVGNLKNLILIAMEV-NLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEV  301 (871)
Q Consensus       225 ~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  301 (871)
                      +++.|+|++|.+++  .+|..+++|++|++|+|++ |.+++.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            46677777777765  3677888888888888876 77887888888888889999999988888788888888889999


Q ss_pred             EccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCC-cEEeccCCCCCCCCccccCCCCCCCEEeCCCCcC
Q 002883          302 DLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSF-VLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKL  380 (871)
Q Consensus       302 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  380 (871)
                      ++++|.+.+.+|..+.++++|+.+++++|.+.+.+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|..
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~  209 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred             ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence            999998888888889999999999999999988888888888776 788999999988888888777554 799999999


Q ss_pred             CCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCCCCc
Q 002883          381 SGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVPSEG  460 (871)
Q Consensus       381 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~  460 (871)
                      .+.+|..+..+++|+.+++++|.+.+.++ .+..+++|+.|+|++|++++.+|..+..+++|++|+|++|+|+|.+|..+
T Consensus       210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~  288 (313)
T d1ogqa_         210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence            98899999999999999999999986554 68889999999999999999999999999999999999999999999877


Q ss_pred             ccccccceeccCCCCCccCCC
Q 002883          461 VFKNVRAVSIIGNNKLCGGSP  481 (871)
Q Consensus       461 ~~~~l~~l~l~~N~~~C~~~~  481 (871)
                      .+.+++.+++.+|+..||.|.
T Consensus       289 ~L~~L~~l~l~~N~~l~g~pl  309 (313)
T d1ogqa_         289 NLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTTS
T ss_pred             cCCCCCHHHhCCCccccCCCC
Confidence            888999999999999999875

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=2.9e-29  Score=275.36  Aligned_cols=206  Identities=28%  Similarity=0.387  Sum_probs=128.2

Q ss_pred             cEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCc
Q 002883          227 IYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGN  306 (871)
Q Consensus       227 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  306 (871)
                      .......|...  ....+..+++++.+++++|.+++..|  +...++|++|++++|+++. + +.+..+++|+.|++++|
T Consensus       178 ~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n  251 (384)
T d2omza2         178 ERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANN  251 (384)
T ss_dssp             CEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSS
T ss_pred             ccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccC
Confidence            33444444332  33445555666666666666664332  3445666677777776662 2 34566666777777777


Q ss_pred             cccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCcc
Q 002883          307 SIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPT  386 (871)
Q Consensus       307 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  386 (871)
                      ++++..+  +..+++|+.|++++|++++..  .+..++.++.+++++|.+.+  ...+..+++++.|++++|++++..  
T Consensus       252 ~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--  323 (384)
T d2omza2         252 QISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--  323 (384)
T ss_dssp             CCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--
T ss_pred             ccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--
Confidence            7664332  566677777777777776332  35666677777777777763  234666777777777777776432  


Q ss_pred             chhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCC
Q 002883          387 SLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFN  450 (871)
Q Consensus       387 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N  450 (871)
                      .+..+++|++|++++|+|+++ + .+.++++|++|++++|++++..|  +..+++|+.|+|++|
T Consensus       324 ~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         324 PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             ccccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            266677777777777777643 2 46777777777777777775443  667777777777776

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=4.8e-29  Score=273.54  Aligned_cols=356  Identities=26%  Similarity=0.304  Sum_probs=234.5

Q ss_pred             ecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCcccccccccccccccccccc
Q 002883           20 DLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSANYLT   99 (871)
Q Consensus        20 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~   99 (871)
                      +++.+.+++.+.  ...+.+|++|+++++.|+. + +.+..|++|++|+|++|+|+ .+| .|++|++|++|++++|+++
T Consensus        28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~-~l~-~l~~L~~L~~L~L~~n~i~  101 (384)
T d2omza2          28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLT-DIT-PLKNLTKLVDILMNNNQIA  101 (384)
T ss_dssp             HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCC-CCG-GGTTCTTCCEEECCSSCCC
T ss_pred             HhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCC-CCc-cccCCcccccccccccccc
Confidence            455555554332  2455666777777777663 3 34666777777777777776 344 2667777777777777776


Q ss_pred             CCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEEecccc
Q 002883          100 GSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRLNFARN  179 (871)
Q Consensus       100 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L~l~~n  179 (871)
                      + ++ .+.++++|+.|++++|.+.+. +...  ....+..+....|.+....+..          ...............
T Consensus       102 ~-i~-~l~~l~~L~~L~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~~  166 (384)
T d2omza2         102 D-IT-PLANLTNLTGLTLFNNQITDI-DPLK--NLTNLNRLELSSNTISDISALS----------GLTSLQQLSFGNQVT  166 (384)
T ss_dssp             C-CG-GGTTCTTCCEEECCSSCCCCC-GGGT--TCTTCSEEEEEEEEECCCGGGT----------TCTTCSEEEEEESCC
T ss_pred             c-cc-ccccccccccccccccccccc-cccc--cccccccccccccccccccccc----------ccccccccccccccc
Confidence            3 22 266677777777776666532 2221  3455666666666654211110          111111111111111


Q ss_pred             cCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeeccccc
Q 002883          180 NLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNL  259 (871)
Q Consensus       180 ~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~  259 (871)
                      .           ...+...+.........|...  .......+ +++..+++++|.+++..|  +...++|+.|++++|.
T Consensus       167 ~-----------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l-~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~  230 (384)
T d2omza2         167 D-----------LKPLANLTTLERLDISSNKVS--DISVLAKL-TNLESLIATNNQISDITP--LGILTNLDELSLNGNQ  230 (384)
T ss_dssp             C-----------CGGGTTCTTCCEEECCSSCCC--CCGGGGGC-TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred             h-----------hhhhccccccccccccccccc--cccccccc-cccceeeccCCccCCCCc--ccccCCCCEEECCCCC
Confidence            1           123334445555556665554  23344444 457778888887775443  4566778888888888


Q ss_pred             ccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCccc
Q 002883          260 LTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPRE  339 (871)
Q Consensus       260 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  339 (871)
                      ++.  +..+..+++|+.|++++|++++..  .+..+++|++|++++|++++..  .+..++.++.+++++|.+++ + ..
T Consensus       231 l~~--~~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~-~~  302 (384)
T d2omza2         231 LKD--IGTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED-I-SP  302 (384)
T ss_dssp             CCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC-C-GG
T ss_pred             CCC--cchhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--cccccccccccccccccccc-c-cc
Confidence            774  346778888888888888887433  3778888899999888887543  37778888999999998874 2 35


Q ss_pred             ccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCC
Q 002883          340 VIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQ  419 (871)
Q Consensus       340 ~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  419 (871)
                      +..+++++.|++++|++++..  .+..+++|++|++++|+|++ ++ .+..+++|++|++++|+|++..|  +.++++|+
T Consensus       303 ~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~  376 (384)
T d2omza2         303 ISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRIT  376 (384)
T ss_dssp             GGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCS
T ss_pred             cchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCC
Confidence            778888999999999998543  37888999999999999983 44 58889999999999999987654  88899999


Q ss_pred             EEeCCCC
Q 002883          420 DLDLSRN  426 (871)
Q Consensus       420 ~L~l~~N  426 (871)
                      .|+|++|
T Consensus       377 ~L~L~~N  383 (384)
T d2omza2         377 QLGLNDQ  383 (384)
T ss_dssp             EEECCCE
T ss_pred             EeeCCCC
Confidence            9999987

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=1.4e-29  Score=269.24  Aligned_cols=252  Identities=29%  Similarity=0.477  Sum_probs=217.9

Q ss_pred             cccEEEccCCcCcc--cCChhhhhccccccEEEccC-CccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcE
Q 002883          200 FLEVVSLSSNSLSG--VLPNSIANFSSHLIYLYMSA-NRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQV  276 (871)
Q Consensus       200 ~L~~L~L~~n~l~~--~~~~~~~~~~~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  276 (871)
                      +++.|+|++|.+++  .+|..+.++ ++|++|+|++ |++++.+|..|++|++|++|+|++|++.+..+..+..+.+|+.
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L-~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANL-PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGC-TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcC-ccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence            57788888888876  478888887 4699999986 7888888888999999999999999999888888888999999


Q ss_pred             EEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCC-CEEecCCCcCCCCCcccccCCCCCcEEeccCCC
Q 002883          277 LSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQL-QKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNH  355 (871)
Q Consensus       277 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~  355 (871)
                      +++++|.+...+|..+..+++|+.+++++|.+.+.+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|.
T Consensus       130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~  208 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM  208 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred             cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence            9999999888888899999999999999999988888888888776 889999999998888888777655 69999999


Q ss_pred             CCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCccc
Q 002883          356 LSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMF  435 (871)
Q Consensus       356 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  435 (871)
                      +.+.+|..+..+++|+.+++++|.+++.+ ..+..+++|+.|+|++|++++.+|..|.++++|++|||++|+|+|.+|. 
T Consensus       209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-  286 (313)
T d1ogqa_         209 LEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-  286 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-
T ss_pred             ccccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-
Confidence            88888888999999999999999998654 4688889999999999999988999999999999999999999988884 


Q ss_pred             ccccccccEEecCCCcC-ccc
Q 002883          436 LNTFRFLQKLNLSFNNL-EGE  455 (871)
Q Consensus       436 ~~~~~~L~~L~l~~N~l-~~~  455 (871)
                      +..+.+|+.+++++|+. +|.
T Consensus       287 ~~~L~~L~~l~l~~N~~l~g~  307 (313)
T d1ogqa_         287 GGNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             STTGGGSCGGGTCSSSEEEST
T ss_pred             cccCCCCCHHHhCCCccccCC
Confidence            57889999999999984 443

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.7e-27  Score=246.35  Aligned_cols=253  Identities=21%  Similarity=0.223  Sum_probs=166.3

Q ss_pred             EEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccCC
Q 002883          203 VVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGN  282 (871)
Q Consensus       203 ~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n  282 (871)
                      .++++++.++ .+|..+.   +.+++|+|++|+|+.+.+..|.                        ++++|++|++++|
T Consensus        15 ~v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~------------------------~l~~L~~L~ls~n   66 (284)
T d1ozna_          15 TTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFR------------------------ACRNLTILWLHSN   66 (284)
T ss_dssp             EEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTT------------------------TCTTCCEEECCSS
T ss_pred             EEEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhh------------------------ccccccccccccc
Confidence            4556666665 4454432   3455666666666544444444                        4455555555555


Q ss_pred             CCCCCCCcccCCCccccEEEc-cCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCc
Q 002883          283 KISGEIPSSLGNLIFLTEVDL-QGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIP  361 (871)
Q Consensus       283 ~l~~~~~~~~~~l~~L~~L~L-~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~  361 (871)
                      ++....+..+..+..++.++. ..|.++...+..|.++++|++|++++|.+....+..+...++|+.+++++|.+++..+
T Consensus        67 ~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~  146 (284)
T d1ozna_          67 VLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD  146 (284)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccCh
Confidence            555444444555555555543 2444554445556666666666666666655555556666666666666666665555


Q ss_pred             cccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCccccccccc
Q 002883          362 LEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRF  441 (871)
Q Consensus       362 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~  441 (871)
                      ..|..+++|+.|++++|++++..+..|.++++|+.+++++|+++++.|..|.++++|++||+++|++++..+..|..+++
T Consensus       147 ~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~  226 (284)
T d1ozna_         147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA  226 (284)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred             hHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccc
Confidence            66777777777777777777667777778888888888888888777888888888888888888888777778888888


Q ss_pred             ccEEecCCCcCcccCCCCcccccccceeccCCCCCccCCCcc
Q 002883          442 LQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGSPEL  483 (871)
Q Consensus       442 L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~C~~~~~~  483 (871)
                      |++|++++|+|.|.++..+....++.+....+...|..|.++
T Consensus       227 L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p~~l  268 (284)
T d1ozna_         227 LQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL  268 (284)
T ss_dssp             CCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGG
T ss_pred             cCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCchHH
Confidence            888888888888877654444456666666677777766554

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=2.2e-26  Score=243.28  Aligned_cols=268  Identities=21%  Similarity=0.278  Sum_probs=153.1

Q ss_pred             CCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccccc
Q 002883           15 ELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVS   94 (871)
Q Consensus        15 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~   94 (871)
                      +.+.+|-++++++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|++++|.++...|..|.++++|++|+++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            4677888888888 6777663  578888888888885555578888888888888888886667778888888888888


Q ss_pred             cccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEE
Q 002883           95 ANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRL  174 (871)
Q Consensus        95 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L  174 (871)
                      +|+++ .+|..+  ...++.|.+..|.+. .++...+.....++.++...|...                          
T Consensus        88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~-~l~~~~~~~~~~~~~l~~~~n~~~--------------------------  137 (305)
T d1xkua_          88 KNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK--------------------------  137 (305)
T ss_dssp             SSCCS-BCCSSC--CTTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCC--------------------------
T ss_pred             CCccC-cCccch--hhhhhhhhccccchh-hhhhhhhhcccccccccccccccc--------------------------
Confidence            88887 444432  234555555555554 334333334444444554444332                          


Q ss_pred             ecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceee
Q 002883          175 NFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIA  254 (871)
Q Consensus       175 ~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~  254 (871)
                              ....    ....+..+++|+.+++++|.++ .+|..+   .++|++|++++|.++...+..|.+++.++.|+
T Consensus       138 --------~~~~----~~~~~~~l~~L~~l~l~~n~l~-~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~  201 (305)
T d1xkua_         138 --------SSGI----ENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLG  201 (305)
T ss_dssp             --------GGGB----CTTGGGGCTTCCEEECCSSCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEE
T ss_pred             --------ccCC----CccccccccccCccccccCCcc-ccCccc---CCccCEEECCCCcCCCCChhHhhccccccccc
Confidence                    1110    1122334444555555555444 233322   13455555555555555555555555555555


Q ss_pred             cccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccc------cCCCCCCEEecC
Q 002883          255 MEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSAL------GNCLQLQKLDLS  328 (871)
Q Consensus       255 l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~------~~l~~L~~L~L~  328 (871)
                      +++|.+++..+..|.++++|++|+|++|+|+ .+|..|..+++|+.|+|++|+|+.+....|      ..+.+|+.|+|+
T Consensus       202 ~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~  280 (305)
T d1xkua_         202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF  280 (305)
T ss_dssp             CCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECC
T ss_pred             cccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECC
Confidence            5555555555555555555555555555555 344455555555555555555553322222      223444555555


Q ss_pred             CCcC
Q 002883          329 DNNL  332 (871)
Q Consensus       329 ~N~l  332 (871)
                      +|.+
T Consensus       281 ~N~~  284 (305)
T d1xkua_         281 SNPV  284 (305)
T ss_dssp             SSSS
T ss_pred             CCcC
Confidence            5544

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=6.7e-26  Score=239.56  Aligned_cols=243  Identities=24%  Similarity=0.290  Sum_probs=110.8

Q ss_pred             cccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccc
Q 002883          170 NLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKN  249 (871)
Q Consensus       170 ~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~  249 (871)
                      .++.++.++++++++|.+       +.  +++++|+|++|+|+...+..+..+ ++|++|++++|.+....|..|.++++
T Consensus        11 ~~~~~~C~~~~L~~lP~~-------l~--~~l~~L~Ls~N~i~~l~~~~f~~l-~~L~~L~l~~n~~~~i~~~~f~~l~~   80 (305)
T d1xkua_          11 HLRVVQCSDLGLEKVPKD-------LP--PDTALLDLQNNKITEIKDGDFKNL-KNLHTLILINNKISKISPGAFAPLVK   80 (305)
T ss_dssp             ETTEEECTTSCCCSCCCS-------CC--TTCCEEECCSSCCCCBCTTTTTTC-TTCCEEECCSSCCCCBCTTTTTTCTT
T ss_pred             cCCEEEecCCCCCccCCC-------CC--CCCCEEECcCCcCCCcChhHhhcc-ccccccccccccccccchhhhhCCCc
Confidence            344455555555554321       10  245555555555542222233333 24555555555555444444555555


Q ss_pred             cceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCcccc--ccCcccccCCCCCCEEec
Q 002883          250 LILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIR--GSIPSALGNCLQLQKLDL  327 (871)
Q Consensus       250 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~L  327 (871)
                      |+.|++++|+++. +|..+  ...++.|++++|.+....+..+.....+..++...|...  ...+..|..+++|+.+++
T Consensus        81 L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l  157 (305)
T d1xkua_          81 LERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI  157 (305)
T ss_dssp             CCEEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEEC
T ss_pred             cCEecccCCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCcccc
Confidence            5555555555542 22221  234455555555554333333444444444444444322  122333444445555555


Q ss_pred             CCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCccccc
Q 002883          328 SDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGP  407 (871)
Q Consensus       328 ~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  407 (871)
                      ++|.++ .+|..+  .++|+.|++++|.++...+..+..++.++.|++++|.+++..+..|.++++|++|+|++|+|+. 
T Consensus       158 ~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-  233 (305)
T d1xkua_         158 ADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-  233 (305)
T ss_dssp             CSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-
T ss_pred             ccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccc-
Confidence            555544 222222  2445555555555444444444445555555555555544444444445555555555555542 


Q ss_pred             CccccCCCCCCCEEeCCCCcCC
Q 002883          408 IHSGFSSLKGLQDLDLSRNNFS  429 (871)
Q Consensus       408 ~~~~~~~l~~L~~L~l~~N~l~  429 (871)
                      +|..|..+++|++|+|++|+|+
T Consensus       234 lp~~l~~l~~L~~L~Ls~N~i~  255 (305)
T d1xkua_         234 VPGGLADHKYIQVVYLHNNNIS  255 (305)
T ss_dssp             CCTTTTTCSSCCEEECCSSCCC
T ss_pred             cccccccccCCCEEECCCCccC
Confidence            2334444555555555555554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2e-26  Score=240.78  Aligned_cols=224  Identities=22%  Similarity=0.213  Sum_probs=157.4

Q ss_pred             cEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccc
Q 002883          172 IRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLI  251 (871)
Q Consensus       172 ~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~  251 (871)
                      ..++.++++++++|..       +.  +++++|+|++|+|+...+..+..+ ++|++|++++|+|..+.+..+.++..++
T Consensus        14 ~~v~c~~~~L~~iP~~-------ip--~~~~~L~Ls~N~i~~i~~~~f~~l-~~L~~L~ls~n~l~~i~~~~~~~~~~~~   83 (284)
T d1ozna_          14 VTTSCPQQGLQAVPVG-------IP--AASQRIFLHGNRISHVPAASFRAC-RNLTILWLHSNVLARIDAAAFTGLALLE   83 (284)
T ss_dssp             CEEECCSSCCSSCCTT-------CC--TTCSEEECTTSCCCEECTTTTTTC-TTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             eEEEcCCCCCCccCCC-------CC--CCCCEEECcCCcCCCCCHHHhhcc-cccccccccccccccccccccccccccc
Confidence            4678899999887642       11  468999999999996555667766 5799999999999988888888888888


Q ss_pred             eeecc-cccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCC
Q 002883          252 LIAME-VNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDN  330 (871)
Q Consensus       252 ~L~l~-~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  330 (871)
                      .+... .|.++...+..|+++++|++|++++|.+....+..+....+|+.+++++|+|+++.+..|..+++|+.|++++|
T Consensus        84 ~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N  163 (284)
T d1ozna_          84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN  163 (284)
T ss_dssp             EEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             ccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccC
Confidence            87654 56677666777777777888888777777556666677777777777777777666666666777777777777


Q ss_pred             cCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCccc
Q 002883          331 NLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQ  405 (871)
Q Consensus       331 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  405 (871)
                      ++++..+..|.++++|+.+++++|++++..|..|..+++|++|++++|++.+..+..|..+++|++|+|++|++.
T Consensus       164 ~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~  238 (284)
T d1ozna_         164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV  238 (284)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred             cccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence            776555566666666666666666666555556666666666666666665555555555555555555555554

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.4e-25  Score=228.59  Aligned_cols=206  Identities=23%  Similarity=0.217  Sum_probs=158.4

Q ss_pred             CCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCE
Q 002883          245 GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQK  324 (871)
Q Consensus       245 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  324 (871)
                      .+...+.+.+++++.++ .+|..+.  ++|++|+|++|+|++..+..|.++++|++|+|++|+|+. ++ .++.+++|+.
T Consensus         7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~   81 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGT   81 (266)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCE
T ss_pred             cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccc
Confidence            34556677788888888 4566553  578888888888886666778888888888888888873 33 3567888888


Q ss_pred             EecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcc
Q 002883          325 LDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSF  404 (871)
Q Consensus       325 L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  404 (871)
                      |+|++|+++ ..+..+.++++|+.|++++|.+....+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+|
T Consensus        82 L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l  160 (266)
T d1p9ag_          82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL  160 (266)
T ss_dssp             EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred             ccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence            888888887 5566777888888888888888766677777788888888888888866667777778888888888888


Q ss_pred             cccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCC
Q 002883          405 QGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVP  457 (871)
Q Consensus       405 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~  457 (871)
                      ++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|.|.+.
T Consensus       161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~  212 (266)
T d1p9ag_         161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (266)
T ss_dssp             SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence            8777777888888888888888887 566666677777777777777777653

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=8.5e-25  Score=225.53  Aligned_cols=205  Identities=22%  Similarity=0.168  Sum_probs=131.2

Q ss_pred             CCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEE
Q 002883          270 YLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLL  349 (871)
Q Consensus       270 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  349 (871)
                      ....+.+++.+++.|+ .+|..+.  ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .++ .+..+++|+.|
T Consensus         8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L   82 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTL   82 (266)
T ss_dssp             CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEE
T ss_pred             ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccc
Confidence            3445556666666666 3454442  35666777777766555566666677777777777666 333 24566667777


Q ss_pred             eccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCC
Q 002883          350 DLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFS  429 (871)
Q Consensus       350 ~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  429 (871)
                      +|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.++++|++++|.++.+.+..+..+++|+.|++++|+|+
T Consensus        83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~  161 (266)
T d1p9ag_          83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT  161 (266)
T ss_dssp             ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             cccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence            77777666 34556666667777777777666556666666666777777777766666666666667777777777776


Q ss_pred             CCCcccccccccccEEecCCCcCcccCCCCcccccccceeccCCCCCccCC
Q 002883          430 GKIPMFLNTFRFLQKLNLSFNNLEGEVPSEGVFKNVRAVSIIGNNKLCGGS  480 (871)
Q Consensus       430 ~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~~~l~~l~l~~N~~~C~~~  480 (871)
                      +..+..+..+++|++|+|++|+|+..++....+..++.+++.+|||.|+|.
T Consensus       162 ~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~  212 (266)
T d1p9ag_         162 ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (266)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             ccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcc
Confidence            666666666667777777777766444434445566666677777777664

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.88  E-value=1e-20  Score=203.68  Aligned_cols=199  Identities=25%  Similarity=0.296  Sum_probs=101.9

Q ss_pred             CCCEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccccc
Q 002883           15 ELRILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVS   94 (871)
Q Consensus        15 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~   94 (871)
                      +++.|||++|+++ .+|+.   +++|++|+|++|+|+ .+|+.+   .+|++|++++|+++ .+++.   .+.|++|+++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~  106 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS  106 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence            4667777777776 45643   346666777777776 555543   35666666666665 33321   1235555555


Q ss_pred             cccccCCCCccccccCCCceeeeeccccccccccccccCCCCccEEEccCccCCCCCCccCcCCCCCCccccCCCcccEE
Q 002883           95 ANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPHYVGFTLPNIRVLLLGSNWFTGEIPPSISNASSIPEDLGKLKNLIRL  174 (871)
Q Consensus        95 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~i~~~~p~~~~~~~~lp~~~~~l~~L~~L  174 (871)
                      +|.+. .+|. +..                         +++|+.|++++|.++           ..|.   ....+..+
T Consensus       107 ~n~l~-~lp~-~~~-------------------------l~~L~~L~l~~~~~~-----------~~~~---~~~~l~~l  145 (353)
T d1jl5a_         107 NNQLE-KLPE-LQN-------------------------SSFLKIIDVDNNSLK-----------KLPD---LPPSLEFI  145 (353)
T ss_dssp             SSCCS-SCCC-CTT-------------------------CTTCCEEECCSSCCS-----------CCCC---CCTTCCEE
T ss_pred             ccccc-cccc-hhh-------------------------hccceeecccccccc-----------cccc---ccccccch
Confidence            55555 3332 334                         445555555555443           1111   12334444


Q ss_pred             ecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceee
Q 002883          175 NFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIA  254 (871)
Q Consensus       175 ~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~  254 (871)
                      .+.++....        ...+..++.++.+++++|.+.. .+...    ...+.+..+++.+. .. ..+..++.|+.++
T Consensus       146 ~~~~~~~~~--------~~~l~~l~~l~~L~l~~n~~~~-~~~~~----~~~~~l~~~~~~~~-~~-~~~~~l~~L~~l~  210 (353)
T d1jl5a_         146 AAGNNQLEE--------LPELQNLPFLTAIYADNNSLKK-LPDLP----LSLESIVAGNNILE-EL-PELQNLPFLTTIY  210 (353)
T ss_dssp             ECCSSCCSS--------CCCCTTCTTCCEEECCSSCCSS-CCCCC----TTCCEEECCSSCCS-SC-CCCTTCTTCCEEE
T ss_pred             hhccccccc--------cccccccccceecccccccccc-ccccc----cccccccccccccc-cc-ccccccccccccc
Confidence            444443332        1234455666666666666652 22211    22455566655554 22 2345566666666


Q ss_pred             cccccccccCCccccCCCCCcEEEccCCCCC
Q 002883          255 MEVNLLTGSIPTSVGYLLKLQVLSLFGNKIS  285 (871)
Q Consensus       255 l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  285 (871)
                      +++|.... .+.   ...++..+.+.+|.+.
T Consensus       211 l~~n~~~~-~~~---~~~~l~~~~~~~~~~~  237 (353)
T d1jl5a_         211 ADNNLLKT-LPD---LPPSLEALNVRDNYLT  237 (353)
T ss_dssp             CCSSCCSS-CCS---CCTTCCEEECCSSCCS
T ss_pred             cccccccc-ccc---cccccccccccccccc
Confidence            66665552 222   2345666666666655

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=3.1e-23  Score=201.93  Aligned_cols=170  Identities=19%  Similarity=0.132  Sum_probs=120.9

Q ss_pred             CCCCceeeccccceEEEEEECCCCcEEEEEEeecccc------------------chHHHHHHHHHHHHcCCCCccceee
Q 002883          561 FSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQR------------------GASKSFIAECEALRSIRHRNLVKII  622 (871)
Q Consensus       561 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~  622 (871)
                      |.+.+.||+|+||+||+|++. +|+.||||+++....                  .......+|+..+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            356789999999999999986 789999998743211                  0123455788899999999999888


Q ss_pred             eeecccCcCCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCce
Q 002883          623 TSCSSIDTRGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHCHTSIVHCDLKPSNV  702 (871)
Q Consensus       623 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  702 (871)
                      ++.         ..+++|||+++..+.              .++...+..++.|++.|++|||+.   ||+||||||+||
T Consensus        81 ~~~---------~~~lvme~~~~~~~~--------------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NI  134 (191)
T d1zara2          81 AWE---------GNAVLMELIDAKELY--------------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV  134 (191)
T ss_dssp             EEE---------TTEEEEECCCCEEGG--------------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             Eec---------CCEEEEEeecccccc--------------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhhe
Confidence            652         137999999875432              244455678999999999999999   999999999999


Q ss_pred             eeCCCCceEEeecccceecCCCCCCccccccccccccccCcccccCCCCCCccchhhHHHHH
Q 002883          703 LLDNEMVAHVGDFGLSRLLHDNSPDQTSTSRVKGSIGYVAPEYGALGEVSTHGDEYSFGILM  764 (871)
Q Consensus       703 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il  764 (871)
                      |++++ .++++|||.|.......... ....   .... -.|. ....|+.++|+||..-.+
T Consensus       135 Lv~~~-~~~liDFG~a~~~~~~~~~~-~l~r---d~~~-~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         135 LVSEE-GIWIIDFPQSVEVGEEGWRE-ILER---DVRN-IITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EEETT-EEEECCCTTCEETTSTTHHH-HHHH---HHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             eeeCC-CEEEEECCCcccCCCCCcHH-HHHH---HHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence            99865 58999999998654321100 0000   0000 0111 235678899999986443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.87  E-value=3.8e-20  Score=199.21  Aligned_cols=221  Identities=28%  Similarity=0.378  Sum_probs=120.7

Q ss_pred             CCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcE
Q 002883          197 NCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQV  276 (871)
Q Consensus       197 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  276 (871)
                      .+++|++|++++|.+.. .+...    ..+..+.+.++...  ....+..++.++.|++++|.+... +.   .....+.
T Consensus       118 ~l~~L~~L~l~~~~~~~-~~~~~----~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~-~~---~~~~~~~  186 (353)
T d1jl5a_         118 NSSFLKIIDVDNNSLKK-LPDLP----PSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL-PD---LPLSLES  186 (353)
T ss_dssp             TCTTCCEEECCSSCCSC-CCCCC----TTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC-CC---CCTTCCE
T ss_pred             hhccceeeccccccccc-ccccc----ccccchhhcccccc--ccccccccccceeccccccccccc-cc---ccccccc
Confidence            34445555555554442 12111    23555555555443  334455666666666666665522 21   1223455


Q ss_pred             EEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCC
Q 002883          277 LSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHL  356 (871)
Q Consensus       277 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l  356 (871)
                      +..+++.+. ..+ .+..++.|+.+++++|... ..+.   ...++..+.+.+|.+.. .+.   ....+...++..|.+
T Consensus       187 l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~~~~---~~~~l~~~~~~~~~~~~-~~~---~~~~l~~~~~~~~~~  256 (353)
T d1jl5a_         187 IVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTD-LPE---LPQSLTFLDVSENIF  256 (353)
T ss_dssp             EECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-SCCS---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCC
T ss_pred             ccccccccc-ccc-ccccccccccccccccccc-cccc---ccccccccccccccccc-ccc---ccccccccccccccc
Confidence            666655554 333 3556677777777777665 2332   23556677777777652 222   234555666665555


Q ss_pred             CCCCccccCC-CCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCccc
Q 002883          357 SGPIPLEVGR-LKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMF  435 (871)
Q Consensus       357 ~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  435 (871)
                      .+     +.. .......++..|.+.+ .+   ..+++|++|+|++|+|+.+ |.   .+++|+.|+|++|+|+ .+|..
T Consensus       257 ~~-----l~~l~~~~~~~~~~~~~~~~-~~---~~~~~L~~L~Ls~N~l~~l-p~---~~~~L~~L~L~~N~L~-~l~~~  322 (353)
T d1jl5a_         257 SG-----LSELPPNLYYLNASSNEIRS-LC---DLPPSLEELNVSNNKLIEL-PA---LPPRLERLIASFNHLA-EVPEL  322 (353)
T ss_dssp             SE-----ESCCCTTCCEEECCSSCCSE-EC---CCCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS-CCCCC
T ss_pred             cc-----cccccchhcccccccCcccc-cc---ccCCCCCEEECCCCccCcc-cc---ccCCCCEEECCCCcCC-ccccc
Confidence            42     111 1344556666666652 22   2346777777777777743 32   3567777888888777 45543


Q ss_pred             ccccccccEEecCCCcCccc
Q 002883          436 LNTFRFLQKLNLSFNNLEGE  455 (871)
Q Consensus       436 ~~~~~~L~~L~l~~N~l~~~  455 (871)
                         +++|++|++++|+++..
T Consensus       323 ---~~~L~~L~L~~N~L~~l  339 (353)
T d1jl5a_         323 ---PQNLKQLHVEYNPLREF  339 (353)
T ss_dssp             ---CTTCCEEECCSSCCSSC
T ss_pred             ---cCCCCEEECcCCcCCCC
Confidence               35677788888887754

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=6.8e-23  Score=229.57  Aligned_cols=109  Identities=19%  Similarity=0.202  Sum_probs=72.8

Q ss_pred             CCCEEecCCCcccccC-CccccCCCcCceeeCCCCcccc----cCCccccCCcccceeeccCccccCCC----Ccccc-c
Q 002883           15 ELRILDLVVNKLEGNI-PSELGNLFKLVGLGLTGNNYTG----SIPQSLSNLSFLQQLSLSENSLSGNI----PSELG-L   84 (871)
Q Consensus        15 ~L~~L~l~~n~i~~~~-~~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~~~----~~~~~-~   84 (871)
                      +|+.||+++|+|++.. .+-+..+++|++|+|++|.++.    .++..+..+++|++|||++|.|+...    ...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            5788999999997532 4446678888999999998873    23455678888999999998876211    11121 1


Q ss_pred             cccccccccccccccCC----CCccccccCCCceeeeeccccc
Q 002883           85 LKQLNMFQVSANYLTGS----IPIQLFNISSMDYFAVTQNKLV  123 (871)
Q Consensus        85 l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~  123 (871)
                      ..+|++|+|++|.+++.    ++..+..+++|++|++++|.+.
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence            24678888888877632    2334555666666666666654

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.80  E-value=3.6e-19  Score=178.27  Aligned_cols=188  Identities=26%  Similarity=0.338  Sum_probs=97.0

Q ss_pred             CCccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCE
Q 002883          245 GNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQK  324 (871)
Q Consensus       245 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  324 (871)
                      +++++|+.|++.+|.|+..  +.+..+++|++|++++|+|++..  .+..+++|+.+++++|.++. + ..++++++|+.
T Consensus        38 ~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~  111 (227)
T d1h6ua2          38 ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLKN-V-SAIAGLQSIKT  111 (227)
T ss_dssp             HHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCE
T ss_pred             HHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccc--cccccccccccccccccccc-c-ccccccccccc
Confidence            4444455555555554422  23455555555555555554322  24555555555555555542 2 23455555555


Q ss_pred             EecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcc
Q 002883          325 LDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSF  404 (871)
Q Consensus       325 L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  404 (871)
                      +++++|...+.  ..+...+.+..+.++++.+...  ..+..+++|+.|++++|.+++.  ..+..+++|++|+|++|++
T Consensus       112 l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l  185 (227)
T d1h6ua2         112 LDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKI  185 (227)
T ss_dssp             EECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred             ccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCCcc
Confidence            55555555422  2244455555555555555422  2244555666666666665522  2255566666666666666


Q ss_pred             cccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecC
Q 002883          405 QGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLS  448 (871)
Q Consensus       405 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~  448 (871)
                      +++.  .+.++++|++|+|++|++++. + .+..+++|+.|+++
T Consensus       186 ~~l~--~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         186 SDIS--PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLT  225 (227)
T ss_dssp             CCCG--GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEE
T ss_pred             CCCh--hhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEee
Confidence            5432  255566666666666666632 2 25566666666654

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=3e-19  Score=181.03  Aligned_cols=219  Identities=15%  Similarity=0.103  Sum_probs=113.6

Q ss_pred             cEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeeccccccccc-CCccccCCCCCcEEEcc
Q 002883          202 EVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGS-IPTSVGYLLKLQVLSLF  280 (871)
Q Consensus       202 ~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~L~  280 (871)
                      +.++.+++.++ .+|..+.   .++++|+|++|+|+.+.+..|.++++|++|++++|.+... .+.+|..++++++|.+.
T Consensus        11 ~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            56777777776 5565543   3567777777777654455566666666666666665532 23445556666666554


Q ss_pred             C-CCCCCCCCcccCCCccccEEEccCccccccCcc-cccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCC
Q 002883          281 G-NKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPS-ALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSG  358 (871)
Q Consensus       281 ~-n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  358 (871)
                      . |++....+..|.++++|++|++++|++....+. .+..+..+..+...++.+....+..|.+++              
T Consensus        87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~--------------  152 (242)
T d1xwdc1          87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS--------------  152 (242)
T ss_dssp             CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSB--------------
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccccc--------------
Confidence            3 445444455555555566666655555422221 122233333444444444433333333322              


Q ss_pred             CCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCc-eeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCccccc
Q 002883          359 PIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLE-YLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLN  437 (871)
Q Consensus       359 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  437 (871)
                               ..++.|++++|+++...+..|. ..+++ .+++++|+|+.+.+..|.++++|++|+|++|+|+...+..|.
T Consensus       153 ---------~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~  222 (242)
T d1xwdc1         153 ---------FESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE  222 (242)
T ss_dssp             ---------SSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCT
T ss_pred             ---------ccceeeeccccccccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHc
Confidence                     2455555555555533332222 23332 234455556555555566666666666666666644444555


Q ss_pred             ccccccEEecC
Q 002883          438 TFRFLQKLNLS  448 (871)
Q Consensus       438 ~~~~L~~L~l~  448 (871)
                      .+++|+.+++.
T Consensus       223 ~l~~L~~l~~~  233 (242)
T d1xwdc1         223 NLKKLRARSTY  233 (242)
T ss_dssp             TCCEEESSSEE
T ss_pred             CCcccccCcCC
Confidence            55555555543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.79  E-value=2e-19  Score=174.70  Aligned_cols=177  Identities=27%  Similarity=0.347  Sum_probs=129.0

Q ss_pred             cEEEccCccccccCcccccCCCCCCEEecCCCcCCC-CCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCC
Q 002883          299 TEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSG-TIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSE  377 (871)
Q Consensus       299 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~  377 (871)
                      ++++.++|+++ .+|..+.  +++++|+|++|+|++ ..+..|.++++|+.|+|++|.+....+..+..+++|++|+|++
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            45666667666 4454443  567777777777764 3345667777777788877777767777777888888888888


Q ss_pred             CcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCcccccccccccEEecCCCcCcccCC
Q 002883          378 NKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVP  457 (871)
Q Consensus       378 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~  457 (871)
                      |+|+...+..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|.+....+ ...-...++.+.+..|.++|..|
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCC
Confidence            88887777778888888888888888888888888888888888888888875332 22223446777888888888766


Q ss_pred             CCcccccccceeccCCCCCccCCC
Q 002883          458 SEGVFKNVRAVSIIGNNKLCGGSP  481 (871)
Q Consensus       458 ~~~~~~~l~~l~l~~N~~~C~~~~  481 (871)
                      ..  +..+..+++..|...|.++.
T Consensus       167 ~~--l~~~~l~~L~~n~l~C~~~~  188 (192)
T d1w8aa_         167 SK--VRDVQIKDLPHSEFKCSSEN  188 (192)
T ss_dssp             TT--TTTSBGGGSCTTTCCCCCC-
T ss_pred             hh--hcCCEeeecCHhhCcCCCCC
Confidence            43  56666777888888887664

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=1.8e-19  Score=182.73  Aligned_cols=220  Identities=15%  Similarity=0.005  Sum_probs=168.6

Q ss_pred             ccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCC-CCCCCCCccc
Q 002883          171 LIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGT-IPTGVGNLKN  249 (871)
Q Consensus       171 L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~-~~~~~~~l~~  249 (871)
                      .+.++.++++++++|..       +.  +++++|+|++|+|+...+..|.++ ++|++|++++|.+... .+..|.++++
T Consensus        10 ~~~i~c~~~~l~~iP~~-------l~--~~l~~L~Ls~n~i~~l~~~~f~~l-~~L~~L~ls~n~~~~~i~~~~f~~l~~   79 (242)
T d1xwdc1          10 NRVFLCQESKVTEIPSD-------LP--RNAIELRFVLTKLRVIQKGAFSGF-GDLEKIEISQNDVLEVIEADVFSNLPK   79 (242)
T ss_dssp             SSEEEEESCSCSSCCSC-------SC--SCCSEEEEESCCCCEECTTTTTTC-TTCCEEEEESCTTCCEECSSSEESCTT
T ss_pred             CCEEEEeCCCCCCcCCC-------CC--CCCCEEECcCCcCCccChhHhhcc-chhhhhhhccccccceeeccccccccc
Confidence            36889999999987753       11  479999999999985444456666 5799999999998754 4567899999


Q ss_pred             cceeeccc-ccccccCCccccCCCCCcEEEccCCCCCCCCCc-ccCCCccccEEEccCccccccCcccccCCC-CCCEEe
Q 002883          250 LILIAMEV-NLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPS-SLGNLIFLTEVDLQGNSIRGSIPSALGNCL-QLQKLD  326 (871)
Q Consensus       250 L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~  326 (871)
                      ++++.+.. |.+....+..|.++++|+.|++++|++....+. .+..+..+..+..+++.+....+..|.+++ .++.|+
T Consensus        80 l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~  159 (242)
T d1xwdc1          80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILW  159 (242)
T ss_dssp             CCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEE
T ss_pred             cccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeee
Confidence            99998764 788888889999999999999999999844332 345567777788888899877777888765 799999


Q ss_pred             cCCCcCCCCCcccccCCCCCcE-EeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecC
Q 002883          327 LSDNNLSGTIPREVIGLSSFVL-LDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSD  401 (871)
Q Consensus       327 L~~N~l~~~~~~~~~~l~~L~~-L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  401 (871)
                      +++|+++...+..+ ...++.. +++++|+++...+..|..+++|++|+|++|+|+...+..|.++++|+.+++.+
T Consensus       160 l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         160 LNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             CCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             cccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            99999985544444 4455444 46778888854455678888888888888888855566677777777776644

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=4.4e-19  Score=177.61  Aligned_cols=204  Identities=22%  Similarity=0.308  Sum_probs=144.7

Q ss_pred             cEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccCCccccCCCCCcEEEccC
Q 002883          202 EVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFG  281 (871)
Q Consensus       202 ~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~  281 (871)
                      ..++++.+++++..  ....+ .+|++|++++|.|+..  ..+..+++|+.|++++|.+++..  .+..+++|+.+++++
T Consensus        22 ~~~~l~~~~~~d~~--~~~~l-~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~   94 (227)
T d1h6ua2          22 IKIAAGKSNVTDTV--TQADL-DGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSG   94 (227)
T ss_dssp             HHHHTTCSSTTSEE--CHHHH-HTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCS
T ss_pred             HHHHhCCCCcCCcC--CHHHc-CCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccc--ccccccccccccccc
Confidence            33445555555432  22333 3577777777777743  35777777888888887777433  377778888888888


Q ss_pred             CCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCc
Q 002883          282 NKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIP  361 (871)
Q Consensus       282 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~  361 (871)
                      |.++. + ..+.++++|+.+++++|...+.  ..+...+.++.+.++++.+...  ..+...++|+.|++++|.+.+.. 
T Consensus        95 n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~-  167 (227)
T d1h6ua2          95 NPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT-  167 (227)
T ss_dssp             CCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG-
T ss_pred             ccccc-c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch-
Confidence            88773 3 3477788888888888877643  3356677888888888887632  34667788888888888887332 


Q ss_pred             cccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCC
Q 002883          362 LEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLS  424 (871)
Q Consensus       362 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  424 (871)
                       .++.+++|+.|+|++|++++ ++ .++.+++|++|+|++|+|+++.+  +.++++|+.|+++
T Consensus       168 -~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls  225 (227)
T d1h6ua2         168 -PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT  225 (227)
T ss_dssp             -GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred             -hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence             37788888888888888874 33 37888888999999888886543  7888889888886

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=7.5e-19  Score=173.22  Aligned_cols=165  Identities=25%  Similarity=0.317  Sum_probs=86.4

Q ss_pred             CCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEe
Q 002883          271 LLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLD  350 (871)
Q Consensus       271 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  350 (871)
                      +.+|+.|++++|.++. ++ .+..+++|++|+|++|+|++..  .++.+++|+.|++++|+|++ ++ .+..+++|+.|+
T Consensus        45 L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~  118 (210)
T d1h6ta2          45 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS  118 (210)
T ss_dssp             HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred             hcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccc
Confidence            3344445555554442 11 2444555555555555554322  23445555555555555542 22 345555555555


Q ss_pred             ccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCC
Q 002883          351 LSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSG  430 (871)
Q Consensus       351 ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  430 (871)
                      +++|.+.. + ..+..++.++.+++++|.+++  +..+..+++|+.+++++|+++++.  .+.++++|++|+|++|++++
T Consensus       119 l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~  192 (210)
T d1h6ta2         119 LEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD  192 (210)
T ss_dssp             CTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB
T ss_pred             cccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC
Confidence            55555542 2 235555566666666666552  234555666666666666665432  25666666666666666653


Q ss_pred             CCcccccccccccEEecCC
Q 002883          431 KIPMFLNTFRFLQKLNLSF  449 (871)
Q Consensus       431 ~~~~~~~~~~~L~~L~l~~  449 (871)
                       +| .+..+++|++|+|++
T Consensus       193 -l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         193 -LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             -CG-GGTTCTTCSEEEEEE
T ss_pred             -Ch-hhcCCCCCCEEEccC
Confidence             33 466666666666653

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=1.1e-21  Score=219.60  Aligned_cols=61  Identities=20%  Similarity=0.247  Sum_probs=35.8

Q ss_pred             cCceeeCCCCcccccC-CccccCCcccceeeccCccccC----CCCcccccccccccccccccccc
Q 002883           39 KLVGLGLTGNNYTGSI-PQSLSNLSFLQQLSLSENSLSG----NIPSELGLLKQLNMFQVSANYLT   99 (871)
Q Consensus        39 ~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~   99 (871)
                      +|+.|+++.|++++.. .+-+..+++++.|+|++|.++.    .++..+..+++|++|+|++|+|+
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~   68 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG   68 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCC
Confidence            4667777777776321 2335556667777777776652    22333455666666666666664

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.77  E-value=8e-19  Score=170.41  Aligned_cols=127  Identities=24%  Similarity=0.381  Sum_probs=70.1

Q ss_pred             eeecccccccccCCccccCCCCCcEEEccCCCCCC-CCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCC
Q 002883          252 LIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISG-EIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDN  330 (871)
Q Consensus       252 ~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  330 (871)
                      .+++++++++ .+|..+.  +++++|+|++|+|+. ..+..|.++++|++|+|++|++....+..|..+++|++|+|++|
T Consensus        12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            3444444444 2333331  355555555555543 22344555556666666666655555555555666666666666


Q ss_pred             cCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCC
Q 002883          331 NLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLS  381 (871)
Q Consensus       331 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  381 (871)
                      +|+++.+..|.++++|++|+|++|+|+...+..|..+++|++|+|++|.+.
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~  139 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred             cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence            665555555555666666666666665444555566666666666666655

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=1.1e-18  Score=170.55  Aligned_cols=162  Identities=27%  Similarity=0.378  Sum_probs=88.8

Q ss_pred             CCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCcEE
Q 002883          270 YLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLL  349 (871)
Q Consensus       270 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  349 (871)
                      .+.++++|++++|.|+. + +.+..+++|++|+|++|+|++..+  ++++++|++|++++|.+. .++ .+.++++|+.|
T Consensus        38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L  111 (199)
T d2omxa2          38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGL  111 (199)
T ss_dssp             HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEE
T ss_pred             HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccccc
Confidence            34455555555555542 2 224555555555555555553222  555555556666555554 222 25555566666


Q ss_pred             eccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCC
Q 002883          350 DLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFS  429 (871)
Q Consensus       350 ~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  429 (871)
                      ++++|.+...  ..+..+++|+.|++++|++. .+ +.+..+++|++|++++|++++..  .++++++|++|++++|+++
T Consensus       112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         112 TLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DI-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS  185 (199)
T ss_dssp             ECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CC-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             cccccccccc--cccchhhhhHHhhhhhhhhc-cc-ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCC
Confidence            6665555422  23555666666666666665 22 24556666666666666666432  3566666777777777666


Q ss_pred             CCCcccccccccccEE
Q 002883          430 GKIPMFLNTFRFLQKL  445 (871)
Q Consensus       430 ~~~~~~~~~~~~L~~L  445 (871)
                      + ++ .+..+++|++|
T Consensus       186 ~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         186 D-IS-VLAKLTNLESL  199 (199)
T ss_dssp             C-CG-GGGGCTTCSEE
T ss_pred             C-Cc-cccCCCCCCcC
Confidence            3 33 35566666654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=3.8e-18  Score=168.10  Aligned_cols=145  Identities=29%  Similarity=0.403  Sum_probs=70.1

Q ss_pred             ccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCc
Q 002883          268 VGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV  347 (871)
Q Consensus       268 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  347 (871)
                      +..+++|++|+|++|+|++. + .++.+++|+.|++++|+|++ ++ .+.++++|+.|++++|.+. .+ ..+..+++|+
T Consensus        64 l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~  137 (210)
T d1h6ta2          64 IQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLE  137 (210)
T ss_dssp             GGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCC
T ss_pred             HhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-ccccccccccccccccccc-cc-cccccccccc
Confidence            34444444444444444421 1 23444455555555555442 22 2444555555555555544 11 2344455555


Q ss_pred             EEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCC
Q 002883          348 LLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLS  424 (871)
Q Consensus       348 ~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  424 (871)
                      .+++++|.+++  +..+..+++|+.+++++|++++ ++ .+..+++|++|+|++|+|+++ + .+.++++|++|+|+
T Consensus       138 ~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         138 SLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELF  208 (210)
T ss_dssp             EEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEE
T ss_pred             ccccccccccc--cccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEcc
Confidence            55555555542  2234445555555555555552 22 255555555556655555532 2 35555666666554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.74  E-value=8.6e-18  Score=164.05  Aligned_cols=162  Identities=27%  Similarity=0.371  Sum_probs=84.5

Q ss_pred             CccccceeecccccccccCCccccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEE
Q 002883          246 NLKNLILIAMEVNLLTGSIPTSVGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKL  325 (871)
Q Consensus       246 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  325 (871)
                      .+++++.|++++|.|+..  +.++.+++|++|++++|+|++..  .++++++|++|++++|.+.. ++ .+.++++|+.|
T Consensus        38 ~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L  111 (199)
T d2omxa2          38 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL  111 (199)
T ss_dssp             HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred             HhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCcc--cccCCccccccccccccccc-cc-ccccccccccc
Confidence            344444445544444421  23445555555555555555322  15555555555555555542 22 25555556666


Q ss_pred             ecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCccc
Q 002883          326 DLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQ  405 (871)
Q Consensus       326 ~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  405 (871)
                      ++++|.+...  ..+..+++|+.|++++|++. .++ .+..+++|+.|++++|++++. + .+.++++|++|++++|+|+
T Consensus       112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         112 TLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVS  185 (199)
T ss_dssp             ECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred             cccccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCC
Confidence            6655555422  23455556666666666654 222 355566666666666666532 2 3556666666666666665


Q ss_pred             ccCccccCCCCCCCEE
Q 002883          406 GPIHSGFSSLKGLQDL  421 (871)
Q Consensus       406 ~~~~~~~~~l~~L~~L  421 (871)
                      ++  ..++++++|+.|
T Consensus       186 ~i--~~l~~L~~L~~L  199 (199)
T d2omxa2         186 DI--SVLAKLTNLESL  199 (199)
T ss_dssp             CC--GGGGGCTTCSEE
T ss_pred             CC--ccccCCCCCCcC
Confidence            43  235556666554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=4.9e-16  Score=160.44  Aligned_cols=221  Identities=18%  Similarity=0.174  Sum_probs=108.7

Q ss_pred             EEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccccccccC-CccccCCCCCcEEEccC
Q 002883          203 VVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVNLLTGSI-PTSVGYLLKLQVLSLFG  281 (871)
Q Consensus       203 ~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~L~~  281 (871)
                      +|||+++.+.......+..  ..+..+.++...+.. .........+|++|++++|.++... ...+..+++|++|+|++
T Consensus         4 ~lDLs~~~l~~~~l~~l~~--~~~~~lrl~~~~~~~-~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~   80 (284)
T d2astb2           4 TLDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQ-PLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG   80 (284)
T ss_dssp             EEECTTCBCCHHHHHHHHH--TTCSEEECTTCEECS-CCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred             EEECCCCCCCchHHHHHHh--ccceEeecccccccc-chhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence            5777777665222222222  135566666655542 2222334456666666666665322 23345566666666666


Q ss_pred             CCCCCCCCcccCCCccccEEEccCc-cccccC-cccccCCCCCCEEecCCC-cCCCC-Cccccc-CCCCCcEEeccCCC-
Q 002883          282 NKISGEIPSSLGNLIFLTEVDLQGN-SIRGSI-PSALGNCLQLQKLDLSDN-NLSGT-IPREVI-GLSSFVLLDLSRNH-  355 (871)
Q Consensus       282 n~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~~-~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~-~l~~L~~L~ls~N~-  355 (871)
                      |.++...+..++.+++|++|+|++| .++... ...+.++++|++|+++++ .+++. ....+. ..++|+.|+++++. 
T Consensus        81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~  160 (284)
T d2astb2          81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK  160 (284)
T ss_dssp             CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred             cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence            6665555555666666666666663 343211 112234566666666664 23211 111121 22455666665432 


Q ss_pred             -CCCC-CccccCCCCCCCEEeCCCC-cCCCCCccchhcccCCceeeecCC-cccccCccccCCCCCCCEEeCCCC
Q 002883          356 -LSGP-IPLEVGRLKGIQQLDLSEN-KLSGEIPTSLASCVGLEYLNFSDN-SFQGPIHSGFSSLKGLQDLDLSRN  426 (871)
Q Consensus       356 -l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~N  426 (871)
                       +++. +...+..+++|++|++++| .+++.....+..+++|++|+|++| .|++.....++.+++|+.|+++++
T Consensus       161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence             2211 1111233555555555554 244444445555555555555553 444444444555555555555554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=1.7e-15  Score=141.36  Aligned_cols=128  Identities=20%  Similarity=0.210  Sum_probs=79.9

Q ss_pred             ccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCc
Q 002883          316 LGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLE  395 (871)
Q Consensus       316 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  395 (871)
                      |.++.+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+ .++ .+..+++|++|++++|+++...+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence            445556666666666666 34444555666666666666666 232 366667777777777777654445556677777


Q ss_pred             eeeecCCcccccCc-cccCCCCCCCEEeCCCCcCCCCC---cccccccccccEEe
Q 002883          396 YLNFSDNSFQGPIH-SGFSSLKGLQDLDLSRNNFSGKI---PMFLNTFRFLQKLN  446 (871)
Q Consensus       396 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~---~~~~~~~~~L~~L~  446 (871)
                      +|++++|+|+.... ..+..+++|++|++++|+++...   +..+..+|+|+.||
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            77777777764432 45667777777777777776322   12466677777766

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.57  E-value=2.8e-15  Score=132.83  Aligned_cols=102  Identities=25%  Similarity=0.359  Sum_probs=74.9

Q ss_pred             CEEecCCCcccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccccccc
Q 002883           17 RILDLVVNKLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQVSAN   96 (871)
Q Consensus        17 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n   96 (871)
                      |.|||++|+|+ .++ .++++.+|++|++++|+|+ .+|+.|+.+++|++|++++|+|+ .+| .++.+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence            57888888887 454 4788888888888888888 67777888888888888888887 555 4788888888888888


Q ss_pred             cccCCC-CccccccCCCceeeeeccccc
Q 002883           97 YLTGSI-PIQLFNISSMDYFAVTQNKLV  123 (871)
Q Consensus        97 ~l~~~~-~~~~~~l~~L~~L~l~~n~l~  123 (871)
                      +++... ...+..+++|+.|++++|.+.
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            887322 234555566666666666554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=2.1e-15  Score=140.64  Aligned_cols=127  Identities=19%  Similarity=0.143  Sum_probs=67.8

Q ss_pred             ccCCCCCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCCcccccCCCCCc
Q 002883          268 VGYLLKLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFV  347 (871)
Q Consensus       268 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  347 (871)
                      |.++.+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+..  +.|..+++|++|++++|++++..+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence            344455666666666665 3344445555666666666666532  2355566666666666666544444444555666


Q ss_pred             EEeccCCCCCCCCc-cccCCCCCCCEEeCCCCcCCCCCcc----chhcccCCceee
Q 002883          348 LLDLSRNHLSGPIP-LEVGRLKGIQQLDLSENKLSGEIPT----SLASCVGLEYLN  398 (871)
Q Consensus       348 ~L~ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~  398 (871)
                      .|++++|+|+.... ..+..+++|++|++++|+++ ..|.    .+..+++|+.||
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred             cceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence            66666666552211 24555566666666666665 2222    344555555544

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.55  E-value=8e-15  Score=129.78  Aligned_cols=87  Identities=34%  Similarity=0.397  Sum_probs=33.1

Q ss_pred             cCCCCCCCEEeCCCCcCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCc-ccccccccc
Q 002883          364 VGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP-MFLNTFRFL  442 (871)
Q Consensus       364 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~~~~L  442 (871)
                      +..+++|++|++++|+|+ .+|..|..+++|+.|++++|+|++. + .+..+++|++|++++|+|++... ..+..+++|
T Consensus        16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L   92 (124)
T d1dcea3          16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL   92 (124)
T ss_dssp             GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred             cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCccCCCCCchhhcCCCCC
Confidence            333333444444444433 2333333344444444444444322 1 23334444444444444432211 233334444


Q ss_pred             cEEecCCCcCc
Q 002883          443 QKLNLSFNNLE  453 (871)
Q Consensus       443 ~~L~l~~N~l~  453 (871)
                      +.|++++|+++
T Consensus        93 ~~L~l~~N~i~  103 (124)
T d1dcea3          93 VLLNLQGNSLC  103 (124)
T ss_dssp             CEEECTTSGGG
T ss_pred             CEEECCCCcCC
Confidence            44444444443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=8e-16  Score=158.81  Aligned_cols=180  Identities=20%  Similarity=0.235  Sum_probs=88.9

Q ss_pred             CcccEEEccCCcCcccCChhhhhccccccEEEccCCccCCCCCCCCCCccccceeecccc-cccccCCcc-ccCCCCCcE
Q 002883          199 TFLEVVSLSSNSLSGVLPNSIANFSSHLIYLYMSANRISGTIPTGVGNLKNLILIAMEVN-LLTGSIPTS-VGYLLKLQV  276 (871)
Q Consensus       199 ~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N-~l~~~~~~~-~~~l~~L~~  276 (871)
                      .+|++|||++|.++......+..-.++|++|+|++|.+++..+..++.+++|+.|+++++ .++...... +..+++|++
T Consensus        46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~  125 (284)
T d2astb2          46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE  125 (284)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred             CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence            456677777666653322333333345666666666665555555556666666666663 344211111 234566666


Q ss_pred             EEccCCC-CCCC-CCcccCC-CccccEEEccCcc--cccc-CcccccCCCCCCEEecCCC-cCCCCCcccccCCCCCcEE
Q 002883          277 LSLFGNK-ISGE-IPSSLGN-LIFLTEVDLQGNS--IRGS-IPSALGNCLQLQKLDLSDN-NLSGTIPREVIGLSSFVLL  349 (871)
Q Consensus       277 L~L~~n~-l~~~-~~~~~~~-l~~L~~L~L~~N~--i~~~-~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L  349 (871)
                      |++++|. ++.. ....+.. .++|+.|+++++.  ++.. +...+.++++|++|++++| .+++.....+..+++|++|
T Consensus       126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L  205 (284)
T d2astb2         126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL  205 (284)
T ss_dssp             EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred             cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence            6666642 3211 1111222 2456666665532  2211 1122234555666666554 3444444455555555555


Q ss_pred             eccCC-CCCCCCccccCCCCCCCEEeCCCC
Q 002883          350 DLSRN-HLSGPIPLEVGRLKGIQQLDLSEN  378 (871)
Q Consensus       350 ~ls~N-~l~~~~~~~~~~l~~L~~L~L~~N  378 (871)
                      ++++| .+++.....++++++|+.|+++++
T Consensus       206 ~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         206 SLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             ECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             ECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            55553 344434444555555555555554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.53  E-value=3.2e-16  Score=167.35  Aligned_cols=187  Identities=18%  Similarity=0.171  Sum_probs=115.1

Q ss_pred             ccCCCCCcEEEccCCCCCCCC----CcccCCCccccEEEccCccccccCccc-------------ccCCCCCCEEecCCC
Q 002883          268 VGYLLKLQVLSLFGNKISGEI----PSSLGNLIFLTEVDLQGNSIRGSIPSA-------------LGNCLQLQKLDLSDN  330 (871)
Q Consensus       268 ~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~N~i~~~~~~~-------------~~~l~~L~~L~L~~N  330 (871)
                      +...++|+.|+|++|.++...    ...+...++|++|++++|.+.......             ....+.|+.|++++|
T Consensus        89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n  168 (344)
T d2ca6a1          89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN  168 (344)
T ss_dssp             HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred             HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence            344556666666666665421    222334566677777666654211111             123567778888887


Q ss_pred             cCCCCC----cccccCCCCCcEEeccCCCCCCC-----CccccCCCCCCCEEeCCCCcCCCC----CccchhcccCCcee
Q 002883          331 NLSGTI----PREVIGLSSFVLLDLSRNHLSGP-----IPLEVGRLKGIQQLDLSENKLSGE----IPTSLASCVGLEYL  397 (871)
Q Consensus       331 ~l~~~~----~~~~~~l~~L~~L~ls~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L  397 (871)
                      .++...    ...+...+.|+.|+|++|.++..     +...+..+++|+.|+|++|.++..    +...+..+++|++|
T Consensus       169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L  248 (344)
T d2ca6a1         169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL  248 (344)
T ss_dssp             CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred             cccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhh
Confidence            776322    22344567788888888877632     233466677888888888887632    33455677888888


Q ss_pred             eecCCcccccCccc----cC--CCCCCCEEeCCCCcCCCC----Cccccc-ccccccEEecCCCcCcc
Q 002883          398 NFSDNSFQGPIHSG----FS--SLKGLQDLDLSRNNFSGK----IPMFLN-TFRFLQKLNLSFNNLEG  454 (871)
Q Consensus       398 ~L~~N~l~~~~~~~----~~--~l~~L~~L~l~~N~l~~~----~~~~~~-~~~~L~~L~l~~N~l~~  454 (871)
                      +|++|.|++.....    +.  ..+.|++|++++|+|+..    +...+. .+++|+.|+|++|++..
T Consensus       249 ~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             ECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             hhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            88888887543222    22  235688888888888632    223332 46788888888888864

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.52  E-value=2.7e-16  Score=167.91  Aligned_cols=251  Identities=16%  Similarity=0.186  Sum_probs=142.2

Q ss_pred             CCCccccCCCcccEEecccccCCCCCCCCccccccccCCCcccEEEccCCcCccc---CChhhhhccccccEEEccCCcc
Q 002883          160 SIPEDLGKLKNLIRLNFARNNLGTGKGNDLRFLDSLVNCTFLEVVSLSSNSLSGV---LPNSIANFSSHLIYLYMSANRI  236 (871)
Q Consensus       160 ~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~---~~~~~~~~~~~L~~L~L~~n~i  236 (871)
                      .+...+.....|++|+|++|.+......  .....+...++|+.|+++++.....   .+..+..+              
T Consensus        22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~--~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l--------------   85 (344)
T d2ca6a1          22 SVFAVLLEDDSVKEIVLSGNTIGTEAAR--WLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL--------------   85 (344)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHH--HHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHH--------------
T ss_pred             HHHHHHhhCCCCCEEECcCCcCCHHHHH--HHHHHHHhCCCCCEEECCCCcccccccccchHHHHH--------------
Confidence            4555666777788888888776542110  1223456667777777776654311   11111111              


Q ss_pred             CCCCCCCCCCccccceeecccccccccC----CccccCCCCCcEEEccCCCCCCCCCcc-------------cCCCcccc
Q 002883          237 SGTIPTGVGNLKNLILIAMEVNLLTGSI----PTSVGYLLKLQVLSLFGNKISGEIPSS-------------LGNLIFLT  299 (871)
Q Consensus       237 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~L~~n~l~~~~~~~-------------~~~l~~L~  299 (871)
                          ...+...++|+.|+|++|.++...    ...+...++|++|++++|.+.......             ....+.|+
T Consensus        86 ----~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~  161 (344)
T d2ca6a1          86 ----LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR  161 (344)
T ss_dssp             ----HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred             ----HHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccc
Confidence                111223344444455544444321    122334456666666666554211100             12345677


Q ss_pred             EEEccCcccccc----CcccccCCCCCCEEecCCCcCCCC-----CcccccCCCCCcEEeccCCCCCCC----CccccCC
Q 002883          300 EVDLQGNSIRGS----IPSALGNCLQLQKLDLSDNNLSGT-----IPREVIGLSSFVLLDLSRNHLSGP----IPLEVGR  366 (871)
Q Consensus       300 ~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~ls~N~l~~~----~~~~~~~  366 (871)
                      .+++++|+++..    +...+...+.|+.|+|++|+|+..     +...+...++|+.|+|++|.++..    +...+..
T Consensus       162 ~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~  241 (344)
T d2ca6a1         162 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS  241 (344)
T ss_dssp             EEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred             eeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccc
Confidence            777777766532    223344567777888877777531     233455677788888888877532    2345667


Q ss_pred             CCCCCEEeCCCCcCCCCCccch----hc--ccCCceeeecCCcccccC----cccc-CCCCCCCEEeCCCCcCCC
Q 002883          367 LKGIQQLDLSENKLSGEIPTSL----AS--CVGLEYLNFSDNSFQGPI----HSGF-SSLKGLQDLDLSRNNFSG  430 (871)
Q Consensus       367 l~~L~~L~L~~N~l~~~~~~~~----~~--l~~L~~L~L~~N~l~~~~----~~~~-~~l~~L~~L~l~~N~l~~  430 (871)
                      +++|++|+|++|.|++.....+    ..  ...|++|++++|+|+...    ...+ .++++|++|+|++|+++.
T Consensus       242 ~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             cccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            7888888888888874433333    22  356888888888886432    2223 256789999999999874

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.43  E-value=1.4e-13  Score=127.16  Aligned_cols=112  Identities=18%  Similarity=0.078  Sum_probs=89.1

Q ss_pred             CCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCC-cCCCCCccchhcccCCceeeecCCcccccCccccCCCCCCCEEe
Q 002883          344 SSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSEN-KLSGEIPTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLD  422 (871)
Q Consensus       344 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  422 (871)
                      ...+.++.+++.+. ..|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|+
T Consensus         8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~   86 (156)
T d2ifga3           8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN   86 (156)
T ss_dssp             SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred             CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence            34566888888887 56777888888899998766 48866677888888899999999998888888888888999999


Q ss_pred             CCCCcCCCCCcccccccccccEEecCCCcCcccCC
Q 002883          423 LSRNNFSGKIPMFLNTFRFLQKLNLSFNNLEGEVP  457 (871)
Q Consensus       423 l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~  457 (871)
                      |++|+|+...+..+..+ +|+.|+|++|+|.|.+.
T Consensus        87 Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~  120 (156)
T d2ifga3          87 LSFNALESLSWKTVQGL-SLQELVLSGNPLHCSCA  120 (156)
T ss_dssp             CCSSCCSCCCSTTTCSC-CCCEEECCSSCCCCCGG
T ss_pred             ccCCCCcccChhhhccc-cccccccCCCcccCCch
Confidence            99999886555555544 68888888888887663

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=2.7e-13  Score=125.24  Aligned_cols=107  Identities=20%  Similarity=0.188  Sum_probs=56.7

Q ss_pred             CCCEEecCCCcCCCCCcccccCCCCCcEEeccCC-CCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCCceeee
Q 002883          321 QLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRN-HLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGLEYLNF  399 (871)
Q Consensus       321 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  399 (871)
                      ..+.++.+++.+. ..|..+.++++|++|++++| .|+...+..|..+++|+.|+|++|+|+.+.+..|..+++|++|+|
T Consensus         9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L   87 (156)
T d2ifga3           9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL   87 (156)
T ss_dssp             SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred             CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence            3444555555555 34455555555555555443 355344445555555555555555555444555555555555555


Q ss_pred             cCCcccccCccccCCCCCCCEEeCCCCcCC
Q 002883          400 SDNSFQGPIHSGFSSLKGLQDLDLSRNNFS  429 (871)
Q Consensus       400 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  429 (871)
                      ++|+|+.+.+..|..+ +|+.|+|++|.+.
T Consensus        88 s~N~l~~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          88 SFNALESLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             CSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             cCCCCcccChhhhccc-cccccccCCCccc
Confidence            5555554444444433 4555555555554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.39  E-value=3.6e-15  Score=144.31  Aligned_cols=110  Identities=25%  Similarity=0.330  Sum_probs=51.9

Q ss_pred             cccCCCCCCEEecCCCcCCCCCcccccCCCCCcEEeccCCCCCCCCccccCCCCCCCEEeCCCCcCCCCCccchhcccCC
Q 002883          315 ALGNCLQLQKLDLSDNNLSGTIPREVIGLSSFVLLDLSRNHLSGPIPLEVGRLKGIQQLDLSENKLSGEIPTSLASCVGL  394 (871)
Q Consensus       315 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  394 (871)
                      .+..+++|++|+|++|+|+. ++ .+.++++|+.|+|++|.|+ .+|..+..+++|+.|++++|+++. + ..+..+++|
T Consensus        43 sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L  117 (198)
T d1m9la_          43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNL  117 (198)
T ss_dssp             HHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHS
T ss_pred             HHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccccc
Confidence            34444444444444444442 22 2444444444444444444 233333334445555555555552 2 234555555


Q ss_pred             ceeeecCCcccccCc-cccCCCCCCCEEeCCCCcCC
Q 002883          395 EYLNFSDNSFQGPIH-SGFSSLKGLQDLDLSRNNFS  429 (871)
Q Consensus       395 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~  429 (871)
                      +.|++++|+|+.... ..+..+++|+.|+|++|+++
T Consensus       118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             cccccccchhccccccccccCCCccceeecCCCccc
Confidence            555555555553321 34555555555555555554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.39  E-value=4.8e-15  Score=143.37  Aligned_cols=127  Identities=23%  Similarity=0.242  Sum_probs=83.1

Q ss_pred             CCCEEecCCC--cccccCCccccCCCcCceeeCCCCcccccCCccccCCcccceeeccCccccCCCCccccccccccccc
Q 002883           15 ELRILDLVVN--KLEGNIPSELGNLFKLVGLGLTGNNYTGSIPQSLSNLSFLQQLSLSENSLSGNIPSELGLLKQLNMFQ   92 (871)
Q Consensus        15 ~L~~L~l~~n--~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~   92 (871)
                      .++.++++++  .++ .+|.+++.|.+|++|+|++|+|+ .++ .|..+++|++|+|++|+|+ .+|..+..+++|++|+
T Consensus        24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~   99 (198)
T d1m9la_          24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW   99 (198)
T ss_dssp             TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEE
T ss_pred             ccceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccc
Confidence            3555666654  344 56677777888888888888877 443 4777778888888888776 5666666667777777


Q ss_pred             cccccccCCCCccccccCCCceeeeecccccccccc-ccccCCCCccEEEccCccCC
Q 002883           93 VSANYLTGSIPIQLFNISSMDYFAVTQNKLVGEIPH-YVGFTLPNIRVLLLGSNWFT  148 (871)
Q Consensus        93 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~~l~~L~~L~l~~n~i~  148 (871)
                      +++|+++. + ..+..+++|+.|++++|++. .++. ..+..+++|+.|+|++|+++
T Consensus       100 l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         100 ISYNQIAS-L-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             CSEEECCC-H-HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             cccccccc-c-ccccccccccccccccchhc-cccccccccCCCccceeecCCCccc
Confidence            77777773 3 23666677777777777665 3332 12235666666666666554

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.63  E-value=1.4e-09  Score=100.55  Aligned_cols=87  Identities=22%  Similarity=0.219  Sum_probs=50.2

Q ss_pred             cCCCCCCCEEeCCCCcCCCCC--ccchhcccCCceeeecCCcccccCccccCCCCCCCEEeCCCCcCCCCCc-------c
Q 002883          364 VGRLKGIQQLDLSENKLSGEI--PTSLASCVGLEYLNFSDNSFQGPIHSGFSSLKGLQDLDLSRNNFSGKIP-------M  434 (871)
Q Consensus       364 ~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-------~  434 (871)
                      +..+++|++|+|++|+|+...  +..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|.+++...       .
T Consensus        61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~  140 (162)
T d1koha1          61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA  140 (162)
T ss_dssp             HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred             HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence            344666666666666666332  2345566677777777777665544344444556777777777664433       2


Q ss_pred             cccccccccEEecCCCcC
Q 002883          435 FLNTFRFLQKLNLSFNNL  452 (871)
Q Consensus       435 ~~~~~~~L~~L~l~~N~l  452 (871)
                      .+..+|+|+.||  |+++
T Consensus       141 i~~~~P~L~~LD--g~~v  156 (162)
T d1koha1         141 IRERFPKLLRLD--GHEL  156 (162)
T ss_dssp             HHTTSTTCCEET--TEEC
T ss_pred             HHHHCCCCCEEC--cCCC
Confidence            245567777654  4444

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.56  E-value=9.7e-08  Score=96.03  Aligned_cols=150  Identities=18%  Similarity=0.126  Sum_probs=102.4

Q ss_pred             HHHHHhhcCCCCCceeeccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC-CCccceeeeeecccCc
Q 002883          552 AELLKATEGFSSANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDT  630 (871)
Q Consensus       552 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  630 (871)
                      .++..-.+.|++.+..+.++.+.||+...  +++.+++|+...........+.+|...+..+. +--+.+++.+....  
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--   82 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--   82 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC--
Confidence            45556667787777655555678998864  56678899886554444456778888887763 43456666654433  


Q ss_pred             CCCceeeEEEeccCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------
Q 002883          631 RGNEFKALVYEFMPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC----------------------  688 (871)
Q Consensus       631 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------  688 (871)
                         +..++||++++|.++.+.....            .....++.++++.++.||+..                      
T Consensus        83 ---~~~~lv~~~l~G~~~~~~~~~~------------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~  147 (263)
T d1j7la_          83 ---GWSNLLMSEADGVLCSEEYEDE------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN  147 (263)
T ss_dssp             ---TEEEEEEECCSSEEHHHHTTTC------------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred             ---CceEEEEEeccccccccccccc------------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHH
Confidence               5578999999998886654221            112334556666666666432                      


Q ss_pred             ----------------------------------CCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          689 ----------------------------------HTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       689 ----------------------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                                                        ...++|+|+.|.||++++++.+-++||+.+..
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                              12389999999999999877677999998864

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.55  E-value=3e-09  Score=98.28  Aligned_cols=104  Identities=23%  Similarity=0.175  Sum_probs=49.2

Q ss_pred             CCcEEEccCCCCCCCCCcccCCCccccEEEccCccccccCcccccCCCCCCEEecCCCcCCCCC--cccccCCCCCcEEe
Q 002883          273 KLQVLSLFGNKISGEIPSSLGNLIFLTEVDLQGNSIRGSIPSALGNCLQLQKLDLSDNNLSGTI--PREVIGLSSFVLLD  350 (871)
Q Consensus       273 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~  350 (871)
                      ..+.|+++++...    ..+..+..+..++...|.+. .++..+..+++|++|+|++|+|+...  +..+..+++|+.|+
T Consensus        23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~   97 (162)
T d1koha1          23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN   97 (162)
T ss_dssp             SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred             hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence            3455566554432    12334444444445444443 34444455666666677776666332  22334455555555


Q ss_pred             ccCCCCCCCCccccCCCCCCCEEeCCCCcCC
Q 002883          351 LSRNHLSGPIPLEVGRLKGIQQLDLSENKLS  381 (871)
Q Consensus       351 ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  381 (871)
                      |++|.|+...+..+....+|+.|++++|+++
T Consensus        98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          98 LSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             cccCccccchhhhhhhccccceeecCCCCcC
Confidence            5555555322212222234445555555444

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.93  E-value=6.4e-06  Score=81.74  Aligned_cols=131  Identities=15%  Similarity=0.071  Sum_probs=81.2

Q ss_pred             eeecccc-ceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCC--CCccceeeeeecccCcCCCceeeEEEec
Q 002883          566 LIGIGGY-GYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIR--HRNLVKIITSCSSIDTRGNEFKALVYEF  642 (871)
Q Consensus       566 ~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~  642 (871)
                      .+..|.. +.||+.... ++..+++|.......   ..+..|+..++.+.  .-.+.+++.+..+.     +..++||++
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-----~~~~~v~~~   87 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLLLGE   87 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEEEEC
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccc-----cceEEEEEe
Confidence            3445543 678999875 566788998754433   34667888777663  23356666654433     457899999


Q ss_pred             cCCCCHHHHhhcccccccccCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 002883          643 MPNGSLENWLNQKEDEQNQRPKLNLMQRLSIAIDVANVLEYLHHHC----------------------------------  688 (871)
Q Consensus       643 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------  688 (871)
                      ++|.++.+..            ...   ...+.+++..++-||+..                                  
T Consensus        88 i~G~~~~~~~------------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (255)
T d1nd4a_          88 VPGQDLLSSH------------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  152 (255)
T ss_dssp             CSSEETTTSC------------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             eecccccccc------------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccch
Confidence            9886543210            110   011223333333333211                                  


Q ss_pred             ---------------------CCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          689 ---------------------HTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       689 ---------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                                           ...++|+|+.|.||+++.+..+-|+||+.+..
T Consensus       153 ~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         153 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                                 22489999999999999877778999998753

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.82  E-value=5.3e-06  Score=76.21  Aligned_cols=88  Identities=15%  Similarity=0.194  Sum_probs=46.0

Q ss_pred             cCCCCCCCEEeCCCCcCCCC----CccchhcccCCceeeecCCccccc----CccccCCCCCCCEEeCCCCcCCCC----
Q 002883          364 VGRLKGIQQLDLSENKLSGE----IPTSLASCVGLEYLNFSDNSFQGP----IHSGFSSLKGLQDLDLSRNNFSGK----  431 (871)
Q Consensus       364 ~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----  431 (871)
                      +...+.|++|+|++|.+...    +...+...+.|++|+|++|.|+..    +..++...+.|++|++++|.+...    
T Consensus        40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~  119 (167)
T d1pgva_          40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV  119 (167)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred             HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHH
Confidence            33444555555555555421    222333445566666666666532    122345556677777777765532    


Q ss_pred             ---CcccccccccccEEecCCCc
Q 002883          432 ---IPMFLNTFRFLQKLNLSFNN  451 (871)
Q Consensus       432 ---~~~~~~~~~~L~~L~l~~N~  451 (871)
                         +...+...++|+.|+++.+.
T Consensus       120 ~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_         120 EMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             HHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHHHHHHhCCCccEeeCcCCC
Confidence               23344445667777766553

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.80  E-value=4e-06  Score=77.03  Aligned_cols=13  Identities=8%  Similarity=0.281  Sum_probs=5.6

Q ss_pred             CCCCCEEeCCCCc
Q 002883          367 LKGIQQLDLSENK  379 (871)
Q Consensus       367 l~~L~~L~L~~N~  379 (871)
                      .+.|++|++++|.
T Consensus        99 n~sL~~L~l~~n~  111 (167)
T d1pgva_          99 TQSIVEFKADNQR  111 (167)
T ss_dssp             TCCCSEEECCCCS
T ss_pred             CCcCCEEECCCCc
Confidence            3444444444443

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.79  E-value=3.7e-05  Score=81.19  Aligned_cols=77  Identities=18%  Similarity=0.127  Sum_probs=49.2

Q ss_pred             CceeeccccceEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHHHHcC-CC--CccceeeeeecccCcCCC
Q 002883          564 ANLIGIGGYGYVYKGILGTEETNVAVKVLDLQQ-------RGASKSFIAECEALRSI-RH--RNLVKIITSCSSIDTRGN  633 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l-~h--~niv~~~~~~~~~~~~~~  633 (871)
                      .+.||.|....||++....+++.|+||.-....       .....+...|+++++.+ .+  ..+++++.+..       
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~-------  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT-------  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-------
Confidence            456899999999999988778899999763211       11234556788888766 22  34666665532       


Q ss_pred             ceeeEEEeccCCCC
Q 002883          634 EFKALVYEFMPNGS  647 (871)
Q Consensus       634 ~~~~lv~e~~~~gs  647 (871)
                      ...++|||++++..
T Consensus       104 ~~~~lvmE~L~~~~  117 (392)
T d2pula1         104 EMAVTVMEDLSHLK  117 (392)
T ss_dssp             TTTEEEECCCTTSE
T ss_pred             CCCEEEEeccCCcc
Confidence            22479999997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.28  E-value=0.0004  Score=70.93  Aligned_cols=145  Identities=12%  Similarity=0.105  Sum_probs=77.9

Q ss_pred             cceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCc--cceeeeeecccCcCCCceeeEEEeccCCCCHH
Q 002883          572 YGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRN--LVKIITSCSSIDTRGNEFKALVYEFMPNGSLE  649 (871)
Q Consensus       572 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~  649 (871)
                      --.||+++.. +|+.|++|+.+.... ..+++..|.+.+..+....  ++..+...........+..+.++++++|..+.
T Consensus        35 EN~vy~v~~~-dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcC-CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            4689999985 788899999875433 3466778888887774222  22222111111112235678999999763321


Q ss_pred             -----HH---------hhcccc--cccccCCCC-------------------HHHHHHHHHHHHHHHHHHhh----cCCC
Q 002883          650 -----NW---------LNQKED--EQNQRPKLN-------------------LMQRLSIAIDVANVLEYLHH----HCHT  690 (871)
Q Consensus       650 -----~~---------l~~~~~--~~~~~~~l~-------------------~~~~~~i~~~i~~~L~~LH~----~~~~  690 (871)
                           .+         ++....  ....+...+                   ......+...+...++.+..    ....
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                 11         000000  000011111                   11111122222223333322    2245


Q ss_pred             CeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          691 SIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       691 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      +++|+|+.+.|||++++  ..++||+-+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            79999999999999743  45899998864

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.15  E-value=2.3e-05  Score=71.85  Aligned_cols=13  Identities=23%  Similarity=0.255  Sum_probs=5.8

Q ss_pred             ccccccEEecCCC
Q 002883          438 TFRFLQKLNLSFN  450 (871)
Q Consensus       438 ~~~~L~~L~l~~N  450 (871)
                      ..++|+.|+++.|
T Consensus       130 ~n~~L~~L~l~~~  142 (166)
T d1io0a_         130 KNTTLLKFGYHFT  142 (166)
T ss_dssp             HCSSCCEEECCCS
T ss_pred             hCCCcCEEeCcCC
Confidence            3444444444443

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.15  E-value=4e-05  Score=70.10  Aligned_cols=11  Identities=9%  Similarity=-0.070  Sum_probs=4.5

Q ss_pred             CCCCCEEeCCC
Q 002883          415 LKGLQDLDLSR  425 (871)
Q Consensus       415 l~~L~~L~l~~  425 (871)
                      .+.|+.|+++.
T Consensus       131 n~~L~~L~l~~  141 (166)
T d1io0a_         131 NTTLLKFGYHF  141 (166)
T ss_dssp             CSSCCEEECCC
T ss_pred             CCCcCEEeCcC
Confidence            33444444433

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.75  E-value=0.0014  Score=68.80  Aligned_cols=74  Identities=18%  Similarity=0.172  Sum_probs=50.5

Q ss_pred             CceeeccccceEEEEEECC-------CCcEEEEEEeeccccchHHHHHHHHHHHHcCC-CCccceeeeeecccCcCCCce
Q 002883          564 ANLIGIGGYGYVYKGILGT-------EETNVAVKVLDLQQRGASKSFIAECEALRSIR-HRNLVKIITSCSSIDTRGNEF  635 (871)
Q Consensus       564 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  635 (871)
                      ++.|+.|-.-.+|++....       ..+.|++++... .. ......+|..+++.+. +.-..++++++..        
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--------  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG--------  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT--------
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--------
Confidence            3568888889999998742       345688888752 22 2235568999988873 4445677777542        


Q ss_pred             eeEEEeccCCCCH
Q 002883          636 KALVYEFMPNGSL  648 (871)
Q Consensus       636 ~~lv~e~~~~gsL  648 (871)
                       .+|+||++|.++
T Consensus       117 -g~I~efi~g~~l  128 (395)
T d1nw1a_         117 -GRLEEYIPSRPL  128 (395)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -ceEEEEeccccC
Confidence             589999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.66  E-value=0.0049  Score=62.26  Aligned_cols=168  Identities=10%  Similarity=0.017  Sum_probs=83.2

Q ss_pred             cCHHHHHHhhcCCCCCceee-----ccccceEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHcCCCCc--ccee
Q 002883          549 ISYAELLKATEGFSSANLIG-----IGGYGYVYKGILGTEETNVAVKVLDLQQRGASKSFIAECEALRSIRHRN--LVKI  621 (871)
Q Consensus       549 ~~~~~~~~~~~~y~~~~~lg-----~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~  621 (871)
                      ++.+++.....+|.+++...     .|.--+.|+.+.. +| .+++|++....  ..+.+..|++++..+....  +...
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence            45677777778887765443     5666788999875 33 58999985432  2244556677776663221  2211


Q ss_pred             eeeecccC-cCCCceeeEEEeccCCCCHHH--------------Hhhccccccc---c-----------------cCCCC
Q 002883          622 ITSCSSID-TRGNEFKALVYEFMPNGSLEN--------------WLNQKEDEQN---Q-----------------RPKLN  666 (871)
Q Consensus       622 ~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~~~---~-----------------~~~l~  666 (871)
                      +....... ..-....+.++.+..+.....              .++.......   .                 .....
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            11100000 000133456666665532210              0000000000   0                 00000


Q ss_pred             HHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceeeCCCCceEEeeccccee
Q 002883          667 LMQRLSIAIDVANVLEYLHH-HCHTSIVHCDLKPSNVLLDNEMVAHVGDFGLSRL  720 (871)
Q Consensus       667 ~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  720 (871)
                      .......+..+...+...+. ....|+||+|+.++||+++++...-++||+.+..
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            11111222222222232222 1245899999999999999988778999998863